PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Marinho, CD; Maioli, MCP; do Amaral, JLM; Lopes, AJ; de Melo, PL				Marinho, Cirlene de Lima; Paixao Maioli, Maria Christina; Machado do Amaral, Jorge Luis; Lopes, Agnaldo Jose; de Melo, Pedro Lopes			Respiratory resistance and reactance in adults with sickle cell anemia: Correlation with functional exercise capacity and diagnostic use	PLOS ONE			English	Article							ACUTE CHEST SYNDROME; MACHINE LEARNING ALGORITHMS; FORCED OSCILLATION MEASUREMENTS; OBSTRUCTIVE PULMONARY-DISEASE; 6-MINUTE WALK TEST; AIRWAY-OBSTRUCTION; LUNG-FUNCTION; YOUNG-ADULTS; BLOOD-FLOW; ASTHMA	Background The improvement in sickle cell anemia (SCA) care resulted in the emergence of a large population of adults living with this disease. The mechanisms of lung injury in this new population are largely unknown. The forced oscillation technique (FOT) represents the current state-of-the-art in the assessment of lung function. The present work uses the FOT to improve our knowledge about the respiratory abnormalities in SCA, evaluates the associations of FOT with the functional exercise capacity and investigates the early detection of respiratory abnormalities. Methodology/Principal findings Spirometric classification of restrictive abnormalities resulted in three categories: controls (n = 23), patients with a normal exam (n = 21) and presenting pulmonary restriction (n = 24). FOT analysis showed that, besides restrictive changes (reduced compliance; p< 0.001), there is also an increase in respiratory resistance (p< 0.001) and ventilation heterogeneity (p< 0.01). FOT parameters are associated with functional exercise capacity (R = -0.38), pulmonary diffusion (R = 0.66), respiratory muscle performance (R = 0.41), pulmonary volumes (R = 0.56) and airway obstruction (R = 0.54). The diagnostic accuracy was evaluated by investigating the area under the receiver operating characteristic curve (AUC). A combination of FOT and machine learning (ML) classifiers showed adequate diagnostic accuracy in the detection of early respiratory abnormalities (AUC = 0.82). Conclusions In this study, the use of FOT showed that adults with SCA develop a mixed pattern of respiratory disease. Changes in FOT parameters are associated with functional exercise capacity decline, abnormal pulmonary mechanics and diffusion. FOT associated with ML methods accurately diagnosed early respiratory abnormalities. This suggested the potential utility of the FOT and ML clinical decision support systems in the identification of respiratory abnormalities in patients with SCA.	[Marinho, Cirlene de Lima; de Melo, Pedro Lopes] Univ Estado Rio De Janeiro, Inst Biol, Biomed Instrumentat Lab, Rio De Janeiro, Brazil; [Marinho, Cirlene de Lima; de Melo, Pedro Lopes] Univ Estado Rio De Janeiro, Fac Engn, Rio De Janeiro, Brazil; [Marinho, Cirlene de Lima; de Melo, Pedro Lopes] Univ Estado Rio De Janeiro, BioVasc Res Lab, Inst Biol, Rio De Janeiro, Brazil; [Paixao Maioli, Maria Christina] Univ Estado Rio De Janeiro, Fac Med Sci, Dept Hematol, Rio De Janeiro, Brazil; [Machado do Amaral, Jorge Luis] Univ Estado Rio De Janeiro, Dept Elect & Telecommun Engn, Rio De Janeiro, Brazil; [Lopes, Agnaldo Jose] Univ Estado Rio De Janeiro, Pulm Funct Testing Lab, Sch Med Sci, Rio De Janeiro, Brazil; [Lopes, Agnaldo Jose] Augusto Motta Univ Ctr, Rehabil Sci Postgrad Program, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade Federal de Juiz de Fora; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Centro Universitario Augusto Motta (UNISUAM)	de Melo, PL (corresponding author), Univ Estado Rio De Janeiro, Inst Biol, Biomed Instrumentat Lab, Rio De Janeiro, Brazil.; de Melo, PL (corresponding author), Univ Estado Rio De Janeiro, Fac Engn, Rio De Janeiro, Brazil.; de Melo, PL (corresponding author), Univ Estado Rio De Janeiro, BioVasc Res Lab, Inst Biol, Rio De Janeiro, Brazil.	plopes@uerj.br	Melo, Pedro/E-8440-2011; Lopes, Agnaldo José/AAB-5944-2019; Amaral, Jorge/U-2498-2017	Melo, Pedro/0000-0002-2081-6619; Lopes, Agnaldo José/0000-0001-8598-4878; Amaral, Jorge/0000-0001-6580-5668	Brazilian Council of Scientific and Technological Development (Conselho Brasileiro para o Desenvolvimento Cientifico e Tecnologico - CNPq); Rio de Janeiro Research Foundation (Fundagao de Apoio a Pesquisa do Estado do Rio de Janeiro - FAPERJ)	Brazilian Council of Scientific and Technological Development (Conselho Brasileiro para o Desenvolvimento Cientifico e Tecnologico - CNPq); Rio de Janeiro Research Foundation (Fundagao de Apoio a Pesquisa do Estado do Rio de Janeiro - FAPERJ)	The present study was funded by the Brazilian Council of Scientific and Technological Development (Conselho Brasileiro para o Desenvolvimento Cientifico e Tecnologico - CNPq) and the Rio de Janeiro Research Foundation (Fundagao de Apoio a Pesquisa do Estado do Rio de Janeiro - FAPERJ) to Pedro Lopes de Melo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexy T, 2010, CLIN HEMORHEOL MICRO, V44, P155, DOI 10.3233/CH-2010-1270; Amaral JLM, 2017, COMPUT METH PROG BIO, V144, P113, DOI 10.1016/j.cmpb.2017.03.023; Amaral JLM, 2015, COMPUT METH PROG BIO, V118, P186, DOI 10.1016/j.cmpb.2014.11.002; Amaral JLM, 2013, COMPUT METH PROG BIO, V112, P441, DOI 10.1016/j.cmpb.2013.08.004; Amaral JLM, 2012, COMPUT METH PROG BIO, V105, P183, DOI 10.1016/j.cmpb.2011.09.009; An P, 2011, J ALLERGY CLIN IMMUN, V127, P1440, DOI 10.1016/j.jaci.2010.12.1114; [Anonymous], 2011, INT J BIOL MED RES, V2, P723; Arteta M, 2014, J PEDIAT HEMATOL ONC, V36, P185, DOI 10.1097/MPH.0000000000000011; Bates JHT, 2011, COMPR PHYSIOL, V1, P1233, DOI 10.1002/cphy.c100058; Bodas P, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-237; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Brashier B, 2015, BREATHE, V11, P57, DOI 10.1183/20734735.020514; Britto RR, 2013, BRAZ J PHYS THER, V17, P556, DOI 10.1590/S1413-35552012005000122; Callahan LA, 2002, AM J RESP CRIT CARE, V165, P1309, DOI 10.1164/rccm.2002036; Cavalcanti JV, 2006, RESP MED, V100, P2207, DOI 10.1016/j.rmed.2006.03.009; Cohen RT, 2011, AM J HEMATOL, V86, P756, DOI 10.1002/ajh.22098; Conneely KN, 2007, AM J HUM GENET, V81, P1158, DOI 10.1086/522036; Connes P, 2011, CLIN HEMORHEOL MICRO, V49, P151, DOI 10.3233/CH-2011-1465; Cook J, 2013, INT J TUBERC LUNG D, V17, P1235, DOI 10.5588/ijtld.12.0965; Crabtree EA, 2011, PEDIATRICS, V127, pE480, DOI 10.1542/peds.2010-3099; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dassios T, 2013, PEDIATR PULM, V48, P865, DOI 10.1002/ppul.22709; de Melo PL, 2000, REV SCI INSTRUM, V71, P2867, DOI 10.1063/1.1150705; de Sa PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161981; de Sa PM, 2013, CLINICS, V68, P644, DOI 10.6061/clinics/2013(05)11; Delclaux C, 2005, CHEST, V128, P3336, DOI 10.1378/chest.128.5.3336; Deo RC, 2015, CIRCULATION, V132, P1920, DOI 10.1161/CIRCULATIONAHA.115.001593; Desai PC, 2013, EXPERT OPIN PHARMACO, V14, P991, DOI 10.1517/14656566.2013.783570; Faria ACD, 2012, CLINICS, V67, P987, DOI 10.6061/clinics/2012(09)01; DUBOIS AB, 1956, J APPL PHYSIOL, V8, P587, DOI 10.1152/jappl.1956.8.6.587; Duda R. O., 2001, PATTERN CLASSIFICATI, Vxx; Elmariah H, 2014, AM J HEMATOL, V89, P530, DOI 10.1002/ajh.23683; Faria ACD, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-22; Faria ACD, 2009, RESPIRATION, V78, P93, DOI 10.1159/000213756; Forsting M, 2017, J NUCL MED, V58, P357, DOI 10.2967/jnumed.117.190397; Gladwin MT, 2008, NEW ENGL J MED, V359, P2254, DOI 10.1056/NEJMra0804411; Goedhart DM, 2005, PHYSIOL MEAS, V26, P1115, DOI 10.1088/0967-3334/26/6/020; Golpe R, 1999, SLEEP, V22, P932; Gonzalez G, 2017, AM J RESP CRITICAL C; Gordeuk VR, 2008, AM J HEMATOL, V83, P15, DOI 10.1002/ajh.21016; Greenough A, 2014, THORAX, V69, P1051, DOI 10.1136/thoraxjnl-2014-205886; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Howard J, 2015, BRIT J HAEMATOL, V169, P492, DOI 10.1111/bjh.13348; Hussain SNA, 1996, J APPL PHYSIOL, V81, P1455, DOI 10.1152/jappl.1996.81.4.1455; Hyatt RE., 1997, INTERPRETATION PULMO; Intzes S, 2013, PEDIATR HEMAT ONCOL, V30, P726, DOI 10.3109/08880018.2012.756961; Kaimakamis E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150163; Klings ES, 2006, AM J RESP CRIT CARE, V173, P1264, DOI 10.1164/rccm.200601-125OC; Knight-Madden J, 2014, PAEDIATR RESPIR REV, V15, P13, DOI 10.1016/j.prrv.2013.10.005; Knight-Madden JM, 2013, LUNG, V191, P95, DOI 10.1007/s00408-012-9435-3; Knight-Madden JM, 2005, THORAX, V60, P206, DOI 10.1136/thx.2004.029165; Ko FWS, 2008, INT J TUBERC LUNG D, V12, P713; LaPrad AS, 2008, RESP PHYSIOL NEUROBI, V163, P64, DOI 10.1016/j.resp.2008.04.015; Liem RI, 2009, AM J HEMATOL, V84, P645, DOI 10.1002/ajh.21507; Lima AN, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0007-7; LOCKHAT D, 1985, J APPL PHYSIOL, V59, P1164, DOI 10.1152/jappl.1985.59.4.1164; Lungu A, 2016, PULM CIRC, V6, P181, DOI 10.1086/686020; Lunt A, 2014, THORAX, V69, P746, DOI 10.1136/thoraxjnl-2013-204809; MacLeod D, 2001, MED BIOL ENG COMPUT, V39, P505, DOI 10.1007/BF02345140; Miller AC, 2012, AM J RESP CRIT CARE, V185, P1154, DOI 10.1164/rccm.201111-2082CI; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miranda IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061657; NAGELS J, 1980, J APPL PHYSIOL, V49, P408, DOI 10.1152/jappl.1980.49.3.408; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P703, DOI 10.1590/S0100-879X1999000600006; Ohara DG, 2014, BRAZ J PHYS THER, V18, P79, DOI 10.1590/S1413-35552012005000139; Ong BA, 2013, BRIT J HAEMATOL, V163, P112, DOI 10.1111/bjh.12481; Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403; Palaniappan R, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-223; Pereira CAC, 1992, J PNEUMOL, V18, P10; PESLIN R, 1986, B EUR PHYSIOPATH RES, V22, P621; Piel FB, 2017, NEW ENGL J MED, V376, P1561, DOI 10.1056/NEJMra1510865; Poole DC, 1997, MED SCI SPORT EXER, V29, P738, DOI 10.1097/00005768-199706000-00003; Ruby A., 2011, HEMOGLOBIN, P1; Santoli F, 1998, EUR RESPIR J, V12, P1124, DOI 10.1183/09031936.98.12051124; SBPT, 2009, J PNEUMOL S3, V38; Souza RB., 2002, J PNEUMOL, V28, P155; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tageja N, 2010, CASE REP MED, V2010, DOI DOI 10.1155/2010/659031; Teague WG, 2014, J ASTHMA, V51, P677, DOI 10.3109/02770903.2014.914535; Trapp R.G., 2004, BASIC CLIN BIOSTATIS, V4th; VALERIANOMARCET J, 1991, ANN INTERN MED, V115, P99, DOI 10.7326/0003-4819-115-2-99; VANNOORD JA, 1989, EUR RESPIR J, V2, P846; Veezhinathan M, 2007, J MED SYST, V31, P461, DOI 10.1007/s10916-007-9085-9; Vicari P, 2004, SOUTH MED J, V97, P894, DOI 10.1097/01.SMJ.0000125172.95454.B7; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Wedderburn CJ, 2014, PEDIATR PULM, V49, P724, DOI 10.1002/ppul.22952	86	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0187833	10.1371/journal.pone.0187833	http://dx.doi.org/10.1371/journal.pone.0187833			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220407	Green Published, Green Submitted, gold			2022-12-27	WOS:000417469900007
J	Khan, SM; Bain, RES; Lunze, K; Unalan, T; Beshanski-Pedersen, B; Slaymaker, T; Johnston, R; Hancioglu, A				Khan, Shane M.; Bain, Robert E. S.; Lunze, Karsten; Unalan, Turgay; Beshanski-Pedersen, Bo; Slaymaker, Tom; Johnston, Richard; Hancioglu, Attila			Optimizing household survey methods to monitor the Sustainable Development Goals targets 6.1 and 6.2 on drinking water, sanitation and hygiene: A mixed-methods field-test in Belize	PLOS ONE			English	Article							CONTAMINATION; MANAGEMENT; COUNTRIES; QUALITY	Background The Sustainable Development Goals (SDGs) require household survey programmes such as the UNICEF-supported Multiple Indicator Cluster Surveys (MICS) to enhance data collection to cover new indicators. This study aims to evaluated methods for assessing water quality, water availability, emptying of sanitation facilities, menstrual hygiene management and the acceptability of water quality testing in households which are key to monitoring SDG targets 6.1 and 6.2 on drinking Water, Sanitation and Hygiene (WASH) and emerging issues. Methods As part of a MICS field test, we interviewed 429 households and 267 women age 15-49 in Stann Creek, Belize in a split-sample experiment. In a concurrent qualitative component, we conducted focus groups with interviewers and cognitive interviews with respondents during and immediately following questionnaire administration in the field to explore their question comprehension and response processes. Findings About 88% of respondents agreed to water quality testing but also desired test results, given the potential implications for their own health. Escherichia coli was present in 36% of drinking water collected at the source, and in 47% of samples consumed in the household. Both questions on water availability necessitated probing by interviewers. About one quarter of households reported emptying of pit latrines and septic tanks, though one-quarter could not provide an answer to the question. Asking questions on menstrual hygiene was acceptable to respondents, but required some clarification and probing. Conclusions In the context of Belize, this study confirmed the feasibility of collecting information on the availability and quality of drinking water, emptying of sanitation facilities and menstrual hygiene in a multi-purpose household survey, indicating specific areas to improve question formulation and field protocols. Improvements have been incorporated into the latest round of MICS surveys which will be a major source of national data for monitoring of SDG targets for drinking water, sanitation and hygiene and emerging issues for WASH sector programming.	[Khan, Shane M.; Bain, Robert E. S.; Unalan, Turgay; Beshanski-Pedersen, Bo; Slaymaker, Tom; Hancioglu, Attila] UNICEF, Div Data Res & Policy, New York, NY 10038 USA; [Lunze, Karsten] Boston Univ, Sch Med, Boston, MA 02118 USA; [Johnston, Richard] World Hlth Org, Dept Publ Hlth Environm & Social Determinants Hlt, Geneva, Switzerland	UNICEF; Boston University; World Health Organization	Khan, SM (corresponding author), UNICEF, Div Data Res & Policy, New York, NY 10038 USA.	smkhan@unicef.org	Lunze, Karsten/AAL-7240-2021	Lunze, Karsten/0000-0001-8495-0350	Netherlands Ministry of Foreign Affairs Directorate General for International Cooperation (DGIS)	Netherlands Ministry of Foreign Affairs Directorate General for International Cooperation (DGIS)	Funding for this study was provided to WHO/UNICEF JMP by the Netherlands Ministry of Foreign Affairs Directorate General for International Cooperation (DGIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KT, 2014, WATER-SUI, V6, P1453, DOI 10.3390/w6051453; Bain RES, 2012, B WORLD HEALTH ORGAN, V90, P228, DOI 10.2471/BLT.11.094284; Bain R, 2014, TROP MED INT HEALTH, V19, P917, DOI 10.1111/tmi.12334; Bain R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001644; Baum R, 2013, ENVIRON SCI TECHNOL, V47, P1994, DOI 10.1021/es304284f; Blackett I, TARGETING URBAN POOR; Burt Z., 2016, GENDER EQUALITY SANI; Grant M, 2013, COMP EDUC REV, V57, P260, DOI 10.1086/669121; International Bank for Reconstruction and Development/ The World Bank, 2014, TARG URB POOR IMPR S; JMP, 2015, JMP GREEN PAP GLOB M; Kumpel E, 2016, ENVIRON SCI TECHNOL, V50, P542, DOI 10.1021/acs.est.5b03973; Loughnan LC, 2015, MEASUREMENT HANDWASH; Medical Research Council, 2014, FRAM FEEDB HLTH REL; Ongena Y. P., 2006, J OFF STAT, V22, P419; Peal A, 2014, J WATER SANIT HYG DE, V4, P563, DOI 10.2166/washdev.2014.026; Presser S, 2004, PUBLIC OPIN QUART, V68, P109, DOI 10.1093/poq/nfh008; Ram P, 2013, PRACTICAL GUIDANCE M; Reygadas F, 2015, WATER RES, V85, P74, DOI 10.1016/j.watres.2015.08.013; Sommer M, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001962; Sommer M, 2013, AM J PUBLIC HEALTH, V103, P1556, DOI 10.2105/AJPH.2013.301374; Sumpter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062004; UNICEF, 2015, MON SIT CHILDR WOM 2; UNICEF, 2015, PROGR SAN DRINK WAT; UNICEF and World Health Organization, SAF MAN DRINK WAT SE; UNICEF and World Health Organization, 2013, 2 M WHO UNICEF JMP T; van Eijk AM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010290; WHO & UNICEF, 2016, COR QUEST IND MON WA; Winkler I, 2014, BRINGING DIRTY BLOOD; World Health Organization United Nations Children's Fund., 2017, PROGR DRINKING WATER; World Health Organization (WHO), 2017, WHO GUID DRINK WAT Q; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x	31	30	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189089	10.1371/journal.pone.0189089	http://dx.doi.org/10.1371/journal.pone.0189089			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216244	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800069
J	McCafferty, CL; Sergeev, YV				McCafferty, Caitlyn L.; Sergeev, Yuri V.			Global computational mutagenesis provides a critical stability framework in protein structures	PLOS ONE			English	Article							FUNCTIONALLY IMPORTANT RESIDUES; SEQUENCE ALIGNMENT; TRANSITION-STATE; MACULAR DEGENERATION; PREDICTION; CONSERVATION; EVOLUTIONARY; DISCOVERY; NETWORK; DISEASE	A protein's amino acid sequence dictates the folds and final structure the macromolecule will form. We propose that by identifying critical residues in a protein's atomic structure, we can select a critical stability framework within the protein structure essential to proper protein folding. We use global computational mutagenesis based on the unfolding mutation screen to test the effect of every possible missense mutation on the protein structure to identify the residues that cannot tolerate a substitution without causing protein misfolding. This method was tested using molecular dynamics to simulate the stability effects of mutating critical residues in proteins involved in inherited disease, such as myoglobin, p53, and the 15 th sushi domain of complement factor H. In addition we prove that when the critical residues are in place, other residues may be changed within the structure without a stability loss. We validate that critical residues are conserved using myoglobin to show that critical residues are the same for crystal structures of 6 different species and comparing conservation indices to critical residues in 9 eye disease-related proteins. Our studies demonstrate that by using a selection of critical elements in a protein structure we can identify a critical protein stability framework. The frame of critical residues can be used in genetic engineering to improve small molecule binding for drug studies, identify loss-of-function disease-causing missense mutations in genetics studies, and aide in identifying templates for homology modeling.	[McCafferty, Caitlyn L.; Sergeev, Yuri V.] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Sergeev, YV (corresponding author), NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA.	sergeevy@nei.nih.gov			NIH Intramural program at the National Eye Institute [ZIA EY000476-07]; NATIONAL EYE INSTITUTE [ZIAEY000476] Funding Source: NIH RePORTER	NIH Intramural program at the National Eye Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Grant ZIA EY000476-07 to Y.V.S. from the NIH Intramural program at the National Eye Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000; Bava KA, 2004, NUCLEIC ACIDS RES, V32, pD120, DOI 10.1093/nar/gkh082; BERNSTEIN FC, 1978, ARCH BIOCHEM BIOPHYS, V185, P584, DOI 10.1016/0003-9861(78)90204-7; Bross P, 1999, PROTEIN MISFOLDING D; Chatzou M., 2015, BRIEF BIOINFORM; Consortium U, 2014, NUCLEIC ACIDS RES; Cusack MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000421; Devos D, 2000, PROTEINS, V41, P98, DOI 10.1002/1097-0134(20001001)41:1<98::AID-PROT120>3.3.CO;2-J; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dolinska MB, 2017, BIOL CHEM; EISENHABER F, 1995, CRIT REV BIOCHEM MOL, V30, P1, DOI 10.3109/10409239509085139; Elcock AH, 2001, J MOL BIOL, V312, P885, DOI 10.1006/jmbi.2001.5009; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Freeman NL, 1996, MOL CELL BIOL, V16, P548; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Gromiha MM, 2010, METHODS MOL BIOL, V609, P97, DOI 10.1007/978-1-60327-241-4_6; Hoelder S, 2012, MOL ONCOL, V6, P155, DOI 10.1016/j.molonc.2012.02.004; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; Johansson F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-388; Krieger E., 2013, YASARA YET ANOTHER S, V993; LESK AM, 1980, J MOL BIOL, V136, P225, DOI 10.1016/0022-2836(80)90373-3; Liu XS, 2008, AMINO ACIDS, V34, P643, DOI 10.1007/s00726-007-0017-2; Lutzke RAP, 1998, J VIROL, V72, P4841, DOI 10.1128/JVI.72.6.4841-4848.1998; Marino SM, 2010, J MOL BIOL, V404, P902, DOI 10.1016/j.jmb.2010.09.027; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; McCafferty CL, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.112; McCafferty CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep37298; Mesa AD, 2003, J MOL BIOL, V326, P1289, DOI 10.1016/S0022-2836(02)01451-1; Mirny LA, 1998, P NATL ACAD SCI USA, V95, P4976, DOI 10.1073/pnas.95.9.4976; Mittenthal Jay, 2012, Frontiers in Genetics, V3, P147, DOI [10.3389/fgene.2012.00147, 10.3389/fgene.2012.00172]; Nishi K, 2009, J PHARM SCI-US, V98, P4316, DOI 10.1002/jps.21697; Parrini C, 2005, STRUCTURE, V13, P1143, DOI 10.1016/j.str.2005.04.022; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; RICHARDS JE, 1995, OPHTHALMOLOGY, V102, P669, DOI 10.1016/S0161-6420(95)30972-4; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; Sergeev Y. V., 2013, HUM MOL GENET; Shatsky M, 2006, PROTEINS, V62, P209, DOI 10.1002/prot.20665; Simpson GL, 2009, CURR OPIN DRUG DISC, V12, P585; Thibert B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-213; Thompson JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018093; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Yampolsky LY, 2005, GENETICS, V170, P1459, DOI 10.1534/genetics.104.039107; Zernant J, 2017, J MED GENET, V54, P404, DOI 10.1136/jmedgenet-2017-104540; Zhan XW, 2013, NAT GENET, V45, P1375, DOI 10.1038/ng.2758; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	48	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189064	10.1371/journal.pone.0189064	http://dx.doi.org/10.1371/journal.pone.0189064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216252	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800062
J	Pinillos-Franco, S; Garcia-Prieto, C				Pinillos-Franco, Sara; Garcia-Prieto, Carmen			The gender gap in self-rated health and education in Spain. A multilevel analysis	PLOS ONE			English	Article							SOCIAL RELATIONSHIPS; EUROPEAN COUNTRIES; SEX-DIFFERENCES; UNITED-STATES; MORTALITY; MEN; WOMEN; INEQUALITIES; DETERMINANTS; EMPLOYMENT	Background Women tend to report poorer self-rated health than men. It is also well established that education has a positive effect on health. However, the issue of how the benefits of education on health differ between men and women has not received enough attention and the few existing studies which do focus on the subject do not draw a clear conclusion. Therefore, this study aims to analyse whether the positive influence of educational attainment on health is higher for women and whether education helps to overcome the gender gap in self-rated health. Methods We analyse cross-sectional data from the 2012 European Union statistics on income and living conditions. We use a logit regression model with odds ratios and a multilevel perspective to carry out a study which includes several individual and contextual control variables. We focused our study on the working population in Spain aged between 25 and 65. The final sample considered is composed of 14,120 subjects: 7,653 men and 6,467 women. Results There is a gender gap in self-rated health only for the less educated. This gap is not statistically significant among more highly educated individuals. Attaining a high level of education has the same positive effect on both women's and men's self-rated health. Conclusions Although we did not find gender disparities when considering the effect of education on health, we show that women's health is poorer among the less educated, mainly due to labour precariousness and household conditions.	[Pinillos-Franco, Sara; Garcia-Prieto, Carmen] Univ Valladolid, Dept Econ Anal, Valladolid, Spain; [Pinillos-Franco, Sara] Avda Valle Esgueva, Valladolid, Spain	Universidad de Valladolid	Pinillos-Franco, S (corresponding author), Univ Valladolid, Dept Econ Anal, Valladolid, Spain.; Pinillos-Franco, S (corresponding author), Avda Valle Esgueva, Valladolid, Spain.	sara.pinillos@uva.es	Pinillos-Franco, Sara/L-2812-2018; García-Prieto, Carmen/O-4089-2014	Pinillos-Franco, Sara/0000-0003-0981-5444; García-Prieto, Carmen/0000-0002-1117-9339	Spanish Ministry of Economics and Competitiveness [FEM2013-43393-P]	Spanish Ministry of Economics and Competitiveness(Spanish Government)	This work was supported by Spanish Ministry of Economics and Competitiveness (FEM2013-43393-P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge Dr. Shane Kavanagh for having suggested certain improvements to the manuscript, and also gratefully acknowledge the financial support received from the Spanish Ministry of Economics and Competitiveness (FEM2013-43393-P).	Andersson MA, 2016, SSM-POPUL HLTH, V2, P549, DOI 10.1016/j.ssmph.2016.08.006; Aparicio Llanos A, 2006, POBLACION SALUD MESO, V4, P1; Bambra C, 2009, J EPIDEMIOL COMMUN H, V63, P38, DOI 10.1136/jech.2007.070292; Becker G.S., 2002, HUMAN CAPITAL, V2, P1; Benach J, 2011, EMPLOYMENT WORKING C; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Case A, 2005, DEMOGRAPHY, V42, P189, DOI 10.1353/dem.2005.0011; Cavelaars AEJM, 2000, BRIT MED J, V320, P1102, DOI 10.1136/bmj.320.7242.1102; Cebolla Boado H., 2013, INTRO ANALISIS MULTI; Chen J, 2011, AM J MED QUAL, V26, P261, DOI 10.1177/1062860610390352; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Cowell AJ, 2006, HEALTH ECON, V15, P125, DOI 10.1002/hec.1019; CRUM RM, 1992, AM J EPIDEMIOL, V135, P989, DOI 10.1093/oxfordjournals.aje.a116411; Cutler DM, 2006, ED HLTH EVALUATING T; DOORNBOS G, 1990, INT J EPIDEMIOL, V19, P374, DOI 10.1093/ije/19.2.374; Elstad JI, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0389-6; Garcia-Prieto C, 2017, INT J MANPOWER, V38, P504, DOI 10.1108/IJM-11-2015-0186; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Kennedy BP, 1998, BRIT MED J, V317, P917; Knesebeck OV, 2006, SOC SCI MED, V63, P1344, DOI 10.1016/j.socscimed.2006.03.043; KOSKINEN S, 1994, SOC SCI MED, V38, P1385, DOI 10.1016/0277-9536(94)90276-3; Laditka JN, 2016, J AGING HEALTH, V28, P1403, DOI 10.1177/0898264315620590; Lahelma E, 2004, J EPIDEMIOL COMMUN H, V58, P327, DOI 10.1136/jech.2003.011148; MacIntyre S, 1996, SOC SCI MED, V42, P617, DOI 10.1016/0277-9536(95)00335-5; Mackenbach JP, 1999, AM J PUBLIC HEALTH, V89, P1800, DOI 10.2105/AJPH.89.12.1800; Manderbacka K, 1998, SCAND J SOC MED, V26, P145, DOI 10.1080/14034949850153671; Marmot M, 2006, SOCIAL DETERMINANTS; Menendez M, 2007, SOC SCI MED, V64, P776, DOI 10.1016/j.socscimed.2006.10.035; Monden CWS, 2003, SOC SCI MED, V57, P1901, DOI 10.1016/S0277-9536(03)00055-8; Regidor E, 2003, EUR J EPIDEMIOL, V18, P395, DOI 10.1023/A:1024296932294; Ross CE, 2006, SOC SCI MED, V63, P1400, DOI 10.1016/j.socscimed.2006.03.013; Ross CE, 2012, DEMOGRAPHY, V49, P1157, DOI 10.1007/s13524-012-0130-z; Ross CE, 2010, SOCIOL QUART, V51, P1, DOI 10.1111/j.1533-8525.2009.01164.x; ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319; Tovar L, 2006, PERCEPCION ESTADO SA; Virtanen M, 2005, INT J EPIDEMIOL, V34, P610, DOI 10.1093/ije/dyi024; Virtanen P, 2003, INT J EPIDEMIOL, V32, P1015, DOI 10.1093/ije/dyg319; WEISSMAN JS, 1991, ANN INTERN MED, V114, P325, DOI 10.7326/0003-4819-114-4-325; Zajacova A, 2006, SOC SCI MED, V63, P2176, DOI 10.1016/j.socscimed.2006.04.031; Zimmerman EWS, 2014, UNDERSTANDING RELATI	43	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0187823	10.1371/journal.pone.0187823	http://dx.doi.org/10.1371/journal.pone.0187823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216212	gold, Green Published, Green Submitted			2022-12-27	WOS:000417337800013
J	Sekizuka, T; Ogasawara, Y; Ohkusa, T; Kuroda, M				Sekizuka, Tsuyoshi; Ogasawara, Yumiko; Ohkusa, Toshifumi; Kuroda, Makoto			Characterization of Fusobacterium varium Fv113-g1 isolated from a patient with ulcerative colitis based on complete genome sequence and transcriptome analysis	PLOS ONE			English	Article							LEMIERRES SYNDROME; MICROBIAL GENOMES; NUCLEATUM; ADHESIN; FADA; CARCINOGENESIS; NECROPHORUM; TECHNOLOGY; SEPTICEMIA; FLAVODOXIN	Fusobacterium spp. present in the oral and gut flora is carcinogenic and is associated with the risk of pancreatic and colorectal cancers. Fusobacterium spp. is also implicated in a broad spectrum of human pathologies, including Crohn's disease and ulcerative colitis (UC). Here we report the complete genome sequence of Fusobacterium varium Fv113-g1 (genome size, 3.96 Mb) isolated from a patient with UC. Comparative genome analyses totally suggested that Fv113-g1 is basically assigned as F. varium, in particular, it could be reclassified as notable F. varium subsp. similar to F. ulcerans because of partial shared orthologs. Compared with the genome sequences of F. varium ATCC 27725 (genome size, 3.30 Mb) and other strains of Fusobacterium spp., Fv113-g1 possesses many accessary pan-genome sequences with noteworthy multiple virulence factors, including 44 autotransporters (type V secretion system, T5SS) and 13 Fusobacterium adhesion (FadA) paralogs involved in potential mucosal inflammation. Indeed, transcriptome analysis demonstrated that Fv113-g1-specific accessary genes, such as multiple T5SS and fadA paralogs, showed notably increased expression with D-MEM cultivation than with brain heart infusion broth. This implied that growth condition may enhance the expression of such potential virulence factors, leading to remarkable survival against other gut microorganisms and to the pathogenicity to human intestinal epithelium.	[Sekizuka, Tsuyoshi; Ogasawara, Yumiko; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Lab Bacterial Genom, Tokyo, Japan; [Ohkusa, Toshifumi] Juntendo Univ, Grad Sch Med, Dept Microbiota Res, Tokyo, Japan	National Institute of Infectious Diseases (NIID); Juntendo University	Kuroda, M (corresponding author), Natl Inst Infect Dis, Pathogen Genom Ctr, Lab Bacterial Genom, Tokyo, Japan.	makokuro@niid.go.jp	大草, 敏史/HGD-2376-2022	Sekizuka, Tsuyoshi/0000-0002-1302-5472; Kuroda, Makoto/0000-0002-0487-4405	Ministry of Health, Labor, and Welfare, Japan [H25-Nanchi-Ippan-031]; Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development [16fk0108119j0001, 17fk0108219j0002]	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported by the grant-in-aid from the Ministry of Health, Labor, and Welfare, Japan (H25-Nanchi-Ippan-031), and the Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (grant numbers: 16fk0108119j0001 and 17fk0108219j0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afra K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-264; Akiba M, 2016, ANTIMICROB AGENTS CH, V60, P2972, DOI 10.1128/AAC.01950-15; Candoni A, 2003, CLIN MICROBIOL INFEC, V9, P1112, DOI 10.1046/j.1469-0691.2003.00717.x; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; Gholizadeh P, 2017, BIOMED PHARMACOTHER, V89, P918, DOI 10.1016/j.biopha.2017.02.102; Gruez A, 2000, J MOL BIOL, V299, P199, DOI 10.1006/jmbi.2000.3748; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Han YPW, 2015, CURR OPIN MICROBIOL, V23, P141, DOI 10.1016/j.mib.2014.11.013; Hasegawa N, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00886-16; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Holm K, 2016, ANAEROBE, V42, P89, DOI 10.1016/j.anaerobe.2016.09.006; Huggan PJ, 2008, J INFECTION, V57, P283, DOI 10.1016/j.jinf.2008.07.016; Ikegami A, 2009, INFECT IMMUN, V77, P3075, DOI 10.1128/IAI.00209-09; Johannesen KM, 2016, INFECT DRUG RESIST, V9, P221, DOI 10.2147/IDR.S95050; Kajava AV, 2001, MOL MICROBIOL, V42, P279, DOI 10.1046/j.1365-2958.2001.02598.x; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Margalit M, 2004, J GASTROEN HEPATOL, V19, P1338, DOI 10.1111/j.1440-1746.2004.03368.x; McGuire AM, 2014, MBIO, V5, DOI 10.1128/mBio.01864-14; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Moyano AJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004163; Ohkusa T, 2002, J GASTROEN HEPATOL, V17, P849, DOI 10.1046/j.1440-1746.2002.02834.x; Ohkusa T, 2009, J MED MICROBIOL, V58, P535, DOI 10.1099/jmm.0.005801-0; Otto TD, 2010, BIOINFORMATICS, V26, P1704, DOI 10.1093/bioinformatics/btq269; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Petkau A, 2010, BIOINFORMATICS, V26, P3125, DOI 10.1093/bioinformatics/btq588; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rodriguez-Cardenas A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161020; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; SHANNON GW, 1983, J FAM PRACTICE, V16, P159; VOGEL LC, 1980, AM J DIS CHILD, V134, P356, DOI 10.1001/archpedi.1980.04490010014005; Wang Y, 2015, EVID-BASED COMPL ALT, V2015, P1, DOI DOI 10.1016/J.MSEA.2015.01.021; Xu MH, 2007, J BIOL CHEM, V282, P25000, DOI 10.1074/jbc.M611567200; YAKUNIN AF, 1993, J BACTERIOL, V175, P6775, DOI 10.1128/jb.175.21.6775-6780.1993; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	36	10	10	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189319	10.1371/journal.pone.0189319	http://dx.doi.org/10.1371/journal.pone.0189319			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216329	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800116
J	Essex, H; Parrott, S; Atkin, K; Ballard, K; Bland, M; Eldred, J; Hewitt, C; Hopton, A; Keding, A; Lansdown, H; Richmond, S; Tilbrook, H; Torgerson, D; Watt, I; Wenham, A; Woodman, J; MacPherson, H				Essex, Holly; Parrott, Steve; Atkin, Karl; Ballard, Kathleen; Bland, Martin; Eldred, Janet; Hewitt, Catherine; Hopton, Ann; Keding, Ada; Lansdown, Harriet; Richmond, Stewart; Tilbrook, Helen; Torgerson, David; Watt, Ian; Wenham, Aniela; Woodman, Julia; MacPherson, Hugh			An economic evaluation of Alexander Technique lessons or acupuncture sessions for patients with chronic neck pain: A randomized trial (ATLAS)	PLOS ONE			English	Article							TRADITIONAL ACUPUNCTURE; COST-EFFECTIVENESS; LIFE; PRACTITIONERS; COORDINATION; EUROQOL; ADVICE; CARE	Objectives To assess the cost-effectiveness of acupuncture and usual care, and Alexander Technique lessons and usual care, compared with usual GP care alone for chronic neck pain patients. Methods An economic evaluation was undertaken alongside the ATLAS trial, taking both NHS and wider societal viewpoints. Participants were offered up to twelve acupuncture sessions or twenty Alexander lessons (equivalent overall contact time). Costs were in pounds sterling. Effectiveness was measured using the generic EQ-5D to calculate quality adjusted life years (QALYs), as well as using a specific neck pain measure-the Northwick Park Neck Pain Questionnaire (NPQ). Results In the base case analysis, incremental QALY gains were 0.032 and 0.025 in the acupuncture and Alexander groups, respectively, in comparison to usual GP care, indicating moderate health benefits for both interventions. Incremental costs were 451 pound for acupuncture and 667 pound for Alexander, mainly driven by intervention costs. Acupuncture was likely to be cost-effective (ICER = 18,767 pound/QALY bootstrapped 95% CI 4,426 pound to 74,562) pound and was robust to most sensitivity analyses. Alexander lessons were not cost-effective at the lower NICE threshold of 20,000 pound/QALY (25,101 pound/QALY bootstrapped 95% CI -150,208 pound to 248,697) pound but may be at 30,000 pound/QALY, however, there was considerable statistical uncertainty in all tested scenarios. Conclusions In comparison with usual care, acupuncture is likely to be cost-effective for chronic neck pain, whereas, largely due to higher intervention costs, Alexander lessons are unlikely to be cost-effective. However, there were high levels of missing data and further research is needed to assess the long-term cost-effectiveness of these interventions.	[Essex, Holly; Parrott, Steve; Atkin, Karl; Bland, Martin; Eldred, Janet; Hewitt, Catherine; Hopton, Ann; Keding, Ada; Lansdown, Harriet; Tilbrook, Helen; Torgerson, David; Watt, Ian; Wenham, Aniela; Woodman, Julia; MacPherson, Hugh] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Ballard, Kathleen; Woodman, Julia] Soc Teachers Alexander Tech, London, England; [Lansdown, Harriet] British Acupuncture Council, London, England; [Richmond, Stewart] Sydera Res Associates, York, N Yorkshire, England; [Watt, Ian] Univ York, Hull York Med Sch, York, N Yorkshire, England	University of York - UK; University of Hull; University of York - UK	Essex, H (corresponding author), Univ York, Dept Hlth Sci, York, N Yorkshire, England.	holly.essex@york.ac.uk	Torgerson, David/L-4566-2019	Torgerson, David/0000-0002-1667-4275; Parrott, Steven James/0000-0002-0165-1150; Hewitt, Catherine Elizabeth/0000-0002-0415-3536	Arthritis Research UK [19702]; Versus Arthritis [19702] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)	This work was supported by Arthritis Research UK (clinical studies grant number 19702 to HM, http://www.arthritisresearchuk.org/).	Ambrosio EMM, 2012, COMPLEMENT THER MED, V20, P364, DOI 10.1016/j.ctim.2012.05.002; Barnes PM, 2008, NATL HLTH STAT REPOR, P1; Cacciatore TW, 2011, HUM MOVEMENT SCI, V30, P74, DOI 10.1016/j.humov.2010.10.002; Cacciatore TW, 2014, J NEUROPHYSIOL, V112, P719, DOI 10.1152/jn.00617.2013; Cacciatore TW, 2011, GAIT POSTURE, V34, P496, DOI 10.1016/j.gaitpost.2011.06.026; Cacciatore TW, 2005, PHYS THER, V85, P565; Coyle D, 1998, INT J TECHNOL ASSESS, V14, P135, DOI 10.1017/S0266462300010588; Curtis L, 2013, UNIT COSTS HLTH SOC; Department of Health, 2013, NHS REF COSTS 2012 2; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Driessen MT, 2012, EUR SPINE J, V21, P1441, DOI 10.1007/s00586-012-2272-5; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF., 2005, METHODS EC EVALUATIO, P55; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Evans M, 2011, J ALTERN COMPLEM MED, V17, P519, DOI 10.1089/acm.2010.0749; Health and Social Care Information Centre, 2015, PRESCR COST AN ENGL; Hill C, 2014, HLTH RESOURCE USE ME; Hollinghurst Sandra, 2008, BMJ, V337, pa2656, DOI 10.1136/bmj.a2656; Hoy D, 2014, ANN RHEUM DIS, V73, P1309, DOI 10.1136/annrheumdis-2013-204431; Jull G.A., 2008, WHIPLASH HEADACHE NE; LEAK AM, 1994, BRIT J RHEUMATOL, V33, P469; Little P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a884; MacPherscon H, 2008, COMPLEMENT THER MED, V16, P101, DOI 10.1016/j.ctim.2008.02.010; MacPherson H, 2015, ANN INTERN MED, V163, P653, DOI 10.7326/M15-0667; MacPherson H, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-209; Miller J, 2010, MANUAL THER, V15, P334, DOI 10.1016/j.math.2010.02.007; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; National Institute for Health and Care Excellence (NICE, 2009, LOW BACK PAIN EARL M; National Institute for Health and Clinical Excellence, 2012, NICE GUIDELINE MAN; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1548; Ratcliffe J, 2006, BRIT MED J, V333, P626, DOI 10.1136/bmj.38932.806134.7C; Richardson G, 2004, HEALTH ECON, V13, P1203, DOI 10.1002/hec.901; Robinson N, 2012, J ETHNOPHARMACOL, V140, P604, DOI 10.1016/j.jep.2012.01.052; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Thomas KJ, 2001, COMPLEMENT THER MED, V9, P2, DOI 10.1054/ctim.2000.0407; Torgerson D, 1999, BMJ-BRIT MED J, V318, P1413, DOI 10.1136/bmj.318.7195.1413; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Willich SN, 2006, PAIN, V125, P107, DOI 10.1016/j.pain.2006.06.006; Witt CM, 2006, PAIN, V125, P98, DOI 10.1016/j.pain.2006.05.013; Woodman JP, 2012, INT J CLIN PRACT, V66, P98, DOI 10.1111/j.1742-1241.2011.02817.x	41	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0178918	10.1371/journal.pone.0178918	http://dx.doi.org/10.1371/journal.pone.0178918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211741	gold, Green Accepted, Green Published			2022-12-27	WOS:000417212200002
J	Martin-Fernandez, J; Ariza-Cardiel, G; Pena-Longobardo, LM; Polentinos-Castro, E; Oliva-Moreno, J; Gil-Lacruz, AI; Medina-Palomino, H; del Cura-Gonzalez, I				Martin-Fernandez, Jesus; Ariza-Cardiel, Gloria; Pena-Longobardo, Luz Ma; Polentinos-Castro, Elena; Oliva-Moreno, Juan; Isabel Gil-Lacruz, Ana; Medina-Palomino, Hector; del Cura-Gonzalez, Isabel			"Gaining or losing": The importance of the perspective in primary care health services valuation	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; INDIVIDUAL RISK ATTITUDES; CONTINGENT VALUATION; COST-EFFECTIVENESS; WTP/WTA DISPARITY; LOSS AVERSION; ACCEPT; WTP; CHOICE; METAANALYSIS	Rationale and objectives Economic theory classifies an intervention as socially beneficial if the total Willingness to Pay (WTP) of those who gain exceeds the total Willingness to accept (WTA) of those who are harmed. This paper examines the differences in health system users' valuation of a health care service in primary care setting based on the WTP and WTA perspectives, discussing the impact of personal and service variables, including risk attitudes, on these disparities. Method Six hundred and sixty two subjects who asked for care in health centres in the Region of Madrid (Spain) were interviewed, using the contingent valuation method to estimate WTP and WTA. Patient sociodemographic characteristics, health needs, satisfaction with the service and risk attitude and behaviour under risk (measured by self-reported scales and lottery games respectively) were collected. Generalised Linear Models were used to estimate the association between the explanatory variables and the WTA/WTP ratio. Results We obtained the WTA/WTP ratio for 570 subjects (mean 1.66 CI 95%: 1.53-1.79; median 1, interquartile range 1-2). People with higher education or in high social groups expressed WTA values closest to WTP. The opposite occurred in patients with the greatest health needs or who were born abroad. Self-reported expression of risk aversion appeared also related to increases in the WTA/WTP ratio. Satisfaction with the service evaluated was the most influential factor in the WTA/WTP ratio. Conclusion Health need, difficulty in obtaining substitutes and satisfaction with the service could serve for profiling people averse to loss for health care services in primary care setting. Self-reported expression of risk aversion could also be related to increases in the WTA/WTP ratio. This would mean that these characteristics should be taken into account both in the design and implementation of new healthcare interventions, as in the making decision for disinvestment.	[Martin-Fernandez, Jesus] Gerencia Asistencial Atenc Primaria, Consultorio Villamanta CS Navalcarnero, Madrid, Spain; [Martin-Fernandez, Jesus; del Cura-Gonzalez, Isabel] Univ Rey Juan Carlos, Fac Ciencias Salud, Alcorcon, Spain; [Martin-Fernandez, Jesus; Ariza-Cardiel, Gloria; Polentinos-Castro, Elena; del Cura-Gonzalez, Isabel] Red Invest Serv Sanitarios & Enfermedades Cron RE, Madrid, Spain; [Martin-Fernandez, Jesus] Univ Educ Distancia UNED, Programa Doctorado Econ, Madrid, Spain; [Ariza-Cardiel, Gloria] Gerencia Asistencial Atenc Primaria, Unidad Docente Multiprofes Atenc Familiar & Comun, Madrid, Spain; [Ariza-Cardiel, Gloria; Polentinos-Castro, Elena; del Cura-Gonzalez, Isabel] Gerencia Asistencial Atenc Primaria, Unidad Apoyo Invest, Madrid, Spain; [Pena-Longobardo, Luz Ma; Oliva-Moreno, Juan] Univ Castilla La Mancha, Fac Ciencias Jurid & Sociales Toledo, Toledo, Spain; [Polentinos-Castro, Elena] Gerencia Asistencial Atenc Primaria, Unidad Docente Multiprofes Atenc Familiar & Comun, Madrid, Spain; [Isabel Gil-Lacruz, Ana] Univ Zaragoza, Escuela Ingn & Arquitectura, Dept Direcc & Org Empresas, Zaragoza, Spain; [Medina-Palomino, Hector] Stichting Medina Care, Rotterdam, Netherlands	Universidad Rey Juan Carlos; Universidad Nacional de Educacion a Distancia (UNED); Universidad de Castilla-La Mancha; University of Zaragoza	Martin-Fernandez, J (corresponding author), Gerencia Asistencial Atenc Primaria, Consultorio Villamanta CS Navalcarnero, Madrid, Spain.; Martin-Fernandez, J (corresponding author), Univ Rey Juan Carlos, Fac Ciencias Salud, Alcorcon, Spain.; Martin-Fernandez, J (corresponding author), Red Invest Serv Sanitarios & Enfermedades Cron RE, Madrid, Spain.; Martin-Fernandez, J (corresponding author), Univ Educ Distancia UNED, Programa Doctorado Econ, Madrid, Spain.	jmfernandez@salud.madrid.org	Oliva, Juan/A-1299-2011; Martín-Fernández, Jesús/U-1006-2019; Lacruz, Ana Isabel Gil/AAI-8302-2021; POLENTINOS-CASTRO, ELENA/B-7373-2019; del Cura-Gonzalez, Isabel/G-9040-2018	Oliva, Juan/0000-0002-8997-0307; Martín-Fernández, Jesús/0000-0001-9545-1549; Lacruz, Ana Isabel Gil/0000-0002-7994-923X; POLENTINOS-CASTRO, ELENA/0000-0001-9460-2966; ARIZA-CARDIEL, GLORIA/0000-0002-4635-9604; del Cura-Gonzalez, Isabel/0000-0002-3931-5304	ISCIII; FEDER Funds [RD12/0001/0012]; Consejeria de Sanidad (Community of Madrid, Spain) [472/2010]	ISCIII(Instituto de Salud Carlos III); FEDER Funds(European Commission); Consejeria de Sanidad (Community of Madrid, Spain)	This work has been partially supported by the funds for research projects in the field of Primary Care health outcomes, established by order 472/2010 of the Consejeria de Sanidad (Community of Madrid, Spain), on September 16, Grant number RS_AP_10/7 to Jesus Martin Fernandez. Publication charges will be supported by of ISCIII and FEDER Funds, Grant 485 Number RD12/0001/0012 to Isabel del Cura-Gonzalez. There was no additional external funding received for this study.	Adler MD, 2016, REGULATORY REV; Arrow KJ, 1950, J POLIT ECON, V58, P328, DOI 10.1086/256963; Barnighausen T, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-114; Borghi J, 2008, HEALTH ECON, V17, P863, DOI 10.1002/hec.1304; Bosch X, 2015, HEALTH POLICY, V119, P107, DOI 10.1016/j.healthpol.2014.10.020; Dohmen T, 2011, J EUR ECON ASSOC, V9, P522, DOI 10.1111/j.1542-4774.2011.01015.x; Domingo Salvany A, 1989, Gac Sanit, V3, P320; Eckermann S, 2015, APPL HEALTH ECON HEA, V13, P7, DOI 10.1007/s40258-014-0136-3; Foster MM, 2010, HEALTH POLICY, V97, P105, DOI 10.1016/j.healthpol.2010.04.005; Gachter S, 2007, CEDEX DISCUSSION PAP; Gandjour A, 2008, PHARMACOECONOMICS, V26, P895, DOI 10.2165/00019053-200826110-00001; Grutters JPC, 2008, VALUE HEALTH, V11, P1110, DOI 10.1111/j.1524-4733.2008.00340.x; Guzman RM, 2007, ENVIRON RESOUR ECON, V37, P465, DOI 10.1007/s10640-006-9034-y; Hagenaars A., 1994, POVERTY STAT LATE 19; Hammitt JK, 2015, J BENEFIT-COST ANAL, V6, P207, DOI 10.1017/bca.2015.1; HANEMANN WM, 1991, AM ECON REV, V81, P635; Hardin JW, 2012, GEN LINEAR MODELS EX, V3rd; Hardisty DJ, 2013, J BEHAV DECIS MAKING, V26, P348, DOI 10.1002/bdm.1771; Herdman M, 2001, Aten Primaria, V28, P425; Horowitz JK, 2003, J ECON BEHAV ORGAN, V51, P537, DOI 10.1016/S0167-2681(02)00216-0; Horowitz JK, 2002, J ENVIRON ECON MANAG, V44, P426, DOI 10.1006/jeem.2001.1215; Jones A.M., 2010, MODELS HLTH CARE; Kim Y, 2015, ANNU REV RESOUR ECON, V7, P169, DOI 10.1146/annurev-resource-100913-012501; KLEINBAUM DG, 2007, APPL REGRESSION ANAL; KRAUS SJ, 1995, PERS SOC PSYCHOL B, V21, P58, DOI 10.1177/0146167295211007; Lonnqvist JE, 2015, J ECON BEHAV ORGAN, V119, P254, DOI 10.1016/j.jebo.2015.08.003; Martin-Fernandez J, 2016, REV ESP SALUD PUBLIC, V90; Martin-Fernandez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062840; Martin-Fernandez J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-236; Martin-Fernandez J, 2010, HEALTH POLICY, V94, P266, DOI 10.1016/j.healthpol.2009.11.001; O'Brien BJ, 1998, MED CARE, V36, P370, DOI 10.1097/00005650-199803000-00013; O'Brien BJ, 2002, HEALTH ECON, V11, P175, DOI 10.1002/hec.655; Plott CR, 2005, AM ECON REV, V95, P530, DOI 10.1257/0002828054201387; Ryan M, 2009, HEALTH ECON, V18, P389, DOI 10.1002/hec.1364; San Martin MI Fernandez, 2008, ATEN PRIM, V40, P611; Sayman S, 2005, J ECON PSYCHOL, V26, P289, DOI 10.1016/j.joep.2004.07.002; Shiell A, 2008, HEALTH ECON, V17, P287, DOI 10.1002/hec.1261; SHOGREN JF, 1994, AM ECON REV, V84, P255; Smith RD, 2008, HEALTH ECON, V17, P607, DOI 10.1002/hec.1280; Smith RD, 2010, HEALTH ECON POLICY L, V5, P91, DOI 10.1017/S1744133109990016; Tuncel T, 2014, J ENVIRON ECON MANAG, V68, P175, DOI 10.1016/j.jeem.2014.06.001; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; van den Berg B, 2005, HEALTH ECON, V14, P363, DOI 10.1002/hec.980; Von Rosenbladt B., 2014, TESTERHEBUNG ZUM SOE; Whynes DK, 2007, SOC SCI MED, V65, P946, DOI 10.1016/j.socscimed.2007.04.014; Wieland A, 2014, JUDGM DECIS MAK, V9, P558; Zhao JH, 2001, ECON LETT, V73, P293, DOI 10.1016/S0165-1765(01)00511-0	47	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188969	10.1371/journal.pone.0188969	http://dx.doi.org/10.1371/journal.pone.0188969			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO8CU	29206847	Green Published, Green Submitted, gold			2022-12-27	WOS:000417110700035
J	Tang, XJ; Zhao, S; Chiu, APY; Wang, X; Yang, L; He, DH				Tang, Xiujuan; Zhao, Shi; Chiu, Alice P. Y.; Wang, Xin; Yang, Lin; He, Daihai			Analysing increasing trends of Guillain-Barre A Syndrome (GBS) and dengue cases in Hong Kong using meteorological data	PLOS ONE			English	Article							BURDEN; FEVER	Background Guillain-Barre A Syndrome (GBS) is a severe paralytic neuropathy associated with virus infections such as Zika virus and Chikungunya virus. There were also case reports of dengue fever preceding GBS. With the aim to understand the mechanisms of GBS and dengue outbreaks, this ecological study investigates the relationships between GBS, dengue, meteorological factors in Hong Kong and global climatic factors from January 2000 to June 2016. Methods The correlations between GBS, dengue, Multivariate El Nino Southern Oscillation Index (MEI) and local meteorological data were explored by Spearman's Rank correlations and cross-correlations. Three Poisson regression models were fitted to identify non-linear associations among GBS, dengue and MEI. Cross wavelet analyses were applied to infer potential non-stationary oscillating associations among GBS, dengue and MEI. Findings and conclusion We report a substantial increasing of local GBS and dengue cases (mainly imported) in recent year in Hong Kong. The seasonalities of GBS and dengue are different, in particular, GBS is low while dengue is high in the summer. We found weak but significant correlations between GBS and local meteorological factors. MEI could explain over 17% of dengue's variations based on Poisson regression analyses. We report a possible non-stationary oscillating association between dengue fever and GBS cases in Hong Kong. This study has led to an improved understanding about the timing and ecological relationships between MEI, GBS and dengue.	[Tang, Xiujuan; Wang, Xin] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Zhao, Shi; Chiu, Alice P. Y.; He, Daihai] Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Hong Kong, Peoples R China; [Yang, Lin] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	Shenzhen Center for Disease Control & Prevention (SZCDC); Hong Kong Polytechnic University; Hong Kong Polytechnic University	Chiu, APY; He, DH (corresponding author), Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Hong Kong, Peoples R China.	alice.py.chiu@polyu.edu.hk; daihai.he@polyu.edu.hk	He, Daihai/AAT-8735-2021; YANG, Lin/F-9601-2014; Zhao, Shi/AAW-6992-2021	YANG, Lin/0000-0002-5964-3233; Zhao, Shi/0000-0001-8722-6149; He, Daihai/0000-0003-3253-654X	Shenzhen Science and Technology Innovation Project Grant [JCYJ20150402102135501]; Start-up Fund for New Recruits from the Hong Kong Polytechnic University	Shenzhen Science and Technology Innovation Project Grant; Start-up Fund for New Recruits from the Hong Kong Polytechnic University	This study was supported by Shenzhen Science and Technology Innovation Project Grant (JCYJ20150402102135501) and Start-up Fund for New Recruits from the Hong Kong Polytechnic University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Shenzhen Science and Technology Innovation Project Grant (JCYJ20150402102135501) and Start-up Fund for New Recruits from the Hong Kong Polytechnic University.	Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Brizzi K, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0561-1; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cazelles B, 2005, PLOS MED, V2, P313, DOI 10.1371/journal.pmed.0020106; Centre for Health Protection, COMM DIS WATCH 2013; Centre for Health Protection, COMM DIS WATCH 2014; Centre for Health Protection, COMM DIS WATCH 2012; Centre for Health Protection, COMM DIS WATCH 2015; Chen TY, 2007, ANN EMERG MED, V50, P94, DOI 10.1016/j.annemergmed.2007.02.026; Chuang Vivien W. M., 2008, Hong Kong Medical Journal, V14, P170; de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612; Goncalves E, 2011, REV INST MED TROP SP, V53, P223, DOI 10.1590/S0036-46652011000400009; Hay SI, 2000, P NATL ACAD SCI USA, V97, P9335, DOI 10.1073/pnas.97.16.9335; Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322; Hui ACF, 2005, J CLIN NEUROSCI, V12, P134, DOI 10.1016/j.jocn.2003.10.018; Hurtado-Diaz M, 2007, TROP MED INT HEALTH, V12, P1327, DOI 10.1111/j.1365-3156.2007.01930.x; Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9; Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168; Kumar Sudhir, 2005, Neurol India, V53, P250; Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482; Ma YM, 2010, PEDIATR INT, V52, P13, DOI 10.1111/j.1442-200X.2009.02951.x; Mazzarella A, 2013, THEOR APPL CLIMATOL, V111, P601, DOI 10.1007/s00704-012-0696-9; Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]; Qureshi N. K., 2012, Journal of Medicine, V13, P246; Ralapanawa Dissanayake Mudiyanselage Priyantha Udaya Kumara, 2015, BMC Res Notes, V8, P729, DOI 10.1186/s13104-015-1672-0; Santos NQ, 2004, ARQ NEURO-PSIQUIAT, V62, P144, DOI 10.1590/S0004-282X2004000100025; Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016; Sulekha C, 2004, INDIAN PEDIAT; Thai KTD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000747; Tipayamongkholgul M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-422; Tsuda Y, 2016, JPN J INFECT DIS, V69, P1, DOI 10.7883/yoken.JJID.2014.576; van Panhuis WG, 2015, P NATL ACAD SCI USA, V112, P13069, DOI 10.1073/pnas.1501375112; Villamil-Gomez W, 2016, ENFERM INFEC MICR CL, V34, P140, DOI 10.1016/j.eimc.2015.05.012; Wang SY, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/3159805; Webb AJS, 2015, J NEUROL NEUROSUR PS, V86, P1196, DOI 10.1136/jnnp-2014-309056; Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1; World Health Organization, 2009, DENGUE GUIDELINES DI; Xu L, 2017, P NATL ACAD SCI USA, V114, P113, DOI 10.1073/pnas.1618558114	42	11	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0187830	10.1371/journal.pone.0187830	http://dx.doi.org/10.1371/journal.pone.0187830			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29200423	Green Published, gold, Green Submitted			2022-12-27	WOS:000417033200002
J	Lin, YY; Chen, CY; Ding, ST				Lin, Yuan-Yu; Chen, Ching-Yi; Ding, Shih-Torng			Adiponectin receptor 1 resists the decline of serum osteocalcin and GPRC6A expression in ovariectomized mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; OSTEOBLAST DIFFERENTIATION; POSTMENOPAUSAL WOMEN; ENERGY-METABOLISM; BETA-CELL; DIET; DISEASES; OBESITY	Hormonal changes that cause metabolic complications are a common problem in postmenopausal women. Adiponectin and osteocalcin are cytokines associated with glucose regulatory and insulin sensitized function in postmenopausal stages. The current study investigated the role of adiponectin signaling and osteocalcin mediated function in glucose metabolism in ovariectomized mice. In a mouse menopausal-related metabolic disorder model, overexpression of adiponectin receptor 1 improved glucose tolerance and caused resistance to body weight increase and decline of serum osteocalcin. Furthermore, adiponectin receptor 1 transgenic ovariectomized mice had higher GPRC6A (the putative osteocalcin receptor) expression in muscle tissue. Immunofluorescence indicated that GPRC6A and adiponectin receptor 1 were co-localized in mouse muscle tissues. The present finding suggested adiponectin receptor 1 can mediate the improvement of glucose metabolism by osteocalcin in ovariectomized mice. Our findings imply the possibility to ameliorate menopause-induced metabolic disorder by GPRC6A and adiponectin signaling.	[Lin, Yuan-Yu] Tunghai Univ, Dept Anim Sci & Biotechnol, Taichung, Taiwan; [Chen, Ching-Yi; Ding, Shih-Torng] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan; [Ding, Shih-Torng] Natl Taiwan Univ, Ctr Biotechnol, Taipei, Taiwan	Tunghai University; National Taiwan University; National Taiwan University	Ding, ST (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan.; Ding, ST (corresponding author), Natl Taiwan Univ, Ctr Biotechnol, Taipei, Taiwan.	sding@ntu.edu.tw	Lin, Yuan-Yu/AAD-5190-2021	Lin, Yuan-Yu/0000-0002-3397-3218; Ding, Shih-Torng/0000-0002-9866-1776; Chen, Ching-Yi/0000-0002-5776-084X	Ministry of Science and Technology in Taiwan [102-2313-B-002-026-MY3, MOST 106-2313-B-002-044]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported in part by the Grants 102-2313-B-002-026-MY3 and MOST 106-2313-B-002-044 grants from Ministry of Science and Technology in Taiwan.	Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chedraui P, 2014, MATURITAS, V79, P86, DOI 10.1016/j.maturitas.2014.06.008; Choudhury AB, 2014, ARCH PHYSIOL BIOCHEM, V120, P73, DOI 10.3109/13813455.2013.877488; Clemmensen C, 2013, J ENDOCRINOL, V217, P151, DOI 10.1530/JOE-12-0550; Edwards BJ, 2013, PERIODONTOL 2000, V61, P177, DOI 10.1111/j.1600-0757.2011.00407.x; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Kaaja Risto J, 2008, Menopause Int, V14, P21, DOI 10.1258/mi.2007.007032; Lee HW, 2009, STEM CELLS, V27, P2254, DOI 10.1002/stem.144; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lin YY, 2014, BONE, V64, P147, DOI 10.1016/j.bone.2014.03.051; Liu BH, 2013, EXP ANIM TOKYO, V62, P347, DOI 10.1538/expanim.62.347; Liu ML, 2014, BEST PRACT RES CL EN, V28, P25, DOI 10.1016/j.beem.2013.06.003; Ludgero-Correia A, 2012, NUTRITION, V28, P316, DOI 10.1016/j.nut.2011.07.014; Oshima K, 2005, BIOCHEM BIOPH RES CO, V331, P520, DOI 10.1016/j.bbrc.2005.03.210; Otani T, 2015, CELL SIGNAL, V27, P532, DOI 10.1016/j.cellsig.2014.12.018; Pi M, 2012, ENDOCRINOLOGY, V153, P2062, DOI 10.1210/en.2011-2117; Pi M, 2011, J BONE MINER RES, V26, P1680, DOI 10.1002/jbmr.390; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Wei JW, 2014, J CLIN INVEST, V124, P1781, DOI 10.1172/JCI72323; Wei JW, 2014, DIABETES, V63, P1021, DOI 10.2337/db13-0887; Yamauchi T, 2013, CELL METAB, V17, P185, DOI 10.1016/j.cmet.2013.01.001	23	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0189063	10.1371/journal.pone.0189063	http://dx.doi.org/10.1371/journal.pone.0189063			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194451	Green Published, gold			2022-12-27	WOS:000416867800018
J	Ha, AS; Ng, JYY				Ha, Amy S.; Ng, Johan Y. Y.			Rope skipping increases bone mineral density at calcanei of pubertal girls in Hong Kong: A quasi-experimental investigation	PLOS ONE			English	Article							WEIGHT-BEARING EXERCISE; ADOLESCENT GIRLS; CHILDREN; MASS; FITNESS; HEALTH	Bone mineral accrual during puberty is important, especially in girls, because it is related to reduced risks of osteoporosis in adulthood. Previous research has shown that jumping or plyometric exercises may be effective in increasing bone mineral density in adolescents. Rope skipping is a form of activity that involves jumping, thus regular skipping may also increase bone mineral density in pubertal girls. To this end, we conducted a quasi-experimental to examine the effects of rope skipping on girls' bone mineral density and cardiovascular fitness. 176 Hong Kong girls (age = 12.23 +/- 1.80 years at baseline) were recruited to take part in the study. Bone density at their forearms and calcanei were measured twice over two academic years (mean time between visits was 10.3 months). Using multilevel modeling analyses and adjusting for participants' height and physical activity, we found that girls who participated in weekly rope skipping activities, compared to those who did not, had higher levels of bone density at the calcanei (B = 0.023, p < .01). However, no differences were found for bone density at forearms or participants' cardiovascular fitness. The rates of change of these variables across time were also not significantly different. Results suggest that regular rope skipping may increase girls' bone density at the lower extremities, irrespective of the amount of self-report physical activity. However, further research is required to examine the potential dose-response relation between skipping behaviors and the measured outcomes.	[Ha, Amy S.; Ng, Johan Y. Y.] Chinese Univ Hong Kong, Dept Sports Sci & Phys Educ, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Ha, AS (corresponding author), Chinese Univ Hong Kong, Dept Sports Sci & Phys Educ, Shatin, Hong Kong, Peoples R China.	sauchingha@cuhk.edu.hk	Ng, Johan/AAP-2441-2020	Ng, Johan/0000-0003-0783-879X	Direct Grant for Research, The Chinese University of Hong Kong	Direct Grant for Research, The Chinese University of Hong Kong(Chinese University of Hong Kong)	This study was funded by the Direct Grant for Research, The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker TE, 2005, ORGAN RES METHODS, V8, P274, DOI 10.1177/1094428105278021; Behringer M, 2014, J BONE MINER RES, V29, P467, DOI 10.1002/jbmr.2036; BONJOUR JP, 1991, J CLIN ENDOCR METAB, V73, P555, DOI 10.1210/jcem-73-3-555; Boot AM, 1997, J CLIN ENDOCR METAB, V82, P57, DOI 10.1210/jc.82.1.57; Cadogan J, 1998, J BONE MINER RES, V13, P1602, DOI 10.1359/jbmr.1998.13.10.1602; Chan NPT, 2010, MATERN CHILD HLTH J, V14, P466, DOI 10.1007/s10995-009-0481-2; COOPER C, 1992, TRENDS ENDOCRIN MET, V3, P224, DOI 10.1016/1043-2760(92)90032-V; Crabtree NJ, 2014, J CLIN DENSITOM, V17, P225, DOI 10.1016/j.jocd.2014.01.003; FROST HM, 1990, ANAT REC, V226, P403, DOI 10.1002/ar.1092260402; Fuchs RK, 2001, J BONE MINER RES, V16, P148, DOI 10.1359/jbmr.2001.16.1.148; Gammon C, 2017, J SPORT SCI, V35, P29, DOI 10.1080/02640414.2016.1154594; Gunter K, 2008, BONE, V42, P710, DOI 10.1016/j.bone.2008.01.002; Gutin B, 2002, AM J CLIN NUTR, V75, P818, DOI 10.1093/ajcn/75.5.818; Hind K, 2007, BONE, V40, P14, DOI 10.1016/j.bone.2006.07.006; Ishikawa S, 2013, SPORTS MED, V43, P875, DOI 10.1007/s40279-013-0060-y; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; KATZMAN DK, 1991, J CLIN ENDOCR METAB, V73, P1332, DOI 10.1210/jcem-73-6-1332; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P174, DOI 10.1123/pes.9.2.174; MacKelvie KJ, 2001, J PEDIATR-US, V139, P501, DOI 10.1067/mpd.2001.118190; McKay HA, 1998, J PEDIATR-US, V133, P682, DOI 10.1016/S0022-3476(98)70112-X; Meredith M. D., 2013, FITNESSGRAM ACTIVITY, V4th; Nikander R, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-47; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Pang B, 2010, EUR PHYS EDUC REV, V16, P223, DOI 10.1177/1356336X10382971; Ridley K, 2008, MED SCI SPORT EXER, V40, P1439, DOI 10.1249/MSS.0b013e31817279ef; Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005; Vicente-Rodriguez G, 2006, SPORTS MED, V36, P561, DOI 10.2165/00007256-200636070-00002; Weeks BK, 2008, J BONE MINER RES, V23, P1002, DOI 10.1359/JBMR.080226; Wren TAL, 2014, J PEDIATR-US, V164, P1280, DOI 10.1016/j.jpeds.2013.12.040; Xu JC, 2016, SPORTS MED, V46, P1165, DOI 10.1007/s40279-016-0494-0	30	8	8	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189085	10.1371/journal.pone.0189085	http://dx.doi.org/10.1371/journal.pone.0189085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220384	Green Submitted, gold, Green Published			2022-12-27	WOS:000417469900031
J	Luo, G; Jacob, L; Bonvalet, M; Ambati, A; Plazzi, G; Pizza, F; Leib, R; Adams, CM; Partinen, M; Mignot, EJM				Luo, Guo; Jacob, Louis; Bonvalet, Melodie; Ambati, Aditya; Plazzi, Giuseppe; Pizza, Fabio; Leib, Ryan; Adams, Christopher M.; Partinen, Markku; Mignot, Emmanuel Jean-Marie			Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy	PLOS ONE			English	Article							INFLUENZA; VACCINATION; PEPTIDE; POPULATION; RESPONSES; CHILDREN; MUTATION; CELLS; CLIP	Background A recent publication suggested molecular mimicry of a nucleoprotein (NP) sequence from A/Puerto Rico/8/1934 (PR8) strain, the backbone used in the construction of the reassortant strain X-179A that was used in Pandemrix (R) vaccine, and reported on anti-hypocretin (HCRT) receptor 2 (anti-HCRTR2) autoantibodies in narcolepsy, mostly in post Pandemrix (R) narcolepsy cases (17 of 20 sera). In this study, we re-examined this hypothesis through mass spectrometry (MS) characterization of Pandemrix (R), and two other pandemic H1N1 (pH1N1)-2009 vaccines, Arepanrix (R) and Focetria (R), and analyzed anti-HCRTR2 autoantibodies in narcolepsy patients and controls using three independent strategies. Methods MS characterization of Pandemrix (R) (2 batches), Arepanrix (R) (4 batches) and Focetriar (1 batch) was conducted with mapping of NP 116I or 116M spectrogram. Two sets of narcolepsy cases and controls were used: 40 post Pandemrix (R) narcolepsy(PP-N) cases and 18 age-matched post Pandemrix (R) controls (PP-C), and 48 recent(<= 6 months) early onset narcolepsy (EO-N) cases and 70 age-matched other controls (O-C). Anti-HCRTR2 autoantibodies were detected using three strategies: (1) Human embryonic kidney (HEK) 293T cells with transient expression of HCRTR2 were stained with human sera and then analyzed by flow cytometer; (2) In vitro translation of [(35) S]-radiolabelled HCRTR2 was incubated with human sera and immune complexes of autoantibody and [(35) S]-radiolabelled HCRTR2 were quantified using a radioligand-binding assay; (3) Optical density (OD) at 450 nm (OD450) of human serum immunoglobulin G (IgG) binding to HCRTR2 stably expressed in Chinese hamster ovary (CHO)-K1 cell line was measured using an in-cell enzyme-linked immunosorbent assay (ELISA). Results NP 116M mutations were predominantly present in all batches of Pandemrix (R), Arepanrix (R) and Focetria (R). The wild- type NP109-123 (ILYDKEEIRRIWRQA), a mimic to HCRTR234-45 (YDDEEFLRYLWR), was not found to bind to DQ0602. Three or four subjects were found positive for anti-HCRTR2 autoantibodies using two strategies or the third one, respectively. None of the post Pandemrix (R) narcolepsy cases (0 of 40 sera) was found positive with all three strategies. Conclusion Anti-HCRTR2 autoantibody is not a significant biological feature of narcolepsy or of post Pandemrix (R) autoimmune responses.	[Luo, Guo; Jacob, Louis; Bonvalet, Melodie; Ambati, Aditya; Mignot, Emmanuel Jean-Marie] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Ctr Sleep Sci, Palo Alto, CA 94304 USA; [Plazzi, Giuseppe; Pizza, Fabio] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Plazzi, Giuseppe; Pizza, Fabio] Inst Neurol Sci, Bologna, Italy; [Leib, Ryan; Adams, Christopher M.] Stanford Univ Mass Spectrometry, Palo Alto, CA USA; [Partinen, Markku] Helsinki Sleep Clin, Helsinki, Finland	Stanford University; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB)	Mignot, EJM (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Ctr Sleep Sci, Palo Alto, CA 94304 USA.	mignot@stanford.edu	Plazzi, Giuseppe/AAB-9627-2020; Jacob, Louis/AAL-3956-2020; Ambati, Aditya/K-4095-2019; Pizza, Fabio/AAC-1794-2020	Jacob, Louis/0000-0003-1071-1239; Ambati, Aditya/0000-0001-8462-3552; Partinen, Markku/0000-0002-8182-9368				Ahmed SS, 2014, J AUTOIMMUN, V50, P1, DOI 10.1016/j.jaut.2014.01.033; Ahmed SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2354; Amatoury M, 2013, JOVE-J VIS EXP, DOI 10.3791/50935; [Anonymous], 2014, R LANG ENV STAT COMP; Aran A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012875; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Bardage C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5956; Chaturvedi P, 2000, INT IMMUNOL, V12, P757, DOI 10.1093/intimm/12.6.757; CLARKE SH, 1990, J IMMUNOL, V144, P2795; Cvetkovic-Lopes V, 2010, J CLIN INVEST, V120, P713, DOI 10.1172/JCI41366; Dalal J, 2013, GENE DEV, V27, P565, DOI 10.1101/gad.207654.112; Dauvilliers Y, 2013, BRAIN, V136, P2486, DOI 10.1093/brain/awt187; Dauvilliers Y, 2010, SLEEP, V33, P1428, DOI 10.1093/sleep/33.11.1428; Deloumeau A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013320; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Dye TJ, 2016, PAEDIAT RESP REV; Faraco J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003270; Feltelius N, 2015, J INTERN MED, V278, P335, DOI 10.1111/joim.12391; Fulvini AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020823; Gadroen K, 2016, VACCINE, V34, P4892, DOI 10.1016/j.vaccine.2016.08.062; Giannoccaro MP, 2016, SLEEP; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Han F, 2012, ANN NEUROLOGY; Han F, 2014, SLEEP, V37, P1601, DOI 10.5665/sleep.4066; Han F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003880; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; Heier MS, 2013, SLEEP MED, V14, P867, DOI 10.1016/j.sleep.2013.03.020; Honda M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004254; HUBLIN C, 1994, ANN NEUROL, V35, P709, DOI 10.1002/ana.410350612; Jacob L, 2015, BRAIN BEHAV IMMUN, V47, P44, DOI 10.1016/j.bbi.2014.11.004; KAO FT, 1969, SCIENCE, V164, P313, DOI 10.1126/science.164.3877.312; KAO FT, 1968, P NATL ACAD SCI USA, V60, P1275, DOI 10.1073/pnas.60.4.1275; KAVALER J, 1991, EUR J IMMUNOL, V21, P2687, DOI 10.1002/eji.1830211107; Koepsell TD, 2010, J SLEEP RES, V19, P80, DOI 10.1111/j.1365-2869.2009.00756.x; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Melen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068402; Mellins ED, 2014, CURR OPIN IMMUNOL, V26, P115, DOI 10.1016/j.coi.2013.11.005; Miller E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f794; Montplaisir J, 2014, PLOS ONE IN PRESS; Nicolson C, 2012, VACCINE, V30, P745, DOI 10.1016/j.vaccine.2011.11.081; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; O'Flanagan D, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.17.20789; O'Flanagan D, 2009, INVESTIGATION ASS ON; Oberle D, 2015, SLEEP, V38, P1619, DOI 10.5665/sleep.5060; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Robertson JS, 2011, VACCINE, V29, P1836, DOI 10.1016/j.vaccine.2010.12.044; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; SMA, 2011, REG BAS COMP COH STU; Stern LJ, 2006, CURR OPIN IMMUNOL, V18, P64, DOI 10.1016/j.coi.2005.11.005; Szakacs A, 2013, NEUROLOGY, V80, P1315, DOI 10.1212/WNL.0b013e31828ab26f; Tanaka S, 2006, SLEEP, V29, P633, DOI 10.1093/sleep/29.5.633; Vaarala O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114361; Van Elssen CHMJ, 2011, J IMMUNOL METHODS, V365, P87, DOI 10.1016/j.jim.2010.12.006; Vassalli A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad2353; Waffarn EE, 2011, J IMMUNOL, V186, P3823, DOI 10.4049/jimmunol.1002090; Winstone AM, 2014, DEV MED CHILD NEUROL, V56, P1117, DOI 10.1111/dmcn.12522; Wu HJ, 2014, SLEEP MED, V15, P607, DOI 10.1016/j.sleep.2013.12.012; Yin LS, 2015, J IMMUNOL, V195, P706, DOI 10.4049/jimmunol.1403190; Zhu YR, 2003, J MOL BIOL, V326, P1157, DOI 10.1016/S0022-2836(02)01437-7	63	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0187305	10.1371/journal.pone.0187305	http://dx.doi.org/10.1371/journal.pone.0187305			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220370	Green Published, Green Submitted, gold			2022-12-27	WOS:000417469900004
J	Chang, VW; Langa, KM; Weir, D; Iwashyna, TJ				Chang, Virginia W.; Langa, Kenneth M.; Weir, David; Iwashyna, Theodore J.			The obesity paradox and incident cardiovascular disease: A population-based study	PLOS ONE			English	Article							BODY-MASS INDEX; CHRONIC HEART-FAILURE; REVERSE CAUSATION; CORONARY EVENTS; SELECTION BIAS; MORTALITY; IMPACT; OUTCOMES; WEIGHT; RISK	Background Prior work suggests that obesity may confer a survival advantage among persons with cardiovascular disease (CVD). This obesity "paradox" is frequently studied in the context of prevalent disease, a stage in the disease process when confounding from illness-related weight loss and selective survival are especially problematic. Our objective was to examine the association of obesity with mortality among persons with incident CVD, where biases are potentially reduced, and to compare these findings with those based on prevalent disease. Methods We used data from the Health and Retirement Study, an ongoing, nationally representative longitudinal survey of U.S. adults age 50 years and older initiated in 1992 and linked to Medicare claims. Cox proportional hazard models were used to estimate the association between weight status and mortality among persons with specific CVD diagnoses. CVD diagnoses were established by self-reported survey data as well as Medicare claims. Prevalent disease models used concurrent weight status, and incident disease models used prediagnosis weight status. Results We examined myocardial infarction, congestive heart failure, stroke, and ischemic heart disease. A strong and significant obesity paradox was consistently observed in prevalent disease models (hazard of death 18-36% lower for obese class I relative to normal weight), replicating prior findings. However, in incident disease models of the same conditions in the same dataset, there was no evidence of this survival benefit. Findings from models using survey-vs. claims-based diagnoses were largely consistent. Conclusion We observed an obesity paradox in prevalent CVD, replicating prior findings in a population-based sample with longer-term follow-up. In incident CVD, however, we did not find evidence of a survival advantage for obesity. Our findings do not offer support for reevaluating clinical and public health guidelines in pursuit of a potential obesity paradox.	[Chang, Virginia W.] NYU, Dept Social & Behav Sci, Coll Global Publ Hlth, New York, NY 10003 USA; [Chang, Virginia W.] NYU, Sch Med, Dept Populat Hlth, New York, NY 10003 USA; [Langa, Kenneth M.; Iwashyna, Theodore J.] Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48104 USA; [Langa, Kenneth M.; Iwashyna, Theodore J.] Vet Affairs Ctr Clin Management Res, Ann Arbor, MI USA; [Langa, Kenneth M.; Iwashyna, Theodore J.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Weir, David] Univ Michigan, Inst Social Res, Ann Arbor, MI USA	New York University; New York University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chang, VW (corresponding author), NYU, Dept Social & Behav Sci, Coll Global Publ Hlth, New York, NY 10003 USA.; Chang, VW (corresponding author), NYU, Sch Med, Dept Populat Hlth, New York, NY 10003 USA.	vc43@nyu.edu		Langa, Kenneth/0000-0002-2798-1836	American Diabetes Association [7-12-CT-12]; National Institute on Aging [U01AG009740]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD041028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG009740] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Clinical Translational Research Award from the American Diabetes Association 7-12-CT-12, www.diabetes.org/ (VVVC), and the National Institute on Aging U01AG009740, https://www.nia.nih.gov/ (KML, DW). The funding organizations had no role in the study design, data analysis, decision to publish, or the preparation of the manuscript. The Health and Retirement Study data collection is supported by the National Institute on Aging.	Arena R, 2009, AM J CARDIOL, V104, P1116, DOI 10.1016/j.amjcard.2009.05.059; Banack HR, 2015, ANN EPIDEMIOL, V25, P342, DOI 10.1016/j.annepidem.2015.02.008; Benesch C, 1997, NEUROLOGY, V49, P660, DOI 10.1212/WNL.49.3.660; Bertoni AG, 2004, DIABETES CARE, V27, P699, DOI 10.2337/diacare.27.3.699; Bozkurt B, 2005, AM HEART J, V150, P1233, DOI 10.1016/j.ahj.2005.02.004; Buccaneer Computer Systems and Services, CHRON COND DAT WAR U; Cicoira M, 2007, EUR J HEART FAIL, V9, P397, DOI 10.1016/j.ejheart.2006.10.016; Clark AL, 2012, AM J CARDIOL, V110, P77, DOI 10.1016/j.amjcard.2012.02.050; Curtis JP, 2005, ARCH INTERN MED, V165, P55, DOI 10.1001/archinte.165.1.55; Davos CH, 2003, J CARD FAIL, V9, P29, DOI 10.1054/jcaf.2003.4; Doehner W, 2015, EUR HEART J; Epstein AJ, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-42; Flegal KM, 2011, AM J EPIDEMIOL, V173, P1, DOI 10.1093/aje/kwq341; Galal W, 2007, AM J CARDIOL, V99, P1485, DOI 10.1016/j.amjcard.2007.01.018; Glymour MM, 2014, EPIDEMIOLOGY, V25, P4, DOI 10.1097/EDE.0000000000000013; Hogue CW, 2009, INTENS CARE MED, V35, P1152, DOI 10.1007/s00134-009-1424-5; Horwich TB, 2001, J AM COLL CARDIOL, V38, P789, DOI 10.1016/S0735-1097(01)01448-6; Hu FB, 2008, OBESITY EPIDEMIOLOGY, P216; Iakobishvili Zaza, 2006, Acute Card Care, V8, P95, DOI 10.1080/17482940600768673; Kaplan RC, 2002, J CLIN EPIDEMIOL, V55, P654, DOI 10.1016/S0895-4356(02)00405-5; Kenchaiah S, 2007, CIRCULATION, V116, P627, DOI 10.1161/CIRCULATIONAHA.106.679779; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Lavie CJ, 2016, PROG CARDIOVASC DIS, V58, P537, DOI 10.1016/j.pcad.2016.01.008; Lavie CJ, 2012, J AM COLL CARDIOL, V60, P1374, DOI 10.1016/j.jacc.2012.05.037; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Lopez-Jimenez F, 2004, CHEST, V125, P1205, DOI 10.1378/chest.125.4.1205; Mehta NK, 2009, DEMOGRAPHY, V46, P851, DOI 10.1353/dem.0.0077; Mehta NK, 2011, OXFORD HDB SOCIAL SC, P502; Niedziela J, 2014, EUR J EPIDEMIOL, V29, P801, DOI 10.1007/s10654-014-9961-9; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Oreopoulos A, 2008, OBESITY, V16, P442, DOI 10.1038/oby.2007.36; Pinder MC, 2007, J CLIN ONCOL, V25, P3808, DOI 10.1200/JCO.2006.10.4976; Rea TD, 2001, AM J CARDIOL, V88, P467, DOI 10.1016/S0002-9149(01)01720-9; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Stokes A, 2015, OBESITY, V23, P2485, DOI 10.1002/oby.21239; U.S. Department of Health and Human Services, 2001, SURG GEN CALL ACT PR; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; World Health Organization, 2000, HLTH ORG TECHN SUPP	40	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188636	10.1371/journal.pone.0188636	http://dx.doi.org/10.1371/journal.pone.0188636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216243	gold, Green Published, Green Submitted			2022-12-27	WOS:000417337800033
J	Cohen, AA; Isaksson, C; Salguero-Gomez, R				Cohen, Alan A.; Isaksson, Caroline; Salguero-Gomez, Roberto			Co-existence of multiple trade-off currencies shapes evolutionary outcomes	PLOS ONE			English	Article							FAST-SLOW CONTINUUM; MAMMALIAN LIFE-HISTORY; OXIDATIVE STRESS; IMMUNE-RESPONSES; SENESCENCE; NUTRITION; PATTERNS; ECOLOGY; TRAITS	Evolutionary studies often assume that energy is the primary resource (i. e. "currency") at the heart of the survival-reproduction trade-off, despite recent evidence to the contrary. The evolutionary consequences of having a single trade-off currency versus multiple competing currencies are unknown. Using simulations, we modeled the evolution of either a single physiological currency between reproduction and survival, or of multiple such currencies. For a wide array of model specifications varying functional forms and strengths of the trade-offs, we show that the presence of multiple currencies (e.g. nutrients, time) generally results in the evolution of higher lifetime reproductive success through partial circumvention of such trade-offs. Evolution of the underlying physiology is also more highly contingent with multiple currencies. These results challenge the paradigm of a single survival-reproduction trade-off as central to life history evolution, suggesting greater roles for physiological constraints and contingency, and implying potential selection for evolution of multiple trade-off currencies.	[Cohen, Alan A.] Univ Sherbrooke, Dept Family Med, PRIMUS Res Grp, Sherbrooke, PQ, Canada; [Isaksson, Caroline] Lund Univ, Dept Biol, Evolutionary Ecol unit, Lund, Sweden; [Salguero-Gomez, Roberto] Univ Sheffield, Dept Anim & Plant Sci, Alfred Denny Bldg, Sheffield, S Yorkshire, England; [Salguero-Gomez, Roberto] Univ Queensland, Ctr Biodivers & Conservat Sci, Sch Biol Sci, St Lucia, Qld, Australia	University of Sherbrooke; Lund University; University of Sheffield; University of Queensland	Cohen, AA (corresponding author), Univ Sherbrooke, Dept Family Med, PRIMUS Res Grp, Sherbrooke, PQ, Canada.	Alan.Cohen@USherbrooke.ca	Salguero-Gomez, Rob/AAB-8488-2022	Salguero-Gomez, Roberto/0000-0002-6085-4433; Cohen, Alan/0000-0003-4113-3988	Canadian Institutes of Health Research; National Science and Engineering Research Council Discovery Grant [402079-2011]; Swedish Research Council [C0361301]; European Union [322217]; Australian Research Council [140100505]; NERC [R/142195-11-1]; Natural Environment Research Council [NE/M018458/1, NE/M018458/2] Funding Source: researchfish; NERC [NE/M018458/1, NE/M018458/2] Funding Source: UKRI	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council Discovery Grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union(European Commission); Australian Research Council(Australian Research Council); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	AAC is a member of the Fonds de recherche du Quebec-sante (FRQ-S; http://www.frqs.gouv.qc.ca/)-supported Centre de recherche sur le vieillissement and Centre de recherche du CHUS, and a funded New Investigator with the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/). This project was supported by National Science and Engineering Research Council Discovery Grant # 402079-2011. CI is a member of Evolutionary Ecology unit in Lund, and was supported by the Swedish Research Council (https://www.vr.se/; #C0361301) and European Union (http://ec.europa.eu/research/mariecurieactions/; FP7-CIG # 322217). RSG is a Natural Environment Research Council (NERC; http://www.nerc.ac.uk/) research fellow and was supported by a Discovery Early Career Researcher Award # 140100505 of the Australian Research Council (http://www.arc.gov.au/) and NERC R/142195-11-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Bielby J, 2007, AM NAT, V169, P748, DOI 10.1086/516847; CODY ML, 1966, EVOLUTION, V20, P174, DOI 10.1111/j.1558-5646.1966.tb03353.x; Cohen AA, 2008, AM NAT, V172, P178, DOI 10.1086/589456; Cohen AA, 2016, BIOGERONTOLOGY, V17, P205, DOI 10.1007/s10522-015-9584-x; Cohen AA, 2009, OIKOS, V118, P1854, DOI 10.1111/j.1600-0706.2009.17785.x; Cotter SC, 2011, FUNCT ECOL, V25, P186, DOI 10.1111/j.1365-2435.2010.01766.x; Daan S, 1996, J ANIM ECOL, V65, P539, DOI 10.2307/5734; DUNHAM AE, 1985, AM NAT, V126, P231, DOI 10.1086/284411; Edward DA, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P137; Fenton A, 2008, PARASITOLOGY, V135, P841, DOI 10.1017/S0031182008000310; Gaillard J.-M., 2016, ENCY EVOLUTIONARY BI, P312, DOI DOI 10.1016/B978-0-12-800049-6.00085-8; GAILLARD JM, 1989, OIKOS, V56, P59, DOI 10.2307/3566088; GLEESON SK, 1992, AM NAT, V139, P1322, DOI 10.1086/285389; Isaksson C, 2011, BIOSCIENCE, V61, P194, DOI 10.1525/bio.2011.61.3.5; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; Kooijman S. A. L. M., 2010, DYNAMIC ENERGY BUDGE; Kramer BH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137969; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Lambers H., 2008, PLANT PHYSL ECOLOGY; Lee WS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2370; Matson KD, 2006, P ROY SOC B-BIOL SCI, V273, P815, DOI 10.1098/rspb.2005.3376; Metcalf CJE, 2016, AM NAT, V187, pIII, DOI 10.1086/685487; Nisbet RM, 2000, J ANIM ECOL, V69, P913, DOI 10.1046/j.1365-2656.2000.00448.x; Oli MK, 2004, BASIC APPL ECOL, V5, P449, DOI 10.1016/j.baae.2004.06.002; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Pedersen AB, 2011, MOL ECOL, V20, P872, DOI 10.1111/j.1365-294X.2010.04938.x; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; Reed WL, 2006, AM NAT, V167, P667, DOI 10.1086/503054; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; Roff DA, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P11; Roff Derek A., 1992; Salguero-Gomez R, 2016, P NATL ACAD SCI USA, V113, P230, DOI 10.1073/pnas.1506215112; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Snell-Rood E, 2015, EVOL APPL, V8, P635, DOI 10.1111/eva.12272; Speakman JR, 2014, BIOESSAYS, V36, P93, DOI 10.1002/bies.201300108; SPITZE K, 1991, EVOLUTION, V45, P1081, DOI 10.1111/j.1558-5646.1991.tb04376.x; Stearns S.C., 1992, pi; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003; Watson H, 2015, EXP GERONTOL, V71, P80, DOI 10.1016/j.exger.2015.08.009; Whitson A.R., 1912, SOILS SOIL FERTILITY; Wikelski Martin, 2001, Trends in Ecology and Evolution, V16, P479, DOI 10.1016/S0169-5347(01)02279-0	46	19	19	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189124	10.1371/journal.pone.0189124	http://dx.doi.org/10.1371/journal.pone.0189124			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216275	gold, Green Published, Green Submitted			2022-12-27	WOS:000417337800076
J	Park, J; Masaki, T; Mezaki, Y; Yokoyama, H; Nakamura, M; Maehashi, H; Fujimi, TJ; Gouraud, SS; Nagatsuma, K; Nakagomi, M; Kimura, N; Matsuura, T				Park, Jonghyuk; Masaki, Takahiro; Mezaki, Yoshihiro; Yokoyama, Hiroshi; Nakamura, Mariko; Maehashi, Haruka; Fujimi, Takahiko J.; Gouraud, Sabine S.; Nagatsuma, Keisuke; Nakagomi, Madoka; Kimura, Naofumi; Matsuura, Tomokazu			Alpha-1 antichymotrypsin is involved in astrocyte injury in concert with arginine-vasopressin during the development of acute hepatic encephalopathy	PLOS ONE			English	Article							ACUTE LIVER-FAILURE; TRAUMATIC BRAIN-INJURY; AQUAPORIN-4 EXPRESSION; ALZHEIMERS-DISEASE; HEPATOCELLULAR-CARCINOMA; PORTACAVAL ANASTOMOSIS; CULTURED ASTROCYTES; EDEMA; AMMONIA; ALPHA-1-ANTICHYMOTRYPSIN	Background and aims We developed a bio-artificial liver (BAL) using a radial-flow bioreactor and rescued mini-pig models with lethal acute liver failure (ALF). The point of the rescue is the recovery from hepatic encephalopathy (HE). HE on ALF has sometimes resulted in brain death following brain edema with astrocyte swelling. Several factors, including ammonia and glutamine, have been reported to induce astrocyte swelling and injury. However, many clinicians believe that there are any other factors involved in the development of HE. Therefore, the aim of this study was to identify novel HE-inducible factors, particularly those inducing astrocyte dysfunction. Methods Mini-pig plasma samples were collected at three time points: before the administration of toxins (a-amanitin and LPS), when HE occurred after the administration of toxins, and after treatment with extracorporeal circulation (EC) by the BAL. To identify the causative factors of HE, each plasma sample was subjected to a comparative proteome analysis with two-dimensional gel electrophoresis and mass spectrometry. To assess the direct effects of candidate factors on the astrocyte function and injury, in vitro experiments with human astrocytes were performed. Results Using a proteome analysis, we identified alpha-1 antichymotrypsin (ACT), which was increased in plasma samples from mini-pigs with HE and decreased in those after treatment with EC by BAL. In in vitro experiments with human astrocytes, ACT showed growth-inhibitory and cytotoxic effects on astrocytes. In addition, the expression of water channel protein aquaporin-4, which is induced in injured astrocytes, was increased following ACT treatment. Interestingly, these effects of ACT were additively enhanced by adding argininevasopressin (AVP) and were canceled by adding an AVP receptor antagonist. Conclusions These results suggest that ACT is involved in astrocyte injury and dysfunction in concert with AVP during the development of acute HE.	[Park, Jonghyuk; Masaki, Takahiro; Mezaki, Yoshihiro; Yokoyama, Hiroshi; Nakamura, Mariko; Maehashi, Haruka; Nagatsuma, Keisuke; Matsuura, Tomokazu] Jikei Univ, Sch Med, Dept Lab Med, Minato Ku, Tokyo, Japan; [Fujimi, Takahiko J.] Bunkyo Univ, Fac Hlth & Nutr, Chigasaki, Kanagawa, Japan; [Gouraud, Sabine S.] Ochanomizu Univ, Fac Sci, Dept Biol, Bunkyo Ku, Tokyo, Japan; [Nakagomi, Madoka] Hatano Res Inst, Food & Drug Safety Ctr, Kanagawa, Japan; [Kimura, Naofumi] Jikei Univ, Sch Med, Dept Pharmacol, Minato Ku, Tokyo, Japan	Jikei University; Ochanomizu University; Jikei University	Matsuura, T (corresponding author), Jikei Univ, Sch Med, Dept Lab Med, Minato Ku, Tokyo, Japan.	matsuurat@jikei.ac.jp	Gouraud, Sabine S. S/N-3395-2018	Gouraud, Sabine S. S/0000-0002-4917-0647; Mezaki, Yoshihiro/0000-0003-4914-0541; Fujimi, Takahiko/0000-0003-1768-9695; Yokoyama, Hiroshi/0000-0003-4559-030X	Jikei University Research Fund for Graduate Students; Otsuka Toshimi Scholarship Foundation; Atsumi International Foundation; Japan Agency for Medical Research and Development [17fk0310112h0001]	Jikei University Research Fund for Graduate Students; Otsuka Toshimi Scholarship Foundation(Otsuka Pharmaceutical); Atsumi International Foundation; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by the Jikei University Research Fund for Graduate Students and Otsuka Toshimi Scholarship Foundation and Atsumi International Foundation, and the Research on the Innovative Development and the Practical Application of New Drugs for Hepatitis B (principal investigator: Soichi Kojima;17fk0310112h0001) provided by Japan Agency for Medical Research and Development.	Abraham CR, 2001, NEUROBIOL AGING, V22, P931, DOI 10.1016/S0197-4580(01)00302-5; Aldridge DR, 2015, J CLIN EXP HEPATOL, V5, pS7, DOI 10.1016/j.jceh.2014.06.004; Asai H, 2013, CELL MOL NEUROBIOL, V33, P393, DOI 10.1007/s10571-013-9905-z; Baker C, 2007, FRONT BIOSCI, V12, P2821, DOI 10.2741/2275; Braghin E, 2009, NEUROSCI LETT, V467, P40, DOI 10.1016/j.neulet.2009.09.057; Chung CH, 2003, J HEPATOL, V39, P193, DOI 10.1016/S0168-8278(03)00185-5; Ciecko-Michalska I, 2012, GASTROENT RES PRACT, V2012; Cordoba J, 1998, J HEPATOL, V29, P589, DOI 10.1016/S0168-8278(98)80154-2; Decaux G, 2008, LANCET, V371, P1624, DOI 10.1016/S0140-6736(08)60695-9; Ding T, 2011, INT J ONCOL, V38, P1521, DOI 10.3892/ijo.2011.983; Ferrin G, 2014, LIVER INT, V34, P438, DOI 10.1111/liv.12277; Ianni Manuela, 2010, Immun Ageing, V7 Suppl 1, pS6, DOI 10.1186/1742-4933-7-S1-S6; Iwasa M, 2015, HEPATOL RES, V45, P1155, DOI 10.1111/hepr.12495; Jia SW, 2016, J STROKE CEREBROVASC, V25, P1289, DOI 10.1016/j.jstrokecerebrovasdis.2016.02.002; Kanai H, 2007, ARTIF ORGANS, V31, P148, DOI 10.1111/j.1525-1594.2007.00354.x; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P151, DOI 10.1007/s00701-012-1558-z; Liang FY, 2015, NEUROSCI LETT, V598, P29, DOI 10.1016/j.neulet.2015.05.006; Liu XQ, 2010, NEUROCRIT CARE, V12, P124, DOI 10.1007/s12028-009-9277-x; Marmarou CR, 2014, BRAIN RES, V1581, P89, DOI 10.1016/j.brainres.2014.06.005; Mehta PD, 2001, NEUROSCI LETT, V304, P102, DOI 10.1016/S0304-3940(01)01754-2; Mihara T, 1999, BRAIN RES BULL, V49, P343, DOI 10.1016/S0361-9230(99)00064-7; Montana V, 2014, CURR NEUROPHARMACOL, V12, P324, DOI 10.2174/1570159X12666140903094700; Padmanabhan J, 2006, BRAIN, V129, P3020, DOI 10.1093/brain/awl255; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Rabinstein AA, 2010, CURR TREAT OPTION NE, V12, P129, DOI 10.1007/s11940-010-0062-0; Rao KVR, 2007, METAB BRAIN DIS, V22, P265, DOI 10.1007/s11011-007-9063-4; Rao KVR, 2014, NEUROBIOL DIS, V63, P222, DOI 10.1016/j.nbd.2013.11.018; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Rao KVR, 2010, J NEUROPATH EXP NEUR, V69, P869, DOI 10.1097/NEN.0b013e3181ebe581; Rao KVR, 2003, NEUROREPORT, V14, P2379, DOI 10.1097/01.wnr.0000099610.19426.a6; Rauen K, 2013, J NEUROTRAUM, V30, P1442, DOI 10.1089/neu.2012.2807; Ritchie A, 2004, MOL BRAIN RES, V131, P88, DOI 10.1016/j.molbrainres.2004.08.012; Tan XF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-274; Thumburu KK, 2014, J NEUROCHEM, V128, P617, DOI 10.1111/jnc.12511; Wendon J, 2008, NEUROCRIT CARE, V9, P97, DOI 10.1007/s12028-008-9123-6; Wijdicks EFM, 2016, NEW ENGL J MED, V375, P1660, DOI 10.1056/NEJMra1600561; Yang MH, 2007, ANAL BIOANAL CHEM, V388, P637, DOI 10.1007/s00216-007-1263-6; Yang W, 2012, MOL CELL NEUROSCI, V49, P406, DOI 10.1016/j.mcn.2012.02.002; Yi MH, 2013, CELL MOL NEUROBIOL, V33, P223, DOI 10.1007/s10571-012-9889-0; Yin C, 2017, RES VET SCI, V111, P140, DOI 10.1016/j.rvsc.2017.02.016; Zhang B, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-30; Zhang R, 2014, BRAIN RES, V1583, P23, DOI 10.1016/j.brainres.2014.08.016	42	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189346	10.1371/journal.pone.0189346	http://dx.doi.org/10.1371/journal.pone.0189346			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216295	Green Submitted, gold, Green Published			2022-12-27	WOS:000417337800120
J	Du, HQ; Shi, YH; Li, DF; Fan, WN; Wang, GQ; Wang, CZ				Du, Hongqi; Shi, Yinghua; Li, Defeng; Fan, Wenna; Wang, Guoqiang; Wang, Chengzhang			Screening and identification of key genes regulating fall dormancy in alfalfa leaves	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; UBIQUITIN LIGASE FAMILY; ABSCISIC-ACID; PLANT-GROWTH; CELL-CYCLE; TRANSCRIPTION FACTORS; PHOTOSYSTEM-II; SEED DORMANCY; TIP GROWTH; ARABIDOPSIS	Fall dormancy (FD) determines the adaptation of an alfalfa variety and affects alfalfa production and quality. However, the molecular mechanism underlying FD remains poorly understood. Here, 44 genes regulating FD were identified by comparison of the transcriptomes from leaves of Maverick (fall-dormant alfalfa) and CUF101(non-fall-dormant), during FD and non-FD and were classified them depending on their function. The transcription of IAA-amino acid hydrolase ILR1-like 1, abscisic acid receptor PYL8, and monogalactosyldiacylglycerol synthase-3 in Maverick leaves was regulated by daylength and temperature, and the transcription of the abscisic acid receptor PYL8 was mainly affected by daylength. The changes in the expression of these genes and the abundance of their messenger RNA (mRNA) in Maverick leaves differed from those in CUF101 leaves, as evidenced by the correlation analysis of their mRNA abundance profiles obtained from April to October. The present findings suggested that these genes are involved in regulating FD in alfalfa.	[Du, Hongqi; Shi, Yinghua; Li, Defeng; Wang, Guoqiang; Wang, Chengzhang] Henan Agr Univ, Coll Anim Sci & Vet Med, Henan Key Lab Innovat & Utilizat Grassland Resour, Zhengzhou, Henan, Peoples R China; [Fan, Wenna] Henan Univ Sci & Technol, Sch Anim Sci & Technol, Luoyang, Henan, Peoples R China	Henan Agricultural University; Henan University of Science & Technology	Wang, CZ (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Henan Key Lab Innovat & Utilizat Grassland Resour, Zhengzhou, Henan, Peoples R China.	wangcz@henau.edu.cn		Wang, Chengzhang/0000-0002-2967-5066	Study and demonstration of high efficiency planting technology of alfalfa in Zhongyuan humid region [201403048-6]; China Forage and Grass Research System [CARS-34]; National Natural Science Foundation of China [31172261]	Study and demonstration of high efficiency planting technology of alfalfa in Zhongyuan humid region; China Forage and Grass Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Thanks for support of Study and demonstration of high efficiency planting technology of alfalfa in Zhongyuan humid region (No.201403048-6), China Forage and Grass Research System(No.CARS-34)and The National Natural Science Foundation of China (No.31172261). Hongqi Du designed the experiment, performed most of the research, analyzed the data and drafted the manuscript. Yinghua Shi plays role in drafting and revising the manuscript. Chengzhang Wang designed the experiment, supervised the study, and revised the manuscript.Defeng Li, Wenna Fan,Yanhua Wang and Guoqiang Wang give some helps in the process of study.; Thanks for support of Study and demonstration of high efficiency planting technology of alfalfa in Zhongyuan humid region (No.201403048-6), China Forage and Grass Research System(No.CARS-34) and The National Natural Science Foundation of China (No.31172261). We express our gratitude to Doc. Yanlei Cui and Doc. Xuyan Peng for their help in the revision of the manuscript.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Alves MS, 2011, PLANT SIGNAL BEHAV, V6, P1993, DOI 10.4161/psb.6.12.18268; [Anonymous], 2008, PHYSIOL PLANTARUM, V132, P79; Awai K, 2001, P NATL ACAD SCI USA, V98, P10960, DOI 10.1073/pnas.181331498; Barford D, 2011, PHILOS T R SOC B, V366, P3605, DOI 10.1098/rstb.2011.0069; Barnes DK, 1979, FALL DORMANCY ALFALF; BARTEL B, 1995, SCIENCE, V268, P1745, DOI 10.1126/science.7792599; Beemster GTS, 2003, TRENDS PLANT SCI, V8, P154, DOI 10.1016/S1360-1385(03)00046-3; Brouwer DJ, 2000, CROP SCI, V40, P1387, DOI 10.2135/cropsci2000.4051387x; Canamero RC, 2006, PLANTA, V224, P995, DOI 10.1007/s00425-006-0280-6; Cao Y, 1990, MODIFIED TECHNIQUE M; Chen P, 2013, GENE DEV, V27, P2109, DOI 10.1101/gad.222174.113; Chen XB, 2010, J INTEGR PLANT BIOL, V52, P946, DOI 10.1111/j.1744-7909.2010.00987.x; COX M.M., 2000, LEHNINGER PRINCIPLES, V3th, P306; de Pellegrini LG, 2010, REV BRAS ZOOTECN, V39, P1894, DOI 10.1590/S1516-35982010000900006; Rodriguez-Gacio MD, 2009, PLANT SIGNAL BEHAV, V4, P1035, DOI 10.4161/psb.4.11.9902; Dormann P, 2002, TRENDS PLANT SCI, V7, P112, DOI 10.1016/S1360-1385(01)02216-6; Du HongQi, 2014, Acta Agrestia Sinica, V22, P572; Edwards A, 2007, MOL PLANT MICROBE IN, V20, P1183, DOI 10.1094/MPMI-20-10-1183; Fan WN, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105304, 10.1371/journal.pone.0114612]; Fan WenNa, 2014, Acta Prataculturae Sinica, V23, P177; [樊文娜 Fan Wenna], 2011, [草地学报, Acta Agrestia Sinica], V19, P975; Feller U, 1998, PLANT PHYSIOL, V116, P539, DOI 10.1104/pp.116.2.539; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gray WM, 2004, PLOS BIOL, V2, P1270, DOI 10.1371/journal.pbio.0020311; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Harvey SH, 2002, GENOME BIOL, V3; Hemsley P.A. TL, 2007, P 18 INT C AR RES BE; Hoenicka H, HETEROLOGOUS OVEREXP, P1001; Jarvis P, 2000, P NATL ACAD SCI USA, V97, P8175, DOI 10.1073/pnas.100132197; JIANG CZ, 1994, PLANT J, V5, P787, DOI 10.1046/j.1365-313X.1994.5060787.x; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kallenbach RL, 2001, CROP SCI, V41, P774, DOI 10.2135/cropsci2001.413774x; Kariola T, 2006, PLANT PHYSIOL, V142, P1559, DOI 10.1104/pp.106.086223; Klein J, 1996, MOL GEN GENET, V250, P7, DOI 10.1007/BF02191820; Kobayashi K, 2007, P NATL ACAD SCI USA, V104, P17216, DOI 10.1073/pnas.0704680104; Koh S, 2002, PLANT PHYSIOL, V128, P21, DOI 10.1104/pp.010332; Kotake T, 2007, BIOSCI BIOTECH BIOCH, V71, P761, DOI 10.1271/bbb.60605; Kumar A, 2009, PHOTOSYNTH RES, V100, P143, DOI 10.1007/s11120-009-9438-y; Kurasawa Y, SSENTIAL ROLES KIF4, P3237; Kurek I, 2007, PLANT CELL, V19, P3230, DOI 10.1105/tpc.107.054171; Kwon M, 2004, MOL BIOL CELL, V15, P219, DOI 10.1091/mbc.E03-07-0489; Lally D, ANTISENSE EXPRESSION, P1317; Larry R., CHARACTERIZATION CER; Lensch M, 2001, J BIOL CHEM, V276, P33645, DOI 10.1074/jbc.M100506200; Li ZG, 2009, J EXP BOT, V60, P3521, DOI 10.1093/jxb/erp195; Liscum E, GENETICS AUX IAA ARF, P387; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MAGNUS V, 1992, J PLANT GROWTH REGUL, V11, P67, DOI 10.1007/BF00198017; Manfield IW, 2007, PLANT PHYSIOL, V143, P941, DOI 10.1104/pp.106.090761; MATE CJ, 1993, PLANT PHYSIOL, V102, P1119, DOI 10.1104/pp.102.4.1119; Mate CJ, 1996, PLANTA, V198, P604, DOI 10.1007/BF00262648; Mazumdar M, 2004, J CELL BIOL, V166, P613, DOI 10.1083/jcb.200401142; Merida A, 1999, PLANT PHYSIOL, V120, P401, DOI 10.1104/pp.120.2.401; Millar AA, 2006, PLANT J, V45, P942, DOI 10.1111/j.1365-313X.2006.02659.x; Muschietti J, ABSCISIC ACID ABA RE; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Null R., 2011, COMPUTING, V1, P12; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Portis R, 1990, ACTIVATION OFRIBULOS, V94, P245; Quail P, 1999, GENE DEV, V13, P2017; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; RINNE P, 1994, PHYSIOL PLANTARUM, V90, P451, DOI 10.1111/j.1399-3054.1994.tb08801.x; Riou-Khamlichi C, 2000, MOL CELL BIOL, V20, P4513, DOI 10.1128/MCB.20.13.4513-4521.2000; Ryan E, 1998, NEW PHYTOL, V138, P49, DOI 10.1046/j.1469-8137.1998.00896.x; Saavedra X, 2010, PLANT PHYSIOL, V152, P133, DOI 10.1104/pp.109.146381; SCHIEFELBEIN J, 1993, PLANT PHYSIOL, V103, P979, DOI 10.1104/pp.103.3.979; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Sedbrook JC, 2002, ARABIDOPSIS SKU5 GEN, P1635; SHIH SC, 1967, CROP SCI, V7, P385, DOI 10.2135/cropsci1967.0011183X000700040033x; Shimojima M, 1997, P NATL ACAD SCI USA, V94, P333, DOI 10.1073/pnas.94.1.333; Staswick P, 2009, PLANT SIGNAL BEHAV, V4, P757, DOI 10.1104/pp.109.138529; STITT M, 1994, PLANT CELL ENVIRON, V17, P465, DOI 10.1111/j.1365-3040.1994.tb00144.x; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; STOUT DG, 1989, CAN J PLANT SCI, V69, P491, DOI 10.4141/cjps89-060; Sultan SE, 2010, CURR OPIN PLANT BIOL, V13, P96, DOI 10.1016/j.pbi.2009.09.021; Tang WJ, 2012, PLANT CELL, V24, P1984, DOI 10.1105/tpc.112.097022; Teuber LR, 1998, 3 N AM ALF IMPR C AG, pA; Tysdal HM, 1933, J AGRIC RES, V46, P0483; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Van Aken O, MITOCHONDRIAL TYPE 1, P850; VERNOS I, 1995, CELL, V81, P117, DOI 10.1016/0092-8674(95)90376-3; Wagner TA, 2001, PLANT CELL, V13, P303, DOI 10.1105/tpc.13.2.303; Wang CZ, 2008, J PLANT NUTR, V31, P1257, DOI 10.1080/01904160802135027; Wetzel CM, 2009, J EXP BOT, V60, P1715, DOI 10.1093/jxb/erp051; Williams ME, 2010, PLANT CELL, V22, P1; Wolters H, 2009, NAT REV GENET, V10, P305, DOI 10.1038/nrg2558; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Wu W, 2013, BBA-BIOENERGETICS, V1827, P709, DOI 10.1016/j.bbabio.2013.02.013; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Yoshida Y, GLYCOPROTEIN SPECIFI, P239; Zhang M, 2010, PLANT J, V63, P312, DOI 10.1111/j.1365-313X.2010.04238.x; Zhang SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122170; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102	101	5	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188964	10.1371/journal.pone.0188964	http://dx.doi.org/10.1371/journal.pone.0188964			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211806	Green Published, Green Submitted, gold			2022-12-27	WOS:000417212200053
J	Garland, EL; Hanley, AW; Goldin, PR; Gross, JJ				Garland, Eric L.; Hanley, Adam W.; Goldin, Phillipe R.; Gross, James J.			Testing the mindfulness-to-meaning theory: Evidence for mindful positive emotion regulation from a reanalysis of longitudinal data	PLOS ONE			English	Article							ORIENTED RECOVERY ENHANCEMENT; SELF-REPORT MINDFULNESS; STRESS REDUCTION; CHRONIC PAIN; INDIVIDUAL-DIFFERENCES; COGNITIVE REAPPRAISAL; ATTENTION; MECHANISMS; MEDITATION; RELAPSE	Background and objective The Mindfulness to Meaning Theory (MMT) provides a detailed process model of mindful positive emotion regulation. Design We conducted a post-hoc reanalysis of longitudinal data (N = 107) derived from a RCT of mindfulness-based stress reduction (MBSR) versus cognitive-behavioral therapy (CBT) for social anxiety disorder to model the core constructs of the MMT (attentional control, decentering, broadened awareness, reappraisal, and positive affect) in a multivariate path analysis. Results Findings indicated that increases in attentional control from baseline to post-training predicted increases in decentering by 3 months post-treatment (p<.01) that in turn predicted increases in broadened awareness of interoceptive and exteroceptive data by 6 months post-treatment (p<.001). In turn, broadened awareness predicted increases in the use of reappraisal by 9 months post-treatment (p<.01), which culminated in greater positive affect at 12 months post-treatment (p<.001). MBSR led to significantly greater increases in decentering (p<.05) and broadened awareness than CBT (p<.05). Significant indirect effects indicated that increases in decentering mediated the effect of mindfulness training on broadening awareness, which in turn mediated enhanced reappraisal efficacy. Conclusion Results suggest that the mechanisms of change identified by the MMT form an iterative chain that promotes long-term increases in positive affectivity. Though these mechanisms may reflect common therapeutic factors that cut across mindfulness-based and cognitive-ehavioral interventions, MBSR specifically boosts the MMT cycle by producing significantly greater increases in decentering and broadened awareness than CBT, providing support for the foundational assumption in the MMT that mindfulness training may be a key means of stimulating downstream positive psychological processes.	[Garland, Eric L.; Hanley, Adam W.] Univ Utah, Coll Social Work, Salt Lake City, UT 84112 USA; [Garland, Eric L.; Hanley, Adam W.] Ctr Mindfulness & Integrat Hlth Intervent Dev, Salt Lake City, UT 84112 USA; [Garland, Eric L.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Goldin, Phillipe R.] Univ Calif Davis, Betty Irene Moore Sch Nursing, Sacramento, CA 95817 USA; [Gross, James J.] Stanford Univ, Stanford, CA 94305 USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of California System; University of California Davis; Stanford University	Garland, EL (corresponding author), Univ Utah, Coll Social Work, Salt Lake City, UT 84112 USA.; Garland, EL (corresponding author), Ctr Mindfulness & Integrat Hlth Intervent Dev, Salt Lake City, UT 84112 USA.; Garland, EL (corresponding author), Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	eric.garland@socwk.utah.edu	Gross, James/AAM-4104-2020		NIMH [R01MH076074]; NIDA [R01DA042033]; NCCIH [R61AT009296]	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NCCIH	This research was supported by an NIMH grant R01MH076074, awarded to James J. Gross. Eric L. Garland was supported by NIDA grant R01DA042033 and NCCIH grant R61AT009296 during the preparation of this manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Baer RA, 2008, ASSESSMENT, V15, P329, DOI 10.1177/1073191107313003; Bernstein A, 2015, PERSPECT PSYCHOL SCI, V10, P599, DOI 10.1177/1745691615594577; Brewer JA, 2013, PSYCHOL ADDICT BEHAV, V27, P366, DOI 10.1037/a0028490; Carmody J, 2008, J BEHAV MED, V31, P23, DOI 10.1007/s10865-007-9130-7; Chan MWC, 2011, PSYCHO-ONCOLOGY, V20, P544, DOI 10.1002/pon.1761; Cunningham WA, 2007, SOC COGNITION, V25, P736, DOI 10.1521/soco.2007.25.5.736; Davis KM, 2009, J COGN PSYCHOTHER, V23, P185, DOI 10.1891/0889-8391.23.3.185; Derryberry D, 2002, J ABNORM PSYCHOL, V111, P225, DOI 10.1037//0021-843X.111.2.225; Desbordes G, 2015, MINDFULNESS, V6, P356, DOI 10.1007/s12671-013-0269-8; Di Francesco SA, 2017, MINDFULNESS, P1; Dockray S, 2010, NEUROSCI BIOBEHAV R, V35, P69, DOI 10.1016/j.neubiorev.2010.01.006; Dorjee D, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01788; Feldman G, 2010, BEHAV RES THER, V48, P1002, DOI 10.1016/j.brat.2010.06.006; Finan PH, 2015, CLIN J PAIN, V31, P177, DOI 10.1097/AJP.0000000000000092; Fredrickson BL, 2013, P NATL ACAD SCI USA, V110, P13684, DOI 10.1073/pnas.1305419110; Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238; Fresco DM, 2007, J CONSULT CLIN PSYCH, V75, P447, DOI 10.1037/0022-006X.75.3.447; Fustos J, 2013, SOC COGN AFFECT NEUR, V8, P911, DOI 10.1093/scan/nss089; Garland EL, 2016, PSYCHOONCOLOGY; Garland EL., 2013, MINDFULNESS ORIENTED; Garland E, 2009, EXPLORE-NY, V5, P37, DOI 10.1016/j.explore.2008.10.001; Garland EL, 2017, COGNITIVE THER RES, V41, P381, DOI 10.1007/s10608-016-9768-y; Garland EL, 2016, ANN NY ACAD SCI, V1373, P25, DOI 10.1111/nyas.13034; Garland EL, 2016, BEHAV RES THER, V77, P7, DOI 10.1016/j.brat.2015.11.012; Garland EL, 2015, PSYCHOL INQ, V26, P377, DOI 10.1080/1047840X.2015.1092493; Garland EL, 2015, PSYCHOL INQ, V26, P293, DOI 10.1080/1047840X.2015.1064294; Garland EL, 2014, J CONSULT CLIN PSYCH, V82, P448, DOI 10.1037/a0035798; Garland EL, 2015, MINDFULNESS, V6, P234, DOI 10.1007/s12671-013-0250-6; Garland EL, 2013, PSYCHOTHER PSYCHOSOM, V82, P311, DOI 10.1159/000348868; Garland EL, 2012, COGNITIVE THER RES, V36, P441, DOI 10.1007/s10608-011-9378-7; Garland EL, 2010, CLIN PSYCHOL REV, V30, P849, DOI 10.1016/j.cpr.2010.03.002; Goldin PR, 2016, J CONSULT CLIN PSYCH, V84, P427, DOI 10.1037/ccp0000092; Gotink RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124344; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Greeson J, 2014, WILEY BLACKWELL HANDBOOK OF MINDFULNESS, VOLS I AND II, P533; Gross JJ, 2015, PSYCHOL INQ, V26, P1, DOI 10.1080/1047840X.2014.940781; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Hadash Y, 2017, MINDFULNESS, P1; Hanley AW, 2015, MINDFULNESS, V6, P1095, DOI 10.1007/s12671-014-0360-9; Hanley AW, 2014, PERS INDIV DIFFER, V66, P146, DOI 10.1016/j.paid.2014.03.014; Hayes-Skelton S, 2013, BEHAV COGN PSYCHOTH, V41, P317, DOI 10.1017/S1352465812000902; Heimberg R.G., 2002, COGNITIVE BEHAV GROU; Holzel BK, 2011, PERSPECT PSYCHOL SCI, V6, P537, DOI 10.1177/1745691611419671; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Huston DC, 2011, J APPL COMMUN RES, V39, P406, DOI 10.1080/00909882.2011.608696; Jankowski T, 2014, CONSCIOUS COGN, V28, P64, DOI 10.1016/j.concog.2014.06.005; Jha AP, 2007, COGN AFFECT BEHAV NE, V7, P109, DOI 10.3758/CABN.7.2.109; Jones SM, 2015, MINDFULNESS, V6, P1115, DOI 10.1007/s12671-014-0362-7; Kabat-Zinn J., 1994, WHEREVER YOU GO THER; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Kever A, 2015, PERS INDIV DIFFER, V87, P20, DOI 10.1016/j.paid.2015.07.014; Kiken LG, 2015, PERS INDIV DIFFER, V81, P41, DOI 10.1016/j.paid.2014.12.044; King LA, 2006, J PERS SOC PSYCHOL, V90, P179, DOI 10.1037/0022-3514.90.1.179; Kline R. B., 2005, PRINCIPLES PRACTICE; Labelle LE, 2015, J POSIT PSYCHOL, V10, P153, DOI 10.1080/17439760.2014.927902; Lazarus RS., 1984, STRESS APPRAISAL COP; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; MacLean KA, 2010, PSYCHOL SCI, V21, P829, DOI 10.1177/0956797610371339; Manera V, 2014, EMOTION, V14, P833, DOI 10.1037/a0037350; Mennin DS, 2015, PSYCHOL INQ, V26, P80, DOI 10.1080/1047840X.2015.969624; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Nelson TO, 1999, CLIN PSYCHOL PSYCHOT, V6, P73, DOI 10.1002/(SICI)1099-0879(199905)6:2<73::AID-CPP187>3.0.CO;2-7; O'Leary Sloan M., 2016, MOMENT INVESTIGATING; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Pressman S. D., 2014, POSITIVE EMOTION INT, P183; Pressman SD, 2005, PSYCHOL BULL, V131, P925, DOI 10.1037/0033-2909.131.6.925; Ruocco AC, 2013, PERS INDIV DIFFER, V54, P226, DOI 10.1016/j.paid.2012.08.037; Sauer S., 2010, ASSESSING MINDFULNES, P25; Schmertz SK, 2009, J PSYCHOPATHOL BEHAV, V31, P60, DOI 10.1007/s10862-008-9086-0; Segerstrom SC, 2010, PSYCHOL SCI, V21, P448, DOI 10.1177/0956797610362061; Shapiro SL, 2006, J CLIN PSYCHOL, V62, P373, DOI 10.1002/jclp.20237; Shiota MN, 2012, J PERS SOC PSYCHOL, V103, P416, DOI 10.1037/a0029208; Shoham A, 2017, J CONSULT CLIN PSYCH, V85, P123, DOI 10.1037/ccp0000154; Spears CA, 2017, J CONSULT CLIN PSYCH; Tang YY, 2015, NAT REV NEUROSCI, V16, P213, DOI 10.1038/nrn3916; Teasdale JD, 2002, J CONSULT CLIN PSYCH, V70, P275, DOI 10.1037//0022-006X.70.2.275; Teasdale JD, 1999, CLIN PSYCHOL PSYCHOT, V6, P146, DOI 10.1002/(SICI)1099-0879(199905)6:2<146::AID-CPP195>3.0.CO;2-E; TEASDALE JD, 1995, BEHAV RES THER, V33, P25, DOI 10.1016/0005-7967(94)E0011-7; Teasdale JD, 2011, CONTEMP BUDDHISM, V12, P103, DOI 10.1080/14639947.2011.564826; Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320; Turner JA, 2016, PAIN, V157, P2434, DOI 10.1097/j.pain.0000000000000635; Vago D., 2011, COGNITIVE THER RES, P1; Vago DR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00296; Valentine E.R., 1999, MENTAL HLTH RELIG CU, V2, P59, DOI DOI 10.1080/13674679908406332; van den Hurk PAM, 2010, Q J EXP PSYCHOL, V63, P1168, DOI 10.1080/17470210903249365; Wadlinger HA, 2011, PERS SOC PSYCHOL REV, V15, P75, DOI 10.1177/1088868310365565; Zilioli S, 2015, J PSYCHOSOM RES, V79, P451, DOI 10.1016/j.jpsychores.2015.09.013	88	58	59	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187727	10.1371/journal.pone.0187727	http://dx.doi.org/10.1371/journal.pone.0187727			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211754	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200019
J	Feng, YP; Kim, SC				Feng, Yongpan; Kim, Suk Chan			Hybrid precoding based on matrix-adaptive method for multiuser large-scale antenna arrays	PLOS ONE			English	Article							MIMO SYSTEMS	Massive multiple-input multiple-output (MIMO) is envisioned to offer a considerable improvement in capacity, but it has a high cost and the radio frequency (RF) chain components have a high power consumption at high frequency. To address this problem, a hybrid analog and digital precoding scheme has been studied recently, which restricts the number of RF chains to far less than the number of antenna elements. In this paper, we consider the downlink communication of a massive multiuser multiple-input single-output (MU-MISO) system and propose an iterative hybrid precoding algorithm to approach the capacity performance of the traditional full digital precoding scheme. We aim to attain a large baseband gain by zero-forcing (ZF) digital precoding on the equivalent channel and then minimize the total power to obtain the optimal RF precoder. Simulation results show that the proposed method can approach the performance of the conventional fully digital precoding with a low computational complexity.	[Feng, Yongpan; Kim, Suk Chan] Pusan Natl Univ, Elect Engn Dept, Busan, South Korea	Pusan National University	Kim, SC (corresponding author), Pusan Natl Univ, Elect Engn Dept, Busan, South Korea.	sckim@pusan.ac.kr						Alkhateeb A., 2013, INF THEOR APPL WORKS; Alkhateeb A, 2015, IEEE T WIREL COMMUN, V14, P6481, DOI 10.1109/TWC.2015.2455980; El Ayach O, 2014, IEEE T WIREL COMMUN, V13, P1499, DOI 10.1109/TWC.2014.011714.130846; Gao XY, 2016, IEEE J SEL AREA COMM, V34, P998, DOI 10.1109/JSAC.2016.2549418; Liang L, 2014, IEEE WIREL COMMUN LE, V3, P653, DOI 10.1109/LWC.2014.2363831; Pi ZY, 2011, IEEE COMMUN MAG, V49, P101, DOI 10.1109/MCOM.2011.5783993; Rappaport TS, 2013, IEEE ACCESS, V1, P335, DOI 10.1109/ACCESS.2013.2260813; Sohrabi F, 2016, IEEE J-STSP, V10, P501, DOI 10.1109/JSTSP.2016.2520912; Yong SK, 2007, EURASIP J WIREL COMM, DOI 10.1155/2007/78907	9	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188723	10.1371/journal.pone.0188723	http://dx.doi.org/10.1371/journal.pone.0188723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29206235	gold, Green Submitted, Green Published			2022-12-27	WOS:000417033200012
J	Hietanen, MA; Price, NSC; Cloherty, SL; Hadjidimitrakis, K; Ibbotson, MR				Hietanen, Markus A.; Price, Nicholas S. C.; Cloherty, Shaun L.; Hadjidimitrakis, Kostas; Ibbotson, Michael R.			Long-term sensorimotor adaptation in the ocular following system of primates	PLOS ONE			English	Article							EYE-MOVEMENTS; NEURAL BASIS; VESTIBULOOCULAR REFLEX; RESPONSES; MONKEY; INACTIVATION; DEPENDENCE; TRACKING; VERMIS	The sudden movement of a wide-field image leads to a reflexive eye tracking response referred to as short-latency ocular following. If the image motion occurs soon after a saccade the initial speed of the ocular following is enhanced, a phenomenon known as post-saccadic enhancement. We show in macaque monkeys that repeated exposure to the same stimulus regime over a period of months leads to progressive increases in the initial speeds of ocular following. The improvement in tracking speed occurs for ocular following with and without a prior saccade. As a result of the improvement in ocular following speeds, the influence of post-saccadic enhancement wanes with increasing levels of training. The improvement in ocular following speed following repeated exposure to the same oculomotor task represents a novel form of sensori-motor learning in the context of a reflexive movement.	[Hietanen, Markus A.; Cloherty, Shaun L.; Ibbotson, Michael R.] Australian Coll Optometry, Natl Vis Res Inst, Carlton, Vic, Australia; [Hietanen, Markus A.; Cloherty, Shaun L.; Ibbotson, Michael R.] Univ Melbourne, ARC Ctr Excellence Integrat Brain Funct, Parkville, Vic, Australia; [Hietanen, Markus A.; Price, Nicholas S. C.; Cloherty, Shaun L.; Ibbotson, Michael R.] Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic, Australia; [Price, Nicholas S. C.; Cloherty, Shaun L.; Hadjidimitrakis, Kostas; Ibbotson, Michael R.] Monash Univ, Dept Physiol, Clayton, Vic, Australia; [Hietanen, Markus A.] Swinburne Univ Technol, Dept Fdn & Pathways, Hawthorn, Vic, Australia	University of Melbourne; University of Melbourne; Monash University; Swinburne University of Technology	Ibbotson, MR (corresponding author), Australian Coll Optometry, Natl Vis Res Inst, Carlton, Vic, Australia.; Ibbotson, MR (corresponding author), Univ Melbourne, ARC Ctr Excellence Integrat Brain Funct, Parkville, Vic, Australia.; Ibbotson, MR (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic, Australia.	mibbotson@nvri.org.au	Cloherty, Shaun L./AAH-5029-2019; Hietanen, Markus A/C-5111-2008; ibbotson, michael/F-9030-2011	Cloherty, Shaun L./0000-0002-7679-1764; ibbotson, michael/0000-0002-3803-6653; Price, Nicholas/0000-0001-9404-7704	Australian Research Council through the Centre of Excellence for Integrative Brain Function [CE140100007]; National Health and Medical Research Council of Australia [GNT1028710]; Lions Clubs of Victoria	Australian Research Council through the Centre of Excellence for Integrative Brain Function(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Lions Clubs of Victoria	This work was supported by the Australian Research Council [http://arc.gov.au] through the Centre of Excellence for Integrative Brain Function (CE140100007 to MRI), by the National Health and Medical Research Council of Australia [http://nhmrc.gov.au] (GNT1028710 to MRI) and the Lions Clubs of Victoria [http://lionsclubs.org.au/] to SLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blazquez PM, 2007, J NEUROPHYSIOL, V97, P1114, DOI 10.1152/jn.00983.2006; Blum J, 2014, J VISION, V14, DOI 10.1167/14.3.23; Bourrelly C, 2016, J NEUROPHYSIOL, V116, P2739, DOI 10.1152/jn.00519.2016; Cloherty SL, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00122; Cloherty SL, 2010, VISION RES, V50, P2683, DOI 10.1016/j.visres.2010.08.020; Fukushima K, 1996, NEUROSCI RES, V25, P391; GELLMAN RS, 1990, VISUAL NEUROSCI, V5, P107, DOI 10.1017/S0952523800000158; GRUSSER OJ, 1994, BEHAV BRAIN SCI, V17, P262, DOI 10.1017/S0140525X00034415; Havermann K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039708; Hopp J, 2004, PROG NEUROBIOL, V72, P27, DOI 10.1016/j.pneurobio.2003.12.002; Ibbotson MR, 2008, J NEUROSCI, V28, P10952, DOI 10.1523/JNEUROSCI.3950-08.2008; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Kahlon M, 1996, J NEUROSCI, V16, P7270; Katoh A, 2005, EUR J NEUROSCI, V21, P1315, DOI 10.1111/j.1460-9568.2005.03946.x; KAWANO K, 1986, J NEUROPHYSIOL, V56, P1355, DOI 10.1152/jn.1986.56.5.1355; Kawano K, 1999, CURR OPIN NEUROBIOL, V9, P467, DOI 10.1016/S0959-4388(99)80070-1; Kojima Y, 2011, BRAIN RES, V1401, P30, DOI 10.1016/j.brainres.2011.05.027; Kuki Y, 2004, NEUROREPORT, V15, P1007, DOI 10.1097/00001756-200404290-00015; LISBERGER SG, 1988, TRENDS NEUROSCI, V11, P147, DOI 10.1016/0166-2236(88)90140-3; LISBERGER SG, 1994, J NEUROPHYSIOL, V72, P974, DOI 10.1152/jn.1994.72.2.974; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; MILES FA, 1986, J NEUROPHYSIOL, V56, P1381, DOI 10.1152/jn.1986.56.5.1381; MILES FA, 1986, J NEUROPHYSIOL, V56, P1321, DOI 10.1152/jn.1986.56.5.1321; Ono S, 2007, J NEUROPHYSIOL, V98, P2918, DOI 10.1152/jn.00115.2007; PARTSALIS AM, 1995, J NEUROPHYSIOL, V73, P632, DOI 10.1152/jn.1995.73.2.632; Price NSC, 2010, J NEUROSCI, V30, P14036, DOI 10.1523/JNEUROSCI.2336-10.2010; Robinson FR, 2006, J NEUROPHYSIOL, V96, P1030, DOI 10.1152/jn.01151.2005; Shutoh F, 2002, NEUROSCI RES, V42, P141, DOI 10.1016/S0168-0102(01)00308-X; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; Takagi M, 2000, J NEUROPHYSIOL, V83, P2047, DOI 10.1152/jn.2000.83.4.2047; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wakita R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04273-9; Wurtz RH, 2013, SCHOLARPEDIA, V8, P12335, DOI DOI 10.4249/SCHOLARPEDIA.12335; Yamamoto K, 2002, ANN NY ACAD SCI, V978, P439, DOI 10.1111/j.1749-6632.2002.tb07586.x; Yamamoto K, 2002, J NEUROPHYSIOL, V87, P1554, DOI 10.1152/jn.00166.2001	36	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0189030	10.1371/journal.pone.0189030	http://dx.doi.org/10.1371/journal.pone.0189030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29200430	Green Published, gold			2022-12-27	WOS:000417033200025
J	Sato, J; Kanazawa, A; Hatae, C; Makita, S; Komiya, K; Shimizu, T; Ikeda, F; Tamura, Y; Ogihara, T; Mita, T; Goto, H; Uchida, T; Miyatsuka, T; Ohmura, C; Watanabe, T; Kobayashi, K; Miura, Y; Iwaoka, M; Hirashima, N; Watada, H				Sato, Junko; Kanazawa, Akio; Hatae, Chie; Makita, Sumiko; Komiya, Koji; Shimizu, Tomoaki; Ikeda, Fuki; Tamura, Yoshifumi; Ogihara, Takeshi; Mita, Tomoya; Goto, Hiromasa; Uchida, Toyoyoshi; Miyatsuka, Takeshi; Ohmura, Chie; Watanabe, Takehito; Kobayashi, Kiyoe; Miura, Yoshiko; Iwaoka, Manami; Hirashima, Nao; Watada, Hirotaka			One year follow-up after a randomized controlled trial of a 130 g/day low-carbohydrate diet in patients with type 2 diabetes mellitus and poor glycemic control	PLOS ONE			English	Article							WEIGHT-LOSS DIETS; LOW-FAT DIET; OBESE ADULTS; MEDITERRANEAN DIET; INTERVENTION; OVERWEIGHT; PROTEIN	Background & aims Recently, we conducted a prospective randomized controlled trial (RCT) showing that a 6-month 130g/day low-carbohydrate diet (LCD) reduced HbA1c and BMI more than a calorie restricted diet (CRD). [1] To assess whether the benefits of the LCD persisted after the intensive intervention, we compared HbA1c and BMI between the LCD and CRD groups at 1 year after the end of the 6-month RCT. Methods Following the end of the 6-month RCT, patients were allowed to manage their own diets with periodic outpatient visits. One year later, we analyzed clinical and nutrition data. Results Of the 66 participants in the original study, 27 in the CRD group and 22 in the LCD group completed this trial. One year after the end of the original RCT, the carbohydrate intake was comparable between the groups (215 [189-243]/day in the CRD group and 214 (176-262) g/day in the LCD group). Compared with the baseline data, HbA1c and BMI were decreased in both groups (CRD: HbA1c -0.4 [-0.9 to 0.3] % and BMI -0.63 [-1.20 to 0.18] kg/m(2); LCD: HbA1c -0.35 [-1.0 to 0.35] % and BMI -0.77 [-1.15 to -0.12] kg/m(2)). There were no significant differences in HbA1c and BMI between the groups. Conclusions One year after the diet therapy intervention, the beneficial effect of the LCD on reduction of HbA1c and BMI did not persist in comparison with CRD. However, combining the data of both groups, significant improvements in HbA1c and BMI from baseline were observed. Although the superiority of the LCD disappeared 1 year after the intensive intervention, these data suggest that well-constructed nutrition therapy programs, both CRD and LCD, were equally effective in improving HbA1c for at least 1 year.	[Sato, Junko; Kanazawa, Akio; Komiya, Koji; Shimizu, Tomoaki; Ikeda, Fuki; Tamura, Yoshifumi; Ogihara, Takeshi; Mita, Tomoya; Goto, Hiromasa; Uchida, Toyoyoshi; Miyatsuka, Takeshi; Ohmura, Chie; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Bunkyo Ku, Tokyo, Japan; [Sato, Junko] Juntendo Univ, Shizuoka Hosp, Dept Diabet Endocrinol & Metab, Izunokuni, Shizuoka, Japan; [Kanazawa, Akio; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Ctr Therapeut Innovat Diabet, Bunkyo Ku, Tokyo, Japan; [Hatae, Chie; Makita, Sumiko; Watanabe, Takehito; Kobayashi, Kiyoe; Miura, Yoshiko; Iwaoka, Manami; Hirashima, Nao] Juntendo Univ Hosp, Dept Nutr, Bunkyo Ku, Tokyo, Japan; [Tamura, Yoshifumi; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Sportol Ctr, Bunkyo Ku, Tokyo, Japan; [Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Ctr Identificat Diabet Therapeut Targets, Bunkyo Ku, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University; Juntendo University; Juntendo University	Sato, J (corresponding author), Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Bunkyo Ku, Tokyo, Japan.; Sato, J (corresponding author), Juntendo Univ, Shizuoka Hosp, Dept Diabet Endocrinol & Metab, Izunokuni, Shizuoka, Japan.	jsato@juntendo.ac.jp	Tamura, Yoshifumi/AFK-2430-2022; Sato, Junko/GQQ-8846-2022	Watada, Hirotaka/0000-0001-5961-1816; Tamura, Yoshifumi/0000-0002-1685-7821; Sato, Junko/0000-0002-9784-5362	Mishima Kaiun Memorial Foundation	Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation)	JS received funds from the Mishima Kaiun Memorial Foundation. http://www.mishima-kaiun.or.jp/.	Academies IoMotN, 2005, DIET REF INT EN CARB, P265; Accurso A, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-9; American Diabetes Association, 2017, Diabetes Care, V40, pS33; [Anonymous], 2014, GUIDELINE DIABETES T; [Anonymous], 1994, HDB PSYCHOL DIABETES; Bazzano LA, 2014, ANN INTERN MED, V161, P309, DOI 10.7326/M14-0180; Bloomfield HE, 2016, ANN INTERN MED, V165, P491, DOI 10.7326/M16-0361; Brehm BJ, 2009, DIABETES CARE, V32, P215, DOI 10.2337/dc08-0687; Coppell KJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3337; Davis NJ, 2009, DIABETES CARE, V32, P1147, DOI 10.2337/dc08-2108; de Souza RJ, 2012, AM J CLIN NUTR, V95, P614, DOI 10.3945/ajcn.111.026328; Elhayany A, 2010, DIABETES OBES METAB, V12, P204, DOI 10.1111/j.1463-1326.2009.01151.x; Emadian A, 2015, BRIT J NUTR, V114, P1656, DOI 10.1017/S0007114515003475; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Feinman RD, 2015, NUTRITION, V31, P1, DOI 10.1016/j.nut.2014.06.011; Guldbrand H, 2012, DIABETOLOGIA, V55, P2118, DOI 10.1007/s00125-012-2567-4; Iqbal N, 2010, OBESITY, V18, P1733, DOI 10.1038/oby.2009.460; Johnston BC, 2014, JAMA-J AM MED ASSOC, V312, P923, DOI 10.1001/jama.2014.10397; Kuroda A, 2014, AMOUNT CARBOHYDRATE, V57, P921; Ministry of Health LaW, NAT HLTH NUTR EX SUR; Nanri A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118377; O'Neil CE, 2012, NUTRIENTS, V4, P2097, DOI 10.3390/nu4122097; Ros E, 2003, AM J CLIN NUTR, V78, p617S, DOI 10.1093/ajcn/78.3.617S; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Saslow LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091027; Sato J, 2016, CLIN NUTR; Stern L, 2004, ANN INTERN MED, V140, P778, DOI 10.7326/0003-4819-140-10-200405180-00007; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Wang DD, 2016, JAMA INTERN MED, V176, P1134, DOI 10.1001/jamainternmed.2016.2417; Wolf AM, 2004, DIABETES CARE, V27, P1570, DOI 10.2337/diacare.27.7.1570; Wright Jacqueline D, 2010, NCHS Data Brief, P1; Yamada Y, 2014, INTERNAL MED, V53, P13, DOI [10.2169/internalmedicine.53.0861, 10.2169/interna]; Ziemer DC, 2003, DIABETES CARE, V26, P1719, DOI 10.2337/diacare.26.6.1719	33	13	14	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188892	10.1371/journal.pone.0188892	http://dx.doi.org/10.1371/journal.pone.0188892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29206237	Green Published, gold, Green Submitted			2022-12-27	WOS:000417033200020
J	Hart, H; Lim, L; Mehta, MA; Chatzieffraimidou, A; Curtis, C; Xu, XH; Breen, G; Simmons, A; Mirza, K; Rubia, K				Hart, Heledd; Lim, Lena; Mehta, Mitul A.; Chatzieffraimidou, Antonia; Curtis, Charles; Xu, Xiaohui; Breen, Gerome; Simmons, Andrew; Mirza, Kah; Rubia, Katya			Reduced functional connectivity of fronto-parietal sustained attention networks in severe childhood abuse	PLOS ONE			English	Article							SCHOOL-AGED CHILDREN; SEROTONIN TRANSPORTER POLYMORPHISM; LONG-TERM CONSEQUENCES; SOCIOECONOMIC-STATUS; 5-HTTLPR GENOTYPES; MONOAMINE-OXIDASE; EARLY DEPRIVATION; HEALTH BEHAVIOR; STRESS-DISORDER; MENTAL-HEALTH	Childhood maltreatment is associated with attention deficits. We examined the effect of childhood abuse and abuse-by-gene (5-HTTLPR, MAOA, FKBP5) interaction on functional brain connectivity during sustained attention in medication/drug-free adolescents. Functional connectivity was compared, using generalised psychophysiological interaction (gPPI) analysis of functional magnetic resonance imaging (fMRI) data, between 21 age-and gender-matched adolescents exposed to severe childhood abuse and 27 healthy controls, while they performed a parametrically modulated vigilance task requiring target detection with a progressively increasing load of sustained attention. Behaviourally, participants exposed to childhood abuse had increased omission errors compared to healthy controls. During the most challenging attention condition abused participants relative to controls exhibited reduced connectivity, with a left-hemispheric bias, in typical fronto-parietal attention networks, including dorsolateral, rostromedial and inferior prefrontal and inferior parietal regions. Abuse-related connectivity abnormalities were exacerbated in individuals homozygous for the risky C-allele of the single nucleotide polymorphism rs3800373 of the FK506 Binding Protein 5 (FKBP5) gene. Findings suggest that childhood abuse is associated with decreased functional connectivity in fronto-parietal attention networks and that the FKBP5 genotype moderates neurobiological vulnerability to abuse. These findings represent a first step towards the delineation of abuse-related neurofunctional connectivity abnormalities, which hopefully will facilitate the development of specific treatment strategies for victims of childhood maltreatment.	[Hart, Heledd; Lim, Lena; Chatzieffraimidou, Antonia; Rubia, Katya] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Child & Adolescent Psychiat, London, England; [Mehta, Mitul A.; Simmons, Andrew] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Neuroimaging, London, England; [Curtis, Charles; Xu, Xiaohui; Breen, Gerome] Inst Psychiat Psychol & Neurosci, MRC SGDP Ctr, NIHR BRC Mental Hlth, London, England; [Curtis, Charles; Xu, Xiaohui; Breen, Gerome] SLaM NHS Trust, Kings Coll London, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London	Hart, H (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Child & Adolescent Psychiat, London, England.	heledd.hart@kcl.ac.uk	Simmons, Andrew/B-8848-2008; Breen, Gerome/Y-2706-2019; Breen, Gerome D/A-5540-2010; Rubia, Katya/H-7497-2012	Simmons, Andrew/0000-0003-2306-5811; Breen, Gerome/0000-0003-2053-1792; Breen, Gerome D/0000-0003-2053-1792; Hart, Heledd/0000-0003-3826-9999; Lim, Lena/0000-0002-3301-923X; Rubia, Katya/0000-0002-1410-7701; Curtis, Charles/0000-0002-2992-1941	Kids Company; Reta Lila Weston Trust for Medical Research; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; King's College London; National Medical Research Council (Singapore); NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust	Kids Company; Reta Lila Weston Trust for Medical Research; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust(National Institute for Health Research (NIHR)); King's College London; National Medical Research Council (Singapore)(National Medical Research Council, Singapore); NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust	The research was supported by Kids Company and the Reta Lila Weston Trust for Medical Research to KR. HH was supported by Kids Company, the Reta Lila Weston Trust for Medical Research and the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. LL was supported by the National Medical Research Council (Singapore), Kids Company and the Reta Lila Weston Trust for Medical Research. AS and KR have received support from the NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PT, 1998, CHILD ABUSE NEGLECT, V22, P759, DOI 10.1016/S0145-2134(98)00062-3; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Beers SR, 2002, AM J PSYCHIAT, V159, P483, DOI 10.1176/appi.ajp.159.3.483; Benoit RG, 2011, CEREB CORTEX; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Bevilacqua L, 2012, ARCH GEN PSYCHIAT, V69, P62, DOI 10.1001/archgenpsychiatry.2011.152; BIFULCO A, 1994, J CHILD PSYCHOL PSYC, V35, P1419, DOI 10.1111/j.1469-7610.1994.tb01284.x; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Bucker J, 2012, COMPR PSYCHIAT, V53, P758, DOI 10.1016/j.comppsych.2011.12.006; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Carrion VG, 2008, DEPRESS ANXIETY, V25, P514, DOI 10.1002/da.20346; Chipman P, 2007, AM J MED GENET B, V144B, P561, DOI 10.1002/ajmg.b.30480; Choi J, 2009, BIOL PSYCHIAT, V65, P227, DOI 10.1016/j.biopsych.2008.06.022; Chorbov VM, 2007, AM J MED GENET B, V144B, P830, DOI 10.1002/ajmg.b.30534; Christakou A, 2013, MOL PSYCHIATR, V18, P236, DOI 10.1038/mp.2011.185; Cicchetti D, 2007, DEV PSYCHOPATHOL, V19, P1161, DOI 10.1017/S0954579407000600; Cooke BM, 2014, HORM BEHAV, V65, P416, DOI 10.1016/j.yhbeh.2014.03.004; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024; Currie CE, 1997, HEALTH EDUC RES, V12, P385, DOI 10.1093/her/12.3.385; Dackis MN, 2012, DEV PSYCHOPATHOL, V24, P1237, DOI 10.1017/S0954579412000673; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; De Bellis MD, 2002, BIOL PSYCHIAT, V51, P544, DOI 10.1016/S0006-3223(01)01374-9; De Bellis MD, 2009, J INT NEUROPSYCH SOC, V15, P868, DOI 10.1017/S1355617709990464; Deckert J, 1999, HUM MOL GENET, V8, P621, DOI 10.1093/hmg/8.4.621; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; DePrince AP, 2009, CHILD ABUSE NEGLECT, V33, P353, DOI 10.1016/j.chiabu.2008.08.002; Edwards VJ, 2003, AM J PSYCHIAT, V160, P1453, DOI 10.1176/appi.ajp.160.8.1453; Elton A, 2014, HUM BRAIN MAPP, V35, P1654, DOI 10.1002/hbm.22280; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; Fonzo GA, 2013, PSYCHIAT RES-NEUROIM, V211, P93, DOI 10.1016/j.pscychresns.2012.08.006; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Gould F, 2012, J PSYCHIATR RES, V46, P500, DOI 10.1016/j.jpsychires.2012.01.005; Hanson JL, 2010, J NEUROSCI, V30, P7466, DOI 10.1523/JNEUROSCI.0859-10.2010; Hart H, 2017, PSYCHOL MED IN PRESS; Hart H, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00052; Heim CM, 2013, AM J PSYCHIAT, V170, P616, DOI 10.1176/appi.ajp.2013.12070950; Huang H, 2012, NEUROPSYCHOPHARMACOL, V37, P2693, DOI 10.1038/npp.2012.133; Jedd K, 2015, DEV PSYCHOPATHOL, V27, P1577, DOI 10.1017/S0954579415000954; Kim-Cohen J, 2006, MOL PSYCHIATR, V11, P903, DOI 10.1038/sj.mp.4001851; Langner R., 2013, SUSTAINING ATTENTION; Laucht M, 2009, INT J NEUROPSYCHOPH, V12, P737, DOI 10.1017/S1461145708009875; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; Lim L, 2015, AM J PSYCHIAT, DOI appiajp201514081042; Lim L., 2014, AM J PSYCHIAT; Lim L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165547; Loman MM, 2013, J CHILD PSYCHOL PSYC, V54, P37, DOI 10.1111/j.1469-7610.2012.02602.x; Maheu FS, 2010, COGN AFFECT BEHAV NE, V10, P34, DOI 10.3758/CABN.10.1.34; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Markett S, 2014, HUM BRAIN MAPP, V35, P1700, DOI 10.1002/hbm.22285; Marshall TR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002272; McDermott JM, 2013, PSYCHOSOCIAL DEPRIVA; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Miyake Y, 2004, ACTA NEUROBIOL EXP, V64, P415; Mueller SC, 2010, NEUROPSYCHOLOGIA, V48, P3037, DOI 10.1016/j.neuropsychologia.2010.06.013; Murphy CM, 2014, AM J PSYCHIAT, V171, P1107, DOI 10.1176/appi.ajp.2014.12030352; Nolin P, 2007, CHILD ABUSE NEGLECT, V31, P631, DOI 10.1016/j.chiabu.2006.12.009; Nugent NR, 2011, PSYCHOPHARMACOLOGY, V214, P175, DOI 10.1007/s00213-010-2151-x; Olsson CA, 2005, MOL PSYCHIATR, V10, P868, DOI 10.1038/sj.mp.4001677; Paul Robert, 2008, Neuropsychiatr Dis Treat, V4, P193; Pollak SD, 2010, CHILD DEV, V81, P224, DOI 10.1111/j.1467-8624.2009.01391.x; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Radford L, 2013, CHILD ABUSE NEGLECT, V37, P801, DOI 10.1016/j.chiabu.2013.02.004; Raine A, 2001, AGGRESSIVE BEHAV, V27, P111, DOI 10.1002/ab.4; Roberts S, 2015, DEPRESS ANXIETY, V32, P861, DOI 10.1002/da.22430; Roy A, 2012, J PSYCHIATR RES, V46, P72, DOI 10.1016/j.jpsychires.2011.09.009; Rubia K, 1998, NEUROPSYCHOLOGIA, V36, P1283, DOI 10.1016/S0028-3932(98)00038-4; Rubia K, 2013, EUR CHILD ADOLES PSY, V22, P719, DOI 10.1007/s00787-012-0291-8; Rubia K, 2009, NEUROPHARMACOLOGY, V57, P640, DOI 10.1016/j.neuropharm.2009.08.013; Rubia K, 2009, AM J PSYCHIAT, V166, P83, DOI 10.1176/appi.ajp.2008.08020212; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shapiro K, 2002, CURR BIOL, V12, P1320, DOI 10.1016/S0960-9822(02)01040-0; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Siegel JS, 2014, HUM BRAIN MAPP, V35, P1981, DOI 10.1002/hbm.22307; Smith AB, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00136; Smith AB, 2011, NEUROIMAGE, V56, P1693, DOI 10.1016/j.neuroimage.2011.01.072; Squire RF, 2013, ANNU REV NEUROSCI, V36, P451, DOI 10.1146/annurev-neuro-062111-150439; Surtees PG, 2006, BIOL PSYCHIAT, V59, P224, DOI 10.1016/j.biopsych.2005.07.014; Tana M G, 2010, Comput Intell Neurosci, P329213, DOI 10.1155/2010/329213; Taylor A, 2007, DEV PSYCHOPATHOL, V19, P1029, DOI 10.1017/S095457940700051X; Tomoda A, 2011, NEUROIMAGE, V54, pS280, DOI 10.1016/j.neuroimage.2010.05.027; Trickett PK, 2011, CHILD ABUSE NEGLECT, V35, P876, DOI 10.1016/j.chiabu.2011.08.001; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van der Werff SJA, 2013, PSYCHOL MED, V43, P1825, DOI 10.1017/S0033291712002942; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wechsler D., 2007, WASI 2 WECHSLER ABBR; Weder N, 2009, BIOL PSYCHIAT, V65, P417, DOI 10.1016/j.biopsych.2008.09.013; Zoroglu SS, 2002, NEUROPSYCHOBIOLOGY, V45, P176, DOI 10.1159/000063667	96	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188744	10.1371/journal.pone.0188744	http://dx.doi.org/10.1371/journal.pone.0188744			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190830	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900116
J	Li, XF; Roevros, N; Dehairs, F; Chou, L				Li, Xuefeng; Roevros, Nathalie; Dehairs, Frank; Chou, Lei			Biological responses of the marine diatom Chaetoceros socialis to changing environmental conditions: A laboratory experiment	PLOS ONE			English	Article							OCEAN ACIDIFICATION; DUST DEPOSITION; SOUTHERN-OCEAN; CLIMATE-CHANGE; MINERAL DUST; WORLD OCEAN; NUTRIENT-LIMITATION; COMMUNITY STRUCTURE; ATMOSPHERIC INPUT; NITROGEN-FIXATION	Diatoms constitute a major group of phytoplankton, accounting for similar to 20% of the world's primary production. It has been shown that iron (Fe) can be the limiting factor for phytoplankton growth, in particular, in the HNLC (High Nutrient Low Chlorophyll) regions. Iron plays thus an essential role in governing the marine primary productivity and the efficiency of biological carbon pump. Oceanic systems are undergoing continuous modifications at varying rates and magnitudes as a result of changing climate. The objective of our research is to evaluate how changing environmental conditions (dust deposition, ocean warming and acidification) can affect marine Fe biogeochemistry and diatom growth. Laboratory culture experiments using a marine diatom Chaetoceros socialis were conducted at two temperatures (13 degrees C and 18 degrees C) and under two pCO(2) (carbon dioxide partial pressure) (400 mu atm and 800 mu atm) conditions. The present study clearly highlights the effect of ocean acidification on enhancing the release of Fe upon dust deposition. Our results also confirm that being a potential source of Fe, dust provides in addition a readily utilizable source of macronutrients such as dissolved phosphate (PO4) and silicate (DSi). However, elevated atmospheric CO2 concentrations may also have an adverse impact on diatom growth, causing a decrease in cell size and possible further changes in phytoplankton composition. Meanwhile, ocean warming may lead to the reduction of diatom production and cell size, inducing poleward shifts in the biogeographic distribution of diatoms. The changing climate has thus a significant implication for ocean phytoplankton growth, cell size and primary productivity, phytoplankton distribution and community composition, and carbon (C), nitrogen (N), phosphorus (P), silicon (Si) and Fe biogeochemical cycles in various ways.	[Li, Xuefeng; Roevros, Nathalie; Chou, Lei] Univ Libre Bruxelles, Serv Biogeochim & Modelisat, Syst Terre Oceanog Chim & Geochim Eaux, Brussels, Belgium; [Li, Xuefeng; Dehairs, Frank] Vrije Univ Brussel, Earth Syst Sci & Analyt, Environm & Geochem, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Li, XF (corresponding author), Univ Libre Bruxelles, Serv Biogeochim & Modelisat, Syst Terre Oceanog Chim & Geochim Eaux, Brussels, Belgium.; Li, XF (corresponding author), Vrije Univ Brussel, Earth Syst Sci & Analyt, Environm & Geochem, Brussels, Belgium.	xuefli@ulb.ac.be			F.R.S.-FNRS (Fonds de la Recherche Scientifique) of the Wallonia-Brussels Federation [FC99216]; Universite A Libre de Bruxelles (ULB); Vrije Universiteit Brussel (VUB); F.R.S.-FNRS (Fonds de la Recherche Scientifique) of the Wallonia-Brussels Federation	F.R.S.-FNRS (Fonds de la Recherche Scientifique) of the Wallonia-Brussels Federation(Fonds de la Recherche Scientifique - FNRS); Universite A Libre de Bruxelles (ULB); Vrije Universiteit Brussel (VUB); F.R.S.-FNRS (Fonds de la Recherche Scientifique) of the Wallonia-Brussels Federation(Fonds de la Recherche Scientifique - FNRS)	This work was financed by F.R.S.-FNRS (Fonds de la Recherche Scientifique) of the Wallonia-Brussels Federation to XL (mandate no. FC99216, www.fnrs.be). Additional funding was provided by the Universite Libre de Bruxelles (ULB) and the Vrije Universiteit Brussel (VUB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financed by F.R.S.-FNRS (Fonds de la Recherche Scientifique) of the Wallonia-Brussels Federation and X. Li was a FNRS Aspirant fellow (mandate no. FC99216). Additional funding was provided by the Universite A Libre de Bruxelles (ULB) and the Vrije Universiteit Brussel (VUB). We would like to thank Master students Raphael Mathieu and Harold Ingber from the ULB for their great help with the culture work. Claire Mourgues, David Verstraten and Debany Fonseca-Batista from the VUB assisted in the EA-IRMS analyses. Prof. Alain Bernard (ULB) performed the XRD analyses of the dust samples. Adriana Anzil and Gaelle Speeckaert of Laboratoire d'Ecolgoie des Systemes Aquatiques (ULB) provided the Chaetoceros socialis strain. We are grateful to all the colleagues who were involved in our research from ULB and VUB.	[Anonymous], 2007, CONTRIBUTION WORKING; [Anonymous], 2006, SCOPE; Astrahan P, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00222; Baker AR, 2010, MAR CHEM, V120, P4, DOI 10.1016/j.marchem.2008.09.003; Baker AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024764; Baker AR, 2006, MAR CHEM, V98, P43, DOI 10.1016/j.marchem.2005.06.004; Bates NR, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003759; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bellerby RGJ, 2008, BIOGEOSCIENCES, V5, P1517, DOI 10.5194/bg-5-1517-2008; Bishop JKB, 2002, SCIENCE, V298, P817, DOI 10.1126/science.1074961; Boelen P, 2011, J EXP MAR BIOL ECOL, V406, P38, DOI 10.1016/j.jembe.2011.06.012; Booth BC, 2002, DEEP-SEA RES PT II, V49, P5003, DOI 10.1016/S0967-0645(02)00175-3; Bopp L, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023653; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Boyd PW, 2003, GLOB CHANGE IGBP SER, P157; Breitbarth E, 2010, BIOGEOSCIENCES, V7, P1075, DOI 10.5194/bg-7-1075-2010; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Carbonnel V, 2009, BIOGEOCHEMISTRY, V96, P49, DOI 10.1007/s10533-009-9344-6; Cassar N, 2007, SCIENCE, V317, P1067, DOI 10.1126/science.1144602; Chen KY, 2010, ATMOS OCEAN SCI LETT, V3, P155, DOI 10.1080/16742834.2010.11446858; De Bodt C, 2010, BIOGEOSCIENCES, V7, P1401, DOI 10.5194/bg-7-1401-2010; Degerlund M, 2012, J PLANKTON RES, V34, P416, DOI 10.1093/plankt/fbs004; Degerlund M, 2010, ESTUAR COAST, V33, P242, DOI 10.1007/s12237-009-9167-7; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dore JE, 2009, P NATL ACAD SCI USA, V106, P12235, DOI 10.1073/pnas.0906044106; Du HQ, 2014, SCI TOTAL ENVIRON, V479, P77, DOI 10.1016/j.scitotenv.2014.01.095; Duarte CM, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000140; Duce RA, 1991, GLOBAL BIOGEOCHEM CY, V5, P193, DOI 10.1029/91GB01778; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Field C.B., 2014, CLIMATE CHANGE 2014, DOI [10.1016/j.renene.2009.11.012, DOI 10.1016/J.RENENE.2009.11.012]; Fowler D, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0164; Fu FX, 2008, HARMFUL ALGAE, V7, P76, DOI 10.1016/j.hal.2007.05.006; Fung IY, 2000, GLOBAL BIOGEOCHEM CY, V14, P697, DOI 10.1029/2000GB900001; Gao KS, 2012, MAR ECOL PROG SER, V470, P167, DOI 10.3354/meps10043; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Gonzalez-Davila M, 2010, BIOGEOSCIENCES, V7, P3067, DOI 10.5194/bg-7-3067-2010; GRAN G, 1952, ANALYST, V77, P661, DOI 10.1039/an9527700661; Gruber N, 2011, PHILOS T R SOC A, V369, P1980, DOI 10.1098/rsta.2011.0003; Guieu C, 2010, BIOGEOSCIENCES, V7, P2765, DOI 10.5194/bg-7-2765-2010; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hansen H., 1983, METHODS SEAWATER ANA, P347; Hare CE, 2007, MAR ECOL PROG SER, V352, P9, DOI 10.3354/meps07182; Herut B, 1999, LIMNOL OCEANOGR, V44, P1683, DOI 10.4319/lo.1999.44.7.1683; Hoffmann LJ, 2008, POLAR BIOL, V31, P1067, DOI 10.1007/s00300-008-0448-6; Hoffmann LJ, 2012, MAR ECOL PROG SER, V470, P191, DOI 10.3354/meps10082; Hopkinson BM, PNAS, V108, P3830; Huseby S, 2012, EUR J PHYCOL, V47, P480, DOI 10.1080/09670262.2012.741714; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; King AL, 2015, MAR ECOL PROG SER, V537, P59, DOI 10.3354/meps11458; Krishnamurthy A, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001115; Krishnamurthy A, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003440; Lauder H.S., 1864, T MICROSCOPICAL SOC, V12, P75, DOI [10.1111/j.1365-2818.1864.tb01628.x, DOI 10.1111/J.1365-2818.1864.TB01628.X]; Lekunberri I, 2010, J PLANKTON RES, V32, P381, DOI 10.1093/plankt/fbp137; Lewis E., 1998, ORNLCDIAC105; Liu XW, 2002, MAR CHEM, V77, P43, DOI 10.1016/S0304-4203(01)00074-3; Luo C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002964; Mahowald N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2008GB003240; Mahowald NM, 2009, ANNU REV MAR SCI, V1, P245, DOI 10.1146/annurev.marine.010908.163727; Mahowald NM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017880; Mahowald NM, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002402; Malviya S, 2016, P NATL ACAD SCI USA, V113, pE1516, DOI 10.1073/pnas.1509523113; Markaki Z, 2003, LIMNOL OCEANOGR, V48, P1557, DOI 10.4319/lo.2003.48.4.1557; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Millero FJ, 2009, OCEANOGRAPHY, V22, P72, DOI 10.5670/oceanog.2009.98; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/NGEO1765, 10.1038/ngeo1765]; Moore CM, 2008, LIMNOL OCEANOGR, V53, P291, DOI 10.4319/lo.2008.53.1.0291; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; Moran XAG, 2010, GLOBAL CHANGE BIOL, V16, P1137, DOI 10.1111/j.1365-2486.2009.01960.x; Neff JC, 2008, NAT GEOSCI, V1, P189, DOI 10.1038/ngeo133; Okin GS, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003858; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Poloczanska ES, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00062; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; Raiswell R, 2012, GEOCHEM PERSPECT, V1, P1, DOI 10.7185/geochempersp.1.1; REDFIELD AC, 1958, AM SCI, V46, P205; Ridame C, 2002, LIMNOL OCEANOGR, V47, P856, DOI 10.4319/lo.2002.47.3.0856; Riebesell U, 2004, J OCEANOGR, V60, P719, DOI 10.1007/s10872-004-5764-z; Schlosser C, 2012, LIMNOL OCEANOGR, V57, P684, DOI 10.4319/lo.2012.57.3.0684; Sedwick PN, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001586; Shi DL, 2010, SCIENCE, V327, P676, DOI 10.1126/science.1183517; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; Sullivan RC, 2007, ATMOS CHEM PHYS, V7, P1213, DOI 10.5194/acp-7-1213-2007; Tan SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057656; Tew KS, 2014, HYDROBIOLOGIA, V741, P79, DOI 10.1007/s10750-014-1856-y; Tortell PD, 2002, LIMNOL OCEANOGR, V47, P1012, DOI 10.4319/lo.2002.47.4.1012; Tortell PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032583; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Usher CR, 2003, CHEM REV, V103, P4883, DOI 10.1021/cr020657y; Viollier E, 2000, APPL GEOCHEM, V15, P785, DOI 10.1016/S0883-2927(99)00097-9; Weber T, 2014, P NATL ACAD SCI USA, V111, P8741, DOI 10.1073/pnas.1317193111; Woodward S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023482; Wu Y, 2010, BIOGEOSCIENCES, V7, P2915, DOI 10.5194/bg-7-2915-2010; YENTSCH CS, 1963, DEEP-SEA RES, V10, P221, DOI 10.1016/0011-7471(63)90358-9; Yu HB, 2015, GEOPHYS RES LETT, V42, P1984, DOI 10.1002/2015GL063040; Zhuang GS, 1992, GLOBAL BIOGEOCHEM CY, V6, P161, DOI 10.1029/92GB00756	100	6	6	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188615	10.1371/journal.pone.0188615	http://dx.doi.org/10.1371/journal.pone.0188615			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190826	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900084
J	Rubin, SP; Miller, IM; Foley, MM; Berry, HD; Duda, JJ; Hudson, B; Elder, NE; Beirne, MM; Warrick, JA; McHenry, ML; Stevens, AW; Eidam, EF; Ogston, AS; Gelfenbaum, G; Pedersen, R				Rubin, Stephen P.; Miller, Ian M.; Foley, Melissa M.; Berry, Helen D.; Duda, Jeffrey J.; Hudson, Benjamin; Elder, Nancy E.; Beirne, Matthew M.; Warrick, Jonathan A.; McHenry, Michael L.; Stevens, Andrew W.; Eidam, Emily F.; Ogston, Andrea S.; Gelfenbaum, Guy; Pedersen, Rob			Increased sediment load during a large-scale dam removal changes nearshore subtidal communities	PLOS ONE			English	Article							GREAT-BARRIER-REEF; ELWHA RIVER; KELP FOREST; CENTRAL CALIFORNIA; ORGANIC-MATTER; ROCKY-SHORE; GRAIN-SIZE; OPEN-COAST; FOOD WEBS; WASHINGTON	The coastal marine ecosystem near the Elwha River was altered by a massive sediment influx D over 10 million tonnes D during the staged three-year removal of two hydropower dams. We used time series of bathymetry, substrate grain size, remotely sensed turbidity, scuba dive surveys, and towed video observations collected before and during dam removal to assess responses of the nearshore subtidal community (3 m to 17 m depth). Biological changes were primarily driven by sediment deposition and elevated suspended sediment concentrations. Macroalgae, predominantly kelp and foliose red algae, were abundant before dam removal with combined cover levels greater than 50%. Where persistent sediment deposits formed, macroalgae decreased greatly or were eliminated. In areas lacking deposition, macroalgae cover decreased inversely to suspended sediment concentration, suggesting impacts from light reduction or scour. Densities of most invertebrate and fish taxa decreased in areas with persistent sediment deposition; however, bivalve densities increased where mud deposited over sand, and flatfish and Pacific sand lance densities increased where sand deposited over gravel. In areas without sediment deposition, most invertebrate and fish taxa were unaffected by increased suspended sediment or the loss of algae cover associated with it; however, densities of tubeworms and flatfish, and primary cover of sessile invertebrates increased suggesting benefits of increased particulate matter or relaxed competition with macroalgae for space. As dam removal neared completion, we saw evidence of macroalgal recovery that likely owed to water column clearing, indicating that long-term recovery from dam removal effects may be starting. Our results are relevant to future dam removal projects in coastal areas and more generally to understanding effects of increased sedimentation on nearshore subtidal benthic communities.	[Rubin, Stephen P.; Duda, Jeffrey J.; Elder, Nancy E.] US Geol Survey, Western Fisheries Res Ctr, Seattle, WA USA; [Miller, Ian M.] Washington Sea Grant, Olymp Peninsula Field Off, Port Angeles, WA USA; [Foley, Melissa M.; Warrick, Jonathan A.; Stevens, Andrew W.; Gelfenbaum, Guy] US Geol Survey, Pacific Coastal & Marine Sci Ctr, Santa Cruz, CA USA; [Berry, Helen D.] Washington State Dept Nat Resources, Olympia, WA USA; [Hudson, Benjamin] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA; [Beirne, Matthew M.; McHenry, Michael L.] Lower Elwha Klallam Tribe, Port Angeles, WA USA; [Eidam, Emily F.; Ogston, Andrea S.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Pedersen, Rob] US EPA, Reg 10, Seattle, WA USA; [Foley, Melissa M.] Auckland Council, Res & Evaluat Unit RIMU, Auckland, New Zealand; [Hudson, Benjamin] Zillow, Seattle, WA USA; [Eidam, Emily F.] Univ Oregon, Dept Earth Sci, Eugene, OR 97403 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; United States Environmental Protection Agency; University of Oregon	Rubin, SP (corresponding author), US Geol Survey, Western Fisheries Res Ctr, Seattle, WA USA.	srubin@usgs.gov	Duda, Jeffrey J./A-7132-2009	Duda, Jeffrey J./0000-0001-7431-8634; Miller, Ian/0000-0002-3289-6337; Rubin, Stephen/0000-0003-3054-7173; Eidam, Emily/0000-0002-1906-8692	U.S. Geological Survey's Coastal Habitats in Puget Sound Program; USGS Mendenhall Research Fellowship Program; Coastal and Marine Geology and Ecosystems Mission Areas; U.S. Environmental Protection Agency (EPA)/Puget Sound Partnership Puget Sound Protection and Restoration Tribal Assistance Program (CFDA) [66.121]; Technical Investigations and Implementation Assistance Program (CFDA) [66.123]	U.S. Geological Survey's Coastal Habitats in Puget Sound Program; USGS Mendenhall Research Fellowship Program; Coastal and Marine Geology and Ecosystems Mission Areas; U.S. Environmental Protection Agency (EPA)/Puget Sound Partnership Puget Sound Protection and Restoration Tribal Assistance Program (CFDA); Technical Investigations and Implementation Assistance Program (CFDA)	This work was supported by funding from: U.S. Geological Survey's Coastal Habitats in Puget Sound Program, USGS Mendenhall Research Fellowship Program, and the Coastal and Marine Geology and Ecosystems Mission Areas; the U.S. Environmental Protection Agency (EPA)/Puget Sound Partnership Puget Sound Protection and Restoration Tribal Assistance Program (CFDA#66.121) and the Technical Investigations and Implementation Assistance Program (CFDA#66.123). Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Airoldi L, 1998, ECOLOGY, V79, P2759, DOI 10.1890/0012-9658(1998)079[2759:RODSSA]2.0.CO;2; Airoldi L, 1997, J EXP MAR BIOL ECOL, V215, P269, DOI 10.1016/S0022-0981(96)02770-0; ALEXANDER RR, 1993, PALAIOS, V8, P289, DOI 10.2307/3515151; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anthony KRN, 2000, CORAL REEFS, V19, P59, DOI 10.1007/s003380050227; Arkema KK, 2009, ECOLOGY, V90, P3126, DOI 10.1890/08-1213.1; Balamurugan G., 1991, THE ENVIRONMENTALIST, V11, P281, DOI DOI 10.1007/BF01266561; Balata D, 2007, ECOLOGY, V88, P2455, DOI 10.1890/07-0053.1; Bates D, 2017, LME4 LINEAR MIXED EF; Benedetti-Cecchi L, 2001, MARINE ECOLOGY PROGR, V214; Berry H.D, 2005, USING HIST DATA ESTI; Bizzarro JJ, 2016, FISH B-NOAA, V114, P445, DOI 10.7755/FB.114.4.7; Bracken MES, 2012, MAR ECOL PROG SER, V459, P53, DOI 10.3354/meps09764; BRANCH GM, 1990, T ROY SOC S AFR, V47, P331, DOI 10.1080/00359199009520246; Braun-Blanquet J., 1964, PFLANZENSOZIOLOGIE G, V3; Bukaveckas PA, 2014, J ENVIRON QUAL, V43, P1614, DOI 10.2134/jeq2013.12.0481; Bustamante RH, 1996, J EXP MAR BIOL ECOL, V196, P1, DOI 10.1016/0022-0981(95)00093-3; Carney D, 1999, POLAR BIOL, V22, P38, DOI 10.1007/s003000050388; Carney Laura T., 2006, Algae, V21, P161; Chandan HC, 2017, ADV FINANC ACCOUNT E, P1, DOI 10.4018/978-1-5225-1031-4.ch001; Cochrane GR, 2008, SEA FLOOR MAPPING BE, P320; Connell SD, 2005, MAR ECOL PROG SER, V289, P53, DOI 10.3354/meps289053; Curran C, SUSPENDED SEDIMENT C; DALY MA, 1977, MAR BIOL, V43, P45, DOI 10.1007/BF00392570; DANTONIO CM, 1986, MAR ECOL PROG SER, V27, P263, DOI 10.3354/meps027263; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; DAYTON PK, 1984, ECOL MONOGR, V54, P253, DOI 10.2307/1942498; DEYSHER LE, 1986, MAR BIOL, V93, P17, DOI 10.1007/BF00428650; DUARTE CM, 1995, OPHELIA, V41, P87, DOI 10.1080/00785236.1995.10422039; Duda J.J., 2011, COASTAL HABITATS ELW, P1; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V312, P67, DOI 10.1016/j.jembe.2004.06.005; Eidam EF, 2016, CONT SHELF RES, V116, P136, DOI 10.1016/j.csr.2016.01.009; Eisenlord ME, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0212; Eriksson BK, 2005, OECOLOGIA, V143, P438, DOI 10.1007/s00442-004-1810-1; FARROW GE, 1983, CAN J FISH AQUAT SCI, V40, P273, DOI 10.1139/f83-289; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Figurski JD, 2016, MAR ECOL PROG SER, V552, P19, DOI 10.3354/meps11763; Finlayson D. P., 2005, COMBINED BATHYMETRY; Finlayson DP, 2011, BATHYMETRY ACOUSTIC, P2011; Fjeldstad HP, 2012, RIVER RES APPL, V28, P753, DOI 10.1002/rra.1529; Foley MM, 2017, WATER RESOUR RES, V53, P5229, DOI 10.1002/2017WR020457; Foley MM, 2017, ECOL MONOGR, V87, P552, DOI 10.1002/ecm.1268; Foley MM, 2015, LIMNOL OCEANOGR, V60, P1719, DOI 10.1002/lno.10129; Foley MM, 2017, EPHEMERAL SEAFLOOR S; Fryirs K, 2013, EARTH SURF PROC LAND, V38, P30, DOI 10.1002/esp.3242; Gelfenbaum G, 2009, MODELING SEDIMENT TR; Gelfenbaum G, 2015, GEOMORPHOLOGY, V246, P649, DOI 10.1016/j.geomorph.2015.01.002; GERARD VA, 1988, MAR BIOL, V97, P25, DOI 10.1007/BF00391242; Goff JR, 1997, MAR GEOL, V138, P105, DOI 10.1016/S0025-3227(97)00018-2; Graham MH, 2002, MAR BIOL, V140, P901, DOI 10.1007/s00227-001-0761-x; Graham MH, 2004, ECOSYSTEMS, V7, P341, DOI 10.1007/s10021-003-0245-6; Grant GE, 2015, ENGINEERING GEOLOGY FOR SOCIETY AND TERRITORY, VOL 3: RIVER BASINS, RESERVOIR SEDIMENTATION AND WATER RESOURCES, P31, DOI 10.1007/978-3-319-09054-2_7; Hawkins AJS, 1996, MAR ECOL PROG SER, V131, P179, DOI 10.3354/meps131179; Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111; Hudson B, 2014, CRYOSPHERE, V8, P1161, DOI 10.5194/tc-8-1161-2014; Ibisate A, 2016, EARTH SURF PROC LAND, V41, P2239, DOI 10.1002/esp.4023; Johansson G, 1998, HYDROBIOLOGIA, V385, P121, DOI 10.1023/A:1003405826222; Kirk J.T.O., 2011, LIGHT PHOTOSYNTHESIS; Komar P., 1997, BEACH PROCESSES SEDI; LEWIS JB, 1984, CAN J ZOOL, V62, P2023, DOI 10.1139/z84-296; LITTLER MM, 1984, J EXP MAR BIOL ECOL, V74, P13, DOI 10.1016/0022-0981(84)90035-2; LITTLER MM, 1983, MAR ECOL PROG SER, V11, P129, DOI 10.3354/meps011129; Lohrer AM, 2004, MAR ECOL PROG SER, V273, P121, DOI 10.3354/meps273121; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; LUNING K, 1978, MAR BIOL, V45, P297, DOI 10.1007/BF00391816; LUNING K, 1980, J PHYCOL, V16, P1; Magilligan F, 2017, POLITICS FRESH WATER; Magirl CS, 2015, GEOMORPHOLOGY, V246, P669, DOI 10.1016/j.geomorph.2014.12.032; Major J. J., 2017, GRAVELBED RIVERS PRO, P355; MANN KH, 1973, SCIENCE, V182, P975, DOI 10.1126/science.182.4116.975; MARINe, PAC ROCK INT MON TRE; McCulloch M, 2003, EARTH PLANET SC LETT, V210, P249, DOI 10.1016/S0012-821X(03)00145-6; Miller IM, 2011, MAR GEOL, V282, P201, DOI 10.1016/j.margeo.2011.02.012; NOAA. NOAA Center for Operational Products and Services (CO-OPS), 2016, 9444090 NOAA; Norris JG, 1997, AQUAT BOT, V58, P269, DOI 10.1016/S0304-3770(97)00040-5; Norris JG, 2011, DEFINING FISH USE SU; O'Connor JE, 2015, SCIENCE, V348, P496, DOI 10.1126/science.aaa9204; Page HM, 2008, MAR ECOL PROG SER, V360, P47, DOI 10.3354/meps07382; PETERSON CH, 1985, PALEOBIOLOGY, V11, P139; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; Pizzuto J, 2002, BIOSCIENCE, V52, P683, DOI 10.1641/0006-3568(2002)052[0683:EODROR]2.0.CO;2; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Pulfrich A, 2003, AQUAT CONSERV, V13, P233, DOI 10.1002/aqc.542; Pulfrich A, 2014, ESTUAR COAST SHELF S, V150, P179, DOI 10.1016/j.ecss.2013.10.017; Pulfrich A, 2014, ESTUAR COAST SHELF S, V150, P165, DOI 10.1016/j.ecss.2013.08.002; REED DC, 1984, ECOLOGY, V65, P937, DOI 10.2307/1938066; Reed DC, 2000, ECOLOGY, V81, P2011; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Rosario-Martinez HD, 2015, PHIA POSTHOC INTERAC; Rubin SP, 2011, COASTAL HABITATS ELW, P131; Ryan Bellmore J, 2017, WIRES WATER, V4, DOI 10.1002/wat2.1164; SANTOS R, 1993, MAR ECOL PROG SER, V94, P181, DOI 10.3354/meps094181; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; SCHROETER SC, 1993, ECOL APPL, V3, P331, DOI 10.2307/1941836; Seavey F, 1995, MARINE RESOURCES ELW; Shaffer JA, 2008, NORTHWEST SCI, V82, P48, DOI 10.3955/0029-344X-82.S.I.48; Shaffer JA, 2017, AQUAT SCI, V79, P643, DOI 10.1007/s00027-017-0526-3; Slattery M, 1997, POLAR BIOL, V18, P172, DOI 10.1007/s003000050174; Spalding H, 2003, J PHYCOL, V39, P273, DOI 10.1046/j.1529-8817.2003.02010.x; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Stevens AW, 2014, BATHYMETRY TOPOGRAPH; Stoner AW, 2007, J SEA RES, V57, P137, DOI 10.1016/j.seares.2006.08.005; Storlazzi CD, 2013, CONT SHELF RES, V55, P40, DOI 10.1016/j.csr.2013.01.013; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Team RC, 2017, THE R STATS PACKAGE; Thomson RE, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003925; Thrush SF, 2004, FRONT ECOL ENVIRON, V2, P299, DOI 10.1890/1540-9295(2004)002[0299:MWESIT]2.0.CO;2; Thrush SF, 2003, ECOL APPL, V13, P1433, DOI 10.1890/02-5198; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; VADAS RL, 1988, J PHYCOL, V24, P338; VOGT H, 1991, MAR ECOL PROG SER, V69, P189, DOI 10.3354/meps069189; WADNR, 2015, PUG SOUND SUBM VEG M; Walling DE, 2003, GLOBAL PLANET CHANGE, V39, P111, DOI 10.1016/S0921-8181(03)00020-1; Warrick JA, 2007, BEACH MORPHOLOGY MON, P288; Warrick JA, 2015, GEOMORPHOLOGY, V246, P729, DOI 10.1016/j.geomorph.2015.01.010; Warrick JA, 2011, CONT SHELF RES, V31, P85, DOI 10.1016/j.csr.2010.11.007; Warrick JA, 2009, GEOMORPHOLOGY, V111, P136, DOI 10.1016/j.geomorph.2009.04.012; Witman JD, 2001, MARINE COMMUNITY ECOLOGY, P339; Wood SN, 2017, MGCV MIXED GAM COMPU; Yorke AF, 2012, AQUAT BIOL, V16, P17, DOI 10.3354/ab00419; Young SM, 2014, ENVIRON EARTH SCI, V72, P2301, DOI 10.1007/s12665-014-3139-3	123	18	18	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0187742	10.1371/journal.pone.0187742	http://dx.doi.org/10.1371/journal.pone.0187742			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220368	gold, Green Published			2022-12-27	WOS:000417469900006
J	Dedman, S; Officer, R; Clarke, M; Reid, DG; Brophy, D				Dedman, Simon; Officer, Rick; Clarke, Maurice; Reid, David G.; Brophy, Deirdre			Gbm.auto: A software tool to simplify spatial modelling and Marine Protected Area planning	PLOS ONE			English	Article							MANAGEMENT; JUVENILE; DESIGN; TRENDS	Boosted Regression Trees. Excellent for data-poor spatial management but hard to use Marine resource managers and scientists often advocate spatial approaches to manage data-poor species. Existing spatial prediction and management techniques are either insufficiently robust, struggle with sparse input data, or make suboptimal use of multiple explanatory variables. Boosted Regression Trees feature excellent performance and are well suited to modelling the distribution of data-limited species, but are extremely complicated and time-consuming to learn and use, hindering access for a wide potential user base and therefore limiting uptake and usage. BRTs automated and simplified for accessible general use with rich feature set We have built a software suite in R which integrates pre-existing functions with new tailor-made functions to automate the processing and predictive mapping of species abundance data: by automating and greatly simplifying Boosted Regression Tree spatial modelling, the gbm. auto R package suite makes this powerful statistical modelling technique more accessible to potential users in the ecological and modelling communities. The package and its documentation allow the user to generate maps of predicted abundance, visualise the representativeness of those abundance maps and to plot the relative influence of explanatory variables and their relationship to the response variables. Databases of the processed model objects and a report explaining all the steps taken within the model are also generated. The package includes a previously unavailable Decision Support Tool which combines estimated escapement biomass (the percentage of an exploited population which must be retained each year to conserve it) with the predicted abundance maps to generate maps showing the location and size of habitat that should be protected to conserve the target stocks (candidate MPAs), based on stakeholder priorities, such as the minimisation of fishing effort displacement. Gbm.auto for management in various settings By bridging the gap between advanced statistical methods for species distribution modelling and conservation science, management and policy, these tools can allow improved spatial abundance predictions, and therefore better management, decision-making, and conservation. Although this package was built to support spatial management of a data-limited marine elasmobranch fishery, it should be equally applicable to spatial abundance modelling, area protection, and stakeholder engagement in various scenarios.	[Dedman, Simon; Officer, Rick; Brophy, Deirdre] Galway Mayo Inst Technol, Marine & Freshwater Res Ctr, Galway, Ireland; [Dedman, Simon; Clarke, Maurice; Reid, David G.] Inst Marine, Oranmore, Galway, Ireland	Galway Mayo Institute of Technology; Marine Institute Ireland	Dedman, S (corresponding author), Galway Mayo Inst Technol, Marine & Freshwater Res Ctr, Galway, Ireland.; Dedman, S (corresponding author), Inst Marine, Oranmore, Galway, Ireland.	simondedman@gmail.com	Reid, David/ABC-5916-2021; Dedman, Simon/E-9668-2017	Dedman, Simon/0000-0002-9108-972X; Officer, Rick/0000-0003-4496-1367; Brophy, Deirdre/0000-0003-4111-762X	European Community's Seventh Framework Programme [289257]; Beaufort Marine Research Award; Marine Institute - Marine Research Sub-Programme of the National Development Plan	European Community's Seventh Framework Programme(European Commission); Beaufort Marine Research Award; Marine Institute - Marine Research Sub-Programme of the National Development Plan	Research funding was received from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement MYFISH number 289257. DGR also acknowledges funding from a Beaufort Marine Research Award, carried out under the Sea Change Strategy and the Strategy for Science Technology and Innovation (2006-2013), with the support of the Marine Institute, funded under the Marine Research Sub-Programme of the National Development Plan 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeare SM, 2009, THESIS; Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Barrett NS, 2007, J EXP MAR BIOL ECOL, V345, P141, DOI 10.1016/j.jembe.2007.02.007; CBD (Convention on Biological Diversity), 2012, AICH BIOD TARG; Christie P, 2004, AM FISH S S, V42, P155; Dedman S, 2016, ICES J MAR SCI; Dedman S, 2017, FISHES-BASEL, V2, DOI 10.3390/fishes2030012; Dedman S, 2015, ECOL MODEL, V312, P77, DOI 10.1016/j.ecolmodel.2015.05.010; Delavenne J, 2011, ICES J MAR SCI; Derous S, 2007, OCEANOLOGIA, V49; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; DUAN N, 1983, J AM STAT ASSOC, V78, P605, DOI 10.2307/2288126; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ellis J.R., 2010, UK FISHERIES SKATES; Ellis JR, 2008, ADVANCES IN FISHERIES SCIENCE: 50 YEARS ON FROM BEVERTON AND HOLT, P184, DOI 10.1002/9781444302653.ch9; Froeschke J., 2013, SEDAR34WP12; Froeschke JT, 2011, FISH RES, V111, P131, DOI 10.1016/j.fishres.2011.07.008; Fulton EA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0278; Game ET, 2013, CONSERV BIOL, V27, P480, DOI 10.1111/cobi.12051; Halpern BS, 2003, P ROY SOC B-BIOL SCI, V270, P1871, DOI 10.1098/rspb.2003.2405; ICES WKLIFE, 2012, ICES IMPL RGLIFE ADV; International Council for the Exploration of the SeaWorking Group on Elasmobranch Fishes (ICES WGEF), 2012, REP WORK GROUP EL FI; International Council for the Exploration of the SeaWorking Group on Elasmobranch Fishes (ICES WGEF), 2012, ICES ADV RAYS SKAT S; IUCN, 2015, IUCN RED LIST CAT SU; Johnston G., 2014, SPAWNING NURSERY ARE; Kelleher G., 1999, GUIDELINES MARINE PR; Kendall MS, 2008, OCEAN COAST MANAGE, V51, P815, DOI 10.1016/j.ocecoaman.2008.09.004; Klein CJ, 2013, CONSERV LETT, V6, P324, DOI 10.1111/conl.12005; Klein CJ, 2010, FRONT ECOL ENVIRON, V8, P349, DOI 10.1890/090047; Loos S.A., 2006, THESIS; Musick J.A, 2005, MANAGEMENT TECHNIQUE; Musick JA, 2000, FISHERIES, V25, P9, DOI 10.1577/1548-8446(2000)025<0009:MOSATR>2.0.CO;2; R Development Core Team, 2009, R LANG ENV STAT COMP; Rassweiler A, 2012, P NATL ACAD SCI USA, V109, P11884, DOI 10.1073/pnas.1116193109; Ridgeway G, 2006, GEN BOOSTED MODELS G, P1; Sale PF, 2008, MAR POLLUT BULL, V56, P805, DOI 10.1016/j.marpolbul.2008.04.009; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Stortini CH, 2015, J NAT CONSERV, V23, P45, DOI 10.1016/j.jnc.2014.07.004; Suuronen P, 2010, MAR POLICY, V34, P237, DOI 10.1016/j.marpol.2009.07.001; Teh LCL, 2012, MAR POLICY, V36, P1290, DOI 10.1016/j.marpol.2012.04.010; Tibshirani R., 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; Vincent M. A., 2004, MARINE NATURE CONSER; Walsh JC, 2015, INVENTORY BARRIERS S; Walsh JC, 2013, ORYX, V47, P134, DOI 10.1017/S003060531100161X; Warton DI, 2015, PLANT ECOL, V216, P669, DOI 10.1007/s11258-014-0366-3; Young JC, 2013, BIOL CONSERV, V158, P359, DOI 10.1016/j.biocon.2012.08.018	50	17	18	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188955	10.1371/journal.pone.0188955	http://dx.doi.org/10.1371/journal.pone.0188955			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216310	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800052
J	Guerster, M; Walter, U				Guerster, Markus; Walter, Ulrich			Aerodynamics of a highly irregular body at transonic speeds-Analysis of STRATOS flight data	PLOS ONE			English	Article							ALTITUDE FREE-FALL	In this paper, we analyze the trajectory and body attitude data of Felix Baumgartner's supersonic free fall through the atmosphere on October 14, 2012. As one of us UW) was scientific advisor to the Red Bull Stratos team, the analysis is based on true body data body mass, wetted pressure suit surface area) and actual atmospheric data from weather balloon measurements. We also present a fully developed theoretical analysis and solution of atmospheric free fall. By matching the flight data against this solution, we are able to derive and track the drag coefficient CD from the subsonic to the transonic and supersonic regime, and back again. Although the subsonic drag coefficient is the expected CD = 0.60 +/- 0.05, surprisingly the transonic compressibility drag coefficient is only 19% of the expected value. We provide a plausible explanation for this unexpected result.	[Guerster, Markus; Walter, Ulrich] Tech Univ Munich, Inst Astronaut, Garching, Germany	Technical University of Munich	Guerster, M (corresponding author), Tech Univ Munich, Inst Astronaut, Garching, Germany.	markus.guerster@tum.de						Anderson J.D., 2011, FUNDAMENTALS AERODYN, P357; [Anonymous], 1960, SKY DIVE EDGE SPACE; Benacka J, 2010, AM J PHYS, V78, P616, DOI 10.1119/1.3298375; Colino JM, 2013, EUR J PHYS, V34, P841, DOI 10.1088/0143-0807/34/4/841; Hoerner S. F, 1965, HOERNER FLUID DYNAMI, V2nd; Markoff J., 2014, NY TIMES; Mohazzabi P, 1996, AM J PHYS, V64, P1242, DOI 10.1119/1.18386; Rygalov VY, 2014, 44 INT C ENV SYST 13; Stratos RB, 2013, SUMMARY REPORT FINDI; Vadim R, 2011, 41 INT C ENV SYST	10	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0187798	10.1371/journal.pone.0187798	http://dx.doi.org/10.1371/journal.pone.0187798			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216204	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800012
J	Nilsson, A; Johansson, C; Skarp, A; Kaden, R; Engstrand, L; Rautelin, H				Nilsson, Anna; Johansson, Cecilia; Skarp, Astrid; Kaden, Rene; Engstrand, Lars; Rautelin, Hilpi			Genomic and phenotypic characteristics of Swedish C. jejuni water isolates	PLOS ONE			English	Article							CAMPYLOBACTER-JEJUNI; LOCUS CLASS; SURVIVAL; COLI; BIOFILMS; INVASION; IDENTIFICATION; INTERLEUKIN-8; ORGANIZATION; RESISTANCE	Campylobacter jejuni is the most common cause of bacterial gastroenteritis. Major reservoirs are warm-blooded animals, poultry in particular, but Campylobacter can also be transmitted via water. In this paper, we have taken a closer look at the biology and potential virulence of C. jejuni water isolates. Seven C. jejuni isolates from incoming surface water at water plants in Sweden were characterized with whole genome sequencing and phenotypical testing. Multi locus sequence typing analysis revealed that these isolates belonged to groups known to include both common (ST48CC) and uncommon (ST1275CC, ST683, ST793 and ST8853) human pathogens. Further genomic characterization revealed that these isolates had potential for arsenic resistance (due to presence of arsB gene in all isolates), an anaerobic dimethyl sulfoxide oxidoreductase (in three isolates) and lacked the MarR-type transcriptional regulator gene rrpB (in all but one isolate) earlier shown to be involved in better survival under oxidative and aerobic stress. As putative virulence factors were concerned, there were differences between the water isolates in the presence of genes coding for cytolethal distending toxin (cdtABC), Type VI secretion system and sialylated LOS, as well as in biofilm formation. However, all isolates were motile and could adhere to and invade the human HT-29 colon cancer cell line in vitro and induce IL-8 secretion suggesting potential to infect humans. This is, to the best of our knowledge, the first study where C. jejuni water isolates have been characterized using whole genome sequencing and phenotypical assays. We found differences and shared traits among the isolates but also potential to infect humans.	[Nilsson, Anna; Johansson, Cecilia; Skarp, Astrid; Kaden, Rene; Rautelin, Hilpi] Uppsala Univ, Clin Microbiol, Dept Med Sci, Uppsala, Sweden; [Engstrand, Lars] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Engstrand, Lars] Sci Life Lab, Stockholm, Sweden; [Skarp, Astrid] Rotterdam Univ Appl Sci, Sch Engn & Appl Sci, Biol & Med Lab Res, Rotterdam, Netherlands	Uppsala University; Karolinska Institutet	Rautelin, H (corresponding author), Uppsala Univ, Clin Microbiol, Dept Med Sci, Uppsala, Sweden.	hilpi.rautelin@medsci.uu.se	Nilsson, Anna/AAJ-6974-2020; Nilsson, Anna/M-4660-2019; Johansson, Cecilia/B-4751-2019; Johansson, Cecilia/O-9433-2019; Kaden, Rene/T-8840-2017	Nilsson, Anna/0000-0001-9219-2385; Johansson, Cecilia/0000-0001-5965-2853; Kaden, Rene/0000-0002-2111-9751; Rautelin, Hilpi/0000-0002-9692-8473	Swedish Research Council FORMAS [221-2012-1442]	Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by the Swedish Research Council FORMAS www.formas.se (grant 221-2012-1442) (HR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048394; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Buswell CM, 1998, APPL ENVIRON MICROB, V64, P733; Carter PE, 2009, APPL ENVIRON MICROB, V75, P6038, DOI 10.1128/AEM.01039-09; Chan KF, 2001, APPL ENVIRON MICROB, V67, P4186, DOI 10.1128/AEM.67.9.4186-4191.2001; Chapman HD, 2002, POULTRY SCI, V81, P356, DOI 10.1093/ps/81.3.356; Cools I, 2003, J APPL MICROBIOL, V94, P886, DOI 10.1046/j.1365-2672.2003.01916.x; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Curtis D, 2014, J FOOD SCI, V79, pR1871, DOI 10.1111/1750-3841.12646; de Haan CPA, 2010, APPL ENVIRON MICROB, V76, P5228, DOI 10.1128/AEM.00581-10; Ekseth OK, 2014, BIOINFORMATICS, V30, P734, DOI 10.1093/bioinformatics/btt582; Ellis-Iversen J, 2009, J FOOD PROTECT, V72, P490, DOI 10.4315/0362-028X-72.3.490; Ellstrom P, 2013, INT J MED MICROBIOL, V303, P134, DOI 10.1016/j.ijmm.2013.01.005; Elvers KT, 2002, MICROBIOL-SGM, V148, P1475, DOI 10.1099/00221287-148-5-1475; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; EVEREST PH, 1992, J MED MICROBIOL, V37, P319, DOI 10.1099/00222615-37-5-319; FAUCHERE JL, 1986, INFECT IMMUN, V54, P283, DOI 10.1128/IAI.54.2.283-287.1986; Gonzalez M, 2009, APPL ENVIRON MICROB, V75, P1208, DOI 10.1128/AEM.01879-08; Gripp E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-584; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; Gundogdu O, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02117; Gundogdu O, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00724; Guzman-Herrador B, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.24.21160; Habib I, 2009, APPL ENVIRON MICROB, V75, P4277, DOI 10.1128/AEM.02269-08; Hanninen ML, 2003, APPL ENVIRON MICROB, V69, P1391, DOI 10.1128/AEM.69.3.1391-1396.2003; Hanninen ML, 1998, J VET MED B, V45, P37, DOI 10.1111/j.1439-0450.1998.tb00764.x; HATTON AD, 1994, ANAL CHEM, V66, P4093, DOI 10.1021/ac00094a036; Hickey TE, 1999, INFECT IMMUN, V67, P88, DOI 10.1128/IAI.67.1.88-93.1999; Hickey TE, 2000, INFECT IMMUN, V68, P6535, DOI 10.1128/IAI.68.12.6535-6541.2000; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; JONES DM, 1991, J GEN MICROBIOL, V137, P2477, DOI 10.1099/00221287-137-10-2477; Kapperud G, 2003, AM J EPIDEMIOL, V158, P234, DOI 10.1093/aje/kwg139; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Levesque S, 2008, J CLIN MICROBIOL, V46, P3404, DOI 10.1128/JCM.00042-08; Louwen R, 2008, INFECT IMMUN, V76, P4431, DOI 10.1128/IAI.00321-08; Mortensen NP, 2009, MICROBES INFECT, V11, P988, DOI 10.1016/j.micinf.2009.07.004; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; Parker CT, 2005, J CLIN MICROBIOL, V43, P2771, DOI 10.1128/JCM.43.6.2771-2781.2005; Pascoe B, 2015, ENVIRON MICROBIOL, V17, P4779, DOI 10.1111/1462-2920.13051; Reeser RJ, 2007, APPL ENVIRON MICROB, V73, P1908, DOI 10.1128/AEM.00740-06; Revez J, 2012, EUR J CLIN MICROBIOL, V31, P2203, DOI 10.1007/s10096-012-1556-3; Revez J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026880; Richards VP, 2013, INFECT GENET EVOL, V14, P200, DOI 10.1016/j.meegid.2012.12.010; ROLLINS DM, 1986, APPL ENVIRON MICROB, V52, P531, DOI 10.1128/AEM.52.3.531-538.1986; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Schonberg-Norio D, 2004, EMERG INFECT DIS, V10, P1474, DOI 10.3201/eid1008.030924; Sellars MJ, 2002, J BACTERIOL, V184, P4187, DOI 10.1128/JB.184.15.4187-4196.2002; Shen ZQ, 2014, ANTIMICROB AGENTS CH, V58, P2021, DOI 10.1128/AAC.02137-13; Shen ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058894; Sheppard SK, 2009, INT J FOOD MICROBIOL, V134, P96, DOI 10.1016/j.ijfoodmicro.2009.02.010; Skarp CPA, 2017, INT J MED MICROBIOL, V307, P233, DOI 10.1016/j.ijmm.2017.04.001; Skarp-de Haan CPA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-129; SKIRROW MB, 1991, INT J FOOD MICROBIOL, V12, P9, DOI 10.1016/0168-1605(91)90044-P; SZYMANSKI CM, 1995, INFECT IMMUN, V63, P4295, DOI 10.1128/IAI.63.11.4295-4300.1995; Thomas C, 1999, J APPL MICROBIOL, V85, p168S, DOI 10.1111/j.1365-2672.1998.tb05296.x; Trigui H, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1595-1; Wang LP, 2009, APPL ENVIRON MICROB, V75, P5064, DOI 10.1128/AEM.00149-09	57	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189222	10.1371/journal.pone.0189222	http://dx.doi.org/10.1371/journal.pone.0189222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216271	gold, Green Published, Green Submitted			2022-12-27	WOS:000417337800098
J	Yeh, CC; Fan, YY; Xu, YC; Yang, YL; Simpson, PC; Mann, MJ				Yeh, Che-Chung; Fan, Yanying; Xu, Yanchun; Yang, Yi-Lin; Simpson, Paul C.; Mann, Michael J.			Shift toward greater pathologic post-myocardial infarction remodeling with loss of the adaptive hypertrophic signaling of alpha1 adrenergic receptors in mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ALPHA(1B)-ADRENERGIC RECEPTORS; MYOCARDIAL-INFARCTION; PRESSURE-OVERLOAD; CARDIAC MYOCYTES; BLOOD-PRESSURE; STIMULATION; APOPTOSIS; KNOCKOUT; SURVIVAL	Rationale We have hypothesized that post-infarction cardiac remodeling can be influenced by shifts in the balance between intracellular mediators of "pathologic" and "physiologic" hypertrophy. Although alpha1 adrenergic receptors (alpha1-ARs) mediate pro-adaptive hypertrophy during pressure overload, little is known about their role or downstream mediators after myocardial infarction. Methods We performed loss-of-function experiments via coronary ligation in alpha1A-AR knockout (AKO) mice. Post-myocardial infarction (MI) remodeling was evaluated via echocardiography, quantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis of cardiac fetal gene expression, histologic analysis of myocyte size, post-MI fibrosis and apoptosis, and Western blot analysis of apoptotic regulators. Results Alpha1A-AR knockout paradoxically increased post-MI hypertrophy compared to wild type controls (WT), but also increased ventricular dilatation, fibrosis, apoptosis, and 4-week post-MI mortality (64% in AKO vs. 25% in WT, P = 0.02), suggesting a shift toward greater pathologic hypertrophy in the absence of pro-adaptive alpha1A effects. alpha1A-AR knockout increased phospho-p38 levels in the pre-MI myocardium compared to WT (0.55 +/- 0.16 vs. 0.03 +/- 0.01, P<0.05) but decreased phospho-ERK1/2 post-MI (0.49 +/- 0.35 arbitrary units vs. 1.55 +/- 0.43 in WT, P<0.05). Furthermore, expression of pro-apoptotic factor Bax was increased (1.19 +/- 0.15 vs. 0.78 +/- 0.08, P<0.05) and expression of anti-apoptotic factors Bcl2 was decreased (0.26 +/- 0.01 vs. 0.55 +/- 0.06, P<0.01) compared to WT. Conclusions Alpha1A-AR provides an important counterbalance to pathologic pathways during post-MI remodeling that may be mediated through ERK1/2 signaling; these observations provide support for further development of an alpha1A-AR/ERK-based molecular intervention for this chronic, often fatal disease.	[Yeh, Che-Chung; Fan, Yanying; Xu, Yanchun; Yang, Yi-Lin; Mann, Michael J.] Univ Calif San Francisco, Cardiothorac Translat Res Lab, San Francisco, CA 94143 USA; [Simpson, Paul C.] Vet Affairs Med Ctr, Div Cardiol, San Francisco, CA 94121 USA; [Simpson, Paul C.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Mann, MJ (corresponding author), Univ Calif San Francisco, Cardiothorac Translat Res Lab, San Francisco, CA 94143 USA.	Michael.Mann@ucsf.edu			National Institutes of Health [K08HL079239, R01HL083118, R01HL31113]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031113] Funding Source: NIH RePORTER; Veterans Affairs [I01BX004314] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health grants K08HL079239, R01HL083118, and R01HL31113 to MJM and PCS (https://www.nih.gov/).	Badenhorst D, 2003, HYPERTENSION, V41, P499, DOI 10.1161/01.HYP.0000056601.29613.DD; COHN JN, 1993, CIRCULATION, V87, P1; Du XJ, 2006, CARDIOVASC RES, V71, P735, DOI 10.1016/j.cardiores.2006.06.015; Du XJ, 2004, J MOL CELL CARDIOL, V37, P979, DOI 10.1016/j.yjmcc.2004.07.010; Frantz S, 2007, BRIT J PHARMACOL, V150, P130, DOI 10.1038/sj.bjp.0706963; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Hosoda C, 2005, MOL PHARMACOL, V67, P912, DOI 10.1124/mol.104.007500; Hosoda C, 2007, AM J PHYSIOL-HEART C, V293, pH514, DOI 10.1152/ajpheart.00626.2006; Hu ZW, 1999, J PHARMACOL EXP THER, V290, P28; Huang Y, 2008, AM J PHYSIOL-HEART C, V295, pH699, DOI 10.1152/ajpheart.01204.2007; Huang Y, 2007, CIRCULATION, V115, P763, DOI 10.1161/CIRCULATIONAHA.106.664862; Kajstura J, 1996, LAB INVEST, V74, P86; Ma XL, 1999, CIRCULATION, V99, P1685, DOI 10.1161/01.CIR.99.13.1685; Mani K, 2002, J MOL CELL CARDIOL, V34, P709, DOI 10.1006/jmcc.2002.2042; McCloskey DT, 2003, J MOL CELL CARDIOL, V35, P1207, DOI 10.1016/S0022-2828(03)00227-X; McCloskey DT, 2002, J MOL CELL CARDIOL, V34, P1007, DOI 10.1006/jmcc.2002.2049; Montgomery MD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168409; O'Connell TD, 2006, J CLIN INVEST, V116, P1005, DOI 10.1172/JCI22811; O'Connell TD, 2003, J CLIN INVEST, V111, P1783, DOI 10.1172/JCI200316100; Qin FZ, 2005, BBA-MOL BASIS DIS, V1740, P499, DOI 10.1016/j.bbadis.2004.11.007; Ren J, 2005, J MOL CELL CARDIOL, V38, P617, DOI 10.1016/j.yjmcc.2005.01.012; Rokosh DG, 2002, P NATL ACAD SCI USA, V99, P9474, DOI 10.1073/pnas.132552699; Rorabaugh BR, 2005, CARDIOVASC RES, V65, P436, DOI 10.1016/j.cardiores.2004.10.009; Woo SH, 1999, PFLUG ARCH EUR J PHY, V437, P335, DOI 10.1007/s004240050787; Yeh CC, 2013, J CELL BIOCHEM, V114, P47, DOI 10.1002/jcb.24299; Yeh CC, 2010, J CELL BIOCHEM, V109, P1185, DOI 10.1002/jcb.22498	26	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188471	10.1371/journal.pone.0188471	http://dx.doi.org/10.1371/journal.pone.0188471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216197	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800025
J	Zomorodian, M; Lai, SH; Homayounfar, M; Ibrahim, S; Pender, G				Zomorodian, Mehdi; Lai, Sai Hin; Homayounfar, Mehran; Ibrahim, Shaliza; Pender, Gareth			Development and application of coupled system dynamics and game theory: A dynamic water conflict resolution method	PLOS ONE			English	Article							DECISION-SUPPORT-SYSTEM; RESOURCES MANAGEMENT; RESERVOIR OPERATION; PROGRAMMING MODEL; COOPERATIVE GAMES; RIVER-BASIN; ALLOCATION; DSS; INFORMATION; RELIABILITY	Conflicts over water resources can be highly dynamic and complex due to the various factors which can affect such systems, including economic, engineering, social, hydrologic, environmental and even political, as well as the inherent uncertainty involved in many of these factors. Furthermore, the conflicting behavior, preferences and goals of stakeholders can often make such conflicts even more challenging. While many game models, both cooperative and non-cooperative, have been suggested to deal with problems over utilizing and sharing water resources, most of these are based on a static viewpoint of demand points during optimization procedures. Moreover, such models are usually developed for a single reservoir system, and so are not really suitable for application to an integrated decision support system involving more than one reservoir. This paper outlines a coupled simulation-optimization modeling method based on a combination of system dynamics (SD) and game theory (GT). The method harnesses SD to capture the dynamic behavior of the water system, utilizing feedback loops between the system components in the course of the simulation. In addition, it uses GT concepts, including pure-strategy and mixed-strategy games as well as the Nash Bargaining Solution (NBS) method, to find the optimum allocation decisions over available water in the system. To test the capability of the proposed method to resolve multi-reservoir and multi-objective conflicts, two different deterministic simulation-optimization models with increasing levels of complexity were developed for the Langat River basin in Malaysia. The later is a strategic water catchment that has a range of different stakeholders and managerial bodies, which are however willing to cooperate in order to avoid unmet demand. In our first model, all water users play a dynamic pure-strategy game. The second model then adds in dynamic behaviors to reservoirs to factor in inflow uncertainty and adjust the strategies for the reservoirs using the mixed-strategy game and Markov chain methods. The two models were then evaluated against three performance indices: Reliability, Resilience and Vulnerability (R-R-V). The results showed that, while both models were well capable of dealing with conflict resolution over water resources in the Langat River basin, the second model achieved a substantially improved performance through its ability to deal with dynamicity, complexity and uncertainty in the river system.	[Zomorodian, Mehdi; Lai, Sai Hin; Ibrahim, Shaliza] Univ Malaya, Dept Civil Engn, Fac Engn, Kuala Lumpur, Malaysia; [Homayounfar, Mehran] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL USA; [Pender, Gareth] Heriot Watt Univ, Sch Energy Geosci Infrastruct & Soc, Edinburgh, Midlothian, Scotland	Universiti Malaya; State University System of Florida; University of Florida; Heriot Watt University	Lai, SH (corresponding author), Univ Malaya, Dept Civil Engn, Fac Engn, Kuala Lumpur, Malaysia.	laish@um.edu.my	Ibrahim, Shaliza/A-5854-2010; Lai, Sai Hin/H-3164-2018; Homayounfar, Mehran/AAH-2141-2020; Pender, Gareth/C-2340-2014	Ibrahim, Shaliza/0000-0001-9413-957X; Lai, Sai Hin/0000-0002-7143-4805; Pender, Gareth/0000-0003-2265-8228; Zomorodian, Mehdi/0000-0002-6855-534X	Government of Malaysia; British Council fund [IF004-2015]; University of Malaya fund the project through the BKS Grant [BKS008-2016]	Government of Malaysia; British Council fund; University of Malaya fund the project through the BKS Grant	The Government of Malaysia and British Council fund this project through the Newton-Ungku Omar Fund with Grant No. IF004-2015. University of Malaya fund the project through the BKS Grant No. BKS008-2016.	ANANDALINGAM G, 1991, EUR J OPER RES, V51, P233, DOI 10.1016/0377-2217(91)90253-R; [Anonymous], MANAGING WATER RESOU; Anzaldi G, 2014, PROCEDIA ENGINEER, V89, P1097, DOI 10.1016/j.proeng.2014.11.230; Castelletti A, 2008, APPL MATH COMPUT, V206, P21, DOI 10.1016/j.amc.2007.09.069; Chae S, 2004, MATH SOC SCI, V48, P37, DOI 10.1016/j.mathsocsci.2003.11.002; Chang FJ, 2013, J HYDROL, V507, P124, DOI 10.1016/j.jhydrol.2013.10.027; DINAR A, 1992, THEOR DECIS, V32, P1, DOI 10.1007/BF00133625; Droubi A, 2008, ENVIRON SCI ENG, P199, DOI 10.1007/978-3-540-85047-2_16; DUNN JC, 1989, J OPTIMIZ THEORY APP, V63, P23, DOI 10.1007/BF00940728; DYER JS, 1973, MANAGE SCI B-APPL, V20, P507, DOI 10.1287/mnsc.20.4.507; Fayaed SS, 2013, WATER RESOUR MANAG, V27, P3679, DOI 10.1007/s11269-013-0373-5; Ganji A, 2008, WATER RESOUR MANAG, V22, P51, DOI 10.1007/s11269-006-9143-y; Ganji A, 2007, ADV WATER RESOUR, V30, P528, DOI 10.1016/j.advwatres.2006.04.004; Ganji A, 2007, ADV WATER RESOUR, V30, P157, DOI 10.1016/j.advwatres.2006.03.008; Ghahraman B, 2002, IRRIGATION SCI, V21, P127, DOI 10.1007/s002710100040; Gohari A, 2013, J HYDROL, V491, P23, DOI 10.1016/j.jhydrol.2013.03.021; Han Z, 2005, IEEE T COMMUN, V53, P1366, DOI 10.1109/TCOMM.2005.852826; HARSANYI JC, 1972, MANAGE SCI B-APPL, V18, pP80; HARSANYI JC, 1963, INT ECON REV, V4, P194, DOI 10.2307/2525487; HASHIMOTO T, 1982, WATER RESOUR RES, V18, P14, DOI 10.1029/WR018i001p00014; Homayoun-Far M, 2010, ADV WATER RESOUR, V33, P752, DOI 10.1016/j.advwatres.2010.04.001; Homayounfar M, 2015, WATER RESOUR MANAG, V29, P2599, DOI 10.1007/s11269-015-0959-1; Homayounfar M, 2014, WATER RESOUR MANAG, V28, P3207, DOI 10.1007/s11269-014-0669-0; Homayounfar M, 2011, WATER RESOUR MANAG, V25, P3427, DOI 10.1007/s11269-011-9863-5; Kahil MT, 2016, WATER RESOUR ECON, V13, P60, DOI 10.1016/j.wre.2015.10.001; Karamouz M., 2003, WATER RESOURCES SYST; Kjeldsen TR, 2004, HYDROLOGICAL SCI J, V49; Li YP, 2009, STOCH ENV RES RISK A, V23, P781, DOI 10.1007/s00477-008-0258-y; Li YP, 2006, ADV WATER RESOUR, V29, P776, DOI 10.1016/j.advwatres.2005.07.008; Madani K, 2014, ENVIRON MODELL SOFTW, V51, P240, DOI 10.1016/j.envsoft.2013.09.029; Madani K, 2010, J HYDROL, V381, P225, DOI 10.1016/j.jhydrol.2009.11.045; Maia R, 2009, DESALINATION, V237, P81, DOI 10.1016/j.desal.2007.12.024; Mirchi A, 2012, WATER RESOUR MANAG, V26, P2421, DOI 10.1007/s11269-012-0024-2; Mousavi H, 2000, ADV WATER RESOUR, V23, P613, DOI 10.1016/S0309-1708(99)00053-6; Mousavi SJ, 2004, ADV WATER RESOUR, V27, P1105, DOI 10.1016/j.advwatres.2004.07.007; Nandalal KDW, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002172; Nash J, 1953, ECONOMETRICA, V21, P128, DOI 10.2307/1906951; ORON G, 1991, J WATER RES PL-ASCE, V117, P287, DOI 10.1061/(ASCE)0733-9496(1991)117:3(287); Park Y, 2008, STOCH ENV RES RISK A, V22, P169, DOI 10.1007/s00477-007-0105-6; Pedro-Monzonis M, 2016, J HYDROL, V533, P1, DOI 10.1016/j.jhydrol.2015.11.034; Philpot S, 2016, J ENVIRON MANAGE, V180, P247, DOI 10.1016/j.jenvman.2016.05.027; Qin HP, 2011, ENVIRON MODELL SOFTW, V26, P1502, DOI 10.1016/j.envsoft.2011.07.003; Reny PJ, 1999, ECONOMETRICA, V67, P1029, DOI 10.1111/1468-0262.00069; Salewicz KA, 2004, GLOBAL ENVIRON CHANG, V14, P25, DOI 10.1016/j.gloenvcha.2003.11.007; Sechi GM, 2013, WATER RESOUR MANAG, V27, P1781, DOI 10.1007/s11269-012-0171-5; Simonovic SP, 2009, WATER RESOUR MANAG, V23, P2163; Singh A, 2014, AGR WATER MANAGE, V141, P23, DOI 10.1016/j.agwat.2014.04.003; Soncini-Sessa R, 2003, ENVIRON MODELL SOFTW, V18, P395, DOI 10.1016/S1364-8152(03)00035-5; TEJADAGUIBERT JA, 1993, WATER RESOUR RES, V29, P3969, DOI 10.1029/93WR02277; TEJADAGUIBERT JA, 1995, WATER RESOUR RES, V31, P2571, DOI 10.1029/95WR02172; United Nations Educational Scientific and Cultural Organization (UNESCO), 2014, WAT POST 2015 DEV AG; Videira N, 2017, ENVIRONMENTAL MODELING WITH STAKEHOLDERS: THEORY, METHODS, AND APPLICATIONS, P241, DOI 10.1007/978-3-319-25053-3_12; Weng SQ, 2010, EXPERT SYST APPL, V37, P8242, DOI 10.1016/j.eswa.2010.05.061; YEH WWG, 1985, WATER RESOUR RES, V21, P1797, DOI 10.1029/WR021i012p01797; Zarghami M, 2015, WATER RESOUR MANAG, V29, P4285, DOI 10.1007/s11269-015-1060-5; Zarghami M, 2012, RESOUR CONSERV RECY, V60, P99, DOI 10.1016/j.resconrec.2011.11.008; Zarghami M, 2011, MULTICRITERIA ANALYSIS: APPLICATIONS TO WATER AND ENVIRONMENT MANAGEMENT, P1, DOI 10.1007/978-3-642-17937-2; Zeng Y, 2012, EXPERT SYST APPL, V39, P10091, DOI 10.1016/j.eswa.2012.02.065	58	13	14	5	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188489	10.1371/journal.pone.0188489	http://dx.doi.org/10.1371/journal.pone.0188489			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216200	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800026
J	Ariel, B; Bland, M; Sutherland, A				Ariel, Barak; Bland, Matthew; Sutherland, Alex			'Lowering the threshold of effective deterrence'-Testing the effect of private security agents in public spaces on crime: A randomized controlled trial in a mass transit system	PLOS ONE			English	Article							HOT-SPOTS; ENVIRONMENTAL-DESIGN; ROUTINE ACTIVITIES; VIOLENT CRIME; PREVENTION; POLICE; PATROL; JUSTICE; CITY; SURVEILLANCE	Supplementing local police forces is a burgeoning multibillion-dollar private security industry. Millions of formal surveillance agents in public settings are tasked to act as preventative guardians, as their high visibility presence is hypothesized to create a deterrent threat to potential offenders. Yet, rigorous evidence is lacking. We randomly assigned all train stations in the South West of England that experienced crime into treatment and controls conditions over a six-month period. Treatment consisted of directed patrol by uniformed, unarmed security agents. Hand-held trackers on every agent yielded precise measurements of all patrol time in the stations. Count-based regression models, estimated marginal means and odds-ratios are used to assess the effect of these patrols on crimes reported to the police by victims, as well as new crimes detected by police officers. Outcomes are measured at both specified target locations to which security guards were instructed to attend, as well as at the entire station complexes. Analyses show that 41% more patrol visits and 29% more minutes spent by security agents at treatment compared to control stations led to a significant 16% reduction in victim-generated crimes at the entirety of the stations' complexes, with a 49% increase in police-generated detections at the target locations. The findings illustrate the efficacy of private policing for crime prevention theory.	[Ariel, Barak; Bland, Matthew] Univ Cambridge, Inst Criminol, Sidgwick Ave, Cambridge, England; [Ariel, Barak] Hebrew Univ Jerusalem, Fac Law, Inst Criminol, Jerusalem, Israel; [Sutherland, Alex] Westbrook Ctr, Communities Safety & Justice RAND Europe, Cambridge, England	University of Cambridge; Hebrew University of Jerusalem	Ariel, B (corresponding author), Univ Cambridge, Inst Criminol, Sidgwick Ave, Cambridge, England.; Ariel, B (corresponding author), Hebrew Univ Jerusalem, Fac Law, Inst Criminol, Jerusalem, Israel.	ba285@cam.ac.uk		Ariel, Barak/0000-0002-6912-2546; Sutherland, Alex/0000-0003-0276-9705	Cambridge University [2016-01-28-A10756]	Cambridge University(University of Cambridge)	This work was supported by Cambridge University (Agreement number 2016-01-28-A10756).	Abrahamsen R, 2006, CONFL SECUR DEV, V6, P1, DOI 10.1080/14678800600590595; Apel R., 2014, ENCY CRIMINOLOGY CRI, P998; Apel R, 2013, J QUANT CRIMINOL, V29, P67, DOI 10.1007/s10940-012-9170-1; Ariel B., 2014, U LOND INT CRIM SCI; Ariel B., 2016, J EXPT CRIMINOLOGY, P1; Ariel B, 2016, J EXP CRIMINOL, V12, P277, DOI 10.1007/s11292-016-9260-4; Ariel B, 2015, J QUANT CRIMINOL, V31, P509, DOI 10.1007/s10940-014-9236-3; Ariel B, 2012, CRIMINOLOGY, V50, P27, DOI 10.1111/j.1745-9125.2011.00256.x; Barclay P, 1996, CRIME PREVENTION STU, V6, P133; Bayley D., 2001, NEW STRUCTURE POLICI; Beavon D.J., 1994, CRIME PREVENTION STU; Bennett T., 1984, BURGLARS BURGLARY PR; Berk R, 2010, CRIMINOL PUBLIC POL, V9, P813, DOI 10.1111/j.1745-9133.2010.00673.x; Bottoms A, 2012, OXFORD HDB CRIMINOLO, P450, DOI DOI 10.1093/HE/9780199590278.003.0016; Bottoms A, 2012, J CRIM LAW CRIM, V102, P119; Bowers K, 2014, J QUANT CRIMINOL, V30, P389, DOI 10.1007/s10940-013-9208-z; Braga A. A., 2012, CAMPBELL SYSTEMATIC, V8, P1, DOI [10.4073/csr.2012.8, DOI 10.4073/CSR.2012.8]; Braga AA, 1999, CRIMINOLOGY, V37, P541, DOI 10.1111/j.1745-9125.1999.tb00496.x; Braga AA, 2008, CRIMINOLOGY, V46, P577, DOI 10.1111/j.1745-9125.2008.00124.x; Braga AA, 2014, JUSTICE Q, V31, P633, DOI 10.1080/07418825.2012.673632; Brantingham P., 1995, EUR J CRIM POLICY RE, V13, P5, DOI [10.1007/BF02242925, DOI 10.1007/BF02242925]; BRODEUR JP, 1983, SOC PROBL, V30, P507, DOI 10.1525/sp.1983.30.5.03a00030; Burke R. H., 2004, NCJ206005, P1; Bushway S, 2008, CRIME JUSTICE, V37, P389, DOI 10.1086/524283; Butterworth B., 1999, MATH BRAIN; Campbell G., 1994, JURISTAT, V14; Clarke R. V., 1995, CRIME JUSTICE, V19, P91, DOI 10.1086/449230; Clarke R.V., 1991, SECUR J, V2, P84; Clarke R.V., 1994, CRIME PREVENTION STU, V2, P165; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; COHEN LE, 1979, AM SOCIOL REV, V44, P588, DOI 10.2307/2094589; Cozens PM, 2002, CITIES, V19, P129, DOI 10.1016/S0264-2751(02)00008-2; De Camargo C., 2012, INTERNET J CRIMINOLO, VI, P1, DOI [10.1358/pojo.2009.82.3.485., DOI 10.1358/POJO.2009.82.3.485]; Dehaene Stanislas, 2011, NUMBER SENSE MIND CR, DOI 10.1016/C2010-0-66570-9; Devine J., 1996, MAXIMUM SECURITY CUL; Devos K., 2014, EXTENSION EC DETERRE, P67; Durlauf SN, 2011, CRIMINOL PUBLIC POL, V10, P13, DOI 10.1111/j.1745-9133.2010.00680.x; Eck J.E., 1994, DRUG MARKETS DRUG PL; Eck J.E., 2007, IMAGINATION CRIME PR, V21, P225; Eck J.E., 1995, CRIME PLACE, V4, P13; Ericson R., 1997, POLICING RISK SOC; Felson M., 1995, CRIME PLACE CRIME PR, V4, P53; Felson M., 2016, CRIME EVERYDAY LIFE; Finney A., 2004, VIOLENCE NIGHT TIME, V214; Frogner L, 2013, EUR J CRIM POLICY RE, V19, P333, DOI 10.1007/s10610-013-9197-3; Giddens A., 1991, MODERNITY SELF IDENT; Goddard N., 2014, ANN AM SOC CRIM SAN; GOLDSTEIN H, 1979, CRIME DELINQUENCY, V25, P236, DOI 10.1177/001112877902500207; Greene J. R., 1988, COMMUNITY POLICING R; Groff ER, 2015, CRIMINOLOGY, V53, P23, DOI 10.1111/1745-9125.12055; HANNAN TH, 1982, J LEGAL STUD, V11, P83, DOI 10.1086/467693; Hermer J., 2002, POLICING; Hesseling R., 1994, CRIME PREVENTION STU, V3, P97; Hesseling R. B, 1995, SECUR J, V1, P21; Hollis-Peel ME, 2012, CRIME LAW SOCIAL CH, V58, P1, DOI 10.1007/s10611-012-9366-1; Jacobs Jane, 1961, DEATH LIFE GREAT AM; Jeffery C.R., 1971, CRIME PREVENTION ENV; Jennings W., 2011, J POLICE CRISIS NEGO, V11, P109, DOI DOI 10.1080/15332586.2011.581511; Johnston L., 2000, POLICING BRITAIN RIS; Jones T., 1998, PRIVATE SECURITY PUB; Kajalo S, 2011, J SMALL BUS ENTERP D, V18, P157, DOI 10.1108/14626001111106488; Kelling G.L., 1982, ATLANTIC, V249, P29, DOI DOI 10.4135/9781412959193.n281; Kelling GeorgeL., 1997, FIXING BROKEN WINDOW; Kempa M, 2004, BRIT J CRIMINOL, V44, P562, DOI 10.1093/bjc/azh027; Koper C.S., 1995, JUSTICE Q, V12, P649, DOI [10.1080/07418829500096231, DOI 10.1080/07418829500096231, https://doi.org/10.1080/07418829500096231]; Koper CS, 2014, J CONTEMP CRIM JUST, V30, P123, DOI 10.1177/1043986214525079; Laycock G., 1992, Security Journal, V3, P154; Lipsey M. W., 2001, PRACTICAL METAANALYS, V49; Loader I, 2000, SOC LEGAL STUD, V9, P323, DOI 10.1177/096466390000900301; Lochner L, 2007, AM ECON REV, V97, P444, DOI 10.1257/aer.97.1.444; Loughran TA, 2012, CRIME DELINQUENCY, V58, P3, DOI 10.1177/0011128709345971; Maahs J. R., 1998, J CRIME JUSTICE, V21, P119; Marquand D., 2004, DECLINE PUBLIC HOLLO; Marsden J., 1990, BANK ROBBERY STRATEG; Mayhew P., 1979, CRIME PUBLIC VIEW; McCarthy B, 2002, ANNU REV SOCIOL, V28, P417, DOI 10.1146/annurev.soc.28.110601.140752; McCulloch C. E., 2008, GEN LINEAR MIXED MOD, V2; Mitchell R. J., 2017, CAMBRIDGE J EVIDENCE, P1; MOFFATT RE, 1983, CAN J CRIMINOL, V25, P19; Nagin DS, 2013, CRIME JUSTICE, V42, P199, DOI 10.1086/670398; Newman O, 1973, EKISTICS, V36, P325; Newman O., 1972, DEFENSIBLE SPACE; Noaks Lesley., 2000, POLIC SOC, V10, P143, DOI [10.1080/10439463.2000.9964837, DOI 10.1080/10439463.2000.9964837]; OMalley P, 1997, SOC LEGAL STUD, V6, P363, DOI 10.1177/096466399700600303; Paternoster R, 2010, J CRIM LAW CRIM, V100, P765; Poyner B., 1994, CRIME PREVENTION STU, V3, P127; Pratt T.C., 2006, TAKING STOCK STATUS, P367, DOI [10.4324/9781315130620-14, DOI 10.4324/9781315130620-14]; Ratcliffe JH, 2009, JUSTICE Q, V26, P746, DOI 10.1080/07418820902873852; Reiner R., 1992, MOD LAW REV, P761, DOI DOI 10.1111/J.1468-2230.1992.TB00940.X; Reynald DM, 2009, EUR J CRIMINOL, V6, P25, DOI 10.1177/1477370808098103; Rigakos G.S., 2000, CAN J LAW SOC, V15, P145, DOI [10.1017/S0829320100006220, DOI 10.1017/S0829320100006220]; Rowland R, 2014, POLIC SOC, V24, P265, DOI 10.1080/10439463.2013.784300; Sampson R, 2010, SECUR J, V23, P37, DOI 10.1057/sj.2009.17; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Sampson RJ, 2010, J QUANT CRIMINOL, V26, P489, DOI 10.1007/s10940-010-9117-3; Savas E.S., 2005, PRIVATIZATION CITY S; Sherman LW, 2014, J CONTEMP CRIM JUST, V30, P95, DOI 10.1177/1043986214525082; SHERMAN LW, 1993, J RES CRIME DELINQ, V30, P445, DOI 10.1177/0022427893030004006; SHERMAN LW, 1989, CRIMINOLOGY, V27, P27, DOI 10.1111/j.1745-9125.1989.tb00862.x; Sherman LW., 1995, JUSTICE Q, V12, P625, DOI [DOI 10.1080/07418829500096221, 10.1080/07418829500096221]; Singh AM, 2005, THEOR CRIMINOL, V9, P153, DOI 10.1177/1362480605051638; Sorg E. T., 2016, JUSTICE Q, P1; Tankebe J, 2013, CRIMINOLOGY, V51, P103, DOI 10.1111/j.1745-9125.2012.00291.x; Taylor B, 2011, J EXP CRIMINOL, V7, P149, DOI 10.1007/s11292-010-9120-6; TAYLOR RB, 1985, J ARCHIT PLAN RES, V2, P261; Telep CW, 2014, JUSTICE Q, V31, P165, DOI 10.1080/07418825.2012.710645; Tonry M, 2008, CRIME JUSTICE, V37, P279, DOI 10.1086/524825; Trojanowicz R., 1998, COMMUNITY POLICING G; Wain N., 2014, POLICING; Wakefield A, 2012, SELLING SECURITY PRI; Weisburd D, 2004, CRIMINOLOGY, V42, P283, DOI 10.1111/j.1745-9125.2004.tb00521.x; Weisburd D., 2012, CRIMINOLOGY PLACE ST; Weisburd D, 2017, CRIMINOLOGY, V55, P137, DOI 10.1111/1745-9125.12131; Weisburd D, 2015, J EXP CRIMINOL, V11, P367, DOI 10.1007/s11292-015-9234-y; Weisburd D, 2015, CRIMINOLOGY, V53, P133, DOI 10.1111/1745-9125.12070; Welsh B.C., 2008, CAMPBELL SYST REV, V2008, P13, DOI DOI 10.4073/CSR.2008.13; Welsh BC, 2010, SECUR J, V23, P299, DOI 10.1057/sj.2008.22; Welsh BC, 2009, JUSTICE Q, V26, P716, DOI 10.1080/07418820802506206; Wilson J. M., 2012, PERFORMANCE BASED AP	119	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187392	10.1371/journal.pone.0187392	http://dx.doi.org/10.1371/journal.pone.0187392			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211735	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200016
J	Patrnogic, J; Leclerc, V				Patrnogic, Jelena; Leclerc, Vincent			The serine protease homolog spheroide is involved in sensing of pathogenic Gram-positive bacteria	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; DROSOPHILA TOLL PATHWAY; DORSOVENTRAL POLARITY; PROTEINASE HOMOLOG; HOST-DEFENSE; ACTIVATION; VIRULENCE; IMMUNITY; GENES; MELANOGASTER	In Drosophila, recognition of pathogens such as Gram-positive bacteria and fungi triggers the activation of proteolytic cascades and the subsequent activation of the Toll pathway. This response can be achieved by either detection of pathogen associated molecular patterns or by sensing microbial proteolytic activities ("danger signals"). Previous data suggested that certain serine protease homologs (serine protease folds that lack an active catalytic triad) could be involved in the pathway. We generated a null mutant of the serine protease homolog spheroide (sphe). These mutant flies are susceptible to Enterococcus faecalis infection and unable to fully activate the Toll pathway. Sphe is required to activate the Toll pathway after challenge with pathogenic Gram-Positive bacteria. Sphe functions in the danger signal pathway, downstream or at the level of Persephone.	[Patrnogic, Jelena; Leclerc, Vincent] Univ Strasbourg, Inst Biol Mol & Cellulaire, CNRS, UPR9022, Strasbourg, France; [Patrnogic, Jelena] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; George Washington University	Leclerc, V (corresponding author), Univ Strasbourg, Inst Biol Mol & Cellulaire, CNRS, UPR9022, Strasbourg, France.	v.leclerc@unistra.fr	Patrnogić, Jelena/AAV-3993-2021		European Research Council [ERC-2009-AdG_20090506]; Fondation pour la Recherche Medicale [FDT20130928085]	European Research Council(European Research Council (ERC)European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This research was supported by the European Research Council grant ERC-2009-AdG_20090506 and Fondation pour la Recherche Medicale grant FDT20130928085 (J.P).	BRAND AH, 1993, DEVELOPMENT, V118, P401; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; Cho YS, 2012, CURR BIOL, V22, P1013, DOI 10.1016/j.cub.2012.03.065; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; El Chamy L, 2008, NAT IMMUNOL, V9, P1165, DOI 10.1038/ni.1643; Felfoldi G, 2011, J IMMUNOL, V186, P4828, DOI 10.4049/jimmunol.1003246; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; HOGG PJ, 1991, J BIOL CHEM, V266, P10953; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kawabata S, 1996, FEBS LETT, V398, P146, DOI 10.1016/S0014-5793(96)01224-0; Kwon TH, 2000, EUR J BIOCHEM, V267, P6188, DOI 10.1046/j.1432-1327.2000.01695.x; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; LETSOU A, 1991, P NATL ACAD SCI USA, V88, P810, DOI 10.1073/pnas.88.3.810; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; MURUGASUOEI B, 1995, GENE DEV, V9, P139, DOI 10.1101/gad.9.2.139; Povelones M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003623; Qin X, 2000, INFECT IMMUN, V68, P2579, DOI 10.1128/IAI.68.5.2579-2586.2000; Qin X, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-135; Qureshi SH, 2014, BBA-PROTEINS PROTEOM, V1844, P1631, DOI 10.1016/j.bbapap.2014.06.011; Reichhart J-M, 2011, DROSOPHILA SERPINS M; Ross J, 2003, GENE, V304, P117, DOI 10.1016/S0378-1119(02)01187-3; Sifri CD, 2002, INFECT IMMUN, V70, P5647, DOI 10.1128/IAI.70.10.5647-5650.2002	28	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188339	10.1371/journal.pone.0188339	http://dx.doi.org/10.1371/journal.pone.0188339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211760	Green Published, Green Submitted, gold			2022-12-27	WOS:000417212200027
J	Campbell, RD; Rosell, F; Newman, C; Macdonald, DW				Campbell, Ruairidh D.; Rosell, Frank; Newman, Chris; Macdonald, David W.			Age-related changes in somatic condition and reproduction in the Eurasian beaver: Resource history influences onset of reproductive senescence	PLOS ONE			English	Article							CASTOR-FIBER; BODY-MASS; OLDER MOTHERS; EVOLUTION; SUCCESS; COSTS; POPULATIONS; PERFORMANCE; ALLOCATION; RESTRAINT	Using 15 years of data from a stable population of wild Eurasian beavers (Castor fiber), we examine how annual and lifetime access to food resources affect individual age-related changes in reproduction and somatic condition. We found an age-related decline in annual maternal reproductive output, after a peak at age 5-6. Rainfall, an established negative proxy of annual resource availability for beavers, was consistently associated with lower reproductive output for females of all ages. In contrast, breeding territory quality, as a measure of local resource history over reproductive lifetimes, caused differences in individual patterns of reproductive senescence; animals from lower quality territories senesced when younger. Litter size was unrelated to maternal age, although adult body weight increased with age. In terms of resource effects, in poorer years but not in better years, older mothers produced larger offspring than did younger mothers, giving support to the constraint theory. Overall, our findings exemplify state-dependent life-history strategies, supporting an effect of resources on reproductive senescence, where cumulative differences in resource access, and not just reproductive strategy, mediate long-term reproductive trade-offs, consistent with the disposable soma and reproductive restraint theories. We propose that flexible life-history schedules could play a role in the dynamics of populations exhibiting reproductive skew, with earlier breeding opportunities leading to an earlier senescence schedule through resource dependent mechanisms.	[Campbell, Ruairidh D.; Rosell, Frank] Univ Coll Southeast Norway, Dept Nat Sci & Environm Hlth, Bo I Telemark, Norway; [Campbell, Ruairidh D.; Newman, Chris; Macdonald, David W.] Univ Oxford, Zool Dept, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Tubney, England; [Campbell, Ruairidh D.] Scottish Nat Heritage, Great Glen House, Inverness, Scotland	University College of Southeast Norway; University of Oxford	Rosell, F (corresponding author), Univ Coll Southeast Norway, Dept Nat Sci & Environm Hlth, Bo I Telemark, Norway.	frank.rosell@usn.no			University College of Southeast Norway; Peoples Trust for Endangered Species	University College of Southeast Norway; Peoples Trust for Endangered Species	This study was financially supported by a University College of Southeast Norway grant to RDC and FR and through a grant from the Peoples Trust for Endangered Species to DWM, also supporting CN.	ABRAMS PA, 1993, EVOLUTION, V47, P877, DOI 10.1111/j.1558-5646.1993.tb01241.x; Barton K., 2012, MUMIN MULTI MODEL IN; Bates D, LME4 LINEAR MIXED EF; Beirne C, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1086; Berube CH, 1999, ECOLOGY, V80, P2555, DOI 10.1890/0012-9658(1999)080[2555:IDLARS]2.0.CO;2; BOGGS CL, 1992, FUNCT ECOL, V6, P508, DOI 10.2307/2390047; Bowen WD, 2006, J ANIM ECOL, V75, P1340, DOI 10.1111/j.1365-2656.2006.01157.x; Broussard DR, 2003, J ANIM ECOL, V72, P212, DOI 10.1046/j.1365-2656.2003.00691.x; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Campbell R.D., 2010, THESIS; Campbell RD, 2005, BEHAV ECOL SOCIOBIOL, V58, P597, DOI 10.1007/s00265-005-0942-6; Campbell RD, 2013, GLOBAL CHANGE BIOL, V19, P1311, DOI 10.1111/gcb.12114; Campbell RD, 2012, GLOBAL CHANGE BIOL, V18, P2730, DOI 10.1111/j.1365-2486.2012.02739.x; Charmantier A, 2014, QUANTITATIVE GENETICS IN THE WILD, P68; Clutton-Brock T.H., 1988, REPROD SUCCESS STUDI; Clutton-Brock TH, 1998, TRENDS ECOL EVOL, V13, P288, DOI 10.1016/S0169-5347(98)01402-5; Crawford JC, 2008, J MAMMAL, V89, P575, DOI 10.1644/07-MAMM-A-251R1.1; CURIO E, 1983, IBIS, V125, P400, DOI 10.1111/j.1474-919X.1983.tb03130.x; de Magalhaes JP, 2002, EXP GERONTOL, V37, P769, DOI 10.1016/S0531-5565(02)00008-6; Dugdale HL, 2011, MOL ECOL, V20, P3261, DOI 10.1111/j.1365-294X.2011.05167.x; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Green WCH, 1990, BEHAV ECOL, V1, P148, DOI 10.1093/beheco/1.2.148; GUSTAFSSON L, 1990, NATURE, V347, P279, DOI 10.1038/347279a0; Hall ME, 2004, P ROY SOC B-BIOL SCI, V271, P1571, DOI 10.1098/rspb.2004.2768; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hartman G, 1997, CAN J ZOOL, V75, P959, DOI 10.1139/z97-116; Hayflick L, 1994, HOW AND WHY WE AGE; Hayward AD, 2015, EXP GERONTOL, V71, P56, DOI 10.1016/j.exger.2015.08.003; Isaac JL, 2005, BIOL LETTERS, V1, P271, DOI 10.1098/rsbl.2005.0326; Jones OR, 2008, ECOL LETT, V11, P664, DOI 10.1111/j.1461-0248.2008.01187.x; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lemaitre JF, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0209; Marshall DJ, 2010, ECOLOGY, V91, P2862, DOI 10.1890/09-0156.1; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; McNamara JM, 2009, P ROY SOC B-BIOL SCI, V276, P4061, DOI 10.1098/rspb.2009.0959; Medawar P., 1952, UNSOLVED PROBLEM BIO; Merila J, 2000, AM NAT, V155, P301, DOI 10.1086/303330; Mysterud A, 2001, P ROY SOC B-BIOL SCI, V268, P911, DOI 10.1098/rspb.2001.1585; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; NOL E, 1987, J ANIM ECOL, V56, P301, DOI 10.2307/4816; NOLET BA, 1994, CAN J ZOOL, V72, P1227, DOI 10.1139/z94-164; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Nussey DH, 2006, ECOL LETT, V9, P1342, DOI 10.1111/j.1461-0248.2006.00989.x; Nussey DH, 2013, AGEING RES REV, V12, P214, DOI 10.1016/j.arr.2012.07.004; Nussey DH, 2011, ECOLOGY, V92, P1936, DOI 10.1890/11-0308.1; Parker H, 2001, WILDLIFE BIOL, V7, P237, DOI 10.2981/wlb.2001.015; Penteriani V, 2009, OIKOS, V118, P321, DOI 10.1111/j.1600-0706.2008.17190.x; Pinheiro J., 2011, R PACKAGE VERSION, V3, P1; R Development Core Team, 2011, R FDN STAT COMP; Reed TE, 2008, AM NAT, V171, pE89, DOI 10.1086/524957; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; Ricklefs RE, 1998, AM NAT, V152, P24, DOI 10.1086/286147; Rosell F, 1999, WILDLIFE BIOL, V5, P119, DOI 10.2981/wlb.1999.015; Rosell F, 2001, WILDLIFE SOC B, V29, P269; Rosell F., 1999, BEVER; Schwarze D, BEAVER NATURAL HIST; Speakman JR, 2010, INTEGR COMP BIOL, V50, P793, DOI 10.1093/icb/icq049; SVENDSEN GE, 1989, CAN J ZOOL, V67, P336, DOI 10.1139/z89-049; Tafani M, 2013, OECOLOGIA, V172, P427, DOI 10.1007/s00442-012-2499-1; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; WILBUR HM, 1974, AM NAT, V108, P805, DOI 10.1086/282956; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilsson L, 1971, VILTREVY, V8, P115	67	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0187484	10.1371/journal.pone.0187484	http://dx.doi.org/10.1371/journal.pone.0187484			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206840	Green Published, gold, Green Submitted			2022-12-27	WOS:000417110700004
J	Contreras, GA; Strieder-Barboza, C; de Souza, J; Gandy, J; Mavangira, V; Lock, AL; Sordillo, LM				Contreras, G. Andres; Strieder-Barboza, Clarissa; de Souza, Jonas; Gandy, Jeff; Mavangira, Vengai; Lock, Adam L.; Sordillo, Lorraine M.			Periparturient lipolysis and oxylipid biosynthesis in bovine adipose tissues	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; HORMONE-SENSITIVE LIPASE; TRANSITION DAIRY-COWS; ADIPOCYTE LIPOLYSIS; LIPID MOBILIZATION; METABOLIC STRESS; LINOLEIC-ACID; PLASMA; INFLAMMATION; MACROPHAGES	The periparturient period of dairy cows is characterized by intense lipolysis in adipose tissues (AT), which induces the release of free fatty acids (FFA) into circulation. Among FFA, polyunsaturated fatty acids are susceptible to oxidation and can modulate inflammatory responses during lipolysis within AT. Linoleic and arachidonic acid oxidized products (oxylipids) such as hydroxy-octadecadienoic acids (HODE) and hydroxy-eicosatetraenoic acids (HETE), were recently identified as products of lipolysis that could modulate AT inflammation during lipolysis. However, the effect of lipolysis intensity during the transition from gestation to lactation on fatty acid substrate availability and subsequent AT oxylipid biosynthesis is currently unknown. We hypothesized that in periparturient dairy cows, alterations in AT and plasma fatty acids and oxylipid profiles coincide with changes in lipolysis intensity and stage of lactation. Blood and subcutaneous AT samples were collected from periparturient cows at -27 +/- 7 (G1) and -10 +/- 5 (G2) d prepartum and at 8 +/- 3 d postpartum (PP). Targeted lipidomic analysis was performed on plasma and AT using HPLC-MS/MS. We report that FFA concentrations increased as parturition approached and were highest at PP. Cows exhibiting high lipolysis rate at PP (FFA> 1.0 mEq/L) had higher body condition scores at G1 compared to cows with low lipolysis rate (FFA<1.0 mEq/L). Concentrations of plasma linoleic and arachidonic acids were increased at PP. In AT, 13-HODE, and 5-, 11- and 15-HETE were increased at PP compared to G1 and G2. Concentrations of beta hydroxybutyrate were positively correlated with those of 13-HODE and 15-HETE in AT. Plasma concentrations of 5- and 20-HETE were increased at PP. These data demonstrate that prepartum adiposity predisposes cows to intense lipolysis post-partum and may exacerbate AT inflammation because of increased production of pro-inflammatory oxylipids including 5-and 15-HETE and 13-HODE. These results support a role for certain linoleic and arachidonic acid-derived oxylipids as positive and negative modulators of AT inflammation during periparturient lipolysis.	[Contreras, G. Andres; Strieder-Barboza, Clarissa; Gandy, Jeff; Mavangira, Vengai; Sordillo, Lorraine M.] Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA; [de Souza, Jonas; Lock, Adam L.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Contreras, GA (corresponding author), Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA.	contre28@msu.edu	Strieder-Barboza, Clarissa/N-7006-2013; Strieder-Barboza, Clarissa/AAD-8089-2021; Contreras, Andres/I-8282-2019; mavangira, vengai/AAN-4454-2020; Lock, Adam/HCH-4180-2022	Strieder-Barboza, Clarissa/0000-0001-8824-4023; Contreras, Andres/0000-0003-4969-2178; mavangira, vengai/0000-0002-6491-8676; Sordillo, Lorraine/0000-0001-8873-3134	USDA-National Institute of Food and Agriculture (Washington, DC) [2014-68004-21972, 2015-67015-23207]; Department of Large Animal Clinical Sciences (East Lansing, MI) research funds; Office of the Associate Dean for Research and Graduate Studies of the College of Veterinary Medicine (East Lansing, MI) research funds; Michigan Alliance for Animal Agriculture (East Lansing, MI) [AA16-023]	USDA-National Institute of Food and Agriculture (Washington, DC); Department of Large Animal Clinical Sciences (East Lansing, MI) research funds; Office of the Associate Dean for Research and Graduate Studies of the College of Veterinary Medicine (East Lansing, MI) research funds; Michigan Alliance for Animal Agriculture (East Lansing, MI)	This project was supported in part by USDA-National Institute of Food and Agriculture (Washington, DC) grants 2014-68004-21972 to LMS and 2015-67015-23207 to GAC, Department of Large Animal Clinical Sciences (East Lansing, MI) research funds to GAC, Office of the Associate Dean for Research and Graduate Studies of the College of Veterinary Medicine (East Lansing, MI) research funds to GAC and LMS, and the Michigan Alliance for Animal Agriculture grant. AA16-023 (East Lansing, MI) to GAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported in part by USDA-National Institute of Food and Agriculture (Washington, DC) grants 2014-68004-21972 and 2015-67015-23207, Department of Large Animal Clinical Sciences (East Lansing, MI), Office of the Associate Dean for Research and Graduate Studies of the College of Veterinary Medicine (East Lansing, MI), and the Michigan Alliance for Animal Agriculture (East Lansing, MI).	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Aitken SL, 2009, J DAIRY SCI, V92, P589, DOI 10.3168/jds.2008-1551; Balvers MGJ, 2012, INT IMMUNOPHARMACOL, V13, P204, DOI 10.1016/j.intimp.2012.03.022; Barquissau V, 2017, BIOCHIMIE, V136, P3, DOI 10.1016/j.biochi.2016.12.012; Bionaz M, 2013, PPAR RES, V2013, DOI 10.1155/2013/684159; Bradford BJ, 2015, J DAIRY SCI, V98, P6631, DOI 10.3168/jds.2015-9683; Casado-Diaz A, 2013, GENES NUTR, V9, P375; Chatterjee M, 2013, MOL CARCINOGEN, V52, P359, DOI 10.1002/mc.21858; Contreras GA, 2010, J DAIRY SCI, V93, P2508, DOI 10.3168/jds.2009-2876; Contreras GA, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0174-4; Contreras GA, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12993; Contreras GA, 2016, J DAIRY SCI, V99, P10009, DOI 10.3168/jds.2016-11552; Contreras GA, 2015, J DAIRY SCI, V98, P6176, DOI 10.3168/jds.2015-9370; De Koster J, 2016, J DAIRY SCI, V99, P2319, DOI 10.3168/jds.2015-10440; Douglas GN, 2007, J DAIRY SCI, V90, P2941, DOI 10.3168/jds.2006-225; ENGELS F, 1986, FEBS LETT, V209, P249, DOI 10.1016/0014-5793(86)81121-8; Farney JK, 2013, AM J PHYSIOL-REG I, V305, pR110, DOI 10.1152/ajpregu.00152.2013; Fruhbeck G, 2014, NUTR RES REV, V27, P63, DOI 10.1017/S095442241400002X; Gandra JR, 2016, J DAIRY SCI, V99, P4590, DOI 10.3168/jds.2015-9974; Garcia-Alonso V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153751; Gartung A, 2016, J BIOL CHEM, V291, P16001, DOI 10.1074/jbc.M116.725937; Giordano S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044610; Girousse A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001485; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hu XQ, 2016, J LIPID RES, V57, P663, DOI 10.1194/jlr.M066530; Iyer A, 2012, DIABETES, V61, P2320, DOI 10.2337/db11-1179; Johansson SM, 2007, ACTA PHYSIOL, V190, P87, DOI 10.1111/j.1365-201X.2007.01692.x; Kabara E, 2014, COMP IMMUNOL MICROB, V37, P49, DOI 10.1016/j.cimid.2013.10.007; Koltes DA, 2011, J DAIRY SCI, V94, P1839, DOI 10.3168/jds.2010-3769; Konkel A, 2011, BBA-PROTEINS PROTEOM, V1814, P210, DOI 10.1016/j.bbapap.2010.09.009; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Kuhn MJ, 2017, J AGR FOOD CHEM, V65, P4980, DOI 10.1021/acs.jafc.7b01602; Kwon HJ, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.190; Lee YH, 2016, AM J PHYSIOL-REG I, V310, pR55, DOI 10.1152/ajpregu.00355.2015; Lee YH, 2014, BBA-MOL BASIS DIS, V1842, P358, DOI 10.1016/j.bbadis.2013.05.011; Lee YH, 2013, CELL METAB, V18, P355, DOI 10.1016/j.cmet.2013.08.003; Locher LF, 2011, J DAIRY SCI, V94, P4514, DOI 10.3168/jds.2011-4145; Long EK, 2013, BBA-MOL CELL BIOL L, V1831, P1199, DOI 10.1016/j.bbalip.2013.04.004; Lopez-Vicario C, 2015, P NATL ACAD SCI USA, V112, P536, DOI 10.1073/pnas.1422590112; Lynes MD, 2017, NAT MED; Mavangira V, 2015, J DAIRY SCI, V98, P6202, DOI 10.3168/jds.2015-9570; McArt JAA, 2013, VET J, V198, P560, DOI 10.1016/j.tvjl.2013.08.011; McNamara JP, 2005, J DAIRY SCI, V88, P2498, DOI 10.3168/jds.S0022-0302(05)72927-1; O'Donnell Valerie B., 2009, V462, P5, DOI 10.1007/978-1-60327-115-8_1; Pearson T, 2009, AM J PHYSIOL-ENDOC M, V297, pE647, DOI 10.1152/ajpendo.00227.2009; RACLOT T, 1993, J LIPID RES, V34, P1515; Raclot T, 2001, J LIPID RES, V42, P2049; Ramsden CE, 2012, PROSTAG LEUKOTR ESS, V87, P135, DOI 10.1016/j.plefa.2012.08.004; Raphael W, 2014, J DAIRY SCI, V97, P3615, DOI 10.3168/jds.2013-7656; Ryman VE, 2015, PROSTAG OTH LIPID M, V121, P207, DOI 10.1016/j.prostaglandins.2015.09.006; Sodhi K, 2012, PROSTAG OTH LIPID M, V98, P133, DOI 10.1016/j.prostaglandins.2011.12.004; Song YS, 2016, PROSTAG OTH LIPID M, V123, P1, DOI 10.1016/j.prostaglandins.2016.02.001; Sordillo LM, 2013, VET CLIN N AM-FOOD A, V29, P267, DOI 10.1016/j.cvfa.2013.03.002; Strieder-Barboza C, 2015, LIVEST SCI, V177, P159, DOI 10.1016/j.livsci.2015.04.020; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vangaveti V, 2010, THER ADV ENDOCRINOL, V1, P51, DOI 10.1177/2042018810375656; Viswanathan S, 2003, J AM COLL NUTR, V22, P502, DOI 10.1080/07315724.2003.10719328; Wamberg L, 2013, INT J OBESITY, V37, P651, DOI 10.1038/ijo.2012.112; Yuan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080316; Zachut M, 2010, J DAIRY SCI, V93, P5877, DOI 10.3168/jds.2010-3427; Zha WB, 2014, J LIPID RES, V55, P2124, DOI 10.1194/jlr.M053199	61	27	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188621	10.1371/journal.pone.0188621	http://dx.doi.org/10.1371/journal.pone.0188621			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206843	Green Published, Green Submitted, gold			2022-12-27	WOS:000417110700015
J	Delabouglise, A; James, A; Valarcher, JF; Hagglund, S; Raboisson, D; Rushton, J				Delabouglise, Alexis; James, Andrew; Valarcher, Jean-Francois; Hagglund, Sara; Raboisson, Didier; Rushton, Jonathan			Linking disease epidemiology and livestock productivity: The case of bovine respiratory disease in France	PLOS ONE			English	Article							CALFHOOD HEALTH-STATUS; WEIGHT-GAIN; FEEDLOT PERFORMANCE; TREATMENT RECORDS; ECONOMIC-IMPACT; MILK-PRODUCTION; CARCASS TRAITS; ANIMAL HEALTH; DAIRY CALVES; VEAL CALVES	Concerns are growing over the impact of livestock farming on environment and public health. The livestock industry is faced with the double constraint of limiting its use of natural resources and antimicrobials while ensuring its economic sustainability. In this context, reliable methods are needed to evaluate the effect of the prevention of endemic animal diseases on the productivity of livestock production systems. In this study, an epidemiological and productivity model was used to link changes in Bovine Respiratory Disease (BRD) incidence with the productivity of the beef and dairy cattle sectors in France. Cattle production parameters significantly affected by BRD were selected through literature review. Previous field study results and national cattle performance estimates were used to infer growth performances, mortality rates and carcass quality in the cattle affected and not affected by BRD. A steady-state deterministic herd production model was used to predict the productivity of the dairy and beef sector and their defined compartments (breeding-fattening, feedlot young bulls, and feedlot veal) in case of BRD incidence reduction by 20%, 50% or 100%. Results suggested that BRD should be controlled at a priority in beef breeding farms as eradication of BRD in beef calves would increase the whole beef sector's productivity by 4.7-5.5% while eradication in other production stages would result in lower productivity gain in their respective sectors. However, the analysis performed at compartment level showed that, in both the beef and dairy sector, young bull and veal feedlot enterprises derive more economic benefits from BRD eradication for their own compartment (increase in productivity of 8.7-12.8% for beef young bulls) than the breeding farms (increase in productivity of 5.1-6% for beef calves), which may limit the investments in BRD control.	[Delabouglise, Alexis; Rushton, Jonathan] Univ London, Royal Vet Coll, Dept Prod & Populat Hlth, Vet Epidemiol Econ & Publ Hlth Grp, Hawkshead Lane, Hatfield, Herts, England; [James, Andrew] Univ Reading, Vet Epidemiol & Econ Res Unit, Reading, Berks, England; [Valarcher, Jean-Francois; Hagglund, Sara] Swedish Univ Agr Sci, Ruminant Med & Vet Epidemiol, Uppsala, Sweden; [Raboisson, Didier] Univ Toulouse, IHAP, INRA, ENVT, Toulouse, France; [Rushton, Jonathan] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England	University of London; University of London Royal Veterinary College; University of Reading; Swedish University of Agricultural Sciences; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; University of Liverpool	Delabouglise, A (corresponding author), Univ London, Royal Vet Coll, Dept Prod & Populat Hlth, Vet Epidemiol Econ & Publ Hlth Grp, Hawkshead Lane, Hatfield, Herts, England.	alexis.delabouglise@gmail.com	VALARCHER, JEAN FRANCOIS/AAE-4857-2020; Raboisson, Didier/AAL-4025-2020; Hägglund, Sara/AAE-4867-2020	VALARCHER, JEAN FRANCOIS/0000-0002-8564-5603; Raboisson, Didier/0000-0003-1630-6218; Hägglund, Sara/0000-0002-6983-5722; Delabouglise, Alexis/0000-0001-5837-7052	SAPHIR (Strengthening Animal Production and Health through the Immune Response) of the Horizon Programme of the European Union [633184]	SAPHIR (Strengthening Animal Production and Health through the Immune Response) of the Horizon Programme of the European Union	The study was funded by the research project SAPHIR (Strengthening Animal Production and Health through the Immune Response) of the Horizon 2020 Programme of the European Union (project ID 633184). SAPHIR aims to develop innovative, safe, affordable and effective vaccine strategies effective against endemic pathogens responsible for high economic losses in livestock. By generating vaccine strategies for these pathogens in pigs, poultry and ruminants, SAPHIR will aid in strengthening the profitability of food animal systems, improve animal welfare and reduce xenobiotic usage in farming with a One Health perspective (http://www.h2020-saphir.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agreste Conjoncture, 2013, AGRESTE CONJONCTURE; Andrews AH, 2000, CATTLE PRACT, V8; [Anonymous], 2014, R LANG ENV STAT COMP; Arcangioli MA, 2008, VET J, V177, P89, DOI 10.1016/j.tvjl.2007.03.008; Assie S., 2003, 10emes Rencontres autour des Recherches sur les Ruminants, Paris, France, 3-4 decembre 2003, P293; Assie S, 2004, PREV VET MED, V63, P271, DOI 10.1016/j.prevetmed.2004.01.014; Assie S, 2001, EIGHTH CONFERENCE ON RUMINANT RESEARCH, P145; Assie S, 2009, VET REC, V165, P195, DOI 10.1136/vr.165.7.195; Assie S, 2004, INCIDENCE IMPACT ECO; Assie S, 2009, PREV VET MED, V91, P218, DOI 10.1016/j.prevetmed.2009.06.003; Babcock AH, 2009, J ANIM SCI, V87, P314, DOI 10.2527/jas.2008-1201; Bareille N, 2008, RENC RECH RUMINANTS, V15; BATEMAN KG, 1990, CAN VET J, V31, P689; BRITNEY JB, 1984, PREV VET MED, V3, P45, DOI 10.1016/0167-5877(84)90023-0; Brooks K. R., 2011, Professional Animal Scientist, V27, P195; Carnell R., LHS LATIN HYPERCUBE; CORREA MT, 1988, PREV VET MED, V6, P253, DOI 10.1016/0167-5877(88)90037-2; CURTIS CR, 1989, PREV VET MED, V7, P173, DOI 10.1016/0167-5877(89)90020-2; Delobel L, 2003, MALADIES RESPIRATOIR; Donovan GA, 1998, PREV VET MED, V33, P1, DOI 10.1016/S0167-5877(97)00059-7; Esslemont R. J., 1999, Bovine Practitioner, V33, P174; Eurostat, MEAT PROD STAT 2014; Fulton Robert W., 2009, Animal Health Research Reviews, V10, P131, DOI 10.1017/S146625230999017X; Fulton RW, 2002, CAN J VET RES, V66, P173; Garcia MD, 2010, J ANIM SCI, V88, P491, DOI 10.2527/jas.2009-1874; Gardner BA, 1999, J ANIM SCI, V77, P3168; Gautier-Bouchardon AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087672; Gay E, 2009, PREV VET MED, V89, P265, DOI 10.1016/j.prevetmed.2009.02.013; Griffin D, 1997, VET CLIN N AM-FOOD A, V13, P367, DOI 10.1016/S0749-0720(15)30302-9; Griffin D, 2014, ANIM HEALTH RES REV, V15, P138, DOI 10.1017/S1466252314000255; Groupe Economie du Betail Institut de l'Elevage, 2011, PROD VIAND BOV FRANC; HEALY AM, 1993, BRIT VET J, V149, P549, DOI 10.1016/S0007-1935(05)80039-9; Holland BP, 2010, J ANIM SCI, V88, P2486, DOI 10.2527/jas.2009-2428; Irsik Max, 2006, Bovine Practitioner, V40, P65; JIM GK, 1993, CAN VET J, V34, P668; Joly M, 2007, INCIDENCE EFFET PERF; Lago A, 2006, J DAIRY SCI, V89, P4014, DOI 10.3168/jds.S0022-0302(06)72445-6; Le Grand D, 2008, B ACAD VET FRANCE, V161, P159; Loneragan GH, 2001, J AM VET MED ASSOC, V219, P1122, DOI 10.2460/javma.2001.219.1122; Martin SW, 1999, CAN VET J, V40, P560; Martineau C, 2007, INDICATEURS ZOOTECHN; Montgomery SP, 2009, J ANIM SCI, V87, P328, DOI 10.2527/jas.2008-0969; National Research Council, 1980, NUTR REQ RUM LIV; National Research Council, 2001, NUTR REQ DAIR CATTL, V7th; Onono JO, 2013, TROP ANIM HEALTH PRO, V45, P423, DOI 10.1007/s11250-012-0233-y; PAN Livestock Services Limited, 1991, LIV PROD EFF CALC US; Pardon B, 2011, VET REC, V169, P278, DOI 10.1136/vr.d4406; Pardon B, 2015, PREV VET MED, V120, P169, DOI 10.1016/j.prevetmed.2015.04.009; Perrin JB, 2011, INRA PROD ANIM, V24, P235; Pesneau E, 2008, INCIDENCE IMPACT PER; Reinhardt CD, 2009, J ANIM SCI, V87, P3030, DOI 10.2527/jas.2008-1293; Rio O., 1999, FREQUENCE RISQUES MO; Roeber D. L., 2001, Professional Animal Scientist, V17, P39; Rossini K.L, 2004, EFFECTS CALFHOOD RES; Rushton J, 2015, ZOONOSES PUBLIC HLTH, V62, P10, DOI 10.1111/zph.12193; Schaffer AP, 2016, JAVMA-J AM VET MED A, V248, P1157, DOI 10.2460/javma.248.10.1157; Schneider MJ, 2009, J ANIM SCI, V87, P1821, DOI 10.2527/jas.2008-1283; SISCHO WM, 1990, PREV VET MED, V8, P141, DOI 10.1016/0167-5877(90)90007-5; Sivula NJ, 1996, PREV VET MED, V27, P155, DOI 10.1016/0167-5877(95)01000-9; Stanton AL, 2012, J DAIRY SCI, V95, P4950, DOI 10.3168/jds.2011-5067; Svensson C, 2003, PREV VET MED, V58, P179, DOI 10.1016/S0167-5877(03)00046-1; Taylor JD, 2010, CAN VET J, V51, P1095; Thompson PN, 2006, J ANIM SCI, V84, P488, DOI 10.2527/2006.842488x; VANDERMEI J, 1987, VET QUART, V9, P203, DOI 10.1080/01652176.1987.9694101; Virtala AMK, 1996, J DAIRY SCI, V79, P1040, DOI 10.3168/jds.S0022-0302(96)76457-3; Waggoner J. W., 2007, Professional Animal Scientist, V23, P174; WALTNERTOEWS D, 1986, CAN J VET RES, V50, P314; Warnick LD, 1997, PREV VET MED, V31, P263, DOI 10.1016/S0167-5877(96)01105-1; Warnick LD, 1995, J DAIRY SCI, V78, P2819, DOI 10.3168/jds.S0022-0302(95)76912-0; WARNICK LD, 1994, KENYA VET, V18, P177; Williams P, 2007, CATTLE PRACT, V15, P244; WITTUM TE, 1994, PREV VET MED, V19, P15, DOI 10.1016/0167-5877(94)90011-6; Wittum TE, 1996, J AM VET MED ASSOC, V209, P814	73	26	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189090	10.1371/journal.pone.0189090	http://dx.doi.org/10.1371/journal.pone.0189090			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206855	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000417110700047
J	Ozdemir, AC; Wynn, GM; Vester, A; Weitzmann, MN; Neigh, GN; Srinivasan, S; Rudd, MK				Ozdemir, Alev Cagla; Wynn, Grace M.; Vester, Aimee; Weitzmann, M. Neale; Neigh, Gretchen N.; Srinivasan, Shanthi; Rudd, M. Katharine			GNB3 overexpression causes obesity and metabolic syndrome	PLOS ONE			English	Article							WHITE ADIPOSE-TISSUE; BROWN ADIPOCYTES; OPEN-FIELD; SOCIAL-INTERACTION; MOLECULAR-BASIS; GAMMA-SUBUNITS; BODY-WEIGHT; G-PROTEINS; MICE; FAT	The G-protein beta subunit 3 (GNB3) gene has been implicated in obesity risk; however, the molecular mechanism of GNB3-related disease is unknown. GNB3 duplication is responsible for a syndromic form of childhood obesity, and an activating DNA sequence variant (C825T) in GNB3 is also associated with obesity. To test the hypothesis that GNB3 overexpression causes obesity, we created bacterial artificial chromosome (BAC) transgenic mice that carry an extra copy of the human GNB3 risk allele. Here we show that GNB3-T/+ mice have increased adiposity, but not greater food intake or a defect in satiety. GNB3-T/+ mice have elevated fasting plasma glucose, insulin, and C-peptide, as well as glucose intolerance, indicating type 2 diabetes. Fasting plasma leptin, triglycerides, cholesterol and phospholipids are elevated, suggesting metabolic syndrome. Based on a battery of behavioral tests, GNB3-T/+ mice did not exhibit anxiety-or depressive-like phenotypes. GNB3-T/+ and wild-type animals have similar activity levels and heat production; however, GNB3-T/+ mice exhibit dysregulation of acute thermogenesis. Finally, Ucp1 expression is significantly lower in white adipose tissue (WAT) in GNB3-T/+ mice, suggestive of WAT remodeling that could lead to impaired cellular thermogenesis. Taken together, our study provides the first functional link between GNB3 and obesity, and presents insight into novel pathways that could be applied to combat obesity and type 2 diabetes.	[Ozdemir, Alev Cagla; Wynn, Grace M.; Rudd, M. Katharine] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Vester, Aimee] Emory Univ, Dept Environm Hlth Sci, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Weitzmann, M. Neale] Emory Univ, Sch Med, Div Endocrinol Metab & Lipids, Atlanta, GA USA; [Weitzmann, M. Neale; Srinivasan, Shanthi] Atlanta VA Med Ctr, Decatur, GA USA; [Neigh, Gretchen N.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA; [Neigh, Gretchen N.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA; [Srinivasan, Shanthi] Emory Univ, Sch Med, Div Digest Dis, Atlanta, GA USA; [Rudd, M. Katharine] Lab Corp Amer Holdings, Ctr Mol Biol & Pathol, Res Triangle Pk, NC 27709 USA	Emory University; Emory University; Rollins School Public Health; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Emory University; Virginia Commonwealth University; Emory University	Rudd, MK (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.; Rudd, MK (corresponding author), Lab Corp Amer Holdings, Ctr Mol Biol & Pathol, Res Triangle Pk, NC 27709 USA.	ruddm2@labcorp.com	Srinivasan, Shanthi/A-6133-2013; Neigh, Gretchen/AAW-5691-2020	Neigh, Gretchen/0000-0003-0955-9161	Emory Discovery Fund; Emory University School of Medicine; Department of Human Genetics at Emory University; Emory Integrated Core Facilities; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	Emory Discovery Fund; Emory University School of Medicine; Department of Human Genetics at Emory University; Emory Integrated Core Facilities; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work received support from the Emory Discovery Fund, an internal grant from the Department of Human Genetics at Emory University.; Some experiments were conducted with the Emory Integrated Genomics Core (EIGC), which is subsidized by the Emory University School of Medicine and is one of the Emory Integrated Core Facilities.	Blakemore AIF, 2010, ANN NY ACAD SCI, V1214, P180, DOI 10.1111/j.1749-6632.2010.05880.x; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Burgado J, 2014, BEHAV BRAIN RES, V275, P120, DOI 10.1016/j.bbr.2014.08.060; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Choquet H, 2011, CURR GENOMICS, V12, P154, DOI 10.2174/138920211795677921; Choquet H, 2011, CURR GENOMICS, V12, P169, DOI 10.2174/138920211795677895; COUSIN B, 1992, J CELL SCI, V103, P931; Crowley VEF, 2008, ANN CLIN BIOCHEM, V45, P245, DOI 10.1258/acb.2007.007193; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; FILE SE, 1980, J NEUROSCI METH, V2, P219, DOI 10.1016/0165-0270(80)90012-6; File SE, 2003, EUR J PHARMACOL, V463, P35, DOI 10.1016/S0014-2999(03)01273-1; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Fukumoto K, 2014, PSYCHOPHARMACOLOGY, V231, P2291, DOI 10.1007/s00213-013-3378-0; Ghorbani M, 1997, INT J OBESITY, V21, P465, DOI 10.1038/sj.ijo.0800432; Goldlust IS, 2013, P NATL ACAD SCI USA, V110, P14990, DOI 10.1073/pnas.1305999110; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Klenke S, 2011, PHARMACOGENET GENOM, V21, P594, DOI 10.1097/FPC.0b013e3283491153; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Lania A, 2001, EUR J ENDOCRINOL, V145, P543, DOI 10.1530/eje.0.1450543; Moxham CM, 1996, NATURE, V379, P840, DOI 10.1038/379840a0; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Obregon MJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00479; Offermanns S, 1998, ONCOGENE, V17, P1375, DOI 10.1038/sj.onc.1202173; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Poon LSW, 2009, CELL SIGNAL, V21, P737, DOI 10.1016/j.cellsig.2009.01.018; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Sabin MA, 2011, BEST PRACT RES CL EN, V25, P207, DOI 10.1016/j.beem.2010.09.010; Sargolini F, 2003, BEHAV BRAIN RES, V138, P153, DOI 10.1016/S0166-4328(02)00238-3; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Siffert W, 1998, NAT GENET, V18, P45, DOI 10.1038/ng0198-45; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Teerds KJ, 2011, HUM REPROD UPDATE, V17, P667, DOI 10.1093/humupd/dmr017; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; World Health Organization, 2016, OB OV FACT SHEET; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xia QH, 2013, ANN NY ACAD SCI, V1281, P178, DOI 10.1111/nyas.12020; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Ye YC, 2014, CELL SIGNAL, V26, P2514, DOI 10.1016/j.cellsig.2014.07.030; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	51	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188763	10.1371/journal.pone.0188763	http://dx.doi.org/10.1371/journal.pone.0188763			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206867	Green Submitted, Green Published, gold			2022-12-27	WOS:000417110700022
J	Kimura, S; Nakao, S; Kitaura, A; Iwamoto, T; Houri, K; Matsushima, M; Hamasaki, S				Kimura, Seishi; Nakao, Shinichi; Kitaura, Atsuhiro; Iwamoto, Tatushige; Houri, Kei; Matsushima, Mayuka; Hamasaki, Shinichi			Sevoflurane causes greater QTc interval prolongation in chronically hyperglycemic patients than in normoglycemic patients	PLOS ONE			English	Article							TORSADE-DE-POINTES; TRANSMURAL DISPERSION; TEND INTERVAL; HEART-RATE; REPOLARIZATION; ANESTHESIA; PROPOFOL	QTc interval prolongation is a serious diabetic complication and increases mortality rate. Hyperglycemia inhibits the rapid component of delayed rectifier potassium channel currents (Ikr) and prolongs the QTc interval on electrocardiograms. Sevoflurane also inhibits the Ikr and causes QTc interval prolongation. In fact, torsade de pointes occurred in a patient with poorly controlled diabetes mellitus during sevoflurane anesthesia. We enrolled 74 patients, including 37 normoglycemic patients (glycated hemoglobin [HbA1c]: <6.5%) (NG group) and 37 chronically hyperglycemic patients (HbA1c: >= 6.5%) (HG group). Anesthesia was induced with 2 mg/kg propofol and 0.3 mu g/kg/min remifentanil, and maintained with 2% sevoflurane in 40% O-2 and 0.2-0.3 mu g/kg/min remifentanil. The QT interval and Tp-e interval (from the peak to the end of the T wave) were measured before and at 5, 10, 30, 60, 90, and 120 min after the administration of sevoflurane and adjusted for the patient's heart rate (QTc and Tp-ec, respectively). P-values of <0.05 were considered statistically significant. The QTc and the Tp-ec intervals of the two groups did not differ significantly before the administration of sevoflurane. The QTc interval gradually increased with time in both groups and was significantly longer than the baseline value at 10 min after the administration of sevoflurane in both groups. The QTc interval of the HG group was significantly longer than that of the NG group at 90 min and 120 min after the administration of sevoflurane. The Tp-ec interval was not affected by sevoflurane in either group. We have demonstrated that sevoflurane significantly prolongs the QTc interval, and that the extent of the prolongation is significantly greater in chronically hyperglycemic patients than in normoglycemic patients. Although Tp-ec is not affected by sevoflurane, it should be noted that the simultaneous blockade of potassium channels would increase the risk of arrhythmias.	[Kimura, Seishi; Nakao, Shinichi; Kitaura, Atsuhiro; Iwamoto, Tatushige; Houri, Kei; Matsushima, Mayuka; Hamasaki, Shinichi] Kindai Univ, Fac Med, Dept Anesthesiol, Osakasayama, Osaka, Japan		Nakao, S (corresponding author), Kindai Univ, Fac Med, Dept Anesthesiol, Osakasayama, Osaka, Japan.	nakaos@med.kindai.ac.jp						Antzelevitch C, 2001, EUR J CLIN INVEST, V31, P555, DOI 10.1046/j.1365-2362.2001.00849.x; Belardinelli L, 2003, TRENDS PHARMACOL SCI, V24, P619, DOI 10.1016/j.tips.2003.10.002; Chua KCM, 2016, HEART RHYTHM, V13, P2181, DOI 10.1016/j.hrthm.2016.08.022; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Hreiche R, 2009, J MOL CELL CARDIOL, V47, P210, DOI 10.1016/j.yjmcc.2009.02.004; Kang JS, 2006, ANESTHESIOLOGY, V104, P1015, DOI 10.1097/00000542-200605000-00018; Nakao S, 2010, ANESTH ANALG, V110, P775, DOI 10.1213/ANE.0b013e3181cde713; Saussine M, 2006, PEDIATR ANESTH, V16, P63, DOI 10.1111/j.1460-9592.2005.01593.x; Stern K, 2016, DIABETIC MED, V33, P1415, DOI 10.1111/dme.13085; Tacken MCT, 2011, ACTA ANAESTH BELG, V62, P105; Thiruvenkatarajan V, 2010, ANAESTH INTENS CARE, V38, P555, DOI 10.1177/0310057X1003800323; Veglio M, 2000, DIABETES CARE, V23, P1381, DOI 10.2337/diacare.23.9.1381; Whitsel EA, 2000, DIABETES CARE, V23, P241, DOI 10.2337/diacare.23.2.241; Whyte SD, 2005, ANESTH ANALG, V100, P71, DOI 10.1213/01.ANE.0000140781.18391.41; Yamada M, 2006, ANESTH ANALG, V102, P98, DOI 10.1213/01.ANE.0000184257.54917.99; Zhang YQ, 2003, J BIOL CHEM, V278, P10417, DOI 10.1074/jbc.M211044200	16	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0188555	10.1371/journal.pone.0188555	http://dx.doi.org/10.1371/journal.pone.0188555			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194447	gold, Green Submitted, Green Published			2022-12-27	WOS:000416867800014
J	Atnaf, M; Yao, N; Martina, K; Dagne, K; Wegary, D; Tesfaye, K				Atnaf, Mulugeta; Yao, Nasser; Martina, Kyalo; Dagne, Kifle; Wegary, Dagne; Tesfaye, Kassahun			Molecular genetic diversity and population structure of Ethiopian white lupin landraces: Implications for breeding and conservation	PLOS ONE			English	Article							CORE COLLECTION; ALBUS L.; ANTHRACNOSE RESISTANCE; GERMPLASM; ISSR; IDENTIFICATION; CULTIVARS; INFERENCE; SOFTWARE; STRATEGY	White lupin is one of the four economically important species of the Lupinus genus and is an important grain legume in the Ethiopian farming system. However, there has been limited research effort to characterize the Ethiopian white lupin landraces. Fifteen polymorphic simple sequence repeat (SSR) markers were used to assess the genetic diversity and population structure of 212 Ethiopian white lupin (Lupinus albus) landraces and two genotypes from different species (Lupinus angustifolius and Lupinus mutabilis) were used as outgroup. The SSR markers revealed 108 different alleles, 98 of them from 212 landraces and 10 from out-group genotypes, with an average of 6.5 alleles per locus. The average gene diversity was 0.31. Twenty eight landraces harbored one or more private alleles from the total of 28 private alleles identified in the 212 white lupin accessions. Seventy-seven rare alleles with a frequency of less than 5% were identified and accounted for 78.6% of the total alleles detected. Analysis of molecular variance (AMOVA) showed that 92% of allelic diversity was attributed to individual accessions within populations while only 8% was distributed among populations. At 70% similarity level, the UPGMA dendrogram resulted in the formation of 13 clusters comprised of 2 to 136 landraces, with the out-group genotypes and five landraces remaining distinct and ungrouped. Population differentiation and genetic distance were relatively high between Gondar and Ethiopian white lupin populations collected by Australians. A model-based population structure analysis divided the white lupin landraces into two populations. All Ethiopian white lupin landrace populations, except most of the landraces collected by Australians (77%) and about 44% from Awi, were grouped together with significant admixtures. The study also suggested that 34 accessions, as core collections, were sufficient to retain 100% of SSR diversity. These accessions (core G-34) represent 16% of the whole 212 Ethiopian white lupin accessions and populations from West Gojam, Awi and Australian collections contributed more accessions to the core collection.	[Atnaf, Mulugeta] Ethiopian Inst Agr Res, Pawe Res Ctr, Pawe, Ethiopia; [Atnaf, Mulugeta; Yao, Nasser; Martina, Kyalo] Biosci Eastern & Cent Africa Int Livestock R, Hub, Nairobi Kenya, Kenya; [Atnaf, Mulugeta; Dagne, Kifle; Tesfaye, Kassahun] Addis Ababa Univ, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia; [Wegary, Dagne] CIMMYT Ethiopia, ILRI Campus,CMC Rd, Addis Ababa, Ethiopia	Ethiopian Institute of Agricultural Research (EIAR); Addis Ababa University; CGIAR; International Livestock Research Institute (ILRI)	Atnaf, M (corresponding author), Ethiopian Inst Agr Res, Pawe Res Ctr, Pawe, Ethiopia.; Atnaf, M (corresponding author), Biosci Eastern & Cent Africa Int Livestock R, Hub, Nairobi Kenya, Kenya.; Atnaf, M (corresponding author), Addis Ababa Univ, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia.	atnafmulugeta@gmail.com			BecA-ILRI Hub through the Africa Biosciences Challenge Fund (ABCF) program; Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership; Syngenta Foundation for Sustainable Agriculture (SFSA); Bill & Melinda Gates Foundation (BMGF); UK Department for International Development (DFID); Swedish International Development Cooperation Agency (Sida)	BecA-ILRI Hub through the Africa Biosciences Challenge Fund (ABCF) program; Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership(Australian Government); Syngenta Foundation for Sustainable Agriculture (SFSA)(Syngenta); Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); UK Department for International Development (DFID); Swedish International Development Cooperation Agency (Sida)	The study was part of PhD research work of the first author (MA) and he is grateful to the Ethiopian Institute of Agricultural Research (EIAR) for giving him study leave. The study was supported by the BecA-ILRI Hub through the Africa Biosciences Challenge Fund (ABCF) program. The ABCF Program is funded by the Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership; the Syngenta Foundation for Sustainable Agriculture (SFSA); the Bill & Melinda Gates Foundation (BMGF); the UK Department for International Development (DFID) and; the Swedish International Development Cooperation Agency (Sida). The landrace accessions were kindly provided by the Ethiopian Biodiversity Institute (EBI).MA would also like to thank Elena Hidalgo (Professor in molecular biology, University of Valladolid, Spain) and Belayneh Admasu (Former director of Holeta National biotechnology laboratory of the Ethiopian Institute of Agricultural Research) for their assistance during the initial stage of this work. Authors would like to thank Helen Altshul for her assistance in language proof reading. This work was approved by EIAR as part of its research activities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was part of PhD research work of the first author (MA) and he is grateful to the Ethiopian Institute of Agricultural Research (EIAR) for giving him study leave. The study was supported by the BecA-ILRI Hub through the Africa Biosciences Challenge Fund (ABCF) program. The ABCF Program is funded by the Australian Department for Foreign Affairs and Trade (DFAT) through the BecA-CSIRO partnership; the Syngenta Foundation for Sustainable Agriculture (SFSA); the Bill & Melinda Gates Foundation (BMGF); the UK Department for International Development (DFID) and; the Swedish International Development Cooperation Agency (Sida). The landrace accessions were kindly provided by the Ethiopian Biodiversity Institute (EBI).MA would also like to thank Elena Hidalgo (Professor in molecular biology, University of Valladolid, Spain) and Belayneh Admasu (Former director of Holeta National biotechnology laboratory of the Ethiopian Institute of Agricultural Research) for their assistance during the initial stage of this work. Authors would like to thank Helen Altshul for her assistance in language proofreading. This work was approved by EIAR as part of its research activities.	Abdie Oumer, 2015, African Journal of Biotechnology, V14, P1552; Adhikari KN, 2009, CROP PASTURE SCI, V60, P472, DOI 10.1071/CP08092; Arnoldi A., 2005, OPTIMIZED PROCESSES; Asfaw A, 2009, THEOR APPL GENET, V120, P1, DOI 10.1007/s00122-009-1154-7; Baraket G, 2011, PLANT MOL BIOL REP, V29, P171, DOI 10.1007/s11105-010-0217-x; Bascur B. G., 2005, Agricultura Tecnica, V65, P135; Beebe S, 2001, CROP SCI, V41, P854, DOI 10.2135/cropsci2001.413854x; BROWN AHD, 1989, GENOME, V31, P818, DOI 10.1139/g89-144; Christiansen JL, 2000, GENET RESOUR CROP EV, V47, P425, DOI 10.1023/A:1008728530116; Coimbra RR, 2009, GENET MOL BIOL, V32, P538, DOI 10.1590/S1415-47572009005000059; Dunn DB, 1966, LUPINES CANADA ALASK; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Forsberg NEG, 2015, HEREDITY, V114, P195, DOI 10.1038/hdy.2014.83; Gepts P, 2000, STADLER GEN, P163; Gilbert JE, 1999, THEOR APPL GENET, V98, P1125, DOI 10.1007/s001220051176; Gong YM, 2011, AGR SCI CHINA, V10, P838, DOI 10.1016/S1671-2927(11)60069-2; Gonzalez-Andres F, 2007, GENET RESOUR CROP EV, V54, P27, DOI 10.1007/s10722-005-1407-5; Gwag JG, 2010, GENES GENOM, V32, P299, DOI 10.1007/s13258-010-0014-9; Hall RS, 2005, ASIA PAC J CLIN NUTR, V14, P91; Hao CY, 2006, MOL BREEDING, V17, P69, DOI 10.1007/s11032-005-2453-6; He QA, 2011, PLANT MOL BIOL REP, V29, P197, DOI 10.1007/s11105-010-0218-9; HONDELMANN W, 1984, THEOR APPL GENET, V68, P1, DOI 10.1007/BF00252301; Hu J, 2000, THEOR APPL GENET, V101, P264, DOI 10.1007/s001220051478; Jin L, 2008, ACTA AGRONO SIN, V34, P1901, DOI DOI 10.1016/S1875-2780(09)60015-8; Johnson SK, 2006, BRIT J NUTR, V95, P372, DOI 10.1079/BJN20051648; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Keneni G, 2005, GENET RESOUR CROP EV, V52, P539, DOI 10.1007/s10722-003-6016-6; Kong QS, 2011, PLANT MOL BIOL REP, V29, P217, DOI 10.1007/s11105-010-0228-7; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kurlovich B.S, 2002, LUPINS GEOGRAPHY CLA; Kuroda Y, 2009, GENET RESOUR CROP EV, V56, P1045, DOI 10.1007/s10722-009-9425-3; Leggett RM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S4-S10; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu Y., 2010, LEGUME GENOMICS GENE, V1, P1, DOI DOI 10.5376/LGG.2010.01.0001; Lqari H, 2005, GRASAS ACEITES, V56, P135; Marita JM, 2000, GENET RESOUR CROP EV, V47, P515, DOI 10.1023/A:1008784610962; Massonneau A, 2001, PLANTA, V213, P534, DOI 10.1007/s004250100529; Mulugeta Atnaf, 2015, African Crop Science Journal, V23, P327, DOI 10.4314/acsj.v23i4.3; Mulugeta Atnaf, 2015, American Journal of Experimental Agriculture, V7, P347, DOI 10.9734/AJEA/2015/11253; Mulugeta Atnaf, 2017, Australian Journal of Crop Science, V11, P55, DOI 10.21475/ajcs.2017.11.01.pne226; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Odong TL, 2013, THEOR APPL GENET, V126, P289, DOI 10.1007/s00122-012-1971-y; Paredes M, 2010, CHIL J AGR RES, V70, P3, DOI 10.4067/S0718-58392010000100001; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier X., 2010, DARWIN SOFTWARE; Peters KJ., 2010, LIVESTOCK RES RURAL, V22; Phan HTT, 2007, DNA RES, V14, P59, DOI 10.1093/dnares/dsm009; Pritchard JK, 2000, GENETICS, V155, P945; Raman R., 2014, OPEN J GENETICS, V4, P87, DOI [10.4236/ojgen.2014.42012, DOI 10.4236/OJGEN.2014.42012]; Rodino AP, 2003, EUPHYTICA, V131, P165, DOI 10.1023/A:1023973309788; Roussel V, 2004, THEOR APPL GENET, V108, P920, DOI 10.1007/s00122-003-1502-y; Rowe HC, 2011, MOL ECOL, V20, P3499, DOI 10.1111/j.1365-294X.2011.05197.x; Rubio J, 2004, EUPHYTICA, V135, P217, DOI 10.1023/B:EUPH.0000014911.70355.c9; Saeed A, 2011, PLANT MOL BIOL REP, V29, P848, DOI 10.1007/s11105-011-0294-5; Sangiri C, 2007, AUST J BOT, V55, P837, DOI 10.1071/BT07105; Sbabou L, 2010, INT J AGRIC BIOL, V12, P26; Sefera T, 2011, CROP PASTURE SCI, V62, P177, DOI 10.1071/CP10165; Sharma SS, 2011, PLANT MOL BIOL REP, V29, P12, DOI 10.1007/s11105-010-0204-2; Talhinhas P, 2003, PLANT BREEDING, V122, P507, DOI 10.1111/j.1439-0523.2003.00892.x; Upadhyaya HD, 2009, CROP SCI, V49, P573, DOI 10.2135/cropsci2008.06.0378; Vaz AC, 2004, FIELD CROP RES, V87, P23, DOI 10.1016/j.fcr.2003.09.006; Wang J, 2014, SCI WORLD J; Wolko B, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: LEGUME CROPS AND FORAGES, P153, DOI 10.1007/978-3-642-14387-8_9; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Xiao LQ, 2004, ANN BOT-LONDON, V94, P133, DOI 10.1093/aob/mch119; Yan W, 2007, CROP SCI, V47, P869, DOI 10.2135/cropsci2006.07.0444; Yang HA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-318; Yifru T, 2006, PLANT BREEDING, V125, P125, DOI 10.1111/j.1439-0523.2006.01147.x; Yonezawa K., 1995, P35; Zhang J, 2010, AFR J BIOTECHNOL, V9, P123; Zong XuXiao, 2008, Acta Agronomica Sinica, V34, P1518, DOI 10.1016/S1875-2780(09)60003-1	74	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188696	10.1371/journal.pone.0188696	http://dx.doi.org/10.1371/journal.pone.0188696			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190792	gold, Green Submitted, Green Published			2022-12-27	WOS:000416841900102
J	Casana, J; Laugier, EJ				Casana, Jesse; Laugier, Elise Jakoby			Satellite imagery-based monitoring of archaeological site damage in the Syrian civil war	PLOS ONE			English	Article							CULTURAL-HERITAGE; SETTLEMENT; PATTERNS; EGYPT; IRAQ	Since the start of the Syrian civil war in 2011, the rich archaeological heritage of Syria and northern Iraq has faced severe threats, including looting, combat-related damage, and intentional demolition of monuments. However, the inaccessibility of the conflict zone to archaeologists or cultural heritage specialists has made it difficult to produce accurate damage assessments, impeding efforts to develop mitigation strategies and policies. This paper presents results of a project, undertaken in collaboration with the American Schools of Oriental Research (ASOR) and the US Department of State, to monitor damage to archaeological sites in Syria, northern Iraq, and southern Turkey using recent, high-resolution satellite imagery. Leveraging a large database of archaeological and heritage sites throughout the region, as well as access to continually updated satellite imagery from DigitalGlobe, this project has developed a flexible and efficient methodology to log observations of damage in a manner that facilitates spatial and temporal queries. With nearly 5000 sites carefully evaluated, analysis reveals unexpected patterns in the timing, severity, and location of damage, helping us to better understand the evolving cultural heritage crisis in Syria and Iraq. Results also offer a model for future remote sensing-based archaeological and heritage monitoring efforts in the Middle East and beyond.	[Casana, Jesse; Laugier, Elise Jakoby] Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA; [Laugier, Elise Jakoby] Dartmouth Coll, Program Ecol Evolut Ecosyst & Soc, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Casana, J (corresponding author), Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA.	jesse.j.casana@dartmouth.edu		Laugier, Elise/0000-0002-4313-4821	US Department of State, Bureau of Near Eastern Affairs; American Schools of Oriental Research's (ASOR) Cultural Heritage Initiatives (CHI); US Department of State [NEA-PSHSS-14-001, S-IZ-100-17-CA021]	US Department of State, Bureau of Near Eastern Affairs; American Schools of Oriental Research's (ASOR) Cultural Heritage Initiatives (CHI); US Department of State	Funding for this research was provided through a grant from the US Department of State, Bureau of Near Eastern Affairs, "Planning for Safeguarding Heritage Sites in Syria and Iraq." Funds were administered to Dartmouth College and the University of Arkansas as subawards from the American Schools of Oriental Research: http://www.asor-syrianheritage.org/cultural-heritage-initiatives-planning-for-safeguarding-heritage-sites-in-syria-and-iraq/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research reported herein was undertaken as a component of the American Schools of Oriental Research's (ASOR) Cultural Heritage Initiatives (CHI), funded through cooperative agreements with the US Department of State from 2014-2016 (NEA-PSHSS-14-001 and S-IZ-100-17-CA021). Thanks in particular is owed to John Russell, Andrew Cohen and Catherine Foster who helped facilitate this research. Numerous colleagues at ASOR also contributed to our work, including Michael Danti, Andrew Vaughn, Susan Ackerman, Allison Cuneo, Scott Branting, and Tate Paulette. Many team members contributed to this project over its two years, and particular credit goes to Adam Barnes, for his work developing and maintaining our database interface, Mitra Panahipour, Eric Jensen, Alyssa Loyless for imagery analysis, and Jackson Cothren for his support of the project. Useful input on various aspects of our work was also provided by Elizabeth Stone, Gil Stein, Emily Hammer, Graham Philip, Dan Lawrence, Bjorn Menze, and McGuire Gibson.	Akkermans P. M. M. G., 2003, ARCHAEOLOGY SYRIA CO; Al Quntar S, 2015, NEAR EAST ARCHAEOL, V78, P154, DOI 10.5615/neareastarch.78.3.0154; [Anonymous], 2015, CBS NEWS; [Anonymous], 2006, PLEIADES COMMUNITY B; [Anonymous], 2017, BBC NEWS; Bassem W., 2017, AL MONITOR; Bjorgo E, 2014, CHS SYRIA SATELLITE; Bonacchi C., 2015, P C COMP APPL QUANT, P279; Bowen EFW, 2017, FRONT ICT, V4; Brodie Neil, 2012, ALL KINGS HORSES ESS, P9; Bruenig E., 2015, NEW REPUBLIC; Burns R., 2009, MONUMENTS SYRIA GUID; Casana J., 2017, NEW AGENDAS REMOTE S; Casana J, 2013, MAPPING ARCHAEOLOGIC, P31; Casana J., 2012, INTERNET ARCHAEOLOGY, V32; Casana J, 2014, ADV ARCHAEOL PRACT, V2, P222, DOI 10.7183/2326-3768.2.3.222; Casana J, 2014, J EAST MEDITERR ARCH, V2, P128; Casana J, 2015, NEAR EAST ARCHAEOL, V78, P142, DOI 10.5615/neareastarch.78.3.0142; Contreras DA, 2010, J FIELD ARCHAEOL, V35, P101, DOI 10.1179/009346910X12707320296838; Contreras Daniel A., 2010, THE SAA ARCHAEOLOGIC, V10, P30; Cuneo A, 2015, SPECIAL REPORT UPDAT; Cunliffe E., 2012, DAMAGE SOUL SYRIAS C; Cunliffe E., 2013, THESIS DURHAM U DURH; Cunliffe E., 2014, INT J HERITAGE DIGIT, P453, DOI [DOI 10.1260/2047-4970.3.3.453, 10.1260/2047-4970.3.3.453]; Daniels Brian, 2015, COUNTERING ILLICIT T, P83; Danti M, 2015, REPORT DESTRUCTION N; Danti M, 2017, GEOSCIENCES, V7, DOI 10.3390/geosciences7040095; Danti MD, 2015, NEAR EAST ARCHAEOL, V78, P132, DOI 10.5615/neareastarch.78.3.0132; DEWAR RE, 1991, AM ANTIQUITY, V56, P604, DOI 10.2307/281539; Duffton A, 2016, CAA 2017 C; Falsone G., 1999, ARCHAEOLOGY UPPER SY, P137; Green E., 2017, ATLANTIC; Griffin J., 2017, PBS NEWSHOUR; Hammer E., 2016, NEWS NOTES ORIENTAL, V228, P4; Hammer E., 2016, ORIENTAL I 2015 201, P18; Hammer J., 2017, SMITHSONIAN MAGAZINE; Harmansah O, 2015, NEAR EAST ARCHAEOL, V78, P170, DOI 10.5615/neareastarch.78.3.0170; Harrower M.J., 2013, MAPPING ARCHAEOLOGIC, V5, P259, DOI DOI 10.1007/978-1-4614-6074-9_22; IHS Markit Conflict Monitor, 2017, IHS MARKIT; Internal Displacement Monitoring Centre (IDMC), 2015, IDP DAT SYR; Kalayci T, 2016, SCI TECHNOL ARCHAEOL, V2, P217, DOI 10.1080/20548923.2016.1247512; Keller A., 2015, TRANSCRIPT REMARKS M; Lasaponara R, 2014, J ARCHAEOL SCI, V42, P216, DOI 10.1016/j.jas.2013.10.032; Lauricella A, 2017, ANTIQUITY, V91, P1344, DOI 10.15184/aqy.2017.90; Lawler A, 2015, NATL GEOGRAPHIC NEWS; Margueron Jean-Claude, 1997, OXFORD ENCY ARCHAEOL, P165; Menze BH, 2012, P NATL ACAD SCI USA, V109, pE778, DOI 10.1073/pnas.1115472109; Office for the Coordination of Humanitarian Affairs (OCHA), 2017, SYR AR REP; Parcak S, 2017, GEOSCIENCES, V7, DOI 10.3390/geosciences7040094; Parcak S, 2015, NEAR EAST ARCHAEOL, V78, P196, DOI 10.5615/neareastarch.78.3.0196; Rayne L, 2016, NEWSLETTER, P15; Rodgers L., 2014, BBC NEWS; Savage S. H., 2015, SLATE; Savage SH, 2017, TERRAWATCHERS CROWDS, P67; Schuetter J, 2013, INT J REMOTE SENS, V34, P6611, DOI 10.1080/01431161.2013.802054; Sconzo P., 2007, SOC HUMAINES CHANGEM, V19, P267; Shabi Rachel, 2015, GUARDIAN 0703; Stinson E., 2016, WIRED; Stone EC, 2008, ANTIQUITY, V82, P125, DOI 10.1017/S0003598X00096496; Stone EC, 2015, NEAR EAST ARCHAEOL, V78, P178, DOI 10.5615/neareastarch.78.3.0178; Stone P., 2008, DESTRUCTION CULTURAL; Tapete D, 2016, REMOTE SENS ENVIRON, V178, P42, DOI 10.1016/j.rse.2016.02.055; Taub Ben., 2015, NEW YORKER; Trier OD, 2009, ARCHAEOL PROSPECT, V16, P1, DOI 10.1002/arp.339; U. S. Department of Defense, SPEC REP INH RES STR; U. S. Department of State D Humanitarian Information Unit, 2017, HUM INF UN; Ur J, 2013, NEAR EAST ARCHAEOL, V76, P28, DOI 10.5615/neareastarch.76.1.0028; White J, 2017, NY TIMES; Wolfinbarger S., 2014, ANCIENT HIST MODERN	69	56	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188589	10.1371/journal.pone.0188589	http://dx.doi.org/10.1371/journal.pone.0188589			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190783	gold, Green Submitted, Green Published			2022-12-27	WOS:000416841900079
J	Muslim, MT; Selamat, H; Alimin, AJ; Haniff, MF				Muslim, Mohd Taufiq; Selamat, Hazlina; Alimin, Ahmad Jais; Haniff, Mohamad Fadzli			Manifold absolute pressure estimation using neural network with hybrid training algorithm	PLOS ONE			English	Article							MODEL	In a modern small gasoline engine fuel injection system, the load of the engine is estimated based on the measurement of the manifold absolute pressure (MAP) sensor, which took place in the intake manifold. This paper present a more economical approach on estimating the MAP by using only the measurements of the throttle position and engine speed, resulting in lower implementation cost. The estimation was done via two-stage multilayer feed-forward neural network by combining Levenberg-Marquardt (LM) algorithm, Bayesian Regularization (BR) algorithm and Particle Swarm Optimization (PSO) algorithm. Based on the results found in 20 runs, the second variant of the hybrid algorithm yields a better network performance than the first variant of hybrid algorithm, LM, LM with BR and PSO by estimating the MAP closely to the simulated MAP values. By using a valid experimental training data, the estimator network that trained with the second variant of the hybrid algorithm showed the best performance among other algorithms when used in an actual retrofit fuel injection system (RFIS). The performance of the estimator was also validated in steadystate and transient condition by showing a closer MAP estimation to the actual value.	[Muslim, Mohd Taufiq] Taman Univ, Apt Touch Sdn Bhd, Skudai, Johor, Malaysia; [Selamat, Hazlina; Haniff, Mohamad Fadzli] Univ Teknol Malaysia, Ctr Artificial Intelligence & Robot CAIRO, Kuala Lumpur, Malaysia; [Alimin, Ahmad Jais] Univ Tun Hussein Onn Malaysia, Mech & Mfg Engn Fac, Batu Pahat, Johor, Malaysia	Universiti Teknologi Malaysia; University of Tun Hussein Onn Malaysia	Muslim, MT (corresponding author), Taman Univ, Apt Touch Sdn Bhd, Skudai, Johor, Malaysia.	mtaufiq23@gmail.com	Selamat, Hazlina/K-6740-2012	Haniff, Mohamad Fadzli/0000-0002-1680-3348; ALIMIN, AHMAD/0000-0002-1141-0094	 [Q.K130000.2509.13H78]		Funded by Q.K130000.2509.13H78, http://rmc.utm.my/, Research University Grant to Hazlina Selamat. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar A. I., 2016, J COMPUTATIONAL THEO, V13, P450, DOI DOI 10.1166/jctn.2016.4826; Ahmadizar F, 2015, ENG APPL ARTIF INTEL, V39, P1, DOI 10.1016/j.engappai.2014.11.003; Aliouane L, 2014, LECT N EARTH SYST SC, P653, DOI 10.1007/978-3-642-32408-6_142; Bennett C, 2017, MECH SYST SIGNAL PR, V85, P126, DOI 10.1016/j.ymssp.2016.07.015; Chen BC, 2013, ESTIMATION INTAKE MA; DICKINSON P, 2014, IFAC PAPERSONLINE, V47, P2987; Eberhart RC, 2000, IEEE C EVOL COMPUTAT, P84, DOI 10.1109/CEC.2000.870279; Hagan M. T, 2014, NEURAL NETWORK DESIG, V2nd; Hushim M. F., 2013, INT J ENV SCI DEV, V4, P375; Kayri Murat, 2016, Mathematical & Computational Applications, V21, DOI 10.3390/mca21020020; Khalid M, 2014, COMPUT-AIDED CIV INF, V29, P221, DOI 10.1111/mice.12005; Kolewe B, 2014, 2014 IEEE 23 INT S I; Kolewe B, 2015, IET CONTROL THEORY A, V9, P1083, DOI 10.1049/iet-cta.2014.0213; MATLAB, MOD FAULT TOL FUEL C; Muslim MT, 2014, RENEW SUST ENERG REV, V35, P279, DOI 10.1016/j.rser.2014.04.037; Muslim MT, 2012, APPL MECH MAT, V229-231, P968; Nakisa Bahareh, 2014, Journal of Computer Science, V10, P1758, DOI 10.3844/jcssp.2014.1758.1765; Nguyen-Truong HT, 2015, CHEM PHYS LETT, V629, P40, DOI 10.1016/j.cplett.2015.04.019; Poland J., 2001, TRAINING, V10, P2; Poloni T, 2014, CONTROL ENG PRACT, V23, P22, DOI 10.1016/j.conengprac.2013.10.011; Slawomir W, 2014, ACTA POLYTECH, V54, P240, DOI 10.14311/AP.2014.54.0240; Suganthan P. N., 1999, Proceedings of the 1999 Congress on Evolutionary Computation-CEC99 (Cat. No. 99TH8406), P1958, DOI 10.1109/CEC.1999.785514	23	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188553	10.1371/journal.pone.0188553	http://dx.doi.org/10.1371/journal.pone.0188553			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190779	Green Published, Green Submitted, gold			2022-12-27	WOS:000416841900073
J	Shi, AN; Qin, J; Mou, BQ; Correll, J; Weng, YJ; Brenner, D; Feng, CD; Motes, D; Yang, W; Dong, LD; Bhattarai, G; Ravelombola, W				Shi, Ainong; Qin, Jun; Mou, Beiquan; Correll, James; Weng, Yuejin; Brenner, David; Feng, Chunda; Motes, Dennis; Yang, Wei; Dong, Lingdi; Bhattarai, Gehendra; Ravelombola, Waltram			Genetic diversity and population structure analysis of spinach by single-nucleotide polymorphisms identified through genotyping-by-sequencing	PLOS ONE			English	Article							MARKER-ASSISTED SELECTION; ASSOCIATION ANALYSIS; RESISTANCE; LANDRACES	Spinach (Spinacia oleracea L., 2n = 2x = 12) is an economically important vegetable crop worldwide and one of the healthiest vegetables due to its high concentrations of nutrients and minerals. The objective of this research was to conduct genetic diversity and population structure analysis of a collection of world-wide spinach genotypes using single nucleotide polymorphisms (SNPs) markers. Genotyping by sequencing (GBS) was used to discover SNPs in spinach genotypes. Three sets of spinach genotypes were used: 1) 268 USDA GRIN spinach germplasm accessions originally collected from 30 countries; 2) 45 commercial spinach F1 hybrids from three countries; and 3) 30 US Arkansas spinach cultivars/breeding lines. The results from this study indicated that there was genetic diversity among the 343 spinach genotypes tested. Furthermore, the genetic background in improved commercial F1 hybrids and in Arkansas cultivars/lines had a different structured populations from the USDA germplasm. In addition, the genetic diversity and population structures were associated with geographic origin and germplasm from the US Arkansas breeding program had a unique genetic background. These data could provide genetic diversity information and the molecular markers for selecting parents in spinach breeding programs.	[Shi, Ainong; Qin, Jun; Weng, Yuejin; Yang, Wei; Dong, Lingdi; Bhattarai, Gehendra; Ravelombola, Waltram] Univ Arkansas, Dept Hort, Fayetteville, AR 72701 USA; [Mou, Beiquan] USDA ARS, Crop Improvement & Protect Res Unit, Salinas, CA USA; [Correll, James; Feng, Chunda] Univ Arkansas, Dept Plant Pathol, Fayetteville, AR 72701 USA; [Brenner, David] Iowa State Univ, Dep Agron, Plant Intro Stn, G212,Agron Hall, Ames, IA USA; [Motes, Dennis] Univ Arkansas, Vegetable Res Ctr, Alma, AR USA	University of Arkansas System; University of Arkansas Fayetteville; United States Department of Agriculture (USDA); University of Arkansas System; University of Arkansas Fayetteville; Iowa State University; University of Arkansas System; University of Arkansas Fayetteville	Shi, AN (corresponding author), Univ Arkansas, Dept Hort, Fayetteville, AR 72701 USA.	ashi@uark.edu; Beiquan.Mou@ARS.USDA.GOV; jcorrell@uark.edu	Shi, Ainong/L-6384-2017; Bhattarai, Gehendra/ABE-4356-2020; Bhattarai, Gehendra/N-2851-2019	Shi, Ainong/0000-0002-1066-7920; Bhattarai, Gehendra/0000-0002-2381-1629; Bhattarai, Gehendra/0000-0002-2381-1629	USDA-ARS GRIN GERMPLASM EVALUATION PROPOSAL for National Plant Germ plasm System (NPGS) by Crop Germplasm Committee (CGC) [58-5030-6-076]; USDA Specialty Crop Multistate Program (SCMP); USDA National Institute of Food and Agriculture Hatch [1002423]	USDA-ARS GRIN GERMPLASM EVALUATION PROPOSAL for National Plant Germ plasm System (NPGS) by Crop Germplasm Committee (CGC); USDA Specialty Crop Multistate Program (SCMP); USDA National Institute of Food and Agriculture Hatch	This work was supported by (1) USDA-ARS GRIN GERMPLASM EVALUATION PROPOSAL for National Plant Germ plasm System (NPGS) by Crop Germplasm Committee (CGC) with Project Number: 58-5030-6-076; (2) USDA Specialty Crop Multistate Program (SCMP); and (3) the USDA National Institute of Food and Agriculture Hatch project accession number 1002423.	[Anonymous], 2005, HORTSCIENCE, V40, P1019; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Correll JC, 2011, EUR J PLANT PATHOL, V129, P193, DOI 10.1007/s10658-010-9713-y; Dicoteau DR, 2000, VEGETABLE CROPS; Dohm JC, 2014, NATURE, V505, P546, DOI 10.1038/nature12817; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ebadi-Segheloo Asghar, 2014, Plant Breeding and Seed Science, V69, P69, DOI 10.1515/plass-2015-0007; Eftekhari S. A., 2010, Iranian Journal of Horticultural Science, V41, P83; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; GOODE MJ, 1988, HORTSCIENCE, V23, P931; Hu JG, 2007, GENET RESOUR CROP EV, V54, P1667, DOI 10.1007/s10722-006-9175-4; HULBERT SH, 1991, MOL GEN GENET, V226, P377, DOI 10.1007/BF00260649; Iquira E, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0408-y; Khattak JZK, 2007, PLANT BREEDING, V126, P454, DOI 10.1111/j.1439-0523.2007.01392.x; Kuwahara K, 2014, PLANT GENET RESOUR-C, V12, P185, DOI 10.1017/S1479262113000464; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li YH, 2008, THEOR APPL GENET, V117, P857, DOI 10.1007/s00122-008-0825-0; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Lv J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046919; Ma JB, 2016, PLANT BREEDING, V135, P399, DOI 10.1111/pbr.12369; Minoche AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0729-7; Moose SP, 2008, PLANT PHYSIOL, V147, P969, DOI 10.1104/pp.108.118232; Morelock Teddy E., 2008, V1, P189; NASS (National Agricultural Statistics Service), 2015, VEGETABLES; Nimmakayala P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-767; Pritchard JK, 2000, GENETICS, V155, P945; Sabaghnia N., 2014, Acta Agriculturae Slovenica, V103, P101, DOI 10.14720/aas.2014.103.1.11; Shi AN, 2016, EUPHYTICA, V212, P17, DOI 10.1007/s10681-016-1740-0; Shi AiNong, 2016, American Journal of Plant Sciences, V7, P1600; Shi AN, 2016, GENOME, V59, P581, DOI 10.1139/gen-2016-0075; Shi AN, 2016, EUPHYTICA, V208, P143, DOI 10.1007/s10681-015-1610-1; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Deynze A, 2014, PLANT AN GEN 22 C JA; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; [吴娅妮 Wu Yani], 2013, [园艺学报, Acta Horticulturae Sinica], V40, P913; Xu C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14598; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Zhang XZ, 2016, PROCEEDINGS 2016 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P2016, DOI 10.1109/ICIT.2016.7475077	41	21	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188745	10.1371/journal.pone.0188745	http://dx.doi.org/10.1371/journal.pone.0188745			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190770	Green Published, Green Submitted, gold			2022-12-27	WOS:000416841900117
J	Wider, D; Picard, D				Wider, Diana; Picard, Didier			Secreted dual reporter assay with Gaussia luciferase and the red fluorescent protein mCherry	PLOS ONE			English	Article							FIREFLY LUCIFERASE; ESTROGEN-RECEPTOR; GENE-EXPRESSION; BIOLUMINESCENT REPORTER; MAMMALIAN-CELLS; IN-VIVO; ACTIVATION; DNA; PATHWAY; CULTURE	The availability of a wide range of reporter proteins, which can easily be quantitated, has had a major impact on many fields of biomedical research. In some experiments with tissue culture cells, it is necessary to control for differences in transfection efficiency and in other expression parameters. This requirement has been very conveniently met with the popular dual luciferase assay. Its disadvantages are the requirement for cell lysis, the inability to analyze the same cells repeatedly, and the cost, at least in its most commonly used commercial format. Here we describe a novel dual reporter assay with the naturally secreted luciferase from Gaussia princeps as the main reporter protein and a secreted version of the red fluorescent protein mCherry as internal standard. After first measuring mCherry fluorescence in the medium, an enzyme buffer with coelenterazine as substrate is added to the same sample to trigger a glow-type luminescence of the luciferase. The simple and cheap assay can easily be adapted to a variety of experimental situations. As a case in point, we have developed a panel of Gaussia luciferase reporter genes for transcriptional activation assays with estrogen and glucocorticoid response elements, and with response elements for fusion proteins with the Gal4 DNA binding domain for use in mammalian cells. Our secreted dual reporter assay should be an attractive alternative to the currently available commercial kits.	[Wider, Diana; Picard, Didier] Univ Geneva, Dept Biol Cellulaire, Sci 3, Geneva, Switzerland	University of Geneva	Picard, D (corresponding author), Univ Geneva, Dept Biol Cellulaire, Sci 3, Geneva, Switzerland.	didier.picard@unige.ch	Wider, Diana/AAZ-9256-2020	Wider, Diana/0000-0002-7573-395X	Swiss National Science Foundation; Medic Foundation; Canton de Geneve	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medic Foundation; Canton de Geneve	This work was supported by the Swiss National Science Foundation, the Medic Foundation and the Canton de Geneve. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Pierre-Andre Briand for generating the plasmid for Ga14.VP16 and to Abhinav Joshi for the HEK 293T variant. We thank Dr. Jay Yang for providing the MMP9-mCherry plasmid. This work was supported by the Swiss National Science Foundation, the Medic Foundation, and the Canton de Geneve.	BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; CULLEN BR, 1992, METHOD ENZYMOL, V216, P362; DEWET JR, 1986, METHOD ENZYMOL, V133, P3; DEWET JR, 1985, P NATL ACAD SCI USA, V82, P7870; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Duellman T, 2015, TRAFFIC, V16, P1108, DOI 10.1111/tra.12312; Duellman T, 2015, ANAL BIOCHEM, V473, P34, DOI 10.1016/j.ab.2014.12.010; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hampf M, 2006, ANAL BIOCHEM, V356, P94, DOI 10.1016/j.ab.2006.04.046; Kaskova ZM, 2016, CHEM SOC REV, V45, P6048, DOI 10.1039/c6cs00296j; Kumita JR, 2000, BIOCHEM BIOPH RES CO, V267, P394, DOI 10.1006/bbrc.1999.1950; KUSHNER PJ, 1994, MOL ENDOCRINOL, V8, P405, DOI 10.1210/me.8.4.405; Maguire CA, 2009, ANAL CHEM, V81, P7102, DOI 10.1021/ac901234r; OW DW, 1986, SCIENCE, V234, P856, DOI 10.1126/science.234.4778.856; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; PICARD D, 1999, NUCL RECEPTORS PRACT; SEIPEL K, 1992, EMBO J, V11, P4961, DOI 10.1002/j.1460-2075.1992.tb05603.x; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sherf BA., 1996, PROMEGA NOTES, V57, P2; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; TORA L, 1989, EMBO J, V8, P1981, DOI 10.1002/j.1460-2075.1989.tb03604.x; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605; Wood Keith V., 1995, Current Opinion in Biotechnology, V6, P50, DOI 10.1016/0958-1669(95)80009-3; WOOD KV, 1998, PROMEGA NOTES, V65, P14; Wu C, 2007, BIOTECHNIQUES, V42, P290, DOI 10.2144/000112428	32	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189403	10.1371/journal.pone.0189403	http://dx.doi.org/10.1371/journal.pone.0189403			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220385	gold, Green Published, Green Submitted			2022-12-27	WOS:000417469900056
J	Banda, HT; Thomson, R; Mortimer, K; Bello, GAF; Mbera, GB; Malmborg, R; Faragher, B; Squire, SB				Banda, Hastings T.; Thomson, Rachael; Mortimer, Kevin; Bello, George A. F.; Mbera, Grace B.; Malmborg, Rasmus; Faragher, Brian; Squire, S. Bertel			Community prevalence of chronic respiratory symptoms in rural Malawi: Implications for policy	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SUB-SAHARAN AFRICA; ASTHMA; TUBERCULOSIS; BURDEN; COPD	Background No community prevalence studies have been done on chronic respiratory symptoms of cough, wheezing and shortness of breath in adult rural populations in Malawi. Case detection rates of tuberculosis (TB) and chronic airways disease are low in resource-poor primary health care facilities. Objective To understand the prevalence of chronic respiratory symptoms and recorded diagnoses of TB in rural Malawian adults in order to improve case detection and management of these diseases. Methods A population proportional, cross-sectional study was conducted to determine the proportion of the population with chronic respiratory symptoms that had a diagnosis of tuberculosis or chronic airways disease in two rural communities in Malawi. Households were randomly selected using Google Earth Pro software. Smart phones loaded with Open Data Kit Essential software were used for data collection. Interviews were conducted with 15795 people aged 15 years and above to enquire about symptoms of chronic cough, wheeze and shortness of breath. Results Overall 3554 (22.5%) participants reported at least one of these respiratory symptoms. Cough was reported by 2933, of whom 1623 (55.3%) reported cough only and 1310 (44.7%) combined with wheeze and/or shortness of breath. Only 4.6% (164/3554) of participants with chronic respiratory symptoms had one or more of the following diagnoses in their health passports (patient held medical records): TB, asthma, bronchitis and chronic obstructive pulmonary disease). Conclusions The high prevalence of chronic respiratory symptoms coupled with limited recorded diagnoses in patient-held medical records in these rural communities suggests a high chronic respiratory disease burden and unmet health need.	[Banda, Hastings T.; Bello, George A. F.; Mbera, Grace B.] Res Equ & Community Hlth Trust, Lilongwe, Malawi; [Thomson, Rachael; Mortimer, Kevin; Faragher, Brian; Squire, S. Bertel] Univ Liverpool Liverpool Sch Trop Med, Collaborat Appl Hlth Res & Delivery, Liverpool, Merseyside, England; [Malmborg, Rasmus] LHL Int, Oslo, Norway	Liverpool School of Tropical Medicine	Squire, SB (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Collaborat Appl Hlth Res & Delivery, Liverpool, Merseyside, England.	bertie.squire@lstmed.ac.uk		Squire, Stephen/0000-0001-7173-9038; Mortimer, Kevin/0000-0002-8118-8871; Thomson, Rachael/0000-0001-5010-3428	Norwegian Heart and Lung Patient Organisation (LHL International Tuberculosis Foundation); ATLAS Alliance; NORAD; National Institute of Health Research	Norwegian Heart and Lung Patient Organisation (LHL International Tuberculosis Foundation); ATLAS Alliance; NORAD(CGIAR); National Institute of Health Research(National Institute for Health Research (NIHR))	This study was funded by the Norwegian Heart and Lung Patient Organisation (LHL International Tuberculosis Foundation), The ATLAS Alliance and NORAD. The funder provided support in the form of salaries for author RM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. We thank the NIHR Global Health Research Unit on Lung Health and TB in Africa at LSTM - "IMPALA" for helping to make this work possible. In relation to IMPALA (grant number 16/136/35) specifically: IMPALA was commissioned by the National Institute of Health Research using Official Development Assistance (ODA) funding. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.	Adeloye D, 2013, CROAT MED J, V54, P519, DOI 10.3325/cmj.2013.54.519; Ahmed R, 2017, MALAWI MED J, V29, P203, DOI 10.4314/mmj.v29i2.24; Ait-Khaled N, 2001, B WORLD HEALTH ORGAN, V79, P971; [Anonymous], 2010, MAL DEM HLTH SURV 20; Banda HT, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1068-4; Bello G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183312; Bousquet J, 2007, ALLERGY, V62, P216, DOI 10.1111/j.1398-9995.2007.01307.x; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Chaulet P., 2004, WHOHTMTB2004; Chisunkha B, 2016, EUR RESPIR J, V47, P1876, DOI 10.1183/13993003.00045-2016; Chung KF, 2008, LANCET, V371, P1364, DOI 10.1016/S0140-6736(08)60595-4; Finney LJ, 2013, INT J TUBERC LUNG D, V17, P583, DOI 10.5588/ijtld.12.0619; Hasselgren M, 2001, SCAND J PRIM HEALTH, V19, P54, DOI 10.1080/028134301300034701; I-Shirawi NA-JH, 2006, PATHOGENESIS ETIOLOG, V1, P41; Kanyerere H., 2005, Malawi Medical Journal, V17, P36; Lainez YB, 2009, TROP MED INT HEALTH, V14, P564, DOI 10.1111/j.1365-3156.2009.02257.x; Makaula P, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-328; Martins P, 2009, ALLERGY, V64, P1061, DOI 10.1111/j.1398-9995.2009.01956.x; Mather, 2006, GLOBAL BURDEN DIS RI; Meghji J, 2016, AM J RESP CRIT CARE, V194, P67, DOI 10.1164/rccm.201509-1807OC; Pauwels R, 2000, CHEST, V117, p332S, DOI 10.1378/chest.117.5_suppl_2.332S; Piddock Katy C, 2014, Ann Am Thorac Soc, V11, P915, DOI 10.1513/AnnalsATS.201311-413OC; van Gemert F, 2011, PRIM CARE RESP J, V20, P240, DOI 10.4104/pcrj.2011.00027; Voll-Aanerud M, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-107; World Health Organization, 2020, GLOBAL TUBERCULOSIS	25	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188437	10.1371/journal.pone.0188437	http://dx.doi.org/10.1371/journal.pone.0188437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216193	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000417337800022
J	Fiocchetti, M; Cipolletti, M; Marino, M				Fiocchetti, Marco; Cipolletti, Manuela; Marino, Maria			Compensatory role of Neuroglobin in nervous and non-nervous cancer cells in response to the nutrient deprivation	PLOS ONE			English	Article							OXYGEN-GLUCOSE DEPRIVATION; OXIDATIVE STRESS; BREAST-CANCER; NEURODEGENERATIVE DISORDERS; HYDROGEN-PEROXIDE; CORTICAL-NEURONS; UP-REGULATION; IN-VITRO; AUTOPHAGY; APOPTOSIS	Environmental factors or adverse growth conditions that may reduce cell function or viability are considered stress. The cell ability to sense and respond to environmental stresses determine its function and survival destiny. We recently defined Neuroglobin (NGB), a heme-protein, as a compensatory protein in the 17 beta-Estradiol (E2) anti-apoptotic activity and as a sensor of oxidative stress in both neurons and breast cancer cells. Here, the possibility that NGB levels could represent a pivotal regulator of integrated response of cancer cells to stress has been evaluated. Data obtained in neuroblastoma and in breast cancer cell lines evidence that nutrient deprivation significantly up-regulated NGB levels at different time points. However, the analysis of autophagy activation led to exclude any possible role of stress-or E2-induced NGB in the upstream regulation of general autophagy. However, the over-expression of Flag-NGB in ERa stable transfected HEK-293 cells completely affects nutrient deprivation-induced decrease in cell number. In addition, reported results indicate that modulation of the anti-apoptotic Bcl-2 level may play a key role in the protective NGB function against energetic stress. Overall, these data define a role of NGB as compensatory protein in the cell machinery activated in response to stress and as general stress adaptation marker of cancer cells susceptible to oxidative stress, oxygen and, as demonstrated here for the first time, even to nutrient willingness. Despite the lacking of any direct NGB role on autophagic flux activated by energetic stress, NGB upregulation appears functional in delaying stress-related cell death allowing an appropriate cell response and adaptation to the changing extracellular conditions.	[Fiocchetti, Marco; Cipolletti, Manuela; Marino, Maria] Univ Rome Tre, Dept Sci, Viale Guglielmo Marconi, Rome, Italy	Italfarmaco; Roma Tre University	Fiocchetti, M; Marino, M (corresponding author), Univ Rome Tre, Dept Sci, Viale Guglielmo Marconi, Rome, Italy.	marco.fiocchetti@uniroma3.it; maria.marino@uniroma3.it	Fiocchetti, Marco/G-1486-2013; Marino, Maria/AAB-6357-2022	Fiocchetti, Marco/0000-0002-4888-0567; Cipolletti, Manuela/0000-0002-0987-2927	Associazione Italiana Ricerca sul Cancro (AIRC, IG) [15221]	Associazione Italiana Ricerca sul Cancro (AIRC, IG)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Associazione Italiana Ricerca sul Cancro (AIRC, IG#15221) to Maria Marino (www.airc.it). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant from Associazione Italiana Ricerca sul Cancro (AIRC, IG#15221) to M.M.	Antao ST, 2010, ANTIOXID REDOX SIGN, V13, P769, DOI 10.1089/ars.2009.2977; Ascenzi P, 2016, MOL ASPECTS MED, V52, P1, DOI 10.1016/j.mam.2016.10.004; Brittain T, 2010, IUBMB LIFE, V62, P878, DOI 10.1002/iub.405; Brittain T, 2010, INT J MOL SCI, V11, P2306, DOI 10.3390/ijms11062306; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; Caro-Maldonado A., 2011, OPEN CELL SIGNAL J, V3, P42, DOI DOI 10.2174/1876390101103010042; Chircop M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00304; De Marinis E, 2013, J NEUROENDOCRINOL, V25, P260, DOI 10.1111/jne.12007; De Marinis E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.30; De Marinis E, 2010, NEUROSIGNALS, V18, P223, DOI 10.1159/000323906; Deng S Y, 2017, Zhonghua Yi Xue Za Zhi, V97, P1505, DOI 10.3760/cma.j.issn.0376-2491.2017.19.016; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Emara M, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-33; Emara M, 2009, MOL ONCOL, V3, P45, DOI 10.1016/j.molonc.2008.11.002; Fan DH, 2015, J CLIN ENDOCR METAB, V100, pE561, DOI 10.1210/jc.2014-3257; Fiocchetti M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.418; Fiocchetti M, 2017, J CELL PHYS IN PRESS; Fiocchetti M, 2016, IUBMB LIFE, V68, P645, DOI 10.1002/iub.1522; Fiocchetti M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154959; Fordel E, 2007, GENE, V398, P114, DOI 10.1016/j.gene.2007.03.022; Fordel E, 2006, NEUROSCI LETT, V410, P146, DOI 10.1016/j.neulet.2006.09.027; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Greenberg DA, 2008, CURR OPIN PHARMACOL, V8, P20, DOI 10.1016/j.coph.2007.09.003; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Hota KB, 2012, J CEREBR BLOOD F MET, V32, P1046, DOI 10.1038/jcbfm.2012.21; Jain K, 2013, AM J CANCER RES, V3, P251; Jin KL, 2008, NEUROSCI LETT, V430, P135, DOI 10.1016/j.neulet.2007.10.031; Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200; Karantza-Wadsworth V, 2007, AUTOPHAGY, V3, P610, DOI 10.4161/auto.4867; Khan AA, 2008, FASEB J, V22, P1737, DOI 10.1096/fj.07-100784; Khan AA, 2007, P NATL ACAD SCI USA, V104, P19114, DOI 10.1073/pnas.0706167104; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lan WB, 2014, BRAIN RES, V1562, P100, DOI 10.1016/j.brainres.2014.03.020; Li LT, 2017, CELL PHYSIOL BIOCHEM, V41, P2027, DOI 10.1159/000475433; Lin Y, 2015, NEUROL RES, V37, P531, DOI 10.1179/1743132814Y.0000000420; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mei J, 2015, HUM REPROD, V30, P1677, DOI 10.1093/humrep/dev100; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nicolis S, 2007, BIOCHEM J, V407, P89, DOI 10.1042/BJ20070372; Pesiri V, 2015, CELL SIGNAL, V27, P2380, DOI 10.1016/j.cellsig.2015.08.021; Raychaudhuri S, 2010, APOPTOSIS, V15, P401, DOI 10.1007/s10495-009-0436-5; Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166; Schmidt-Kastner R, 2006, BRAIN RES, V1103, P173, DOI 10.1016/j.brainres.2006.05.047; Shang AJ, 2006, BRAIN RES, V1078, P219, DOI 10.1016/j.brainres.2006.01.064; Shanle EK, 2015, AM J TRANSL RES, V7, P1246; Simmons SO, 2009, TOXICOL SCI, V111, P202, DOI 10.1093/toxsci/kfp140; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Totta P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23727; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Watanabe S, 2012, J BIOL CHEM, V287, P30128, DOI 10.1074/jbc.M112.373381; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Yang YH, 2013, APOPTOSIS, V18, P1363, DOI 10.1007/s10495-013-0867-x; Yu ZY, 2013, NEUROBIOL DIS, V56, P95, DOI 10.1016/j.nbd.2013.04.015; Yu ZY, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/756989; Yu ZY, 2012, INT J MOL SCI, V13, P6995, DOI 10.3390/ijms13066995; Zhou GY, 2013, NEUROL SCI, V34, P1771, DOI 10.1007/s10072-013-1333-9	60	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189179	10.1371/journal.pone.0189179	http://dx.doi.org/10.1371/journal.pone.0189179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216269	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800087
J	Tsang, PWK; Fong, WP; Samaranayake, LP				Tsang, Paul Wai-Kei; Fong, Wing-Ping; Samaranayake, Lakshman Perera			Candida albicans orf19.3727 encodes phytase activity and is essential for human tissue damage	PLOS ONE			English	Article							INVASIVE CANDIDIASIS; GENE; EXPRESSION; INFECTION; DISEASE	Candida albicans is a clinically important human fungal pathogen. We previously identified the presence of cell-associated phytase activity in C. albicans. Here, we reveal for the first time, that orf19.3727 contributes to phytase activity in C. albicans and ultimately to its virulence potency. Compared with its wild type counterpart, disruption of C. albicans orf19.3727 led to decreased phytase activity, reduced ability to form hyphae, attenuated in vitro adhesion, and reduced ability to penetrate human epithelium, which are the major virulence attributes of this yeast. Thus, orf19.3727 of C. albicans plays a key role in fungal pathogenesis. Further, our data uncover a putative novel strategy for anti-Candidal drug design through inhibition of phytase activity of this common pathogen.	[Tsang, Paul Wai-Kei] Technol & Higher Educ Inst Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Fong, Wing-Ping] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Samaranayake, Lakshman Perera] Univ Sharjah, Coll Dent Med, University City, U Arab Emirates	Chinese University of Hong Kong; University of Sharjah	Tsang, PWK (corresponding author), Technol & Higher Educ Inst Hong Kong, Hong Kong, Hong Kong, Peoples R China.	paulwktsang@vtc.edu.hk		TSANG, Paul Wai-Kei/0000-0001-9163-4217	Health and Medical Research Fund; Food and Health Bureau of the Government of the HKSAR [11100992]; University Grants Council [UGC/FDS25/M04/15, UGC/FDS25/M02/16]	Health and Medical Research Fund; Food and Health Bureau of the Government of the HKSAR; University Grants Council	This work was supported by Health and Medical Research Fund, the Food and Health Bureau of the Government of the HKSAR (Project No. 11100992 to PWKT), and partially supported by Faculty Development Scheme of the University Grants Council (UGC/FDS25/M04/15 and UGC/FDS25/M02/16 to PWKT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Health and Medical Research Fund, the Food and Health Bureau of the Government of the HKSAR (Project No. 11100992 to PWKT), and partially supported by Faculty Development Scheme of the University Grants Council (UGC/FDS25/M04/15 and UGC/FDS25/M02/16 to PWKT). We thank Mr. N.F. Li, Mr. K.Y. Chau, Mr. Y.Y. Chui, and Mr. A.Wong for their excellent technical assistance. We thank Dr. J. Chao-Chu for manuscript editing.	Antinori S, 2016, EUR J INTERN MED, V34, P21, DOI 10.1016/j.ejim.2016.06.029; Bizzarri M, 2016, EXPERT OPIN DRUG MET, V12, P1181, DOI 10.1080/17425255.2016.1206887; Chen YL, 2008, INFECT IMMUN, V76, P2793, DOI 10.1128/IAI.01514-07; Dennison PMJ, 2005, FUNGAL GENET BIOL, V42, P737, DOI 10.1016/j.fgb.2005.05.006; Eggimann P, 2015, J HOSP INFECT, V89, P302, DOI 10.1016/j.jhin.2014.11.006; Haros M, 2005, FEMS MICROBIOL LETT, V247, P231, DOI 10.1016/j.femsle.2005.05.008; Jacobsen ID, 2012, EXPERT REV ANTI-INFE, V10, P85, DOI [10.1586/eri.11.152, 10.1586/ERI.11.152]; Lazado CC, 2010, FISH PHYSIOL BIOCHEM, V36, P883, DOI 10.1007/s10695-009-9364-0; Lim CSY, 2012, EUR J CLIN MICROBIOL, V31, P21, DOI 10.1007/s10096-011-1273-3; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Nakamura Y, 2000, BIOSCI BIOTECH BIOCH, V64, P841, DOI 10.1271/bbb.64.841; Quan CS, 2001, J BIOSCI BIOENG, V92, P154, DOI 10.1016/S1389-1723(01)80217-6; Samaranayake YH, 2006, APMIS, V114, P857, DOI 10.1111/j.1600-0463.2006.apm_479.x; Samaranayake YH, 2005, J MED MICROBIOL, V54, P583, DOI 10.1099/jmm.0.45762-0; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; Schaller M, 2006, NAT PROTOC, V1, P2767, DOI 10.1038/nprot.2006.474; Shao N, 2008, J MICROBIOL BIOTECHN, V18, P1221; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Tsang PWK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050866; Tsang PWK, 2011, MYCOPATHOLOGIA, V172, P473, DOI 10.1007/s11046-011-9453-3; Tsang PWK, 2010, YEAST, V27, P53, DOI 10.1002/yea.1732; Walther A, 2008, NAT PROTOC, V3, P1414, DOI 10.1038/nprot.2008.137	24	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189219	10.1371/journal.pone.0189219	http://dx.doi.org/10.1371/journal.pone.0189219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216308	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800097
J	Yamashita, J; Ohmoto, M; Yamaguchi, T; Matsumoto, I; Hirota, J				Yamashita, Junpei; Ohmoto, Makoto; Yamaguchi, Tatsuya; Matsumoto, Ichiro; Hirota, Junji			Skn-1a/Pou2f3 functions as a master regulator to generate Trpm5-expressing chemosensory cells in mice	PLOS ONE			English	Article							SOLITARY CHEMORECEPTOR CELLS; TASTE RECEPTOR-CELLS; TUFT CELLS; CATION CHANNEL; NASAL CAVITY; TRPM5; ACETYLCHOLINE; EPITHELIUM; IMMUNITY; GUT	Transient receptor potential channel M5 (Trpm5)-expressing cells, such as sweet, umami, and bitter taste cells in the oropharyngeal epithelium, solitary chemosensory cells in the nasal respiratory epithelium, and tuft cells in the small intestine, that express taste-related genes function as chemosensory cells. Previous studies demonstrated that Skn-1a/Pou2f3, a POU homeodomain transcription factor is expressed in these Trpm5-expressing chemosensory cells, and is necessary for their generation. Trpm5-expressing cells have recently been found in trachea, auditory tube, urethra, thymus, pancreatic duct, stomach, and large intestine. They are considered to be involved in protective responses to potential hazardous compounds as Skn-1a-dependent bitter taste cells, respiratory solitary chemosensory cells, and intestinal tuft cells are. In this study, we examined the expression and function of Skn1a/Pou2f3 in Trpm5-expressing cells in trachea, auditory tube, urethra, thymus, pancreatic duct, stomach, and large intestine. Skn-1a/Pou2f3 is expressed in a majority of Trpm5-expressing cells in all tissues examined. In Skn-1a/Pou2f3-deficient mice, the expression of Trpm5 as well as marker genes for Trpm5-expressing cells were absent in all tested tissues. Immunohistochemical analyses demonstrated that two types of microvillous cells exist in trachea, urethra, and thymus, Trpm5-positive and Trpm5-negative cells. In Skn-1a/Pou2f3-deficient mice, a considerable proportion of Trpm5-negative and villin-positive microvillous cells remained present in these tissues. Thus, we propose that Skn-1a/Pou2f3 is the master regulator for the generation of the Trpm5-expressing microvillous cells in multiple tissues.	[Yamashita, Junpei; Yamaguchi, Tatsuya; Hirota, Junji] Tokyo Inst Technol, Grad Sch Life Sci & Technol, Dept Life Sci & Technol, Yokohama, Kanagawa, Japan; [Ohmoto, Makoto; Matsumoto, Ichiro] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA; [Hirota, Junji] Tokyo Inst Technol, Ctr Biol Resources & Informat, Yokohama, Kanagawa, Japan	Tokyo Institute of Technology; Monell Chemical Senses Center; Tokyo Institute of Technology	Hirota, J (corresponding author), Tokyo Inst Technol, Grad Sch Life Sci & Technol, Dept Life Sci & Technol, Yokohama, Kanagawa, Japan.; Hirota, J (corresponding author), Tokyo Inst Technol, Ctr Biol Resources & Informat, Yokohama, Kanagawa, Japan.	jhirota@bio.titech.ac.jp	Hirota, Junji/O-9315-2019; Hirota, Junji/G-1357-2019	Hirota, Junji/0000-0002-5741-0655; Hirota, Junji/0000-0002-5741-0655	MEXT KAKENHI [JP20570208, JP16K07366]; JSPS KAKENHI; Yamazaki Spice Promotion Foundation [131]; NIH [R01DC015491];  [JP15J05301]; Grants-in-Aid for Scientific Research [16K07366, 15J05301] Funding Source: KAKEN; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC015491] Funding Source: NIH RePORTER	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Yamazaki Spice Promotion Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by grant support from MEXT KAKENHI (Grant Number JP20570208 and JP16K07366 to J.H.), JSPS KAKENHI, Grant-in-Aid for JSPS Fellows (JP15J05301 to J.Y.), the Yamazaki Spice Promotion Foundation (131 to J.H.), an NIH grant (R01DC015491 to IM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crowder EA, 2007, J PHYSIOL-LONDON, V582, P1047, DOI 10.1113/jphysiol.2007.134577; Deckmann K, 2014, P NATL ACAD SCI USA, V111, P8287, DOI 10.1073/pnas.1402436111; DelGiorno KE, 2014, GASTROENTEROLOGY, V146, P233, DOI 10.1053/j.gastro.2013.08.053; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Gerbe F, 2011, J CELL BIOL, V192, P767, DOI 10.1083/jcb.201010127; Gerbe F, 2009, GASTROENTEROLOGY, V137, P2179, DOI 10.1053/j.gastro.2009.06.072; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Kaske S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-49; Krasteva G, 2012, LIFE SCI, V91, P992, DOI 10.1016/j.lfs.2012.06.014; Krasteva G, 2012, HISTOCHEM CELL BIOL, V137, P483, DOI 10.1007/s00418-012-0911-x; Krasteva G, 2011, P NATL ACAD SCI USA, V108, P9478, DOI 10.1073/pnas.1019418108; Lemons K, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0135-17.2017; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Matsumoto I, 2011, NAT NEUROSCI, V14, P685, DOI 10.1038/nn.2820; Ogura T, 2011, J NEUROPHYSIOL, V106, P1274, DOI 10.1152/jn.00186.2011; Ogura T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011924; Ohmoto M, 2008, MOL CELL NEUROSCI, V38, P505, DOI 10.1016/j.mcn.2008.04.011; Ohmoto M, 2013, BIOSCI BIOTECH BIOCH, V77, P2154, DOI 10.1271/bbb.130454; Panneck AR, 2014, CELL TISSUE RES, V358, P737, DOI 10.1007/s00441-014-2002-x; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Prandi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082820; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Saqui-Salces M, 2011, HISTOCHEM CELL BIOL, V136, P191, DOI 10.1007/s00418-011-0831-1; Saunders CJ, 2014, P NATL ACAD SCI USA, V111, P6075, DOI 10.1073/pnas.1402251111; Schutz B, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00087; Tizzano M, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-3; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Tomonari H, 2012, CHEM SENSES, V37, P241, DOI 10.1093/chemse/bjr098; Ushiama S, 2016, EBIOMEDICINE, V8, P60, DOI 10.1016/j.ebiom.2016.04.031; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Yamaguchi T, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-13	33	57	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189340	10.1371/journal.pone.0189340	http://dx.doi.org/10.1371/journal.pone.0189340			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216297	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800119
J	Yannarelli, G; Pacienza, N; Montanari, S; Santa-Cruz, D; Viswanathan, S; Keating, A				Yannarelli, Gustavo; Pacienza, Natalia; Montanari, Sonia; Santa-Cruz, Diego; Viswanathan, Sowmya; Keating, Armand			OCT4 expression mediates partial cardiomyocyte reprogramming of mesenchymal stromal cells	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; EMBRYONIC STEM-CELLS; BONE-MARROW; CARDIAC-FUNCTION; FUNCTIONAL CARDIOMYOCYTES; DIFFERENTIATION CAPACITY; INDUCED PLURIPOTENCY; DIRECT CONVERSION; EMERGING CONCEPTS; PROGENITOR CELLS	Mesenchymal stem/stromal cells (MSCs) are in numerous cell therapy clinical trials, including for injured myocardium. Acquisition of cardiomyocyte characteristics by MSCs may improve cardiac regeneration but the mechanisms regulating this process are unclear. Here, we investigated whether the pluripotency transcription factor OCT4 is involved in the activation of cardiac lineage genetic programs in MSCs. We employed our established co-culture model of MSCs with rat embryonic cardiomyocytes showing co-expression of cardiac markers on MSCs independent of cell fusion. Bone marrow-derived MSCs were isolated from transgenic mice expressing GFP under the control of the cardiac-specific amyosin heavy chain promoter. After 5 days of co-culture, MSCs expressed cardiac specific genes, including Nkx2.5, atrial natriuretic factor and a-cardiac actin. The frequency of GFP+cells was 7.6 +/- 1.9%, however, these cells retained the stromal cell phenotype, indicating, as expected, only partial differentiation. Global OCT4 expression increased 2.6 +/- 0.7-fold in co-cultured MSCs and of interest, 87-5% vs 79-4% of MSCs expressed OCT4 by flow cytometry in controls and after co-culture, respectively. Consistent with the latter observation, the GFP+ cells did not express nuclear OCT4 and showed a significant increase in OCT4 promoter methylation compared with undifferentiated MSCs (92% vs 45%), inferring that OCT4 is regulated by an epigenetic mechanism. We further showed that siRNA silencing of OCT4 in MSCs resulted in a reduced frequency of GFP+ cells in co-culture to less than 1%. Our data infer that OCT4 expression may have a direct effect on partial cardiomyocyte reprogramming of MSCs and suggest a new mechanism(s) associated with MSC multipotency and a requirement for crosstalk with the cardiac microenvironment.	[Yannarelli, Gustavo; Montanari, Sonia; Viswanathan, Sowmya; Keating, Armand] Univ Hlth Network, Princess Margaret Canc Ctr, Cell Therapy Program, Toronto, ON, Canada; [Yannarelli, Gustavo; Pacienza, Natalia; Santa-Cruz, Diego] Univ Favaloro, CONICET, Inst Med Traslac Trasplante & Bioingn IMeTTyB, Lab Regulac Gen & Celulas Madre, Buenos Aires, DF, Argentina	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Yannarelli, G (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Cell Therapy Program, Toronto, ON, Canada.; Yannarelli, G (corresponding author), Univ Favaloro, CONICET, Inst Med Traslac Trasplante & Bioingn IMeTTyB, Lab Regulac Gen & Celulas Madre, Buenos Aires, DF, Argentina.	gyannarelli@favaloro.edu.ar	Viswanathan, Sowmya/GRO-4533-2022; Viswanathan, Sowmya/N-1983-2019; Yannarelli, Gustavo/J-6055-2019	Viswanathan, Sowmya/0000-0002-4552-0179; Yannarelli, Gustavo/0000-0003-1450-5483; Keating, Armand/0000-0002-7676-6059; Santa-Cruz, Diego/0000-0001-7419-6120; Pacienza, Natalia/0000-0002-6124-5269	Orsino Translational Research Laboratory of Princess Margaret Hospital; Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation of University Health Network; University of Toronto; Agencia Nacional de Promocion Cientffica y Tecnologica (ANPCyT) of Argentina [PICT-2014-1198]	Orsino Translational Research Laboratory of Princess Margaret Hospital; Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation of University Health Network; University of Toronto(University of Toronto); Agencia Nacional de Promocion Cientffica y Tecnologica (ANPCyT) of Argentina(ANPCyT)	This work was supported by the Orsino Translational Research Laboratory of Princess Margaret Hospital, by the Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation of University Health Network and the University of Toronto held by AK, and by Grant PICT-2014-1198 from the Agencia Nacional de Promocion Cientffica y Tecnologica (ANPCyT) of Argentina held by GY.	Afzal MR, 2015, CIRC RES, V117, P558, DOI 10.1161/CIRCRESAHA.114.304792; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Altun G, 2010, J CELL BIOCHEM, V109, P1, DOI 10.1002/jcb.22374; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Behfar A, 2010, J AM COLL CARDIOL, V56, P721, DOI 10.1016/j.jacc.2010.03.066; Davani S, 2003, CIRCULATION, V108, P253, DOI 10.1161/01.cir.0000089186.09692.fa; Dayan V, 2011, BASIC RES CARDIOL, V106, P1299, DOI 10.1007/s00395-011-0221-9; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eguchi G, 1993, CURR OPIN CELL BIOL, V5, P1023, DOI 10.1016/0955-0674(93)90087-7; Fisher SA, 2015, CIRC RES, V116, P1361, DOI 10.1161/CIRCRESAHA.116.304386; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Gallo MP, 2007, J CELL BIOCHEM, V100, P86, DOI 10.1002/jcb.21012; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Greco SJ, 2007, STEM CELLS, V25, P3143, DOI 10.1634/stemcells.2007-0351; Halkos ME, 2008, BASIC RES CARDIOL, V103, P525, DOI 10.1007/s00395-008-0741-0; Hao Q, 2015, CELL REPROGRAM, V17, P347, DOI 10.1089/cell.2015.0025; Hermann A, 2010, CYTOTHERAPY, V12, P17, DOI 10.3109/14653240903313941; Hodgkinson CP, 2016, CIRC RES, V118, P95, DOI 10.1161/CIRCRESAHA.115.305373; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Li Q, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt213; Liu TM, 2009, STEM CELLS DEV, V18, P1013, DOI 10.1089/scd.2008.0335; Liu Y, 2011, STEM CELLS, V29, P2077, DOI 10.1002/stem.764; Liu Y, 2010, CELL BIOL INT, V34, P1075, DOI 10.1042/CBI20100516; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maniatis T, 1989, MOL CLONING LAB MANU, V2; Merrell AJ, 2016, NAT REV MOL CELL BIO, V17, P413, DOI 10.1038/nrm.2016.24; Nagura S, 2013, CELL REPROGRAM, V15, P471, DOI 10.1089/cell.2013.0002; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Noiseux N, 2006, MOL THER, V14, P840, DOI 10.1016/j.ymthe.2006.05.016; Nowbar AN, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2688; Papp B, 2013, CELL, V152, P1324, DOI 10.1016/j.cell.2013.02.043; Pei DQ, 2009, J BIOL CHEM, V284, P3365, DOI 10.1074/jbc.R800063200; Pochampally RR, 2004, BLOOD, V103, P1647, DOI 10.1182/blood-2003-06-1967; Prockop DJ, 2016, MATRIX BIOL, V51, P7, DOI 10.1016/j.matbio.2016.01.010; Radzisheuskaya A, 2014, TRENDS CELL BIOL, V24, P275, DOI 10.1016/j.tcb.2013.11.010; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Rose RA, 2008, STEM CELLS, V26, P2884, DOI 10.1634/stemcells.2008-0329; Rui YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11056; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; SHIMAZAKI T, 1993, EMBO J, V12, P4489, DOI 10.1002/j.1460-2075.1993.tb06138.x; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Singh A, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0341-0; Song L, 2004, FASEB J, V18, P980, DOI 10.1096/fj.03-1100fje; Sterneckert J, 2012, STEM CELLS, V30, P15, DOI 10.1002/stem.765; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tantin D, 2013, DEVELOPMENT, V140, P2857, DOI 10.1242/dev.095927; Torper O, 2013, P NATL ACAD SCI USA, V110, P7038, DOI 10.1073/pnas.1303829110; Ullah M, 2014, INT J BIOCHEM CELL B, V46, P124, DOI 10.1016/j.biocel.2013.11.010; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Yannarelli G, 2014, STEM CELL REV REP, V10, P304, DOI 10.1007/s12015-013-9483-y; Yannarelli G, 2013, CELL TRANSPLANT, V22, P1651, DOI 10.3727/096368912X657675; Yannarelli G, 2013, STEM CELLS, V31, P215, DOI 10.1002/stem.1262; Yoon CH, 2010, CIRCULATION, V121, P2001, DOI 10.1161/CIRCULATIONAHA.109.909291; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	58	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189131	10.1371/journal.pone.0189131	http://dx.doi.org/10.1371/journal.pone.0189131			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216265	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800080
J	Yin, N; Fang, L; Shi, XH; Huang, HQ; Zhang, L				Yin, Ning; Fang, Lei; Shi, Xiaohua; Huang, Hongqiang; Zhang, Li			A comprehensive scoring system in correlation with perioperative airway management for neonatal Pierre Robin Sequence	PLOS ONE			English	Article							LARYNGEAL MASK AIRWAY; TRACHEAL INTUBATION	Purpose To evaluate a comprehensive scoring system which combines clinical manifestations of Pierre Robin Sequence (PRS) including severity of breathing difficulties, body weight and preoperative Cormack-Lehane grade, for its correlation with perioperative PRS airway management decision. Design Forty PRS children were retrospectively recruited after surgery. Specialists examined all subjects and scored for clinical manifestations (1' - 4'), weight gain (1' - 4'), dyspnea scores (1' - 4'), and Cormack- Lehane grade (1' - 4'). The correlation of the integrated scores and the necessity of endotracheal intubation or laryngeal mask application were analyzed. In addition, the score correlation with postoperative dyspnea and/or low pulse oxygen saturation (SPO2) levels after extubation was determined. Findings In our study every individual patient had a score from 0' to 16', while the higher in the numbers represented higher risk of breathing difficulty. All patients with comprehensive scores < 10 points underwent endotracheal intubation successfully. Patients scoring 10-12 points had an intubation success rate of 47%, whereas all patients scored > 13 points required a laryngeal mask assisted airway management and were considered to have difficult airways. Dyspnea after extubation and postoperative low SPO2 occurred among patients who scored over 10 points. Conclusion In PRS patients, preoperative weight gaining status and severity of dyspnea in combination with Cormack-Lehane classification provide a scoring system that could help to optimize airway management decisions such as endotracheal intubation or laryngeal mask airway placement and has the potential to predict postoperative dyspnea or low SPO2 levels.	[Yin, Ning] Nanjing Med Univ, Sir Run Run Hosp, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China; [Yin, Ning; Fang, Lei] Southeast Univ, Zhongda Hosp, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China; [Yin, Ning; Fang, Lei] Southeast Univ, Sch Med, Nanjing, Jiangsu, Peoples R China; [Shi, Xiaohua; Huang, Hongqiang; Zhang, Li] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China; Southeast University - China; Nanjing Medical University	Yin, N (corresponding author), Nanjing Med Univ, Sir Run Run Hosp, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China.; Yin, N (corresponding author), Southeast Univ, Zhongda Hosp, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China.; Yin, N (corresponding author), Southeast Univ, Sch Med, Nanjing, Jiangsu, Peoples R China.	yinning882000@126.com						BARAKA A, 1995, ANESTHESIOLOGY, V83, P645; CAOUETTELABERGE L, 1994, PLAST RECONSTR SURG, V93, P934, DOI 10.1097/00006534-199404001-00006; Cladis F, 2014, ANESTH ANALG, V119, P400, DOI 10.1213/ANE.0000000000000301; CORMACK RS, 1984, ANAESTHESIA, V39, P1105, DOI 10.1111/j.1365-2044.1984.tb08932.x; Dinwiddie Robert, 2004, Paediatr Respir Rev, V5, P17, DOI 10.1016/j.prrv.2003.10.001; Gandini D, 2003, PAEDIATR ANAESTH, V13, P181, DOI 10.1046/j.1460-9592.2003.01019_4.x; Gangopadhyay Noopur, 2012, Semin Plast Surg, V26, P76, DOI 10.1055/s-0032-1320065; HANSEN TG, 1995, ACTA ANAESTH SCAND, V39, P129, DOI 10.1111/j.1399-6576.1995.tb05604.x; Hong Paul, 2015, Ear Nose Throat J, V94, pE25; Mackay DR, 2011, J CRANIOFAC SURG, V22, P415, DOI 10.1097/SCS.0b013e3182074799; MARKAKIS DA, 1992, ANESTH ANALG, V75, P823; Marston AP, 2012, LARYNGOSCOPE, V122, P1401, DOI 10.1002/lary.23260; Ryan G, 2016, SEMIN FETAL NEONAT M, V21, P230, DOI 10.1016/j.siny.2016.03.002; Smith MC, 2006, INT J PEDIATR OTORHI, V70, P319, DOI 10.1016/j.ijporl.2005.07.003; St-Hilaire H, 2000, OTOLARYNG CLIN N AM, V33, P1241, DOI 10.1016/S0030-6665(05)70279-6; Xiong X, 2007, MATERN CHILD HLTH J, V11, P57, DOI 10.1007/s10995-006-0140-9	16	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189052	10.1371/journal.pone.0189052	http://dx.doi.org/10.1371/journal.pone.0189052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216230	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800061
J	Zhao, Q; Lu, YZ; Gan, XQ; Yu, HY				Zhao, Qian; Lu, Yuezhi; Gan, Xueqi; Yu, Haiyang			Low magnitude high frequency vibration promotes adipogenic differentiation of bone marrow stem cells via P38 MAPK signal (vol 12, e0172954, 2017)	PLOS ONE			English	Correction									[Zhao, Qian; Lu, Yuezhi; Gan, Xueqi; Yu, Haiyang] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China	Sichuan University	Zhao, Q (corresponding author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China.							QIAN Z, 2017, PLOS ONE, V12, DOI DOI 10.1371/JOURNAL.PONE.0172954; Zhao Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172954	2	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189547	10.1371/journal.pone.0189547	http://dx.doi.org/10.1371/journal.pone.0189547			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216316	gold, Green Published, Green Submitted			2022-12-27	WOS:000417337800126
J	Cassidy, S; Trenell, MI; Anderson, KN				Cassidy, Sophie; Trenell, Michael I.; Anderson, Kirstie N.			The cardio-metabolic impact of taking commonly prescribed analgesic drugs in 133,401 UK Biobank participants	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; UNITED-STATES; SLEEP DURATION; METAANALYSIS; OBESITY; RISK; PAIN; QUESTIONNAIRE; VALIDITY; ADULTS	Objective There has been a significant increase in the prescribing of medication for chronic non-cancer pain. In a UK population sample, we aimed to assess cardio-metabolic (CM) health in those taking these chronic pain medications. Methods 133,401 participants from the UK Biobank cohort were studied. BMI, waist cm and hypertension were compared between those on drugs prescribed for chronic pain and CM drugs to those on CM drugs only. Multiple confounders were controlled for. Results Those taking opiates and CM drugs had the worst CM health profile with a 95%, 82% and 63% increased odds of reporting obesity, 'ery high risk' waist circumference and hypertension, respectively (OR [95% CI] 1.95 [1.75-2.17], 1.82 [1.63-2.03], 1.63 [1.45-1.84]), compared to those on CM drugs alone. Those taking neuropathic pain medications and CM drugs also demonstrate worse CM profile than those taking CM drugs only. Conclusions The impact of medications for chronic pain and sleep upon CM health and obesity is of concern for these classes of drugs which have been recently labelled as dependency forming medications. The results from this cross sectional study warrants further investigation and adds further support to calls for these medications to be prescribed for shorter periods.	[Cassidy, Sophie; Trenell, Michael I.] Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Anderson, Kirstie N.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Cassidy, S (corresponding author), Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.	sophie.cassidy@ncl.ac.uk		cassidy, sophie/0000-0002-0228-7274; Trenell, Michael/0000-0001-8253-5620; Anderson, Kirstie N/0000-0001-5767-918X	Medical Research Council [MR/L016354/1, MC_QA137853, G0700718] Funding Source: Medline; Alzheimer&apos;s Society [189] Funding Source: Medline; Department of Health [SRF-2011-04-017] Funding Source: Medline; ESRC [ES/K007688/1] Funding Source: UKRI; MRC [MR/L016354/1, G0700718] Funding Source: UKRI; Medical Research Council [MC_qA137853] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer&apos;s Society; Department of Health; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		[Anonymous], PRESCRIBING PATTERNS; BERKEN GH, 1984, J AFFECT DISORDERS, V7, P133, DOI 10.1016/0165-0327(84)90031-4; Bohra MH, 2014, BRIT J PAIN, V8, P107, DOI 10.1177/2049463714525355; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Broussard JL, 2016, CURR OPIN ENDOCRINOL, V23, P353, DOI 10.1097/MED.0000000000000276; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Cassidy S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010038; Caulfield M, 2003, LANCET, V361, P2118, DOI 10.1016/S0140-6736(03)13722-1; Colameco S, 2009, POSTGRAD MED, V121, P61, DOI 10.3810/pgm.2009.07.2032; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; Freeman R, 2008, DIABETES CARE, V31, P1448, DOI 10.2337/dc07-2105; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hardy T, 2007, DIABETES CARE, V30, P21, DOI 10.2337/dc06-0947; IPAQ, 2005, GUIDELINES DATA PROC; Li Q, 2015, PHARMACOECONOMICS, V33, P735, DOI 10.1007/s40273-014-0248-5; Markota M, 2016, MAYO CLIN PROC, V91, P1632, DOI 10.1016/j.mayocp.2016.07.024; Moore RA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008242.pub3; Mysels David J, 2010, J Opioid Manag, V6, P445; Domecq JP, 2015, J CLIN ENDOCR METAB, V100, P363, DOI 10.1210/jc.2014-3421; Pak TY, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0081-5; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Quilici S, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-6; Ray WA, 2016, JAMA-J AM MED ASSOC, V315, P2415, DOI 10.1001/jama.2016.7789; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Ruscitto A, 2015, EUR J PAIN, V19, P59, DOI 10.1002/ejp.520; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shaheed CA, 2016, JAMA INTERN MED, V176, P958, DOI 10.1001/jamainternmed.2016.1251; Toth C, 2014, THER ADV DRUG SAF, V5, P38, DOI 10.1177/2042098613505614; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086	31	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187982	10.1371/journal.pone.0187982	http://dx.doi.org/10.1371/journal.pone.0187982			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211804	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200023
J	Cohen, RL; Murray, J; Jack, S; Arscott-Mills, S; Verardi, V				Cohen, Robert L.; Murray, John; Jack, Susan; Arscott-Mills, Sharon; Verardi, Vincenzo			Impact of multisectoral health determinants on child mortality 1980-2010: An analysis by country baseline mortality	PLOS ONE			English	Article							TRANSMISSION; TRANSITION; NUTRITION; NEWBORN; ENGLAND; DECLINE; WALES; CARE	Introduction Some health determinants require relatively stronger health system capacity and socioeconomic development than others to impact child mortality. Few quantitative analyses have analyzed how the impact of health determinants varies by mortality level. Methods 149 low- and middle-income countries were stratified into high, moderate, low, and very low baseline levels of child mortality in 1990. Data for 52 health determinants were collected for these countries for 1980-2010. To quantify how changes in health determinants were associated with mortality decline, univariable and multivariable regression models were constructed. An advanced statistical technique that is new for child mortality analyses D MM-estimation with first differences and country clustering D controlled for outliers, fixed effects, and variation across decades. Findings Some health determinants (immunizations, education) were consistently associated with child mortality reduction across all mortality levels. Others (staff availability, skilled birth attendance, fertility, water and sanitation) were associated with child mortality reduction mainly in low or very low mortality settings. The findings indicate that the impact of some health determinants on child mortality was only apparent with stronger health systems, public infrastructure and levels of socioeconomic development, whereas the impact of other determinants was apparent at all stages of development. Multisectoral progress was essential to mortality reduction at all baseline mortality levels. Conclusion Policy-makers can use such analyses to direct investments in health and non-health sectors and to set five-year child mortality targets appropriate for their baseline mortality levels and local context.	[Cohen, Robert L.] US Agcy Int Dev, Washington, DC 20523 USA; [Jack, Susan] Univ Otago, Dunedin, New Zealand; [Arscott-Mills, Sharon] ICF, Fairfax, VA USA; [Verardi, Vincenzo] Univ Libre Bruxelles, Brussels, Belgium	United States Agency for International Development (USAID); University of Otago; Universite Libre de Bruxelles	Cohen, RL (corresponding author), US Agcy Int Dev, Washington, DC 20523 USA.	rcohen@usaid.gov	Dangal, Ganesh/O-1989-2017	Dangal, Ganesh/0000-0002-5834-5525; Cohen, Robert/0000-0002-5666-117X	Partnership for Maternal, Newborn, and Child Health (PMNCH); Belgian National Science Foundation	Partnership for Maternal, Newborn, and Child Health (PMNCH); Belgian National Science Foundation	This project was supported by consulting fees for authors (RC, JM, SJ, SAM) from the Partnership for Maternal, Newborn, and Child Health (PMNCH). VV received financial support from the Belgian National Science Foundation. JM (independent consultant) does not consult for any commercial entities and received no other funding for work on this project. SAM is employed by ICF, a commercial entity, and received no funding from ICF for work on this project. The funders provided support in the form of salaries, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the author contributions section.; We acknowledge Shyama Kuruvilla, Nicholas Furtado, Jennifer Franz-Vasdeki and Rachael Hinton for discussion. VV acknowledges financial support from the Belgian National Science Foundation. This paper was completed by the authors in their personal capacity. The views expressed within do not necessarily represent the views of their associated institutions.	Andre FE, 2008, B WORLD HEALTH ORGAN, V86, P140, DOI 10.2471/BLT.07.040089; Austin A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S2-S1; Bhutta ZA, 2013, LANCET, V382, P486, DOI 10.1016/S0140-6736(13)60716-3; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Bishai DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144908; Burstrom B, 2005, AM J PUBLIC HEALTH, V95, P208, DOI 10.2105/AJPH.2003.034900; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Chi BH, 2013, CURR OPIN HIV AIDS, V8, P498, DOI 10.1097/COH.0b013e3283637f7a; Clasen TF, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007180.pub2; Cohen RL, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0067-7; Dangour AD, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009382.pub2; De Brouwere V, 1998, TROP MED INT HEALTH, V3, P771, DOI 10.1046/j.1365-3156.1998.00310.x; Dehon C, 2012, ADV ECONOMETRICS, V29; Dickson KE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S1; Dieleman JL, 2016, LANCET, V387, P2536, DOI 10.1016/S0140-6736(16)30168-4; Every Woman Every Child, 2016, COUNTR DAT U ACC MON; Fink G, 2011, INT J EPIDEMIOL, V40, P1196, DOI 10.1093/ije/dyr102; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Imdad A, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008524.pub3; Kirk D, 1996, POP STUD-J DEMOG, V50, P361, DOI 10.1080/0032472031000149536; Knippenberg R, 2005, LANCET, V365, P1087, DOI 10.1016/S0140-6736(05)74233-1; Kuruvilla S, 2014, B WORLD HEALTH ORGAN, V92, P533, DOI 10.2471/BLT.14.138131; Lawson DW, 2012, P R SOC B, P1; Lim SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001091; Lucas R., 1976, PHILLIPS CURVE LABOR, P19; MCKEOWN T, 1975, POP STUD-J DEMOG, V29, P391, DOI 10.2307/2173935; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Pritchett L, 1996, J HUM RESOUR, V31, P841, DOI 10.2307/146149; Roushdy R, 2012, IMPACT WATER SUPPLY, V24; Shenk MK, 2013, P NATL ACAD SCI USA, V110, P8045, DOI 10.1073/pnas.1217029110; Shiffman J, 2000, STUD FAMILY PLANN, V31, P274, DOI 10.1111/j.1728-4465.2000.00274.x; StataCorp, 2013, STATA STAT SOFTW REL; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Szreter S, 2002, AM J PUBLIC HEALTH, V92, P722, DOI 10.2105/AJPH.92.5.722; Szreter Simon, 1988, SOCIAL SCI MED, V1, P1, DOI DOI 10.1145/1073943.1073950; UN Inter-Agency Group for Mortality Estimation, 2015, LEV TRENDS CHILD MOR; Verardi V, 2009, STATA J, V9, P439, DOI 10.1177/1536867X0900900306; Walker N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S1; Wang H, 2014, GLOBAL REGIONAL NATL; Wettstein C, 2012, AIDS, V26, P2361, DOI 10.1097/QAD.0b013e328359ab0c; WHO, SUCC FACT WOM CHILDR; WHO,, 2014, POL GUID IMPL ESS IN; WHO Aga Khan University PMNCH, 2011, ESS INT COMM GUID RE; WHO UNICEF, 2017, TRACK PROGR BREASTF; WOODS RI, 1989, POP STUD-J DEMOG, V43, P113, DOI 10.1080/0032472031000143876; WOODS RI, 1988, POP STUD-J DEMOG, V42, P343, DOI 10.1080/0032472031000143516; World Health Organization & UNICEF, 2014, COUNTD 2015 FULF HLT	48	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188762	10.1371/journal.pone.0188762	http://dx.doi.org/10.1371/journal.pone.0188762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211765	gold, Green Published, Green Submitted			2022-12-27	WOS:000417212200047
J	Fong, EA; Wilhite, AW				Fong, Eric A.; Wilhite, Allen W.			Authorship and citation manipulation in academic research	PLOS ONE			English	Article							HONORARY AUTHORSHIP; MISBEHAVIOR; PLAGIARISM; SCIENTISTS; JOURNALS	Some scholars add authors to their research papers or grant proposals even when those individuals contribute nothing to the research effort. Some journal editors coerce authors to add citations that are not pertinent to their work and some authors pad their reference lists with superfluous citations. How prevalent are these types of manipulation, why do scholars stoop to such practices, and who among us is most susceptible to such ethical lapses? This study builds a framework around how intense competition for limited journal space and research funding can encourage manipulation and then uses that framework to develop hypotheses about who manipulates and why they do so. We test those hypotheses using data from over 12,000 responses to a series of surveys sent to more than 110,000 scholars from eighteen different disciplines spread across science, engineering, social science, business, and health care. We find widespread misattribution in publications and in research proposals with significant variation by academic rank, discipline, sex, publication history, coauthors, etc. Even though the majority of scholars disapprove of such tactics, many feel pressured to make such additions while others suggest that it is just the way the game is played. The findings suggest that certain changes in the review process might help to stem this ethical decline, but progress could be slow.	[Fong, Eric A.] Univ Alabama, Dept Management, Huntsville, AL 35899 USA; [Wilhite, Allen W.] Univ Alabama, Dept Econ, Huntsville, AL 35899 USA	University of Alabama System; University of Alabama Huntsville; University of Alabama System; University of Alabama Huntsville	Wilhite, AW (corresponding author), Univ Alabama, Dept Econ, Huntsville, AL 35899 USA.	wilhitea@uah.edu		Wilhite, Allen/0000-0002-0787-1314	Office of Research Integrity through Department of Health and Human Services [ORIIR130003]	Office of Research Integrity through Department of Health and Human Services	This publication was made possible by a grant from the Office of Research Integrity through the Department of Health and Human Services: Grant Number ORIIR130003. Contents are solely the responsibility of the authors and do not necessarily represent the official views of the Department of Health and Human Services or the Office of Research Integrity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Herz W, 2014, J MED ETHICS, V40, P346, DOI 10.1136/medethics-2012-101311; Alvesson M, 2011, ACAD MANAGE REV, V36, P247, DOI 10.5465/AMR.2011.59330882; Anderson MS, 2007, SCI ENG ETHICS, V13, P387, DOI 10.1007/s11948-007-9047-0; Anderson MS, 2007, ACAD MED, V82, P853, DOI 10.1097/ACM.0b013e31812f764c; [Anonymous], 2016, RES POLICY, V45, P1; Arce DG, 2008, B ECON RES, V60, P231, DOI 10.1111/j.1467-8586.2008.00280.x; Beall J, 2012, NATURE, V489, P179, DOI 10.1038/489179a; Davis P., 2012, SCHOLARLY KIT   0410; Dominici F., 2009, ACADEME          JUL; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Feeser VR, 2008, ACAD EMERG MED, V15, P963, DOI 10.1111/j.1553-2712.2008.00239.x; Ferguson C, 2014, NATURE, V515, P480, DOI 10.1038/515480a; Flanagin A, 1998, JAMA-J AM MED ASSOC, V280, P222, DOI 10.1001/jama.280.3.222; Frandsen TF, 2011, J AM SOC INF SCI TEC, V62, P807, DOI 10.1002/asi.21503; Gardiner M., 2007, HIGH EDUC RES DEV, V26, P425, DOI [10.1080/07294360701658633, DOI 10.1080/07294360701658633]; Greenland P, 2012, SCIENCE; Haley MR, 2017, APPL ECON LETT, V24, P85, DOI 10.1080/13504851.2016.1164812; Haug CJ, 2015, NEW ENGL J MED, V373, P2393, DOI 10.1056/NEJMp1512330; ICJME, 2014, DEF ROL AUTH CONTR; Kornhaber RA, 2015, INT J NANOMED, V10, DOI 10.2147/IJN.S87585; Kovacs J, 2017, MED HEALTH CARE PHIL, V20, P51, DOI 10.1007/s11019-016-9722-5; Liebowitz SJ, 2013, ECON INQ, V52, P1267; Lynch JG, 2012, SCIENCE, V335, P1169, DOI 10.1126/science.335.6073.1169-a; Martin BR, 2013, RES POLICY, V42, P1005, DOI 10.1016/j.respol.2013.03.011; Martinson BC, 2009, ACAD MED, V84, P1491, DOI 10.1097/ACM.0b013e3181bb2ca6; Marusic A, 2011, PLOS ONE, V6; McDonald D., 2017, GOLDEN PASSPORT HARV; Monastersky R., 2005, CHRON HIGHER EDUC; Necker S, 2014, RES POLICY, V43, P1747, DOI 10.1016/j.respol.2014.05.002; Oberlander SE, 2006, ETHICS BEHAV, V16, P217, DOI 10.1207/s15327019eb1603_3; Priem J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048753; Rennie D, 1997, JAMA, V278; Sugimoto C, 2013, SCIENTOMETRICS, V95, P851, DOI 10.1007/s11192-012-0845-z; SUITS DB, 1984, REV ECON STAT, V66, P177, DOI 10.2307/1924713; Thombs BD, 2015, J PSYCHOSOM RES, V78, P1, DOI 10.1016/j.jpsychores.2014.09.015; Todd M, 2014, SOCIAL SCI SPACE; Walker RL, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-21; Ward K, 2013, CHRON HIGHER ED 1203; Wilhite AW, 2012, SCIENCE, V335, P542, DOI 10.1126/science.1212540; Wislar JS, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6128	40	67	68	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187394	10.1371/journal.pone.0187394	http://dx.doi.org/10.1371/journal.pone.0187394			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211744	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200017
J	Hoyle, D; Aslam, TM				Hoyle, David; Aslam, Tariq Mehmood			Generative mathematical modelling to demonstrate virtual simulations of neovascular age related macular degeneration	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RANIBIZUMAB; VEGF; CHORIOCAPILLARIS; BEVACIZUMAB; AFLIBERCEPT; BINDING; CELLS	Purpose To develop a generative mathematical model of wet age-related macular degeneration (AMD) and model the impact of injections of anti-vascular endothelial growth factor to virtual patients with the condition. Methods We isolated key pathophysiological components of macular degeneration in terms of macular edema development and response to anti-vascular endothelial growth factor (VEGF) agents. We developed mathematical models for each of these components using constants determined from published biological experimentation. Consequently, we combined the mathematical models of the separate components to arrive at an end-to-end model of the evolution of macular edema size and its response to treatment. Results We present a series of simulations based upon our idealised model. Initially, we demonstrate the theoretical change in macular edema height in wet macular degeneration over time without and with anti-VEGF interventions. In our final simulation, we demonstrate the powerful possibilities of virtual clinical trials by simulating a virtual model of a landmark study using our existing mathematical AMD model. Conclusions Using our mathematical modelling based upon known pathological and pharmacological processes we have been able to model the effect of intravitreal injection of an anti-VEGF agent on macular edema from age related macular degeneration. We were subsequently able to mathematically simulate a major clinical trial with results that mirror many key features of the clinical established study. We anticipate that the generative model presented here can evolve to be a useful supportive tool in the challenge to deliver optimal therapy for patients with wet macular degeneration.	[Aslam, Tariq Mehmood] Univ Manchester, Sch Pharm & Optometry, Fac Biol Med & Hlth, Manchester, Lancs, England; [Aslam, Tariq Mehmood] NHS Cent Manchester Univ Hosp, Royal Eye Hosp, Manchester, Lancs, England; [Aslam, Tariq Mehmood] Heriot Watt Univ, Edinburgh, Midlothian, Scotland	University of Manchester; Manchester Royal Eye Hospital; Heriot Watt University	Aslam, TM (corresponding author), Univ Manchester, Sch Pharm & Optometry, Fac Biol Med & Hlth, Manchester, Lancs, England.; Aslam, TM (corresponding author), NHS Cent Manchester Univ Hosp, Royal Eye Hosp, Manchester, Lancs, England.; Aslam, TM (corresponding author), Heriot Watt Univ, Edinburgh, Midlothian, Scotland.	Tariq.aslam@manchester.ac.uk	; Aslam, Tariq/A-8532-2016	Hoyle, David/0000-0003-3483-5885; Aslam, Tariq/0000-0002-9739-7280				Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Chong V, 2016, EYE, V30, P1526, DOI 10.1038/eye.2016.202; Della NG, 1996, INVEST OPHTH VIS SCI, V37, P1921; Ferreira A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133968; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; Imoukhuede PI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044791; Klettner A, 2014, BRIT J OPHTHALMOL, V98, P1448, DOI 10.1136/bjophthalmol-2014-305105; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; Miller JW, 2013, AM J OPHTHALMOL, V155, P1, DOI 10.1016/j.ajo.2012.10.018; Moshfeghi DM, 2007, RETINA-J RET VIT DIS, V27, P269, DOI 10.1097/IAE.0b013e31802e3e9b; Ohno-Matsui Kyoko, 2004, Curr Opin Ophthalmol, V15, P197, DOI 10.1097/01.icu.0000120709.35941.e9; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; RCoreTeam, 2015, LANGUAGE ENV STAT CO; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Schmidt-Erfurth U, 2014, OPHTHALMOLOGY, V121, P193, DOI 10.1016/j.ophtha.2013.08.011; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; Stefanini MO, 2010, CANCER RES, V70, P9886, DOI 10.1158/0008-5472.CAN-10-1419; Strunnikova NV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008402; Yang JH, 2014, MOL PHARMACEUT, V11, P3421, DOI 10.1021/mp500160v	21	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189053	10.1371/journal.pone.0189053	http://dx.doi.org/10.1371/journal.pone.0189053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211782	Green Published, gold			2022-12-27	WOS:000417212200061
J	Schober, DA; Croy, CH; Ruble, CL; Tao, R; Felder, CC				Schober, Douglas A.; Croy, Carrie H.; Ruble, Cara L.; Tao, Ran; Felder, Christian C.			Identification, expression and functional characterization of M4L, a muscarinic acetylcholine M-4 receptor splice variant	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ALLOSTERIC MODULATION; SURFACE EXPRESSION; SYSTEM; SCHIZOPHRENIA; SEQUENCE; DNA	Rodent genomic alignment sequences support a 2-exon model for muscarinic M-4 receptor. Using this model a novel N-terminal extension was discovered in the human muscarinic acetylcholine M-4 receptor. An open reading frame was discovered in the human, mouse and rat with a common ATG (methionine start codon) that extended the N-terminus of the muscarinic acetylcholine M-4 receptor subtype by 155 amino acids resulting in a longer variant. Transcriptional evidence for this splice variant was confirmed by RNA-Seq and RT-PCR experiments performed from human donor brain prefrontal cortices. We detected a human upstream exon indicating the translation of the mature longer M-4 receptor transcript. The predicted size for the longer two-exon M-4 receptor splice variant with the additional 155 amino acid N-terminal extension, designated M4L is 69.7 kDa compared to the 53 kDa canonical single exon M-4 receptor (M4S). Western blot analysis from a mammalian overexpression system, and saturation radioligand binding with [H-3]-NMS (N-methyl-scopolamine) demonstrated the expression of this new splice variant. Comparative pharmacological characterization between the M4L and M4S receptors revealed that both the orthosteric and allosteric binding sites for both receptors were very similar despite the addition of an N-terminal extension.	[Schober, Douglas A.; Croy, Carrie H.; Ruble, Cara L.; Felder, Christian C.] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Neurosci, Indianapolis, IN 46285 USA; [Tao, Ran] Lieber Inst Brain Dev, Baltimore, MD USA	Eli Lilly	Felder, CC (corresponding author), Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Neurosci, Indianapolis, IN 46285 USA.	felder_christian@lilly.com		Felder, Christian/0000-0003-1134-8881	Eli Lilly and Company; Lieber Institute for Brain Development; Johns Hopkins University School of Medicine; LIBD	Eli Lilly and Company(Eli Lilly); Lieber Institute for Brain Development; Johns Hopkins University School of Medicine(Johns Hopkins University); LIBD	Funding for this study was supported by Eli Lilly and Company, a commercial organization and the Lieber Institute for Brain Development, a non-profit Maryland Medical Research Institution affiliated with The Johns Hopkins University School of Medicine. The Eli Lilly and Company and LIBD provided support in the form of salaries for authors DAS, CCF, CHC, CLR and RT, respectively. They did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Buchli R, 1999, J CELL BIOCHEM, V74, P264, DOI 10.1002/(SICI)1097-4644(19990801)74:2<264::AID-JCB11>3.0.CO;2-Z; Bymaster FP, 2003, NEUROCHEM RES, V28, P437, DOI 10.1023/A:1022844517200; Carruthers SP, 2015, NEUROSCI BIOBEHAV R, V55, P393, DOI 10.1016/j.neubiorev.2015.05.011; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chan WY, 2008, P NATL ACAD SCI USA, V105, P10978, DOI 10.1073/pnas.0800567105; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Croy CH, 2014, MOL PHARMACOL, V86, P106, DOI 10.1124/mol.114.091751; Dautzenberg FM, 1999, J NEUROENDOCRINOL, V11, P941; Duran-Prado M, 2009, J CLIN ENDOCR METAB, V94, P2634, DOI 10.1210/jc.2008-2564; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Gentles AJ, 1999, TRENDS GENET, V15, P47, DOI 10.1016/S0168-9525(98)01648-5; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Gonzalez A, 2011, BIOCHEMISTRY-US, V50, P4981, DOI 10.1021/bi2001278; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Markovic D, 2009, CELL MOL LIFE SCI, V66, P3337, DOI 10.1007/s00018-009-0093-4; McMillan DR, 2002, J BIOL CHEM, V277, P785, DOI 10.1074/jbc.M108929200; Minneman K P, 2001, Mol Interv, V1, P108; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ruble CL, 2016, BMC GENET, V17, DOI 10.1186/s12863-015-0325-6; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; Sarmiento JM, 2004, J BIOL CHEM, V279, P47017, DOI 10.1074/jbc.M410011200; Schober DA, 2014, MOL PHARMACOL, V86, P116, DOI 10.1124/mol.114.091785; Seck T, 2003, J BIOL CHEM, V278, P23085, DOI 10.1074/jbc.M211280200; Thal D, 2016, NATURE IN PRESS; Thompson MD, 2005, CRIT REV CL LAB SCI, V42, P311, DOI 10.1080/10408360591001895; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	30	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188330	10.1371/journal.pone.0188330	http://dx.doi.org/10.1371/journal.pone.0188330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211764	Green Submitted, gold, Green Published			2022-12-27	WOS:000417212200026
J	Andrade-Gomez, E; Garcia-Esquinas, E; Ortola, R; Martinez-Gomez, D; Rodriguez-Artalejo, F				Andrade-Gomez, Elena; Garcia-Esquinas, Esther; Ortola, Rosario; Martinez-Gomez, David; Rodriguez-Artalejo, Fernando			Watching TV has a distinct sociodemographic and lifestyle profile compared with other sedentary behaviors: A nationwide population-based study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; OLDER-ADULTS; ALCOHOL-CONSUMPTION; METABOLIC SYNDROME; AUSTRALIAN ADULTS; ASSOCIATION; RISK; PATTERNS; OBESITY; HEALTH	Watching TV has been consistently associated with higher risk of adverse health outcomes, but the effect of other sedentary behaviors (SB) is uncertain. Potential explanations are that watching TV is not a marker of a broader sedentary pattern and that each SB reflects different sociodemographic and health characteristics. Data were taken form a survey on 10,199 individuals, representative of the Spanish population aged >= 18 years. SB and other health behaviors were ascertained using validated questionnaires. Watching TV was the predominant SB (45.4% of the total sitting time), followed by sitting at the computer (22.7%). TV watching time showed no correlation with total time on other SB (r: -0.02, p = 0.07). By contrast, time spent at the computer was directly correlated with time spent on commuting (r: 0.07, p < 0.01), listening to music (r: 0.10, p < 0.01) and reading (r: 0.08, p < 0.01). TV watching time was greater in those with older age, lower education, unhealthier lifestyle, and with diabetes or osteomuscular disease. More time spent at the computer or in commuting was linked to younger age, male gender, higher education and having a sedentary job. In conclusion, watching TV is not correlated with other SB and shows a distinct demographic and lifestyle profile.	[Andrade-Gomez, Elena; Garcia-Esquinas, Esther; Ortola, Rosario; Rodriguez-Artalejo, Fernando] Univ Autonoma Madrid, IdiPaz, Dept Prevent Med & Publ Hlth, Madrid, Spain; [Andrade-Gomez, Elena; Garcia-Esquinas, Esther; Ortola, Rosario; Rodriguez-Artalejo, Fernando] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Martinez-Gomez, David] Univ Autonoma Madrid, Dept Phys Educ Sport & Human Movement, Sch Teacher Training & Educ, Madrid, Spain; [Rodriguez-Artalejo, Fernando] IMDEA Food Inst, Madrid, Spain; [Rodriguez-Artalejo, Fernando] CEI UAM CSIC, Madrid, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)	Andrade-Gomez, E (corresponding author), Univ Autonoma Madrid, IdiPaz, Dept Prevent Med & Publ Hlth, Madrid, Spain.; Andrade-Gomez, E (corresponding author), CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.	elena.andrade@uam.es	garcia, esther/AAR-8372-2021; Andrade Gómez, Elena/F-2254-2019; Ortolá, Rosario/V-4807-2019	Andrade Gómez, Elena/0000-0002-7685-1085; Ortolá, Rosario/0000-0001-6952-9533; Andrade Gomez, Elena/0000-0002-4059-0805; garcia-esquinas, Esther/0000-0002-8688-5174; Rodriguez Artalejo, Fernando/0000-0001-9317-5755	State Secretary R+D+I and FEDER/FSE [FIS 16/609]; Plan Nacional sobre Drogas (Ministry of Health) [02/2014]; Secretary R+D+I and FEDER/FSE [DEP2013-47786-R]	State Secretary R+D+I and FEDER/FSE; Plan Nacional sobre Drogas (Ministry of Health); Secretary R+D+I and FEDER/FSE	This work was supported by grants from FIS 16/609 (State Secretary of R+D+I and FEDER/FSE), DEP2013-47786-R (Secretary of R+D+I and FEDER/FSE), and Plan Nacional sobre Drogas 02/2014 (Ministry of Health). The funding agencies had no role in study design, data analysis, interpretation of results, manuscript preparation or in the decision to submit this manuscript for publication.	Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bertrais S, 2005, OBES RES, V13, P936, DOI 10.1038/oby.2005.108; Dunstan DW, 2007, DIABETES CARE, V30, P516, DOI 10.2337/dc06-1996; Dunstan DW, 2005, DIABETOLOGIA, V48, P2254, DOI 10.1007/s00125-005-1963-4; Dunstan DW, 2004, DIABETES CARE, V27, P2603, DOI 10.2337/diacare.27.11.2603; Guallar-Castillon P, 2014, PREV MED, V67, P248, DOI 10.1016/j.ypmed.2014.08.015; Guallar-Castillon P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086074; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Basterra-Gortari FJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000864; Kesse-Guyot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047831; Kikuchi H, 2014, PREV MED, V67, P335, DOI 10.1016/j.ypmed.2014.08.011; Leon-Munoz LM, 2015, J ACAD NUTR DIET, V115, P213, DOI 10.1016/j.jand.2014.08.017; Lopez-Garcia E, 2008, AM J CLIN NUTR, V87, P310, DOI 10.1093/ajcn/87.2.310; Martinez-Gonzalez MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745; Nang EEK, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-70; Ortola R, 2016, J GERONTOL A-BIOL, V71, P251, DOI 10.1093/gerona/glv125; Pols MA, 1997, INT J EPIDEMIOL, V26, pS181, DOI 10.1093/ije/26.suppl_1.S181; Pulsford RM, 2013, AM J PREV MED, V44, P132, DOI 10.1016/j.amepre.2012.10.009; Rhodes RE, 2012, AM J PREV MED, V42, pE3, DOI 10.1016/j.amepre.2011.10.020; Rodriguez-Artalejo F, 2011, REV ESP CARDIOL, V64, P876, DOI 10.1016/j.recesp.2011.05.019; Salmon J, 2000, INT J OBESITY, V24, P600, DOI 10.1038/sj.ijo.0801203; Schmid D, 2014, JNCI-J NATL CANCER I, V16, P106; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; Spence JC, 2017, AM J PREV MED, V52, P403, DOI 10.1016/j.amepre.2016.10.019; Stamatakis E, 2012, PREV MED, V54, P82, DOI 10.1016/j.ypmed.2011.10.009; Sugiyama T, 2008, ANN BEHAV MED, V35, P245, DOI 10.1007/s12160-008-9017-z; Tudor-Locke C, 2010, AM J PREV MED, V39, pE13, DOI 10.1016/j.amepre.2010.05.017; Vandelanotte C, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1084; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Wijndaele K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020058; Young DR, 2016, CIRCULATION, V134, pE262, DOI 10.1161/CIR.0000000000000440	31	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188836	10.1371/journal.pone.0188836	http://dx.doi.org/10.1371/journal.pone.0188836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206883	Green Submitted, gold, Green Published			2022-12-27	WOS:000417110700027
J	Singh, M; Friess, DA; Vilela, B; De Alban, JDT; Monzon, AKV; Veridiano, RKA; Tumaneng, RD				Singh, Minerva; Friess, Daniel A.; Vilela, Bruno; De Alban, Jose Don T.; Monzon, Angelica Kristina V.; Veridiano, Rizza Karen A.; Tumaneng, Roven D.			Spatial relationships between above-ground biomass and bird species biodiversity in Palawan, Philippines	PLOS ONE			English	Article							TROPICAL FOREST; ALOS-PALSAR; REDD PLUS; CARBON; RICHNESS; HABITAT; DEFORESTATION; TEXTURE; DEGRADATION; DIVERSITY	This study maps distribution and spatial congruence between Above-Ground Biomass (AGB) and species richness of IUCN listed conservation-dependent and endemic avian fauna in Palawan, Philippines. Grey Level Co-Occurrence Texture Matrices (GLCMs) extracted from Landsat and ALOS-PALSAR were used in conjunction with local field data to model and map local-scale field AGB using the Random Forest algorithm (r = 0.92 and RMSE = 31.33 Mg.ha(-1)). A support vector regression (SVR) model was used to identify the factors influencing variation in avian species richness at a 1km scale. AGB is one of the most important determinants of avian species richness for the study area. Topographic factors and anthropogenic factors such as distance from the roads were also found to strongly influence avian species richness. Hotspots of high AGB and high species richness concentration were mapped using hotspot analysis and the overlaps between areas of high AGB and avian species richness was calculated. Results show that the overlaps between areas of high AGB with high IUCN red listed avian species richness and endemic avian species richness were fairly limited at 13% and 8% at the 1-km scale. The overlap between 1) low AGB and low IUCN richness, and 2) low AGB and low endemic avian species richness was higher at 36% and 12% respectively. The enhanced capacity to spatially map the correlation between AGB and avian species richness distribution will further assist the conservation and protection of forest areas and threatened avian species.	[Singh, Minerva] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Friess, Daniel A.] Natl Univ Singapore, Dept Geog, 1Arts Link, Singapore, Singapore; [Vilela, Bruno] Washington Univ St Louis, Dept Biol, St Louis, MO USA; [De Alban, Jose Don T.; Monzon, Angelica Kristina V.; Veridiano, Rizza Karen A.; Tumaneng, Roven D.] Fauna & Flora Int, Philippines Programme, Tagaytay City, Cavite, Philippines; [De Alban, Jose Don T.] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Monzon, Angelica Kristina V.] Univ Cambridge, Dept Geog, Cambridge, England; [Veridiano, Rizza Karen A.] Johann Heinrich von Thunen Inst Int Forestry & Fo, Hamburg, Germany; [Tumaneng, Roven D.] Philippine Council Ind Energy & Emerging Technol, Emerging Technol Dev Div, Dept Sci & Technol, Taguig City, Philippines	University of Cambridge; National University of Singapore; Washington University (WUSTL); National University of Singapore; University of Cambridge; Johann Heinrich von Thunen Institute; Department of Science & Technology (DOST), Philippines	Singh, M (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	minerva_singh@yahoo.co.in	Vilela, Bruno/L-1594-2015; De Alban, Jose Don/C-7742-2019; Friess, Dan/G-2056-2011	Vilela, Bruno/0000-0003-4072-0558; De Alban, Jose Don/0000-0002-1671-5786; Veridiano, Rizza Karen/0000-0002-2323-8383; Friess, Daniel/0000-0002-3087-5233; Singh, Minerva/0000-0002-7148-0078; Jaojoco, Angelica Kristina/0000-0002-1583-584X	EU; IUCN-EA	EU(European Commission); IUCN-EA	This work was supported by EU-funded Improving Forest Governance and Sustainable Upland Development through Climate Change Mitigation Financing Strategies in Southern Palawan (ADVANCE REDD+), and the IUCN-EA-funded Forest Conservation through Non-Timber Forest Products Sustainable Management and REDD+. Funding was received by JA. The funders played no role in the study design, data collection, analysis, decision to publish or preparation of manuscript.	Achard F, 2014, GLOBAL CHANGE BIOL, V20, P2540, DOI 10.1111/gcb.12605; Advanced Land Observing Satellite, 2012, NEW GLOB 25M RES PAL; Ahmed SE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1742; Castillo-Santiago MA, 2010, INT J REMOTE SENS, V31, P2767, DOI 10.1080/01431160903095460; [Anonymous], 2016, SUMM HOTSP AN PAR RE; [Anonymous], 2011, CBD TECHNICAL SERIES, V59; Asner GP, 2009, J APPL REMOTE SENS, V3, DOI 10.1117/1.3223675; Avitabile V, 2016, GLOBAL CHANGE BIOL, V22, P1406, DOI 10.1111/gcb.13139; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Barlow J, 2016, NATURE, V535, P144, DOI 10.1038/nature18326; Barooah, 2013, INT J ADV RES ELECT, V2, P4206; Basnet TB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150498; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Beaudrot L, 2016, ECOL APPL, V26, P1098, DOI 10.1890/15-0935; Birdlife International, 2016, IMP BIRD BIOD AR FAC; BirdLife International and Nature Serve, 2015, BIRD SPEC DISTR MAPS; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown S, 1997, ESTIMATING BIOMASS B, P134; Bustamante MMC, 2016, GLOBAL CHANGE BIOL, V22, P92, DOI 10.1111/gcb.13087; Canterbury GE, 2000, CONSERV BIOL, V14, P544, DOI 10.1046/j.1523-1739.2000.98235.x; Carandang AP, 2012, ANAL KEY DRIVERS DEF; Carreiras JMB, 2013, REMOTE SENS-BASEL, V5, P1524, DOI 10.3390/rs5041524; Couteron P, 2005, J APPL ECOL, V42, P1121, DOI 10.1111/j.1365-2664.2005.01097.x; Crain BJ, 2014, DIVERS DISTRIB, V20, P652, DOI 10.1111/ddi.12179; Cutler MEJ, 2012, ISPRS J PHOTOGRAMM, V70, P66, DOI 10.1016/j.isprsjprs.2012.03.011; Davies RG, 2007, P ROY SOC B-BIOL SCI, V274, P1189, DOI 10.1098/rspb.2006.0061; De Alban JT, 2013, FOREST CHANGE DETECT; Drake JM, 2006, J APPL ECOL, V43, P424, DOI 10.1111/j.1365-2664.2006.01141.x; Dube T, 2014, SENSORS-BASEL, V14, P15348, DOI 10.3390/s140815348; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Dutra LV, 2009, AN 14 S BRAS SENS RE; Eckert S, 2012, REMOTE SENS-BASEL, V4, P810, DOI 10.3390/rs4040810; Englhart S., 2013, THESIS; ESA, 2016, ESA DAT US EL; Foody GM, 2001, GLOBAL ECOL BIOGEOGR, V10, P379, DOI 10.1046/j.1466-822X.2001.00248.x; Gaese K., 1997, J BIOGEOGR, V24, P49; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Gil-Tena A, 2010, FOREST SYST, V19, P113; Gleason CJ, 2012, REMOTE SENS ENVIRON, V125, P80, DOI 10.1016/j.rse.2012.07.006; Grainger A, 2009, CURR BIOL, V19, pR974, DOI 10.1016/j.cub.2009.10.001; Guneralp I, 2014, INT J APPL EARTH OBS, V33, P119, DOI 10.1016/j.jag.2014.05.004; Haines-Young R, 2009, LAND USE POLICY, V26, pS178, DOI 10.1016/j.landusepol.2009.08.009; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Herzog S.K., 2011, CLIMATE CHANGE BIODI; Jachowski NRA, 2013, APPL GEOGR, V45, P311, DOI 10.1016/j.apgeog.2013.09.024; Jaeger J. A. G., 2011, Landscape fragmentation in Europe; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Jones Z., 2015, P 73 ANN MPSA C; Kapos V, 2008, CARBON BIODIVERSITY, V101, P163; Kattan GH, 2004, GLOBAL ECOL BIOGEOGR, V13, P451, DOI 10.1111/j.1466-822X.2004.00117.x; Koh CN, 2006, DIVERS DISTRIB, V12, P546, DOI 10.1111/j.1366-9516.2006.00238.x; Krauss J, 2004, BIODIVERS CONSERV, V13, P1427, DOI 10.1023/B:BIOC.0000021323.18165.58; Kuhn M, 2015, CARET CLASSIFICATION; Kumar R, 2014, ECOL INDIC, V45, P444, DOI 10.1016/j.ecolind.2014.05.003; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Langner A, 2015, LAND-BASEL, V4, P656, DOI 10.3390/land4030656; Lasco RD, 2013, MITIG ADAPT STRAT GL, V18, P1109, DOI 10.1007/s11027-012-9411-5; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Lees AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122432; LETOAN T, 1992, IEEE T GEOSCI REMOTE, V30, P403, DOI 10.1109/36.134089; Mallari NAD, 2011, ORYX, V45, P234, DOI 10.1017/S0030605310001031; Mallari NAD, 2001, KEY CONSERVATION SIT, P485; Mallari NAD, 2013, ENVIRON MANAGE, V51, P1236, DOI 10.1007/s00267-013-0053-5; Martin T, 2010, CONSERV SOC, V8, P127, DOI DOI 10.4103/0972-4923.68914; McCain C.M., 2010, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0022548, DOI 10.1002/9780470015902.A0022548]; Mermoz S, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8030217; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Mitchard ETA, 2012, BIOGEOSCIENCES, V9, P179, DOI 10.5194/bg-9-179-2012; Mitchard ETA, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/049001; Mitchard Edward Ta, 2013, Carbon Balance Manag, V8, P10, DOI 10.1186/1750-0680-8-10; Moura MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152468; Murray JP, 2015, CONSERV BIOL, V29, P1434, DOI 10.1111/cobi.12500; Nadal-Romero E, 2014, EARTH SURF PROC LAND, V39, P1705, DOI 10.1002/esp.3549; NASA JPL, 2009, ASTER GLOB DIG EL MO; Newman ME, 2014, FOREST ECOL MANAG, V315, P138, DOI 10.1016/j.foreco.2013.12.033; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Osti M, 2014, USING SPATIAL ANAL E; Ouma YO, 2006, J ENVIRON INFORM, V8, P70, DOI 10.3808/jei.200600078; Panela S., 2015, PALAWAN PALM OIL PRE; Pereira RA, 2006, BANWA, P130; Pfeifer M, 2016, REMOTE SENS ENVIRON, V176, P84, DOI 10.1016/j.rse.2016.01.014; Phelps J, 2012, BIOL CONSERV, V154, P53, DOI 10.1016/j.biocon.2011.12.031; Phelps J, 2010, GLOBAL ENVIRON CHANG, V20, P322, DOI 10.1016/j.gloenvcha.2010.01.002; QUINNELL R, 1988, Oryx, V22, P30; Rejou-Mechain M, 2015, REMOTE SENS ENVIRON, V169, P93, DOI 10.1016/j.rse.2015.08.001; Richards DR, 2016, P NATL ACAD SCI USA, V113, P344, DOI 10.1073/pnas.1510272113; Rocha R, 2015, TROPICAL CONSERVATIO, V8; Rompre G, 2007, J BIOGEOGR, V34, P802, DOI 10.1111/j.1365-2699.2006.01657.x; Rosenqvist A, 2007, IEEE T GEOSCI REMOTE, V45, P3307, DOI 10.1109/TGRS.2007.901027; Shataee S., 2012, International Journal of Remote Sensing, V33, P6254, DOI 10.1080/01431161.2012.682661; Simard M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001708; Singh M, 2015, J TROP FOR SCI, V27, P227; Singh M, 2015, REMOTE SENS-BASEL, V7, P5057, DOI 10.3390/rs70505057; Singh M, 2014, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083695; Strassburg BBN, 2010, CONSERV LETT, V3, P98, DOI 10.1111/j.1755-263X.2009.00092.x; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Summers PD, 2011, J APPL ECOL, V48, P1527, DOI 10.1111/j.1365-2664.2011.02041.x; Suresh M, 2014, INT ARCH PHOTOGRAMM, V40-8, P651, DOI 10.5194/isprsarchives-XL-8-651-2014; Tavora JF, 2012, CLIMATE RELEVANT MOD; Thapa RB, 2015, REMOTE SENS ENVIRON, V160, P122, DOI 10.1016/j.rse.2015.01.007; Thapa RB, EXAMINING HIGH RESOL; Venter O, 2009, CONSERV LETT, V2, P123, DOI 10.1111/j.1755-263X.2009.00059.x; Vilela B, 2015, PROJECT LETSR TITLE; WorldClim, 2016, WORDCL TIL; Zhang ZY, 2016, FORESTS, V7, DOI 10.3390/f7060122	105	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0186742	10.1371/journal.pone.0186742	http://dx.doi.org/10.1371/journal.pone.0186742			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29206228	gold, Green Published, Green Submitted			2022-12-27	WOS:000417033200001
J	Bindusree, G; Natarajan, P; Kalva, S; Madasamy, P				Bindusree, Ganigara; Natarajan, Purushothaman; Kalva, Sukesh; Madasamy, Parani			Whole genome sequencing of Oryza sativa L. cv. Seeragasamba identifies a new fragrance allele in rice	PLOS ONE			English	Article							SNP-SEEK DATABASE; FUNCTIONAL MARKERS; QUANTITATIVE TRAIT; MOLECULAR MARKERS; AROMATIC RICE; GENE; DISCOVERY; 2-ACETYL-1-PYRROLINE; POLYMORPHISMS; COMPOUND	Fragrance of rice is an important trait that confers a large economic benefit to the farmers who cultivate aromatic rice varieties. Several aromatic rice varieties have limited geographic distribution, and are endowed with variety-specific unique fragrances. BADH2 was identified as a fragrance gene in 2005, and it is essential to identify the fragrance alleles from diverse geographical locations and genetic backgrounds. Seeragasamba is a short-grain aromatic rice variety of the indica type, which is cultivated in a limited area in India. Whole genome sequencing of this variety identified a new badh2 allele (badh2-p) with an 8 bp insertion in the promoter region of the BADH2 gene. When the whole genome sequences of 76 aromatic varieties in the 3000 rice genome project were analyzed, the badh2-p allele was present in 13 varieties (approximately 17%) of both indica and japonica types. In addition, the badh2-p allele was present in 17 varieties that already had the loss-of-function allele, badh2-E7. Taken together, the frequency of badh2-p allele (approximately 40%) was found to be greater than that of the badh2-E7 allele (approximately 34%) among the aromatic rice varieties. Therefore, it is suggested to include badh2-p as a predominant allele when screening for fragrance alleles in aromatic rice varieties.	[Bindusree, Ganigara; Natarajan, Purushothaman; Kalva, Sukesh; Madasamy, Parani] SRM Univ, Dept Genet Engn, Genom Lab, Kattankulathur, India	SRM Institute of Science & Technology Chennai	Madasamy, P (corresponding author), SRM Univ, Dept Genet Engn, Genom Lab, Kattankulathur, India.	parani.m@ktr.srmuniv.ac.in	Natarajan, Purushothaman/A-1093-2013; Madasamy, Parani/H-4911-2012	Natarajan, Purushothaman/0000-0001-5505-7109; Parani, Madasamy/0000-0002-2265-1715	SRM-DBT Partnership Platform for Contemporary Research Services and Skill Development in Advanced Life Sciences Technologies, SRM University, Chennai, Tamil Nadu, India [BT/PR12987/INF/22/205/2015]	SRM-DBT Partnership Platform for Contemporary Research Services and Skill Development in Advanced Life Sciences Technologies, SRM University, Chennai, Tamil Nadu, India	This study was financially supported by SRM-DBT Partnership Platform for Contemporary Research Services and Skill Development in Advanced Life Sciences Technologies (Order No. BT/PR12987/INF/22/205/2015), SRM University, Chennai, Tamil Nadu, India.; This study was financially supported by SRM-DBT Partnership Platform for Contemporary Research Services and Skill Development in Advanced Life Sciences Technologies (Order No. BT/PR12987/INF/22/205/2015), SRM University, Chennai, Tamil Nadu, India. The HPCC facility (Genome Server) at SRM University was used for the genome analysis.	AHN SN, 1992, THEOR APPL GENET, V84, P825, DOI 10.1007/BF00227391; Alexandrov N, 2015, NUCLEIC ACIDS RES, V43, pD1023, DOI 10.1093/nar/gku1039; Amarawathi Y, 2008, MOL BREEDING, V21, P49, DOI 10.1007/s11032-007-9108-8; Andrews S., 2010, REFERENCE SOURCE; Bradbury LMT, 2005, PLANT BIOTECHNOL J, V3, P363, DOI 10.1111/j.1467-7652.2005.00131.x; Bradbury LMT, 2008, PLANT MOL BIOL, V68, P439, DOI 10.1007/s11103-008-9381-x; Buttery R, IDENTIFICATION RICE; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Giraud G, 2013, INT FOOD AGRIBUS MAN, V16, P1; He Q, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0412-4; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kovach MJ, 2009, P NATL ACAD SCI USA, V106, P14444, DOI 10.1073/pnas.0904077106; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lorieux M, 1996, THEOR APPL GENET, V93, P1145, DOI 10.1007/BF00230138; Mansueto L, 2017, NUCLEIC ACIDS RES, V45, pD1075, DOI 10.1093/nar/gkw1135; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mohan M. M., 2013, Electronic Journal of Plant Breeding, V4, P1148; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Myint KM, 2012, RICE, V5, P1, DOI 10.1186/1939-8433-5-20; Ootsuka K, 2014, BREEDING SCI, V64, P115, DOI 10.1270/jsbbs.64.115; Rai VP, 2015, TURK J BOT, V39, P209, DOI 10.3906/bot-1405-117; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Roy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129607; Sakthivel K, 2009, MOL BREEDING, V24, P185, DOI 10.1007/s11032-009-9283-x; Shao GN, 2011, PLANT BREEDING, V130, P172, DOI 10.1111/j.1439-0523.2009.01764.x; Shao GN, 2013, GENOMICS, V101, P157, DOI 10.1016/j.ygeno.2012.11.010; Shi WW, 2008, MOL BREEDING, V22, P185, DOI 10.1007/s11032-008-9165-7; Shi YQ, 2014, MOL BREEDING, V33, P701, DOI 10.1007/s11032-013-9986-x; Tyagi AK, 2004, J GENET, V83, P79, DOI 10.1007/BF02715832; Wakte K, 2017, J SCI FOOD AGR, V97, P384, DOI 10.1002/jsfa.7875; Wettewa W, 2014, J AGR SCI, V9; Yoshihashi T, 2002, J AGR FOOD CHEM, V50, P2001, DOI 10.1021/jf011268s; Zhang HY, 2008, MOL PLANT, V1, P720, DOI 10.1093/mp/ssn022	34	12	14	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188920	10.1371/journal.pone.0188920	http://dx.doi.org/10.1371/journal.pone.0188920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190814	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900169
J	Schausberger, P; Walzer, A; Murata, Y; Osakabe, M				Schausberger, Peter; Walzer, Andreas; Murata, Yasumasa; Osakabe, Masahiro			Low level of polyandry constrains phenotypic plasticity of male body size in mites	PLOS ONE			English	Article							SEXUAL SELECTION; REPRODUCTIVE SUCCESS; PHYTOSEIULUS-PERSIMILIS; SPERM COMPETITION; MATING-BEHAVIOR; MATE CHOICE; EVOLUTION; COSTS; CONSEQUENCES; LIMITS	Polyandry, i.e. females mating with multiple males, is more common than previously anticipated and potentially provides both direct and indirect fitness benefits to females. The level of polyandry (defined by the lifetime number of male mates of a female) is an important determinant of the occurrence and intensity of sexual selection acting on male phenotypes. While the forces of sexual selection acting on phenotypic male traits such as body size are relatively well understood, sexual selection acting on phenotypic plasticity of these traits is unexplored. We tackled this issue by scrutinizing the link between polyandry and phenotypic plasticity of male body size in two sympatric plant-inhabiting predatory mite species, Phytoseiulus persimilis and Neoseiulus californicus. These two species are similar in life history, ecological niche requirements, mating behavior, polygyny and female body size plasticity but strikingly differ in the level of both polyandry and phenotypic plasticity of male body size (both lower in P. persimilis). We hypothesized that deviations from standard body size, i.e. the size achieved under favorable conditions, incur higher costs for males in the less polyandrous P. persimilis. To test our hypotheses, we conducted two experiments on (i) the effects of male body size on spermatophore transfer in singly mating females and (ii) the effects of mate sequence (switching the order of standard-sized and small males) on mating behavior and paternity success in doubly mating females. In P. persimilis but not N. californicus, small males transferred fewer but larger spermatophores to the females; in both species, females re-mated more likely with standard-sized following small than small following standard-sized males; in P. persimilis, first standardsized males sired a higher proportion of offspring produced after re-mating by the female than first small males, whereas in N. californicus the paternity success of small and standard- sized males was independent of the mating sequence. Based on our results and pertinent previous studies, which showed that females of P. persimilis, but not N. californicus, prefer mating with standard-sized over small males and allow them fertilizing more eggs, the lack of interspecific difference in female body size plasticity, and the absence of any clue pointing at a role of natural selection, we suggest that the interspecific difference in male body size plasticity is sexually selected. Our study provides an indication of sexual selection constraining plasticity of male phenotypes, suggesting that the level of polyandry may be an important co-determinant of the level of phenotypic plasticity of male body size.	[Schausberger, Peter] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Schausberger, Peter; Walzer, Andreas] Dept Crop Sci, Grp Arthropod Ecol & Behav, Vienna, Austria; [Murata, Yasumasa; Osakabe, Masahiro] Kyoto Univ, Grad Sch Agr, Lab Ecol Informat, Sakyo Ku, Kyoto, Japan	University of Vienna; Kyoto University	Schausberger, P (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.; Schausberger, P (corresponding author), Dept Crop Sci, Grp Arthropod Ecol & Behav, Vienna, Austria.	peter.schausberger@univie.ac.at	Osakabe, Masahiro/H-8587-2019	Osakabe, Masahiro/0000-0002-2246-3431; Schausberger, Peter/0000-0002-1529-3198	Austria Science Fund (FWF) [P 23504-617]; Austrian Science Fund (FWF) [P 23504, P 25876] Funding Source: researchfish	Austria Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was financed by a grant from the Austria Science Fund (FWF; P 23504-617) to PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANO H, 1979, ACAROLOGIA, V20, P196; Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; Andersson Malte, 1994; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist G, 1999, BEHAV ECOL, V10, P358, DOI 10.1093/beheco/10.4.358; Auld HL, 2016, ETHOLOGY, V122, P597, DOI 10.1111/eth.12506; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; Blanckenhorn WU, 2005, ETHOLOGY, V111, P977, DOI 10.1111/j.1439-0310.2005.01147.x; Collet J, 2012, P NATL ACAD SCI USA, V109, P8641, DOI 10.1073/pnas.1200219109; Croft BA, 1999, EXP APPL ACAROL, V23, P599, DOI 10.1023/A:1006236310613; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Enigl M, 2004, ENTOMOL EXP APPL, V112, P21, DOI 10.1111/j.0013-8703.2004.00175.x; Gotoh T, 2008, EXP APPL ACAROL, V44, P185, DOI 10.1007/s10493-008-9143-0; Harano T, 2012, J ETHOL, V30, P337, DOI 10.1007/s10164-012-0331-3; Helle W., 1985, SPIDER MITES THEIR A, V1; Hunt J, 2009, J EVOLUTION BIOL, V22, P13, DOI 10.1111/j.1420-9101.2008.01633.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Klemme I, 2007, BEHAV ECOL SOCIOBIOL, V61, P1911, DOI 10.1007/s00265-007-0431-1; Knuttel H, 2001, J EXP BIOL, V204, P2447; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Krantz GW, MANUAL ACAROLOGY; Kraus FB, 2004, BEHAV ECOL SOCIOBIOL, V55, P494, DOI 10.1007/s00265-003-0706-0; Kvarnemo C, 2004, BIOL J LINN SOC, V83, P369, DOI 10.1111/j.1095-8312.2004.00395.x; Kvarnemo C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0042; Murren CJ, 2015, HEREDITY, V115, P293, DOI 10.1038/hdy.2015.8; Nonaka E, 2014, EVOL ECOL, V28, P1057, DOI 10.1007/s10682-014-9728-5; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; PARTRIDGE L, 1987, ANIM BEHAV, V35, P555, DOI 10.1016/S0003-3472(87)80281-6; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Pizzari T, 2008, TRENDS ECOL EVOL, V23, P131, DOI 10.1016/j.tree.2007.12.003; Price TD, 2006, J EXP BIOL, V209, P2368, DOI 10.1242/jeb.02183; Relyea RA, 2002, AM NAT, V159, P272, DOI 10.1086/338540; Sabelis Maurice W., 1994, P70; SABELIS MW, 1988, EXP APPL ACAROL, V4, P301, DOI 10.1007/BF01196192; Saleh NW, 2014, J INSECT BEHAV, V27, P346, DOI 10.1007/s10905-013-9425-1; Savalli UM, 1998, ANIM BEHAV, V55, P473, DOI 10.1006/anbe.1997.0622; Schausberger P, 1997, EXP APPL ACAROL, V21, P131, DOI 10.1023/A:1018478418010; Schausberger P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154355; Shuster SM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0046; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 2008, EVOLUTION, V62, P2580, DOI 10.1111/j.1558-5646.2008.00479.x; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Stennett MD, 1997, J CHEM ECOL, V23, P2803, DOI 10.1023/A:1022519228346; Stillwell RC, 2010, ANNU REV ENTOMOL, V55, P227, DOI 10.1146/annurev-ento-112408-085500; THORNHILL R, 1983, AM NAT, V122, P765, DOI 10.1086/284170; Walzer A, 2015, ANIM BEHAV, V100, P96, DOI 10.1016/j.anbehav.2014.11.017; Walzer A, 2014, BIOL J LINN SOC, V111, P889, DOI 10.1111/bij.12235; Walzer A, 2011, BIOL J LINN SOC, V102, P650, DOI 10.1111/j.1095-8312.2010.01593.x	50	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188924	10.1371/journal.pone.0188924	http://dx.doi.org/10.1371/journal.pone.0188924			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190832	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900170
J	Dorta-Estremera, S; Nehete, PN; Yang, GJ; He, H; Nehete, BP; Shelton, KK; Barry, MA; Sastry, KJ				Dorta-Estremera, Stephanie; Nehete, Pramod N.; Yang, Guojun; He, Hong; Nehete, Bharti P.; Shelton, Kathryn K.; Barry, Michael A.; Sastry, K. Jagannadha			Minimally invasive monitoring of CD4 T cells at multiple mucosal tissues after intranasal vaccination in rhesus macaques	PLOS ONE			English	Article							HIV; TRANSMISSION; IMMUNITY; TRIAL; STEP	Studies in nonhuman primates (NHP) for prospective immune cell monitoring subsequent to infection and/or vaccination usually rely on periodic sampling of the blood samples with only occasional collections of biopsies from mucosal tissues because of safety concerns and practical constraints. Here we present evidence in support of cytobrush sampling of oral, rectal, and genital mucosal tissues as a minimally invasive approach for the phenotypic analyses of different T cells subsets de novo as well as prospectively after intranasal immunization in rhesus macaques. Significant percentages of viable lymphocytes were obtained consistently from both naive and chronically SIV-infected rhesus macaques. The percentages of CD3+ T cells in the blood were significantly higher compared to those in the mucosal tissues analyzed in the naive animals, while in the SIV+ animals the CD3+ T cells were significantly elevated in the rectal tissues, relative to all other sites analyzed. In the naive, but not SIV+ macaques, the rectal and vaginal mucosal tissues, compared to oral mucosa and blood, showed higher diversity and percentages of CD4+ T cells expressing the HIV entry co-receptor CCR5 and mucosal specific adhesion (CD103) as well as activation (HLA-DR) and proliferation (Ki67) markers. Sequential daily cytobrush sampling from the oral, rectal, and genital mucosal tissues was performed in SIV+ animals from an ongoing study where they were administered intranasal immunization with adenoviral vectored vaccines incorporating the green fluorescent protein (GFP) reporter gene. We detected a transient increase in GFP+ CD4 T cells in only oral mucosa suggesting limited mucosal trafficking. In general, CD4+ and CD8+ T cells expressing Ki67 transiently increased in all mucosal tissues, but those expressing the CCR5, HLA-DR, and CD103 markers exhibited minor changes. We propose the minimally invasive cytobrush sampling as a practical approach for effective and prospective immune monitoring of the oral-genital mucosal tissues in NHP.	[Dorta-Estremera, Stephanie; Yang, Guojun; Sastry, K. Jagannadha] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Nehete, Pramod N.; Nehete, Bharti P.; Shelton, Kathryn K.; Sastry, K. Jagannadha] Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Bastrop, TX 78602 USA; [Nehete, Pramod N.; Sastry, K. Jagannadha] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77004 USA; [He, Hong] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Houston, TX 77030 USA; [Barry, Michael A.] Mayo Clin, Dept Internal Med, Div Infect Dis, Rochester, MN USA; [Barry, Michael A.] Mayo Clin, Dept Mol Med, Rochester, MN USA; [Barry, Michael A.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Barry, Michael A.] Mayo Clin, Translat Immunol Virol & Biodef Program, Rochester, MN USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Sastry, KJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.; Sastry, KJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Bastrop, TX 78602 USA.; Sastry, KJ (corresponding author), Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77004 USA.	jsastry@mdanderson.org		Nehete, Pramod/0000-0002-2815-2677; Sastry, Jagannadha/0000-0002-6987-4422; Dorta-Estremera, Stephanie/0000-0003-4440-6806	NIH [R01 A1096967, R01 CM 36945]; Walter & Lucille Rubin Fund in Infectious Diseases Honoring Michael Camilleri, M.D., at Mayo Clinic; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA136945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096967] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Walter & Lucille Rubin Fund in Infectious Diseases Honoring Michael Camilleri, M.D., at Mayo Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants R01 A1096967 and R01 CM 36945 and the Walter & Lucille Rubin Fund in Infectious Diseases Honoring Michael Camilleri, M.D., at Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH grants R01 AI096967 and R01 CA136945 and the Walter & Lucille Rubin Fund in Infectious Diseases Honoring Michael Camilleri, M.D. at Mayo Clinic. We would like to thank Mary Barry for excellent technical assistance.	Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burgener A, 2015, CURR OPIN IMMUNOL, V36, P22, DOI 10.1016/j.coi.2015.06.004; Byrareddy SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075556; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Girard MP, 2011, VACCINE, V29, P6191, DOI [10.1016/j.vaccine.2011.08.031, 10.1016/j.vaccine.2011.06.085]; Gomez-Roman Victor Raul, 2003, AIDS Reviews, V5, P178; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Hasselrot K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047570; Holland NT, 2003, MUTAT RES-REV MUTAT, V543, P217, DOI 10.1016/S1383-5742(02)00090-X; Huot N, 2016, CURR OPIN VIROL, V19, P37, DOI 10.1016/j.coviro.2016.06.011; Juno JA, 2014, JOVE-J VIS EXP, DOI 10.3791/51906; Lehner T, 2002, AIDS, V16, pS125, DOI 10.1097/00002030-200216004-00017; McKinnon LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085675; McKinnon LR, 2011, J IMMUNOL, V187, P6032, DOI 10.4049/jimmunol.1101836; Qureshi H, 2012, J VIROL, V86, P2239, DOI 10.1128/JVI.06175-11; Shaw GM, 2012, COLD SPRING HARB PER, V2; Singh Shailbala, 2014, Methods Mol Biol, V1184, P417, DOI 10.1007/978-1-4939-1115-8_24; Tenbusch M, 2012, J VIROL, V86, P10533, DOI 10.1128/JVI.00796-12; Weaver EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067574; Weaver EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005059	20	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188807	10.1371/journal.pone.0188807	http://dx.doi.org/10.1371/journal.pone.0188807			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220358	gold, Green Published, Green Submitted			2022-12-27	WOS:000417469900018
J	Rohde, D; Merriman, NA; Doyle, F; Bennett, K; Williams, D; Hickey, A				Rohde, Daniela; Merriman, Niamh A.; Doyle, Frank; Bennett, Kathleen; Williams, David; Hickey, Anne			Does cognitive impairment impact adherence? A systematic review and meta-analysis of the association between cognitive impairment and medication non-adherence in stroke	PLOS ONE			English	Review							SECONDARY PREVENTION; OLDER-ADULTS; ATRIAL-FIBRILLATION; VASCULAR RISK; MORTALITY; ANTICOAGULATION; PERSISTENCE; SURVIVORS; DEMENTIA; DECLINE	Background While medication adherence is essential for the secondary prevention of stroke, it is often sub-optimal, and can be compromised by cognitive impairment. This study aimed to systematically review and meta-analyse the association between cognitive impairment and medication non-adherence in stroke. Methods A systematic literature search of longitudinal and cross-sectional studies of adults with any stroke type, which reported on the association between any measure of non-adherence and cognitive impairment, was carried out according to PRISMA guidelines. Odds ratios and 95% confidence intervals were the primary measure of effect. Risk of bias was assessed using the Cochrane Bias Methods Group's Tool to Assess Risk of Bias in Cohort Studies, with evidence quality assessed according to the GRADE approach. We conducted sensitivity analyses according to measure of cognitive impairment, measure of medication adherence, population, risk of bias and adjustment for covariates. The protocol was registered with PROSPERO. Results From 1,760 titles and abstracts, we identified 9 studies for inclusion. Measures of cognitive impairment varied from dementia diagnosis to standardised cognitive assessments. Medication adherence was assessed through self-report or administrative databases. The majority of studies were of medium risk of bias (n = 6); two studies had low risk of bias. Findings were mixed; when all studies were pooled, there was no evidence of an association between cognitive impairment and medication non-adherence post-stroke [OR (95% CI): 0.85 (0.66, 1.03)]. However, heterogeneity was substantial [I-2 = 90.9%, p < .001], and the overall evidence quality was low. Conclusions Few studies have explored associations between cognitive impairment and medication adherence post-stroke, with substantial heterogeneity in study populations, and definitions and assessments of non-adherence and cognitive impairment. Further research using clear, standardised and objective assessments is needed to clarify the association between cognitive impairment and medication non-adherence in stroke.	[Rohde, Daniela; Merriman, Niamh A.; Doyle, Frank; Bennett, Kathleen; Hickey, Anne] Royal Coll Surgeons Ireland, Div Populat Hlth Sci, Dublin, Ireland; [Williams, David] Beaumont Hosp, Dept Geriatr & Stroke Med, Dublin, Ireland; [Williams, David] Beaumont Hosp, Royal Coll Surg Ireland, Dublin, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland	Rohde, D (corresponding author), Royal Coll Surgeons Ireland, Div Populat Hlth Sci, Dublin, Ireland.	danielamrohde@rcsi.ie	Rohde, Daniela/M-7906-2017; Merriman, Niamh/I-8281-2016; Doyle, Frank/C-2750-2012	Rohde, Daniela/0000-0001-8834-2539; Doyle, Frank/0000-0002-3785-7433; Williams, David/0000-0002-1923-462X; Merriman, Niamh A./0000-0002-5327-7762; Bennett, Kathleen/0000-0002-2861-7665	Irish Health Research Board [SPHeRE 2013/1, RL-15-1579]	Irish Health Research Board	This work was supported by the Irish Health Research Board (grant nos. SPHeRE 2013/1 and RL-15-1579; http//:www.hrb.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnio K, 2014, STROKE, V45, P2670, DOI 10.1161/STROKEAHA.114.005648; Al AlShaikh S, 2016, EUROPEAN STROKE J; Allan LM, 2011, BRAIN, V134, P3713, DOI 10.1093/brain/awr273; Alosco ML, 2012, PSYCHOSOM MED, V74, P965, DOI 10.1097/PSY.0b013e318272ef2a; Bergstrom L, 2017, STROKE, V48, P2046, DOI 10.1161/STROKEAHA.117.016815; Bjorck F, 2015, THROMB RES, V136, P744, DOI 10.1016/j.thromres.2015.07.028; Brainin M, 2015, EUR J NEUROL, V22, P229, DOI 10.1111/ene.12626; Brewer L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0466-2; Campbell NL, 2012, AM J GERIATR PHARMAC, V10, P165, DOI 10.1016/j.amjopharm.2012.04.004; Cochrane Bias Methods Group, 2013, TOOL ASS RISK BIAS C; Coetzee N, 2008, BRAIN IMPAIR, V9, P122, DOI 10.1375/brim.9.2.122; Crayton E, 2017, ANN BEHAV MED, V51, P833, DOI 10.1007/s12160-017-9906-0; De Simoni A, 2015, BRIT J GEN PRACT, V65, pE789, DOI 10.3399/bjgp15X687589; DeCoster J., EFFECT SIZE CONVERTE; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Dhamoon MS, 2015, NEUROLOGY, V84, P1002, DOI 10.1212/WNL.0000000000001331; Douiri A, 2013, CIRCULATION, V128, P1341, DOI 10.1161/CIRCULATIONAHA.113.002236; Gumbinger C, 2015, EUR NEUROL, V73, P184, DOI 10.1159/000371574; Hankey GJ, 2014, LANCET NEUROL, V13, P178, DOI 10.1016/S1474-4422(13)70255-2; Hawkins LA, 2012, HEART LUNG, V41, P572, DOI 10.1016/j.hrtlng.2012.06.001; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Jefferson AL, 2015, J ALZHEIMERS DIS, V44, P1361, DOI 10.3233/JAD-141812; Kirkpatrick AC, 2014, AM J MED, V127, P1243, DOI 10.1016/j.amjmed.2014.08.010; Kronish IM, 2013, PROG CARDIOVASC DIS, V55, P590, DOI 10.1016/j.pcad.2013.02.001; Leung DYP, 2015, GERIATR GERONTOL INT, V15, P789, DOI 10.1111/ggi.12342; Lipsey M. W., 2001, PRACTICAL METAANALYS, DOI DOI 10.1016/J.AUTNEU.2007.06.087; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Murphy SJX, 2016, J NEUROL SCI, V361, P13, DOI 10.1016/j.jns.2015.12.009; O'Carroll R, 2011, ANN BEHAV MED, V41, P383, DOI 10.1007/s12160-010-9257-6; O'Carroll RE, 2013, ANN BEHAV MED, V46, P358, DOI 10.1007/s12160-013-9515-5; Pendlebury ST, 2012, INT J STROKE, V7, P570, DOI 10.1111/j.1747-4949.2012.00837.x; Polymeris AA, 2016, EUR NEUROL, V76, P187, DOI 10.1159/000450750; Rajan KB, 2014, STROKE, V45, P2563, DOI 10.1161/STROKEAHA.114.005143; Rohde D, 2017, CARDIOVASC THER, V35, DOI 10.1111/1755-5922.12300; Rohde D, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014819; Sch_unemann H, 2013, GRADE HDB; Shah R, 2016, MED CARE, V54, P907, DOI 10.1097/MLR.0000000000000589; Sjolander M, 2016, EUR STROKE J, V1, P101, DOI 10.1177/2396987316646026; Sjolander M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003551; Smith D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170651; Sterne JAC, 2004, STATA J, V4, P127, DOI 10.1177/1536867X0400400204; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Unverzagt FW, 2011, NEUROLOGY, V77, P1729, DOI 10.1212/WNL.0b013e318236ef23; Vinyoles E, 2008, CURR MED RES OPIN, V24, P3331, DOI [10.1185/03007990802538724, 10.1185/03007990802538724 ]; Vrijens B, 2012, BRIT J CLIN PHARMACO, V73, P691, DOI 10.1111/j.1365-2125.2012.04167.x; Wawruch M, 2016, PHARMACOEPIDEMIOL DR; Wawruch M, 2016, DRUG AGING, V33, P365, DOI 10.1007/s40266-016-0365-2; Wessol JL, 2017, J NEUROSCI NURS, V49, P120, DOI 10.1097/JNN.0000000000000266; White CL, 2010, STROKE, V41, pE290; Wilke T, 2015, J THROMB THROMBOLYS, V40, P97, DOI 10.1007/s11239-014-1136-8; Wilson D.B, PRACTICAL METAANALYS	51	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189339	10.1371/journal.pone.0189339	http://dx.doi.org/10.1371/journal.pone.0189339			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP2SV	29220386	gold, Green Published, Green Submitted			2022-12-27	WOS:000417469900051
J	Diana, A; Manzanilla, EG; Diaz, JAC; Leonard, FC; Boyle, LA				Diana, Alessia; Manzanilla, Edgar G.; Diaz, Julia A. Calderon; Leonard, Finola C.; Boyle, Laura A.			Do weaner pigs need in-feed antibiotics to ensure good health and welfare? (vol 12, 2017)	PLOS ONE			English	Correction													Manzanilla, Edgar Garcia/B-2974-2012; Diana, Alessia/W-2392-2019	Manzanilla, Edgar Garcia/0000-0002-2301-2560; Boyle, Laura/0000-0001-7080-1776; Diana, Alessia/0000-0002-8571-1295				Diana A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185622	1	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189434	10.1371/journal.pone.0189434	http://dx.doi.org/10.1371/journal.pone.0189434			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216293	Green Published, gold			2022-12-27	WOS:000417337800122
J	Dieze, A; Stephan, T; Hilzendegen, C; Stroebele-Benschop, N				Dieze, Anastasia; Stephan, Theodora; Hilzendegen, Carolin; Stroebele-Benschop, Nanette			The impact of viewing a video with and without head phones on snack intake: A pilot study	PLOS ONE			English	Article							DUTCH EATING BEHAVIOR; INCREASED MEAL INTAKE; FOOD-INTAKE; ENVIRONMENTAL-FACTORS; QUESTIONNAIRE DEBQ; TELEVISION; OBESITY; INCREASES; ASSOCIATION; ADOLESCENTS	Research shows that many small changes to the environment impact one's eating behavior. The aim of this study was to examine whether the type of audio transmission would affect snack intake depending on the degree of immersion. A sample of 174 university students were randomized to either viewing a movie wearing headphones or listening over loud speakers while consuming a snack of their choice. Significant differences were found with more snacks consumed in the group without headphones compared to the group wearing headphones. Particularly women tend to eat less (about 10% of the offered snack less) when wearing headphones while viewing a movie. The results seem to indicate that audio transmission mode might impact eating behavior.	[Dieze, Anastasia; Stephan, Theodora; Hilzendegen, Carolin; Stroebele-Benschop, Nanette] Univ Hohenheim, Inst Nutr Med, Dept Nutr Psychol, Stuttgart, Germany	University Hohenheim	Stroebele-Benschop, N (corresponding author), Univ Hohenheim, Inst Nutr Med, Dept Nutr Psychol, Stuttgart, Germany.	n.stroebele@uni-hohenheim.de						Arno A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3272-x; Barrada JR, 2016, EUR EAT DISORD REV, V24, P503, DOI 10.1002/erv.2448; Bellisle F, 2004, APPETITE, V43, P175, DOI 10.1016/j.appet.2004.04.004; Bellisle F, 2001, AM J CLIN NUTR, V74, P197; Blass EM, 2006, PHYSIOL BEHAV, V88, P597, DOI 10.1016/j.physbeh.2006.05.035; Boulos R, 2012, PHYSIOL BEHAV, V107, P146, DOI 10.1016/j.physbeh.2012.05.022; Braude L, 2014, APPETITE, V76, P9, DOI 10.1016/j.appet.2014.01.005; Chaput JP, 2011, AM J CLIN NUTR, V93, P1196, DOI 10.3945/ajcn.110.008680; Cleland VJ, 2008, AM J CLIN NUTR, V87, P1148, DOI 10.1093/ajcn/87.5.1148; Hawkes C, 2015, LANCET, V385, P2410, DOI 10.1016/S0140-6736(14)61745-1; Hetherington MM, 2006, PHYSIOL BEHAV, V88, P498, DOI 10.1016/j.physbeh.2006.04.025; Hill JO, 2008, OBES REV, V9, P41, DOI 10.1111/j.1467-789X.2007.00437.x; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Jastreboff AM, 2014, EAT BEHAV, V15, P286, DOI 10.1016/j.eatbeh.2014.03.008; Kaiser D, 2016, PSYCHOL MUSIC, V44, P1419, DOI 10.1177/0305735616636207; Kallinen K, 2007, COMPUT HUM BEHAV, V23, P303, DOI 10.1016/j.chb.2004.10.014; Lombard M, 1997, J CMC, V3; Lyons EJ, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-60; Marsh S, 2013, APPETITE, V71, P259, DOI 10.1016/j.appet.2013.08.017; Mekhmoukh A, 2012, APPETITE, V59, P90, DOI 10.1016/j.appet.2012.03.021; Nagl M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162510; Oh J, 2014, J MEDIA PSYCHOL-GER, V26, P81, DOI 10.1027/1864-1105/a000114; Peneau S, 2009, BRIT J NUTR, V102, P1854, DOI 10.1017/S0007114509991280; Rosiek A, 2015, INT J ENV RES PUB HE, V12, P9408, DOI 10.3390/ijerph120809408; Spence C., 2014, FLAVOUR, DOI [10.1186/2044-7248-3-9, DOI 10.1186/2044-7248-3-9]; Stroebele N, 2004, APPETITE, V42, P111, DOI 10.1016/j.appet.2003.09.001; Stroebele N, 2006, APPETITE, V47, P285, DOI 10.1016/j.appet.2006.04.001; Swinburn B, 2008, INT J OBESITY, V32, pS132, DOI 10.1038/ijo.2008.249; Temple JL, 2007, AM J CLIN NUTR, V85, P355, DOI 10.1093/ajcn/85.2.355; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Velema E, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3927-7; Wansink B, 2004, ANNU REV NUTR, V24, P455, DOI 10.1146/annurev.nutr.24.012003.132140; Wansink B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077055; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686	34	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188457	10.1371/journal.pone.0188457	http://dx.doi.org/10.1371/journal.pone.0188457			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216205	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800023
J	Feldmann-Wustefeld, T; Miyakoshi, M; Petilli, MA; Schubo, A; Makeig, S				Feldmann-Wustefeld, Tobias; Miyakoshi, Makoto; Petilli, Marco Alessandro; Schubo, Anna; Makeig, Scott			Reduced visual attention in heterogeneous textures is reflected in occipital alpha and theta band activity	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; SEARCH; OSCILLATIONS; DISSOCIATION; PERFORMANCE; MECHANISM; SALIENCE; MODELS; N2PC; POP	Increasing context heterogeneity has been found to reduce attention deployment towards an embedded target item. Heterogeneity in visual search tasks is typically induced by segmenting the background into several perceptual groups. In the present study, however, context heterogeneity was induced by varying whole-field heterogeneity, i.e., the degree of distractor variability within the entire context. This allowed us to (i) more gradually vary context heterogeneity, and (ii) investigate attention deployment on a whole-field scale. Results showed that both search performance and amplitude of the N2pc (lateralized ERP; posterior contralateral negativity in the N2 range) monotonically decreased with increasing context heterogeneity, which confirmed that there was less efficient attention deployment for more heterogeneous contexts. The amplitude of the bilateral N2 exhibited a U-shaped function, suggesting global perception for the lowest and highest levels of heterogeneity, but local processing for intermediate heterogeneity levels. Independent component analyses revealed an occipital ERP-contributing effective source cluster that may reflect stimulus representations on a saliency map. With increasing heterogeneity, these sources exhibited more theta band activity for distractors and less theta band activity for targets. Alpha band activity of a second component cluster varied with heterogeneity level, and low-theta/delta activity of a third source cluster distinguished target presence versus absence. In sum, our results suggest that independent brain sources contributed to the differential processing of heterogeneous versus homogeneous contexts.	[Feldmann-Wustefeld, Tobias] Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA; [Miyakoshi, Makoto; Petilli, Marco Alessandro; Makeig, Scott] Univ Calif San Diego, Swartz Ctr Computat Neurosci, Inst Neural Computat, San Diego, CA 92103 USA; [Petilli, Marco Alessandro] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Schubo, Anna] Philipps Univ Marburg, Fac Psychol Expt & Biol Psychol, Marburg, Germany	University of Chicago; University of California System; University of California San Diego; University of Milano-Bicocca; Philipps University Marburg	Feldmann-Wustefeld, T (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	tobiasfw@uchicago.edu	Petilli, Marco A/AAQ-3337-2020	Petilli, Marco A/0000-0002-9948-0029; Miyakoshi, Makoto/0000-0002-4062-6679	Deutsche Forschungsgemeinschaft (German Research Foundation) [SFB/TRR135]; Deutsche Studienstiftung	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Deutsche Studienstiftung	This research was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation; SFB/TRR135, TP B3) to AS, by a Ph.D. grant to TFW by the Deutsche Studienstiftung, and by a gift to SM from The Swartz Foundation (Old Field NY).; This research was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation; SFB/TRR135, TP B3) to AS, by a Ph.D. grant to TFW by the Deutsche Studienstiftung, and by a gift to S.M. from The Swartz Foundation (Old Field NY). The authors wish to thank Nicole Hakim for her valuable comments.	Avraham T, 2008, J VISION, V8, DOI 10.1167/8.4.9; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Donk M, 2010, J EXP PSYCHOL HUMAN, V36, P286, DOI 10.1037/a0017605; Dowdall JR, 2012, NEUROPSYCHOLOGIA, V50, P2442, DOI 10.1016/j.neuropsychologia.2012.06.015; Dugue L, THETA OSCILLATIONS M, P945; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Feldmann-Wustefeld T, 2014, VISION RES, V97, P108, DOI 10.1016/j.visres.2014.02.008; Feldmann-Wustefeld T, 2013, ATTEN PERCEPT PSYCHO, V75, P1644, DOI 10.3758/s13414-013-0508-z; Feldmann-Wustefeld T, 2013, PSYCHOPHYSIOLOGY, V50, P722, DOI 10.1111/psyp.12061; Feldmann-Wustefeld T, 2013, J VISION, V13, DOI 10.1167/13.3.11; Foster JJ, 2016, J NEUROPHYSIOL, V115, P168, DOI 10.1152/jn.00860.2015; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Friston KJ, 1998, TRENDS COGN SCI, V2, P373, DOI 10.1016/S1364-6613(98)01227-3; Hanslmayr S, 2011, BRAIN RES REV, V67, P331, DOI 10.1016/j.brainresrev.2011.04.002; HEINZE HJ, 1993, NEUROPSYCHOLOGIA, V31, P841, DOI 10.1016/0028-3932(93)90132-J; HUMPHREYS GW, 1989, J EXP PSYCHOL GEN, V118, P258, DOI 10.1037/0096-3445.118.3.258; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Jensen O, 2012, TRENDS COGN SCI, V16, P200, DOI 10.1016/j.tics.2012.03.002; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Knierim JJ, 1992, NEURONAL RESPONSES S, V67; Koch C, 2007, TRENDS COGN SCI, V11, P16, DOI 10.1016/j.tics.2006.10.012; Landau AN, 2012, CURR BIOL, V22, P1000, DOI 10.1016/j.cub.2012.03.054; Li ZP, 1999, P NATL ACAD SCI USA, V96, P10530, DOI 10.1073/pnas.96.18.10530; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; Luck SJ, 1994, LUCK 1994 JEPHPP N2P; Madden DJ, 2007, NEUROBIOL AGING, V28, P459, DOI 10.1016/j.neurobiolaging.2006.01.005; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 1999, J NEUROSCI, V19, P2665; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Makeig S, 1996, ADV NEUR IN, V8, P145; Mangun GR, 1997, HUM BRAIN MAPP, V5, P273, DOI 10.1002/(SICI)1097-0193(1997)5:4<273::AID-HBM12>3.0.CO;2-F; Marrufo MV, 2001, COGNITIVE BRAIN RES, V12, P315; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Mazza V, 2009, PSYCHOPHYSIOLOGY, V46, P771, DOI 10.1111/j.1469-8986.2009.00814.x; Mazza V, 2009, CORTEX, V45, P879, DOI 10.1016/j.cortex.2008.10.009; Meinecke C, 2002, PERCEPTION, V31, P591, DOI 10.1068/p3201; Mullen TR, 2015, IEEE T BIO-MED ENG, V62, P2553, DOI 10.1109/TBME.2015.2481482; Navalpakkam V, 2005, VISION RES, V45, P205, DOI 10.1016/j.visres.2004.07.042; NOTHDURFT HC, 1992, PERCEPT PSYCHOPHYS, V52, P355, DOI 10.3758/BF03206697; Onton J, 2006, PROG BRAIN RES, V159, P99, DOI 10.1016/S0079-6123(06)59007-7; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Palmer J a, 2008, COMPLEX CROSS SPECTR, V12, P660; Pfurtscheller G, 2003, EPILEPSIA, V44, P2, DOI 10.1111/j.0013-9580.2003.12001.x; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Rosenholtz R, 2001, J EXP PSYCHOL HUMAN, V27, P985, DOI 10.1037//0096-1523.27.4.985; Schubo A, 2004, COGNITIVE BRAIN RES, V21, P317, DOI 10.1016/j.cogbrainres.2004.06.007; Schubo A, 2007, BRAIN RES; Schubo A, 2007, BRAIN RES, V1138, P136, DOI 10.1016/j.brainres.2006.12.059; Schubo A, 2011, NEUROSCI LETT, V502, P46, DOI 10.1016/j.neulet.2011.07.022; Talsma D, 2009, BRAIN STRUCTURES INV, P761; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Wei P, 2009, NEUROIMAGE, V45, P993, DOI 10.1016/j.neuroimage.2008.12.053; Wykowska A, 2011, ATTEN PERCEPT PSYCHO, V73, P1034, DOI 10.3758/s13414-011-0122-x	62	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0187763	10.1371/journal.pone.0187763	http://dx.doi.org/10.1371/journal.pone.0187763			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216195	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000417337800011
J	Oh, SH; Kim, DK; Lee, SU; Jung, SH; Lee, SY				Oh, Sang-Ho; Kim, Don-Kyu; Lee, Shi-Uk; Jung, Se Hee; Lee, Sang Yoon			Association between exercise type and quality of life in a community-dwelling older people: A cross-sectional study	PLOS ONE			English	Article							FRAIL ELDERLY-PEOPLE; PHYSICAL-ACTIVITY; WATER EXERCISE; HEALTH; EUROQOL; EQ-5D; PREVENTION; PROGRAM; INTERVENTION; POPULATION	Objectives This study aimed to investigate the effects of three major representative exercises (resistance, flexibility, and walking) on quality of life (QoL) in a population of community-dwelling older adults. Materials and methods This cross-sectional study used public data from the Sixth Korean National Health and Nutrition Examination Survey in 2014 (n = 1,586 older people). Demographic factors, three types of exercise, five EuroQoL subsets (mobility, self-care, usual activities, pain/discomfort, anxiety/depression), and QoL scores (EQ-VAS) were investigated. The independent associations between each exercise and the five QoL subsets were determined using odds ratios (OR) adjusted for three demographic factors (age group, sex, and area of residence), using multivariate logistic regression analysis. Results The EQ-VAS scores of the exercisers was significantly higher than those of the non-exercisers for all exercise types. Subjects with problems in mobility dimension performed less exercise of all types of than those with normal mobility (resistance: OR, 0.687; flexibility: OR, 0.733, and walking: OR, 0.489). The self-care dimension was independently correlated with flexibility (OR, 0.558) and walking (OR, 0.485). Conclusion All types of exercisers showed higher QoL scores than non-exercisers. Among the QoL dimensions, mobility and self-care were independently associated with flexibility and walking exercise in this older people, suggesting that engaging in regular flexibility and walking exercise is important for achieving higher QoL in the older people.	[Oh, Sang-Ho; Kim, Don-Kyu] Chung Ang Univ, Dept Phys Med & Rehabil, Coll Med, Seoul, South Korea; [Lee, Shi-Uk; Jung, Se Hee; Lee, Sang Yoon] Seoul Natl Univ, Dept Rehabil Med, Boramae Med Ctr, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University Hospital	Lee, SY (corresponding author), Seoul Natl Univ, Dept Rehabil Med, Boramae Med Ctr, Seoul, South Korea.	rehabilee@gmail.com	Lee, Sang Yoon/AAD-5045-2019	Lee, Sang Yoon/0000-0002-2906-3094; Jung, Se Hee/0000-0002-0623-8752				Bigley AB, 2013, MATURITAS, V76, P51, DOI 10.1016/j.maturitas.2013.06.010; Bullo V, 2018, REJUV RES, V21, P141, DOI 10.1089/rej.2017.1921; Chen CH, 2014, KAOHSIUNG J MED SCI, V30, P521, DOI 10.1016/j.kjms.2014.08.004; Cheung PWH, 2016, SCOLIOSIS SPINAL DIS, V11, DOI 10.1186/s13013-016-0083-x; Dechamps A, 2010, ARCH INTERN MED, V170, P162, DOI 10.1001/archinternmed.2009.489; Eaglehouse YL, 2016, QUAL LIFE RES, V25, P1903, DOI 10.1007/s11136-016-1240-7; Fielding RA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182155; Fortuno-Godes J, 2013, CURR GERONTOL GERIAT, V2013, DOI DOI 10.1155/2013/168482; Franco-Martin M, 2013, REV NEUROLOGIA, V56, P545, DOI 10.33588/rn.5611.2012570; Hagins Marshall, 2007, BMC Complement Altern Med, V7, P40, DOI 10.1186/1472-6882-7-40; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hatswell AJ, 2016, HEALTH ECON REV, V6, DOI 10.1186/s13561-016-0091-9; Heesch KC, 2016, PREV MED, V91, P299, DOI 10.1016/j.ypmed.2016.09.012; Horder H, 2013, QUAL LIFE RES, V22, P1213, DOI 10.1007/s11136-012-0267-7; Huppertz-Hauss G, 2016, GASTROENT RES PRACT, V2016; Janyacharoen T, 2017, J SPORT MED PHYS FIT, V57, P1344, DOI 10.23736/S0022-4707.16.06439-2; Katz P, 2001, J AM GERIATR SOC, V49, P808; Kim MH, 2005, QUAL LIFE RES, V14, P1401, DOI 10.1007/s11136-004-5681-z; Kim SH, 2012, SUPPORT CARE CANCER, V20, P3155, DOI 10.1007/s00520-012-1457-0; Kim SH, 2015, IEEE T COMP PACK MAN, V5, P3, DOI 10.1109/TCPMT.2014.2369053; King JT, 2009, NEUROSURGERY, V65, P565, DOI 10.1227/01.NEU.0000350980.01519.D8; Lattari Eduardo, 2014, Clin Pract Epidemiol Ment Health, V10, P126, DOI 10.2174/1745017901410010126; Neto GAM, 2015, CNS NEUROL DISORD-DR, V14, P1152, DOI 10.2174/1871527315666151111130045; Morris JN, 1997, SPORTS MED, V23, P306, DOI 10.2165/00007256-199723050-00004; Mura Gioia, 2014, Clin Pract Epidemiol Ment Health, V10, P36, DOI 10.2174/1745017901410010036; Noradechanunt C, 2017, J SCI MED SPORT, V20, P494, DOI 10.1016/j.jsams.2016.10.007; Park SY, 2015, J PHYS THER SCI, V27, P2061, DOI 10.1589/jpts.27.2061; Park SW, 2012, UROLOGY, V80, P299, DOI 10.1016/j.urology.2011.12.060; Park Y, 2016, J PHYS THER SCI, V28, P190, DOI [10.1589/jpts.28.190, 10.1589/jpts.28.1904]; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Pescatello LS, 2004, MED SCI SPORT EXER, V36, P533, DOI 10.1249/01.MSS.0000115224.88514.3A; Pihl E, 2011, EUR J CARDIOVASC NUR, V10, P150, DOI 10.1016/j.ejcnurse.2011.03.002; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rugbeer Nivash, 2017, Pan Afr Med J, V26, P35, DOI 10.11604/pamj.2017.26.35.10518; Sato D, 2007, QUAL LIFE RES, V16, P1577, DOI 10.1007/s11136-007-9269-2; Sato D, 2009, DISABIL REHABIL, V31, P84, DOI 10.1080/09638280701817552; Savoia E, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-47; Schoenfeld BJ, 2016, SPORTS MED, V46, P1689, DOI 10.1007/s40279-016-0543-8; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; World Health Organization, 2001, MEN AG HLTH	42	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188335	10.1371/journal.pone.0188335	http://dx.doi.org/10.1371/journal.pone.0188335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216283	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800020
J	Saade, S; Kutlu, B; Draba, V; Forster, K; Schumann, E; Tester, M; Pillen, K; Maurer, A				Saade, Stephanie; Kutlu, Burcu; Draba, Vera; Forster, Karin; Schumann, Erika; Tester, Mark; Pillen, Klaus; Maurer, Andreas			A donor-specific QTL, exhibiting allelic variation for leaf sheath hairiness in a nested association mapping population, is located on barley chromosome 4H	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; SERINE-PROTEASE; FLOWERING TIME; RNA-BINDING; GENE; HOMOLOG; GROWTH; RECOMBINANT; RESISTANCE; PUBESCENCE	Leaf sheath hairiness is a morphological trait associated with various advantages, including tolerance to both abiotic and biotic stresses, thereby increasing yield. Understanding the genetic basis of this trait in barley can therefore improve the agronomic performance of this economically important crop. We scored leaf sheath hairiness in a two-year field trial in 1,420 BC1S3 lines from the wild barley nested association mapping (NAM) population HEB-25. Leaf sheath hairiness segregated in six out of 25 families with the reference parent Barke being glabrous. We detected the major hairy leaf sheath locus Hs (syn. Hsh) on chromosome 4H (111.3 cM) with high precision. The effects of the locus varied across the six different wild barley donors, with donor of HEB family 11 conferring the highest score of leaf sheath hairiness. Due to the high mapping resolution present in HEB-25, we were able to discuss physically linked pentatricopeptide repeat genes and subtilisin-like proteases as potential candidate genes underlying this locus. In this study, we proved that HEB-25 provides an appropriate tool to further understand the genetic control of leaf sheath hairiness in barley. Furthermore, our work represents a perfect starting position to clone the gene responsible for the 4H locus observed.	[Saade, Stephanie; Tester, Mark] KAUST, BESE, Thuwal, Saudi Arabia; [Kutlu, Burcu] Ege Univ, Dept Biotechnol, Erzene, Bornova Izmir, Turkey; [Draba, Vera; Schumann, Erika; Pillen, Klaus; Maurer, Andreas] Martin Luther Univ Halle Wittenberg, Dept Plant Breeding, Inst Agr & Nutr Sci, Halle, Germany; [Forster, Karin] Martin Luther Univ Halle Wittenberg, Dept Agron & Organ Farming, Inst Agr & Nutr Sci, Halle, Germany	King Abdullah University of Science & Technology; Ege University; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Maurer, A (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Plant Breeding, Inst Agr & Nutr Sci, Halle, Germany.	andreas.maurer@landw.uni-halle.de	Pillen, Klaus/I-6511-2012; Tester, Mark/J-2368-2017	Pillen, Klaus/0000-0003-4646-6351; Maurer, Andreas/0000-0002-2916-7475; Tester, Mark/0000-0002-5085-8801; saade, stephanie/0000-0003-3817-7234	German Research Foundation (DFG) [Pi339/7-1, Pi339/8-1]; Interdisciplinary Centre for Crop Plant Research (IZN), Halle; King Abdullah University of Science and Technology (KAUST); Ege University Erasmus Programme	German Research Foundation (DFG)(German Research Foundation (DFG)); Interdisciplinary Centre for Crop Plant Research (IZN), Halle; King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); Ege University Erasmus Programme	This project was funded by German Research Foundation (DFG) via Grants Pi339/7-1 and Pi339/8-1 (AM): http://www.dfg.de/; Interdisciplinary Centre for Crop Plant Research (IZN), Halle (VD): http://www.uni-halle.de/izn/; King Abdullah University of Science and Technology (KAUST) (SS): https://www./kaust.edu.sa/en; Ege University Erasmus Programme (BK): http://ebys. ege.edu.tr/ogrenci/ebp/llp-erasmus.htm.	Alqudah AM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00896; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; Berger D, 2000, GENE DEV, V14, P1119; Cantalapiedra CP, 2015, MOL BREEDING, V35; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; DEVOS KM, 1993, THEOR APPL GENET, V85, P673, DOI 10.1007/BF00225004; Dobrovolskaya O, 2007, EUPHYTICA, V155, P285, DOI 10.1007/s10681-006-9329-7; EHLERINGER JR, 1978, OECOLOGIA, V37, P183, DOI 10.1007/BF00344990; GRACE J, 1977, J EXP BOT, V28, P268, DOI 10.1093/jxb/28.2.268; Graham J, 2006, THEOR APPL GENET, V112, P818, DOI 10.1007/s00122-005-0184-z; Gutierrez-Marcos JF, 2007, PLANT CELL, V19, P196, DOI 10.1105/tpc.105.039594; Hameed M., 2002, International Journal of Agriculture and Biology, V4, P12; HOLM S, 1979, SCAND J STAT, V6, P65; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; JOHNSON HB, 1975, BOT REV, V41, P233, DOI 10.1007/BF02860838; Jost M, 2016, PLANT PHYSIOL, V171, P1113, DOI 10.1104/pp.16.00124; Kim HJ, 2011, THEOR APPL GENET, V122, P1051, DOI 10.1007/s00122-010-1510-7; Korzun V, 1999, GENOME, V42, P960, DOI 10.1139/gen-42-5-960; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; LARKIN JC, 1994, PLANT CELL, V6, P1065, DOI 10.1105/tpc.6.8.1065; LEVIN DA, 1973, Q REV BIOL, V48, P3, DOI 10.1086/407484; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Li M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00037; Liu J, 2006, PLANT CELL PHYSIOL, V47, P1274, DOI 10.1093/pcp/pcj097; Liu W, 2011, THEOR APPL GENET, V123, P545, DOI 10.1007/s00122-011-1606-8; Luo M, 2009, INT J MOL SCI, V10, P1896, DOI 10.3390/ijms10041896; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Ma SS, 2006, J EXP BOT, V57, P1097, DOI 10.1093/jxb/erj098; Marks MD, 1997, ANNU REV PLANT PHYS, V48, P137, DOI 10.1146/annurev.arplant.48.1.137; Mascher M, 2017, NATURE, V544, P426, DOI 10.1038/nature22043; Mascher M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r78; Maurer A, 2017, HEREDITY, V118, P477, DOI 10.1038/hdy.2016.121; Maurer A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1459-7; Meierhoff K, 2003, PLANT CELL, V15, P1480, DOI 10.1105/tpc.010397; Nakamura T, 2004, BIOCHEM SOC T, V32, P571, DOI 10.1042/BST0320571; PATTERSON FRED L., 1957, AGRON JOUR, V49, P218; Pickering RA, 1997, GENOME, V40, P195, DOI 10.1139/g97-028; Reif JC, 2010, THEOR APPL GENET, V121, P1489, DOI 10.1007/s00122-010-1405-7; Saha D, 2007, PLANT PHYSIOL BIOCH, V45, P521, DOI 10.1016/j.plaphy.2007.03.026; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Spyropoulou EA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-402; Taketa S, 1997, GENES GENET SYST, V72, P101, DOI 10.1266/ggs.72.101; Tanaka H, 2001, DEVELOPMENT, V128, P4681; Turner S.D., 2018, BIORXIV, V3, P731, DOI [10.21105/joss.00731, 10.1101/005165, DOI 10.1101/005165.V1]; Utz HF, 2000, GENETICS, V154, P1839; von Groll U, 2002, PLANT CELL, V14, P1527, DOI 10.1105/tpc.001016; Wan HS, 2015, EUPHYTICA, V205, P275, DOI 10.1007/s10681-015-1457-5; Wang MH, 2012, THEOR APPL GENET, V124, P233, DOI 10.1007/s00122-011-1697-2; Wang SC, 2008, PLANT CELL PHYSIOL, V49, P1792, DOI 10.1093/pcp/pcn159; Werker E, 2000, ADV BOT RES, V31, P1, DOI 10.1016/S0065-2296(00)31005-9; Wurschum T, 2012, HEREDITY, V108, P332, DOI 10.1038/hdy.2011.78; Zeng YH, 2013, CHINESE SCI BULL, V58, P2992, DOI 10.1007/s11434-013-5737-y	54	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189446	10.1371/journal.pone.0189446	http://dx.doi.org/10.1371/journal.pone.0189446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216333	Green Submitted, Green Published, gold			2022-12-27	WOS:000417337800123
J	Yang, CP; Hsieh, ML; Chiang, JH; Chang, HY; Hsieh, VCR				Yang, Chun-Pai; Hsieh, Meng-Lun; Chiang, Jen-Huai; Chang, Hsing-Yi; Hsieh, Vivian Chia-Rong			Migraine and risk of narcolepsy in children: A nationwide longitudinal study	PLOS ONE			English	Article							INCREASED FREQUENCY; DISORDERS; HEADACHE; NEURONS; TAIWAN; SLEEP	Background The association between migraine and narcolepsy remains controversial. We aim to investigate whether migraine is associated with an increased risk of developing narcolepsy in children. Methods In this longitudinal study, nationwide medical-claims data of pediatric patients (0-17y) with migraine are identified using the National Health Insurance Research Database (NHIRD) between 1997 and 2010 in Taiwan. Two cohorts are selected: migraine cases (n = 8,923) and propensity score-matched non-migraine controls (n = 35,692). Children with previous history of narcolepsy or headache before the index date are excluded. Cohorts are followed until the end of 2012, their withdrawal from the NHI program, or incidence of narcolepsy (ICD-9-CM: 347). Cox proportional hazards regression models are used to estimate hazard ratios (HRs) and 95% confidence intervals of developing narcolepsy in children with migraine compared to their non-migraine controls. Results A total of 13 incident cases with narcolepsy are observed during follow-up, with incidence rates of 0.1915 and 0.0278 per 1,000 person-years in migraine and non-migraine children, respectively. After a mean follow-up period of 4.68 and 5.04 years in the case and control cohort, respectively, the former exhibited a greater risk of developing narcolepsy compared to the latter (adjusted hazard ratio (aHR) = 5.30, 95% confidence interval (CI): 1.61, 17.4; p = 0.006). This finding persisted after controlling for potential confounders like baseline comorbidities and concurrent medication uptake, and in our analyses with migraine subtypes. Conclusions Migraine is an independent risk factor for narcolepsy development in children. Further studies are needed to validate our findings and to explore the exact pathophysiological mechanisms linking migraine and narcolepsy.	[Yang, Chun-Pai] Kuang Tien Gen Hosp, Dept Neurol, Taichung, Taiwan; [Yang, Chun-Pai] Huang Kuang Univ, Dept Nutr, Taichung, Taiwan; [Hsieh, Meng-Lun] Taipei Vet Gen Hosp, Dept Med Educ, Taipei, Taiwan; [Hsieh, Meng-Lun] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan; [Chiang, Jen-Huai] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chiang, Jen-Huai] China Med Univ, Coll Med, Taichung, Taiwan; [Chang, Hsing-Yi] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Hsieh, Vivian Chia-Rong] China Med Univ, Coll Publ Hlth, Dept Hlth Serv Adm, Taichung, Taiwan	Taipei Veterans General Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan	Hsieh, VCR (corresponding author), China Med Univ, Coll Publ Hlth, Dept Hlth Serv Adm, Taichung, Taiwan.	hsiehchiarong@gmail.com		Hsieh, Vivian Chia-Rong/0000-0001-9635-0897	Taiwan Ministry of Health and Welfare Clinical Trial Center [MOHW106-TDU-B-212-113004]; Bureau of Health Promotion, Department of Health, Taiwan [D0H99-HP-1205]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial Center; Bureau of Health Promotion, Department of Health, Taiwan; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW106-TDU-B-212-113004), Bureau of Health Promotion, Department of Health, Taiwan (D0H99-HP-1205), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW106-TDU-B-212-113004), Bureau of Health Promotion, Department of Health, Taiwan (DOH99-HP-1205), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.	Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Cevoli S, 2012, NEUROL SCI, V33, pS43, DOI 10.1007/s10072-012-1030-0; CHALLAMEL MJ, 1994, SLEEP, V17, pS17, DOI 10.1093/sleep/17.suppl_8.S17; Dahmen N, 1999, NEUROLOGY, V52, P1291, DOI 10.1212/WNL.52.6.1291; Dahmen N, 2003, CEPHALALGIA, V23, P14, DOI 10.1046/j.1468-2982.2003.00343.x; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; Evers S, 2003, CEPHALALGIA, V23, P786, DOI 10.1046/j.1468-2982.2003.00594.x; Evers S, 2010, HEADACHE, V50, P1246, DOI 10.1111/j.1526-4610.2010.01730.x; Goadsby PJ, 2009, NEUROSCIENCE, V161, P327, DOI 10.1016/j.neuroscience.2009.03.019; Goadsby PJ, 2012, ANN INDIAN ACAD NEUR, V15, P15, DOI 10.4103/0972-2327.99993; Holland PR, 2009, CEPHALALGIA, V29, P1, DOI 10.1111/j.1468-2982.2009.02027.x; Liu CY, 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Malick A, 2000, J NEUROPHYSIOL, V84, P2078, DOI 10.1152/jn.2000.84.4.2078; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Wang SJ, 2008, J FORMOS MED ASSOC, V107, P485, DOI 10.1016/S0929-6646(08)60157-6; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wijnans L, 2013, VACCINE, V31, P1246, DOI 10.1016/j.vaccine.2012.12.015	17	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189231	10.1371/journal.pone.0189231	http://dx.doi.org/10.1371/journal.pone.0189231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216286	gold, Green Published, Green Submitted			2022-12-27	WOS:000417337800102
J	de Francisco, P; Martin-Gonzalez, A; Turkewitz, AP; Gutierrez, JC				de Francisco, Patricia; Martin-Gonzalez, Ana; Turkewitz, Aaron P.; Gutierrez, Juan Carlos			Extreme metal adapted, knockout and knockdown strains reveal a coordinated gene expression among different Tetrahymena thermophila metallothionein isoforms	PLOS ONE			English	Article							STRESS-INDUCIBLE METALLOTHIONEIN; TRANSCRIPTION FACTOR-IIIA; ZINC; CLONING; COPPER; INDUCTION; TOLERANCE; EVOLUTION; NEMATODE; SINGLE	Metallothioneins (MT) constitute a superfamily of small cytosolic proteins that are able to bind metal cations through numerous cysteine (Cys) residues. Like other organisms the ciliate Tetrahymena thermophila presents several MT isoforms, which have been classified into two subfamilies (Cd-and Cu-metallothioneins). The main aim of this study was to examine the specific functions and transcriptional regulation of the five MT isoforms present in T. thermophila, by using several strains of this ciliate. After a laboratory evolution experiment over more than two years, three different T. thermophila strains adapted to extreme metal stress (Cd2+, Cu2+ or Pb2+) were obtained. In addition, three knockout and/or knockdown strains for different metallothionein (MT) genes were generated. These strains were then analyzed for expression of the individual MT isoforms. Our results provide a strong basis for assigning differential roles to the set of MT isoforms. MTT1 appears to have a key role in adaptation to Cd. In contrast, MTT2/4 are crucial for Cu-adaptation and MTT5 appears to be important for Pb-adaptation and might be considered as an "alarm" MT gene for responding to metal stress. Moreover, results indicate that likely a coordinated transcriptional regulation exists between the MT genes, particularly among MTT1, MTT5 and MTT2/4. MTT5 appears to be an essential gene, a first such report in any organism of an essential MT gene.	[de Francisco, Patricia; Martin-Gonzalez, Ana; Gutierrez, Juan Carlos] UCM, Fac Biol, Dept Microbiol 3, Madrid, Spain; [Turkewitz, Aaron P.] Univ Chicago, Dept Mol Genet & Cell Biol, Cummings Life Sci Ctr, 920 E 58Th St, Chicago, IL 60637 USA	Complutense University of Madrid; University of Chicago	Gutierrez, JC (corresponding author), UCM, Fac Biol, Dept Microbiol 3, Madrid, Spain.	juancar@bio.ucm.es	De Francisco, Patricia/AAC-4045-2021; MARTIN, ANA/ABG-7710-2020; De Francisco, Patricia/W-1289-2017	De Francisco, Patricia/0000-0003-0806-5514; Gutierrez, Juan Carlos/0000-0003-0909-3349	MINECO [CGL2016-75494-R]; NIH [GM-105783]; Spanish Ministry of Education [FPU12/02789]	MINECO(Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Education(Spanish Government)	This work was supported by MINECO CGL2016-75494-R; NIH GM-105783; A PhD scholarship was awarded to PdF by the Spanish Ministry of Education (FPU12/02789). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A PhD scholarship was awarded to PdF by the Spanish Ministry of Education (FPU12/02789).	Adamo GM, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-1; Amaro F, 2008, GENE, V423, P85, DOI 10.1016/j.gene.2008.07.002; Amaro F, 2014, BIOMETALS, V27, P195, DOI 10.1007/s10534-014-9704-0; Ambjorn M, 2008, J NEUROCHEM, V104, P21, DOI 10.1111/j.1471-4159.2007.05036.x; Atrian Silvia, 2013, Biomol Concepts, V4, P143, DOI 10.1515/bmc-2012-0049; Blindauer CA, 2008, J INORG BIOCHEM, V102, P507, DOI 10.1016/j.jinorgbio.2007.10.032; Boldrin F, 2006, EUKARYOT CELL, V5, P422, DOI 10.1128/EC.5.2.422-425.2006; Boldrin F, 2002, PROTIST, V153, P283, DOI 10.1078/1434-4610-00105; Butler PR, 1996, BIOTECHNOL BIOENG, V49, P185, DOI 10.1002/(SICI)1097-0290(19960120)49:2<185::AID-BIT7>3.0.CO;2-M; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CassidyHanley D, 1997, GENETICS, V146, P135; Cheung, 2005, BBA-GENE STRUCT EXPR, V1731, P191, DOI [10.1016/j.bbaexp.2005.09.006, 10.1016/j.bbaexp.2005.9.006]; Costa D, 2012, ECOTOXICOLOGY, V21, P2078, DOI 10.1007/s10646-012-0961-9; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Daniels MJ, 2006, GENES CELLS, V11, P647; de Francisco P, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2658-6; Diaz S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000291; Dondero F, 2004, PROTIST, V155, P157, DOI 10.1078/143446104774199565; Egli D, 2006, MOL CELL BIOL, V26, P2286, DOI 10.1128/MCB.26.6.2286-2296.2006; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Espart Anna, 2015, Int J Biol Sci, V11, P456, DOI 10.7150/ijbs.11060; Fu CJ, 2006, PROTIST, V157, P193, DOI 10.1016/j.protis.2006.02.006; Gadd GM, 2000, ENCY MICROBIOLOGY, P607; Guimaraes PMR, 2008, APPL ENVIRON MICROB, V74, P1748, DOI 10.1128/AEM.00186-08; Guo LN, 2008, GENE, V423, P29, DOI 10.1016/j.gene.2008.04.023; Gutierrez JC, 2011, J BIOL INORG CHEM, V16, P1025, DOI 10.1007/s00775-011-0820-9; Gutierrez JC, 2009, BIOESSAYS, V31, P805, DOI 10.1002/bies.200900011; Hockner M, 2011, J BIOL INORG CHEM, V16, P1057, DOI 10.1007/s00775-011-0826-3; Huang M, 2004, J INORG BIOCHEM, V98, P639, DOI 10.1016/j.jinorgbio.2004.02.004; Huang Y, 2016, PLOS GENET, V12, P1; Huggins CJ, 2016, MOL CELL BIOL, V36, P693, DOI 10.1128/MCB.00911-15; Hughes S, 2007, ENVIRON POLLUT, V145, P395, DOI 10.1016/j.envpol.2006.06.003; Kataoka K, 2010, J MICROBIOL METH, V82, P342, DOI 10.1016/j.mimet.2010.07.009; Klaassen CD, 1998, ENVIRON HEALTH PERSP, V106, P297, DOI 10.2307/3433930; Knipp M, 2005, BIOCHEMISTRY-US, V44, P3159, DOI 10.1021/bi047636d; Kumar G, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-107; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Leonard SS, 2004, FREE RADICAL BIO MED, V37, P1921, DOI 10.1016/j.freeradbiomed.2004.09.010; Li WH, 2005, TRENDS GENET, V21, P602, DOI 10.1016/j.tig.2005.08.006; Liu J, 1996, FUND APPL TOXICOL, V29, P294, DOI 10.1006/faat.1996.0034; Liu N, 1998, INSECT BIOCHEM MOLEC, V28, P531, DOI 10.1016/S0965-1748(98)00039-3; Maret W, 1999, P NATL ACAD SCI USA, V96, P1936, DOI 10.1073/pnas.96.5.1936; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; MICHALSKA AE, 1993, P NATL ACAD SCI USA, V90, P8088, DOI 10.1073/pnas.90.17.8088; Miles AT, 2000, CRIT REV BIOCHEM MOL, V35, P35, DOI 10.1080/10409230091169168; Minty JJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-18; Niederwanger M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081747; Orihuela R, 2011, CHEM COMMUN, V47, P12155, DOI 10.1039/c1cc14819b; Ostrakhovitch EA, 2006, FEBS LETT, V580, P1235, DOI 10.1016/j.febslet.2006.01.036; Pedrini-Martha V, 2017, COMP BIOCHEM PHYS C, V199, P38, DOI 10.1016/j.cbpc.2017.02.009; Penkowa M, 2000, J CEREBR BLOOD F MET, V20, P1174, DOI 10.1097/00004647-200008000-00003; Quiming NS, 2005, J HEALTH SCI, V51, P8, DOI 10.1248/jhs.51.8; Sakulsak N, 2012, INT J MORPHOL, V30, P1007, DOI 10.4067/S0717-95022012000300039; Timmermans MJTN, 2005, ECOTOXICOLOGY, V14, P727, DOI 10.1007/s10646-005-0020-x; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; van Straalen NM, 2011, ECOTOXICOLOGY, V20, P574, DOI 10.1007/s10646-011-0631-3; Viarengo A, 2000, CELL MOL BIOL, V46, P407; Vidal F, 1993, ZYGOTE, V1, P225, DOI 10.1017/S0967199400001507; Winkler AA, 2007, ADV BIOCHEM ENG BIOT, V10, P57, DOI DOI 10.1007/10_; Wysocki R, 2010, FEMS MICROBIOL REV, V34, P925, DOI 10.1111/j.1574-6976.2010.00217.x; ZENG J, 1991, P NATL ACAD SCI USA, V88, P9984, DOI 10.1073/pnas.88.22.9984	61	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189076	10.1371/journal.pone.0189076	http://dx.doi.org/10.1371/journal.pone.0189076			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206858	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000417110700044
J	El-Bassossy, HM; Al-Thubiani, WS; Elberry, AA; Mujallid, MI; Ghareib, SA; Azhar, AS; Banjar, ZM; Watson, ML				El-Bassossy, Hany M.; Al-Thubiani, Wafaa S.; Elberry, Ahmed A.; Mujallid, Mohammad I.; Ghareib, Salah A.; Azhar, Ahmad S.; Banjar, Zainy M.; Watson, Malcolm L.			Zingerone alleviates the delayed ventricular repolarization and AV conduction in diabetes: Effect on cardiac fibrosis and inflammation	PLOS ONE			English	Article							MYOCARDIAL INFARCTED RATS; ARRHYTHMOGENIC CARDIOMYOPATHY; INSULIN-RESISTANCE; HEART-FAILURE; NITRIC-OXIDE; INHIBITION; MECHANISMS; DIAGNOSIS; MODEL; AORTA	Background The study aims to analyse the action of zingerone in diabetes-related cardiac arrhythmias. Methods Diabetes was induced by streptozocin while treatment groups received 20 mg/kg zingerone daily. Following extra seven weeks, electrocardiography, extraction of blood, urine and heart for biochemical analysis, histopathology and immunofluorescence were undertaken. Results The suppression of QT and QTc prolongation in diabetic rats was indicative of prolonged cardiac repolarisation that was greatly reduced by zingerone treatment. In addition, the reduction in PR interval attested that zingerone improved AV delay in diabetic rats. The fibrogenic transforming growth factor beta 1 upregulation in diabetic hearts was suppressed by zingerone. The marked glycogen deposition and muscle degeneration seen in diabetic heart sections were also alleviated by zingerone. Furthermore, zingerone prevented the decrease in of the serum anti-inflammatory cytokine adiponectin in diabetics. The heightened levels of oxidative stress markers 8-isoprostane and uric acid in diabetic rats were suppressed. In the diabetic heart, the reduced catalase activity was improved and the excessive expression of angiotensin receptor 1 was inhibited by zingerone. Conclusion Cardiac delayed repolarisation and AV conduction in rats with diabetes were halted by zingerone. It appears that inhibition of cardiac fibrosis and associated inflammation-oxidative stress signalling underpins the zingerone effect.	[El-Bassossy, Hany M.] King Abdulaziz Univ, Fac Pharm, Dept Pharmacol & Toxicol, Jeddah, Saudi Arabia; [El-Bassossy, Hany M.] Zagazig Univ, Fac Pharm, Zagazig, Egypt; [Al-Thubiani, Wafaa S.] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah, Saudi Arabia; [Al-Thubiani, Wafaa S.] Umm AL Qura Univ, Fac Sci Appl, Mecca, Saudi Arabia; [Elberry, Ahmed A.] Beni Suef Univ, Fac Med, Dept Pharmacol, Bani Suwayf, Egypt; [Mujallid, Mohammad I.] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah, Saudi Arabia; [Ghareib, Salah A.] Zagazig Univ, Dept Pharmacol, Fac Pharm, Zagazig, Egypt; [Azhar, Ahmad S.] King Abdulaziz Univ, Dept Pediat, Fac Med, Jeddah, Saudi Arabia; [Banjar, Zainy M.] King Abdulaziz Univ, Fac Med, Dept Clin Biochem, Jeddah, Saudi Arabia; [Watson, Malcolm L.] Univ Bath, Dept Pharm & Pharmacol, Bath, Avon, England	King Abdulaziz University; Egyptian Knowledge Bank (EKB); Zagazig University; King Abdulaziz University; Umm Al Qura University; Egyptian Knowledge Bank (EKB); Beni Suef University; King Abdulaziz University; Egyptian Knowledge Bank (EKB); Zagazig University; King Abdulaziz University; King Abdulaziz University; University of Bath	El-Bassossy, HM (corresponding author), King Abdulaziz Univ, Fac Pharm, Dept Pharmacol & Toxicol, Jeddah, Saudi Arabia.; El-Bassossy, HM (corresponding author), Zagazig Univ, Fac Pharm, Zagazig, Egypt.	helbassossy@kau.edu.sa	El-Bassossy, Hany M/I-1576-2012; Watson, Malcolm/AAA-6435-2020; El-Bassossy, Hany/O-2242-2019; Elberry, Ahmed A/I-1539-2012; Mujallid, Mohammad/AAL-4064-2020	El-Bassossy, Hany M/0000-0002-6838-6945; El-Bassossy, Hany/0000-0002-6838-6945; Elberry, Ahmed A/0000-0002-0073-3066; AL-Thubiani, wafa/0000-0003-3075-0681; Watson, Malcolm/0000-0001-9902-9521	National Plan for Science, Technology and Innovation (MAARIFAH) - King Abdulaziz City for Science and Technology - Saudi Arabia [12-MED-3063-03]; National Plan for Science, Technology and Innovation (MAARIFAH)-King Abdulaziz City for Science and Technology Saudi Arabia [12-MED-3063-03]	National Plan for Science, Technology and Innovation (MAARIFAH) - King Abdulaziz City for Science and Technology - Saudi Arabia; National Plan for Science, Technology and Innovation (MAARIFAH)-King Abdulaziz City for Science and Technology Saudi Arabia	This project was funded by the National Plan for Science, Technology and Innovation (MAARIFAH) - King Abdulaziz City for Science and Technology - Saudi Arabia, https://www.kacst.edu.sa/eng/Pages/default.aspx - award number (12-MED-3063-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by the National Plan for Science, Technology and Innovation (MAARIFAH)-King Abdulaziz City for Science and Technology Saudi Arabia, https://www. kacst.edu.sa/eng/Pages/default.aspx -award number (12-MED-3063-03). The authors also acknowledge with thanks the Science and Technology Unit, King Abdulaziz University, for technical support.	Ahmad B., 2015, SCI WORLD J, V2015; Ahmad Bilal, 2015, ScientificWorldJournal, V2015, P816364, DOI 10.1155/2015/816364; An D, 2006, AM J PHYSIOL-HEART C, V291, pH1489, DOI 10.1152/ajpheart.00278.2006; Asimaki A, 2015, CAN J CARDIOL, V31, P1313, DOI 10.1016/j.cjca.2015.04.012; Azhar A, 2015, J ENDOCRINOL INVEST, V38, P437, DOI 10.1007/s40618-014-0209-z; Azhar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098281; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Cheong KO, 2016, ARCH PHARM RES, V39, P279, DOI 10.1007/s12272-015-0696-2; Choi MH, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6842568; El-Bassossy HM, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0445-9; El-Bassossy HM, 2013, BRIT J PHARMACOL, V169, P693, DOI 10.1111/bph.12144; El-Bassossy HM, 2011, N-S ARCH PHARMACOL, V384, P277, DOI 10.1007/s00210-011-0669-z; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; Fisman EZ, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-103; Freckmann Guido, 2012, J Diabetes Sci Technol, V6, P1060; Ghareib SA, 2016, EUR J PHARMACOL, V780, P174, DOI 10.1016/j.ejphar.2016.03.046; Ghareib SA, 2015, DRUG DES DEV THER, V9, P6019, DOI 10.2147/DDDT.S94346; Gliemann L, 2014, FREE RADICAL RES, V48, P71, DOI 10.3109/10715762.2013.835045; GRIMM W, 1990, PACE, V13, P2086, DOI 10.1111/j.1540-8159.1990.tb06947.x; Hayat SA, 2004, CLIN SCI, V107, P539, DOI 10.1042/CS20040057; Hemalatha KL, 2016, EUR J PHARMACOL, V791, P595, DOI 10.1016/j.ejphar.2016.08.023; Hemalatha KL, 2015, J BIOCHEM MOL TOXIC, V29, P182, DOI 10.1002/jbt.21683; Hemalatha KL, 2015, J BIOCHEM MOL TOXIC, V29, P63, DOI 10.1002/jbt.21668; Hemalatha KL, 2016, RSC ADV, V6, P112332, DOI 10.1039/c6ra23330a; Kmecova J, 2010, EUR J PHARMACOL, V641, P187, DOI 10.1016/j.ejphar.2010.05.038; Lu Z, 2008, CIRC RES, V103, P269, DOI 10.1161/CIRCRESAHA.107.166678; Miguel-Carrasco JL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/726940; Mahmoud MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063784; Major P, 2016, BRIT J PHARMACOL, V173, P2046, DOI 10.1111/bph.13500; Mani V, 2016, MICROCHIM ACTA, P1; Miki T, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0125-8; Movahed MR, 2007, DIABETES OBES METAB, V9, P276, DOI 10.1111/j.1463-1326.2006.00609.x; Nguyen TP, 2014, J MOL CELL CARDIOL, V70, P83, DOI 10.1016/j.yjmcc.2013.10.018; PODLAHA R, 1992, HORM METAB RES, V26, P84; Riegersperger M, 2011, INT UROL NEPHROL, V43, P441, DOI 10.1007/s11255-011-9929-6; Sen-Chowdhry S, 2010, ANNU REV MED, V61, P233, DOI 10.1146/annurev.med.052208.130419; Sharma V, 2006, CAN J CARDIOL, V22, P305, DOI 10.1016/S0828-282X(06)70914-X; Tanaka K, 2014, CIRC-HEART FAIL, V7, P976, DOI 10.1161/CIRCHEARTFAILURE.114.001279; TOMASELLI GF, 1994, CIRCULATION, V90, P2534, DOI 10.1161/01.CIR.90.5.2534; Tompkins AJ, 2006, BBA-MOL BASIS DIS, V1762, P223, DOI 10.1016/j.bbadis.2005.10.001; van Noord C, 2010, BRIT J CLIN PHARMACO, V70, P16, DOI 10.1111/j.1365-2125.2010.03660.x; Vinothkumar R, 2014, EUR J CANCER PREV, V23, P361, DOI 10.1097/CEJ.0b013e32836473ac; Wagner S, 2011, CIRC RES, V108, P555, DOI 10.1161/CIRCRESAHA.110.221911; Yiu WH, 2010, LAB INVEST, V90, P620, DOI 10.1038/labinvest.2010.38	44	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189074	10.1371/journal.pone.0189074	http://dx.doi.org/10.1371/journal.pone.0189074			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206854	Green Published, gold, Green Submitted			2022-12-27	WOS:000417110700043
J	Gaye, A; Gibbons, GH; Barry, C; Quarells, R; Davis, SK				Gaye, Amadou; Gibbons, Gary H.; Barry, Charles; Quarells, Rakale; Davis, Sharon K.			Influence of socioeconomic status on the whole blood transcriptome in African Americans	PLOS ONE			English	Article							GENE-EXPRESSION; CORTISOL-LEVELS; SOCIAL STRESS; HEALTH; INFLAMMATION; DISEASE; SUSCEPTIBILITY; DISPARITIES; ARTHRITIS; POVERTY	Background The correlation between low socioeconomic status (SES) and poor health outcome or higher risk of disease has been consistently reported by many epidemiological studies across various race/ancestry groups. However, the biological mechanisms linking low SES to disease and/or disease risk factors are not well understood and remain relatively understudied. The analysis of the blood transcriptome is a promising window for elucidating how social and environmental factors influence the molecular networks governing health and disease. To further define the mechanistic pathways between social determinants and health, this study examined the impact of SES on the blood transcriptome in a sample of African-Americans. Methods An integrative approach leveraging three complementary methods (Weighted Gene Co-expression Network Analysis, Random Forest and Differential Expression) was adopted to identify the most predictive and robust transcriptome pathways associated with SES. We analyzed the expression of 15079 genes (RNA-seq) from whole blood across 36 samples. Results The results revealed a cluster of 141 co-expressed genes over-expressed in the low SES group. Three pro-inflammatory pathways (IL-8 Signaling, NF-kappa B Signaling and Dendritic Cell Maturation) are activated in this module and over-expressed in low SES. Random Forest analysis revealed 55 of the 141 genes that, collectively, predict SES with an area under the curve of 0.85. One third of the 141 genes are significantly over-expressed in the low SES group. Conclusion Lower SES has consistently been linked to many social and environmental conditions acting as stressors and known to be correlated with vulnerability to chronic illnesses (e.g. asthma, diabetes) associated with a chronic inflammatory state. Our unbiased analysis of the blood transcriptome in African-Americans revealed evidence of a robust molecular signature of increased inflammation associated with low SES. The results provide a plausible link between the social factors and chronic inflammation.	[Gaye, Amadou; Gibbons, Gary H.; Davis, Sharon K.] NHGRI, NIH, Bethesda, MD 20892 USA; [Gibbons, Gary H.] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA; [Barry, Charles] Brown Univ, Providence, RI 02912 USA; [Quarells, Rakale] Morehouse Sch Med, Cardiovasc Res Inst, Community Hlth & Prevent Med, Atlanta, GA 30310 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Brown University; Morehouse School of Medicine	Gaye, A (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	amadou.gaye@nih.gov		Gaye, Amadou/0000-0002-1180-2792	National Institutes of Health [1RC4M D005964-0]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Minority Health Genomics and Translational Research Bio-Repository Database (MH-GRID) was supported by the National Institutes of Health grant #1RC4M D005964-0 to GHG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bruce MA, 2015, ADV CHRONIC KIDNEY D, V22, P46, DOI 10.1053/j.ackd.2014.06.008; Bruce MA, 2009, J INVEST MED, V57, P583, DOI 10.2310/JIM.0b013e31819dbb91; Chen E, 2009, THORAX, V64, P38, DOI 10.1136/thx.2007.095091; Chen E, 2003, PSYCHOSOM MED, V65, P984, DOI 10.1097/01.PSY.0000097340.54195.3C; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Chow JCC, 2003, AM J PUBLIC HEALTH, V93, P792, DOI 10.2105/AJPH.93.5.792; Cohen S, 1997, PSYCHOSOM MED, V59, P213, DOI 10.1097/00006842-199705000-00001; COHEN S, 1991, PSYCHOL BULL, V109, P5, DOI 10.1037/0033-2909.109.1.5; Cohen S, 1998, HEALTH PSYCHOL, V17, P214, DOI 10.1037/0278-6133.17.3.214; Cole SW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004601; Costello EJ, 2001, AM J PUBLIC HEALTH, V91, P1494, DOI 10.2105/AJPH.91.9.1494; Dowd JB, 2009, EPIDEMIOLOGY, V20, P902, DOI 10.1097/EDE.0b013e3181bb5302; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; GLASER R, 1994, PSYCHONEUROENDOCRINO, V19, P765, DOI 10.1016/0306-4530(94)90023-X; Gosling JA, 2014, SLEEP MED, V15, P979, DOI 10.1016/j.sleep.2014.04.007; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kiecolt-Glaser JK, 1998, AM PSYCHOL, V53, P1209, DOI 10.1037/0003-066X.53.11.1209; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Langfelder P, 2014, DATA ANAL QUESTIONS; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Laugero KD, 2011, PROSTAG LEUKOTR ESS, V84, P71, DOI 10.1016/j.plefa.2010.12.003; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lipscomb MF, 2002, PHYSIOL REV, V82, P97, DOI 10.1152/physrev.00023.2001; Marucha PT, 1998, PSYCHOSOM MED, V60, P362, DOI 10.1097/00006842-199805000-00025; Miller GE, 2015, P NATL ACAD SCI USA, V112, P10325, DOI 10.1073/pnas.1505063112; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Piper C, 2014, ARTHRITIS RHEUMATOL, V66, P1955, DOI 10.1002/art.38647; Powell ND, 2013, P NATL ACAD SCI USA, V110, P16574, DOI 10.1073/pnas.1310655110; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; REYNES JF, 1993, AM J PREV MED, V9, P365, DOI 10.1016/S0749-3797(18)30689-5; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Slavich GM, 2013, CLIN PSYCHOL SCI, V1, P331, DOI 10.1177/2167702613478594; Stringhini S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24780; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; TOSATO G, 1990, BLOOD, V75, P1305, DOI 10.1182/blood.V75.6.1305.1305; Tung J, 2012, P NATL ACAD SCI USA, V109, P6490, DOI 10.1073/pnas.1202734109; Wang XD, 2015, INT J CLIN EXP PATHO, V8, P7929; Winkleby MA, 2003, J EPIDEMIOL COMMUN H, V57, P444, DOI 10.1136/jech.57.6.444; Wu H, 2015, BIOINFORMATICS, V31, P233, DOI 10.1093/bioinformatics/btu640; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252	49	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0187290	10.1371/journal.pone.0187290	http://dx.doi.org/10.1371/journal.pone.0187290			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO8CU	29206834	gold, Green Published, Green Submitted			2022-12-27	WOS:000417110700003
J	Leuning, DG; Engelse, MA; Lievers, E; Bijkerk, R; Reinders, MEJ; de Boer, HC; van Kooten, C; Rabelink, TJ				Leuning, Danielle G.; Engelse, Marten A.; Lievers, Ellen; Bijkerk, Roel; Reinders, Marlies E. J.; de Boer, Hetty C.; van Kooten, Cees; Rabelink, Ton J.			The human kidney capsule contains a functionally distinct mesenchymal stromal cell population	PLOS ONE			English	Article							RENAL CAPSULE; STEM-CELLS; PRECURSORS	We recently demonstrated that the adult human kidney cortex contains a perivascular stromal cell (kPSC) that shows organotypic properties and is important for repair and stabilisation of kidney function. Not only the kidney cortex but also the kidney capsule contains stromal cells that are important for the three dimensional organisation of the kidney during nephrogenesis. They provide the barrier function of the capsule which is critical for homeostatic processes such as pressure natriuresis. We postulated that stromal cells derived from the kidney capsule may therefore also have specific properties and functions. To this end, we isolated these capsule mesenchymal stromal cells (cMSC) from human cadaveric kidneys that were not suitable for transplantation. There were several similarities between cMSCs and kPSCs including support of vascular plexus formation, phenotypic marker expression and resistance against myofibroblast transformation. However, compared to kPSCs, cMSCs showed distinct mRNA and miRNA expression profiles, showed increased immunosuppressive capacity, and displayed strongly reduced HGF production, contributing to the inability to enhance kidney epithelial repair. Therefore cMSCs are a distinct, novel human kidney-derived MSC-population and these data underpin the large functional diversity of phenotypic similar stromal cells in relation to their anatomic site, even within one organ.	[Leuning, Danielle G.; Engelse, Marten A.; Lievers, Ellen; Bijkerk, Roel; Reinders, Marlies E. J.; de Boer, Hetty C.; van Kooten, Cees; Rabelink, Ton J.] Leiden Univ, Med Ctr, Einthoven Lab Vasc & Regenerat Med, Dept Internal Med,Div Nephrol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rabelink, TJ (corresponding author), Leiden Univ, Med Ctr, Einthoven Lab Vasc & Regenerat Med, Dept Internal Med,Div Nephrol, Leiden, Netherlands.	a.j.rabelink@lumc.nl	Bijkerk, Roel/AAC-6977-2020; van Kooten, Cees/E-5694-2018; Rabelink, Ton J./A-5316-2008; Reinders, Marlies/AAF-2710-2019	Bijkerk, Roel/0000-0002-6438-4133; van Kooten, Cees/0000-0002-6257-0899; Rabelink, Ton J./0000-0001-6780-5186; Reinders, Marlies/0000-0001-9543-567X	European Community's Seventh Framework Program [305436]	European Community's Seventh Framework Program	The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement number 305436 (STELLAR), http://cordis.europa.eu/project/rcn/105515_en.html.; The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement number 305436 (STELLAR).	Boivin FJ, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00081; Boivin FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120347; Bruno Stefania, 2012, Methods Mol Biol, V879, P367, DOI 10.1007/978-1-61779-815-3_22; Chen WCW, 2015, STEM CELLS, V33, P557, DOI 10.1002/stem.1868; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; GARCIAESTAN J, 1989, AM J PHYSIOL, V256, pF63, DOI 10.1152/ajprenal.1989.256.1.F63; Leuning DG, 2014, SEMIN NEPHROL, V34, P351, DOI 10.1016/j.semnephrol.2014.06.002; Leuning DG, 2016, STEM CELLS TRANSL ME; Levinson RS, 2005, DEVELOPMENT, V132, P529, DOI 10.1242/dev.01604; Li W, 2014, DEV DYNAM, V243, P853, DOI [10.1002/dvdy.24134, 10.1002/DVDY.24134]; Little MH, 2016, NAT REV NEPHROL, V12, P624, DOI 10.1038/nrneph.2016.126; Naftali-Shani N, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000253; Orlova VV, 2014, NAT PROTOC, V9, P1514, DOI 10.1038/nprot.2014.102; Park HC, 2010, AM J PHYSIOL-RENAL, V298, pF1254, DOI 10.1152/ajprenal.00406.2009; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Wystrychowski W, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0343-y; Yallowitz AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023410	19	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0187118	10.1371/journal.pone.0187118	http://dx.doi.org/10.1371/journal.pone.0187118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206835	Green Submitted, gold, Green Published			2022-12-27	WOS:000417110700002
J	Bulut, T; Hung, YH; Tzeng, O; Wu, DH				Bulut, Talat; Hung, Yi-Hui; Tzeng, Ovid; Wu, Denise H.			Neural correlates of processing sentences and compound words in Chinese	PLOS ONE			English	Article							BROCAS AREA; CORTICAL REPRESENTATION; SYNTACTIC STRUCTURE; FUNCTIONAL-ANATOMY; TEMPORAL CORTEX; LANGUAGE; COMPREHENSION; BRAIN; FMRI; ACTIVATION	Sentence reading involves multiple linguistic operations including processing of lexical and compositional semantics, and determining structural and grammatical relationships among words. Previous studies on Indo-European languages have associated left anterior temporal lobe (aTL) and left interior frontal gyrus (IFG) with reading sentences compared to reading unstructured word lists. To examine whether these brain regions are also involved in reading a typologically distinct language with limited morphosyntax and lack of agreement between sentential arguments, an FMRI study was conducted to compare passive reading of Chinese sentences, unstructured word lists and disconnected character lists that are created by only changing the order of an identical set of characters. Similar to previous findings from other languages, stronger activation was found in mainly left-lateralized anterior temporal regions (including aTL) for reading sentences compared to unstructured word and character lists. On the other hand, stronger activation was identified in left posterior temporal sulcus for reading unstructured words compared to unstructured characters. Furthermore, reading unstructured word lists compared to sentences evoked stronger activation in left IFG and left inferior parietal lobule. Consistent with the literature on Indo-European languages, the present results suggest that left anterior temporal regions subserve sentence-level integration, while left IFG supports restoration of sentence structure. In addition, left posterior temporal sulcus is associated with morphological compounding. Taken together, reading Chinese sentences engages a common network as reading other languages, with particular reliance on integration of semantic constituents.	[Bulut, Talat; Wu, Denise H.] Natl Cent Univ, Inst Cognit Neurosci, Zhongli, Taiwan; [Bulut, Talat] Istanbul Medipol Univ, Dept Speech & Language Therapy, Istanbul, Turkey; [Hung, Yi-Hui] Yale Univ, Haskins Labs, New Haven, CT USA; [Hung, Yi-Hui] Natl Yang Ming Univ, Inst Neurosci, Taipei, Taiwan; [Tzeng, Ovid] Acad Sinica, Inst Linguist, Taipei, Taiwan	National Central University; Istanbul Medipol University; Yale University; Haskins Laboratories; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Wu, DH (corresponding author), Natl Cent Univ, Inst Cognit Neurosci, Zhongli, Taiwan.	denisewu@cc.ncu.edu.tw		Hung, Yi-Hui/0000-0003-2777-8341; Tzeng, Ovid J. L./0000-0002-0844-7865	National Science Council of Taiwan (NSC) [1022628-H-008-002-MY3]	National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan)	This work was supported by grants from National Science Council of Taiwan (NSC 1022628-H-008-002-MY3). [vim most goy tv]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from National Science Council Taiwan (NSC 102-2628-H008-002-MY3).	[Anonymous], 1993, LECT GOVT BINDING PI; [Anonymous], 2013, SPM8 MANUAL; Ben-Shachar M, 2004, NEUROIMAGE, V21, P1320, DOI 10.1016/j.neuroimage.2003.11.027; Ben-Shachar M, 2003, PSYCHOL SCI, V14, P433, DOI 10.1111/1467-9280.01459; Bornkessel I, 2005, NEUROIMAGE, V26, P221, DOI 10.1016/j.neuroimage.2005.01.032; Bozic M, 2010, LANG LINGUIST COMPAS, V4, P1063, DOI 10.1111/j.1749-818x.2010.00254.x; Brennan J, 2012, NEUROIMAGE, V60, P1139, DOI 10.1016/j.neuroimage.2012.01.030; Caplan D, 1998, J COGNITIVE NEUROSCI, V10, P541, DOI 10.1162/089892998562843; Caplan D, 2000, HUM BRAIN MAPP, V9, P65; Caplan D, 2008, CORTEX, V44, P257, DOI 10.1016/j.cortex.2006.06.005; Chomsky N., 2014, ASPECTS THEORY SYNTA; Chomsky N., 2002, SYNTACTIC STRUCTURES, V2nd; Culicover PW, 2006, TRENDS COGN SCI, V10, P413, DOI 10.1016/j.tics.2006.07.007; Dapretto M, 1999, NEURON, V24, P427, DOI 10.1016/S0896-6273(00)80855-7; Embick D, 2000, P NATL ACAD SCI USA, V97, P6150, DOI 10.1073/pnas.100098897; Feng SW, 2015, J NEUROLINGUIST, V33, P104, DOI 10.1016/j.jneuroling.2014.09.002; Fiebach CJ, 2005, HUM BRAIN MAPP, V24, P79, DOI 10.1002/hbm.20070; Friederici AD, 2000, BRAIN LANG, V74, P289, DOI 10.1006/brln.2000.2313; Friedrich R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005599; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hagoort P, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00416; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Huang K, 2012, NEUROPSYCHOLOGIA, V50, P2598, DOI 10.1016/j.neuropsychologia.2012.07.011; Humphries C, 2006, J COGNITIVE NEUROSCI, V18, P665, DOI 10.1162/jocn.2006.18.4.665; Humphries C, 2005, HUM BRAIN MAPP, V26, P128, DOI 10.1002/hbm.20148; Hung YH, 2015, NEUROIMAGE, V122, P33, DOI 10.1016/j.neuroimage.2015.07.045; Jackendoff R, 2007, BRAIN RES, V1146, P2, DOI 10.1016/j.brainres.2006.08.111; Jobard G, 2007, NEUROIMAGE, V34, P784, DOI 10.1016/j.neuroimage.2006.06.067; Kaan E, 2002, TRENDS COGN SCI, V6, P350, DOI 10.1016/S1364-6613(02)01947-2; Laine M, 1999, NEUROSCI LETT, V271, P85, DOI 10.1016/S0304-3940(99)00527-3; Lehtonen M, 2006, BRAIN LANG, V98, P182, DOI 10.1016/j.bandl.2006.04.011; Luke KK, 2002, HUM BRAIN MAPP, V16, P133, DOI 10.1002/hbm.10029; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Makuuchi M, 2012, PHILOS T R SOC B, V367, P2033, DOI 10.1098/rstb.2012.0095; Marangolo P, 2006, CORTEX, V42, P1093, DOI 10.1016/S0010-9452(08)70221-1; Maruyama M, 2012, NEUROIMAGE, V61, P1444, DOI 10.1016/j.neuroimage.2012.04.020; MAZOYER BM, 1993, J COGNITIVE NEUROSCI, V5, P467, DOI 10.1162/jocn.1993.5.4.467; Meinzer M, 2009, NEUROPSYCHOLOGIA, V47, P1964, DOI 10.1016/j.neuropsychologia.2009.03.008; Meyer L, 2012, NEUROIMAGE, V62, P1987, DOI 10.1016/j.neuroimage.2012.05.052; Myers J., 2006, REPRESENTATION PROCE, P169, DOI 10.1093/acprof:oso/9780199228911.003.0008; Pallier C, 2011, P NATL ACAD SCI USA, V108, P2522, DOI 10.1073/pnas.1018711108; Pinker S, 2005, COGNITION, V95, P201, DOI 10.1016/j.cognition.2004.08.004; Rogalsky C, 2009, CEREB CORTEX, V19, P786, DOI 10.1093/cercor/bhn126; Sakai KL, 2002, NEURON, V35, P1177, DOI 10.1016/S0896-6273(02)00873-5; Schneider W., 2002, PSYCHOL SOFTWARE TOO, V3, P1, DOI [10.1186/1756-0381-3-1, DOI 10.1186/1756-0381-3-1]; Snijders TM, 2009, CEREB CORTEX, V19, P1493, DOI 10.1093/cercor/bhn187; Stowe LA, 1998, NEUROREPORT, V9, P2995, DOI 10.1097/00001756-199809140-00014; Stowe LA, 2005, LINGUA, V115, P997, DOI 10.1016/j.lingua.2004.01.013; Stromswold K, 1996, BRAIN LANG, V52, P452, DOI 10.1006/brln.1996.0024; Tyler LK, 2005, NEUROPSYCHOLOGIA, V43, P1963, DOI 10.1016/j.neuropsychologia.2005.03.008; Vandenberghe R, 2002, J COGNITIVE NEUROSCI, V14, P550, DOI 10.1162/08989290260045800; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Wang SP, 2008, NEUROPSYCHOLOGIA, V46, P1371, DOI 10.1016/j.neuropsychologia.2007.12.020; Wang XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124388; Xu J, 2005, NEUROIMAGE, V25, P1002, DOI 10.1016/j.neuroimage.2004.12.013; Zhu ZD, 2012, NEUROIMAGE, V60, P2230, DOI 10.1016/j.neuroimage.2012.02.036; Zhu ZD, 2009, NEUROIMAGE, V47, P756, DOI 10.1016/j.neuroimage.2009.04.086	57	6	6	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0188526	10.1371/journal.pone.0188526	http://dx.doi.org/10.1371/journal.pone.0188526			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO5CX	29194453	Green Published, gold, Green Submitted			2022-12-27	WOS:000416867800013
J	Kondori, NR; Paul, P; Robbins, JP; Liu, K; Hildyard, JCW; Wells, DJ; de Belleroche, JS				Kondori, Nazanin Rahmani; Paul, Praveen; Robbins, Jacqueline P.; Liu, Ke; Hildyard, John C. W.; Wells, Dominic J.; de Belleroche, Jacqueline S.			Characterisation of the pathogenic effects of the in vivo expression of an ALS-linked mutation in D-amino acid oxidase: Phenotype and loss of spinal cord motor neurons	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSGENIC MOUSE MODEL; D-SERINE; PROLONGS SURVIVAL; ANIMAL-MODEL; DEGENERATION; RECEPTOR; TDP-43; GENES; MICE	Amyotrophic lateral sclerosis (ALS) is the most common adult-onset neuromuscular disorder characterised by selective loss of motor neurons leading to fatal paralysis. Current therapeutic approaches are limited in their effectiveness. Substantial advances in understanding ALS disease mechanisms has come from the identification of pathogenic mutations in dominantly inherited familial ALS (FALS). We previously reported a coding mutation in D-amino acid oxidase (DAO(R199W)) associated with FALS. DAO metabolises D-serine, an essential co-agonist at the N-Methyl-D-aspartic acid glutamate receptor subtype (NMDAR). Using primary motor neuron cultures or motor neuron cell lines we demonstrated that expression of DAO(R199W), promoted the formation of ubiquitinated protein aggregates, activated autophagy and increased apoptosis. The aim of this study was to characterise the effects of DAO(R199W) in vivo, using transgenic mice overexpressing DAO(R199W). Marked abnormal motor features, e.g. kyphosis, were evident in mice expressing DAO(R199W), which were associated with a significant loss (19%) of lumbar spinal cord motor neurons, analysed at 14 months. When separated by gender, this effect was greater in females (26%; p<0.0132). In addition, we crossed the DAO(R199W) transgenic mouse line with the SOD1(G93A) mouse model of ALS to determine whether the effects of SOD1(G93A) were potentiated in the double transgenic line (DAO(R199W)/SOD1(G93A)). Although overall survival was not affected, onset of neurological signs was significantly earlier in female double transgenic animals than their female SOD1(G93A) littermates (125 days vs 131 days, P = 0.0239). In summary, some significant in vivo effects of DAO(R199W) on motor neuron function (i.e. kyphosis and loss of motor neurons) were detected which were most marked in females and could contribute to the earlier onset of neurological signs in double transgenic females compared to SOD1(G93A) littermates, highlighting the importance of recognizing gender effects present in animal models of ALS.	[Kondori, Nazanin Rahmani; Paul, Praveen; Robbins, Jacqueline P.; de Belleroche, Jacqueline S.] Imperial Coll London, Neurogenet Grp, Div Brain Sci, Hammersmith Hosp Campus, London, England; [Kondori, Nazanin Rahmani; Liu, Ke; Hildyard, John C. W.; Wells, Dominic J.] Royal Vet Coll, Dept Comparat Biomed Sci, Neuromuscular Dis Grp, London, England; [Robbins, Jacqueline P.] Univ Oxford, Dept Psychiat, Oxford, England; [Liu, Ke] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool, Merseyside, England	Imperial College London; University of London; University of London Royal Veterinary College; University of Oxford; University of Liverpool	de Belleroche, JS (corresponding author), Imperial Coll London, Neurogenet Grp, Div Brain Sci, Hammersmith Hosp Campus, London, England.	j.belleroche@imperial.ac.uk	Hildyard, John/AAB-2260-2021	Hildyard, John/0000-0003-2283-2118; Robbins, Jacqueline P/0000-0002-6556-5999; de Belleroche, Jacqueline/0000-0002-0689-9577; Wells, Dominic/0000-0002-1425-6344	Motor Neurone Disease Association (UK)	Motor Neurone Disease Association (UK)	This project was funded by the Motor Neurone Disease Association (UK) following rigorous review of study design, methods for data collection and analysis provided in the grant application. They were not involved in the subsequent study or manuscript preparation.; We are grateful to the Motor Neurone Disease Association (UK) for funding this project.	Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Almond SL, 2006, MOL CELL NEUROSCI, V32, P324, DOI 10.1016/j.mcn.2006.05.003; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Azzouz M, 1997, MUSCLE NERVE, V20, P45, DOI 10.1002/(SICI)1097-4598(199701)20:1<45::AID-MUS6>3.0.CO;2-H; Chen H. J, 2012, ENDOPLASMIC RETICULU, P323; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Gill A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006489; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hampton TG, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/235354; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Jotova I, 1999, AMINO ACIDS, V17, P267, DOI 10.1007/BF01366925; Kaneb HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024189; Kaneb HMJ, 2012, PRECLINICAL TESTING; KONNO R, 1984, J NUTR, V114, P1617, DOI 10.1093/jn/114.9.1617; KONNO R, 1983, GENETICS, V103, P277; Li Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2779; Lincecum JM, 2010, NAT GENET, V42, P392, DOI 10.1038/ng.557; Martinez FJ, 2016, NEURON, V92, P780, DOI 10.1016/j.neuron.2016.09.050; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; Mitchell J, 2010, P NATL ACAD SCI USA, V107, P7556, DOI 10.1073/pnas.0914128107; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; NEWMAN DS, 1995, J NEUROL SCI, V129, P38, DOI 10.1016/0022-510X(95)00058-A; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Paul P, 2014, NEUROBIOL AGING, V35, P876, DOI 10.1016/j.neurobiolaging.2013.09.005; Paul P, 2012, AMINO ACIDS, V43, P1823, DOI 10.1007/s00726-012-1385-9; Piesla MJ, 2009, BRAIN RES, V1295, P89, DOI 10.1016/j.brainres.2009.07.091; Sasabe J, 2007, EMBO J, V26, P4149, DOI 10.1038/sj.emboj.7601840; Sasabe J, 2012, P NATL ACAD SCI USA, V109, P627, DOI 10.1073/pnas.1114639109; SASAKI M, 1992, BIOCHIM BIOPHYS ACTA, V1139, P315, DOI 10.1016/0925-4439(92)90107-X; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Sharp PS, 2008, NEUROBIOL DIS, V30, P42, DOI 10.1016/j.nbd.2007.12.002; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Tedeschi G, 2012, METHODS MOL BIOL, V794, P381, DOI 10.1007/978-1-61779-331-8_26; Tudor EL, 2010, NEUROSCIENCE, V167, P774, DOI 10.1016/j.neuroscience.2010.02.035; Vincelette J, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2331; Wang LJ, 2002, J NEUROSCI, V22, P6920; Watson C., 2008, SPINAL CORD; Wu LS, 2012, J BIOL CHEM, V287, P27335, DOI 10.1074/jbc.M112.359000; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Zheng CY, 2004, ANN NEUROL, V56, P564, DOI 10.1002/ana.20223	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0188912	10.1371/journal.pone.0188912	http://dx.doi.org/10.1371/journal.pone.0188912			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194436	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000416867800016
J	Rodriguez, IB; Ho, TY				Rodriguez, Irene B.; Ho, Tung-Yuan			Interactive effects of spectral quality and trace metal availability on the growth of Trichodesmium and Symbiodinium	PLOS ONE			English	Article							DIAZOTROPHIC CYANOBACTERIA TRICHODESMIUM; NITROGEN-FIXATION; MARINE CYANOBACTERIUM; BIOOPTICAL PROPERTIES; N-2 FIXATION; LIGHT; PHYTOPLANKTON; LIMITATION; PHOTOSYNTHESIS; ZOOXANTHELLAE	Light and trace metals are critical growth factors for algae but how the interdependence of light quality and metal availability affects algal growth remains largely unknown. Our previous studies have demonstrated the importance of Ni and Fe on the growth of Trichodesmium and Symbiodinium, respectively, two important marine primary producers inhabiting environments with high light intensities. Here, we investigated the effects of light quality and intensity with availability of either Ni or Fe on their growth. For Trichodesmium, we found that specific growth rates for high Ni treatments were all significantly higher than in corresponding low Ni treatments with varying light quality and intensity. The inhibitory effect of low intensity red light was also countered by sufficient Ni supply. For Symbiodinium, we found that growth rates and biomass were reduced by 75% under low intensity red light and the stress can only be partially relieved by sufficient Fe supply. The results show that trace metal availability plays an important role in relieving the stress induced by low red light condition for both Trichodesmium and Symbiodinium although the cyanobacterium performs better in this growth condition. The difference may be attributed to the presence of phycocyanin, a unique pigment attuned to absorption of red light, in Trichodesmium. Our study shows that the concerted effects of light intensity and quality compounded with trace metal availability may influence the growth of photosynthetic organisms in the ocean.	[Rodriguez, Irene B.; Ho, Tung-Yuan] Acad Sinica, Res Ctr Environm Changes, Taipei, Taiwan; [Ho, Tung-Yuan] Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Ho, TY (corresponding author), Acad Sinica, Res Ctr Environm Changes, Taipei, Taiwan.; Ho, TY (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan.	tyho@gate.sinica.edu.tw	Ho, Tung-Yuan/F-2323-2017	Rodriguez, Irene/0000-0001-9848-9526	Taiwan Ministry of Science and Technology [106-2611-M-001 -003 -, 105-2119-M-001 -039 -MY3]; Academia Sinica	Taiwan Ministry of Science and Technology; Academia Sinica(Academia Sinica - Taiwan)	This research was financially supported by Taiwan Ministry of Science and Technology grants numbers 106-2611-M-001 -003 -, 105-2119-M-001 -039 -MY3 and Career Development Award from Academia Sinica.	Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Barros MP, 2013, AQUAT TOXICOL, V142, P195, DOI 10.1016/j.aquatox.2013.08.012; Bell PRF, 2005, HYDROBIOLOGIA, V543, P25, DOI 10.1007/s10750-004-5713-2; Breitbarth E, 2004, LIMNOL OCEANOGR-METH, V2, P282, DOI 10.4319/lom.2004.2.282; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Capone DG, 2001, METHOD MICROBIOL, V30, P501, DOI 10.1016/S0580-9517(01)30060-0; Carpenter EJ, 2004, DEEP-SEA RES PT I, V51, P173, DOI 10.1016/j.dsr.2003.10.006; Dupont CL, 2008, APPL ENVIRON MICROB, V74, P23, DOI 10.1128/AEM.01007-07; DYKENS JA, 1982, NATURE, V297, P579, DOI 10.1038/297579a0; Enriquez S, 2005, LIMNOL OCEANOGR, V50, P1025, DOI 10.4319/lo.2005.50.4.1025; Fu FX, 2003, FEMS MICROBIOL ECOL, V45, P203, DOI 10.1016/S0168-6496(03)00157-0; GALLON JR, 1981, TRENDS BIOCHEM SCI, V6, P19, DOI 10.1016/0968-0004(81)90008-6; Ho TY, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00139; Ho TY, 2013, LIMNOL OCEANOGR, V58, P112, DOI 10.4319/lo.2013.58.1.0112; Ho TY, 2003, J PHYCOL, V39, P1145, DOI 10.1111/j.0022-3646.2003.03-090.x; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hsieh P, 2014, PHOTOCHEM PHOTOBIOL, V90, P533, DOI 10.1111/php.12208; Hsieh P, 2013, INT BIODETER BIODEGR, V84, P258, DOI 10.1016/j.ibiod.2012.11.007; King AL, 2011, ISME J, V5, P1388, DOI 10.1038/ismej.2010.211; KINZIE RA, 1984, MAR BIOL, V78, P239, DOI 10.1007/BF00393009; KOK B, 1956, BIOCHIM BIOPHYS ACTA, V21, P234, DOI 10.1016/0006-3002(56)90003-8; Lesser MP, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P405, DOI 10.1007/978-94-007-0114-4_23; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Letelier RM, 1998, AQUAT MICROB ECOL, V15, P265, DOI 10.3354/ame015265; Lin SJ, 2015, SCIENCE, V350, P691, DOI 10.1126/science.aad0408; Marcelino LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061492; Maruyama S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119406; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Rodriguez IB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00082; Rodriguez IB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04445; Roth MS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00422; SIDDIQUI PJA, 1992, J PHYCOL, V28, P320, DOI 10.1111/j.0022-3646.1992.00320.x; Subramaniam A, 1999, LIMNOL OCEANOGR, V44, P608, DOI 10.4319/lo.1999.44.3.0608; Subramaniam A, 1999, LIMNOL OCEANOGR, V44, P618, DOI 10.4319/lo.1999.44.3.0618; Sunda W, 2003, MAR CHEM, V84, P35, DOI 10.1016/S0304-4203(03)00101-4; Sunda WG, 1998, SCI TOTAL ENVIRON, V219, P165, DOI 10.1016/S0048-9697(98)00226-5; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Tamagnini P, 2002, MICROBIOL MOL BIOL R, V66, P1, DOI 10.1128/MMBR.66.1.1-20.2002; WALSBY AE, 1978, BRIT PHYCOL J, V13, P103, DOI 10.1080/00071617800650121; Walters K.J., 2013, COMMUN INTEGR BIOL, V6, DOI DOI 10.4161/cib.25005; Wang DL, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00427, 10.3389/fmicb.2012.00316]; Westall J. C., 1976, 18 MASS I TECHN; Wijgerde T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092781; Williams R.J.P., 1991, BIOL CHEM ELEMENTS	45	5	5	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188777	10.1371/journal.pone.0188777	http://dx.doi.org/10.1371/journal.pone.0188777			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190820	Green Submitted, Green Published, gold			2022-12-27	WOS:000416841900121
J	Hornum, L; Hansen, AJ; Tornehave, D; Fjording, MS; Colmenero, P; Watjen, IF; Nielsen, NHS; Bliddal, H; Bartels, EM				Hornum, Lars; Hansen, Anker Jon; Tornehave, Ditte; Fjording, Marianne Scheel; Colmenero, Paula; Watjen, Inger Falbe; Nielsen, Niels Henrik Soe; Bliddal, Henning; Bartels, Else Marie			C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid	PLOS ONE			English	Article							COMPLEMENT PATHWAY ACTIVATION; COLLAGEN-INDUCED ARTHRITIS; COLONY-STIMULATING FACTOR; CARTILAGE DESTRUCTION; MONOCLONAL-ANTIBODY; FELTYS-SYNDROME; NEUTROPHILS; RECEPTOR; CELL; TISSUE	Complement activation correlates to rheumatoid arthritis disease activity, and increased amounts of the complement split product C5a is observed in synovial fluids from rheumatoid arthritis patients. Blockade of C5a or its receptor (C5aR) is efficacious in several arthritis models. The aim of this study was to investigate the role of C5a and C5aR in human rheumatoid arthritis and psoriatic arthritis-both with respect to expression and function. Synovial fluid, blood and synovial samples were obtained from rheumatoid arthritis, psoriatic arthritis and osteoarthritis patients as a less inflammatory arthritis type, and blood from healthy subjects. Cells infiltrating synovial tissue were analysed by immunohistochemistry and flow cytometry. SF and blood were analysed for biomarkers by flow cytometry or ELISA. The effect of a blocking anti-human C5aR mAb on leukocyte migration was determined using a Boyden chamber. Appropriate statistical tests were applied for comparisons. C5aR(+) cells were detected in most rheumatoid arthritis, in all psoriatic arthritis, but not in non-inflammatory control synovia. C5aR(+) cells were primarily neutrophils and macrophages. C5aR(+) macrophages were mainly found in lymphoid aggregates in close contact with T cells. C5a levels were increased in both rheumatoid arthritis and psoriatic arthritis synovial fluid compared to osteoarthritis, and in blood from rheumatoid arthritis compared to healthy subjects. Neutrophil and monocyte migration to rheumatoid arthritis synovial fluid was significantly inhibited by anti-C5aR. The data support that the C5a-C5aR axis may be driving the infiltration of inflammatory cells into the synovial fluid and synovium in both rheumatoid and psoriatic arthritis, and suggest that C5a or C5aR may be a promising treatment target in both diseases.	[Hornum, Lars; Hansen, Anker Jon; Tornehave, Ditte; Fjording, Marianne Scheel] Novo Nordisk AS, Malov, Denmark; [Colmenero, Paula] Univ Oxford, Radcliffe Dept Med, Oxford, England; [Watjen, Inger Falbe; Bliddal, Henning; Bartels, Else Marie] Copenhagen Univ Hosp, Parker Inst, Frederiksberg, Denmark; [Nielsen, Niels Henrik Soe] Herlev & Gentofte Hosp, Hand Sect, Dept Orthopaed, Gentofte, Denmark; [Bliddal, Henning] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark	Novo Nordisk; University of Oxford; University of Copenhagen; University of Copenhagen	Bartels, EM (corresponding author), Copenhagen Univ Hosp, Parker Inst, Frederiksberg, Denmark.	else.marie.bartels@regionh.dk	Bliddal, Henning/AAB-3168-2019	Bliddal, Henning/0000-0002-7951-1668	OAK Foundation [OCAY-13-309]; Novo Nordisk A/S; Gentofte University Hospital, Denmark	OAK Foundation; Novo Nordisk A/S(Novo Nordisk); Gentofte University Hospital, Denmark	The Parker Institute is supported by an unspecified grant from the OAK Foundation (OCAY-13-309). Novo Nordisk A/S supported acquisition of antibodies and some technical assistance, and the funder provided support in the form of salaries for authors [LH, AJH, DT, MSF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The Parker Institute is supported by a grant from the OAK Foundation (OCAY-13-309).; We wish to thank the Staff of the Department of Anesthesiology and Day Care Surgery, Herlev and Gentofte University Hospital, Denmark for support when collecting the biopsy samples, and Pia Birn, Hanife Dzaferi Farizi and Steen Kryger, NOVO Nordisk A/S, and Eva Littrup Andersen and Jack Kvistgaard Olsen, the Parker Institute, for technical support.	Ally MMTM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/183653; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Andersson C, 2014, CLIN EXP IMMUNOL, V177, P219, DOI 10.1111/cei.12338; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Ballanti E, 2013, IMMUNOL RES, V56, P477, DOI 10.1007/s12026-013-8422-y; Ballanti E, 2011, AUTOIMMUN REV, V10, P617, DOI 10.1016/j.autrev.2011.04.012; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Banda NK, 2012, J IMMUNOL, V188, P1469, DOI 10.4049/jimmunol.1102310; CAPSONI F, 1995, HAEMATOLOGICA, V80, P123; Cassatella MA, 1999, ADV IMMUNOL, V73, P369, DOI 10.1016/S0065-2776(08)60791-9; Cedergren J, 2007, J RHEUMATOL, V34, P2162; den Broeder AA, 2003, J RHEUMATOL, V30, P232; DOHERTY M, 1988, ANN RHEUM DIS, V47, P190, DOI 10.1136/ard.47.3.190; Dularay B, 1988, Autoimmunity, V1, P159, DOI 10.3109/08916938808997161; Dunkelberger J, 2012, J IMMUNOL, V188, P4032, DOI 10.4049/jimmunol.1103141; Dunkelberger JR, 2010, MOL IMMUNOL, V47, P2176, DOI 10.1016/j.molimm.2010.05.008; EDWARDS SW, 1988, BIOCHEM J, V250, P81, DOI 10.1042/bj2500081; EMERY P, 1988, ANN RHEUM DIS, V47, P34, DOI 10.1136/ard.47.1.34; Gerlag DM, 2004, ARTHRITIS RHEUM, V50, P3783, DOI 10.1002/art.20664; Giles JL, 2015, J IMMUNOL, V194, P3029, DOI 10.4049/jimmunol.1402956; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; HAYAT SQ, 1995, CLIN RHEUMATOL, V14, P211, DOI 10.1007/BF02214946; Hietala MA, 2002, J IMMUNOL, V169, P454, DOI 10.4049/jimmunol.169.1.454; HOGASEN K, 1995, J RHEUMATOL, V22, P24; KAPLAN RA, 1980, ARTHRITIS RHEUM, V23, P911, DOI 10.1002/art.1780230806; Kessel C, 2014, ARTHRITIS RHEUMATOL, V66, P610, DOI 10.1002/art.38237; KITSIS E, 1991, CLIN ORTHOP RELAT R, P63; Kolev M, 2013, SEMIN IMMUNOL, V25, P12, DOI 10.1016/j.smim.2013.04.012; Kraan MC, 2000, ARTHRITIS RHEUM, V43, P1820, DOI 10.1002/1529-0131(200008)43:8<1820::AID-ANR18>3.0.CO;2-D; Kwan WH, 2012, IMMUNOL RES, V54, P247, DOI 10.1007/s12026-012-8327-1; Lee H, 2008, IMMUNOL CELL BIOL, V86, P153, DOI 10.1038/sj.icb.7100166; MAKINDE VA, 1989, ANN RHEUM DIS, V48, P302, DOI 10.1136/ard.48.4.302; MCMULLIN MF, 1995, CLIN RHEUMATOL, V14, P204, DOI 10.1007/BF02214945; Mehta G, 2015, J IMMUNOL, V194, P5446, DOI 10.4049/jimmunol.1403012; MENNINGER H, 1980, Z RHEUMATOL, V39, P145; MOHR W, 1978, Z RHEUMATOL, V37, P81; MOHR W, 1995, J RHEUMATOL, V22, P1436; Molenaar ETH, 2001, ARTHRITIS RHEUM, V44, P997, DOI 10.1002/1529-0131(200105)44:5<997::AID-ANR178>3.3.CO;2-3; Mulherin D, 1996, ARTHRITIS RHEUM, V39, P115, DOI 10.1002/art.1780390116; Neumann E, 2002, ARTHRITIS RHEUM, V46, P934, DOI 10.1002/art.10183; NURCOMBE HL, 1991, ANN RHEUM DIS, V50, P147, DOI 10.1136/ard.50.3.147; PALMER DG, 1986, PATHOLOGY, V18, P431, DOI 10.3109/00313028609087564; PILLINGER MH, 1995, RHEUM DIS CLIN N AM, V21, P691; Quayle JA, 1997, IMMUNOLOGY, V91, P266; Sadik CD, 2012, P NATL ACAD SCI USA, V109, pE3177, DOI 10.1073/pnas.1213797109; Sarma JV, 2012, CELL HEALTH CYTOSKEL, V4, P73, DOI 10.2147/CHC.S27233; Song JJ, 2011, J CLIN INVEST, V121, P3517, DOI 10.1172/JCI46387; Subramanian H, 2011, MOL PHARMACOL, V79, P1005, DOI 10.1124/mol.111.071472; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Thurlings RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007865; Trouw LA, 2017, NAT REV RHEUMATOL, V13, DOI 10.1038/nrrheum.2017.125; VELVART M, 1981, RHEUMATOL INT, V1, P121, DOI 10.1007/BF00541256; Vergunst CE, 2007, RHEUMATOLOGY, V46, P1773, DOI 10.1093/rheumatology/kem222; VIDARSSON B, 1995, AM J MED, V98, P589, DOI 10.1016/S0002-9343(99)80019-9; WATSON F, 1993, ANN RHEUM DIS, V52, P354, DOI 10.1136/ard.52.5.354; Woodruff TM, 2002, ARTHRITIS RHEUM-US, V46, P2476, DOI 10.1002/art.10449; Wouters D, 2006, ARTHRITIS RHEUM, V54, P1143, DOI 10.1002/art.21729; Youssef PP, 1996, ARTHRITIS RHEUM, V39, P216, DOI 10.1002/art.1780390207	60	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189017	10.1371/journal.pone.0189017	http://dx.doi.org/10.1371/journal.pone.0189017			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220376	Green Published, Green Submitted, gold			2022-12-27	WOS:000417469900025
J	Lin, TT; Wu, CK; Liao, MT; Yang, YH; Chen, PC; Yeih, DF; Lin, LY				Lin, Ting-Tse; Wu, Cho-Kai; Liao, Min-Tsun; Yang, Yao-Hsu; Chen, Pau-Chung; Yeih, Dong-Feng; Lin, Lian-Yu			Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis - A nationwide cohort study	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; CARDIOVASCULAR EVENTS; PROPENSITY SCORE; RISK-FACTORS; INFLAMMATION; THERAPY; MORTALITY; DISEASE; METHOTREXATE; MORBIDITY	Background Rheumatoid arthritis (RA) is regarded as a high risk factor for myocardial infarction. Hypertension is a major modifiable risk factor contributing to increased risk of myocardial infarction (MI). Dual blood pressure (BP)-lowering and anti-inflammatory effect of renin-angiotensinsystem (RAS) inhibitors may possess protective effect from MI in RA population. However, treatment of hypertension with RAS inhibitors and MI in RA population remains unclear. Methods We investigated whether RAS blockade could decrease risk of incident MI in hypertensive patients with RA. We identified patients with RA and hypertension from the Registry for Catastrophic Illness, a nation-wide database encompassing almost all of the RA patients in Taiwan from 1995 to 2008. The primary endpoint was MI and the median duration of follow up was 2,986 days. Propensity score weighting and Cox proportional hazards regression models were used to estimate hazard ratios for MI. Results Among 27,335 subjects, 9.9% received angiotensin-converting enzyme inhibitors (ACEIs), 25.9% received angiotensin II receptor blockers (ARBs) and 20.0% received ACEIs or ARBs alternatively. The incidence of MI significantly decreased in patients treated with ACEIs (hazard ratio 0.707; 95% confidence interval 0.595 - 0.840), ARBs (0.641; 0.550 - 0.747) and ACEIs/ARBs (0.631; 0.539 - 0.739). The protective effect of ACEI or ARB therapy was significantly better in patients taking longer duration. The effect remained robust in subgroup analyses. Conclusions Therapy of ACEIs or ARBs is associated with a lower risk of MI among patients with RA. Hence, hypertension in patients with RA could comprise a compelling indication for RAS inhibitors.	[Lin, Ting-Tse; Liao, Min-Tsun] Natl Taiwan Univ Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan; [Lin, Ting-Tse] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Lin, Ting-Tse] Natl Chiao Tung Univ, Inst Biomed Engn, Hsinchu, Taiwan; [Wu, Cho-Kai; Lin, Lian-Yu] Natl Taiwan Univ Coll Med & Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Yang, Yao-Hsu] Chiayi Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Hlth Informat & Epidemiol Lab, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Univ, Sch Tradit Chinese Med, Coll Med, Taoyuan, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan; [Yeih, Dong-Feng] Fu Jen Catholic Univ Hosp, Dept Internal Med, New Taipei, Taiwan; [Yeih, Dong-Feng] Fu Jen Catholic Univ, Dept Internal Med, Sch Med, New Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; Fu Jen Catholic University; Fu Jen Catholic University Hospital; Fu Jen Catholic University	Lin, LY (corresponding author), Natl Taiwan Univ Coll Med & Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.; Yeih, DF (corresponding author), Fu Jen Catholic Univ Hosp, Dept Internal Med, New Taipei, Taiwan.; Yeih, DF (corresponding author), Fu Jen Catholic Univ, Dept Internal Med, Sch Med, New Taipei, Taiwan.	ocean0829@yahoo.com; h11151@hch.gov.tw	Chen, Pau-Chung/H-5686-2011; 楊, 曜旭/A-3450-2019	Chen, Pau-Chung/0000-0002-6242-5974; 楊, 曜旭/0000-0002-8080-0504; WU, CHO-KAI/0000-0002-3867-150X; LIN, TING-TSE/0000-0002-8810-5127; LIAO, MIN-TSUN/0000-0002-6283-6554	National Taiwan University College of Medicine [106-2314-B-002-046-MY2]; Ministry of Science and Technology, from the National Taiwan University Hospital Hsinchu Branch [105-HCH065, 106-HCH056]	National Taiwan University College of Medicine(National Taiwan University); Ministry of Science and Technology, from the National Taiwan University Hospital Hsinchu Branch	This work was supported by Grant 106-2314-B-002-046-MY2 from National Taiwan University College of Medicine and Ministry of Science and Technology, Grant 105-HCH065 and 106-HCH056 from the National Taiwan University Hospital Hsinchu Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Grant 106-2314-B-002-046-MY2 from National Taiwan University College of Medicine and Ministry of Science and Technology, Grant 105-HCH065 and 106-HCH056 from the National Taiwan University Hospital Hsinchu Branch.	Agca R, 2017, ANN RHEUM DIS, V76, P17, DOI 10.1136/annrheumdis-2016-209775; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; Brookhart MA, 2013, CIRC-CARDIOVASC QUAL, V6, P604, DOI 10.1161/CIRCOUTCOMES.113.000359; Cice G, 2010, J AM COLL CARDIOL, V56, P1701, DOI 10.1016/j.jacc.2010.03.105; Dessein PH, 2006, ARTHRITIS RHEUM-US, V54, P2765, DOI 10.1002/art.22053; Dixon WG, 2007, ARTHRITIS RHEUM, V56, P2905, DOI 10.1002/art.22809; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Flammer AJ, 2008, CIRCULATION, V117, P2262, DOI 10.1161/CIRCULATIONAHA.107.734384; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Gabriel SE, 2008, AM J MED, V121, P9, DOI 10.1016/j.amjmed.2008.06.011; Gamboa JL, 2012, J AM SOC NEPHROL, V23, P334, DOI 10.1681/ASN.2011030287; Hikosaka M, 2000, AM J CARDIOL, V86, P1241, DOI 10.1016/S0002-9149(00)01209-1; Imbens GW, 2000, BIOMETRIKA, V87, P706, DOI 10.1093/biomet/87.3.706; Karpouzas GA, 2014, ANN RHEUM DIS, V73, P1797, DOI 10.1136/annrheumdis-2013-203617; Lazzerini PE, 2016, EUR HEART J, P1; Libby P, 2008, AM J MED, V121, P21, DOI 10.1016/j.amjmed.2008.06.014; Lin TT, 2015, KIDNEY INT, V88, P378, DOI 10.1038/ki.2015.96; Linden A, 2014, J EVAL CLIN PRACT, V20, P1065, DOI 10.1111/jep.12254; Lopez-Mejias R, 2016, AUTOIMMUN REV, V15, P1013, DOI 10.1016/j.autrev.2016.07.026; Mancia G, 2014, BLOOD PRESSURE, V23, P3, DOI 10.3109/08037051.2014.868629; MARTIN MFR, 1984, LANCET, V1, P1325; Myasoedova E, 2011, J RHEUMATOL, V38, P1601, DOI 10.3899/jrheum.100979; Naranjo A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2383; Panoulas VF, 2008, RHEUMATOLOGY, V47, P1286, DOI 10.1093/rheumatology/ken159; Perry ME, 2008, ANN RHEUM DIS, V67, P1646, DOI 10.1136/ard.2007.082917; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Pfeffer MA, 1997, CIRCULATION, V95, P2643, DOI 10.1161/01.CIR.95.12.2643; Price A, 2007, ARTHRITIS RHEUM-US, V56, P441, DOI 10.1002/art.22335; Rakugi H, 1996, AM HEART J, V132, P213, DOI 10.1016/S0002-8703(05)80002-X; Refaat R, 2013, EUR J PHARMACOL, V698, P421, DOI 10.1016/j.ejphar.2012.10.024; Roubille C, 2015, ANN RHEUM DIS, V74, P480, DOI 10.1136/annrheumdis-2014-206624; Sattar N, 2005, CURR OPIN RHEUMATOL, V17, P286, DOI 10.1097/01.bor.0000158150.57154.f9; Sattar N, 2003, CIRCULATION, V108, P2957, DOI 10.1161/01.CIR.0000099844.31524.05; Souza DG, 2003, BRIT J PHARMACOL, V139, P129, DOI 10.1038/sj.bjp.0705200; Tikiz C, 2005, J RHEUMATOL, V32, P2095; Turnbull F, 2003, LANCET, V362, P1527; Weissmann G, 2006, BULL HOSP JT DIS, V64, P12; WILSON PWF, 1994, AM J HYPERTENS, V7, pS7, DOI 10.1093/ajh/7.7.7S; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2000, NEW ENGL J MED, V342, P145	45	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188720	10.1371/journal.pone.0188720	http://dx.doi.org/10.1371/journal.pone.0188720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216228	gold, Green Submitted, Green Published			2022-12-27	WOS:000417337800038
J	Adnan, M; Aslam, F; Nawaz, Z; Sarwar, SM				Adnan, Muhammad; Aslam, Faisal; Nawaz, Zubair; Sarwar, Syed Mansoor			Rubus: A compiler for seamless and extensible parallelism	PLOS ONE			English	Article								Nowadays, a typical processor may have multiple processing cores on a single chip. Furthermore, a special purpose processing unit called Graphic Processing Unit (GPU), originally designed for 2D/3D games, is now available for general purpose use in computers and mobile devices. However, the traditional programming languages which were designed to work with machines having single core CPUs, cannot utilize the parallelism available on multi-core processors efficiently. Therefore, to exploit the extraordinary processing power of multi-core processors, researchers are working on new tools and techniques to facilitate parallel programming. To this end, languages like CUDA and OpenCL have been introduced, which can be used to write code with parallelism. The main shortcoming of these languages is that programmer needs to specify all the complex details manually in order to parallelize the code across multiple cores. Therefore, the code written in these languages is difficult to understand, debug and maintain. Furthermore, to parallelize legacy code can require rewriting a significant portion of code in CUDA or OpenCL, which can consume significant time and resources. Thus, the amount of parallelism achieved is proportional to the skills of the programmer and the time spent in code optimizations. This paper proposes a new open source compiler, Rubus, to achieve seamless parallelism. The Rubus compiler relieves the programmer from manually specifying the low-level details. It analyses and transforms a sequential program into a parallel program automatically, without any user intervention. This achieves massive speedup and better utilization of the underlying hardware without a programmer's expertise in parallel programming. For five different benchmarks, on average a speedup of 34.54 times has been achieved by Rubus as compared to Java on a basic GPU having only 96 cores. Whereas, for a matrix multiplication benchmark the average execution speedup of 84 times has been achieved by Rubus on the same GPU. Moreover, Rubus achieves this performance without drastically increasing the memory footprint of a program.	[Adnan, Muhammad; Aslam, Faisal; Nawaz, Zubair; Sarwar, Syed Mansoor] Univ Punjab, Punjab Univ, Coll Informat Technol, Lahore, Pakistan	University of Punjab	Adnan, M (corresponding author), Univ Punjab, Punjab Univ, Coll Informat Technol, Lahore, Pakistan.	adnanmitf09@gmail.com	Adnan, Muhammad/HDL-9249-2022					Aarnio T, WEBCL WORKING DRAFT; Aho Alfred V, 1986, COMPILERS PRINCIPLES; Alfred V. Aho, 2003, COMPILERS PRINCIPLES; Blender Foundation, 2016, BIG BUCK BUNN; Branner Bodil, 1989, P S APPL MATH, V39; Bruneton Eric, 2002, ADAPTABLE EXTENSIBLE, V30, P19; Calvert Peter, 2010, PARALLELISATION JAVA; Carrotsearch Labs, 2008, JUN; Catanzaro B, 2011, ACM SIGPLAN NOTICES, V46, P47, DOI 10.1145/1941553.1941562; Chafik O, 2009, JAVACL OPENSOURCE JA; Fung J., 2005, 13th Annual ACM International Conference on Multimedia, P849, DOI 10.1145/1101149.1101334; Hayashi A., 2013, P 2013 INT C PRINC P, P124, DOI [10.1145/2500828.2500840, DOI 10.1145/2500828.2500840]; Herhut S, 2013, ACM SIGPLAN NOTICES, V48, P729, DOI [10.1145/2509136.2509516, 10.1145/2544173.2509516]; Hutter M, 2011, JOCL JAVA BINDINGS O; John E Stone, 2010, COMPUTING SCI ENG, V12; Klockner Andreas, 2011, PYOPENCL; Klockner Andreas, 2009, 911 ARXIV; Manferdelli JL, 2008, P IEEE, V96, P808, DOI 10.1109/JPROC.2008.917730; Newburn CJ, 2011, INT SYM CODE GENER, P224, DOI 10.1109/CGO.2011.5764690; Nvidia corporation, NVIDIA CUDA C PROGR; Nystrom N, 2011, GPCE 11: PROCEEDINGS OF THE TENTH INTERNATIONAL CONFERENCE ON GENERATIVE PROGRAMMING AND COMPONENT ENGINEERING, P107; Pignotti Alessandro, 2012, P 8 S DYN LANG DLS 1, P53, DOI [10.1145/2384577.2384585, DOI 10.1145/2384577.2384585]; Pratt-Szeliga PC, 2012, IEEE I C EMBED SOFTW, P375, DOI 10.1109/HPCC.2012.57; Steven S.M., 1997, ADV COMPILER DESIGN; Wienke S, 2012, LECT NOTES COMPUT SC, V7484, P859, DOI 10.1007/978-3-642-32820-6_85; Yan Yonghong, 2009, EUROPAR C PAR PROC	26	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188721	10.1371/journal.pone.0188721	http://dx.doi.org/10.1371/journal.pone.0188721			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211758	Green Submitted, gold, Green Published			2022-12-27	WOS:000417212200044
J	Bernabo, N; Ciccarelli, R; Greco, L; Ordinelli, A; Mattioli, M; Barboni, B				Bernabo, Nicola; Ciccarelli, Rosa; Greco, Luana; Ordinelli, Alessandra; Mattioli, Mauro; Barboni, Barbara			Scientometric study of the effects of exposure to non-ionizing electromagnetic fields on fertility: A contribution to understanding the reasons of partial failure	PLOS ONE			English	Article							ENDOCANNABINOID SYSTEM; ALCOHOL-CONSUMPTION; REPRODUCTION; VARICOCELE; MARIJUANA; SMOKING	The exposure to Non-Ionizing-Electromagnetic Fields (NI-EMFs) is often indicated as a cofactor responsible for the fertility reduction, which has been described in recent years. Despite the great interest in this topic and the research effort in exploring it, to date, there are no reliable data. Therefore, we carried out a scientometric analysis of the scientific literature published in peer reviewed Journals concerning this topic to better understand the reasons of this partial failure. To this aim, we identified and analysed 104 papers, published in last 26 years in peer-reviewed Journals, present in ISI Web of Knowledge Core Collection. Then, we analysed the impact of the Journals in which the papers were published as well as that of the single papers, the paper citation dynamics, the keywords citation busts, the geographical localization of citations and the co-authorship dynamics of the Authors. As a result, we found that different animal models (rodent, rabbit, guinea pig, and swine) and different experimental approaches (epidemiological vs. experimental studies) have the same impact, highlighting the lack of universally adopted standard in research activity. The analysis of the temporal trend in keywords and the high differences in citations between the different countries (also in those belonging to the same geographical and socio-economical area) pointed out the difficulties in approaching this branch of study. Lastly, it was evident that the Authors did not behave as a connected community, but as unconnected clusters of very small size. In conclusion, based on the results of our analysis, we think that important efforts must be undertaken to adopt more standardized models and to improve the research quality and the information exchange within the scientific community, with the aim of improving the reliability and usefulness of the results of research regarding the effect of NI-EMFs on fertility.	[Bernabo, Nicola; Ciccarelli, Rosa; Greco, Luana; Ordinelli, Alessandra; Mattioli, Mauro; Barboni, Barbara] Univ Teramo, Fac Biosci & Agrofood & Environm Technol, Teramo, Italy	University of Teramo	Bernabo, N (corresponding author), Univ Teramo, Fac Biosci & Agrofood & Environm Technol, Teramo, Italy.	nbernabo@unite.it	Ordinelli, Alessandra/G-5543-2019	Ordinelli, Alessandra/0000-0003-1001-1590; Bernabo, Nicola/0000-0001-5140-9656				Agarwal A, 2014, ASIAN J ANDROL, V17, P433; Alshahrani S, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-103; Alvarez S, 2015, FERTIL STERIL, V103, P22, DOI 10.1016/j.fertnstert.2014.11.008; Bernabo N, 2010, THERIOGENOLOGY, V73, P1293, DOI 10.1016/j.theriogenology.2009.12.010; Bernabo N, 2016, CURR CHEM BIOL, V10, P18; Bernabo N, 2016, SCIENTOMETRICS, V109, P103, DOI 10.1007/s11192-016-1969-3; Bomer K, 2011, SBE 2020 WHITE PAP, V69, P1; Brents Lisa K., 2016, Yale Journal of Biology and Medicine, V89, P175; Brezina Paul R, 2012, J Reprod Infertil, V13, P3; Chaouat G, 2008, NAT MED, V14, P1218, DOI 10.1038/nm1108-1218; Cho CL, 2016, ASIAN J ANDROL, V18, P186, DOI 10.4103/1008-682X.170441; Dai JB, 2015, ASIAN J ANDROL, V17, P954, DOI 10.4103/1008-682X.150847; Department of Energy South Africa, 2013, WHAT IS SOL PARK INF, P1; Dondorp W, 2010, HUM REPROD, V25, P578, DOI 10.1093/humrep/dep458; du Plessis SS, 2015, J ASSIST REPROD GEN, V32, P1575, DOI 10.1007/s10815-015-0553-8; European Commisson, 2006, HEAL ELECTROMAGN FIE, V1994, P1; GARFIELD E, 1980, CURR CONTENTS, P5; Gonzalez-Alcaide G, 2008, FERTIL STERIL, V90, P941, DOI 10.1016/j.fertnstert.2007.07.1378; Harlev A, 2015, WORLD J MENS HEALTH, V33, P143, DOI 10.5534/wjmh.2015.33.3.143; IARC, 2016, IARC MONOGR, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2]; Klonoff-Cohen H, 2003, FERTIL STERIL, V79, P330, DOI 10.1016/S0015-0282(02)04582-X; Kumar Shiv Basant, 2015, Asian Pac J Cancer Prev, V16, P6967; Park B, 2004, PROSTAG LEUKOTR ESS, V70, P189, DOI 10.1016/j.plefa.2003.04.007; Practice T., 2012, FERTIL STERIL, V98, P1400; Reuters T., 2014, WEB SCI COR COLL, P1; Romeo C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/912878; Science E, 2016, GUIDE ICT RELATED AC; Sedha S, 2015, ROLE OXIDATIVE STRES; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sikka SC, 2008, ASIAN J ANDROL, V10, P134, DOI 10.1111/j.1745-7262.2008.00370.x; Snijder CA, 2012, HUM REPROD UPDATE, V18, P284, DOI 10.1093/humupd/dms005; Sun J, 2016, BIOL TRACE ELEM RES, V22; Union E, 2015, DEMOGRAPHY REPORT SH; Wdowiak A, 2014, ANN AGR ENV MED, V21, P450, DOI 10.5604/1232-1966.1108623; Wesselink AK, 2016, REPROD TOXICOL, V62, P39, DOI 10.1016/j.reprotox.2016.04.022; Xu B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15512; Xu C, 2016, TOXICOLOGICAL ASSESS, V7; Zalata A, 2015, INT J FERTIL STERIL, V9, P129	38	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187890	10.1371/journal.pone.0187890	http://dx.doi.org/10.1371/journal.pone.0187890			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211813	gold, Green Published, Green Submitted			2022-12-27	WOS:000417212200022
J	Chou, CY; Huang, CY; Huang, YJ; Lin, GH; Huang, SL; Lee, SC; Hsieh, CL				Chou, Chia-Yeh; Huang, Chien-Yu; Huang, Yi-Jing; Lin, Gong-Hong; Huang, Sheau-Ling; Lee, Shu-Chun; Hsieh, Ching-Lin			Comparison of construct validity of two short forms of Stroke-Specific Quality of Life scale	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSIS; PSYCHOMETRIC CHARACTERISTICS; ISCHEMIC-STROKE; RELIABILITY; VALIDATION; MODEL; INDEX; QUESTIONNAIRE; NEUROLOGISTS; VERSION	Background No studies have compared the 2-factor structures of Wong's and Post's versions of the short-form Stroke-Specific Quality of Life (i.e., 12-item SSQOL) scale. This study compared the construct validity of 2 short-forms of the 12-item-SSQOL (not the 12-domain-SSQOL). Methods Data were obtained from a previous validation study of the original 49-item SSQOL in 263 patients. Construct validity was tested by confirmatory factor analysis (CFA) to examine whether the two-factor structure, including psychosocial and physical domains, was supported in both versions. The CFA tested the data-model fit by indices: chi-square chi(2)/df ratio, root mean square error of approximation (RMSEA), comparative fit index (CFI), non-normative fit index (NNFI), standard root mean square residual (SRMR), and parsimony normed fit index (PNFI). Item factor loadings (cutoffs:.50) were examined. Model fit was compared using Akaike information criterion (AIC) and consistent AIC (i.e., CAIC) values. Results All model fit indices for Post's version fell within expected ranges: chi(2)/df ratio = 2.02, RMSEA = 0.05, CFI = 0.97, NNFI = 0.97, SRMR = 0.06, and PNFI = 0.76. In the psychosocial domain, the item factor loadings ranged from 0.46 to 0.63. In the physical domain, all items (except the language and vision items) had acceptable factor loadings (0.68 to 0.88). However, in Wong's version, none of the model indices met the criteria for good fit. In model fit comparisons, Post's version had smaller AIC and CAIC values than did Wong's version. Conclusions All fit indices supported Post's version, but not Wong's version. The construct validity of Post's version with a 2-factor structure was confirmed, and this version of the 12-item SSQOL is recommended.	[Chou, Chia-Yeh] Fu Jen Catholic Univ, Dept Occupat Therapy, Coll Med, New Taipei, Taiwan; [Chou, Chia-Yeh; Huang, Yi-Jing; Lin, Gong-Hong; Huang, Sheau-Ling; Lee, Shu-Chun; Hsieh, Ching-Lin] Natl Taiwan Univ, Sch Occupat Therapy, Coll Med, Taipei, Taiwan; [Huang, Chien-Yu] I Shou Univ, Dept Occupat Therapy, Kaohsiung, Kaohsiung Count, Taiwan; [Huang, Sheau-Ling; Hsieh, Ching-Lin] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Lee, Shu-Chun] Taipei City Hosp, Taipei City Psychiat Ctr, Taipei, Taiwan; [Hsieh, Ching-Lin] Asia Univ, Dept Occupat Therapy, Coll Med & Hlth Sci, Taichung, Taiwan	Fu Jen Catholic University; National Taiwan University; I Shou University; National Taiwan University; National Taiwan University Hospital; Taipei City Hospital; Asia University Taiwan	Hsieh, CL (corresponding author), Natl Taiwan Univ, Sch Occupat Therapy, Coll Med, Taipei, Taiwan.; Hsieh, CL (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.; Hsieh, CL (corresponding author), Asia Univ, Dept Occupat Therapy, Coll Med & Hlth Sci, Taichung, Taiwan.	clhsieh@ntu.edu.tw	Hsieh, Ching-Lin/G-6057-2011; Huang, Yi-Jing/ACO-3817-2022	Hsieh, Ching-Lin/0000-0001-9468-9969; HUANG, SHEAU-LING/0000-0002-2675-2302; Lee, Shu-Chun/0000-0002-8007-0409; Huang, Yi-Jing/0000-0003-2943-8287	Taiwan National Science Council [NSC 97-2314-B-030-005-MY2]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This study received funding support for the recruitment of sample and data from Taiwan National Science Council (NSC 97-2314-B-030-005-MY2) which did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Boosman H, 2010, J NEUROL NEUROSUR PS, V81, P485, DOI 10.1136/jnnp.2009.184960; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Browne MW., 1993, SOCIOL METHOD RES, V154, P136; Carod-Artal FJ, 2009, J NEUROL SCI, V284, P63, DOI 10.1016/j.jns.2009.04.008; Chang KC, 2003, STROKE, V34, pE219, DOI 10.1161/01.STR.0000095565.12945.18; Chin WW, 1998, QUANT METH SER, P295; Chiu EC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130702; Chou CY, 2015, CLIN REHABIL, V29, P816, DOI 10.1177/0269215514555137; Costello A. B., 2005, PRACTICAL ASSESSMENT, V10, P173, DOI DOI 10.1234/12345678; Dewey HM, 1999, CEREBROVASC DIS, V9, P323, DOI 10.1159/000016006; Fabrigar L. R., 2011, EXPLORATORY FACTOR A; Fischer U, 2010, STROKE, V41, P661, DOI 10.1161/STROKEAHA.109.572883; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gao Fei, 2004, Health Qual Life Outcomes, V2, P63, DOI 10.1186/1477-7525-2-63; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Goldstein LB, 1997, STROKE, V28, P307, DOI 10.1161/01.STR.28.2.307; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Hair J., 2010, MULTIVARIATE DATA AN, V7; Haughton DM O J, 1997, COMMUNICATIONS STAT; Herman T, 2011, GERONTOLOGY, V57, P203, DOI 10.1159/000314963; Hsueh IP, 2011, ARCH PHYS MED REHAB, V92, P1113, DOI 10.1016/j.apmr.2011.02.008; Hsueh IP, 2001, J FORMOS MED ASSOC, V100, P526; Hsueh IP, 2002, J NEUROL NEUROSUR PS, V73, P188, DOI 10.1136/jnnp.73.2.188; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jackson DL, 2009, PSYCHOL METHODS, V14, P6, DOI 10.1037/a0014694; James LR, 1982, CAUSALANALYSIS MODEL; MAHONEY F I, 1965, Md State Med J, V14, P61; Mattsson M, 2008, SCAND J RHEUMATOL, V37, P269, DOI 10.1080/03009740801914868; Muus I, 2007, CLIN REHABIL, V21, P620, DOI 10.1177/0269215507075504; Myers N, 2011, RES Q EXERCISE SPORT, V82, P79, DOI 10.1080/02701367.2011.10599724; Nunnally J. C., 1978, PSYCHOMETRIC THEORY, V2nd; Panzini L, 2006, TUMORI J, V92, P373, DOI 10.1177/030089160609200501; Parent EC, 2007, SPINE, V32, P1767, DOI 10.1097/BRS.0b013e3180b9f7a5; Post MWM, 2011, J NEUROL NEUROSUR PS, V82, P283, DOI 10.1136/jnnp.2009.196394; Santos NC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124229; Satorra A., 1994, LATENT VARIABLES ANA, P399, DOI DOI 10.2307/2291370; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Smith GT, 2005, PSYCHOL ASSESSMENT, V17, P396, DOI 10.1037/1040-3590.17.4.396; Smith GT, 2005, PSYCHOL ASSESSMENT, V17, P413, DOI 10.1037/1040-3590.17.4.413; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Strauss ME, 2009, ANNU REV CLIN PSYCHO, V5, P1, DOI 10.1146/annurev.clinpsy.032408.153639; Thompson B, 2004, EXPLORATORY CONFIRMA; Ullman JB, 2006, J PERS ASSESS, V87, P35, DOI 10.1207/s15327752jpa8701_03; Williams LS, 1999, STROKE, V30, P1362, DOI 10.1161/01.STR.30.7.1362; Wong GKC, 2013, J NEUROL SCI, V335, P204, DOI 10.1016/j.jns.2013.09.033; Wong GKC, 2012, J NEUROL SCI, V320, P97, DOI 10.1016/j.jns.2012.06.025	48	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188478	10.1371/journal.pone.0188478	http://dx.doi.org/10.1371/journal.pone.0188478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211759	Green Submitted, gold, Green Published			2022-12-27	WOS:000417212200035
J	Dong, XX; Shulzhenko, N; Lemaitre, J; Greer, RL; Peremyslova, K; Quamruzzaman, Q; Rahman, M; Ibn Hasan, OS; Joya, SA; Golam, M; Christiani, DC; Morgun, A; Kile, ML				Dong, Xiaoxi; Shulzhenko, Natalia; Lemaitre, Julien; Greer, Renee L.; Peremyslova, Kate; Quamruzzaman, Quazi; Rahman, Mahmudar; Ibn Hasan, Omar Sharif; Joya, Sakila Afroz; Golam, Mostofa; Christiani, David C.; Morgun, Andriy; Kile, Molly L.			Arsenic exposure and intestinal microbiota in children from Sirajdikhan, Bangladesh	PLOS ONE			English	Article							HUMAN GUT MICROBIOME; CARDIOVASCULAR-DISEASE; METAL RESISTANCE; SEQUENCING DATA; DRINKING-WATER; MECHANISMS; PREGNANCY; DATABASE; GENOMES; SEARCH	Background Arsenic has antimicrobial properties at high doses yet few studies have examined its effect on gut microbiota. This warrants investigation since arsenic exposure increases the risk of many diseases in which gut microbiota have been shown to play a role. We examined the association between arsenic exposure from drinking water and the composition of intestinal microbiota in children exposed to low and high arsenic levels during prenatal development and early life. Results 16S rRNA gene sequencing revealed that children with high arsenic exposure had a higher abundance of Proteobacteria in their stool compared to matched controls with low arsenic exposure. Furthermore, whole metagenome shotgun sequencing identified 332 bacterial SEED functions that were enriched in the high exposure group. A separate model showed that these genes, which included genes involved in virulence and multidrug resistance, were positively correlated with arsenic concentration within the group of children in the high arsenic group. We performed reference free genome assembly, and identified strains of E. coli as contributors to the arsenic enriched SEED functions. Further genome annotation of the E. coli genome revealed two strains containing two different arsenic resistance operons that are not present in the gut microbiome of a recently described European human cohort (Metagenomics of the Human Intestinal Tract, MetaHIT). We then performed quantification by qPCR of two arsenic resistant genes (ArsB, ArsC). We observed that the expression of these two operons was higher among the children with high arsenic exposure compared to matched controls. Conclusions This preliminary study indicates that arsenic exposure early in life was associated with altered gut microbiota in Bangladeshi children. The enrichment of E. coli arsenic resistance genes in the high exposure group provides an insight into the possible mechanisms of how this toxic compound could affect gut microbiota.	[Dong, Xiaoxi; Peremyslova, Kate; Morgun, Andriy] Oregon State Univ, Coll Pharm, Corvallis, OR 97331 USA; [Shulzhenko, Natalia; Lemaitre, Julien; Greer, Renee L.] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA; [Quamruzzaman, Quazi; Rahman, Mahmudar; Ibn Hasan, Omar Sharif; Joya, Sakila Afroz; Golam, Mostofa] Dhaka Community Hosp, Wireless Railgate, Dhaka, Bangladesh; [Christiani, David C.] Harvard TH Chan Sch Publ Hlth, Dept Environm Heath, Boston, MA USA; [Kile, Molly L.] Oregon State Univ, Coll Publ Hlth & Human Sci, Sch Biol & Populat Hlth Sci, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Harvard University; Harvard T.H. Chan School of Public Health; Oregon State University	Morgun, A (corresponding author), Oregon State Univ, Coll Pharm, Corvallis, OR 97331 USA.; Kile, ML (corresponding author), Oregon State Univ, Coll Publ Hlth & Human Sci, Sch Biol & Populat Hlth Sci, Corvallis, OR 97331 USA.	anemorgun@hotmail.com; molly.kile@oregonstate.edu		dong, xiaoxi/0000-0003-3852-331X; Lemaitre, Julien/0000-0001-6239-0110	Division of Health Sciences at Oregon State University; National Institute of Environmental Health Sciences [R01ES023441, R01ES015533, K01ES017800, P30E5000210]	Division of Health Sciences at Oregon State University; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We would like to acknowledge funding from the Division of Health Sciences at Oregon State University and National Institute of Environmental Health Sciences R01ES023441, R01ES015533, K01ES017800, and P30E5000210. Funding bodies did not have influence on design of the study, collection, analysis, interpretation of data or writing the manuscript.	Alava P, 2013, J HAZARD MATER, V262, P1237, DOI 10.1016/j.jhazmat.2012.05.042; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amini M, 2008, ENVIRON SCI TECHNOL, V42, P3669, DOI 10.1021/es702859e; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Baker-Austin C, 2006, TRENDS MICROBIOL, V14, P176, DOI 10.1016/j.tim.2006.02.006; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; DeSesso JM, 1998, REPROD TOXICOL, V12, P385, DOI 10.1016/S0890-6238(98)00021-5; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fangstrom B, 2009, TOXICOL APPL PHARM, V239, P208, DOI 10.1016/j.taap.2008.12.019; Farzan SF, 2013, ENVIRON RES, V126, P24, DOI 10.1016/j.envres.2013.05.001; Fenosa A, 2009, J ANTIMICROB CHEMOTH, V63, P668, DOI 10.1093/jac/dkp027; Fisher RA, 1934, STAT METHODS RES WOR, V5th; Graessler J, 2013, PHARMACOGENOMICS J, V13, P514, DOI 10.1038/tpj.2012.43; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; HUYSMANS KD, 1990, WATER AIR SOIL POLL, V53, P159, DOI 10.1007/BF00155000; Kile ML, 2005, CANCER EPIDEM BIOMAR, V14, P2419, DOI 10.1158/1055-9965.EPI-05-0306; Kile ML, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-29; Kitchin KT, 2010, CHEM RES TOXICOL, V23, P327, DOI 10.1021/tx900343d; Kitchin KT, 2001, TOXICOL APPL PHARM, V172, P249, DOI 10.1006/taap.2001.9157; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lu K, 2014, ENVIRON HEALTH PERSP, V122, P284, DOI 10.1289/ehp.1307429; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mandal BK, 2002, TALANTA, V58, P201, DOI 10.1016/S0039-9140(02)00268-0; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; Miller WH, 2002, CANCER RES, V62, P3893; Milton AH, 2005, EPIDEMIOLOGY, V16, P82, DOI 10.1097/01.ede.0000147105.94041.e6; Monira S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00228; Moon KA, 2013, ANN INTERN MED, V159, P649, DOI 10.7326/0003-4819-159-10-201311190-00719; Morgun A, 2015, GUT; Nickson R, 1998, NATURE, V395, P338, DOI 10.1038/26387; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pal C, 2014, NUCLEIC ACIDS RES, V42, pD737, DOI 10.1093/nar/gkt1252; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Pop M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r76; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rahman A, 2007, AM J EPIDEMIOL, V165, P1389, DOI 10.1093/aje/kwm025; Rahman A, 2011, ENVIRON HEALTH PERSP, V119, P719, DOI 10.1289/ehp.1002265; Rodrigues EG, 2015, J EXPO SCI ENV EPID, V25, P639, DOI 10.1038/jes.2015.45; Salnikow K, 2008, CHEM RES TOXICOL, V21, P28, DOI 10.1021/tx700198a; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Schwartz S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r32; Sheik CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040059; Simon R, 2007, CANCER INFORM, V3, P11; Smith AH, 2002, SCIENCE, V296, P2145, DOI 10.1126/science.1072896; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Wang W, 2013, J EPIDEMIOLOGY COMMU; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; White AG, 2014, INT J ENV RES PUB HE, V11, P2299, DOI 10.3390/ijerph110202299; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	62	24	27	6	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188487	10.1371/journal.pone.0188487	http://dx.doi.org/10.1371/journal.pone.0188487			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211769	Green Published, Green Submitted, gold			2022-12-27	WOS:000417212200036
J	Foye, C; Yan, IK; David, W; Shukla, N; Habboush, Y; Chase, L; Ryland, K; Kesari, V; Patel, T				Foye, Catherine; Yan, Irene K.; David, Waseem; Shukla, Neha; Habboush, Yacob; Chase, Lori; Ryland, Kristen; Kesari, Vivek; Patel, Tushar			Comparison of miRNA quantitation by Nanostring in serum and plasma samples	PLOS ONE			English	Article								Circulating microRNAs that are associated with specific diseases have garnered much attention for use in diagnostic assays. However, detection of disease-associated miRNA can be affected by several factors such as release of contaminating cellular miRNA during sample collection, variations due to amplification of transcript for detection, or controls used for normalization for accurate quantitation. We analyzed circulating miRNA in serum and plasma samples obtained concurrently from 28 patients, using a Nanostring quantitative assay platform. Total RNA concentration ranged from 32-125 mu g/ml from serum and 30- 220 mu g/ml from plasma. Of 798 miRNAs, 371 miRNAs were not detected in either serum or plasma samples. 427 were detected in either serum or plasma but not both, whereas 151 miRNA were detected in both serum and plasma samples. The diversity of miRNA detected was greater in plasma than in serum samples. In serum samples, the number of detected miRNA ranged from 3 to 82 with a median of 17, whereas in plasma samples, the number of miRNA detected ranged from 25 to 221 with a median of 91. Several miRNA such as miR451a, miR 16-5p, miR-223-3p, and mir25-3p were highly abundant and differentially expressed between serum and plasma. The detection of endogenous and exogenous control miRNAs varied in serum and plasma, with higher levels observed in plasma. Gene expression stability identified candidate invariant microRNA that were highly stable across all samples, and could be used for normalization. In conclusion, there are significant differences in both the number of miRNA detected and the amount of miRNA detected between serum and plasma. Normalization using miRNA with constant expression is essential to minimize the impact of technical variations. Given the challenges involved, ideal candidates for blood based biomarkers would be those that are indifferent to type of body fluid, are detectable and can be reliably quantitated.	[Foye, Catherine; Yan, Irene K.; David, Waseem; Shukla, Neha; Habboush, Yacob; Chase, Lori; Ryland, Kristen; Kesari, Vivek; Patel, Tushar] Mayo Clin, Dept Transplantat, Jacksonville, FL 32224 USA	Mayo Clinic	Patel, T (corresponding author), Mayo Clin, Dept Transplantat, Jacksonville, FL 32224 USA.	patel.tushar@mayo.edu		Kesari, Vivek/0000-0002-5195-4811; Chase, Lori/0000-0003-0415-0375	National Center for Advancing Translational Sciences, National Institutes of Health [UH3 TR000884]	National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funded by National Center for Advancing Translational Sciences, National Institutes of Health, UH3 TR000884 (TP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerlaan W, 2016, BIOPRESERV BIOBANK, V14, P390, DOI 10.1089/bio.2015.0125; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Basso D, 2017, CLIN BIOCHEM, V50, P186, DOI 10.1016/j.clinbiochem.2016.11.005; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Enelund L, 2017, MICRORNA; Glinge C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167969; Koberle V, 2016, TRANSL RES, V169, P40, DOI 10.1016/j.trsl.2015.10.010; Lee JE, 2017, OMICS, V21, P499, DOI 10.1089/omi.2017.0109; Nielsen T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-177; Pogribny IP, 2017, EXP BIOL MED; Shah JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153200; Tay J W, 2017, BMC Res Notes, V10, P312, DOI 10.1186/s13104-017-2636-3; Tsang HF, 2017, EXPERT REV MOL DIAGN, V17, P95, DOI 10.1080/14737159.2017.1268533; Veldman-Jones MH, 2015, CANCER RES, V75, P2587, DOI 10.1158/0008-5472.CAN-15-0262; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561	15	52	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189165	10.1371/journal.pone.0189165	http://dx.doi.org/10.1371/journal.pone.0189165			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211799	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200073
J	Fu, KQ; Miyamoto, Y; Sumi, K; Saika, E; Muramatsu, S; Uno, K; Nitta, A				Fu, Kequan; Miyamoto, Yoshiaki; Sumi, Kazuyuki; Saika, Eriko; Muramatsu, Shin-ichi; Uno, Kyosuke; Nitta, Atsumi			Overexpression of transmembrane protein 168 in the mouse nucleus accumbens induces anxiety and sensorimotor gating deficit	PLOS ONE			English	Article							ACOUSTIC STARTLE REFLEX; DEPRESSION-LIKE BEHAVIOR; CENTRAL-NERVOUS-SYSTEM; PREPULSE INHIBITION; MOOD DISORDERS; METHAMPHETAMINE; MICE; SCHIZOPHRENIA; SHATI/NAT8L; IMPAIRMENT	Transmembrane protein 168 (TMEM168) comprises 697 amino acid residues, including some putative transmembrane domains. It is reported that TMEM168 controls methamphetamine (METH) dependence in the nucleus accumbens (NAc) of mice. Moreover, a strong link between METH dependence-induced adaptive changes in the brain and mood disorders has been evaluated. In the present study, we investigated the effects of accumbal TMEM168 in a battery of behavioral paradigms. The adeno-associated virus (AAV) Tmem168 vector was injected into the NAc of C57BL/6J mice (NAc-TMEM mice). Subsequently, the accumbal TMEM168 mRNA was increased approximately by seven-fold when compared with the NAc-Mock mice (controls). The NAc-TMEM mice reported no change in the locomotor activity, cognitive ability, social interaction, and depression-like behaviors; however, TMEM168 overexpression enhanced anxiety in the elevated-plus maze and light/dark box test. The increased anxiety was reversed by pretreatment with the antianxiety drug diazepam (0.3 mg/kg i.p.). Moreover, the NAc-TMEM mice exhibited decreased prepulse inhibition (PPI) in the startle response test, and the induced schizophrenia-like behavior was reversed by pretreatment with the antipsychotic drug risperidone (0.01 mg/kg i.p.). Furthermore, accumbal TMEM168 overexpression decreased the basal levels of extracellular GABA in the NAc and the high K+ (100 mM)-stimulated GABA elevation; however, the total contents of GABA in the NAc remained unaffected. These results suggest that the TMEM168-regulated GABAergic neuronal system in the NAc might become a novel target while studying the etiology of anxiety and sensorimotor gating deficits.	[Fu, Kequan; Miyamoto, Yoshiaki; Sumi, Kazuyuki; Saika, Eriko; Uno, Kyosuke; Nitta, Atsumi] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Fac Pharmaceut Sci, Dept Pharmaceut Therapy & Neuropharmacol, Toyama, Toyama, Japan; [Muramatsu, Shin-ichi] Jichi Med Univ, Div Neurol, Dept Med, Shimotsuke, Tochigi, Japan; [Muramatsu, Shin-ichi] Univ Tokyo, Inst Med Sci, Ctr Gene & Cell Therapy, Tokyo, Japan	University of Toyama; Jichi Medical University; University of Tokyo	Nitta, A (corresponding author), Univ Toyama, Grad Sch Med & Pharmaceut Sci, Fac Pharmaceut Sci, Dept Pharmaceut Therapy & Neuropharmacol, Toyama, Toyama, Japan.	nitta@pha.u-toyama.ac.jp	Nitta, Atsumi/AAF-4211-2019; Muramatsu, Shinichi/ABC-6093-2021	Muramatsu, Shinichi/0000-0002-3185-7790; Nitta, Atsumi/0000-0001-6916-9160	Program for Next Generation World-Leading Researchers [NEXT] [LS047]; Japan Society for the Promotion of Science [26293213, JP15H04662, JP15K15050, JP17K19801]; Japan Agency for Medical Research and Development (AMED) [16mk0101076h0001]; Smoking Research Foundation Grant for Biomedical Research and Foundation; Kobayashi International Foundation	Program for Next Generation World-Leading Researchers [NEXT]; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Smoking Research Foundation Grant for Biomedical Research and Foundation; Kobayashi International Foundation	This work was supported by Program for Next Generation World-Leading Researchers [NEXT Program LS047]; the grant-in-aid for Scientific Research (KAKENHI) (B) [JSPS KAKENHI Grant Number, 26293213, JP15H04662], Challenging Exploratory Research [JSPS KAKENHI Grant Number, JP15K15050 and JP17K19801] from the Japan Society for the Promotion of Science, http://www.jsps.go.jp/english/index.html (SM, AN); Japan Agency for Medical Research and Development (AMED) [16mk0101076h0001], http://www.amed.go.jp/en/ (AN); Smoking Research Foundation Grant for Biomedical Research and Foundation, http://www.srf.or.jp/ (AN); and Kobayashi International Foundation, http://www.kisf.or.jp/english/index.html (KF, AN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkam T, 2007, BEHAV BRAIN RES, V180, P139, DOI 10.1016/j.bbr.2007.03.001; Arai S, 2008, NEUROPSYCHOPHARMACOL, V33, P3164, DOI 10.1038/npp.2008.41; Azogu I, 2017, NEUROPHARMACOLOGY; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Barrot M, 2005, P NATL ACAD SCI USA, V102, P8357, DOI 10.1073/pnas.0500587102; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Calhoon GG, 2015, NAT NEUROSCI, V18, P1394, DOI 10.1038/nn.4101; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; Dai HM, 2004, ANN NY ACAD SCI, V1025, P257, DOI 10.1196/annals.1316.032; Davidson BL, 2000, P NATL ACAD SCI USA, V97, P3428, DOI 10.1073/pnas.050581197; de la Tremblaye PB, 2016, EXP NEUROL, V284, P84, DOI 10.1016/j.expneurol.2016.07.019; Fatemi SH, 2000, MOL PSYCHIATR, V5, P654, DOI 10.1038/sj.mp.4000783; Fatemi SH, 2005, SCHIZOPHR RES, V72, P109, DOI 10.1016/j.schres.2004.02.017; Fletcher PJ, 2001, NEUROPSYCHOPHARMACOL, V24, P399, DOI 10.1016/S0893-133X(00)00215-3; Fu KQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13289-0; Fu KQ, 2016, PSYCHOPHARMACOLOGY, V233, P831, DOI 10.1007/s00213-015-4159-8; Furukawa-Hibi Y, 2012, NEUROSCI LETT, V526, P79, DOI 10.1016/j.neulet.2012.08.028; Furukawa-Hibi Y, 2010, NEUROREPORT, V21, P1177, DOI 10.1097/WNR.0b013e3283411685; Grant KM, 2012, J NEUROIMMUNE PHARM, V7, P113, DOI 10.1007/s11481-011-9288-1; Grossmann A, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145968; Hellem TL, 2016, J SUBST ABUSE TREAT, V71, P16, DOI 10.1016/j.jsat.2016.08.011; Homer BD, 2008, PSYCHOL BULL, V134, P301, DOI 10.1037/0033-2909.134.2.301; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Krzyzosiak A, 2010, NEURON, V66, P908, DOI 10.1016/j.neuron.2010.05.004; Lang DJ, 2001, AM J PSYCHIAT, V158, P625, DOI 10.1176/appi.ajp.158.4.625; Liu WS, 2001, P NATL ACAD SCI USA, V98, P3477, DOI 10.1073/pnas.051614698; Lubbers BR, 2014, PROG BRAIN RES, V214, P263, DOI 10.1016/B978-0-444-63486-3.00012-8; Lydiard RB, 2003, J CLIN PSYCHIAT, V64, P21; MANSBACH RS, 1988, PSYCHOPHARMACOLOGY, V94, P507, DOI 10.1007/BF00212846; Matsuki T, 2008, J CELL SCI, V121, P1869, DOI 10.1242/jcs.027334; Merikangas KR, 1998, ADDICT BEHAV, V23, P893, DOI 10.1016/S0306-4603(98)00076-8; Mierzejewski P, 2016, EUR J PHARMACOL, V773, P51, DOI 10.1016/j.ejphar.2016.01.009; Miyamoto Y, 2001, J NEUROSCI, V21, P750, DOI 10.1523/JNEUROSCI.21-02-00750.2001; Miyamoto Y, 2014, INT J NEUROPSYCHOPH, V17, P1283, DOI 10.1017/S146114571400011X; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Niwa M, 2007, J NEUROSCI, V27, P7604, DOI 10.1523/JNEUROSCI.1575-07.2007; Ouagazzal AM, 2001, PSYCHOPHARMACOLOGY, V156, P273, DOI 10.1007/s002130100763; Park TJ, 2008, J NEUROSCI, V28, P13551, DOI 10.1523/JNEUROSCI.4323-08.2008; Park YK, 2016, NAT REV NEUROSCI, V17, P745, DOI 10.1038/nrn.2016.138; Paxions G, 2008, MOUSE BRAININ STEREO; Riss J, 2008, ACTA NEUROL SCAND, V118, P69, DOI 10.1111/j.1600-0404.2008.01004.x; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Schutova B, 2010, PHYSIOL BEHAV, V99, P381, DOI 10.1016/j.physbeh.2009.12.004; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Talalaenko A N, 2006, Neurosci Behav Physiol, V36, P749, DOI 10.1007/s11055-006-0083-z; Tenenbaum L, 2004, J GENE MED, V6, pS212, DOI 10.1002/jgm.506; Toriumi K, 2015, EUR NEUROPSYCHOPHARM, V25, P2108, DOI 10.1016/j.euroneuro.2015.08.003; Uede T, 2011, PATHOL INT, V61, P265, DOI 10.1111/j.1440-1827.2011.02649.x; Warner-Schmidt JL, 2012, P NATL ACAD SCI USA, V109, P11360, DOI 10.1073/pnas.1209293109	50	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189006	10.1371/journal.pone.0189006	http://dx.doi.org/10.1371/journal.pone.0189006			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211814	Green Submitted, Green Published, gold			2022-12-27	WOS:000417212200054
J	Sanz-Veiga, PA; Jorge, LR; Benitez-Vieyra, S; Amorim, FW				Sanz-Veiga, Priscila Andre; Jorge, Leonardo Re; Benitez-Vieyra, Santiago; Amorim, Felipe W.			Pericarpial nectary-visiting ants do not provide fruit protection against pre-dispersal seed predators regardless of ant species composition and resource availability	PLOS ONE			English	Article							BEARING EXTRAFLORAL NECTARIES; EXTRA-FLORAL NECTARIES; PLANT-PROTECTION; HERBIVORE INTERACTIONS; REPRODUCTIVE FITNESS; DEFENSE; FORMICIDAE; SECRETION; RUBIACEAE; COMMUNITY	Extrafloral nectaries can occur in both vegetative and reproductive plant structures. In many Rubiaceae species in the Brazilian Cerrado, after corolla abscission, the floral nectary continues to secret nectar throughout fruit development originating post-floral pericarpial nectaries which commonly attract many ant species. The occurrence of such nectar secreting structures might be strategic for fruit protection against seed predators, as plants are expected to invest higher on more valuable and vulnerable parts. Here, we performed ant exclusion experiments to investigate whether the interaction with ants mediated by the pericarpial nectaries of Tocoyena formosa affects plant reproductive success by reducing the number of pre-dispersal seed predators. We also assessed whether ant protection was dependent on ant species composition and resource availability. Although most of the plants were visited by large and aggressive ant species, such as Ectatomma tuberculatum and species of the genus Camponotus, ants did not protect fruits against seed predators. Furthermore, the result of the interaction was neither related to ant species composition nor to the availability of resources. We suggest that these results may be related to the nature and behavior of the most important seed predators, like Hemicolpus abdominalis weevil which the exoskeleton toughness prevent it from being predated by most ant species. On the other hand, not explored factors, such as reward quality, local ant abundance, ant colony characteristics and/or the presence of alternative energetic sources could also account for variations in ant frequency, composition, and finally ant protective effects, highlighting the conditionality of facultative plant-ant mutualisms.	[Sanz-Veiga, Priscila Andre; Amorim, Felipe W.] Univ Estadual Paulista, LEPI, Programa Posgrad Ciencias Biol Bot, Inst Biociencias, Sao Paulo, Brazil; [Jorge, Leonardo Re] Univ Estadual Campinas, Dept Biol Anim, Sao Paulo, Brazil; [Benitez-Vieyra, Santiago] Univ Nacl Cordoba, CONICET, Inst Multidisciplinario Biol Vegetal, Cordoba, Argentina; [Amorim, Felipe W.] Univ Estadual Paulista, LEPI, Dept Bot, Inst Biociencias, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Estadual de Campinas; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Universidade de Sao Paulo; Universidade Estadual Paulista	Sanz-Veiga, PA; Amorim, FW (corresponding author), Univ Estadual Paulista, LEPI, Programa Posgrad Ciencias Biol Bot, Inst Biociencias, Sao Paulo, Brazil.; Amorim, FW (corresponding author), Univ Estadual Paulista, LEPI, Dept Bot, Inst Biociencias, Sao Paulo, Brazil.	psanzveiga@gmail.com; amorimfelipe@yahoo.com.br	Jorge, Leonardo Ré/A-1528-2009; Benitez-Vieyra, Santiago/AAT-3076-2020; Veiga, Priscila Andre Sanz/AAH-9229-2021; Amorim, Felipe W./AAE-6641-2020; Sanz-Veiga, Priscila/D-4550-2019	Jorge, Leonardo Ré/0000-0003-4518-4328; Benitez-Vieyra, Santiago/0000-0003-4116-7969; Veiga, Priscila Andre Sanz/0000-0002-7096-2411; Amorim, Felipe W./0000-0002-6026-0395; Sanz-Veiga, Priscila/0000-0002-7096-2411	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [484469/2013-2014]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [14/16082-9]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Proc. 484469/2013-2014: http://cnpq.br/) to FWA. PASV was supported by a Masters scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes: http://www.capes.gov.br/). LRJ was supported by a postdoc scholarship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Proc. 14/16082-9: http//www.fapesp.br/). SBV is staff researcher of Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET: http://www.conicet.gov.ar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Silva E, 2016, AUSTRAL ECOL, V41, P263, DOI 10.1111/aec.12307; Alves-Silva E, 2015, J NAT HIST, V49, P841, DOI 10.1080/00222933.2014.954020; Amorim Felipe Wanderley, 2006, Braz. J. Bot., V29, P353, DOI 10.1590/S0100-84042006000300003; Anzaldo SS, 2017, ZOOKEYS, P51, DOI 10.3897/zookeys.683.12080; Apple JL, 2001, OECOLOGIA, V127, P409, DOI 10.1007/s004420000605; Assuncao MA, 2014, FLORA, V209, P244, DOI 10.1016/j.flora.2014.03.003; Baker-Meio B, 2012, J ECOL, V100, P242, DOI 10.1111/j.1365-2745.2011.01892.x; BARTON AM, 1986, ECOLOGY, V67, P495, DOI 10.2307/1938592; Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; Belchior C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158283; BENTLEY BL, 1977, J ECOL, V65, P27, DOI 10.2307/2259060; BENTLEY BL, 1977, ANNU REV ECOL SYST, V8, P407, DOI 10.1146/annurev.es.08.110177.002203; BENTLEY BL, 1976, ECOLOGY, V57, P815, DOI 10.2307/1936195; Bluthgen N, 2004, ECOLOGY, V85, P1479, DOI 10.1890/03-0430; Bronstein JL, 1998, BIOTROPICA, V30, P150, DOI 10.1111/j.1744-7429.1998.tb00050.x; BRONSTEIN JL, 1994, TRENDS ECOL EVOL, V9, P214, DOI 10.1016/0169-5347(94)90246-1; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Byk J, 2010, ACTA ETHOL, V13, P33, DOI 10.1007/s10211-010-0071-8; CEPAGRI-CENTRO DE PESQUISAS METEOROLOGICAS E CLIMATICAS APLICADAS A AGRICULTURA, 2015, CLIM MUN PAUL; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Dattilo W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099838; DAVIDSON DW, 1991, ANT - PLANT INTERACTIONS, P289; Davidson DW, 2004, OECOLOGIA, V139, P255, DOI 10.1007/s00442-004-1508-4; de la Fuente MAS, 1999, OECOLOGIA, V118, P192, DOI 10.1007/s004420050718; DEJEAN A, 1992, INSECT SOC, V39, P129, DOI 10.1007/BF01249289; Del-Claro K, 2016, INSECT SOC, V63, P207, DOI 10.1007/s00040-016-0466-2; Del-Claro K, 2013, SOCIOBIOLOGY, V60, P217; Del-Claro K, 2015, BIOTROPICA, V47, P459, DOI 10.1111/btp.12227; DelClaro K, 1996, J TROP ECOL, V12, P887, DOI 10.1017/S0266467400010142; Di Giusto B, 2001, OECOLOGIA, V129, P367, DOI 10.1007/s004420100734; Eberhard WG, 1999, BIOTROPICA, V31, P535, DOI 10.1111/j.1744-7429.1999.tb00399.x; ELIAS TS, 1978, BRITTONIA, V30, P175, DOI 10.2307/2806648; Falcao JCF, 2014, J PLANT INTERACT, V9, P137, DOI 10.1080/17429145.2013.782513; Freitas L, 2000, FLORA, V195, P398; Grasso DA, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv002; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; HEADS PA, 1985, ECOL ENTOMOL, V10, P29, DOI 10.1111/j.1365-2311.1985.tb00532.x; Heil M, 2004, J TROP ECOL, V20, P201, DOI 10.1017/S026646740300110X; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Holland JN, 2009, J ECOL, V97, P89, DOI 10.1111/j.1365-2745.2008.01446.x; Hsieh TC, 2016, INT SYMP WIREL; INOUYE DW, 1979, ECOLOGY, V60, P1, DOI 10.2307/1936460; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; Jones IM, 2017, FLA ENTOMOL, V100, P539, DOI 10.1653/024.100.0308; Jones IM, 2017, BIOTROPICA, V49, P83, DOI 10.1111/btp.12363; KEELER KH, 1981, AM J BOT, V68, P295, DOI 10.2307/2442861; Kersch MF, 2005, ECOLOGY, V86, P2117, DOI 10.1890/04-1916; KOPTUR S, 1988, ECOLOGY, V69, P278, DOI 10.2307/1943183; Koptur S, 2005, PLANT-PROVIDED FOOD FOR CARNIVOROUS INSECTS: PROTECTIVE MUTUALISM AND ITS APPLICATIONS, P75, DOI 10.1017/CBO9780511542220.004; KOPTUR S, 1984, ECOLOGY, V65, P1787, DOI 10.2307/1937775; Koptur S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138157; Koricheva J, 2012, BIOL LETTERS, V8, P628, DOI 10.1098/rsbl.2012.0271; Lanan MC, 2013, OECOLOGIA, V172, P779, DOI 10.1007/s00442-012-2528-0; Lange D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169492; Lange D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105574; Lange D, 2013, ECOL ENTOMOL, V38, P463, DOI 10.1111/een.12036; Lenoir L, 2006, ECOL ENTOMOL, V31, P601, DOI 10.1111/j.1365-2311.2006.00818.x; Miller TEX, 2013, J ECOL, V102, P496; Miller TEX, 2007, OIKOS, V116, P500, DOI 10.1111/j.2007.0030-1299.15317.x; Mody K, 2004, ECOL ENTOMOL, V29, P217, DOI 10.1111/j.1365-2311.2004.0588.x; Nascimento EA, 2010, FLORA, V205, P754, DOI 10.1016/j.flora.2009.12.040; Ness JH, 2009, ECOLOGY, V90, P2823, DOI 10.1890/08-1580.1; Nogueira A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123806; Nogueira A, 2012, PLANT ECOL, V213, P289, DOI 10.1007/s11258-011-9974-3; ODOWD DJ, 1983, OECOLOGIA, V59, P191, DOI 10.1007/BF00378837; Oksanen J., 2017, Ordination methods, diversity analysis and other functions for community and vegetation ecologists version 2.4-3; Oliveira PS, 1997, FUNCT ECOL, V11, P323, DOI 10.1046/j.1365-2435.1997.00087.x; RASHBROOK VK, 1992, ECOLOGY, V73, P2167, DOI 10.2307/1941464; Ratter J. A., 2003, Edinburgh Journal of Botany, V60, P57, DOI 10.1017/S0960428603000064; Rhoades DF, 1979, HERBIVORES THEIR INT, P4; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; RICOGRAY V, 1989, OECOLOGIA, V81, P487, DOI 10.1007/BF00378956; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; Rudgers JA, 2004, ECOLOGY, V85, P192, DOI 10.1890/02-0625; Ruhren S, 2003, PLANT ECOL, V166, P189, DOI 10.1023/A:1023248431116; Santos Jean Carlos, 2001, Revista Brasileira de Zoociencias, V3, P77; SCHEMSKE DW, 1980, J ECOL, V68, P959, DOI 10.2307/2259468; Schoereder Jose H., 2010, Terrestrial Arthropod Reviews, V3, P3, DOI 10.1163/187498310X487785; Sendoya SF, 2016, ARTHROPOD-PLANT INTE, V10, P183, DOI 10.1007/s11829-016-9423-2; SILBERBA.I, 1972, OSTERR BOT Z, V120, P1, DOI 10.1007/BF01373254; SILBERBAUERGOTTSBERGER I, 1975, PLANT SYST EVOL, V123, P157, DOI 10.1007/BF00989402; Sobrinho TG, 2002, SOCIOBIOLOGY, V39, P353; Paiva EAS, 2009, ANN BOT-LONDON, V104, P937, DOI 10.1093/aob/mcp175; Trager MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014308; Wackers FL, 2004, ECOLOGY, V85, P1512, DOI 10.1890/03-0422; Whitehead SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102604	86	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188445	10.1371/journal.pone.0188445	http://dx.doi.org/10.1371/journal.pone.0188445			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211790	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200033
J	Niemela, O; Niemela, M; Bloigu, R; Aalto, M; Laatikainen, T				Niemela, Onni; Niemela, Markus; Bloigu, Risto; Aalto, Mauri; Laatikainen, Tiina			Where should the safe limits of alcohol consumption stand in light of liver enzyme abnormalities in alcohol consumers?	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; SERUM ALANINE AMINOTRANSFERASE; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; GLOBAL BURDEN; REDUCED MORTALITY; HEART-DISEASE; RISK-FACTOR; ALL-CAUSE	Objectives To estimate the prevalence and risk factors for abnormal liver enzymes in a large age- and gender stratified population- based sample of apparently healthy individuals with or without alcohol consumption and other health-related risk factors (adiposity, physical inactivity, smoking). Methods Data on alcohol use, smoking, diet and physical activity were recorded using structured questionnaires from 13,976 subjects (6513 men, 7463 women, aged 25-74 years) in the national FINRISK studies. Alcohol data was used to categorize the participants into abstainers, light drinkers, moderate drinkers and heavy drinkers. Serum gamma-glutamyltransferase (GGT) and alanine aminotransferase (ALT) activities were measured using standard kinetic methods. Results Male light drinkers, moderate drinkers and heavy drinkers showed significantly higher relative risks of abnormal GGT than abstainers: 1.37 (95% confidence interval 1.11 to 1.71, p < 0.01), 2.72 (2.08 to 3.56, p < 0.0005), and 6.10 (4.55 to 7.17, p < 0.0005), respectively. Corresponding values for women were 1.22 (0.99 to 1.51, p = 0.065), 1.90 (1.44 to 2.51, p < 0.0005), and 5.91 (3.80 to 9.17, p < 0.0005). Estimated threshold doses for a significant GGT elevation was 14 standard weekly alcohol doses for men and 7 for women. Excess body weight and age over 40 years modulated the thresholds towards smaller quantities of alcohol. The risk of abnormal GGT was also significantly influenced by physical inactivity and smoking. The relative risks of abnormal ALT activities were increased in male heavy drinkers, especially in those presenting with adiposity and sedentary lifestyle. Conclusions Alcohol use markedly increases the risk for abnormal liver enzyme activities in those presenting with age over 40 years, obesity, smoking or sedentary lifestyle. The data should be considered in public health recommendations and in the definitions of safe limits of alcohol use.	[Niemela, Onni] Seinajoki Cent Hosp, Dept Lab Med, Seinajoki, Finland; [Niemela, Onni] Seinajoki Cent Hosp, Med Res Unit, Seinajoki, Finland; [Niemela, Onni] Univ Tampere, Seinajoki, Finland; [Niemela, Markus] Univ Oulu, Dept Med, Oulu, Finland; [Bloigu, Risto] Univ Oulu, Med Informat & Stat Res Grp, Oulu, Finland; [Aalto, Mauri] Seinajoki Cent Hosp, Dept Psychiat, Tampere, Finland; [Aalto, Mauri] Univ Tampere, Tampere, Finland; [Laatikainen, Tiina] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Laatikainen, Tiina] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland	Seinajoki Central Hospital; Seinajoki Central Hospital; University of Oulu; University of Oulu; Seinajoki Central Hospital; Finland National Institute for Health & Welfare; University of Eastern Finland	Niemela, O (corresponding author), Seinajoki Cent Hosp, Dept Lab Med, Seinajoki, Finland.	onni.niemela@epshp.fi	Laatikainen, Tiina/ABD-6622-2021	Laatikainen, Tiina/0000-0002-6614-4782; Aalto, Mauri/0000-0003-3424-3767				Alatalo PI, 2008, AM J CLIN NUTR, V88, P1097, DOI 10.1093/ajcn/88.4.1097; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Bagnardi V, 2013, ANN ONCOL, V24, P301, DOI 10.1093/annonc/mds337; Breitling LP, 2009, HEPATOLOGY, V49, P802, DOI 10.1002/hep.22727; Cao Y, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4238; Carmiel-Haggai M, 2003, GASTROENTEROLOGY, V125, P1818, DOI 10.1053/j.gastro.2003.09.019; Caro AA, 2004, ANNU REV PHARMACOL, V44, P27, DOI 10.1146/annurev.pharmtox.44.101802.121704; Catena C, 2016, HYPERTENSION, V68, P1208, DOI 10.1161/HYPERTENSIONAHA.116.08145; Choi Y., 2017, CANC RES TREAT; Conigrave KM, 2002, ALCOHOL CLIN EXP RES, V26, P332, DOI 10.1097/00000374-200203000-00005; Connor JP, 2016, LANCET, V387, P988, DOI 10.1016/S0140-6736(15)00122-1; Danielsson J, 2014, WORLD J GASTROENTERO, V20, P11743, DOI 10.3748/wjg.v20.i33.11743; Danielsson J, 2013, ALCOHOL ALCOHOLISM, V48, P303, DOI 10.1093/alcalc/agt017; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Duffy JC, 1992, J OFF STAT, V8, P327; Emdin M, 2005, CIRCULATION, V112, P2078, DOI 10.1161/CIRCULATIONAHA.105.571919; Fillmore KM, 2007, ANN EPIDEMIOL, V17, pS16, DOI 10.1016/j.annepidem.2007.01.005; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Ghouri N, 2010, HEPATOLOGY, V52, P1156, DOI 10.1002/hep.23789; Gluud C, 2005, BRIT MED J, V330, P724, DOI 10.1136/bmj.330.7493.724; Goh GBB, 2014, HEPATOLOGY, V60, P661, DOI 10.1002/hep.27054; Gunzerath L, 2004, ALCOHOL CLIN EXP RES, V28, P829, DOI 10.1097/01.ALC.0000128382.79375.B6; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Kazemi-Shirazi L, 2007, CLIN CHEM, V53, P940, DOI 10.1373/clinchem.2006.081620; Kim WR, 2008, HEPATOLOGY, V47, P1363, DOI 10.1002/hep.22109; Klatsky AL, 2015, J INTERN MED, V278, P238, DOI 10.1111/joim.12390; Kozakova M, 2012, HEPATOLOGY, V55, P1406, DOI 10.1002/hep.25555; Kuulasmaa K, 2017, EUROPEAN HLTH RISK M; Kyu HH, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3857; LANCA AJ, 1991, HEPATOLOGY, V14, P857, DOI 10.1002/hep.1840140518; Lau K, 2015, ALIMENT PHARM THER, V41, P467, DOI 10.1111/apt.13067; Lawlor DA, 2005, AM J EPIDEMIOL, V161, P1081, DOI 10.1093/aje/kwi125; Lee DH, 2004, FREE RADICAL RES, V38, P535, DOI 10.1080/10715760410001694026; Lee DH, 2003, CLIN CHEM, V49, P1358, DOI 10.1373/49.8.1358; Lee DH, 2006, EUR HEART J, V27, P2170, DOI 10.1093/eurheartj/ehl086; Lee TH, 2008, HEPATOLOGY, V47, P880, DOI 10.1002/hep.22090; LEMMENS P, 1992, J STUD ALCOHOL, V53, P476, DOI 10.15288/jsa.1992.53.476; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c912; Loomba R, 2009, ALIMENT PHARM THER, V30, P1137, DOI 10.1111/j.1365-2036.2009.04141.x; Mannisto S, 2014, BR J NUTR, V111, P887; McManus DD, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004060; Mu RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072916; Niemela O, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020166; Park EY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063439; Peltonen M, 2008, KANSALLINEN FINRISKI; Perreault K, 2017, BRIT J SPORT MED, V51, P651, DOI 10.1136/bjsports-2016-096194; Rehm J, 2013, J HEPATOL, V59, P160, DOI 10.1016/j.jhep.2013.03.007; Ruhl CE, 2005, CLIN GASTROENTEROL H, V3, P1260, DOI 10.1016/S1542-3565(05)00743-3; Ruhl CE, 2012, HEPATOLOGY, V55, P447, DOI 10.1002/hep.24725; Ruhl CE, 2009, GASTROENTEROLOGY, V136, P477, DOI 10.1053/j.gastro.2008.10.052; Rustad P, 2004, SCAND J CLIN LAB INV, V64, P271, DOI 10.1080/00365510410006324; Ruttmann E, 2005, CIRCULATION, V112, P2130, DOI 10.1161/CIRCULATIONAHA.105.552547; Sipila P, 2016, ADDICTION, V111, P245, DOI 10.1111/add.13152; SPEISKY H, 1990, HEPATOLOGY, V11, P843, DOI 10.1002/hep.1840110520; Stockwell T, 2016, J STUD ALCOHOL DRUGS, V77, P185, DOI 10.15288/jsad.2016.77.185; Sturgill MG, 1997, CLIN CHEM, V43, P1512; Sundberg CJ, 2016, BRIT J SPORT MED, V50, P319, DOI 10.1136/bjsports-2016-096026; Targher G, 2007, DIABETES CARE, V30, P2119, DOI 10.2337/dc07-0349; Topiwala A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2353; Tsai J, 2012, J BEHAV MED, V35, P200, DOI 10.1007/s10865-011-9353-5; TSUKAMOTO H, 1995, J CLIN INVEST, V96, P620, DOI 10.1172/JCI118077; Warburton DER, 2016, CAN J CARDIOL, V32, P495, DOI 10.1016/j.cjca.2016.01.024; Wittchen HU, 2012, SCIENCE, V338, P15, DOI 10.1126/science.1230817; Xiao Q, 2014, HEPATOLOGY, V60, P2091, DOI 10.1002/hep.27367; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zhang HQ, 2009, AM J RESP CELL MOL, V41, P509, DOI 10.1165/rcmb.2009-0169TR	70	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188574	10.1371/journal.pone.0188574	http://dx.doi.org/10.1371/journal.pone.0188574			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206836	Green Published, gold			2022-12-27	WOS:000417110700014
J	Parker, RL; O'Neill, HC; Henley, BM; Wageman, CR; Drenan, RM; Marks, MJ; Miwa, JM; Grady, SR; Lester, HA				Parker, Rell L.; O'Neill, Heidi C.; Henley, Beverley M.; Wageman, Charles R.; Drenan, Ryan M.; Marks, Michael J.; Miwa, Julie M.; Grady, Sharon R.; Lester, Henry A.			Deletion of lynx1 reduces the function of alpha 6*nicotinic receptors	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; VENTRAL TEGMENTAL AREA; DOPAMINE RELEASE; SUBUNIT STOICHIOMETRY; RNA-SEQ; EXPRESSION; MODULATION; ACTIVATION; MECHANISMS; SUBTYPES	The alpha 6 nicotinic acetylcholine receptor (nAChR) subunit is an attractive drug target for treating nicotine addiction because it is present at limited sites in the brain including the reward pathway. Lynx1 modulates several nAChR subtypes; lynx1-nAChR interaction sites could possibly provide drug targets. We found that dopaminergic cells from the substantia nigra pars compacta (SNc) express lynx1 mRNA transcripts and, as assessed by co-immunoprecipitation, alpha 6 receptors form stable complexes with lynx1 protein, although co-transfection with lynx1 did not affect nicotine-induced currents from cell lines transfected with alpha 6 and beta 2. To test whether lynx1 is important for the function of alpha 6 nAChRs in vivo, we bred transgenic mice carrying a hypersensitive mutation in the alpha 6 nAChR subunit (alpha 6L90S) with lynx1 knockout mice, providing a selective probe of the effects of lynx1 on alpha 6* nAChRs. Lynx1 removal reduced the alpha 6 component of nicotine-mediated rubidium efflux and dopamine (DA) release from synaptosomal preparations with no effect on numbers of alpha 6 beta 2 binding sites, indicating that lynx1 is functionally important for alpha 6* nAChR activity. No effects of lynx1 removal were detected on nicotine-induced currents in slices from SNc, suggesting that lynx1 affects presynaptic alpha 6* nAChR function more than somatic function. In the absence of agonist, lynx1 removal did not alter DA release in dorsal striatum as measured by fast scan cyclic voltammetry. Lynx1 removal affected some behaviors, including a novel-environment assay and nicotine-stimulated locomotion. Trends in 24-hour home-cage behavior were also suggestive of an effect of lynx1 removal. Conditioned place preference for nicotine was not affected by lynx1 removal. The results show that some functional and behavioral aspects of alpha 6nAChRs are modulated by lynx1.	[Parker, Rell L.; Henley, Beverley M.; Lester, Henry A.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [O'Neill, Heidi C.; Wageman, Charles R.; Marks, Michael J.; Grady, Sharon R.] Univ Colorado Boulder, Inst Behav Genet, Boulder, CO USA; [Drenan, Ryan M.] Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA; [Marks, Michael J.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Miwa, Julie M.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	California Institute of Technology; University of Colorado System; University of Colorado Boulder; Northwestern University; Feinberg School of Medicine; University of Colorado System; University of Colorado Boulder; Lehigh University	Parker, RL (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.		O'Neill, Heidi/AAP-8909-2021	Henley, Beverley M./0000-0002-6211-2433; Parker, Rell/0000-0002-4538-1818; Miwa, Julie/0000-0002-4418-3756	California Tobacco-Related Diseases Research Program [22DT-0008, 19KT-0032]; NIH / NIDA [DA003194, DA012242, P30-DA015663, DA017279, DA019375, DA030396, DA035942, DA033831, DA032464]	California Tobacco-Related Diseases Research Program; NIH / NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This research was supported by funds provided by California Tobacco-Related Diseases Research Program (tittp//www.trdrp.org), Grant 22DT-0008 to RLP, and 19KT-0032 to JMM. Additional support was provided by NIH / NIDA(https://www.drugabuse.gov/) grants, DA003194, DA012242, and P30-DA015663 to MJM, DA017279 to HAL, and DA019375 to HAL and MJM, DA030396 and DA035942 to RMD, and DA033831, DA032464 to JMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddick CG, 2011, BIOCHEM PHARMACOL, V82, P828, DOI 10.1016/j.bcp.2011.04.019; Bordia T, 2015, NEUROSCIENCE, V295, P187, DOI 10.1016/j.neuroscience.2015.03.040; Brunzell DH, 2012, NICOTINE TOB RES, V14, P1258, DOI 10.1093/ntr/nts089; Champtiaux N, 2003, J NEUROSCI, V23, P7820; Chen C, 2013, J NEUROCHEM, V126, P318, DOI 10.1111/jnc.12199; Cohen BN, 2012, NEUROSCIENCE, V200, P31, DOI 10.1016/j.neuroscience.2011.10.047; Drenan RM, 2008, NEURON, V60, P123, DOI 10.1016/j.neuron.2008.09.009; Drenan RM, 2008, MOL PHARMACOL, V73, P27, DOI 10.1124/mol.107.039180; Drenan RM, 2012, PHARMACOL REV, V64, P869, DOI 10.1124/pr.111.004671; Drenan RM, 2010, J NEUROSCI, V30, P9877, DOI 10.1523/JNEUROSCI.2056-10.2010; Exley R, 2008, NEUROPSYCHOPHARMACOL, V33, P2158, DOI 10.1038/sj.npp.1301617; George AA, 2017, FASEB J, V31, P1398, DOI 10.1096/fj.201600733R; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Grady SR, 2007, BIOCHEM PHARMACOL, V74, P1235, DOI 10.1016/j.bcp.2007.07.032; Grady SR, 2009, J NEUROSCI, V29, P2272, DOI 10.1523/JNEUROSCI.5121-08.2009; Henderson BJ, 2014, J GEN PHYSIOL, V143, P51, DOI 10.1085/jgp.201311102; Henley BM, 2013, BIOCHEM PHARMACOL, V86, P1074, DOI 10.1016/j.bcp.2013.07.031; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Jackson KJ, 2009, J PHARMACOL EXP THER, V331, P547, DOI 10.1124/jpet.109.155457; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Labarca C, 2001, P NATL ACAD SCI USA, V98, P2786, DOI 10.1073/pnas.041582598; Letchworth SR, 2011, BIOCHEM PHARMACOL, V82, P862, DOI 10.1016/j.bcp.2011.06.022; Lyukmanova EN, 2013, J BIOL CHEM, V288, P15888, DOI 10.1074/jbc.M112.436576; Lyukmanova EN, 2011, J BIOL CHEM, V288, P15888; Mackey EDW, 2012, J NEUROSCI, V32, P10226, DOI 10.1523/JNEUROSCI.0007-12.2012; Marks MJ, 2007, NEUROPHARMACOLOGY, V53, P390, DOI 10.1016/j.neuropharm.2007.05.021; Marks MJ, 2011, J PHARMACOL EXP THER, V337, P187, DOI 10.1124/jpet.110.178236; Matta JA, 2017, CELL REP, V19, P688, DOI 10.1016/j.celrep.2017.04.008; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Miwa JM, 2006, NEURON, V51, P587, DOI 10.1016/j.neuron.2006.07.025; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Nashmi R, 2007, J NEUROSCI, V27, P8202, DOI 10.1523/JNEUROSCI.2199-07.2007; Nichols WA, 2014, J BIOL CHEM, V289, P31423, DOI 10.1074/jbc.M114.573667; Perez XA, 2008, J NEUROCHEM, V105, P1861, DOI 10.1111/j.1471-4159.2008.05268.x; Perez XA, 2013, J NEUROCHEM, V127, P762, DOI 10.1111/jnc.12442; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Powers MS, 2013, GENES BRAIN BEHAV; Quik M, 2011, BIOCH PHARM; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Sajo M, 2016, J NEUROSCI, V36, P9472, DOI 10.1523/JNEUROSCI.0580-16.2016; Sanjakdar SS, 2015, NEUROPSYCHOPHARMACOL, V40, P350, DOI 10.1038/npp.2014.177; Shih PY, 2014, J NEUROSCI, V34, P9789, DOI 10.1523/JNEUROSCI.0476-14.2014; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Thomsen MS, 2016, NEUROBIOL AGING, V46, P13, DOI 10.1016/j.neurobiolaging.2016.06.009; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wall T, 2015, TI299423 CAL I TECHN; Watkins Simon, 2009, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1216s48; Whiteaker P, 2000, MOL PHARMACOL, V57, P913; Wu ML, 2015, J BIOL CHEM, V290, P24509, DOI 10.1074/jbc.M115.647248; Xiao C, 2011, BIOCHEM PHARMACOL, V82, P852, DOI 10.1016/j.bcp.2011.05.005	51	11	11	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188715	10.1371/journal.pone.0188715	http://dx.doi.org/10.1371/journal.pone.0188715			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206881	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000417110700017
J	Rogan, A; McCarthy, K; McGregor, G; Hamborg, T; Evans, G; Hewins, S; Aldridge, N; Fletcher, S; Krishnan, N; Higgins, R; Zehnder, D; Ting, SM				Rogan, A.; McCarthy, K.; McGregor, G.; Hamborg, T.; Evans, G.; Hewins, S.; Aldridge, N.; Fletcher, S.; Krishnan, N.; Higgins, R.; Zehnder, D.; Ting, S. M.			Quality of life measures predict cardiovascular health and physical performance in chronic renal failure patients (vol 12, e0183926, 2017)	PLOS ONE			English	Correction													McGregor, Gordon/AAP-1917-2020	McGregor, Gordon/0000-0001-8963-9107; Rogan, Alice/0000-0003-1305-0325				Rogan A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183926	1	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189382	10.1371/journal.pone.0189382	http://dx.doi.org/10.1371/journal.pone.0189382			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206877	gold, Green Submitted, Green Published			2022-12-27	WOS:000417110700053
J	Williams, E; Villar-Prados, A; Bowser, J; Broaddus, R; Gladden, AB				Williams, Erin; Villar-Prados, Alejandro; Bowser, Jessica; Broaddus, Russell; Gladden, Andrew B.			Loss of polarity alters proliferation and differentiation in low-grade endometrial cancers by disrupting Notch signaling	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITIONS; ADHERENS JUNCTIONS; ACTIVATION; ADENOCARCINOMA; ORIENTATION; EXPRESSION; CARCINOMA; SURFACE; MERLIN	Cell adhesion and apicobasal polarity together maintain epithelial tissue organization and homeostasis. Loss of adhesion has been described as a prerequisite for the epithelial to mesenchymal transition. However, what role misregulation of apicobasal polarity promotes tumor initiation and/or early progression remains unclear. We find that human low-grade endometrial cancers are associated with disrupted localization of the apical polarity protein Par3 and Ezrin while, the adhesion molecule E-cadherin remains unchanged, accompanied by decreased Notch signaling, and altered Notch receptor localization. Depletion of Par3 or Ezrin, in a cell-based model, results in loss of epithelial architecture, differentiation, increased proliferation, migration and decreased Notch signaling. Re-expression of Par3 in endometrial cancer cell lines with disrupted Par3 protein levels blocks proliferation and reduces migration in a Notch dependent manner. These data uncover a function for apicobasal polarity independent of cell adhesion in regulating Notch-mediated differentiation signals in endometrial epithelial cells.	[Williams, Erin; Villar-Prados, Alejandro; Gladden, Andrew B.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Williams, Erin; Villar-Prados, Alejandro; Broaddus, Russell; Gladden, Andrew B.] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX 77030 USA; [Bowser, Jessica] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Broaddus, Russell] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Gladden, AB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.; Gladden, AB (corresponding author), Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX 77030 USA.	agladden@mdanderson.org		Villar-Prados, Alejandro/0000-0001-6900-3267; Bowser, Jessica L./0000-0003-0655-7769; Gladden, Andrew/0000-0003-4519-5510	National Center for Research Resources [TL1RR024147]; Department of Defense-Congressionally Directed Medical Research Program [W81XWH-14-1-0053]; National Cancer Institute, Uterine Cancer SPORE [P50CA098258]; NIH/NCI [P30CA016672]; NATIONAL CANCER INSTITUTE [P50CA098258] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Defense-Congressionally Directed Medical Research Program(United States Department of Defense); National Cancer Institute, Uterine Cancer SPORE; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Center for Research Resources TL1RR024147 Jessica Bowser; Department of Defense-Congressionally Directed Medical Research Program, http://cdmrp.army.mil/default (W81XWH-14-1-0053), A.B.G.; National Cancer Institute, Uterine Cancer SPORE, https://www.cancer.gov (P50CA098258), R.B. Supported by the NIH/NCI under award number P30CA016672 and use of the Tissue Biospecimen and Pathology Resource. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar Y, 2012, FASEB J, V26, P282, DOI 10.1096/fj.11-184663; Anant S, 1998, DEVELOPMENT, V125, P1361; Bryant DM, 2014, DEV CELL, V31, P171, DOI 10.1016/j.devcel.2014.08.027; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; CHEON HK, 1969, OBSTET GYNECOL, V34, P680; Clement PB, 2002, ADV ANAT PATHOL, V9, P145, DOI 10.1097/00125480-200205000-00001; Cobellis L, 2008, J ANAT, V213, P464, DOI 10.1111/j.1469-7580.2008.00963.x; Danjo Y, 1998, J CELL SCI, V111, P3323; Daudet N, 2007, DEVELOPMENT, V134, P2369, DOI 10.1242/dev.001842; Duong LM, 2011, J WOMENS HEALTH, V20, P1157, DOI 10.1089/jwh.2010.2529; Duvic B, 2002, CURR BIOL, V12, P1923, DOI 10.1016/S0960-9822(02)01297-6; Elia N, CURR PROTOC CELL BIO, p209AD; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gladden AB, 2010, DEV CELL, V19, P727, DOI 10.1016/j.devcel.2010.10.008; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Guentchev M, 2006, EUR J NEUROSCI, V23, P2289, DOI 10.1111/j.1460-9568.2006.04766.x; Hao Y, 2010, CURR BIOL, V18, P1492; Hassounah NB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068521; Hebert AM, 2012, GENE DEV, V26, P2709, DOI 10.1101/gad.194027.112; HENDRICKSON MR, 1983, AM J SURG PATHOL, V7, P819, DOI 10.1097/00000478-198307080-00011; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Jalali A, 2011, J NEUROSCI RES, V89, P299, DOI 10.1002/jnr.22562; Jonusiene V, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0438-y; Jundt F, 2015, JAGGED1 INDUCED NOTC, V103, P3511; Kaelin WG, 2005, COLD SH Q B, V70, P159, DOI 10.1101/sqb.2005.70.001; Kaelin WG, 2007, CLIN CANCER RES, V13, p680S, DOI 10.1158/1078-0432.CCR-06-1865; Kaitu'u-Lino TJ, 2009, ENDOCRINOLOGY, V150, P1904, DOI 10.1210/en.2008-0738; Karst W M H., 1988, DIFFERENTIATION BEHA, V22, P211; Kopan R., 2012, COLD SPRING HARB PER, V4, P1; Kurman RJ, 1994, BLAUSTEINS PATHOLOGY; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Liu ZY, 2013, DEV CELL, V25, P585, DOI 10.1016/j.devcel.2013.05.022; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; MASTERTON R, 1975, J REPROD FERTIL, V42, P537; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; McConechy MK, 2012, J PATHOL, V228, P20, DOI 10.1002/path.4056; McMurray RJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03545; Mitsuhashi Y, 2012, HISTOPATHOLOGY, V60, P826, DOI 10.1111/j.1365-2559.2011.04158.x; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Novak E, 1924, J AMER MED ASSOC, V83, P900, DOI 10.1001/jama.1924.02660120016004; Okuda H, 2001, J BIOL CHEM, V276, P43611, DOI 10.1074/jbc.M107880200; Pinnix CC, 2009, CANCER RES, V69, P5312, DOI 10.1158/0008-5472.CAN-08-3767; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Qiu MT, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-78; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; Schlumbrecht MP, 2011, MODERN PATHOL, V24, P453, DOI 10.1038/modpathol.2010.211; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Silverberg SG, 2000, MODERN PATHOL, V13, P309, DOI 10.1038/modpathol.3880053; Sorosky JI, 2012, OBSTET GYNECOL, V120, P383, DOI 10.1097/AOG.0b013e3182605bf1; Tan O, 2012, FERTIL STERIL, V97, P192, DOI 10.1016/j.fertnstert.2011.10.039; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tian JQ, 1999, AM J PHYSIOL, V21, P1245; Wang Z, 2010, J CELL BIOCH, V736; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Whelan JT, 2009, J CELL BIOCHEM, V107, P992, DOI 10.1002/jcb.22199; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6; Yang CC, 2015, P NATL ACAD SCI USA, V112, P1785, DOI 10.1073/pnas.1420850112; YOCHEM J, 1988, NATURE, V335, P547, DOI 10.1038/335547a0	63	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189081	10.1371/journal.pone.0189081	http://dx.doi.org/10.1371/journal.pone.0189081			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206870	Green Published, gold, Green Submitted			2022-12-27	WOS:000417110700045
J	Jones, AR; Coleman, EL; Husni, NR; Deeney, JT; Raval, F; Steenkamp, D; Dooms, H; Nikolajczyk, BS; Corkey, BE				Jones, Albert R.; Coleman, Emily L.; Husni, Nicholas R.; Deeney, Jude T.; Raval, Forum; Steenkamp, Devin; Dooms, Hans; Nikolajczyk, Barbara S.; Corkey, Barbara E.			Type 1 diabetes alters lipid handling and metabolism in human fibroblasts and peripheral blood mononuclear cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FATTY-ACID OXIDATION; OXYGEN; CYTOKINES; TNF; SUSCEPTIBILITY; INTERLEUKIN-1; INFLAMMATION; SUPEROXIDE; INHIBITION	Triggers of the autoimmune response that leads to type 1 diabetes (T1D) remain poorly understood. A possibility is that parallel changes in both T cells and target cells provoke autoimmune attack. We previously documented greater Ca2+ transients in fibroblasts from T1D subjects than non-T1D after exposure to fatty acids (FA) and tumor necrosis factor alpha (TNF alpha). These data indicate that metabolic and signal transduction defects present in T1D can be elicited ex vivo in isolated cells. Changes that precede T1D, including inflammation, may activate atypical responses in people that are genetically predisposed to T1D. To identify such cellular differences in T1D, we quantified a panel of metabolic responses in fibroblasts and peripheral blood cells (PBMCs) from age-matched T1D and non-T1D subjects, as models for non-immune and immune cells, respectively. Fibroblasts from T1D subjects accumulated more lipid, had higher LC-CoA levels and converted more FA to CO2, with less mitochondrial proton leak in response to oleate alone or with TNF alpha, using the latter as a model of inflammation. T1D-PBMCs contained and also accumulated more lipid following FA exposure. In addition, they formed more peroxidized lipid than controls following FA exposure. We conclude that both immune and non-immune cells in T1D subjects differ from controls in terms of responses to FA and TNF alpha. Our results suggest a differential sensitivity to inflammatory insults and FA that may precede and contribute to T1D by priming both immune cells and their targets for autoimmune reactions.	[Jones, Albert R.; Husni, Nicholas R.; Deeney, Jude T.; Corkey, Barbara E.] Boston Univ, Sch Med, Evans Dept Med, Obes Res Ctr, Boston, MA 02118 USA; [Coleman, Emily L.] Yale Univ, Sch Med, New Haven, CT USA; [Raval, Forum] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Steenkamp, Devin] Boston Univ, Sch Med, Evans Dept Med, Endocrinol Sect, Boston, MA 02118 USA; [Dooms, Hans] Boston Univ, Sch Med, Evans Dept Med, Rheumatol Sect, Boston, MA 02118 USA; [Nikolajczyk, Barbara S.] Univ Kentucky, Sch Med, Dept Translat Res Diabet, Lexington, KY 40536 USA; [Nikolajczyk, Barbara S.] Univ Kentucky, Sch Med, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA	Boston University; Yale University; Boston University; Boston University; Boston University; University of Kentucky; University of Kentucky	Corkey, BE (corresponding author), Boston Univ, Sch Med, Evans Dept Med, Obes Res Ctr, Boston, MA 02118 USA.	bcorkey@bu.edu	Corkey, Barbara/E-7712-2015	Corkey, Barbara/0000-0002-5467-1630; Dooms, Hans/0000-0001-7964-0876	Zoltan Kohn Endowment; National Center for Advancing Translational Sciences, National Institutes of Health, through BU-CTSI [1UL1TR001430]; National Institute of Health [DK46200-24, DK099618-01, DK074778-09, DK056690-12, DK035914-27, R01DK108056, R01 DE025383, NIDDK P30DK057521]	Zoltan Kohn Endowment; National Center for Advancing Translational Sciences, National Institutes of Health, through BU-CTSI; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Zoltan Kohn Endowment, the National Center for Advancing Translational Sciences, National Institutes of Health, through BU-CTSI Grant Number 1UL1TR001430 and the following grants from the National Institute of Health: DK46200-24, DK099618-01, DK074778-09, DK056690-12, DK035914-27 to BEC; R01DK108056 and R01 DE025383 to BSN; and NIDDK P30DK057521 (BADERC) to HD.	Aon MA, 2010, BBA-BIOENERGETICS, V1797, P865, DOI 10.1016/j.bbabio.2010.02.016; Bartee E, 2013, CYTOKINE, V63, P237, DOI 10.1016/j.cyto.2013.04.036; Beyan H, 2010, DIABETES, V59, P1751, DOI 10.2337/db09-1433; Brunaldi K, 2010, J LIPID RES, V51, P120, DOI [10.1194/M900200-JLR200, 10.1194/jlr.M900200-JLR200]; CAMPBELL IL, 1989, J CELL BIOCHEM, V40, P57, DOI 10.1002/jcb.240400107; Caramori ML, 2012, DIABETES, V61, P739, DOI 10.2337/db11-0617; Chee J, 2011, J IMMUNOL, V187, P1702, DOI 10.4049/jimmunol.1100511; CHOSICH N, 1994, AUTOIMMUNITY, V18, P163, DOI 10.3109/08916939409007992; Coppieters K. T., 2012, COLD SPRING HARB PER, V2, P1, DOI [10.1101/cshperspect.a007682, DOI 10.1101/cshperspect.a007682]; CORKEY BE, 1988, METHOD ENZYMOL, V166, P55; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Eerligh P, 2004, GENES IMMUN, V5, P36, DOI 10.1038/sj.gene.6364036; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; FEINGOLD KR, 1992, ENDOCRINOLOGY, V130, P10, DOI 10.1210/en.130.1.10; FEINGOLD KR, 1989, ENDOCRINOLOGY, V124, P2336, DOI 10.1210/endo-124-5-2336; FEINGOLD KR, 1987, J CLIN INVEST, V80, P184, DOI 10.1172/JCI113046; Glisic S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036040; GRUNFELD C, 1988, J LIPID RES, V29, P1327; GUTTERIDGE JMC, 1979, BIOCHEM J, V184, P469, DOI 10.1042/bj1840469; Ha J, 1997, J PHARMACOL EXP THER, V281, P1457; Hartman ML, 2014, VASC MED, V19, P67, DOI 10.1177/1358863X14521315; HOEK JB, 1988, BIOCHEM J, V254, P1; Husni NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087068; Hussain MJ, 1996, DIABETOLOGIA, V39, P60; Hyoty HL, 2002, ANN MED, V34, P138, DOI 10.1080/713782135; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; MEIER B, 1989, BIOCHEM J, V263, P539, DOI 10.1042/bj2630539; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Mosaad YM, 2012, WORLD J DIABETES, V3, P149, DOI 10.4239/wjd.v3.i8.149; NACHIAPPAN V, 1994, SHOCK, V1, P123, DOI 10.1097/00024382-199402000-00007; Nemeth ZH, 2007, FASEB J, V21, P2379, DOI 10.1096/fj.07-8213com; Peltz M, 2004, SURGERY, V136, P150, DOI 10.1016/j.surg.2004.04.007; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Saadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030200; Schneider DA, 2014, DIABETOLOGIA, V57, P2009, DOI 10.1007/s00125-014-3340-7; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Tauriainen S, 2011, SEMIN IMMUNOPATHOL, V33, P45, DOI 10.1007/s00281-010-0207-y; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Weaver JR, 2012, MOL CELL ENDOCRINOL, V358, P88, DOI 10.1016/j.mce.2012.03.004; Xie XY, 2012, PHYTOMEDICINE, V20, P3, DOI 10.1016/j.phymed.2012.09.003	43	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188474	10.1371/journal.pone.0188474	http://dx.doi.org/10.1371/journal.pone.0188474			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29206239	Green Published, gold, Green Submitted			2022-12-27	WOS:000417033200007
J	Jonsdottir, J; Thorsen, R; Aprile, I; Galeri, S; Spannocchi, G; Beghi, E; Bianchi, E; Montesano, A; Ferrarin, M				Jonsdottir, Johanna; Thorsen, Rune; Aprile, Irene; Galeri, Silvia; Spannocchi, Giovanna; Beghi, Ettore; Bianchi, Elisa; Montesano, Angelo; Ferrarin, Maurizio			Arm rehabilitation in post stroke subjects: A randomized controlled trial on the efficacy of myoelectrically driven FES applied in a task-oriented approach	PLOS ONE			English	Article							FUNCTIONAL ELECTRICAL-STIMULATION; INDUCED MOVEMENT THERAPY; UPPER EXTREMITY FUNCTION; ROBOT-ASSISTED THERAPY; UPPER-LIMB RECOVERY; MOTOR RECOVERY; NEUROMUSCULAR STIMULATION; INTERRATER RELIABILITY; DYSFUNCTION; POSTSTROKE	Purpose Motor recovery of persons after stroke may be enhanced by a novel approach where residual muscle activity is facilitated by patient-controlled electrical muscle activation. Myoelectric activity from hemiparetic muscles is then used for continuous control of functional electrical stimulation (MeCFES) of same or synergic muscles to promote restoration of movements during task-oriented therapy (TOT). Use of MeCFES during TOT may help to obtain a larger functional and neurological recovery than otherwise possible. Study design Multicenter randomized controlled trial. Methods Eighty two acute and chronic stroke victims were recruited through the collaborating facilities and after signing an informed consent were randomized to receive either the experimental (MeCFES assisted TOT (M-TOT) or conventional rehabilitation care including TOT (CTOT). Both groups received 45 minutes of rehabilitation over 25 sessions. Outcomes were Action Research Arm Test (ARAT), Upper Extremity Fugl-Meyer Assessment (FMA-UE) scores and Disability of the Arm Shoulder and Hand questionnaire. Results Sixty eight subjects completed the protocol (Mean age 66.2, range 36.5 +/- 88.7, onset months 12.7, range 0.8 +/- 19.1) of which 45 were seen at follow up 5 weeks later. There were significant improvements in both groups on ARAT (median improvement: MeCFES TOT group 3.0; C-TOT group 2.0) and FMA-UE (median improvement: M-TOT 4.5; C-TOT 3.5). Considering subacute subjects (time since stroke < 6 months), there was a trend for a larger proportion of improved patients in the M-TOT group following rehabilitation (57.9%) than in the C-TOT group (33.2%) (difference in proportion improved 24.7%; 95% CI -4.0; 48.6), though the study did not meet the planned sample size. Conclusion This is the first large multicentre RCT to compare MeCFES assisted TOT with conventional care TOT for the upper extremity. No adverse events or negative outcomes were encountered, thus we conclude that MeCFES can be a safe adjunct to rehabilitation that could promote recovery of upper limb function in persons after stroke, particularly when applied in the subacute phase.	[Jonsdottir, Johanna; Thorsen, Rune; Aprile, Irene; Galeri, Silvia; Spannocchi, Giovanna; Montesano, Angelo; Ferrarin, Maurizio] IRCCS Don Gnocchi Fdn Onlus, Milan, Italy; [Beghi, Ettore; Bianchi, Elisa] IRCCS Ist Ric Farmacol Mario Negri, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Thorsen, R (corresponding author), IRCCS Don Gnocchi Fdn Onlus, Milan, Italy.	rthorsen@dongnocchi.it	Beghi, Ettore/AAA-7426-2020; Montesano, Angelo/Y-9596-2019; aprile, irene/AAC-4986-2022; Ferrarin, Maurizio/I-3230-2012; JONSDOTTIR, JOHANNA/X-9348-2019; Bianchi, Elisa/ABF-8173-2020	Beghi, Ettore/0000-0003-2542-0469; Ferrarin, Maurizio/0000-0002-7797-2399; JONSDOTTIR, JOHANNA/0000-0002-8287-4881; Bianchi, Elisa/0000-0002-0279-0128; Aprile, Irene/0000-0001-8123-9977; Thorsen, Rune/0000-0003-1990-8839	Italian region Lombardia 'Regione Lombardia, Ricerca Indipendente'; Italian Ministry of Health 'Ricerca Corrente'	Italian region Lombardia 'Regione Lombardia, Ricerca Indipendente'; Italian Ministry of Health 'Ricerca Corrente'(Ministry of Health, Italy)	This project was funded by a research grant from the Italian region Lombardia 'Regione Lombardia, Ricerca Indipendente' and the Italian Ministry of Health 'Ricerca Corrente'.	Alon G, 2007, NEUROREHAB NEURAL RE, V21, P207, DOI 10.1177/1545968306297871; Bayona Nestor A, 2005, Top Stroke Rehabil, V12, P58; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Cauraugh J, 2000, STROKE, V31, P1360, DOI 10.1161/01.STR.31.6.1360; Chae J, 1998, STROKE, V29, P975, DOI 10.1161/01.STR.29.5.975; de Kroon JR, 2005, J REHABIL MED, V37, P65, DOI 10.1080/16501970410024190; Dorsch S, 2014, CLIN REHABIL, V28, P482, DOI 10.1177/0269215513510011; DUNCAN PW, 1992, STROKE, V23, P1084, DOI 10.1161/01.STR.23.8.1084; Fugl-Meyer AR, 1975, SCAND J REHAB MED, V7; Houwink A, 2013, ARCH PHYS MED REHAB, V94, P839, DOI 10.1016/j.apmr.2012.11.031; Howlett OA, 2015, ARCH PHYS MED REHAB, V96, P934, DOI 10.1016/j.apmr.2015.01.013; Jonsdottir J, 2010, NEUROREHAB NEURAL RE, V24, P478, DOI 10.1177/1545968309355986; Kendall FP, 1983, MUSCLES TESTING FUNC; Kennedy CA., 2011, DISABILITIES ARM SHO, V3rd; Knutson JS, 2016, STROKE, V47, P2596, DOI 10.1161/STROKEAHA.116.013791; Kwakkel G, 2003, STROKE, V34, P2181, DOI 10.1161/01.STR.0000087172.16305.CD; Kwakkel G, 2008, NEUROREHAB NEURAL RE, V22, P111, DOI 10.1177/1545968307305457; Kwakkel G, 2016, NEUROREHAB NEURAL RE, V30, P804, DOI 10.1177/1545968315624784; Kwakkel G, 2015, ARCH PHYS MED REHAB, V96, P991, DOI 10.1016/j.apmr.2015.02.004; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; Nijland RHM, 2010, STROKE, V41, P745, DOI 10.1161/STROKEAHA.109.572065; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Page SJ, 2012, ARCH PHYS MED REHAB, V93, P200, DOI 10.1016/j.apmr.2011.09.016; Patel AT, 2000, ARCH PHYS MED REHAB, V81, P1357, DOI 10.1053/apmr.2000.9397; Pomeroy VM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003241.pub2; Quandt Fanny, 2014, Exp Transl Stroke Med, V6, P9, DOI 10.1186/2040-7378-6-9; Shin HK, 2008, NEUROSCI LETT, V442, P174, DOI 10.1016/j.neulet.2008.07.026; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Subramanian SK, 2010, NEUROREHAB NEURAL RE, V24, P113, DOI 10.1177/1545968309349941; Taub E, 2012, BEHAV ANALYST, V35, P155, DOI 10.1007/BF03392276; Thorsen R, 2001, IEEE T NEUR SYS REH, V9, P161, DOI 10.1109/7333.928576; Thorsen R, 2013, SCI WORLD J, DOI 10.1155/2013/836959; Thorsen R, 2013, J REHABIL RES DEV, V50, P785, DOI 10.1682/JRRD.2012.07.0123; Thorsen R, 2009, MED ENG PHYS, V31, P1032, DOI 10.1016/j.medengphy.2009.06.006; Thorsen RA, 2006, J REHABIL RES DEV, V43, P247, DOI 10.1682/JRRD.2005.04.0068; Thrasher TA, 2008, NEUROREHAB NEURAL RE, V22, P706, DOI 10.1177/1545968308317436; van der Lee JH, 2002, CLIN REHABIL, V16, P646, DOI 10.1191/0269215502cr534oa; Van der Lee JH, 2001, ARCH PHYS MED REHAB, V82, P14, DOI 10.1053/apmr.2001.18668; Van Peppen RPS, 2004, CLIN REHABIL, V18, P833, DOI 10.1191/0269215504cr843oa; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; WHO, 2001, WHO INT CLASS FUNCT; Wilson RD, 2016, NEUROREHAB NEURAL RE, V30, P978, DOI 10.1177/1545968316650278; Winstein CJ, 2016, JAMA-J AM MED ASSOC, V315, P571, DOI 10.1001/jama.2016.0276; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095	46	21	24	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188642	10.1371/journal.pone.0188642	http://dx.doi.org/10.1371/journal.pone.0188642			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO7EC	29200424	Green Submitted, Green Published, gold			2022-12-27	WOS:000417033200010
J	Laviola, G; Zoratto, F; Ingiosi, D; Carito, V; Huzard, D; Fiore, M; Macri, S				Laviola, Giovanni; Zoratto, Francesca; Ingiosi, Danilo; Carito, Valentina; Huzard, Damien; Fiore, Marco; Macri, Simone			Low empathy-like behaviour in male mice associates with impaired sociability, emotional memory, physiological stress reactivity and variations in neurobiological regulations	PLOS ONE			English	Article							CALLOUS-UNEMOTIONAL TRAITS; NEUROTROPHIC FACTOR; CONDUCT DISORDER; MORPHINE ANALGESIA; SOCIAL MODULATION; INBRED STRAINS; DEFICIENT MICE; FORMALIN TEST; MOUSE MODEL; OXYTOCIN	Deficits in empathy have been proposed to constitute a hallmark of several psychiatric disturbances like conduct disorder, antisocial and narcissistic personality disorders. Limited sensitivity to punishment, shallow or deficient affect and reduced physiological reactivity to environmental stressors have been often reported to co-occur with limited empathy and contribute to the onset of antisocial phenotypes. Empathy in its simplest form (i.e. emotional contagion) is addressed in preclinical models through the evaluation of the social transmission of emotional states: mice exposed to a painful stimulus display a higher response if in the presence of a familiar individual experiencing a higher degree of discomfort, than in isolation. In the present study, we investigated whether a reduction of emotional contagion can be considered a predictor of reduced sociality, sensitivity to punishment and physiological stress reactivity. To this aim, we first evaluated emotional contagion in a group of Balb/cJ mice and then discretised their values in four quartiles. The upper (i.e. Emotional Contagion Prone, ECP) and the lower (i.e. Emotional Contagion Resistant, ECR) quartiles constituted the experimental groups. Our results indicate that mice in the lower quartile are characterized by reduced sociability, impaired memory of negative events and dampened hypothalamic- pituitary-adrenocortical reactivity to external stressors. Furthermore, in the absence of changes in oxytocin receptor density, we show that these mice exhibit elevated concentrations of oxytocin and vasopressin and reduced density of BDNF receptors in behaviourall-relevant brain areas. Thus, not only do present results translate to the preclinical investigation of psychiatric disturbances, but also they can contribute to the study of emotional contagion in terms of its adaptive significance.	[Laviola, Giovanni; Zoratto, Francesca; Ingiosi, Danilo; Macri, Simone] ISS, Reference Ctr Behav Sci & Mental Hlth, Rome, Italy; [Carito, Valentina; Fiore, Marco] Natl Res Council Italy CNR, Inst Cell Biol & Neurobiol, Rome, Italy; [Huzard, Damien] Ecole Polytech Fed Lausanne, Lab Behav Genet, Brain Mind Inst, Lausanne, Switzerland	Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Laviola, G (corresponding author), ISS, Reference Ctr Behav Sci & Mental Hlth, Rome, Italy.	giovanni.laviola@iss.it	Zoratto, Francesca/K-6031-2016; Laviola, Giovanni/K-4392-2016; Laviola, Giovanni/AAA-2391-2022; Pippi, Pippo/B-6112-2015; Fiore, Marco/GLT-0780-2022	Zoratto, Francesca/0000-0002-3626-8928; Laviola, Giovanni/0000-0003-0388-0835; Laviola, Giovanni/0000-0003-0388-0835; fiore, marco/0000-0001-6806-9715; Macri, Simone/0000-0003-2946-4784	European Community's Seventh Framework Programme [603016, 278367]	European Community's Seventh Framework Programme	The authors of this manuscript received funding from the European Community's Seventh Framework Programme (FP7) under grant agreement no 603016 (Project MATRICS) and no 278367 (Project EMTICS). This paper reflects only the authors' views and the European Unionis not liable for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Akel A, 2014, PSYCHOL MED, V44, P3523, DOI 10.1017/S003329171400097X; Abu-Akel A, 2015, SOC NEUROSCI-UK, V10, P7, DOI 10.1080/17470919.2014.948637; ALLEVA E, 1986, PHYSIOL BEHAV, V36, P779, DOI 10.1016/0031-9384(86)90368-9; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637; Bales KL, 2004, HORM BEHAV, V45, P354, DOI 10.1016/j.yhbeh.2004.01.004; Barry CT, 2000, J ABNORM PSYCHOL, V109, P335, DOI [10.1037/0021-843X.109.2.335, 10.1037//0021-843X.109.2.335]; Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Blair RJR, 2014, NEW ENGL J MED, V371, P2207, DOI 10.1056/NEJMra1315612; Blair RJR, 2013, NAT REV NEUROSCI, V14, P786, DOI 10.1038/nrn3577; Bos PA, 2015, NEUROIMAGE, V113, P217, DOI 10.1016/j.neuroimage.2015.03.049; Bos PA, 2012, FRONT NEUROENDOCRIN, V33, P17, DOI 10.1016/j.yfrne.2011.01.002; Branchi I, 2013, PSYCHONEUROENDOCRINO, V38, P522, DOI 10.1016/j.psyneuen.2012.07.010; Branchi I, 2009, PHYSIOL BEHAV, V96, P532, DOI 10.1016/j.physbeh.2008.12.003; Brodkin ES, 2007, BEHAV BRAIN RES, V176, P53, DOI 10.1016/j.bbr.2006.06.025; Chen QL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004387; Cirulli F, 1996, PHARMACOL BIOCHEM BE, V54, P99, DOI 10.1016/0091-3057(95)02169-8; Crawley J. N., 2007, WHATS WRONG MY MOUSE; De Dreu CKW, 2012, HORM BEHAV, V61, P419, DOI 10.1016/j.yhbeh.2011.12.009; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Decety J, 2011, ANN NY ACAD SCI, V1231, P35, DOI 10.1111/j.1749-6632.2011.06027.x; Decety J, 2010, DEVELOPMENTAL SCI, V13, P886, DOI 10.1111/j.1467-7687.2009.00940.x; Diamantopoulou A, 2012, BRAIN RES, V1466, P112, DOI 10.1016/j.brainres.2012.05.016; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; Eisenbarth H, 2016, J YOUTH ADOLESCENCE, V45, P1889, DOI 10.1007/s10964-016-0520-4; Elsenberg N, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P71; Fairchild G, 2008, BIOL PSYCHIAT, V64, P599, DOI 10.1016/j.biopsych.2008.05.022; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Ferreira R, 2016, HORM BEHAV, V84, P84, DOI 10.1016/j.yhbeh.2016.05.017; FESTING MFW, 1976, NATURE, V263, P230, DOI 10.1038/263230a0; Festing MFW, 2016, METHODS MOL BIOL, V1438, P1, DOI 10.1007/978-1-4939-3661-8_1; Finger EC, 2011, AM J PSYCHIAT, V168, P152, DOI 10.1176/appi.ajp.2010.10010129; Fluttert M, 2000, LAB ANIM, V34, P372, DOI 10.1258/002367700780387714; Frick P J, 1999, Clin Child Fam Psychol Rev, V2, P149; Frick PJ, 2014, PSYCHOL BULL, V140, P1, DOI 10.1037/a0033076; GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347; Gioiosa L, 2008, HORM BEHAV, V53, P124, DOI 10.1016/j.yhbeh.2007.09.003; Gioiosa L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004143; Gonzalez-Liencres C, 2014, BEHAV BRAIN RES, V263, P16, DOI 10.1016/j.bbr.2014.01.020; Gonzalez-Liencres C, 2013, NEUROSCI BIOBEHAV R, V37, P1537, DOI 10.1016/j.neubiorev.2013.05.001; Goubert L, 2005, PAIN, V118, P285, DOI 10.1016/j.pain.2005.10.025; Hagewoud R, 2011, J SLEEP RES, V20, P259, DOI 10.1111/j.1365-2869.2010.00895.x; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Keum S, 2016, GENES BRAIN BEHAV, V15, P231, DOI 10.1111/gbb.12278; Kirsch P, 2015, DIALOGUES CLIN NEURO, V17, P463; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Lariviere WR, 2002, PAIN, V97, P75, DOI 10.1016/S0304-3959(01)00492-4; Lipps T, 1903, ARCH GESAMTE PSYCHOL, V1, P185; Loney BR, 2003, J CLIN CHILD ADOLESC, V32, P66, DOI 10.1207/15374420360533077; LORENZ K., 1935, Journal fur Ornithologie, V83, P137, DOI 10.1007/BF01905355; Lutz PE, 2013, CURR OPIN NEUROBIOL, V23, P473, DOI 10.1016/j.conb.2013.02.005; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Macri S, 2017, NEUROSCIENCE BIOBEHA; Macri S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13257; Malki K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1431-6; Marco EM, 2012, J PSYCHOPHARMACOL, V26, P150, DOI 10.1177/0269881111408459; Maroun M, 2016, BIOL PSYCHIAT, V79, P203, DOI 10.1016/j.biopsych.2015.07.016; Martin LJ, 2015, CURR BIOL, V25, P326, DOI 10.1016/j.cub.2014.11.028; McDonald N.M., 2011, FREE WILL EMOTIONS M; Meyza KZ, 2017, NEUROSCI BIOBEHAV R, V76, P216, DOI 10.1016/j.neubiorev.2016.10.028; MILLER PA, 1988, PSYCHOL BULL, V103, P324, DOI 10.1037/0033-2909.103.3.324; Moffitt T E, 1994, Prog Exp Pers Psychopathol Res, P233; Mogil JS, 2015, PAIN, V156, pS35, DOI 10.1097/01.j.pain.0000460341.62094.77; Mogil JS, 2012, TRENDS COGN SCI, V16, P143, DOI 10.1016/j.tics.2011.12.012; Mogil JS, 1999, PAIN, V80, P83, DOI 10.1016/S0304-3959(98)00196-1; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Morley-Fletcher S, 2003, PSYCHONEUROENDOCRINO, V28, P386, DOI 10.1016/S0306-4530(02)00030-6; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Nelson KB, 2001, ANN NEUROL, V49, P597, DOI 10.1002/ana.1024.abs; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; Nistico R, 2012, NEUROMOL MED, V14, P262, DOI 10.1007/s12017-012-8184-z; OFFORD DR, 1994, J AM ACAD CHILD PSY, V33, P1069, DOI 10.1097/00004583-199410000-00001; Oosterlaan J, 2005, PSYCHIAT RES, V134, P1, DOI 10.1016/j.psychres.2004.12.005; Palanza P, 2001, PHYSIOL BEHAV, V72, P255, DOI 10.1016/S0031-9384(00)00406-6; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Panksepp J, 2013, TRENDS NEUROSCI, V36, P489, DOI 10.1016/j.tins.2013.04.009; Panksepp J, 2009, BIOL PSYCHIAT, V65, P725, DOI 10.1016/j.biopsych.2009.02.004; Panksepp JB, 2011, NEUROSCI BIOBEHAV R, V35, P1864, DOI 10.1016/j.neubiorev.2011.05.013; Papaleo F, 2008, J NEUROSCI, V28, P8709, DOI 10.1523/JNEUROSCI.2077-08.2008; Peaston AE, 2006, MAMM GENOME, V17, P365, DOI 10.1007/s00335-005-0180-2; PIAZZA PV, 1991, P NATL ACAD SCI USA, V88, P2088, DOI 10.1073/pnas.88.6.2088; PIAZZA PV, 1993, P NATL ACAD SCI USA, V90, P11738, DOI 10.1073/pnas.90.24.11738; PIERETTI S, 1991, GEN PHARMACOL, V22, P929, DOI 10.1016/0306-3623(91)90232-U; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Resendez SL, 2013, REV NEUROSCIENCE, V24, P51, DOI 10.1515/revneuro-2012-0068; Rosas-Vidal LE, 2014, NEUROPSYCHOPHARMACOL, V39, P2161, DOI 10.1038/npp.2014.64; ROSLAND JH, 1990, PAIN, V42, P235, DOI 10.1016/0304-3959(90)91167-H; Scattoni ML, 2013, BEHAV BRAIN RES, V251, P35, DOI 10.1016/j.bbr.2012.12.028; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sivaselvachandran S, 2018, NEUROSCI BIOBEHAV R, V91, P130, DOI 10.1016/j.neubiorev.2016.06.007; Smith A, 2006, PSYCHOL REC, V56, P3, DOI 10.1007/BF03395534; Smith ML, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600855; Sprenger T, 2006, PAIN, V122, P63, DOI 10.1016/j.pain.2006.01.003; Stadler C, 2011, PSYCHIAT RES, V187, P204, DOI 10.1016/j.psychres.2010.05.004; Sufka KJ, 1998, EUR J PAIN-LONDON, V2, P351, DOI 10.1016/S1090-3801(98)90033-7; Takahashi M, 2000, MOL PSYCHIATR, V5, P293, DOI 10.1038/sj.mp.4000718; Terranova ML, 2001, PHYSIOL BEHAV, V73, P393, DOI 10.1016/S0031-9384(01)00447-4; Theodoridou A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00197; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Valverde O, 2012, NEUROSCIENCE, V204, P193, DOI 10.1016/j.neuroscience.2011.09.031; van Goozen SHM, 2000, J AM ACAD CHILD PSY, V39, P1438, DOI 10.1097/00004583-200011000-00019; Van Loo PLP, 2001, PHYSIOL BEHAV, V72, P675, DOI 10.1016/S0031-9384(01)00425-5; VANYUKOV MM, 1993, PSYCHIAT RES, V46, P9, DOI 10.1016/0165-1781(93)90003-Y; Velez L, 2010, BEHAV GENET, V40, P201, DOI 10.1007/s10519-009-9325-5; von Polier GG, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/349530; Wager TD, 2007, P NATL ACAD SCI USA, V104, P11056, DOI 10.1073/pnas.0702413104; Watanabe S., 2011, PLOS ONE, V6, DOI 10.1371/journal,pone.0023357; Watt D., 2000, CONSCIOUSNESS EMOTIO, V1, P91, DOI DOI 10.1075/CE.1.1.06WAT; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116; ZAHNWAXLER C, 1995, DEV PSYCHOPATHOL, V7, P27, DOI 10.1017/S0954579400006325; Zoratto F, 2011, PROG NEURO-PSYCHOPH, V35, P1479, DOI 10.1016/j.pnpbp.2011.02.016	115	29	29	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188907	10.1371/journal.pone.0188907	http://dx.doi.org/10.1371/journal.pone.0188907			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29200428	Green Published, Green Submitted, gold			2022-12-27	WOS:000417033200022
J	Lozano-Velasco, E; Wangensteen, R; Quesada, A; Garcia-Padilla, C; Osorio, JA; Ruiz-Torres, MD; Aranega, A; Franco, D				Lozano-Velasco, Estefania; Wangensteen, Rosemary; Quesada, Andres; Garcia-Padilla, Carlos; Osorio, Julia A.; Dolores Ruiz-Torres, Maria; Aranega, Amelia; Franco, Diego			Hyperthyroidism, but not hypertension, impairs PITX2 expression leading to Wnt-microRNA-ion channel remodeling	PLOS ONE			English	Article							FAMILIAL ATRIAL-FIBRILLATION; OF-FUNCTION MUTATION; THYROID-HORMONE; REDOX REGULATION; ARTERIAL-HYPERTENSION; ACUTE EXPOSURE; RISK; MECHANISMS; HEART; GENE	PITX2 is a homeobox transcription factor involved in embryonic left/right signaling and more recently has been associated to cardiac arrhythmias. Genome wide association studies have pinpointed PITX2 as a major player underlying atrial fibrillation (AF). We have previously described that PITX2 expression is impaired in AF patients. Furthermore, distinct studies demonstrate that Pitx2 insufficiency leads to complex gene regulatory network remodeling, i.e. Wnt>microRNAs, leading to ion channel impairment and thus to arrhythmogenic events in mice. Whereas large body of evidences has been provided in recent years on PITX2 downstream signaling pathways, scarce information is available on upstream pathways influencing PITX2 in the context of AF. Multiple risk factors are associated to the onset of AF, such as e.g. hypertension (HTN), hyperthyroidism (HTD) and redox homeostasis impairment. In this study we have analyzed whether HTN, HTD and/or redox homeostasis impact on PITX2 and its downstream signaling pathways. Using rat models for spontaneous HTN (SHR) and experimentally-induced HTD we have observed that both cardiovascular risk factors lead to severe Pitx2 downregulation. Interesting HTD, but not SHR, leads to upregulation of Wnt signaling as well as deregulation of multiple microRNAs and ion channels as previously described in Pitx2 insufficiency models. In addition, redox signaling is impaired in HTD but not SHR, in line with similar findings in atrial-specific Pitx2 deficient mice. In vitro cell culture analyses using gain- and loss-of-function strategies demonstrate that Pitx2, Zfhx3 and Wnt signaling influence redox homeostasis in cardiomyocytes. Thus, redox homeostasis seems to play a pivotal role in this setting, providing a regulatory feedback loop. Overall these data demonstrate that HTD, but not HTN, can impair Pitx2>>Wnt pathway providing thus a molecular link to AF.	[Lozano-Velasco, Estefania; Garcia-Padilla, Carlos; Osorio, Julia A.; Dolores Ruiz-Torres, Maria; Aranega, Amelia; Franco, Diego] Univ Jaen, Dept Expt Biol, Cardiac & Skeletal Muscle Dev Grp, Jaen, Spain; [Wangensteen, Rosemary; Quesada, Andres] Univ Jaen, Dept Hlth Sci, Jaen, Spain	Universidad de Jaen; Universidad de Jaen	Franco, D (corresponding author), Univ Jaen, Dept Expt Biol, Cardiac & Skeletal Muscle Dev Grp, Jaen, Spain.	dfranco@ujaen.es	Velasco, Estefanía Lozano/B-2209-2017; Aranega, Amelia/AAA-8908-2019	Velasco, Estefanía Lozano/0000-0002-5615-2754; Aranega, Amelia/0000-0002-0046-9410; Garcia-Padilla, Carlos/0000-0003-2061-3157; Franco, Diego/0000-0002-5669-7164	Ministerio de Economia y Competitividad, Gobierno de Espana [BFU2012-38111, BFU2015-67131]; Junta de Andalucia Regional Council [CTS -1614]; Carlos III Health Institute of Spain "Feder una manera de hacer Europa" [P13/02384]	Ministerio de Economia y Competitividad, Gobierno de Espana; Junta de Andalucia Regional Council(Junta de Andalucia); Carlos III Health Institute of Spain "Feder una manera de hacer Europa"	This study was partially supported by grants BFU2012-38111, BFU2015-67131 (Ministerio de Economia y Competitividad, Gobierno de Espana), and CTS -1614 (Junta de Andalucia Regional Council) to DF and AA. This study was supported by the grant P13/02384 from Carlos III Health Institute of Spain "Feder una manera de hacer Europa" to RW. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal NT, 2013, ANTIOXID REDOX SIGN, V18, P432, DOI 10.1089/ars.2011.4234; Aguirre LA, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0138-0; Anderson EJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000713; Anumonwo JMB, 2014, CARDIOL CLIN, V32, P485, DOI 10.1016/j.ccl.2014.07.007; ARAI M, 1991, CIRC RES, V69, P266, DOI 10.1161/01.RES.69.2.266; Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Berenfeld O, 2014, CARDIOL CLIN, V32, P495, DOI 10.1016/j.ccl.2014.07.001; Biondi B, 2010, NAT REV ENDOCRINOL, V6, P431, DOI 10.1038/nrendo.2010.105; Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; Chen WJ, 2011, BASIC RES CARDIOL, V106, P163, DOI 10.1007/s00395-010-0149-5; Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008; Chinchilla A, 2011, CIRC-CARDIOVASC GENE, V4, P269, DOI 10.1161/CIRCGENETICS.110.958116; Daimi H, 2015, HEART RHYTHM, V12, P1333, DOI 10.1016/j.hrthm.2015.02.018; de Lange FJ, 2003, GENESIS, V37, P1, DOI 10.1002/gene.10220; DUDLEY SC, 1993, CIRC RES, V73, P301, DOI 10.1161/01.RES.73.2.301; Dzeshka MS, 2015, J AM COLL CARDIOL, V66, P943, DOI 10.1016/j.jacc.2015.06.1313; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Emdin CA, 2015, EUROPACE, V17, P701, DOI 10.1093/europace/euv021; Franco D, 2011, CARDIOVASC RES, V91, P223, DOI 10.1093/cvr/cvr078; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Goudis CA, 2015, J CARDIOL; Grais IM, 2014, AM J MED, V127, P691, DOI 10.1016/j.amjmed.2014.03.009; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Hakim FA, 2014, FUTUR CARDIOL, V10, P745, DOI [10.2217/FCA.14.32, 10.2217/fca.14.32]; Jalife J, 2015, TRENDS CARDIOVAS MED, V25, P475, DOI 10.1016/j.tcm.2014.12.015; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Jiang M, 2000, AM J PHYSIOL-HEART C, V278, pH1429, DOI 10.1152/ajpheart.2000.278.5.H1429; Joseph BK, 2013, PHARMACOL RES, V70, P126, DOI 10.1016/j.phrs.2013.01.008; Kirchhof P, 2011, CIRC-CARDIOVASC GENE, V4, P123, DOI 10.1161/CIRCGENETICS.110.958058; Kohler AC, 2014, J MOL CELL CARDIOL, V73, P92, DOI 10.1016/j.yjmcc.2014.03.001; Kreuzberg U, 2000, AM J PHYSIOL-HEART C, V278, pH723, DOI 10.1152/ajpheart.2000.278.3.H723; Kumar Kartik R, 2015, Card Electrophysiol Clin, V7, P173, DOI 10.1016/j.ccep.2015.03.002; L'honore A, 2014, DEV CELL, V29, P392, DOI 10.1016/j.devcel.2014.04.006; Laumanns IP, 2009, AM J RESP CELL MOL, V40, P683, DOI 10.1165/rcmb.2008-0153OC; Li YD, 2015, MOL MED REP, V12, P3243, DOI 10.3892/mmr.2015.3831; Liao CX, 2016, MOL BIOSYST, V12, P328, DOI 10.1039/c5mb00806a; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozano-Velasco E, 2016, CARDIOVASC RES, V109, P55, DOI 10.1093/cvr/cvv207; Lozano-Velasco E, 2011, CELLS TISSUES ORGANS, V194, P349, DOI 10.1159/000323533; Luo XB, 2013, J CLIN INVEST, V123, P1939, DOI 10.1172/JCI62185; MAGER S, 1992, PFLUG ARCH EUR J PHY, V421, P425, DOI 10.1007/BF00370252; Martinez-Gonzalez MA, 2014, CIRCULATION, V130, P18, DOI 10.1161/CIRCULATIONAHA.113.006921; Montaigne D, 2013, J AM COLL CARDIOL, V62, P1466, DOI 10.1016/j.jacc.2013.03.061; Okamoto K., 1963, JAP CIRC J, V27, P282; Philippen LE, 2015, J MOL CELL CARDIOL, V89, P51, DOI 10.1016/j.yjmcc.2015.03.014; Reilly SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac4296; Rodriguez-Gomez I, 2013, J ENDOCRINOL, V216, P43, DOI 10.1530/JOE-12-0208; Schnabel RB, 2011, CIRC-CARDIOVASC GENE, V4, P557, DOI 10.1161/CIRCGENETICS.110.959197; Scridon A, 2015, EUROPACE, V17, P160, DOI 10.1093/europace/euu139; Shan HL, 2013, INT J CARDIOL, V167, P2798, DOI 10.1016/j.ijcard.2012.07.009; Shimoni Y, 1997, J PHYSIOL-LONDON, V500, P65, DOI 10.1113/jphysiol.1997.sp021999; Tao G, 2016, NATURE, V534, P119, DOI 10.1038/nature17959; Tao Y, 2014, CIRC-CARDIOVASC GENE, V7, P23, DOI 10.1161/CIRCGENETICS.113.000259; Terentyev D, 2009, CIRC RES, V104, P514, DOI 10.1161/CIRCRESAHA.108.181651; Violi F, 2014, EUROPACE, V16, P1107, DOI 10.1093/europace/euu040; Wagner S, 2013, ANTIOXID REDOX SIGN, V18, P1063, DOI 10.1089/ars.2012.4818; Wang J, 2014, P NATL ACAD SCI USA, V111, P9181, DOI 10.1073/pnas.1405411111; Wang YG, 2003, J PHYSIOL-LONDON, V546, P491, DOI 10.1113/jphysiol.2002.032847; Wolke C, 2015, BBA-GEN SUBJECTS, V1850, P1555, DOI 10.1016/j.bbagen.2014.12.012; Xia M, 2005, BIOCHEM BIOPH RES CO, V332, P1012, DOI 10.1016/j.bbrc.2005.05.054; Yadava M, 2014, CARDIOL CLIN, V32, P627, DOI 10.1016/j.ccl.2014.07.002; Yang YQ, 2004, AM J HUM GENET, V75, P899, DOI 10.1086/425342; Youn JY, 2013, J MOL CELL CARDIOL, V62, P72, DOI 10.1016/j.yjmcc.2013.04.019; Zhang QT, 2014, CARDIOVASC THER, V32, P233, DOI 10.1111/1755-5922.12089; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019	66	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0188473	10.1371/journal.pone.0188473	http://dx.doi.org/10.1371/journal.pone.0188473			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194452	gold, Green Submitted, Green Published			2022-12-27	WOS:000416867800011
J	Carnesecchi, J; Cerutti, C; Vanacker, JM; Forcet, C				Carnesecchi, Julie; Cerutti, Catherine; Vanacker, Jean-Marc; Forcet, Christelle			ERR alpha protein is stabilized by LSD1 in a demethylation-independent manner	PLOS ONE			English	Article							ESTROGEN-RELATED-RECEPTOR; CANCER-CELL-MIGRATION; BREAST-CANCER; PROSTATE-CANCER; GENE-EXPRESSION; IN-VIVO; TARGET; PROLIFERATION; METHYLATION; BIOMARKERS	The LSD1 histone demethylase is highly expressed in breast tumors where it constitutes a factor of poor prognosis and promotes traits of cancer aggressiveness such as cell invasiveness. Recent work has shown that the Estrogen-Related Receptor a (ERR alpha) induces LSD1 to demethylate the Lys 9 of histone H3. This results in the transcriptional activation of a number of common target genes, several of which being involved in cellular invasion. High expression of ERR alpha protein is also a factor of poor prognosis in breast tumors. Here we show that, independently of its demethylase activities, LSD1 protects ERR alpha from ubiquitination, resulting in overexpression of the latter protein. Our data also suggests that the elevation of LSD1 mRNA and protein in breast cancer (as compared to normal tissue) may be a key event to increase ERRa protein, independently of its corresponding mRNA.	[Carnesecchi, Julie; Cerutti, Catherine; Vanacker, Jean-Marc; Forcet, Christelle] Univ Lyon 1, Inst Genom Fonct Lyon, CNRS UMR5242, Ecole Normale Super Lyon, Lyon, France; [Carnesecchi, Julie] Heidelberg Univ, COS Heidelberg, Dept Dev Biol, Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Ruprecht Karls University Heidelberg	Forcet, C (corresponding author), Univ Lyon 1, Inst Genom Fonct Lyon, CNRS UMR5242, Ecole Normale Super Lyon, Lyon, France.	christelle.forcet@ens-lyon.fr		Cerutti, Catherine/0000-0002-7396-9387; Carnesecchi, Julie/0000-0002-3872-2215	Ligue contre le Cancer (comite Rhone)	Ligue contre le Cancer (comite Rhone)	This work was funded by Ligue contre le Cancer (comite Rhone). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariazi EA, 2002, CANCER RES, V62, P6510; Barry JB, 2005, CANCER RES, V65, P6120, DOI 10.1158/0008-5472.CAN-05-0922; Bianco S, 2012, J STEROID BIOCHEM, V130, P180, DOI 10.1016/j.jsbmb.2011.03.014; Cai CM, 2014, CELL REP, V9, P1618, DOI 10.1016/j.celrep.2014.11.008; Cai Q, 2013, ONCOGENE, V32, P2079, DOI 10.1038/onc.2012.221; Carnesecchi J, 2017, P NATL ACAD SCI US; Cavallini A, 2005, EUR J CANCER, V41, P1487, DOI 10.1016/j.ejca.2005.04.008; Chang CY, 2011, CANCER CELL, V20, P500, DOI 10.1016/j.ccr.2011.08.023; Cho HS, 2011, CANCER RES, V71, P655, DOI 10.1158/0008-5472.CAN-10-2446; Deblois G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12156; Derr RS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-604; Dwyer MA, 2010, CANCER RES, V70, P9298, DOI 10.1158/0008-5472.CAN-10-0226; Fujimoto J, 2009, J STEROID BIOCHEM, V116, P71, DOI 10.1016/j.jsbmb.2009.04.012; Fujimura T, 2007, INT J CANCER, V120, P2325, DOI 10.1002/ijc.22363; Han L, 2016, TUMOR BIOL, V37, P13205, DOI 10.1007/s13277-016-5200-1; Hino S, 2016, CANCER SCI, V107, P1187, DOI 10.1111/cas.13004; Horard B, 2003, J MOL ENDOCRINOL, V31, P349, DOI 10.1677/jme.0.0310349; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Kallen J, 2007, J BIOL CHEM, V282, P23231, DOI 10.1074/jbc.M703337200; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Kroiss A, 2015, ONCOGENE, V34, P2846, DOI 10.1038/onc.2014.222; Laganiere J, 2004, J BIOL CHEM, V279, P18504, DOI 10.1074/jbc.M313543200; Lanvin O, 2007, J BIOL CHEM, V282, P28328, DOI 10.1074/jbc.M704295200; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Maiques-Diaz A, 2016, EPIGENOMICS-UK, V8, P1103, DOI 10.2217/epi-2016-0009; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Nagasawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118002; Nair SS, 2010, EMBO REP, V11, P438, DOI 10.1038/embor.2010.62; Sailland J, 2014, P NATL ACAD SCI USA, V111, P15108, DOI 10.1073/pnas.1402094111; Serce N, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-13; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sun PM, 2005, J MOL MED, V83, P457, DOI 10.1007/s00109-005-0639-3; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Tam IS, 2016, J STEROID BIOCHEM, V157, P13, DOI 10.1016/j.jsbmb.2015.06.009; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Tiwari A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17621; Tribollet V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156445; Vanacker JM, 1999, MOL ENDOCRINOL, V13, P764, DOI 10.1210/me.13.5.764; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Zhao YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039102; Zou C, 2014, J PATHOL, V233, P61, DOI 10.1002/path.4329	44	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188871	10.1371/journal.pone.0188871	http://dx.doi.org/10.1371/journal.pone.0188871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190800	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900151
J	Chatterjee, PK; Yeboah, MM; Solanki, MH; Kumar, G; Xue, XY; Pavlov, VA; Al-Abed, Y; Metz, CN				Chatterjee, Prodyot K.; Yeboah, Michael M.; Solanki, Malvika H.; Kumar, Gopal; Xue, Xiangying; Pavlov, Valentin A.; Al-Abed, Yousef; Metz, Christine N.			Activation of the cholinergic anti-inflammatory pathway by GTS-21 attenuates cisplatin-induced acute kidney injury in mice	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; VAGUS NERVE-STIMULATION; INHIBITS CYTOKINE PRODUCTION; MITOCHONDRIAL DYSFUNCTION; CELL-DEATH; IN-VITRO; ACETYLCHOLINE; RECEPTORS; APOPTOSIS; NEPHROTOXICITY	Acute kidney injury (AKI) is the most common side effect of cisplatin, a widely used chemotherapy drug. Although AKI occurs in up to one third of cancer patients receiving cisplatin, effective renal protective strategies are lacking. Cisplatin targets renal proximal tubular epithelial cells leading to inflammation, reactive oxygen species, tubular cell injury, and eventually cell death. The cholinergic anti-inflammatory pathway is a vagus nerve-mediated reflex that suppresses inflammation via alpha 7 nicotinic acetylcholine receptors (alpha 7nAChRs). Our previous studies demonstrated the renoprotective and anti-inflammatory effects of cholinergic agonists, including GTS-21. Therefore, we examined the effect of GTS-21 on cisplatin-induced AKI. Male C57BL/6 mice received either saline or GTS-21 (4mg/kg, i.p.) twice daily for 4 days before cisplatin and treatment continued through euthanasia; 3 days post-cisplatin mice were euthanized and analyzed for markers of renal injury. GTS-21 significantly reduced cisplatin-induced renal dysfunction and injury (p< 0.05). GTS-21 significantly attenuated renal Ptgs2/COX-2 mRNA and IL-6, IL-1 beta, and CXCL1 protein expression, as well as neutrophil infiltration after cisplatin. GTS-21 blunted cisplatin-induced renal ERK1/2 activation, as well as renal ATP depletion and apoptosis (p< 0.05). GTS-21 suppressed the expression of CTR1, a cisplatin influx transporter and enhanced the expression of cisplatin efflux transporters MRP2, MRP4, and MRP6 (p< 0.05). Using breast, colon, and lung cancer cell lines we showed that GTS-21 did not inhibit cisplatin's tumor cell killing activity. GTS-21 protects against cisplatin-AKI by attenuating renal inflammation, ATP depletion and apoptosis, as well as by decreasing renal cisplatin influx and increasing efflux, without impairing cisplatin-mediated tumor cell killing. Our results support further exploring the cholinergic anti-inflammatory pathway for preventing cisplatin-induced AKI.	[Chatterjee, Prodyot K.; Xue, Xiangying; Pavlov, Valentin A.; Metz, Christine N.] Northwell Hlth, Feinstein Inst Med Res, Ctr Biomed Sci, Manhasset, NY 11030 USA; [Yeboah, Michael M.] Med Coll Wisconsin, Dept Med, Div Nephrol, Milwaukee, WI 53226 USA; [Solanki, Malvika H.; Kumar, Gopal; Pavlov, Valentin A.; Al-Abed, Yousef; Metz, Christine N.] Northwell Hlth, Elmezzi Grad Sch Mol Med, Manhasset, NY 11030 USA; [Solanki, Malvika H.] Med Coll Wisconsin, Dept Pathol & Lab Med, Milwaukee, WI 53226 USA; [Pavlov, Valentin A.; Al-Abed, Yousef; Metz, Christine N.] Donald & Barbara Zucker Sch Med Hofstra Northwell, Hempstead, NY 11549 USA; [Al-Abed, Yousef] Northwell Hlth, Feinstein Inst Med Res, Ctr Mol Innovat, Manhasset, NY USA	Northwell Health; Medical College of Wisconsin; Northwell Health; Medical College of Wisconsin; Northwell Health	Metz, CN (corresponding author), Northwell Hlth, Feinstein Inst Med Res, Ctr Biomed Sci, Manhasset, NY 11030 USA.; Metz, CN (corresponding author), Northwell Hlth, Elmezzi Grad Sch Mol Med, Manhasset, NY 11030 USA.; Metz, CN (corresponding author), Donald & Barbara Zucker Sch Med Hofstra Northwell, Hempstead, NY 11549 USA.	cmetz@northwell.edu		Pavlov, Valentin/0000-0002-1994-2853; Christine, Metz/0000-0002-1013-1691	Feinstein Institute for Medical Research; Elmezzi Graduate School of Molecular Medicine at Northwell Health	Feinstein Institute for Medical Research; Elmezzi Graduate School of Molecular Medicine at Northwell Health	This work was supported, in part, by the Feinstein Institute for Medical Research to CNM and the Elmezzi Graduate School of Molecular Medicine at Northwell Health. In addition, Mr. Chander Iyer sponsored the Advancing Women in Science and Medicine (AWSM) Scientific Achievement Award (to CNM). Role of sponsors/funders had no role in study design, data colection and analysis, decision to publish, or preparation of the manuscript.	Akcay A, 2011, J AM SOC NEPHROL, V22, P2057, DOI 10.1681/ASN.2010091011; Al-Sharea A, 2017, ATHEROSCLEROSIS, V265, P47, DOI 10.1016/j.atherosclerosis.2017.08.010; Aleksunes LM, 2008, TOXICOLOGY, V250, P82, DOI 10.1016/j.tox.2008.06.009; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Bonaz B, 2016, NEUROGASTROENT MOTIL, V28, P948, DOI 10.1111/nmo.12792; Briggs CA, 1997, PHARMACOL BIOCHEM BE, V57, P231, DOI 10.1016/S0091-3057(96)00354-1; Chatterjee PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035361; Chatterjee PK, 2009, AM J PHYSIOL-CELL PH, V297, pC1294, DOI 10.1152/ajpcell.00160.2009; Chavan SS, 2017, J IMMUNOL, V198, P3389, DOI 10.4049/jimmunol.1601613; Choi YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135083; Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113; Criado M, 2016, FUTURE MED CHEM, V8, P731, DOI 10.4155/fmc-2015-0001; Cui N, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/912726; Dowling O, 2007, MOL MED, V13, P576, DOI 10.2119/2007-00067.Dowling; Eguchi Y, 1997, CANCER RES, V57, P1835; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Faubel S, 2007, J PHARMACOL EXP THER, V322, P8, DOI 10.1124/jpet.107.119792; Fernandez-Rojas B, 2015, MOL CELL BIOCHEM, V406, P183, DOI 10.1007/s11010-015-2436-9; Gergalova G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031361; Gigliotti JC, 2013, J AM SOC NEPHROL, V24, P1451, DOI 10.1681/ASN.2013010084; Guzman-Mejia F, 2017, J NEUROIMMUNE PHARM; Han KQ, 2015, INT J ONCOL, V47, P2131, DOI 10.3892/ijo.2015.3203; Han ZY, 2014, J NEUROCHEM, V131, P498, DOI 10.1111/jnc.12817; Hanada K, 2000, J PHARM PHARMACOL, V52, P1345, DOI 10.1211/0022357001777496; Hanna NH, 2014, NEW ENGL J MED, V371, P2005, DOI 10.1056/NEJMra1407550; Honma S, 2013, EUR J PHARMACOL, V715, P181, DOI 10.1016/j.ejphar.2013.05.023; Howell SB, 2010, MOL PHARMACOL, V77, P887, DOI 10.1124/mol.109.063172; Inoue T, 2016, J CLIN INVEST, V126, P1939, DOI 10.1172/JCI83658; Jiang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102342; Jo SK, 2005, KIDNEY INT, V67, P458, DOI 10.1111/j.1523-1755.2005.67102.x; JOHNSSON A, 1995, CANCER CHEMOTH PHARM, V37, P23; JUNG KY, 1989, TOXICOL APPL PHARM, V100, P369, DOI 10.1016/0041-008X(89)90285-8; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kitagawa H, 2003, NEUROPSYCHOPHARMACOL, V28, P542, DOI 10.1038/sj.npp.1300028; Koopman FA, 2016, P NATL ACAD SCI USA, V113, P8284, DOI 10.1073/pnas.1605635113; Lai NY, 2017, J INTERN MED; Li DJ, 2014, CELL PHYSIOL BIOCHEM, V33, P468, DOI 10.1159/000358627; Linkermann A, 2014, J AM SOC NEPHROL, V25, P2689, DOI 10.1681/ASN.2014030262; Liu N, 2012, J AM SOC NEPHROL, V23, P854, DOI 10.1681/ASN.2011050493; Liu Y, 2015, CELL PHYSIOL BIOCHEM, V35, P627, DOI 10.1159/000369724; Loram LC, 2012, J PAIN, V13, P1162, DOI 10.1016/j.jpain.2012.08.009; Lu B, 2014, MOL MED, V20, P350, DOI 10.2119/molmed.2013.00117; Lykhmus O, 2014, INT J BIOCHEM CELL B, V53, P246, DOI 10.1016/j.biocel.2014.05.030; Meyer EM, 1997, BRAIN RES, V768, P49, DOI 10.1016/S0006-8993(97)00536-2; MILLARD RE, 1979, J CLIN PATHOL, V32, P1045, DOI 10.1136/jcp.32.10.1045; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Nowak G, 2002, J BIOL CHEM, V277, P43377, DOI 10.1074/jbc.M206373200; Nowak G, 2006, AM J PHYSIOL-RENAL, V291, pF840, DOI 10.1152/ajprenal.00219.2005; Ozkok A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/967826; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Pabla N, 2009, AM J PHYSIOL-RENAL, V296, pF505, DOI 10.1152/ajprenal.90545.2008; Parada E, 2010, FREE RADICAL BIO MED, V49, P1815, DOI 10.1016/j.freeradbiomed.2010.09.017; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; Pavlov VA, 2017, NAT NEUROSCI, V20, P156, DOI 10.1038/nn.4477; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Rosas-Ballina M, 2009, MOL MED, V15, P195, DOI 10.2119/molmed.2009.00039; Sadis C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000469; Sanchez-Gonzalez PD, 2011, CRIT REV TOXICOL, V41, P803, DOI 10.3109/10408444.2011.602662; Shord SS, 2006, ANTI-CANCER DRUG, V17, P207, DOI 10.1097/00001813-200602000-00013; Sodani K, 2012, CHIN J CANCER, V31, P58, DOI 10.5732/cjc.011.10329; Solanki MH, 2014, AM J PHYSIOL-RENAL, V307, pF369, DOI 10.1152/ajprenal.00127.2014; Sun P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069424; Touchette DR, 2006, J AGING PHARMACOTHER, V13, P109, DOI DOI 10.3109/J397V13N02_; Tracey KJ, 2016, CELL, V164, P343, DOI 10.1016/j.cell.2016.01.018; TRESKES M, 1993, CANCER CHEMOTH PHARM, V33, P93, DOI 10.1007/BF00685326; TRESKES M, 1992, ANTICANCER RES, V12, P2261; Truong LD, 2015, FASEB J, V29, P3558, DOI 10.1096/fj.14-262493; Vukelic M, 2013, J IMMUNOL, V191, P1800, DOI 10.4049/jimmunol.1203467; Wang X, 2015, 3RD INTERNATIONAL CONFERENCE ON ADVANCED COMPOSITE MATERIALS AND MANUFACTURING ENGINEERING (CMME 2015), P10; Yamamato E, 2012, EXP TOXICOL PATHOL, V64, P625, DOI 10.1016/j.etp.2010.12.005; Yang M, 2015, EXP BIOL MED, V240, P1717, DOI 10.1177/1535370215589906; Yeboah MM, 2008, KIDNEY INT, V74, P62, DOI 10.1038/ki.2008.94; Yeboah MM, 2008, AM J PHYSIOL-RENAL, V295, pF654, DOI 10.1152/ajprenal.90255.2008; Yu XW, 2017, AM J TRANSL RES, V9, P1222; Zhou Z, 2015, MOL MED REP, V12, P6925, DOI 10.3892/mmr.2015.4318	75	16	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188797	10.1371/journal.pone.0188797	http://dx.doi.org/10.1371/journal.pone.0188797			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190774	Green Submitted, Green Published, gold			2022-12-27	WOS:000416841900126
J	Fouad, S; Randell, D; Galton, A; Mehanna, H; Landini, G				Fouad, Shereen; Randell, David; Galton, Antony; Mehanna, Hisham; Landini, Gabriel			Unsupervised morphological segmentation of tissue compartments in histopathological images	PLOS ONE			English	Article							COLOR; IDENTIFICATION; ALGORITHM	Algorithmic segmentation of histologically relevant regions of tissues in digitized histopathological images is a critical step towards computer-assisted diagnosis and analysis. For example, automatic identification of epithelial and stromal tissues in images is important for spatial localisation and guidance in the analysis and characterisation of tumour micro-environment. Current segmentation approaches are based on supervised methods, which require extensive training data from high quality, manually annotated images. This is often difficult and costly to obtain. This paper presents an alternative data-independent framework based on unsupervised segmentation of oropharyngeal cancer tissue micro-arrays (TMAs). An automated segmentation algorithm based on mathematical morphology is first applied to light microscopy images stained with haematoxylin and eosin. This partitions the image into multiple binary 'virtual-cells', each enclosing a potential 'nucleus' (dark basins in the haematoxylin absorbance image). Colour and morphology measurements obtained from these virtual-cells as well as their enclosed nuclei are input into an advanced unsupervised learning model for the identification of epithelium and stromal tissues. Here we exploit two Consensus Clustering (CC) algorithms for the unsupervised recognition of tissue compartments, that consider the consensual opinion of a group of individual clustering algorithms. Unlike most unsupervised segmentation analyses, which depend on a single clustering method, the CC learning models allow for more robust and stable detection of tissue regions. The proposed framework performance has been evaluated on fifty-five hand-annotated tissue images of oropharyngeal tissues. Qualitative and quantitative results of the proposed segmentation algorithm compare favourably with eight popular tissue segmentation strategies. Furthermore, the unsupervised results obtained here outperform those obtained with individual clustering algorithms.	[Fouad, Shereen; Randell, David; Landini, Gabriel] Univ Birmingham, Inst Clin Sci, Sch Dent, Birmingham, W Midlands, England; [Galton, Antony] Univ Exeter, Dept Comp Sci, Exeter, Devon, England; [Mehanna, Hisham] Univ Birmingham, Inst Canc & Genom Sci, Inst Head & Neck Studies & Educ, Birmingham, W Midlands, England	University of Birmingham; University of Exeter; University of Birmingham	Fouad, S (corresponding author), Univ Birmingham, Inst Clin Sci, Sch Dent, Birmingham, W Midlands, England.	s.a.fouad@bham.ac.uk		Mehanna, Hisham/0000-0002-5544-6224; Landini, Gabriel/0000-0002-9689-0989; Fouad, Shereen/0000-0002-4965-7017	Engineering and Physical Sciences Research Council (EPSRC), UK [EP/M023869/1]; Engineering and Physical Sciences Research Council [EP/M023869/1] Funding Source: researchfish; EPSRC [EP/M023869/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC), UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Sciences Research Council (EPSRC), UK through funding under grant EP/M023869/1 "Novel context -based segmentation algorithms for intelligent microscopy" (https://www.epsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Engineering and Physical Sciences Research Council (EPSRC), UK through funding under grant EP/M023869/1 "Novel context-based segmentation algorithms for intelligent microscopy".	Achanta R., 2010, TECHNICAL REPORT; Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; Beucher S, 1994, COMP IMAG VIS, V2, P69; Beucher S, INT WORKSH IM PROC R; Bonnet N, 2002, PATTERN RECOGN, V35, P2319, DOI 10.1016/S0031-3203(02)00057-2; Borovec KJ J, 2014, COMP VIS WINT WORKSH; Chen B, 2010, SDPS 2010 TRANSF SYS; Choromanska A, 2011, P 2011 INT C ON LIN, V26, P1; Cooper LAD, 2012, J AM MED INFORM ASSN, V19, P317, DOI 10.1136/amiajnl-2011-000700; Datar M, 2008, I S BIOMED IMAGING, P292, DOI 10.1109/ISBI.2008.4540990; DEFAYS D, 1977, COMPUT J, V20, P364, DOI 10.1093/comjnl/20.4.364; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Fern X. Z., 2008, STAT ANAL DATA MIN, V1, P128, DOI DOI 10.1002/SAM.10008; Fouad S, 2017, COMM COM INF SC, V723, P767, DOI 10.1007/978-3-319-60964-5_67; Fouad S, 2016, LECT NOTES COMPUT SC, V9730, P599, DOI 10.1007/978-3-319-41501-7_67; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; Frank E., 2016, WEKA WORKBENCH ONLIN, V4th; Fred ALN, 2005, IEEE T PATTERN ANAL, V27, P835, DOI 10.1109/TPAMI.2005.113; Gunduz-Demir C, 2010, MED IMAGE ANAL, V14, P1, DOI 10.1016/j.media.2009.09.001; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Hadjitodorov ST, 2006, INFORM FUSION, V7, P264, DOI 10.1016/j.inffus.2005.01.008; Hall M. A., 1998, CORRELATION BASED FE; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hiary H, 2013, SIGNAL IMAGE VIDEO P, V7, P1229, DOI 10.1007/s11760-012-0393-2; HUANG LK, 1995, PATTERN RECOGN, V28, P41, DOI 10.1016/0031-3203(94)E0043-K; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Kapur J N, IJ PLUGINS SEGMENTAT; Kapur J N, 2002, COMPUTER VISION GRAP, V29, P273; Khan AM, 2012, P MED IM UND AN SWAN, P17; Kohonen T, 1995, SELF ORG MAPS, P175, DOI [10.1007/978-3-642-97610-0, DOI 10.1007/978-3-642-97610-0]; Lambert J.H., 1760, PHOTOMETRIA SIVE MEN; Landini G, 2004, CYTOM PART A, V61A, P45, DOI 10.1002/cyto.a.20082; Landini G, 2016, J MICROSC-OXFORD, P1; Landini G., P 2 IMAGEJ US DEV C, P116; Landini G, 2010, ANAL QUANT CYTOL, V32, P30; Liao PS, 2001, J INF SCI ENG, V17, P713; Linder N, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-22; Madabhushi A, 2016, MED IMAGE ANAL, V33, P170, DOI 10.1016/j.media.2016.06.037; Naqvi S, 2009, INVESTIGATION USE FU, P1; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Powers D., 2011, J MACH LEARN TECHNOL, V2, P37; Rasband W., 2006, IMAGEJ; Rogojanu R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/569071; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sage D., 2011, IMAGEJ PLUGIN APPLY; Shih FY, 2005, IMAGE VISION COMPUT, V23, P877, DOI 10.1016/j.imavis.2005.05.015; Soille P., 1999, MORPHOLOGICAL IMAGE, DOI 10.1007/978-3-662-05088-0; Topchy AP, 2004, FOURTH IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P225, DOI 10.1109/ICDM.2004.10100; Tosa Y., IJ PLUGINS MULTIOTSU; Vega-Pons S, 2011, INT J PATTERN RECOGN, V25, P337, DOI 10.1142/S0218001411008683; Vincent L, 1993, IEEE T IMAGE PROCESS, V2, P176, DOI 10.1109/83.217222; Wang CQF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025832, 10.1371/journal.pone.0018907]; Wang Y, 2017, MED IMAGE ANAL, V40, P1, DOI 10.1016/j.media.2017.05.005; Xu J, 2016, NEUROCOMPUTING, V191, P214, DOI 10.1016/j.neucom.2016.01.034; Zhou XB, 2009, IEEE T INF TECHNOL B, V13, P152, DOI 10.1109/TITB.2008.2007098	57	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188717	10.1371/journal.pone.0188717	http://dx.doi.org/10.1371/journal.pone.0188717			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190786	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000416841900107
J	Sahu, PK; Mondal, S; Sharma, D; Vishwakarma, G; Kumar, V; Das, BK				Sahu, Parmeshwar Kumar; Mondal, Suvendu; Sharma, Deepak; Vishwakarma, Gautam; Kumar, Vikash; Das, Bikram Kishore			InDel marker based genetic differentiation and genetic diversity in traditional rice (Oryza sativa L.) landraces of Chhattisgarh, India	PLOS ONE			English	Article							MAP-BASED CLONING; MULTILOCUS GENOTYPE DATA; MICROSATELLITE MARKERS; RESISTANCE GENES; GENOME; CULTIVARS; ARABIDOPSIS; INFERENCE; POTATO; SYSTEM	Rice has been cultivating and utilizing by humans for thousands of years under diverse environmental conditions. Therefore, tremendous genetic differentiation and diversity has occurred at various agro-ecosystems. The significant indica japonica differentiation in rice provides great opportunities for its genetic improvement. In the present investigation, a total of 42 polymorphic InDel markers were used for differentiating 188 rice landraces and two local varieties of Chhattisgarh, India into indica and japonica related genotypes based on `InDel molecular index'. Frequency of japonica alleles varied from 0.11 to 0.89 among landraces. Results revealed that 104 rice landraces have indica type genetic architecture along with three tested indica cultivars Swarna, Mahamaya and Rajeshwari. Another 60 landraces were placed under 'close to indica' type. It was found that three rice landraces i.e. Kalajeera, Kapri, Tulsimala were 'close to japonica' type and 21 landraces were 'intermediate' type. The result from the calculation of `InDel molecular index' was further verified with STRUCTURE, AMOVA, PCA and cluster analysis. Population structure analysis revealed two genetically distinct populations within the 190 rice landraces/genotypes. Based on AMOVA, 'intermediate' type, 'close to japonica' type and Dongjinbyeo (a japonica cultivar from Republic of Korea) displayed significant genetic differentiation phi(PT) = 0.642, P = 0.000) from 'indica' and ` close to indica' groups. The PCA scatter plot and dendrogram demonstrated a clear pattern of two major group differentiations. 'Close to japonica' type and ` intermediate' type landraces/genotypes were grouped with Dongjinbyeo and formed a separate cluster at 30% Jaccard's similarity level from rest of the landraces/genotypes which were ` close to indica' or ` indica' type. Such a significant genetic differentiation among the locally adapted landraces could be exploited for the development of rice varieties introgressing higher yield potential and better plant types of japonica type as per the need of consumers and rice traders.	[Sahu, Parmeshwar Kumar; Sharma, Deepak] Indira Gandhi Krishi Vishwavidyalaya, Dept Genet & Plant Breeding, Raipur, Chhattisgarh, India; [Mondal, Suvendu; Vishwakarma, Gautam; Kumar, Vikash; Das, Bikram Kishore] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay, Maharashtra, India	Indira Gandhi Krishi Vishwavidyalaya (IGKV); Bhabha Atomic Research Center (BARC)	Sharma, D (corresponding author), Indira Gandhi Krishi Vishwavidyalaya, Dept Genet & Plant Breeding, Raipur, Chhattisgarh, India.; Mondal, S (corresponding author), Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay, Maharashtra, India.	suvenduhere@yahoo.co.in; deepakigkv@gmail.com	Sahu, Parmeshwar K/GYU-5561-2022; Mondal, Suvendu/E-6354-2011; Sahu, Dr. Parmeshwar K./M-7265-2018	Mondal, Suvendu/0000-0001-7638-140X; Sharma, Deepak/0000-0002-9456-4805; Sahu, Dr. Parmeshwar K./0000-0003-2199-1790	Department of Science and Technology, government of India	Department of Science and Technology, government of India(Department of Science & Technology (India))	PKS got the INSPIRE fellowship for his PhD study from the Department of Science and Technology, government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAR DS, 2003, MONOGRAPH GENUS ORYZ, P283; CALLEN DF, 1993, AM J HUM GENET, V52, P922; Cao X.X., 2007, FRONTIERS BIOL CHINA, V2, P291, DOI [10.1007/s11515-007-0042-2, DOI 10.1007/S11515-007-0042-2]; Cheng K., 1984, ACTA AGRON SIN, V10, P271; Choudhury DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113094; Das B, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-71; Das S, 2015, DNA RES, V22, P377, DOI 10.1093/dnares/dsv020; Deepak Sharma, 2013, African Journal of Agricultural Research, V8, P5004; Edwards JD, 2004, MOL GENET GENOMICS, V271, P298, DOI 10.1007/s00438-004-0979-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, GENETICS, V164, P1567; FAO Rice Market Monitor and Agricultural Organization of the United Nations, 2017, RIC MARK MON, VXX, P1, DOI DOI 10.1016/J.KNEE.2017.11.005; Frankel OH, 1981, CONSERVATION EVOLUTI; Fukuoka S, 2006, GENET RESOUR CROP EV, V53, P753, DOI 10.1007/s10722-004-4635-1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hayashi K, 2006, THEOR APPL GENET, V113, P251, DOI 10.1007/s00122-006-0290-6; Hou XH, 2010, PLANT J, V63, P880, DOI 10.1111/j.1365-313X.2010.04277.x; Jain S, 2004, THEOR APPL GENET, V109, P965, DOI 10.1007/s00122-004-1700-2; Khush GS, 2001, NAT REV GENET, V2, P815, DOI 10.1038/35093585; Kottapalli KR, 2010, BIOTECHNOL LETT, V32, P989, DOI 10.1007/s10529-010-0249-1; Liu P, 2012, J SYST EVOL, V50, P1, DOI 10.1111/j.1759-6831.2011.00173.x; Lu BR, 2009, PROG NAT SCI-MATER, V19, P1241, DOI 10.1016/j.pnsc.2009.01.011; Milbourne D, 1997, MOL BREEDING, V3, P127, DOI 10.1023/A:1009633005390; Morishima H, 1984, BIOL RICE, P3; Niihama M, 2015, BREEDING SCI, V65, P357, DOI 10.1270/jsbbs.65.357; Pacurar DI, 2012, J EXP BOT, V63, P2491, DOI 10.1093/jxb/err422; Panigrahi P., 2016, THESIS, P177; Peng S., 2004, P 4 INT CROP SCI C; Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200; Prevost A, 1999, THEOR APPL GENET, V98, P107, DOI 10.1007/s001220051046; Pritchard JK, 2000, GENETICS, V155, P945; Raman H, 2006, MOL BREEDING, V18, P171, DOI 10.1007/s11032-006-9025-2; RICHHARIA R H, 1979, Oryza, V16, P1; Roy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129607; Shen YJ, 2004, PLANT PHYSIOL, V135, P1198, DOI 10.1104/pp.103.038463; Smouse PE, 2015, MOL ECOL RESOUR, V15, P1375, DOI 10.1111/1755-0998.12422; Steele KA, 2008, FIELD CROP RES, V105, P81, DOI 10.1016/j.fcr.2007.08.001; Sun J, 2013, NEW PHYTOL, V197, P290, DOI 10.1111/nph.12012; [王俊 Wang Jun], 2003, [世界科技研究与发展, World Sci-Tech R and D], V25, P35; Wu DH, 2013, EUPHYTICA, V192, P131, DOI 10.1007/s10681-013-0925-z; Xiong ZY, 2010, GENET RESOUR CROP EV, V57, P891, DOI 10.1007/s10722-009-9528-x; Yamaki S, 2013, BREEDING SCI, V63, P246, DOI 10.1270/jsbbs.63.246; Yonemaru JI, 2015, BREEDING SCI, V65, P249, DOI 10.1270/jsbbs.65.249; Zeng YX, 2013, GENET MOL RES, V12, P5226, DOI 10.4238/2013.October.30.7	45	9	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188864	10.1371/journal.pone.0188864	http://dx.doi.org/10.1371/journal.pone.0188864			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190790	Green Submitted, Green Published, gold			2022-12-27	WOS:000416841900149
J	Serrano-Villar, S; Hernandez-Novoa, B; de Benito, A; del Romero, J; Ocampo, A; Blanco, JR; Masia, M; Sendagorta, E; Sanz, G; Moreno, S; Perez-Molina, JA				Serrano-Villar, Sergio; Hernandez-Novoa, Beatriz; de Benito, Amparo; del Romero, Jorge; Ocampo, Antonio; Ramon Blanco, Jose; Masia, Mar; Sendagorta, Elena; Sanz, Gonzalo; Moreno, Santiago; Perez-Molina, Jose A.			Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM	PLOS ONE			English	Article							CANCER PRECURSORS; MESSENGER-RNA; CYTOLOGY; PERFORMANCE; WOMEN; BIOMARKERS; EXPRESSION; DYSPLASIA	Background Screening of anal cancer in HIV-infected MSM with anal cytology results in high rates of false positive results and elevated burden of high-resolution anoscopies. High-risk HPV upregulates p16 and Ki67 expression in epithelial cells. We assessed the usefulness of P16/Ki-67 immunostaining cytology for the diagnosis of precancerous anal lesions. Methodology Cross-sectional multicenter study. Concomitant anal liquid cytology with p16/Ki-67 immunostaining and HRA with biopsy of acetowhite lugol-negative lesions was performed in HIV-infected MSM. We compared the diagnostic performance of an abnormal anal cytology and p16/Ki-67 immunostaining relative to HRA-guided biopsy by logistic regression and comparison of ROC areas. Results We included 328 HIV-infected MSM. HSIL was histologically diagnosed in 72 subjects (25.1%), and 2 (0.6%) were diagnosed with anal cancer. An abnormal cytology showed a sensitivity of 95.6% and a specificity of 58.8% for the diagnosis of biopsy-proven HSIL. P16/Ki67 positivity was associated with the presence of biopsy-proven HSIL (P trend = 0.004) but with low sensitivity (41.2%) and specificity (71%). The combination of standard cytology with P16/Ki67 immunostaining did not increment the predictive value of standard cytology alone (AUC 0.685 vs. 0.673, respectively, P = 0.688). Conclusion In HIV-infected MSM P16/Ki67 immunostaining does not improve the diagnostic accuracy of anal cytology, which shows a high sensitivity yet poor specificity. Other approaches aimed at improving the diagnostic accuracy of current techniques for the diagnostic of precancerous HSIL are warranted.	[Serrano-Villar, Sergio; Hernandez-Novoa, Beatriz; Moreno, Santiago; Perez-Molina, Jose A.] Univ Alcala, Hosp Unversitario Ramon y Cajal, Fac Med, Dept Infect Dis,IRYCIS, Madrid, Spain; [de Benito, Amparo] Hosp Univ Ramon y Cajal, Dept Histopathol, Madrid, Spain; [del Romero, Jorge] Ctr Sandoval, Madrid, Spain; [Ocampo, Antonio] Hosp Univ Vigo, HIV Unit, Vigo, Spain; [Ramon Blanco, Jose] Hosp San Pedro, Ctr Invest Biomed, Logrono, Spain; [Masia, Mar] Hosp Univ Elche, Infect Dis Unit, Elche, Spain; [Sendagorta, Elena] Hosp Univ La Paz, Dept Dermatol, Madrid, Spain; [Sanz, Gonzalo] Hosp Univ Clin San Carlos, Dept Gen Surg, Madrid, Spain; [Hernandez-Novoa, Beatriz] Viiv Healthcare Med Dept, Madrid, Spain	Universidad de Alcala; Hospital Universitario Ramon y Cajal; Complexo Hospitalario Universitario de Vigo; Hospital Universitario La Paz	Serrano-Villar, S (corresponding author), Univ Alcala, Hosp Unversitario Ramon y Cajal, Fac Med, Dept Infect Dis,IRYCIS, Madrid, Spain.	sergio.serrano@salud.madrid.org	Blanco, Jose-Ramon/L-6768-2018; Serrano-Villar, Sergio/AEU-8833-2022; Masia, Mar/U-7510-2017	Blanco, Jose-Ramon/0000-0002-4268-0150; Serrano-Villar, Sergio/0000-0002-5447-3554; Masia, Mar/0000-0001-9878-2458; Perez-Molina, Jose Antonio/0000-0001-8735-4124; , IIS Galicia Sur/0000-0003-3812-7413	Redes Tematicas de Investigacion en SIDA (ISCIII RETIC) [RD12/0017/0029, RD12/0017/0037]; Evaluacion de la citologia anal frente a la anoscopia de alta resolucion (AAR) en el diagnostico y seguimiento de las lesiones preneoplasicas [EC11-143]; Instituto de Salud Carlos III [PI15/00345]; European Development Regional Fund "A way to achieve Europe" (ERDF); Spanish Ministry of Science and Innovation	Redes Tematicas de Investigacion en SIDA (ISCIII RETIC)(Instituto de Salud Carlos III); Evaluacion de la citologia anal frente a la anoscopia de alta resolucion (AAR) en el diagnostico y seguimiento de las lesiones preneoplasicas; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Development Regional Fund "A way to achieve Europe" (ERDF)(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Redes Tematicas de Investigacion en SIDA (ISCIII RETIC RD12/0017/0029 and RD12/0017/0037), EC11-143 "Evaluacion de la citologia anal frente a la anoscopia de alta resolucion (AAR) en el diagnostico y seguimiento de las lesiones preneoplasicas", and by the Instituto de Salud Carlos III (Plan Estatal de I+D+i 2013-2016, project PI15/00345) and co-financed by the European Development Regional Fund "A way to achieve Europe" (ERDF). S.S.V. is supported by the Spanish Ministry of Science and Innovation (Contratos Juan Rodes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, CORRELATION HISTOLOG, DOI DOI 10.1016/J.YGYN0.2012.05.004; [Anonymous], 2017, EACS GUIDELINES; Darragh TM, 2012, J LOW GENIT TRACT DI, V16, P205, DOI 10.1097/PGP.0b013e31826916c7; Darragh TM, 2001, BETHESDA SYSTEM REPO; Dona MG, 2012, GYNECOL ONCOL, V126, P198, DOI 10.1016/j.ygyno.2012.05.004; Dupin C, 2015, DIGEST LIVER DIS, V47, P423, DOI 10.1016/j.dld.2015.01.150; Jin F, 2017, AIDS, V31, P1303, DOI [10.1097/QAD.0000000000001462, 10.1097/qad.0000000000001462]; Jin FY, 2016, CANCER CYTOPATHOL, V124, P415, DOI 10.1002/cncy.21702; Ordi J, 2014, CANCER CYTOPATHOL, V122, P227, DOI 10.1002/cncy.21366; Palefsky JM, 1997, J ACQ IMMUN DEF SYND, V14, P415, DOI 10.1097/00042560-199704150-00004; Reuschenbach M, 2010, GYNECOL ONCOL, V119, P98, DOI 10.1016/j.ygyno.2010.06.011; Sano T, 1998, AM J PATHOL, V153, P1741, DOI 10.1016/S0002-9440(10)65689-1; Schmidt D, 2011, CANCER CYTOPATHOL, V119, P158, DOI 10.1002/cncy.20140; Silverberg MJ, 2015, ANN INTERN MED, V163, P507, DOI 10.7326/M14-2768; Silverberg MJ, 2012, CLIN INFECT DIS, V54, P1026, DOI 10.1093/cid/cir1012; Tornesello ML, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/519619; Uijterwaal MH, 2015, INT J CANCER, V136, P2361, DOI 10.1002/ijc.29290; Wentzensen N, 2012, AIDS, V26, P2185, DOI 10.1097/QAD.0b013e328359f255; Wentzensen N, 2012, CLIN CANCER RES, V18, P4154, DOI 10.1158/1078-0432.CCR-12-0270; Zucchetto A, 2016, JAIDS-J ACQ IMM DEF, V73, P190, DOI 10.1097/QAI.0000000000001033	20	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188851	10.1371/journal.pone.0188851	http://dx.doi.org/10.1371/journal.pone.0188851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190817	Green Submitted, Green Published, gold			2022-12-27	WOS:000416841900143
J	Guran, R; Vanickova, L; Horak, V; Krizkova, S; Michalek, P; Heger, Z; Zitka, O; Adam, V				Guran, Roman; Vanickova, Lucie; Horak, Vratislav; Krizkova, Sona; Michalek, Petr; Heger, Zbynek; Zitka, Ondrej; Adam, Vojtech			MALDI MSI of MeLiM melanoma: Searching for differences in protein profiles	PLOS ONE			English	Article							IMAGING MASS-SPECTROMETRY; INDUCED BREAKDOWN SPECTROSCOPY; CUTANEOUS MALIGNANT-MELANOMA; METALLOTHIONEIN-OVEREXPRESSION; TOF MS; CANCER; TISSUES; EXPRESSION; TOOL; METASTASIS	Background Treatment of advanced cutaneous melanoma remains challenging, and new data on melanoma biology are required. The most widely accepted criteria for the prognostic evaluation of melanoma are histopathological and clinical parameters, and the identification of additional tumor markers is thus of paramount importance. Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI), an important tool in cancer research, is useful for unraveling the molecular profile of melanoma. Methodology/Principal findings In this report, we used the melanoma-bearing Libechov minipig (MeLiM), a unique animal model that allows observation of the complete spontaneous regression of invasive cutaneous melanoma, to investigate i) the differences between melanoma and healthy skin protein profiles and ii) the proteins potentially involved in spontaneous regression. The MeLiM tissues were cryosected, histologically characterized, analyzed by MALDI MSI, and immunohistologically stained. Multivariate statistical analyses of the MALDI MSI data revealed ten relevant m/z ions, of which the expression levels varied significantly among the studied MeLiM tissues. These ion peaks were used to create mass ion images/maps and visualize the differences between tumor and healthy skin specimens, as well as among histologically characterized tissue regions. Conclusions/Significance Protein profiles comprising ten statistically significant mass ion peaks useful for differentiating cutaneous melanoma and healthy skin tissues were determined. Peaks at m/z 3044, 6011, 6140 and 10180 were overexpressed in melanoma compared with healthy skin tissue. More specifically, m/z 6140 was expressed at significantly (p < 0.05) higher levels in normally growing melanoma regions than in regions with early and late spontaneous regression. This study demonstrates the clinical utility of MALDI MSI for the analysis of tissue cryosections at a molecular level.	[Guran, Roman; Vanickova, Lucie; Krizkova, Sona; Michalek, Petr; Heger, Zbynek; Zitka, Ondrej; Adam, Vojtech] Mendel Univ Brno, Dept Chem & Biochem, Brno, Czech Republic; [Guran, Roman; Krizkova, Sona; Michalek, Petr; Heger, Zbynek; Zitka, Ondrej; Adam, Vojtech] Brno Univ Technol, Cent European Inst Technol, Brno, Czech Republic; [Horak, Vratislav] Acad Sci Czech Republ, Inst Anim Physiol & Genet, Vvi, Libechov, Czech Republic	Mendel University in Brno; Brno University of Technology; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences	Adam, V (corresponding author), Mendel Univ Brno, Dept Chem & Biochem, Brno, Czech Republic.; Adam, V (corresponding author), Brno Univ Technol, Cent European Inst Technol, Brno, Czech Republic.	vojtech.adam@mendelu.cz	Horak, Vratislav/G-7172-2014; Zitka, Ondrej/L-5588-2019; Heger, Zbyněk/D-1973-2013; Guran, Roman/C-2610-2016; Adam, Vojtech/D-7686-2012; Zitka, Ondrej/E-1107-2012; Vanickova, Lucie/L-7034-2016; Krizkova, Sona/E-9617-2012	Horak, Vratislav/0000-0002-5878-3138; Zitka, Ondrej/0000-0001-7607-5058; Heger, Zbyněk/0000-0002-3915-7270; Guran, Roman/0000-0002-2912-714X; Adam, Vojtech/0000-0002-8527-286X; Zitka, Ondrej/0000-0001-7607-5058; Michalek, Petr/0000-0002-0121-0128; Vanickova, Lucie/0000-0001-7744-3246; Krizkova, Sona/0000-0002-0479-8369	Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC [LQ1601]; National Sustainability Program [LO1609]; RVO [67985904]; European Union's Horizon research and innovation programme under the Marie Sklodowska-Curie [6SA17676]; South Moravian Region [665860]	Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC; National Sustainability Program; RVO; European Union's Horizon research and innovation programme under the Marie Sklodowska-Curie; South Moravian Region	This research has been financially supported by the Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC 2020 (LQ1601) and the National Sustainability Program (project No. LO1609), and RVO 67985904. LV was supported by project 6SA17676 that received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie and which is co financed by the South Moravian Region under grant agreement No. 665860.	Aichler M, 2015, LAB INVEST, V95, P422, DOI 10.1038/labinvest.2014.156; Anyz J, 2017, SCI REP-UK, V7, DOI 10.1038/srep40169; Borovansky J, 2003, MELANOMA RES, V13, P543, DOI 10.1097/01.cmr.0000056276.15046.21; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Casadonte R, 2014, PROTEOMICS, V14, P956, DOI 10.1002/pmic.201300430; Cazares LH, 2009, CLIN CANCER RES, V15, P5541, DOI 10.1158/1078-0432.CCR-08-2892; Donato R., 2003, MICROSC RES TECH, V60; Elsner M, 2012, J PROTEOMICS, V75, P4693, DOI 10.1016/j.jprot.2012.02.012; Emri E, 2013, J EUR ACAD DERMATOL, V27, pe320, DOI 10.1111/j.1468-3083.2012.04653.x; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Geffrotin C, 2000, BBA-GEN SUBJECTS, V1524, P196, DOI 10.1016/S0304-4165(00)00158-6; Hardesty WM, 2011, J PROTEOMICS, V74, P1002, DOI 10.1016/j.jprot.2011.04.013; Konecna M, 2014, SPECTROCHIM ACTA B, V101, P220, DOI 10.1016/j.sab.2014.08.037; Kriegsmann J, 2015, INT J ONCOL, V46, P893, DOI 10.3892/ijo.2014.2788; Krizkova S, 2008, SENSORS-BASEL, V8, P3106, DOI 10.3390/s8053106; Lesniak W, 2009, BIOCHEM BIOPH RES CO, V390, P1087, DOI 10.1016/j.bbrc.2009.10.150; Maelandsmo GM, 1997, INT J CANCER, V74, P464, DOI 10.1002/(SICI)1097-0215(19970822)74:4<464::AID-IJC19>3.0.CO;2-9; Moncayo S, 2017, SPECTROCHIM ACTA B, V133, P40, DOI 10.1016/j.sab.2017.04.013; Mueller L, 2017, ANAL BIOANAL CHEM, V409, P3667, DOI 10.1007/s00216-017-0310-1; Nylund C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045382; Oetjen J, 2016, ANAL BIOANAL CHEM, V408, P6729, DOI 10.1007/s00216-016-9793-4; Pote N, 2013, HEPATOLOGY, V58, P983, DOI 10.1002/hep.26433; Rauser S, 2010, J PROTEOME RES, V9, P1854, DOI 10.1021/pr901008d; Rodrigo MAM, 2014, J PHARMACEUT BIOMED, V95, P245, DOI 10.1016/j.jpba.2014.03.007; Sabel Michael S, 2011, Int J Proteomics, V2011, P181890, DOI 10.1155/2011/181890; Sasaki M, 2004, EXP DERMATOL, V13, P465, DOI 10.1111/j.0906-6705.2004.00204.x; Shen HW, 2015, APPL IMMUNOHISTO M M, V23, P303, DOI 10.1097/PAI.0000000000000075; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Sugita K, 2001, AM J DERMATOPATH, V23, P29, DOI 10.1097/00000372-200102000-00005; Tomalova I, 2014, ANAL CHEM, V86, P647, DOI 10.1021/ac402941e; Veselkov KA, 2014, P NATL ACAD SCI USA, V111, P1216, DOI 10.1073/pnas.1310524111; Vincent-Naulleau S, 2004, PIGM CELL RES, V17, P24, DOI 10.1046/j.1600-0749.2003.00101.x; Weinlich G, 2007, J EUR ACAD DERMATOL, V21, P669, DOI 10.1111/j.1468-3083.2006.02051.x; Weinlich G, 2006, BRIT J CANCER, V94, P835, DOI 10.1038/sj.bjc.6603028; Weinlich G, 2009, GIORN ITAL DERMAT V, V144, P27; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111	36	21	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189305	10.1371/journal.pone.0189305	http://dx.doi.org/10.1371/journal.pone.0189305			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220390	gold, Green Published, Green Submitted			2022-12-27	WOS:000417469900046
J	Pei, FQ; Li, DB; Tong, YF; He, F				Pei, Feng-Que; Li, Dong-Bo; Tong, Yi-Fei; He, Fei			Process service quality evaluation based on Dempster-Shafer theory and support vector machine	PLOS ONE			English	Article							CLASSIFIER; RULE	Human involvement influences traditional service quality evaluations, which triggers an evaluation's low accuracy, poor reliability and less impressive predictability. This paper proposes a method by employing a support vector machine (SVM) and Dempster-Shafer evidence theory to evaluate the service quality of a production process by handling a high number of input features with a low sampling data set, which is called SVMs-DS. Features that can affect production quality are extracted by a large number of sensors. Preprocessing steps such as feature simplification and normalization are reduced. Based on three individual SVM models, the basic probability assignments (BPAs) are constructed, which can help the evaluation in a qualitative and quantitative way. The process service quality evaluation results are validated by the Dempster rules; the decision threshold to resolve conflicting results is generated from three SVM models. A case study is presented to demonstrate the effectiveness of the SVMs-DS method.	[Pei, Feng-Que; Li, Dong-Bo; Tong, Yi-Fei; He, Fei] Nanjing Univ Sci & Technol, Sch Mech Engn, Nanjing, Jiangsu, Peoples R China	Nanjing University of Science & Technology	Tong, YF (corresponding author), Nanjing Univ Sci & Technol, Sch Mech Engn, Nanjing, Jiangsu, Peoples R China.	tyf51129@aliyun.com		Pei, Feng-Que/0000-0002-9532-570X	National Defense Science and Technology Project Foundation [0106142]; MOE (Ministry of Education in China) Project of Humanities and Social Sciences [17YJC630139]	National Defense Science and Technology Project Foundation; MOE (Ministry of Education in China) Project of Humanities and Social Sciences	This study was supported by the National Defense Science and Technology Project Foundation (no. 0106142), and MOE (Ministry of Education in China) Project of Humanities and Social Sciences (no. 17YJC630139).; This work was financially supported by the National Defense Science and Technology Project Foundation (No. 0106142), and MOE (Ministry of Education in China) Project of Humanities and Social Sciences (No. 17YJC630139). The supports are gratefully acknowledged.	Alabi AA, 2015, AM J SIGNAL PROCESSI, V5, P32; [Anonymous], 2015, 2015 INT JOINT C NEU, DOI DOI 10.1109/IJCNN.2015.7280360; Appannah G, 2014, BRIT J NUTR, V112, P609, DOI 10.1017/S0007114514001111; Audhkhasi K, 2010, IETE J RES, V56, P111, DOI 10.4103/0377-2063.63087; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; [车红昆 Che Hongkun], 2010, [机械工程学报, Chinese Journal of Mechanical Engineering], V46, P101; Chen B, 2014, INT J ADV MANUF TECH, V71, P91, DOI 10.1007/s00170-013-5288-z; Chen H., 2010, THESIS; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Daniel GM, 2014, INT J PRECIS ENG MAN, V15, P1283, DOI 10.1007/s12541-014-0468-9; DENOEUX T, 1995, IEEE T SYST MAN CYB, V25, P804, DOI 10.1109/21.376493; Denoeux T, 2000, IEEE T SYST MAN CY A, V30, P131, DOI 10.1109/3468.833094; Hrehova S, 2016, PROCEDIA ENGINEER, V149, P149, DOI 10.1016/j.proeng.2016.06.649; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Jiang HL, 2016, NEUROCOMPUTING, V207, P189, DOI 10.1016/j.neucom.2016.03.074; Kadar B, 2003, BRIT J HAEMATOL, V165, P722; Korugan A, 2014, INT J ADV MANUF TECH, V74, P715, DOI 10.1007/s00170-014-5977-2; Park S, 2014, RADIOENGINEERING, V23, P642; Ruiz-Gonzalez R, 2014, SENSORS-BASEL, V14, P20713, DOI 10.3390/s141120713; Shafer G, 2016, INT J APPROX REASON, V79, P7, DOI 10.1016/j.ijar.2016.07.009; Shalet KS, 2015, INT J APPL ENG RES, V10, P8401; Tang JY, 2007, INT C EL MEAS INSTR; [王磊 Wang Lei], 2013, [遥感信息, Remote Sensing Information], V28, P102; Wei DJ, 2013, PHYSICA A, V392, P2564, DOI 10.1016/j.physa.2013.01.054; Yang Guang, 2014, Optics and Precision Engineering, V22, P489, DOI 10.3788/OPE.20142202.0489; [袁宪锋 Yuan Xianfeng], 2015, [振动、测试与诊断, Journal of Vibration, Measurement and Diagnosis], V35, P434; Zhang Yi, 2009, East China Electric Power, V37, P0339; Zhou C, 2016, NEUROCOMPUTING, V182, P145, DOI 10.1016/j.neucom.2015.11.081; Zong Q., 2014, BEIJING SURVEYING MA, V3, P15; Zouhal LM, 1998, IEEE T SYST MAN CY C, V28, P263, DOI 10.1109/5326.669565	32	2	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189189	10.1371/journal.pone.0189189	http://dx.doi.org/10.1371/journal.pone.0189189			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220393	Green Published, gold, Green Submitted			2022-12-27	WOS:000417469900038
J	Rusin, T; Araujo, WMC; Faiad, C; Vital, HD				Rusin, Tiago; Coelho Araujo, Wilma Maria; Faiad, Cristiane; Vital, Helio de Carvalho			Construction and validation of a psychometric scale to measure awareness on consumption of irradiated foods	PLOS ONE			English	Article							CONSUMER ACCEPTANCE; SAFETY KNOWLEDGE; TECHNOLOGIES	Although food irradiation has been used to ensure food safety, most consumers are unaware of the basic concepts of irradiation, misinterpreting information and demonstrating a negative attitude toward food items treated with ionizing radiation. This research is aimed at developing a tool to assess the awareness on the consumption of irradiated food. The sample was composed by employees from different social classes and school levels of Brazilian universities, who reflect the end-users of the irradiated foods, representative of the views of lay consumers. The total number of respondents was 614. In order to assess the Awareness Scale on Consumption of Irradiated Foods (ASCIF), an instrument has been developed and submitted to semantic tests and judge's validation. The instrument, that included 32 items, contemplated four construct factors: concepts (6 items), awareness (10 items), labeling (7 items) and safety of Irradiated foods (9 items). The data were collected by electronic means, through the site < https://pt.surveymonkey.com/>. By using exploratory factorial analysis (EFA) 4 factors have been found. They summarize the 31 items included. These factors account for 64.32% of the variance of the items and the internal consistency of the factors has been deemed good. An Exploratory Structural Equation Modeling (ESEM) was conducted to evaluate the factor structure of the instrument. The proposed instrument has been found to meet consistency criteria as an efficient tool for indicating assessing potential challenges and opportunities for the irradiated food markets.	[Rusin, Tiago; Coelho Araujo, Wilma Maria] Univ Brasilia, Coll Hlth Sci, Campus Darcy Ribeiro, Brasilia, DF, Brazil; [Rusin, Tiago] Esplanada Minist, Minist Environm, Brasilia, DF, Brazil; [Faiad, Cristiane] Univ Brasilia, Inst Psychol, Dept Social & Work Psychol, Campus Darcy Ribeiro, Brasilia, DF, Brazil; [Vital, Helio de Carvalho] Mil Engn Inst IME, Dept Nucl Engn, Rio De Janeiro, Brazil	Universidade de Brasilia; Universidade de Brasilia; Instituto Militar de Engenharia (IME)	Rusin, T (corresponding author), Univ Brasilia, Coll Hlth Sci, Campus Darcy Ribeiro, Brasilia, DF, Brazil.; Rusin, T (corresponding author), Esplanada Minist, Minist Environm, Brasilia, DF, Brazil.	eng.rusin@gmail.com	Faiad, Cristiane/B-8818-2017	Faiad, Cristiane/0000-0002-8012-8893; Coelho Araujo, Wilma Maria/0000-0001-5549-3568; Vital, Helio/0000-0003-3063-3725				Ibarra AA, 2010, J SCI FOOD AGR, V90, P2342, DOI 10.1002/jsfa.4087; American Educational Research Association American Psychological Association Na- tional Council on Measurement in Education, 2014, STAND ED PSYCH TEST; Asparouhov T, 2009, STRUCT EQU MODELING, V16, P397, DOI 10.1080/10705510903008204; Behrens JH, 2009, INNOV FOOD SCI EMERG, V10, P383, DOI 10.1016/j.ifset.2009.01.001; Bruhn C. M., 2014, Food Protection Trends, V34, P318; BRUHN CM, 1986, FOOD TECHNOL-CHICAGO, V40, P86; Bruhn CM, 1999, J FOOD SAFETY, V19, P73, DOI 10.1111/j.1745-4565.1999.tb00235.x; Cardello AV, 2003, APPETITE, V40, P217, DOI 10.1016/S0195-6663(03)00008-4; Crowley M. L., 2002, Food Service Technology, V2, P173, DOI 10.1046/j.1471-5740.2002.00050.x; Diehl J. F., 1995, SAFETY IRRADIATED FO; Diehl JF, 2002, RADIAT PHYS CHEM, V63, P211, DOI 10.1016/S0969-806X(01)00622-3; Enzmann D, 1997, APPL PSYCH MEAS, V21, P232, DOI 10.1177/01466216970213003; FAO, 2017, FUT FOOD AGR TRENDS; FAO, 2003, 1061983 FAO; Farkas J, 2011, TRENDS FOOD SCI TECH, V22, P121, DOI 10.1016/j.tifs.2010.04.002; Feng YaoHua, 2016, Food Protection Trends, V36, P272; Finten G, 2017, RADIAT PHYS CHEM, V130, P247, DOI 10.1016/j.radphyschem.2016.09.004; Frenzen PD, 2001, J FOOD PROTECT, V64, P2020, DOI 10.4315/0362-028X-64.12.2020; Frewer LJ, 2011, TRENDS FOOD SCI TECH, V22, P442, DOI 10.1016/j.tifs.2011.05.005; Frewer L. J., 1995, British Food Journal, V97, P31, DOI 10.1108/00070709510100118; Frewer L. J., 1996, British Food Journal, V98, P48, DOI 10.1108/00070709610119883; FSANZ, 2014, A1092 FSANZ; Gorsuch R., 1983, FACTOR ANAL; Gunes G, 2006, LWT-FOOD SCI TECHNOL, V39, P444, DOI 10.1016/j.lwt.2005.03.001; Hair J.F., 2009, AN LISE MULTIVARIADA, V6th ed.; IAEA, 2001, P FIN RES COORD M OR; Icgfi, 1999, FACTS FOOD IRR; Junqueira-Goncalves MP, 2011, RADIAT PHYS CHEM, V80, P119, DOI 10.1016/j.radphyschem.2010.08.001; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Lima T, 2015, FOOD RES INT, V72, P126, DOI 10.1016/j.foodres.2015.03.023; Medeiros LC, 2004, J AM DIET ASSOC, V104, P1671, DOI 10.1016/j.jada.2004.08.030; Messick S. L., 1989, ED MEASUREMENT, V3rd, P13, DOI DOI 10.7203/RELIEVE.22.1.8248; Parlato A, 2014, TRENDS FOOD SCI TECH, V38, P60, DOI 10.1016/j.tifs.2014.04.001; Pasquali L., 2012, ANALISE FATORIAL PES, P40; Pasquali L., 2010, INATRUMENTACAO PSICO; RESURRECCION AVA, 1995, J FOOD PROTECT, V58, P193, DOI 10.4315/0362-028X-58.2.193; Roberts PB, 2014, RADIAT PHYS CHEM, V105, P78, DOI 10.1016/j.radphyschem.2014.05.016	37	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189314	10.1371/journal.pone.0189314	http://dx.doi.org/10.1371/journal.pone.0189314			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220375	Green Published, Green Submitted, gold			2022-12-27	WOS:000417469900047
J	Silvent, J; Akiva, A; Brumfeld, V; Reznikov, N; Rechav, K; Yaniv, K; Addadi, L; Weiner, S				Silvent, Jeremie; Akiva, Anat; Brumfeld, Vlad; Reznikov, Natalie; Rechav, Katya; Yaniv, Karina; Addadi, Lia; Weiner, Steve			Zebrafish skeleton development: High resolution micro-CT and FIB-SEM block surface serial imaging for phenotype identification	PLOS ONE			English	Article							DANIO-RERIO OSTARIOPHYSI; 3-DIMENSIONAL STRUCTURE; AXIAL SKELETON; LAMELLAR BONE; INNER-EAR; MUTATIONS; CALCEIN; MODEL; MINERALIZATION; PIGMENTATION	Although bone is one of the most studied living materials, many questions about the manner in which bones form remain unresolved, including fine details of the skeletal structure during development. In this study, we monitored skeleton development of zebrafish larvae, using calcein fluorescence, high-resolution micro-CT 3D images and FIB-SEM in the block surface serial imaging mode. We compared calcein staining of the skeletons of the wild type and nacre mutants, which are transparent zebrafish, with micro-CT for the first 30 days post fertilization embryos, and identified significant differences. We quantified the bone volumes and mineral contents of bones, including otoliths,during development, and showed that such developmental differences, including otolith development, could be helpful in identifying phenotypes. In addition, high-resolution imaging revealed the presence of mineralized aggregates in the notochord, before the formation of the first bone in the axial skeleton. These structures might play a role in the storage of the mineral. Our results highlight the potential of these high-resolution 3D approaches to characterize the zebrafish skeleton, which in turn could prove invaluable information for better understanding the development and the characterization of skeletal phenotypes.	[Silvent, Jeremie; Akiva, Anat; Addadi, Lia; Weiner, Steve] Weizmann Inst Sci, Dept Biol Struct, Rehovot, Israel; [Brumfeld, Vlad; Rechav, Katya] Weizmann Inst Sci, Dept Chem Res Support, Rehovot, Israel; [Reznikov, Natalie] Imperial Coll London, Inst Biomed Engn, Dept Mat, London, England; [Reznikov, Natalie] Imperial Coll London, Inst Biomed Engn, Dept Bioengn, London, England; [Yaniv, Karina] Weizmann Inst Sci, Dept Regulat Biol, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Imperial College London; Imperial College London; Weizmann Institute of Science	Silvent, J (corresponding author), Weizmann Inst Sci, Dept Biol Struct, Rehovot, Israel.	silvent.jeremie@gmail.com	Akiva, Anat/A-2086-2017	Reznikov, Natalie/0000-0001-5293-4647; Akiva, Anat/0000-0003-0414-889X	ISRAEL SCIENCE FOUNDATION [875/15]; Clore-Krenter-Katz postdoctoral fellowship	ISRAEL SCIENCE FOUNDATION(Israel Science Foundation); Clore-Krenter-Katz postdoctoral fellowship	This research was supported by the ISRAEL SCIENCE FOUNDATION (grant number 875/15). J.S. is supported by a Clore-Krenter-Katz postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiva A, 2015, BONE, V75, P192, DOI 10.1016/j.bone.2015.02.020; Antinucci P, 2016, SCI REP-UK, V6, DOI 10.1038/srep29490; Atkins A, 2015, ACTA BIOMATER, V13, P311, DOI 10.1016/j.actbio.2014.10.025; Baker CVH, 1997, DEVELOPMENT, V124, P3077; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Bennet M, 2014, BIOPHYS J, V106, pL17, DOI 10.1016/j.bpj.2014.01.002; Bensimon-Brito A, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0102-4; Bensimon-Brito A, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-28; Bever MM, 2002, DEV DYNAM, V223, P536, DOI 10.1002/dvdy.10062; Bird NC, 2003, DEV DYNAM, V228, P337, DOI 10.1002/dvdy.10387; Boonrungsiman S, 2012, P NATL ACAD SCI USA, V109, P14170, DOI 10.1073/pnas.1208916109; Borovansky J, 1994, Sb Lek, V95, P309; Cubbage CC, 1996, J MORPHOL, V229, P121, DOI 10.1002/(SICI)1097-4687(199608)229:2<121::AID-JMOR1>3.0.CO;2-4; Donoghue PCJ, 2008, BIOESSAYS, V30, P530, DOI 10.1002/bies.20767; Du SJ, 2001, DEV BIOL, V238, P239, DOI 10.1006/dbio.2001.0390; Eames BF, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-23; Fisher S, 1999, NAT GENET, V23, P442, DOI 10.1038/70557; Fisher S, 2003, DEV BIOL, V264, P64, DOI 10.1016/S0012-1606(03)00399-3; FRENZ DA, 1991, DEV BIOL, V144, P38, DOI 10.1016/0012-1606(91)90476-J; GERAUDIE J, 1984, TISSUE CELL, V16, P217, DOI 10.1016/0040-8166(84)90046-6; Geurtzen K, 2014, DEVELOPMENT, V141, P2225, DOI 10.1242/dev.105817; Goldsmith JR, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/817341; Goodrich ES, 1904, Q J MICROSC SCI, V47, P465; Haddon C, 1996, J COMP NEUROL, V365, P113, DOI 10.1002/(SICI)1096-9861(19960129)365:1<113::AID-CNE9>3.0.CO;2-6; Hale LV, 2000, CALCIFIED TISSUE INT, V67, P80, DOI 10.1007/s00223001101; Hayes M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5777; Heisenberg CP, 1996, DEVELOPMENT, V123, P191; Inoue M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02114; Jarvik E., 2016, ANAT REC; Javidan Y, 2004, METHOD CELL BIOL, V76, P415; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; Kanazawa T, 2016, J ORTHOP RES, V34, P969, DOI 10.1002/jor.23111; Kelsh RN, 1996, DEVELOPMENT, V123, P369; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lister JA, 1999, DEVELOPMENT, V126, P3757; LIU ZQ, 1991, APPL OPTICS, V30, P1369, DOI 10.1364/AO.30.001369; Mackay Eirinn W, 2013, Bonekey Rep, V2, P445, DOI 10.1038/bonekey.2013.179; Magal RA, 2014, J STRUCT BIOL, V186, P253, DOI 10.1016/j.jsb.2014.03.007; MILOS N, 1978, J EXP ZOOL, V205, P205, DOI 10.1002/jez.1402050205; Moran AL, 2000, MAR BIOL, V137, P893, DOI 10.1007/s002270000390; Naveh GRS, 2013, J STRUCT BIOL, V181, P108, DOI 10.1016/j.jsb.2012.10.008; Neues F, 2006, MATERIALWISS WERKST, V37, P426, DOI 10.1002/mawe.200600009; Nicenboim J, 2015, NATURE, V522, P56, DOI 10.1038/nature14425; Noden DM, 2005, J ANAT, V207, P575, DOI 10.1111/j.1469-7580.2005.00473.x; Odenthal J, 1996, DEVELOPMENT, V123, P391; Otis JP, 2015, DIS MODEL MECH, V8, P295, DOI 10.1242/dmm.018754; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Parker MO, 2013, ZEBRAFISH, V10, P466, DOI 10.1089/zeb.2013.0878; Pasco-Viel E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011293; PAUL H, 1983, ARTHRITIS RHEUM, V26, P191, DOI 10.1002/art.1780260211; Reznikov N, 2014, ACTA BIOMATER, V10, P3815, DOI 10.1016/j.actbio.2014.05.024; Reznikov N, 2014, BONE, V59, P93, DOI 10.1016/j.bone.2013.10.023; Reznikov N, 2013, BONE, V52, P676, DOI 10.1016/j.bone.2012.10.034; Riley BB, 2000, J NEUROBIOL, V43, P329, DOI 10.1002/1097-4695(20000615)43:4<329::AID-NEU2>3.3.CO;2-8; Sassen W. A., 2015, Advances in Genomics and Genetics, V5, P151; Schneider P, 2011, BONE, V49, P304, DOI 10.1016/j.bone.2011.04.005; Seritrakul P, 2012, FASEB J, V26, P5014, DOI 10.1096/fj.12-209304; Spoorendonk KM, 2010, J APPL ICHTHYOL, V26, P219, DOI 10.1111/j.1439-0426.2010.01409.x; Storer NY, 2013, DEVELOPMENT, V140, P3040, DOI 10.1242/dev.087858; Van der Heyden C, 2000, DEV DYNAM, V219, P486; Wang S, 2013, J ANAT, V223, P159, DOI 10.1111/joa.12067; Weiner A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005602; Wenner M, 2009, NAT MED, V15, P1106, DOI 10.1038/nm1009-1106; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Whitfield TT, 1996, DEVELOPMENT, V123, P241; WILSON CA, 1987, T AM FISH SOC, V116, P668, DOI 10.1577/1548-8659(1987)116<668:CAAFMO>2.0.CO;2; Zuiderveld K.J., 1994, GRAPHICS GEMS, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6	68	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0177731	10.1371/journal.pone.0177731	http://dx.doi.org/10.1371/journal.pone.0177731			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220379	gold, Green Published, Green Submitted			2022-12-27	WOS:000417469900001
J	Wu, XH; Wang, W; Yin, CM; Hou, HJ; Xie, KJ; Xie, XL				Wu, Xiao Hong; Wang, Wei; Yin, Chun Mei; Hou, Hai Jun; Xie, Ke Jun; Xie, Xiao Li			Water consumption, grain yield, and water productivity in response to field water management in double rice systems in China	PLOS ONE			English	Article							IRRIGATED LOWLAND RICE; PHILIPPINES; MOVEMENT; ENERGY; CROP; ASIA	Rice cultivation has been challenged by increasing food demand and water scarcity. We examined the responses of water use, grain yield, and water productivity to various modes of field water managements in Chinese double rice systems. Four treatments were studied in a long-term field experiment (1998-2015): continuous flooding (CF), flooding-midseason drying-flooding (F-D-F), flooding-midseason drying-intermittent irrigation without obvious standing water (F-D-S), and flooding-rain-fed (F-RF). The average precipitation was 483 mm in early-rice season and 397 mm in late-rice season. The irrigated water for CF, F-D-F, F-D-S, and F-RF, respectively, was 263, 340, 279, and 170 mm in early-rice season, and 484, 528, 422, and 206 mm in late-rice season. Grain yield for CF, F-D-F, F-D-S, and F-RF, respectively, was 4,722, 4,597, 4,479, and 4,232 kgha(-1) in early-rice season, and 5,420, 5,402, 5,366, and 4,498 kgha(-1) in late-rice season. Compared with CF, F-D-F consumed more irrigated water, which still decreased grain yield, leading to a decrease in water productivity by 25% in early-rice season and by 8% in late-rice season. Compared with F-D-F, F-D-S saved much irrigated water with a small yield reduction, leading to an increase in water productivity by 22% in early-rice season and by 26% in late-rice season. The results indicate that CF is best for early-rice and FDS is best for late-rice in terms of grain yield and water productivity.	[Wu, Xiao Hong] Cent South Univ Forestry & Technol, Fac Life Sci & Technol, Changsha, Hunan, Peoples R China; [Wang, Wei; Yin, Chun Mei; Hou, Hai Jun; Xie, Xiao Li] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China; [Xie, Ke Jun] Hunan Agr Resources & Environm Protect Management, Changsha, Hunan, Peoples R China	Central South University of Forestry & Technology; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS	Wang, W (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China.	wangw@isa.ac.cn	Yu, Hongwei/L-3754-2017	Yu, Hongwei/0000-0002-5607-0628; , Wang/0000-0003-0542-661X	National Natural Science Foundation of China [41401292, 41503081]; International Science & Technology Cooperation Program of China [2015DFA90450]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China	This work was supported by the National Natural Science Foundation of China (grant numbers 41401292) to WW (http:/www.nsfc.gov.cn/); International Science & Technology Cooperation Program of China (grant number 2015DFA90450) to WW (http://www.istcp.org.cn/) and the National Natural Science Foundation of China (grant number 41503081) to XHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto MCR, 2011, AGR WATER MANAGE, V98, P1417, DOI 10.1016/j.agwat.2011.04.011; Bates B.C., 2008, TECHNICAL PAPER INTE, DOI DOI 10.1016/J.JMB.2010.08.039; Belder P, 2004, AGR WATER MANAGE, V65, P193, DOI 10.1016/j.agwat.2003.09.002; Bouman BAM, 2007, ADV AGRON, V92, P187, DOI 10.1016/S0065-2113(04)92004-4; Bouman BAM, 2007, AGR SYST, V93, P43, DOI 10.1016/j.agsy.2006.04.004; Bouman BAM, 2001, AGR WATER MANAGE, V49, P11, DOI 10.1016/S0378-3774(00)00128-1; Bouman BAM, 2007, WATER MANAGEMENT IRR, P44; Cabangon RJ, 2004, PADDY WATER ENVIRON, V2, P195, DOI 10.1007/s10333-004-0062-3; Chen SK, 2002, J HYDROL, V268, P259, DOI 10.1016/S0022-1694(02)00180-4; Chen SK, 2002, J HYDROL, V260, P206, DOI 10.1016/S0022-1694(01)00615-1; Dawe D, 2005, PLANT PROD SCI, V8, P221, DOI 10.1626/pps.8.221; Escasinas RO, 2011, PHILIPP J CROP SCI, V36, P37; Fong JDM, 2016, PADDY WATER ENVIRON, V14, P211, DOI 10.1007/s10333-015-0491-1; Frolking S., 2002, GLOBAL BIOGEOCHEM CY, V16; Janssen M, 2007, SOIL TILL RES, V94, P133, DOI 10.1016/j.still.2006.07.010; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Lampayan RM, 2015, FIELD CROP RES, V170, P95, DOI 10.1016/j.fcr.2014.10.013; Lu J, 2000, PLANT SOIL, V223, P209, DOI 10.1023/A:1004898504550; Nguyen HT, 2009, FIELD CROP RES, V112, P189, DOI 10.1016/j.fcr.2009.03.004; Pan SG, 2009, J FOOD AGRIC ENVIRON, V7, P559; Shao GC, 2015, AGR WATER MANAGE, V149, P156, DOI 10.1016/j.agwat.2014.11.002; Singh YV, 2013, PADDY WATER ENVIRON, V11, P531, DOI 10.1007/s10333-012-0346-y; Stuerz S, 2014, FIELD CROP RES, V163, P74, DOI 10.1016/j.fcr.2014.04.001; Tabbal DF, 2002, AGR WATER MANAGE, V56, P93, DOI 10.1016/S0378-3774(02)00007-0; Tan XZ, 2013, PADDY WATER ENVIRON, V11, P381, DOI 10.1007/s10333-012-0328-0; Tuong TP, 2003, COMP ASSESS WAT MAN, V1, P53, DOI 10.1079/9780851996691.0053; Xiong W, 2010, AGR ECOSYST ENVIRON, V135, P58, DOI 10.1016/j.agee.2009.08.015; Yan TT, 2015, ECOL MODEL, V318, P226, DOI 10.1016/j.ecolmodel.2014.12.021; Zhang QT, 2013, J INTEGR AGR, V12, P1363, DOI 10.1016/S2095-3119(13)60544-4	29	19	19	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189280	10.1371/journal.pone.0189280	http://dx.doi.org/10.1371/journal.pone.0189280			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216292	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800112
J	Zavrel, T; Ocenasova, P; Cerveny, J				Zavrel, Tomas; Ocenasova, Petra; Cerveny, Jan			Phenotypic characterization of Synechocystis sp PCC 6803 substrains reveals differences in sensitivity to abiotic stress	PLOS ONE			English	Article							SP STRAIN PCC-6803; HIGH-TEMPERATURE; SP PCC6803; CYANOBACTERIUM; GROWTH; RESPONSES; ACCLIMATION; GENE; PHOTOBIOREACTOR; IDENTIFICATION	Synechocystis sp. PCC 6803 is a widely used model cyanobacterium, whose substrains can vary on both genotype and phenotype levels. Previously described phenotypic variations include ability of mixotrophic growth, ability of movement on agar plates and variations in pigments composition or cell size. In this study, we report for the first time significant variation among Synechocystis substrains in complex cellular traits such as growth rate, photosynthesis efficiency, cellular dry weight and cellular composition (including protein or carbohydrates content). We also confirmed previously reported differences in cell size. Synechocystis cultures were cultivated in controlled environment of flat panel photobioreactors under red, blue and white light of intensities up to 790 mu mol(photons) m(-2) s(-1), temperatures 23 degrees C-60 degrees C, input CO2 concentrations ranging from 400 to 15 000 ppm and in BG11 cultivation medium with and without addition of NaCl. Three Synechocystis substrains were used for the comparative experiments: GT-L, GT-B (Brno, CZ) and PCC-B (Brno, CZ). Growth rates of Synechocystis GT-B were inhibited under high intensities of red light (585-670 nm), and growth rates of both substrains GT-B and PCC-B were inhibited under photons of wavelengths 485-585 nm and 670-700 nm. Synechocystis GT-B was more sensitive to low temperatures than the other two tested substrains, and Synechocystis GT-L was sensitive to the presence of NaCl in the cultivation media. The results suggest that stress sensitivity of commonly used Synechocystis substrains can strongly vary, similarly as glucose tolerance or motility as reported previously. Our study further supports the previous statement that emphasizes importance of proper Synechocystis substrains selection and awareness of phenotypical differences among Synechocystis substrains which is crucial for comparative and reproducible research. This is highly relevant for studies related to stress physiology and development of sustainable biotechnological applications.	[Zavrel, Tomas; Ocenasova, Petra; Cerveny, Jan] Global Change Res Inst CAS, Dept Adapt Biotechnol, Brno, Czech Republic	Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences	Zavrel, T (corresponding author), Global Change Res Inst CAS, Dept Adapt Biotechnol, Brno, Czech Republic.	zavrel.t@czechglobe.cz	Zavřel, Tomáš/L-5814-2019; Červený, Jan/J-1911-2012	Zavřel, Tomáš/0000-0002-0849-3503; Červený, Jan/0000-0002-5046-3105	Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Program I (NPU I) [LO1415]; GA CR [15-17367S]; Czech research infrastructure for systems biology C4SYS [LM2015055]	Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Program I (NPU I); GA CR(Grant Agency of the Czech Republic); Czech research infrastructure for systems biology C4SYS	T.Z and J.O. were supported by the Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Program I (NPU I), grant number LO1415. J.C. and P.O. were also supported by GA CR, Grant number 15-17367S and J.O. was also supported by the Czech research infrastructure for systems biology C4SYS (project no LM2015055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Dr. Maria Sinetova for valuable advices on experimental setup and discussion of the results, Petra Litera A kova A for technical assistance and Dr. Kristy A na Vecerova A for analysis of cellular fatty acid composition. T.Z and J.C. were supported by the Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Program I (NPU I), grant number LO1415. J.C. and P.O. were also supported by GA CR, Grant number 15-17367S. Access to instruments and other facilities was supported by the Czech research infrastructure for systems biology C4SYS (project no LM2015055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have declared that no competing interests exist.	BENNETT A, 1973, J CELL BIOL, V58, P419, DOI 10.1083/jcb.58.2.419; Cerveny Jan, 2015, Life-Basel, V5, P676, DOI 10.3390/life5010676; Cerveny J, 2009, ENG LIFE SCI, V9, P247, DOI 10.1002/elsc.200800123; Danika T, 2012, DNA RES, V19, P435, DOI 10.1093/dnares/dss024; Dilley RA, 2001, J BIOENERG BIOMEMBR, V33, P135, DOI 10.1023/A:1010752531909; Ding QL, 2015, INT J MOL SCI, V16, P24081, DOI 10.3390/ijms161024081; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fang F, 2003, CURR MICROBIOL, V47, P341, DOI 10.1007/s00284-002-4015-z; Fulda S, 2006, PROTEOMICS, V6, P2733, DOI 10.1002/pmic.200500538; GRIGORIEVA G, 1982, FEMS MICROBIOL LETT, V13, P367, DOI 10.1111/j.1574-6968.1982.tb08289.x; Grundel M, 2012, MICROBIOL-SGM, V158, P3032, DOI 10.1099/mic.0.062950-0; Hagemann M, 2011, FEMS MICROBIOL REV, V35, P87, DOI 10.1111/j.1574-6976.2010.00234.x; Hihara Y, 1997, PHOTOSYNTH RES, V53, P243, DOI 10.1023/A:1005879905365; HUFLEJT ME, 1990, PLANT PHYSIOL, V94, P1512, DOI 10.1104/pp.94.4.1512; Ikeuchi M, 2001, PHOTOSYNTH RES, V70, P73, DOI 10.1023/A:1013887908680; Inoue N, 2001, PLANT CELL PHYSIOL, V42, P1140, DOI 10.1093/pcp/pce147; Joseph A, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0017-z; Kahlon S, 2006, MICROBIOL-SGM, V152, P647, DOI 10.1099/mic.0.28510-0; Kana R, 2012, BBA-BIOENERGETICS, V1817, P1237, DOI 10.1016/j.bbabio.2012.02.024; Kaneko T, 1996, DNA Res, V3, P109; Kaneko T, 1995, DNA Res, V2, P153, DOI 10.1093/dnares/2.4.153; Kanesaki Y, 2012, DNA RES, V19, P67, DOI 10.1093/dnares/dsr042; Kirilovsky D., 2014, NONPHOTOCHEMICAL QUE; Kreslavski VD, 2012, J PHOTOCH PHOTOBIO C, V13, P190, DOI 10.1016/j.jphotochemrev.2012.01.002; Marin K, 2004, PLANT PHYSIOL, V136, P300, DOI DOI 10.1104/PP.104.045047; Mironov KS, 2016, LIGHT REGULATION COL, P881; Morris JN, 2014, NEW ZEAL J BOT, V52, P36, DOI 10.1080/0028825X.2013.846267; Morris JN, 2016, NZ J BOT; Nanjo Y, 2010, BBA-BIOENERGETICS, V1797, P1483, DOI 10.1016/j.bbabio.2010.03.014; Nazarenko LV, 2003, MICROBIOL-SGM, V149, P1147, DOI 10.1099/mic.0.26074-0; Nedbal L, 2008, BIOTECHNOL BIOENG, V100, P902, DOI 10.1002/bit.21833; Pade Nadin, 2015, Life-Basel, V5, P25, DOI 10.3390/life5010025; PLATT T, 1980, J MAR RES, V38, P687; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Sarsekeyeva F, 2015, PHOTOSYNTH RES, V125, P329, DOI 10.1007/s11120-015-0103-3; Sheng J, 2011, BIORESOURCE TECHNOL, V102, P11218, DOI 10.1016/j.biortech.2011.09.083; Sinetova MA, 2016, MOL BIOL+, V50, P606, DOI 10.1134/S0026893316040117; Sinetova MA, 2016, BBA-GEN SUBJECTS, V1860, P2391, DOI 10.1016/j.bbagen.2016.07.006; Sinetova MA, 2012, J BIOTECHNOL, V162, P148, DOI 10.1016/j.jbiotec.2012.04.009; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Tajima N, 2011, DNA RES, V18, P393, DOI 10.1093/dnares/dsr026; Tichy M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00648; Torrecilla I, 2001, PLANT CELL ENVIRON, V24, P641, DOI 10.1046/j.0016-8025.2001.00708.x; Touloupakis E, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0319-7; WADA H, 1990, PLANT PHYSIOL, V92, P1062, DOI 10.1104/pp.92.4.1062; Wijffels RH, 2013, CURR OPIN BIOTECH, V24, P405, DOI 10.1016/j.copbio.2013.04.004; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Zavrel T., 2015, BIO-PROTOCOL, V5, P1, DOI [10.21769/BioProtoc.1467, DOI 10.21769/BIOPROTOC.1467]; Zavrel T, 2015, ENG LIFE SCI, V15, P122, DOI 10.1002/elsc.201300165; Zerulla K, 2016, MICROBIOL-SGM, V162, P730, DOI 10.1099/mic.0.000264	50	24	24	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189130	10.1371/journal.pone.0189130	http://dx.doi.org/10.1371/journal.pone.0189130			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216280	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800079
J	Ferro, A; Carbone, E; Zhang, J; Marzouk, E; Villegas, M; Siegel, A; Nguyen, D; Possidente, T; Hartman, J; Polley, K; Ingram, MA; Berry, G; Reynolds, TH; Possidente, B; Frederick, K; Ives, S; Lagalwar, S				Ferro, Austin; Carbone, Emily; Zhang, Jenny; Marzouk, Evan; Villegas, Monica; Siegel, Asher; Nguyen, Donna; Possidente, Thomas; Hartman, Jessilyn; Polley, Kailen; Ingram, Melissa A.; Berry, Georgia; Reynolds, Thomas H.; Possidente, Bernard; Frederick, Kimberley; Ives, Stephen; Lagalwar, Sarita			Short-term succinic acid treatment mitigates cerebellar mitochondrial OXPHOS dysfunction, neurodegeneration and ataxia in a Purkinje-specific spinocerebellar ataxia type 1 (SCA1) mouse model	PLOS ONE			English	Article							COMPLEX-I; TRANSGENIC MICE; CAG REPEAT; PROTEIN; DISEASE; EXPRESSION; ONSET; PHOSPHORYLATION; LOCALIZATION; PROGRESSION	Mitochondrial dysfunction plays a significant role in neurodegenerative disease including ataxias and other movement disorders, particularly those marked by progressive degeneration in the cerebellum. In this study, we investigate the role of mitochondrial oxidative phosphorylation (OXPHOS) deficits in cerebellar tissue of a Purkinje cell-driven spinocerebellar ataxia type 1 (SCA1) mouse. Using RNA sequencing transcriptomics, OXPHOS complex assembly analysis and oxygen consumption assays, we report that in the presence of mutant polyglutamine-expanded ataxin-1, SCA1 mice display deficits in cerebellar OXPHOS complex I (NADH-coenzyme Q oxidoreductase). Complex I genes are upregulated at the time of symptom onset and upregulation persists into late stage disease; yet, functional assembly of complex I macromolecules are diminished and oxygen respiration through complex I is reduced. Acute treatment of postsymptomatic SCA1 mice with succinic acid, a complex II (succinate dehydrogenase) electron donor to bypass complex I dysfunction, ameliorated cerebellar OXPHOS dysfunction, reduced cerebellar pathology and improved motor behavior. Thus, exploration of mitochondrial dysfunction and its role in neurodegenerative ataxias, and warrants further investigation.	[Ferro, Austin; Carbone, Emily; Zhang, Jenny; Marzouk, Evan; Villegas, Monica; Nguyen, Donna; Possidente, Thomas; Hartman, Jessilyn; Polley, Kailen; Berry, Georgia; Possidente, Bernard; Lagalwar, Sarita] Skidmore Coll, Neurosci Program, Saratoga Springs, NY 12866 USA; [Siegel, Asher; Frederick, Kimberley] Skidmore Coll, Dept Chem, Saratoga Springs, NY 12866 USA; [Ingram, Melissa A.] Univ Minnesota, Dept Lab Med & Pathol, Inst Translat Neurosci, Minneapolis, MN 55455 USA; [Reynolds, Thomas H.; Ives, Stephen] Skidmore Coll, Hlth & Exercise Sci Dept, Saratoga Springs, NY 12866 USA; [Possidente, Bernard] Skidmore Coll, Dept Biol, Saratoga Springs, NY 12866 USA; [Ferro, Austin] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN USA	Skidmore College; Skidmore College; University of Minnesota System; University of Minnesota Twin Cities; Skidmore College; Skidmore College; University of Minnesota System; University of Minnesota Twin Cities	Lagalwar, S (corresponding author), Skidmore Coll, Neurosci Program, Saratoga Springs, NY 12866 USA.	slagalwa@skidmore.edu	Siegel, Asher/ABD-8259-2021; Ives, Steve/GNH-0750-2022	Reynolds, Thomas/0000-0002-0290-528X; Carbone, Emily/0000-0002-6377-2847	National Science Foundation MRI [DBI-1337280]	National Science Foundation MRI(National Science Foundation (NSF))	The work was supported by National Science Foundation MRI (DBI-1337280) to Sarita Lagalwar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo-Molina A, 2013, NUTR CANC; Archer DF, 2013, MENOPAUSE, V20, P47, DOI 10.1097/gme.0b013e3182775fe9; Ariza Ana Carolina, 2012, Front Endocrinol (Lausanne), V3, P22, DOI 10.3389/fendo.2012.00022; BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8; Breuer ME, 2012, NEUROBIOL DIS; Breuer ME, 2012, J INHERIT METAB DIS, V35, P193, DOI 10.1007/s10545-011-9375-8; Budd SL, 1998, ESSAYS BIOCHEM, V33, P43, DOI 10.1042/bse0330043; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Burright EN, 1997, BRAIN PATHOL, V7, P965, DOI 10.1111/j.1750-3639.1997.tb00896.x; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Chakrabarti L, 2010, NEURON, V66, P835, DOI 10.1016/j.neuron.2010.05.024; Clark HB, 1997, J NEUROSCI, V17, P7385; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Duvick L, 2010, NEURON, V67, P929, DOI 10.1016/j.neuron.2010.08.022; Ebadi M, 2001, BIOL SIGNAL RECEPT, V10, P224; Ergoenuel PG, 2010, CZECH J FOOD SCI, V28, P202, DOI 10.17221/1379-CJFS; Ferro A, 2017, JOVE-J VIS EXP, DOI 10.3791/53758; Fonseca MD, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0126-1; Gilissen J, 2016, PHARMACOL THERAPEUT, V159, P56, DOI 10.1016/j.pharmthera.2016.01.008; Girard M, 2012, P NATL ACAD SCI USA, V109, P1661, DOI 10.1073/pnas.1113166109; Hagenauer MH, 2011, HORM BEHAV, V60, P46, DOI 10.1016/j.yhbeh.2011.03.001; HAINES JL, 1984, NEUROLOGY, V34, P1542, DOI 10.1212/WNL.34.12.1542; Heidari MM, 2009, CAN J NEUROL SCI, V36, P26, DOI 10.1017/S0317167100006260; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hinke SA, 2007, BRIT J PHARMACOL, V150, P1031, DOI 10.1038/sj.bjp.0707189; Ingram M, 2016, NEURON, V89, P1194, DOI 10.1016/j.neuron.2016.02.011; Jorgensen ND, 2009, J NEUROCHEM, V110, P675, DOI 10.1111/j.1471-4159.2009.06164.x; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lagalwar Sarita, 2013, Methods Mol Biol, V1010, P201, DOI 10.1007/978-1-62703-411-1_13; Lai B, 2005, EXP NEUROL, V194, P484, DOI 10.1016/j.expneurol.2005.03.005; Lai SJ, 2011, J BIOL CHEM, V286, P34606, DOI 10.1074/jbc.M111.238527; Leach RM, 2001, J PHYSIOL-LONDON, V536, P211, DOI 10.1111/j.1469-7793.2001.00211.x; Liebowitz MR, 2007, J CLIN PSYCHIAT, V68, P1663, DOI 10.4088/JCP.v68n1105; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Manczak M, 2004, NEUROMOL MED, V5, P147, DOI 10.1385/NMM:5:2:147; Martin MA, 2005, ARCH NEUROL-CHICAGO, V62, P659, DOI 10.1001/archneur.62.4.659; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Nie Y., 2015, BIO PROTOC, V5; Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328; Nowak G, 2008, J PHARMACOL EXP THER, V324, P1155, DOI 10.1124/jpet.107.130872; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Oyedotun KS, 2004, J BIOL CHEM, V279, P9424, DOI 10.1074/jbc.M311876200; Park J, 2013, NATURE, V498, P325, DOI 10.1038/nature12204; Peskov AB, 2005, B EXP BIOL MED+, V140, P312, DOI 10.1007/s10517-005-0476-y; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Sandhir R, 2010, NEUROCHEM INT, V57, P579, DOI 10.1016/j.neuint.2010.07.005; Saratikov A. S., 2000, Eksperimental'naya i Klinicheskaya Farmakologiya, V63, P56; Schulz JB, 1997, MOL CELL BIOCHEM, V174, P193, DOI 10.1023/A:1006852306789; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Stucki DM, 2016, FREE RADICAL BIO MED, V97, P427, DOI 10.1016/j.freeradbiomed.2016.07.005; Sugino T, 1999, NEUROSCI LETT, V259, P9, DOI 10.1016/S0304-3940(98)00875-1; Tretter L, 2016, BBA-BIOENERGETICS, V1857, P1086, DOI 10.1016/j.bbabio.2016.03.012; VANDAELE S, 1991, GENE DEV, V5, P1136, DOI 10.1101/gad.5.7.1136; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25; Zhu J, 2007, P NATL ACAD SCI USA, V104, P4864, DOI 10.1073/pnas.0607812104; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609	61	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188425	10.1371/journal.pone.0188425	http://dx.doi.org/10.1371/journal.pone.0188425			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211771	Green Submitted, Green Published, gold			2022-12-27	WOS:000417212200031
J	Silva, DN; Oria, AP; Araujo, NL; Martins, E; Muramoto, C; Liborio, FD; Estrela-Lima, A				Silva, Danielle Nascimento; Oria, Arianne Pontes; Araujo, Nayone Lantyer; Martins-Filho, Emanoel; Muramoto, Caterina; Liborio, Fernanda de Azevedo; Estrela-Lima, Alessandra			Morphological study of the eye and adnexa in capuchin monkeys (Sapajus sp.)	PLOS ONE			English	Article							ANATOMICAL VARIATIONS; PRIMATES; ORIGINS; ORBIT	The objective of this study was to describe the anatomic and histologic features of the Sapajus sp. eye, comparing similarities and differences of humans and other species of non-human primates for biomedical research purposes. Computed tomography (CT) of adnexa, eye and orbit live animal, as well as formolized pieces of the same structures of Sapajus sp. for anatomical and histological study were also performed. The anatomical description of the eye and adnexa was performed using the techniques of topographic dissection and exenteration. Histological fragments were fixated in buffered formalin 10%, processed by the routine paraffin inclusion technique, stained with hematoxylin-eosin and special stains. CT scan evaluation showed no differences between the live animal and the formolized head on identification of visual apparatus structures. Anatomic and histologic evaluation revealed rounded orbit, absence of the supraorbital foramen and frontal notch, little exposure of the sclera, with slight pigmentation of the exposed area and marked pigmentation at the sclerocorneal junction. Masson's Trichrome revealed the Meibomian glands, the corneal epithelium and Bowman's membrane; in the choroid, melanocytes and Bruch's membrane were observed; and in the retina, cones and rods as well as, optic nerve, the lamina cribrosa of the nerve fibers bundles. Toluidine blue highlighted the membranes: Bowman, Descemet and the endothelium; in the choroid: melanocytes; and in the retina: nuclear layers and retinal pigment epithelium. In view of the observed results Sapajus sp. is an important experimental model for research in the ophthalmology field, which has been shown due to the high similarity of its anatomical and histological structures with the human species.	[Silva, Danielle Nascimento; Oria, Arianne Pontes; Araujo, Nayone Lantyer; Estrela-Lima, Alessandra] Univ Fed Bahia, Postgrad Program Anim Sci Trop, Salvador, BA, Brazil; [Oria, Arianne Pontes; Muramoto, Caterina; Estrela-Lima, Alessandra] Univ Fed Bahia, Dept Anat Pathol & Vet Clin, Salvador, BA, Brazil; [Martins-Filho, Emanoel] Fdn Res Support State Bahia, Reg Sci & Technol Dev Program, Salvador, BA, Brazil; [Liborio, Fernanda de Azevedo] Brazilian Inst Environm & Renewable Nat Resources, Screening Ctr Wild Anim, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia	Estrela-Lima, A (corresponding author), Univ Fed Bahia, Postgrad Program Anim Sci Trop, Salvador, BA, Brazil.; Estrela-Lima, A (corresponding author), Univ Fed Bahia, Dept Anat Pathol & Vet Clin, Salvador, BA, Brazil.	alestrela@gmail.com	Estrela-Lima, Alessandra/AAL-2745-2021; Oriá, Arianne Pontes/AAB-7059-2019; Filho, Emanoel Ferreira Martins/AAK-7178-2021	Estrela-Lima, Alessandra/0000-0002-9879-7999; Oriá, Arianne Pontes/0000-0001-5093-6841; Filho, Emanoel Ferreira Martins/0000-0002-0542-5468; Araujo, Nayone/0000-0002-3305-3147				Agthong S, 2005, J ORAL MAXIL SURG, V63, P800, DOI 10.1016/j.joms.2005.02.016; Altavini TS, 2012, INT J PRIMATOL, V33, P1467, DOI 10.1007/s10764-012-9638-8; Ankel-Simons F, 2007, PRIMATE ANATOMY INTR, P470; [Anonymous], 2014, TRATADO ANIMAIS SELV; ARAO T, 1968, ANAT REC, V162, P53, DOI 10.1002/ar.1091620106; Archana Sarma, 1998, INDIAN J VET ANATOMY, V10, P5; Aviv RI, 2005, CLIN RADIOL, V60, P279, DOI 10.1016/j.crad.2004.05.017; Banzato T, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-53; Beer GM, 1998, PLAST RECONSTR SURG, V102, P334, DOI 10.1097/00006534-199808000-00006; Bicca-Marques JC, 2005, AM J PRIMATOL, V65, P141, DOI 10.1002/ajp.20104; Borthakur S., 2000, Indian Journal of Veterinary Anatomy, V12, P1; Bron AJ., 1997, WOLFFS ANATOMY EYE O, V8; Chastain JB, 2006, OTOLARYNG CLIN N AM, V39, P855, DOI 10.1016/j.otc.2006.07.003; Daniel GB, 1999, CLIN TECH SMALL AN P, V14, P160, DOI 10.1016/S1096-2867(99)80032-2; Diesem C, 1975, ANATOMIA ANIMAIS DOM, P207; Diesem C, 1975, SISSON GROSSMAN ANAT, P207; Dua HS, 2013, OPHTHALMOLOGY, V120, P1778, DOI 10.1016/j.ophtha.2013.01.018; Elias M. G., 2004, Int. J. Morphol., V22, P273, DOI 10.4067/S0717-95022004000400006; Ettl A, 2000, SURV OPHTHALMOL, V44, P303, DOI 10.1016/S0039-6257(99)00115-0; Fernandez JRR, 2013, VET OPHTHALMOL, V16, P94, DOI 10.1111/vop.12070; Ferreira RGF, 2012, ACTA SCI MED, V5, P2; Gartner LP, 2014, COLOR ATLAS TEXT HIS, P454; Gasser K, 2011, VET OPHTHALMOL, V14, P26, DOI 10.1111/j.1463-5224.2010.00836.x; Getty R, 1975, SISSON GROSSMAN ANAT, V5th; Gilroy AM, 2014, ATLAS ANATOMIA BASEA; Heesy CP, 2001, J HUM EVOL, V40, P111, DOI 10.1006/jhev.2000.0447; Junqueira L., 2004, HISTOLOGIA BASICA; Kawana K, 2004, BRIT J OPHTHALMOL, V88, P466, DOI 10.1136/bjo.2003.030361; Kirk EC, 2006, J HUM EVOL, V51, P159, DOI 10.1016/j.jhevol.2006.02.004; Knapp S, 2007, VET OPHTHALMOL, V10, P357, DOI 10.1111/j.1463-5224.2007.00568.x; Kobayashi H, 2001, J HUM EVOL, V40, P419, DOI 10.1006/jhev.2001.0468; Krebs W., 1991, PRIMATE RETINA CHORO; Lange RR, 2012, VET OPHTHALMOL, V15, P376, DOI 10.1111/j.1463-5224.2012.00998.x; Leite A. G. B., 2013, Ars Veterinaria, V29, P42; Martin RD, 2012, CURR BIOL, V22, pR785, DOI 10.1016/j.cub.2012.07.015; McMinn RMH, 2005, ATLAS COLORIDO ANATO; Meekins JM, 2015, VET OPHTHALMOL, V19, P1; Merindano DM, 2002, EUR J ANAT, V6, P133; Montiani-Ferreira F, 2008, VET OPHTHALMOL, V11, P197, DOI 10.1111/j.1463-5224.2008.00620.x; NATORI Y, 1995, NEUROSURGERY, V36, P762, DOI 10.1227/00006123-199504000-00018; Penninck D, 2001, CLIN TECH SMALL AN P, V16, P22, DOI 10.1053/svms.2001.22802; Pereira CB, 1979, MANUAL CRANIOMETRIC; Perrett DI., 1990, COMP PERCEPTION, P187; Pissinatti A, 2014, HUMAN PRIMATES SCI U; Prophet E. B., 1992, LAB METHODS HISTOTEC; Raposo ACS, 2015, J MED PRIMATOL, V44, P381, DOI 10.1111/jmp.12200; Ross C, 1996, AM J PRIMATOL, V40, P205, DOI 10.1002/(SICI)1098-2345(1996)40:3<205::AID-AJP1>3.0.CO;2-1; ROSS CF, 1995, J HUM EVOL, V29, P201, DOI 10.1006/jhev.1995.1057; Ross CF, 2000, ANNU REV ANTHROPOL, V29, P147, DOI 10.1146/annurev.anthro.29.1.147; Samuelson DA, 2013, VET OPHTHALMOL, P39; Sarma K, 2002, INDIAN J ANIM SCI, V72, P13; Sarma Kamal, 2006, Int. J. Morphol., V24, P449, DOI 10.4067/S0717-95022006000400025; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Saylam C, 2003, J CRANIOFAC SURG, V14, P10, DOI 10.1097/00001665-200301000-00003; Silva JV, 2013, ANATOMICAL FUNCTIONA, P5; Silva JV, 2013, DISCIPLINE OPHTHALMO, P5; Silveira LCL, 2003, PROG BRAIN RES, V144, P21, DOI 10.1016/S0079-6123(03)14400-2; Slatter DH, FUNDAMENTO OFTALMOLO; Sobotta J., 2007, SOBOTTA ATLAS HISTOL; Sobotta J, 2006, SOBOTTA ATLAS ANATOM, V1; TENAZA RR, 1989, AM J PRIMATOL, V17, P81, DOI 10.1002/ajp.1350170108; The Association for Research in Vision and Ophthalmology, 1985, NAT I HLTH PUBL; Torres LB, 2010, AM J PRIMATOL, V72, P1055, DOI 10.1002/ajp.20864; Turvey TA, 2012, ORAL MAXIL SURG CLIN, V24, P525, DOI 10.1016/j.coms.2012.08.003; Wichmann W, 2004, EUR J RADIOL, V49, P8, DOI 10.1016/j.ejrad.2003.11.001	65	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0186569	10.1371/journal.pone.0186569	http://dx.doi.org/10.1371/journal.pone.0186569			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO8CU	29206882	Green Submitted, Green Published, gold			2022-12-27	WOS:000417110700001
J	Tahtali, D; Bohmann, F; Kurka, N; Rostek, P; Todorova-Rudolph, A; Buchkremer, M; Abruscato, M; Hartmetz, AK; Kuhlmann, A; Henke, C; Stegemann, A; Menon, S; Misselwitz, B; Reihs, A; Weidauer, S; Thonke, S; Meyding-Lamade, U; Singer, O; Steinmetz, H; Pfeilschifter, W				Tahtali, Damla; Bohmann, Ferdinand; Kurka, Natalia; Rostek, Peter; Todorova-Rudolph, Anelia; Buchkremer, Martin; Abruscato, Mario; Hartmetz, Ann-Kathrin; Kuhlmann, Andrea; Henke, Christian; Stegemann, Andre; Menon, Sanjay; Misselwitz, Bjeorn; Reihs, Anke; Weidauer, Stefan; Thonke, Sven; Meyding-Lamade, Uta; Singer, Oliver; Steinmetz, Helmuth; Pfeilschifter, Waltraud			Implementation of stroke teams and simulation training shortened process times in a regional stroke network-A network-wide prospective trial	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; CREW RESOURCE-MANAGEMENT; THROMBOLYSIS; HOSPITALS; THERAPY; TRENDS	Background To meet the requirements imposed by the time-dependency of acute stroke therapies, it is necessary 1) to initiate structural and cultural changes in the breadth of stroke-ready hospitals and 2) to find new ways to train the personnel treating patients with acute stroke. We aimed to implement and validate a composite intervention of a stroke team algorithm and simulation-based stroke team training as an effective quality initiative in our regional interdisciplinary neurovascular network consisting of 7 stroke units. Methods We recorded door-to-needle times of all consecutive stroke patients receiving thrombolysis at seven stroke units for 3 months before and after a 2 month intervention which included setting up a team-based stroke workflow at each stroke unit, a train-the-trainer seminar for stroke team simulation training and a stroke team simulation training session at each hospital as well as a recommendation to take up regular stroke team trainings. Results The intervention reduced the network-wide median door-to-needle time by 12 minutes from 43,0 (IQR 29,8-60,0, n = 122) to 31,0 (IQR 24,0-42,0, n = 112) minutes (p < 0.001) and substantially increased the share of patients receiving thrombolysis within 30 minutes of hospital arrival from 41.5% to 59.6% (p < 0.001). Stroke team training participants stated a significant increase in knowledge on the topic of acute stroke care and in the perception of patient safety. The overall course concept was regarded as highly useful by most participants from different professional backgrounds. Conclusions The composite intervention of a binding team-based algorithm and stroke team simulation training showed to be well-transferable in our regional stroke network. We provide suggestions and materials for similar campaigns in other stroke networks.	[Tahtali, Damla; Bohmann, Ferdinand; Kurka, Natalia; Singer, Oliver; Steinmetz, Helmuth; Pfeilschifter, Waltraud] Univ Hosp Frankfurt, Dept Neurol, Frankfurt, Germany; [Rostek, Peter] Univ Hosp Frankfurt, NICU Nursing Staff, Frankfurt, Germany; [Todorova-Rudolph, Anelia; Buchkremer, Martin] Vitos Weil Lahn, Dept Neurol, Weilmunster, Germany; [Abruscato, Mario; Thonke, Sven] Klinikum Hanau, Dept Neurol, Hanau, Germany; [Hartmetz, Ann-Kathrin; Kuhlmann, Andrea; Meyding-Lamade, Uta] Krankenhaus NW Frankfurt, Dept Neurol, Frankfurt, Germany; [Henke, Christian] Helios HSK Wiesbaden, Dept Neurol, Wiesbaden, Germany; [Stegemann, Andre; Weidauer, Stefan] Sankt Katharinen Krankenhaus, Dept Neurol, Frankfurt, Germany; [Menon, Sanjay] Klinikum Aschaffenburg Alzenau, Dept Neurol, Aschaffenburg, Germany; [Misselwitz, Bjeorn; Reihs, Anke] GQH, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Krankenhaus Nordwest	Pfeilschifter, W (corresponding author), Univ Hosp Frankfurt, Dept Neurol, Frankfurt, Germany.	w.pfeilschifter@med.uni-frankfurt.de			Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	Boehringer Ingelheim supported this study with a research grant of 10.000,00 Euros to WP. The funder had not role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Flin R, 2015, BEST PRACT RES-CLIN, V29, P27, DOI 10.1016/j.bpa.2015.02.002; Foerch C, 2008, DTSCH ARZTEBL INT, V105, P467, DOI 10.3238/arztebl.2008.0467; Gaba DM, 2000, BRIT MED J, V320, P785, DOI 10.1136/bmj.320.7237.785; Gal J, CLIN EMERGENCY MED I; Goyal M, 2016, RADIOLOGY, V279, P888, DOI 10.1148/radiol.2016160204; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Kohrmann M, 2011, INT J STROKE, V6, P493, DOI 10.1111/j.1747-4949.2011.00585.x; Leys D, 2007, STROKE, V38, P2985, DOI 10.1161/STROKEAHA.107.487967; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; Meretoja A, 2012, NEUROLOGY, V79, P306, DOI 10.1212/WNL.0b013e31825d6011; Saver JL, 2009, STROKE, V40, P2433, DOI 10.1161/STROKEAHA.108.543561; Schwamm LH, 2013, CIRC-CARDIOVASC QUAL, V6, P543, DOI 10.1161/CIRCOUTCOMES.111.000303; Strbian D, 2015, STROKE, V46, P1275, DOI 10.1161/STROKEAHA.114.007170; Tahtali D, 2016, NERVENARZT, V87, P1322, DOI 10.1007/s00115-016-0162-5; Tahtali D, 2017, JOVE-J VIS EXP, DOI 10.3791/55138	17	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188231	10.1371/journal.pone.0188231	http://dx.doi.org/10.1371/journal.pone.0188231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206838	Green Published, gold, Green Submitted			2022-12-27	WOS:000417110700009
J	Xu, WY; Ohanjanian, L; Sun, JF; Cui, XZ; Suffredini, D; Li, Y; Welsh, J; Eichacker, PQ				Xu, Wanying; Ohanjanian, Lernik; Sun, Junfeng; Cui, Xizhong; Suffredini, Dante; Li, Yan; Welsh, Judith; Eichacker, Peter Q.			A systematic review and meta-analysis of preclinical trials testing anti-toxin therapies for B. anthracis infection: A need for more robust study designs and results	PLOS ONE			English	Correction																		Xu WY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182879	1	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0189239	10.1371/journal.pone.0189239	http://dx.doi.org/10.1371/journal.pone.0189239			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29200425	Green Published, Green Submitted, gold			2022-12-27	WOS:000417033200029
J	Neureiter, E; Hajfani, L; Ahnis, A; Mierke, A; Rose, M; Danzer, G; Klapp, BF				Neureiter, Elisabeth; Hajfani, Loreen; Ahnis, Anne; Mierke, Annett; Rose, Matthias; Danzer, Gerhard; Klapp, Burghard F.			An introduction to the 'Psycho-PhysiologicalStress- Test' (PPST)-A standardized instrument for evaluating stress reactions	PLOS ONE			English	Article								Using a standardized instrument to evaluate patients' stress reactions has become more important in daily clinical routines. Different signs or symptoms of stress are often unilaterally explored: the physiological, psychological or social aspects of stress disorders are each viewed on a single dimension. However, all dimensions afflict patients who have persistent health problems due to chronic stress. Therefore, it is important to use a multidimensional approach to acquire data. The 'Psycho-Physiological-Stress-Test' (PPST) was established to achieve a comprehensive understanding of stress and was further developed at the Charite A-Universitatsmedizin Berlin in collaboration with the Psychological Department of Freie Universitat Berlin. The PPST includes a series of varying stress phases, embedded in two periods of rest. Physiological and psychological parameters are simultaneously measured throughout the test session. Specifically, the PPST activates the sympathetic stress axis, which is measured by heart rate, blood pressure, respiration depth and rate, electro dermal activation and muscle tension (frontalis, masseter, trapezius). Psychological data are simultaneously collected, and include performance, motivation, emotion and behavior. After conducting this diagnostic test, it is possible to identify individual stress patterns that can be discussed with the individual patient to develop and recommend (outpatient) treatment strategies. This paper introduces the PPST as a standardized way to evaluate stress reactions by presenting the results from a sample of psychosomatic inpatients (n = 139) who were treated in Charite A-Universitatsmedizin Berlin, Germany. We observed that the varying testing conditions provoked adjusted changes in the different physiological parameters and psychological levels.	[Neureiter, Elisabeth; Hajfani, Loreen; Ahnis, Anne; Mierke, Annett; Rose, Matthias; Danzer, Gerhard; Klapp, Burghard F.] Charite, Ctr Internal Med & Dermatol, Div Gen Internal & Psychosomat Med, Berlin, Germany; [Neureiter, Elisabeth; Danzer, Gerhard] Alpen Adria Univ Klagenfurt, Klagenfurt, Austria; [Danzer, Gerhard] Med Univ Brandenburg, Div Gen Internal & Psychosomat Med, Campus Ruppiner Kliniken, Neuruppin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Klagenfurt	Neureiter, E (corresponding author), Charite, Ctr Internal Med & Dermatol, Div Gen Internal & Psychosomat Med, Berlin, Germany.	elisabeth.neureiter@charite.de		Neureiter, Elisabeth/0000-0002-9441-8963				Bibbey A, 2013, INT J PSYCHOPHYSIOL, V90, P28, DOI 10.1016/j.ijpsycho.2012.10.018; Burch AE, 2014, INT J PSYCHOPHYSIOL, V94, P1, DOI 10.1016/j.ijpsycho.2014.07.002; Bussmann JBJ, 2009, EUR PSYCHOL, V14, P142, DOI 10.1027/1016-9040.14.2.142; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Crum AJ, 2013, J PERS SOC PSYCHOL, V104, P716, DOI 10.1037/a0031201; Fairburn CG, 1999, BEHAV RES THER, V37, P1, DOI 10.1016/S0005-7967(98)00102-8; Feher R., 2013, THESIS; Fliege H., 2001, DIAGNOSTICA, P510; FREDRIKSON M, 1989, J PSYCHOSOM RES, V33, P753, DOI 10.1016/0022-3999(89)90091-3; Gerhardt M., 2004, THESIS; Gromen A., 2002, THESIS; Hellhammer J, 2012, PSYCHONEUROENDOCRINO, V37, P119, DOI 10.1016/j.psyneuen.2011.05.012; Henningsen P, 2003, PSYCHOSOM MED, V65, P528, DOI 10.1097/01.PSY.0000075977.90337.E7; Horhold M., 1994, PSYCHOPHYSIOLOGIE BE; Iliceto P, 2013, STRESS, V16, P143, DOI 10.3109/10253890.2012.689896; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kirschbaum C., 1991, PERSPECTIVES PROMISE, P67, DOI [10.1007/978-1-4899-3674-5_7, DOI 10.1007/978-1-4899-3674-5_7]; Klapp B. F., 2010, UEXKULL PSYCHOSOMATI, P43; Kolotylova T, 2010, PSYCHOTHER PSYCH MED, V60, P64, DOI 10.1055/s-0028-1103297; Kreibig SD, 2013, PSYCHOPHYSIOLOGY, V50, P799, DOI 10.1111/psyp.12064; LAZARUS RS, 1963, ADMIN SCI QUART, V8, P192, DOI 10.2307/2390899; LAZARUS RS, 1974, INT J PSYCHIAT MED, V5, P321, DOI 10.2190/T43T-84P3-QDUR-7RTP; Lazarus RS., 1984, STRESS APPRAISAL COP; Mutsuura H, 2009, APPL PSYCHOPHYS BIOF, V34, P291, DOI 10.1007/s10484-009-9110-5; POLLAK MH, 1994, PSYCHOSOM MED, V56, P271, DOI 10.1097/00006842-199405000-00015; Reid S, 2002, BRIT J PSYCHIAT, V180, P248, DOI 10.1192/bjp.180.3.248; Rief W, 2004, J AFFECT DISORDERS, V82, P271, DOI 10.1016/j.jad.2003.11.006; Selye H, 1975, Compr Ther, V1, P9; SELYE H, 1973, AM SCI, V61, P692; Sugaya N, 2012, INT J PSYCHOPHYSIOL, V84, P39, DOI 10.1016/j.ijpsycho.2012.01.006; Tureba A., 2013, BRAIN BEHAV IMMUN, P11; WATERINK W, 1994, BIOL PSYCHOL, V37, P183, DOI 10.1016/0301-0511(94)90001-9; World Health Organisation, 2019, INT STAT CLASS DIS R, V11th	33	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0187859	10.1371/journal.pone.0187859	http://dx.doi.org/10.1371/journal.pone.0187859			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO5CX	29194437	Green Published, gold, Green Submitted			2022-12-27	WOS:000416867800009
J	Popowicz, ND; Lansley, SM; Cheah, HM; Kay, ID; Carson, CF; Waterer, GW; Paton, JC; Brown, JS; Lee, YCG				Popowicz, Natalia D.; Lansley, Sally M.; Cheah, Hui M.; Kay, Ian D.; Carson, Christine F.; Waterer, Grant W.; Paton, James C.; Brown, Jeremy S.; Lee, Y. C. Gary			Human pleural fluid is a potent growth medium for Streptococcus pneumoniae	PLOS ONE			English	Article							IRON UPTAKE; PARAPNEUMONIC EMPYEMA; ABC TRANSPORTER; VIRULENCE; PNEUMOLYSIN; MICE; PSAA; MECHANISMS; AUTOLYSIN; CHILDREN	Empyema is defined by the presence of bacteria and/or pus in pleural effusions. However, the biology of bacteria within human pleural fluid has not been studied. Streptococcus pneumoniae is the most common cause of pediatric and frequent cause of adult empyema. We investigated whether S. pneumoniae can proliferate within human pleural fluid and if growth is affected by the cellular content of the fluid and/or characteristics of pneumococcal surface proteins. Invasive S. pneumoniae isolates (n = 24) and reference strain recovered from human blood or empyema were inoculated (1.5x10(6) CFU/mL) into sterile human malignant pleural fluid samples (n = 11). All S. pneumoniae (n = 25) strains proliferated rapidly, increasing by a median of 3009 (IQR 1063-9846) from baseline at 24hrs in all pleural effusions tested. Proliferation was greater than in commercial pneumococcal culture media and concentrations were maintained for 48hrs without autolysis. A similar magnitude of proliferation was observed in pleural fluid before and after removal of its cellular content, p = 0.728. S. pneumoniae (D39 strain) wild-type, and derivatives (n = 12), each with mutation(s) in a different gene required for full virulence were inoculated into human pleural fluid (n = 8). S. pneumoniae with pneumococcal surface antigen A (triangle psaA) mutation failed to grow (2207-fold lower than wild-type), p< 0.001, however growth was restored with manganese supplementation. Growth of other common respiratory pathogens (n = 14) across pleural fluid samples (n = 7) was variable and inconsistent, with some strains failing to grow. We establish for the first time that pleural fluid is a potent growth medium for S. pneumoniae and proliferation is dependent on the PsaA surface protein and manganese.	[Popowicz, Natalia D.] Sir Charles Gairdner Hosp, Pharm Dept, Perth, WA, Australia; [Popowicz, Natalia D.; Carson, Christine F.; Waterer, Grant W.; Lee, Y. C. Gary] Univ Western Australia, Div Med, Perth, WA, Australia; [Popowicz, Natalia D.; Lansley, Sally M.; Cheah, Hui M.; Lee, Y. C. Gary] Univ Western Australia, Inst Resp Hlth, Perth, WA, Australia; [Kay, Ian D.] Royal Perth Hosp, PathWest Lab Med, Dept Microbiol & Infect Dis, Perth, WA, Australia; [Waterer, Grant W.] Royal Perth Hosp, Resp Dept, Perth, WA, Australia; [Paton, James C.] Univ Adelaide, Dept Mol & Cellular Biol, Res Ctr Infect Dis, Adelaide, SA, Australia; [Brown, Jeremy S.] UCL, Ctr Inflammat & Tissue Repair, Resp Med, London, England; [Lee, Y. C. Gary] Sir Charles Gairdner Hosp, Resp Dept, Perth, WA, Australia	University of Western Australia; University of Western Australia; Royal Perth Hospital; Royal Perth Hospital; University of Western Australia; University of Adelaide; University of London; University College London; University of Western Australia	Lee, YCG (corresponding author), Univ Western Australia, Div Med, Perth, WA, Australia.; Lee, YCG (corresponding author), Univ Western Australia, Inst Resp Hlth, Perth, WA, Australia.; Lee, YCG (corresponding author), Sir Charles Gairdner Hosp, Resp Dept, Perth, WA, Australia.	Gary.lee@uwa.edu.au	Carson, Christine F/F-1521-2013; Waterer, Grant/AAG-2385-2021; CHeah, Hui Min/AAU-3478-2020; Popowicz, Natalia/M-7505-2018; Lee, Y C Gary/H-5264-2014	Carson, Christine F/0000-0003-3669-1651; Popowicz, Natalia/0000-0003-0200-1819; Brown, Jeremy/0000-0002-5650-5361; Lee, Yun Chor Gary/0000-0002-0036-511X; Cheah, Hui Min/0000-0003-1292-4561	NHMRC; New South Wales Dust Disease Board (DDB); Sir Charles Gairdner Research Advisory Committee; Institute for Respiratory Health Westcare Alan King Grants; Cancer Council of Western Australia; Department of Health's NIHR Biomedical Research Centre's funding scheme	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Dust Disease Board (DDB); Sir Charles Gairdner Research Advisory Committee; Institute for Respiratory Health Westcare Alan King Grants; Cancer Council of Western Australia(Cancer Council Western Australia); Department of Health's NIHR Biomedical Research Centre's funding scheme(National Institute for Health Research (NIHR))	YCGL is a National Health & Medical Research Council (NHMRC) Career Development Fellow and receives project grant funding from the NHMRC, New South Wales Dust Disease Board (DDB), Sir Charles Gairdner Research Advisory Committee, Institute for Respiratory Health Westcare Alan King Grants and the Cancer Council of Western Australia. JSB is partially funded from the Department of Health's NIHR Biomedical Research Centre's funding scheme. JCP is a NHMRC Senior Principal Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AABERGE IS, 1995, MICROB PATHOGENESIS, V18, P141, DOI 10.1016/S0882-4010(95)90125-6; Basavanna S, 2009, INFECT IMMUN, V77, P3412, DOI 10.1128/IAI.01543-08; Bayle L, 2011, MOL MICROBIOL, V82, P904, DOI 10.1111/j.1365-2958.2011.07862.x; Berry AM, 1999, INFECT IMMUN, V67, P981, DOI 10.1128/IAI.67.2.981-985.1999; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; BERRY AM, 1989, INFECT IMMUN, V57, P2324, DOI 10.1128/IAI.57.8.2324-2330.1989; Brown JS, 2002, INFECT IMMUN, V70, P4389, DOI 10.1128/IAI.70.8.4389-4398.2002; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Brown JS, 2001, INFECT IMMUN, V69, P6702, DOI 10.1128/IAI.69.11.6702-6706.2001; Brown LR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146785; Burgos J, 2013, CURR OPIN PULM MED, V19, P350, DOI 10.1097/MCP.0b013e3283606ab5; CANVIN JR, 1995, J INFECT DIS, V172, P119, DOI 10.1093/infdis/172.1.119; Davies HE, 2010, THORAX, V65, P41, DOI 10.1136/thx.2010.137000; Finley C, 2008, CAN RESPIR J, V15, P85, DOI 10.1155/2008/975312; Gosink KK, 2000, INFECT IMMUN, V68, P5690, DOI 10.1128/IAI.68.10.5690-5695.2000; Grijalva CG, 2011, THORAX, V66, P663, DOI 10.1136/thx.2010.156406; Harvey RM, 2011, INFECT IMMUN, V79, P4122, DOI 10.1128/IAI.05418-11; Johnston JW, 2004, INFECT IMMUN, V72, P5858, DOI 10.1128/IAI.72.10.5858-5867.2004; Light Richard W, 2006, Proc Am Thorac Soc, V3, P75, DOI 10.1513/pats.200510-113JH; Marra A, 2002, MICROBIOL-SGM, V148, P1483, DOI 10.1099/00221287-148-5-1483; Maskell NA, 2006, AM J RESP CRIT CARE, V174, P817, DOI 10.1164/rccm.200601-074OC; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Plumptre CD, 2014, MOL MICROBIOL, V91, P834, DOI 10.1111/mmi.12504; Proesmans M, 2014, EUR J PEDIATR, V173, P1339, DOI 10.1007/s00431-014-2319-1; Strachan RE, 2011, EMERG INFECT DIS, V17, P1839, DOI 10.3201/eid1710.101825; Stroeher UH, 2003, INFECT IMMUN, V71, P3206, DOI 10.1128/IAI.71.6.3206-3212.2003; TALKINGTON DF, 1991, INFECT IMMUN, V59, P1285, DOI 10.1128/IAI.59.4.1285-1289.1991; Thomas R, 2016, CHEST, V149, P1494, DOI 10.1016/j.chest.2016.01.001; Tseng HJ, 2002, INFECT IMMUN, V70, P1635, DOI 10.1128/IAI.70.3.1635-1639.2002; Wilkosz S, 2012, AM J RESP CELL MOL, V46, P180, DOI 10.1165/rcmb.2011-0182OC; World Health Organization, 2004, REV GLOB BURD DIS 20	31	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188833	10.1371/journal.pone.0188833	http://dx.doi.org/10.1371/journal.pone.0188833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190798	Green Published, Green Submitted, gold			2022-12-27	WOS:000416841900137
J	Guo, HR; Ding, EM; Bai, Y; Zhang, HD; Shen, HX; Wang, J; Song, XP; Cai, WY; Guo, JD; Zhu, BL				Guo, Haoran; Ding, Enmin; Bai, Ying; Zhang, Hengdong; Shen, Huanxi; Wang, Jun; Song, Xianping; Cai, Wenyan; Guo, Jiadi; Zhu, Baoli			Association of genetic variations in FOXO3 gene with susceptibility to noise induced hearing loss in a Chinese population	PLOS ONE			English	Article							OXIDATIVE STRESS; MICE; MECHANISMS; DISEASE; CANCER; LOCI	Noise induced hearing loss (NIHL), a multifactorial disease involving both genetic and environmental factors, is one of the most important occupational health hazards. Nonetheless, the influence of FOXO3 variants on NIHL risk have not been illuminated. This research was conducted to explore the effects of FOXO3 polymorphisms on individual susceptibility to NIHL. A total of 2689 industrial workers from one textile factory of east China were recruited to participate in the current research. Venous blood was collected, questionnaire and pure-tone audiometry (PTA) was conducted by specialist physicians. Then, we performed genotyping of three selected SNPs (rs2802292, rs10457180, and rs12206094) in FOXO3 gene in 566 NIHL patients and 566 controls. Subsequently, the main effects of genotype and its interactions were evaluated. Our results revealed that individuals with the G allele of rs2802292, G allele of rs10457180, T allele of rs12206094 (OR = 1.43, 1.43, and 1.31 respectively) and the haplotype GAC and others (TGT/GGT/GGC/GAT) (rs2802292-rs10457180-rs12206094) (OR = 1.49 and 2.09 respectively) are associated with an increased risk of NIHL in a Chinese population. Stratified analysis showed that an increased NIHL risk was found in the subjects who exposed to noise > 16 years with rs2802292 GG/GT and rs10457180 AG/GG genotype with an OR of 1.62 and 1.66 respectively. Multifactor dimensionality reduction analysis indicated that rs10457180, rs2802292, and rs12206094 have interactions and are related to increased NIHL risk (OR = 1.53). The genetic polymorphism rs2802292, rs10457180, and rs12206094 within FOXO3 gene are associated with an increased risk of NIHL in a Chinese population and have potential to be biomarkers for noise exposed workers.	[Guo, Haoran; Wang, Jun; Zhu, Baoli] Southeast Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Guo, Haoran; Ding, Enmin; Bai, Ying; Zhang, Hengdong; Zhu, Baoli] Jiangsu Prov Ctr Dis Prevent & Control, Inst Occupat Dis Prevent, Nanjing, Jiangsu, Peoples R China; [Shen, Huanxi] Kunshan Ctr Dis Prevent & Control, Kunshan, Jiangsu, Peoples R China; [Song, Xianping; Cai, Wenyan; Guo, Jiadi] Nanjing Med Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Nanjing Medical University	Zhu, BL (corresponding author), Southeast Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China.; Zhu, BL (corresponding author), Jiangsu Prov Ctr Dis Prevent & Control, Inst Occupat Dis Prevent, Nanjing, Jiangsu, Peoples R China.	zhubl@jscdc.cn			Jiangsu Provinces Outstanding Medical Academic Leader program [CXTDA2017029]; Huanxi Shen was funded by Jiangsu Program for Young Medical Talents [QNRC2016528]	Jiangsu Provinces Outstanding Medical Academic Leader program; Huanxi Shen was funded by Jiangsu Program for Young Medical Talents	Baoli Zhu was funded by Jiangsu Provinces Outstanding Medical Academic Leader program (CXTDA2017029) and Huanxi Shen was funded by Jiangsu Program for Young Medical Talents (QNRC2016528).	Carlsson PI, 2005, HEARING RES, V202, P87, DOI 10.1016/j.heares.2004.09.005; Chang NC, 2011, AUDIOL NEURO-OTOL, V16, P168, DOI 10.1159/000317119; Davis RR, 2001, HEARING RES, V155, P82, DOI 10.1016/S0378-5955(01)00250-7; Du WW, 2016, NUCLEIC ACIDS RES, V44, P2846, DOI 10.1093/nar/gkw027; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gilels F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01142-3; Gilels F, 2013, J NEUROSCI, V33, P18409, DOI 10.1523/JNEUROSCI.2529-13.2013; Greer EL, 2008, ACTA PHYSIOL, V192, P19, DOI 10.1111/j.1748-1716.2007.01780.x; Guo HY, 2016, NAT GENET, V48, P1142, DOI 10.1038/ng.3637; HENDERSON D, 1993, EAR HEARING, V14, P152, DOI 10.1097/00003446-199306000-00002; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Hwang JW, 2011, J IMMUNOL, V187, P987, DOI 10.4049/jimmunol.1001861; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Jiang RH, 2003, PHARMACOGENOMICS, V4, P779; Konings A, 2009, EAR HEARING, V30, P151, DOI 10.1097/AUD.0b013e3181987080; Kowalski TJ, 2014, OTOL NEUROTOL, V35, P358, DOI 10.1097/MAO.0b013e3182a00332; Le Prell C G, 2003, Noise Health, V5, P1; Le Prell CG, 2007, HEARING RES, V226, P22, DOI 10.1016/j.heares.2006.10.006; Lee JC, 2013, CELL, V155, P57, DOI 10.1016/j.cell.2013.08.034; Meyer KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002165; Shen HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089662; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Shimokawa I, 2015, AGING CELL, V14, P707, DOI 10.1111/acel.12340; White CH, 2009, MAMM GENOME, V20, P207, DOI 10.1007/s00335-009-9178-5; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhang XH, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0063-2	27	16	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189186	10.1371/journal.pone.0189186	http://dx.doi.org/10.1371/journal.pone.0189186			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220389	gold, Green Published, Green Submitted			2022-12-27	WOS:000417469900037
J	Kuwabara, WMT; Panveloski-Costa, AC; Yokota, CNF; Pereira, JNB; Mancini, J; Torres, RP; Hirabara, SM; Curi, R; Alba-Loureiro, TC				Tatagiba Kuwabara, Wilson Mitsuo; Panveloski-Costa, Ana Carolina; Fukusawa Yokota, Caroline Naomi; Bertaglia Pereira, Joice Naiara; Mancini Filho, Jorge; Torres, Rosangela Pavan; Hirabara, Sandro Massao; Curi, Rui; Alba-Loureiro, Tatiana Carolina			Comparison of Goto-Kakizaki rats and high fat diet-induced obese rats: Are they reliable models to study Type 2 Diabetes mellitus?	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; BETA-CELL MASS; INSULIN-RESISTANCE; GK RAT; ADIPOSE-TISSUE; GLUCOSE; INFLAMMATION; PROTEIN; PLASMA; LIVER	Type 2 Diabetes mellitus (T2DM) is an evident growing disease that affects different cultures throughout the world. T2DM occurs under the influence of three main factors: the genetic background, environmental and behavioral components. Obesity is strongly associated to the development of T2DM in the occident, while in the orient most of the diabetic patients are considered lean. Genetics may be a key factor in the development of T2DM in societies where obesity is not a recurrent public health problem. Herein, two different models of rats were used to understand their differences and reliability as experimental models to study the pathophysiology of T2DM, in two different approaches: the genetic (GK rats) and the environmental (HFD-induced obese rats) influences. GK rats were resistant to weight gain even though food/energy consumption (relative to body weight) was higher in this group. HFD, on the other hand, induced obesity in Wistar rats. White adipose tissue (WAT) expansion in this group was accompanied by immune cells infiltration, inflammation and insulin resistance. GK rats also presented WAT inflammation and insulin resistance; however, no immune cells infiltration was observed in the WAT of this group. Liver of HFD group presented fat accumulation without differences in inflammatory cytokines content, while liver of GK rats didn't present fat accumulation, but showed an increase of IL-6 and IL-10 content and glycogen. Also, GK rats showed increased plasma GOT and GPT. Soleus muscle of HFD presented normal insulin signaling, contrary to GK rats, which presented higher content of basal phosphorylation of GSK-3 beta. Our results demonstrated that HFD developed a mild insulin resistance in Wistar rats, but was not sufficient to develop T2DM. In contrast, GK rats presented all the typical hallmarks of T2DM, such as insulin resistance, defective insulin production, fasting hyperglycemia/hyperinsulinemia and lipid plasma alteration. Thus, on the given time point of this study, we may conclude that only GK rats shown to be a reliable model to study T2DM.	[Tatagiba Kuwabara, Wilson Mitsuo; Panveloski-Costa, Ana Carolina; Fukusawa Yokota, Caroline Naomi; Bertaglia Pereira, Joice Naiara; Curi, Rui; Alba-Loureiro, Tatiana Carolina] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Bertaglia Pereira, Joice Naiara; Hirabara, Sandro Massao; Curi, Rui] Cruzeiro do Sul Univ, Sao Paulo, Brazil; [Mancini Filho, Jorge; Torres, Rosangela Pavan] Univ Sao Paulo, Fac Pharmaceut Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Kuwabara, WMT (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil.	wilsonk@icb.usp.br	Kuwabara, Wilson MT/H-9492-2017; Hirabara, Sandro Massao/C-4014-2012; Curi, Rui/AAT-7970-2021; Mancini-Filho, Jorge/F-3950-2018; Loureiro, Tatiana C Alba/U-9436-2018	Kuwabara, Wilson MT/0000-0001-5307-6218; Hirabara, Sandro Massao/0000-0002-7392-0444; Curi, Rui/0000-0001-5095-9154; Panveloski-Costa, Ana Carolina/0000-0003-4025-6644	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP - 2015/03175-1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [CAPES 88881.068515/2014-01]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq 163439/2013-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - 2015/03175-1), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES 88881.068515/2014-01) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq 163439/2013-3). There was no additional external funding received for this study.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Almon RR, 2009, J ENDOCRINOL, V200, P331, DOI [10.1677/JOE-80-0404, 10.1677/JOE-08-0404]; Asghar A, 2017, CELL IMMUNOL, V315, P18, DOI 10.1016/j.cellimm.2017.03.001; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Barbu A, 2009, MOL CELL ENDOCRINOL, V299, P163, DOI 10.1016/j.mce.2008.11.019; Berthelier C, 1997, METABOLISM, V46, P890, DOI 10.1016/S0026-0495(97)90075-5; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; BISBIS S, 1993, AM J PHYSIOL, V265, pE807, DOI 10.1152/ajpendo.1993.265.5.E807; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Calderari S, 2007, DIABETOLOGIA, V50, P1463, DOI 10.1007/s00125-007-0676-2; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; CERASI E, 1995, DIABETOLOGIA, V38, P992, DOI 10.1007/BF00400591; CHALLISS RAJ, 1983, BIOSCIENCE REP, V3, P675, DOI 10.1007/BF01172878; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; CRETTAZ M, 1980, BIOCHEM J, V186, P525, DOI 10.1042/bj1860525; Dadke SS, 2000, BIOCHEM BIOPH RES CO, V274, P583, DOI 10.1006/bbrc.2000.3188; Del Prato S, 2010, INT J CLIN PRACT, V64, P295, DOI 10.1111/j.1742-1241.2009.02227.x; Dourmashkin JT, 2005, INT J OBESITY, V29, P1368, DOI 10.1038/sj.ijo.0803017; Eckel RH, 2011, J CLIN ENDOCR METAB, V96, P1654, DOI 10.1210/jc.2011-0585; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Gallagher EJ, 2010, MT SINAI J MED, V77, P511, DOI 10.1002/msj.20212; Galli J, 1996, NAT GENET, V12, P31, DOI 10.1038/ng0196-31; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1111/j.1574-695X.1999.tb01397.x; Giroix MH, 2011, DIABETOLOGIA, V54, P2451, DOI 10.1007/s00125-011-2223-4; Golson ML, 2010, OPEN ENDOCRINOL, V4, P66, DOI [10.2174/1874216501004010066, DOI 10.2174/1874216501004010066]; GOTO Y, 1976, TOHOKU J EXP MED, V119, P85, DOI 10.1620/tjem.119.85; Granhall C, 2006, DIABETES, V55, P3494, DOI 10.2337/db06-0796; Helrich K, 2012, OFFICIAL METHODS ANA, P20; Hirabara SM, 2013, J NUTR BIOCHEM, V24, P1136, DOI 10.1016/j.jnutbio.2012.08.014; Hirabara SM, 2006, BBA-BIOENERGETICS, V1757, P57, DOI 10.1016/j.bbabio.2005.11.007; Jiang MH, 2011, ENDOCRINOLOGY, V152, P1284, DOI 10.1210/en.2010-1162; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Keller MP, 2010, ANNU REV NUTR, V30, P341, DOI 10.1146/annurev.nutr.012809.104747; Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leibowitz G, 2011, J DIABETES INVEST, V2, P82, DOI 10.1111/j.2040-1124.2010.00094.x; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Liu TW, 2015, LIPIDS, V50, P997, DOI 10.1007/s11745-015-4061-5; Mandarim-De-Lacerda CA, 1995, METODOS QUANTITATIVO, P195; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066570; Miralles F, 2001, DIABETES, V50, pS84, DOI 10.2337/diabetes.50.2007.S84; Moraes RC, 2003, ENDOCRINOLOGY, V144, P4773, DOI 10.1210/en.2003-0456; Movassat J, 1997, DIABETOLOGIA, V40, P916, DOI 10.1007/s001250050768; Movassat J, 2007, DIABETES OBES METAB, V9, P187, DOI 10.1111/j.1463-1326.2007.00786.x; Padilla DJ, 2007, RESP PHYSIOL NEUROBI, V156, P187, DOI 10.1016/j.resp.2006.08.008; Pan M, 2006, J PINEAL RES, V41, P79, DOI 10.1111/j.1600-079X.2006.00346.x; Panveloski-Costa AC, 2016, ACTA PHYSIOL, V217, P130, DOI 10.1111/apha.12647; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Pettersson US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022480; PicarelBlanchot F, 1996, AM J PHYSIOL-ENDOC M, V271, pE755; Plachot C, 2001, HISTOCHEM CELL BIOL, V116, P131; Portha B, 2005, DIABETES-METAB RES, V21, P495, DOI 10.1002/dmrr.566; Portha B, 2009, MOL CELL ENDOCRINOL, V297, P73, DOI 10.1016/j.mce.2008.06.013; Portha B, 2001, DIABETES, V50, pS89, DOI 10.2337/diabetes.50.2007.S89; Portha Bernard, 2012, Methods Mol Biol, V933, P125, DOI 10.1007/978-1-62703-068-7_9; Portha Bernard, 2007, Expert Rev Endocrinol Metab, V2, P785, DOI 10.1586/17446651.2.6.785; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shirai N, 2005, ANAL BIOCHEM, V343, P48, DOI 10.1016/j.ab.2005.04.037; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sinitskaya N, 2007, CLIN SCI, V113, P417, DOI 10.1042/CS20070182; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Tanaka S, 2011, J ATHEROSCLER THROMB, V18, P115, DOI 10.5551/jat.5926; Tziomalos Konstantinos, 2015, Rev Diabet Stud, V12, P110, DOI 10.1900/RDS.2015.12.110; van der Heijden RA, 2015, AGING-US, V7, P256, DOI 10.18632/aging.100738; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wongchitrat P, 2017, NUTR RES, V42, P51, DOI 10.1016/j.nutres.2017.04.011; Xie W, 2011, DIABETES OBES METAB, V13, P289, DOI 10.1111/j.1463-1326.2010.01336.x; Xue B, 2015, GENE REGUL SYST BIO, V9, P15, DOI 10.4137/GRSB.S25172; Xue B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017386	78	43	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189622	10.1371/journal.pone.0189622	http://dx.doi.org/10.1371/journal.pone.0189622			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220408	Green Published, gold, Green Submitted			2022-12-27	WOS:000417469900063
J	Brinkmann, C; Hoffmann, M; Lubke, A; Nehlmeier, I; Kramer-Kuhl, A; Winkler, M; Pohlmann, S				Brinkmann, Constantin; Hoffmann, Markus; Luebke, Anastasia; Nehlmeier, Inga; Kraemer-Kuehl, Annika; Winkler, Michael; Poehlmann, Stefan			The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cells	PLOS ONE			English	Article							MATRIX PROTEIN; HIV-1 VPU; RESTRICTION FACTOR; HEALTHY-ADULTS; VIRAL FUSION; INTERFERON; GENE; IMMUNOGENICITY; BST-2/TETHERIN; TRANSCRIPTION	Vesicular stomatitis virus (VSV) release from infected cells is inhibited by the interferon (IFN)-inducible antiviral host cell factor tetherin (BST-2, CD317). However, several viruses encode tetherin antagonists and it is at present unknown whether residual VSV spread in tetherin-positive cells is also promoted by a virus-encoded tetherin antagonist. Here, we show that the viral glycoprotein (VSV-G) antagonizes tetherin in transfected cells, although with reduced efficiency as compared to the HIV-1 Vpu protein. Tetherin antagonism did not involve alteration of tetherin expression and was partially dependent on a GXXXG motif in the transmembrane domain of VSV-G. However, mutation of the GXXXG motif did not modulate tetherin sensitivity of infectious VSV. These results identify VSV-G as a tetherin antagonist in transfected cells but fail to provide evidence for a contribution of tetherin antagonism to viral spread.	[Brinkmann, Constantin; Hoffmann, Markus; Luebke, Anastasia; Nehlmeier, Inga; Kraemer-Kuehl, Annika; Winkler, Michael; Poehlmann, Stefan] German Primate Ctr, Infect Biol Unit, Kellnerweg 4, Gottingen, Germany; [Kraemer-Kuehl, Annika] Boehringer Ingelheim Vet Res Ctr GmbH & Co KG, Hannover, Germany	Deutsches Primatenzentrum (DPZ); Boehringer Ingelheim	Pohlmann, S (corresponding author), German Primate Ctr, Infect Biol Unit, Kellnerweg 4, Gottingen, Germany.	spoehlmann@dpz.eu	Hoffmann, Markus/J-7836-2018; Pöhlmann, Stefan/H-2395-2011	Hoffmann, Markus/0000-0003-4603-7696; Pöhlmann, Stefan/0000-0001-6086-9136; Winkler, Michael/0000-0002-6198-554X	Deutsche Forschungsgemeinschaft (DFG) [PO -716/8-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding has been obtained from Deutsche Forschungsgemeinschaft (DFG, PO -716/8-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew AJ, 2011, J VIROL, V85, P2611, DOI 10.1128/JVI.02080-10; Balachandran S, 2001, J VIROL, V75, P3474, DOI 10.1128/JVI.75.7.3474-3479.2001; Barallon R, 2010, IN VITRO CELL DEV-AN, V46, P727, DOI 10.1007/s11626-010-9333-z; Berger RM, 2011, PLOS ONE, V6; Brinkmann C, 2016, J VIROL, V90, P11075, DOI 10.1128/JVI.01563-16; Butler John M, 2007, Biotechniques, V43, pii; Chow J, 2015, VIROLOGY, V479, P104, DOI 10.1016/j.virol.2015.02.051; Cleverley DZ, 1998, P NATL ACAD SCI USA, V95, P3425, DOI 10.1073/pnas.95.7.3425; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2011, TRAFFIC, V12, P1714, DOI 10.1111/j.1600-0854.2011.01277.x; ElSherif MS, 2017, CAN MED ASSOC J, V189, pE819, DOI 10.1503/cmaj.170074; Ferran MC, 1997, J VIROL, V71, P371, DOI 10.1128/JVI.71.1.371-377.1997; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Hacke M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8688; HALLUM JV, 1970, J VIROL, V6, P156, DOI 10.1128/JVI.6.2.156-162.1970; Halperin SA, 2017, J INFECT DIS; Hanika A, 2005, J GEN VIROL, V86, P1455, DOI 10.1099/vir.0.80788-0; Heppner DG, 2017, LANCET INFECT DIS, V17, P854, DOI [10.1016/s1473-3099(17)30313-4, 10.1016/S1473-3099(17)30313-4]; Hoffmann M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149651; Hoffmann M, 2010, J GEN VIROL, V91, P2782, DOI 10.1099/vir.0.023978-0; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kopecky SA, 2003, J VIROL, V77, P5524, DOI 10.1128/JVI.77.9.5524-5528.2003; Kuhl A, 2011, J INFECT DIS, V204, pS850, DOI 10.1093/infdis/jir378; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; Letchworth GJ, 1999, VET J, V157, P239, DOI 10.1053/tvjl.1998.0303; Liberatore RA, 2017, J VIROL, V91, DOI 10.1128/JVI.02286-16; Lichty BD, 2004, TRENDS MOL MED, V10, P210, DOI 10.1016/j.molmed.2004.03.003; Lopez LA, 2012, J VIROL, V86, P5467, DOI 10.1128/JVI.06280-11; Lopez LA, 2010, J VIROL, V84, P7243, DOI 10.1128/JVI.02636-09; LYLES DS, 1992, J VIROL, V66, P349, DOI 10.1128/JVI.66.1.349-358.1992; MALDARELLI F, 1993, J VIROL, V67, P5056, DOI 10.1128/JVI.67.8.5056-5061.1993; Marzi A, 2006, VIROLOGY, V352, P345, DOI 10.1016/j.virol.2006.04.038; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Mead DG, 2000, SCIENCE, V287, P485, DOI 10.1126/science.287.5452.485; Melzer MK, 2017, BIOMEDICINES, V5, DOI 10.3390/biomedicines5010008; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2013, CURR TOP MICROBIOL, V371, P67, DOI 10.1007/978-3-642-37765-5_3; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Rieder M, 2009, J INTERF CYTOK RES, V29, P499, DOI 10.1089/jir.2009.0068; Rodriguez LL, 2002, VIRUS RES, V85, P211, DOI 10.1016/S0168-1702(02)00026-6; Sauter D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00163; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt S, 2011, MBIO, V2, DOI 10.1128/mBio.00036-11; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schnell MJ, 1996, J VIROL, V70, P2318, DOI 10.1128/JVI.70.4.2318-2323.1996; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sun X, 2008, J BIOL CHEM, V283, P6418, DOI 10.1074/jbc.M708955200; SUTTER G, 1995, FEBS LETT, V371, P9, DOI 10.1016/0014-5793(95)00843-X; Taylor JK, 2015, J VIROL, V89, P11820, DOI 10.1128/JVI.02274-15; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10	55	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189073	10.1371/journal.pone.0189073	http://dx.doi.org/10.1371/journal.pone.0189073			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216247	Green Published, gold			2022-12-27	WOS:000417337800066
J	Guo, Q; Wan, FY				Guo, Qing; Wan, Fangyi			Complete synchronization of the global coupled dynamical network induced by Poisson noises	PLOS ONE			English	Article							INDUCED REGIME SHIFTS; CHAOS; BIFURCATION; NEURON; SYSTEM; DELAYS; MODEL; P53	The different Poisson noise-induced complete synchronization of the global coupled dynamical network is investigated. Based on the stability theory of stochastic differential equations driven by Poisson process, we can prove that Poisson noises can induce synchronization and sufficient conditions are established to achieve complete synchronization with probability 1. Furthermore, numerical examples are provided to show the agreement between theoretical and numerical analysis.	[Guo, Qing; Wan, Fangyi] Northwestern Polytech Univ, Sch Aeronaut, Xian, Shaanxi, Peoples R China	Northwestern Polytechnical University	Wan, FY (corresponding author), Northwestern Polytech Univ, Sch Aeronaut, Xian, Shaanxi, Peoples R China.	fwan@nwpu.edu.cn	Wan, Fang-Yi/N-4519-2019	Wan, Fang-Yi/0000-0002-4404-5820				Cao J, 2007, PHYSICA A, V385, P718, DOI 10.1016/j.physa.2007.06.043; CHUA LO, 1993, IEEE T CIRCUITS-I, V40, P732, DOI 10.1109/81.246149; Gao ZL, 2016, J APPL PROBAB, V53, P307, DOI 10.1017/jpr.2015.27; Garcia M.A., 1994, STOCH MODELS, V10, P335; Gihman I. I., 1972, STOCHASTIC DIFFERENT; Han QL, 2014, PHYSICA A, V408, P96, DOI 10.1016/j.physa.2014.04.015; HERZEL H, 1995, PHYS REV E, V52, P3238, DOI 10.1103/PhysRevE.52.3238; Kushner H. J, 1967, STOCHASTIC STABILITY; Lai CH, 1998, EUROPHYS LETT, V43, P376, DOI 10.1209/epl/i1998-00368-1; Lin W, 2006, CHAOS, V16, DOI 10.1063/1.2183734; Lin W, 2005, CHAOS, V15, DOI 10.1063/1.1938627; Lv M, 2016, NONLINEAR DYNAM, V85, P1479, DOI 10.1007/s11071-016-2773-6; Ma J, 2015, SCI CHINA TECHNOL SC, V58, P2038, DOI 10.1007/s11431-015-5961-6; PIKOVSKY AS, 1994, PHYS REV LETT, V73, P2931, DOI 10.1103/PhysRevLett.73.2931; Qian Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12333-3; Qian Y, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.032807; Qin HX, 2014, SCI CHINA TECHNOL SC, V57, P936, DOI 10.1007/s11431-014-5534-0; Samhouri JF, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1860; Shiraki Y, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036101; Ting Y, 1999, SOOCHOW J MATH, V25, P145; Wang ST, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.018103; Wang XF, 2002, IEEE T CIRCUITS-I, V49, P54, DOI 10.1109/81.974874; Wang XF, 2002, INT J BIFURCAT CHAOS, V12, P885, DOI 10.1142/S0218127402004802; Wu J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174330; Xiao YZ, 2012, CHAOS, V22, DOI 10.1063/1.3677253; Xiao YZ, 2009, CHAOS, V19, DOI 10.1063/1.3080194; Xu Y, 2015, MATH METHOD APPL SCI, V38, P2120, DOI 10.1002/mma.3208; Xu Y, 2013, PHYSICA A, V392, P4739, DOI 10.1016/j.physa.2013.06.010; Xu Y, 2013, CHAOS, V23, DOI 10.1063/1.4775758; Xu Y, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056215; Yin CC, 2014, FRONT MATH CHINA, V9, P1453, DOI 10.1007/s11464-013-0186-5; Yin CC, 2014, ASTIN BULL, V44, P635, DOI 10.1017/asb.2014.12; Yin CC, 2011, STAT PROBABIL LETT, V81, P1841, DOI 10.1016/j.spl.2011.07.022; Yin CC, 2010, METHODOL COMPUT APPL, V12, P391, DOI 10.1007/s11009-008-9109-z; Yu Q., 2017, SCI REPORTS, V7, P5746; Zeng CH, 2015, ECOL COMPLEX, V22, P102, DOI 10.1016/j.ecocom.2015.02.005; Zeng CH, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/10/P10017; Zeng CH, 2012, ECOL MODEL, V233, P52, DOI 10.1016/j.ecolmodel.2012.03.025; Zeng JK, 2016, PHYSICA A, V462, P1273, DOI 10.1016/j.physa.2016.06.115; Zhang XP, 2011, P NATL ACAD SCI USA, V108, P8990, DOI 10.1073/pnas.1100600108; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106; ZOU F, 1993, IEEE T CIRCUITS-I, V40, P166, DOI 10.1109/81.222797	42	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188632	10.1371/journal.pone.0188632	http://dx.doi.org/10.1371/journal.pone.0188632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216214	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800032
J	Huang, CN; Wang, CJ; Lin, CL; Lin, HT; Peng, CH				Huang, Chien-Ning; Wang, Chau-Jong; Lin, Chih-Li; Lin, Hui-Ting; Peng, Chiung-Huei			The nutraceutical benefits of subfractions of Abelmoschus esculentus in treating type 2 diabetes mellitus	PLOS ONE			English	Article							POLYSACCHARIDE AMELIORATES HYPERGLYCEMIA; INDUCED INSULIN-RESISTANCE; LIPOPROTEIN-LIPASE; SKELETAL-MUSCLE; CELL; GLUCOSIDASE; PATHWAY; AMYLASE; MOENCH; ALPHA	Abelmoschus esculentus (AE), a commonly consumed vegetable, is well-known for its antihyperglycemic effects. However, few scientific reports have identified its targets because mucilage increases the difficulty of manipulation. We recently reported extraction steps to obtain subfractions of AE, which were found to attenuate the adverse effects of high glucose and fatty acid in vitro. In this study, we used modified extraction steps and type 2 diabetic rats to explore whether AE subfractions can improve the metabolic disturbances caused by insulin resistance in vivo. AE subfractions (F1, F2, and FR) were prepared. The type 2 diabetes model was induced by feeding male Sprague-Dawley rats with a high-fat diet and injecting them with 35 mg/kgbw streptozotocin when their body weight reached 475 +/- 15 g. After a hyperglycemic status had been confirmed, the rats were tube-fed with or without different doses of AE subfractions. Serum glucose, lipid markers, insulin, HbA1c and HOMAIR were measured in the following 12 weeks. Serum glucose promptly increased and insulin resistance was noted in the diabetic rats (glucose: 360-500 mg/dl, HOMA-IR 9.8-13.8). F2, rich in polysaccharides and carbohydrates, was most effective in attenuating hyperglycemia and insulin resistance (glucose: 200 mg/dl; HOMA-IR: 5.3) and especially HbA1C (from 8.0% to 6.5%). All of the AE subfractions lowered the level of triglycerides and free fatty acid, but not the level of total cholesterol. FR significantly increased the high-density lipoprotein/low-density lipoprotein ratio, indicating its benefits for lipoprotein profiles. While F2 and FR were associated with weight gain, F1 possessed an anti-obese effect. In conclusion, whether it is consumed as a vegetable or as a nutraceutical, AE has the potential to be an adjuvant therapy for diabetes. AE subfractions could be developed individually and deserve further investigation.	[Huang, Chien-Ning] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Huang, Chien-Ning; Lin, Chih-Li] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Wang, Chau-Jong; Lin, Hui-Ting] Chung Shan Med Univ, Inst Biochem Microbiol & Immunol, Taichung, Taiwan; [Peng, Chiung-Huei] Hungkuang Univ, Div Basic Med Sci, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Hungkuang University	Peng, CH (corresponding author), Hungkuang Univ, Div Basic Med Sci, Taichung, Taiwan.	a222907@sunrise.hk.edu.tw	Lin, Chih-Li/GQZ-6480-2022; Lin, Chih-Li/H-9515-2019	Lin, Chih-Li/0000-0003-4553-3727; Peng, Chiung-Huei/0000-0003-1833-5522	Ministry of Science and Techonology, Taiwan [MOST 104-2320-B-241-001, MOST 105-2320-B-241-004-MY2]	Ministry of Science and Techonology, Taiwan	This work was supported by the grant MOST 104-2320-B-241-001, and MOST 105-2320-B-241-004-MY2 of Ministry of Science and Techonology, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Ahn J, 2008, BIOCHEM BIOPH RES CO, V373, P545, DOI 10.1016/j.bbrc.2008.06.077; Chiu N, 1995, ILLUSTRATED MED PLAN, VI.; Corrado F, 2011, DIABETIC MED, V28, P972, DOI 10.1111/j.1464-5491.2011.03284.x; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; Huang CN, 2017, PLOS ONE, V12; Kitajima S, 2004, DIABETOLOGIA, V47, P1202, DOI 10.1007/s00125-004-1429-0; Li WJ, 2015, J AGR FOOD CHEM, V63, P8182, DOI 10.1021/acs.jafc.5b03462; Lu YY, 2016, J FUNCT FOODS, V20, P463, DOI 10.1016/j.jff.2015.10.037; Ma XL, 2014, GLYCOCONJUGATE J, V31, P355, DOI 10.1007/s10719-014-9526-x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Panarotto D, 2002, EUR J CLIN INVEST, V32, P84, DOI 10.1046/j.1365-2362.2002.00945.x; Peng CH, 2016, FOOD FUNCT, V7, P728, DOI [10.1039/C5FO01214G, 10.1039/c5fo01214g]; Peng CH, 2009, J AGR FOOD CHEM, V57, P8812, DOI 10.1021/jf902143x; Ravelojaona V, 2006, BIOMED PHARMACOTHER, V60, P359, DOI 10.1016/j.biopha.2006.06.019; Sabitha V., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS162; Sabitha V, 2011, J PHARM BIOALLIED SC, V3, P397, DOI 10.4103/0975-7406.84447; Sabitha Vijayakumar, 2012, J Ayurveda Integr Med, V3, P188, DOI 10.4103/0975-9476.104432; Wang H, 2009, DIABETES, V58, P116, DOI 10.2337/db07-1839; Yang YS, 2013, J FUNCT FOODS, V5, P810, DOI 10.1016/j.jff.2013.01.027; Ye Jianping, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P65; Zhao M, 2012, MOLECULES, V17, P7083, DOI 10.3390/molecules17067083; Zhou J, 2015, J ETHNOPHARMACOL, V164, P229, DOI 10.1016/j.jep.2015.02.026; Zhu KX, 2013, INT J BIOL MACROMOL, V57, P142, DOI 10.1016/j.ijbiomac.2013.03.009	24	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189065	10.1371/journal.pone.0189065	http://dx.doi.org/10.1371/journal.pone.0189065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216237	gold, Green Submitted, Green Published			2022-12-27	WOS:000417337800063
J	Khairallah, RJ; O'Shea, KM; Ward, CW; Butteiger, DN; Mukherjea, R; Krul, ES				Khairallah, Ramzi J.; O'Shea, Karen M.; Ward, Christopher W.; Butteiger, Dustie N.; Mukherjea, Ratna; Krul, Elaine S.			Chronic dietary supplementation with soy protein improves muscle function in rats	PLOS ONE			English	Article							SKELETAL-MUSCLE; WHEY-PROTEIN; ISOFLAVONE GENISTEIN; RESISTANCE EXERCISE; MASS INDEX; MDX MICE; ACTIVATION; BLEND; ISOLATE; MEN	Athletes as well as elderly or hospitalized patients use dietary protein supplementation to maintain or grow skeletal muscle. It is recognized that high quality protein is needed for muscle accretion, and can be obtained from both animal and plant-based sources. There is interest to understand whether these sources differ in their ability to maintain or stimulate muscle growth and function. In this study, baseline muscle performance was assessed in 50 adult Sprague-Dawley rats after which they were assigned to one of five semi-purified "Western" diets (n = 10/group) differing only in protein source, namely 19 kcal% protein from either milk protein isolate (MPI), whey protein isolate (WPI), soy protein isolate (SPI), soy protein concentrate (SPC) or enzyme-treated soy protein (SPE). The diets were fed for 8 weeks at which point muscle performance testing was repeated and tissues were collected for analysis. There was no significant difference in food consumption or body weights over time between the diet groups nor were there differences in terminal organ and muscle weights or in serum lipids, creatinine or myostatin. Compared with MPI-fed rats, rats fed WPI and SPC displayed a greater maximum rate of contraction using the in vivo measure of muscle performance (p<0.05) with increases ranging from 13.3-27.5% and 22.8-29.5%, respectively at 60, 80, 100 and 150 Hz. When the maximum force was normalized to body weight, SPC-fed rats displayed increased force compared to MPI (p<0.05), whereas when normalized to gastrocnemius weight, WPI-fed rats displayed increased force compared to MPI (p<0.05). There was no difference between groups using in situ muscle performance. In conclusion, soy protein consumption, in high-fat diet, resulted in muscle function comparable to whey protein and improved compared to milk protein. The benefits seen with soy or whey protein were independent of changes in muscle mass or fiber cross-sectional area.	[Khairallah, Ramzi J.; O'Shea, Karen M.; Ward, Christopher W.] Myol LLC, New Market, MD 21774 USA; [Ward, Christopher W.] Univ Maryland, Sch Med, Dept Orthoped, Baltimore, MD 21201 USA; [Butteiger, Dustie N.; Mukherjea, Ratna; Krul, Elaine S.] DuPont Nutr & Hlth, St Louis, MO USA	University System of Maryland; University of Maryland Baltimore; DuPont	Khairallah, RJ (corresponding author), Myol LLC, New Market, MD 21774 USA.	rkhairallah@myologica.com			DuPont Nutrition Health	DuPont Nutrition Health	The funder, DuPont Nutrition & Health, provided support in the form of salaries to DNB, ESK and RM, and in the form fee for service to Myologica LLC (KMO, RJK). The funder did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The funder, DuPont Nutrition & Health provided support in the form of salaries to DNB, ESK and RM, and in the form fee for service to Myologica LLC (KMO, RJK). The funder did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section."	Anthony TG, 2007, J NUTR, V137, P357, DOI 10.1093/jn/137.2.357; Aubertin-Leheudre M, 2009, BRIT J NUTR, V102, P1803, DOI 10.1017/S0007114509991310; Beavers KM, 2015, J NUTR HEALTH AGING, V19, P87, DOI 10.1007/s12603-015-0438-7; Borack MS, 2016, J NUTR, V146, P2468, DOI 10.3945/jn.116.231159; Butteiger DN, 2013, CLIN NUTR, V32, P585, DOI 10.1016/j.clnu.2012.10.001; Chan R, 2014, J NUTR HEALTH AGING, V18, P171, DOI 10.1007/s12603-013-0379-y; Elia D, 2006, EUR J NUTR, V45, P259, DOI 10.1007/s00394-006-0593-z; Hashimoto R, 2015, J MED INVESTIG, V62, P177, DOI 10.2152/jmi.62.177; Hirasaka K, 2013, J NUTR SCI VITAMINOL, V59, P317, DOI 10.3177/jnsv.59.317; Hoffman JR, 2004, J SPORT SCI MED, V3, P118; Kojima N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132523; Kraemer WJ, 2013, J AM COLL NUTR, V32, P66, DOI 10.1080/07315724.2013.770648; Malarde L, 2013, J MED FOOD, V16, P176, DOI 10.1089/jmf.2012.0095; Matta J, 2016, J NUTR HEALTH AGING, V20, P90, DOI 10.1007/s12603-015-0554-4; Messina S, 2015, BIOFACTORS, V41, P324, DOI 10.1002/biof.1226; Messina S, 2011, NEUROMUSCULAR DISORD, V21, P579, DOI 10.1016/j.nmd.2011.04.014; Millward D. Joe, 1995, Nutrition Research Reviews, V8, P93, DOI 10.1079/NRR19950008; Morse CI, 1985, J APPL PHYSIOL, V2005, P1050; Palacios-Gonzalez B, 2014, BBA-MOL CELL BIOL L, V1841, P132, DOI 10.1016/j.bbalip.2013.08.018; Reidy PT, 2017, MED SCI SPORT EXER, V49, P1197, DOI 10.1249/MSS.0000000000001224; Reidy PT, 2013, J NUTR, V143, P410, DOI 10.3945/jn.112.168021; TANG JE, 1985, J APPL PHYSIOL, V107, P987, DOI DOI 10.1152/JAPPLPHYSI0L; Tomlinson DJ, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12030; WHO, 2007, WHO TECH REP SER, V935, P1	24	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189246	10.1371/journal.pone.0189246	http://dx.doi.org/10.1371/journal.pone.0189246			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216301	gold, Green Published			2022-12-27	WOS:000417337800107
J	Echenique, P; Cavasotto, CN; De Marco, M; Garcia-Risueno, P; Alonso, JL				Echenique, Pablo; Cavasotto, Claudio N.; De Marco, Monica; Garcia-Risueno, Pablo; Alonso, J. L.			An Exact Expression to Calculate the Derivatives of Position-Dependent Observables in Molecular Simulations with Flexible Constraints (vol 6, e24563, 2011)	PLOS ONE			English	Correction													Cavasotto, Claudio/GQY-7627-2022	Cavasotto, Claudio/0000-0002-1372-0379				Echenique P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024563	1	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189454	10.1371/journal.pone.0189454	http://dx.doi.org/10.1371/journal.pone.0189454			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211794	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200079
J	Kasangian, AA; Gherardi, G; Biagioli, E; Torri, V; Moretti, A; Bernardin, E; Cordovana, A; Farina, G; Bramati, A; Piva, S; Dazzani, MC; Paterno, E; La Verde, NM				Kasangian, Anaid Anna; Gherardi, Giorgio; Biagioli, Elena; Torri, Valter; Moretti, Anna; Bernardin, Elena; Cordovana, Andrea; Farina, Gabriella; Bramati, Annalisa; Piva, Sheila; Dazzani, Maria Chiara; Paterno, Emanuela; La Verde, Nicla Maria			The prognostic role of tumor size in early breast cancer in the era of molecular biology	PLOS ONE			English	Article							CARCINOMA	Background The prognosis of early breast cancer (EBC) depends on patient and tumor characteristics. The association between tumor size, the largest diameter in TNM staging, and prognosis is well recognized. According to TNM, tumors classified as T2, could have very different volumes; e.g. a tumor of 2.1 cm has a volume of 4500 mm(3), while a tumor of 4.9 cm has a volume of 60.000 mm(3) even belonging to the same class. The aim of the study is to establish if the prognostic role of tumor size, expressed as diameter and volume, has been overshadowed by other factors. Methods The primary objective is to evaluate the association between tumor dimensions and overall survival (OS)/disease free survival (DFS), in our institution from January 1st 2005 to September 30th 2013 in a surgical T1-T2 population. Volume was evaluated with the measurement of three half-diameters of the tumor (a, b and c), and calculated using the following formula: 4/3 pi x a x b x c. Results 341 patients with T1-T2 EBC were included. 86.5% were treated with conservative surgery. 85.1% had a Luminal subtype, 9.1% were Triple negative and 7.4% were HER2 positive. Median volume was 942 mm 3 (range 0.52 +/- 31.651.2). 44 patients (12.9%) relapsed and 23 patients died. With a median follow-up of 6.5 years, the univariate analysis for DFS showed an association between age, tumor size, volume, histological grading and molecular subtype. The multivariate analysis confirmed the statistically significant association only for molecular subtype (p 0.005), with a worse prognosis for Triple negative and HER2 positive subtypes compared with Luminal (HR: 2.65; 95% CI: 1.34-5.22). Likewise for OS, an association was shown by the multivariate analysis solely for molecular subtype (HER2 and Triple negative vs. Luminal. HR: 2.83; 95% CI: 1.46-5.49; p 0.002). Conclusions In our study, the only parameter that strongly influences survival is molecular subtype. These findings encourage clinicians to choose adjuvant treatment not based on dimensional criteria but on biological features.	[Kasangian, Anaid Anna; Bernardin, Elena; Cordovana, Andrea] ASST Fatebenefratelli Sacco PO Fatebenefratelli, Breast Surg Unit, Milan, Italy; [Gherardi, Giorgio] ASST Fatebenefratelli Sacco PO Fatebenefratelli, Dept Pathol, Milan, Italy; [Biagioli, Elena; Torri, Valter] IRCCS Mario Negri Inst Pharmacol Res, Lab Methodol Biomed Res, Milan, Italy; [Moretti, Anna; Farina, Gabriella; Bramati, Annalisa; Piva, Sheila; Dazzani, Maria Chiara; Paterno, Emanuela; La Verde, Nicla Maria] ASST Fatebenefratelli Sacco PO Fatebenefratelli, Dept Oncol, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Moretti, A (corresponding author), ASST Fatebenefratelli Sacco PO Fatebenefratelli, Dept Oncol, Milan, Italy.	anna.moretti@asst-fbf-sacco.it	Biagioli, Elena/AAB-1999-2020; la verde, nicla/AAW-9398-2020; Torri, Valter/H-7550-2015	Biagioli, Elena/0000-0002-2066-3827; la verde, nicla/0000-0002-2884-1632; Torri, Valter/0000-0001-9541-9354				Boggs Drexell Hunter, 2015, J Gastrointest Cancer, V46, P131, DOI 10.1007/s12029-015-9699-y; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Chang CC, 2002, HEAD NECK-J SCI SPEC, V24, P940, DOI 10.1002/hed.10151; Chang CC, 2001, J OTOLARYNGOL, V30, P231, DOI 10.2310/7070.2001.19764; Dempsey MF, 2005, AM J NEURORADIOL, V26, P770; Lester SC, 2009, ARCH PATHOL LAB MED, V133, P1515, DOI 10.1043/1543-2165-133.10.1515; Maisonneuve P, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3679; Monetti F, 2004, LUNG CANCER-J IASLC, V43, P71, DOI 10.1016/j.lungcan.2003.07.005; Moon HG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143811; Tolaney SM, 2015, NEW ENGL J MED, V372, P134, DOI 10.1056/NEJMoa1406281; Uematsu T, 2009, RADIOLOGY, V250, P638, DOI 10.1148/radiol.2503081054; Veronesi U, 2009, BREAST J, V15, P291, DOI 10.1111/j.1524-4741.2009.00719.x; Wapnir IL, 1996, BREAST CANCER RES TR, V41, P15, DOI 10.1007/BF01807032	13	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189127	10.1371/journal.pone.0189127	http://dx.doi.org/10.1371/journal.pone.0189127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211792	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200067
J	Leong, C; Neumann, C; Ramasamy, S; Rout, B; Wee, LY; Bigliardi-Qi, M; Bigliardi, PL				Leong, Cheryl; Neumann, Christine; Ramasamy, Srinivas; Rout, Bhimsen; Wee, Lim Yi; Bigliardi-Qi, Mei; Bigliardi, Paul L.			Investigating endogenous mu-opioid receptors in human keratinocytes as pharmacological targets using novel fluorescent ligand	PLOS ONE			English	Article							OPIATE RECEPTOR; BETA-ENDORPHIN; CHRONIC PRURITUS; NERVE-ENDINGS; IN-VITRO; H-3 CTOP; INTERNALIZATION; EXPRESSION; BINDING; ITCH	Opioids in skin function during stress response, regeneration, ageing and, particularly in regulating sensation. In chronic pruritus, topical treatment with Naltrexone changes mu-opioid receptor (mu-OR) localization to relieve itch. The molecular mechanisms behind the effects of Naltrexone on mu-OR function in reduction of itching behavior has not been studied. There is an immediate need to understand the endogenous complexity of mu-OR dynamics in normal and pathological skin conditions. Here we evaluate real-time behavior of mu-OR-Endomorphine complexes in the presence of agonist and antagonists. The mu-OR ligand Endomorphine-1 (EM) was conjugated to the fluorescent dye Tetramethylrhodamine (TAMRA) to investigate the effects of agonist and antagonists in N/TERT-1 keratinocytes. The cellular localization of the EM-TAMRA was followed through time resolved confocal microscopy and population analysis was performed by flow cytometry. The in vitro analyses demonstrate fast internalization and trafficking of the endogenous EM-TAMRA-mu-OR interactions in a qualitative manner. Competition with Endomorphine-1, Naltrexone and CTOP show both canonical and non-canonical effects in basal and differentiated keratinocytes. Acute and chronic treatment with Naltrexone and Endomorphine-1 increases EM-TAMRA binding to skin cells. Although Naltrexone is clinically effective in relieving itch, the mechanisms behind re-distribution of mu-ORs during clinical treatments are not known. Our study has given insight into cellular mechanisms of mu-OR ligand-receptor interactions after opioid agonist and antagonist treatments in vitro. These findings potentially offer opportunities in using novel treatment strategies for skin and peripheral sensory disorders.	[Leong, Cheryl; Neumann, Christine; Ramasamy, Srinivas; Rout, Bhimsen; Bigliardi-Qi, Mei; Bigliardi, Paul L.] ASTAR, Inst Med Biol, Singapore, Singapore; [Wee, Lim Yi] ASTAR, Inst Chem & Engn Sci, Singapore, Singapore; [Bigliardi, Paul L.] Univ Med Cluster, Natl Univ Hosp, Div Rheumatol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Sustainability for Chemicals, Energy & Environment (ISCE2); National University of Singapore	Bigliardi-Qi, M; Bigliardi, PL (corresponding author), ASTAR, Inst Med Biol, Singapore, Singapore.; Bigliardi, PL (corresponding author), Univ Med Cluster, Natl Univ Hosp, Div Rheumatol, Singapore, Singapore.	mei.bigliardi-qi@imb.a-star.edu.sg; paul.bigliardi@imb.a-star.edu.sg		Bigliardi, Paul Lorenz/0000-0003-4567-9080; Srinivas, Ramasamy/0000-0001-9528-1981	Singapore Biomedical Research Council of the Singapore Agency for Science, Technology and Research (A*STAR)	Singapore Biomedical Research Council of the Singapore Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	These studies were supported by funding from the Singapore Biomedical Research Council of the Singapore Agency for Science, Technology and Research (A*STAR).	Al-Hasani R, 2011, ANESTHESIOLOGY, V115, P1363, DOI 10.1097/ALN.0b013e318238bba6; Alvarez VA, 2002, J NEUROSCI, V22, P5769; Andoh T, 2004, J INVEST DERMATOL, V123, P196, DOI 10.1111/j.0022-202X.2004.22704.x; Andoh T, 2008, J PHARMACOL SCI, V106, P667, DOI 10.1254/jphs.08004SC; Arttamangkul S, 2000, MOL PHARMACOL, V58, P1570, DOI 10.1124/mol.58.6.1570; Arttamangkul S, 2006, J NEUROSCI, V26, P4118, DOI 10.1523/JNEUROSCI.0303-06.2006; Bigliardi PL, 2015, BRIT J PHARMACOL, V172, P501, DOI 10.1111/bph.12687; Bigliardi PL, 2007, J AM ACAD DERMATOL, V56, P979, DOI 10.1016/j.jaad.2007.01.007; Bigliardi PL, 2009, EXP DERMATOL, V18, P424, DOI 10.1111/j.1600-0625.2009.00844.x; Bigliardi PL, 1998, J INVEST DERMATOL, V111, P297, DOI 10.1046/j.1523-1747.1998.00259.x; Bigliardi PL, 2003, J INVEST DERMATOL, V120, P145, DOI 10.1046/j.1523-1747.2003.12018.x; Bigliardi PL, 2002, J RECEPT SIGNAL TR R, V22, P191, DOI 10.1081/RRS-120014595; Bigliardi-Qi M, 2006, DIFFERENTIATION, V74, P174, DOI 10.1111/j.1432-0436.2006.00065.x; Bigliardi-Qi M, 2005, DERMATOLOGY, V210, P91, DOI 10.1159/000082563; Bigliardi-Qi M, 2004, DERMATOLOGY, V209, P183, DOI 10.1159/000079887; Bigliardi-Qi M, 2000, J INVEST DERMATOL, V114, P527, DOI 10.1046/j.1523-1747.2000.00801.x; Burford NT, 1998, EUR J PHARMACOL, V342, P123, DOI 10.1016/S0014-2999(97)01556-2; Cassano N, 2010, AM J CLIN DERMATOL, V11, P399, DOI 10.2165/11317620-000000000-00000; Castex-Rizzi N, 2014, BRIT J DERMATOL, V170, P12, DOI 10.1111/bjd.13106; Chuquilin M, 2016, J AM ACAD DERMATOL, V74, P197, DOI 10.1016/j.jaad.2015.04.060; Cohen AS, 2016, BIOCONJUGATE CHEM, V27, P427, DOI 10.1021/acs.bioconjchem.5b00516; Emmerson PJ, 1997, BIOCHEM PHARMACOL, V54, P1315, DOI 10.1016/S0006-2952(97)00374-2; GLINSKI W, 1995, ACTA DERM-VENEREOL, V75, P9; GLINSKI W, 1994, INT J DERMATOL, V33, P356, DOI 10.1111/j.1365-4362.1994.tb01068.x; GLINSKI W, 1994, BRIT J DERMATOL, V131, P260; Goldberg IE, 1998, J PHARMACOL EXP THER, V286, P1007; Halls ML, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac9177; HAWKINS KN, 1989, J PHARMACOL EXP THER, V248, P73; HAWKINS KN, 1988, LIFE SCI, V42, P2541, DOI 10.1016/0024-3205(88)90322-0; Horner KA, 2004, BRAIN RES, V1028, P121, DOI 10.1016/j.brainres.2004.07.055; Ignatowski TA, 1998, J PHARMACOL EXP THER, V284, P298; Janecka A, 2004, CURR TOP MED CHEM, V4, P1, DOI 10.2174/1568026043451618; Karaji AG, 2005, INT IMMUNOPHARMACOL, V5, P1019, DOI 10.1016/j.intimp.2005.01.012; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Ko M.C., 2014, ITCH MECH TREATMENT; Lee CH, 2006, BRIT J DERMATOL, V154, P1100, DOI 10.1111/j.1365-2133.2006.07191.x; Lee J, 2016, CHILD YOUTH SERV REV, V63, P28, DOI 10.1016/j.childyouth.2016.02.003; Lengyel I, 2016, J PHYSIOL PHARMACOL, V67, P605; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Madsen BW, 2000, J NEUROSCI METH, V97, P123, DOI 10.1016/S0165-0270(00)00175-8; Morello JP, 2000, TRENDS PHARMACOL SCI, V21, P466, DOI 10.1016/S0165-6147(00)01575-3; Neumann C, 2015, J INVEST DERMATOL, V135, P471, DOI 10.1038/jid.2014.370; Phan NQ, 2012, ACTA DERM-VENEREOL, V92, P555, DOI 10.2340/00015555-1353; Nissen JB, 1997, ARCH DERMATOL RES, V289, P265, DOI 10.1007/s004030050191; Nissen JB, 1997, EXP DERMATOL, V6, P222, DOI 10.1111/j.1600-0625.1997.tb00166.x; Pereira MP, 2016, CURR PROBL DERMATOL, V50, P71, DOI 10.1159/000446046; Petaja-Repo UE, 2014, PHARMACOL RES, V83, P52, DOI 10.1016/j.phrs.2013.12.001; Phan NQ, 2010, J AM ACAD DERMATOL, V63, P680, DOI 10.1016/j.jaad.2009.08.052; Siemens W, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008320.pub3; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; SLOMINSKI A, 1991, ANN NY ACAD SCI, V642, P459; SLOMINSKI A, 1993, J LAB CLIN MED, V122, P658; Slominski A. T., 2012, ADV ANATOMY EMBRYOLO, V212, P115, DOI DOI 10.1007/978-3-642-19683-6_1; Slominski AT, 2015, J INVEST DERMATOL, V135, P333, DOI 10.1038/jid.2014.458; Slominski AT, 2011, J INVEST DERMATOL, V131, P613, DOI 10.1038/jid.2010.376; Stoddart LA, 2015, NEUROPHARMACOLOGY, V98, P48, DOI 10.1016/j.neuropharm.2015.04.033; Tominaga M, 2007, J INVEST DERMATOL, V127, P2228, DOI 10.1038/sj.jid.5700942; YAMAZAKI T, 1993, J MED CHEM, V36, P708, DOI 10.1021/jm00058a007; Yu X, 2003, J PHARMACOL EXP THER, V306, P447, DOI 10.1124/jpet.103.048694; Zadina JE, 1997, NATURE, V386, P499, DOI 10.1038/386499a0	60	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188607	10.1371/journal.pone.0188607	http://dx.doi.org/10.1371/journal.pone.0188607			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211767	Green Published, Green Submitted, gold			2022-12-27	WOS:000417212200041
J	Vukovic, R; Milenkovic, T; Stojan, G; Vukovic, A; Mitrovic, K; Todorovic, S; Soldatovic, I				Vukovic, Rade; Milenkovic, Tatjana; Stojan, George; Vukovic, Ana; Mitrovic, Katarina; Todorovic, Sladjana; Soldatovic, Ivan			Pediatric siMS score: A new, simple and accurate continuous metabolic syndrome score for everyday use in pediatrics	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSIS; SYNDROME RISK SCORE; BODY-MASS INDEX; PHYSICAL-ACTIVITY; AMERICAN CHILDREN; OBESE CHILDREN; QUEBEC-FAMILY; CVD RISK; ADOLESCENTS; PREVALENCE	Background The dichotomous nature of the current definition of metabolic syndrome (MS) in youth results in loss of information. On the other hand, the calculation of continuous MS scores using standardized residuals in linear regression (Z scores) or factor scores of principal component analysis (PCA) is highly impractical for clinical use. Recently, a novel, easily calculated continuous MS score called siMS score was developed based on the IDF MS criteria for the adult population. Objective To develop a Pediatric siMS score (PsiMS), a modified continuous MS score for use in the obese youth, based on the original siMS score, while keeping the score as simple as possible and retaining high correlation with more complex scores. Subjects and methods The database consisted of clinical data on 153 obese (BMI >= 95th percentile) children and adolescents. Continuous MS scores were calculated using Z scores and PCA, as well as the original siMS score. Four variants of PsiMS score were developed in accordance with IDF criteria for MS in youth and correlation of these scores with PCA and Z score derived MS continuous scores was assessed. Results PsiMS score calculated using formula: (2xWaist/Height) + (Glucose(mmol/l)/5.6) + (triglycerides( mmol/l)/1.7) + (Systolic BP/130)-(HDL(mmol/l)/1.02) showed the highest correlation with most of the complex continuous scores (0.792-0.901). The original siMS score also showed high correlation with continuous MS scores. Conclusion PsiMS score represents a practical and accurate score for the evaluation of MS in the obese youth. The original siMS score should be used when evaluating large cohorts consisting of both adults and children.	[Vukovic, Rade; Mitrovic, Katarina; Todorovic, Sladjana] Mother & Child Hlth Care Inst Serbia Dr Vukan Cup, Dept Endocrinol, Belgrade, Serbia; [Milenkovic, Tatjana] Mother & Child Hlth Care Inst Serbia Dr Vukan Cup, Belgrade, Serbia; [Stojan, George] Harvard Med Sch, BIDMC, Boston, MA USA; [Vukovic, Ana] Univ Belgrade, Sch Dent Med, Dept Pediat & Prevent Dent, Belgrade, Serbia; [Soldatovic, Ivan] Univ Belgrade, Inst Med Stat & Informat, Sch Med, Belgrade, Serbia	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Belgrade; University of Belgrade	Soldatovic, I (corresponding author), Univ Belgrade, Inst Med Stat & Informat, Sch Med, Belgrade, Serbia.	soldatovic.ivan@gmail.com	Vukovic, Rade/H-3344-2019; Todorovic, Sladjana/GVS-4184-2022; Stojan, George/AAP-3878-2020	Vukovic, Rade/0000-0002-1592-4105; Stojan, George/0000-0001-5758-5052; Soldatovic, Ivan/0000-0003-4893-1683; Todorovic, Sladjana/0000-0002-9981-8923				Ahrens W, 2014, INT J OBESITY, V38, pS4, DOI 10.1038/ijo.2014.130; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Cali AMG, 2008, J CLIN ENDOCR METAB, V93, pS31, DOI 10.1210/jc.2008-1363; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; DuBose KD, 2015, PEDIATR EXERC SCI, V27, P364, DOI [10.1123/pes.2014-01340, 10.1123/pes.2014-0134]; Eisenmann JC, 2005, INT J OBESITY, V29, P1077, DOI 10.1038/sj.ijo.0802995; Eisenmann JC, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-8; Eisenmann JC, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-17; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Friend A, 2013, METAB SYNDR RELAT D, V11, P71, DOI 10.1089/met.2012.0122; Kahn R, 2007, CIRCULATION, V115, P1806, DOI 10.1161/CIRCULATIONAHA.106.658336; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P190, DOI 10.1016/S0895-4356(00)00315-2; Li CY, 2007, DIABETES CARE, V30, P1556, DOI 10.2337/dc06-2481; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Okosun IS, 2010, J CLIN HYPERTENS, V12, P636, DOI 10.1111/j.1751-7176.2010.00338.x; Olza J, 2015, ANN NUTR METAB, V66, P72, DOI 10.1159/000369981; Pandit D, 2011, INT J OBESITY, V35, P1318, DOI 10.1038/ijo.2011.138; Pirkola J, 2008, ARCH DIS CHILD, V93, P945, DOI 10.1136/adc.2007.132951; Pladevall M, 2006, DIABETES CARE, V29, P113, DOI 10.2337/diacare.29.1.113; Shi P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138979; Soldatovic I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146143; Viitasalo A, 2014, DIABETOLOGIA, V57, P940, DOI 10.1007/s00125-014-3172-5; Villa Julia Khéde Dourado, 2015, Rev. paul. pediatr., V33, P187, DOI 10.1016/j.rpped.2014.11.001; Vukovic R, 2012, INT J OBESITY, V36, P1479, DOI 10.1038/ijo.2011.273; Vukovic R, 2015, J PEDIATR ENDOCR MET, V28, P903, DOI 10.1515/jpem-2014-0533; WHO, 2009, WHO ANTHR PERS COMP; Wijndaele K, 2006, DIABETES CARE, V29, P2329, DOI 10.2337/dc06-1341; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	30	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189232	10.1371/journal.pone.0189232	http://dx.doi.org/10.1371/journal.pone.0189232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211786	Green Submitted, gold, Green Published			2022-12-27	WOS:000417212200076
J	Warden, CH; Bettaieb, A; Min, E; Fisler, JS; Haj, FG; Stern, JS				Warden, Craig H.; Bettaieb, Ahmed; Min, Esther; Fisler, Janis S.; Haj, Fawaz G.; Stern, Judith S.			Chow fed UC Davis strain female Lepr fatty Zucker rats exhibit mild glucose intolerance, hypertriglyceridemia, and increased urine volume, all reduced by a Brown Norway strain chromosome 1 congenic donor region	PLOS ONE			English	Article							SUITABLE HOUSEKEEPING GENES; BODY-MASS INDEX; RENAL-DISEASE; KIDNEY-DISEASE; RT-PCR; OBESE; MOUSE; INJURY; IDENTIFICATION; NORMALIZATION	Our objective is to identify genes that influence the development of any phenotypes of type 2 diabetes (T2D) or kidney disease in obese animals. We use the reproductively isolated UC Davis fatty Zucker strain rat model in which the defective chromosome 4 leptin receptor (Lepr(faSte/faSte)) results in fatty obesity. We previously produced a congenic strain with the distal half of chromosome 1 from the Brown Norway strain (BN) on a Zucker (ZUC) background (BN.ZUC-D1Rat183-D1Rat90). Previously published studies in males showed that the BN congenic donor region protects from some phenotypes of renal dysfunction and T2D. We now expand our studies to include females and expand phenotyping to gene expression. We performed diabetes and kidney disease phenotyping in chow-fed females of the BN. ZUC-D1Rat183-D1Rat90 congenic strain to determine the specific characteristics of the UC Davis model. Fatty Lepr(faSte/faSte) animals of both BN and ZUC genotype in the congenic donor region had prediabetic levels of fasting blood glucose and blood glucose 2 hours after a glucose tolerance test. We observed significant congenic strain chromosome 1 genotype effects of the BN donor region in fatty females that resulted in decreased food intake, urine volume, glucose area under the curve during glucose tolerance test, plasma triglyceride levels, and urine glucose excretion per day. In fatty females, there were significant congenic strain BN genotype effects on non-fasted plasma urea nitrogen, triglyceride, and creatinine. Congenic region genotype effects were observed by quantitative PCR of mRNA from the kidney for six genes, all located in the chromosome 1 BN donor region, with potential effects on T2D or kidney function. The results are consistent with the hypothesis that the BN genotype chromosome 1 congenic region influences traits of both type 2 diabetes and kidney function in fatty UC Davis ZUC females and that there are many positional candidate genes.	[Warden, Craig H.] Univ Calif Davis, Dept Pediat Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Bettaieb, Ahmed] Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA; [Min, Esther; Fisler, Janis S.; Haj, Fawaz G.; Stern, Judith S.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Stern, Judith S.] Univ Calif Davis, Internal Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of Tennessee System; University of Tennessee Knoxville; University of California System; University of California Davis; University of California System; University of California Davis	Warden, CH (corresponding author), Univ Calif Davis, Dept Pediat Neurobiol Physiol & Behav, Davis, CA 95616 USA.	chwarden@ucdavis.edu			Nora Eccles Treadwell Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095359] Funding Source: NIH RePORTER	Nora Eccles Treadwell Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by Nora Eccles Treadwell Foundation grant to JSS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; [Anonymous], 2011, SEX DEPENDENT HEPATI; Baddela VS, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-118; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bettaieb A, 2017, FEBS J, V284, P1970, DOI 10.1111/febs.14100; CHAN CP, 1982, AM J PHYSIOL, V242, pE19, DOI 10.1152/ajpendo.1982.242.1.E19; Clee SM, 2006, NAT GENET, V38, P688, DOI 10.1038/ng1796; Corsetti JP, 2000, ATHEROSCLEROSIS, V148, P231, DOI 10.1016/S0021-9150(99)00265-8; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Dominguez JH, 2006, KIDNEY INT, V69, P1969, DOI 10.1038/sj.ki.5000406; Etgen GJ, 2000, METABOLISM, V49, P684, DOI 10.1016/S0026-0495(00)80049-9; Fisler JS, 1997, J NUTR, V127, pS1909, DOI 10.1093/jn/127.9.1909S; Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94; Fram EB, 2016, UROLOGY, V87, P52, DOI 10.1016/j.urology.2015.10.013; Gades MD, 1998, KIDNEY INT, V53, P130, DOI 10.1046/j.1523-1755.1998.00746.x; Gades MD, 1999, KIDNEY INT, V56, P1779, DOI 10.1046/j.1523-1755.1999.00731.x; Gularte-Merida R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1191-8; Hanukoglu I, 2016, GENE, V579, P95, DOI 10.1016/j.gene.2015.12.061; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Hsu MF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00564-3; Iida M, 1996, BIOCHEM BIOPH RES CO, V224, P597, DOI 10.1006/bbrc.1996.1070; Johnson PR, 1997, AM J CLIN NUTR, V66, P890, DOI 10.1093/ajcn/66.4.890; KASISKE BL, 1986, AM J CLIN NUTR, V44, P56, DOI 10.1093/ajcn/44.1.56; Kessler MA, 1997, ANAL BIOCHEM, V248, P180, DOI 10.1006/abio.1997.2113; Kessler MA, 1997, CLIN CHEM, V43, P996; Kim K, 2010, PHYSL GENOMICS; Kitada M, 2016, INT J NEPHROL RENOV, V9, P279, DOI 10.2147/IJNRD.S103784; Koppelkamm A, 2010, INT J LEGAL MED, V124, P371, DOI 10.1007/s00414-010-0433-9; Lapierre LA, 2012, MOL BIOL CELL, V23, P2302, DOI 10.1091/mbc.E11-08-0681; Lazar J, 2013, PHYSIOL GENOMICS, V45, P720, DOI 10.1152/physiolgenomics.00089.2013; Liu TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141859; Maric-Bilkan C, 2013, MED CLIN N AM, V97, P59, DOI 10.1016/j.mcna.2012.10.010; Navaneethan SD, 2016, KIDNEY INT, V89, P675, DOI 10.1016/j.kint.2015.12.002; Olden M, 2014, J AM SOC NEPHROL, V25, P1869, DOI 10.1681/ASN.2013070781; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P673, DOI 10.2215/CJN.07891109; Reznichenko A, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-78; Sarahan KA, 2011, PHYSIOL GENOMICS, V43, P1049, DOI 10.1152/physiolgenomics.00134.2010; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Stanhope KL, 2008, AM J CLIN NUTR, V87, P1194, DOI 10.1093/ajcn/87.5.1194; Stevenson FT, 2000, KIDNEY INT, V57, P1927, DOI 10.1046/j.1523-1755.2000.00042.x; Stevenson FT, 2001, OBES RES, V9, P492, DOI 10.1038/oby.2001.64; Takata K, 2008, HISTOCHEM CELL BIOL, V130, P197, DOI 10.1007/s00418-008-0457-0; Tan SC, 2012, MOL BIOL REP, V39, P4857, DOI 10.1007/s11033-011-1281-5; Tan YC, 2011, BBA-MOL BASIS DIS, V1812, P1202, DOI 10.1016/j.bbadis.2011.03.002; Valente V, 2014, ANN NEUROSCI, V21, P62, DOI 10.5214/ans.0972.7531.210207; Vesentini Nicoletta, 2012, BMC Res Notes, V5, P124, DOI 10.1186/1756-0500-5-124; WARDEN CH, 1993, J CLIN INVEST, V92, P773, DOI 10.1172/JCI116649; WARDEN CH, 1995, J CLIN INVEST, V95, P1545, DOI 10.1172/JCI117827; Warden CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087770; Warden CH, 2012, PHYSIOL GENOMICS, V44, P1052, DOI 10.1152/physiolgenomics.00134.2011; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wickman C, 2013, SEMIN NEPHROL, V33, P14, DOI 10.1016/j.semnephrol.2012.12.006; Xu M, 2016, EBIOMEDICINE, V6, P162, DOI 10.1016/j.ebiom.2016.02.032; Yazdi FT, 2015, PEERJ, V3, DOI 10.7717/peerj.856; Zhu W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150006	57	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188175	10.1371/journal.pone.0188175	http://dx.doi.org/10.1371/journal.pone.0188175			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211750	Green Published, gold			2022-12-27	WOS:000417212200025
J	Tang, JJ; Zhang, S; Zou, YJ; Liu, F				Tang, Jinjun; Zhang, Shen; Zou, Yajie; Liu, Fang			An adaptive map-matching algorithm based on hierarchical fuzzy system from vehicular GPS data	PLOS ONE			English	Article							TRANSPORT; PATTERNS	An improved hierarchical fuzzy inference method based on C-measure map-matching algorithm is proposed in this paper, in which the C-measure represents the certainty or probability of the vehicle traveling on the actual road. A strategy is firstly introduced to use historical positioning information to employ curve-curve matching between vehicle trajectories and shapes of candidate roads. It improves matching performance by overcoming the disadvantage of traditional map-matching algorithm only considering current information. An average historical distance is used to measure similarity between vehicle trajectories and road shape. The input of system includes three variables: distance between position point and candidate roads, angle between driving heading and road direction, and average distance. As the number of fuzzy rules will increase exponentially when adding average distance as a variable, a hierarchical fuzzy inference system is then applied to reduce fuzzy rules and improve the calculation efficiency. Additionally, a learning process is updated to support the algorithm. Finally, a case study contains four different routes in Beijing city is used to validate the effectiveness and superiority of the proposed method.	[Tang, Jinjun] Cent S Univ, Sch Traff & Transportat Engn, Key Lab Smart Transport Hunan Prov, Changsha, Hunan, Peoples R China; [Zhang, Shen] Harbin Inst Technol, Sch Transportat Sci & Engn, Harbin, Heilongjiang, Peoples R China; [Zou, Yajie] Tongji Univ, Key Lab Rd & Traff Engn, Minist Educ, Shanghai, Peoples R China; [Liu, Fang] Inner Mongolia Agr Univ, Sch Energy & Transportat Engn, Hohhot, Peoples R China	Central South University; Harbin Institute of Technology; Tongji University; Inner Mongolia Agricultural University	Zou, YJ (corresponding author), Tongji Univ, Key Lab Rd & Traff Engn, Minist Educ, Shanghai, Peoples R China.	yajiezou@hotmail.com		Zou, Yajie/0000-0002-3505-168X	National Natural Science Foundation of China [71701215, 61573009, 71403068]; Foundation of Central South University [502045002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Central South University	This research was funded in part by the National Natural Science Foundation of China (grant nos. 71701215, 61573009 and 71403068), Foundation of Central South University (grant nos. 502045002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded in part by the National Natural Science Foundation of China (grant nos. 71701215 and 71403068), Foundation of Central South University (grant nos. 502045002).	[Anonymous], 2010, P 18 SIGSPATIAL INT, DOI DOI 10.1145/1869790.1869807; Blazquez CA, 2005, TRANSPORT RES REC, P68, DOI 10.3141/1935-08; Fu MY, 2004, ITSC 2004: 7TH INTERNATIONAL IEEE CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS, PROCEEDINGS, P613, DOI 10.1109/ITSC.2004.1398971; Greenfeld J., 2002, 81 ANN M TRANSP RES; Kim S, 2001, IEEE T IND ELECTRON, V48, P432, DOI 10.1109/41.915423; Li ZH, 2005, 2005 IEEE INTELLIGENT TRANSPORTATION SYSTEMS CONFERENCE (ITSC), P425; Ma XL, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040818; Ma XL, 2017, J TRANSP GEOGR, V58, P135, DOI 10.1016/j.jtrangeo.2016.12.001; Ma XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119044; Ochieng W. Y., 2004, BRAZILIAN J CARTOGRA, V55, P1; Phuyal B., 2002, I NAV ION ANN C PORT; Quddus MA, 2007, TRANSPORT RES C-EMER, V15, P312, DOI 10.1016/j.trc.2007.05.002; Quddus MA, 2006, J INTELL TRANSPORT S, V10, P103, DOI 10.1080/15472450600793560; RAJU GVS, 1991, INT J CONTROL, V54, P1201, DOI 10.1080/00207179108934205; Syed S, 2004, I NAV ION NAT TECHN; Tang JJ, 2017, IEEE T INTELL TRANSP, V18, P2340, DOI 10.1109/TITS.2016.2643005; Tang JJ, 2018, EXPERT SYST APPL, V91, P452, DOI 10.1016/j.eswa.2017.09.025; Tang JJ, 2016, IEEE T INTELL TRANSP, V17, P3318, DOI 10.1109/TITS.2016.2544140; Tang JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147263; Tang JJ, 2015, PHYSICA A, V438, P140, DOI 10.1016/j.physa.2015.06.032; White CE, 2000, TRANSPORT RES C-EMER, V8, P91, DOI 10.1016/S0968-090X(00)00026-7; Yan Y, 2017, PHYSICA A, V477, P149, DOI 10.1016/j.physa.2017.02.040; Yang D, 2003, 2003 IEEE INTELLIGENT TRANSPORTATION SYSTEMS PROCEEDINGS, VOLS. 1 & 2, P1246; YU HY, 2017, SENSORS BASEL, V17, DOI DOI 10.3390/S17071501; Zhang S, 2017, J TRANSP GEOGR, V61, P72, DOI 10.1016/j.jtrangeo.2017.04.009; Zhao Y., 1997, VEHICLE LOCATION NAV	26	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188796	10.1371/journal.pone.0188796	http://dx.doi.org/10.1371/journal.pone.0188796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206866	Green Published, gold, Green Submitted			2022-12-27	WOS:000417110700023
J	Jhun, BW; Jung, WJ; Hwang, NY; Park, HY; Jeon, K; Kang, ES; Koh, WJ				Jhun, Byung Woo; Jung, Woo Jin; Hwang, Na Young; Park, Hye Yun; Jeon, Kyeongman; Kang, Eun-Suk; Koh, Won-Jung			Risk factors for the development of chronic pulmonary aspergillosis in patients with nontuberculous mycobacterial lung disease	PLOS ONE			English	Article							SERUM ITRACONAZOLE LEVELS; CLINICAL CHARACTERISTICS; CYSTIC-FIBROSIS; ANTIBIOTIC-TREATMENT; PRACTICE GUIDELINES; TREATMENT OUTCOMES; AVIUM; DIAGNOSIS; THERAPY; ABSCESSUS	Nontuberculous mycobacterial lung disease (NTM-LD) is increasingly recognized as an important predisposing condition for the development of chronic pulmonary aspergillosis (CPA), but there are limited data on the risk factors for CPA development in NTM-LD patients. We reviewed the medical records of 566 patients who, at the time of diagnosis of NTM-LD, did not have CPA and who received >= 12 months of treatment for NTM-LD between January 2010 and June 2015. Of these patients, 41 (7.2%) developed CPA (NTM-CPA group), whereas the remaining 525 patients did not develop CPA (NTM group). The median time to the development of CPA was 18.0 months from treatment initiation for NTM-LD. The NTM-CPA group was older and had significantly higher proportions of males, current smokers, and patients with a low body mass index (< 18.5 kg/m(2)), when compared to the NTM group. Moreover, the NTM-CPA group was more likely to have a history of tuberculosis and chronic obstructive lung disease and to have used inhaled or systemic steroids. In the NTM-CPA group, more than 40% of patients had Mycobacterium abscessus complex (MABC) as the cause of NTM-LD, and the fibrocavitary form of NTM-LD was the most common; both associations were higher than in the NTM group. Overall, 17 (3%) patients died, and the NTM-CPA group had a higher mortality rate than did the NTM group (19.5% vs. 1.7%, respectively; P<0.001). In a multivariable analysis, old age, male gender, low body mass index, chronic obstructive lung disease, systemic steroids, MABC as the etiologic organism, and the fibrocavitary form of NTM-LD remained significant predictors of development of CPA. In conclusion, CPA occurred in 7.2% of patients after initiation of treatment for NTM-LD, and some risk factors were associated with CPA development. Given the worse prognosis, early diagnosis and treatment of CPA are important in patients with NTM-LD.	[Jhun, Byung Woo; Jung, Woo Jin; Park, Hye Yun; Jeon, Kyeongman; Koh, Won-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea; [Hwang, Na Young] Samsung Med Ctr, Dept Stat, Seoul, South Korea; [Kang, Eun-Suk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Koh, WJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea.	wjkoh@skku.edu	Koh, Won-Jung/D-9586-2018; Jeon, Kyeongman/F-5963-2019	Koh, Won-Jung/0000-0002-4756-3527; Jeon, Kyeongman/0000-0002-4822-1772	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [NRF-2015R1A2A1A01003959]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C2778]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (NRF-2015R1A2A1A01003959) and by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (HI15C2778). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Denning DW, 2016, EUR RESPIR J, V47, P45, DOI 10.1183/13993003.00583-2015; Fleshner M, 2016, INT J TUBERC LUNG D, V20, P582, DOI 10.5588/ijtld.15.0807; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Griffith DE, 2015, CHEST, V147, P1369, DOI 10.1378/chest.14-1297; Hafeez I, 2000, THORAX, V55, P717, DOI 10.1136/thorax.55.8.717; Jeong BH, 2015, AM J RESP CRIT CARE, V191, P96, DOI 10.1164/rccm.201408-1545OC; Jhun BW, 2013, MED MYCOL, V51, P811, DOI 10.3109/13693786.2013.806826; Kang YA, 2016, EXPERT REV RESP MED, V10, P557, DOI 10.1586/17476348.2016.1165611; Kobashi Y, 2006, RESPIROLOGY, V11, P809, DOI 10.1111/j.1440-1843.2006.00952.x; Koh WJ, 2006, CHEST, V129, P341, DOI 10.1378/chest.129.2.341; Koh WJ, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02503-2016; Koh WJ, 2017, CLIN INFECT DIS, V64, P309, DOI 10.1093/cid/ciw724; Koh WJ, 2016, CHEST, V150, P1211, DOI 10.1016/j.chest.2016.05.003; Koh WJ, 2012, CHEST, V142, P1482, DOI 10.1378/chest.12-0494; Koh WJ, 2011, AM J RESP CRIT CARE, V183, P405, DOI 10.1164/rccm.201003-0395OC; Kosmidis C, 2015, THORAX, V70, P270, DOI 10.1136/thoraxjnl-2014-206291; Kunst H, 2006, EUR RESPIR J, V28, P352, DOI 10.1183/09031936.06.00139005; Kwon YS, 2016, J KOREAN MED SCI, V31, P649, DOI 10.3346/jkms.2016.31.5.649; Limper AH, 2011, AM J RESP CRIT CARE, V183, P96, DOI 10.1164/rccm.2008-740ST; Moon SM, 2017, J INFECT CHEMOTHER, V23, P658, DOI 10.1016/j.jiac.2017.02.004; Moon SM, 2015, ANTIMICROB AGENTS CH, V59, P663, DOI 10.1128/AAC.04075-14; Mussaffi H, 2005, EUR RESPIR J, V25, P324, DOI 10.1183/09031936.05.00058604; Nam HS, 2010, INT J INFECT DIS, V14, pE479, DOI 10.1016/j.ijid.2009.07.011; Noni M, 2014, MED MYCOL, V52, P715, DOI 10.1093/mmy/myu038; Ohba H, 2012, RESP MED, V106, P724, DOI 10.1016/j.rmed.2012.01.014; Patterson TF, 2016, CLIN INFECT DIS, V63, pE1, DOI 10.1093/cid/ciw326; Ryu YJ, 2016, TUBERC RESPIR DIS, V79, P74, DOI 10.4046/trd.2016.79.2.74; Smith NL, 2011, EUR RESPIR J, V37, P865, DOI 10.1183/09031936.00054810; Stout JE, 2016, INT J INFECT DIS, V45, P123, DOI 10.1016/j.ijid.2016.03.006; Takeda K, 2016, MED MYCOL, V54, P120, DOI 10.1093/mmy/myv093; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Zoumot Z, 2014, RESPIROLOGY, V19, P714, DOI 10.1111/resp.12287	32	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188716	10.1371/journal.pone.0188716	http://dx.doi.org/10.1371/journal.pone.0188716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190796	Green Published, gold			2022-12-27	WOS:000416841900106
J	Thiagarajan, D; Shea, KO; Sreejit, G; Ananthakrishnan, R; Quadri, N; Li, Q; Schmidt, AM; Gabbay, K; Ramasamy, R				Thiagarajan, Devi; Shea, Karen O'; Sreejit, Gopalkrishna; Ananthakrishnan, Radha; Quadri, Nosirudeen; Li, Qing; Schmidt, Ann Marie; Gabbay, Kenneth; Ramasamy, Ravichandran			Aldose reductase modulates acute activation of mesenchymal markers via the beta-catenin pathway during cardiac ischemia-reperfusion	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; MYOCARDIAL-INFARCTION; MATRIX METALLOPROTEINASE-2; ENDOTHELIAL-CELLS; INJURY; MATRIX-METALLOPROTEINASE-9; PROTECTS; INHIBITION; FIBROSIS; HEART	Aldose reductase (AR: human, AKR1B1; mouse, AKR1B3), the first enzyme in the polyol pathway, plays a key role in mediating myocardial ischemia/reperfusion (I/R) injury. In earlier studies, using transgenic mice broadly expressing human AKR1B1 to human-relevant levels, mice devoid of Akr1b3, and pharmacological inhibitors of AR, we demonstrated that AR is an important component of myocardial I/R injury and that inhibition of this enzyme protects the heart from I/R injury. In this study, our objective was to investigate if AR modulates the beta-catenin pathway and consequent activation of mesenchymal markers during I/R in the heart. To test this premise, we used two different experimental models: in vivo, Akr1b3 null mice and wild type C57BL/6 mice (WT) were exposed to acute occlusion of the left anterior descending coronary artery (LAD) followed by recovery for 48 hours or 28 days, and ex-vivo, WT and Akr1b3 null murine hearts were perfused using the Langendorff technique (LT) and subjected to 30 min of global (zero-flow) ischemia followed by 60 min of reperfusion. Our in vivo results reveal reduced infarct size and improved functional recovery at 48 hours in mice devoid of Akr1b3 compared to WT mice. We demonstrate that the cardioprotection observed in Akr1b3 null mice was linked to acute activation of the beta-catenin pathway and consequent activation of mesenchymal markers and genes linked to fibrotic remodeling. The increased activity of the beta-catenin pathway at 48 hours of recovery post-LAD was not observed at 28 days post-infarction, thus indicating that the observed increase in beta-catenin activity was transient in the mice hearts devoid of Akr1b3. In ex vivo studies, inhibition of beta-catenin blocked the cardioprotection observed in Akr1b3 null mice hearts. Taken together, these data indicate that AR suppresses acute activation of beta-catenin and, thereby, blocks consequent induction of mesenchymal markers during early reperfusion after myocardial ischemia. Inhibition of AR might provide a therapeutic opportunity to optimize cardiac remodeling after I/R injury.	[Thiagarajan, Devi; Shea, Karen O'; Sreejit, Gopalkrishna; Ananthakrishnan, Radha; Quadri, Nosirudeen; Li, Qing; Schmidt, Ann Marie; Ramasamy, Ravichandran] NYU, Langone Med Ctr, Dept Med, Diabet Res Program, New York, NY 10003 USA; [Gabbay, Kenneth] Baylor Coll Med, Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA	New York University; NYU Langone Medical Center; Baylor College of Medicine	Ramasamy, R (corresponding author), NYU, Langone Med Ctr, Dept Med, Diabet Res Program, New York, NY 10003 USA.	ramasr02@nyumc.org	sreejit, Gopalkrishna/AAF-4772-2020	Ramasamy, Ravichandran/0000-0002-3666-3346; sreejit, gopalkrishna/0000-0003-4616-8397	NIH [HL60901, AG026467]; Harry B & Aileen B. Gordon Foundation; Agar Corporation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harry B & Aileen B. Gordon Foundation; Agar Corporation	This work was supported in part by grants from NIH - HL60901(RR & AMS), and AG026467 (RR & AMS), and the Harry B & Aileen B. Gordon Foundation (KHG), and the Agar Corporation (KHG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdillahi M, 2012, AM J PHYSIOL-HEART C, V303, pH297, DOI 10.1152/ajpheart.00999.2011; Adluri RS, 2011, J MOL CELL CARDIOL, V50, P239, DOI 10.1016/j.yjmcc.2010.11.002; Aleshin A, 2008, AM J PHYSIOL-HEART C, V294, pH1823, DOI 10.1152/ajpheart.01210.2007; Ananthakrishnan R, 2013, ARTIF CELL NANOMED B, V41, P428, DOI 10.3109/21691401.2012.762370; Buja LM, 2005, CARDIOVASC PATHOL, V14, P170, DOI 10.1016/j.carpath.2005.03.006; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Calderone V, 2010, J PHARM PHARMACOL, V62, P107, DOI 10.1211/jpp.62.01.0012; CAMICI P, 1989, PROG CARDIOVASC DIS, V32, P217, DOI 10.1016/0033-0620(89)90027-3; Chen QS, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/928315, 10.1155/2013/434010]; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Chrobak I, 2013, J CELL PHYSIOL, V228, P1774, DOI 10.1002/jcp.24337; DeCoux A, 2014, J MOL CELL CARDIOL, V77, P64, DOI 10.1016/j.yjmcc.2014.09.016; Distler A, 2013, ANN RHEUM DIS, V72, P1575, DOI 10.1136/annrheumdis-2012-202275; Douglas IS, 2006, AM J RESP CELL MOL, V34, P274, DOI 10.1165/rcmb.2005-0277OC; Duan JZ, 2012, EMBO J, V31, P429, DOI 10.1038/emboj.2011.418; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Euler G, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00066; Fujiu K, 2014, J MOL CELL CARDIOL, V70, P64, DOI 10.1016/j.yjmcc.2014.01.013; Gabbay KH, 2010, J BIOL CHEM, V285, P19510, DOI 10.1074/jbc.M110.110247; Gerczuk PZ, 2012, J AM COLL CARDIOL, V59, P969, DOI 10.1016/j.jacc.2011.07.054; Hu BL, 2016, SCI REP-UK, V6, DOI 10.1038/srep36436; Hwang YYC, 2005, FASEB J, V19, P795, DOI 10.1096/fj.04-2780fje; Hwang YYC, 2004, FASEB J, V18, P1192, DOI 10.1096/fj.03-1400com; Inoue T, 2016, J CARDIOL, V67, P305, DOI 10.1016/j.jjcc.2015.09.002; Iwata K, 2006, J PHARMACOL SCI, V102, P37, DOI 10.1254/jphs.FP0060218; Iyer RP, 2016, J MOL CELL CARDIOL, V100, P109, DOI 10.1016/j.yjmcc.2016.10.005; Jacob-Ferreira AL, 2013, ARCH BIOCHEM BIOPHYS, V540, P82, DOI 10.1016/j.abb.2013.09.019; Juhaszova M, 2009, CIRC RES, V104, P1240, DOI 10.1161/CIRCRESAHA.109.197996; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Kisseleva T, 2006, J GASTROEN HEPATOL, V21, pS84, DOI 10.1111/j.1440-1746.2006.04584.x; Leask A, 2015, CIRC RES, V116, P1269, DOI 10.1161/CIRCRESAHA.116.305381; Lee SC, 2015, ONCOTARGET, V6, P27146, DOI 10.18632/oncotarget.4354; Lehwald N, 2011, GASTROENTEROLOGY, V141, P707, DOI 10.1053/j.gastro.2011.04.051; Lim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066558; Lindsey ML, 2006, AM J PHYSIOL-HEART C, V290, pH232, DOI 10.1152/ajpheart.00457.2005; Liu P, 2010, J CELL PHYSIOL, V225, P810, DOI 10.1002/jcp.22292; LOPASCHUK GD, 1988, CIRC RES, V63, P1036, DOI 10.1161/01.RES.63.6.1036; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Nie L, 2014, AM J PHYSIOL-CELL PH, V307, pC859, DOI 10.1152/ajpcell.00081.2014; NISHIMURA C, 1994, CLIN CHEM, V40, P889; Paruchuri S, 2006, CIRC RES, V99, P861, DOI 10.1161/01.RES.0000245188.41002.2c; Ramasamy R, 1997, DIABETES, V46, P292, DOI 10.2337/diabetes.46.2.292; Ramasamy R, 1999, CARDIOVASC RES, V42, P130, DOI 10.1016/S0008-6363(98)00303-4; Ruiz-Villalba A, 2015, J AM COLL CARDIOL, V65, P2057, DOI 10.1016/j.jacc.2015.03.520; SAUTNER T, 1995, EUR J SURG, V161, P97; Scholten D, 2011, AM J PATHOL, V179, P189, DOI 10.1016/j.ajpath.2011.03.049; Shaikh G, 2016, BRIT J PHARMACOL, V173, P3279, DOI 10.1111/bph.13615; Son NHP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046549; Thirunavukkarasu M, 2008, ANTIOXID REDOX SIGN, V10, P1475, DOI 10.1089/ars.2008.2042; Thirunavukkarasu M, 2015, J PHYSIOL BIOCHEM, V71, P623, DOI 10.1007/s13105-015-0426-8; Tracey WR, 2000, AM J PHYSIOL-HEART C, V279, pH1447, DOI 10.1152/ajpheart.2000.279.4.H1447; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; Warboys CM, 2014, CARDIOVASC RES, V104, P116, DOI 10.1093/cvr/cvu173; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Xin Yi, 2012, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V28, P1194; Ye B, 2013, CARDIOVASC PATHOL, V22, P54, DOI 10.1016/j.carpath.2012.03.004; Yoshimoto Tetsuyuki, 1997, Hokkaido Journal of Medical Science, V72, P97; Zamilpa R, 2012, J MOL CELL CARDIOL, V53, P599, DOI 10.1016/j.yjmcc.2012.07.017; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865; Zhou SH, 2013, J ORTHOP RES, V31, P554, DOI 10.1002/jor.22244	64	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188981	10.1371/journal.pone.0188981	http://dx.doi.org/10.1371/journal.pone.0188981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190815	gold, Green Published, Green Submitted			2022-12-27	WOS:000416841900183
J	Guan, H; Li, WM; Li, YY; Wang, JC; Li, Y; Tang, YA; Lu, SY				Guan, Hao; Li, Weiming; Li, Yuanyuan; Wang, Jichang; Li, Yan; Tang, Yanan; Lu, Shaoying			MicroRNA-93 promotes proliferation and metastasis of gastric cancer via targeting TIMP2	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; PROGRESSION; MIRNAS; TUMORIGENESIS; STATISTICS; MECHANISMS; PATHWAY; EMT	MicroRNAs (miRNAs) are important regulators of pathobiological processes in various cancer. In the present study, we demonstrated that miR-93 expression was significantly up-regulated in gastric cancer tissues compared with that in matched normal mucosal tissues. High expression of miR-93 was significantly associated with lymph node metastasis and tumor-node-metastasis (TNM) stage. Functionally, ectopic expression of miR-93 promoted cell proliferation, migration, invasion, EMT phenotypes, and repressed apoptosis and G1 cell cycle arrest in vitro, and promoted tumor formation in vivo. We further identified that tissue inhibitor of metalloproteinase 2 (TIMP2) was a direct target of miR-93 by using luciferase reporter assay, qRT-PCR, and immunoblotting assay. Furthermore, knockdown of TIMP2 with specific siRNA showed similar oncogenic effects in gastric cancer cells with that transfected with miR-93 mimics. Our findings indicated that miR-93 serves as a tumor promoter in human gastric carcinogenesis by targeting TIMP2, suggesting that miR-93 might be a promising biomarker and therapeutic target for treatment of gastric cancer.	[Guan, Hao; Li, Weiming; Wang, Jichang; Li, Yan; Tang, Yanan; Lu, Shaoying] Xi An Jiao Tong Univ, Dept Vasc Surg, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Li, Yuanyuan] Shaanxi Univ Chinese Med, Dept Translat Med Ctr, Affiliated Hosp 2, Xianyang, Peoples R China	Xi'an Jiaotong University; Shaanxi University of Chinese Medicine	Lu, SY (corresponding author), Xi An Jiao Tong Univ, Dept Vasc Surg, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China.	robertlu@mail.xjtu.edu.cn	Li, Yang/GWM-7879-2022; Li, Yuan/GXV-1310-2022; li, yong/HDN-3885-2022; 黎, 伟/GXM-4040-2022; Wang, Ji-Chang/U-9675-2018	Wang, Ji-Chang/0000-0003-2987-8880	National Natural Science Foundation of China [81172359, 81472747]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from National Natural Science Foundation of China (No. 81172359 and 81472747, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beermann J, 2016, PHYSIOL REV, V96, P1297, DOI 10.1152/physrev.00041.2015; Chen S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165776; Chen X, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0304-6; Chen X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160780; Cheng GF, 2015, ADV DRUG DELIVER REV, V81, P75, DOI 10.1016/j.addr.2014.09.001; He C, 2017, GASTROENTEROLOGY, V152, P1434, DOI 10.1053/j.gastro.2017.01.049; Jafri MA, 2017, SEMIN CANCER BIOL, V44, P117, DOI 10.1016/j.semcancer.2017.02.004; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CM, 2017, J CANCER, V8, P870, DOI 10.7150/jca.17958; Li FX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178427; Li FX, 2013, SURG ONCOL, V22, pE7, DOI 10.1016/j.suronc.2013.01.003; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Ohta K, 2015, ONCOTARGET, V6, P3211, DOI 10.18632/oncotarget.3085; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Shimoda M, 2014, NAT CELL BIOL, V16, P889, DOI 10.1038/ncb3021; Shyamasundar S, 2016, INT J ONCOL, V49, P2629, DOI 10.3892/ijo.2016.3761; Sun HL, 2016, CANCER CELL, V30, P723, DOI 10.1016/j.ccell.2016.10.001; Thrumurthy SG, 2015, NAT REV CLIN ONCOL, V12, P676, DOI 10.1038/nrclinonc.2015.132; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang Z, 2015, ONCOGENE, V34, P1407, DOI 10.1038/onc.2014.75; Xiang Y, 2017, EXP CELL RES, V357, P135, DOI 10.1016/j.yexcr.2017.05.007; Yan A, 2015, CELL PHYSIOL BIOCHEM, V37, P55, DOI 10.1159/000430333; Yen CS, 2016, WORLD J GASTROENTERO, V22, P5183, DOI 10.3748/wjg.v22.i22.5183; Yu JY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13884; Zhang L, 2017, ONCOL REP, V3; Zheng LL, 2016, NUCLEIC ACIDS RES, V44, pD196, DOI 10.1093/nar/gkv1273; Zhou JN, 2015, HEPATOLOGY, V62, P801, DOI 10.1002/hep.27887	30	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189490	10.1371/journal.pone.0189490	http://dx.doi.org/10.1371/journal.pone.0189490			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220395	gold, Green Published, Green Submitted			2022-12-27	WOS:000417469900062
J	Min, JL; Wang, P; Hu, JF				Min, Jianliang; Wang, Ping; Hu, Jianfeng			Driver fatigue detection through multiple entropy fusion analysis in an EEG-based system	PLOS ONE			English	Article							APPROXIMATE ENTROPY; SAMPLE ENTROPY; MENTAL FATIGUE; SLEEP; CLASSIFICATION; RELIABILITY; SENSITIVITY; FEATURES; ONSET	Driver fatigue is an important contributor to road accidents, and fatigue detection has major implications for transportation safety. The aim of this research is to analyze the multiple entropy fusion method and evaluate several channel regions to effectively detect a driver's fatigue state based on electroencephalogram (EEG) records. First, we fused multiple entropies, i.e., spectral entropy, approximate entropy, sample entropy and fuzzy entropy, as features compared with autoregressive (AR) modeling by four classifiers. Second, we captured four significant channel regions according to weight-based electrodes via a simplified channel selection method. Finally, the evaluation model for detecting driver fatigue was established with four classifiers based on the EEG data from four channel regions. Twelve healthy subjects performed continuous simulated driving for 1-2 hours with EEG monitoring on a static simulator. The leave-one-out cross-validation approach obtained an accuracy of 98.3%, a sensitivity of 98.3% and a specificity of 98.2%. The experimental results verified the effectiveness of the proposed method, indicating that the multiple entropy fusion features are significant factors for inferring the fatigue state of a driver.	[Min, Jianliang; Wang, Ping; Hu, Jianfeng] Jiangxi Univ Technol, Ctr Collaborat & Innovat, Nanchang, Jiangxi, Peoples R China		Hu, JF (corresponding author), Jiangxi Univ Technol, Ctr Collaborat & Innovat, Nanchang, Jiangxi, Peoples R China.	huguess211@hotmail.com	Min, liang jian/HHZ-1665-2022	Min, liang jian/0000-0002-3375-1148; Hu, Jianfeng/0000-0002-0669-4328	National Natural Science Foundation of China [61762045]; Project of Department of Science and Technology, Jiangxi Province [20171BAB202031]; Project of Department of Education, Jiangxi Province [GJJ151146, GJJ161143]; Project of Nanchang Science and Technology Program [113]; Project of Natural Science Research, Jiangxi University of Technology [ZR15QN01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Department of Science and Technology, Jiangxi Province; Project of Department of Education, Jiangxi Province; Project of Nanchang Science and Technology Program; Project of Natural Science Research, Jiangxi University of Technology	This work was supported by National Natural Science Foundation of China (61762045), Project of Department of Science and Technology, Jiangxi Province (20171BAB202031), Project of Department of Education, Jiangxi Province (GJJ151146 and GJJ161143), Project of Nanchang Science and Technology Program (No. 113), and Project of Natural Science Research, Jiangxi University of Technology (ZR15QN01). Patent transformation Project of Intellectual Property Office of Jiangxi Province [The application and popularization of the digital method to distinguish the direction of rotation photoelectric encoder in identification].	Acharya UR, 2015, KNOWL-BASED SYST, V88, P85, DOI 10.1016/j.knosys.2015.08.004; Acharya UR, 2012, BIOMED SIGNAL PROCES, V7, P401, DOI 10.1016/j.bspc.2011.07.007; Apker Gregory, 2013, Foundations of Augmented Cognition. 7th International Conference, AC 2013. Held as Part of HCI International 2013. Proceedings, P231, DOI 10.1007/978-3-642-39454-6_24; Azar AT, 2014, NEURAL COMPUT APPL, V24, P1163, DOI 10.1007/s00521-012-1324-4; Azarnoosh M, 2011, CHAOS SOLITON FRACT, V44, P1054, DOI 10.1016/j.chaos.2011.08.012; Barwick F, 2012, CLIN NEUROPHYSIOL, V123, P278, DOI 10.1016/j.clinph.2011.06.027; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; Borghini G, 2012, IEEE ENG MED BIO, P6442, DOI 10.1109/EMBC.2012.6347469; Borghini G, 2014, NEUROSCI BIOBEHAV R, V44, P58, DOI 10.1016/j.neubiorev.2012.10.003; Boulesteix AL, 2012, WIRES DATA MIN KNOWL, V2, P493, DOI 10.1002/widm.1072; Cao T, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-28; Chai RF, 2017, IEEE J BIOMED HEALTH, V21, P715, DOI 10.1109/JBHI.2016.2532354; Chen CX, 2013, DISPLAYS, V34, P81, DOI 10.1016/j.displa.2013.01.002; Chen LL, 2015, EXPERT SYST APPL, V42, P7344, DOI 10.1016/j.eswa.2015.05.028; Convertino M, 2014, ENVIRON MODELL SOFTW, V51, P296, DOI 10.1016/j.envsoft.2013.10.001; Convertino M, 2015, STOCH ENV RES RISK A, V29, P1085, DOI 10.1007/s00477-014-0999-8; Craig A, 2012, PSYCHOPHYSIOLOGY, V49, P574, DOI 10.1111/j.1469-8986.2011.01329.x; Davenne D, 2012, ACCIDENT ANAL PREV, V45, P677, DOI 10.1016/j.aap.2011.09.046; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Dong YC, 2011, IEEE T INTELL TRANSP, V12, P596, DOI 10.1109/TITS.2010.2092770; Ellis RS, 2012, ENTROPY LARGE DEVIAT; Figueiredo E, 2011, COMPUT-AIDED CIV INF, V26, P225, DOI 10.1111/j.1467-8667.2010.00685.x; Ftouni S, 2013, J SLEEP RES, V22, P58, DOI 10.1111/j.1365-2869.2012.01038.x; Gao ZK, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S0129065717500058; Gao ZK, 2016, EPL-EUROPHYS LETT, V116, DOI 10.1209/0295-5075/116/50001; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Correa AG, 2014, MED ENG PHYS, V36, P244, DOI 10.1016/j.medengphy.2013.07.011; Gurudath N, 2014, PROCEDIA COMPUT SCI, V34, P400, DOI 10.1016/j.procs.2014.07.045; Hagan M. T, 2014, NEURAL NETWORK DESIG, V2nd; Han J, 2012, MOR KAUF D, P1; Horovitz SG, 2008, HUM BRAIN MAPP, V29, P671, DOI 10.1002/hbm.20428; Hu JF, 2015, J MED IMAG HEALTH IN, V5, P862, DOI 10.1166/jmihi.2015.1471; Huang CL, 2006, EXPERT SYST APPL, V31, P231, DOI 10.1016/j.eswa.2005.09.024; Jagannath M, 2014, APPL ERGON, V45, P1140, DOI 10.1016/j.apergo.2014.02.001; Jain A, 2005, PATTERN RECOGN, V38, P2270, DOI 10.1016/j.patcog.2005.01.012; Jo J, 2014, EXPERT SYST APPL, V41, P1139, DOI 10.1016/j.eswa.2013.07.108; Kang HB, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION WORKSHOPS (ICCVW), P616, DOI 10.1109/ICCVW.2013.85; Kannathal N, 2005, COMPUT METH PROG BIO, V80, P187, DOI 10.1016/j.cmpb.2005.06.012; Kar S, 2010, TRANSPORT RES F-TRAF, V13, P297, DOI 10.1016/j.trf.2010.06.006; Ko LW, 2015, IEEE IJCNN, DOI 10.1109/IJCNN.2015.7280817; Kosmadopoulos A, 2015, ACCIDENT ANAL PREV, V99, P445; Lee BG, 2014, SENSORS-BASEL, V14, P17915, DOI 10.3390/s141017915; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Li W, 2012, NEUROSCI LETT, V506, P235, DOI 10.1016/j.neulet.2011.11.014; Liang SF, 2012, IEEE T INSTRUM MEAS, V61, P1649, DOI 10.1109/TIM.2012.2187242; Liu JP, 2010, BIOMED SIGNAL PROCES, V5, P124, DOI 10.1016/j.bspc.2010.01.001; Ludtke N, 2008, J R SOC INTERFACE, V5, P223, DOI 10.1098/rsif.2007.1079; Rodriguez-Sotelo JL, 2014, ENTROPY-SWITZ, V16, P6573, DOI 10.3390/e16126573; Matteo C, 2013, PLOS ONE, V8; Melnicuk V, 2016, IEEE INT VEH SYM, P1392, DOI 10.1109/IVS.2016.7535572; Mu Z, 2016, INT J PATTERN RECOGN; Mu ZD, 2016, ENTROPY-SWITZ, V18, DOI 10.3390/e18120432; Nicolaou N, 2012, EXPERT SYST APPL, V39, P202, DOI 10.1016/j.eswa.2011.07.008; Nugraha B.T., 2016, J THEOR APPL INF TEC, V86, P54; Pal NR, 2008, EURASIP J ADV SIG PR, V2008, P192; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rigas G., 2011, INT J VEHICULAR TECH; Sahayadhas A, 2012, SENSORS-BASEL, V12, P16937, DOI 10.3390/s121216937; Saini V., 2014, INT J COMPUT SCI INF, V5, P4245; Saito T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118432; Schmidt E, 2016, IEEE INT VEH SYM, P1380, DOI 10.1109/IVS.2016.7535570; Simon M, 2011, CLIN NEUROPHYSIOL, V122, P1168, DOI 10.1016/j.clinph.2010.10.044; Song YD, 2012, J NEUROSCI METH, V210, P132, DOI 10.1016/j.jneumeth.2012.07.003; Vapnik V.N., 2006, ESTIMATION DEPENDENC, VVolume 40; Wang H, 2015, MOBICOM '15: PROCEEDINGS OF THE 21ST ANNUAL INTERNATIONAL CONFERENCE ON MOBILE COMPUTING AND NETWORKING, P155, DOI 10.1145/2789168.2790121; Xiang J, 2015, J NEUROSCI METH, V243, P18, DOI 10.1016/j.jneumeth.2015.01.015; Xiong Y., 2016, INT J CONTROL AUTOMA, V9, P329, DOI [10.14257/ijca.2016.9.3.30, DOI 10.14257/IJCA.2016.9.3.30]; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3; Yin J, 2016, HEALTHCARE TECHNOLOG, P1; Yuan Wang, 2015, 2015 Fifth International Conference on Instrumentation and Measurement, Computer, Communication and Control (IMCCC), P715, DOI 10.1109/IMCCC.2015.156; Zhang C, 2014, IEEE T INTELL TRANSP, V15, P168, DOI 10.1109/TITS.2013.2275192; Zhao CL, 2011, INT J INNOV COMPUT I, V7, P1157; Zhendong M., 2015, METALL MIN IND, V7, P266	74	54	55	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188756	10.1371/journal.pone.0188756	http://dx.doi.org/10.1371/journal.pone.0188756			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220351	Green Published, gold, Green Submitted			2022-12-27	WOS:000417469900015
J	Tshimanga, M; Makunike-Chikwinya, B; Mangwiro, T; Gundidza, PT; Chatikobo, P; Murenje, V; Herman-Roloff, A; Kilmarx, PH; Holec, M; Gwinji, G; Mugurungi, O; Murwira, M; Xaba, S; Barnhart, S; Feldacker, C				Tshimanga, Mufuta; Makunike-Chikwinya, Batsirai; Mangwiro, Tonderayi; Gundidza, Patricia Tapiwa; Chatikobo, Pesanai; Murenje, Vernon; Herman-Roloff, Amy; Kilmarx, Peter H.; Holec, Marrianne; Gwinji, Gerald; Mugurungi, Owen; Murwira, Munyaradzi; Xaba, Sinokuthemba; Barnhart, Scott; Feldacker, Caryl			Safety and efficacy of the PrePex device in HIV-positive men: A single-arm study in Zimbabwe	PLOS ONE			English	Article							MEDICAL MALE CIRCUMCISION; ADULT MALE CIRCUMCISION; RANDOMIZED CONTROLLED-TRIAL; RISK HUMAN-PAPILLOMAVIRUS; INFECTED MEN; SCALE-UP; YOUNG MEN; RAKAI; PREVENTION; HIV/AIDS	Male circumcision (MC) for sexually active, HIV-negative men reduces HIV transmission and averts HIV infections. Excluding HIV-positive men from MC decreases access to additional health and hygiene benefits. In settings where HIV-testing is, or is perceived to be, required for MC, testing may reduce MC uptake. Reducing promotion of HIV testing within MC settings and promoting device-based MC may speed MC scale-up. To assess safety and efficacy of PrePex MC device among HIV-positive men, we conducted a one-arm, open-label, prospective study in otherwise healthy HIV-positive men in Zimbabwe. Methods We aimed to determine if the adverse event (AE) rate was non-inferior to an AE rate of 2%, a rate considered the global standard of MC safety. Study procedures, AE definitions, and study staff were unchanged from previous PrePex Zimbabwe trials. After PrePex placement and removal, weekly visits assessed wound healing. Men returned on Day 90. Safety was defined as occurrence of moderate and serious clinical AEs. Efficacy was defined as ability to reach the endpoint of complete circumcision. Results Among 400 healthy, HIV-positive, consenting adults, median age was 40 years (IQR: 34, 46); 79.5% in WHO stage 2; median CD4 was 336.5c/mu l (IQR: 232, 459); 337 (85%) on anti-retroviral therapy. Among 385 (96%) observed completely healed, median days to complete healing was 42 (IQR: 35-49). There was no association between time to healing and CD4 (p = 0.66). Four study-related severe AEs and no moderate AEs were reported: severe/moderate AE rate of 1.0% (95% CI: 0.27% to 2.5). This was non-inferior to 2% AEs (p = 0.0003). All AEs were device displacements resulting in surgical MC and, subsequently, complete healing. Conclusion Male circumcision among healthy, HIV-positive men using PrePex is safe and effective. Reducing the barrier of HIV testing while improving counseling for safer sex practices among all MC clients could increase MC uptake and avert more HIV infections.	[Tshimanga, Mufuta; Gundidza, Patricia Tapiwa; Chatikobo, Pesanai] Zimbabwe Community Hlth Intervent Project ZiCHIRe, Harare, Zimbabwe; [Makunike-Chikwinya, Batsirai; Murenje, Vernon] Int Training & Educ Ctr Hlth I TECH, Harare, Zimbabwe; [Mangwiro, Tonderayi] Univ Zimbabwe, Dept Hlth Sci, Harare, Zimbabwe; [Herman-Roloff, Amy; Kilmarx, Peter H.] US Ctr Dis Control & Prevent, Harare, Zimbabwe; [Holec, Marrianne; Barnhart, Scott; Feldacker, Caryl] Int Training & Educ Ctr Hlth I TECH, Seattle, WA 98195 USA; [Gwinji, Gerald; Mugurungi, Owen; Xaba, Sinokuthemba] Minist Hlth & Child Care, Harare, Zimbabwe; [Murwira, Munyaradzi] Zimbabwe Natl Family Planning Council, Harare, Zimbabwe; [Barnhart, Scott] Univ Washington, Dept Med, Seattle, WA USA; [Barnhart, Scott; Feldacker, Caryl] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	University of Zimbabwe; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Feldacker, C (corresponding author), Int Training & Educ Ctr Hlth I TECH, Seattle, WA 98195 USA.; Feldacker, C (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	cfeld@uw.edu		Murenje, Vernon/0000-0002-0715-9837; Feldacker, Caryl/0000-0002-8152-6754	Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [U2GGH000972]	Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID))	This work has been supported by the Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of Cooperative Agreement #: U2GGH000972. Authors MT BM TM PTG PC VM MH SB and CF received funding under this grant to implement this research. The funders, specifically PHK, and AHR, contributed to design of the study and preparation of the manuscript but had no role in study data collection, analysis, or supervision.	Albero G, 2012, SEX TRANSM DIS, V39, P104, DOI 10.1097/OLQ.0b013e3182387abd; [Anonymous], 2011, STAT STAT SOFTW REL; Ashengo TA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-858; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; Awad SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170641; Baggaley R, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21348; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bitega JP, 2011, JAIDS-J ACQ IMM DEF, V58, pE127, DOI 10.1097/QAI.0b013e3182354e65; Bochner AF, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21394; Byabagambi J, GUIDE IMPROVING QUAL; Chiringa IO, 2016, AFR J PRIM HEALTH CA, V8, DOI 10.4102/phcfm.v8i2.966; Duffy K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063134; Feldblum PJ, 2016, JAIDS-J ACQ IMM DEF, V72, pS24, DOI 10.1097/QAI.0000000000000736; Feldblum PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095357; Galukande M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104893; Galukande M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086631; George G, 2014, AJAR-AFR J AIDS RES, V13, P179, DOI 10.2989/16085906.2014.943253; Go Zimbabwe, 2017, DHIS2; Godfrey K, 2013, BJU INT; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hatzold K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085051; Herman-Roloff A, 2012, B WORLD HEALTH ORGAN, V90, P773, DOI 10.2471/BLT.12.106112; Innocent C, 2016, INT J HLTH SCI RES I, V6, P330; Kelly R, 1999, AIDS, V13, P399, DOI 10.1097/00002030-199902250-00013; Kigozi G, 2008, PLOS MED, V5, P911, DOI 10.1371/journal.pmed.0050116; Kigozi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100008; Kigozi G, 2014, BJU INT, V113, P127, DOI 10.1111/bju.12406; Kigozi G, 2014, UROLOGY, V83, P294, DOI 10.1016/j.urology.2013.08.038; Larke N, 2011, J INFECT DIS, V204, P1375, DOI 10.1093/infdis/jir523; Larke NL, 2011, CANCER CAUSE CONTROL, V22, P1097, DOI 10.1007/s10552-011-9785-9; Lebina L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138755; Lissouba P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000309; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Mahomed M, 2014, AIDS RES HUM RETROV, V30, pA198, DOI 10.1089/aid.2014.5426b.abstract; Marongwe P., 2016, KEY VMMC FOLLOW UP V; Medical Research Council of Zimbabwe, 2012, TR025 MED RES COUNC; Ministry of Health and Child Care MOHCC Z, 2017, ZIMB POP BAS HIV IMP; Ministry of Health and Child Care Zimbabwe, 2014, ACC STRAT OP PLAN 20; Morris BJ, 2011, ADV UROL, V2011, DOI 10.1155/2011/812368; Moses S, 1998, SEX TRANSM INFECT, V74, P368, DOI 10.1136/sti.74.5.368; Moyo S, 2015, MENS ATTITUDES HINDR, P1; Musiige AM, 2016, JAIDS-J ACQ IMM DEF, V72, pS73, DOI 10.1097/QAI.0000000000000765; Mutabazi Vincent, 2014, Urol Nurs, V34, P303; Mutabazi V, 2014, AFR J REPROD HEALTH, V18, P61; Mutabazi V, 2013, JAIDS-J ACQ IMM DEF, V63, P315, DOI 10.1097/QAI.0b013e31828e6412; Njeuhmeli E, 2014, JAIDS-J ACQ IMM DEF, V66, pS193, DOI 10.1097/QAI.0000000000000179; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Obiero W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053380; Odoyo-June E, 1999, J ACQUIRED IMMUNE DE; Overview National, 2016, VMMC REV PLANN M KAD; Phili R, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19275; Population Services International CoSoE Central and Southern Africa (COSECSA) U.S. Centers for Disease Control and Prevention, 2016, ADV EV ACT GUID VOL; Reed J, 1999, J ACQ IMMUN DEF SYND, P2015; Rogers JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061725; Serwadda D, 2010, J INFECT DIS, V201, P1463, DOI 10.1086/652185; Skolnik L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1119; Sokal DC, 2014, JAIDS-J ACQ IMM DEF, V65, P447, DOI 10.1097/QAI.0000000000000061; Tobian AAR, 2014, ANNU REV MED, V65, P293, DOI 10.1146/annurev-med-092412-090539; Tshimanga M, RANDOMIZED CONTROLLE; Tshimanga M, 2013, EVALUATION SAFETY EF; Tshimanga M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156220; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Weiss HA, 2009, LANCET INFECT DIS, V9, P669, DOI 10.1016/S1473-3099(09)70235-X; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; WHO,, 2016, WHO PROGR BRIEF VOL; WHO, 2013, GUID US DEV AD MAL C; WHO U., 2011, JOINT STRAT ACT FRAM; WHO/UNAIDS, 2010, FRAM CLIN EV DEV AD; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; World Health Organization, FRAM VOL MED MAL CIR; World Health Organization, 2015, WHO TECHN ADV GROUP; World Health Organization, 2013, WHO TECHN ADV GROUP; Zimbabwe Ministry of Health and Child Care, 2014, ACC STRAT OP PALN 20; 김현진, 2015, [The KSFM Journal of Fluid Machinery, 한국유체기계학회 논문집], V18, P12, DOI 10.5293/kfma.2015.18.3.012	75	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189146	10.1371/journal.pone.0189146	http://dx.doi.org/10.1371/journal.pone.0189146			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220392	Green Submitted, Green Published, gold			2022-12-27	WOS:000417469900035
J	Choi, YY; Noh, SH; An, JY				Choi, Yoon Young; Noh, Sung Hoon; An, Ji Yeong			A randomized controlled trial of Roux-en-Y gastrojejunostomy vs. gastroduodenostomy with respect to the improvement of type 2 diabetes mellitus after distal gastrectomy in gastric cancer patients	PLOS ONE			English	Article							SHORT-TERM OUTCOMES; SLEEVE GASTRECTOMY; KG/M(2); BYPASS; RECONSTRUCTION; METAANALYSIS; GHRELIN; GLP-1	The purpose of this study is to compare the effect of diabetes control induced by Roux-en-Y gastrojejunostomy(RY) vs Billroth-I reconstruction(BI) after distal gastrectomy in patients with early gastric cancer(EGC) and type 2 diabetes(T2DM). Forty EGC patients with T2DM, aged 20-80 years, who were expected to undergo curative distal gastrectomy were randomized 1: 1 to RY(n = 20) or BI(n = 20). Diabetes medication status, biochemical and hormonal data including blood glucose, HbA1c, insulin, C-peptide, HOMA-IR, ghrelin, leptin, GLP-1, PYY, and GIP were evaluated for 12 months after surgery. Although pre- and postoperative 12-month fasting and postprandial glucose levels did not show a significant difference, HbA1c, C-peptide, and HOMA-IR levels were significantly improved at 12 months after surgery in both BI and RY groups. Sixty percent of RY patients and 20% of BI patients decreased their medication satisfying FBS<126 mg/dL and HbA1c<6.5% and 5% of BI patients stopped their medication satisfying the criteria of FBS<126 mg/dL and HbA1c<6.0%. The improvement patterns were more sustainable with less fluctuation in RY than in BI. On hormonal analysis, ghrelin and leptin levels were decreased and PYY and GIP levels were increased at 12 months after surgery in both groups without significant difference according to the reconstruction type and diabetic improvement status except ghrelin. In gastric cancer surgery, RY reconstruction showed better and more durable diabetes control compared to BI during the first year after surgery. Gastric cancer surgery led to decreased ghrelin and leptin and increased PYY and GIP, which might have a role in improving insulin resistance and glucose homeostasis.	[Choi, Yoon Young; Noh, Sung Hoon] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [An, Ji Yeong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea	Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center	An, JY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea.	jar319.an@samsung.com		Choi, Yoon Young/0000-0002-2179-7851; Noh, Sung Hoon/0000-0003-4386-6886				An JY, 2014, YONSEI MED J, V55, P162, DOI 10.3349/ymj.2014.55.1.162; An JY, 2013, WORLD J GASTROENTERO, V19, P9410, DOI 10.3748/wjg.v19.i48.9410; Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076; Karra E, 2010, MOL CELL ENDOCRINOL, V316, P120, DOI 10.1016/j.mce.2009.06.010; Kim DG, 2013, SURG ENDOSC, V27, P3153, DOI 10.1007/s00464-013-2869-8; Kim JW, 2015, ANN SURG TREAT RES, V88, P215, DOI 10.4174/astr.2015.88.4.215; Kim JW, 2012, WORLD J GASTROENTERO, V18, P49, DOI 10.3748/wjg.v18.i1.49; Kim MJ, 2014, OBES SURG, V24, P1044, DOI 10.1007/s11695-014-1202-5; Kwon Y, 2015, SURG OBES RELAT DIS, V11, P1386, DOI 10.1016/j.soard.2015.01.001; Lee W, 2012, OBES SURG, V22, P1238, DOI 10.1007/s11695-011-0580-1; Nakajima Toshifusa, 2002, Gastric Cancer, V5, P1, DOI 10.1007/s101200200000; Paschetta E, 2011, OBES REV, V12, P813, DOI 10.1111/j.1467-789X.2011.00897.x; Scopinaro N, 2011, OBES SURG, V21, P880, DOI 10.1007/s11695-011-0407-0; Shen ZY, 2015, HEPATO-GASTROENTEROL, V62, P245, DOI 10.5754/hge14857; Vigneshwaran B, 2016, OBES SURG, V26, P2817, DOI 10.1007/s11695-016-2226-9; Xiong SW, 2014, WORLD J GASTROENTERO, V20, P18427, DOI 10.3748/wjg.v20.i48.18427; Yang JT, 2010, J SURG RES, V164, pE67, DOI 10.1016/j.jss.2010.07.004; Yousseif A, 2014, OBES SURG, V24, P241, DOI 10.1007/s11695-013-1066-0	18	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188904	10.1371/journal.pone.0188904	http://dx.doi.org/10.1371/journal.pone.0188904			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216250	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800047
J	Fu, MC; Xue, Y; Zhou, WH; Yuan, TF				Fu, Mingchen; Xue, Yan; Zhou, Weihe; Yuan, Ti-Fei			Parental absence predicts suicide ideation through emotional disorders	PLOS ONE			English	Article							LEFT-BEHIND CHILDREN; MULTIDIMENSIONAL ANXIETY SCALE; STUDIES DEPRESSION SCALE; RURAL CHINA; ADOLESCENTS; SEPARATION; MOTHERS; MASC	The objectives of the study were to investigate the association between the parental absence and suicide ideation and to examine the roles of emotional disorders in the aforementioned relationship. Four thousand five hundred and thirteen children from rural areas in Jiangsu Province, China, participated in the study. Among the participants, 2416 were nonleft- behind children (children living with both parents) and 1997 were left-behind children (children living with the absence of at least one parent). All participants responded to the Center for Epidemiological Studies Depression Scale for Children, the Multidimensional Anxiety Scale for Children, and a question regarding respondents' suicide ideation. Results indicated that as compared with non-left-behind children, the left-behind children with bothparents absence were statistically more likely to show suicide ideation. Furthermore, all the three types parental absence D father absence, mother absence, and both-parents absence were significantly associated with negative emotional outcomes. Moreover, depression, social anxiety, and physical anxiety were shown to be significant mediators in the relationship of parental absence and suicide ideation of children. The stress of parental absence and its negative impact on children's mental health are discussed.	[Fu, Mingchen] Nanjing Normal Univ, Sch Educ Sci, Nanjing, Jiangsu, Peoples R China; [Fu, Mingchen] Univ Hong Kong, Fac Educ, Hong Kong, Hong Kong, Peoples R China; [Xue, Yan] Nanjing Normal Univ, Sch Psychol, Nanjing, Jiangsu, Peoples R China; [Zhou, Weihe] Wenzhou Med Univ, Eye Hosp, Wenzhou, Peoples R China; [Yuan, Ti-Fei] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai Key Lab Psychot Disorders, Shanghai, Peoples R China; [Yuan, Ti-Fei] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Jiangsu, Peoples R China	Nanjing Normal University; University of Hong Kong; Nanjing Normal University; Wenzhou Medical University; Shanghai Jiao Tong University; Nantong University	Xue, Y (corresponding author), Nanjing Normal Univ, Sch Psychol, Nanjing, Jiangsu, Peoples R China.; Yuan, TF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai Key Lab Psychot Disorders, Shanghai, Peoples R China.; Yuan, TF (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Jiangsu, Peoples R China.	xueyanshuilan@gmail.com; ytf0707@126.com			Social Science Foundation of Jiangsu Province (China) [15JY13016]; National Natural Science Foundation of China grants [31771215]; YESS from CAST	Social Science Foundation of Jiangsu Province (China); National Natural Science Foundation of China grants(National Natural Science Foundation of China (NSFC)); YESS from CAST	This study is supported by Social Science Foundation of Jiangsu Province (China) (15JY13016) to YX, and National Natural Science Foundation of China grants (31771215) and YESS from CAST to TY.	All-China Women's Federation, 2013, CHINESE WOMENS MOVEM, V6, P30; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Betancourt T, 2012, J AM ACAD CHILD PSY, V51, P1284, DOI 10.1016/j.jaac.2012.09.003; Bowlby J, 1973, ATTACHMENT LOSS; Byrne B.M., 2013, STRUCTURAL EQUATION, DOI 10.4324/9781410600219; FAULSTICH ME, 1986, AM J PSYCHIAT, V143, P1024; Field TM, 1986, CHILD DEV, V55, P1308; Geng LN, 2013, SOC BEHAV PERSONAL, V41, P377, DOI 10.2224/sbp.2013.41.3.377; GLUECK CJ, 1994, PEDIATR RES, V35, P602, DOI 10.1203/00006450-199405000-00013; Gould MS, 1998, J AM ACAD CHILD PSY, V37, P155, DOI 10.1097/00004583-199802000-00007; Guo J, 2012, CYBERPSYCH BEH SOC N, V15, P585, DOI 10.1089/cyber.2012.0261; Haavisto A, 2003, J AFFECT DISORDERS, V76, P211, DOI 10.1016/S0165-0327(02)00093-9; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Howard K, 2011, ATTACH HUM DEV, V13, P5, DOI 10.1080/14616734.2010.488119; Hu HW, 2014, CHILD YOUTH SERV REV, V46, P1, DOI 10.1016/j.childyouth.2014.07.021; Ivarsson T, 2006, NORD J PSYCHIAT, V60, P107, DOI 10.1080/08039480600588067; Jamison J, 2015, MINERVA PSICH, V56, P117; Jia ZB, 2010, CHILD CARE HLTH DEV, V36, P812, DOI 10.1111/j.1365-2214.2010.01110.x; Liu XC, 2005, J ADOLESCENT HEALTH, V37, P443, DOI 10.1016/j.jadohealth.2004.08.027; Madianou M, 2011, NEW MEDIA SOC, V13, P457, DOI 10.1177/1461444810393903; March JS, 1997, J AM ACAD CHILD PSY, V36, P554, DOI 10.1097/00004583-199704000-00019; Martin MS, 2016, SOC PSYCH PSYCH EPID, V51, P1477, DOI 10.1007/s00127-016-1250-3; Muller C, 2001, SOCIOL INQ, V71, P241, DOI 10.1111/j.1475-682X.2001.tb01110.x; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Olsson G, 1997, EUR CHILD ADOLES PSY, V6, P81, DOI 10.1007/BF00566670; Shirley M, 1941, J PSYCHOL, V12, P251, DOI 10.1080/00223980.1941.9917074; Su S, 2013, CHILD CARE HLTH DEV, V39, P162, DOI 10.1111/j.1365-2214.2012.01400.x; Tan L, 2016, INT J PSYCHOL J INT; Tomsa R, 2015, PSYCHOL REP, V116, P485, DOI 10.2466/10.17.PR0.116k19w1; Wang LF, 2015, J AFFECT DISORDERS, V177, P36, DOI 10.1016/j.jad.2015.01.002; Wasserman Danuta, 2005, World Psychiatry, V4, P114; WEISSMAN MM, 1980, J NERV MENT DIS, V168, P736, DOI 10.1097/00005053-198012000-00005; Yen CF, 2010, CHILD PSYCHIAT HUM D, V41, P342, DOI 10.1007/s10578-010-0172-7; Zhao X, 2014, ACTA PAEDIATR, V103, P665, DOI 10.1111/apa.12602	35	32	33	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188823	10.1371/journal.pone.0188823	http://dx.doi.org/10.1371/journal.pone.0188823			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216233	Green Submitted, gold, Green Published			2022-12-27	WOS:000417337800042
J	Heffer, A; Marquart, GD; Aquilina-Beck, A; Saleem, N; Burgess, HA; Dawid, IB				Heffer, Alison; Marquart, Gregory D.; Aquilina-Beck, Allisan; Saleem, Nabil; Burgess, Harold A.; Dawid, Igor B.			Generation and characterization of Kctd15 mutations in zebrafish	PLOS ONE			English	Article							HYPOTHALAMIC INFERIOR-LOBE; NEURAL CREST SPECIFICATION; CELL-DIFFERENTIATION; GUSTATORY SYSTEM; UBIQUITIN LIGASE; GENE; EXPRESSION; CONNECTIONS; PROTEIN; DOMAIN	Potassium channel tetramerization domain containing 15 (Kctd15) was previously found to have a role in early neural crest (NC) patterning, specifically delimiting the region where NC markers are expressed via repression of transcription factor AP-2a and inhibition of Wnt signaling. We used transcription activator-like effector nucleases (TALENs) to generate null mutations in zebrafish kctd15a and kctd15b paralogs to study the in vivo role of Kctd15. We found that while deletions producing frame-shift mutations in each paralog showed no apparent phenotype, kctd15a/b double mutant zebrafish are smaller in size and show several phenotypes including some affecting the NC, such as expansion of the early NC domain, increased pigmentation, and craniofacial defects. Both melanophore and xantho-phore pigment cell numbers and early markers are up-regulated in the double mutants. While we find no embryonic craniofacial defects, adult mutants have a deformed maxillary segment and missing barbels. By confocal imaging of mutant larval brains we found that the torus lateralis (TLa), a region implicated in gustatory networks in other fish, is absent. Ablation of this brain tissue in wild type larvae mimics some aspects of the mutant growth phenotype. Thus kctd15 mutants show deficits in the development of both neural crest derivatives, and specific regions within the central nervous system, leading to a strong reduction in normal growth rates.	[Heffer, Alison; Marquart, Gregory D.; Aquilina-Beck, Allisan; Saleem, Nabil; Burgess, Harold A.; Dawid, Igor B.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Dev Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dawid, IB (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Dev Biol, NIH, Bethesda, MD 20892 USA.	idawid@nih.gov		Marquart, Gregory David/0000-0001-9811-5372	National Institute of Child Health and Human Development, Division of Intramural Research [HD008809]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008884] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development, Division of Intramural Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research has been funded in its entirety by the National Institute of Child Health and Human Development, Division of Intramural Research. The project number is HD008809. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, the manuscript was subjected to the clearing process required for all articles and other communications from this Institute.	Ahrens K, 2002, J COMP NEUROL, V449, P43, DOI 10.1002/cne.10264; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bayon Y, 2008, FEBS J, V275, P3900, DOI 10.1111/j.1742-4658.2008.06537.x; Braasch I, 2009, PIGM CELL MELANOMA R, V22, P839, DOI 10.1111/j.1755-148X.2009.00614.x; Camp E, 2001, DEV GENES EVOL, V211, P150, DOI 10.1007/s004270000125; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Castro A, 2009, J COMP NEUROL, V513, P685, DOI 10.1002/cne.21977; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Curran K, 2009, DEV BIOL, V332, P408, DOI 10.1016/j.ydbio.2009.06.010; de Croze N, 2011, P NATL ACAD SCI USA, V108, P155, DOI 10.1073/pnas.1010740107; Ding XF, 2009, J CELL BIOCHEM, V106, P285, DOI 10.1002/jcb.22002; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Dutta S, 2010, DEVELOPMENT, V137, P3013, DOI 10.1242/dev.047548; Folgueira M, 2003, J COMP NEUROL, V465, P604, DOI 10.1002/cne.10879; Gammill LS, 2003, NAT REV NEUROSCI, V4, P795, DOI 10.1038/nrn1219; Gharbi N, 2012, DEV GROWTH DIFFER, V54, P241, DOI 10.1111/j.1440-169X.2011.01326.x; Hansen A, 2002, DEV DYNAM, V223, P483, DOI 10.1002/dvdy.10074; Herzog W, 2003, DEV BIOL, V254, P36, DOI 10.1016/S0012-1606(02)00124-0; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Johnson SL, 2011, DEV BIOL, V350, P405, DOI 10.1016/j.ydbio.2010.12.004; Kaltschmidt B, 2012, STEM CELL REV REP, V8, P658, DOI 10.1007/s12015-011-9340-9; Kato T, 2011, J COMP NEUROL, V519, P3102, DOI 10.1002/cne.22669; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kelsh RN, 2000, DEV BIOL, V225, P277, DOI 10.1006/dbio.2000.9840; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knecht AK, 2001, DEV BIOL, V234, P365, DOI 10.1006/dbio.2001.0275; LaBonne C, 1999, ANNU REV CELL DEV BI, V15, P81, DOI 10.1146/annurev.cellbio.15.1.81; LeClair EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008737; LEDOUARIN N, 1991, GLIA, V4, P175; Leon-Mimila P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070640; Li Xiang, 2014, ScientificWorldJournal, V2014, P540496, DOI 10.1155/2014/540496; Liang SS, 2015, DOMEST ANIM ENDOCRIN, V50, P65, DOI 10.1016/j.domaniend.2014.09.006; Lister JA, 2006, DEV BIOL, V290, P92, DOI 10.1016/j.ydbio.2005.11.014; Lister JA, 1999, DEVELOPMENT, V126, P3757; Lister JA, 2011, DEV DYNAM, V240, P2529, DOI 10.1002/dvdy.22743; Liu ZP, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-45; Lopes SS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000026; Luo T, 2003, P NATL ACAD SCI USA, V100, P532, DOI 10.1073/pnas.0237226100; Lv D, 2015, GENE, V560, P149, DOI 10.1016/j.gene.2015.01.054; Marquart GD, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00078; McMenamin SK, 2013, ENDOCRINOLOGY, V154, P1476, DOI 10.1210/en.2012-1734; Minchin JEN, 2008, DEV BIOL, V317, P508, DOI 10.1016/j.ydbio.2008.02.058; Mork L, 2015, CURR TOP DEV BIOL, V115, P235, DOI 10.1016/bs.ctdb.2015.07.001; Muto A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15029; Ng MCY, 2010, J CLIN ENDOCR METAB, V95, P2418, DOI 10.1210/jc.2009-2077; Nord H, 2016, MOL BIOL CELL, V27, P1853, DOI 10.1091/mbc.E15-12-0821; Parichy DM, 1999, DEVELOPMENT, V126, P3425; Parichy DM, 2000, DEVELOPMENT, V127, P3031; Parichy DM, 2000, DEV BIOL, V227, P294, DOI 10.1006/dbio.2000.9899; Pelletier I, 2001, MECH DEVELOP, V109, P99, DOI 10.1016/S0925-4773(01)00516-0; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Quigley IK, 2002, MICROSC RES TECHNIQ, V58, P442, DOI 10.1002/jemt.10162; Randlett O, 2015, NAT METHODS, V12, P1039, DOI 10.1038/NMETH.3581; Rink E, 1998, J COMP NEUROL, V394, P152, DOI 10.1002/(SICI)1096-9861(19980504)394:2<152::AID-CNE2>3.0.CO;2-1; Rogers CD, 2012, WIRES DEV BIOL, V1, P52, DOI 10.1002/wdev.8; SaintJeannet JP, 1997, P NATL ACAD SCI USA, V94, P13713, DOI 10.1073/pnas.94.25.13713; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; Skoblov M, 2013, BIOESSAYS, V35, P586, DOI 10.1002/bies.201300002; Steventon B, 2012, DEV BIOL, V367, P55, DOI 10.1016/j.ydbio.2012.04.025; Thisse B, 2004, FAST RELEASE C UNPUB; VANCE ML, 1990, CLIN CHEM, V36, P415; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Williams MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004499; Williams MJ, 2014, GENETICS, V196, P349, DOI 10.1534/genetics.113.158402; Won MH, 2015, P NATL ACAD SCI USA, V112, P12426, DOI 10.1073/pnas.1517033112; Wong TCB, 2016, INT J DEV BIOL, V60, P159, DOI 10.1387/ijdb.160058id; Yoganathan P, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-65; Zarelli VE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075016; Zarelli VE, 2013, P NATL ACAD SCI USA, V110, P2870, DOI 10.1073/pnas.1300203110; Zhao XY, 2014, GENE, V535, P299, DOI 10.1016/j.gene.2013.11.006; Ziegler I, 2003, PIGM CELL RES, V16, P172, DOI 10.1034/j.1600-0749.2003.00044.x; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	79	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189162	10.1371/journal.pone.0189162	http://dx.doi.org/10.1371/journal.pone.0189162			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216270	Green Submitted, Green Published, gold			2022-12-27	WOS:000417337800083
J	Schmidt, FA; Ruprecht, K; Connolly, F; Maas, MB; Paul, F; Hoffmann, J; Harms, L; Schreiber, SJ				Schmidt, Felix A.; Ruprecht, Klemens; Connolly, Florian; Maas, Matthew B.; Paul, Friedemann; Hoffmann, Jan; Harms, Lutz; Schreiber, Stephan J.			B-mode ultrasound assessment of pupillary function: Feasibility, reliability and normal values	PLOS ONE			English	Article							LIGHT REFLEX; PUPILLOMETRY	Purpose To evaluate B-mode ultrasound as a novel method for the examination of pupillary function and to provide normal values for the pupillary reflex as assessed by B-mode ultrasound. Methods 100 subjects (49 female, 51 male, mean [range] age 51 [18-80 years]) with no history of ophthalmologic disease, no clinically detectable pupillary defects, and corrected visual acuity >= 0.8 were included in this prospective observational study. B-mode ultrasound was performed with the subjects eyes closed using an Esaote-Mylab25 system according to current guidelines for orbital insonation. A standardized light stimulus was applied. Results The mean +/- standard deviation left and right pupillary diameters (PD) at rest were 4.7 +/- 0.8 and 4.5 +/- 0.8 mm. Following an ipsilateral light stimulus (L-stim), left and right constricted PD were 2.8 +/- 0.6 and 2.7 +/- 0.6 mm. Following a contralateral L-stim, left and right constricted PD were 2.7 +/- 0.6 and 2.6 +/- 0.5 mm. Left and right pupillary constriction time (PCT) following ipsilateral L-stim were 970 +/- 261.6 and 967 +/- 220 ms. Left and right PCT following a contralateral L-stim were 993.8 +/- 192.6 and 963 +/- 189.4 ms. Patient age was inversely correlated with PD at rest and with PD after ipsilateral and contralateral L-stim (all p<0.001), but not with PCT. Conclusions B-mode ultrasound is a simple, rapid and objective method for the quantitative assessment of pupillary function, which may prove useful in a variety of settings where eyelid retraction is impeded or an infrared pupillometry device is unavailable.	[Schmidt, Felix A.; Ruprecht, Klemens; Connolly, Florian; Paul, Friedemann; Harms, Lutz] Charite, Dept Neurol, Berlin, Germany; [Schmidt, Felix A.; Paul, Friedemann] Charite, NeuroCure Clin Res Ctr, Berlin, Germany; [Maas, Matthew B.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Paul, Friedemann] Max Delbruck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany; [Paul, Friedemann] Charite, Berlin, Germany; [Hoffmann, Jan] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Schreiber, Stephan J.] Asklepios Fachklinikum Brandenburg, Dept Neurol, Brandenburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Northwestern University; Feinberg School of Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schmidt, FA (corresponding author), Charite, Dept Neurol, Berlin, Germany.; Schmidt, FA (corresponding author), Charite, NeuroCure Clin Res Ctr, Berlin, Germany.	felix.schmidt@charite.de	Paul, Friedemann/ABF-9415-2020; Hoffmann, Jan/AAP-8376-2020	paul, friedemann/0000-0002-6378-0070				Adhikari P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161175; Bergamin O, 2003, OPHTHALMOLOGY, V110, P106, DOI 10.1016/S0161-6420(02)01445-8; Bremner FD, 2012, INVEST OPHTH VIS SCI, V53, P7343, DOI 10.1167/iovs.12-10881; Chang DS, 2013, OPHTHALMOLOGY, V120, P2217, DOI 10.1016/j.ophtha.2013.04.012; Fotiou D F, 2007, Electromyogr Clin Neurophysiol, V47, P11; Harries A, 2010, AM J EMERG MED, V28, P956, DOI 10.1016/j.ajem.2009.06.026; Kardon R, 1995, Curr Opin Ophthalmol, V6, P20, DOI 10.1097/00055735-199512000-00004; LOEWENFELD IE, 1974, AM J OPHTHALMOL, V78, P304, DOI 10.1016/0002-9394(74)90093-2; LONGTIN A, 1989, B MATH BIOL, V51, P605; MCGRAW P, 1995, BRIT MED J, V310, P1481, DOI 10.1136/bmj.310.6993.1481; Muppidi S, 2013, CLIN AUTON RES, V23, P297, DOI 10.1007/s10286-013-0209-7; Payen J-F, 2012, Ann Fr Anesth Reanim, V31, pe155, DOI 10.1016/j.annfar.2012.04.020; Trier H G, 1982, Ultraschall Med, V3, P164, DOI 10.1055/s-2007-1010120; Wachler BSB, 1999, OPHTHALMOLOGY, V106, P319; Wilhelm H, 2003, J NEURO-OPHTHALMOL, V23, P42, DOI 10.1097/00041327-200303000-00010; Wilhelm H, 1998, J NEUROL, V245, P573, DOI 10.1007/s004150050248	16	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189016	10.1371/journal.pone.0189016	http://dx.doi.org/10.1371/journal.pone.0189016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211788	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000417212200056
J	Sket, R; Treichel, N; Kublik, S; Debevec, T; Eiken, O; Mekjavic, I; Schloter, M; Vital, M; Chandler, J; Tiedje, JM; Murovec, B; Prevorsek, Z; Likar, M; Stres, B				Sket, Robert; Treichel, Nicole; Kublik, Susanne; Debevec, Tadej; Eiken, Ola; Mekjavic, Igor; Schloter, Michael; Vital, Marius; Chandler, Jenna; Tiedje, James M.; Murovec, Bostjan; Prevorsek, Zala; Likar, Matevz; Stres, Blaz			Hypoxia and inactivity related physiological changes precede or take place in absence of significant rearrangements in bacterial community structure: The PlanHab randomized trial pilot study	PLOS ONE			English	Article							FALSE DISCOVERY RATE; BED-REST; MICROBIAL COMMUNITIES; GUT MICROBIOTA; EXERCISE; METABOLISM; INFLAMMATION; CONFINEMENT; BACTEROIDES; HIBERNATION	We explored the assembly of intestinal microbiota in healthy male participants during the randomized crossover design of run-in (5 day) and experimental phases (21-day normoxic bed rest (NBR), hypoxic bed rest (HBR) and hypoxic ambulation (HAmb) in a strictly controlled laboratory environment, with balanced fluid and dietary intakes, controlled circadian rhythm, microbial ambiental burden and 24/7 medical surveillance. The fraction of inspired O-2 (FiO2) and partial pressure of inspired O-2 (PiO2) were 0.209 and 133.1 +/- 0.3 mmHg for NBR and 0.141 +/- 0.004 and 90.0 +/- 0.4 mmHg for both hypoxic variants (HBR and HAmb; similar to 4000 m simulated altitude), respectively. A number of parameters linked to intestinal environment such as defecation frequency, intestinal electrical conductivity (IEC), sterol and polyphenol content and diversity, indole, aromaticity and spectral characteristics of dissolved organic matter (DOM) were measured (64 variables). The structure and diversity of bacterial microbial community was assessed using 16S rRNA amplicon sequencing. Inactivity negatively affected frequency of defecation and in combination with hypoxia increased IEC (p < 0.05). In contrast, sterol and polyphenol diversity and content, various characteristics of DOM and aromatic compounds, the structure and diversity of bacterial microbial community were not significantly affected over time. A new in-house PlanHab database was established to integrate all measured variables on host physiology, diet, experiment, immune and metabolic markers (n = 231). The observed progressive decrease in defecation frequency and concomitant increase in IEC suggested that the transition from healthy physiological state towards the developed symptoms of low magnitude obesity-related syndromes was dose dependent on the extent of time spent in inactivity and preceded or took place in absence of significant rearrangements in bacterial microbial community. Species B. thetaiotamicron, B. fragilis, B. dorei and other Bacteroides with reported relevance for dysbiotic medical conditions were significantly enriched in HBR, characterized with most severe inflammation symptoms, indicating a shift towards host mucin degradation and proinflammatory immune crosstalk.	[Sket, Robert; Prevorsek, Zala; Stres, Blaz] Univ Ljubljana, Dept Anim Sci, Biotech Fac, Ljubljana, Slovenia; [Treichel, Nicole; Kublik, Susanne; Schloter, Michael] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Comparat Microbiome Anal, Neuherberg, Germany; [Debevec, Tadej; Mekjavic, Igor] Jozef Stefan Inst, Dept Automat Biocybernet & Robot, Ljubljana, Slovenia; [Debevec, Tadej] Univ Ljubljana, Fac Sport, Ljubljana, Slovenia; [Eiken, Ola] Royal Inst Technol, Dept Environm Physiol, Swedish Aerosp Physiol Ctr, Stockholm, Sweden; [Vital, Marius; Chandler, Jenna; Tiedje, James M.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; [Murovec, Bostjan] Univ Ljubljana, Lab Artificial Sight & Automat, Fac Elect Sci, Ljubljana, Slovenia; [Likar, Matevz] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia; [Stres, Blaz] Univ Ljubljana, Ctr Clin Neurophysiol, Fac Med, Ljubljana, Slovenia	University of Ljubljana; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; Royal Institute of Technology; Michigan State University; University of Ljubljana; University of Ljubljana; University of Ljubljana	Stres, B (corresponding author), Univ Ljubljana, Dept Anim Sci, Biotech Fac, Ljubljana, Slovenia.; Stres, B (corresponding author), Univ Ljubljana, Ctr Clin Neurophysiol, Fac Med, Ljubljana, Slovenia.	blaz.stres@bf.uni-lj.si	Schloter, 1Michael/H-9151-2013; Debevec, Tadej/D-7917-2013; Stres, Blaz/AAF-7279-2020; Mekjavic, Igor/AAM-6962-2021	Debevec, Tadej/0000-0001-7053-3978; Stres, Blaz/0000-0003-2972-2907; Mekjavic, Igor/0000-0001-5930-2159	European Union [284438]; European Space Agency (ESA) [40001043721/11/NL/KML]; Slovene Research Agency [L3-3654]; Slovenian Research Agency [37426]; COST Action [CM 5120]	European Union(European Commission); European Space Agency (ESA)(European Space AgencyEuropean Commission); Slovene Research Agency(Slovenian Research Agency - Slovenia); Slovenian Research Agency(Slovenian Research Agency - Slovenia); COST Action(European Cooperation in Science and Technology (COST))	The study was funded by the European Union programme FP7 (PlanHab project; Grant no. 284438; https://ec.europa.eu/research/fp7; http://cordis.europa.eu/project/rcn/104127_en.html), the European Space Agency (ESA) Programme for European Cooperating States (ESTEC/Contract No. 40001043721/11/NL/KML: Planetary Habitat Simulation; www.esa.int/), and the Slovene Research Agency (Contract no. L3-3654: Zero and reduced gravity simulation: The effect on the cardiovascular and musculoskeletal systems; https://www.arrs.gov.si/). BS, ZP, RS, BM, ML acknowledge the support of Slovenian Research Agency (https://www.arrs.gov.si/) next generation sequencing research grants and Young Research Fellowship awarded to BS for RS (SRA#37426). COST Action CM 5120 Open Multiscale Systems Medicine (OpenMultiMed) is acknowledged for support and fruitful discussions during the final preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton W, 2017, GUT; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bermon S, 2015, EXERC IMMUNOL REV, V21, P70; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Campos-Rodriguez R, 2016, INT J SPORTS MED, V37, P63, DOI 10.1055/s-0035-1559697; Carey HV, 2013, AM J PHYSIOL-REG I, V304, pR33, DOI 10.1152/ajpregu.00387.2012; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Clarke SF, 2014, GUT, V63, P1913, DOI 10.1136/gutjnl-2013-306541; Clayton JB, 2016, P NATL ACAD SCI USA, V113, P10376, DOI 10.1073/pnas.1521835113; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Colgan SP, 2013, DIGEST DIS SCI, V58, P602, DOI 10.1007/s10620-013-2575-3; Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017; Cronin O, 2016, CURR OPIN GASTROEN, V32, P67, DOI 10.1097/MOG.0000000000000240; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Debevec T, 2016, APPETITE, V107, P28, DOI 10.1016/j.appet.2016.07.005; Debevec T, 2014, EUR J APPL PHYSIOL, V114, P2411, DOI 10.1007/s00421-014-2963-1; Debevec T, 2014, J APPL PHYSIOL, V116, P1255, DOI 10.1152/japplphysiol.00873.2013; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; ESA, 2009, 2018706NLVJ ESA ESTE; Faber F, 2014, IMMUNOL LETT, V162, P48, DOI 10.1016/j.imlet.2014.04.014; Fichot CG, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00007; Gilbert JA, 2016, GUT, V65, P1, DOI 10.1136/gutjnl-2015-310043; Glover LE, 2016, J CLIN INVEST, V126, P3680, DOI 10.1172/JCI84429; Helms JR, 2008, LIMNOL OCEANOGR, V53, P955, DOI 10.4319/lo.2008.53.3.0955; Hoff P, 2015, CELL MOL IMMUNOL, V12, P483, DOI 10.1038/cmi.2014.106; Holmes AJ, 2017, CELL METAB, V25, P140, DOI 10.1016/j.cmet.2016.10.021; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jayewardene AF, 2016, J CELL PHYSIOL, V231, P1671, DOI 10.1002/jcp.25281; Johnson EL, 2017, J MOL MED, V95, P1, DOI 10.1007/s00109-016-1492-2; Keramidas ME, 2016, AM J PHYSIOL-HEART C, V311, pH453, DOI 10.1152/ajpheart.00304.2016; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kumar MT, 2015, J ENV ANAL CHEM, V02, DOI [10.4172/2380-2391.1000152, DOI 10.4172/2380-2391.1000152]; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; LI K, 2013, PLOS ONE, V8; Villanueva-Canas JL, 2014, INTEGR COMP BIOL, V54, P452, DOI 10.1093/icb/icu048; Mach N, 2016, J SPORT HEA IN PRESS; Martens EC, 2009, J BIOL CHEM, V284, P18445, DOI 10.1074/jbc.M109.008094; Matsumoto M, 2008, BIOSCI BIOTECH BIOCH, V72, P572, DOI 10.1271/bbb.70474; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moeller AH, 2014, P NATL ACAD SCI USA, V111, P16431, DOI 10.1073/pnas.1419136111; Pham NM, 2012, JPN J CLIN ONCOL, V42, P2, DOI 10.1093/jjco/hyr160; Nichol KE, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-13; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ravcheev DA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-873; Ringseis R, 2015, EXERC IMMUNOL REV, V21, P58; Rios-Covian D, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0773-9; Rios-Covian D, 2013, APPL ENVIRON MICROB, V79, P7518, DOI 10.1128/AEM.02545-13; Rittweger J, 2016, BONE, V91, P130, DOI 10.1016/j.bone.2016.07.013; Rodriguez-Castano GP, 2017, FRONT GENET, V7, DOI 10.3389/fgene.2016.00224; Schloss PD, 2008, ISME J, V2, P265, DOI 10.1038/ismej.2008.5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Simpson EJ, 2016, J APPL PHYSIOL, V120, P947, DOI 10.1152/japplphysiol.00897.2015; Sket R, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00250; Sommer F, 2016, CELL REP, V14, P1655, DOI 10.1016/j.celrep.2016.01.026; Stavrou NA, 2016, 14 EUR LIF SCI S 37, P187; Strewe C, 2017, STRESS, V20, P131, DOI 10.1080/10253890.2017.1292246; Takahashi S., 2014, PLOS ONE, V9; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Uva B, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00411; van Dijk JW, 2012, DIABETOLOGIA, V55, P1273, DOI 10.1007/s00125-011-2380-5; Vantrepotte V, 2015, OPT EXPRESS, V23, P33, DOI 10.1364/OE.23.000033; Vineis JH, 2016, MBIO, V7, DOI [10.1128/mBio.01713-16, 10.1128/mbio.01713-16]; Voreades N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00494; Warnes M.G.R., 2016, PACKAGE GPLOTS VARIO; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Weyhenmeyer GA, 2014, PLOS ONE, V9; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Zeitouni Nathalie E, 2016, Mol Cell Pediatr, V3, P14, DOI 10.1186/s40348-016-0041-y	76	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188556	10.1371/journal.pone.0188556	http://dx.doi.org/10.1371/journal.pone.0188556			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211803	Green Published, Green Submitted, gold			2022-12-27	WOS:000417212200039
J	Yang-Huang, J; van Grieken, A; Moll, HA; Jaddoe, VWV; Wijtzes, AI; Raat, H				Yang-Huang, Junwen; van Grieken, Amy; Moll, Henriette A.; Jaddoe, Vincent W. V.; Wijtzes, Anne I.; Raat, Hein			Socioeconomic differences in children's television viewing trajectory: A population-based prospective cohort study	PLOS ONE			English	Article							SEDENTARY BEHAVIOR GUIDELINES; TIME; ADOLESCENTS; OVERWEIGHT; RISK	We aimed to evaluate the association between family socioeconomic status and repeatedly measured child television viewing time from early childhood to the school period. We analyzed data on 3,561 Dutch children from the Generation R Study, a population-based study in the Netherlands. Parent-reported television viewing time for children aged 2, 3, 4, 6 and 9 years were collected by questionnaires sent from April 2004 until January 2015. Odds ratios of watching television >= 1 hour/day at each age were calculated for children of mothers with low, mid-low, mid-high and high (reference group) education and children from low, middle and high (reference group) income households. A generalized logistic mixed model was used to assess the association between family socioeconomic status and child television viewing time trajectory. The percentage of children watching television >= 1 hour/day increased from age 2 to 9 years for all children (24.2%-85.0% for children of low-educated mothers; 4.7%-61.4% for children of high-educated mothers; 17.2%-74.9% for children from low income households; 6.2%-65.1% for children from high income households). Independent socioeconomic effect in child television viewing time was found for maternal educational level. The interaction between net household income and child age in longitudinal analyses was significant (p = 0.01), indicating that the television viewing time trajectories were different in household income subgroups. However the interaction between maternal educational level and child age was not significant (p = 0.19). Inverse socioeconomic gradients in child television viewing time were found from the preschool period to the late school period. The educational differences between the various educational subgroups remained stable with increasing age, but the differences between household income groups changed over time. Intervention developers and healthcare practitioners need to raise awareness among non-highly educated parents that the socioeconomic gradient in television viewing time has a tracking effect starting from preschool age.	[Yang-Huang, Junwen; Jaddoe, Vincent W. V.] Erasmus MC, Generat R Study Grp, Rotterdam, Netherlands; [Yang-Huang, Junwen; van Grieken, Amy; Raat, Hein] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Moll, Henriette A.; Jaddoe, Vincent W. V.] Erasmus MC, Dept Pediat, Rotterdam, Netherlands; [Jaddoe, Vincent W. V.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Wijtzes, Anne I.] Katholieke Univ Leuven, Dept Kinesiol, Leuven, Belgium	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; KU Leuven	Raat, H (corresponding author), Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	h.raat@erasmusmc.nl			China Scholarship Council (CSC); CSC [201506100001]; Erasmus Medical Center, Erasmus University Rotterdam, Rotterdam; Netherlands Organization for Health Research and Development (ZonMw)	China Scholarship Council (CSC)(China Scholarship Council); CSC; Erasmus Medical Center, Erasmus University Rotterdam, Rotterdam; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	Junwen Yang-Huang is supported by China Scholarship Council (CSC) PhD Fellowship for her PhD study in Erasmus MC, Rotterdam, the Netherlands. The scholarship file number is 201506100001, CSC URL: [http://www.csc.edu.cn/]. The Generation R Study is made possible by financial support from Erasmus Medical Center, Erasmus University Rotterdam, Rotterdam, and the Netherlands Organization for Health Research and Development (ZonMw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arundell L, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0419-1; Australian Government Department of Health and Ageing, 2009, GET GROW HLTH EAT PH; Biddle SJH, 2010, PREV MED, V51, P345, DOI 10.1016/j.ypmed.2010.07.018; Bryant MJ, 2007, OBES REV, V8, P197, DOI 10.1111/j.1467-789X.2006.00295.x; Christakis DA, 2004, J PEDIATR-US, V145, P652, DOI 10.1016/j.jpeds.2004.06.078; Colley RC, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-54; Commonwealth of Australia (Australian Communications and Media Authority), 2015, CHILDR TEL VIEW RES; Cooper K., 2013, DOES MONEY AFFECT CH; Council On Communications and Media, 2016, PEDIATRICS, V138; DeMaio T., 1984, SURVEYING SUBJECTIVE, P257, DOI 10.2458/v7i2.20321; Department of Health, 2014, PHYS ACT SED BEH GUI; Drenowatz C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-214; Fuller-Tyszkiewicz M, 2012, APPETITE, V59, P945, DOI 10.1016/j.appet.2012.09.009; Gebremariam MK, 2015, OBES REV, V16, P988, DOI 10.1111/obr.12314; Gorely T, 2004, INT J BEHAV MED, V11, P152, DOI 10.1207/s15327558ijbm1103_4; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Cillero IH, 2010, PREV MED, V51, P3, DOI 10.1016/j.ypmed.2010.04.012; Jaddoe VWV, 2006, EUR J EPIDEMIOL, V21, P475, DOI 10.1007/s10654-006-9022-0; Janssen X, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0413-7; Kooijman MN, 2016, EUR J EPIDEMIOL, V31, P1243, DOI 10.1007/s10654-016-0224-9; Kourlaba G, 2009, J PUBLIC HEALTH-UK, V31, P222, DOI 10.1093/pubmed/fdp011; Kristiansen H, 2013, ACTA PAEDIATR, V102, P199, DOI 10.1111/apa.12066; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Moraeus L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1635-3; Pearson N, 2011, PREV MED, V53, P268, DOI 10.1016/j.ypmed.2011.07.014; Robinson S, 2015, J PEDIATR-US, V167, P1239, DOI 10.1016/j.jpeds.2015.08.067; Sisson SB, 2011, J PHYS ACT HEALTH, V8, pS188, DOI 10.1123/jpah.8.s2.s188; Sisson SB, 2009, INT J PEDIATR OBES, V4, P353, DOI 10.3109/17477160902934777; Smith L, 2015, J EPIDEMIOL COMMUN H, V69, P309, DOI 10.1136/jech-2014-204365; Statistics Netherlands, 2004, STAND OND 2003; Statistics Netherlands, 2010, JAARR INT 2010; Straker LM, 2006, CHILD CARE HLTH DEV, V32, P343, DOI 10.1111/j.1365-2214.2006.00599.x; Tandon PS, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-88; Tremblay MS, 2012, APPL PHYSIOL NUTR ME, V37, P370, DOI [10.1139/h2012-019, 10.1139/H2012-019, 10.1139/h2012-029, 10.1139/H2012-029]; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P65, DOI 10.1139/H11-013; Verloigne M, 2016, INT J BEHAV NUTR PHY, V13, DOI [10.1186/s12966-016-0395-5, 10.1186/s12966-016-0397-3]; Wijtzes AI, 2012, PREV MED, V55, P325, DOI 10.1016/j.ypmed.2012.07.023	38	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188363	10.1371/journal.pone.0188363	http://dx.doi.org/10.1371/journal.pone.0188363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211770	Green Published, gold			2022-12-27	WOS:000417212200028
J	Yu, GC; Ye, B; Chen, D; Zhong, FM; Chen, G; Yang, J; Xu, LL; Xu, XD				Yu, Guocan; Ye, Bo; Chen, Da; Zhong, Fangming; Chen, Gang; Yang, Jun; Xu, Liliang; Xu, Xudong			Comparison between the diagnostic validities of Xpert MTB/RIF and interferon-gamma release assays for tuberculous pericarditis using pericardial tissue	PLOS ONE			English	Article								Background This study aimed to assess the diagnostic performance of Xpert MTB/RIF for tuberculous pericarditis (TBP) using pericardial tissues. Methods The study involved 30 patients admitted with suspected TBP from January-December 2016; three patients were later excluded. The interferon-gamma release assay (T-SPOT.TB) and the Xpert MTB/RIF test were performed using peripheral blood and pericardial tissues, respectively. TBP was confirmed using pericardial histopathology and a composite reference standard (CRS). We analyzed the sensitivity, specificity, predictive value (PV), likelihood ratio (LR), and area under curve (AUC) of both assays. Results Fourteen patients were confirmed as TBP, 10 as non-TBP, and 3 as probable TBP. The sensitivity, specificity, positive PV (PPV), negative PV (NPV), PLR, NLR, and AUC (95% confidence interval [CI]) of the Xpert MTB/RIF assay were 78.6% (49.2-95.3%) and 70.6% (44.0-89.7%); 92.3% (64.0-99.8%) and 100% (69.2-100%); 91.7% (61.5-99.8%) and 100% (73.5-100%); 80.0% (51.9-95.7%) and 66.7% (38.4-88.2%); 10.21 (1.52-68.49) and the PLR value was undefined with CRS as the reference; 0.23 (0.08-0.64) and 0.29 (0.14-0.61); and 0.854 (0.666-0.959) and 0.853 (0.664-0.959), against histopathology and CRS, respectively. The sensitivity, specificity, PPV, NPV, PLR, NLR, and AUC values (95% CI) of T-SPOT.TB were 92.9% (66.1-99.8%) and 94.1% (71.3-99.9%); 15.4% (1.9-45.5%) and 20.0% (2.5-55.6%); 54.2% (32.8-74.5%) and 66.7% (44.7-84.4%); 66.7% (9.4-99.2%) and 66.7% (9.4-99.2%); 1.10 (0.83-1.44) and 1.18 (0.84-1.6); 0.46 (0.05-4.53) and 0.29 (0.03-2.85); and 0.541(0.340-0.733) and 0.571(0.367-0.758), against histopathology and CRS, respectively. The differences in sensitivity, PPV, and AUC of Xpert MTB/RIF and T-SPOT.TB were not statistically significant (P > 0.05), compared to those of histopathology and CRS. However, the differences in specificity and NPV of the two assays were significant (P < 0.05), compared to those of histopathology and CRS. Conclusions Xpert MTB/RIF test is a valid diagnostic technique for TBP with higher sensitivity and specificity than T-SPOT.TB.	[Yu, Guocan; Ye, Bo; Chen, Da; Zhong, Fangming; Chen, Gang; Yang, Jun; Xu, Liliang; Xu, Xudong] Hangzhou Red Cross Hosp, Dept Thorac Surg, Hangzhou, Zhejiang, Peoples R China		Xu, XD (corresponding author), Hangzhou Red Cross Hosp, Dept Thorac Surg, Hangzhou, Zhejiang, Peoples R China.	xuxudong234@163.com	Yu, Guocan/D-2963-2014	Yu, Guocan/0000-0003-1157-4184	Health and Family Planning Commission of Zhejiang province (Program name: Standardization construction of tuberculosis tissue bank and its application in translational medicine) [2015KYA186]	Health and Family Planning Commission of Zhejiang province (Program name: Standardization construction of tuberculosis tissue bank and its application in translational medicine)	This research was supported by Health and Family Planning Commission of Zhejiang province (Program name: Standardization construction of tuberculosis tissue bank and its application in translational medicine, Program number: 2015KYA186, http://www.zjwjw.gov.cn/).	Banaei Niaz, 2016, J Clin Microbiol, V54, P845, DOI 10.1128/JCM.02803-15; Bathoorn E, 2011, CLIN VACCINE IMMUNOL, V18, P874, DOI 10.1128/CVI.00031-11; Biadglegne F, 2014, TUBERCULOSIS, V94, P502, DOI 10.1016/j.tube.2014.05.002; Bian SN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165008; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chew MY, 2016, INT J TUBERC LUNG D, V20, P1668, DOI 10.5588/ijtld.16.0123; Dhana AV, 2013, BMJ CASE REP; Feng YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046275; Gao L, 2015, LANCET INFECT DIS, V15, P310, DOI 10.1016/S1473-3099(14)71085-0; Jung IY, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2062-5; Kang JY, 2012, TUBERC RESPIR DIS, V73, P143, DOI 10.4046/trd.2012.73.3.143; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Li G, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00117; Ma W, 2012, HERZ, V37, P183, DOI 10.1007/s00059-011-3428-5; Mayosi BM, 2005, CIRCULATION, V112, P3608, DOI 10.1161/CIRCULATIONAHA.105.543066; Mayosi BM, 2008, SAMJ S AFR MED J, V98, P36; Mazzola Ester, 2016, Infez Med, V24, P304; Meldau R, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-58; Ntsekhe M, 2013, HEART FAIL REV, V18, P367, DOI 10.1007/s10741-012-9310-6; Pandie S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32924; Pandie S, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-101; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; STRANG G, 1991, LANCET, V338, P1600, DOI 10.1016/0140-6736(91)92433-3; Suzana S, 2016, TROP MED INT HEALTH, V21, P385, DOI 10.1111/tmi.12655; Syed FF, 2007, PROG CARDIOVASC DIS, V50, P218, DOI 10.1016/j.pcad.2007.03.002; WHO, 2016, GLOB TUB REP; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; Xie DL, 2015, EUR REV MED PHARMACO, V19, P4411	28	16	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188704	10.1371/journal.pone.0188704	http://dx.doi.org/10.1371/journal.pone.0188704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211755	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200043
J	Baker, KK; Padhi, B; Torondel, B; Das, P; Dutta, A; Sahoo, KC; Das, B; Dreibelbis, R; Caruso, B; Freeman, MC; Sager, L; Panigrahi, P				Baker, Kelly K.; Padhi, Bijaya; Torondel, Belen; Das, Padmalaya; Dutta, Ambarish; Sahoo, Krushna Chandra; Das, Bhabani; Dreibelbis, Robert; Caruso, Bethany; Freeman, Matthew C.; Sager, Lauren; Panigrahi, Pinaki			From menarche to menopause: A population-based assessment of water, sanitation, and hygiene risk factors for reproductive tract infection symptoms over life stages in rural girls and women in India	PLOS ONE			English	Article							ABNORMAL VAGINAL DISCHARGE; LOW-BIRTH-WEIGHT; BACTERIAL VAGINOSIS; PREGNANT-WOMEN; EMOTIONAL DISTRESS; PRETERM DELIVERY; HEALTH; ASSOCIATION; INSECURITY; STRESS	Women face greater challenges than men in accessing water, sanitation, and hygiene (WASH) resources to address their daily needs, and may respond to these challenges by adopting unsafe practices that increase the risk of reproductive tract infections (RTIs). WASH practices may change as women transition through socially-defined life stage experiences, like marriage and pregnancy. Thus, the relationship between WASH practices and RTIs might vary across female reproductive life stages. This cross-sectional study assessed the relationship between WASH exposures and self-reported RTI symptoms in 3,952 girls and women from two rural districts in India, and tested whether social exposures represented by reproductive life stage was an effect modifier of associations. In fully adjusted models, RTI symptoms were less common in women using a latrine without water for defecation versus open defecation (Odds Ratio (OR) = 0.69; Confidence Interval (CI) = 0.48, 0.98) and those walking shorter distances to a bathing location (OR = 0.79, CI = 0.63, 0.99), but there was no association between using a latrine with a water source and RTIs versus open defecation (OR = 1.09; CI = 0.69, 1.72). Unexpectedly, RTI symptoms were more common for women bathing daily with soap (OR = 6.55, CI = 3.60, 11.94) and for women washing their hands after defecation with soap (OR = 10.27; CI = 5.53, 19.08) or ash/soil/ mud (OR = 6.02; CI = 3.07, 11.77) versus water only or no hand washing. WASH practices of girls and women varied across reproductive life stages, but the associations between WASH practices and RTI symptoms were not moderated by or confounded by life stage status. This study provides new evidence that WASH access and practices are associated with self-reported reproductive tract infection symptoms in rural Indian girls and women from different reproductive life stages. However, the counterintuitive directions of effect for soap use highlights that causality and mechanisms of effect cannot be inferred from this study design. Future research is needed to understand whether improvements in water and sanitation access could improve the practice of safe hygiene behaviors and reduce the global burden of RTIs in women.	[Baker, Kelly K.; Sager, Lauren] Univ Iowa, Coll Publ Hlth, Iowa City, IA 52242 USA; [Padhi, Bijaya; Das, Padmalaya; Dutta, Ambarish; Sahoo, Krushna Chandra; Das, Bhabani] Asian Inst Publ Hlth, Bhubaneswar, India; [Torondel, Belen] London Sch Hyg & Trop Med, London, England; [Dreibelbis, Robert] Univ Oklahoma, Norman, OK 73019 USA; [Caruso, Bethany; Freeman, Matthew C.] Emory Univ, Atlanta, GA 30322 USA; [Panigrahi, Pinaki] Univ Nebraska Med Ctr, Omaha, NE USA	University of Iowa; University of London; London School of Hygiene & Tropical Medicine; University of Oklahoma System; University of Oklahoma - Norman; Emory University; University of Nebraska System; University of Nebraska Medical Center	Baker, KK (corresponding author), Univ Iowa, Coll Publ Hlth, Iowa City, IA 52242 USA.	kelly-k-baker@uiowa.edu	Padhi, Bijaya K/E-7102-2010; Sahoo, Krushna Chandra/AAF-2813-2020; Padhi, Bijaya Kumar/AAW-2384-2021	Padhi, Bijaya K/0000-0002-2828-2375; Padhi, Bijaya Kumar/0000-0002-2828-2375; Dreibelbis, Robert/0000-0002-9716-0419; Baker, Kelly/0000-0002-3774-2628; Das, Bhabani Sankar/0000-0001-8492-9033; Caruso, Bethany/0000-0001-9738-9857; Dutta, Ambarish/0000-0002-4019-7472	Sanitation and Hygiene Applied Research for Equity (SHARE) consortium; UK Department for International Development [PO 6981]	Sanitation and Hygiene Applied Research for Equity (SHARE) consortium; UK Department for International Development	This research received financial support from the Sanitation and Hygiene Applied Research for Equity (SHARE) consortium (https//www..shareresearchorg/), which was funded by the UK Department for International Development (grant no. PO 6981). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal Arun Kumar, 2004, Journal of Communicable Diseases, V36, P1; Ahuja Maninder, 2016, J Midlife Health, V7, P126; Al Riyami A, 2005, MED PRIN PRACT, V14, P92, DOI 10.1159/000083918; Alexander M, 2007, INT FAM PLAN PERSPEC, V33, P150, DOI 10.1363/ifpp.33.150.07; Alijahan Rahele, 2014, Iran J Reprod Med, V12, P47; Anand E, 2015, SEX REPROD HEALTHC, V6, P249, DOI 10.1016/j.srhc.2015.06.001; Ashorn P, 2015, NESTLE NUTR WORKS SE, V81, P37, DOI 10.1159/000365802; Bahram Amini, 2009, Oman Med J, V24, P288, DOI 10.5001/omj.2009.58; Balsara ZP, 2010, J HEALTH POPUL NUTR, V28, P501; Bennett DA, 2001, AUST NZ J PUBL HEAL, V25, P464, DOI 10.1111/j.1467-842X.2001.tb00294.x; Benova L, 2014, TROP MED INT HEALTH, V19, P368, DOI 10.1111/tmi.12275; Betha K, 2016, INFECT DIS OBSTET GY, V2016; Bhilwar Meenakshi, 2015, J Nat Sci Biol Med, V6, pS29, DOI 10.4103/0976-9668.166059; Brotman RM, 2008, AM J EPIDEMIOL, V168, P188, DOI 10.1093/aje/kwn103; Cammack AL, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.054; Caruso BA, 2015, LANCET, V386, P650, DOI 10.1016/S0140-6736(15)61497-0; Chen QX, 2013, AM J PUBLIC HEALTH, V103, pE67, DOI 10.2105/AJPH.2012.300995; Clasen T, 2014, LANCET GLOB HEALTH, V2, pE645, DOI 10.1016/S2214-109X(14)70307-9; Cohen BE, 2012, WOMEN HEALTH ISS, V22, pE461, DOI 10.1016/j.whi.2012.06.005; Contzen N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136445; Crucitti T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016310; Culhane JF, 2002, AM J OBSTET GYNECOL, V187, P1272, DOI 10.1067/mob.2002.127311; Dambhare Dharampal G, 2012, Glob J Health Sci, V4, P105, DOI 10.5539/gjhs.v4n1p105; Das P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130777; Donati L, 2010, ARCH GYNECOL OBSTET, V281, P589, DOI 10.1007/s00404-009-1318-3; Eschenbach DA, 2007, CLIN INFECT DIS, V44, P220, DOI 10.1086/509584; Fisher J, 2008, P I CIVIL ENG-MUNIC, V161, P223, DOI 10.1680/muen.2008.161.4.223; Goto A, 2005, J EPIDEMIOL, V15, P163, DOI 10.2188/jea.15.163; Hassan WM, 2007, SEX TRANSM DIS, V34, P384, DOI 10.1097/01.olq.0000243624.74573.63; HILL GB, 1993, AM J OBSTET GYNECOL, V169, P450, DOI 10.1016/0002-9378(93)90339-K; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hulland KRS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141883; Jaya, 2009, INT PERSPECT SEX R H, V35, P97, DOI 10.1363/ipsrh.35.097.09; Kenyon C, 2013, AM J OBSTET GYNECOL, V209, P505, DOI 10.1016/j.ajog.2013.05.006; Kenyon CR, 2014, CURR OPIN OBSTET GYN, V26, P448, DOI 10.1097/GCO.0000000000000112; Kerubo E, 2016, SEX TRANSM INFECT, V92, P251, DOI 10.1136/sextrans-2015-052371; Khanna T, 2016, GLOB PUBLIC HEALTH, V11, P1185, DOI 10.1080/17441692.2015.1062905; Khawaja M, 2009, J WOMENS HEALTH, V18, P1701, DOI 10.1089/jwh.2008.0962; Klebanoff MA, 2010, SEX TRANSM DIS, V37, P94, DOI 10.1097/OLQ.0b013e3181bc063c; Kojima N, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2282-3; Krupp K, 2007, Glob Public Health, V2, P395, DOI 10.1080/17441690701238031; Lata Indu, 2010, Indian J Community Med, V35, P285, DOI 10.4103/0970-0218.66855; Li XD, 2014, EUR J CLIN MICROBIOL, V33, P1525, DOI 10.1007/s10096-014-2103-1; Lien PT, 2002, STUD FAMILY PLANN, V33, P217, DOI 10.1111/j.1728-4465.2002.00217.x; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; ManunEbo M, 1997, TROP MED INT HEALTH, V2, P1015, DOI 10.1046/j.1365-3156.1997.d01-180.x; Mbizvo M E, 2004, Cent Afr J Med, V50, P41; McClelland RS, 2008, SEX TRANSM DIS, V35, P617, DOI 10.1097/OLQ.0b013e31816907fa; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; Murphy K, 2016, J INFECT DIS, V214, pS29, DOI 10.1093/infdis/jiw140; Nagarkar Aarti, 2015, Indian J Sex Transm Dis AIDS, V36, P18, DOI 10.4103/0253-7184.156690; Narayankhedkar A., 2015, J SEX TRANSM DIS, V2015; Ness RB, 2005, AM J EPIDEMIOL, V162, P585, DOI 10.1093/aje/kwi243; Onderdonk AB, 2016, CLIN MICROBIOL REV, V29, P223, DOI 10.1128/CMR.00075-15; Padhi BK, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001851; Paige DM, 1998, J NURSE-MIDWIFERY, V43, P83, DOI 10.1016/S0091-2182(97)00161-4; Patel V, 2006, SEX TRANSM INFECT, V82, P243, DOI 10.1136/sti.2005.016451; Patel V, 2006, ARCH GEN PSYCHIAT, V63, P404, DOI 10.1001/archpsyc.63.4.404; Patel V, 2005, INT J EPIDEMIOL, V34, P853, DOI 10.1093/ije/dyi072; Patel V, 2008, J PSYCHOSOM RES, V64, P255, DOI 10.1016/j.jpsychores.2007.10.015; Payne SC, 2010, J AM ACAD NURSE PRAC, V22, P101, DOI 10.1111/j.1745-7599.2009.00474.x; Romoren M, 2007, B WORLD HEALTH ORGAN, V85, P297, DOI 10.2471/BLT.06.031922; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Sahoo KC, 2015, SOC SCI MED, V139, P80, DOI 10.1016/j.socscimed.2015.06.031; SCHIEVE LA, 1994, AM J PUBLIC HEALTH, V84, P405, DOI 10.2105/AJPH.84.3.405; Sharma A. K., 2004, Journal of Communicable Diseases, V36, P93; Stevenson EGJ, 2012, SOC SCI MED, V75, P392, DOI 10.1016/j.socscimed.2012.03.022; Sumpter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062004; Svare JA, 2006, BJOG-INT J OBSTET GY, V113, P1419, DOI 10.1111/j.1471-0528.2006.01087.x; Sznajder KK, 2014, INT J OCCUP ENV HEAL, V20, P33, DOI 10.1179/2049396713Y.0000000053; Taha TE, 1999, J ACQ IMMUN DEF SYND, V20, P52, DOI 10.1097/00042560-199901010-00008; Tsai AC, 2016, J WATER HEALTH, V14, P280, DOI 10.2166/wh.2015.165; Tumwine JK, 2002, UGANDA COUNTRY STUDY, Vxix; van Eijk AM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010290; Winter SC, 2016, INT J ENVIRON HEAL R, V26, P291, DOI 10.1080/09603123.2015.1111309; Wojcik A, 2013, INT J OCCUP MED ENV, V26, P477, DOI 10.2478/s13382-013-0118-y; Wutich A, 2009, MED ANTHROPOL Q, V23, P436, DOI 10.1111/j.1548-1387.2009.01072.x; Wutich A, 2008, SOC SCI MED, V67, P2116, DOI 10.1016/j.socscimed.2008.09.042; ZURAYK H, 1995, STUD FAMILY PLANN, V26, P14, DOI 10.2307/2138047	79	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188234	10.1371/journal.pone.0188234	http://dx.doi.org/10.1371/journal.pone.0188234			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO8CU	29206842	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000417110700010
J	Celma, L; Corbinais, C; Vercruyssen, J; Veaute, X; Li de la Sierra-Gallay, IL; Guerois, R; Busso, D; Mathieu, A; Marsin, S; Quevillon-Cheruel, S; Radicella, JP				Celma, Louisa; Corbinais, Christopher; Vercruyssen, Julien; Veaute, Xavier; Li de la Sierra-Gallay, Ines; Guerois, Raphael; Busso, Didier; Mathieu, Aurelie; Marsin, Stephanie; Quevillon-Cheruel, Sophie; Radicella, J. Pablo			Structural basis for the substrate selectivity of Helicobacter pylori NucT nuclease activity	PLOS ONE			English	Article							REPRESSOR-OPERATOR INTERACTION; PHOSPHOLIPASE-D SUPERFAMILY; CRYSTAL-STRUCTURE; PIRNA BIOGENESIS; PLASMID PKM101; D FAMILY; RECOMBINATION; SEQUENCE; SERVER; MEMBER	The Phospholipase D (PLD) superfamily of proteins includes a group of enzymes with nuclease activity on various nucleic acid substrates. Here, with the aim of better understanding the substrate specificity determinants in this subfamily, we have characterised the enzymatic activity and the crystal structure of NucT, a nuclease implicated in Helicobacter pylori purine salvage and natural transformation and compared them to those of its bacterial and mammalian homologues. NucT exhibits an endonuclease activity with a strong preference for single stranded nucleic acids substrates. We identified histidine124 as essential for the catalytic activity of the protein. Comparison of the NucT crystal structure at 1.58 angstrom resolution reported here with those of other members of the sub-family suggests that the specificity of NucT for single-stranded nucleic acids is provided by the width of a positively charged groove giving access to the catalytic site.	[Celma, Louisa; Vercruyssen, Julien; Li de la Sierra-Gallay, Ines; Guerois, Raphael; Marsin, Stephanie; Quevillon-Cheruel, Sophie] Univ Paris Sud, CNRS, CEA, I2BC, Gif Sur Yvette, France; [Corbinais, Christopher; Veaute, Xavier; Busso, Didier; Mathieu, Aurelie; Marsin, Stephanie; Radicella, J. Pablo] CEA, Inst Mol & Cellular Radiobiol, Fontenay Aux Roses, France; [Corbinais, Christopher; Veaute, Xavier; Busso, Didier; Mathieu, Aurelie; Marsin, Stephanie; Radicella, J. Pablo] Univ Paris Diderot, CEA, INSERM, UMR967, Fontenay Aux Roses, France; [Corbinais, Christopher; Veaute, Xavier; Busso, Didier; Mathieu, Aurelie; Marsin, Stephanie; Radicella, J. Pablo] Univ Paris Sud, Fontenay Aux Roses, France; [Mathieu, Aurelie] INRA, UMR1319, Micalis Inst, Jouy En Josas, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Quevillon-Cheruel, S (corresponding author), Univ Paris Sud, CNRS, CEA, I2BC, Gif Sur Yvette, France.; Radicella, JP (corresponding author), CEA, Inst Mol & Cellular Radiobiol, Fontenay Aux Roses, France.; Radicella, JP (corresponding author), Univ Paris Diderot, CEA, INSERM, UMR967, Fontenay Aux Roses, France.; Radicella, JP (corresponding author), Univ Paris Sud, Fontenay Aux Roses, France.	sophie.quevillon-cheruel@i2bc.paris-saclay.fr; pablo.radicella@cea.fr	Radicella, J. Pablo/AAU-3178-2020; , raph/AAF-4380-2019	Radicella, J. Pablo/0000-0002-8807-7226; GUEROIS, Raphael/0000-0001-5294-2858; CELMA, Louisa/0000-0002-6473-8915; MARSIN, Stephanie/0000-0002-7074-7818	Commissariat a l'Energie Atomique; Centre National de la Recherche Scientifique; Institut National pour la Sante et la recherche Medicale [UMR967]; University Paris-Sud 11 [UMR8619]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; Indo-French Centre for Promotion of Advanced research (CEFIPRA) [5203-5]; French Ministry of Education; DIM-Malinf	Commissariat a l'Energie Atomique(French Atomic Energy Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National pour la Sante et la recherche Medicale; University Paris-Sud 11; French Infrastructure for Integrated Structural Biology (FRISBI); Indo-French Centre for Promotion of Advanced research (CEFIPRA); French Ministry of Education; DIM-Malinf	This work was supported by funds from the Commissariat a l'Energie Atomique, the Centre National de la Recherche Scientifique and Institut National pour la Sante et la recherche Medicale (UMR967), by the University Paris-Sud 11 (UMR8619), by the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01 and by a grant from the Indo-French Centre for Promotion of Advanced research (CEFIPRA) (grant number 5203-5 to JPR). LC and CC were supported by Ph.D fellowships from the French Ministry of Education and the DIM-Malinf, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; DeLano W.L, PYMOL MOL GRAPHICS S; DeYonker NJ, 2013, J AM CHEM SOC, V135, P13764, DOI 10.1021/ja4042753; Dupaigne P, 2008, MOL CELL, V29, P243, DOI 10.1016/j.molcel.2007.11.033; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gottlin EB, 1998, P NATL ACAD SCI USA, V95, P9202, DOI 10.1073/pnas.95.16.9202; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Humbert O, 2011, MOL MICROBIOL, V79, P387, DOI 10.1111/j.1365-2958.2010.07456.x; Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LACKEY D, 1977, J BACTERIOL, V131, P583, DOI 10.1128/JB.131.2.583-588.1977; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leiros I, 2000, STRUCTURE, V8, P655, DOI 10.1016/S0969-2126(00)00150-7; Liechti G, 2012, J BACTERIOL, V194, P839, DOI 10.1128/JB.05757-11; Liechti GW, 2013, J BACTERIOL, V195, P4387, DOI 10.1128/JB.00388-13; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moon AF, 2011, NUCLEIC ACIDS RES, V39, P2943, DOI 10.1093/nar/gkq1152; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimasu H, 2012, NATURE, V491, P284, DOI 10.1038/nature11509; Nureki Osamu, 2014, Biomed J, V37, P369, DOI 10.4103/2319-4170.132909; O'Rourke EJ, 2004, J BACTERIOL, V186, P2586, DOI 10.1128/JB.186.9.2586-2593.2004; POHLMAN RF, 1993, NUCLEIC ACIDS RES, V21, P4867, DOI 10.1093/nar/21.21.4867; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; RIGGS AD, 1970, J MOL BIOL, V48, P67, DOI 10.1016/0022-2836(70)90219-6; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Voigt F, 2012, RNA, V18, P2128, DOI 10.1261/rna.034967.112; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao Y, 1997, PROTEIN SCI, V6, P2655	33	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0189049	10.1371/journal.pone.0189049	http://dx.doi.org/10.1371/journal.pone.0189049			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29206236	Green Submitted, Green Published, gold			2022-12-27	WOS:000417033200026
J	Neadle, D; Allritz, M; Tennie, C				Neadle, Damien; Allritz, Matthias; Tennie, Claudio			Food cleaning in gorillas: Social learning is a possibility but not a necessity	PLOS ONE			English	Article							IMPENETRABLE NATIONAL-PARK; MOUNTAIN GORILLAS; PAN-TROGLODYTES; EVOLUTION; VARIABILITY; CHIMPANZEES; CULTURES; PRIMATE; DIET	Food cleaning is widespread in the animal kingdom, and a recent report confirmed that (amongst other behaviours) wild western lowland gorillas also show food cleaning. The authors of this report conclude that this behaviour, based on its distribution patterns, constitutes a potential candidate for culture. While different conceptualisations of culture exist, some more and some less reliant on behavioural form copying, all of them assign a special role to social learning processes in explaining potentially cultural behaviours. Here we report the results of an experiment that tested to what extent food cleaning behaviour in a group of captive Western lowland gorillas (Gorilla gorilla gorilla) relies on social learning processes. Subjects were provided with clean and dirty apples. When they were provided with dirty apples, all subjects showed evidence of food cleaning in at least 75% of trials. Preferred cleaning techniques differed between individuals, four out of five of subjects expressed a behaviour analogous to that reported in wild conspecifics. Given this occurrence of food cleaning in a culturally unconnected population of gorillas, we conclude that social learning is unlikely to play a central role in the emergence of the food cleaning behavioural form in Western lowland gorillas; instead, placing a greater emphasis on individual learning of food cleaning's behavioural form.	[Neadle, Damien] Univ Birmingham, Sch Psychol, Birmingham, W Midlands, England; [Allritz, Matthias] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Tennie, Claudio] Univ Tubingen, Dept Early Prehist & Quaternary Ecol, Tubingen, Germany	University of Birmingham; University of St Andrews; Eberhard Karls University of Tubingen	Neadle, D (corresponding author), Univ Birmingham, Sch Psychol, Birmingham, W Midlands, England.	DLN521@bham.ac.uk		Neadle, Damien/0000-0001-8559-436X; Tennie, Claudio/0000-0002-5302-4925	Economic and Social Research Council [ES/J50001X/1]; European Research Council under the European Union's Seventh Framework Programme/ERC [609819]; European Research Council under the European Union's Horizon Programme (H2020-EU.1.1.)/ERC [714658]	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); European Research Council under the European Union's Seventh Framework Programme/ERC(European Research Council (ERC)); European Research Council under the European Union's Horizon Programme (H2020-EU.1.1.)/ERC	Damien Neadle has received funding from the Economic and Social Research Council, under a full PhD Studentship ES/J50001X/1. Matthias Allritz has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no 609819 (SOMICS). Claudio Tennie has received funding from the European Research Council under the European Union's Horizon 2020 Programme (H2020-EU.1.1.)/ERC grant agreement no 714658. The funders had no role in study design,data collection and analysis, decision to publish,or preparation of the manuscript.	Alem S, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002564; Allritz M, 2013, PRIMATES, V54, P361, DOI 10.1007/s10329-013-0355-5; Bandini E, 2017, PEERJ, V5, DOI 10.7717/peerj.3814; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd Robert, 1996, Proceedings of the British Academy, V88, P77; Byrne RW, 2009, CURR BIOL, V19, pR111, DOI 10.1016/j.cub.2008.11.027; BYRNE RW, 1993, AM J PRIMATOL, V31, P241, DOI 10.1002/ajp.1350310402; Caldwell CA, 2009, PSYCHOL SCI, V20, P1478, DOI 10.1111/j.1467-9280.2009.02469.x; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Doran DM, 2002, AM J PRIMATOL, V58, P91, DOI 10.1002/ajp.10053; Doran-Sheehy D, 2009, AM J PHYS ANTHROPOL, V140, P727, DOI 10.1002/ajpa.21118; Fraser D, 2011, J MORPHOL, V272, P1513, DOI 10.1002/jmor.11001; Galef B.G., 1976, ADV STUDY BEHAV VOL, V6, P77, DOI DOI 10.1016/S0065-3454(08)60082-0; Garner KJ, 1996, MOL PHYLOGENET EVOL, V6, P39, DOI 10.1006/mpev.1996.0056; Hirata S, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P487; Kendal RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006541; Kis A, 2015, ANIM COGN, V18, P325, DOI 10.1007/s10071-014-0803-7; Koops K, 2013, ANIM BEHAV, V85, P175, DOI 10.1016/j.anbehav.2012.10.022; Laland K. N., 2009, QUESTION ANIMAL CULT; Langergraber KE, 2011, P ROY SOC B-BIOL SCI, V278, P408, DOI 10.1098/rspb.2010.1112; LEFEBVRE L, 1995, BEHAV PROCESS, V34, P43, DOI 10.1016/0376-6357(94)00051-H; Lewis HM, 2012, PHILOS T R SOC B, V367, P2171, DOI 10.1098/rstb.2012.0119; Luncz LV, 2012, CURR BIOL, V22, P922, DOI 10.1016/j.cub.2012.03.031; Nakamichi M, 1998, FOLIA PRIMATOL, V69, P35, DOI 10.1159/000021561; Nkurunungi JB, 2004, AFR J ECOL, V42, P289, DOI 10.1111/j.1365-2028.2004.00523.x; Pradhan GR, 2012, J HUM EVOL, V63, P180, DOI 10.1016/j.jhevol.2012.04.008; Reindl E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01715-2; Reindl E, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2402; Robbins MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160483; Robbins MM, 2003, INT J PRIMATOL, V24, P467, DOI 10.1023/A:1023741328338; RUVOLO M, 1994, P NATL ACAD SCI USA, V91, P8900, DOI 10.1073/pnas.91.19.8900; Sarabian C, 2015, BIOL LETTERS, V11, P1; Sargent BL, 2009, QUESTION ANIMAL CULT, P152; Sommer V, 2016, ANIM COGN, V19, P245, DOI 10.1007/s10071-015-0903-z; Tennie C, 2008, AM J PRIMATOL, V70, P584, DOI 10.1002/ajp.20532; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; Terkel Joseph, 1996, P17, DOI 10.1016/B978-012273965-1/50003-0; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; Tomasello M, 1998, DEVELOPMENTAL SCI, V1, P1, DOI 10.1111/1467-7687.00002; Tomasello Michael, 1999, CULTURAL ORIGINS HUM; van de Waal E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035694; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; VISALBERGHI E, 1995, J COMP PSYCHOL, V109, P52, DOI 10.1037/0735-7036.109.1.52; WATTS DP, 1984, AM J PRIMATOL, V7, P323, DOI 10.1002/ajp.1350070403; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2000, COGNITIVE SCI, V24, P477; Wilson A.C., 1985, Scientific American, V253, P148	49	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188866	10.1371/journal.pone.0188866	http://dx.doi.org/10.1371/journal.pone.0188866			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO7EC	29200437	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000417033200017
J	Zhang, L; Du, HR; Zhao, YN; Wu, RW; Zhang, XL				Zhang, Lu; Du, Hongru; Zhao, Yannan; Wu, Rongwei; Zhang, Xiaolei			Urban networks among Chinese cities along "the Belt and Road": A case of web search activity in cyberspace	PLOS ONE			English	Article							WORLD CITY NETWORK; INTERCITY LINKAGES; INTERNET; GEOGRAPHY; TELECOMMUNICATIONS; BACKBONE	"The Belt and Road" initiative has been expected to facilitate interactions among numerous city centers. This initiative would generate a number of centers, both economic and political, which would facilitate greater interaction. To explore how information flows are merged and the specific opportunities that may be offered, Chinese cities along "the Belt and Road" are selected for a case study. Furthermore, urban networks in cyberspace have been characterized by their infrastructure orientation, which implies that there is a relative dearth of studies focusing on the investigation of urban hierarchies by capturing information flows between Chinese cities along "the Belt and Road". This paper employs Baidu, the main web search engine in China, to examine urban hierarchies. The results show that urban networks become more balanced, shifting from a polycentric to a homogenized pattern. Furthermore, cities in networks tend to have both a hierarchical system and a spatial concentration primarily in regions such as Beijing-Tianjin-Hebei, Yangtze River Delta and the Pearl River Delta region. Urban hierarchy based on web search activity does not follow the existing hierarchical system based on geospatial and economic development in all cases. Moreover, urban networks, under the framework of "the Belt and Road", show several significant corridors and more opportunities for more cities, particularly western cities. Furthermore, factors that may influence web search activity are explored. The results show that web search activity is significantly influenced by the economic gap, geographical proximity and administrative rank of the city.	[Zhang, Lu; Du, Hongru; Wu, Rongwei; Zhang, Xiaolei] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China; [Zhang, Lu] Univ Ghent, Dept Geog, Ghent, Belgium; [Zhang, Lu; Zhao, Yannan; Wu, Rongwei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Lu] Sinobelgian Joint Lab Geoinformat, Urumqi, Peoples R China; [Zhang, Lu] Sinobelgian Joint Lab Geoinformat, Ghent, Belgium; [Zhao, Yannan] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Ghent University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Du, HR; Zhang, XL (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China.	duhongru@sina.com; zhangxl@ms.xjb.ac.cn	; Zhang, Lu/C-4821-2019	zhao, Yan-nan/0000-0002-4717-5022; Zhang, Lu/0000-0001-9002-621X	Main Service Project 3 of Characteristic Institute, Chinese Academy of Sciences [TSS-2015-014-FW-3-3]	Main Service Project 3 of Characteristic Institute, Chinese Academy of Sciences	This research has received financial support by the Main Service Project 3 of Characteristic Institute, Chinese Academy of Sciences (TSS-2015-014-FW-3-3)	Adams PC, 1997, GEOGR REV, V87, P155, DOI 10.2307/216003; Allen J., 1999, CITIES POWER INFLUEN; Allen J, 2010, URBAN STUD, V47, P2895, DOI 10.1177/0042098010377364; [Anonymous], 2012, RISE NETWORK SOC, DOI DOI 10.1002/9781444319514; [Anonymous], 2014, TRADE TRANSPORT CORR; Batty M, 1997, FUTURES, V29, P337, DOI 10.1016/S0016-3287(97)00018-9; Batty M., 1990, EDITORIAL; Beaverstock J.V., 2002, GLOBAL NETW, V2, P111, DOI [10.1111/1471-0374.00031, DOI 10.1111/1471-0374.00031]; Boulton A., 2011, ICTS MOBILE UBIQUITO, P67, DOI 10.4018/978-1-60960-051-8.ch005; Burch H, 1999, COMPUTER, V32, P97, DOI 10.1109/2.755008; Castells M., 2001, RISE INFORM SOC; Choi JH, 2006, GLOBAL NETW, V6, P81, DOI 10.1111/j.1471-0374.2006.00134.x; CNNIC, STAT REP CHIN INT DE; Derudder B, 2005, URBAN STUD, V42, P2371, DOI 10.1080/00420980500379503; Derudder B, 2013, CHINESE GEOGR SCI, V23, P261, DOI 10.1007/s11769-013-0604-y; Devriendt L, 2008, J URBAN TECHNOL, V15, P5, DOI 10.1080/10630730802401926; Devriendt L, 2010, TELECOMMUN POLICY, V34, P417, DOI 10.1016/j.telpol.2010.05.009; Dicken P., 2001, GLOBAL NETW, V1, P89, DOI DOI 10.1111/1471-0374.00007; Grace J., 2004, INFORM COMMUNICATION; Graham S, 1999, URBAN STUD, V36, P929, DOI 10.1080/0042098993286; Greenstein S., 2007, MOTION IMAGING J SMP, V117, P32; Grubesic TH, 2005, TELECOMMUN POLICY, V29, P69, DOI 10.1016/j.telpol.2004.08.001; Grubesic TH, 2011, J TRANSP GEOGR, V19, P93, DOI 10.1016/j.jtrangeo.2009.12.006; Hillis K, 1998, PROG HUM GEOG, V22, P543, DOI 10.1191/030913298669028680; Jarv O, 2015, URBAN STUD, V52, P2680, DOI 10.1177/0042098014550459; Junde L., 2006, EC GEOGRAPHY, V6; Kellerman A, 1997, TELECOMMUN POLICY, V21, P553, DOI 10.1016/S0308-5961(97)00025-6; Liebelson D., 2014, MAP HERE ARE COUNTRI; Liu XJ, 2016, REG STUD, V50, P1302, DOI 10.1080/00343404.2015.1004535; Long M., 2011, AREAL RES DEV, V30, P93, DOI [10.3969/j.issn.1003-2363.2011.03.019, DOI 10.3969/J.ISSN.1003-2363.2011.03.019]; Lu LC, 2012, CHINESE GEOGR SCI, V22, P602, DOI 10.1007/s11769-012-0555-8; Malecki EJ, 2002, ECON GEOGR, V78, P399, DOI 10.2307/4140796; Moss ML, 1997, J URBAN TECHNOL, V4, P261; Nannan Z, 2002, HUMAN GEOGRAPHY, V17, P20; OTA M, 1993, REG SCI URBAN ECON, V23, P695, DOI 10.1016/0166-0462(93)90018-A; [潘峰华 Pan Fenghua], 2013, [地理学报, Acta Geographica Sinica], V68, P449; Pred A., 1977, CITY SYSTEMS ADV EC; Rutherford J, 2004, J URBAN TECHNOL, V11, P1, DOI 10.1080/10630730500064166; Short JR, 1996, INT J URBAN REGIONAL, V20, P697, DOI 10.1111/j.1468-2427.1996.tb00343.x; Summers T, 2016, THIRD WORLD Q, V37, P1628, DOI 10.1080/01436597.2016.1153415; Tao M., 2016, FEATURE CHINA BUILT; TAYLOR P.J., 2008, GAWC RES B, P1; Taylor PJ, 2009, ENVIRON PLANN A, V41, P2550, DOI 10.1068/a42235; Taylor PJ, 2002, URBAN STUD, V39, P2367, DOI 10.1080/00420980220080011; Terlouw K, 2011, GEOFORUM, V42, P578, DOI 10.1016/j.geoforum.2011.05.003; Tian S., 2016, SPOTLIGHT PUTIN EYES; Timberlake M, 2008, J AM PLANN ASSOC, V74, P384, DOI 10.1080/01944360802146410; Townsend AM, 2001, AM BEHAV SCI, V44, P1697, DOI 10.1177/00027640121957998; Vijver EVD, 2016, PROMET D TRAFFIC D T, V28; Wall R, 2009, NETSCAPE CITIES GLOB; Wheeler DC, 1999, PROF GEOGR, V51, P327, DOI 10.1111/0033-0124.00169; Williams J.F., 2004, ASIAN GEOGR, V23, P121, DOI [10.1080/10225706.2004.9684116, DOI 10.1080/10225706.2004.9684116]; [赵映慧 Zhao Yinghui], 2017, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V31, P51; [钟业喜 ZHONG Yexi], 2011, [地理研究, Geographical Research], V30, P785; Zook M, 2006, ANNU REV INFORM SCI, V40, P53, DOI 10.1002/aris.1440400109; Zook MA, 2001, AM BEHAV SCI, V44, P1679, DOI 10.1177/00027640121958113	56	12	14	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188868	10.1371/journal.pone.0188868	http://dx.doi.org/10.1371/journal.pone.0188868			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO7EC	29200421	Green Submitted, gold, Green Published			2022-12-27	WOS:000417033200018
J	Ortega-Moreno, L; Giraldez, BG; Soto-Insuga, V; Losada-Del Pozo, R; Rodrigo-Moreno, M; Alarcon-Morcillo, C; Sanchez-Martin, G; Diaz-Gomez, E; Guerrero-Lopez, R; Serratosa, JAM				Ortega-Moreno, Laura; Giraldez, Beatriz G.; Soto-Insuga, Victor; Losada-Del Pozo, Rebeca; Rodrigo-Moreno, Maria; Alarcon-Morcillo, Cristina; Sanchez-Martin, Gema; Diaz-Gomez, Esther; Guerrero-Lopez, Rosa; Serratosa, Jose A. M.		Grp Espanol Genetica Epilepsias	Molecular diagnosis of patients with epilepsy and developmental delay using a customized panel of epilepsy genes	PLOS ONE			English	Article							DE-NOVO MUTATIONS; DNA-SEQUENCING DATA; INFANTILE SPASMS; MENTAL-RETARDATION; CLINICAL-PRACTICE; ENCEPHALOPATHY; GENETICS; DISORDERS; PHENOTYPE; SEIZURES	Pediatric epilepsies are a group of disorders with a broad phenotypic spectrum that are associated with great genetic heterogeneity, thus making sequential single-gene testing an impractical basis for diagnostic strategy. The advent of next-generation sequencing has increased the success rate of epilepsy diagnosis, and targeted resequencing using genetic panels is the a most cost-effective choice. We report the results found in a group of 87 patients with epilepsy and developmental delay using targeted next generation sequencing (custom-designed Haloplex panel). Using this gene panel, we were able to identify disease-causing variants in 17 out of 87 (19.5%) analyzed patients, all found in known epilepsyassociated genes (KCNQ2, CDKL5, STXBP1, SCN1A, PCDH19, POLG, SLC2A1, ARX, ALG13, CHD2, SYNGAP1, and GRIN1). Twelve of 18 variants arose de novo and 6 were novel. The highest yield was found in patients with onset in the first years of life, especially in patients classified as having early-onset epileptic encephalopathy. Knowledge of the underlying genetic cause provides essential information on prognosis and could be used to avoid unnecessary studies, which may result in a greater diagnostic cost-effectiveness.	[Ortega-Moreno, Laura; Giraldez, Beatriz G.; Alarcon-Morcillo, Cristina; Sanchez-Martin, Gema; Diaz-Gomez, Esther; Guerrero-Lopez, Rosa; Serratosa, Jose A. M.] UAM, IIS Fdn Jimenez Diaz, Dept Neurol, Epilepsy Unit, Madrid, Spain; [Ortega-Moreno, Laura; Giraldez, Beatriz G.; Alarcon-Morcillo, Cristina; Sanchez-Martin, Gema; Diaz-Gomez, Esther; Guerrero-Lopez, Rosa; Serratosa, Jose A. M.] UAM, IIS Fdn Jimenez Diaz, Dept Neurol, Neurol Lab, Madrid, Spain; [Ortega-Moreno, Laura; Giraldez, Beatriz G.; Alarcon-Morcillo, Cristina; Sanchez-Martin, Gema; Diaz-Gomez, Esther; Guerrero-Lopez, Rosa; Serratosa, Jose A. M.] CIBERER, Madrid, Spain; [Soto-Insuga, Victor; Losada-Del Pozo, Rebeca; Rodrigo-Moreno, Maria] UAM, Hosp Univ Fdn Jimenez Diaz, Dept Pediat, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Autonomous University of Madrid	Guerrero-Lopez, R; Serratosa, JAM (corresponding author), UAM, IIS Fdn Jimenez Diaz, Dept Neurol, Epilepsy Unit, Madrid, Spain.; Guerrero-Lopez, R; Serratosa, JAM (corresponding author), UAM, IIS Fdn Jimenez Diaz, Dept Neurol, Neurol Lab, Madrid, Spain.; Guerrero-Lopez, R; Serratosa, JAM (corresponding author), CIBERER, Madrid, Spain.	rguerrero@fjd.es; jmserratosa@me.com		Gil-Nagel MD PhD, Antonio/0000-0003-4515-0793; Serratosa, Jose/0000-0003-2239-8948	Ministerio de Economia y Competitividad [SAF2010-18586, SAF2013-48960-P]; Fundacion Conchita Rabago de Jimenez Diaz; Centro de Investigacion Biomedica en Red de Enfermedades Raras	Ministerio de Economia y Competitividad(Spanish Government); Fundacion Conchita Rabago de Jimenez Diaz; Centro de Investigacion Biomedica en Red de Enfermedades Raras	This work was supported by the Ministerio de Economia y Competitividad (SAF2010-18586 and SAF2013-48960-P) to GSM, LOM (www.mineco.gob.es); Fundacion Conchita Rabago de Jimenez Diaz (www.fundamonconchitarabago.net) to LOM and Centro de Investigacion Biomedica en Red de Enfermedades Raras (www.ciberer.es) to RGL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Allen NM, 2016, EPILEPSIA, V57, pE12, DOI 10.1111/epi.13250; Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Ataman ZA, 2007, STRUCTURE, V15, P1603, DOI 10.1016/j.str.2007.10.012; Bahi-Buisson N, 2012, AM J MED GENET A, V158A, P1612, DOI 10.1002/ajmg.a.35401; Baulac S, 1999, AM J HUM GENET, V65, P1078, DOI 10.1086/302593; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Berkovic S, 2012, EPILEPSIA, V53, P1457, DOI 10.1111/j.1528-1167.2012.03511.x; Capelli LP, 2012, EUR J MED GENET, V55, P132, DOI 10.1016/j.ejmg.2011.10.004; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Coll M, 2016, INT J LEGAL MED, V130, P331, DOI 10.1007/s00414-015-1269-0; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cornford EM, 1998, J CEREBR BLOOD F MET, V18, P26, DOI 10.1097/00004647-199801000-00003; Della Mina E, 2015, EUR J HUM GENET, V23, P354, DOI 10.1038/ejhg.2014.92; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dibbens LM, 2008, NAT GENET, V40, P776, DOI 10.1038/ng.149; Dimassi S, 2016, CLIN GENET, V89, P198, DOI 10.1111/cge.12636; Ding YX, 2010, DEV MED CHILD NEUROL, V52, P1028, DOI 10.1111/j.1469-8749.2010.03746.x; Dolk H, 2016, NEUROLOGY, V86, P1716, DOI 10.1212/WNL.0000000000002540; Dulac O, 2001, EPILEPSIA, V42, P23, DOI 10.1046/j.1528-1157.2001.042suppl.3023.x; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Gursoy S, 2016, J CHILD NEUROL, V31, P523, DOI 10.1177/0883073815599262; Hata Y, 2016, BRAIN PATHOL; Helbig KL, 2016, GENETICS MED OFFICIA; Hildebrand MS, 2016, NEUROLOGY, V86, P1605, DOI 10.1212/WNL.0000000000002608; Hildebrand MS, 2013, J MED GENET, V50, P271, DOI 10.1136/jmedgenet-2012-101448; Hirose S, 2013, EPILEPSIA, V54, P946, DOI 10.1111/epi.12168; Holland KD, 2010, NEUROLOGY, V75, P1132, DOI 10.1212/WNL.0b013e3181f6bc97; Kalscheuer VM, 2003, AM J HUM GENET, V72, P1401, DOI 10.1086/375538; Kobayashi Y, 2016, BRAIN DEV-JPN, V38, P285, DOI 10.1016/j.braindev.2015.09.011; Kodera H, 2013, EPILEPSIA, V54, P1262, DOI 10.1111/epi.12203; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kwong AKY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126446; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Lemke JR, 2016, NEUROLOGY; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marini C, 2012, EPILEPSIA, V53, P2111, DOI 10.1111/j.1528-1167.2012.03649.x; Marth G, 2012, ARXIV12073907V2; Martin HC, 2014, HUM MOL GENET, V23, P3200, DOI 10.1093/hmg/ddu030; Mastrangelo M, 2012, PEDIATR NEUROL, V46, P24, DOI 10.1016/j.pediatrneurol.2011.11.003; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mercimek-Mahmutoglu S, 2015, EPILEPSIA, V56, P707, DOI 10.1111/epi.12954; Michaud JL, 2014, HUM MOL GENET, V23, P4846, DOI 10.1093/hmg/ddu199; Moller RS, 2016, MOL SYNDROMOL, V7, P210, DOI 10.1159/000448369; Orsini A, 2017, NEUROSCIENCE LETT; Ottman R, 2010, EPILEPSIA, V51, P655, DOI 10.1111/j.1528-1167.2009.02429.x; Parrini E, 2016, HUMAN MUTATION; Poduri A, 2014, NAT REV NEUROL, V10, P293, DOI 10.1038/nrneurol.2014.60; Pong AW, 2011, PEDIATR NEUROL, V44, P317, DOI 10.1016/j.pediatrneurol.2011.01.017; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robinson PN, 2014, GENOME RES, V24, P340, DOI 10.1101/gr.160325.113; Romaniello R, 2015, NEUROREPORT, V26, P254, DOI 10.1097/WNR.0000000000000337; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; Saitsu H, 2010, EPILEPSIA, V51, P2397, DOI 10.1111/j.1528-1167.2010.02728.x; Scheffer IE, 2014, NEUROPEDIATRICS, V45, P70, DOI 10.1055/s-0034-1371508; Scheffer IE, 2011, EPILEPSY CURR, V11, P107, DOI 10.5698/1535-7511-11.4.107; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Striano P, 2016, PHARMACOL RES, V107, P426, DOI 10.1016/j.phrs.2016.04.006; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Joseph DSAB, 2017, CURR OPIN NEUROL, V30, P193, DOI 10.1097/WCO.0000000000000433; Thomas RH, 2014, NAT REV NEUROL, V10, P283, DOI 10.1038/nrneurol.2014.62; Trump N, 2016, J MED GENETICS; Tuchman R, 2009, BRAIN DEV-JPN, V31, P95, DOI 10.1016/j.braindev.2008.09.009; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65; van Harssel JJT, 2013, NEUROGENETICS, V14, P23, DOI 10.1007/s10048-013-0353-1; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201; Wang J, 2017, SEIZURE-EUR J EPILEP, V44, P11, DOI 10.1016/j.seizure.2016.11.030; Weber YG, 2017, EXPERT REV MOL DIAGN, V17, P739, DOI 10.1080/14737159.2017.1335598; Weckhuysen S, 2013, NEUROLOGY, V81, P1697, DOI 10.1212/01.wnl.0000435296.72400.a1; Zollino M, 2011, EUR J HUM GENET, V19, P239, DOI 10.1038/ejhg.2010.172	74	45	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188978	10.1371/journal.pone.0188978	http://dx.doi.org/10.1371/journal.pone.0188978			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190809	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900182
J	Eigenbrod, S; Frick, P; Bertsch, U; Mitteregger-Kretzschmar, G; Mielke, J; Maringer, M; Piening, N; Hepp, A; Daude, N; Windl, O; Levin, J; Giese, A; Sakthivelu, V; Tatzelt, J; Kretzschmar, H; Westaway, D				Eigenbrod, Sabina; Frick, Petra; Bertsch, Uwe; Mitteregger-Kretzschmar, Gerda; Mielke, Janina; Maringer, Marko; Piening, Niklas; Hepp, Alexander; Daude, Nathalie; Windl, Otto; Levin, Johannes; Giese, Armin; Sakthivelu, Vignesh; Tatzelt, Joerg; Kretzschmar, Hans; Westaway, David			Substitutions of PrP N-terminal histidine residues modulate scrapie disease pathogenesis and incubation time in transgenic mice	PLOS ONE			English	Article							CELLULAR PRION PROTEIN; CREUTZFELDT-JAKOB-DISEASE; OCTAREPEAT REGION; COPPER-BINDING; FULL-LENGTH; BETA-CLEAVAGE; IN-VITRO; AMINO-TERMINUS; INFECTED MICE; REPEAT REGION	Prion diseases have been linked to impaired copper homeostasis and copper induced-oxidative damage to the brain. Divalent metal ions, such as Cu2+ and Zn2+, bind to cellular prion protein (PrPC) at octapeptide repeat (OR) and non-OR sites within the N-terminal half of the protein but information on the impact of such binding on conversion to the misfolded isoform often derives from studies using either OR and non-OR peptides or bacterially-expressed recombinant PrP. Here we created new transgenic mouse lines expressing PrP with disrupted copper binding sites within all four histidine-containing OR's (sites 1-4, H60G, H68G, H76G, H84G, "TetraH>G" allele) or at site 5 (composed of residues His-95 and His-110; "H95G" allele) and monitored the formation of misfolded PrP in vivo. Novel transgenic mice expressing PrP(TetraH>G) at levels comparable to wild-type (wt) controls were susceptible to mouse-adapted scrapie strain RML but showed significantly prolonged incubation times. In contrast, amino acid replacement at residue 95 accelerated disease progression in corresponding PrP(H95G) mice. Neuropathological lesions in terminally ill transgenic mice were similar to scrapie-infected wt controls, but less severe. The pattern of PrPSc deposition, however, was not synaptic as seen in wt animals, but instead dense globular plaque-like accumulations of PrPSc in TgPrP (TetraH>G) mice and diffuse PrPSc deposition in (TgPrP(H95G) mice), were observed throughout all brain sections. We conclude that OR and site 5 histidine substitutions have divergent phenotypic impacts and that cis interactions between the OR region and the site 5 region modulate pathogenic outcomes by affecting the PrP globular domain.	[Eigenbrod, Sabina; Frick, Petra; Bertsch, Uwe; Mitteregger-Kretzschmar, Gerda; Mielke, Janina; Maringer, Marko; Piening, Niklas; Hepp, Alexander; Windl, Otto; Levin, Johannes; Giese, Armin; Kretzschmar, Hans] Ludwig Maximilians Univ Munchen, Ctr Neuropathol & Prion Res, Munich, Germany; [Daude, Nathalie; Westaway, David] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Sakthivelu, Vignesh; Tatzelt, Joerg] Ludwig Maximilians Univ Munchen, Dept Metab Biochem Neurobiochem, Adolf Butenandt Inst, Munich, Germany; [Eigenbrod, Sabina] Servier Deutschland GmbH, Munich, Germany; [Frick, Petra] German Ctr Neurodegenerat Dis, Tubingen, Germany; [Bertsch, Uwe] Louisenlund Sch, Guby, Germany; [Maringer, Marko] MFD Diagnost GmbH, Wendelsheim, Germany; [Piening, Niklas] BASF SE, Ludwigshafen, Germany; [Hepp, Alexander] Klenze Secondary Sch Munich, Munich, Germany; [Levin, Johannes] Univ Hosp Munich, Dept Neurol, Munich, Germany; [Sakthivelu, Vignesh] Univ Cologne, Cluster Excellence Cellular Stress Responses Agin, Cologne, Germany; [Tatzelt, Joerg] Ruhr Univ Bochum, Dept Biochem Neurodegenerat Dis, Bochum, Germany	University of Munich; University of Alberta; University of Munich; Servier; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); BASF; University of Munich; University of Cologne; Ruhr University Bochum	Frick, P (corresponding author), Ludwig Maximilians Univ Munchen, Ctr Neuropathol & Prion Res, Munich, Germany.; Frick, P (corresponding author), German Ctr Neurodegenerat Dis, Tubingen, Germany.	petra.frick@dzne.de	Giese, Armin/F-3271-2010; Levin, Johannes/E-4052-2010; Hepp, Alexander/M-7731-2016	Giese, Armin/0000-0002-8238-4102; Levin, Johannes/0000-0001-5092-4306; Hepp, Alexander/0000-0003-1288-925X; Tatzelt, Jorg/0000-0001-5017-5528	State of Bavaria (ForPrion grants) [LMU2, LMU9]; German Research Foundation [TA 167/6]	State of Bavaria (ForPrion grants); German Research Foundation(German Research Foundation (DFG))	This work was supported by grants from the State of Bavaria (ForPrion grants LMU2 and LMU9) and German Research Foundation (TA 167/6) to JT. The funder provided support in the form of salaries for authors (SE, PF, UB, MM, AH, NP, AG, JM, GM, OW), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bocharova OV, 2005, BIOCHEMISTRY-US, V44, P6776, DOI 10.1021/bi050251q; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; BRUCE ME, 1985, J NEUROPATH EXP NEUR, V44, P285, DOI 10.1097/00005072-198505000-00006; Bruce ME, 2002, J GEN VIROL, V83, P695, DOI 10.1099/0022-1317-83-3-695; BRUCE ME, 1996, PRION DIS, P223; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Burns CS, 2003, BIOCHEMISTRY-US, V42, P6794, DOI 10.1021/bi027138+; CARLSON GA, 1986, CLIN RES, V34, pA675; Caughey B, 1999, METHOD ENZYMOL, V309, P122; Chattopadhyay M, 2005, J AM CHEM SOC, V127, P12647, DOI 10.1021/ja053254z; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Cox DL, 2006, BIOPHYS J, V91, pL11, DOI 10.1529/biophysj.106.083642; Croes EA, 2004, J NEUROL NEUROSUR PS, V75, P1166, DOI 10.1136/jnnp.2003.020198; DICKINSON AG, 1971, MOL GEN GENET, V112, P73, DOI 10.1007/BF00266934; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Evans EGB, 2016, STRUCTURE, V24, P1057, DOI 10.1016/j.str.2016.04.017; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Frankenfield KN, 2005, PROTEIN SCI, V14, P2154, DOI 10.1110/ps.051434005; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; FRASER H, 1967, NATURE, V216, P1310, DOI 10.1038/2161310a0; Giachin G, 2015, SCI REP-UK, V5, DOI 10.1038/srep15253; Giese A, 2004, BIOCHEM BIOPH RES CO, V320, P1240, DOI 10.1016/j.bbrc.2004.06.075; GOLDFARB LG, 1991, P NATL ACAD SCI USA, V88, P10926, DOI 10.1073/pnas.88.23.10926; Haigh CL, 2005, MOL CELL NEUROSCI, V30, P186, DOI 10.1016/j.mcn.2005.07.001; Hijazi N, 2003, BRAIN RES, V993, P192, DOI 10.1016/j.brainres.2003.09.014; Hodak M, 2009, P NATL ACAD SCI USA, V106, P11576, DOI 10.1073/pnas.0903807106; HOPE J, 1986, EMBO J, V5, P2591, DOI 10.1002/j.1460-2075.1986.tb04539.x; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Jansen K, 2001, BIOL CHEM, V382, P683, DOI 10.1515/BC.2001.081; Klewpatinond M, 2008, J BIOL CHEM, V283, P1870, DOI 10.1074/jbc.M708472200; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Kong Qingzhong, 2004, VVolume 41, P673; KRASEMANN S, 1995, MOL BRAIN RES, V34, P173, DOI 10.1016/0169-328X(95)00175-R; Lau A, 2015, EMBO MOL MED, V7, P339, DOI 10.15252/emmm.201404588; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leliveld SR, 2008, BIOCHEMISTRY-US, V47, P6267, DOI 10.1021/bi800253c; Leliveld SR, 2006, J BIOL CHEM, V281, P3268, DOI 10.1074/jbc.M510606200; Malaise M, 2008, FREE RADICAL BIO MED, V45, P1622, DOI 10.1016/j.freeradbiomed.2008.08.024; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; MCCARTHY K, 1963, LANCET, V2, P593; McDonald AJ, 2014, J BIOL CHEM, V289, P803, DOI 10.1074/jbc.M113.502351; McMahon HEM, 2001, J BIOL CHEM, V276, P2286, DOI 10.1074/jbc.M007243200; Mitteregger G, 2007, BRAIN PATHOL, V17, P174, DOI 10.1111/j.1750-3639.2007.00061.x; Miura T, 1996, FEBS LETT, V396, P248, DOI 10.1016/0014-5793(96)01104-0; Moore RC, 1998, NAT GENET, V18, P118, DOI 10.1038/ng0298-118; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Piening N, 2006, J BIOL CHEM, V281, P9373, DOI 10.1074/jbc.M512239200; Post K, 1998, BIOL CHEM, V379, P1307, DOI 10.1515/bchm.1998.379.11.1307; PRUSINER SB, 1986, BIOESSAYS, V5, P281, DOI 10.1002/bies.950050612; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Pushie MJ, 2008, BIOPHYS J, V95, P5084, DOI 10.1529/biophysj.108.139568; Pushie MJ, 2011, METALLOMICS, V3, P206, DOI 10.1039/c0mt00037j; Pushie MJ, 2009, J TOXICOL ENV HEAL A, V72, P1040, DOI 10.1080/15287390903084389; Redecke L, 2007, J STRUCT BIOL, V157, P308, DOI 10.1016/j.jsb.2006.06.013; Requena JR, 2001, P NATL ACAD SCI USA, V98, P7170, DOI 10.1073/pnas.121190898; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Ruiz FH, 2000, BIOCHEM BIOPH RES CO, V269, P491, DOI 10.1006/bbrc.2000.2270; Schulz-Schaeffer WJ, 2000, AM J PATHOL, V156, P51, DOI 10.1016/S0002-9440(10)64705-0; Sigurdsson EM, 2003, J BIOL CHEM, V278, P46199, DOI 10.1074/jbc.C300303200; Solomon IH, 2010, CURR ISSUES MOL BIOL, V12, P51; Spevacek AR, 2013, STRUCTURE, V21, P236, DOI 10.1016/j.str.2012.12.002; Stevens DJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000390; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Thackray AM, 2002, BIOCHEM J, V362, P253, DOI 10.1042/0264-6021:3620253; Thakur AK, 2011, J BIOL CHEM, V286, P38533, DOI 10.1074/jbc.M111.265645; Thompsett AR, 2005, J BIOL CHEM, V280, P42750, DOI 10.1074/jbc.M506521200; Walter ED, 2009, CURR PROTEIN PEPT SC, V10, P529, DOI 10.2174/138920309789352056; Watt NT, 2005, J BIOL CHEM, V280, P35914, DOI 10.1074/jbc.M507327200; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; Wong BS, 2001, J NEUROCHEM, V79, P689, DOI 10.1046/j.1471-4159.2001.00625.x; Wong BS, 2001, J NEUROCHEM, V78, P1400, DOI 10.1046/j.1471-4159.2001.00522.x; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004; Xu K, 2011, J MOL NEUROSCI, V43, P225, DOI 10.1007/s12031-010-9387-0; Yamamoto N, 2009, J BIOL INORG CHEM, V14, P1209, DOI 10.1007/s00775-009-0564-y; Yen CF, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600014; Yin SM, 2007, P NATL ACAD SCI USA, V104, P7546, DOI 10.1073/pnas.0610827104; Yu SL, 2008, FEBS J, V275, P5564, DOI 10.1111/j.1742-4658.2008.06680.x	79	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188989	10.1371/journal.pone.0188989	http://dx.doi.org/10.1371/journal.pone.0188989			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220360	Green Published, Green Submitted, gold			2022-12-27	WOS:000417469900024
J	Glass, DG; McAlinden, N; Millington, OR; Wright, AJ				Glass, David G.; McAlinden, Niall; Millington, Owain R.; Wright, Amanda J.			A minimally invasive optical trapping system to understand cellular interactions at onset of an immune response	PLOS ONE			English	Article							DENDRITIC CELLS; T-CELLS; INTERACTION FORCES; ACTIVATION; TWEEZERS; KINASE; PHASE	T-cells and antigen presenting cells are an essential part of the adaptive immune response system and how they interact is crucial in how the body effectively fights infection or responds to vaccines. Much of the experimental work studying interaction forces between cells has looked at the average properties of bulk samples of cells or applied microscopy to image the dynamic contact between these cells. In this paper we present a novel optical trapping technique for interrogating the force of this interaction and measuring relative interaction forces at the single-cell level. A triple-spot optical trap is used to directly manipulate the cells of interest without introducing foreign bodies such as beads to the system. The optical trap is used to directly control the initiation of cell-cell contact and, subsequently to terminate the interaction at a defined time point. The laser beam power required to separate immune cell pairs is determined and correlates with the force applied by the optical trap. As proof of concept, the antigen-specific increase in interaction force between a dendritic cell and a specific T-cell is demonstrated. Furthermore, it is demonstrated that this interaction force is completely abrogated when T-cell signalling is blocked. As a result the potential of using optical trapping to interrogate cellular interactions at the single cell level without the need to introduce foreign bodies such as beads is clearly demonstrated.	[Glass, David G.; McAlinden, Niall] Univ Strathclyde, Inst Photon, SUPA, Glasgow, Lanark, Scotland; [Glass, David G.; Millington, Owain R.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Wright, Amanda J.] Univ Nottingham, Dept Elect & Elect Engn, Opt & Photon Grp, Nottingham, England	University of Strathclyde; University of Strathclyde; University of Nottingham	Wright, AJ (corresponding author), Univ Nottingham, Dept Elect & Elect Engn, Opt & Photon Grp, Nottingham, England.	amanda.wright@nottingham.ac.uk	McAlinden, Niall/AAM-9767-2021	McAlinden, Niall/0000-0002-0369-8788; Wright, Amanda/0000-0002-4866-5699	EPSRC [EP/H024891/1]; Engineering and Physical Sciences Research Council [EP/H024891/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by EPSRC, https://www.epsc.ac.uk/, EP/H024891/1.	Addae-Mensah KA, 2008, EXP BIOL MED, V233, P792, DOI 10.3181/0710-MR-278; Andersson M, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2752606; Anvari B, 2004, J BIOMED OPT, V9, P865, DOI 10.1117/1.1778178; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; Bowman RW, 2014, COMPUT PHYS COMMUN, V185, P268, DOI 10.1016/j.cpc.2013.08.008; Curtis JE, 2002, OPT COMMUN, V207, P169, DOI 10.1016/S0030-4018(02)01524-9; Dumont FJ, 1998, J IMMUNOL, V160, P2579; Hoffmann S, 2011, IMMUNOL LETT, V136, P13, DOI 10.1016/j.imlet.2010.11.005; Hosseini BH, 2009, P NATL ACAD SCI USA, V106, P17852, DOI 10.1073/pnas.0905384106; Husson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019680; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Koike T, 2003, J BIOL CHEM, V278, P15685, DOI 10.1074/jbc.M210829200; Lim TS, 2011, J IMMUNOL, V187, P258, DOI 10.4049/jimmunol.1100267; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maklygin AY, 2012, QUANTUM ELECTRON+, V42, P500, DOI 10.1070/QE2012v042n06ABEH014886; McAlinden N, 2014, BIOMED OPT EXPRESS, V5, P1026, DOI 10.1364/BOE.5.001026; McAlinden N, 2011, PROC SPIE, V8097, DOI 10.1117/12.895232; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Millington OR, 2007, PLOS PATHOG, V3, P1380, DOI 10.1371/journal.ppat.0030143; Morrison VL, 2014, NATURE COMMUNICATION, V5, P1; Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; O'Garra A, 2011, NAT IMMUNOL, V12, P288, DOI 10.1038/ni.2003; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Oddos S, 2008, BIOPHYS J, V95, pL66, DOI 10.1529/biophysj.108.143198; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Rush CM, 2009, IMMUNOLOGY, V128, P463, DOI 10.1111/j.1365-2567.2009.03124.x; SEEGER S, 1991, CYTOMETRY, V12, P497, DOI 10.1002/cyto.990120606; Simmons RM, 1996, BIOPHYS J, V70, P1813, DOI 10.1016/S0006-3495(96)79746-1; Tam JM, 2010, CONTROL MANIPULATION, V5, P15251; Wei SH, 2007, J IMMUNOL, V179, P1586, DOI 10.4049/jimmunol.179.3.1586; Wei XB, 1999, P NATL ACAD SCI USA, V96, P8471, DOI 10.1073/pnas.96.15.8471; Wei XB, 2000, CELL IMMUNOL, V201, P6, DOI 10.1006/cimm.2000.1637; Wright AJ, 2003, J MOD OPTIC, V50, P1521, DOI 10.1080/0950034021000036232; Wright AJ, 2011, P SOC PHOTO-OPT INS, V8097; Zhang H, 2008, J R SOC INTERFACE, V5, P671, DOI 10.1098/rsif.2008.0052	39	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188581	10.1371/journal.pone.0188581	http://dx.doi.org/10.1371/journal.pone.0188581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220398	Green Published, Green Accepted, gold			2022-12-27	WOS:000417469900011
J	Rathleff, MS; Rathleff, CR; Stephenson, A; Mellor, R; Matthews, M; Crossley, K; Vicenzino, B				Rathleff, Michael Skovdal; Rathleff, Camilla Rams; Stephenson, Aoife; Mellor, Rebecca; Matthews, Mark; Crossley, Kay; Vicenzino, Bill			Adults with patellofemoral pain do not exhibit manifestations of peripheral and central sensitization when compared to healthy pain-free age and sex matched controls - An assessor blinded cross-sectional study	PLOS ONE			English	Article							KNEE PAIN; MODULATION; OSTEOARTHRITIS; ADOLESCENCE; MECHANISMS; FEMALES	Patellofemoral Pain (PFP) is highly prevalent among adults and adolescents. Localized mechanical hyperalgesia around the knee and tibialis anterior have been observed in people with PFP, but limited knowledge of potential manifestations of central sensitisation exists. The aims of this study were to study conditioned pain modulation (CPM) and wide-spread hyperalgesia in adults with PFP. This assessor-blinded cross-sectional study design compared CPM and mechanical pressure pain thresholds (PPT) between 33 adults (23 females) diagnosed with PFP and 32 age and sex matched pain-free controls. The investigator taking the PPT measurements was blinded to which participants had PFP. PPTs were reliably measured using a Somedic hand-held pressure algometer at three sites: 1) The centre of the patella, 2) the tibialis anterior muscle and 3) a remote site on the lateral epicondyle. For the assessment of CPM, experimental pain was induced to the contralateral hand by immersion into a cold water bath (conditioning stimulus), and assessment of PPTs (the test stimulus) was performed before and immediately after the conditioning stimulation. On average, the CPM paradigm induced a significant increase in PPTs across the three sites (6.3-13.5%, P<0.05), however there was no difference in CPM between young adults with PFP compared to the control group, (F(1,189) = 0.39, P = 0.89). There was no difference in mechanical PPTs between the two groups (F(1,189) = 0.03, P = 0.86). Contrary to our a-priori hypothesis, we found no difference in CPM or PPT between young adults with PFP and age and sex matched pain-free controls.	[Rathleff, Michael Skovdal] Aalborg Univ, Res Unit Gen Practice Aalborg, Dept Clin Med, Aalborg, Denmark; [Rathleff, Michael Skovdal; Rathleff, Camilla Rams] Aalborg Univ Hosp, Orthopaed Surg Res Unit, Aalborg, Denmark; [Stephenson, Aoife; Mellor, Rebecca; Matthews, Mark; Crossley, Kay; Vicenzino, Bill] Univ Queensland, Sch Hlth & Rehabil Sci Physiotherapy, Brisbane, Qld, Australia; [Crossley, Kay] La Trobe Univ, Coll Sci Hlth & Engn, Bundoora, Vic, Australia	Aalborg University; Aalborg University; Aalborg University Hospital; University of Queensland; La Trobe University	Rathleff, MS (corresponding author), Aalborg Univ, Res Unit Gen Practice Aalborg, Dept Clin Med, Aalborg, Denmark.; Rathleff, MS (corresponding author), Aalborg Univ Hosp, Orthopaed Surg Res Unit, Aalborg, Denmark.	misr@hst.aau.dk	Mellor, Rebecca/A-1363-2011; Vicenzino, Bill/A-8492-2011; Mellor, Rebecca/N-1502-2019	Vicenzino, Bill/0000-0003-0253-5933; Mellor, Rebecca/0000-0001-8198-5291; Crossley, Kay/0000-0001-5892-129X; Stephenson, Aoife/0000-0001-8766-5272; Rathleff, Michael Skovdal/0000-0003-1173-0335				Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Boudreau SA, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1521-5; Collins N, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1735; Crossley KM, 2016, BRIT J SPORT MED, V50, P839, DOI 10.1136/bjsports-2016-096384; de Lalouviere LL, 2014, NAT REV RHEUMATOL, V10, P205, DOI 10.1038/nrrheum.2014.4; Granovsky Y, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0361-8; Graven-Nielsen T, 2012, ARTHRITIS RHEUM-US, V64, P2907, DOI 10.1002/art.34466; Graven-Nielsen T, 2010, NAT REV RHEUMATOL, V6, P599, DOI 10.1038/nrrheum.2010.107; Kosek E, 2000, PAIN, V88, P69, DOI 10.1016/S0304-3959(00)00310-9; KUJALA UM, 1993, ARTHROSCOPY, V9, P159, DOI 10.1016/S0749-8063(05)80366-4; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Lewis GN, 2012, J PAIN, V13, P936, DOI 10.1016/j.jpain.2012.07.005; Liao TC, 2015, MED SCI SPORT EXER, V47, P1775, DOI 10.1249/MSS.0000000000000617; Maclachlan LR, 2017, BRIT J SPORT MED, V51, P732, DOI 10.1136/bjsports-2016-096705; Molgaard C, 2011, J AM PODIAT MED ASSN, V101, P215, DOI 10.7547/1010215; Noehren B, 2016, CLIN J PAIN, V32, P915, DOI 10.1097/AJP.0000000000000331; Oono Y, 2011, SCAND J PAIN, V2, P162, DOI 10.1016/j.sjpain.2011.05.006; Rathleff MS, 2015, SPORTS MED, V45, P1489, DOI 10.1007/s40279-015-0364-1; Rathleff MS, 2015, BRIT J SPORT MED, V49, P406, DOI 10.1136/bjsports-2014-093929; Rathleff MS, 2016, AM J SPORT MED, V44, P1165, DOI 10.1177/0363546515622456; Rathleff MS, 2013, J ORTHOP SPORT PHYS, V43, P414, DOI 10.2519/jospt.2013.4383; Rathleff MS, 2016, PAIN MED, V17, P980, DOI 10.1093/pm/pnv017; Thompson LR, 2009, ARTHRIT RHEUM-ARTHR, V61, P725, DOI 10.1002/art.24543; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Witvrouw E, 2000, AM J SPORT MED, V28, P480, DOI 10.1177/03635465000280040701; Wood Laurence, 2011, Prim Health Care Res Dev, V12, P157, DOI 10.1017/S1463423610000460	26	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188930	10.1371/journal.pone.0188930	http://dx.doi.org/10.1371/journal.pone.0188930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220355	gold, Green Published			2022-12-27	WOS:000417469900021
J	Canche-Pech, JR; Conde-Ferraez, L; Puerto-Solis, M; Gonzalez-Losa, R; Granja-Perez, P; Villanueva-Jorge, S; Chan-Gasca, M; Gomez-Carballo, J; Lopez-Ochoa, L; Jimenez-Delgadillo, B; Rodriguez-Sanchez, I; Ramirez-Prado, J; Ayora-Talavera, G				Reyes Canche-Pech, Jose; Conde-Ferraez, Laura; Puerto-Solis, Marylin; Gonzalez-Losa, Refugio; Granja-Perez, Pilar; Villanueva-Jorge, Salha; Chan-Gasca, Maria; Gomez-Carballo, Jesus; Lopez-Ochoa, Luisa; Jimenez-Delgadillo, Bertha; Rodriguez-Sanchez, Iram; Ramirez-Prado, Jorge; Ayora-Talavera, Guadalupe			Temporal distribution and genetic variants in influenza A(H1N1)pdm09 virus circulating in Mexico, seasons 2012 and 2013	PLOS ONE			English	Article							A/H1N1 INFLUENZA; WINTER 2013-2014; ANTIGENIC SITES; H1N1 2009; HEMAGGLUTININ; EVOLUTION; NEURAMINIDASE; EPIDEMIOLOGY; ANTIBODY	The 2012 and 2013 annual influenza epidemics in Mexico were characterized by presenting different seasonal patterns. In 2012 the A(H1N1)pdm09 virus caused a high incidence of influenza infections after a two-year period of low circulation; whereas the 2013 epidemic presented circulation of the A(H1N1) pdm09 virus throughout the year. We have characterized the molecular composition of the Hemagglutinin (HA) and Neuraminidase (NA) genes of the A(H1N1) pdm09 virus from both epidemic seasons, emphasizing the genetic characteristics of viruses isolated from Yucatan in Southern Mexico. The molecular analysis of viruses from the 2012 revealed that all viruses from Mexico were predominantly grouped in clade 7. Strikingly, the molecular characterization of viruses from 2013 revealed that viruses circulating in Yucatan were genetically different to viruses from other regions of Mexico. In fact, we identified the occurrence of two genetic variants containing relevant mutations at both the HA and NA surface antigens. There was a difference on the temporal circulation of each genetic variant, viruses containing the mutations HA-A141T / NA-N341S were detected in May, June and July; whereas viruses containing the mutations HA-S162I / NA-L206S circulated in August and September. We discuss the significance of these novel genetic changes.	[Reyes Canche-Pech, Jose; Conde-Ferraez, Laura; Puerto-Solis, Marylin; Gonzalez-Losa, Refugio; Gomez-Carballo, Jesus; Ayora-Talavera, Guadalupe] Univ Autonoma Yucatan, Ctr Invest Reg Dr Hideyo Noguchi, Av Ctr, Cp Merida, Yucatan, Mexico; [Granja-Perez, Pilar; Villanueva-Jorge, Salha; Chan-Gasca, Maria] Serv Salud Yucatan, Lab Estatal Salud Publ, Merida, Yucatan, Mexico; [Lopez-Ochoa, Luisa] Ctr Invest Cient Yucatan AC, Unidad Bioquim & Biol Mol Plantas, Cp Merida, Yucatan, Mexico; [Jimenez-Delgadillo, Bertha] Univ Autonoma Yucatan, Fac Med, Av Ctr, Cp Merida, Yucatan, Mexico; [Rodriguez-Sanchez, Iram] Univ Autonoma Nuevo Leon, Fac Med, Dept Genet, Av Gonzalitos S-N Cruce Con, Cp Monterrey, Nuevo Leon, Mexico; [Ramirez-Prado, Jorge] Unidad Biotecnol, Ctr De Merida, Yucatan, Mexico	Universidad Autonoma de Yucatan; Centro de Investigacion Cientifica de Yucatan; Universidad Autonoma de Yucatan; Universidad Autonoma de Nuevo Leon	Ayora-Talavera, G (corresponding author), Univ Autonoma Yucatan, Ctr Invest Reg Dr Hideyo Noguchi, Av Ctr, Cp Merida, Yucatan, Mexico.	talavera@correo.uady.mx	Ramirez-Prado, Jorge H/A-3012-2011; Ayora-Talavera, Guadalupe/AAH-3165-2019; Conde-Ferráez, Laura/L-6177-2018	Ramirez-Prado, Jorge H/0000-0003-2780-5223; Ayora-Talavera, Guadalupe/0000-0002-2829-6945; Conde-Ferráez, Laura/0000-0002-8095-7106; GOMEZ CARBALLO, JESUS GILBERTO/0000-0001-6850-0667; Lopez-Ochoa, Luisa/0000-0003-1029-7381	Fondo Mixto [FOMIX-YUC-SA-003/12]; Fondo Mixto	Fondo Mixto; Fondo Mixto	This work was supported by Fondo Mixto FOMIX-YUC-SA-003/12. JRCP was under contract by the Fondo Mixto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIR GM, 1985, VIROLOGY, V145, P237, DOI 10.1016/0042-6822(85)90157-6; Arellano-Llamas R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180419; Ayora-Talavera G, 2017, VACCINE; Borja-Aburto VH, 2012, ARCH MED RES, V43, P563, DOI 10.1016/j.arcmed.2012.09.005; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Chowell G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041069; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; COLMAN PM, 1983, NATURE, V303, P41, DOI 10.1038/303041a0; Comas-Garcia A, 2011, INFLUENZA OTHER RESP, V5, P76, DOI 10.1111/j.1750-2659.2010.00187.x; Davila-Torres J, 2015, ARCH MED RES, V46, P63, DOI 10.1016/j.arcmed.2014.11.005; de la Rosa-Zamboni D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050116; DGE, 2012, INF REL INFL; DGE, 2013, INF REL INFL; DGE, 2014, INF REL INFL; DGE, 2015, LIN VIG EP INFL LAB; ECDC, 2016, INFL VIR CHAR SUMM E; Fang QX, 2015, ARCH VIROL, V160, P1083, DOI 10.1007/s00705-015-2362-x; Fereidouni SR, 2009, EUROSURVEILLANCE, V14, P2; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gomez-Gomez A, 2010, EMERG INFECT DIS, V16, P27, DOI 10.3201/eid1601.090941; Guadalupe AT, 2012, REV BIOMED, V23, P39; Houng HSH, 2012, J CLIN VIROL, V53, P12, DOI 10.1016/j.jcv.2011.09.004; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Klein EY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093632; Klimov AI, 2012, VACCINE, V30, P6461, DOI 10.1016/j.vaccine.2012.07.089; Koel BF, 2013, SCIENCE, V342, P976, DOI 10.1126/science.1244730; Lee AJ, 2015, J VIROL, V89, P5427, DOI 10.1128/JVI.03636-14; Mullick J, 2011, INFECT GENET EVOL, V11, P997, DOI 10.1016/j.meegid.2011.03.015; Nakajima S, 2007, MICROBIOL IMMUNOL, V51, P1179, DOI 10.1111/j.1348-0421.2007.tb04013.x; Nelson MI, 2011, J VIROL, V85, P828, DOI 10.1128/JVI.01762-10; Skowronski D, 2014, PLOS ONE, V3; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; Su YCF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8952; Sun SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018392; Vazquez-Perez JA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-41; WHO, REC COMP INFL VIR VA; WHO, 2009, SEQ 1 PROT; WHO, 2013, REC COMP INFL VIR VA; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; World Health Organization, 2009, CDC PROT REALT RTPCR	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189363	10.1371/journal.pone.0189363	http://dx.doi.org/10.1371/journal.pone.0189363			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220381	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000417469900054
J	Canini, L; Imamura, M; Kawakami, Y; Uprichard, SL; Cotler, SJ; Dahari, H; Chayama, K				Canini, Laetitia; Imamura, Michio; Kawakami, Yoshiiku; Uprichard, Susan L.; Cotler, Scott J.; Dahari, Harel; Chayama, Kazuaki			HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients	PLOS ONE			English	Article							SOFOSBUVIR COMBINATION THERAPIES; CHRONIC HEPATITIS-C; PROTEASE INHIBITOR; PLUS ASUNAPREVIR; NULL RESPONDERS; DUAL THERAPY; CIRRHOSIS; REGIMENS; TIME	Background & aims High cure rates are achieved in HCV genotype-1b patients treated with daclatasvir and asunaprevir, DCV/ASV. Here we analyzed early HCV kinetics in genotype-1b infected Japanese subjects treated with DCV/ASV and retrospectively projected, using mathematical modeling, whether shorter treatment durations might be effective. Methods HCV RNA levels were measured frequently during DCV/ASV therapy in 95 consecutively treated patients at a single center in Japan. Mathematical modeling was used to predict the time to cure, i.e, <1 virus copy in the extracellular body fluid. Patients with HCV<15 IU/ml at week 1 (n = 27) were excluded from modeling analysis due to insufficient HCV RNA data points. Results Eighty nine of the 95 included patients (94%) achieved cure, 3 (3%) relapsed due to treatment-emergent resistance, and 3 (3%) completed therapy but were lost during follow up. Model fits from 68 patients with sufficient data points indicate that after a short pharmacological delay (15.4 min [relative standard error, rse = 26%]), DCV/ASV effectiveness in blocking HCV production was 0.999 [rse similar to 0%], HCV half-life in blood was t(1/2) = 1.7 hr [rse = 21%], and HCV-infected cell loss rate was 0.391/d [rse = 5%]. Modeling predicted that 100% and 98.5% of patients who had HCV< 15 IU/ml at days 14 and 28 might have been cured with 6 and 8 weeks of therapy, respectively. There was a trend (p = 0.058) between younger age and shorter time to cure. Conclusion Modeling early HCV kinetics under DCV/ASV predicts that most patients would achieve cure with short treatment durations, suggesting that 24 weeks of DCV/ASV treatment can be significantly shortened.	[Canini, Laetitia; Uprichard, Susan L.; Cotler, Scott J.; Dahari, Harel] Loyola Univ, Med Ctr, Dept Med, Program Expt & Theoret Modeling,Div Hepatol, Maywood, IL 60153 USA; [Canini, Laetitia] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Imamura, Michio; Kawakami, Yoshiiku; Chayama, Kazuaki] Hiroshima Univ, Dept Gastroenterol & Metab, Appl Life Sci, Inst Biomed & Hlth Sci, Hiroshima, Japan	Loyola University Chicago; University of Edinburgh; Hiroshima University	Dahari, H (corresponding author), Loyola Univ, Med Ctr, Dept Med, Program Expt & Theoret Modeling,Div Hepatol, Maywood, IL 60153 USA.; Chayama, K (corresponding author), Hiroshima Univ, Dept Gastroenterol & Metab, Appl Life Sci, Inst Biomed & Hlth Sci, Hiroshima, Japan.	hdahari@luc.edu; chayama@mba.ocn.ne.jp	Canini, Laetitia/K-1278-2019	Canini, Laetitia/0000-0001-7643-1219; Chayama, Kazuaki/0000-0002-5530-5341	U.S. National Institute of Health (NIH) [R01 -A1078881, R01GM121600]; UK Biotechnology and Biological Sciences Research Council [1698:BB/L001330/1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121600] Funding Source: NIH RePORTER	U.S. National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported in part by the U.S. National Institute of Health (NIH) grants R01 -A1078881 and R01GM121600 and by the UK Biotechnology and Biological Sciences Research Council (grant reference 1698:BB/L001330/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Dahari H, 2016, J HEPATOL, V65, P462, DOI 10.1016/j.jhep.2016.05.028; Dahari H, 2016, J HEPATOL, V64, P1232, DOI 10.1016/j.jhep.2016.02.022; Dahari H, 2015, LIVER INT, V35, P289, DOI 10.1111/liv.12692; Gambato M, 2016, J HEPATOL, V64, pS795, DOI 10.1016/S0168-8278(16)01550-6; Goyal A, 2017, ANTIVIR RES, V144, P281, DOI 10.1016/j.antiviral.2017.06.019; Hayes CN, 2017, EXPERT REV GASTROENT, V11, P103, DOI 10.1080/17474124.2017.1270205; Hayes CN, 2015, J FORMOS MED ASSOC, V114, P204, DOI 10.1016/j.jfma.2014.09.001; Ikeda K, 2000, HEPATOL RES, V18, P252, DOI 10.1016/S1386-6346(00)00074-7; Kao JH, 2017, J GASTROEN HEPATOL, V32, P966, DOI 10.1111/jgh.13709; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Lok AS, 2014, J HEPATOL, V60, P490, DOI 10.1016/j.jhep.2013.10.019; Maasoumy B, 2016, J HEPATOL, V65, P473, DOI 10.1016/j.jhep.2016.04.006; Malespin M, 2017, THER ADV GASTROENTER, V10, P68, DOI 10.1177/1756283X16672392; Morio K, 2017, J GASTROEN HEPATOL, V32, P645, DOI 10.1111/jgh.13511; Rong LB, 2012, B MATH BIOL, V74, P1789, DOI 10.1007/s11538-012-9736-y; Sansone N, 2014, HEPATOLOGY, V60, p1165A; Sulkowski MS, 2017, LIVER INT, V37, P836, DOI 10.1111/liv.13335; Nguyen TT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03591-2; Toyota J, 2017, J GASTROENTEROL, V52, P385, DOI 10.1007/s00535-016-1245-6; WHO &VERBAR; Guidelines for the screening, CAR TREATM PERS CHRO	21	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0187409	10.1371/journal.pone.0187409	http://dx.doi.org/10.1371/journal.pone.0187409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216198	Green Submitted, Green Published, gold			2022-12-27	WOS:000417337800007
J	Lee, SK; Jung, JI; Hyun, JO; Kim, HW; Youn, HJ				Lee, Seul Ki; Jung, Jung Im; Hyun, Joo O.; Kim, Hwan Wook; Youn, Ho Joong			Coronary-to-pulmonary artery fistula in adults: Evaluation with thallium-201 myocardial perfusion SPECT	PLOS ONE			English	Article							EMISSION COMPUTED-TOMOGRAPHY; PROGNOSTIC VALUE; CT; ANGIOGRAPHY; INFARCTION; SCINTIGRAPHY; PREVALENCE; PREDICTORS; EXPERIENCE; SECONDARY	Objectives With the increasing use of multi-detector CT, the number of detected cases with coronary-to-pulmonary artery fistula (CPAF) has increased. Several previous studies reported severe cases of angina, but no appropriate tests to evaluate myocardial perfusion for patients with CPAF have been established. We evaluated the hemodynamic characteristics of CPAF using thallium-201 (Tl-201) single photon emission computed tomography (SPECT). Materials and methods Tl-201 SPECT was performed in 17 patients with CPAF, but without evidence of coronary artery disease on coronary computed tomography angiography (CCTA) (age, 58.5 +/- 13.3 years; 8 men). Quantitative analysis of scintigraphic data was performed. Additionally, perfusion abnormalities were compared with CCTA findings. Medical records were obtained to define clinical data, diagnostic findings, symptoms, management, follow-up data, and major adverse cardiac events (MACE). Results Six patients (35.2%) showed perfusion abnormalities on SPECT studies and could be classified as follows: 3 patients, no reversible ischemia (3/17, 17.6%); 1 patient, mild ischemia (1/17, 5.8%); and 2 patients, moderate ischemia (2/17, 11.7%). During the follow-up, ten patients (58.8%) improved under medical management and 5 patients (29.4%) underwent surgical ligation for CPAF with symptomatic improvement in 4 patients. Seven patients performed follow-up myocardial perfusion SPECT, and symptomatic improvement correlated well with scintigraphic perfusion improvement in 6 patients No MACE was observed. Clinical significance Tl-201 myocardial perfusion SPECT might be useful for determining the hemodynamic status and for risk stratification in patients with CPAF.	[Lee, Seul Ki; Jung, Jung Im] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Radiol, Seoul, South Korea; [Hyun, Joo O.] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Nucl Med, Seoul, South Korea; [Kim, Hwan Wook] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Youn, Ho Joong] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Seul Ki] Dongguk Univ, Ilsan Hosp, Dept Radiol, Goyang Si, Gyeonggi Do, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Dongguk University; NHIS Ilsan Hospital	Jung, JI (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Radiol, Seoul, South Korea.	jijung@catholic.ac.kr		Jung, Jung Im/0000-0001-8264-9388; Lee, Seul Ki/0000-0002-6296-5559				Angelini P, 2002, TEX HEART I J, V29, P271; BARTORELLI AL, 1994, AM HEART J, V127, P207, DOI 10.1016/0002-8703(94)90527-4; Canga Y, 2012, CARDIOL J, V19, P278, DOI 10.5603/CJ.2012.0050; Chen ML, 2009, CLIN NUCL MED, V34, P96, DOI 10.1097/RLU.0b013e318192c497; Chiu CZ, 2008, CIRC J, V72, P1242, DOI 10.1253/circj.72.1242; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Goto Y, 1998, CARDIOLOGY, V89, P252, DOI 10.1159/000006796; Hachamovitch R, 1998, CIRCULATION, V97, P535; Harle T, 2012, CLIN RES CARDIOL, V101, P313, DOI 10.1007/s00392-011-0405-1; Holly TA, 2010, J NUCL CARDIOL, V17, P941, DOI 10.1007/s12350-010-9246-y; HOUGHTON JL, 1993, AM HEART J, V125, P886, DOI 10.1016/0002-8703(93)90187-E; Keeley EC, 2001, J AM COLL CARDIOL, V38, P659, DOI 10.1016/S0735-1097(01)01420-6; Kim MS, 2010, INT J CARDIOVAS IMAG, V26, P273, DOI 10.1007/s10554-010-9711-3; Konopka A, 2011, KARDIOL POL, V69, P940; LADENHEIM ML, 1986, J AM COLL CARDIOL, V7, P464, DOI 10.1016/S0735-1097(86)80454-5; Latson LA, 2007, CATHETER CARDIO INTE, V70, P110, DOI 10.1002/ccd.21125; Lee CM, 2016, J COMPUT ASSIST TOMO, V40, P398, DOI 10.1097/RCT.0000000000000370; Lim JJ, 2014, AM J ROENTGENOL, V203, pW237, DOI 10.2214/AJR.13.11613; Lindner O, 2007, DTSCH ARZTEBL, V104, P952; Palloshi A, 2008, J CARDIOVASC MED, V9, P1163, DOI 10.2459/JCM.0b013e3283117d1f; Papadopoulos DP, 2008, HELL J CARDIOL, V49, P111; Raff Gilbert L, 2009, J Cardiovasc Comput Tomogr, V3, P122, DOI 10.1016/j.jcct.2009.01.001; Rubini G, 1998, ANGIOLOGY, V49, P55, DOI 10.1177/000331979804900107; Said SAM, 2011, NETH HEART J, V19, P183, DOI 10.1007/s12471-011-0088-2; Said SAM, 2014, CLIN CARDIOL, V37, P536, DOI 10.1002/clc.22297; SAID SAM, 1992, INT J CARDIOL, V35, P270, DOI 10.1016/0167-5273(92)90189-A; Said SAM, 2006, INT J CARDIOL, V106, P323, DOI 10.1016/j.ijcard.2005.01.047; Saito Aya, 2006, Asian Cardiovasc Thorac Ann, V14, pe4; Sato F, 2005, INT HEART J, V46, P355, DOI 10.1536/ihj.46.355; Svensson A, 2004, EUR J NUCL MED MOL I, V31, P229, DOI 10.1007/s00259-003-1361-4; Umana E, 2002, ANGIOLOGY, V53, P353, DOI 10.1177/000331970205300315; Vijayvergiya R, 2010, INT J CARDIOL, V140, pE30, DOI 10.1016/j.ijcard.2008.11.074; Yang SW, 2013, BMJ CASE REPORTS, V2013; Yun H, 2011, CHINESE MED J-PEKING, V124, P4172, DOI 10.3760/cma.j.issn.0366-6999.2011.24.010; Zellweger MJ, 2014, JACC-CARDIOVASC INTE, V7, P615, DOI 10.1016/j.jcin.2014.01.161; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064; Zhang LJ, 2014, ACTA RADIOL, V55, P1031, DOI 10.1177/0284185113512299	37	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189269	10.1371/journal.pone.0189269	http://dx.doi.org/10.1371/journal.pone.0189269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216309	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800111
J	Poplova, M; Sovka, P; Cifra, M				Poplova, Michaela; Sovka, Pavel; Cifra, Michal			Poisson pre-processing of nonstationary photonic signals: Signals with equality between mean and variance	PLOS ONE			English	Article							NEUTROPHILS IN-VITRO; PHOTOCOUNT STATISTICS; CHEMILUMINESCENCE; FLUCTUATIONS; LIGHT; EMISSION; SENSOR; IONS	Photonic signals are broadly exploited in communication and sensing and they typically exhibit Poisson-like statistics. In a common scenario where the intensity of the photonic signals is low and one needs to remove a nonstationary trend of the signals for any further analysis, one faces an obstacle: due to the dependence between the mean and variance typical for a Poisson-like process, information about the trend remains in the variance even after the trend has been subtracted, possibly yielding artifactual results in further analyses. Commonly available detrending or normalizing methods cannot cope with this issue. To alleviate this issue we developed a suitable pre-processing method for the signals that originate from a Poisson-like process. In this paper, a Poisson pre-processing method for nonstationary time series with Poisson distribution is developed and tested on computer-generated model data and experimental data of chemiluminescence from human neutrophils and mung seeds. The presented method transforms a nonstationary Poisson signal into a stationary signal with a Poisson distribution while preserving the type of photocount distribution and phase-space structure of the signal. The importance of the suggested pre-processing method is shown in Fano factor and Hurst exponent analysis of both computer-generated model signals and experimental photonic signals. It is demonstrated that our pre-processing method is superior to standard detrending-based methods whenever further signal analysis is sensitive to variance of the signal.	[Poplova, Michaela; Cifra, Michal] Czech Acad Sci, Inst Photon & Elect, Chaberska 57, Prague 18251 8, Czech Republic; [Poplova, Michaela; Sovka, Pavel] Czech Tech Univ, Fac Elect Engn, Tech 2, Prague 16627 6, Czech Republic	Czech Academy of Sciences; Institute of Photonics & Electronics of the Czech Academy of Sciences; Czech Technical University Prague	Cifra, M (corresponding author), Czech Acad Sci, Inst Photon & Elect, Chaberska 57, Prague 18251 8, Czech Republic.	cifra@ufe.cz	Cifra, Michal/D-4416-2013	Cifra, Michal/0000-0002-8853-9523	Czech Science Foundation [GA13-29294S]; Czech Technical University in Prague [SGS15/198/OHK3/3T/13]; Czech Academy of Sciences [SAV-15-22]; Slovak Academy of Sciences [SAV-15-22]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Technical University in Prague; Czech Academy of Sciences(Czech Academy of Sciences); Slovak Academy of Sciences(Slovak Academy of Sciences)	The authors acknowledge the support from the Czech Science Foundation (grant no. GA13-29294S) to M.C. and a grant from the Czech Technical University in Prague (grant no. SGS15/198/OHK3/3T/13). M.C. and M.P. participate in COST Actions BM1309, CA15211 and project no. SAV-15-22 between Czech and Slovak Academies of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the support from the Czech Science Foundation (grant no. GA13-29294S) and a grant from the Czech Technical University in Prague (grant no. SGS15/198/OHK3/3T/13). M.C. and M.P. participate in COST Actions BM1309, CA15211 and project no. SAV-15-22 between Czech and Slovak Academies of Sciences. Honorata Nawrocka-Bogusz is acknowledged for introducing the neutrophil isolation method to us.	[Anonymous], 1936, J R STAT SOC B, DOI DOI 10.2307/2983678; ANSCOMBE FJ, 1948, BIOMETRIKA, V35, P246, DOI 10.1093/biomet/35.3-4.246; Azzari L, 2016, IEEE SIGNAL PROC LET, V23, P1086, DOI 10.1109/LSP.2016.2580600; Bajpai RP, 2008, INDIAN J EXP BIOL, V46, P420; Bajpai RP, 2013, J PHOTOCH PHOTOBIO B, V129, P6, DOI 10.1016/j.jphotobiol.2013.09.002; Bendat J. S., 1966, MEASUREMENT ANAL BIN; Bland EJ, 2001, MOL BIOTECHNOL, V19, P125, DOI 10.1385/MB:19:2:125; Bryce RM, 2012, SCI REP-UK, V2, P1, DOI 10.1038/srep00315; Bunde A, 2000, PHYS REV LETT, V85, P3736, DOI 10.1103/PhysRevLett.85.3736; Cifra M, 2015, J LUMIN, V164, P38, DOI 10.1016/j.jlumin.2015.03.020; Cifra M, 2014, J PHOTOCH PHOTOBIO B, V139, P2, DOI 10.1016/j.jphotobiol.2014.02.009; Costa D, 2006, FREE RADICAL BIO MED, V40, P632, DOI 10.1016/j.freeradbiomed.2005.09.017; FANO U, 1947, PHYS REV, V72, P26, DOI 10.1103/PhysRev.72.26; Feder J., 2013, FRACTALS; Freltas M, 2008, CLIN BIOCHEM, V41, P570, DOI 10.1016/j.clinbiochem.2007.12.021; Garcia D, 2010, COMPUT STAT DATA AN, V54, P1167, DOI 10.1016/j.csda.2009.09.020; Guan Y, 2009, STAT PROBABIL LETT, V79, P1621, DOI 10.1016/j.spl.2009.04.010; Guderian A, 1999, CHEM PHYS LETT, V312, P440, DOI 10.1016/S0009-2614(99)00931-8; Halvorson RA, 2010, ENVIRON SCI TECHNOL, V44, P7749, DOI 10.1021/es101228z; HURST HE, 1951, T AM SOC CIV ENG, V116, P770; Im H, 2014, NAT BIOTECHNOL, V32, P490, DOI 10.1038/nbt.2886; Iranifam M, 2010, LUMINESCENCE, V25, P409, DOI 10.1002/bio.1203; Kim HN, 2012, CHEM SOC REV, V41, P3210, DOI 10.1039/c1cs15245a; King MR, 2010, NUMERICAL STAT METHO; Kobayashi M, 1998, PHYS REV E, V57, P2129, DOI 10.1103/PhysRevE.57.2129; Kobayashi M, 2000, APPL OPTICS, V39, P183, DOI 10.1364/AO.39.000183; Larose D.T., 2015, DATA MINING PREDICTI, V2nd ed.; Malchus N, 2010, J FLUORESC, V20, P19, DOI 10.1007/s10895-009-0517-4; MANDELBR.BB, 1969, WATER RESOUR RES, V5, P967, DOI 10.1029/WR005i005p00967; Manolakis DG, 2005, STAT ADAPTIVE SIGNAL, V46; Miao WJ, 2008, CHEM REV, V108, P2506, DOI 10.1021/cr068083a; Nawrocka-Bogusz H, 2011, J PHYS CONF SER, V329, DOI 10.1088/1742-6596/329/1/012023; Neely A, 2009, ACS NANO, V3, P2834, DOI 10.1021/nn900813b; O'Brien JL, 2009, NAT PHOTONICS, V3, P687, DOI 10.1038/nphoton.2009.229; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Piliarik M, 2009, BIOSENS BIOELECTRON, V24, P1399, DOI 10.1016/j.bios.2008.08.012; Poniedzialek B, 2013, ELECTROMAGN BIOL MED, V32, P333, DOI 10.3109/15368378.2012.721845; Rafieiolhosseini N, 2016, J PHOTOCH PHOTOBIO B, V162, P50, DOI 10.1016/j.jphotobiol.2016.06.001; Ramanujan VK, 2014, METHODS, V66, P222, DOI 10.1016/j.ymeth.2013.08.027; Ramanujan VK, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2928154; Ramanujan VK, 2006, BIOPHYS J, V90, pL70, DOI 10.1529/biophysj.106.083501; Rigler R., 2012, FLUORESCENCE CORRELA, V65; SAMUNI A, 1991, FREE RADICAL BIO MED, V10, P305, DOI 10.1016/0891-5849(91)90037-4; Shao YH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00835; Sperling J, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.023820; Teich M. C., 1989, Quantum Optics, V1, P153, DOI 10.1088/0954-8998/1/2/006; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; van Wijk E, 2011, J PHYS CONF SER, V329, DOI 10.1088/1742-6596/329/1/012021; Van Wijk EPA, 2008, INDIAN J EXP BIOL, V46, P345; Van Wijk EPA, 2010, J PHOTOCH PHOTOBIO B, V99, P133, DOI 10.1016/j.jphotobiol.2010.03.008; Van Wijk R, 2006, J PHOTOCH PHOTOBIO B, V84, P46, DOI 10.1016/j.jphotobiol.2006.01.010; Walls D., 2008, QUANTUM OPT, DOI DOI 10.1007/978-3-540-28574-8	52	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188622	10.1371/journal.pone.0188622	http://dx.doi.org/10.1371/journal.pone.0188622			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216207	Green Submitted, Green Published, gold			2022-12-27	WOS:000417337800031
J	Ribeiro, T; Lemos, F; Preto, M; Azevedo, J; Sousa, ML; Leao, PN; Campos, A; Linder, S; Vitorino, R; Vasconcelos, V; Urbatzka, R				Ribeiro, Tiago; Lemos, Filipa; Preto, Marco; Azevedo, Joana; Sousa, Maria Ligla; Leao, Pedro N.; Campos, Alexandre; Linder, Stig; Vitorino, Rui; Vasconcelos, Vitor; Urbatzka, Ralph			Cytotoxicity of portoamides in human cancer cells and analysis of the molecular mechanisms of action	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; KAPPA-B ACTIVITIES; COMPLEX-I; DEATH; CYANOBACTERIUM; MITOCHONDRIA; PROTEINS; INSIGHTS; DISEASE; VITRO	Portoamides are cyclic peptides produced and released by the cyanobacterial strain Phormidium sp. presumably to interfere with other organisms in their ecosystems (" allelopathy"). Portoamides were previously demonstrated to have an antiproliferative effect on human lung carcinoma cells, but the underlying mechanism of this activity has not been described. In the present work, the effects of portoamides on proliferation were examined in eight human cancer cell lines and two non-carcinogenic cell lines, and major differences in sensitivities were observed. To generate hypotheses with regard to molecular mechanisms of action, quantitative proteomics using 2D gel electrophoresis and MALDI-TOF/ TOF were performed on the colon carcinoma cell line HT-29. The expression of proteins involved in energy metabolism (mitochondrial respiratory chain and pentose phosphate pathway) was found to be affected. The hypothesis of altered energy metabolism was tested in further experiments. Exposure to portoamides resulted in reduced cellular ATP content, likely due to decreased mitochondrial energy production. Mitochondrial hyperpolarization and reduced mitochondrial reductive capacity was observed in treated cells. Furthermore, alterations in the expression of peroxiredoxins (PRDX4, PRDX6) and components of proteasome subunits (PSB4, PSA6) were observed in portoamide-treated cells, but these alterations were not associated with detectable increases in oxidative stress. We conclude that the cytotoxic activity of portoamides is associated with disturbance of energy metabolism, and alterations in mitochondrial structure and function.	[Ribeiro, Tiago; Lemos, Filipa; Preto, Marco; Azevedo, Joana; Sousa, Maria Ligla; Leao, Pedro N.; Campos, Alexandre; Vasconcelos, Vitor; Urbatzka, Ralph] CIIMAR, Interdisciplinary Ctr Marine & Environm Res, Oporto, Portugal; [Linder, Stig] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Linder, Stig] Linkoping Univ, Dept Med & Hlth Sci, Fac Hlth Sci, Linkoping, Sweden; [Vitorino, Rui] Univ Aveiro, Inst Biomed iBiMED, Dept Med Sci, Aveiro, Portugal; [Vitorino, Rui] Univ Porto, Dept Physiol & Cardiothorac Surg, Fac Med, Oporto, Portugal; [Vasconcelos, Vitor] Univ Porto, Dept Biol, Fac Sci, FCUP, Oporto, Portugal	Universidade do Porto; Karolinska Institutet; Linkoping University; Universidade de Aveiro; Universidade do Porto; Universidade do Porto	Urbatzka, R (corresponding author), CIIMAR, Interdisciplinary Ctr Marine & Environm Res, Oporto, Portugal.	rurbatzka@ciimar.up.pt	Vasconcelos, Vitor/A-8933-2008; Vitorino, Rui/AAJ-3621-2021; Vitorino, Rui/G-7356-2014; azevedo, joana/AAE-4868-2020; Campos, Alexandre/AGP-3558-2022; Urbatzka, Ralph/G-8907-2013; Leão, Pedro N./E-1630-2011; Sousa, Maria Lígia/AAC-9071-2020; CIIMAR, BYT/N-6498-2017	Vasconcelos, Vitor/0000-0003-3585-2417; Vitorino, Rui/0000-0003-3636-5805; Vitorino, Rui/0000-0003-3636-5805; azevedo, joana/0000-0002-3757-8143; Campos, Alexandre/0000-0003-4621-885X; Urbatzka, Ralph/0000-0001-7476-9195; Leão, Pedro N./0000-0001-5064-9164; Sousa, Maria Lígia/0000-0003-0012-7493; Ribeiro, Tiago/0000-0002-2457-8339; CIIMAR, BYT/0000-0002-3703-4402; Correia Preto, Marco Aurelio/0000-0002-9697-5579	Structured Program of R&D&I INNOVMAR - Innovation and Sustainability in the Management and Exploitation of Marine Resources - Northern Regional Operational Program (NORTE) through the European Regional Development Fund (ERDF) [NORTE-01-0145-FEDER-000035]; national funds (FCT, Foundation for Science and Technology) [UID/Multi/04423/2013, UID/BIM/04501/2013, UID/IC/00051/2013]; RNEM (National Mass Spectrometry Network); FCT [IF/01358/2014, SFRH/BPD/112287/2015]	Structured Program of R&D&I INNOVMAR - Innovation and Sustainability in the Management and Exploitation of Marine Resources - Northern Regional Operational Program (NORTE) through the European Regional Development Fund (ERDF); national funds (FCT, Foundation for Science and Technology); RNEM (National Mass Spectrometry Network); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This research was supported by the Structured Program of R&D&I INNOVMAR - Innovation and Sustainability in the Management and Exploitation of Marine Resources (reference NORTE-01-0145-FEDER-000035, Research Line NOVELMAR), funded by the Northern Regional Operational Program (NORTE2020) through the European Regional Development Fund (ERDF). The project was additionally supported by national funds (FCT, Foundation for Science and Technology) with the reference UID/Multi/04423/2013, UID/BIM/04501/2013, UID/IC/00051/2013 and RNEM (National Mass Spectrometry Network). PNL was supported by grant IF/01358/2014 (FCT), and Ralph Urbatrka by grant SFRH/BPD/112287/2015 (FCT).; This research was supported by the Structured Program of R&D&I INNOVMAR-Innovation and Sustainability in the Management and Exploitation of Marine Resources (reference NORTE-01-0145-FEDER-000035, Research Line NOVELMAR), funded by the Northern Regional Operational Program (NORTE2020) through the European Regional Development Fund (ERDF). The project was additionally supported by national funds (FCT, Foundation for Science and Technology) with the reference UID/Multi/04423/2013, UID/BIM/04501/2013, UID/IC/00051/2013 and RNEM (National Mass Spectrometry Network). PNL was supported by grant IF/01358/2014 (FCT), and Ralph Urbatzka by grant SFRH/BPD/112287/2015 (FCT). We thank Dr. Jonathan Mark Wilson (Wilfrid Laurier University, Waterloo, Canada) for the correction of the English in the manuscript.	Aghazadeh Y, 2016, DRUG DISCOV TODAY, V21, P278, DOI 10.1016/j.drudis.2015.09.012; Balaji S, 2013, ALGAL RES, V2, P278, DOI 10.1016/j.algal.2013.03.002; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Eakins J, 2016, TOXICOL IN VITRO, V34, P161, DOI 10.1016/j.tiv.2016.03.016; Erwin PM, 2010, ECOL ECON, V70, P445, DOI 10.1016/j.ecolecon.2010.09.030; Freeman AK, 2011, SEMIN CELL DEV BIOL, V22, P681, DOI 10.1016/j.semcdb.2011.08.009; Freitas S, 2016, MAR DRUGS, V14, DOI 10.3390/md14090158; Freitas S, 2016, TOXICON, V119, P140, DOI 10.1016/j.toxicon.2016.05.016; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Huang G, 2007, CELL DEATH DIFFER, V14, P327, DOI 10.1038/sj.cdd.4402004; Johansson K, 2017, ANTIOXID REDOX SIGN, V26, P229, DOI 10.1089/ars.2015.6419; Kamalian L, 2015, TOXICOL IN VITRO, V29, P732, DOI 10.1016/j.tiv.2015.02.011; Katz J, 2011, CLIN CANCER RES, V17, P6428, DOI 10.1158/1078-0432.CCR-11-0488; Kipp AP, 2017, REDOX BIOL, V12, P403, DOI 10.1016/j.redox.2017.03.013; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Leao PN, 2010, P NATL ACAD SCI USA, V107, P11183, DOI 10.1073/pnas.0914343107; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Liu D, 2014, INT IMMUNOPHARMACOL, V21, P509, DOI 10.1016/j.intimp.2014.06.014; Mallikarjun V, 2012, FREE RADICAL BIO MED, V53, P280, DOI 10.1016/j.freeradbiomed.2012.04.034; Mevers E, 2011, J NAT PROD, V74, P928, DOI 10.1021/np200077f; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; PAGE B, 1993, INT J ONCOL, V3, P473; Paul S, 2015, FREE RADICAL BIO MED, V89, P1218, DOI 10.1016/j.freeradbiomed.2015.11.006; Perl A, 2011, TRENDS MOL MED, V17, P395, DOI 10.1016/j.molmed.2011.01.014; Rabow AA, 2002, J MED CHEM, V45, P818, DOI 10.1021/jm010385b; Riganti C, 2012, FREE RADICAL BIO MED, V53, P421, DOI 10.1016/j.freeradbiomed.2012.05.006; Senkowski W, 2015, MOL CANCER THER, V14, P1504, DOI 10.1158/1535-7163.MCT-14-0792; Vander Heiden MG, 1999, MOL CELL, V3, P159; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Zhang XN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4295	33	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188817	10.1371/journal.pone.0188817	http://dx.doi.org/10.1371/journal.pone.0188817			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216224	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800041
J	Tanaka, M; Endo, S; Kotake, F; Al-Saari, N; Amin, AKMR; Feng, G; Mino, S; Doi, H; Ogura, Y; Hayashi, T; Suda, W; Hattori, M; Yumoto, I; Sawabe, T; Sawabe, T; Araki, T				Tanaka, Mami; Endo, Shoko; Kotake, Fumihito; Al-Saari, Nurhidayu; Amin, A. K. M. Rohul; Feng, Gao; Mino, Sayaka; Doi, Hidetaka; Ogura, Yoshitoshi; Hayashi, Tetsuya; Suda, Wataru; Hattori, Masahira; Yumoto, Isao; Sawabe, Toko; Sawabe, Tomoo; Araki, Toshiyoshi			Vibrio aphrogenes sp. nov., in the Rumoiensis clade isolated from a seaweed (vol 12, e0180053, 2017)	PLOS ONE			English	Correction													Suda, Wataru/AAF-4469-2019; Hattori, Masahira/AAD-3785-2019	Al-saari, Nurhidayu/0000-0002-2952-7039				Tanaka M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180053	1	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189555	10.1371/journal.pone.0189555	http://dx.doi.org/10.1371/journal.pone.0189555			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216306	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800130
J	Tornyos, A; Aradi, D; Horvath, IG; Konyi, A; Magyari, B; Pinter, T; Vorobcsuk, A; Tornyos, D; Komocsi, A				Tornyos, Adrienn; Aradi, Daniel; Horvath, Ivan G.; Konyi, Attila; Magyari, Balazs; Pinter, Tunde; Vorobcsuk, Andras; Tornyos, Daniel; Komocsi, Andras			Clinical outcomes in patients treated for coronary in-stent restenosis with drug-eluting balloons: Impact of high platelet reactivity	PLOS ONE			English	Article							ASSOCIATION/AMERICAN STROKE ASSOCIATION; OPTICAL COHERENCE TOMOGRAPHY; HEALTH-CARE PROFESSIONALS; FOLLOW-UP; MYOCARDIAL-INFARCTION; DEFINITION; INTERVENTION; METAANALYSIS; CLOPIDOGREL; CATHETER	Background The impact of high platelet reactivity (HPR) on clinical outcomes after elective percutaneous coronary interventions (PCI) with drug-eluting balloons (DEB) due to in-stent restenosis (ISR) is unknown. Objective We sought to evaluate the prognostic importance of HPR together with conventional risk factors in patients treated with DEB. Methods Patients treated with DEB due to ISR were enrolled in a single-centre, prospective registry between October 2009 and March 2015. Only patients with recent myocardial infarction (MI) received prasugrel, others were treated with clopidogrel. HPR was defined as an ADP-test >46U with the Multiplate assay and no adjustments were done based on results. The primary endpoint of the study was a composite of cardiovascular mortality, MI, any revascularization or stroke during one-year follow-up. Results 194 stable angina patients were recruited of whom 90% were treated with clopidogrel. Clinical characteristics and procedural data were available for all patients; while platelet function testing was performed in 152 subjects of whom 32 (21%) had HPR. Patients with HPR had a higher risk for the primary endpoint (HR: 2.45; CI: 1.01-5.92; p = 0.03). The difference was primarily driven by a higher risk for revascularization and MI. According to the multivariate analysis, HPR remained a significant, independent predictor of the primary endpoint (HR: 2.88; CI: 1.02-8.14; p = 0.04), while total DEB length and statin treatment were other independent correlates of the primary outcome. Conclusion HPR was found to be an independent predictor of repeat revascularization and MI among elective patients with ISR undergoing PCI with DEB.	[Tornyos, Adrienn; Horvath, Ivan G.; Konyi, Attila; Magyari, Balazs; Pinter, Tunde; Vorobcsuk, Andras; Tornyos, Daniel; Komocsi, Andras] Univ Pecs, Inst Heart, Dept Intervent Cardiol, Pecs, Hungary; [Aradi, Daniel] Semmelweis Univ, Ctr Heart, Balatonfured & Heart & Vasc Ctr, Budapest, Hungary	University of Pecs; Semmelweis University	Komocsi, A (corresponding author), Univ Pecs, Inst Heart, Dept Intervent Cardiol, Pecs, Hungary.	komocsi.andras@pte.hu	Vorobcsuk, András Dr./AAR-9971-2020	Vorobcsuk, András Dr./0000-0002-6884-3130	University of Pecs, Hungary [AOK-KA 2015-17]	University of Pecs, Hungary	The research was supported by the University of Pecs, Hungary [AOK-KA 2015-17 to Andras Komocsi].	Agostoni P, 2013, JACC-CARDIOVASC INTE, V6, P569, DOI 10.1016/j.jcin.2012.12.132; Aradi D, 2014, J AM COLL CARDIOL, V63, P1061, DOI 10.1016/j.jacc.2013.12.023; Aradi D, 2010, AM HEART J, V160, P543, DOI 10.1016/j.ahj.2010.06.004; Bossi I, 2000, J AM COLL CARDIOL, V35, P1569, DOI 10.1016/S0735-1097(00)00584-2; Cale R, 2013, REV PORT CARDIOL, V32, P361, DOI 10.1016/j.repc.2012.09.006; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Frohlich GM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-123; Giacoppo D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5392; Indermuehle A, 2013, HEART, V99, P327, DOI 10.1136/heartjnl-2012-302945; Lupi A, 2013, INT J CARDIOL, V168, P4608, DOI 10.1016/j.ijcard.2013.07.161; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Nayak AK, 2006, CIRC J, V70, P1026, DOI 10.1253/circj.70.1026; Poerner TC, 2014, CIRC-CARDIOVASC INTE, V7, P760, DOI 10.1161/CIRCINTERVENTIONS.113.001146; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Scheller B, 2004, CIRCULATION, V110, P810, DOI 10.1161/01.CIR.0000138929.71660.E0; Scheller B, 2008, CLIN RES CARDIOL, V97, P773, DOI 10.1007/s00392-008-0682-5; Scheller B, 2012, JACC-CARDIOVASC INTE, V5, P323, DOI 10.1016/j.jcin.2012.01.008; Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Unverdorben M, 2009, CIRCULATION, V119, P2986, DOI 10.1161/CIRCULATIONAHA.108.839282; Valenti R, 2015, J THROMB THROMBOLYS, V40, P76, DOI 10.1007/s11239-014-1159-1; Walters DL, 2002, AM J CARDIOL, V89, P491, DOI 10.1016/S0002-9149(01)02285-8	25	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188493	10.1371/journal.pone.0188493	http://dx.doi.org/10.1371/journal.pone.0188493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216314	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800027
J	Yong, HS; Song, SL; Lim, PE; Eamsobhana, P				Yong, Hoi-Sen; Song, Sze-Looi; Lim, Phaik-Eem; Eamsobhana, Praphathip			Complete mitochondrial genome of Zeugodacus tau (Insecta: Tephritidae) and differentiation of Z. tau species complex by mitochondrial cytochrome c oxidase subunit I gene	PLOS ONE			English	Article							PUMPKIN FRUIT-FLY; DIPTERA TEPHRITIDAE; MOLECULAR PHYLOGENY; TRANSFER-RNA; SOUTHEAST-ASIA; WALKER DIPTERA; COI SEQUENCES; FLIES DIPTERA; DACINI TRIBE; BACTROCERA	The tephritid fruit fly Zeugodacus tau (Walker) is a polyphagous fruit pest of economic importance in Asia. Studies based on genetic markers indicate that it forms a species complex. We report here (1) the complete mitogenome of Z. tau from Malaysia and comparison with that of China as well as the mitogenome of other congeners, and (2) the relationship of Z. tau taxa from different geographical regions based on sequences of cytochrome c oxidase subunit I gene. The complete mitogenome of Z. tau had a total length of 15631 bp for the Malaysian specimen (ZT3) and 15835 bp for the China specimen (ZT1), with similar gene order comprising 37 genes (13 protein-coding genes-PCGs, 2 rRNA genes, and 22 tRNA genes) and a non-coding A + T-rich control region (D-loop). Based on 13 PCGs and 15 mt-genes, Z. tau NC_027290 (China) and Z. tau ZT1 (China) formed a sister group in the lineage containing also Z. tau ZT3 (Malaysia). Phylogenetic analysis based on partial sequences of cox1 gene indicates that the taxa from China, Japan, Laos, Malaysia, Bangladesh, India, Sri Lanka, and Z. tau sp. A from Thailand belong to Z. tau sensu stricto. A complete cox1 gene (or 13 PCGs or 15 mt-genes) instead of partial sequence is more appropriate for determining phylogenetic relationship.	[Yong, Hoi-Sen] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Song, Sze-Looi; Lim, Phaik-Eem] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Eamsobhana, Praphathip] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Parasitol, Bangkok, Thailand	Universiti Malaya; Universiti Malaya; Mahidol University	Song, SL; Lim, PE (corresponding author), Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia.	szelooi@um.edu.my; phaikeem@um.edu.my	LIM, Phaik Eem/B-5331-2010; song, sl/GRS-1884-2022; Yong, Hoi Sen/C-1548-2010; Song, Sze-Looi/E-7939-2015; Eamsobhana, Praphathip/H-3343-2012	LIM, Phaik Eem/0000-0001-9186-1487; Yong, Hoi Sen/0000-0002-9832-8826; Song, Sze Looi/0000-0002-1188-9728	University of Malaya Research Grant [H-5620009]	University of Malaya Research Grant	Funding for this work was provided in part by University of Malaya Research Grant H-5620009.	Agirrezabala X, 2009, Q REV BIOPHYS, V42, P159, DOI 10.1017/S0033583509990060; [Anonymous], 1992, FRUIT FLIES EC SIGNI; Baimai V, 2000, BIOL J LINN SOC, V69, P399, DOI 10.1111/j.1095-8312.2000.tb01213.x; CARROLL LE, 2004, PEST FRUIT FLIES WOR; Chan CW, 2013, WIRES RNA, V4, P507, DOI 10.1002/wrna.1175; Choudhary JS, 2015, GENE, V569, P191, DOI 10.1016/j.gene.2015.05.066; Chua TH, 2010, PEST MANAG SCI, V66, P379, DOI 10.1002/ps.1886; CLARY DO, 1985, NUCLEIC ACIDS RES, V13, P4029, DOI 10.1093/nar/13.11.4029; De Re FC, 2014, GENETICA, V142, P525, DOI 10.1007/s10709-014-9799-9; Drosopoulou E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05132-3; HARDY D E, 1973, Pacific Insects Monograph, V31, P1; Hendrickson TL, 2001, P NATL ACAD SCI USA, V98, P13473, DOI 10.1073/pnas.251549298; Hu J, 2008, GENETICA, V134, P319, DOI 10.1007/s10709-007-9239-1; Isaza JP, 2017, MITOCHONDRIAL DNA B, V2, P210, DOI 10.1080/23802359.2017.1307706; Jamnongluk W, 2003, GENOME, V46, P112, DOI 10.1139/G02-113; Jeong SY, 2017, MITOCHONDRIAL DNA B, V2, P85, DOI 10.1080/23802359.2017.1285212; Jiang F, 2014, MOL ECOL RESOUR, V14, P1114, DOI 10.1111/1755-0998.12259; Jiang F, 2013, B ENTOMOL RES, V103, P363, DOI 10.1017/S0007485312000806; Jiang F, 2016, SCI REP-UK, V6, DOI 10.1038/srep36426; Juhling F, 2012, NUCLEIC ACIDS RES, V40, P2833, DOI 10.1093/nar/gkr1131; Khan M, 2011, RES J AGR BIOL SCI, V7, P343; Kitthawee S, 2010, ZOOLOGY, V113, P243, DOI 10.1016/j.zool.2009.12.002; Leblanc L, 2015, ZOOKEYS, P339, DOI 10.3897/zookeys.540.9786; Lim PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037276; Nardi F, 2003, INSECT MOL BIOL, V12, P605, DOI 10.1046/j.1365-2583.2003.00445.x; Nardi F, 2010, MOL PHYLOGENET EVOL, V57, P678, DOI 10.1016/j.ympev.2010.08.008; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Prabhakar CS, 2013, BIOCHEM SYST ECOL, V51, P291, DOI 10.1016/j.bse.2013.09.008; Saelee Anchalee, 2006, Songklanakarin Journal of Science and Technology, V28, P249; Shi W, 2014, J ECON ENTOMOL, V107, P1256, DOI 10.1603/EC13266; Spanos L, 2000, INSECT MOL BIOL, V9, P139, DOI 10.1046/j.1365-2583.2000.00165.x; Tan MH, 2016, MITOCHONDRIAL DNA A, V27, P2502, DOI 10.3109/19401736.2015.1036249; Thanaphum S, 2003, ANN ENTOMOL SOC AM, V96, P44, DOI 10.1603/0013-8746(2003)096[0044:ROFWTB]2.0.CO;2; Vargas RI, 2015, INSECTS, V6, P297, DOI 10.3390/insects6020297; Virgilio M, 2015, MOL PHYLOGENET EVOL, V85, P171, DOI 10.1016/j.ympev.2015.01.007; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Yong H-S, 2014, J SCI TECHNOLOGY TRO, V10, P95; Yong HS, 2016, GENETICA, V144, P513, DOI 10.1007/s10709-016-9919-9; Yong HS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148201; Yong HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15155; Yong HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129455; Zhang B, 2010, FLA ENTOMOL, V93, P369, DOI 10.1653/024.093.0308; Zhang KJ, 2016, MITOCHONDRIAL DNA A, V27, P4314, DOI 10.3109/19401736.2015.1089479; Zhang LJ, 2016, MITOCHONDRIAL DNA B, V1, P680, DOI 10.1080/23802359.2016.1219638	44	7	8	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189325	10.1371/journal.pone.0189325	http://dx.doi.org/10.1371/journal.pone.0189325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216281	Green Submitted, gold, Green Published			2022-12-27	WOS:000417337800118
J	Zhang, XY; Qiu, BS; Wei, ZJ; Yan, F; Shi, CY; Su, S; Liu, X; Ji, JX; Xie, GX				Zhang, Xiaoyong; Qiu, Bensheng; Wei, Zijun; Yan, Fei; Shi, Caiyun; Su, Shi; Liu, Xin; Ji, Jim X.; Xie, Guoxi			Three-dimensional self-gated cardiac MR imaging for the evaluation of myocardial infarction in mouse model on a 3T clinical MR system	PLOS ONE			English	Article							CINE MRI; MICE; HEART; QUANTIFICATION; RECONSTRUCTION; ACQUISITION; SCANNER; TESLA	Purpose To develop and assess a three-dimensional (3D) self-gated technique for the evaluation of myocardial infarction (MI) in mouse model without the use of external electrocardiogram (ECG) trigger and respiratory motion sensor on a 3T clinical MR system. Methods A 3D T1-weighted GRE sequence with stack-of-stars sampling trajectories was developed and performed on six mice with MIs that were injected with a gadolinium-based contrast agent at a 3T clinical MR system. Respiratory and cardiac self-gating signals were derived from the Cartesian mapping of the k-space center along the partition encoding direction by bandpass filtering in image domain. The data were then realigned according to the predetermined self-gating signals for the following image reconstruction. In order to accelerate the data acquisition, image reconstruction was based on compressed sensing (CS) theory by exploiting temporal sparsity of the reconstructed images. In addition, images were also reconstructed from the same realigned data by conventional regridding method for demonstrating the advantageous of the proposed reconstruction method. Furthermore, the accuracy of detecting MI by the proposed method was assessed using histological analysis as the standard reference. Linear regression and Bland-Altman analysis were used to assess the agreement between the proposed method and the histological analysis. Results Compared to the conventional regridding method, the proposed CS method reconstructed images with much less streaking artifact, as well as a better contrast-to-noise ratio (CNR) between the blood and myocardium (4.1 +/- 2.1 vs. 2.9 +/- 1.1, p = 0.031). Linear regression and Bland-Altman analysis demonstrated that excellent correlation was obtained between infarct sizes derived from the proposed method and histology analysis. Conclusion A 3D T1-weighted self-gating technique for mouse cardiac imaging was developed, which has potential for accurately evaluating MIs in mice at 3T clinical MR system without the use of external ECG trigger and respiratory motion sensor.	[Zhang, Xiaoyong; Qiu, Bensheng] Univ Sci & Technol China, Ctr Biomed Engn, Hefei, Anhui, Peoples R China; [Zhang, Xiaoyong; Wei, Zijun; Yan, Fei; Shi, Caiyun; Su, Shi; Liu, Xin] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China; [Ji, Jim X.] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX USA; [Xie, Guoxi] Guangzhou Med Univ, Affiliated Hosp 6, Guangzhou, Guangdong, Peoples R China; [Xie, Guoxi] Guangzhou Med Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Texas A&M University System; Texas A&M University College Station; Guangzhou Medical University; Guangzhou Medical University	Qiu, BS (corresponding author), Univ Sci & Technol China, Ctr Biomed Engn, Hefei, Anhui, Peoples R China.; Xie, GX (corresponding author), Guangzhou Med Univ, Affiliated Hosp 6, Guangzhou, Guangdong, Peoples R China.; Xie, GX (corresponding author), Guangzhou Med Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China.	bqiu@ustc.edu.cn; guoxixie@163.com			International Cooperation and Exchange of the National Science Foundation of China [81371537, 81571669, 81571701]; SIAT [Y5G003]; Natural Science Foundation of Shenzhen [JCYJ20140417113430603, JCYJ20160531174850658, JCYJ20160331185933583, KQCX2015033117354154]	International Cooperation and Exchange of the National Science Foundation of China; SIAT; Natural Science Foundation of Shenzhen	This project was supported by the International Cooperation and Exchange of the National Science Foundation of China (http://www.nsfc.gov.cn): (81371537(BQ), 81571669(GX), 81571701(FY)); the Excellent Youth Scholars of SIAT (http://www.siat.ac.cn): (Y5G003(CS)), and the Natural Science Foundation of Shenzhen (http://www.szsti.gov.cn): (JCYJ20140417113430603 (GX), JCYJ20160531174850658(CS), JCYJ20160331185933583(GX), and KQCX2015033117354154(GX)).	Bohl S, 2009, AM J PHYSIOL-HEART C, V296, pH1200, DOI 10.1152/ajpheart.01294.2008; Bovens SM, 2011, NMR BIOMED, V24, P307, DOI 10.1002/nbm.1593; Buonincontri G, 2014, NMR BIOMED, V27, P733, DOI 10.1002/nbm.3116; Buonincontri G, 2013, J MAGN RESON IMAGING, V38, P468, DOI 10.1002/jmri.24001; Croisille P, 2007, INVEST RADIOL, V42, P1, DOI 10.1097/01.rli.0000248892.35531.ea; Delattre BMA, 2010, NMR BIOMED, V23, P503, DOI 10.1002/nbm.1489; Deng C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058371; Doevendans PA, 1998, CARDIOVASC RES, V39, P34, DOI 10.1016/S0008-6363(98)00073-X; Feng L, 2014, MAGN RESON MED, V72, P707, DOI 10.1002/mrm.24980; Gaurav, 2011, SCI PROGRAMMING-NETH, V19, P199, DOI 10.3233/SPR-2011-0328; Gilson WD, 2007, METHODS, V43, P35, DOI 10.1016/j.ymeth.2007.03.012; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Hiba B, 2007, MAGN RESON MED, V58, P745, DOI 10.1002/mrm.21355; Higano NS, 2017, MAGN RESON MED, V77, P1284, DOI 10.1002/mrm.26212; James JF, 1998, CIRC RES, V82, P407, DOI 10.1161/01.RES.82.4.407; Kramer M, 2015, NMR BIOMED, V28, P162, DOI 10.1002/nbm.3234; Lauzon ML, 1998, MAGNET RESON MED, V40, P769, DOI 10.1002/mrm.1910400519; Liu J, 2010, MAGN RESON MED, V63, P1230, DOI 10.1002/mrm.22306; Mao YJ, 2012, ENDOCRINOLOGY, V153, P3426, DOI 10.1210/en.2012-1065; Montesinos P, 2014, MAGN RESON MED, V72, P369, DOI 10.1002/mrm.24936; Nahrendorf M, 2007, AM J PHYSIOL-HEART C, V292, pH3172, DOI 10.1152/ajpheart.01307.2006; Nieman BJ, 2009, MAGN RESON MED, V61, P1148, DOI 10.1002/mrm.21945; Pang JN, 2014, MAGN RESON MED, V72, P1208, DOI 10.1002/mrm.25450; Pang JN, 2014, MAGN RESON MED, V71, P67, DOI 10.1002/mrm.24628; Polson M J, 1982, Clin Phys Physiol Meas, V3, P231, DOI 10.1088/0143-0815/3/3/008; Ratering D, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-43; Rottman JN, 2007, ECHOCARDIOGR-J CARD, V24, P83, DOI 10.1111/j.1540-8175.2006.00356.x; Ruff J, 2000, J MAGN RESON, V146, P290, DOI 10.1006/jmre.2000.2147; Schneider JE, 2003, J MAGN RESON IMAGING, V18, P691, DOI 10.1002/jmri.10411; SHETTY AN, 1988, MAGNET RESON MED, V8, P84, DOI 10.1002/mrm.1910080110; Sintorn E, 2008, J PARALLEL DISTR COM, V68, P1381, DOI 10.1016/j.jpdc.2008.05.012; Sun DD, 2012, PLOS ONE, V7; Timmers L, 2009, CIRC RES, V104, P699, DOI 10.1161/CIRCRESAHA.108.189746; Trotier AJ, 2016, J MAGN RESON IMAGING, V44, P355, DOI 10.1002/jmri.25150; van Laake LW, 2007, NAT PROTOC, V2, P2551, DOI 10.1038/nprot.2007.371; Voelkl JGJ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/185683; Wech T, 2016, IEEE T MED IMAGING, V35, P912, DOI 10.1109/TMI.2015.2501832; Wech T, 2011, J MAGN RESON IMAGING, V34, P1072, DOI 10.1002/jmri.22718; Wildgruber M, 2012, J MAGN RESON IMAGING, V36, P1372, DOI 10.1002/jmri.23789; Zhang XQ, 2010, SIAM J IMAGING SCI, V3, P253, DOI 10.1137/090746379	40	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189286	10.1371/journal.pone.0189286	http://dx.doi.org/10.1371/journal.pone.0189286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216303	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800113
J	Adikusuma, F; Pfitzner, C; Thomas, PQ				Adikusuma, Fatwa; Pfitzner, Chandran; Thomas, Paul Quinton			Versatile single-step-assembly CRISPR/Cas9 vectors for dual gRNA expression	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; MOUSE MODEL; RNA; CAS9; NUCLEASES; CRISPR-CAS9; SPECIFICITY; GENERATION; NICKASES; SYSTEM	CRISPR/Cas9 technology enables efficient, rapid and cost-effective targeted genomic modification in a wide variety of cellular contexts including cultured cells. Some applications such as generation of double knock-outs, large deletions and paired-nickase cleavage require simultaneous expression of two gRNAs. Although single plasmids that enable multiplex expression of gRNAs have been developed, these require multiple rounds of cloning and/or PCR for generation of the desired construct. Here, we describe a series of vectors that enable generation of customized dual-gRNA expression constructs via an easy onestep golden gate cloning reaction using two annealed oligonucleotide inserts with different overhangs. Through nucleofection of mouse embryonic stem cells, we demonstrate highly efficient cleavage of the target loci using the dual-guide plasmids, which are available as Cas9-nuclease or Cas9-nickase expression constructs, with or without selection markers. These vectors are a valuable addition to the CRISPR/Cas9 toolbox and will be made available to all interested researchers via the Addgene plasmid repository.	[Adikusuma, Fatwa; Pfitzner, Chandran; Thomas, Paul Quinton] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Adikusuma, Fatwa] Diponegoro Univ, Fac Med, Ctr Biomed Res, Semarang, Central Java, Indonesia; [Pfitzner, Chandran; Thomas, Paul Quinton] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia; [Thomas, Paul Quinton] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	University of Adelaide; Diponegoro University; Robinson Research Institute; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI)	Thomas, PQ (corresponding author), Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia.; Thomas, PQ (corresponding author), Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia.; Thomas, PQ (corresponding author), South Australian Hlth & Med Res Inst, Adelaide, SA, Australia.	paul.thomas@adelaide.edu.au	Adikusuma, Fatwa/ABA-2989-2020	Adikusuma, Fatwa/0000-0003-2163-0514; Pfitzner, Chandran/0000-0001-6151-5479				Adikusuma F, 2017, MOL THER, V25, P1736, DOI 10.1016/j.ymthe.2017.05.021; Adikusuma F, 2017, GENETICS, V206, P1495, DOI 10.1534/genetics.117.202549; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Han K, 2017, NAT BIOTECHNOL, V35, P463, DOI 10.1038/nbt.3834; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Quadros RM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1220-4; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Vidigal JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9083	28	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187236	10.1371/journal.pone.0187236	http://dx.doi.org/10.1371/journal.pone.0187236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211736	gold, Green Published, Green Submitted			2022-12-27	WOS:000417212200015
J	Agarwal, S; Ying, J; Boucher, KM; Agarwal, JP				Agarwal, Shailesh; Ying, Jian; Boucher, Kenneth M.; Agarwal, Jayant P.			The association between socioeconomic factors and breast cancer-specific survival varies by race	PLOS ONE			English	Article							RACIAL DISPARITIES; TUMOR MICROENVIRONMENT; AFRICAN-AMERICAN; WHITE WOMEN; OUTCOMES; POPULATION; ETHNICITY; IMPACT	Although racial disparity is well described for oncologic outcomes, factors associated with survival within racial groups remains unexplored. The objective of this study is to determine whether breast cancer survival among White or Black patients is associated with differing patient factors. Women diagnosed with breast cancer from 1998 through 2012 were identified in the Surveillance, Epidemiology, and End Results (SEER) database. Cox proportional hazard logistic regression was used to estimate cause-specific survival in the combined cohort, and separate cohorts of Black or White patients only. Main outcomes included cause-specific survival in cohorts of Black only, White only, or all patients adjusted for demographic and oncologic factors. A total of 406,907 Black (10.8%) or White (89.2%) patients diagnosed with breast cancer from 1998 through 2012 were isolated. Cancer-specific survival analysis of the combined cohort showed significantly decreased hazard ratio (H.R.) in patients from the higher economic quartiles (Q1: 1.0 (ref), Q2: 0.95 (p<0.01), Q3: 0.94 (p<0.01), Q4: 0.87 (p<0.001)). Analysis of the White only cohort showed a similar relationship with income (Q1: 1.0 (ref), Q2: 0.95 (p<0.01), Q3: 0.95 (p<0.01), Q4: 0.86 (p<0.001)). However, analysis of the Black only cohort did not show a relationship with income (Q1: 1.0 (ref), Q2: 1.04 (p = 0.34), Q3: 0.97 (p = 0.53), Q4: 1.04 (p = 0.47)). A test of interaction confirmed that the association between income and cancer-specific survival is dependent on patient race, both with and without adjustment for demographic and oncologic characteristics (p<0.01). While median county income is positively associated with cancer-specific survival among White patients, this is not the case with Black patients. Similar findings were noted for education level. These findings suggest that the association between socioeconomic status and breast cancer survival commonly reported in the literature is specific to White patients. These findings provide insight into differences between White and Black patients in cancer-specific survival.	[Agarwal, Shailesh] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Ying, Jian; Boucher, Kenneth M.] Univ Utah, Biostat Core, Huntsman Canc Inst, Salt Lake City, UT USA; [Agarwal, Jayant P.] Univ Utah, Dept Surg, Div Plast Surg, Salt Lake City, UT 84112 USA	University of Michigan System; University of Michigan; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Agarwal, JP (corresponding author), Univ Utah, Dept Surg, Div Plast Surg, Salt Lake City, UT 84112 USA.	jay.agarwal@hsc.utah.edu						Conway K, 2015, CANCER EPIDEM BIOMAR, V24, P921, DOI 10.1158/1055-9965.EPI-14-1228; Deshmukh SK, 2017, CANCER LETT, V396, P21, DOI 10.1016/j.canlet.2017.03.010; Deshmukh SK, 2017, CARCINOGENESIS, V38, P757, DOI 10.1093/carcin/bgx037; Evans-Knowell A, 2017, ADV CANCER RES, V133, P51, DOI 10.1016/bs.acr.2016.08.003; Iqbal J, 2015, JAMA-J AM MED ASSOC, V313, P165, DOI 10.1001/jama.2014.17322; Keenan T, 2015, J CLIN ONCOL, V33, P3621, DOI 10.1200/JCO.2015.62.2126; Kish Jonathan K., 2014, Journal of the National Cancer Institute Monographs, P236, DOI 10.1093/jncimonographs/lgu020; Komenaka IK, 2010, J NATL CANCER I, V102, P1178, DOI 10.1093/jnci/djq215; Koru-Sengul T, 2016, BREAST CANCER RES TR, V158, P113, DOI 10.1007/s10549-016-3847-3; Silber JH, 2014, ANN INTERN MED, V161, P845, DOI 10.7326/M14-0900; Silber JH, 2013, JAMA-J AM MED ASSOC, V310, P389, DOI 10.1001/jama.2013.8272; Singal V, 2012, J CANCER RES CLIN, V138, P715, DOI 10.1007/s00432-012-1156-8; Vidal G, 2017, CANCER MED-US, V6, P1776, DOI 10.1002/cam4.1117; Yu XQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-364; Zeng C, 2015, JAMA ONCOL, V1, P88, DOI DOI 10.1001/JAMA0NC0L.2014.161	15	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187018	10.1371/journal.pone.0187018	http://dx.doi.org/10.1371/journal.pone.0187018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211739	Green Published, Green Submitted, gold			2022-12-27	WOS:000417212200011
J	Gray, TA; Dumville, JC; Christie, J; Cullum, NA				Gray, Trish A.; Dumville, Jo C.; Christie, Janice; Cullum, Nicky A.			Rapid research and implementation priority setting for wound care uncertainties	PLOS ONE			English	Article							NOMINAL GROUP TECHNIQUE; TACKLING TREATMENT UNCERTAINTIES; DECISION-MAKING; RESEARCH QUESTIONS; CLINICAL-RESEARCH; MANAGEMENT; HEALTH; PARTNERSHIP; EDUCATION; PATIENT	Introduction People with complex wounds are more likely to be elderly, living with multimorbidity and wound related symptoms. A variety of products are available for managing complex wounds and a range of healthcare professionals are involved in wound care, yet there is a lack of good evidence to guide practice and services. These factors create uncertainty for those who deliver and those who manage wound care. Formal priority setting for research and implementation topics is needed to more accurately target the gaps in treatment and services. We solicited practitioner and manager uncertainties in wound care and held a priority setting workshop to facilitate a collaborative approach to prioritising wound care-related uncertainties. Methods We recruited healthcare professionals who regularly cared for patients with complex wounds, were wound care specialists or managed wound care services. Participants submitted up to five wound care uncertainties in consultation with their colleagues, via an online survey and attended a priority setting workshop. Submitted uncertainties were collated, sorted and categorised according professional group. On the day of the workshop, participants were divided into four groups depending on their profession. Uncertainties submitted by their professional group were viewed, discussed and amended, prior to the first of three individual voting rounds. Participants cast up to ten votes for the uncertainties they judged as being high priority. Continuing in the professional groups, the top 10 uncertainties from each group were displayed, and the process was repeated. Groups were then brought together for a plenary session in which the final priorities were individually scored on a scale of 0-10 by participants. Priorities were ranked and results presented. Nominal group technique was used for generating the final uncertainties, voting and discussions. Results Thirty-three participants attended the workshop comprising; 10 specialist nurses, 10 district nurses, seven podiatrists and six managers. Participants had been qualified for a mean of 20.7 years with a mean of 16.8 years of wound care experience. One hundred and thirty-nine uncertainties were submitted electronically and a further 20 were identified on the day of the workshop following lively, interactive group discussions. Twenty-five uncertainties from the total of 159 generated made it to the final prioritised list. These included six of the 20 new uncertainties. The uncertainties varied in focus, but could be broadly categorised into three themes: service delivery and organisation, patient centred care and treatment options. Specialist nurses were more likely to vote for service delivery and organisation topics, podiatrists for patient centred topics, district nurses for treatment options and operational leads for a broad range. Conclusions This collaborative priority setting project is the first to engage front-line clinicians in prioritising research and implementation topics in wound care. We have shown that it is feasible to conduct topic prioritisation in a short time frame. This project has demonstrated that with careful planning and rigor, important questions that are raised in the course of clinicians' daily decision making can be translated into meaningful research and implementation initiatives that could make a difference to service delivery and patient care.	[Gray, Trish A.; Dumville, Jo C.; Christie, Janice; Cullum, Nicky A.] Univ Manchester, Sch Hlth Sci, Div Nursing Midwifery & Social Work, Manchester, Lancs, England; [Cullum, Nicky A.] Cent Manchester Univ Hosp NHS Fdn Trust, Res & Innovat Div, Manchester, Lancs, England	University of Manchester; University of Manchester	Gray, TA (corresponding author), Univ Manchester, Sch Hlth Sci, Div Nursing Midwifery & Social Work, Manchester, Lancs, England.	Trish.Gray@manchester.ac.uk	Gray, Trish/O-8790-2014; Christie, Janice/O-9320-2014; Cullum, Nicky/AAT-5888-2020; Dumville, Jo/O-7867-2014	Gray, Trish/0000-0002-8088-0698; Christie, Janice/0000-0001-6176-6075; Cullum, Nicky/0000-0003-2631-123X; Dumville, Jo/0000-0002-6546-3685	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) Greater Manchester; National Institute for Health Research [NF-SI-0512-10028] Funding Source: researchfish	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) Greater Manchester; National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) Greater Manchester. The NIHR CLAHRC Greater Manchester is a partnership between providers and commissioners from the NHS, industry and the third sector, as well as clinical and research staff from the University of Manchester. NC received funding for the project, details of which can be found at http://clahrc-gm.nihr.ac.uk/our-work/wound-care/. NC, JD and TG are partially supported by the funding. The views expressed in this article are those of the authors and not necessarily those of the NHS, NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batchelor JM, 2013, BRIT J DERMATOL, V168, P577, DOI 10.1111/bjd.12040; Bell-Syer Sally E M, 2007, Adv Skin Wound Care, V20, P283, DOI 10.1097/01.ASW.0000269316.68757.0e; Blevins D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-76; Boddy C, 2012, QUAL MARK RES, V15, P6, DOI 10.1108/13522751211191964; Bratzke LC, 2015, INT J NURS STUD, V52, P744, DOI 10.1016/j.ijnurstu.2014.10.010; Buckley Brian S, 2010, Nurs Times, V106, P36; Carney O, 1996, J ADV NURS, V23, P1024, DOI 10.1046/j.1365-2648.1996.09623.x; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chalmers I, 2013, J ROY SOC MED, V106, P482, DOI 10.1177/0141076813493063; Chalmers I, 2009, OBSTET GYNECOL, V114, P1341, DOI 10.1097/AOG.0b013e3181c3020d; Cheung C, 2010, ADV SKIN WOUND CARE, V23, P39, DOI 10.1097/01.ASW.0000363487.01977.a9; Chitama D, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-46; Cooke J, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0014-y; Cowan K, 2010, J AMBUL CARE MANAG, V33, P241, DOI 10.1097/JAC.0b013e3181e62cda; Cowman S, 2012, J CLIN NURS, V21, P344, DOI 10.1111/j.1365-2702.2011.03950.x; Crowe Sally, 2015, Res Involv Engagem, V1, P2, DOI 10.1186/s40900-015-0003-x; Cullum N, 2016, PROGRAMME GRANTS APP, V4; Dalheim A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-367; Deane KHO, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006434; Dowsett C, 2014, J WOUND CARE, V23, P552, DOI 10.12968/jowc.2014.23.11.552; Elwyn G, 2010, J EVAL CLIN PRACT, V16, P627, DOI 10.1111/j.1365-2753.2009.01262.x; Forsman H, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-46; Friman A, 2014, PRIM HEALTH CARE RES, V15, P386, DOI 10.1017/S1463423613000303; Gadsby R, 2012, DIABETIC MED, V29, P1321, DOI 10.1111/j.1464-5491.2012.03755.x; Gillespie BM, 2015, J ADV NURS, V71, P1238, DOI 10.1111/jan.12598; Hall J, 2014, WOUND REPAIR REGEN, V22, P694, DOI 10.1111/wrr.12230; Harvey N, 2012, INT J NURS PRACT, V18, P188, DOI 10.1111/j.1440-172X.2012.02017.x; Hastings Clare, 2014, Nurs Manage, V45, P9, DOI 10.1097/01.NUMA.0000452006.79838.67; Hodgson R, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-19; Jacob E, 2017, J ADV NURS, V73, P1982, DOI 10.1111/jan.13306; Kelly S, 2015, AGE AGEING, V44, P985, DOI 10.1093/ageing/afv143; Knight SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162136; Layton A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008085; Lophatananon A, 2011, BJU INT, V108, P1040, DOI 10.1111/j.1464-410X.2011.10609.x; Madden M., 2016, RES INVOLVEMENT ENGA, V2, P1, DOI [10.1186/s40900-016-0026-y, DOI 10.1186/S40900-016-0026-Y]; McMillan SS, 2016, INT J CLIN PHARM; Naimoli JF, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0041-3; Norris R, 2012, J WOUND CARE, V21, P216, DOI 10.12968/jowc.2012.21.5.216; Petit-Zeman S, 2010, LANCET, V376, P667, DOI 10.1016/S0140-6736(10)60712-X; Pollock A, 2014, J HEALTH SERV RES PO, V19, P12, DOI 10.1177/1355819613500665; Rangan A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010412; Renner R, 2014, ACTA DERM-VENEREOL, V94, P50, DOI 10.2340/00015555-1635; Rowe F, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004905; Sibbald SL, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-43; Squires JE, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-21; Stone PW, 2002, APPL NURS RES, V15, P197, DOI 10.1053/apnr.2002.34181; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; Thomas RH, 2010, J NEUROL NEUROSUR PS, V81, P918, DOI 10.1136/jnnp.2009.192716; Tong A, 2008, NEPHROL DIAL TRANSPL, V23, P3206, DOI 10.1093/ndt/gfn207; Tong A, 2015, AM J KIDNEY DIS, V66, P212, DOI 10.1053/j.ajkd.2015.02.341; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; van der Veer SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128228; Vedhara K, 2010, DIABETOLOGIA, V53, P1590, DOI 10.1007/s00125-010-1743-7; Viergever RF, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-36; Vowden K, 2005, INTERNURSECOM S2, V10, pS6; Walburn J, 2009, J PSYCHOSOM RES, V67, P253, DOI 10.1016/j.jpsychores.2009.04.002; West C, 2012, NURS EDUC TODAY, V32, P576, DOI 10.1016/j.nedt.2011.07.002; Whiffin Charlotte Jane, 2013, Br J Nurs, V22, P831; Woo Kevin Y, 2012, Surg Technol Int, V22, P57	59	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188958	10.1371/journal.pone.0188958	http://dx.doi.org/10.1371/journal.pone.0188958			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO8CU	29206884	Green Published, Green Submitted, gold			2022-12-27	WOS:000417110700033
J	Lopez-Torrecillas, F; Lopez-Quirantes, EM; Maldonado, A; Albein-Urios, N; Rueda, MD; Verdejo-Garcia, A				Lopez-Torrecillas, Francisca; Maria Lopez-Quirantes, Eva; Maldonado, Antonio; Albein-Urios, Natalia; del Mar Rueda, Ma; Verdejo-Garcia, Antonio			Decisional balance and processes of change in community-recruited with moderate-high versus mild severity of cannabis dependence	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; NICOTINE DEPENDENCE; SMOKING-CESSATION; FAGERSTROM TEST; ALCOHOL-USE; SCALE SDS; BEHAVIORS; USERS; RELIABILITY; RELAPSERS	Decisional Balance and Processes of Change are generally addressed in motivational interventions for the treatment of cannabis use disorders. However, specific aspects of these multifaceted constructs, with greater relevance for severe cannabis users, need to be ascertained to enable better interventions. This study aimed to compare the different facets of decisional balance and processes of change between mild and severe cannabis users in a community-based sample of young undergraduates. Thirty-one severe cannabis users and 31 mild cannabis users, indicated with the Severity of Dependence Scale, were assessed using the Decisional Balance Questionnaire (DBQ) and the Processes of Change Questionnaire (PCQ). We found that severe cannabis users had higher scores in the DBQ dimensions of Utilitarian Gains for the Self, Utilitarian Gains for Significant Others, and Selfapproval, as well as in the total subscale of Gains but not Losses. The group of severe cannabis users also had higher scores in the PCQ dimensions of Self-revaluations and Counter-conditioning. Our results pinpoint specific dimensions of Decisional Balance and Processes of Change that are endorsed by severe cannabis users. This knowledge could be applied to inform motivational interventions targeting severe cannabis users.	[Lopez-Torrecillas, Francisca; Maria Lopez-Quirantes, Eva; Maldonado, Antonio] Univ Granada, Dept Expt Psychol, Learning Emot & Decis Grp, Granada, Spain; [Lopez-Torrecillas, Francisca; Maria Lopez-Quirantes, Eva; Maldonado, Antonio] Univ Granada, Ctr Res Mind Brain & Behav CIMCYC, Granada, Spain; [Albein-Urios, Natalia] Deakin Univ, Sch Psychol, Burwood, Vic, Australia; [del Mar Rueda, Ma] Univ Granada, Dept Stat & Operat Res, Granada, Spain; [Verdejo-Garcia, Antonio] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia	University of Granada; University of Granada; Deakin University; University of Granada; Monash University	Lopez-Torrecillas, F (corresponding author), Univ Granada, Dept Expt Psychol, Learning Emot & Decis Grp, Granada, Spain.; Lopez-Torrecillas, F (corresponding author), Univ Granada, Ctr Res Mind Brain & Behav CIMCYC, Granada, Spain.	fcalopez@ugr.es	Albein-Urios, Natalia/A-4514-2016; Verdejo-Garcia, Antonio/AAV-1147-2021; Lopez-Torrecillas, Francisca/C-8267-2018; Maldonado, Antonio/E-9540-2018; Rueda, Maria del Mar/F-9571-2015	Albein-Urios, Natalia/0000-0001-7841-018X; Verdejo-Garcia, Antonio/0000-0001-8874-9339; Maldonado, Antonio/0000-0001-5903-3833; lopez-torrecillas, francisca/0000-0002-4541-5184; Rueda, Maria del Mar/0000-0002-2903-8745				Becona E, 1998, PSYCHOL REP, V83, P1455, DOI 10.2466/pr0.1998.83.3f.1455; Brown JL, 2013, CURR HIV-AIDS REP, V10, P356, DOI 10.1007/s11904-013-0174-8; Bruijnzeel AW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153327; Cataldo JK, 2010, ONCOLOGY-BASEL, V78, P289, DOI 10.1159/000319937; Cooper K, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19560; Cuenca-Royo AM, 2012, ADDICT BEHAV, V37, P709, DOI 10.1016/j.addbeh.2012.02.012; D'Amico EJ, 2015, J CONSULT CLIN PSYCH, V83, P68, DOI 10.1037/a0038155; Davis ML, 2015, EVAL HEALTH PROF, V38, P94, DOI 10.1177/0163278714529970; Elliott JC, 2011, PSYCHOL ADDICT BEHAV, V25, P90, DOI 10.1037/a0021743; Enzi B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119150; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), ANN REP 2015; Girle R, 2004, ARGUMENTATION LIB, V9, P55; Gokbayrak NS, 2015, ADDICT BEHAV, V42, P176, DOI 10.1016/j.addbeh.2014.11.022; Gonzalez-Pinto A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160949; GOSSOP M, 1995, ADDICTION, V90, P607, DOI 10.1111/j.1360-0443.1995.tb02199.x; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hides L, 2007, ADDICTION, V102, P35, DOI 10.1111/j.1360-0443.2006.01669.x; Koenders L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152482; Longmire-Avital B, 2010, ANN BEHAV MED, V40, P176, DOI 10.1007/s12160-010-9194-4; Lorenzetti V, 2016, FRONT BEHAV NEUROSCI, V10; Martin G, 2006, DRUG ALCOHOL DEPEN, V83, P90, DOI 10.1016/j.drugalcdep.2005.10.014; Migneault JP, 1999, SUBST USE MISUSE, V34, P1325, DOI 10.3109/10826089909029387; Norman GJ, 1998, ADDICT BEHAV, V23, P139, DOI 10.1016/S0306-4603(97)00039-7; PROCHASKA JO, 1988, J CONSULT CLIN PSYCH, V56, P520, DOI 10.1037/0022-006X.56.4.520; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; PROCHASKA JO, 1994, HEALTH PSYCHOL, V13, P39, DOI 10.1037/0278-6133.13.1.39; Redding CA, 2011, SUBST USE MISUSE, V46, P1664, DOI 10.3109/10826084.2011.565853; Rohsenow D., 1992, 26 ANN CONV ASS ADV; Sun X, 2007, ADDICT BEHAV, V32, P2707, DOI 10.1016/j.addbeh.2007.04.005; Tejero A., 2003, INSTRUMENTOS 150 NIC, P23; Tejero A, 1994, DROGODEPENDENCIAS IN, P163; Troup LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149764; Trujols J, 1997, ADICCIONES, V9, P331; van Winkel R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137625; Velasquez MM, 2009, J CONSULT CLIN PSYCH, V77, P657, DOI 10.1037/a0015519; VELICER WF, 1985, J PERS SOC PSYCHOL, V48, P1279, DOI 10.1037/0022-3514.48.5.1279	36	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188476	10.1371/journal.pone.0188476	http://dx.doi.org/10.1371/journal.pone.0188476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO7EC	29206230	Green Published, gold			2022-12-27	WOS:000417033200008
J	Dilley, RJ; Ash, OG				Dilley, Rodney J.; Ash, Oliver G.			Addressing the cost of infractions in the online literature and databases	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION	Myocardial infarction sometimes appears misspelt as myocardial infraction in the cardiovascular research literature. With accurate citation of literature contributions important to advancing the field and its contributors, in this study we aimed to document the frequency and explore the causes and impact of this error specific to the cardiology literature. Literature databases (PubMed, Scopus, Web of Science, WIPO, Google Scholar, Google) were searched to identify the rate of myocardial infraction errors and found an error rate between 0.2% and 1.6%, with substantial differences between search tools used. A Scopus search was used to show changes in errors over time, differences between journals and by specific authors. Myocardial infraction occurred at increasing annual rates over time and at higher rates than other errors. Increasing error rates were associated with increased volume of searchable material rather than quality of the literature. Transcription from article to database is a common source of error and some databases have higher rates of these errors. Simple measures to avoid and to correct these errors in the literature and the databases are also discussed.	[Dilley, Rodney J.] Univ Western Australia, Ear Sci Inst Australia, Sch Med, Nedlands, WA, Australia; [Dilley, Rodney J.] Univ Western Australia, Sch Med, Div Surg, Ear Sci Ctr, Nedlands, WA, Australia; [Ash, Oliver G.] Univ Notre Dame, Fremantle, WA, Australia	Ear Science Institute Australia; University of Western Australia; University of Western Australia; University of Notre Dame Australia	Dilley, RJ (corresponding author), Univ Western Australia, Ear Sci Inst Australia, Sch Med, Nedlands, WA, Australia.; Dilley, RJ (corresponding author), Univ Western Australia, Sch Med, Div Surg, Ear Sci Ctr, Nedlands, WA, Australia.	rodney.dilley@uwa.edu.au	Dilley, Rodney/A-9921-2008	Dilley, Rodney/0000-0003-4681-7502				FRIEDBERG CK, 1972, CIRCULATION, V45, P179, DOI 10.1161/01.CIR.45.1.179; GIANNUZZI P, 1993, J AM COLL CARDIOL, V22, P1821, DOI 10.1016/0735-1097(93)90764-R; LAWRIE DM, 1969, LANCET, V2, P1085; Poder TG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177476; Shultz M, 2007, J MED LIBR ASSOC, V95, P442, DOI 10.3163/1536-5050.95.4.442; Wallentin L, 2016, LANCET, V388, P1903, DOI 10.1016/S0140-6736(16)31276-4; Wirtz VJ, 2016, CIRCULATION, V133, P2076, DOI 10.1161/CIRCULATIONAHA.115.008722; Wright K, 1989, Sci Am, V261, P30; Zhu D, 2016, J AM COLL CARDIOL, V67, P2803, DOI 10.1016/j.jacc.2016.03.568	9	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188761	10.1371/journal.pone.0188761	http://dx.doi.org/10.1371/journal.pone.0188761			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190782	gold, Green Published			2022-12-27	WOS:000416841900119
J	Mathavan, K; Khedgikar, V; Bartolo, V; Alfandari, D				Mathavan, Ketan; Khedgikar, Vikram; Bartolo, Vanessa; Alfandari, Dominique			The ectodomain of cadherin-11 binds to erbB2 and stimulates Akt phosphorylation to promote cranial neural crest cell migration	PLOS ONE			English	Article							SOLUBLE-E-CADHERIN; GROWTH-FACTOR RECEPTOR; N-CADHERIN; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAYS; XENOPUS; ADHESION; PROTEOLYSIS; ADAM13; ACTIN	During development, a multi-potent group of cells known as the cranial neural crest (CNC) migrate to form craniofacial structures. Proper migration of these cells requires proteolysis of cell adhesion molecules, such as cadherins. In Xenopus laevis, preventing extracellular cleavage of cadherin-11 impairs CNC migration. However, overexpression of the soluble cleavage product (EC1-3) is capable of rescuing this phenotype. The mechanism by which EC1-3 promotes CNC migration has not been investigated until now. Here we show that EC1-3 stimulates phosphorylation of Akt, a target of PI3K, in X. laevis CNC. Through immunoprecipitation experiments, we determined that EC1-3 interacts with all ErbB receptors, PDGFR alpha, and FGFR1. Of these receptors, only ErbB2 was able to produce an increase in Akt phosphorylation upon treatment with a recombinant EC1-3. This increase was abrogated by mubritinib, an inhibitor of ErbB2. We were able to recapitulate this decrease in Akt phosphorylation in vivo by knocking down ErbB2 in CNC cells. Knockdown of the receptor also significantly reduced CNC migration in vivo. We confirmed the importance of ErbB2 and ErbB receptor signaling in CNC migration using mubritinib and canertinib, respectively. Mubritinib and the PI3K inhibitor LY294002 significantly decreased cell migration while canertinib nearly prevented it altogether. These data show that ErbB2 and Akt are important for CNC migration and implicate other ErbB receptors and Akt-independent signaling pathways. Our findings provide the first example of a functional interaction between the extracellular domain of a type II classical cadherin and growth factor receptors.	[Mathavan, Ketan; Khedgikar, Vikram; Bartolo, Vanessa; Alfandari, Dominique] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Alfandari, D (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA.	alfandar@vasci.umass.edu		alfandari, dominique/0000-0002-0557-1246	National Institutes of Health, U.S. Public Health Service [RO1-DE016289]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016289] Funding Source: NIH RePORTER	National Institutes of Health, U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health, U.S. Public Health Service, Grant RO1-DE016289 to D.A.	Abbruzzese G, 2016, DEV BIOL, V415, P383, DOI 10.1016/j.ydbio.2015.07.018; Abbruzzese G, 2015, J CELL SCI, V128, P1139, DOI 10.1242/jcs.163063; Alfandari D, 2003, DEV BIOL, V260, P449, DOI 10.1016/S0012-1606(03)00277-X; ATALIOTIS P, 1995, DEVELOPMENT, V121, P3099; Bahm I, 2017, DEVELOPMENT; Borchers A, 2001, DEVELOPMENT, V128, P3049; Brouxhon SM, 2014, ONCOGENE, V33, P225, DOI 10.1038/onc.2012.563; Brouxhon SM, 2014, MOL CARCINOGEN, V53, P893, DOI 10.1002/mc.22048; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; Coles EG, 2007, DEV BIOL, V312, P533, DOI 10.1016/j.ydbio.2007.09.056; Cousin H, 2000, DEV BIOL, V227, P197, DOI 10.1006/dbio.2000.9871; Cousin H, 2011, DEV CELL, V20, P256, DOI 10.1016/j.devcel.2010.12.009; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; De Wever O, 2007, CLIN EXP METASTAS, V24, P685, DOI 10.1007/s10585-007-9104-8; Delaune E, 2005, DEVELOPMENT, V132, P299, DOI 10.1242/dev.01582; Dell'Albani P, 1998, J NEUROSCI RES, V54, P191, DOI 10.1002/(SICI)1097-4547(19981015)54:2<191::AID-JNR7>3.3.CO;2-#; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Grieve AG, 2014, J CELL SCI, V127, P3331, DOI 10.1242/jcs.147926; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Huang CF, 2010, CANCER RES, V70, P4580, DOI 10.1158/0008-5472.CAN-09-3016; Inge LJ, 2011, EXP CELL RES, V317, P838, DOI 10.1016/j.yexcr.2010.12.025; JOHNSTON MC, 1995, CRIT REV ORAL BIOL M, V6, P368, DOI 10.1177/10454411950060040601; Kashef J, 2009, GENE DEV, V23, P1393, DOI 10.1101/gad.519409; Khedgikar V, 2017, ELIFE, V6, DOI 10.7554/eLife.26898; Komatsu K, 2007, DEV BIOL, V303, P82, DOI 10.1016/j.ydbio.2006.10.037; Kulesa PM, 2010, DEV BIOL, V344, P543, DOI 10.1016/j.ydbio.2010.04.010; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; May C, 2005, BLOOD, V105, P4337, DOI 10.1182/blood-2005-01-0010; McCusker C, 2009, MOL BIOL CELL, V20, P78, DOI 10.1091/mbc.E08-05-0535; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Moriyama Y, 2011, BIOCHEM BIOPH RES CO, V404, P974, DOI 10.1016/j.bbrc.2010.12.093; Najy AJ, 2008, J BIOL CHEM, V283, P18393, DOI 10.1074/jbc.M801329200; Neuner R, 2009, MECH DEVELOP, V126, P240, DOI 10.1016/j.mod.2008.10.010; Nie SY, 2006, DEV DYNAM, V235, P301, DOI 10.1002/dvdy.20623; Noe V, 2001, J CELL SCI, V114, P111; NOH DY, 1995, BBA-REV CANCER, V1242, P99, DOI 10.1016/0304-419X(95)00006-0; PARADIES NE, 1993, J NEUROSCI RES, V36, P33, DOI 10.1002/jnr.490360105; Parisiadou L, 2004, NEURODEGENER DIS, V1, P184, DOI 10.1159/000080984; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Porlan E, 2014, NAT CELL BIOL, V16, P629, DOI 10.1038/ncb2993; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Scarpa E, 2015, DEV CELL, V34, P421, DOI 10.1016/j.devcel.2015.06.012; Schiffmacher AT, 2016, J CELL BIOL, V215, P735, DOI 10.1083/jcb.201604006; Schiffmacher AT, 2014, MOL BIOL CELL, V25, P41, DOI 10.1091/mbc.E13-08-0459; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shirakabe K, 2001, J BIOL CHEM, V276, P9352, DOI 10.1074/jbc.M007913200; Shoval I, 2007, DEVELOPMENT, V134, P491, DOI 10.1242/dev.02742; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Theisen CS, 2007, MOL BIOL CELL, V18, P1220, DOI 10.1091/mbc.E06-10-0960; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Wicki A, 2016, PHYSIOL REV, V96, P805, DOI 10.1152/physrev.00024.2015; WILSON P, 1991, DEVELOPMENT, V112, P289; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	63	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188963	10.1371/journal.pone.0188963	http://dx.doi.org/10.1371/journal.pone.0188963			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190819	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900179
J	Moura, MD; Diniz, HHL; Droguett, EL; da Cunha, BS; Lins, ID; Simoni, VR				Moura, Marcio das Chagas; Lima Diniz, Helder Henrique; Droguett, Enrique Lopez; da Cunha, Beatriz Sales; Lins, Isis Didier; Simoni, Vicente Ribeiro			Embedding resilience in the design of the electricity supply for industrial clients	PLOS ONE			English	Article							CRITICAL INFRASTRUCTURES; POWER GRIDS; NETWORKS; METRICS; DISRUPTION; FRAMEWORK; RISK; OPTIMIZATION; ROBUSTNESS; SELECTION	This paper proposes an optimization model, using Mixed-Integer Linear Programming (MILP), to support decisions related to making investments in the design of power grids serving industrial clients that experience interruptions to their energy supply due to disruptive events. In this approach, by considering the probabilities of the occurrence of a set of such disruptive events, the model is used to minimize the overall expected cost by determining an optimal strategy involving pre- and post-event actions. The pre-event actions, which are considered during the design phase, evaluate the resilience capacity (absorption, adaptation and restoration) and are tailored to the context of industrial clients dependent on a power grid. Four cases are analysed to explore the results of different probabilities of the occurrence of disruptions. Moreover, two scenarios, in which the probability of occurrence is lowest but the consequences are most serious, are selected to illustrate the model's applicability. The results indicate that investments in pre-event actions, if implemented, can enhance the resilience of power grids serving industrial clients because the impacts of disruptions either are experienced only for a short time period or are completely avoided.	[Moura, Marcio das Chagas; Lima Diniz, Helder Henrique; Droguett, Enrique Lopez; da Cunha, Beatriz Sales; Lins, Isis Didier] Univ Fed Pernambuco, Ctr Risk Anal & Environm Modeling CEERMA, Recife, PE, Brazil; [Moura, Marcio das Chagas; Lima Diniz, Helder Henrique; Droguett, Enrique Lopez; da Cunha, Beatriz Sales; Lins, Isis Didier] Univ Fed Pernambuco, Dept Prod Engn, Recife, PE, Brazil; [Droguett, Enrique Lopez] Univ Chile, Mech Engn Dept, Santiago, Chile; [Droguett, Enrique Lopez] Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA; [Simoni, Vicente Ribeiro] Co Hidro Eletr Sao Francisco Chesf, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidad de Chile; University System of Maryland; University of Maryland College Park	Droguett, EL (corresponding author), Univ Fed Pernambuco, Ctr Risk Anal & Environm Modeling CEERMA, Recife, PE, Brazil.; Droguett, EL (corresponding author), Univ Fed Pernambuco, Dept Prod Engn, Recife, PE, Brazil.; Droguett, EL (corresponding author), Univ Chile, Mech Engn Dept, Santiago, Chile.; Droguett, EL (corresponding author), Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA.	elopezdroguett@ing.uchile.cl	Lins, Isis/L-6094-2013; Droguett, Enrique/AAC-9758-2019; Moura, Márcio das Chagas/L-3246-2013	Moura, Márcio das Chagas/0000-0001-5486-2093; Lins, Isis Didier/0000-0002-4090-5109; Lopez Droguett, Enrique/0000-0002-0790-8439				Ambulkar S, 2015, J OPER MANAG, V33-34, P111, DOI 10.1016/j.jom.2014.11.002; [Anonymous], 2014, INT J PROD ECON, V157, P89; [Anonymous], 2015, ESEA FLEX B, V35, P1; Banos R, 2011, WATER RESOUR MANAG, V25, P2351, DOI 10.1007/s11269-011-9812-3; Barker K, 2013, RELIAB ENG SYST SAFE, V117, P89, DOI 10.1016/j.ress.2013.03.012; Bartos M, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/11/114008; Bhatia U, 2015, PLOS ONE, V10, P1; Bode C, 2011, ACAD MANAGE J, V54, P833, DOI 10.5465/AMJ.2011.64870145; Campbell R.J., 2012, WEATHER RELATED POWE; Cardoso SR, 2015, OMEGA-INT J MANAGE S, V56, P53, DOI 10.1016/j.omega.2015.03.008; Carvalho R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090265; Chen LC, 2012, TRANSPORT SCI, V46, P109, DOI 10.1287/trsc.1110.0376; Chopra SS, 2014, J ENVIRON MANAGE, V141, P86, DOI 10.1016/j.jenvman.2013.12.038; CNI-National Confederation of Industry, 2016, SPEC REP IND EN IND, P1; Correio Brazilience, 2012, IND CALC LOSS 6 MILL; Cuadra L, 2015, ENERGIES, V8, P9211, DOI 10.3390/en8099211; Dewenter T, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/1/015005; Dixit V, 2016, COMPUT IND ENG, V93, P205, DOI 10.1016/j.cie.2015.12.029; Espinoza S, 2016, ELECTR POW SYST RES, V136, P352, DOI 10.1016/j.epsr.2016.03.019; Fang YP, 2017, RELIAB ENG SYST SAFE, V159, P161, DOI 10.1016/j.ress.2016.10.028; Faturechi R, 2014, TRANSPORT RES B-METH, V70, P47, DOI 10.1016/j.trb.2014.08.007; Faturechi R, 2014, COMPUT OPER RES, V43, P335, DOI 10.1016/j.cor.2013.10.009; Filippini R, 2014, RELIAB ENG SYST SAFE, V125, P82, DOI 10.1016/j.ress.2013.09.010; Francis R, 2014, RELIAB ENG SYST SAFE, V121, P90, DOI 10.1016/j.ress.2013.07.004; Ganin AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19540; Garg A, 2015, ENERG POLICY, V81, P226, DOI 10.1016/j.enpol.2014.12.007; Ghanem DA, 2016, ENERG POLICY, V92, P171, DOI 10.1016/j.enpol.2016.02.003; Haimes YY, 2009, RISK ANAL, V29, P498, DOI 10.1111/j.1539-6924.2009.01216.x; Henry D, 2012, RELIAB ENG SYST SAFE, V99, P114, DOI 10.1016/j.ress.2011.09.002; Hillier FS, 2015, INTRO OPERATIONS RES, V10th; Hokstad P., 2012, RISK INTERDEPENDENCI; Hosseini S, 2016, RELIAB ENG SYST SAFE, V145, P47, DOI 10.1016/j.ress.2015.08.006; Johansson J, 2013, RELIAB ENG SYST SAFE, V120, P27, DOI 10.1016/j.ress.2013.02.027; Kjolle GH, 2012, RELIAB ENG SYST SAFE, V105, P80, DOI 10.1016/j.ress.2012.02.006; Koc Y, 2014, IEEE INT C NETW SENS, P386, DOI 10.1109/ICNSC.2014.6819657; Kwasinski A, 2016, ENERGIES, V9, DOI 10.3390/en9020093; Labaka L, 2015, RELIAB ENG SYST SAFE, V141, P92, DOI 10.1016/j.ress.2015.03.009; Levalle RR, 2015, COMPUT IND ENG, V90, P67, DOI 10.1016/j.cie.2015.08.017; Linkov I, 2014, NAT CLIM CHANGE, V4, P407, DOI 10.1038/nclimate2227; Lundberg J, 2015, RELIAB ENG SYST SAFE, V141, P22, DOI 10.1016/j.ress.2015.03.013; Mari SI, 2014, SUSTAINABILITY-BASEL, V6, P6666, DOI 10.3390/su6106666; Mattsson LG, 2015, TRANSPORTATION RES A; McDonald J. D., 2007, ELECT POWER SUBSTATI; Mendonca D, 2015, RELIAB ENG SYST SAFE, V141, P83, DOI 10.1016/j.ress.2015.03.017; Miller-Hooks E, 2012, COMPUT OPER RES, V39, P1633, DOI 10.1016/j.cor.2011.09.017; Nan C, 2017, RELIAB ENG SYST SAFE, V157, P35, DOI 10.1016/j.ress.2016.08.013; Nezamoddini N, 2017, ELECTR POW SYST RES, V143, P329, DOI 10.1016/j.epsr.2016.08.046; Omer M, 2009, IEEE SYST J, V3, P295, DOI 10.1109/JSYST.2009.2022570; Ouyang M, 2014, RELIAB ENG SYST SAFE, V121, P43, DOI 10.1016/j.ress.2013.06.040; Panteli M, 2015, ELECTR POW SYST RES, V127, P259, DOI 10.1016/j.epsr.2015.06.012; Pepyne DL, 2007, J SYST SCI SYST ENG, V16, P202, DOI 10.1007/s11518-007-5044-8; Prieto F, 2014, INT J ELEC POWER, V54, P10, DOI 10.1016/j.ijepes.2013.06.033; Raby A, 2015, INT J DISAST RISK RE, V14, P332, DOI 10.1016/j.ijdrr.2015.08.009; Ramirez-Marquez JE, 2012, COMPUT IND ENG, V63, P235, DOI 10.1016/j.cie.2012.02.016; Reed DA, 2009, IEEE SYST J, V3, P174, DOI 10.1109/JSYST.2009.2017396; Roege PE, 2014, ENERG POLICY, V72, P249, DOI 10.1016/j.enpol.2014.04.012; Rokstad MM, 2015, RELIAB ENG SYST SAFE, V142, P148, DOI 10.1016/j.ress.2015.05.014; Salami O, 2011, MATH COMPUT MODEL, V53, P2219, DOI 10.1016/j.mcm.2010.08.027; Sawik T, 2013, OMEGA-INT J MANAGE S, V41, P259, DOI 10.1016/j.omega.2012.05.003; Shukla A, 2011, INT J PHYS DISTR LOG, V41, P623, DOI 10.1108/09600031111147844; Tang C., 2006, INT J LOGIST-RES APP, V9, P33, DOI [10.1080/13675560500405584, DOI 10.1080/13675560500405584]; Turnquist Mark, 2013, Environment Systems & Decisions, V33, P104, DOI 10.1007/s10669-012-9428-z; Utne IB, 2011, RELIAB ENG SYST SAFE, V96, P671, DOI 10.1016/j.ress.2010.12.006; Vugrin ED, 2010, SUSTAINABLE AND RESILIENT CRITICAL INFRASTRUCTURE SYSTEMS: SIMULATION, MODELING, AND INTELLIGENT ENGINEERING, P77, DOI 10.1007/978-3-642-11405-2_3; Wang XR, 2015, 2015 7TH INTERNATIONAL WORKSHOP ON RELIABLE NETWORKS DESIGN AND MODELING (RNDM) PROCE4EDINGS, P208, DOI 10.1109/RNDM.2015.7325231; Wei DQ, 2012, PHYSICA A, V391, P2771, DOI 10.1016/j.physa.2011.12.030; Zhang GH, 2008, 2008 THIRD INTERNATIONAL CONFERENCE ON ELECTRIC UTILITY DEREGULATION AND RESTRUCTURING AND POWER TECHNOLOGIES, VOLS 1-6, P1554, DOI 10.1109/DRPT.2008.4523652; Zhang M, 2016, RESOURCES CONSERVATI; Zhang X, 2015, J TRANSP GEOGR, V46, P35, DOI 10.1016/j.jtrangeo.2015.05.006; Zhao S, 2017, RELIAB ENG SYST SAFE, V164, P84, DOI 10.1016/j.ress.2017.02.009	70	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188875	10.1371/journal.pone.0188875	http://dx.doi.org/10.1371/journal.pone.0188875			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190777	Green Submitted, gold, Green Published			2022-12-27	WOS:000416841900155
J	Huang, MF; Lin, SJ; Ko, TP; Liao, YT; Hsu, KC; Wang, HC				Huang, Ming-Fen; Lin, Shin-Jen; Ko, Tzu-Ping; Liao, Yi-Ting; Hsu, Kai-Cheng; Wang, Hao-Ching			The monomeric form of Neisseria DNA mimic protein DMP19 prevents DNA from binding to the histone-like HU protein	PLOS ONE			English	Article							ESCHERICHIA-COLI; MASS-SPECTROMETRY; GLYCOSYLASE; SYSTEM; SAUGI	DNA mimicry is a direct and effective strategy by which the mimic competes with DNA for the DNA binding sites on other proteins. Until now, only about a dozen proteins have been shown to function via this strategy, including the DNA mimic protein DMP19 from Neisseria meningitides. We have shown previously that DMP19 dimer prevents the operator DNA from binding to the transcription factor NHTF. Here, we provide new evidence that DMP19 monomer can also interact with the Neisseria nucleoid-associated protein HU. Using BS3 crosslinking, gel filtration and isothermal titration calorimetry assays, we found that DMP19 uses its monomeric form to interact with the Neisseria HU dimer. Crosslinking conjugated mass spectrometry was used to investigate the binding mode of DMP19 monomer and HU dimer. Finally, an electrophoretic mobility shift assay (EMSA) confirmed that the DNA binding affinity of HU is affected by DMP19. These results showed that DMP19 is bifunctional in the gene regulation of Neisseria through its variable oligomeric forms.	[Huang, Ming-Fen; Liao, Yi-Ting; Wang, Hao-Ching] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Translat Med, Taipei, Taiwan; [Lin, Shin-Jen] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Tainan, Taiwan; [Ko, Tzu-Ping] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Liao, Yi-Ting; Wang, Hao-Ching] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan; [Liao, Yi-Ting; Wang, Hao-Ching] Acad Sinica, Taipei, Taiwan; [Hsu, Kai-Cheng] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan	Taipei Medical University; National Cheng Kung University; Academia Sinica - Taiwan; Taipei Medical University; Academia Sinica - Taiwan; Taipei Medical University	Wang, HC (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Translat Med, Taipei, Taiwan.; Wang, HC (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan.; Wang, HC (corresponding author), Acad Sinica, Taipei, Taiwan.	wanghc@tmu.edu.tw		Liao, Yi-Ting/0000-0001-5050-7481; Wang, Hao-Ching/0000-0003-2396-717X	Ministry of Science and Technology [MOST 103-2311-B-038 -005, MOST 106-2311-B-038 -002]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported financially by Ministry of Science and Technology (Grant MOST 103-2311-B-038 -005 and MOST 106-2311-B-038 -002). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported financially by the Ministry of Science and Technology (Grant MOST 103-2311-B-038-005 and MOST 106-2311-B-038-002). LTQ-Orbitrap data and additional technical assistance were provided by Dr Shu-Yu Lin of the Academia Sinica Common Mass Spectrometry Facilities located at the Institute of Biological Chemistry. We also thank Dr Shu-Chuan Jao of the Biophysics Core Facility, Department of Academic Affairs and Instrument Service at Academia Sinica for her help in ITC analysis.	Balandina A, 2002, J BIOL CHEM, V277, P27622, DOI 10.1074/jbc.M201978200; Balandina A, 2001, MOL MICROBIOL, V39, P1069, DOI 10.1046/j.1365-2958.2001.02305.x; Chodavarapu S, 2008, MOL MICROBIOL, V67, P781, DOI 10.1111/j.1365-2958.2007.06094.x; Dorman CJ, 2003, CURR OPIN GENET DEV, V13, P179, DOI 10.1016/S0959-437X(03)00025-X; Dryden DTF, 2006, TRENDS BIOTECHNOL, V24, P378, DOI 10.1016/j.tibtech.2006.06.004; Grove A, 2011, CURR ISSUES MOL BIOL, V13, P1; Hammel M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600650; Ho CH, 2014, J BIOL CHEM, V289, P27046, DOI 10.1074/jbc.M114.590851; Lee CC, 2014, ANGEW CHEM INT EDIT, V53, P13054, DOI 10.1002/anie.201405664; Lee HL, 2016, MOL CELL PROTEOMICS, V15, P1572, DOI 10.1074/mcp.M115.053603; Macvanin M, 2012, J BACTERIOL, V194, P6046, DOI 10.1128/JB.00961-12; Muller MQ, 2009, J MED CHEM, V52, P2875, DOI 10.1021/jm9000665; Naveen V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157165; Parsons LM, 2005, PROTEIN SCI, V14, P1684, DOI 10.1110/ps.041275705; Parsons LX, 2004, PROTEINS, V54, P375, DOI 10.1002/prot.10607; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Putnam CD, 2005, DNA REPAIR, V4, P1410, DOI 10.1016/j.dnarep.2005.08.007; Qian Z, 2015, MBIO, V6, DOI 10.1128/mBio.00998-15; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; Wang HC, 2016, NUCLEIC ACIDS RES, V44, P4440, DOI 10.1093/nar/gkw185; Wang HC, 2014, BIOCHEMISTRY-US, V53, P2865, DOI 10.1021/bi5002689; Wang HC, 2014, NUCLEIC ACIDS RES, V42, P1354, DOI 10.1093/nar/gkt964; Wang HC, 2013, NUCLEIC ACIDS RES, V41, P5127, DOI 10.1093/nar/gkt201; Wang HC, 2012, NUCLEIC ACIDS RES, V40, P5718, DOI 10.1093/nar/gks177; Wang HC, 2008, P NATL ACAD SCI USA, V105, P20758, DOI 10.1073/pnas.0811233106; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322	27	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189461	10.1371/journal.pone.0189461	http://dx.doi.org/10.1371/journal.pone.0189461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220372	Green Submitted, gold, Green Published			2022-12-27	WOS:000417469900059
J	Moreels, L; Bhat, C; Voracova, M; Peigneur, S; Goovaerts, H; Maki-Lohiluoma, E; Zahed, F; Pardo, LA; Yli-Kauhaluoma, J; Kiuru, P; Tytgat, J				Moreels, Lien; Bhat, Chinmay; Voracova, Manuela; Peigneur, Steve; Goovaerts, Hannah; Maki-Lohiluoma, Eero; Zahed, Farrah; Pardo, Luis A.; Yli-Kauhaluoma, Jari; Kiuru, Paula; Tytgat, Jan			Synthesis of novel purpurealidin analogs and evaluation of their effect on the cancerrelevant potassium channel K(V)10.1	PLOS ONE			English	Article							SPONGE PSAMMAPLYSILLA-PURPUREA; MARINE SPONGE; BROMOTYROSINE ALKALOIDS; CANCER; METABOLITES; APOPTOSIS; CELLS	In the search for novel anticancer drugs, the potassium channel K(V)10.1 has emerged as an interesting cancer target. Here, we report a new group of K(V)10.1 inhibitors, namely the purpurealidin analogs. These alkaloids are produced by the Verongida sponges and are known for their wide variety of bioactivities. In this study, we describe the synthesis and characterization of 27 purpurealidin analogs. Structurally, bromine substituents at the central phenyl ring and a methoxy group at the distal phenyl ring seem to enhance the activity on K(V)10.1. The mechanism of action of the most potent analog 5 was investigated. A shift of the activation curve to more negative potentials and an apparent inactivation was observed. Since K(V)10.1 inhibitors can be interesting anticancer drug lead compounds, the effect of 5 was evaluated on cancerous and non-cancerous cell lines. Compound 5 showed to be cytotoxic and appeared to induce apoptosis in all the evaluated cell lines.	[Moreels, Lien; Peigneur, Steve; Goovaerts, Hannah; Tytgat, Jan] Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Toxicol & Pharmacol, KU Leuven, Leuven, Belgium; [Bhat, Chinmay; Voracova, Manuela; Maki-Lohiluoma, Eero; Yli-Kauhaluoma, Jari; Kiuru, Paula] Univ Helsinki, Div Pharmaceut Chem & Technol, Drug Res Program, Fac Pharm, Helsinki, Finland; [Zahed, Farrah] Max Planck Inst Expt Med, Oncophysiol Grp, Gottingen, Germany; [Bhat, Chinmay] Univ Mysore, Govt Grade Coll Chamarajanagar 1, Mysore, Karnataka, India	KU Leuven; University of Helsinki; Max Planck Society; University of Mysore	Tytgat, J (corresponding author), Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Toxicol & Pharmacol, KU Leuven, Leuven, Belgium.	jan.tytgat@kuleuven.be	Pardo, Luis/C-5066-2013; Voráčová, Manuela/AAY-6190-2021; Moreels, Lien/P-6865-2017	Pardo, Luis/0000-0003-1375-4349; Voracova, Manuela/0000-0002-3404-8147; Kiuru, Paula/0000-0001-6084-684X; Moreels, Lien/0000-0002-7173-7195; Yli-Kauhaluoma, Jari/0000-0003-0370-7653; Tytgat, Jan/0000-0003-1778-6022; Peigneur, Steve/0000-0003-0504-5702; Bhat, Chinmay/0000-0002-5142-0115	Agency for Innovation by Science and Technology in Flanders [IWT 131231]; Marie Curie Initial Training Network lon TraC [289648]; Academy of Finland [285103]	Agency for Innovation by Science and Technology in Flanders; Marie Curie Initial Training Network lon TraC; Academy of Finland(Academy of Finland)	The project MAREX, Exploring Marine Resources for Bioactive Compounds: From Discovery to Sustainable Production and Industrial Applications 2010-2014, was funded by the European Union Seventh Framework Programme grant no. FP7-KBBE-2009-3-245137 and is sincerely acknowledged (http://cordis.eurapa.eu/project/rcn/950066_en. htm). LM is a recipient of a fellowship from the Agency for Innovation by Science and Technology in Flanders (IWT 131231) (hittps://www.iwt.be.english/welcomNt.be/english/welcome). FZ was funded by Marie Curie Initial Training Network lon TraC(Grant# 289648) (https://campus.uni-b m uensteb0e/ontratitiomei). PK and JY-K thank Academy of Finland for the project No. 285103 (http://www.aka.fi/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEVILLARD C, 1993, BIOCHEM J, V289, P599, DOI 10.1042/bj2890599; Dai JQ, 2016, BIOORG MED CHEM LETT, V26, P499, DOI 10.1016/j.bmcl.2015.11.086; Dyshlovoy SA, 2015, MAR DRUGS, V13, P5657, DOI 10.3390/md13095657; Essack M, 2011, MAR DRUGS, V9, P1580, DOI 10.3390/md9091580; Gomez-Lagunas F, 2017, J CELL PHYSIOL, V232, P2019, DOI 10.1002/jcp.25448; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; Hartung F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-109; Kim S., 2014, HDB ANTICANCER DRUGS, P1; Kotoku N, 2005, TETRAHEDRON, V61, P7211, DOI 10.1016/j.tet.2005.05.038; Kottakota SK, 2012, J NAT PROD, V75, P1090, DOI 10.1021/np300102z; Mebs D., 2002, VENOMOUS POISONOUS A; Mora FD, 2006, J NAT PROD, V69, P547, DOI 10.1021/np050397q; Pardo LA, 2012, CURR MED CHEM, V19, P675, DOI 10.2174/092986712798992011; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Peng Jiangnan, 2005, Alkaloids Chem Biol, V61, P59, DOI 10.1016/S1099-4831(05)61002-4; Pina IC, 2003, J ORG CHEM, V68, P3866, DOI 10.1021/jo034248t; Schwab A, 2008, PHYSIOLOGY, V23, P212, DOI 10.1152/physiol.00003.2008; Tilvi S, 2004, TETRAHEDRON, V60, P10207, DOI 10.1016/j.tet.2004.09.009; Tilvi S, 2012, EUR J MASS SPECTROM, V18, P333, DOI 10.1255/ejms.1181; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094; World Health Organization, 2017, CANC FACT SHEET; Yoshida M, 2008, CHEM PHARM BULL, V56, P1362, DOI 10.1248/cpb.56.1362; Zhang Y, 2013, ADV MECH ENG, V2013, P1, DOI [DOI 10.4225/08/58B5BAAD4FCC2, DOI 10.3864/J.ISSN.0578-1752.2013.10.014]	23	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188811	10.1371/journal.pone.0188811	http://dx.doi.org/10.1371/journal.pone.0188811			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220359	Green Published, Green Submitted, gold			2022-12-27	WOS:000417469900019
J	Tobino, K; Hirai, T; Johkoh, T; Fujimoto, K; Kawaguchi, A; Tomiyama, N; Takahashi, K; Seyama, K				Tobino, Kazunori; Hirai, Toyohiro; Johkoh, Takeshi; Fujimoto, Kiminori; Kawaguchi, Atsushi; Tomiyama, Noriyuki; Takahashi, Kazuhisa; Seyama, Kuniaki			Difference of the progression of pulmonary cysts assessed by computed tomography among COPD, lymphangioleiomyomatosis, and Birt-Hogg-Dube A syndrome	PLOS ONE			English	Article							THIN-SECTION CT; MATRIX METALLOPROTEINASES; SPONTANEOUS PNEUMOTHORAX; TUBEROUS SCLEROSIS; CHEST CT; EMPHYSEMA; MUTATIONS; GENE; PATHOGENESIS; FAMILIES	Many groups developed the methods to quantitatively analyze low attenuation area (LAA) on chest CT in patients with cystic lung diseases. Especially in COPD, it was reported that the cumulative size distribution of LAA clusters follows a power law characterized by the exponent D, which reflect the fractal dimension of terminal airspace geometry. We hypoyhesized that the quantitative charateristics of LAA clusters including fractal property might indicate the different features of the progression of cysts in cystic lung diseases. The aim of this study was to apply the CT image-based method of characterizing the size distribution of LAA clusters for lymphangioleiomyomatosis (LAM) and Birt-Hogg-Dube A syndrome (BHDS) to disclose their features of the progression of pulmonary cysts. 40 patients with COPD, 52 patients with LAM, and 18 patients with BHDS who had undergone CT scans at our institute between January 2002 and August 2009 were included. Differences among these diseases in the quantitative characteristics of LAA clusters {i.e., extent, number, size, fractal property, and the relationship between these quantitatives} were assessed. The Chi-sqsuare test, unpaired t-test, and one-way analyses of variance with Tukey post-hoc tests were used to compare groups, spline model with an interaction terms were used to assess the relationship between extent and number, and exponential regression model was used to assess the relationship between extent and size. Statistically significant differences separated the three diseases in extent and number (P < 0.001). Number was significantly correlated with extent in COPD (P < 0.001), but was not so in LAM and BHDS when extent exceeded 11.5% and 20.8%, respectively. Size was significantly correlated with extent in COPD and LAM (P < 0.001), but was not so in BHDS. The percentage of CT images with fractal property was higher in COPD than that in LAM and BHDS (95.8%, 92.9% and 63.0%, respectively). In conclusion, our study has demonstrated for the first time the different characteristics of the size distribution of LAA clusters among COPD, LAM and BHDS, and indicated that this method is useful for exploration of the pathophysiology in cystic lung diseases.	[Tobino, Kazunori] Iizuka Hosp, Dept Resp Med, Iizuka, Fukuoka, Japan; [Tobino, Kazunori; Takahashi, Kazuhisa; Seyama, Kuniaki] Juntendo Univ, Fac Med, Div Resp Med, Tokyo, Japan; [Tobino, Kazunori; Takahashi, Kazuhisa; Seyama, Kuniaki] Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Tobino, Kazunori; Seyama, Kuniaki] Study Grp Pneumothorax & Cyst Lung Dis, Setagaya Ku, Tokyo, Japan; [Hirai, Toyohiro] Kyoto Univ, Dept Resp Med, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Johkoh, Takeshi] Kinki Cent Hosp, Mutual Aid Assoc, Publ Sch Teachers, Dept Radiol, Itami, Hyogo, Japan; [Fujimoto, Kiminori] Kurume Univ, Sch Med, Dept Radiol, Kurume, Fukuoka, Japan; [Fujimoto, Kiminori] Kurume Univ Hosp, Ctr Diagnost Imaging, Kurume, Fukuoka, Japan; [Kawaguchi, Atsushi] Saga Univ, Fac Med, Ctr Comprehens Community Med, Saga, Saga, Japan; [Tomiyama, Noriyuki] Osaka Univ, Dept Radiol, Grad Sch Med, Osaka, Japan	Juntendo University; Kyoto University; Kurume University; Kurume University; Saga University; Osaka University	Tobino, K (corresponding author), Iizuka Hosp, Dept Resp Med, Iizuka, Fukuoka, Japan.; Tobino, K (corresponding author), Juntendo Univ, Fac Med, Div Resp Med, Tokyo, Japan.; Tobino, K (corresponding author), Grad Sch Med, Bunkyo Ku, Tokyo, Japan.; Tobino, K (corresponding author), Study Grp Pneumothorax & Cyst Lung Dis, Setagaya Ku, Tokyo, Japan.	tobino@juntendo.ac.jp						Avila NA, 2002, RADIOLOGY, V223, P189, DOI 10.1148/radiol.2231010315; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Furuya M, 2012, AM J SURG PATHOL, V36, P589, DOI 10.1097/PAS.0b013e3182475240; Goncharova EA, 2014, CELL REP, V7, P412, DOI 10.1016/j.celrep.2014.03.025; Graham RB, 2005, AM J RESP CRIT CARE, V172, P39, DOI 10.1164/rccm.200501-143OC; Gunji Y, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049874; Hayashi T, 1997, HUM PATHOL, V28, P1071, DOI 10.1016/S0046-8177(97)90061-7; Kumasaka T, 2014, HISTOPATHOLOGY, V65, P100, DOI 10.1111/his.12368; LENOIR S, 1990, RADIOLOGY, V175, P329, DOI 10.1148/radiology.175.2.2326456; Matsui K, 2000, ARCH PATHOL LAB MED, V124, P267; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Ohara T, 2006, RESPIROLOGY, V11, P579, DOI 10.1111/j.1440-1843.2006.00899.x; Painter JN, 2005, AM J HUM GENET, V76, P522, DOI 10.1086/428455; Pallisa E, 2002, RADIOGRAPHICS, V22, pS185, DOI 10.1148/radiographics.22.suppl_1.g02oc13s185; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; SAKAI N, 1994, CHEST, V106, P1319, DOI 10.1378/chest.106.5.1319; Schmidt LS, 2005, AM J HUM GENET, V76, P1023, DOI 10.1086/430842; Sharafkhaneh Amir, 2008, Proc Am Thorac Soc, V5, P475, DOI 10.1513/pats.200708-126ET; SNIDER GL, 1985, AM REV RESPIR DIS, V132, P182; Suki B, 2003, AM J RESP CRIT CARE, V168, P516, DOI 10.1164/rccm.200208-908PP; Sullivan EJ, 1998, CHEST, V114, P1689, DOI 10.1378/chest.114.6.1689; Tanabe N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044993; Tobino K, 2012, EUR J RADIOL, V81, P1340, DOI 10.1016/j.ejrad.2011.03.039; Tonan T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033868; Travis WD, 1999, LUNG BIOL HEALTH DIS, V131, P171; Winkler Tilo, 2011, Critical Reviews in Biomedical Engineering, V39, P263, DOI 10.1615/CritRevBiomedEng.v39.i4.20; Zhe XN, 2003, AM J RESP CELL MOL, V28, P504, DOI 10.1165/rcmb.2002-0124OC	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188771	10.1371/journal.pone.0188771	http://dx.doi.org/10.1371/journal.pone.0188771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220357	Green Published, Green Submitted, gold			2022-12-27	WOS:000417469900016
J	Chakraborty, J; Langdon-Embry, L; Cunanan, KM; Escalon, JG; Allen, PJ; Lowery, MA; O'Reilly, EM; Gonen, M; Do, RG; Simpson, AL				Chakraborty, Jayasree; Langdon-Embry, Liana; Cunanan, Kristen M.; Escalon, Joanna G.; Allen, Peter J.; Lowery, Maeve A.; O'Reilly, Eileen M.; Gonen, Mithat; Do, Richard G.; Simpson, Amber L.			Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients	PLOS ONE			English	Article							ADENOCARCINOMA; CLASSIFICATION; GEMCITABINE; INFORMATION; RESECTION; PATTERNS; FEATURES	Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers in the United States with a five-year survival rate of 7.2% for all stages. Although surgical resection is the only curative treatment, currently we are unable to differentiate between resectable patients with occult metastatic disease from those with potentially curable disease. Identification of patients with poor prognosis via early classification would help in initial management including the use of neoadjuvant chemotherapy or radiation, or in the choice of postoperative adjuvant therapy. PDAC ranges in appearance from homogeneously isoattenuating masses to heterogeneously hypovascular tumors on CT images; hence, we hypothesize that heterogeneity reflects underlying differences at the histologic or genetic level and will therefore correlate with patient outcome. We quantify heterogeneity of PDAC with texture analysis to predict 2-year survival. Using fuzzy minimum-redundancy maximum-relevance feature selection and a naive Bayes classifier, the proposed features achieve an area under receiver operating characteristic curve (AUC) of 0.90 and accuracy (Ac) of 82.86% with the leave-one-image-out technique and an AUC of 0.80 and Ac of 75.0% with three-fold cross-validation. We conclude that texture analysis can be used to quantify heterogeneity in CT images to accurately predict 2-year survival in patients with pancreatic cancer. From these data, we infer differences in the biological evolution of pancreatic cancer subtypes measurable in imaging and identify opportunities for optimized patient selection for therapy.	[Chakraborty, Jayasree; Langdon-Embry, Liana; Allen, Peter J.; Simpson, Amber L.] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Cunanan, Kristen M.; Gonen, Mithat] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Escalon, Joanna G.; Do, Richard G.] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA; [Lowery, Maeve A.; O'Reilly, Eileen M.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Simpson, Amber L.] Mem Sloan Kettering Canc Ctr, Dept Surg, Hepatopancreatobiliary Serv, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Simpson, AL (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.; Simpson, AL (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Hepatopancreatobiliary Serv, 1275 York Ave, New York, NY 10021 USA.	simpsonl@mskcc.org	lowery, maeve/AAG-2575-2019; Gonen, Mithat/E-4826-2012; Chakraborty, Jayasree/Q-2424-2019	lowery, maeve/0000-0003-1354-7606; Gonen, Mithat/0000-0001-8683-8477; O'Reilly, Eileen M./0000-0002-8076-9199; Chakraborty, Jayasree/0000-0003-4434-8861	NIH/NCI Cancer Center Support Grant [P30 CA008748]; Cycle for Survival	NIH/NCI Cancer Center Support Grant; Cycle for Survival	This work was supported in part by NIH/NCI P30 CA008748 Cancer Center Support Grant and Cycle for Survival (cycleforsurvival.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen T, 2009, LECT NOTES COMPUT SC, V5575, P61, DOI 10.1007/978-3-642-02230-2_7; Al-Ani A, 2012, COMM COM INF SC, V322, P430; Al-Hawary MM, 2014, GASTROENTEROLOGY, V146, P291, DOI 10.1053/j.gastro.2013.11.004; Al-Kadi OS, 2008, IEEE T BIO-MED ENG, V55, P1822, DOI 10.1109/TBME.2008.919735; American Cancer Society, 2014, CANC FACTS FIG 2014; Andriulli A, 2012, ANN SURG ONCOL, V19, P1644, DOI 10.1245/s10434-011-2110-8; Antonelli M., 2013, LECT NOTES COMPUTER, V8256, P36, DOI DOI 10.1007/978-3-319-03200-9_4; Assifi MM, 2011, SURGERY, V150, P466, DOI 10.1016/j.surg.2011.07.006; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Balagurunathan Y, 2014, TRANSL ONCOL, V7, P72, DOI 10.1593/tlo.13844; Banik S, 2013, INT J COMPUT ASS RAD, V8, P121, DOI 10.1007/s11548-012-0681-x; Bilici A, 2014, WORLD J GASTROENTERO, V20, P10802, DOI 10.3748/wjg.v20.i31.10802; Brennan MF, 2004, ANN SURG, V240, P293, DOI 10.1097/01.sla.0000133125.85489.07; Buczkowski S, 1998, PATTERN RECOGN, V31, P411, DOI 10.1016/S0031-3203(97)00054-X; Callery MP, 2009, ANN SURG ONCOL, V16, P1727, DOI 10.1245/s10434-009-0408-6; Chakraborty J., 2016, SPIE MED IMAGING 201; Chakraborty J, 2013, INT CONF BIOMED, P111, DOI 10.1109/BMEI.2013.6746917; Chakraborty J, 2012, J ELECTRON IMAGING, V21, DOI 10.1117/1.JEI.21.3.033010; Costa A. F., 2012, 2012 XXV SIBGRAPI - Conference on Graphics, Patterns and Images (SIBGRAPI 2012), P39, DOI 10.1109/SIBGRAPI.2012.15; Duda R O, 2001, PATTERN CLASSIFICATI; Erkan MM, 2009, NEOPLASIA, V11, P497, DOI 10.1593/neo.81618; Gatenby RA, 2013, RADIOLOGY, V269, P8, DOI 10.1148/radiol.13122697; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; Hallemeier Christopher L, 2011, Am J Clin Oncol, V34, P567, DOI 10.1097/COC.0b013e3181f946fc; Hanania AN, 2016, ONCOTARGET, V7, P85776, DOI 10.18632/oncotarget.11769; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hastie T., 2009, SPRINGER SERIES STAT, DOI 10.1007/978-0-387-84858-7; Howlader N., 2021, SEER CANC STAT REV, P1975; Khushaba RN, 2011, IEEE T BIO-MED ENG, V58, P121, DOI 10.1109/TBME.2010.2077291; Koay EJ, 2014, J CLIN INVEST, V124, P1525, DOI 10.1172/JCI73455; Li DN, 2015, SEMIN ONCOL, V42, P134, DOI 10.1053/j.seminoncol.2014.12.012; Liu L, 2014, IEEE T IMAGE PROCESS, V23, P3071, DOI 10.1109/TIP.2014.2325777; Lloyd Mark C, 2010, J Pathol Inform, V1, P29, DOI 10.4103/2153-3539.74186; Lowery MA, 2012, PHARMACOGENOMICS J, V12, P1, DOI 10.1038/tpj.2011.52; Mehta Rakesh, 2013, Proceedings of the 2nd International Conference on Pattern Recognition Applications and Methods. ICPRAM 2013, P497; Midya A, 2015, I S BIOMED IMAGING, P411, DOI 10.1109/ISBI.2015.7163899; O'Reilly EM, 2014, ANN SURG, V260, P142, DOI 10.1097/SLA.0000000000000251; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Pang Kwok Kuen, 2003, J Chin Med Assoc, V66, P655; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pietikainen M, 2011, COMPUT IMAGING VIS, V40, P13, DOI 10.1007/978-0-85729-748-8_2; Prigarin S. M., 2013, INT J BIOMATH, V2, P167; Puleo F, 2015, WORLD J GASTROENTERO, V21, P2281, DOI 10.3748/wjg.v21.i8.2281; Spiteri M, 2015, J MED IMAGING, V2, DOI 10.1117/1.JMI.2.4.044502; Tang XO, 1998, IEEE T IMAGE PROCESS, V7, P1602, DOI 10.1109/83.725367; Urayama S, 2015, WORLD J GASTROENTERO, V21, P1707, DOI 10.3748/wjg.v21.i6.1707; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Winter JM, 2012, ANN SURG ONCOL, V19, P169, DOI 10.1245/s10434-011-1900-3; Xu CP, 2014, J CANCER RES CLIN, V140, P549, DOI 10.1007/s00432-013-1572-4; Yang XF, 2012, MED PHYS, V39, P5732, DOI 10.1118/1.4747526; Yoon SH, 2011, RADIOLOGY, V259, P442, DOI 10.1148/radiol.11101133	52	48	50	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188022	10.1371/journal.pone.0188022	http://dx.doi.org/10.1371/journal.pone.0188022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216209	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800017
J	Mauro, F; Monleon, VJ; Temesgen, H; Ford, KR				Mauro, Francisco; Monleon, Vicente J.; Temesgen, Hailemariam; Ford, Kevin R.			Analysis of area level and unit level models for small area estimation in forest inventories assisted with LiDAR auxiliary information	PLOS ONE			English	Article							TIMBER VOLUME; PREDICTION	Forest inventories require estimates and measures of uncertainty for subpopulations such as management units. These units often times hold a small sample size, so they should be regarded as small areas. When auxiliary information is available, different small area estimation methods have been proposed to obtain reliable estimates for small areas. Unit level empirical best linear unbiased predictors (EBLUP) based on plot or grid unit level models have been studied more thoroughly than area level EBLUPs, where the modelling occurs at the management unit scale. Area level EBLUPs do not require a precise plot positioning and allow the use of variable radius plots, thus reducing fieldwork costs. However, their performance has not been examined thoroughly. We compared unit level and area level EBLUPs, using LiDAR auxiliary information collected for inventorying 98,104 ha coastal coniferous forest. Unit level models were consistently more accurate than area level EBLUPs, and area level EBLUPs were consistently more accurate than field estimates except for large management units that held a large sample. For stand density, volume, basal area, quadratic mean diameter, mean height and Lorey's height, root mean squared errors (rmses) of estimates obtained using area level EBLUPs were, on average, 1.43, 2.83, 2.09, 1.40, 1.32 and 1.64 times larger than those based on unit level estimates, respectively. Similarly, direct field estimates had rmses that were, on average, 1.37, 1.45, 1.17, 1.17, 1.26, and 1.38 times larger than rmses of area level EBLUPs. Therefore, area level models can lead to substantial gains in accuracy compared to direct estimates, and unit level models lead to very important gains in accuracy compared to area level models, potentially justifying the additional costs of obtaining accurate field plot coordinates.	[Mauro, Francisco; Temesgen, Hailemariam] Oregon State Univ, Coll Forestry, Forest Engn Resources & Management Dept, Corvallis, OR 97331 USA; [Monleon, Vicente J.] US Forest Serv, Pacific Northwest Res Stn, Forestry Sci Lab, Corvallis, OR USA; [Ford, Kevin R.] Bur Land Management Oregon, Washington State Off, Portland, OR USA	Oregon State University; United States Department of Agriculture (USDA); United States Forest Service	Mauro, F (corresponding author), Oregon State Univ, Coll Forestry, Forest Engn Resources & Management Dept, Corvallis, OR 97331 USA.	francisco.mauro@oregonstate.edu	Mauro, Francisco/AEP-2302-2022; Mauro, Francisco/F-9484-2016	Mauro, Francisco/0000-0002-7832-6268	US Bureau of Land Management [17-JV-11261989-018]	US Bureau of Land Management	This work was funded by the US Bureau of Land Management grant #17-JV-11261989-018. The funder participated in the study design and data collection.	Andersen HE, 2005, REMOTE SENS ENVIRON, V94, P441, DOI 10.1016/j.rse.2004.10.013; BATTESE GE, 1988, J AM STAT ASSOC, V83, P28, DOI 10.2307/2288915; Boubeta M, 2015, J ENVIRON MANAGE, V154, P151, DOI 10.1016/j.jenvman.2015.02.009; Breidenbach J., 2012, EUROPEAN J FOREST RE, V131, P1; Breidenbach J, 2016, REMOTE SENS ENVIRON, V173, P274, DOI 10.1016/j.rse.2015.07.026; Datta GS, 2015, J AM STAT ASSOC, V110, P1735, DOI 10.1080/01621459.2015.1016526; FAY RE, 1979, J AM STAT ASSOC, V74, P269, DOI 10.1080/01621459.1979.10482505; Goerndt ME, 2013, FOREST SCI, V59, P536, DOI 10.5849/forsci.12-073; Goerndt ME, 2011, CAN J FOREST RES, V41, P1189, DOI [10.1139/X11-033, 10.1139/x11-033]; Gonzalez-Ferreiro E., 2012, FORESTRY; Hawbaker TJ, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000870; Hayashi R, 2014, FORESTS, V5, P363, DOI 10.3390/f5020363; Heinisch O., 1963, PREIS S BIOM J, V1965, P203, DOI [10.1002/bimj.19650070312, DOI 10.1002/BIMJ.19650070312]; Magnussen S, EUR J FOR R IN PRESS; Mauro F, 2016, ENVIRONMETRICS, V27, P225, DOI 10.1002/env.2387; Mauro F, 2017, CAN J FOR RES; Mcgaughey R, 2014, FUSION LDV SOFTWARE, V3; Naesset E, 2002, REMOTE SENS ENVIRON, V80, P88, DOI 10.1016/S0034-4257(01)00290-5; Rahlf J, 2014, REMOTE SENS ENVIRON, V155, P325, DOI 10.1016/j.rse.2014.08.036; Rao JB, 2015, IEEE T VEH TECHNOL, P1; Rao JNK, 2003, EMPIRICAL BEST LINEA, P115; Rao JNK, 2015, EMPIRICAL BEST LINEA, P123; Sarndal C-E, 2003, SPRINGER SERIES STAT, P694; Shin J, 2016, CAN J REMOTE SENS, V42, P739, DOI 10.1080/07038992.2016.1252908; Sinha SK, 2009, CAN J STAT, V37, P381, DOI 10.1002/cjs.10029; Sugasawa S, 2017, J MULTIVARIATE ANAL, V153, P52, DOI 10.1016/j.jmva.2016.09.011; United States Department of Interior, 2016, PROP RES MAN PLAN W, V1; Valbuena R., 2013, SPANISH J AGR RES, DOI [10.5424/sjar/2010084-1242, DOI 10.5424/SJAR/2010084-1242]; Yingfang W., 2015, VOLUME ESTIMATOR LIB	29	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189401	10.1371/journal.pone.0189401	http://dx.doi.org/10.1371/journal.pone.0189401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216290	Green Submitted, gold, Green Published			2022-12-27	WOS:000417337800121
J	Tanaka, K; Nishigami, T; Mibu, A; Manfuku, M; Yono, S; Shinohara, Y; Tanabe, A; Ono, R				Tanaka, Katsuyoshi; Nishigami, Tomohiko; Mibu, Akira; Manfuku, Masahiro; Yono, Satoko; Shinohara, Yoshikazu; Tanabe, Akihito; Ono, Rei			Validation of the Japanese version of the Central Sensitization Inventory in patients with musculoskeletal disorders	PLOS ONE			English	Article							CENTRAL SENSITIVITY SYNDROMES; QUALITY-OF-LIFE; TOTAL KNEE ARTHROPLASTY; CHRONIC PAIN SAMPLE; LOW-BACK-PAIN; CHRONIC WHIPLASH; POSTOPERATIVE PAIN; WIDESPREAD PAIN; GLOBAL BURDEN; HEALTH-STATUS	Background Many musculoskeletal pain conditions are characterized by hypersensitivity, which is induced by central sensitization (CS). A questionnaire, the Central Sensitization Inventory (CSI), was recently developed to help clinicians identify patients whose presenting symptoms may be related to central sensitivity syndrome (CSS). The aims of the present study were to examine criterion validity and construct validity of the Japanese version of the CSI (CSI-J), and to investigate prevalence rates of CS severity levels in patients with musculoskeletal disorders. Methods Translation of the CSI into Japanese was conducted using a forward-backward method. Two hundred and ninety patients with musculoskeletal pain disorders completed the resultant CSI-J. A subset of the patients (n = 158) completed the CSI-J again one week later. The relationships between CSI and clinical symptoms, EuroQol 5-dimension (EQ-5D) and Brief Pain Inventory (BPI), were examined for criterion validity. EQ-5D assesses Health-related QOL and BPI measures pain intensity and pain interference. The psychometric properties were evaluated with analyses of construct validity, factor structure and internal consistency, and subsequently investigate the prevalence rates of CS severity levels. Results The CSI-J demonstrated high internal consistency (Cronbach's a = 0.89) and test-retest reliability was excellent value (ICC = 0.85). The CSI-J was significantly correlated with EQ-5D (r = -0.44), pain intensity (r = 0.42), and pain interference (r = 0.48) (p < 0.01 for all). Ten percent of the participants were above the cutoff "40". The exploratory factor analysis resulted in 5-factor model. Conclusions This study reported that the CSI-J was a useful and psychometrically sound tool to assess CSS in Japanese patients with musculoskeletal disorders. The finding of the prevalence rates of CS severity levels in patients with musculoskeletal disorders may help clinicians to decide strategy of treatment.	[Tanaka, Katsuyoshi; Mibu, Akira; Manfuku, Masahiro; Yono, Satoko; Shinohara, Yoshikazu; Tanabe, Akihito] Tanabe Orthopaed, Dept Rehabil, Osaka, Osaka, Japan; [Tanaka, Katsuyoshi; Ono, Rei] Kobe Univ, Dept Community Hlth Sci, Grad Sch Hlth Sci, Kobe, Hyogo, Japan; [Nishigami, Tomohiko; Mibu, Akira] Konan Womens Univ, Dept Nursing & Phys Therapy, Kobe, Hyogo, Japan	Kobe University	Nishigami, T (corresponding author), Konan Womens Univ, Dept Nursing & Phys Therapy, Kobe, Hyogo, Japan.	t-nishi@konan-wu.ac.jp		ONO, Rei/0000-0002-0176-2870	Japan Society for the Promotion of Science KAKENHI [JP17K01543]; JSPS KAKENHI [JP17K01543]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding provided by the Japan Society for the Promotion of Science KAKENHI Grant Number JP17K01543 (https://www.dsps.go.jp/english/e-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Yuko Inoue, Yuno Yonezaki, and Akihisa Watanabe for assistance with data collection and data analysis. This study was supported by JSPS KAKENHI Grant Number JP17K01543.	Abdel-Aziz Shaimaa Baher, 2017, Asian Pac J Cancer Prev, V18, P2409, DOI 10.22034/APJCP.2017.18.9.2409; Aggarwal VR, 2006, INT J EPIDEMIOL, V35, P468, DOI 10.1093/ije/dyi265; Al-Harthy M, 2017, J ORAL REHABIL, V44, P415, DOI 10.1111/joor.12499; Ang DC, 2011, J PAIN, V12, P384, DOI 10.1016/j.jpain.2010.09.004; Bennett EE, 2017, WORLD NEUROSURG, V104, P594, DOI 10.1016/j.wneu.2017.04.166; Brantingham JW, 2013, J MANIP PHYSIOL THER, V36, P143, DOI 10.1016/j.jmpt.2013.04.001; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Coombes BK, 2012, CLIN J PAIN, V28, P595, DOI 10.1097/AJP.0b013e31823dd333; Coppieters I, 2015, PAIN PHYSICIAN, V18, pE389; Costello AB, 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [DOI 10.7275/JYJ1-4868, DOI 10.1316/S0782-051X03024046-9]; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Ferreira-Valente MA, 2014, CLIN J PAIN, V30, P713, DOI 10.1097/AJP.0000000000000027; Giesecke T, 2004, ARTHRITIS RHEUM-US, V50, P613, DOI 10.1002/art.20063; Herren-Gerber R, 2004, PAIN MED, V5, P366, DOI 10.1111/j.1526-4637.2004.04055.x; Hoy DG, 2014, ANN RHEUM DIS, V73, P982, DOI 10.1136/annrheumdis-2013-204344; Cuesta-Vargas AI, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3515-4; Jull G, 2007, PAIN, V129, P28, DOI 10.1016/j.pain.2006.09.030; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; Kim SH, 2015, PAIN PRACT, V15, pE46, DOI 10.1111/papr.12311; Kindler LL, 2010, J PAIN, V11, P1320, DOI 10.1016/j.jpain.2010.03.007; Kregel J, 2016, CLIN J PAIN, V32, P624, DOI 10.1097/AJP.0000000000000306; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lin K, 2017, CLIN ORTHOP RELAT R, V475, P2992, DOI 10.1007/s11999-017-5495-2; Lluch E, 2014, EUR J PAIN, V18, P1367, DOI 10.1002/j.1532-2149.2014.499.x; Loeser JD, 2008, PAIN, V137, P473, DOI 10.1016/j.pain.2008.04.025; Lunn TH, 2013, PAIN, V154, P1878, DOI 10.1016/j.pain.2013.06.008; Mayer TG, 2012, PAIN PRACT, V12, P276, DOI 10.1111/j.1533-2500.2011.00493.x; Mease PJ, 2011, J RHEUMATOL, V38, P1546, DOI 10.3899/jrheum.100759; Meeus M, 2007, CLIN RHEUMATOL, V26, P465, DOI 10.1007/s10067-006-0433-9; Meeus M, 2012, SEMIN ARTHRITIS RHEU, V41, P556, DOI 10.1016/j.semarthrit.2011.08.001; Mendoza TR, 2012, J PAIN, V13, P564, DOI 10.1016/j.jpain.2012.03.003; Moeller-Bertram T, 2014, PAIN MED, V15, P762, DOI 10.1111/pme.12424; Neblett R, 2017, PAIN PRACT, V17, P166, DOI 10.1111/papr.12440; Neblett R, 2015, CLIN J PAIN, V31, P323, DOI 10.1097/AJP.0000000000000113; Neblett R, 2013, J PAIN, V14, P438, DOI 10.1016/j.jpain.2012.11.012; Pitance L, 2016, INT FED ORTH PHYS TH; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rief W, 2001, PSYCHOSOM MED, V63, P595, DOI 10.1097/00006842-200107000-00012; Robinson-Lane Sheria G, 2017, J Gerontol Nurs, P1, DOI 10.3928/00989134-20170224-03; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Roussel NA, 2013, CLIN J PAIN, V29, P625, DOI 10.1097/AJP.0b013e31826f9a71; Sampalli T, 2012, PATIENT PREFER ADHER, V6, P757, DOI 10.2147/PPA.S35201; Schur EA, 2007, J GEN INTERN MED, V22, P818, DOI 10.1007/s11606-007-0140-5; Staud R, 2011, CURR RHEUMATOL REP, V13, P513, DOI 10.1007/s11926-011-0206-6; Sterling M, 2002, J MUSCULOSKELET PAIN, V10, P69, DOI 10.1300/J094v10n03_05; Sterling M, 2003, PAIN, V104, P509, DOI 10.1016/S0304-3959(03)00078-2; Struyf F, 2013, CLIN RHEUMATOL, V32, P73, DOI 10.1007/s10067-012-2093-2; Suokas AK, 2012, OSTEOARTHR CARTILAGE, V20, P1075, DOI 10.1016/j.joca.2012.06.009; Tanaka K, 2017, J MUSCULOSKELET PAIN, V9, P34; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673; Uki J, 1998, J PAIN SYMPTOM MANAG, V16, P364, DOI 10.1016/S0885-3924(98)00098-0; van Wilgen CP, 2013, SCAND J MED SCI SPOR, V23, P149, DOI 10.1111/j.1600-0838.2011.01375.x; VELICER WF, 1990, MULTIVAR BEHAV RES, V25, P1, DOI 10.1207/s15327906mbr2501_1; Vierck CJ, 2006, PAIN, V124, P242, DOI 10.1016/j.pain.2006.06.001; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Yunus MB, 2007, BEST PRACT RES CL RH, V21, P481, DOI 10.1016/j.berh.2007.03.006; Yunus MB, 2007, SEMIN ARTHRITIS RHEU, V36, P339, DOI 10.1016/j.semarthrit.2006.12.009	60	52	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188719	10.1371/journal.pone.0188719	http://dx.doi.org/10.1371/journal.pone.0188719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216211	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800037
J	Wang, Y; Wang, Q; Taylor, JE				Wang, Yan; Wang, Qi; Taylor, John E.			Aggregated responses of human mobility to severe winter storms: An empirical study	PLOS ONE			English	Article							WEATHER; IMPACT	Increasing frequency of extreme winter storms has resulted in costly damages and a disruptive impact on the northeastern United States. It is important to understand human mobility patterns during such storms for disaster preparation and relief operations. We investigated the effects of severe winter storms on human mobility during a 2015 blizzard using 2.69 million Twitter geolocations. We found that displacements of different trip distances and radii of gyration of individuals' mobility were perturbed significantly. We further explored the characteristics of perturbed mobility during the storm, and demonstrated that individuals' recurrent mobility does not have a higher degree of similarity with their perturbed mobility, when comparing with its similarity to non-perturbed mobility. These empirical findings on human mobility impacted by severe winter storms have potential long-term implications on emergency response planning and the development of strategies to improve resilience in severe winter storms.	[Wang, Yan] Virginia Tech, Charles E Via Jr Dept Civil & Environm Engn, Blacksburg, VA USA; [Wang, Qi] Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA; [Taylor, John E.] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA	Virginia Polytechnic Institute & State University; Northeastern University; University System of Georgia; Georgia Institute of Technology	Taylor, JE (corresponding author), Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA.	jet@gatech.edu		Taylor, John/0000-0002-8949-3248; Wang, Yan/0000-0002-3946-9418	National Science Foundation [1142379]; Virginia Tech BioBuild Interdisciplinary Graduate Education Program (IGEP) grant; Directorate For Engineering [1733695] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Virginia Tech BioBuild Interdisciplinary Graduate Education Program (IGEP) grant; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	J.E.T. was supported by a National Science Foundation (https://www.nsf.gov/) under Grant No. 1142379. J.E.T. received and Y.W. and Q.W. were supported by a Virginia Tech BioBuild Interdisciplinary Graduate Education Program (IGEP) grant. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the National Science Foundation under Grant No. 1142379 and by the Virginia Tech BioBuild Interdisciplinary Graduate Education Program (IGEP) grant. Correspondence and requests for material should be addressed to J.E.T. (jet@gatech.edu).	Alessandretti L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171686; Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; Call DA, 2011, WEATHER CLIM SOC, V3, P71, DOI 10.1175/WCAS-D-10-05008.1; Cools M, 2010, TRANSPORT RES REC, P22, DOI 10.3141/2157-03; Datla S, 2008, J TRANSP GEOGR, V16, P358, DOI 10.1016/j.jtrangeo.2007.12.003; de Montigny L, 2011, ENV BEHAV; de Montjoye YA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01376; Department of Homeland Security Office of Cyber and Infrastructure Analysis, 2014, CRITICAL INFRASTRUCT; FEMA, 2015, 2015 DECL DIS; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Horanont T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081153; Koetse MJ, 2009, TRANSPORT RES D-TR E, V14, P205, DOI 10.1016/j.trd.2008.12.004; Kunkel KE, 2013, B AM METEOROL SOC, V94, P499, DOI 10.1175/BAMS-D-11-00262.1; Lu XF, 2013, SCI REP-UK, V3, DOI 10.1038/srep02955; Lu X, 2012, P NATL ACAD SCI USA, V109, P11576, DOI 10.1073/pnas.1203882109; Maze TH, 2006, TRANSPORT RES REC, P170; National Oceanic and Atmospheric Administration (NOAA), STORM EV DAT; NOAA, 2016, CLIM CHANG EXTR SNOW; NOAA, REG SNOWF IND RSI; Pappalardo L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9166; Pavalanathan U., 2015, ARXIV150602275; Peng C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038614; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Song X, 2014, P 20 ACM SIGKDD INT; Squires MF, 2014, B AM METEOROL SOC, V95, P1835, DOI 10.1175/BAMS-D-13-00101.1; Swier N, 2015, USING GEOLOCATED TWI; Wang Q, 2016, J COMPUT CIVIL ENG, V30, DOI 10.1061/(ASCE)CP.1943-5487.0000469; Wang Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147299; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112608; Zhao K, 2015, SCI REPORTS, V5	35	26	26	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188734	10.1371/journal.pone.0188734	http://dx.doi.org/10.1371/journal.pone.0188734			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216236	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800040
J	Carlin, DE; Paull, EO; Graim, K; Wong, CK; Bivol, A; Ryabinin, P; Ellrott, K; Sokolov, A; Stuart, JM				Carlin, Daniel E.; Paull, Evan O.; Graim, Kiley; Wong, Christopher K.; Bivol, Adrian; Ryabinin, Peter; Ellrott, Kyle; Sokolov, Artem; Stuart, Joshua M.			Prophetic Granger Causality to infer gene regulatory networks	PLOS ONE			English	Article							COEXPRESSION NETWORK; EXPRESSION; TOPOLOGY; INHIBITION; ALGORITHM; DISCOVERY; REVEALS; PATHWAY; MODELS; YAP	We introduce a novel method called Prophetic Granger Causality (PGC) for inferring gene regulatory networks (GRNs) from protein-level time series data. The method uses an L1-penalized regression adaptation of Granger Causality to model protein levels as a function of time, stimuli, and other perturbations. When combined with a data-independent network prior, the framework outperformed all other methods submitted to the HPN-DREAM 8 breast cancer network inference challenge. Our investigations reveal that PGC provides complementary information to other approaches, raising the performance of ensemble learners, while on its own achieves moderate performance. Thus, PGC serves as a valuable new tool in the bioinformatics toolkit for analyzing temporal datasets. We investigate the general and cell-specific interactions predicted by our method and find several novel interactions, demonstrating the utility of the approach in charting new tumor wiring.	[Carlin, Daniel E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Paull, Evan O.; Graim, Kiley; Wong, Christopher K.; Bivol, Adrian; Ryabinin, Peter; Sokolov, Artem; Stuart, Joshua M.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Ellrott, Kyle] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR USA	University of California System; University of California San Diego; University of California System; University of California Santa Cruz; Oregon Health & Science University	Sokolov, A; Stuart, JM (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA.	Artem.Sokolov@gmail.com; jstuart@ucsc.edu		Sokolov, Artem/0000-0002-8056-0504; Stuart, Joshua/0000-0002-2171-565X; Ellrott, Kyle/0000-0002-6573-5900; Graim, Kiley/0000-0002-4569-8444	National Cancer Institute [U24-CA143858, 1R01CA180778]; National Human Genome Research Institute [5U54HG006097]; National Institute for General Medical Sciences [5R01GM109031]; National Science Foundation Office of Cyberinfrastructure [0845783]; West Coast Prostate Cancer Dream Team by Stand Up to Cancer/ AACR/Prostate Cancer Foundation [SU2C-AACR-DT0812]; Movember Foundation; NATIONAL CANCER INSTITUTE [R01CA180778, U24CA210990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109031] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation Office of Cyberinfrastructure; West Coast Prostate Cancer Dream Team by Stand Up to Cancer/ AACR/Prostate Cancer Foundation; Movember Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Cancer Institute U24-CA143858, National Cancer Institute 1R01CA180778, National Human Genome Research Institute 5U54HG006097, National Institute for General Medical Sciences 5R01GM109031,and a National Science Foundation Office of Cyberinfrastructure 0845783. Supported by the West Coast Prostate Cancer Dream Team supported by Stand Up to Cancer/ AACR/Prostate Cancer Foundation SU2C-AACR-DT0812 (O.N.W. co-PI). This research Grant is made possible by the generous support of the Movember Foundation. Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdam R, 2015, MOL BIOSYST, V11, P942, DOI 10.1039/c4mb00413b; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Batsche E, 2005, J BIOL CHEM, V280, P19746, DOI 10.1074/jbc.M413428200; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Cerami Ethan G, 2011, Nucleic Acids Res, V39, pD685, DOI 10.1093/nar/gkq1039; Chai LE, 2014, COMPUT BIOL MED, V48, P55, DOI 10.1016/j.compbiomed.2014.02.011; Cheng DH, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P382, DOI 10.1145/2623330.2623709; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Emmert-Streib Frank, 2012, Frontiers in Genetics, V3, P8, DOI [10.3389/fgene.2012.00313, 10.3389/fgene.2012.00008]; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman J, 2007, ANN APPL STAT, V1, P302, DOI 10.1214/07-AOAS131; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hill SM, 2016, NAT METHODS, V13, P310, DOI [10.1038/NMETH.3773, 10.1038/nmeth.3773]; Hill SM, 2012, BIOINFORMATICS, V28, P2804, DOI 10.1093/bioinformatics/bts514; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Kiani NA, 2016, SEMIN CELL DEV BIOL, V51, P44, DOI 10.1016/j.semcdb.2016.01.012; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li LL, 2013, FEBS LETT, V587, P3921, DOI 10.1016/j.febslet.2013.10.042; Liu F, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005024; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/NMETH.2016, 10.1038/nmeth.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Mukhopadhyay ND, 2007, BIOINFORMATICS, V23, P442, DOI 10.1093/bioinformatics/btl598; Nair A, 2015, MOL BIOSYST, V11, P2449, DOI 10.1039/c5mb00122f; Norel R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.70; Petryszak R, 2013, NUCLEIC ACIDS RES; Press MF, 2007, DRUGS, V67, P2045, DOI 10.2165/00003495-200767140-00006; Quinlan JR, 1996, PROCEEDINGS OF THE THIRTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE EIGHTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE, VOLS 1 AND 2, P725; Rau A, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1513; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Shmulevich I, 2002, BIOINFORMATICS, V18, P1319, DOI 10.1093/bioinformatics/18.10.1319; Shojaie A, 2010, BIOINFORMATICS, V26, pi517, DOI 10.1093/bioinformatics/btq377; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tam GHF, 2013, IET SYST BIOL, V7, P195, DOI 10.1049/iet-syb.2012.0063; Vaske CJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000274; Yao S, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0710-1; Yeung KY, 2011, P NATL ACAD SCI USA, V108, P19436, DOI 10.1073/pnas.1116442108; Young WC, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-47; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zhang XJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1315; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou C, 2015, INT J DATA MIN BIOIN, V12, P328, DOI 10.1504/IJDMB.2015.069658	53	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0170340	10.1371/journal.pone.0170340	http://dx.doi.org/10.1371/journal.pone.0170340			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211761	Green Submitted, gold, Green Published			2022-12-27	WOS:000417212200001
J	Holtman, GA; Lisman-van Leeuwen, Y; Kollen, BJ; Norbruis, OF; Escher, JC; Walhout, LC; Kindermann, A; de Rijke, YB; van Rheenen, PF; Berger, MY				Holtman, Gea A.; Lisman-van Leeuwen, Yvonne; Kollen, Boudewijn J.; Norbruis, Obbe F.; Escher, Johanna C.; Walhout, Laurence C.; Kindermann, Angelika; de Rijke, Yolanda B.; van Rheenen, Patrick F.; Berger, Marjolein Y.			Diagnostic test strategies in children at increased risk of inflammatory bowel disease in primary care	PLOS ONE			English	Article							RECURRENT ABDOMINAL-PAIN; FECAL CALPROTECTIN; PREDICTION MODELS; IMPUTATION; VALUES; ACCURACY; MARKERS; EVENTS; IBD	Background In children with symptoms suggestive of inflammatory bowel disease (IBD) who present in primary care, the optimal test strategy for identifying those who require specialist care is unclear. We evaluated the following three test strategies to determine which was optimal for referring children with suspected IBD to specialist care: 1) alarm symptoms alone, 2) alarm symptoms plus c-reactive protein, and 3) alarm symptoms plus fecal calprotectin. Methods A prospective cohort study was conducted, including children with chronic gastrointestinal symptoms referred to pediatric gastroenterology. Outcome was defined as IBD confirmed by endoscopy, or IBD ruled out by either endoscopy or unremarkable clinical 12 month follow-up with no indication for endoscopy. Test strategy probabilities were generated by logistic regression analyses and compared by area under the receiver operating characteristic curves (AUC) and decision curves. Results We included 90 children, of whom 17 (19%) had IBD (n = 65 from primary care physicians, n = 25 from general pediatricians). Adding fecal calprotectin to alarm symptoms increased the AUC significantly from 0.80 (0.67-0.92) to 0.97 (0.93-1.00), but adding c-reactive protein to alarm symptoms did not increase the AUC significantly (p > 0.05). Decision curves confirmed these patterns, showing that alarm symptoms combined with fecal calprotectin produced the diagnostic test strategy with the highest net benefit at reasonable threshold probabilities. Conclusion In primary care, when children are identified as being at high risk for IBD, adding fecal calprotectin testing to alarm symptoms was the optimal strategy for improving risk stratification.	[Holtman, Gea A.; Lisman-van Leeuwen, Yvonne; Kollen, Boudewijn J.; Berger, Marjolein Y.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands; [Norbruis, Obbe F.] Isala Hosp, Dept Pediat, Zwolle, Netherlands; [Escher, Johanna C.; Walhout, Laurence C.] Erasmus MC Sophia Childrens Hosp, Dept Pediat Gastroenterol, Rotterdam, Netherlands; [Kindermann, Angelika] Acad Med Ctr, Dept Pediat Gastroenterol, Emma Childrens Hosp, Amsterdam, Netherlands; [de Rijke, Yolanda B.] Univ Med Ctr, Dept Clin Chem, Erasmus MC, Rotterdam, Netherlands; [van Rheenen, Patrick F.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Gastroenterol, Groningen, Netherlands	University of Groningen; Erasmus University Rotterdam; Erasmus MC; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; University of Groningen	Holtman, GA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands.	g.a.holtman@umcg.nl	de Rijke, Yolanda/AAQ-5497-2020	/0000-0003-3867-2665; Lisman-van Leeuwen, Yvonne/0000-0003-4126-526X	Netherlands Fonds NutsOhra [0802-099]; University Medical Centre Groningen doelmatigheidsonderzoek [689 302]	Netherlands Fonds NutsOhra; University Medical Centre Groningen doelmatigheidsonderzoek	This study was funded by a grant from the Netherlands Fonds NutsOhra (grant number 0802-099) and a grant from the University Medical Centre Groningen doelmatigheidsonderzoek (grant number 689 302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEACH Program AIHW General Practice Statistics and Classification Unit, 2004, Aust Fam Physician, V33, P968; de Ridder Lissy, 2010, Ned Tijdschr Geneeskd, V154, pA1898; Degraeuwe PLJ, 2015, J PEDIATR GASTR NUTR, V60, P339, DOI 10.1097/MPG.0000000000000615; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Di Lorenzo C, 2005, J PEDIATR GASTR NUTR, V40, P249, DOI 10.1097/01.MPG.0000154661.39488.AC; Gieteling MJ, 2008, J PEDIATR GASTR NUTR, V47, P316, DOI 10.1097/MPG.0b013e31815bc1c1; Gieteling MJ, 2011, ANN FAM MED, V9, P337, DOI 10.1370/afm.1268; Gieteling MJ., 2012, HUISARTS WET, V55, P404; Gisbert JP, 2009, DIGEST LIVER DIS, V41, P56, DOI 10.1016/j.dld.2008.05.008; Holtman GA, 2016, ANN FAM MED, V14, P437, DOI 10.1370/afm.1949; Holtman GA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2126; Holtman GA, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-179; Kim SC, 2004, GASTROENTEROLOGY, V126, P1550, DOI 10.1053/j.gastro.2004.03.022; Knottnerus JA, 1997, BRIT MED J, V315, P1109; Kokkonen J, 2004, ACTA PAEDIATR, V93, P880, DOI [10.1080/08035250410024907, 10.1111/j.1651-2227.2004.tb02684.x]; Levine A, 2014, J PEDIATR GASTR NUTR, V58, P795, DOI 10.1097/MPG.0000000000000239; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Mack DR, 2007, PEDIATRICS, V119, P1113, DOI 10.1542/peds.2006-1865; Marshall A, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-57; Miele E, 2004, PEDIATRICS, V114, P73, DOI 10.1542/peds.114.1.73; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Moons KGM, 2012, CLIN CHEM, V58, P1408, DOI 10.1373/clinchem.2012.182550; Naaktgeboren CA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i402; Naaktgeboren CA, 2013, ANN INTERN MED, V159, P195, DOI 10.7326/0003-4819-159-3-201308060-00009; Oord T, 2014, SCAND J CLIN LAB INV, V74, P254, DOI 10.3109/00365513.2013.879732; Oostenbrink R, 2003, J CLIN EPIDEMIOL, V56, P501, DOI 10.1016/S0895-4356(03)00080-5; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Pels LPM, 2010, J PEDIATR GASTR NUTR, V51, P708, DOI 10.1097/MPG.0b013e3181da4d8b; Rasquin A, 2006, GASTROENTEROLOGY, V130, P1527, DOI 10.1053/j.gastro.2005.08.063; Spee LAA, 2013, SCAND J PRIM HEALTH, V31, P197, DOI 10.3109/02813432.2013.844405; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Thomson S, 2011, INT PROFILES HLTH CA; Van de Vijver E, 2012, ARCH DIS CHILD, V97, P1014, DOI 10.1136/archdischild-2011-301206; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; van Tilburg ML, 2006, GASTROENTEROL NURS, V29, P50, DOI 10.1097/00001610-200601000-00009; Vermeire S, 2006, GUT, V55, P426, DOI 10.1136/gut.2005.069476; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i6; Vink G, 2014, STAT NEERL, V68, P61, DOI 10.1111/stan.12023; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052	41	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189111	10.1371/journal.pone.0189111	http://dx.doi.org/10.1371/journal.pone.0189111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211800	gold, Green Published, Green Submitted			2022-12-27	WOS:000417212200065
J	Shinomiya, H; Shinomiya, H; Kubo, M; Saito, Y; Yoshida, M; Ando, M; Teshima, M; Otsuki, N; Kiyota, N; Sasaki, R; Nibu, K				Shinomiya, Hirotaka; Shinomiya, Hitomi; Kubo, Mie; Saito, Yuki; Yoshida, Masafumi; Ando, Mizuo; Teshima, Masanori; Otsuki, Naoki; Kiyota, Naomi; Sasaki, Ryohei; Nibu, Kenichi			Prognostic value of ALDH2 polymorphism for patients with oropharyngeal cancer in a Japanese population	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; UPPER AERODIGESTIVE TRACT; ALDEHYDE DEHYDROGENASE 2; HUMAN-PAPILLOMAVIRUS; ALCOHOL-CONSUMPTION; RISK; NECK; HEAD; DRINKING; SURVIVAL	Background Half of Japanese possess a polymorphism of aldehyde dehydrogenase 2(ALDH2), while few white individuals possess this mutation. The purpose of this study was to investigate the possibility of ALDH2 polymorphism as a prognostic factor for oropharyngeal cancer (OPC) among Japanese population. Methods We analyzed 82 Japanese patients with OPC treated between 2006 and 2011. The median observation period was 50 months. P16-staining and ALDH2 polymorphisms were investigated. To examine the frequencies of second primary pharyngeal and esophageal cancers (SPPEC), 37 Japanese patients with OPC treated at Tokyo University Hospital were included for statistical analysis. Results Statistically significant differences were noted in OS among sex, age, N classification, and p16 (p = 0.045, 0.024, 0.020, 0.007, respectively). In addition, OS and DSS rates of the patients with heterozygous ALDH2 tended to be worse than those of the patients with homozygous ALDH2 (p = 0.21, 0.086, respectively). Of note, OS and DSS of the patients with p16-negative OPC and heterozygous ALDH2 was significant poorer than those of the patients with p16-positive OPC (p = 0.002, 0.006, respectively), while there was no significant difference in OS and DSS between patients with p16-positive OPC and patients with p16-negative OPC and homozygous ALDH2. Conclusions ALDH2 polymorphism might be a promising prognostic factor for Japanese patients with p16-negative OPC.	[Shinomiya, Hirotaka; Shinomiya, Hitomi; Kubo, Mie; Teshima, Masanori; Otsuki, Naoki; Nibu, Kenichi] Kobe Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kobe, Hyogo, Japan; [Saito, Yuki; Yoshida, Masafumi; Ando, Mizuo] Univ Tokyo, Dept Head & Neck Surg Otolaryngol, Tokyo, Japan; [Kiyota, Naomi] Kobe Univ, Grad Sch Med, Dept Med Oncol & Hematol, Kobe, Hyogo, Japan; [Sasaki, Ryohei] Kobe Univ, Grad Sch Med, Dept Radiat Oncol, Kobe, Hyogo, Japan	Kobe University; University of Tokyo; Kobe University; Kobe University	Shinomiya, H; Nibu, K (corresponding author), Kobe Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kobe, Hyogo, Japan.	hshino@med.kobe-u.ac.jp; nibu@med.kobe-u.ac.jp	Kiyota, Naomi/K-3226-2016; Otsuki, Naoki/AAH-2468-2020; Shinomiya, Hirotaka/AAF-5067-2020	Kiyota, Naomi/0000-0001-8021-6116; Shinomiya, Hirotaka/0000-0003-1667-7545; Ando, Mizuo/0000-0002-0754-2545; Otsuki, Naoki/0000-0002-9682-2548; Saito, Yuki/0000-0002-4825-7783	Japan Agency for Medical Research and Development [16ck0106223h001];  [26861379];  [16H0548];  [16H05481]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); ; ; 	This work is partly supported by Grant-in-Aid for Scientific Research (26861379, H. S. & 16H0548, 16H05481 K.N) and Japan Agency for Medical Research and Development (16ck0106223h001, K.N.).	Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Asakage T, 2007, CARCINOGENESIS, V28, P865, DOI 10.1093/carcin/bgl206; Boccia S, 2009, CANCER EPIDEM BIOMAR, V18, P248, DOI 10.1158/1055-9965.EPI-08-0462; Chang JS, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0327-y; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Hama T, 2014, ONCOLOGY-BASEL, V87, P173, DOI 10.1159/000360991; Ji YB, 2011, ORAL ONCOL, V47, P583, DOI 10.1016/j.oraloncology.2011.04.007; Kawakita D, 2016, J EPIDEMIOL, V26, P292, DOI 10.2188/jea.JE20140240; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Li QD, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-74; MIZOI Y, 1994, ALCOHOL ALCOHOLISM, V29, P707; Oze I, 2010, CANCER SCI, V101, P1875, DOI 10.1111/j.1349-7006.2010.01599.x; Oze I, 2009, CANCER EPIDEM BIOMAR, V18, P3097, DOI 10.1158/1055-9965.EPI-09-0499; Saito Y, 2014, JPN J CLIN ONCOL, V44, P564, DOI 10.1093/jjco/hyu042; Saito Y, 2013, CANCER-AM CANCER SOC, V119, P2005, DOI 10.1002/cncr.28015; Schache AG, 2011, CLIN CANCER RES, V17, P6262, DOI 10.1158/1078-0432.CCR-11-0388; Ye B, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-12; Yokoyama Akira, 2010, Keio Journal of Medicine, V59, P115, DOI 10.2302/kjm.59.115	20	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0187992	10.1371/journal.pone.0187992	http://dx.doi.org/10.1371/journal.pone.0187992			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206831	Green Published, gold, Green Submitted			2022-12-27	WOS:000417110700007
J	Wollison, BM; Thai, E; Mckinney, A; Ward, A; Clapp, A; Clinton, C; Nag, A; Thorner, AR; Gastier-Foster, JM; Crompton, BD				Wollison, Bruce M.; Thai, Edwin; Mckinney, Aimee; Ward, Abigail; Clapp, Andrea; Clinton, Catherine; Nag, Anwesha; Thorner, Aaron R.; Gastier-Foster, Julie M.; Crompton, Brian D.			Blood collection in cell-stabilizing tubes does not impact germline DNA quality for pediatric patients	PLOS ONE			English	Article							CIRCULATING TUMOR DNA; SEQUENCING DATA; LUNG-CANCER; PLASMA; MUTATIONS; GENES; HETEROGENEITY; RESISTANCE; FRAMEWORK; VARIANTS	Objectives Liquid biopsy technologies allow non-invasive tumor profiling for patients with solid tumor malignancies by sequencing circulating tumor DNA. These studies may be useful in risk-stratification, monitoring for relapse, and understanding tumor evolution. The quality of DNA obtained for these studies is improved when blood samples are collected in tubes that stabilizing white blood cells (WBC). However, ongoing germline research in pediatric oncology generally requires obtaining blood samples in EDTA tubes, which do not contain a WBC-stabilizing preservative. In this study, we explored whether blood samples collected in WBC-stabilizing tubes could be used for both liquid biopsy and germline studies simultaneously, minimizing blood collection volumes for pediatric patients. Methods Blood was simultaneously collected from three patients in both EDTA and Streck Cell-Free DNA BCT (R) tubes. Germline DNA was extracted from all blood samples and subjected to whole-exome sequencing and microarray profiling. Results Quality control metrics of DNA quality, sequencing library preperation and whole-exome sequencing alignment were virtually identical regardless of the sample collection method. There was no discernable difference in patterns of variant calling for paired samples by either whole-exome sequencing or microarray analysis. Conclusion Our study demonstrates that high-quality genomic studies may be performed from germline DNA obtained in Streck tubes. Therefore, these tubes may be used to simultaneously obtain samples for both liquid biopsy and germline studies in pediatric patients when the volume of blood available for research studies may be limited.	[Wollison, Bruce M.; Thai, Edwin; Clapp, Andrea; Nag, Anwesha; Thorner, Aaron R.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Mckinney, Aimee; Gastier-Foster, Julie M.] Nationwide Childrens Hosp, Inst Genom Med, Columbus, OH USA; [Ward, Abigail; Clinton, Catherine; Crompton, Brian D.] Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA 02115 USA; [Gastier-Foster, Julie M.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Crompton, Brian D.] Broad Inst Harvard & MIT, Canc Program, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; University System of Ohio; Ohio State University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Crompton, BD (corresponding author), Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA 02115 USA.; Crompton, BD (corresponding author), Broad Inst Harvard & MIT, Canc Program, Cambridge, MA 02142 USA.	briand_crompton@dfci.harvard.edu		Crompton, Brian/0000-0001-9404-6621	NIH [K08 - 5K08CA188073-03]; Children's Oncology Group - Translational Pilot Studies Program for Solid Malignancies; Go 4 the Goal Foundation Grant; NATIONAL CANCER INSTITUTE [K08CA188073] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Oncology Group - Translational Pilot Studies Program for Solid Malignancies; Go 4 the Goal Foundation Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH K08 - 5K08CA188073-03 (BDC), Children's Oncology Group - Translational Pilot Studies Program for Solid Malignancies (BDC), and Go 4 the Goal Foundation Grant (BDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Chabon JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11815; Cherukuri PF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2107-y; Chicard M, 2016, CLIN CANCER RES, V22, P5564, DOI 10.1158/1078-0432.CCR-16-0500; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Couch F. J., 2017, JAMA ONCOL; Curras-Freixes M, 2017, J MOL DIAGN; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Denis MG, 2015, CLIN CHEM, V61, P886, DOI 10.1373/clinchem.2015.238352; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gadd S, 2017, NAT GENET, V49, P1487, DOI 10.1038/ng.3940; Garcia-Murillas I, 2015, SCI TRANSL MED, V7, DOI [10.1126/scitranslmed.aab0021, 10.1126/scitranslmed.aac7551]; Gray ES, 2015, ONCOTARGET, V6, P42008, DOI 10.18632/oncotarget.5788; Hayashi M, 2016, CANCER-AM CANCER SOC, V122, P3015, DOI 10.1002/cncr.30144; Hedges DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018595; Kline CN, 2017, NEURO-ONCOLOGY, V19, P699, DOI 10.1093/neuonc/now254; Krumbholz M, 2016, CLIN CANCER RES, V22, P4356, DOI 10.1158/1078-0432.CCR-15-3028; Kurihara S, 2015, J PEDIATR SURG, V50, P2094, DOI 10.1016/j.jpedsurg.2015.08.033; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linderman MD, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-20; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mertes F, 2011, BRIEF FUNCT GENOMICS, V10, P374, DOI 10.1093/bfgp/elr033; Norton SE, 2013, CLIN BIOCHEM, V46, P1561, DOI 10.1016/j.clinbiochem.2013.06.002; Pratt VM, 2016, J MOL DIAGN, V18, P109, DOI 10.1016/j.jmoldx.2015.08.005; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Rothwell DG, 2016, MOL ONCOL, V10, P566, DOI 10.1016/j.molonc.2015.11.006; Sacher AG, 2016, JAMA ONCOL, V2, P1014, DOI 10.1001/jamaoncol.2016.0173; Tie J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6219; Toro PV, 2015, CLIN BIOCHEM, V48, P993, DOI 10.1016/j.clinbiochem.2015.07.097; Trubicka J, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3211-y; Van Allen EM, 2016, ONCOTARGET, V7, P52888, DOI 10.18632/oncotarget.9184; Warton K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-476; Yanagita M, 2016, CLIN CANCER RES, V22, P6010, DOI 10.1158/1078-0432.CCR-16-0909; Zhang JH, 2015, NEW ENGL J MED, V373, P2336, DOI 10.1056/NEJMoa1508054	35	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188835	10.1371/journal.pone.0188835	http://dx.doi.org/10.1371/journal.pone.0188835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206863	Green Published, gold, Green Submitted			2022-12-27	WOS:000417110700026
J	Reveiz, L; Haby, MM; Martinez-Vega, R; Pinzon-Flores, CE; Elias, V; Smith, E; Pinart, M; Broutet, N; Becerra-Posada, F; Aldighieri, S; Van Kerkhove, MD				Reveiz, Ludovic; Haby, Michelle M.; Martinez-Vega, Ruth; Pinzon-Flores, Carlos E.; Elias, Vanessa; Smith, Emma; Pinart, Mariona; Broutet, Nathalie; Becerra-Posada, Francisco; Aldighieri, Sylvain; Van Kerkhove, Maria D.			Risk of bias and confounding of observational studies of Zika virus infection: A scoping review of research protocols (vol 12, e0180220, 2017)	PLOS ONE			English	Correction													Pinart Gilberga, Mariona/GLS-8842-2022; Martínez-Vega, Ruth/AAD-3601-2019; Haby, Michelle/AGL-3386-2022	Pinart Gilberga, Mariona/0000-0002-8223-1325; Martínez-Vega, Ruth/0000-0002-6477-334X; Haby, Michelle/0000-0001-6203-9195; Van Kerkhove, Maria/0000-0002-6135-0018				Reveiz L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180220	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0189027	10.1371/journal.pone.0189027	http://dx.doi.org/10.1371/journal.pone.0189027			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190803	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900194
J	Ringstad, G; Lindstrom, EK; Vatnehol, SAS; Mardal, KA; Emblem, KE; Eide, PK				Ringstad, Geir; Lindstrom, Erika Kristina; Vatnehol, Svein Are Sirirud; Mardal, Kent-Andre; Emblem, Kyrre Eeg; Eide, Per Kristian			Non-invasive assessment of pulsatile intracranial pressure with phase-contrast magnetic resonance imaging	PLOS ONE			English	Article							CEREBROSPINAL-FLUID FLOW; AQUEDUCTAL STROKE VOLUME; CHIARI MALFORMATION; CSF FLOW; CEREBRAL AQUEDUCT; CINE MRI; HYDROCEPHALUS; MANAGEMENT; GRADIENT; SURGERY	Invasive monitoring of pulsatile intracranial pressure can accurately predict shunt response in patients with idiopathic normal pressure hydrocephalus, but may potentially cause complications such as bleeding and infection. We tested how a proposed surrogate parameter for pulsatile intracranial pressure, the phase-contrast magnetic resonance imaging derived pulse pressure gradient, compared with its invasive counterpart. In 22 patients with suspected idiopathic normal pressure hydrocephalus, preceding invasive intracranial pressure monitoring, and any surgical shunt procedure, we calculated the pulse pressure gradient from phase-contrast magnetic resonance imaging derived cerebrospinal fluid flow velocities obtained at the upper cervical spinal canal using a simplified Navier-Stokes equation. Repeated measurements of the pulse pressure gradient were also undertaken in four healthy controls. Of 17 shunted patients, 16 responded, indicating high proportion of "true" normal pressure hydrocephalus in the patient cohort. However, there was no correlation between the magnetic resonance imaging derived pulse pressure gradient and pulsatile intracranial pressure (R = -.18, P = .43). Pulse pressure gradients were also similar in patients and healthy controls (P = .26), and did not differ between individuals with pulsatile intracranial pressure above or below established thresholds for shunt treatment (P = .97). Assessment of pulse pressure gradient at level C2 was therefore not found feasible to replace invasive monitoring of pulsatile intracranial pressure in selection of patients with idiopathic normal pressure hydrocephalus for surgical shunting. Unlike invasive, overnight monitoring, the pulse pressure gradient from magnetic resonance imaging comprises short-term pressure fluctuations only. Moreover, complexity of cervical cerebrospinal fluid flow and -pulsatility at the upper cervical spinal canal may render the pulse pressure gradient a poor surrogate marker for intracranial pressure pulsations.	[Ringstad, Geir] Natl Hosp Norway, Dept Radiol & Nucl Med, Oslo Univ Hosp, Oslo, Norway; [Ringstad, Geir; Vatnehol, Svein Are Sirirud; Eide, Per Kristian] Univ Oslo, Fac Med, Oslo, Norway; [Lindstrom, Erika Kristina; Mardal, Kent-Andre] Univ Oslo, Fac Math & Nat Sci, Dept Math, Oslo, Norway; [Vatnehol, Svein Are Sirirud; Emblem, Kyrre Eeg] Oslo Univ Hosp, Intervent Ctr, Oslo, Norway; [Eide, Per Kristian] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Ringstad, G (corresponding author), Natl Hosp Norway, Dept Radiol & Nucl Med, Oslo Univ Hosp, Oslo, Norway.; Ringstad, G (corresponding author), Univ Oslo, Fac Med, Oslo, Norway.	gringsta@ous-hf.no	Mardal, Kent-Andre/G-8296-2018; Emblem, Kyrre/H-6691-2012	Mardal, Kent-Andre/0000-0002-4946-1110; Vatnehol, Svein Are Sirirud/0000-0002-7900-0534; Emblem, Kyrre/0000-0002-6580-9519; Ringstad, Geir/0000-0003-0919-4510	South Eastern Norway Regional Health Authority [2013069]	South Eastern Norway Regional Health Authority	Kyrre Eeg Emblem received Grant #2013069 from South Eastern Norway Regional Health Authority (http://www.helse-sorost.no/fag/forskning-og-innovasjon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PKE has a financial interest (shares) in the software company (dPCom AS, Oslo) manufacturing the software (Sensometrics Software) used for analysis of the ICP recordings. For the remaining authors none were declared. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; Alperin N, 2005, J NEUROSURG, V103, P46, DOI 10.3171/jns.2005.103.1.0046; Alperin NJ, 2000, RADIOLOGY, V217, P877, DOI 10.1148/radiology.217.3.r00dc42877; Alperin N, 2015, J MAGN RESON IMAGING, V42, P1158, DOI 10.1002/jmri.24882; Alperin N, 2014, NEUROSURGERY, V75, P515, DOI 10.1227/NEU.0000000000000507; Bradley WG, 1996, RADIOLOGY, V198, P523, DOI 10.1148/radiology.198.2.8596861; Cheng S, 2014, J BIOMECH, V47, P2826, DOI 10.1016/j.jbiomech.2014.04.027; Daouk J, 2017, ACTA RADIOL, V58, P977, DOI 10.1177/0284185116676655; Dixon GR, 2002, MAYO CLIN PROC, V77, P509, DOI 10.4065/77.6.509; Dreha-Kulaczewski S, 2015, J NEUROSCI, V35, P2485, DOI 10.1523/JNEUROSCI.3246-14.2015; Eide PK, 2016, WORLD NEUROSURG, V86, P186, DOI 10.1016/j.wneu.2015.09.067; Eide PK, 2010, NEUROSURGERY, V66, P80, DOI 10.1227/01.NEU.0000363408.69856.B8; Eide PK, 2015, WORLD NEUROSURGERY; Fric R, 2015, ACTA NEUROCHIR, V157, P1411, DOI 10.1007/s00701-015-2465-x; Glick RP, 2006, NEUROSURGERY, V59, P1052, DOI 10.1227/01.NEU.0000245586.23710.EF; Greitz D, 2004, NEUROSURG REV, V27, P145, DOI 10.1007/s10143-004-0326-9; Haughton V, 2014, AM J NEURORADIOL, V35, P1864, DOI 10.3174/ajnr.A4023; Jaeger M, 2016, J CLIN NEUROSCI, V33, P169, DOI 10.1016/j.jocn.2016.03.029; Kahlon B, 2007, NEUROSURGERY, V60, P124, DOI 10.1227/01.NEU.0000249208.04344.A3; Koskinen LOD, 2013, ACTA NEUROCHIR, V155, P2141, DOI 10.1007/s00701-013-1856-0; Lorenz R, 2014, MAGN RESON MED, V72, P33, DOI 10.1002/mrm.24885; Loth F, 2001, J BIOMECH ENG-T ASME, V123, P71, DOI 10.1115/1.1336144; Luetmer PH, 2002, NEUROSURGERY, V50, P534, DOI 10.1097/00006123-200203000-00020; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; Martin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075335; Mase M, 2005, ACT NEUR S, V95, P303; Muehlmann M, 2013, INVEST RADIOL, V48, P543, DOI 10.1097/RLI.0b013e31828ad504; Pahlavian SH, 2015, ANN BIOMED ENG, V43, P2911, DOI 10.1007/s10439-015-1355-y; Pahlavian SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091888; Ringstad G, 2015, AM J NEURORADIOL, V36, P1623, DOI 10.3174/ajnr.A4340; Roldan A, 2009, AM J NEURORADIOL, V30, P941, DOI 10.3174/ajnr.A1489; Rutkowska G, 2012, AM J NEURORADIOL, V33, P1756, DOI 10.3174/ajnr.A3047; Sharma AK, 2008, CLIN NEUROL NEUROSUR, V110, P363, DOI 10.1016/j.clineuro.2007.12.021	33	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188896	10.1371/journal.pone.0188896	http://dx.doi.org/10.1371/journal.pone.0188896			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190788	Green Published, Green Submitted, gold			2022-12-27	WOS:000416841900162
J	Schneider, F; Martin, J; Hapfelmeier, A; Jordan, D; Schneider, G; Schulz, CM				Schneider, Frederick; Martin, Jan; Hapfelmeier, Alexander; Jordan, Denis; Schneider, Gerhard; Schulz, Christian M.			The validity of linear and non-linear heart rate metrics as workload indicators of emergency physicians	PLOS ONE			English	Article							RATE-VARIABILITY; MENTAL WORKLOAD; ANESTHETISTS WORKLOAD; APPROXIMATE ENTROPY; PERMUTATION ENTROPY; TIME-SERIES; EXPERIENCE; TRACKING; INDEXES; STRESS	Background It has been shown that linear and non-linear heart rate variability (HRV) metrics are suitable to assess workload of anesthetists administering anesthesia. In pre-hospital emergency care, these parameters have not yet been evaluated. We hypothesized that heart rate (HR) and HRV metrics discriminate between differing workload levels of an emergency physician. Methods Electrocardiograms were obtained from 13 emergency physicians. Mean HR, ten linear and seven non-linear HRV metrics were analyzed. For each sortie, four different levels of workload were defined. Mixed-effects models and the area under the receiver operating characteristics curve (AUC) were used to test and quantify the HR and HRV metrics' ability to discriminate between levels of workload. This was conducted for mean HR and each HRV metric as well as for groups of metrics (time domain vs. frequency domain vs. non-linear metrics). Results The non-linear HRV metric Permutation entropy (PeEn) discriminated best between the time before the alarm and primary patient care (AUC = 0.998, 1st rank of 18 HRV metrics). In contrast, AUC of the mean HR was low (0.558, 17th rank). In the multivariable approach, the non-linear HRV metrics provided a higher AUC (0.998) compared to the frequency domain (0.677) and to the time domain metrics (0.680). Conclusion Non-linear heart rate metrics and, specifically, PeEn provided good validity for the assessment of different levels of a physician's workload in the setting of pre-hospital emergency care. In contradiction to earlier findings, the physicians' mean HR was not a valid marker of workload.	[Schneider, Frederick; Martin, Jan; Schneider, Gerhard; Schulz, Christian M.] Tech Univ Munich, Klinikum Rechts Isar, Dept Anesthesiol, Munich, Germany; [Hapfelmeier, Alexander] Tech Univ Munich, Klinikum Rechts Isar, Inst Med Stat & Epidemiol, Munich, Germany; [Jordan, Denis] Fachhsch Nordwestschweiz, Inst Vermessung & Geoinformat, Hsch Architektur Bau & Geomat, Muttenz, Switzerland	Technical University of Munich; Technical University of Munich; FHNW University of Applied Sciences & Arts Northwestern Switzerland	Schneider, F (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Anesthesiol, Munich, Germany.	frederick.schneider@tum.de	Hapfelmeier, Alexander/I-9966-2019	Hapfelmeier, Alexander/0000-0001-6765-6352; Schneider, Gerhard/0000-0002-4903-0118; Schneider, Frederick/0000-0002-1952-0124				Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Berka C, 2007, AVIAT SPACE ENVIR MD, V78, pB231; BERNTSON GG, 1990, PSYCHOPHYSIOLOGY, V27, P586, DOI 10.1111/j.1469-8986.1990.tb01982.x; Bolea J, 2014, IEEE ENG MED BIO, P3252, DOI 10.1109/EMBC.2014.6944316; Burden A, 2014, SITUATIONAL AWARENES; Byrne AJ, 2013, ANAESTHESIA, V68, P1266, DOI 10.1111/anae.12455; Camm AJ, 1996, EUR HEART J, V17, P354; Cao YH, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046217; Cinaz B, 2013, PERS UBIQUIT COMPUT, V17, P229, DOI 10.1007/s00779-011-0466-1; Crewther BT, 2015, SURG ENDOSC; Dimitriev DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146131; Guzzetti S, 1996, CARDIOVASC RES, V31, P441; Henelius A, 2009, IEEE ENG MED BIO, P1836; Hjortskov N, 2004, EUR J APPL PHYSIOL, V92, P84, DOI 10.1007/s00421-004-1055-z; Hsu BW, 2015, PERCEPT MOTOR SKILL, V121, P94, DOI 10.2466/22.PMS.121c12x5; Huber S, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0252-1; Ilper H, 2013, DEUT MED WOCHENSCHR, V138, P880, DOI 10.1055/s-0033-1343128; Jordan D, 2008, ANESTHESIOLOGY, V109, P1014, DOI 10.1097/ALN.0b013e31818d6c55; Kaufmann T, 2011, BEHAV RES METHODS, V43, P1161, DOI 10.3758/s13428-011-0107-7; Leedal JM, 2005, BRIT J ANAESTH, V94, P702, DOI 10.1093/bja/aei131; Levin S, 2006, HUM FACTORS, V48, P526, DOI 10.1518/001872006778606903; Luque-Casado A, 2016, BIOL PSYCHOL, V113, P83, DOI 10.1016/j.biopsycho.2015.11.013; Mansikka H, 2016, ERGONOMICS, V59, P1344, DOI 10.1080/00140139.2015.1136699; Martin J, 2016, BRIT J ANAESTH, V117, P767, DOI 10.1093/bja/aew342; Melillo P, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-96; Obuchowski NA, 1997, BIOMETRICS, V53, P567, DOI 10.2307/2533958; PAGANI M, 1991, CIRCULATION, V83, P43; Pincus S, 1996, P NATL ACAD SCI USA, V93, P2083, DOI 10.1073/pnas.93.5.2083; R Core Team, 2015, R LANGUAGE ENV STAT; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rieger A, 2014, INT ARCH OCC ENV HEA, V87, P165, DOI 10.1007/s00420-013-0847-z; Sauvet F, 2009, AVIAT SPACE ENVIR MD, V80, P862, DOI 10.3357/ASEM.2531.2009; Schneider G, 2014, ANESTHESIOLOGY, V120, P819, DOI 10.1097/ALN.0000000000000151; Schoenenberger S, 2014, INT J OCCUP SAF ERGO, V20, P551, DOI 10.1080/10803548.2014.11077071; Schulz CM, 2011, BRIT J ANAESTH, V106, P44, DOI 10.1093/bja/aeq307; Schulz CM, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0172-7; Schulz CM, 2013, ANESTHESIOLOGY, V118, P729, DOI 10.1097/ALN.0b013e318280a40f; Schulz CM, 2016, QUALITY SAFETY ANEST, P98; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Weinger MB, 2004, ANESTH ANALG, V98, P1419, DOI 10.1213/01.ANE.0000106838.66901.D2; WEINGER MB, 1994, ANESTHESIOLOGY, V80, P77, DOI 10.1097/00000542-199401000-00015; Zbilut JP, 2002, MED ENG PHYS, V24, P53, DOI 10.1016/S1350-4533(01)00112-6	42	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188635	10.1371/journal.pone.0188635	http://dx.doi.org/10.1371/journal.pone.0188635			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190808	Green Submitted, gold, Green Published			2022-12-27	WOS:000416841900089
J	Zhang, C; Li, XH; Brecht, ML; Koniak-Griffin, D				Zhang, Ci; Li, Xianhong; Brecht, Mary-Lynn; Koniak-Griffin, Deborah			Can self-testing increase HIV testing among men who have sex with men: A systematic review and meta-analysis	PLOS ONE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; HIGH-RISK; BISEXUAL MEN; GAY; MSM; ACCEPTABILITY; INFECTION; FREQUENCY; CHINA; BEHAVIORS	Background Globally, four out of ten individuals living with HIV have not been tested for HIV. Testing is especially important for men who have sex with men (MSM), among whom an increasing HIV epidemic has been identified in many regions of the world. As a supplement to site-based HIV testing services, HIV self-testing (HIVST) provides a promising approach to promote HIV testing. However, evidence is scattered and not well-summarized on the effect of HIVST to improve HIV testing behaviors, especially for MSM. Methods Seven databases (PubMed, Web of Science, Cochrane Library, PsycINFO, CINAHL Plus, WanFang, and China National Knowledge Internet) and conference abstracts from six HIV/sexually transmitted infections conferences were searched from January 2000-April 2017. Results Of 1,694 records retrieved, 23 studies were identified, 9 conducted in resource-limited countries and 14 in high-income countries. The pooled results showed that HIVST increased HIV test frequency for MSM by one additional test in a 6-month period (mean difference = 0.88 [95% CI 0.52 +/- 1.24]). The pooled proportion of first-time testers among those who took HIVST was 18.7% (95% CI: 9.9 +/- 32.4) globally, with a rate 3.32 times higher in resource-limited country settings (32.9% [95% CI: 21.3 +/- 47.6]) than in high-income countries (9.9% [95% CI: 7.4 +/- 13.8]). The pooled proportions included non-recent testers, 32.9% (95% CI: 28.1 +/- 38.3); ever or currently married MSM, 16.7% (95% CI: 14.5 +/- 19.4); and HIV positive men, 3.8% (95% CI: 2.0 +/- 5.7) globally; 6.5% [95% CI: 0.38 +/- 12.3] in resource-limited country settings; and 2.9% [95% CI: 2.0 +/- 5.0] in high-income countries). The rates reported for linkage to care ranged from 31.3% to 100%. Conclusions HIVST could increase HIV testing frequency and potentially have capacity equivalent to that of site-based HIV testing services to reach first-time, delayed, married, and HIV-infected testers among MSM and link them to medical care. However, more rigorous study designs are needed to explore the specific self-testing approach (oral-fluid based or finger-prick based) on improving HIV testing for MSM in different social and economic settings.	[Zhang, Ci; Li, Xianhong] Cent South Univ, Xiangya Nursing Sch, Changsha, Hunan, Peoples R China; [Brecht, Mary-Lynn; Koniak-Griffin, Deborah] UCLA, Sch Nursing, Los Angeles, CA 90024 USA	Central South University; University of California System; University of California Los Angeles	Li, XH (corresponding author), Cent South Univ, Xiangya Nursing Sch, Changsha, Hunan, Peoples R China.	xianhong_li228@hotmail.com		Li, Xianhong/0000-0002-3554-7693; Koniak-Griffin, Deborah/0000-0002-0974-2815; Zhang, Ci/0000-0002-1031-9803	Fogarty International Center Award [D43 TW009579]; National Social Science Fund [15C5H037]; FOGARTY INTERNATIONAL CENTER [D43TW009579] Funding Source: NIH RePORTER	Fogarty International Center Award; National Social Science Fund; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study is funded by Fogarty International Center Award (D43 TW009579) (https.//www.fic.nih.gov/Pages/Default.aspx), and partly funded by National Social Science Fund (15C5H037) (http://www.npopss-cn.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is funded by Fogarty International Center Award (D43 TW009579) (https://www.fic.nih.gov/Pages/Defaulh.aspx), and partly funded by National Social Science Fund (15CSH037) (htip://www.npopss-cn.gov.cn/). The authors have declared that no competing interests exist.	[Anonymous], 2010, EMIS 2010 EUR MEN WH; Bai X, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18848; Bilardi JE, 2013, AIDS BEHAV, V17, P2093, DOI 10.1007/s10461-012-0395-7; Campbell S, 2006, J CLIN MICROBIOL, V44, P3473, DOI 10.1128/JCM.01511-06; Carballo-Dieguez A, 2012, AIDS BEHAV, V16, P1753, DOI 10.1007/s10461-012-0274-2; Chavez P. R, 2016, HIV DIAGN C 2016 MAY; Daniels J, 2016, J ASSOC NURSE AIDS C, V27, P722, DOI 10.1016/j.jana.2016.05.002; Elliot E, 2016, SEX TRANSM INFECT, V92, P470, DOI 10.1136/sextrans-2015-052090; Eric PC, 2011, BMC INFECT DIS, V11, P1; Figueroa C, 2015, AIDS BEHAV, V19, P1949, DOI 10.1007/s10461-015-1097-8; Flowers P, 2017, HIV MED, V18, P245, DOI 10.1111/hiv.12420; Frye V, 2015, AIDS PATIENT CARE ST, V29, P617, DOI 10.1089/apc.2015.0100; Go VF, 2004, JAIDS-J ACQ IMM DEF, V35, P314, DOI 10.1097/00126334-200403010-00014; Greacen T, 2012, SEX TRANSM INFECT, V88, P368, DOI 10.1136/sextrans-2011-050405; Grov C, 2016, SEX RES SOC POLICY, V13, P1, DOI 10.1007/s13178-015-0212-y; Han L, 2014, JAIDS-J ACQ IMM DEF, V67, P216, DOI 10.1097/QAI.0000000000000278; Huang E, 2016, AIDS EDUC PREV, V28, P341, DOI 10.1521/aeap.2016.28.4.341; Jamil MS, 2017, LANCET HIV, V4, pE241, DOI 10.1016/S2352-3018(17)30023-1; Katz D, 2015, 8 INT AIDS SOC C 201; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Li Jian, 2014, Zhonghua Liu Xing Bing Xue Za Zhi, V35, P809; Li Youfang, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P72, DOI 10.3760/cma.j.issn.0254-6450.2016.01.015; Linkedin Corporation, 2015, 2014 CHIN WORKPL STR; Marcus U, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3759-5; Marcus U, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1945-5; Marley G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-422; Marlin RW, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1226; Mayer KH, 2015, SEX TRANSM DIS, V42, P629, DOI 10.1097/OLQ.0000000000000344; McDaid LM, 2016, HIV MED, V17, P683, DOI 10.1111/hiv.12373; Mdodo R, 2014, PUBLIC HEALTH REP, V129, P328, DOI 10.1177/003335491412900407; Ministry of Health of the People's Republic of China, 2012, 2012 CHIN AIDS RESP; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Pant Pai Nitika, 2013, PLoS Med, V10, pe1001414, DOI 10.1371/journal.pmed.1001414; Patel RR, 2014, INT J STD AIDS, V25, P213, DOI 10.1177/0956462413497700; Qin YL, 2017, SEX TRANSM DIS, V44, P233, DOI [10.1097/OLQ.0000000000000581, 10.1097/olq.0000000000000581]; Read TRH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5086; Rosengren AL, 2016, SEX HEALTH, V13, P389, DOI 10.1071/SH15236; Solomon SS, 2010, AIDS BEHAV, V14, P1001, DOI 10.1007/s10461-010-9711-2; Spielberg F, 2004, LANCET INFECT DIS, V4, P640, DOI 10.1016/S1473-3099(04)01150-8; State Council, 2017, 13 5 YEAR PLAN HIV P; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Tao J, 2014, IEEE PAC VIS SYMP, P9, DOI 10.1109/PacificVis.2014.12; Templeton DJ, 2014, SEX HEALTH, V11, P217, DOI 10.1071/SH14003; The Henry J. Kaiser Family Foundation, 2017, GLOB HIV AIDS EP; The Joanna Briggs Institute, 2016, JOANN BRIGGS I REV M; The Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK END AIDS; UNAIDS, 2016, AIDS NUMB AIDS IS NO; UNAIDS, 2014, 2014 PROGR REP SUBM; US Department of Health and Human Services, 2017, HIV AIDS 101 GLOB ST; Valdiserri RO, 2007, PLOS MED, V4, P975, DOI 10.1371/journal.pmed.0040200; Viswanathan M, 2008, METHODS GUIDE EFFECT; Volk JE, 2016, INT J STD AIDS, V27, P531, DOI 10.1177/0956462415586676; Wang HY, 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/850132; Wei CY, 2014, AIDS CARE, V26, P372, DOI 10.1080/09540121.2013.824538; WHO, 2016, GUID HIV SELF TEST P; Wong HTH, 2015, AIDS BEHAV, V19, P505, DOI 10.1007/s10461-014-0881-1; Woods WJ, 2016, AIDS CARE, V28, P111, DOI 10.1080/09540121.2016.1146399; Wright AA, 2006, NEW ENGL J MED, V354, P437, DOI 10.1056/NEJMp058302; Yan HJ, 2015, AIDS BEHAV, V19, P485, DOI 10.1007/s10461-014-0968-8; Zhong F, 2017, HIV MED, V18, P376, DOI 10.1111/hiv.12437; Zhou Y., 2015, SCI PUBL POLICY, V1, P1; Zou HC, 2012, AIDS BEHAV, V16, P1717, DOI 10.1007/s10461-012-0225-y; Zou HC, 2010, JAIDS-J ACQ IMM DEF, V53, pS81, DOI 10.1097/QAI.0b013e3181c7dd2b	63	42	45	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188890	10.1371/journal.pone.0188890	http://dx.doi.org/10.1371/journal.pone.0188890			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190791	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900158
J	Cangelosi, Q; Means, SA; Ho, H				Cangelosi, Quentin; Means, Shawn A.; Ho, Harvey			A multi-scale spatial model of hepatitis-B viral dynamics	PLOS ONE			English	Article							VIRUS-REPLICATION; HEPATOCYTE TURNOVER; LIVER; INFECTION; CELLS; DNA; TRANSIENT; INTERFERON; METABOLISM; AGONISTS	Chronic hepatitis B viral infection (HBV) afflicts around 250 million individuals globally and few options for treatment exist. Once infected, the virus entrenches itself in the liver with a notoriously resilient colonisation of viral DNA (covalently-closed circular DNA, cccDNA). The majority of infections are cleared, yet we do not understand why 5% of adult immune responses fail leading to the chronic state with its collateral morbid effects such as cirrhosis and eventual hepatic carcinoma. The liver environment exhibits particularly complex spatial structures for metabolic processing and corresponding distributions of nutrients and transporters that may influence successful HBV entrenchment. We assembled a multi-scaled mathematical model of the fundamental hepatic processing unit, the sinusoid, into a whole-liver representation to investigate the impact of this intrinsic spatial heterogeneity on the HBV dynamic. Our results suggest HBV may be exploiting spatial aspects of the liver environment. We distributed increased HBV replication rates coincident with elevated levels of nutrients in the sinusoid entry point (the periportal region) in tandem with similar distributions of hepatocyte transporters key to HBV invasion (e.g., the sodium-taurocholate cotransporting polypeptide or NTCP), or immune system activity. According to our results, such co-alignment of spatial distributions may contribute to persistence of HBV infections, depending on spatial distributions and intensity of immune response as well. Moreover, inspired by previous HBV models and experimentalist suggestions of extra-hepatic HBV replication, we tested in our model influence of HBV blood replication and observe an overall nominal effect on persistent liver infection. Regardless, we confirm prior results showing a solo cccDNA is sufficient to re-infect an entire liver, with corresponding concerns for transplantation and treatment.	[Cangelosi, Quentin] Inst Natl Sci Appl, Computat & Math Engn, Toulouse, France; [Means, Shawn A.; Ho, Harvey] Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand	Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National des Sciences Appliquees de Toulouse; University of Auckland	Means, SA (corresponding author), Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand.	s.means@auckland.ac.nz			Faculty Research Development Fund of The University of Auckland, New Zealand [3707110, 3712133]; Medical Technologies Centre of Research Excellence (MedTech CoRE) - Tertiary Education Commission of New Zealand	Faculty Research Development Fund of The University of Auckland, New Zealand; Medical Technologies Centre of Research Excellence (MedTech CoRE) - Tertiary Education Commission of New Zealand	This study was financially supported by the Faculty Research Development Fund (No. 3707110 & 3712133) of The University of Auckland, New Zealand and the Medical Technologies Centre of Research Excellence (MedTech CoRE) funded by the Tertiary Education Commission of New Zealand to HH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the financial support from the Faculty Research Development Fund (No. 3707110 & 3712133) of The University of Auckland, New Zealand. HH also acknowledges the financial support from the Medical Technologies Centre of Research Excellence (MedTech CoRE) funded by the Tertiary Education Commission of New Zealand.	Allweiss L, 2017, GUT; Amaya MJ, 2013, COMPR PHYSIOL, V3, P515, DOI 10.1002/cphy.c120013; Baratta JL, 2009, HISTOCHEM CELL BIOL, V131, P713, DOI 10.1007/s00418-009-0577-1; Bianconi E, 2013, ANN HUM BIOL, V40, P463, DOI 10.3109/03014460.2013.807878; Chalhoub E, 2007, ANN BIOMED ENG, V35, P474, DOI 10.1007/s10439-006-9217-2; Chang JH, 2015, ANTIVIR RES, V121, P152, DOI 10.1016/j.antiviral.2015.07.006; Chisari FV, 2010, PATHOL BIOL, V58, P258, DOI 10.1016/j.patbio.2009.11.001; Ciupe SM, 2007, P NATL ACAD SCI USA, V104, P5050, DOI 10.1073/pnas.0603626104; Ciupe SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003730; Ciupe SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039591; de Sousa BC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012512; DEJEAN A, 1984, J GEN VIROL, V65, P651, DOI 10.1099/0022-1317-65-3-651; GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5; Goyal A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161978; Grellier L, 1996, LANCET, V348, P1212, DOI 10.1016/S0140-6736(96)04444-3; Guidotti LG, 2015, CURR OPIN IMMUNOL, V36, P61, DOI 10.1016/j.coi.2015.06.016; Guidotti LG, 2015, CELL, V161, P486, DOI 10.1016/j.cell.2015.03.005; Guo JT, 2000, J VIROL, V74, P1495, DOI 10.1128/JVI.74.3.1495-1505.2000; Guo JT, 2015, ANTIVIR RES, V122, P91, DOI 10.1016/j.antiviral.2015.08.005; Ho H, 2013, MED ENG PHYS, V35, P1053, DOI 10.1016/j.medengphy.2012.10.008; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Hoofnagle JH, 2009, HEPATOLOGY, V49, pS156, DOI 10.1002/hep.22945; Huang YX, 2016, MED SCI MONITOR, V22, P1673, DOI 10.12659/MSM.898680; Ikeda K, 2009, J VIRAL HEPATITIS, V16, P437, DOI 10.1111/j.1365-2893.2009.01085.x; Jhuang HJ, 2015, ONCOTARGET, V6, P7788, DOI 10.18632/oncotarget.3050; Li AP, 2007, CHEM-BIOL INTERACT, V168, P16, DOI 10.1016/j.cbi.2007.01.001; Mason A, 2005, AM J GASTROENTEROL, V100, P972, DOI 10.1111/j.1572-0241.2005.41308.x; MASON A, 1993, HEPATOLOGY, V18, P781, DOI 10.1002/hep.1840180406; Mason WS, 2007, J VIRAL HEPATITIS, V14, P22, DOI 10.1111/j.1365-2893.2007.00911.x; Mason WS, 2009, J VIROL, V83, P1778, DOI 10.1128/JVI.01587-08; Murray JM, 2005, P NATL ACAD SCI USA, V102, P17780, DOI 10.1073/pnas.0508913102; Murray JM, 2015, J THEOR BIOL, V366, P91, DOI 10.1016/j.jtbi.2014.11.020; NATHANSON MH, 1992, HEPATOLOGY, V15, P107, DOI 10.1002/hep.1840150119; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Qesmi R, 2011, SIAM J APPL MATH, V71, P1509, DOI 10.1137/10079690X; Reaiche-Miller GY, 2013, VIROLOGY, V446, P357, DOI 10.1016/j.virol.2013.08.014; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Schmeltzer P, 2010, DIGEST DIS SCI, V55, P3328, DOI 10.1007/s10620-010-1413-0; Schweitzer A, 2015, LANCET; Schwen LO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133653; Seeger C, 2015, VIROLOGY, V479, P672, DOI 10.1016/j.virol.2015.02.031; Stieger B, 2011, HANDB EXP PHARMACOL, V201, P205, DOI 10.1007/978-3-642-14541-4_5; SUMMERS J, 1990, J VIROL, V64, P2819, DOI 10.1128/JVI.64.6.2819-2824.1990; Wambaugh J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000756; Watashi K, 2014, INT J MOL SCI, V15, P2892, DOI 10.3390/ijms15022892; Wieland SF, 2000, J VIROL, V74, P4165, DOI 10.1128/JVI.74.9.4165-4173.2000; Wieland SF, 2004, P NATL ACAD SCI USA, V101, P2129, DOI 10.1073/pnas.0308478100; Zhang YZ, 2003, P NATL ACAD SCI USA, V100, P12372, DOI 10.1073/pnas.2033898100	48	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188209	10.1371/journal.pone.0188209	http://dx.doi.org/10.1371/journal.pone.0188209			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216213	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800019
J	Mave, V; Kinikar, A; Kagal, A; Nimkar, S; Koli, H; Khwaja, S; Bharadwaj, R; Gerona, R; Wen, A; Ramachandran, G; Kumar, H; Bacchetti, P; Dooley, KE; Gupte, N; Gupta, A; Gandhi, M				Mave, Vidya; Kinikar, Aarti; Kagal, Anju; Nimkar, Smita; Koli, Hari; Khwaja, Sultanat; Bharadwaj, Renu; Gerona, Roy; Wen, Anita; Ramachandran, Geetha; Kumar, Hemanth; Bacchetti, Peter; Dooley, Kelly E.; Gupte, Nikhil; Gupta, Amita; Gandhi, Monica			Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis	PLOS ONE			English	Article							DRUG; INTERMITTENT; VARIABILITY; EFAVIRENZ; FAILURE; HISTORY	We measured hair and plasma concentrations of isoniazid among sixteen children with tuberculosis who underwent personal or video-assisted directly observed therapy and thus had 100% adherence. This study therefore defined typical isoniazid exposure parameters after two months of treatment among fully-adherent patients in both hair and plasma ( plasma area under the concentration-time curve, AUC, estimated using pharmacokinetic data collected 0, 2, 4, and 6 hours after drug administration). We found that INH levels in hair among highly-adherent individuals did not correlate well with plasma AUC or trough concentrations, suggesting that each measure may provide incremental and complementary information regarding drug exposure in the context of TB treatment.	[Mave, Vidya; Kinikar, Aarti; Kagal, Anju; Nimkar, Smita; Koli, Hari; Khwaja, Sultanat; Bharadwaj, Renu; Gupte, Nikhil; Gupta, Amita] Johns Hopkins Univ, Byramjee Jeejeebhoy Govt Med Coll, Clin Res Site, Pune, Maharashtra, India; [Mave, Vidya; Dooley, Kelly E.; Gupte, Nikhil; Gupta, Amita] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Kinikar, Aarti; Kagal, Anju; Bharadwaj, Renu] Byramjee Jeejeebhoy Govt Med Coll, Pune, Maharashtra, India; [Gerona, Roy; Wen, Anita; Bacchetti, Peter; Gandhi, Monica] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Ramachandran, Geetha; Kumar, Hemanth] Natl Inst Res TB, Madras, Tamil Nadu, India	B.J. Govt. Medical College & Sassoon General Hospitals, Pune; Johns Hopkins University; Johns Hopkins University; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; University of California System; University of California San Francisco; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Mave, V (corresponding author), Johns Hopkins Univ, Byramjee Jeejeebhoy Govt Med Coll, Clin Res Site, Pune, Maharashtra, India.; Mave, V (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	vidyamave@gmail.com		Gupta, Amita/0000-0001-7036-2718	JHU CFAR NIH/NIAID fund [1P30AI094189-01A1, 1R21AI127149-01]; Government of India's (GOI) Department of Biotechnology (DBT); Indian Council of Medical Research (ICMR); United States National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID); Office of AIDS Research (OAR); NIH BWI Clinical Trials Unit for NIAID Networks (UM1) [UM1A1069465]; NIAID/NIH [2R01 AI098472, R01AI123024]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, R01AI123024] Funding Source: NIH RePORTER	JHU CFAR NIH/NIAID fund; Government of India's (GOI) Department of Biotechnology (DBT); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of AIDS Research (OAR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH BWI Clinical Trials Unit for NIAID Networks (UM1); NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was primarily supported by JHU CFAR NIH/NIAID fund 1P30AI094189-01A1 and 1R21AI127149-01 (P.I. Mave). Data in this manuscript in part were collected as part of the Regional Prospective Observational Research for Tuberculosis (RePORT) India Consortium. This project has been funded in whole or in part with Federal funds from the Government of India's (GOI) Department of Biotechnology (DBT), the Indian Council of Medical Research (ICMR), the United States National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Office of AIDS Research (OAR), and distributed in part by CRDF Global. The contents of this publication are solely the responsibility of the authors and do not represent the official views of the DBT, the ICMR, the NIH, or CRDF Global and R03 HD061059 (P.I. Jain S/Bharadwaj R). VM, NG, SM, HK, SK, AG are also supported by the NIH BWI Clinical Trials Unit for NIAID Networks (UM1) (P.I. Flexner/Gupta, UM1A1069465). MG, RG, and AW are supported by NIAID/NIH 2R01 AI098472 and hair assay development was partially supported by NIAID/NIH R01AI123024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any mention of trade names, commercial projects, or organizations does not imply endorsement by any of the sponsoring organizations. The content of this paper is solely the responsibility of the authors and does not necessary represent the official views of the funders.	Alffenaar JWC, 2012, J INFECT DIS, V205, P1765, DOI 10.1093/infdis/jis270; Baxi SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129100; Chideya S, 2009, CLIN INFECT DIS, V48, P1685, DOI 10.1086/599040; Edelbroek PM, 2009, THER DRUG MONIT, V31, P327, DOI 10.1097/FTD.0b013e31819e91ce; Eisenhut M., 2012, TUBERC RES TREAT; Gandhi M, 2002, ANN INTERN MED, V137, P696, DOI 10.7326/0003-4819-137-8-200210150-00016; Gandhi M, 2015, J INFECT DIS, V212, P1402, DOI 10.1093/infdis/jiv239; Gandhi M, 2013, JAIDS-J ACQ IMM DEF, V63, P578, DOI 10.1097/QAI.0b013e31829c48ad; Gandhi M, 2012, J INFECT DIS, V206, P1453, DOI 10.1093/infdis/jis508; Gandhi M, 2011, CLIN INFECT DIS, V52, P1267, DOI 10.1093/cid/cir131; Gandhi M, 2009, AIDS, V23, P471, DOI 10.1097/QAD.0b013e328325a4a9; Garcia-Martin E, 2008, CURR DRUG METAB, V9, P487, DOI 10.2174/138920008784892155; Gerona R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155887; Hickey MD, 2014, JAIDS-J ACQ IMM DEF, V66, P311, DOI 10.1097/QAI.0000000000000154; Kumar AKH, 2015, INT J TUBERC LUNG D, V19, P805, DOI 10.5588/ijtld.14.0702; Kumar AKH, 2012, SAARC J TB LUNG DIS, V9, P13, DOI DOI 10.3126/SAARCTB.V9I1.6960; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Mave V, 2016, INT J TUBERC LUNG D, V20, P844, DOI 10.5588/ijtld.15.0882; MITCHISON DA, 1985, TUBERCLE, V66, P219, DOI 10.1016/0041-3879(85)90040-6; Pasipanodya JG, 2012, CLIN INFECT DIS, V55, P169, DOI 10.1093/cid/cis353; Peloquin C, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TNMI7-0029-2016; Podsadecki TJ, 2008, HIV CLIN TRIALS, V9, P238, DOI 10.1310/hct0904-238; Ramachandran G, 2015, ANTIMICROB AGENTS CH, V59, P1162, DOI 10.1128/AAC.04338-14; Swaminathan S, 2016, CLIN INFECT DIS, V63, pS63, DOI 10.1093/cid/ciw471; Tsatsakis AM, 2000, J CLIN PSYCHOPHARM, V20, P560, DOI 10.1097/00004714-200010000-00012; WHO, 2016, GLOB TUB REP; WHO, ROADM CHILDH TB ZER; Wiltshire CS, 2014, J INT AIDS SOC, V17, P65, DOI 10.7448/IAS.17.4.19585	28	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189101	10.1371/journal.pone.0189101	http://dx.doi.org/10.1371/journal.pone.0189101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216273	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000417337800072
J	Ooishi, Y; Mukai, H; Watanabe, K; Kawato, S; Kashino, M				Ooishi, Yuuki; Mukai, Hideo; Watanabe, Ken; Kawato, Suguru; Kashino, Makio			Increase in salivary oxytocin and decrease in salivary cortisol after listening to relaxing slow-tempo and exciting fast-tempo music	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; HEART-RATE; SUBJECTIVE RESPONSES; HEALTHY-MEN; TESTOSTERONE; THERAPY; ANXIETY; REACTIVITY; NEURONS; SYSTEM	Relaxation and excitation are components of the effects of music listening. The tempo of music is often considered a critical factor when determining these effects: listening to slow-tempo and fast-tempo music elicits relaxation and excitation, respectively. However, the chemical bases that underlie these relaxation and excitation effects remain unclear. Since parasympathetic and sympathetic nerve activities are facilitated by oxytocin and glucocorticoid, respectively, we hypothesized that listening to relaxing slow-tempo and exciting fast-tempo music is accompanied by increases in the oxytocin and cortisol levels, respectively. We evaluated the change in the salivary oxytocin and cortisol levels of participants listening to slow-tempo and fast-tempo music sequences. We measured the heart rate (HR) and calculated the heart rate variability (HRV) to evaluate the strength of autonomic nerve activity. After listening to a music sequence, the participants rated their arousal and valence levels. We found that both the salivary oxytocin concentration and the high frequency component of the HRV (HF) increased and the HR decreased when a slow-tempo music sequence was presented. The salivary cortisol level decreased and the low frequency of the HRV (LF) to HF ratio (LF/HF) increased when a fast-tempo music sequence was presented. The ratio of the change in the oxytocin level was correlated with the change in HF, LF/HF and HR, whereas that in the cortisol level did not show any correlation with indices of autonomic nerve activity. There was no correlation between the change in oxytocin level and self-reported emotions, while the change in cortisol level correlated with the arousal level. These findings suggest that listening to slow-tempo and fast-tempo music is accompanied by an increase in the oxytocin level and a decrease in the cortisol level, respectively, and imply that such music listening-related changes in oxytocin and cortisol are involved in physiological relaxation and emotional excitation, respectively.	[Ooishi, Yuuki; Watanabe, Ken; Kashino, Makio] NTT Corp, NTT Commun Sci Labs, Morinosato Wakamiya Atsu, Kanagawa, Japan; [Mukai, Hideo] Meiji Univ, Sch Sci & Technol, Dept Comp Sci, Tama Ku, Kawasaki, Kanagawa, Japan; [Mukai, Hideo; Kawato, Suguru] Univ Tokyo, Grad Sch Arts & Sci, Dept Biophys & Life Sci, Meguro Ku, Tokyo, Japan; [Watanabe, Ken; Kashino, Makio] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Informat Proc, Midori Ku, Yokohama, Kanagawa, Japan; [Kashino, Makio] Japan Sci & Technol Agcy, CREST, JST, Atsugi, Kanagawa, Japan	Nippon Telegraph & Telephone Corporation; Meiji University; University of Tokyo; Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Ooishi, Y (corresponding author), NTT Corp, NTT Commun Sci Labs, Morinosato Wakamiya Atsu, Kanagawa, Japan.	ooishi.yuuki@lab.ntt.co.jp	nyakky, k/GXF-5548-2022; Campailla, Jasmin/AAK-2420-2021	Ooishi, Yuuki/0000-0003-1231-7366; Watanabe, Ken/0000-0002-3035-1333	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency; NTT Corporation	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); NTT Corporation	This work was supported by Core Research for Evolutional Science and Technology, Japan Science and Technology Agency to M.K. NTT Corporation provided support in the form of salaries for authors Yuuki Ooishi, Ken Watanabe and Makio Kashino. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the'author contributions' section.	Arch JJ, 2014, PSYCHONEUROENDOCRINO, V42, P49, DOI 10.1016/j.psyneuen.2013.12.018; Bernardi L, 2006, HEART, V92, P445, DOI 10.1136/hrt.2005.064600; Boccia ML, 2013, NEUROSCIENCE, V253, P155, DOI 10.1016/j.neuroscience.2013.08.048; Camm AJ, 1996, EUR HEART J, V17, P354; Carter CS, 2007, ANN NY ACAD SCI, V1098, P312, DOI 10.1196/annals.1384.006; Chanda ML, 2013, TRENDS COGN SCI, V17, P179, DOI 10.1016/j.tics.2013.02.007; Elliott D, 2011, J MUSIC THER, V48, P264, DOI 10.1093/jmt/48.3.264; Gerra G, 1998, INT J PSYCHOPHYSIOL, V28, P99, DOI 10.1016/S0167-8760(97)00071-8; GOLCZYNSKA A, 1995, CLIN PHARMACOL THER, V58, P90, DOI 10.1016/0009-9236(95)90076-4; Gomez P, 2007, EMOTION, V7, P377, DOI 10.1037/1528-3542.7.2.377; Goncharov N, 2006, AGING MALE, V9, P111, DOI 10.1080/13685530600713060; Grewe O, 2007, EMOTION, V7, P774, DOI 10.1037/1528-3542.7.4.774; Grewen KM, 2011, BIOL PSYCHOL, V87, P340, DOI 10.1016/j.biopsycho.2011.04.003; Grippo AJ, 2009, PSYCHONEUROENDOCRINO, V34, P1542, DOI 10.1016/j.psyneuen.2009.05.017; HAAS F, 1986, J APPL PHYSIOL, V61, P1185, DOI 10.1152/jappl.1986.61.3.1185; HALPERN DL, 1986, PERCEPT PSYCHOPHYS, V39, P77, DOI 10.3758/BF03211488; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; Het S, 2012, PSYCHOSOM MED, V74, P23, DOI 10.1097/PSY.0b013e31823a4a25; Hofman LF, 2001, J NUTR, V131, p1621S, DOI 10.1093/jn/131.5.1621S; Iwanaga M, 1999, J MUSIC THER, V36, P26, DOI 10.1093/jmt/36.1.26; Kern P, 2013, J MUSIC THER, V50, P274, DOI 10.1093/jmt/50.4.274; Khalfa S, 2003, ANN NY ACAD SCI, V999, P374, DOI 10.1196/annals.1284.045; Knight WEJ, 2001, J MUSIC THER, V38, P254, DOI 10.1093/jmt/38.4.254; Koelsch S, 2015, EUR HEART J, V36, P3043, DOI 10.1093/eurheartj/ehv430; Koelsch S, 2014, NAT REV NEUROSCI, V15, P170, DOI 10.1038/nrn3666; Kumagai H, 2012, HYPERTENS RES, V35, P132, DOI 10.1038/hr.2011.208; Leman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067932; Leow LA, 2015, ANN NY ACAD SCI, V1337, P53, DOI 10.1111/nyas.12658; Matsui F, 2009, ENDOCR J, V56, P1083, DOI 10.1507/endocrj.K09E-186; Nilsson U, 2009, J CLIN NURS, V18, P2153, DOI 10.1111/j.1365-2702.2008.02718.x; Okada K, 2009, INT HEART J, V50, P95, DOI 10.1536/ihj.50.95; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; PORGES SW, 1995, PSYCHOPHYSIOLOGY, V32, P301, DOI 10.1111/j.1469-8986.1995.tb01213.x; Rickard N.S., 2004, PSYCHOL MUSIC, V32, P371, DOI [DOI 10.1177/0305735604046096, 10.1177%2F0305735604046096]; Rimmele U, 2003, NEUROREPORT, V14, P2485, DOI 10.1097/00001756-200312190-00038; Ring RH, 2006, PSYCHOPHARMACOLOGY, V185, P218, DOI 10.1007/s00213-005-0293-z; Rong WF, 1999, BRAIN RES, V815, P51, DOI 10.1016/S0006-8993(98)01090-7; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Salimpoor VN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007487; SAPOLSKY RM, 1994, SEMIN NEUROSCI, V6, P261, DOI 10.1006/smns.1994.1033; Schommer NC, 2003, PSYCHOSOM MED, V65, P450, DOI 10.1097/01.PSY.0000035721.12441.17; STANDLEY JM, 1986, J MUSIC THER, V23, P56, DOI 10.1093/jmt/23.2.56; Suda M, 2008, NEUROREPORT, V19, P75, DOI 10.1097/WNR.0b013e3282f3476f; Theodoridou A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00197; Whitehead-Pleaux AM, 2006, J MUSIC THER, V43, P136, DOI 10.1093/jmt/43.2.136; Yamashita K, 2009, STEROIDS, V74, P920, DOI 10.1016/j.steroids.2009.06.007; Zhou P, 2010, INT CONF BIOMED, P965, DOI 10.1109/BMEI.2010.5639814	47	30	32	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189075	10.1371/journal.pone.0189075	http://dx.doi.org/10.1371/journal.pone.0189075			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211795	Green Published, Green Submitted, gold			2022-12-27	WOS:000417212200063
J	Courjon, J; Lemaignen, A; Ghout, I; Therby, A; Belmatoug, N; Dinh, A; Gras, G; Bernard, L				Courjon, Johan; Lemaignen, Adrien; Ghout, Idir; Therby, Audrey; Belmatoug, Nadia; Dinh, Aurelien; Gras, Guillaume; Bernard, Louis		DTS Study Grp	Pyogenic vertebral osteomyelitis of the elderly: Characteristics and outcomes	PLOS ONE			English	Article							INFECTIVE ENDOCARDITIS; EPIDEMIOLOGY; FEATURES	Background The incidence of pyogenic vertebral osteomyelitis (PVO) has increased over the past two decades. One possible cause of this increase is the aging of the population, which results in more comorbidities in high income countries. Objective To better characterize the clinical presentation and outcome of PVO in the elderly. Design We conducted a post-hoc analysis of a previously published trial that studied treatment duration in PVO and compared the presentation and outcomes according to age. Participants Our analysis included 351 patients among whom 85 (24%) were 75-years-old or more. Results There were no significant differences in the socio-demographics of the patients. Neoplasia and chronic inflammatory diseases were more common in the older group: 34% vs. 19% (p = 0.021) and 9% versus 1% (p = 0.004), respectively. There were no significant differences in clinical and radiological presentations between the groups in terms of back pain (337/351, 97%), fever (182/351, 52%), PVO localization, neurological signs and epidural abscess. Associated infective endocarditis (IE) was more frequent in the older group (37% vs. 14%, p<0.001). Streptococci were more frequently involved in infections of older patients 29% vs. 14%, p = 0.003) in contrast to Staphylococcus aureus (31% vs. 45%, p = 0.03). Older patients displayed higher mortality rates at 1 year (21% vs. 3%, p< 0.001) and more adverse events related to cardiorespiratory failure (10.6% vs. 3.8%, p = 0.025), but had similar quality of life among the survivors. Conclusion During PVO, the clinical and radiological findings are similar in older patients. Global mortality rates are higher in older patients compared to younger patients, which could be explained by the increased frequency of neoplasia at diagnosis and higher prevalence of associated IE in the elderly.	[Courjon, Johan] Univ Hosp Nice, Hop Archet 1, Dept Infect Dis, Nice, France; [Courjon, Johan] Univ Cote Azur, Nice, France; [Lemaignen, Adrien; Gras, Guillaume; Bernard, Louis] Univ Hosp Tours, Hop Bretonneau, Dept Internal Med & Infect Dis, Tours, France; [Lemaignen, Adrien; Bernard, Louis] Francois Rabelais Univ, Tours, France; [Ghout, Idir] Hop Ambroise Pare, AP HP, Clin Res Unit, Boulogne, France; [Therby, Audrey] Hop Mignot, Ctr Hosp Versailles, Dept Internal Med & Infect Dis, Le Chesnay, France; [Belmatoug, Nadia] Hop Beaujon, AP HP, Dept Internal Med, Clichy, France; [Dinh, Aurelien] Hop Raymond Poincare, AP HP, Dept Infect Dis, Garches, France	CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP	Courjon, J (corresponding author), Univ Hosp Nice, Hop Archet 1, Dept Infect Dis, Nice, France.; Courjon, J (corresponding author), Univ Cote Azur, Nice, France.	courjon.j@chu-nice.fr	Dinh, Aurélien/AAI-5355-2021; Courjon, Joha/G-2768-2018; Lemaignen, Adrien/L-5921-2018	Lemaignen, Adrien/0000-0001-5974-5689; Courjon, Johan/0000-0002-0445-5104	French Ministry of Health through national Hospital Program for Clinical Research	French Ministry of Health through national Hospital Program for Clinical Research	The DTS trial was funded by French Ministry of Health through a national Hospital Program for Clinical Research to Louis Bernard. The funder of the study had no role in study design, data collection, data analysis, data interpretation or writing of the report.	Akiyama T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002412; [Anonymous], R FDN STAT COMP; Belzunegui J, 2000, CLIN RHEUMATOL, V19, P344, DOI 10.1007/PL00011175; Bernard L, 2015, LANCET, V385, P875, DOI 10.1016/S0140-6736(14)61233-2; CAHILL DW, 1991, J NEUROSURG, V74, P878, DOI 10.3171/jns.1991.74.6.0878; Carragee EJ, 1997, J BONE JOINT SURG AM, V79A, P874, DOI 10.2106/00004623-199706000-00011; Chelsom J, 1998, SCAND J INFECT DIS, V30, P147, DOI 10.1080/003655498750003537; Doutchi Mahamadou, 2015, New Microbes and New Infections, V7, P1, DOI 10.1016/j.nmni.2015.04.008; Durante-Mangoni E, 2008, ARCH INTERN MED, V168, P2095, DOI 10.1001/archinte.168.19.2095; Grammatico L, 2008, EPIDEMIOL INFECT, V136, P653, DOI 10.1017/S0950268807008850; Grammatico-Guillon L, 2012, J HOSP INFECT, V82, P40, DOI 10.1016/j.jhin.2012.04.025; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Koslow M, 2014, AM J MED, V127, DOI 10.1016/j.amjmed.2014.02.023; Le Moal G, 2002, EUR J CLIN MICROBIOL, V21, P671, DOI 10.1007/s10096-002-0798-x; McHenry MC, 2002, CLIN INFECT DIS, V34, P1342, DOI 10.1086/340102; Mulleman D, 2006, J RHEUMATOL, V33, P91; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Murillo O, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.007; Murillo O, 2014, CLIN MICROBIOL INFEC, V20, pO33, DOI 10.1111/1469-0691.12302; THOMPSON D, 1988, BRIT MED J, V296, P1309, DOI 10.1136/bmj.296.6632.1309; Zimmerli W, 2010, NEW ENGL J MED, V362, P1022, DOI 10.1056/NEJMcp0910753	21	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188470	10.1371/journal.pone.0188470	http://dx.doi.org/10.1371/journal.pone.0188470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206837	Green Submitted, Green Published, gold			2022-12-27	WOS:000417110700012
J	Flotre, CH; Varsi, K; Helm, T; Bolann, B; Bjorke-Monsen, AL				Flotre, Christina Herland; Varsi, Kristin; Helm, Thea; Bolann, Bjorn; Bjorke-Monsen, Anne-Lise			Predictors of mercury, lead, cadmium and antimony status in Norwegian never-pregnant women of fertile age	PLOS ONE			English	Article							TRACE-ELEMENTS; BLOOD CADMIUM; FISH CONSUMPTION; REFERENCE VALUES; HEAVY-METALS; CORD BLOOD; POPULATION; EXPOSURE; HEALTH; HAIR	Background The toxic trace elements mercury (Hg), lead (Pb), cadmium (Cd) and antimony (Sb) are transferred over the placenta to the fetus and secreted into the breastmilk. All four elements bioaccumulate in the body and as maternal age at delivery is increasing in industrialized countries, the burden of toxic trace elements in never-pregnant women of fertile age is of concern. Methods Healthy, never-pregnant women aged 18 to 40 years (n = 158) were recruited between June 2012 and March 2015 in Bergen, Norway. Clinical data were collected and non-fasting venous blood samples were analyzed for whole blood Hg, Pb and Cd and serum Sb by ICPMS and related to diet and life style factors. Results In a multiple linear regression model, increasing age was associated with higher levels of Hg and Sb, but diet and life style factors were more important predictors. Median whole blood Hg was increased by a factor of 70 in women who had fish for dinner >= 1/week, compared to women who rarely or never ate fish (p< 0.001). Alcohol intake was the strongest predictor for whole blood Pb, while use of tobacco was the strongest predictor for whole blood Cd. Being a vegetarian was associated with lower levels of both Hg and Sb. Conclusions As toxic trace elements tend to bioaccumulate in the body, increasing maternal age at delivery may represent a threat to the next generation. In a group of healthy Norwegian neverpregnant women, age contributed to Hg and Sb levels, but diet and life style factors were stronger determinants of whole blood Hg, Pb, Cd and serum Sb levels. Continuous public actions are needed to reduce modifiable and preventable sources of potentially deleterious toxins to minimize the exposure in children and fertile women.	[Flotre, Christina Herland; Helm, Thea] Univ Bergen, Fac Med, Bergen, Norway; [Varsi, Kristin; Bolann, Bjorn; Bjorke-Monsen, Anne-Lise] Haukeland Hosp, Lab Clin Biochem, Bergen, Norway; [Bolann, Bjorn] Univ Bergen, Fac Med & Dent, Dept Clin Sci, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen	Bjorke-Monsen, AL (corresponding author), Haukeland Hosp, Lab Clin Biochem, Bergen, Norway.	almo@helse-bergen.no						Abadin H, 2007, TOXICOLOGICAL PROFIL; Abass K, 2017, ENVIRON SCI POLLUT R, V24, P1347, DOI 10.1007/s11356-016-7824-5; Aoki Y, 2017, ENVIRON RES, V155, P193, DOI 10.1016/j.envres.2017.02.016; Arbuckle TE, 2016, CHEMOSPHERE, V163, P270, DOI 10.1016/j.chemosphere.2016.08.023; Barbieri FL, 2016, INT J ENVIRON HEAL R, V26, P158, DOI 10.1080/09603123.2015.1061114; Birgisdottir BE, 2013, SCI TOTAL ENVIRON, V463, P836, DOI 10.1016/j.scitotenv.2013.06.078; Bolann BJ, 2015, J TRACE ELEM MED BIO, V31, P225, DOI 10.1016/j.jtemb.2014.07.021; Carolan M, 2003, JOGNN-J OBST GYN NEO, V32, P19, DOI 10.1177/0884217502239797; Cerna M, 2012, INT J HYG ENVIR HEAL, V215, P109, DOI 10.1016/j.ijheh.2011.09.007; Christophersen A G, 2014, ALCOHOL OTHER PSYCHO; Cleary-Goldman J, 2005, OBSTET GYNECOL, V105, P983, DOI 10.1097/01.AOG.0000158118.75532.51; Cobbina SJ, 2015, CHEMOSPHERE, V132, P79, DOI 10.1016/j.chemosphere.2015.03.013; Cooper Ross G, 2009, Indian J Occup Environ Med, V13, P3, DOI 10.4103/0019-5278.50716; Counter SA, 2004, TOXICOL APPL PHARM, V198, P209, DOI 10.1016/j.taap.2003.11.032; De Boeck M, 2003, MUTAT RES-FUND MOL M, V533, P135, DOI 10.1016/j.mrfmmm.2003.07.012; Ek WE, 2017, HUM MOL GEN; Fontaine J, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-25; Fu ZY, 2016, SCI TOTAL ENVIRON, V539, P97, DOI 10.1016/j.scitotenv.2015.08.146; GRITZ ER, 1981, CLIN PHARMACOL THER, V30, P201, DOI 10.1038/clpt.1981.149; Hornell A, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.20823; Hosomi Ryota, 2012, Glob J Health Sci, V4, P72, DOI 10.5539/gjhs.v4n3p72; Huang Y, 2015, ENVIRON SCI POLLUT R, V22, P4173, DOI 10.1007/s11356-014-3653-6; Hviid MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174770; IYENGAR GV, 1982, SCI TOTAL ENVIRON, V24, P267, DOI 10.1016/0048-9697(82)90005-5; Jackson LW, 2011, HUM REPROD, V26, P2887, DOI 10.1093/humrep/der250; Jain RB, 2013, J TOXICOL ENV HEAL A, V76, P58, DOI 10.1080/15287394.2012.722524; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jenssen MTS, 2012, SCI TOTAL ENVIRON, V439, P220, DOI 10.1016/j.scitotenv.2012.09.024; Kim KH, 2016, J HAZARD MATER, V306, P376, DOI 10.1016/j.jhazmat.2015.11.031; Kim SC, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111063; Krajcovicova-Kudlackova Marica, 2006, Central European Journal of Public Health, V14, P126; Kuno R, 2013, INT J HYG ENVIR HEAL, V216, P243, DOI 10.1016/j.ijheh.2012.05.010; Kvaavik E, 2016, NICOTINE TOB RES, V18, P431, DOI 10.1093/ntr/ntv126; Lee BK, 2015, TRENDS MOL MED, V21, P118, DOI 10.1016/j.molmed.2014.11.005; Lee JW, 2012, INT J HYG ENVIR HEAL, V215, P449, DOI 10.1016/j.ijheh.2012.01.002; Leonard A, 1996, MUTAT RES-REV GENET, V366, P1, DOI 10.1016/S0165-1110(96)90003-2; Li JQ, 2014, CELL BIOCHEM BIOPHYS, V70, P1663, DOI 10.1007/s12013-014-0110-6; Midttun O, 2013, ANAL BIOANAL CHEM, V405, P2009, DOI 10.1007/s00216-012-6602-6; Mielke HW, 1998, ENVIRON HEALTH PERSP, V106, P217, DOI 10.2307/3433922; Naughton DP, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-22; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Nisse C, 2017, INT J HYG ENVIR HEAL, V220, P341, DOI 10.1016/j.ijheh.2016.09.020; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Rebelo FM, 2016, ENVIRON RES, V151, P671, DOI 10.1016/j.envres.2016.08.027; Rodrigues EG, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0127-y; Rosofsky A, 2017, ENVIRON RES, V154, P73, DOI 10.1016/j.envres.2016.12.011; Rossi V, 2016, TOXICOL LETT, V258, pS109, DOI 10.1016/j.toxlet.2016.06.1453; Saghazadeh A, 2017, PROG NEURO-PSYCHOPH, V79, P340, DOI 10.1016/j.pnpbp.2017.07.011; Sanders Alison P, 2015, Curr Environ Health Rep, V2, P284, DOI 10.1007/s40572-015-0058-8; Saravanabhavan G, 2017, INT J HYG ENVIR HEAL, V220, P189, DOI 10.1016/j.ijheh.2016.10.006; Satarug S, 2017, FOOD CHEM TOXICOL, V106, P430, DOI 10.1016/j.fct.2017.06.013; Schwalfenberg G, 2013, J TOXICOL-US, V2013, DOI 10.1155/2013/370460; Scinicariello F, 2015, PSYCHOL MED, V45, P807, DOI 10.1017/S0033291714001883; Song MA, 2016, TOXICOL LETT, V245, P68, DOI 10.1016/j.toxlet.2016.01.012; SRIKUMAR TS, 1992, AM J CLIN NUTR, V55, P885, DOI 10.1093/ajcn/55.4.885; Tang ML, 2016, CHEMOSPHERE, V148, P270, DOI 10.1016/j.chemosphere.2016.01.058; Taylor CM, 2014, J DEV ORIG HLTH DIS, V5, P16, DOI 10.1017/S2040174413000500; Tchounwou P.B., 2012, EXPERIENTIA SUPPL, V101, P133, DOI [10.1007/978-3-7643-8340-4_6, DOI 10.1007/978-3-7643-8340-4_6, 10.1007/978-3-7643-8340-4]; Yaginuma-Sakurai K, 2012, J TOXICOL SCI, V37, P123, DOI 10.2131/jts.37.123; Zahir F, 2005, ENVIRON TOXICOL PHAR, V20, P351, DOI 10.1016/j.etap.2005.03.007; Zheng GC, 2014, BIOL TRACE ELEM RES, V160, P437, DOI 10.1007/s12011-014-0057-x	62	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189169	10.1371/journal.pone.0189169	http://dx.doi.org/10.1371/journal.pone.0189169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO8CU	29206878	Green Submitted, gold, Green Published			2022-12-27	WOS:000417110700052
J	Buchanan, E				Buchanan, Elizabeth			Considering the ethics of big data research: A case of Twitter and ISIS/ISIL	PLOS ONE			English	Article								This is a formal commentary, responding to Matthew Curran Benigni, Kenneth Joseph, and Kathleen Carley's contribution, "Online extremism and the communities that sustain it: Detecting the ISIS supporting community on Twitter". This brief review reflects on the ethics of big data research methodologies, and how novel methods complicate long-standing principles of research ethics. Specifically, the concept of the "data subject" as a corollary, or replacement, of "human subject" is considered.	[Buchanan, Elizabeth] Univ Wisconsin Stout, Off Res & Sponsored Programs, Ctr Appl Eth, Menomonie, WI 54751 USA	University of Wisconsin System; University of Wisconsin Stout	Buchanan, E (corresponding author), Univ Wisconsin Stout, Off Res & Sponsored Programs, Ctr Appl Eth, Menomonie, WI 54751 USA.	buchanane@uwstout.edu		Buchanan, Elizabeth/0000-0002-1087-6394				[Anonymous], 2017, FED REGISTER, V82, P7149; [Anonymous], 2017, CBS NEWS; Benigni MC, PLOS ONE; Braman S., 2017, 1 MONDAY, V22, P5; Christian M., 2017, HILL; Conway M., 2013, POWER SECURITY INFOR; Do Q, 2014, NY TIMES; National Academy of Education, BIG DAT ED BAL BEN E; National Science Foundation and Computing Research Association, 2015, DAT INT RES ED CURR; NWABR/ MSMR, 2013, 3 I S C IACUCS IBCS; Samson F., 2016, POLICE J, V90, P55; U. S. Department of Health & Human Services, 2016, HUM SUBJ RES IMPL BI; VOX-Pol Network of Excellence, 2017, VOX POL TRAIN AC TOP	13	7	7	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0187155	10.1371/journal.pone.0187155	http://dx.doi.org/10.1371/journal.pone.0187155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194443	Green Published, gold, Green Submitted			2022-12-27	WOS:000416867800004
J	Koparde, V; Razzaq, BA; Suntum, T; Sabo, R; Scalora, A; Serrano, M; Jameson-Lee, M; Hall, C; Kobulnicky, D; Sheth, N; Feltz, J; Contaifer, D; Wijesinghe, D; Reed, J; Roberts, C; Qayyum, R; Buck, G; Neale, M; Toor, A				Koparde, Vishal; Razzaq, Badar Abdul; Suntum, Tara; Sabo, Roy; Scalora, Allison; Serrano, Myrna; Jameson-Lee, Max; Hall, Charles; Kobulnicky, David; Sheth, Nihar; Feltz, Juliana; Contaifer, Daniel, Jr.; Wijesinghe, Dayanjan; Reed, Jason; Roberts, Catherine; Qayyum, Rehan; Buck, Gregory; Neale, Michael; Toor, Amir			Dynamical system modeling to simulate donor T cell response to whole exome sequencing-derived recipient peptides: Understanding randomness in alloreactivity incidence following stem cell transplantation	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; PERIPHERAL-BLOOD; ACUTE-LEUKEMIA; MALIGNANCIES; PROPHYLAXIS; EXPRESSION; REGIMEN; GRAFTS; TRIAL	Quantitative relationship between the magnitude of variation in minor histocompatibility antigens (mHA) and graft versus host disease (GVHD) pathophysiology in stem cell transplant (SCT) donor-recipient pairs (DRP) is not established. In order to elucidate this relationship, whole exome sequencing (WES) was performed on 27 HLA matched related (MRD), & 50 unrelated donors (URD), to identify nonsynonymous single nucleotide polymorphisms (SNPs). An average 2,463 SNPs were identified in MRD, and 4,287 in URD DRP (p<0.01); resulting peptide antigens that may be presented on HLA class I molecules in each DRP were derived in silico (NetMHCpan ver2.0) and the tissue expression of proteins these were derived from determined (GTex). MRD DRP had an average 3,670 HLA-binding-alloreactive peptides, putative mHA (pmHA) with an IC50 of <500 nM, and URD, had 5,386 (p<0.01). To simulate an alloreactive donor cytotoxic T cell response, the array of pmHA in each patient was considered as an operator matrix modifying a hypothetical cytotoxic T cell clonal vector matrix; each responding T cell clone's proliferation was determined by the logistic equation of growth, accounting for HLA binding affinity and tissue expression of each alloreactive peptide. The resulting simulated organ-specific alloreactive T cell clonal growth revealed marked variability, with the T cell count differences spanning orders of magnitude between different DRP. Despite an estimated, uniform set of constants used in the model for all DRP, and a heterogeneously treated group of patients, higher total and organ-specific T cell counts were associated with cumulative incidence of moderate to severe GVHD in recipients. In conclusion, exome wide sequence differences and the variable alloreactive peptide binding to HLA in each DRP yields a large range of possible alloreactive donor T cell responses. Our findings also help understand the apparent randomness observed in the development of alloimmune responses.	[Koparde, Vishal; Serrano, Myrna; Sheth, Nihar; Feltz, Juliana; Buck, Gregory] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Razzaq, Badar Abdul; Suntum, Tara; Scalora, Allison; Jameson-Lee, Max; Hall, Charles; Kobulnicky, David; Roberts, Catherine; Toor, Amir] Virginia Commonwealth Univ, Massey Canc Ctr, Dept Internal Med, Bone Marrow Transplant Program, Richmond, VA 23284 USA; [Sabo, Roy] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA; [Contaifer, Daniel, Jr.; Wijesinghe, Dayanjan] Virginia Commonwealth Univ, Sch Pharm, Richmond, VA USA; [Reed, Jason] Virginia Commonwealth Univ, Dept Phys, Richmond, VA 23284 USA; [Qayyum, Rehan] Virginia Commonwealth Univ, Dept Internal Med, Sect Hosp Med, Richmond, VA USA; [Buck, Gregory] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Neale, Michael] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Neale, Michael] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Toor, A (corresponding author), Virginia Commonwealth Univ, Massey Canc Ctr, Dept Internal Med, Bone Marrow Transplant Program, Richmond, VA 23284 USA.	amir.toor@vcuhealth.org	Toor, Amir Ahmed/GNM-9504-2022; Neale, Michael/AAD-5056-2020	Toor, Amir Ahmed/0000-0001-5317-8433; Koparde, Vishal/0000-0001-8978-8495; Contaifer Junior, Daniel/0000-0002-3165-4192; Qayyum, Rehan/0000-0003-3086-8014	NIH-NCI Cancer Center Support Grant [P30-CA016059]; Virginia's Commonwealth Health Research Board Grant [236-11-13]	NIH-NCI Cancer Center Support Grant; Virginia's Commonwealth Health Research Board Grant	This study conducted at Virginia Commonwealth University's Massey Cancer Center was supported, in part, by research funding from the NIH-NCI Cancer Center Support Grant (P30-CA016059; PI: Gordon Ginder, MD) and by research funding from Virginia's Commonwealth Health Research Board Grant #236-11-13 (PI: Michael Neale, PhD).	Anasetti C, 2012, NEW ENGL J MED, V367, P1487, DOI 10.1056/NEJMoa1203517; Armand P, 2016, BRIT J HAEMATOL, V173, P96, DOI 10.1111/bjh.13931; Bayraktar UD, 2016, BIOL BLOOD MARROW TR, V22, P505, DOI 10.1016/j.bbmt.2015.10.020; Benjamin A., 2015, MAGIC COUNTING MAGIC, pp71; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bolkhovskaya OV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108658; Brunstein CG, 2011, BLOOD, V118, P282, DOI 10.1182/blood-2011-03-344853; Ciurea SO, 2015, BLOOD, V126, P1033, DOI 10.1182/blood-2015-04-639831; Czerw T, 2016, ONCOTARGET, V7, P27255, DOI 10.18632/oncotarget.8463; Diez-Rivero CM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-479; Eapen M, 2015, J CLIN ONCOL, V33, P364, DOI 10.1200/JCO.2014.57.2446; El-Cheikh J, 2015, CANCER-AM CANCER SOC, V121, P1809, DOI 10.1002/cncr.29271; Freund JE, 1973, PROBABILITY INTRO PR, pp33; GILPIN ME, 1973, P NATL ACAD SCI USA, V70, P3590, DOI 10.1073/pnas.70.12.3590; Holtick U, 2015, CRIT REV ONCOL HEMAT, V94, P179, DOI 10.1016/j.critrevonc.2014.12.007; Inamoto Y, 2011, BIOL BLOOD MARROW TR, V17, P1088, DOI 10.1016/j.bbmt.2011.01.017; Jameson-Lee M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00529; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kanda Y, 2016, BONE MARROW TRANSPL, V51, P103, DOI 10.1038/bmt.2015.222; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Koreth J, 2015, BIOL BLOOD MARROW TR, V21, P1907, DOI 10.1016/j.bbmt.2015.05.027; Kroger N, 2016, NEW ENGL J MED, V374, P43, DOI 10.1056/NEJMoa1506002; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Meier J, 2013, BIOL BLOOD MARROW TR, V19, P366, DOI 10.1016/j.bbmt.2012.12.004; Morishima Y, 2015, BLOOD, V125, P1189, DOI 10.1182/blood-2014-10-604785; Morrison F., 1991, ART MODELING DYNAMIC, pp165; Murray JD, 2002, MATH BIOL, P94; Pandiyan P, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00060; Petersdorf EW, 2007, PLOS MED, V4, P59, DOI 10.1371/journal.pmed.0040008; Petersdorf EW, 2015, NEW ENGL J MED, V373, P599, DOI 10.1056/NEJMoa1500140; Petersdorf EW, 2014, BLOOD, V124, P3996, DOI 10.1182/blood-2014-09-599969; Petersen SL, 2007, DAN MED BULL, V54, P112; Pidala J, 2013, BLOOD, V122, P3651, DOI 10.1182/blood-2013-05-501510; Razzaq BA, 2016, BIOL BLOOD MARROW TR, V22, P850, DOI 10.1016/j.bbmt.2015.11.1103; Ringden O, 2016, LEUKEMIA, V30, P447, DOI 10.1038/leu.2015.232; Ringden O, 2014, TRANSPLANTATION, V98, P569, DOI 10.1097/TP.0000000000000102; Russ Brendan E., 2013, Frontiers in Genetics, V4, P218, DOI 10.3389/fgene.2013.00218; Sampson JK, 2014, BRIT J HAEMATOL, V166, P566, DOI 10.1111/bjh.12898; Storb R, 2013, BIOL BLOOD MARROW TR, V19, P792, DOI 10.1016/j.bbmt.2013.02.006; Susskind L, 2014, MATH INTERLUDE VECTO, P24; Susskind L, 2014, QUANTUM MECH THEORET, P52; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Toor AA, 2015, BIOL BLOOD MARROW TR, V21, P1237, DOI 10.1016/j.bbmt.2015.03.011; Toor AA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00613; Valcarcel D, 2011, BIOL BLOOD MARROW TR, V17, P640, DOI 10.1016/j.bbmt.2010.07.022; Woolfrey A, 2011, BIOL BLOOD MARROW TR, V17, P885, DOI 10.1016/j.bbmt.2010.09.012	46	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0187771	10.1371/journal.pone.0187771	http://dx.doi.org/10.1371/journal.pone.0187771			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194460	Green Published, Green Submitted, gold			2022-12-27	WOS:000416867800008
J	Vanli, G; Cuesta-Marban, A; Widmann, C				Vanli, Guliz; Cuesta-Marban, Alvaro; Widmann, Christian			Evaluation and validation of commercial antibodies for the detection of Shb	PLOS ONE			English	Article							MAMMALIAN-CELLS; SPECIFICITY; EXPRESSION	Antibodies are among the most important tools for protein detection but, prior to their usage, proper validation of their appropriateness for given applications is required. The utility of an antibody depends on its sensitivity and specificity. We studied these two aspects in a panel of commercial antibodies against Shb, a platform protein involved in receptor tyrosine kinase signalling, but the function of which is still incompletely understood. Several of the antibodies showed shortcomings or were not acceptable for detection of the endogenous protein. The few that could detect Shb were doing so in either western blotting or immunoprecipitation experiments but a given antibody could not work in both applications. This article provides a resource for the available molecular tools that can be used in future research on Shb.	[Vanli, Guliz; Cuesta-Marban, Alvaro; Widmann, Christian] Univ Lausanne, Dept Physiol, Lausanne, Switzerland	University of Lausanne	Widmann, C (corresponding author), Univ Lausanne, Dept Physiol, Lausanne, Switzerland.	christian.widmannn@unil.ch	Widmann, Christian/N-9851-2013	Widmann, Christian/0000-0002-6881-0363; Cuesta Marban, Alvaro/0000-0002-7144-0500	Swiss National Science Foundation [CRSII3_154420, 31003A_160181, IZCSZ0-174639]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the Swiss National Science Foundation (http://www.snf.ch/en/Pages/default.aspx, grant numbers CRSII3_154420, 31003A_160181, and IZCSZ0-174639 to CW).	Akoumianaki T, 2009, J CELL SCI, V122, P1111, DOI 10.1242/jcs.043034; Baker M, 2015, NATURE, V527, P545, DOI 10.1038/527545a; Baker M, 2015, NATURE, V521, P274, DOI 10.1038/521274a; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Chiang TWW, 2016, SCI REP-UK, V6, DOI 10.1038/srep24356; Fonseca SG, 2012, NAT CELL BIOL, V14, P1105, DOI 10.1038/ncb2578; Freedman LP, 2016, BIOTECHNIQUES, V61, P16, DOI 10.2144/000114431; Gilda JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135392; Haataja L, 2008, CELL BIOCHEM BIOPHYS, V51, P105, DOI 10.1007/s12013-008-9019-2; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Karlsson T, 1997, EXP CELL RES, V231, P269, DOI 10.1006/excr.1996.3471; Kriz V, 2007, DEV DYNAM, V236, P2485, DOI 10.1002/dvdy.21257; Marcon E, 2015, NAT METHODS, V12, P725, DOI [10.1038/NMETH.3472, 10.1038/nmeth.3472]; Naegle KM, 2010, MOL CELL PROTEOMICS, V9, P2558, DOI 10.1074/mcp.M110.001206; Petryszak R, 2016, NUCLEIC ACIDS RES, V44, pD746, DOI 10.1093/nar/gkv1045; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Schonbrunn A, 2014, MOL ENDOCRINOL, V28, P1403, DOI 10.1210/me.2014-1230; Welsh M, 2016, J MOL ENDOCRINOL, V56, pR21, DOI 10.1530/JME-15-0228	18	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0188311	10.1371/journal.pone.0188311	http://dx.doi.org/10.1371/journal.pone.0188311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194461	Green Published, gold, Green Submitted			2022-12-27	WOS:000416867800010
J	Dzoic, T; Paklar, GB; Grbec, B; Ivatek-Sahdan, S; Zorica, B; Segvic-Bubic, T; Kec, VC; Pleic, IL; Mladineo, I; Grubisic, L; Verley, P				Dzoic, Tomislav; Paklar, Gordana Beg; Grbec, Branka; Ivatek-Sahdan, Stjepan; Zorica, Barbara; Segvic-Bubic, Tanja; Kec, Vanja Cikes; Pleic, Ivana Lepen; Mladineo, Ivona; Grubisic, Leon; Verley, Philippe			Spillover of the Atlantic bluefin tuna offspring from cages in the Adriatic Sea: A multidisciplinary approach and assessment	PLOS ONE			English	Article							THUNNUS-THYNNUS L.; SIZE; AGE	During routine monitoring of commercial purse seine catches in 2011, 87 fingerling specimens of scombrids were collected in the southern Adriatic Sea. Sequencing of the mitochondrial DNA control region locus inferred that specimens belonged to the Atlantic bluefin tuna, Thunnus thynnus (Linnaeus, 1758) (N = 29), bullet tuna, Auxis rochei (Risso, 1810) (N = 30) and little tunny, Euthynnus alletteratus, Rafinesque, 1810 (N = 28). According to previously published growth parameters, the age of the collected specimens was estimated at approximately 30-40 days, suggesting they might have been spawned in the Adriatic Sea, contrary to the current knowledge. A coupled modelling system with hydrodynamic (ROMS) and individual based model (IBM-Ichthyop) was set up to determine the location of the spawning event. Numerical simulations with the IBM model, both backward and forward in time, indicate commercial tuna cages in the middle Adriatic coastal area as possible spawning location. The two other non-commercial species likely opportunistically use the positive environmental (abiotic and biotic) conditions to spawn in the same area.	[Dzoic, Tomislav; Paklar, Gordana Beg; Grbec, Branka] Inst Oceanog & Fisheries, Phys Oceanog Lab, Split, Croatia; [Ivatek-Sahdan, Stjepan] Meteorol & Hydrol Serv, Res & Dev Div, Zagreb, Croatia; [Zorica, Barbara; Kec, Vanja Cikes] Inst Oceanog & Fisheries, Lab Fisheries Sci & Management Pelag & Demersal R, Split, Croatia; [Segvic-Bubic, Tanja; Pleic, Ivana Lepen; Mladineo, Ivona; Grubisic, Leon] Inst Oceanog & Fisheries, Lab Aquaculture, Split, Croatia; [Verley, Philippe] Inst Rech Dev, UMR Bot & Modelling Plant Architecture & Vegetat, Montpellier, France	Croatian Institute of Oceanography & Fisheries (IZOR); Croatian Institute of Oceanography & Fisheries (IZOR); Croatian Institute of Oceanography & Fisheries (IZOR); Institut de Recherche pour le Developpement (IRD)	Dzoic, T (corresponding author), Inst Oceanog & Fisheries, Phys Oceanog Lab, Split, Croatia.	dzoic@izor.hr	Pleić, Ivana Lepen/AAX-7178-2020; Mladineo, Ivona/AAC-5813-2021; Džoić, Tomislav/AAM-8951-2020; Segvic-Bubic, Tanja/O-6841-2016	Pleić, Ivana Lepen/0000-0002-0548-4062; Segvic-Bubic, Tanja/0000-0003-4405-1611; Dzoic, Tomislav/0000-0001-9585-8779; Zorica, Barbara/0000-0002-9131-4675	Croatian Science Foundation [IP-2014-09-9050, IP-2014-09-3606, 001-0013077-0532]; project PERIMON	Croatian Science Foundation; project PERIMON	This work was supported by the Croatian Science Foundation: IP-2014-09-9050 (www.izor.hr/aquapop). The authors who received the funding - TSB, LG. It was also supported by the Croatian Science Foundation: IP-2014-09-3606 (http://jadran.izorhr/-kovac/mariplan/). The authors who received the funding - GBP, TDZ, BG. Croatian Science Foundation: 001-0013077-0532 (http://www.izor.hr) also supported this work. The authors who received the funding - BZ, VCK. Also project PERIMON is added to the list of projects that financially supported our study. The author who received the funding - VCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany F, 2010, PROG OCEANOGR, V86, P21, DOI 10.1016/j.pocean.2010.04.014; Alemany F., 1997, THESIS; [Anonymous], 2016, ADV TUNA AQUACULTURE; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Bray L, 2017, MAR ENVIRON RES, V125, P73, DOI 10.1016/j.marenvres.2017.01.006; Brickman D, 2002, J ATMOS OCEAN TECH, V19, P83, DOI 10.1175/1520-0426(2002)019<0083:LSMICO>2.0.CO;2; Cermeno P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116638; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Collette BB, 1999, PROCEEDINGS OF THE 5TH INDO-PACIFIC FISH CONFERENCE, P149; Corriero A, 2005, J APPL ICHTHYOL, V21, P483, DOI 10.1111/j.1439-0426.2005.00700.x; Cushman-Roisin B, PHYS OCEANOGRAPHY AD; De la Gandara F, 2011, P AQ EUR 2011 EUR AQ, P249; De la Gandara F, 2016, ADV TUNA AQUACULTURE, P115; Deflorio M., 2005, COLLECT VOL SCI PAP, V56, P630; DHMZ (Meteorological and Hydrological Service), 2013, REV NO23 CLIM MON AS; Druon JN, 2016, PROG OCEANOGR, V142, P30, DOI 10.1016/j.pocean.2016.01.002; Fossette S, 2012, MAR ECOL PROG SER, V457, P285, DOI 10.3354/meps09581; Gordoa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090691; Grbec B, I OCEANOGRAPHY FISHE; Grubisic L, 2013, FISHERIES, V38, P410, DOI 10.1080/03632415.2013.826201; Juan-Jorda MJ, 2011, P NATL ACAD SCI USA, V108, P20650, DOI 10.1073/pnas.1107743108; Kahraman AE, 2008, J APPL ICHTHYOL, V24, P551, DOI 10.1111/j.1439-0426.2008.01068.x; Karakulak S, 2004, J APPL ICHTHYOL, V20, P318, DOI 10.1111/j.1439-0426.2004.00561.x; La Mesa M, 2005, SCI MAR, V69, P241, DOI 10.3989/scimar.2005.69n2241; Lett C, 2008, ENVIRON MODELL SOFTW, V23, P1210, DOI 10.1016/j.envsoft.2008.02.005; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mariani P, 2010, PROG OCEANOGR, V86, P45, DOI 10.1016/j.pocean.2010.04.027; Mather FJ, 1995, HIST DOCUMENT LIFE H, P1; Melia P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23705; Mylonas CC, 2007, REV FISH SCI, V15, P183, DOI 10.1080/10641260701484572; Naro-Maciel E, 2017, ECOGRAPHY, V40, P586, DOI 10.1111/ecog.02056; North EW, 2009, ICES INT COUNC EXPLO; Pasaric M., 2006, ACTA ADRIAT, V47, P219; Putman NF, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1689; Putman NF, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0979; Reglero P, 39 ANN LARV FISH C 2; Santamaria N., 2000, BIOL MARINA MEDITERR, V8, P765; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Shchepetkin AF, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001047; Ticina V, 2007, AQUACULTURE, V269, P538, DOI 10.1016/j.aquaculture.2007.05.029; Uchida RN, 1981, FAO FISH SYNOPS, V124; ZOREARMANDA M, 1968, STUD REV GEN FISH CO, V34, P1	42	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188956	10.1371/journal.pone.0188956	http://dx.doi.org/10.1371/journal.pone.0188956			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190825	gold, Green Published			2022-12-27	WOS:000416841900178
J	Fabre, AL; Luis, A; Colotte, M; Tuffet, S; Bonnet, J				Fabre, Anne-Lise; Luis, Aurelie; Colotte, Marthe; Tuffet, Sophie; Bonnet, Jacques			High DNA stability in white blood cells and buffy coat lysates stored at ambient temperature under anoxic and anhydrous atmosphere	PLOS ONE			English	Article							LYOPHILIZED LIPID/DNA COMPLEXES; PERIPHERAL-BLOOD; QUALITY-CONTROL; NUCLEIC-ACIDS; GENOMIC DNA; STORAGE; DEGRADATION; BIOSPECIMENS; AMPLIFICATION; PRESERVATION	Conventional storage of blood-derived fractions relies on cold. However, lately, ambient temperature preservation has been evaluated by several independent institutions that see economic and logistic advantages in getting rid of the cold chain. Here we validated a novel procedure for ambient temperature preservation of DNA in white blood cell and buffy coat lysates based on the confinement of the desiccated biospecimens under anoxic and anhydrous atmosphere in original hermetic minicapsules. For this validation we stored encapsulated samples either at ambient temperature or at several elevated temperatures to accelerate aging. We found that DNA extracted from stored samples was of good quality with a yield of extraction as expected. Degradation rates were estimated from the average fragment size of denatured DNA run on agarose gels and from qPCR reactions. At ambient temperature, these rates were too low to be measured but the degradation rate dependence on temperature followed Arrhenius' law, making it possible to extrapolate degradation rates at 25 degrees C. According to these values, the DNA stored in the encapsulated blood products would remain larger than 20 kb after one century at ambient temperature. At last, qPCR experiments demonstrated the compatibility of extracted DNA with routine DNA downstream analyses. Altogether, these results showed that this novel storage method provides an adequate environment for ambient temperature long term storage of high molecular weight DNA in dehydrated lysates of white blood cells and buffy coats.	[Fabre, Anne-Lise; Luis, Aurelie; Tuffet, Sophie; Bonnet, Jacques] Univ Bordeaux, R&D Dept, Imagene, ENSTBB, 146 Rue Leo Saignat, Bordeaux, France; [Fabre, Anne-Lise; Colotte, Marthe] Prod Platform, Imagene, Rue Henri Desbrueres,Genopole Campus 1,Bat 6, Evry, France; [Bonnet, Jacques] Univ Bordeaux, INSERM, U1218, Inst Bergonie, 229 Cours Argonne, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Genopole; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie	Fabre, AL (corresponding author), Univ Bordeaux, R&D Dept, Imagene, ENSTBB, 146 Rue Leo Saignat, Bordeaux, France.; Fabre, AL (corresponding author), Prod Platform, Imagene, Rue Henri Desbrueres,Genopole Campus 1,Bat 6, Evry, France.	fabre@imagene.eu		Fabre, Anne-Lise/0000-0003-4871-0637	Imagene	Imagene	The work described here was funded by Imagene to A-LF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2008, MOL BIOL CEL, V5th ed.; Allison SD, 2000, J PHARM SCI, V89, P682, DOI 10.1002/(SICI)1520-6017(200005)89:5<682::AID-JPS14>3.0.CO;2-#; Bialkowski K, 1996, Z NATURFORSCH C, V51, P119; Bonnet J, 2010, NUCLEIC ACIDS RES, V38, P1531, DOI 10.1093/nar/gkp1060; Bruskov VI, 2002, NUCLEIC ACIDS RES, V30, P1354, DOI 10.1093/nar/30.6.1354; Bulla A, 2016, BIOPRESERV BIOBANK, P1429; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Caboux E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039821; Cataldo F, 2006, INT J BIOL MACROMOL, V38, P248, DOI 10.1016/j.ijbiomac.2006.02.029; Cayuela JM, 2015, CLIN BIOCHEM, V48, P982, DOI 10.1016/j.clinbiochem.2015.04.004; Clermont D, 2014, BIOPRESERV BIOBANK, V12, P176, DOI 10.1089/bio.2013.0082; Colotte M, 2009, ANAL BIOCH; Colotte M, 2011, BIOPRESERV BIOBANK, V9, P47, DOI 10.1089/bio.2010.0028; Estillore AD, 2016, CHEM SCI, V7, P6604, DOI 10.1039/c6sc02353c; Evans RK, 2000, J PHARM SCI, V89, P76, DOI 10.1002/(SICI)1520-6017(200001)89:1<76::AID-JPS8>3.0.CO;2-U; Fabre AL, 2014, EUR J HUM GENET, V22, P379, DOI 10.1038/ejhg.2013.145; Fleming AM, 2015, CHEM RES TOXICOL, V28, P1292, DOI 10.1021/acs.chemrestox.5b00096; Grass RN, 2015, ANGEW CHEM INT EDIT, V54, P2552, DOI 10.1002/anie.201411378; GUTHRIE R, 1961, JAMA-J AM MED ASSOC, V178, P863, DOI 10.1001/jama.1961.03040470079019; Holden MJ, 2009, J AGR FOOD CHEM, V57, P7221, DOI 10.1021/jf901165h; Huang LH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184692; Hubel A, 2014, BIOPRESERV BIOBANK, V12, P165, DOI 10.1089/bio.2013.0084; Johnson BM, 2017, J ARCHAEOL SCI-REP, V11, P683, DOI 10.1016/j.jasrep.2017.01.006; King CE, 2009, BIOTECHNIQUES, V47, P941, DOI 10.2144/000113244; Kontanis EJ, 2006, J FORENSIC SCI, V51, P795, DOI 10.1111/j.1556-4029.2006.00182.x; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3618, DOI 10.1021/bi00769a019; Liu XP, 2015, BIOPRESERV BIOBANK, V13, P49, DOI 10.1089/bio.2014.0060; MADISEN L, 1987, AM J MED GENET, V27, P379, DOI 10.1002/ajmg.1320270216; Malentacchi F, 2013, CLIN CHIM ACTA, V424, P274, DOI 10.1016/j.cca.2013.05.012; Malentacchi F, 2016, CLIN CHIM ACTA, V454, P10, DOI 10.1016/j.cca.2015.12.032; MATSUO S, 1995, BIOCHEM BIOPH RES CO, V208, P1021, DOI 10.1006/bbrc.1995.1436; Molina MDC, 2008, BBA-BIOMEMBRANES, V1778, P2119, DOI 10.1016/j.bbamem.2008.04.003; Molina MD, 2004, J PHARM SCI-US, V93, P2259, DOI 10.1002/jps.20138; Muller R, 2016, BIOPRESERV BIOBANK, V14, P89, DOI 10.1089/bio.2015.0022; Mychaleckyj JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-91; Nederhand RJ, 2003, J THROMB HAEMOST, V1, P987, DOI 10.1046/j.1538-7836.2003.00216.x; Pogocki D, 2000, J PHARM SCI-US, V89, P443, DOI 10.1002/(SICI)1520-6017(200004)89:4<443::AID-JPS2>3.3.CO;2-N; Potts M, 1999, EUR J PHYCOL, V34, P319, DOI 10.1017/S0967026299002267; Rahikainen AL, 2016, FORENSIC SCI INT; Rathbun MM, 2017, FORENSIC SCI INT-GEN, V26, P1, DOI 10.1016/j.fsigen.2016.09.008; ROSS KS, 1990, J MED GENET, V27, P569, DOI 10.1136/jmg.27.9.569; Shabihkhani M, 2014, CLIN BIOCHEM, V47, P258, DOI 10.1016/j.clinbiochem.2014.01.002; Shao W, 2012, BIOPRESERV BIOBANK, V10, P4, DOI 10.1089/bio.2011.0016; Sharma VK, 2007, PHARM RES-DORDR, V24, P168, DOI 10.1007/s11095-006-9138-7; Shirkey B, 2003, NUCLEIC ACIDS RES, V31, P2995, DOI 10.1093/nar/gkg404; SORIANO P, 1981, EUR J BIOCHEM, V115, P235, DOI 10.1111/j.1432-1033.1981.tb05228.x; SVAREN J, 1987, NUCLEIC ACIDS RES, V15, P8739, DOI 10.1093/nar/15.21.8739; Tuffet S, 2009, International patent, Patent No. [WO 2009115761A2, 2009115761]; Wilfinger WW, 1997, BIOTECHNIQUES, V22, P474, DOI 10.2144/97223st01; Zhang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06542-z; Zhou GD, 2016, BIOPRESERV BIOBANK, V14, P165, DOI 10.1089/bio.2015.0075; Zhou JY, 2015, BIOPRESERV BIOBANK, V13, P13, DOI 10.1089/bio.2014.0094	54	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188547	10.1371/journal.pone.0188547	http://dx.doi.org/10.1371/journal.pone.0188547			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190767	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900072
J	Jiang, CM; Shen, QXJ; Wang, B; He, B; Xiao, SQ; Chen, L; Yu, TQ; Ke, X; Zhong, QF; Fu, J; Chen, Y; Wang, LX; Yin, FY; Zhang, DY; Ghidan, W; Huang, XQ; Cheng, ZQ				Jiang, Chunmiao; Shen, Qingxi J.; Wang, Bo; He, Bin; Xiao, Suqin; Chen, Ling; Yu, Tengqiong; Ke, Xue; Zhong, Qiaofang; Fu, Jian; Chen, Yue; Wang, Lingxian; Yin, Fuyou; Zhang, Dunyu; Ghidan, Walid; Huang, Xingqi; Cheng, Zaiquan			Transcriptome analysis of WRKY gene family in Oryza officinalis Wall ex Watt and WRKY genes involved in responses to Xanthomonas oryzae pv. oryzae stress	PLOS ONE			English	Article							DEFENSE-RELATED GENES; ABSCISIC-ACID; DNA-BINDING; NEGATIVE REGULATORS; EXPRESSION ANALYSIS; SIGNALING PATHWAY; RICE; SUPERFAMILY; ARABIDOPSIS; RESISTANCE	Oryza officinalis Wall ex Watt, a very important and special wild rice species, shows abundant genetic diversity and disease resistance features, especially high resistance to bacterial blight. The molecular mechanisms of bacterial blight resistance in O. officinalis have not yet been elucidated. The WRKY transcription factor family is one of the largest gene families involved in plant growth, development and stress response. However, little is known about the numbers, structure, molecular phylogenetics, and expression of the WRKY genes under Xanthomonas oryzae pv. oryzae (Xoo) stress in O. officinalis due to lacking of O. officinalis genome. Therefore, based on the RNA-sequencing data of O. officinalis, we performed a comprehensive study of WRKY genes in O. officinalis and identified 89 OoWRKY genes. Then 89 OoWRKY genes were classified into three groups based on the WRKY domains and zinc finger motifs. Phylogenetic analysis strongly supported that the evolution of OoWRKY genes were consistent with previous studies of WRKYs, and subgroup IIc OoWRKY genes were the original ancestors of some group II and group III OoWRKYs. Among the 89 OoWRKY genes, eight OoWRKYs displayed significantly different expression (>2-fold, p<0.01) in the O. officinalis transcriptome under Xoo strains PXO99 and C5 stress 48 h, suggesting these genes might play important role in PXO99 and C5 stress responses in O. officinalis. QRT-PCR analysis and confirmation of eight OoWRKYs expression patterns revealed that they responded strongly to PXO99 and C5 stress 24 h, 48 h, and 72 h, and the trends of these genes displaying marked changes were consistent with the 48 h RNA-sequencing data, demonstrated these genes played important roles in response to biotic stress and might even involved in the bacterial blight resistance. Tissue expression profiles of eight OoWRKY genes revealed that they were highly expressed in root, stem, leaf, and flower, especially in leaf (except OoWRKY71), suggesting these genes might be also important for plant growth and organ development. In this study, we analyzed the WRKY family of transcription factors in O. officinalis. Insight was gained into the classification, evolution, and function of the OoWRKY genes, revealing the putative roles of eight significantly different expression OoWRKYs in Xoo strains PXO99 and C5 stress responses in O. officinalis. This study provided a better understanding of the evolution and functions of O. officinalis WRKY genes, and suggested that manipulating eight significantly different expression OoWRKYs would enhance resistance to bacterial blight.	[Jiang, Chunmiao; Wang, Bo; Xiao, Suqin; Chen, Ling; Yu, Tengqiong; Ke, Xue; Zhong, Qiaofang; Fu, Jian; Chen, Yue; Wang, Lingxian; Yin, Fuyou; Zhang, Dunyu; Huang, Xingqi; Cheng, Zaiquan] Yunnan Acad Agr Sci, Biotechnol & Genet Germplasm Inst, Kunming, Yunnan, Peoples R China; [Jiang, Chunmiao; Huang, Xingqi] Yunnan Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China; [Shen, Qingxi J.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [He, Bin] Jiangxi Sci & Technol Normal Univ, Nanchang, Jiangxi, Peoples R China; [Ghidan, Walid] Agr Res Ctr, Field Crops Res Inst, Rice Res & Training Ctr, Sakha, Kafr Elsheikh, Egypt	Yunnan Academy of Agricultural Sciences; Yunnan University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Jiangxi Science & Technology Normal University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt	Huang, XQ (corresponding author), Yunnan Acad Agr Sci, Biotechnol & Genet Germplasm Inst, Kunming, Yunnan, Peoples R China.; Huang, XQ (corresponding author), Yunnan Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China.	hxq311@126.com; czquan-99@163.com	Ghidan, Walid/AAW-5861-2020		NSFC-Yunnan Project [U1302265]; NSFC [31460054, 31460478, 31401707]; Yunnan Key Project [2012CI]	NSFC-Yunnan Project; NSFC(National Natural Science Foundation of China (NSFC)); Yunnan Key Project	This study was supported by the NSFC-Yunnan Project (U1302265) and NSFC Project (31460054 to XK, 31460478 to WL, 31401707 to SX) and granted from Yunnan Key Project (2012CI) to XQH.	Antoni R, 2011, CURR OPIN PLANT BIOL, V14, P547, DOI 10.1016/j.pbi.2011.06.004; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bakshi M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27700; Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Brand LH, 2013, NUCLEIC ACIDS RES, V41, P9764, DOI 10.1093/nar/gkt732; Cheng Zai-Quan, 2004, Acta Botanica Yunnanica, V26, P267; Chuio T, 2007, BBA-GENE STRUCT EXPR, V1769, P497, DOI 10.1016/j.bbaexp.2007.04.006; Chujo T, 2006, PLANT CELL PHYSL; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Diao WP, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.00211, 10.3389/fpls.2016.01727]; Dorn R, 2003, GENETICA, V117, P165, DOI 10.1023/A:1022983810016; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Fu XL, 2011, AGR SCI CHINA, V10, P1489, DOI 10.1016/S1671-2927(11)60143-0; Han M, 2013, J PLANT BIOL, V56, P258, DOI 10.1007/s12374-013-0160-0; Harborne JB, 1999, BIOCHEM SYST ECOL, V27, P335, DOI 10.1016/S0305-1978(98)00095-7; Hasegawa M, 2014, MOLECULES, V19, P11404, DOI 10.3390/molecules190811404; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Jang JY, 2010, PLANT PATHOLOGY J, V26, P110, DOI 10.5423/PPJ.2010.26.2.110; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Koonin EV, 2000, TRENDS BIOCHEM SCI, V25, P223, DOI 10.1016/S0968-0004(00)01577-2; Li SJ, 2011, PLANTA, V233, P1237, DOI 10.1007/s00425-011-1375-2; Lin RC, 2004, PLANT PHYSIOL, V136, P4010, DOI 10.1104/pp.104.052191; Liu XQ, 2007, J PLANT PHYSIOL, V164, P969, DOI 10.1016/j.jplph.2006.07.006; Liu XQ, 2005, CELL RES, V15, P593, DOI 10.1038/sj.cr.7290329; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeo K, 2001, BIOSCI BIOTECH BIOCH, V65, P2428, DOI 10.1271/bbb.65.2428; Mangelsen E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-194; Monticone M, 2010, J CELL PHYSIOL, V225, P767, DOI 10.1002/jcp.22279; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Peng XX, 2012, PLANTA, V236, P1485, DOI 10.1007/s00425-012-1698-7; Peng Y, 2010, RICE, V3, P36, DOI 10.1007/s12284-010-9039-6; Qiu DY, 2008, MOL PLANT, V1, P538, DOI 10.1093/mp/ssn012; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Rinerson CI, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0456-y; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Rushton PJ, 2008, PLANT PHYSIOL, V147, P280, DOI 10.1104/pp.107.114041; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Ryu HS, 2006, PLANT CELL REP, V25, P836, DOI 10.1007/s00299-006-0138-1; Schluttenhofer C, 2015, PLANT PHYSIOL, V167, P295, DOI 10.1104/pp.114.251769; Song H, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/420128; Song Y, 2010, RICE SCI, V17, P60, DOI 10.1016/S1672-6308(08)60105-5; Tan Guang-Xuan, 2004, Acta Genetica Sinica, V31, P724; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wu KL, 2005, DNA RES, V12, P9, DOI 10.1093/dnares/12.1.9; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Xu HJ, 2016, DNA RES, V23, P311, DOI 10.1093/dnares/dsw025; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhang LY, 2015, PLANT SCI, V236, P214, DOI 10.1016/j.plantsci.2015.04.014; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zhang ZL, 2004, PLANT PHYSIOL, V134, P1500, DOI 10.1104/pp.103.034967; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x	54	7	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188742	10.1371/journal.pone.0188742	http://dx.doi.org/10.1371/journal.pone.0188742			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190793	Green Submitted, Green Published, gold			2022-12-27	WOS:000416841900114
J	Lee, SJ; Kwon, S; Gatti, JR; Korcari, E; Gresser, TE; Felix, PC; Keep, SG; Pasquale, KC; Bai, TX; Blanchett-Anderson, SA; Wu, NW; Obeng-Nyarko, C; Senagbe, KM; Young, KC; Maripudi, S; Yalavarthi, BC; Korcari, D; Liu, AY; Schaffler, BC; Keep, RF; Wang, MM				Lee, Soo Jung; Kwon, Soonhyung; Gatti, John R.; Korcari, Ejona; Gresser, Ty E.; Felix, Princess C.; Keep, Simon G.; Pasquale, Kevin C.; Bai, Tongxu; Blanchett-Anderson, Sabrina A.; Wu, Nancy W.; Obeng-Nyarko, Charissa; Senagbe, Kossi M.; Young, Kathy C.; Maripudi, Snehaa; Yalavarthi, Bharath C.; Korcari, Dajana; Liu, Andre Y.; Schaffler, Benjamin C.; Keep, Richard F.; Wang, Michael M.			Large-scale identification of human cerebrovascular proteins: Inter-tissue and intracerebral vascular protein diversity	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; SMOOTH-MUSCLE-CELLS; TARGETED ABSOLUTE PROTEOMICS; ENDOTHELIAL-CELLS; MOLECULAR-BIOLOGY; EXPRESSION; TRANSCRIPTOME; MOUSE; TRANSPORTERS; ASTROCYTES	The human cerebrovascular system is responsible for regulating demand-dependent perfusion and maintaining the blood-brain barrier (BBB). In addition, defects in the human cerebrovasculature lead to stroke, intracerebral hemorrhage, vascular malformations, and vascular cognitive impairment. The objective of this study was to discover new proteins of the human cerebrovascular system using expression data from the Human Protein Atlas, a large-scale project which allows public access to immunohistochemical analysis of human tissues. We screened 20,158 proteins in the HPA and identified 346 expression patterns correlating to blood vessels in human brain. Independent experiments showed that 51/ 52 of these distributions could be experimentally replicated across different brain samples. Some proteins (40%) demonstrated endothelial cell (EC)-enriched expression, while others were expressed primarily in vascular smooth muscle cells (VSMC; 18%); 39% of these proteins were expressed in both cell types. Most brain EC markers were tissue oligospecific; that is, they were expressed in endothelia in an average of 4.8 out of 9 organs examined. Although most markers expressed in endothelial cells of the brain were present in all cerebral capillaries, a significant number (21%) were expressed only in a fraction of brain capillaries within each brain sample. Among proteins found in cerebral VSMC, virtually all were also expressed in peripheral VSMC and in non-vascular smooth muscle cells (SMC). Only one was potentially brain specific: VHL (Von Hippel-Lindau tumor suppressor). HRC (histidine rich calcium binding protein) and VHL were restricted to VSMC and not found in non-vascular tissues such as uterus or gut. In conclusion, we define a set of brain vascular proteins that could be relevant to understanding the unique physiology and pathophysiology of the human cerebrovasculature. This set of proteins defines inter-organ molecular differences in the vasculature and confirms the broad heterogeneity of vascular cells within the brain.	[Lee, Soo Jung; Gatti, John R.; Korcari, Ejona; Gresser, Ty E.; Felix, Princess C.; Keep, Simon G.; Pasquale, Kevin C.; Bai, Tongxu; Blanchett-Anderson, Sabrina A.; Wu, Nancy W.; Obeng-Nyarko, Charissa; Senagbe, Kossi M.; Young, Kathy C.; Maripudi, Snehaa; Yalavarthi, Bharath C.; Korcari, Dajana; Liu, Andre Y.; Schaffler, Benjamin C.; Wang, Michael M.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Kwon, Soonhyung] Univ Michigan, Sch Social Work, Ann Arbor, MI 48109 USA; [Keep, Richard F.] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Keep, Richard F.; Wang, Michael M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Wang, Michael M.] VA Ann Arbor Healthcare Syst, Neurol Serv, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Wang, MM (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.; Wang, MM (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.; Wang, MM (corresponding author), VA Ann Arbor Healthcare Syst, Neurol Serv, Ann Arbor, MI USA.	micwang@umich.edu		Young, Kathy/0000-0003-1538-8733; Felix, Princess/0000-0002-7901-8670; Gatti, John/0000-0001-9759-2855; Keep, Simon/0000-0002-4139-1672	NIH [NS052681, NS054724, NS062816, HL108842]; Department of Veterans Affairs [BX000375, BX003824]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS099783] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003824] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	NIH (NS052681, NS054724, NS062816, and HL108842) and the Department of Veterans Affairs (BX000375 and BX003824) provided funding for these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NIH (NS052681, NS054724, NS062816, and HL108842) and the Department of Veterans Affairs (BX000375 and BX003824) provided funding for these studies. We also thank the following individuals for assistance with this project: Vernesha Jones, Neel Bhattacharyya, Jonathan Markowitz, Claire Kim, Nya Greenstone, Jon Dean, Hollister Swanson, and Molly Zimmerman.	AIRD WC, 1995, P NATL ACAD SCI USA, V92, P4567, DOI 10.1073/pnas.92.10.4567; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Beutner C, 2013, GLIA, V61, P1429, DOI 10.1002/glia.22524; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cheung CYY, 2016, INVEST OPHTH VIS SCI, V57, P5518, DOI 10.1167/iovs.16-20094; Claxton S, 2004, GENE EXPR PATTERNS, V5, P123, DOI 10.1016/j.modgep.2004.05.004; Cornford EM, 1996, J NEUROTRAUM, V13, P523, DOI 10.1089/neu.1996.13.523; Dahlin A, 2009, J PHARMACOL EXP THER, V329, P558, DOI 10.1124/jpet.108.149831; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Dong HR, 2013, STROKE, V44, P1456, DOI 10.1161/STROKEAHA.111.000721; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Enerson BE, 2006, J CEREBR BLOOD F MET, V26, P959, DOI 10.1038/sj.jcbfm.9600249; GABBIANI G, 1981, P NATL ACAD SCI-BIOL, V78, P298, DOI 10.1073/pnas.78.1.298; Huang JH, 2015, P NATL ACAD SCI USA, V112, P4447, DOI 10.1073/pnas.1420363112; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Kanai Y, 2001, CURR DRUG METAB, V2, P339, DOI 10.2174/1389200013338324; Karaca E, 2014, CELL, V157, P636, DOI 10.1016/j.cell.2014.02.058; Kim SH, 2015, BIOCHEM BIOPH RES CO, V460, P404, DOI 10.1016/j.bbrc.2015.03.046; Kusuhara Hiroyuki, 2005, NeuroRx, V2, P73, DOI 10.1602/neurorx.2.1.73; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; LEESMILLER JP, 1987, BIOCHEM J, V244, P705, DOI 10.1042/bj2440705; Lerch JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030417; Long XC, 2011, ARTERIOSCL THROM VAS, V31, P2172, DOI 10.1161/ATVBAHA.111.232785; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Munot P, 2012, BRAIN, V135, P2506, DOI 10.1093/brain/aws172; Ohtsuki S, 2014, EXPERT REV PROTEOMIC, V11, P303, DOI 10.1586/14789450.2014.893830; OSBORN M, 1981, DIFFERENTIATION, V20, P196, DOI 10.1111/j.1432-0436.1981.tb01176.x; Pardridge WM, 2005, MOL BIOTECHNOL, V30, P57, DOI 10.1385/MB:30:1:057; Patching SG, 2017, MOL NEUROBIOL, V54, P1046, DOI 10.1007/s12035-015-9672-6; PATHAK RK, 1992, J MUSCLE RES CELL M, V13, P366, DOI 10.1007/BF01766464; Rossner MJ, 2006, J NEUROSCI, V26, P9956, DOI 10.1523/JNEUROSCI.0468-06.2006; Ruchoux MM, 1997, J NEUROPATH EXP NEUR, V56, P947, DOI 10.1097/00005072-199709000-00001; Sameshima T, 2000, INT J CANCER, V88, P21, DOI 10.1002/1097-0215(20001001)88:1<21::AID-IJC4>3.0.CO;2-S; Starke RM, 2014, TRANSL STROKE RES, V5, P338, DOI 10.1007/s12975-013-0290-1; Takanaga T, 2001, J CEREBR BLOOD F MET, V21, P1232, DOI 10.1097/00004647-200110000-00012; Uchida Y, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-21; Uchida Y, 2011, J NEUROCHEM, V117, P333, DOI 10.1111/j.1471-4159.2011.07208.x; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; vanEys GJJM, 1997, CELL STRUCT FUNCT, V22, P65, DOI 10.1247/csf.22.65; Wang MM, 2013, NEUROREPORT, V24, P79, DOI 10.1097/WNR.0b013e32835c93a2; WONG VLY, 1991, BRAIN RES, V556, P1, DOI 10.1016/0006-8993(91)90540-C; Wylie CJ, 2010, J NEUROSCI, V30, P670, DOI 10.1523/JNEUROSCI.4656-09.2010; Xu R, 2003, AM J PHYSIOL-HEART C, V284, pH1398, DOI 10.1152/ajpheart.00737.2002; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013	44	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188540	10.1371/journal.pone.0188540	http://dx.doi.org/10.1371/journal.pone.0188540			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190776	gold, Green Published, Green Submitted			2022-12-27	WOS:000416841900069
J	Alazawi, W; Bernabe, E; Tai, D; Janicki, T; Kemos, P; Samsuddin, S; Syn, WK; Gillam, D; Turner, W				Alazawi, William; Bernabe, Eduardo; Tai, David; Janicki, Tomasz; Kemos, Polychronis; Samsuddin, Salma; Syn, Wing-Kin; Gillam, David; Turner, Wendy			Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; UNITED-STATES; HEALTH; PREVALENCE	Background and aims Non-alcoholic fatty liver disease (NAFLD) has a bidirectional association with metabolic syndrome. It affects up to 30% of the general population, 70% of individuals with diabetes and 90% with obesity. The main histological hallmark of progressive NAFLD is fibrosis. There is a bidirectional epidemiological link between periodontitis and metabolic syndrome. NAFLD, periodontitis and diabetes share common risk factors, are characterised by inflammation and associated with changes in commensal bacteria. Therefore we tested the hypothesis that periodontitis is associated with NAFLD and with significant fibrosis in two study groups. Methods We analyzed data from a population-based survey and a patient-based study. NHANES III participants with abdominal ultrasound and sociodemographic, clinical, and oral examination data were extracted and appropriate weighting applied. In a separate patient-based study, consenting patients with biopsy-proved NAFLD (or with liver indices too mild to justify biopsy) underwent dental examination. Basic Periodontal Examination score was recorded. Results In NHANES, periodontitis was significantly associated with steatosis in 8172 adults even after adjusting for sociodemographic factors. However, associations were fully explained after accounting for features of metabolic syndrome. In the patient-based study, periodontitis was significantly more common in patients with biopsy-proven NASH and any fibrosis (F0-F4) than without NASH (p = 0.009). Periodontitis was more common in patients with NASH and significant fibrosis (F2-4) than mild or no fibrosis (F0-1, p = 0.04). Conclusions Complementary evidence from an epidemiological survey and a clinical study show that NAFLD is associated with periodontitis and that the association is stronger with significant liver fibrosis.	[Alazawi, William; Tai, David; Kemos, Polychronis; Samsuddin, Salma; Syn, Wing-Kin] Queen Mary Univ London, Blizard Inst, London, England; [Bernabe, Eduardo] Kings Coll London, Inst Dent, London, England; [Janicki, Tomasz; Gillam, David; Turner, Wendy] Queen Mary Univ London, Dent Inst, London, England; [Syn, Wing-Kin] Ralph H Johnson Vet Affairs Med Ctr, Sect Gastroenterol, Charleston, SC USA; [Syn, Wing-Kin] Med Univ South Carolina, Div Gastroenterol & Hepatol, Charleston, SC USA	University of London; Queen Mary University London; University of London; King's College London; University of London; Queen Mary University London; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina	Alazawi, W (corresponding author), Queen Mary Univ London, Blizard Inst, London, England.	w.alazawi@qmul.ac.uk	Bernabe, Eduardo/R-3441-2017; Syn, Wing-Kin/AAB-8406-2020	Bernabe, Eduardo/0000-0002-1858-3713; Turner, Wendy/0000-0002-4280-8345; Gillam, David/0000-0002-8669-6138; Alazawi, William/0000-0002-3891-5914	Diabetes Research and Wellness Fund; MRC New Investigator Award; MRC [MR/N00308X/1] Funding Source: UKRI; Medical Research Council [MR/N00308X/1] Funding Source: researchfish; National Institute for Health Research [ACF-2016-19-012] Funding Source: researchfish	Diabetes Research and Wellness Fund; MRC New Investigator Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the Diabetes Research and Wellness Fund. WA is in receipt of an MRC New Investigator Award. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimatsu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04828; Ballestri S, 2015, EXPERT REV GASTROENT, V9, P603, DOI 10.1586/17474124.2015.1007955; Bambha K, 2012, HEPATOLOGY, V55, P769, DOI 10.1002/hep.24726; Batchelor P, 2014, BRIT DENT J, V217, P405, DOI 10.1038/sj.bdj.2014.912; Demmer RT, 2012, DIABETES CARE, V35, P2036, DOI 10.2337/dc11-2453; Dumitrescu A. L., 2015, FRONT PUBLIC HEALTH, V3, P278, DOI [DOI 10.3389/fpubh.2015.00278, 10.3389/fpubh.2015.00278]; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Eke PI, 2010, J DENT RES, V89, P1208, DOI 10.1177/0022034510377793; EMRICH LJ, 1991, J PERIODONTOL, V62, P123, DOI 10.1902/jop.1991.62.2.123; Engebretson SP, 2013, JAMA-J AM MED ASSOC, V310, P2523, DOI 10.1001/jama.2013.282431; Fitzpatrick E, 2014, WORLD J GASTROENTERO, V20, P10851, DOI 10.3748/wjg.v20.i31.10851; Goodson JM, 2009, J DENT RES, V88, P519, DOI 10.1177/0022034509338353; Guggenheimer J, 2007, LIVER TRANSPLANT, V13, P280, DOI 10.1002/lt.21038; Hayashi J, 2017, BMC ORAL HEALTH, V17, DOI 10.1186/s12903-017-0369-2; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Jimenez M, 2012, OBESITY, V20, P1718, DOI 10.1038/oby.2011.291; Kinane D.F., 2017, PERIODONTAL DIS NAT, V3, P17038, DOI [10.1038/nrdp.2017.38, DOI 10.1038/NRDP.2017.38]; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Lazo M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6891; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Ma JT, 2017, J HEPATOL, V66, P390, DOI 10.1016/j.jhep.2016.09.022; Mantovani A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020217; Merchant AT, 2007, J CLIN PERIODONTOL, V34, P1007, DOI 10.1111/j.1600-051X.2007.01148.x; Nibali L, 2013, J CLIN ENDOCR METAB, V98, P913, DOI 10.1210/jc.2012-3552; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Periodontology BSo, 2011, BAS PER EX BPE 2011; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Schenkein HA, 2013, J CLIN PERIODONTOL, V40, pS51, DOI [10.1111/jcpe.12060, 10.1902/jop.2013.134006]; SHLOSSMAN M, 1990, J AM DENT ASSOC, V121, P532, DOI 10.14219/jada.archive.1990.0211; Simpson TC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004714.pub3; Socransky SS, 2000, PERIODONTOLOGY, V28, P12, DOI DOI 10.1034/J.1600-0757.2002.280102.X; Soskolne W A, 2001, Ann Periodontol, V6, P91, DOI 10.1902/annals.2001.6.1.91; Suvan J, 2011, OBES REV, V12, pe381, DOI 10.1111/j.1467-789X.2010.00808.x; Tai FWD, 2015, DIABETIC MED, V32, P1121, DOI 10.1111/dme.12725; Taylor G W, 1998, Ann Periodontol, V3, P30, DOI 10.1902/annals.1998.3.1.30; Tonetti MS, 2013, J CLIN PERIODONTOL, V40, pS24, DOI 10.1111/jcpe.12089; Tsai C, 2002, COMMUNITY DENT ORAL, V30, P182, DOI 10.1034/j.1600-0528.2002.300304.x; White DA, 2012, BRIT DENT J, V213, P567, DOI 10.1038/sj.bdj.2012.1088; Yoneda M, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-16	42	37	39	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0185902	10.1371/journal.pone.0185902	http://dx.doi.org/10.1371/journal.pone.0185902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220367	Green Published, Green Submitted, gold			2022-12-27	WOS:000417469900002
J	Okamoto, C; Hayakawa, Y; Aoyama, T; Komaki, H; Minatoguchi, S; Iwasa, M; Yamada, Y; Kanamori, H; Kawasaki, M; Nishigaki, K; Mikami, A; Minatoguchi, S				Okamoto, Chihiro; Hayakawa, Yuka; Aoyama, Takuma; Komaki, Hisaaki; Minatoguchi, Shingo; Iwasa, Masamitsu; Yamada, Yoshihisa; Kanamori, Hiromitsu; Kawasaki, Masanori; Nishigaki, Kazuhiko; Mikami, Atsushi; Minatoguchi, Shinya			Excessively low salt diet damages the heart through activation of cardiac (pro) renin receptor, renin-angiotensin-aldosterone, and sympatho-adrenal systems in spontaneously hypertensive rats	PLOS ONE			English	Article							BLOOD-PRESSURE; URINARY SODIUM; EXCRETION; RISK	Objective A high salt intake causes hypertension and leads to cardiovascular disease. Therefore, a low salt diet is now recommended to prevent hypertension and cardiovascular disease. However, it is still unknown whether an excessively low salt diet is beneficial or harmful for the heart. Methods Wistar Kyoto rats (WKYs) and spontaneously hypertensive rats (SHRs) received normal salt chow (0.9% salt diet) and excessively low salt chow (0.01% salt diet referred to as saltless diet) for 8 weeks from 8 to 16 weeks of age. The effects of the excessively low salt diet on the cardiac (pro) renin receptor, renin-angiotensin-aldosterone, and sympatho-adrenal systems were investigated. Results The excessively low salt diet did not affect the systolic blood pressure but significantly increased the heart rate both in WKYs and SHRs. The excessively low salt diet significantly elevated plasma renin activity, plasma angiotensin I, II and aldosterone concentrations, and plasma noradrenaline and adrenaline concentrations both in WKYs and SHRs. Cardiac expressions of renin, prorenin, (P)RR, angiotensinogen, and angiotensin II AT1 receptor and phosphorylated (p)-ERK1/2, p-HSP27, p-38MAPK, and TGF-beta 1 were significantly enhanced by the excessively low salt diet in both WKYs and SHRs. The excessively low salt diet accelerated cardiac interstitial and perivascular fibrosis and increased the cardiomyocyte size and interventricular septum thickness in WKYs and SHRs but the extent was greater in SHRs. Conclusion An excessively low salt diet damages the heart through activation of plasma renin-angiotensin-aldosterone and sympatho-adrenal systems and activation of cardiac (P) RR and angiotensin II AT1 receptor and their downstream signals both in WKYs and SHRs.	[Okamoto, Chihiro; Hayakawa, Yuka; Aoyama, Takuma; Komaki, Hisaaki; Minatoguchi, Shingo; Iwasa, Masamitsu; Yamada, Yoshihisa; Kanamori, Hiromitsu; Kawasaki, Masanori; Nishigaki, Kazuhiko; Mikami, Atsushi; Minatoguchi, Shinya] Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu, Japan	Gifu University	Minatoguchi, S (corresponding author), Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu, Japan.	minatos@gifu-u.ac.jp			Gifu University Graduate School of Medicine; Salt Science Research Foundation; Suzuken Memorial Foundation	Gifu University Graduate School of Medicine; Salt Science Research Foundation; Suzuken Memorial Foundation	This work was supported by a grant from the Gifu University Graduate School of Medicine (to Shinya. Minatoguchi) and from Salt Science Research Foundation (to Shinya. Minatoguchi) and from Suzuken Memorial Foundation (to Y Yamada, C Okamoto and Shinya Minatoguchi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERMAN MH, 1991, NEW ENGL J MED, V324, P1098, DOI 10.1056/NEJM199104183241605; Carillo BA, 2007, REGUL PEPTIDES, V140, P5, DOI 10.1016/j.regpep.2006.11.007; COHN JN, 1995, CLIN CARDIOL, V18, P4; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Cook NR, 2014, CIRCULATION, V129, P981, DOI 10.1161/CIRCULATIONAHA.113.006032; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; DENTON D, 1995, NAT MED, V1, P1009, DOI 10.1038/nm1095-1009; ELLIOTT P, 1988, BRIT MED J, V297, P319; Freel EM, 2004, J AM SOC NEPHROL, V15, P1993, DOI 10.1097/01.ASN.0000132473.50966.14; Morales MG, 2012, INT J BIOCHEM CELL B, V44, P1993, DOI 10.1016/j.biocel.2012.07.028; Hayakawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120453; Hodge G, 2002, ACTA PHYSIOL SCAND, V174, P209, DOI 10.1046/j.1365-201x.2002.00937.x; Huang Y, 2007, KIDNEY INT, V72, P45052; Ichihara A, 2006, HYPERTENSION, V47, P894, DOI 10.1161/01.HYP.0000215838.48170.0b; LEENEN FHH, 1989, J HYPERTENS, V7, P57, DOI 10.1097/00004872-198901000-00009; Manger WM., 1982, ADV CARDIOL, V30, P17; Muhlestein JB, 2010, AM J CARDIOL, V106, P764, DOI 10.1016/j.amjcard.2010.04.040; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; REID JL, 1986, AM J CARDIOL, V57, pE6, DOI 10.1016/0002-9149(86)90716-2; Sakoda M, 2007, HYPERTENS RES, V30, P1139, DOI 10.1291/hypres.30.1139; Saris JJ, 2006, HYPERTENSION, V48, P564, DOI 10.1161/01.HYP.0000240064.19301.1b; Schroten NF, 2012, HEART FAIL REV, V17, P191, DOI 10.1007/s10741-011-9262-2; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; WARREN S E, 1980, Clinical Cardiology, V3, P348	24	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189099	10.1371/journal.pone.0189099	http://dx.doi.org/10.1371/journal.pone.0189099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220406	Green Submitted, gold, Green Published			2022-12-27	WOS:000417469900033
J	Shionoya, Y; Sunada, K; Shigeno, K; Nakada, A; Honda, M; Nakamura, T				Shionoya, Yoshiki; Sunada, Katsuhisa; Shigeno, Keiji; Nakada, Akira; Honda, Michitaka; Nakamura, Tatsuo			Can nerve regeneration on an artificial nerve conduit be enhanced by ethanol-induced cervical sympathetic ganglion block?	PLOS ONE			English	Article							RAT SCIATIC-NERVE; GROWTH-FACTOR; BLOOD-FLOW; POLYGLYCOLIC ACID; SCHWANN-CELLS; COLLAGEN TUBE; SURGICAL-TREATMENT; PERIPHERAL-NERVES; MOLECULAR-BASIS; GUIDE TUBE	This study aimed to determine whether nerve regeneration by means of an artificial nerve conduit is promoted by ethanol-induced cervical sympathetic ganglion block (CSGB) in a canine model. This study involved two experiments-in part I, the authors examined the effect of CSGB by ethanol injection on long-term blood flow to theorofacial region; part II involved evaluation of the effect of CSGB by ethanol injection on inferior alveolar nerve (IAN) repair using polyglycolic acid-collagen tubes. In part I, seven Beagles were administered left CSGB by injection of 99.5% ethanol under direct visualization by means of thoracotomy, and changes in oral mucosal blood flow in the mental region and nasal skin temperature were evaluated. The increase in blood flow on the left side lasted for 7 weeks, while the increase in average skin temperature lasted 10 weeks on the left side and 3 weeks on the right. In part II, fourteen Beagles were each implanted with a polyglycolic acid-collagen tube across a 10-mm gap in the left IAN. A week after surgery, seven of these dogs were administered CSGB by injection of ethanol. Electrophysiological findings at 3 months after surgery revealed significantly higher sensory nerve conduction velocity and recovery index (ratio of left and right IAN peak amplitudes) after nerve regeneration in the reconstruction+CSGB group than in the reconstruction-only group. Myelinated axons in the reconstruction+CSGB group were greater in diameter than those in the reconstruction-only group. Administration of CSGB with ethanol resulted in improved nerve regeneration in some IAN defects. However, CSGB has several physiological effects, one of which could possibly be the long-term increase in adjacent blood flow.	[Shionoya, Yoshiki] Nippon Dent Univ Hosp Tokyo, Dept Dent Anesthesia, Tokyo, Japan; [Sunada, Katsuhisa] Nippon Dent Univ Tokyo, Dept Dent Anesthesiol, Sch Life Dent Tokyo, Tokyo, Tokyo, Japan; [Shigeno, Keiji; Nakada, Akira; Honda, Michitaka; Nakamura, Tatsuo] Kyoto Univ, Inst Frontier Med Sci, Dept Bioartificial Organs, Kyoto, Japan	Nippon Dental University; Nippon Dental University; Kyoto University	Shionoya, Y (corresponding author), Nippon Dent Univ Hosp Tokyo, Dept Dent Anesthesia, Tokyo, Japan.	ysk.shionoya@gmail.com	Honda, Michitaka/GRX-6955-2022; sunada, katsuhisa/ABA-4418-2020	sunada, katsuhisa/0000-0003-1904-0160; Shionoya, Yoshiki/0000-0001-5012-4907				ALBORCH E, 1977, CIRC RES, V41, P278, DOI 10.1161/01.RES.41.3.278; De Luigi A, 1998, NEUROSCIENCE, V83, P1245, DOI 10.1016/S0306-4522(97)00381-3; DELATORRE JC, 1988, NEUROSCI LETT, V94, P269, DOI 10.1016/0304-3940(88)90029-8; DELLON AL, 1988, PLAST RECONSTR SURG, V82, P849, DOI 10.1097/00006534-198811000-00020; Evans GRD, 2000, SEMIN SURG ONCOL, V19, P312, DOI 10.1002/1098-2388(200010/11)19:3<312::AID-SSU13>3.0.CO;2-M; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Ghai A, 2016, ACTA ANAESTH BELG, V67, P6; Haapaniemi T, 1998, EXP NEUROL, V149, P433, DOI 10.1006/exnr.1997.6745; HEUMANN R, 1987, J EXP BIOL, V132, P133; Higa K, 2006, ANESTHESIOLOGY, V105, P1238, DOI 10.1097/00000542-200612000-00024; Ichihara S, 2009, TISSUE ENG PART C-ME, V15, P387, DOI 10.1089/ten.tec.2008.0508; Ide C, 1998, EXP NEUROL, V154, P99, DOI 10.1006/exnr.1998.6921; IJkema-Paassen J, 2004, BIOMATERIALS, V25, P1583, DOI 10.1016/S0142-9612(03)00504-0; Inada Y, 2005, PAIN, V117, P251, DOI 10.1016/j.pain.2005.05.033; Inada Yuji, 2007, Neurosurgery, V61, pE1105; Kakuyama M, 2000, REGION ANESTH PAIN M, V25, P389, DOI 10.1053/rapm.2000.6450; Kim Y, 2009, J PERIODONTAL RES, V44, P695, DOI 10.1111/j.1600-0765.2008.01177.x; Kingham PJ, 2006, J ANAT, V209, P511, DOI 10.1111/j.1469-7580.2006.00623.x; Liao CD, 2017, PAIN MED, V18, P488, DOI 10.1093/pm/pnw145; Liao CD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167476; LINDHOLM D, 1987, NATURE, V330, P658, DOI 10.1038/330658a0; LUNDBORG G, 1982, J NEUROPATH EXP NEUR, V41, P412, DOI 10.1097/00005072-198207000-00004; Maquet V, 2000, J BIOMED MATER RES, V52, P639, DOI 10.1002/1097-4636(20001215)52:4<639::AID-JBM8>3.3.CO;2-7; MARTINI R, 1994, J NEUROSCI, V14, P7180; MILLESI H, 1972, J BONE JOINT SURG AM, VA 54, P727, DOI 10.2106/00004623-197254040-00004; Millesi H., 1987, MICRORECONSTRUCTION, P223; Nakamura T, 2004, BRAIN RES, V1027, P18, DOI 10.1016/j.brainres.2004.08.040; Narouze S, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0424-5; Ohno K, 1997, ANESTH ANALG, V85, P1312, DOI 10.1097/00000539-199712000-00024; Rodriguez FJ, 2000, EXP NEUROL, V161, P571, DOI 10.1006/exnr.1999.7315; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; SANDERS FK, 1946, J PHYSIOL-LONDON, V105, P152, DOI 10.1113/jphysiol.1946.sp004160; Seo K, 2016, PAIN MED, V17, P2360, DOI 10.1093/pm/pnw088; Suzuki Y, 1999, NEUROSCI LETT, V259, P75, DOI 10.1016/S0304-3940(98)00924-0; Terakawa Y, 2009, REGION ANESTH PAIN M, V34, P553, DOI 10.1097/AAP.0b013e3181b4c505; THOENEN H, 1988, CELL MOL NEUROBIOL, V8, P35, DOI 10.1007/BF00712909; Wang YC, 2001, NEUROSURGERY, V49, P628, DOI 10.1097/00006123-200109000-00017; WULF H, 1992, ANAESTHESIST, V41, P146; Yamanaka T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092258; Yoshitani M, 2007, J THORAC CARDIOV SUR, V133, P726, DOI 10.1016/j.jtcvs.2006.08.089; ZHANG Y, 1995, J COMP NEUROL, V361, P193, DOI 10.1002/cne.903610202	41	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189297	10.1371/journal.pone.0189297	http://dx.doi.org/10.1371/journal.pone.0189297			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220373	Green Published, gold, Green Submitted			2022-12-27	WOS:000417469900045
J	Ahsendorf, T; Muller, FJ; Topkar, V; Gunawardena, J; Eils, R				Ahsendorf, Tobias; Mueller, Franz-Josef; Topkar, Ved; Gunawardena, Jeremy; Eils, Roland			Transcription factors, coregulators, and epigenetic marks are linearly correlated and highly redundant	PLOS ONE			English	Article							HUMAN CELL-TYPES; CHROMATIN-STATE; ERYTHROID-DIFFERENTIATION; HISTONE MODIFICATIONS; GENE-EXPRESSION; FACTOR-BINDING; X-RECEPTOR; REPRESSOR; COMPLEX; PROMOTER	The DNA microstates that regulate transcription include sequence-specific transcription factors (TFs), coregulatory complexes, nucleosomes, histone modifications, DNA methylation, and parts of the three-dimensional architecture of genomes, which could create an enormous combinatorial complexity across the genome. However, many proteins and epigenetic marks are known to colocalize, suggesting that the information content encoded in these marks can be compressed. It has so far proved difficult to understand this compression in a systematic and quantitative manner. Here, we show that simple linear models can reliably predict the data generated by the ENCODE and Roadmap Epigenomics consortia. Further, we demonstrate that a small number of marks can predict all other marks with high average correlation across the genome, systematically revealing the substantial information compression that is present in different cell lines. We find that the linear models for activating marks are typically cell line-independent, while those for silencing marks are predominantly cell line-specific. Of particular note, a nuclear receptor corepressor, transducin beta-like 1 X-linked receptor 1 (TBLR1), was highly predictive of other marks in two hematopoietic cell lines. The methodology presented here shows how the potentially vast complexity of TFs, coregulators, and epigenetic marks at eukaryotic genes is highly redundant and that the information present can be compressed onto a much smaller subset of marks. These findings could be used to efficiently characterize cell lines and tissues based on a small number of diagnostic marks and suggest how the DNA microstates, which regulate the expression of individual genes, can be specified.	[Ahsendorf, Tobias; Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Baden Wurttembe, Germany; [Ahsendorf, Tobias; Eils, Roland] Heidelberg Univ, Bioquant, Inst Pharm & Mol Biotechnol, Heidelberg, Baden Wurttembe, Germany; [Ahsendorf, Tobias; Topkar, Ved; Gunawardena, Jeremy] Harvard Med Sch, Dept Syst Biol, Boston, MA USA; [Mueller, Franz-Josef] Zentrum Integrat Psychiat, Kiel, Germany; [Topkar, Ved] Harvard Univ, Boston, MA USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Harvard University; Harvard Medical School; Harvard University	Eils, R (corresponding author), German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Baden Wurttembe, Germany.; Eils, R (corresponding author), Heidelberg Univ, Bioquant, Inst Pharm & Mol Biotechnol, Heidelberg, Baden Wurttembe, Germany.	r.eils@dkfz.de	Eils, Roland/B-6121-2009; Müller, Franz-Josef/E-3336-2010	Eils, Roland/0000-0002-0034-4036; Müller, Franz-Josef/0000-0001-9478-8430				Ahsendorf T, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0102-4; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; [Anonymous], 2014, R LANG ENV STAT COMP; Arvey A, 2012, GENOME RES, V22, P1723, DOI 10.1101/gr.127712.111; Baron MH, 2013, BLOOD, V122, P3701, DOI 10.1182/blood-2013-10-531673; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bogdanovic O, 2012, GENOME RES, V22, P2043, DOI 10.1101/gr.134833.111; Bresnick E.H., 2012, NUC ACIDS RES; Bu Y, 2007, J BIOL CHEM, V282, P26725, DOI 10.1074/jbc.M702885200; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Clabby ML, 2003, J BIOL CHEM, V278, P5760, DOI 10.1074/jbc.M208173200; Cui SAY, 2011, MOL CELL BIOL, V31, P3298, DOI 10.1128/MCB.05310-11; Das A, 2006, J BIOL CHEM, V281, P39105, DOI 10.1074/jbc.M607720200; Dong XJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r53; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2015, NAT BIOTECHNOL, V33, P364, DOI 10.1038/nbt.3157; Ernst J, 2013, GENOME RES, V23, P1142, DOI 10.1101/gr.144840.112; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feng YE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139280; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Galvin KM, 1997, MOL CELL BIOL, V17, P3723, DOI 10.1128/MCB.17.7.3723; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gupta AP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003170; Hadjiagapiou C, 2005, AM J PHYSIOL-GASTR L, V288, pG1118, DOI 10.1152/ajpgi.00312.2004; Hoffmann E, 2005, J BIOL CHEM, V280, P9706, DOI 10.1074/jbc.M407071200; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kihara-Negishi F, 2005, BIOCHEM BIOPH RES CO, V335, P477, DOI 10.1016/j.bbrc.2005.07.098; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kuang Z, 2014, NAT STRUCT MOL BIOL, V21, P854, DOI 10.1038/nsmb.2881; Lee CC, 2012, J BIOL CHEM, V287, P2798, DOI 10.1074/jbc.M111.258947; Lee SH, 2010, CARCINOGENESIS, V31, P719, DOI 10.1093/carcin/bgq016; Li JY, 2015, AM J CLIN EXP UROL, V3, P13; Perner J, 2014, NUCLEIC ACIDS RES, V42, P13689, DOI 10.1093/nar/gku1234; Phan D, 2004, CANCER RES, V64, P3072, DOI 10.1158/0008-5472.CAN-03-3730; Pinello L, 2014, P NATL ACAD SCI USA, V111, pE344, DOI 10.1073/pnas.1322570111; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Rekhtman N, 2003, MOL CELL BIOL, V23, P7460, DOI 10.1128/MCB.23.21.7460-7474.2003; Ridinger-Saison M, 2013, CELL DEATH DIFFER, V20, P1268, DOI 10.1038/cdd.2013.88; Ruzov A, 2004, DEVELOPMENT, V131, P6185, DOI 10.1242/dev.01549; Scibetta AG, 2007, MOL CELL BIOL, V27, P7220, DOI 10.1128/MCB.00274-07; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Tan LJ, 2003, J BIOL CHEM, V278, P17688, DOI 10.1074/jbc.M301676200; Tanabe O, 2002, EMBO J, V21, P3434, DOI 10.1093/emboj/cdf340; Tsankov AM, 2015, NATURE, V518, P344, DOI 10.1038/nature14233; van Steensel B, 2010, GENOME RES, V20, P190, DOI 10.1101/gr.098822.109; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yano K, 2000, GENOMICS, V65, P75, DOI 10.1006/geno.2000.6140; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Yu H, 2008, GENOME RES, V18, P1314, DOI 10.1101/gr.073080.107; Zheng WW, 2014, STEM CELLS, V32, P2278, DOI 10.1002/stem.1723	56	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0186324	10.1371/journal.pone.0186324	http://dx.doi.org/10.1371/journal.pone.0186324			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216191	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800003
J	Panmanee, W; Charoenlap, N; Atichartpongkul, S; Mahavihakanont, A; Whiteside, MD; Winsor, G; Brinkman, FSL; Mongkolsuk, S; Hassett, DJ				Panmanee, Warunya; Charoenlap, Nisanart; Atichartpongkul, Sopapan; Mahavihakanont, Aekkapol; Whiteside, Matthew D.; Winsor, Geoff; Brinkman, Fiona S. L.; Mongkolsuk, Skorn; Hassett, Daniel J.			The OxyR-regulated phnW gene encoding 2-aminoethylphosphonate: pyruvate aminotransferase helps protect Pseudomonas aeruginosa from tert-butyl hydroperoxide	PLOS ONE			English	Article							OXIDATIVE STRESS; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; GENOME DATABASE; EXPRESSION; CONSTRUCTION; PATHOGENESIS; DEGRADATION; SELECTION; VECTORS	The LysR member of bacterial transactivators, OxyR, governs transcription of genes involved in the response to H2O2 and organic (alkyl) hydroperoxides (AHP) in the Gram-negative pathogen, Pseudomonas aeruginosa. We have previously shown that organisms lacking OxyR are rapidly killed by < 2 or 500 mM H2O2 in planktonic and biofilm bacteria, respectively. In this study, we first employed a bioinformatic approach to elucidate the potential regulatory breadth of OxyR by scanning the entire P. aeruginosa PAO1 genome for canonical OxyR promoter recognition sequences (ATAG-N-7-CTAT-N-7-ATAG-N-7-CTAT). Of > 100 potential OxyR-controlled genes, 40 were strategically selected that were not predicted to be involved in the direct response to oxidative stress (e.g., catalase, peroxidase, etc.) and screened such genes by RT-PCR analysis for potentially positive or negative control by OxyR. Differences were found in 7 of 40 genes when comparing an oxyR mutant vs. PAO1 expression that was confirmed by beta-galactosidase reporter assays. Among these, phnW, encoding 2-aminoethylphosphonate: pyruvate aminotransferase, exhibited reduced expression in the oxyR mutant compared to wild-type bacteria. Electrophoretic mobility shift assays indicated binding of OxyR to the phnW promoter and DNase I footprinting analysis also revealed the sequences to which OxyR bound. Interestingly, a phnW mutant was more susceptible to t-butyl-hydroperoxide (t-BOOH) treatment than wild-type bacteria. Although we were unable to define the direct mechanism underlying this phenomenon, we believe that this may be due to a reduced efficiency for this strain to degrade t-BOOH relative to wild-type organisms because of modulation of AHP gene transcription in the phnW mutant.	[Panmanee, Warunya; Hassett, Daniel J.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Charoenlap, Nisanart; Atichartpongkul, Sopapan; Mongkolsuk, Skorn] Chulabhorn Res Inst, Biotechnol Lab, Bangkok, Thailand; [Mahavihakanont, Aekkapol; Mongkolsuk, Skorn] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC, Canada; [Whiteside, Matthew D.; Winsor, Geoff; Brinkman, Fiona S. L.] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok, Thailand	University System of Ohio; University of Cincinnati; Chulabhorn Research Institute; Simon Fraser University; Mahidol University	Hassett, DJ (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.	Daniel.Hassett@UC.Edu	Brinkman, Fiona/N-3195-2013	Brinkman, Fiona/0000-0002-0584-4099; Winsor, Geoffrey/0000-0001-6848-1638	National Institutes of Health [R01 GM-69845-01]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health R01 GM-69845-01.	Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Borisova SA, 2011, J BIOL CHEM, V286, P22283, DOI 10.1074/jbc.M111.237735; CHRISTMAN MF, 1985, CELL, V41, P753, DOI 10.1016/S0092-8674(85)80056-8; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; DUMORA C, 1983, EUR J BIOCHEM, V133, P119, DOI 10.1111/j.1432-1033.1983.tb07436.x; FARINHA MA, 1990, J BACTERIOL, V172, P3496, DOI 10.1128/jb.172.6.3496-3499.1990; Gay C, 1999, ANAL BIOCHEM, V273, P149, DOI 10.1006/abio.1999.4208; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Grosser N, 2004, BIOCHEM BIOPH RES CO, V314, P351, DOI 10.1016/j.bbrc.2003.12.089; Hasset DJ, 2000, J BACTERIOL, V182, P4557, DOI 10.1128/JB.182.16.4557-4563.2000; Hassett DJ, 2014, J MICROBIOL, V52, P211, DOI 10.1007/s12275-014-4068-2; Heo YJ, 2010, J BACTERIOL, V192, P381, DOI 10.1128/JB.00980-09; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Kim AD, 2002, J BACTERIOL, V184, P4134, DOI 10.1128/JB.184.15.4134-4140.2002; Kruczek C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149229; Miller JH., 1992, SHORT COURSE BACTERI, P72; Morgan R, 2006, J BACTERIOL, V188, P7335, DOI 10.1128/JB.00599-06; Ochsner UA, 2001, J BACTERIOL, V183, P773, DOI 10.1128/JB.183.2.773-778.2001; Ochsner UA, 1999, J BACTERIOL, V181, P1099, DOI 10.1128/JB.181.4.1099-1109.1999; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; Seth D, 2012, SCIENCE, V336, P470, DOI 10.1126/science.1215643; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; Vattanaviboon P, 2002, BIOCHEM BIOPH RES CO, V299, P177, DOI 10.1016/S0006-291X(02)02602-5; Wei Q, 2012, NUCLEIC ACIDS RES, V40, P4320, DOI 10.1093/nar/gks017; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Winsor GL, 2005, NUCLEIC ACIDS RES, V33, pD338, DOI 10.1093/nar/gki047; World Health Organization, WORLD HLTH STAT; Zheng M, 2001, J BACTERIOL, V183, P4571, DOI 10.1128/JB.183.15.4571-4579.2001	31	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189066	10.1371/journal.pone.0189066	http://dx.doi.org/10.1371/journal.pone.0189066			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216242	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800064
J	Davies, G; Lobanova, L; Dawicki, W; Groot, G; Gordon, JR; Bowen, M; Harkness, T; Arnason, T				Davies, Gerald; Lobanova, Liubov; Dawicki, Wojciech; Groot, Gary; Gordon, John R.; Bowen, Matthew; Harkness, Troy; Arnason, Terra			Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer	PLOS ONE			English	Article							OVEREXPRESSED P53 PROTEIN; MULTIPLE-DRUG RESISTANCE; INDUCIBLE FACTOR-I; MULTIDRUG-RESISTANCE; DEACETYLASE INHIBITORS; CELL-DEATH; PHOSPHORYLATION; DOXORUBICIN; SERINE-392; PHENOTYPE	Multiple drug resistant (MDR) malignancy remains a predictable and often terminal event in cancer therapy, and affects individuals with many cancer types, regardless of the stage at which they were originally diagnosed or the interval from last treatment. Protein biomarkers of MDR are not globally used for clinical decision-making, but include the overexpression of drug-efflux pumps (ABC transporter family) such as MDR-1 and BCRP, as well as HIF1 alpha, a stress responsive transcription factor found elevated within many MDR tumors. Here, we present the important in vitro discovery that the development of MDR (in breast cancer cells) can be prevented, and that established MDR could be resensitized to therapy, by adjunct treatment with metformin. Metformin is prescribed globally to improve insulin sensitivity, including in those individuals with Type 2 Diabetes Mellitus (DM2). We demonstrate the effectiveness of metformin in resensitizing MDR breast cancer cell lines to their original treatment, and provide evidence that metformin may function through a mechanism involving post-translational histone modifications via an indirect histone deacetylase inhibitor (HDACi) activity. We find that metformin, at low physiological concentrations, reduces the expression of multiple classic protein markers of MDR in vitro and in preliminary in vivo models. Our demonstration that metformin can prevent MDR development and resensitize MDR cells to chemotherapy in vitro, provides important medical relevance towards metformin's potential clinical use against MDR cancers.	[Davies, Gerald; Lobanova, Liubov; Harkness, Troy; Arnason, Terra] Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada; [Dawicki, Wojciech; Gordon, John R.; Bowen, Matthew; Arnason, Terra] Univ Saskatchewan, Dept Med, Saskatoon, SK, Canada; [Groot, Gary] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Arnason, T (corresponding author), Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada.; Arnason, T (corresponding author), Univ Saskatchewan, Dept Med, Saskatoon, SK, Canada.	terra.arnason@usask.ca		Groot, Gary/0000-0002-8307-5125	Canadian Breast Cancer Foundation; Saskatchewan Health Research Foundation; Canadian Foundation for Innovation; Department of Medicine, University of Saskatchewan	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Saskatchewan Health Research Foundation; Canadian Foundation for Innovation(Canada Foundation for Innovation); Department of Medicine, University of Saskatchewan	Funded by Canadian Breast Cancer Foundation (TH and TA), Saskatchewan Health Research Foundation (TH, TA, JRG, GG), Canadian Foundation for Innovation (TH and TA), and Department of Medicine, University of Saskatchewan (TA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnason T, 2015, CANCERS, V7, P2063, DOI 10.3390/cancers7040877; Asensio-Lopez MC, 2014, FREE RADICAL BIO MED, V67, P19, DOI 10.1016/j.freeradbiomed.2013.11.003; Bang S, 2014, MOL ENDOCRINOL, V28, P1186, DOI 10.1210/me.2014-1134; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Binkhathlan Z, 2013, CURR CANCER DRUG TAR, V13, P326, DOI 10.2174/15680096113139990076; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Broxterman HJ, 2009, DRUG RESIST UPDATE, V12, P114, DOI 10.1016/j.drup.2009.07.001; Chan TS, 2017, ONCOTARGETS THER, V10, P347, DOI 10.2147/OTT.S93528; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; Cole AJ, 2015, ENDOCR-RELAT CANCER, V22, pT19, DOI 10.1530/ERC-14-0185; Comerford KM, 2002, CANCER RES, V62, P3387; Cooper AC, 2015, J CANCER RES CLIN, V141, P1523, DOI 10.1007/s00432-015-1909-2; Coyle C, 2016, ANN ONCOL, V27, P2184, DOI 10.1093/annonc/mdw410; Davies GF, 2010, CANCER LETT, V288, P236, DOI 10.1016/j.canlet.2009.07.011; Davies GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084611; Davies GF, 2009, DRUG DES DEV THER, V3, P79; Davies GF, 2005, LEUKEMIA LYMPHOMA, V46, P1199, DOI 10.1080/10428190500102555; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Duo J, 2013, DNA CELL BIOL, V32, P156, DOI 10.1089/dna.2012.1926; (FDA) Food and drug administration, METF HYDR TABL; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Fox EM, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00145; Frid A, 2010, DIABETES CARE, V33, P1291, DOI 10.2337/dc09-1284; Furihata M, 2002, J PATHOL, V197, P82, DOI 10.1002/path.1082; Gandini S, 2014, CANCER PREV RES, V7, P867, DOI 10.1158/1940-6207.CAPR-13-0424; Guo QQ, 2016, MOL MED REP, V13, P2590, DOI 10.3892/mmr.2016.4830; Hadad SM, 2014, CLIN TRANSL ONCOL, V16, P746, DOI 10.1007/s12094-013-1144-8; Hatoum D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/548436; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Katz TA, 2014, ANN MED, V46, P397, DOI 10.3109/07853890.2014.923740; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kim HG, 2011, BRIT J PHARMACOL, V162, P1096, DOI 10.1111/j.1476-5381.2010.01101.x; Kim J, 2017, IUBMB LIFE, V69, P459, DOI 10.1002/iub.1633; Kim J, 2016, ONCOL REP, V35, P2553, DOI 10.3892/or.2016.4675; Laubach JP, 2017, EXPERT REV HEMATOL, V10, P229, DOI 10.1080/17474086.2017.1280388; Lee JO, 2012, J BIOL CHEM, V287, P44121, DOI 10.1074/jbc.M112.361386; Leone A, 2014, CANCER TREAT RES, V159, P355, DOI 10.1007/978-3-642-38007-5_21; Ling SB, 2014, MOL MED REP, V10, P2891, DOI 10.3892/mmr.2014.2614; Long JP, 2016, WORLD J CLIN ONCOL, V7, P122, DOI 10.5306/wjco.v7.i1.122; Loubiere C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05052-2; MA J, 2014, BMC CANCER, V14; Ma SJ, 2016, ONCOTARGET, V7, P66202, DOI 10.18632/oncotarget.11033; Martinez-Outschoorn UE, 2011, CANCER BIOL THER, V12, P924, DOI 10.4161/cbt.12.10.17780; Matsumoto M, 2004, ONCOLOGY-BASEL, V67, P143, DOI 10.1159/000081001; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Montemurro F, 2016, EXPERT REV ANTICANC, V16, P211, DOI 10.1586/14737140.2016.1128327; Mottamal M, 2015, MOLECULES, V20, P3898, DOI 10.3390/molecules20033898; Nounou MI, 2015, BREAST CANCER-BASIC, V9, P17, DOI 10.4137/BCBCR.S29420; Ocana A, 2017, ONCOTARGET, V8, P22218, DOI 10.18632/oncotarget.14731; Patani N, 2014, MOL CELL ENDOCRINOL, V382, P683, DOI 10.1016/j.mce.2013.09.038; Peng M, 2017, CANCER TREAT REV, V54, P24, DOI 10.1016/j.ctrv.2017.01.005; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Samanta D, 2014, P NATL ACAD SCI USA, V111, pE5429, DOI 10.1073/pnas.1421438111; Semenza GL, 2016, BBA-MOL CELL RES, V1863, P382, DOI 10.1016/j.bbamcr.2015.05.036; Semenza GL, 2015, CLIN SCI, V129, P1037, DOI 10.1042/CS20150451; Shen Garry X., 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P106; Soares HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057289; Strober W, 2015, CURR PROTOC IMMUNOL, V111; Sukhai M, 2000, J PHARM PHARM SCI, V3, P268; Tampio M, 2008, TOXICOL LETT, V178, P152, DOI 10.1016/j.toxlet.2008.03.006; Tarrado-Castellarnau M, 2016, ONCOTARGET, V7, P62726, DOI 10.18632/oncotarget.10911; Velez J, 2016, ONCOTARGET, V7, P51435, DOI 10.18632/oncotarget.9843; Wan GX, 2016, ONCOTARGET, V7, P35437, DOI 10.18632/oncotarget.8881; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Westover D, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0275-x; Yang T, 2015, J BREAST CANCER, V18, P264, DOI 10.4048/jbc.2015.18.3.264; Yousef M, 2017, CANCERS, V9, DOI 10.3390/cancers9050045; Zakikhani M, 2010, BREAST CANCER RES TR, V123, P271, DOI 10.1007/s10549-010-0763-9; Zhou G, 2016, CURR MOL MED, V16, P83, DOI 10.2174/1566524016666151222145551; Zhou J, 2009, INT J BIOCHEM CELL B, V41, P2334, DOI 10.1016/j.biocel.2009.06.007; Zhu H, 2013, J BIOL CHEM, V288, P16495, DOI 10.1074/jbc.M112.443580; Zhuang YX, 2011, MOL CANCER RES, V9, P603, DOI 10.1158/1541-7786.MCR-10-0343	72	34	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187191	10.1371/journal.pone.0187191	http://dx.doi.org/10.1371/journal.pone.0187191			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211738	Green Published, Green Submitted, gold			2022-12-27	WOS:000417212200012
J	Hadj-Hammou, J; Loiselle, S; Ophof, D; Thornhill, I				Hadj-Hammou, Jeneen; Loiselle, Steven; Ophof, Daniel; Thornhill, Ian			Getting the full picture: Assessing the complementarity of citizen science and agency monitoring data	PLOS ONE			English	Article							WATER-QUALITY	While the role of citizen science in engaging the public and providing large-scale datasets has been demonstrated, the nature of and potential for this science to supplement environmental monitoring efforts by government agencies has not yet been fully explored. To this end, the present study investigates the complementarity of a citizen science programme to agency monitoring of water quality. The Environment Agency (EA) is the governmental public body responsible for, among other duties, managing and monitoring water quality and water resources in England. FreshWater Watch (FWW) is a global citizen science project that supports community monitoring of freshwater quality. FWW and EA data were assessed for their spatio-temporal complementarity by comparing the geographical and seasonal coverage of nitrate (N-NO3) sampling across the River Thames catchment by the respective campaigns between spring 2013 and winter 2015. The analysis reveals that FWW citizen science-collected data complements EA data by filling in both gaps in the spatial and temporal coverage as well as gaps in waterbody type and size. In addition, partial spatio-temporal overlap in sampling efforts by the two actors is discovered, but EA sampling is found to be more consistent than FWW sampling. Statistical analyses indicate that regardless of broader geographical overlap in sampling effort, FWW sampling sites are associated with a lower stream order and water bodies of smaller surface areas than EA sampling sites. FWW also samples more still-water body sites than the EA. As a possible result of such differences in sampling tendencies, nitrate concentrations, a measure of water quality, are lower for FWW sites than EA sites. These findings strongly indicate that citizen science has clear potential to complement agency monitoring efforts by generating information on freshwater ecosystems that would otherwise be under reported.	[Hadj-Hammou, Jeneen; Loiselle, Steven; Ophof, Daniel; Thornhill, Ian] Earthwatch Inst Europe, Mayfield House, Oxford, England; [Hadj-Hammou, Jeneen] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Loiselle, Steven] Univ Siena, Dept Biotechnol Chem & Pharm, Siena, Italy; [Thornhill, Ian] Bath Spa Univ, CoLA Culture & Environm, Bath, Avon, England	Lancaster University; University of Siena; Bath Spa University	Hadj-Hammou, J (corresponding author), Earthwatch Inst Europe, Mayfield House, Oxford, England.; Hadj-Hammou, J (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster, England.	j.hadj-hammou@lancaster.ac.uk	Loiselle, Steven/ABA-3324-2020	Loiselle, Steven/0000-0001-7414-0389; Thornhill, Ian/0000-0003-3818-1380; Hadj-Hammou, Jeneen/0000-0003-2150-7591	Environmental Change Institute at the University of Oxford	Environmental Change Institute at the University of Oxford	This project was made possible by the long-term partnership between Earthwatch and the Hong Kong and Shanghai Banking Corporation (HSBC), under the HSBC Water Programme (https://www.thewaterhub.org/). The Environmental Change Institute at the University of Oxford (http://www.eci.ox.ac.uk/) also provided funding for an internship programme in conjunction with Earthwatch which enabled this paper to be written. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2016, BIOSCIENCE; [Anonymous], [No title captured]; [Anonymous], 2012, NE379; [Anonymous], 2013, CATCHMENT BASED APPR; Biggs J., 2016, HYDROBIOLOGIA, P1; Biggs J., 2013, WORKSH PROT MAN SMAL; Birch C, 2007, ECOL MODELL; Boakes E, 2016, SCIENTIFIC; Bogardi JJ, 2012, CURR OPIN ENV SUST, V4, P35, DOI 10.1016/j.cosust.2011.12.002; Brabec K, 2004, ASSESS RUN; Bussi G, 2017, SCI TOTAL ENVIRON, V590, P818, DOI 10.1016/j.scitotenv.2017.03.069; Buytaert W., 2016, CITIZEN SCI WATER RE; Carr D, 1992, CARTOGR GEOGR; Castilla EP, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4912-9; Celleri R., 2009, UNDERSTANDING HYDROL; Cereghino R, 2008, HYDROBIOLOGIA; Connors JP, 2012, ANN ASSOC AM GEOGR, V102, P1267, DOI 10.1080/00045608.2011.627058; Conrad C, 2011, ENV MONIT ASSESS; Conrad CT, 2008, ENVIRON MANAGE, V41, P358, DOI 10.1007/s00267-007-9042-x; Couvet D, 2015, ENV DEV; Crooks S, 2001, PHYS CHEM EARTH B; Delaney DG, 2008, BIOL INVASIONS, V10, P117, DOI 10.1007/s10530-007-9114-0; Devictor V, 2010, DIVERS DISTRIB, V16, P354, DOI 10.1111/j.1472-4642.2009.00615.x; Dickinson J, 2010, ANN REV ECOL; Downing J, 2006, LIMNOL OCEANOGR; Ellis PS, 2011, TALANTA, V84, P98, DOI 10.1016/j.talanta.2010.12.028; Environment Agency, WHATS YOUR BACK; Environment Agency, US; European Environment Agency, 2016, EUR FRESHW MON NETW; Ferster C, 2016, INT J DIGIT EARTH; Field SA, 2007, AUSTRAL ECOL, V32, P485, DOI 10.1111/j.1442-9993.2007.01715.x; Galloway A, 2006, WILDL SOC B; Gesser-Edelsburg A, 2016, HLTH COMMUN; Goodchild M.F., 2007, GEOJOURNAL; Haklay M., 2008, IEEE PERVASIVE COMPU; Heijden J, 2012, ENV POLICY GOV; Isaac NJB, 2014, METHODS ECOL EVOL, V5, P1052, DOI 10.1111/2041-210X.12254; Joint Nature Conservation Committee, 2016, COMM STAND MON GUID; Kinchy A, 2015, ENVIRON PLANN C, P1; Kinchy A, 2014, POLIT POWER SOC THEO, V27, P259, DOI 10.1108/S0198-871920140000027017; Kosmala M, 2016, ASSESSING DATA QUALI; Kummu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020578; Lave R., 2012, ENV SOC ADV RES; Ledford S, 2015, HYDROL PROCESS; Lehner B, 2013, HYDROL PROCESS; Lillesand T. M., 2002, P NAT MON C NAT WAT, P1; Loperfido JV, 2010, ENVIRON SCI TECHNOL, V44, P7193, DOI 10.1021/es100164c; Mayfield C, 2001, ADV ENVIRON RES, V5, P385; McGoff E, 2017, SCI TOTAL ENVIRON, V581, P105, DOI 10.1016/j.scitotenv.2016.11.215; Montreuil O, 2010, FRESHW BIOL, VAvailable; Moss B, 2008, SCI TOTAL ENV; Nicholson E, 2002, WATER SCI TECHNOL, V45, P193, DOI 10.2166/wst.2002.0395; Nicolet P, 2004, BIOLOGICAL; Penning-Rowsell E., 1997, LANDSCAPE RES, V22, P5, DOI DOI 10.1080/01426399708706497; Pratt B, 2012, J HAZARD MAT; Rosset V, 2014, J APPL ECOL, V51, P415, DOI 10.1111/1365-2664.12201; Rowney N, 2009, TOXICOL CHEM; Scott AB, 2017, SCI TOTAL ENVIRON, V592, P738, DOI 10.1016/j.scitotenv.2017.01.201; Sharpe T, 2000, ALTERN J; Sheppard S, 2011, 7 INT S WIK; Silvertown J, 2009, TRENDS ECOL EVOL; Snik F, 2014, GEOPHYS RES LETT, V41, P7351, DOI 10.1002/2014GL061462; Steyaert P, 2007, ECOL SOC, V12; Strahler AN, 1957, EOS T AM GEOPHYS UNI; Strickland J.D.H., 1972, PRACTICAL HDB SEWATE, DOI [10.2307/1979241, DOI 10.2307/1979241]; Taboada-Castro MM, ASSESSMENT SEASONAL, V106; Thornhill I, 2016, BIOSCIENCE, V66, P720, DOI 10.1093/biosci/biw089; Tulloch A, 2013, DIVERS; Vorosmarty CJ, 2010, NATURE; Water Framework Directive UKTAG, 2016, UKTAG JAGDAG; Whitelaw G, 2003, MONIT ASSESS; Wiggins Andrea, 2011, SYST SCI HICSS 2011; *WORLD WAT ASS PRO, 2009, 3 UNESCO WORLD WAT A	73	44	44	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188507	10.1371/journal.pone.0188507	http://dx.doi.org/10.1371/journal.pone.0188507			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211752	Green Published, gold			2022-12-27	WOS:000417212200037
J	Ivic, N; Bilokapic, S; Halic, M				Ivic, Nives; Bilokapic, Silvija; Halic, Mario			Preparative two-step purification of recombinant H1.0 linker histone and its domains	PLOS ONE			English	Article							TERMINAL DOMAIN; NUCLEOSOME STRUCTURE; CRYSTAL-STRUCTURE; CHROMATIN; BINDING; DNA; AFFINITY; PHOSPHORYLATION; EXPRESSION; CHAPERONE	H1 linker histones are small basic proteins that have a key role in the formation and maintenance of higher-order chromatin structures. Additionally, many examples have shown that linker histones play an important role in gene regulation, modulated by their various sub-types and posttranslational modifications. Obtaining high amounts of very pure linker histones, especially for efficient antibody production, remains a demanding and challenging procedure. Here we present an easy and fast method to purify human linker histone H1.0 overexpressed in Escherichia coli, as well as its domains: N-terminal/globular domain and C-terminal intrinsically disordered domain. This purification protocol relies on a simple affinity chromatography step followed by cation exchange due to the highly basic properties of histone proteins. Therefore, this protocol can also be applied to other linker histones. Highly pure proteins in amounts sufficient for most biochemical experiments can be obtained. The functional quality of purified H1.0 histone and its domains has been confirmed by pull-down, gel-mobility shift assays and the nuclear import assay.	[Ivic, Nives; Bilokapic, Silvija; Halic, Mario] Univ Munich LMU, Dept Biochem, Gene Ctr, Munich, Germany; [Ivic, Nives] Rudjer Boskovic Inst, Dept Phys Chem, Zagreb, Croatia	University of Munich; Rudjer Boskovic Institute	Bilokapic, S (corresponding author), Univ Munich LMU, Dept Biochem, Gene Ctr, Munich, Germany.	bilokapic@genzentrum.lmu.de	Halic, Mario/X-2163-2018; Bilokapic, Silvija/H-5108-2018	Halic, Mario/0000-0002-0061-7372	Gene Center; BioSysNet; ERC-smallRNAhet [309584]; European Union Seventh Framework Programme [291823]; NEWFELPRO [26]	Gene Center; BioSysNet; ERC-smallRNAhet; European Union Seventh Framework Programme(European Commission); NEWFELPRO	This work was supported by the core funding of Gene Center, BioSysNet, and ERC-smallRNAhet-309584. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7 2007-2013) under grant agreement no 291823 Marie Curie FP7-PEOPLE-2011-COFUND (The new International Fellowship Mobility Programme for Experienced Researchers in Croatia- NEWFELPRO). This article has been prepared as a part of a project "Importins-H1 complex" which has received funding through NEWFELPRO project under grant agreement no 26.; We would like to thank Joseph Bartho for reading the manuscript. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7 2007-2013) under grant agreement no 291823 Marie Curie FP7-PEOPLE-2011-COFUND (The new International Fellowship Mobility Programme for Experienced Researchers in Croatia-NEWFELPRO). This article has been prepared as a part of a project "Structural characterization of importin beta:importin7:H1 complex (Importins-H 1 complex)" which has received funding through NEWFELPRO project under grant agreement no 26.	Bernier M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10152; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Cassany Aurelia, 2008, V464, P181; Caterino TL, 2011, MOL CELL BIOL, V31, P2341, DOI 10.1128/MCB.05145-11; Catez F, 2006, NAT STRUCT MOL BIOL, V13, P305, DOI 10.1038/nsmb1077; GERCHMAN SE, 1994, PROTEIN EXPRES PURIF, V5, P242, DOI 10.1006/prep.1994.1037; Happel N, 2009, CELL CYCLE, V8, P2226, DOI 10.4161/cc.8.14.8982; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Hayashihara K, 2010, MOL BIOTECHNOL, V44, P148, DOI 10.1007/s12033-009-9223-3; Hendzel MJ, 2004, J BIOL CHEM, V279, P20028, DOI 10.1074/jbc.M400070200; Hergeth SP, 2011, J CELL SCI, V124, P1623, DOI 10.1242/jcs.084947; Hondele M, 2011, CURR OPIN STRUC BIOL, V21, P698, DOI 10.1016/j.sbi.2011.10.003; Ivic N, 2016, CROAT CHEM ACTA, V89, DOI 10.5562/cca2806; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; Jakel S, 1999, IMPORTIN HETERODIMER, V18, P2411; Kepert JF, 2005, J BIOL CHEM, V280, P34063, DOI 10.1074/jbc.M507322200; Klinker H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104029; Lee YT, 2015, PROTEIN EXPRES PURIF, V110, P89, DOI 10.1016/j.pep.2015.02.007; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; McGinty RK, 2015, CHEM REV, V115, P2255, DOI 10.1021/cr500373h; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Oberg C, 2012, BIOCHEM BIOPH RES CO, V420, P321, DOI 10.1016/j.bbrc.2012.02.157; Pyo SH, 2001, PROTEIN EXPRES PURIF, V23, P38, DOI 10.1006/prep.2001.1471; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Roque A, 2005, J BIOL CHEM, V280, P32141, DOI 10.1074/jbc.M505636200; Shintomi K, 2005, P NATL ACAD SCI USA, V102, P8210, DOI 10.1073/pnas.0500822102; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Syed SH, 2010, P NATL ACAD SCI USA, V107, P9620, DOI 10.1073/pnas.1000309107; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; Th'ng JPH, 2005, J BIOL CHEM, V280, P27809, DOI 10.1074/jbc.M501627200; Ulrich A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053360; van Holde KE., 1989, SPRINGER SERIES MOL; Vyas P, 2012, J BIOL CHEM, V287, P11778, DOI 10.1074/jbc.M111.312819; Wellman SE, 1997, BIOTECHNOL APPL BIOC, V26, P117; White AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep19122; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Zhou BR, 2013, P NATL ACAD SCI USA, V110, P19390, DOI 10.1073/pnas.1314905110; Zhou BR, 2015, STRUCTURAL MECHANISM, V59, P628	42	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189040	10.1371/journal.pone.0189040	http://dx.doi.org/10.1371/journal.pone.0189040			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206861	Green Published, gold, Green Submitted			2022-12-27	WOS:000417110700040
J	Nozza, S; Cozzi-Lepri, A; Bai, F; Rusconi, S; Gori, A; Cinque, P; Ammassari, A; Caramello, P; Tambussi, G; Monforte, AD; Marchetti, G				Nozza, Silvia; Cozzi-Lepri, Alessandro; Bai, Francesca; Rusconi, Stefano; Gori, Andrea; Cinque, Paola; Ammassari, Adriana; Caramello, Pietro; Tambussi, Giuseppe; Monforte, Antonella D'Arminio; Marchetti, Giulia		Icona Foundation Study Grp	Proportion and factors associated with recent HIV infection in a cohort of patients seen for care in Italy over 1996-2014: Data from the ICONA Foundation Study cohort	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MEN; INITIATION; SEX; INDIVIDUALS; BEHAVIORS; IMPACT; RISK; MSM	In Italy the prevalence of recent HIV infection (RHI) isn't currently monitored. Early diagnosis is crucial to allow introduction of antiretroviral therapy (cART) in the recent phase of infection. We aimed to estimate the proportion and the determinants of RHI among patients enrolled in the ICONA cohort; we explored differences in the median time from HIV diagnosis to cART initiation and in the viro-immunological response between RHI and Less Recent HIV infections (NRHI). We included antiretroviral-naive HIV-positive patients enrolled in the cohort with documented dates of HIV-negative and positive antibodies tests, grouped in RHI (estimated date of seroconversion within 12 months of enrolment) and NRHI. Proportion of RHI and the trend of this proportion by calendar period (1996-2014) were investigated (Chi-square test). Logistic regression analysis was employed to identify factors associated with RHI. The time from seroconversion to cART initiation was compared in RHI and NRHI overall and after stratification by calendar period (survival analysis). We finally explored the time from starting cART to HIV-RNA < 50 copies/mL and to CD4+ gain >= 200 cells/mmc by Cox regression. HIV seroconversion could be estimated for 2608/12,616 patients: 981/2608 (37.6%) were RHI. Proportion of RHI increased in recent calendar periods and was associated with younger age, baseline higher HIV-RNA and CD4+ count. There wasn't difference in the 2-year estimates of cART start between RHI and NRHI, regardless of calendar period. Rates and hazards of virological response were similar in RHI versus NRHI. RHI showed a 1.5-fold higher probability of CD4+ gain, also following adjustment for calendar period and cART regimen, and for age, HCV and smoking; the difference in probability was however attenuated after further controlling for baseline HIV-RNA and CD4+ T-cells. The increased proportion of RHI over time suggests that in recent years in Italy HIV infections are more likely to be detected earlier than before. The similar rates of cART introduction and viro-immunological response in RHI and NRHI probably reflect the efficacy of the modern cART regimens. An improvement of the prevention services is warranted to allow an early cART access, also in the perspective of therapy as prevention.	[Nozza, Silvia; Cinque, Paola; Tambussi, Giuseppe] Ist Sci San Raffaele, Infect Dis Dept, Milan, Italy; [Cozzi-Lepri, Alessandro] UCL Med Sch, Div Populat Hlth, Dept Infect & Populat Hlth, Royal Free Campus, London, England; [Bai, Francesca; Monforte, Antonella D'Arminio; Marchetti, Giulia] Univ Milan, S Paolo Hosp, ASST Santi Paolo & Carlo, Dept Hlth Sci,Clin Infect Dis, Milan, Italy; [Rusconi, Stefano] Univ Milan, DIBIC Luigi Sacco, Clin Infect Dis, Milan, Italy; [Gori, Andrea] Univ Milano Bicocca, San Gerardo Hosp, ASST Monza Brianza, Div Infect Dis, Monza, Italy; [Ammassari, Adriana] INMI Spallanzani Hosp, Clin Infect Dis, Rome, Italy; [Caramello, Pietro] Amedeo di Savoia Hosp, Infect & Trop Dis Unit, Turin, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of London; University College London; University of Milan; University of Milan; Luigi Sacco Hospital; San Gerardo Hospital; University of Milano-Bicocca; IRCCS Lazzaro Spallanzani	Marchetti, G (corresponding author), Univ Milan, S Paolo Hosp, ASST Santi Paolo & Carlo, Dept Hlth Sci,Clin Infect Dis, Milan, Italy.	giulia.marchetti@unimi.it	Cinque, Paola/AAA-1227-2019; Rusconi, Stefano/H-9263-2012; Bai, Francesca/K-4823-2018; Marchetti, Giulia/GPX-7655-2022; NOZZA, SILVIA/AAC-5445-2022; PELLICANO', GIOVANNI FRANCESCO/W-4077-2019; Gori, Andrea/AAC-6078-2022; MARCHETTI, GIULIA CARLA/K-4384-2018	Rusconi, Stefano/0000-0002-0375-9990; PELLICANO', GIOVANNI FRANCESCO/0000-0002-9640-8742; MARCHETTI, GIULIA CARLA/0000-0002-4498-4828; Cinque, Paola/0000-0003-2448-5957; Tambussi, Giuseppe/0000-0002-0604-2960; Ammassari, Adriana/0000-0002-0284-0340	BMS; Gilead; Janssen; MSD; ViiV Italy	BMS(Bristol-Myers Squibb); Gilead(Gilead Sciences); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); MSD; ViiV Italy	Icona Foundation is sponsored by unrestricted grants of BMS, Gilead, Janssen, MSD and ViiV Italy.; Icona Foundation is sponsored by unrestricted grants of BMS, Gilead, Janssen, MSD and ViiV Italy	Aghaizu A, 2016, LANCET HIV, V3, pE431, DOI 10.1016/S2352-3018(16)30037-6; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 2014, 909090 UNAIDS; Blaser N, 2014, AIDS, V28, P1021, DOI 10.1097/QAD.0000000000000135; Cohen M, 2016, CLIN INFECT DIS, V63, P1679, DOI 10.1093/cid/ciw673; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; European Centre for Disease Prevention and Control WHO Regional Office for Europe, 2016, HI AIDS SURV EUR 201; Giuliani M, 2014, EUROSURVEILLANCE, V19, P20969, DOI DOI 10.2807/1560-7917.ES2014.19.47.20969; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; GUNTHARD HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI DOI 10.1001/JAMA.2016.8900; Henn A, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0588-3; Herout S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152910; Janiec J, 2013, EUROSURVEILLANCE, V18, P20644; Karris MY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005315; Laanani M, 2015, CLIN INFECT DIS, V60, P1715, DOI 10.1093/cid/civ171; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Linley L, 2016, MMWR-MORBID MORTAL W, V65, P999, DOI 10.15585/mmwr.mm6537a3; Lodi S, 2016, AIDS, V30, P2659, DOI 10.1097/QAD.0000000000001243; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Mangal TD, 2017, AIDS, V31, P1073, DOI 10.1097/QAD.0000000000001437; Marcellusi A, 2016, CLIN DRUG INVEST, V36, P377, DOI 10.1007/s40261-016-0382-2; Marzel A, 2016, CLIN INFECT DIS, V62, P115, DOI 10.1093/cid/civ732; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Nozza S, 2016, J ANTIMICROB CHEMOTH; Patrick R, 2017, JAIDS-J ACQ IMM DEF, V75, pS397, DOI 10.1097/qai.0000000000001417; Pharris A, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.47.20968; Pines HA, 2017, AIDS BEHAV, V21, P3026, DOI 10.1007/s10461-017-1855-x; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Rosinska M, 2013, AIDS RES HUM RETROV, V29, P805, DOI [10.1089/aid.2012.0314, 10.1089/AID.2012.0314]; Ryom L, 2016, HIV MED, V17, P83, DOI 10.1111/hiv.12322; Sargin F, 2016, INT J INFECT DIS, V48, P52, DOI 10.1016/j.ijid.2016.05.006; Shadaker S, 2017, JAIDS-J ACQ IMM DEF, V75, pS281, DOI [10.1097/QAI.0000000000001403, 10.1097/qai.0000000000001403]; Simmons R., 2016, PLOS ONE, V8, P11, DOI DOI 10.1371/J0URNAL.P0NE.0157179; Soodla P, 2017, HIV MED; Su S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2648923; Thornhill J, 2016, JAIDS-J ACQ IMM DEF, V73, P69, DOI 10.1097/QAI.0000000000001013	37	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189045	10.1371/journal.pone.0189045	http://dx.doi.org/10.1371/journal.pone.0189045			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206853	Green Submitted, Green Published, gold			2022-12-27	WOS:000417110700041
J	van Eldik, W; den Adel, B; Monshouwer-Kloots, J; Salvatori, D; Maas, S; van der Made, I; Creemers, EE; Frank, D; Frey, N; Boontje, N; van der Velden, J; Steendijk, P; Mummery, C; Passier, R; Beqqali, A				van Eldik, Willemijn; den Adel, Brigit; Monshouwer-Kloots, Jantine; Salvatori, Daniela; Maas, Saskia; van der Made, Ingeborg; Creemers, Esther E.; Frank, Derk; Frey, Norbert; Boontje, Nicky; van der Velden, Jolanda; Steendijk, Paul; Mummery, Christine; Passier, Robert; Beqqali, Abdelaziz			Z-disc protein CHAPb induces cardiomyopathy and contractile dysfunction in the postnatal heart	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; INDUCED CARDIAC-HYPERTROPHY; DILATED CARDIOMYOPATHY; VENTRICULAR CONDUCTION; EXPRESSION; ATRIAL; DISRUPTION; FAILURE; MOUSE; CONNEXIN43	Aims The Z-disc is a crucial structure of the sarcomere and is implicated in mechanosensation/ transduction. Dysregulation of Z-disc proteins often result in cardiomyopathy. We have previously shown that the Z-disc protein Cytoskeletal Heart-enriched Actin-associated Protein (CHAP) is essential for cardiac and skeletal muscle development. Furthermore, the CHAP gene has been associated with atrial fibrillation in humans. Here, we studied the misregulated expression of CHAP isoforms in heart disease. Methods and results Mice that underwent transverse aortic constriction and calcineurin transgenic (Tg) mice, both models of experimental heart failure, displayed a significant increase in cardiac expression of fetal isoform CHAPb. To investigate whether increased expression of CHAPb postnatally is sufficient to induce cardiomyopathy, we generated CHAPb Tg mice under the control of the cardiac-specific alpha MHC promoter. CHAPb Tg mice displayed cardiac hypertrophy, interstitial fibrosis and enlargement of the left atrium at three months, which was more pronounced at the age of six months. Hypertrophy and fibrosis were confirmed by evidence of activation of the hypertrophic gene program (Nppa, Nppb, Myh7) and increased collagen expression, respectively. Connexin40 and 43 were downregulated in the left atrium, which was associated with delayed atrioventricular conduction. Tg hearts displayed both systolic and diastolic dysfunction partly caused by impaired sarcomere function evident from a reduced force generating capacity of single cardiomyocytes. This co-incided with activation of the actin signalling pathway leading to the formation of stress fibers. Conclusion This study demonstrated that the fetal isoform CHAPb initiates progression towards cardiac hypertrophy, which is accompanied by delayed atrioventricular conduction and diastolic dysfunction. Moreover, CHAP may be a novel therapeutic target or candidate gene for screening in cardiomyopathies and atrial fibrillation.	[van Eldik, Willemijn; den Adel, Brigit; Monshouwer-Kloots, Jantine; Salvatori, Daniela; Maas, Saskia; Mummery, Christine; Passier, Robert; Beqqali, Abdelaziz] Leiden Univ, Dept Anat & Embryol, Med Ctr, Leiden, Netherlands; [van Eldik, Willemijn] ICIN, Utrecht, Netherlands; [Salvatori, Daniela; Maas, Saskia] Leiden Univ, Med Ctr, Cent Lab Anim Facil, Leiden, Netherlands; [van der Made, Ingeborg; Creemers, Esther E.; Beqqali, Abdelaziz] Acad Med Ctr, Dept Expt Cardiol, Amsterdam, Netherlands; [Frank, Derk; Frey, Norbert] Univ Kiel, Dept Cardiol & Angiol, UKSH, Kiel, Germany; [Boontje, Nicky; van der Velden, Jolanda] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Lab Physiol, Amsterdam, Netherlands; [Steendijk, Paul] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; University of Kiel; Schleswig Holstein University Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Beqqali, A (corresponding author), Leiden Univ, Dept Anat & Embryol, Med Ctr, Leiden, Netherlands.; Beqqali, A (corresponding author), Acad Med Ctr, Dept Expt Cardiol, Amsterdam, Netherlands.	a.beqqali@icloud.com	Frey, Norbert/A-9695-2010; Beqqali, Abdelaziz/F-8568-2013; Steendijk, Paul/ABF-8636-2021; Frey, Norbert/M-7749-2019	Beqqali, Abdelaziz/0000-0003-1390-5821; Steendijk, Paul/0000-0002-8454-4499; Frey, Norbert/0000-0001-7611-378X; van der Velden, Jolanda/0000-0001-5224-5788; Mummery, Christine/0000-0002-4549-6535; Creemers, Esther/0000-0002-9001-3854	Netherlands Heart Foundation [2006B209]; European Community's Sixth Framework Programme [LSHM-CT-2005-018630]	Netherlands Heart Foundation(Netherlands Heart Foundation); European Community's Sixth Framework Programme	This study was supported by the Netherlands Heart Foundation grant 2006B209 (WE), and by European Community's Sixth Framework Programme contract (HeartRepair) LSHM-CT-2005-018630 (AB).	Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Ahuja P, 2007, EXP CELL RES, V313, P1270, DOI 10.1016/j.yexcr.2007.01.009; Arai A, 2002, J BIOL CHEM, V277, P24453, DOI 10.1074/jbc.M202216200; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Bajanca F, 2004, DEV DYNAM, V231, P402, DOI 10.1002/dvdy.20136; Balza RO, 2006, J BIOL CHEM, V281, P6498, DOI 10.1074/jbc.M509487200; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Beqqali A, 2010, J CELL SCI, V123, P1141, DOI 10.1242/jcs.063859; Bevilacqua LM, 2000, J INTERV CARD ELECTR, V4, P459, DOI 10.1023/A:1009800328836; Bierhuizen MFA, 2008, J MOL CELL CARDIOL, V45, P373, DOI 10.1016/j.yjmcc.2008.06.011; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Guerrero PA, 1997, J CLIN INVEST, V99, P1991, DOI 10.1172/JCI119367; Henkens IR, 2007, AM J PHYSIOL-HEART C, V293, pH1300, DOI 10.1152/ajpheart.01359.2006; Ikeda Y, 2009, J BIOL CHEM, V284, P35839, DOI 10.1074/jbc.M109.057273; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Kindermann M, 2008, TRENDS CARDIOVAS MED, V18, P280, DOI 10.1016/j.tcm.2008.12.003; Kirchhoff S, 1998, CURR BIOL, V8, P299, DOI 10.1016/S0960-9822(98)70114-9; Kong SW, 2010, CIRC-CARDIOVASC GENE, V3, P138, DOI 10.1161/CIRCGENETICS.109.904698; Kraja AT, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.117.001778; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; Kuwahara K, 2007, J CLIN INVEST, V117, P1324, DOI 10.1172/JCI31240; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Lubitz SA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006284; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Parlakian A, 2005, CIRCULATION, V112, P2930, DOI 10.1161/CIRCULATIONAHA.105.533778; Perez MV, 2009, AM HEART J, V158, P622, DOI 10.1016/j.ahj.2009.08.002; Phrommintikul A, 2008, AM J PHYSIOL-HEART C, V294, pH1804, DOI 10.1152/ajpheart.01078.2007; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Sah VP, 1999, J CLIN INVEST, V103, P1627, DOI 10.1172/JCI6842; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Thomas SA, 1998, CIRCULATION, V97, P686, DOI 10.1161/01.CIR.97.7.686; van der Velden J, 2011, PFLUG ARCH EUR J PHY, V462, P155, DOI 10.1007/s00424-011-0960-3; van Eldik W, 2011, INT J DEV BIOL, V55, P649, DOI 10.1387/ijdb.103207wv; van Laake LW, 2007, NAT PROTOC, V2, P2551, DOI 10.1038/nprot.2007.371; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; Weeland CJ, 2015, J MOL CELL CARDIOL, V81, P107, DOI 10.1016/j.yjmcc.2015.02.008; Wei L, 2004, FASEB J, V18, P857, DOI 10.1096/fj.03-0664fje; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Zaremba R, 2007, PROTEOM CLIN APPL, V1, P1285, DOI 10.1002/prca.200600891; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200	47	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189139	10.1371/journal.pone.0189139	http://dx.doi.org/10.1371/journal.pone.0189139			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206857	Green Published, gold, Green Submitted			2022-12-27	WOS:000417110700051
J	Zuo, Y; Xie, WF; Pang, Y; Li, TS; Li, QW; Li, YY				Zuo, Yu; Xie, Wenfang; Pang, Yue; Li, Tiesong; Li, Qingwei; Li, Yingying			Bacterial community composition in the gut content of Lampetra japonica revealed by 16S rRNA gene pyrosequencing	PLOS ONE			English	Article							SEA LAMPREY; MICROBIOTA; EVOLUTION; IMMUNITY; DIVERSIFICATION; RECEPTORS; DEAMINASE; RESPONSES; DISEASE; SHAPES	The composition of the bacterial communities in the hindgut contents of Lampetrs japonica was surveyed by Illumina MiSeq of the 16S rRNA gene. An average of 32385 optimized reads was obtained from three samples. The rarefaction curve based on the operational taxonomic units tended to approach the asymptote. The rank abundance curve representing the species richness and evenness was calculated. The composition of microbe in six classification levels was also analyzed. Top 20 members in genera level were displayed as the classification tree. The abundance of microorganisms in different individuals was displayed as the pie charts at the branch nodes in the classification tree. The differences of top 50 genera in abundance between individuals of lamprey are displayed as a heatmap. The pairwise comparison of bacterial taxa abundance revealed that there are no significant differences of gut microbiota between three individuals of lamprey at a given rarefied depth. Also, the gut microbiota derived from L. japonica displays little similarity with other aquatic organism of Vertebrata after UPGMA analysis. The metabolic function of the bacterial communities was predicted through KEGG analysis. This study represents the first analysis of the bacterial community composition in the gut content of L. japonica. The investigation of the gut microbiota associated with L. japonica will broaden our understanding of this unique organism.	[Zuo, Yu; Xie, Wenfang; Pang, Yue; Li, Tiesong; Li, Qingwei; Li, Yingying] Liaoning Normal Univ, Sch Life Sci, Dalian, Peoples R China; [Zuo, Yu; Xie, Wenfang; Pang, Yue; Li, Tiesong; Li, Qingwei; Li, Yingying] Liaoning Normal Univ, Lamprey Res Ctr, Dalian, Peoples R China	Liaoning Normal University; Liaoning Normal University	Li, QW; Li, YY (corresponding author), Liaoning Normal Univ, Sch Life Sci, Dalian, Peoples R China.; Li, QW; Li, YY (corresponding author), Liaoning Normal Univ, Lamprey Res Ctr, Dalian, Peoples R China.	liqw@263.net; liyingying16@163.com	Xie, Wen-Fang/AFM-0704-2022		Natural Science Foundation of China [31500106]; China Postdoctoral Science Foundation [2016M590233]; General Scientific Research Foundation of Liaoning Educational Committee [L201683674]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); General Scientific Research Foundation of Liaoning Educational Committee	The research was supported by the Natural Science Foundation of China (No. 31500106), the China Postdoctoral Science Foundation (No. 2016M590233), and the General Scientific Research Foundation of Liaoning Educational Committee (No. L201683674), all to Yingying Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya CT, 2007, CURR OPIN IMMUNOL, V19, P535, DOI 10.1016/j.coi.2007.08.003; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang CW, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0660-4; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Das S, 2013, P NATL ACAD SCI USA, V110, P6043, DOI 10.1073/pnas.1302500110; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Freese HM, 2011, MICROB ECOL, V62, P882, DOI 10.1007/s00248-011-9886-8; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Ghanbari M, 2013, INTECH, V81, P100; Havenaar R., 1992, SELECTION STRAINS PR, P209, DOI DOI 10.1007/978-94-011-2364-8_9; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Keenan SW, 2013, SCI REP-UK, V3, DOI 10.1038/srep02877; Kim DH, 2007, J APPL MICROBIOL, V102, P1654, DOI 10.1111/j.1365-2672.2006.03185.x; Kuraku S, 2009, JAWLESS FISHES CYCLO; Li H, 2014, AQUACULTURE RES, V46; Li YY, 2016, ANTON LEEUW INT J G, V109, P979, DOI 10.1007/s10482-016-0699-0; McCurley N, 2012, CURR GENOMICS, V13, P86, DOI 10.2174/138920212799860670; Moeller AH, 2016, SCIENCE, V353, P380, DOI 10.1126/science.aaf3951; Nayak SK, 2010, FISH SHELLFISH IMMUN, V29, P2, DOI 10.1016/j.fsi.2010.02.017; Osorio J, 2008, DEV GENES EVOL, V218, P221, DOI 10.1007/s00427-008-0208-1; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Price LB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006462; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sharon G, 2014, CELL METAB, V20, P719, DOI 10.1016/j.cmet.2014.10.016; Sower SA, 2006, GEN COMP ENDOCR, V148, P22, DOI 10.1016/j.ygcen.2005.11.009; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Xiao Y, 2015, MICROB ECOL, V69, P492, DOI 10.1007/s00248-014-0492-4; Yang HL, 2014, DIS AQUAT ORGAN, V111, P119, DOI 10.3354/dao02772	32	14	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188919	10.1371/journal.pone.0188919	http://dx.doi.org/10.1371/journal.pone.0188919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206846	Green Published, gold, Green Submitted			2022-12-27	WOS:000417110700031
J	Colabella, C; Corte, L; Roscini, L; Shapaval, V; Kohler, A; Tafintseva, V; Tascini, C; Cardinali, G				Colabella, Claudia; Corte, Laura; Roscini, Luca; Shapaval, Volha; Kohler, Achim; Tafintseva, Valeria; Tascini, Carlo; Cardinali, Gianluigi			Merging FT-IR and NGS for simultaneous phenotypic and genotypic identification of pathogenic Candida species	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; INTERNAL TRANSCRIBED SPACER; RAPID IDENTIFICATION; RELIABLE IDENTIFICATION; BASIDIOMYCETOUS YEASTS; RIBOSOMAL DNA; BACTERIAL; DIFFERENTIATION; FUNGI; TOOL	The rapid and accurate identification of pathogen yeast species is crucial for clinical diagnosis due to the high level of mortality and morbidity induced, even after antifungal therapy. For this purpose, new rapid, high-throughput and reliable identification methods are required. In this work we described a combined approach based on two high-throughput techniques in order to improve the identification of pathogenic yeast strains. Next Generation Sequencing (NGS) of ITS and D1/D2 LSU marker regions together with FTIR spectroscopy were applied to identify 256 strains belonging to Candida genus isolated in nosocomial environments. Multivariate data analysis (MVA) was carried out on NGS and FT-IR datasets, separately. Strains of Candida albicans, C. parapsilosis, C. glabrata and C. tropicalis, were identified with high-throughput NGS sequencing of ITS and LSU markers and then with FTIR. Inter-and intra-species variability was investigated by consensus principal component analysis (CPCA) which combines high-dimensional data of the two complementary analytical approaches in concatenated PCA blocks normalized to the same weight. The total percentage of correct identification reached around 97.4% for C. albicans and 74% for C. parapsilosis while the other two species showed lower identification rates. Results suggested that the identification success increases with the increasing number of strains actually used in the PLS analysis. The absence of reliable FT-IR libraries in the current scenario is the major limitation in FTIR-based identification of strains, although this metabolomics fingerprint represents a valid and affordable aid to rapid and high-throughput to clinical diagnosis. According to our data, FT-IR libraries should include some tens of certified strains per species, possibly over 50, deriving from diverse sources and collected over an extensive time period. This implies a multidisciplinary effort of specialists working in strain isolation and maintenance, molecular taxonomy, FT-IR technique and chemo-metrics, data management and data basing.	[Colabella, Claudia; Corte, Laura; Roscini, Luca; Cardinali, Gianluigi] Univ Perugia, Dept Pharmaceut Sci Microbiol, Perugia, Italy; [Shapaval, Volha; Kohler, Achim; Tafintseva, Valeria] Norwegian Univ Life Sci, Dept Math Sci & Technol, As, Norway; [Tascini, Carlo] Azienda Osped Colli, Osped Cotugno, Naples, Italy; [Cardinali, Gianluigi] Univ Perugia, Dept Chem Biol & Biotechnol, CEMIN, Perugia, Italy	University of Perugia; Norwegian University of Life Sciences; University of Perugia	Cardinali, G (corresponding author), Univ Perugia, Dept Pharmaceut Sci Microbiol, Perugia, Italy.; Cardinali, G (corresponding author), Univ Perugia, Dept Chem Biol & Biotechnol, CEMIN, Perugia, Italy.	gianluigi.cardinali@unipg.it	Tafintseva, Valeria/Q-9556-2019; Corte, Laura/I-5498-2012; Tascini, Carlo/L-5942-2017; Cardinali, Gianluigi/B-8622-2011	Tafintseva, Valeria/0000-0001-6015-0893; Corte, Laura/0000-0002-4723-7254; Tascini, Carlo/0000-0001-9625-6024; Kohler, Achim/0000-0001-5759-1989; Colabella, Claudia/0000-0002-2156-4150; Cardinali, Gianluigi/0000-0002-4522-7925	Gilead Fellowship Project "Caratterizzazione del biofilm ed efficacia del trattamento con Amfotericina B liposomiale in ceppi filmogeni del gruppo Candida parapsilosis sensu lato"	Gilead Fellowship Project "Caratterizzazione del biofilm ed efficacia del trattamento con Amfotericina B liposomiale in ceppi filmogeni del gruppo Candida parapsilosis sensu lato"	GC, CT and LC received funding for this work by Gilead Fellowship Project "Caratterizzazione del biofilm ed efficacia del trattamento con Amfotericina B liposomiale in ceppi filmogeni del gruppo Candida parapsilosis sensu lato" (URL: http://www.itfellowshipprogram.it).	Adamowicz Sarah J, 2015, Genome, V58, P151, DOI 10.1139/gen-2015-0094; Adt I, 2006, ARCH MICROBIOL, V185, P277, DOI 10.1007/s00203-006-0094-8; Anderssen E, 2006, CHEMOMETR INTELL LAB, V84, P69, DOI 10.1016/j.chemolab.2006.04.021; [Anonymous], STUDIES MYCOLOGY; Antonielli L.V., 2011, OPEN APPL INFORM J, V5, P11, DOI DOI 10.2174/1874136301005010011; Baayen RP, 2001, PHYTOPATHOLOGY, V91, P1037, DOI 10.1094/PHYTO.2001.91.11.1037; Baldrian P, 2013, FUNGAL ECOL, V6, P1, DOI 10.1016/j.funeco.2012.10.002; Buchl NR, 2008, YEAST, V25, P787, DOI 10.1002/yea.1633; Cardinali G, 2001, ANN MICROBIOL, V51, P121; Corte L, 2016, SCI REP-UK, V6, DOI 10.1038/srep26860; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; DEAK T, 1993, J FOOD PROTECT, V56, P777, DOI 10.4315/0362-028X-56.9.777; DOERN GV, 1994, J CLIN MICROBIOL, V32, P1757, DOI 10.1128/JCM.32.7.1757-1762.1994; Druzhinina IS, 2005, FUNGAL GENET BIOL, V42, P813, DOI 10.1016/j.fgb.2005.06.007; Erukhimovitch V, 2005, J PHARMACEUT BIOMED, V37, P1105, DOI 10.1016/j.jpba.2004.08.010; Erukhimovitch V., 2005, J AGR TECHNOL, V1, P145; Essendoubi M, 2005, BBA-GEN SUBJECTS, V1724, P239, DOI 10.1016/j.bbagen.2005.04.019; Essendoubi M, 2007, J MICROBIOL METH, V71, P325, DOI 10.1016/j.mimet.2007.09.018; Fell JW, 2000, INT J SYST EVOL MICR, V50, P1351, DOI 10.1099/00207713-50-3-1351; Fischer G, 2006, J MICROBIOL METH, V64, P63, DOI 10.1016/j.mimet.2005.04.005; Geiser DM, 2007, STUD MYCOL, P1, DOI 10.3114/sim.2007.59.01; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hofstetter V, 2007, MOL PHYLOGENET EVOL, V44, P412, DOI 10.1016/j.ympev.2006.10.016; Howlett BJ, 1997, MICROBIOL RES, V152, P261, DOI 10.1016/S0944-5013(97)80038-9; Irinyi L, 2015, MED MYCOL, V53, P313, DOI 10.1093/mmy/myv008; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kohler A, 2008, BIOMEDICAL VIBRATION, P333; Kohler A, 2007, MODERN CONCEPTS BIOM, P333; Kohler A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118052; Kummerle M, 1998, APPL ENVIRON MICROB, V64, P2207; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; MANTEL N, 1967, CANCER RES, V27, P209; Maquelin K, 2003, J CLIN MICROBIOL, V41, P324, DOI 10.1128/JCM.41.1.324-329.2003; MARTENS H, 1991, J PHARMACEUT BIOMED, V9, P625, DOI 10.1016/0731-7085(91)80188-F; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0; O'Donnell K, 2013, FUNGAL GENET BIOL, V52, P20, DOI 10.1016/j.fgb.2012.12.004; Orsini F, 2000, J MICROBIOL METH, V42, P17, DOI 10.1016/S0167-7012(00)00168-8; Oust A, 2004, FEMS MICROBIOL LETT, V239, P111, DOI 10.1016/j.femsle.2004.08.024; Putignani L, 2011, MOL BIOSYST, V7, P620, DOI 10.1039/c0mb00138d; Sandt C, 2003, J CLIN MICROBIOL, V41, P954, DOI 10.1128/JCM.41.3.954-959.2003; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schoch CL, 2009, SYST BIOL; Schoch CL, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau061; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Scorzetti G, 2002, FEMS YEAST RES, V2, P495, DOI 10.1111/j.1567-1364.2002.tb00117.x; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; Shapaval V, 2013, ANALYST, V138, P4129, DOI 10.1039/c3an00304c; Shapaval V, 2013, J APPL MICROBIOL, V114, P788, DOI 10.1111/jam.12092; Shapaval V, 2010, J BIOPHOTONICS, V3, P512, DOI 10.1002/jbio.201000014; Stielow JB, 2015, PERSOONIA, V35, P242, DOI 10.3767/003158515X689135; Timmins EM, 1998, J CLIN MICROBIOL, V36, P367, DOI 10.1128/JCM.36.2.367-374.1998; Toubas D, 2007, ANAL BIOANAL CHEM, V387, P1729, DOI 10.1007/s00216-006-1005-1; Vu D, STUDIES MYCOLOGY; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Wenning M, 2013, APPL MICROBIOL BIOT, V97, P7111, DOI 10.1007/s00253-013-5087-3; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Zhao HJ, 2004, APPL ENVIRON MICROB, V70, P6619, DOI 10.1128/AEM.70.11.6619-6627.2004; Zimmermann B, 2013, APPL SPECTROSC, V67, P892, DOI 10.1366/12-06723	60	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188104	10.1371/journal.pone.0188104	http://dx.doi.org/10.1371/journal.pone.0188104			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29206226	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000417033200004
J	Ross, MH; Smith, MD; Vicenzino, B				Ross, Megan H.; Smith, Michelle D.; Vicenzino, Bill			Reported selection criteria for adult acquired flatfoot deformity and posterior tibial tendon dysfunction: Are they one and the same? A systematic review	PLOS ONE			English	Review							FLEXOR DIGITORUM LONGUS; RANDOMIZED CONTROLLED-TRIAL; MEDIAL SOFT-TISSUE; TERM-FOLLOW-UP; STAGE-II PTTD; CALCANEAL OSTEOTOMY; FOOT KINEMATICS; LATERAL COLUMN; NONOPERATIVE MANAGEMENT; DISTRACTION ARTHRODESIS	Background Posterior tibial tendon dysfunction (PTTD) and adult acquired flatfoot deformity (AAFD) are used interchangeably, although both suggest quite different pathological processes. Objective To investigate key differences in selection criteria used for inclusion into research studies. Methods An electronic database search was performed from inception to June 2016. All primary research articles with clear inclusion/diagnostic criteria for PTTD or AAFD were included in the review. All criteria were extracted and synthesised into one aggregate list. Frequencies of recurring criteria were calculated and reported for each stage of the conditions. Results Of the potentially eligible papers, 148 (65%) did not specify inclusion/selection criteria for PTTD or AAFD and were excluded. Eligibility criteria were reported 82 times in the 80 included papers, with 69 descriptions for PTTD and 13 for AAFD. After synthesis of criteria from all papers, there were 18 key signs and symptoms. Signs and symptoms were considered to be those relating to tendon pathology and those relating to structural deformity. The total number of individual inclusion/diagnostic criteria ranged from 2 to 9. The majority of articles required signs of both tendon dysfunction and structural deformity (84% for AAFD and 81% for PTTD). Across both groups, the most frequently reported criteria were abduction of the forefoot (11.5% of total criteria used), the presence of a flexible deformity (10.2%) and difficulty performing a single leg heel raise (10.0%). This was largely the case for the PTTD articles, whereas the AAFD articles were more focused on postural issues such as forefoot abduction, medial arch collapse, and hindfoot valgus (each 16.7%). Conclusion As well as synthesising the available literature and providing reporting recommendations, this review has identified that many papers investigating PTTD/AAFD do not state condition-specific selection criteria and that this limits their clinical applicability. Key signs and symptoms of PTTD and AAFD appear similar, except in early PTTD where no structural deformity is present. We recommend that PTTD is the preferred terminology for the condition associated with signs of local tendon dysfunction with pain and/or swelling along the tendon and difficulty with inversion and/or single leg heel raise characterising stage I and difficulty with single leg heel raise and a flexible flatfoot deformity characterizing stage II PTTD. While AAFD may be useful as an umbrella term for acquired flatfoot deformities, the specific associated aetiology should be reported in studies to aid consolidation and implementation of research into practice.	[Ross, Megan H.; Smith, Michelle D.; Vicenzino, Bill] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia	University of Queensland	Vicenzino, B (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia.	b.vicenzino@uq.edu.au	Smith, Michelle D/F-7529-2010; Vicenzino, Bill/A-8492-2011; Ross, Megan H/V-6776-2017	Smith, Michelle D/0000-0002-7860-1581; Vicenzino, Bill/0000-0003-0253-5933; Ross, Megan H/0000-0001-5467-3559				Alvarez RG, 2006, FOOT ANKLE INT, V27, P2, DOI 10.1177/107110070602700102; Arangio G, 2009, FOOT ANKLE INT, V30, P1078, DOI 10.3113/FAI.2009.1078; Arangio GA, 2006, FOOT ANKLE INT, V27, P685, DOI 10.1177/107110070602700905; Arangio GA, 2006, FOOT ANKLE INT, V27, P636, DOI 10.1177/107110070602700813; Arnoldner MA, 2015, EUR J RADIOL, V84, P1777, DOI 10.1016/j.ejrad.2015.05.021; Augustin Jeffrey F, 2003, Foot Ankle Clin, V8, P491, DOI 10.1016/S1083-7515(03)00036-6; Bluman Eric M, 2007, Foot Ankle Clin, V12, P233, DOI 10.1016/j.fcl.2007.03.003; Bolt PM, 2007, FOOT ANKLE INT, V28, P1115, DOI 10.3113/FAI.2007.1115; Brilhault J, 2012, FOOT ANKLE INT, V33, P813, DOI 10.3113/FAI.2012.0813; Brodsky JW, 2009, FOOT ANKLE INT, V30, P613, DOI 10.3113/FAI.2009.0613; Brodsky JW, 2004, FOOT ANKLE INT, V25, P96, DOI 10.1177/107110070402500210; Bubra Preet Singh, 2015, J Family Med Prim Care, V4, P26, DOI 10.4103/2249-4863.152245; Bulstra Gythe H, 2006, Foot Ankle Clin, V11, P421, DOI 10.1016/j.fcl.2006.03.001; Chadwick C, 2015, BONE JOINT J, V97B, P346, DOI 10.1302/0301-620X.97B3.34386; Chao W, 1996, FOOT ANKLE INT, V17, P736, DOI 10.1177/107110079601701204; Chen YJ, 1997, J ULTRAS MED, V16, P417; Chimenti RL, 2014, J ORTHOP SPORT PHYS, V44, P283, DOI 10.2519/jospt.2014.4939; Chow HT, 2005, KNEE SURG SPORT TR A, V13, P695, DOI 10.1007/s00167-005-0635-8; Conti SF, 2002, FOOT ANKLE INT, V23, P521, DOI 10.1177/107110070202300609; Cook JL, 2009, BRIT J SPORT MED, V43, P409, DOI 10.1136/bjsm.2008.051193; Cooper AJ, 2007, FOOT ANKLE INT, V28, P1124, DOI 10.3113/FAI.2007.1124; Crates JM, 1999, CLIN ORTHOP RELAT R, P46; Deland JT, 2008, J AM ACAD ORTHOP SUR, V16, P399, DOI 10.5435/00124635-200807000-00005; Deland JT, 2005, FOOT ANKLE INT, V26, P427, DOI 10.1177/107110070502600601; DiDomenico L, 2011, J FOOT ANKLE SURG, V50, P293, DOI 10.1053/j.jfas.2010.12.011; Fayazi AH, 2002, FOOT ANKLE INT, V23, P1107, DOI 10.1177/107110070202301205; FUNK DA, 1986, J BONE JOINT SURG AM, V68A, P95, DOI 10.2106/00004623-198668010-00012; Giorgini R, 2010, J FOOT ANKLE SURG, V49, P411, DOI 10.1053/j.jfas.2010.06.012; Giza Eric, 2007, Foot Ankle Clin, V12, P251, DOI 10.1016/j.fcl.2007.03.008; Greisberg J, 2005, CLIN ORTHOP RELAT R, P197, DOI 10.1097/01.blo.0000157658.17056.46; Greisberg J, 2003, FOOT ANKLE INT, V24, P530, DOI 10.1177/107110070302400704; Groshar D, 1997, J NUCL MED, V38, P247; Harper MC, 1999, CLIN ORTHOP RELAT R, P65; Henceroth W D 2nd, 1982, Foot Ankle, V2, P304; Hintermann B, 1999, FOOT ANKLE INT, V20, P622, DOI 10.1177/107110079902001002; HOLMES GB, 1992, FOOT ANKLE, V13, P70, DOI 10.1177/107110079201300204; Houck J, 2015, FOOT ANKLE INT, V36, P1006, DOI 10.1177/1071100715579906; Houck J, 2009, J ORTHOP SPORT PHYS, V39, P593, DOI 10.2519/jospt.2009.3040; Houck JR, 2008, FOOT ANKLE INT, V29, P895, DOI 10.3113/FAI.2008.0895; Houck JR, 2009, FOOT ANKLE INT, V30, P530, DOI 10.3113/FAI.2009.0530; Hsu TC, 1997, FOOT ANKLE INT, V18, P34, DOI 10.1177/107110079701800107; Hua YH, 2015, KNEE SURG SPORT TR A, V23, P879, DOI 10.1007/s00167-013-2629-2; Imai K, 2011, J ORTHOP SCI, V16, P638, DOI 10.1007/s00776-011-0103-x; Jeng CL, 2011, FOOT ANKLE INT, V32, P21, DOI 10.3113/FAI.2011.0021; JOHNSON KA, 1983, CLIN ORTHOP RELAT R, P140; JOHNSON KA, 1989, CLIN ORTHOP RELAT R, P196, DOI 10.1097/00003086-198902000-00022; Kang S, 2013, FOOT ANKLE INT, V34, P392, DOI 10.1177/1071100712465738; Kitaoka HB, 1997, CLIN ORTHOP RELAT R, P187; Knupp M, 2007, FOOT ANKLE INT, V28, P416, DOI 10.3113/FAI.2007.0416; Kohls-Gatzoulis J, 2009, Foot Ankle Surg, V15, P75, DOI 10.1016/j.fas.2008.08.003; Kohls-Gatzoulis J, 2004, BMJ-BRIT MED J, V329, P1328, DOI 10.1136/bmj.329.7478.1328; Kohls-Gatzoulis J., 2004, FOOT, V14, P207, DOI [10.1016/j.foot.2004.06.003, DOI 10.1016/J.FOOT.2004.06.003]; Kou JX, 2012, FOOT ANKLE INT, V33, P602, DOI [10.3113/FAI.2012.0602, 10.3113/FAI.2012.0001]; Krause F, 2008, FOOT ANKLE INT, V29, P1095, DOI 10.3113/FAI.2008.1095; Kulig K, 2015, FOOT ANKLE INT, V36, P83, DOI 10.1177/1071100714551020; Kulig K, 2011, J ORTHOP SPORT PHYS, V41, P687, DOI 10.2519/jospt.2011.3427; Kulig K, 2009, FOOT ANKLE INT, V30, P877, DOI 10.3113/FAI.2009.0877; Kulig K, 2009, PHYS THER, V89, P26, DOI 10.2522/ptj.20070242; LANGENSK.A, 1967, ACTA ORTHOP SCAND, V38, P301, DOI 10.3109/17453676708989643; Lee Michael S, 2005, J Foot Ankle Surg, V44, P78, DOI 10.1053/j.jfas.2004.12.001; Lim PS, 1997, FOOT ANKLE INT, V18, P658, DOI 10.1177/107110079701801011; Lin YC, 2015, AM J ROENTGENOL, V204, P354, DOI 10.2214/AJR.14.12645; MANN RA, 1985, J BONE JOINT SURG AM, V67A, P556, DOI 10.2106/00004623-198567040-00009; Migues A., 2007, FOOT ANKLE SURG, V13, P167; Myerson MS, 2004, FOOT ANKLE INT, V25, P445, DOI 10.1177/107110070402500701; Myerson MS, 1996, J BONE JOINT SURG AM, V78A, P780, DOI 10.2106/00004623-199605000-00020; Nair P, 2015, CURR ORTHOP PRACT, V26, P160, DOI 10.1097/BCO.0000000000000215; Needleman RL, 2006, FOOT ANKLE INT, V27, P9, DOI 10.1177/107110070602700103; Neville C, 2007, J ORTHOP SPORT PHYS, V37, P661, DOI 10.2519/jospt.2007.2539; Neville C, 2016, J ORTHOP SPORT PHYS, V46, P26, DOI 10.2519/jospt.2016.5618; Neville C, 2013, FOOT ANKLE INT, V34, P131, DOI 10.1177/1071100712460181; Neville C, 2012, FOOT ANKLE INT, V33, P406, DOI 10.3113/FAI.2012.0406; Neville C, 2010, FOOT ANKLE INT, V31, P320, DOI 10.3113/FAI.2010.0320; Neville C, 2009, J ORTHOP SPORT PHYS, V39, P201, DOI 10.2519/jospt.2009.2908; Niki H, 2012, FOOT ANKLE INT, V33, P940, DOI 10.3113/FAI.2012.0940; Parsons S, 2010, CLIN ORTHOP RELAT R, V468, P1025, DOI 10.1007/s11999-009-1122-1; Perry MB, 2003, CLIN ORTHOP RELAT R, P225, DOI 10.1097/01.blo.0000053344.97749.ef; Pinney SJ, 2006, FOOT ANKLE INT, V27, P66, DOI 10.1177/107110070602700113; Rabbito M, 2011, J ORTHOP SPORT PHYS, V41, P776, DOI 10.2519/jospt.2011.3545; Rosenfeld PF, 2005, FOOT ANKLE INT, V26, P671, DOI 10.1177/107110070502600902; Sanhudo Jose Antonio Veiga, 2014, Foot Ankle Spec, V7, P119, DOI 10.1177/1938640014522096; Satomi E, 2008, CLINICS, V63, P9, DOI 10.1590/S1807-59322008000100003; Sharma P, 2003, FOOT, V13, P1; Silva MGAN, 2015, FOOT ANKLE INT, V36, P165, DOI 10.1177/1071100714556758; Spratley EM, 2014, ANN BIOMED ENG, V42, P1913, DOI 10.1007/s10439-014-1048-y; Stroud C, 2000, PEDIATRIC GAIT: A NEW MILLENNIUM IN CLINICAL CARE AND MOTION ANALYSIS TECHNOLOGY, P173, DOI 10.1109/PG.2000.858891; TEASDALL RD, 1994, FOOT ANKLE INT, V15, P646, DOI 10.1177/107110079401501203; Thomas RL, 2001, FOOT ANKLE INT, V22, P107, DOI 10.1177/107110070102200205; Tome J, 2006, J ORTHOP SPORT PHYS, V36, P968; Toolan BC, 1999, J BONE JOINT SURG AM, V81A, P1545, DOI 10.2106/00004623-199911000-00006; Valderrabano V, 2004, FOOT ANKLE INT, V25, P85, DOI 10.1177/107110070402500209; Viladot R, 2003, FOOT ANKLE INT, V24, P600, DOI 10.1177/107110070302400806; Wacker J, 2003, FOOT ANKLE INT, V24, P354, DOI 10.1177/107110070302400409; Wacker JT, 2002, J BONE JOINT SURG BR, V84B, P54, DOI 10.1302/0301-620X.84B1.11847; Weil L S Jr, 1998, J Foot Ankle Surg, V37, P467; Wukich DK, 2008, FOOT ANKLE INT, V29, P730, DOI 10.3113/FAI.2008.0730; Yoshioka N, 2016, J ORTHOP SCI, V21, P154, DOI 10.1016/j.jos.2015.12.001	97	13	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0187201	10.1371/journal.pone.0187201	http://dx.doi.org/10.1371/journal.pone.0187201			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194449	Green Submitted, gold, Green Published			2022-12-27	WOS:000416867800005
J	Kuin, NC; Masthoff, EDM; Munafo, MR; Penton-Voak, IS				Kuin, Niki C.; Masthoff, Erik D. M.; Munafo, Marcus R.; Penton-Voak, Ian S.			Perceiving the evil eye: Investigating hostile interpretation of ambiguous facial emotional expression in violent and non-violent offenders	PLOS ONE			English	Article							INFORMATION-PROCESSING MECHANISMS; AGGRESSIVE-BEHAVIOR; PROACTIVE AGGRESSION; ATTRIBUTIONAL BIAS; PSYCHOPATHY; RECOGNITION; ANGER; PERCEPTION; QUESTIONNAIRE; DISORDER	Research into the causal and perpetuating factors influencing aggression has partly focused on the general tendency of aggression-prone individuals to infer hostile intent in others, even in ambiguous circumstances. This is referred to as the 'hostile interpretation bias'. Whether this hostile interpretation bias also exists in basal information processing, such as perception of facial emotion, is not yet known, especially with respect to the perception of ambiguous expressions. In addition, little is known about how this potential bias in facial emotion perception is related to specific characteristics of aggression. In the present study, conducted in a penitentiary setting with detained male adults, we investigated if violent offenders (n = 71) show a stronger tendency to interpret ambiguous facial expressions on a computer task as angry rather than happy, compared to non-violent offenders (n = 14) and to a control group of healthy volunteers (n = 32). We also investigated if hostile perception of facial expressions is related to specific characteristics of aggression, such as proactive and reactive aggression. No clear statistical evidence was found that violent offenders perceived facial emotional expressions as more angry than non-violent offenders or healthy volunteers. A regression analysis in the violent offender group showed that only age and a self-report measure of hostility predicted outcome on the emotion perception task. Other traits, such as psychopathic traits, intelligence, attention and a tendency to jump to conclusions were not associated with interpretation of anger in facial emotional expressions. We discuss the possible impact of the study design and population studied on our results, as well as implications for future studies.	[Kuin, Niki C.; Masthoff, Erik D. M.] Penitentiary Inst Vught, Vught, Netherlands; [Munafo, Marcus R.; Penton-Voak, Ian S.] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England; [Munafo, Marcus R.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England	University of Bristol; University of Bristol	Kuin, NC (corresponding author), Penitentiary Inst Vught, Vught, Netherlands.	n.kuin@dji.minjus.nl	Munafo, Marcus/AAE-2306-2020	Munafo, Marcus/0000-0002-4049-993X; Penton-Voak, Ian/0000-0003-4232-0953	British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research, under the UK Clinical Research Collaboration; Medical Research Council [MC_UU_12013/6] Funding Source: researchfish; MRC [MC_UU_12013/6] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research, under the UK Clinical Research Collaboration; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors received no specific funding for this work. MRM is a member of the UK Centre for Tobacco and Alcohol Studies, a UKCRC Public Health Research: Centre of Excellence. Funding from British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. These funders had no role in any aspect of the present study.	Auty KM, 2015, EUR J CRIMINOL, V12, P562, DOI 10.1177/1477370815578198; Bailey CA, 2008, J YOUTH ADOLESCENCE, V37, P713, DOI 10.1007/s10964-007-9211-5; Bogaerts S, 2013, INT J OFFENDER THER, V57, P544, DOI 10.1177/0306624X12442825; Bouma A, 2012, HDB NEUROPSYCHOLOGIS; Brazil IA, 2009, BIOL PSYCHIAT, V65, P137, DOI 10.1016/j.biopsych.2008.08.011; Burt SA, 2009, AGGRESSIVE BEHAV, V35, P453, DOI 10.1002/ab.20324; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Cadesky EB, 2000, J AM ACAD CHILD PSY, V39, P1160, DOI 10.1097/00004583-200009000-00016; Carstensen LL, 2003, MOTIV EMOTION, V27, P103, DOI 10.1023/A:1024569803230; Chen P, 2012, AGGRESSIVE BEHAV, V38, P47, DOI 10.1002/ab.21407; Cima M, 2013, AGGRESSIVE BEHAV, V39, P99, DOI 10.1002/ab.21458; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Crick NR, 1996, CHILD DEV, V67, P993, DOI 10.1111/j.1467-8624.1996.tb01778.x; Dadds MR, 2006, BRIT J PSYCHIAT, V189, P280, DOI 10.1192/bjp.bp.105.018150; de Castro BO, 2002, CHILD DEV, V73, P916, DOI 10.1111/1467-8624.00447; DODGE KA, 1987, J PERS SOC PSYCHOL, V53, P1146, DOI 10.1037/0022-3514.53.6.1146; Dodge KA, 2006, DEV PSYCHOPATHOL, V18, P791, DOI 10.1017/S0954579406060391; Eisenbarth H, 2008, PSYCHIAT RES, V159, P189, DOI 10.1016/j.psychres.2007.09.001; Fellows RP, 2017, CLIN NEUROPSYCHOL, V31, P154, DOI 10.1080/13854046.2016.1238510; Geurts DEM, 2016, SOC COGN AFFECT NEUR, V11, P1326, DOI 10.1093/scan/nsw040; Ghaddar A, 2011, STRESS HEALTH, V27, P170, DOI 10.1002/smi.1322; Gillespie SM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00595; Hall CW, 2006, J PSYCHOL, V140, P255, DOI 10.3200/JRLP.140.3.255-267; Hornsveld RHJ, 2009, DRIE ZELFRAPPORTAGE; HUQ SF, 1988, Q J EXP PSYCHOL-A, V40, P801, DOI 10.1080/14640748808402300; Jusyte A, 2017, EUR ARCH PSY CLIN N, V267, P257, DOI 10.1007/s00406-016-0727-0; Knyazev GG, 2009, AGGRESSIVE BEHAV, V35, P502, DOI 10.1002/ab.20318; Kobes MHBM, 2012, ARCH PSYCHIAT NURS, V26, P487, DOI 10.1016/j.apnu.2012.04.004; Kret ME, 2013, EXP BRAIN RES, V228, P399, DOI 10.1007/s00221-013-3557-6; Kuin NC, 2016, J FORENSIC PSYCHOL, V01; Kunst MJJ, 2009, STRESS HEALTH, V25, P387, DOI 10.1002/smi.1247; Kuyck WGE, 2013, INT J FORENSIC MENT, V12, P172, DOI 10.1080/14999013.2013.819396; Lilienfeld S.O., 2005, PROFESSIONAL MANUAL; Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003; Marshall AD, 2011, J PSYCHOL, V145, P521, DOI 10.1080/00223980.2011.599822; Mather M, 2003, PSYCHOL SCI, V14, P409, DOI 10.1111/1467-9280.01455; Mellentin AI, 2015, AGGRESS VIOLENT BEH, V25, P373, DOI 10.1016/j.avb.2015.09.001; Miller JD, 2012, PERSONAL DISORD, V3, P305, DOI 10.1037/a0024567; Munro GES, 2007, BIOL PSYCHOL, V76, P31, DOI 10.1016/j.biopsycho.2007.05.004; Munro GES, 2007, NEUROSCI LETT, V418, P149, DOI 10.1016/j.neulet.2007.03.017; NASBY W, 1980, J ABNORM PSYCHOL, V89, P459, DOI 10.1037/0021-843X.89.3.459; Ohrmann P, 2010, DEPRESS ANXIETY, V27, P1034, DOI 10.1002/da.20721; Partington JE., 1949, PSYCHOL SERVICE CTR, V168, P111; Penton-Voak IS, 2013, PSYCHOL SCI, V24, P688, DOI 10.1177/0956797612459657; Putman P, 2004, EMOTION, V4, P305, DOI 10.1037/1528-3542.4.3.305; Raine A, 2006, AGGRESSIVE BEHAV, V32, P159, DOI 10.1002/ab.20115; Raine A, 1998, BEHAV SCI LAW, V16, P319, DOI 10.1002/(SICI)1099-0798(199822)16:3<319::AID-BSL311>3.0.CO;2-G; Raven J., 2000, RAVEN MANUAL; Ross RM, 2016, COGN NEUROPSYCHIATRY, V21, P300, DOI 10.1080/13546805.2016.1192025; Ruffman T, 2008, NEUROSCI BIOBEHAV R, V32, P863, DOI 10.1016/j.neubiorev.2008.01.001; Schonenberg M, 2014, PSYCHOL MED, V44, P1043, DOI 10.1017/S0033291713001517; Schonenberg M, 2014, EUR ARCH PSY CLIN N, V264, P61, DOI 10.1007/s00406-013-0440-1; Schwenck C, 2014, EUR CHILD ADOLES PSY, V23, P13, DOI 10.1007/s00787-013-0416-8; SERIN RC, 1991, J INTERPERS VIOLENCE, V6, P423, DOI 10.1177/088626091006004002; Smeijers D, BEHAV THERAPY UNPUB; Smeijers D, AGGRESSIVE IN PRESS, V9999, P1; Stanford MS, 2003, ASSESSMENT, V10, P183, DOI 10.1177/1073191103010002009; Stoddard J, 2016, J CHILD ADOL PSYCHOP, V26, P49, DOI 10.1089/cap.2015.0100; Verhage F., 1964, INTELLIGENTIE LEEFTI; Vitale JE, 2005, AGGRESSIVE BEHAV, V31, P99, DOI 10.1002/ab.20050; Wegrzyn Martin, 2017, BMC Psychol, V5, P16, DOI 10.1186/s40359-017-0186-z; Wilkowski BM, 2007, J RES PERS, V41, P650, DOI 10.1016/j.jrp.2006.07.003; Wilkowski BM, 2012, PERS SOC PSYCHOL B, V38, P540, DOI 10.1177/0146167211430233; WISTEDT B, 1990, PHARMACOPSYCHIATRY, V23, P249, DOI 10.1055/s-2007-1014514	64	5	6	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0187080	10.1371/journal.pone.0187080	http://dx.doi.org/10.1371/journal.pone.0187080			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190802	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900013
J	Mundre, RS; Koka, P; Dhanaraj, P; Khatri, N; Vig, S; Chandramohan, Y; Dhanasekaran, A				Mundre, Reddy Sailaja; Koka, Pavani; Dhanaraj, Prakash; Khatri, Nitin; Vig, Sanjana; Chandramohan, Yamini; Dhanasekaran, Anuradha			Synergistic role of 5-azacytidine and ascorbic acid in directing cardiosphere derived cells to cardiomyocytes in vitro by downregulating Wnt signaling pathway via phosphorylation of beta-catenin	PLOS ONE			English	Article							CARDIAC STEM-CELLS; PROGENITOR CELLS; DIFFERENTIATION; HEART; TRANSPLANTATION; MULTIPLE; POTENCY; AXIN	Background Cardiosphere derived cells (CDCs) represent a valuable source in stem cell based therapy for cardiovascular diseases, yet poor differentiation rate hinders the transplantation efficiency. The aim of this study is to check the ability of 5-Azacytidine (Aza) alone and in combination with ascorbic acid (Aza+AA) in delineating CDCs to cardiomyogenesis and the underlying Wnt signaling mechanism in induced differentiation. Methods CDCs were treated with Aza and Aza+AA for a period of 14 days to examine the expression of cardiac specific markers and Wnt downstream regulators by immunofluorescence, real time PCR and western blot. Results Results revealed that Aza+AA induced efficient commitment of CDCs to cardiomyogenic lineage. Immunofluorescence analysis showed significant augment for Nkx 2.5, GATA 4 and a-Sarcomeric actinin markers in Aza+AA group than control group (p = 0.0118, p = 0.009 and p = 0.0091, respectively). Relative upregulation of cardiac markers, Nkx 2.5 (p = 0.0156), GATA 4 (p = 0.0087) and down regulation of Wnt markers, beta-catenin (p = 0.0107) and Cyclin D1 (p = 0. 0116) in Aza+AA group was revealed by RNA expression analysis. Moreover, the Aza+AA induced prominent expression of GATA 4, a-Sarcomeric actinin and phospho beta-catenin while non phospho beta-catenin and Cyclin D1 expression was significantly suppressed as displayed in protein expression analysis. Generation of spontaneous beating in Aza+AA treated CDCs further reinforced that Aza+AA accelerates the cardiomyogenic potential of CDCs. Conclusion Combined treatment of Aza along with AA implicit in inducing cardiomyogenic potential of CDCs and is associated with down regulating Wnt signaling pathway. Altogether, CDCs represent a valuable tool for the treatment of cardiovascular disorders.	[Mundre, Reddy Sailaja; Koka, Pavani; Dhanaraj, Prakash; Khatri, Nitin; Vig, Sanjana; Chandramohan, Yamini; Dhanasekaran, Anuradha] Anna Univ, Ctr Biotechnol, Madras, Tamil Nadu, India	Anna University; Anna University Chennai	Dhanasekaran, A (corresponding author), Anna Univ, Ctr Biotechnol, Madras, Tamil Nadu, India.	anu@annauniv.edu	Dhanasekaran, Anuradha/AAF-3160-2022; Dhanasekaran, Anuradha/AFH-8265-2022	Vig, Sanjana/0000-0001-7939-6500; Dhanasekaran, Anuradha/0000-0002-0195-9681	Department of Science and Technology, New Delhi, India under DST-INSPIRE Fellowship [DST/INSPIRE Fellowship/2012/143]; MHRDCEMA [5-3/2015-TS VII]; BUILDER [BT/PR12153/INF/22/200/2014]	Department of Science and Technology, New Delhi, India under DST-INSPIRE Fellowship(Department of Science & Technology (India)); MHRDCEMA; BUILDER	The authors are thankful to Department of Science and Technology, New Delhi, India for the financial support under DST-INSPIRE Fellowship (No: DST/INSPIRE Fellowship/2012/143) granted to RSM. We acknowledge the financial support from MHRDCEMA F.NO-5-3/2015-TS VII and BUILDER program BT/PR12153/INF/22/200/2014 to AD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Anton R, 2007, FEBS LETT, V581, P5247, DOI 10.1016/j.febslet.2007.10.012; Antonitsis Polychronis, 2007, Interact Cardiovasc Thorac Surg, V6, P593, DOI 10.1510/icvts.2007.157875; Arminan A, 2009, STEM CELLS DEV, V18, P907, DOI 10.1089/scd.2008.0292; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann MW, 2010, CIRC RES, V107, P1198, DOI 10.1161/CIRCRESAHA.110.223768; Bonios M, 2011, J AM SOC ECHOCARDIOG, V24, P808, DOI 10.1016/j.echo.2011.03.003; Cao N, 2012, CELL RES, V22, P219, DOI 10.1038/cr.2011.195; Cheng K, 2014, JACC-HEART FAIL, V2, P49, DOI 10.1016/j.jchf.2013.08.008; Choi KM, 2008, J BIOSCI BIOENG, V105, P586, DOI 10.1263/jbb.105.586; Chung TL, 2010, STEM CELLS, V28, P1848, DOI 10.1002/stem.493; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; Davis DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007195; Dhanasekaran A, 2008, AM J PHYSIOL-HEART C, V294, pH724, DOI 10.1152/ajpheart.00979.2007; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Gao Q, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/162024; HAAF T, 1995, PHARMACOL THERAPEUT, V65, P19, DOI 10.1016/0163-7258(94)00053-6; Hoyos I, 2016, PLOS ONE, V11; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Li TS, 2010, STEM CELLS, V28, P2088, DOI 10.1002/stem.532; Liu ZQ, 2009, BBA-MOL CELL RES, V1793, P300, DOI 10.1016/j.bbamcr.2008.08.013; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Mishra R, 2011, CIRCULATION, V123, P364, DOI 10.1161/CIRCULATIONAHA.110.971622; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Oyama T, 2007, J CELL BIOL, V176, P329, DOI 10.1083/jcb.200603014; Parvin AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107453; Qian Q, 2012, STEM CELLS DEV, V21, P67, DOI 10.1089/scd.2010.0519; Riazi AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005698; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Tan JJ, 2011, CURR PROTOC STEM C C, V2C; Tateishi K, 2007, BIOCHEM BIOPH RES CO, V352, P635, DOI 10.1016/j.bbrc.2006.11.096; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; van Vliet P, 2008, NETH HEART J, V16, P163, DOI 10.1007/BF03086138; Weiser B, 2009, CELLS TISSUES ORGANS, V189, P373, DOI 10.1159/000154270; Zakharova L, 2010, CARDIOVASC RES, V87, P40, DOI 10.1093/cvr/cvq027; Zelarayan LC, 2008, P NATL ACAD SCI USA, V105, P19762, DOI 10.1073/pnas.0808393105; Zhang Yihua, 2009, Interact Cardiovasc Thorac Surg, V9, P943, DOI 10.1510/icvts.2009.211490	47	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188805	10.1371/journal.pone.0188805	http://dx.doi.org/10.1371/journal.pone.0188805			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190771	Green Submitted, Green Published, gold			2022-12-27	WOS:000416841900130
J	Hueber, S; Kuehlein, T; Gerlach, R; Tauscher, M; Schedlbauer, A				Hueber, Susann; Kuehlein, Thomas; Gerlach, Roman; Tauscher, Martin; Schedlbauer, Angela			"What they see is what you get": Prescribing antibiotics for respiratory tract infections in primary care: Do high prescribers diagnose differently? An analysis of German routine data	PLOS ONE			English	Article							GENERAL-PRACTITIONERS; EUROPE; INDEX; RATES	Background Characteristics of high and low prescribers of antibiotics in German primary care were analysed using population data. We aimed to evaluate differences in prescribing rates and factors being associated with high prescribing, and whether high prescribers made the diagnosis of perceived bacterial infections more often. Methods Routine data were provided by the Bavarian Association of Statutory Health Insurance Physicians. Routine data are delivered by primary care practices on a quarterly basis. We analysed data from 2011 and 2012. Patients older than 15 years with respiratory tract infections consulting a primary care physician were selected (6.647 primary care practices). Patient and physician characteristics associated with high prescribing were identified using stepwise logistic regression. Results Mean prescribing rate of antibiotics was 24.9%. Prescribing rate for high prescribers was 43.5% compared to 8.5% for low prescribers. High prescribers made the diagnosis of perceived bacterial infections more often (Mhigh = 64.5%, Mlow = 45.2%). In the adjusted regression model, perceived bacterial infections were strongly associated with high prescribing (OR = 13.9, 95% CI [10.2, 18.8]). Treating patients with comorbidities was associated with lower prescribing of antibiotics (OR = 0.6, 95% CI [0.4, 0.8]). High prescribers had a higher practice volume, a higher degree of prescribing dominance, and were situated more often in deprived areas and in rural settings. Interpretation Compared to findings of studies in other European countries, prescribing rates were low. There was a considerable difference between prescribing rates of high and low prescribers. Diagnostic labelling was the best predictor for high prescribing. Current guidelines recommend considering antibiotic treatment for patients with co-morbidities. In our study, treating a large number of high-risk patients was not associated with high prescribing.	[Hueber, Susann; Kuehlein, Thomas; Schedlbauer, Angela] Univ Klinikum Erlangen, Erlangen, Germany; [Gerlach, Roman; Tauscher, Martin] Kassenarztl Vereinigung Bayern, Munich, Germany	University of Erlangen Nuremberg	Hueber, S (corresponding author), Univ Klinikum Erlangen, Erlangen, Germany.	susann.hueber@uk-erlangen.de	Hueber, Susann/U-9754-2018	Hueber, Susann/0000-0003-0844-0919				Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P3, DOI 10.1093/jac/dkr453; [Anonymous], 2005, ICPC 2 R INT CLASSIF; Aspinall SL, 2009, AM J EMERG MED, V27, P544, DOI 10.1016/j.ajem.2008.04.015; Barlam TF, 2015, INFECT CONT HOSP EP, V36, P153, DOI 10.1017/ice.2014.21; Blommaert A, 2014, J ANTIMICROB CHEMOTH, V69, P535, DOI 10.1093/jac/dkt377; Cadieux G, 2007, CAN MED ASSOC J, V177, P877, DOI 10.1503/cmaj.070151; Coenen Samuel, 2002, BMC Fam Pract, V3, P16, DOI 10.1186/1471-2296-3-16; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; De Sutter AI, 2001, FAM PRACT, V18, P209, DOI 10.1093/fampra/18.2.209; Dekker ARJ, 2015, FAM PRACT, V32, P401, DOI 10.1093/fampra/cmv019; Deschepper R, 2002, PATIENT EDUC COUNS, V48, P161, DOI 10.1016/S0738-3991(02)00017-4; Duijn HJ, 2007, BMC FAMILY PRACTICE, V8, P1; Fiegen H, 2002, Z ALLG MED, V81, P372; GERRITY MS, 1990, MED CARE, V28, P724, DOI 10.1097/00005650-199008000-00005; Gerrity MS, 1995, MOTIV EMOTION, V19, P175, DOI 10.1007/BF02250510; Gjelstad S, 2011, J ANTIMICROB CHEMOTH, V66, P2425, DOI 10.1093/jac/dkr295; Gjelstad S, 2009, SCAND J PRIM HEALTH, V27, P208, DOI 10.3109/02813430903438718; Grover ML, 2012, J FAM PRACTICE, V61, P330; Gulliford MC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006245; Gulliford MC, 2014, ANN FAM MED, V12, P344, DOI 10.1370/afm.1659; Hering R, 2014, ENTWICKLUNG AMBULANT; Howie J G, 1972, J R Coll Gen Pract, V22, P310; Hutchinson JM, 2001, CAN FAM PHYSICIAN, V47, P1217; Hutchinson JM, 1999, CAN MED ASSOC J, V160, P1013; Koller D, 2013, INFECTION, V41, P121, DOI 10.1007/s15010-012-0302-1; Linder JA, 2003, CLIN THER, V25, P2419, DOI 10.1016/S0149-2918(03)80284-9; Maier W, 2012, GESUNDHEITSWESEN, V74, P416, DOI 10.1055/s-0031-1280846; Mainous AG, 1998, ARCH PEDIAT ADOL MED, V152, P349; Mazzaglia G, 2003, EUR J CLIN PHARMACOL, V59, P651, DOI 10.1007/s00228-003-0669-0; NICE CfCPa, 2008, RESP TRACT INF ANT P; Schulz M, 2014, ANTIBIOTIKAVERORDU 2; Steffensen FH, 1997, SCAND J INFECT DIS, V29, P409, DOI 10.3109/00365549709011839; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Tell D, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008096; Velasco E, 2011, Infection, V39, P289, DOI 10.1007/s15010-011-0137-1; VERHEIJ TJM, 1990, FAM PRACT, V7, P175, DOI 10.1093/fampra/7.3.175; Wang KY, 2009, BRIT J GEN PRACT, V59, P724, DOI 10.3399/bjgp09X472593	37	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188521	10.1371/journal.pone.0188521	http://dx.doi.org/10.1371/journal.pone.0188521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220399	Green Published, gold			2022-12-27	WOS:000417469900010
J	Mukamurigo, J; Dencker, A; Ntaganira, J; Berg, M				Mukamurigo, Judith; Dencker, Anna; Ntaganira, Joseph; Berg, Marie			The meaning of a poor childbirth experience - A qualitative phenomenological study with women in Rwanda	PLOS ONE			English	Article							RESPECTFUL MATERNITY CARE; DISRESPECT; ABUSE; BIRTH; INTERVENTIONS; MOTHERHOOD; FACILITIES; TRANSITION; AFRICA	Objective Being pregnant and giving birth is a pivotal life event and one that a woman ordinarily remembers for most of her life. A negative childbirth experience can affect a woman's health well beyond the episode of the labour and birth itself. This study explored the meaning of a poor childbirth experience, as expressed by women who had given birth in Rwanda. Methods In a cross-sectional household study conducted in Northern Province and in Kigali City, the capital of Rwanda, a structured questionnaire was answered by women who had given birth one to 13 months earlier. One question, answered by 898 women, asked them to rate their overall experience of childbirth from 0 (very bad) to 10 (very good). Of these, 28 women (3.1%) who had rated their childbirth experience as bad (<= 4) were contacted for individual interviews. Seventeen of these women agreed to participate in individual in-depth interviews. The texts were analysed with a reflective lifeworld approach. Results The essential meaning of a "poor" childbirth experience was that the women had been exposed to disrespectful care, constituted by neglect, verbal or physical abuse, insufficient information, and denial of their husband as a companion. The actions of carers included abandonment, humiliation, shaming and insult, creating feelings of insecurity, fear and distrust in the women. Two of the women did not report any experience of poor care; their low rating was related to having suffered from medical complications. Conclusion It is challenging that the main finding is that women are exposed to disrespectful care. In an effort to provide an equitable and high quality maternal health care system in Rwanda, there is a need to focus on activities to implement respectful, evidence-based care for all. One such activity is to develop and provide education programmes for midwives and nurses about professional behaviour when caring for and working with women during labour and birth.	[Mukamurigo, Judith; Dencker, Anna; Berg, Marie] Univ Gothenburg, Sahlgrenska Acad, Inst Hlth & Care Sci, Gothenburg, Sweden; [Mukamurigo, Judith; Ntaganira, Joseph] Univ Rwanda, Sch Publ Hlth, Coll Med & Hlth Sci, Kigali, Rwanda	University of Gothenburg; University of Rwanda	Mukamurigo, J (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Hlth & Care Sci, Gothenburg, Sweden.; Mukamurigo, J (corresponding author), Univ Rwanda, Sch Publ Hlth, Coll Med & Hlth Sci, Kigali, Rwanda.	Judith.mukamurigo@gu.se						Abuya T, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0645-6; Alkema L, 2015, LANCET LONDON ENGLAN; [Anonymous], 2012, STUD FAMILY PLANN, V43, P153, DOI 10.1111/j.1728-4465.2012.00313.x; Binagwaho A, 2014, LANCET, V384, P371, DOI 10.1016/S0140-6736(14)60574-2; Bohren MA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001847; Bowser D, 2010, EXPLORING EVIDENCE D; Bradley S, 2016, SOC SCI MED, V169, P157, DOI 10.1016/j.socscimed.2016.09.039; Chadwick RJ, 2014, MIDWIFERY, V30, P862, DOI 10.1016/j.midw.2013.12.014; Dahlberg K., 2008, REFLECTIVE LIFEWORLD, V2nd ed.; Dahlberg K., 2011, LIFEWORD PHENOMENOLO; Farmer PE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f65; Freedman LP, 2014, LANCET, V384, pE42, DOI 10.1016/S0140-6736(14)60859-X; Halldorsdottir S, 1996, Health Care Women Int, V17, P361; Kululanga LI, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-141; Logie DE, 2008, LANCET, V372, P256, DOI 10.1016/S0140-6736(08)60962-9; Miller S, 2016, LANCET, V388, P2176, DOI 10.1016/S0140-6736(16)31472-6; Miller S, 2015, INT J GYNECOL OBSTET, V131, pS49, DOI 10.1016/j.ijgo.2015.02.005; Ministry of Health, 2014, RWAND ANN HLTH STAT; Mukamurigo JU, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1363-z; Nathan LM, 2015, MATERN CHILD HLTH J, V19, P1949, DOI 10.1007/s10995-015-1702-5; Nelson AM, 2003, JOGNN, V32, P465, DOI 10.1177/0884217503255199; Okafor II, 2015, INT J GYNECOL OBSTET, V128, P110, DOI 10.1016/j.ijgo.2014.08.015; Pafs J, 2015, MIDWIFERY, V31, P1149, DOI 10.1016/j.midw.2015.09.010; Pats J, 2016, RWANDA GLOBAL HLTH A, V9, P31482; Prinds C, 2014, MIDWIFERY, V30, P733, DOI 10.1016/j.midw.2013.06.021; Ratcliffe HL, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0187-z; Rosen HE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0728-4; Roxburgh Michelle, 2009, Nurse Educ Pract, V9, P349, DOI 10.1016/j.nepr.2009.08.001; Sayinzoga F, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1351-4; Smarandache A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0903-2; Vehvilainen-Julkunen K, 2014, ANN MED HEALTH SCI R, V4, P511, DOI 10.4103/2141-9248.139290; Warren N, 2015, MIDWIFERY, V31, P1073, DOI 10.1016/j.midw.2015.07.007	32	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189371	10.1371/journal.pone.0189371	http://dx.doi.org/10.1371/journal.pone.0189371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP2SV	29220391	Green Submitted, Green Published, gold			2022-12-27	WOS:000417469900055
J	Amiri, P; Jalali-Farahani, S; Karimi, M; Taherian, R; Kazempour-Ardebili, S; Hosseini-Esfahani, F; Mirmiran, P; Azizi, F				Amiri, Parisa; Jalali-Farahani, Sara; Karimi, Mehrdad; Taherian, Reza; Kazempour-Ardebili, Sara; Hosseini-Esfahani, Firoozeh; Mirmiran, Parvin; Azizi, Fereidoun			Factors associated with pre-diabetes in Tehranian men and women: A structural equations modeling	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; RISK-FACTORS; CARDIOVASCULAR RISK; PHYSICAL-ACTIVITY; NATIONAL-HEALTH; SEX-DIFFERENCES; FOLLOW-UP; POPULATION; DISEASE; QUESTIONNAIRE	Objective To examine associations of sex-specific related factors with pre-diabetes in Tehranian nondiabetic adults. Methods This study has been conducted within the framework of the Tehran Lipid and Glucose Study (TLGS) between 2008-2010. A total of 5568 (55.4% female) non-diabetic adults, aged >= 20 years, selected from among participants of the TLGS, were recruited for the study. Data on socio-behavioral factors, family history of diabetes and cardio-metabolic risk factors were included in the hypothesized model to test their direct and indirect associations with pre-diabetes in men and women separately, using structural equation modeling. Results Pre-diabetes was diagnosed in 23.6% of participants, with significantly higher prevalence in men compared to women (27.4% and 20.5%, respectively; p < 0.001). Body mass index (BMI) and triglycerides (TG) in both sexes and hypertension and high density lipoprotein only in women, were directly associated with pre-diabetes (p < 0.05). Poor diet in women was the only behavioral factor directly associated with pre-diabetes (p < 0.05). Age in both sexes and education, only in women, were directly associated with pre-diabetes. In both genders, age, marital status, education, employment, poor diet and leisure time physical activity were indirectly associated with pre-diabetes through cardio-metabolic risk factors. Conclusions The main modifiable factors directly associated with pre-diabetes were TG in women and BMI in men, which need to be prioritized in health policies for diabetes prevention programs in Tehranian adults. Future research should focus on the gender-specific determinants and underlying mechanisms for TG levels and BMI status among this population.	[Amiri, Parisa; Jalali-Farahani, Sara; Karimi, Mehrdad; Taherian, Reza] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Res Ctr Social Determinants Hlth, Tehran, Iran; [Jalali-Farahani, Sara; Taherian, Reza] Shahid Beheshti Univ Med Sci, Student Res Comm, Tehran, Iran; [Karimi, Mehrdad] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Kazempour-Ardebili, Sara; Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran; [Hosseini-Esfahani, Firoozeh; Mirmiran, Parvin] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Nutr & Endocrine Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Azizi, F (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran.	azizi@endocrine.ac.ir	Azizi, Fereidoun/ABD-4136-2021; Mirmiran, Parvin/V-1433-2019; amiri, parisa/K-1575-2017	Azizi, Fereidoun/0000-0002-6470-2517; amiri, parisa/0000-0002-6693-1057; JalaliFarahani, Sara/0000-0003-4905-0191; Dehbozorgian, Forough/0000-0002-1943-8198; Mirmiran, Parvin/0000-0003-2391-4924; Karimi, Mehrdad/0000-0001-8952-5839				Al-Shafaee MA, 2011, INT J DIABETES DEV C, V31, P166, DOI 10.1007/s13410-011-0038-y; Anjana RM, 2011, DIABETOLOGIA, V54, P3022, DOI 10.1007/s00125-011-2291-5; Azizi F, 2002, SOZ PRAVENTIV MED, V47, P408, DOI 10.1007/s000380200008; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Bardenheier BH, 2013, DIABETES CARE, V36, P2655, DOI 10.2337/dc12-2608; CASTELLI WP, 1992, AM J CARDIOL, V70, pH3, DOI 10.1016/0002-9149(92)91083-G; Diaz-Redondo A, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-014-0216-3; Esfahani FH, 2010, J EPIDEMIOL, V20, P150, DOI 10.2188/jea.JE20090083; Esmaillzadeh A, 2007, J NUTR, V137, P992, DOI 10.1093/jn/137.4.992; Esteghamati A, 2014, DIABETES RES CLIN PR, V103, P319, DOI 10.1016/j.diabres.2013.12.034; Farni K, 2014, PEERJ, V2, DOI 10.7717/peerj.499; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Ghazali SM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1432-z; Golozar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026725; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Hadaegh F, 2017, DIABETIC MED, V34, P69, DOI 10.1111/dme.13034; Hadaegh F, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-176; Haffner SM, 1997, DIABETOLOGIA, V40, P711, DOI 10.1007/s001250050738; Javanbakht M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026864; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Karastergiou K, 2013, J CLIN ENDOCR METAB, V98, P362, DOI 10.1210/jc.2012-2953; KRISKA AM, 1990, DIABETES CARE, V13, P401, DOI 10.2337/diacare.13.4.401; Lee DS, 2013, PUBLIC HEALTH, V127, P554, DOI 10.1016/j.puhe.2013.02.001; Li SX, 2014, J DIABETES COMPLICAT, V28, P470, DOI 10.1016/j.jdiacomp.2014.03.015; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; McNaughton SA, 2009, J NUTR, V139, P734, DOI 10.3945/jn.108.096784; Mohieldein AH, 2014, DIABETES METABOLIC S; Murray CJ, 2015, LANCET, V386, pP2145; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Njolstad I, 1998, AM J EPIDEMIOL, V147, P49; Rezazadeh A, 2010, NUTRITION, V26, P337, DOI 10.1016/j.nut.2009.06.019; Roche MM, 2014, J CLIN TRANSL ENDOCR, V1, P77, DOI 10.1016/j.jcte.2014.07.002; Roman-Urrestarazu A, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2016-000231; Sadeghi M, 2015, J DIABETES; stenson C-G, 2014, DIABETES RES CLIN PR; Thurston RC, 2005, AM J EPIDEMIOL, V162, P57, DOI 10.1093/aje/kwi159; Williams ED, 2013, ANN BEHAV MED, V46, P62, DOI 10.1007/s12160-013-9473-y; Zheng J, 2014, FRONT MED-PRC, V8, P477, DOI 10.1007/s11684-014-0346-y; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	39	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188898	10.1371/journal.pone.0188898	http://dx.doi.org/10.1371/journal.pone.0188898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216229	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800046
J	Matsuhashi, Y; Sameshima, K; Yamamoto, Y; Umezu, M; Iwasaki, K				Matsuhashi, Yuki; Sameshima, Kei; Yamamoto, Yoshiki; Umezu, Mitsuo; Iwasaki, Kiyotaka			Real-time visualization of thrombus formation at the interface between connectors and tubes in medical devices by using optical coherence tomography	PLOS ONE			English	Article							PHOSPHOLIPID POLYMER; CONTINUOUS-FLOW	Background Blood-contacting devices have contributed to improving the treatment of patients. However, thrombus formation at the interface between a connector and tube is still a potential source of thrombus-related complications that induce stroke or myocardial infarction. We aimed to develop a non-blood-contacting real-time method for visualizing thrombus formation, and to experimentally investigate the time-dependent phenomenon of thrombus formation at the interface between a connector and a tube in a medical device. Methods and findings An optical coherence tomography device with a center wavelength of 1330 nm was used to visualize thrombus formation during porcine blood circulation for 50 min in a closed 50-mL circulation system isolated from ambient air. The thrombus formation sites at the interface between a tube and connector were visualized. The area of the thrombus formation at the interface between the inlet of the connector and the tube was found to be 0.012 +/- 0.011 mm 2. Conversely, at the interface between the outlet of the connector and the tube, the area was found to be 0.637 +/- 0.306 mm(2). Thus, significantly larger amounts of thrombus were formed at the outlet interface (p < 0.01). The thrombus formation area at the outlet interface increased over time. Conversely, the area of thrombus formation showed repeated increasing and decreasing behavior at the inlet interface. Flow visualization with particle image velocimetry showed the presence of a flow separated area in the minimal flow phase at the inlet interface and a large recirculating slow flow region at the outlet interface in the minimal flow phase. These data suggested that the recirculating stagnant flow region contributed to thrombus growth. Conclusions The method presented here was effective in quantitatively assessing time-dependent phenomena of thrombus formation at the connector-tube interface. The method may contribute to the assessment of thrombogenicity of a novel design of connector.	[Matsuhashi, Yuki; Sameshima, Kei; Umezu, Mitsuo; Iwasaki, Kiyotaka] Waseda Univ, Dept Integrat Biosci & Biomed Engn, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo, Japan; [Yamamoto, Yoshiki; Umezu, Mitsuo] Waseda Univ, Dept Modern Mech Engn, Grad Sch Creat Sci & Engn, Shinjuku Ku, Tokyo, Japan; [Iwasaki, Kiyotaka] Waseda Univ, Cooperat Major Adv Biomed Sci, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo, Japan; [Iwasaki, Kiyotaka] Waseda Univ, Cooperat Major Adv Biomed Sci, Grad Sch Adv Sci & Engn, Tokyo, Japan	Waseda University; Waseda University; Waseda University; Waseda University	Iwasaki, K (corresponding author), Waseda Univ, Dept Integrat Biosci & Biomed Engn, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo, Japan.; Iwasaki, K (corresponding author), Waseda Univ, Cooperat Major Adv Biomed Sci, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo, Japan.; Iwasaki, K (corresponding author), Waseda Univ, Cooperat Major Adv Biomed Sci, Grad Sch Adv Sci & Engn, Tokyo, Japan.	iwasaki@waseda.jp			Research on Regulatory Science of Pharmaceuticals and Medical Devices from Japan Agency for Medical Research and development, AMED [17mk0102029j0003]	Research on Regulatory Science of Pharmaceuticals and Medical Devices from Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED))	This research was supported by the Research on Regulatory Science of Pharmaceuticals and Medical Devices from Japan Agency for Medical Research and development, AMED (No. 17mk0102029j0003).	Bosschaart N, 2014, LASER MED SCI, V29, P453, DOI 10.1007/s10103-013-1446-7; Cook S, 2009, CIRCULATION, V120, P391, DOI 10.1161/CIRCULATIONAHA.109.854398; Dalton HJ, 2015, PEDIATR CRIT CARE ME, V16, P167, DOI 10.1097/PCC.0000000000000317; Fercher AF, 2003, REP PROG PHYS, V66, P239, DOI [10.1088/0034-4885/66/2/204, 10.2184/lsj.31.635]; Finkel KW, 2009, SEMIN DIALYSIS, V22, P155, DOI 10.1111/j.1525-139X.2008.00550.x; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Hanafusa N, 2015, BLOOD PURIFICAT, V40, P312, DOI 10.1159/000441579; Hastings SM, 2017, ASAIO J, V63, P86, DOI 10.1097/MAT.0000000000000444; Hoefer D, 2014, NEW ENGL J MED, V370, P1464, DOI 10.1056/NEJMc1401768; ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809; ISHIHARA K, 1994, J BIOMED MATER RES, V28, P225, DOI 10.1002/jbm.820280213; Ishihara K, 1999, BIOMATERIALS, V20, P1553, DOI 10.1016/S0142-9612(98)00206-3; Ishihara K, 2009, J R SOC INTERFACE, V6, pS279, DOI [10.1098/rsif.2008.0335.focus, 10.1098/rsif.2008.0335]; Jaffer IH, 2015, J THROMB HAEMOST, V13, pS72, DOI 10.1111/jth.12961; Joannidis M, 2007, CRIT CARE, V11, DOI 10.1186/cc5937; Kihara S, 2003, ARTIF ORGANS, V27, P188, DOI 10.1046/j.1525-1594.2003.t01-2-06993.x; Kindel SJ, 2016, CARDIOL YOUNG, V26, P851, DOI 10.1017/S1047951116000184; Lafc G, 2014, HEART LUNG CIRC, V23, P10, DOI 10.1016/j.hlc.2013.08.009; Meinke M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2435177; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PATTERSON M S, 1991, Lasers in Medical Science, V6, P379, DOI 10.1007/BF02042460; Saito S, 2014, J HEART LUNG TRANSPL, V33, P599, DOI 10.1016/j.healun.2014.02.015; Sakota D, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.057007; Srinivasan VJ, 2012, BIOMED OPT EXPRESS, V3, P612, DOI 10.1364/BOE.3.000612; Tolwani AJ, 2009, SEMIN DIALYSIS, V22, P141, DOI 10.1111/j.1525-139X.2008.00545.x; Xu XQ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3615667	26	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188729	10.1371/journal.pone.0188729	http://dx.doi.org/10.1371/journal.pone.0188729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216225	Green Submitted, Green Published, gold			2022-12-27	WOS:000417337800039
J	Rossetti, G; Milli, L; Giannotti, F; Pedreschi, D				Rossetti, Giulio; Milli, Letizia; Giannotti, Fosca; Pedreschi, Dino			Forecasting success via early adoptions analysis: A data-driven study	PLOS ONE			English	Article							EARLY PREDICTION; DIFFUSION; BEHAVIOR	Innovations are continuously launched over markets, such as new products over the retail market or new artists over the music scene. Some innovations become a success; others don't. Forecasting which innovations will succeed at the beginning of their lifecycle is hard. In this paper, we provide a data-driven, large-scale account of the existence of a special niche among early adopters, individuals that consistently tend to adopt successful innovations before they reach success: we will call them Hit-Savvy. Hit-Savvy can be discovered in very different markets and retain over time their ability to anticipate the success of innovations. As our second contribution, we devise a predictive analytical process, exploiting Hit-Savvy as signals, which achieves high accuracy in the early-stage prediction of successful innovations, far beyond the reach of state-of-the-art time series forecasting models. Indeed, our findings and predictive model can be fruitfully used to support marketing strategies and product placement.	[Rossetti, Giulio; Milli, Letizia; Giannotti, Fosca] CNR, ISTI, Knowledge Discovery & Data Min Lab, Pisa, Italy; [Milli, Letizia; Pedreschi, Dino] Univ Pisa, Comp Sci Dept, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienza e Tecnologie dell'Informazione "Alessandro Faedo" (ISTI-CNR); University of Pisa	Rossetti, G (corresponding author), CNR, ISTI, Knowledge Discovery & Data Min Lab, Pisa, Italy.	giulio.rossetti@isti.cnr.it	Rossetti, Giulio/AAH-7567-2020; Milli, Letizia/ABB-7425-2021; MILLI, LETIZIA/GRJ-9002-2022	Rossetti, Giulio/0000-0003-3373-1240; Milli, Letizia/0000-0001-5283-0477; PEDRESCHI, DINO/0000-0003-4801-3225	European Community's H Program [641191, 654024]	European Community's H Program	This work was funded by the European Community's H2020 Program under the funding scheme "FETPROACT-1-2014: Global Systems Science (GSS)", grant agreement #641191 "CIMPLEX Bringing Citizens, Models and Data together in Participatory, Interactive SociaL EXploratories", https://www.cimplex-project.eu and under the founding scheme "INFRAIA-1-2014-2015: Research Infrastructures" grant agreement #654024 "SoBigData: Social Mining & Big Data Ecosystem", http://www.sobigdata.eu. There was no additional external funding received for this study.	Cervellini P, 2016, IEEE S SERIES COMPUT, P1; Cintia P, 2013, INT CONF DAT MIN WOR, P147, DOI 10.1109/ICDMW.2013.41; Condon EM, 1999, COMPUT OPER RES, V26, P1243, DOI 10.1016/S0305-0548(99)00003-9; Coscia M., 2013, P INT AAAI C WEB SOC, VVolume 7, P100; DellaVigna S., 2016, PREDICTING EXPT RESU; Figueiredo F, 2016, INFORM SCIENCES, V349, P172, DOI 10.1016/j.ins.2016.02.025; Fourt L.A., 1960, J MARKETING, V25, P31, DOI 10.2307/1248608; Ghalwash MF, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P402, DOI 10.1145/2623330.2623694; Gupta S, 2015, WWW'15 COMPANION: PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P39, DOI 10.1145/2740908.2742743; HAINES GH, 1964, MANAGE SCI, V10, P634, DOI 10.1287/mnsc.10.4.634; Huh YE, 2008, J BUS RES, V61, P40, DOI 10.1016/j.jbusres.2006.05.007; Jeong YS, 2011, PATTERN RECOGN, V44, P2231, DOI 10.1016/j.patcog.2010.09.022; Kleinberg JM, 1999, ACM COMPUT SURV, V31; Krauss J, 2008, ECIS, P2026; Li C. -T., 2012, P WWW 2012 POSTER PR, P557, DOI [10.1145/2187980.2188125, DOI 10.1145/2187980.2188125]; MAHAJAN V, 1990, J MARKETING RES, V27, P37, DOI 10.2307/3172549; Mahajan V., 1985, MODELS INNOVATION DI; Martinez-Torres MR, 2013, EXPERT SYST APPL, V40, P2503, DOI 10.1016/j.eswa.2012.10.070; Mehmood Y, 2016, KNOWL INF SYST, V48, P1, DOI 10.1007/s10115-015-0889-5; Mele I., 2012, P 21 ACM INT C INF K, P1682; Mellers B, 2015, PERSPECT PSYCHOL SCI, V10, P267, DOI 10.1177/1745691615577794; Moore G.A., 1991, CROSSING CHASM MARKE; Paparrizos J, 2015, SIGMOD'15: PROCEEDINGS OF THE 2015 ACM SIGMOD INTERNATIONAL CONFERENCE ON MANAGEMENT OF DATA, P1855, DOI 10.1145/2723372.2737793; Pennacchioli Diego, 2013, Social Informatics. 5th International Conference, SocInfo 2013. Proceedings: LNCS 8238, P319, DOI 10.1007/978-3-319-03260-3_28; PETERSON RA, 1973, J MARKETING RES, V10, P325, DOI 10.2307/3149704; Rogers EM, 1968, DIFFUSION INNOVATION; Ryan B, 1943, RURAL SOCIOL, V8, P15; Saez-Trumper D., 2012, P 18 ACM SIGKDD INT, P1014; Sarigol E, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds/s13688-014-0009-x; Sha X, 2013, P 2013 C COMP SUPP C, P1365; Sinatra R, 2016, SCIENCE, V354, DOI 10.1126/science.aaf5239; Tetlock P.E., 2016, SUPERFORECASTING ART; Tetlock PE, 2017, SCIENCE, V355, P481, DOI 10.1126/science.aal3147; Thorleuchter D, 2012, EXPERT SYST APPL, V39, P13026, DOI 10.1016/j.eswa.2012.05.096; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Weissbock J, 2014, LECT NOTES COMPUT SC, V8436, P251, DOI 10.1007/978-3-319-06483-3_22; Yu SP, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P333, DOI 10.1145/2939672.2939707; Zhao WX, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P1935, DOI 10.1145/2623330.2623351	39	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189096	10.1371/journal.pone.0189096	http://dx.doi.org/10.1371/journal.pone.0189096			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216255	gold, Green Published, Green Submitted			2022-12-27	WOS:000417337800071
J	Shin, JE; Choi, CH; Lee, JM; Kwon, JS; Lee, SH; Kim, HC; Han, NY; Choi, SH; Yoo, SY				Shin, Jung Eun; Choi, Chi-Hoon; Lee, Jong Min; Kwon, Jun Soo; Lee, So Hee; Kim, Hyun-Chung; Han, Na Young; Choi, Soo-Hee; Yoo, So Young			Association between memory impairment and brain metabolite concentrations in North Korean refugees with posttraumatic stress disorder	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; HIPPOCAMPAL N-ACETYLASPARTATE; PERFORMANCE VALIDITY; WHITE-MATTER; PTSD; VETERANS; CORTISOL; EXTINCTION; COGNITION; SYMPTOMS	Individuals with posttraumatic stress disorder (PTSD) had experiences of enormous psychological stress that can result in neurocognitive and neurochemical changes. To date, the causal relationship between them remains unclear. The present study is to investigate the association between neurocognitive characteristics and neural metabolite concentrations in North Korean refugees with PTSD. A total of 53 North Korean refugees with or without PTSD underwent neurocognitive function tests. For neural metabolite scanning, magnetic resonance spectroscopy of the hippocampus and anterior cingulate cortex (ACC) has been conducted. We assessed between-group differences in neurocognitive test scores and metabolite levels. Additionally, a multiple regression analysis was carried out to evaluate the association between neurocognitive function and metabolite levels in patients with PTSD. Memory function, but not other neurocognitive functions, was significantly lower in the PTSD group compared with the non-PTSD group. Hippocampal N-acetylaspartate (NAA) levels were not different between groups; however, NAA levels were significantly lower in the ACC of the PTSD group than the non-PTSD group (t = 2.424, p = 0.019). The multiple regression analysis showed a negative association between hippocampal NAA levels and delayed recall score on the auditory verbal learning test (beta = -1.744, p = 0.011) in the non-PTSD group, but not in the PTSD group. We identified specific memory impairment and the role of NAA levels in PTSD. Our findings suggest that hippocampal NAA has a protective role in memory impairment and development of PTSD after exposure to traumatic events.	[Shin, Jung Eun; Kwon, Jun Soo; Han, Na Young; Choi, Soo-Hee] Seoul Natl Univ Hosp, Dept Psychiat, Seoul, South Korea; [Choi, Chi-Hoon] Chungbuk Natl Univ Hosp, Dept Radiol, Cheongju, South Korea; [Lee, Jong Min] Hanyang Univ, Dept Biomed Engn, Computat NeuroImage Anal Lab, Seoul, South Korea; [Kwon, Jun Soo; Choi, Soo-Hee] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Kwon, Jun Soo; Choi, Soo-Hee] Seoul Natl Univ, Coll Med, Inst Human Behav Med SNU MRC, Seoul, South Korea; [Lee, So Hee; Kim, Hyun-Chung; Yoo, So Young] Natl Med Ctr, Dept Psychiat, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Chungbuk National University; Chungbuk National University Hospital; Hanyang University; Seoul National University (SNU); Seoul National University (SNU); National Medical Center - Korea	Choi, SH (corresponding author), Seoul Natl Univ Hosp, Dept Psychiat, Seoul, South Korea.; Choi, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea.; Choi, SH (corresponding author), Seoul Natl Univ, Coll Med, Inst Human Behav Med SNU MRC, Seoul, South Korea.; Yoo, SY (corresponding author), Natl Med Ctr, Dept Psychiat, Seoul, South Korea.	soohchoi@snu.ac.kr; soyoung.yoo@nmc.or.kr	Lee, Jeong Min/V-3429-2019; Lee, So Hee/B-5940-2016	Lee, Jeong Min/0000-0003-0561-8777; Lee, So Hee/0000-0002-9005-3207; Choi, Chi-Hoon/0000-0003-4137-7376	National Medical Center, Research Institute [NMC2012-MS-03]	National Medical Center, Research Institute	This work was supported by Research Program funded by National Medical Center, Research Institute (grant number: NMC2012-MS-03). The funding sources had no further role in the study design, collection, analysis, interpretation of the data, writing of the report, and in the decision to submit this report for publication. The corresponding authors had full access to the data in the study and had final responsibility for the decision to submit for publication.	Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P38; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Arnold DL, 2001, ANN NEUROL, V50, P823, DOI 10.1002/ana.10013; Bae SM, 2014, CLIN PSYCHOPHARM NEU, V12, P41, DOI 10.9758/cpn.2014.12.1.41; Bartlett DJ, 2004, SLEEP MED, V5, P593, DOI 10.1016/j.sleep.2004.08.004; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bertholdo D, 2013, NEUROIMAG CLIN N AM, V23, P359, DOI 10.1016/j.nic.2012.10.002; BLANCHARD EB, 1995, BEHAV RES THER, V33, P471, DOI 10.1016/0005-7967(94)00064-Q; Bremner JD, 2006, ANN NY ACAD SCI, V1071, P80, DOI 10.1196/annals.1364.008; Brown ES, 2004, BIOL PSYCHIAT, V55, P538, DOI 10.1016/j.biopsych.2003.09.010; Conrad CD, 1999, NEUROBIOL LEARN MEM, V72, P39, DOI 10.1006/nlme.1998.3898; Danckwerts A, 2003, NEUROPSYCHOL REV, V13, P221, DOI 10.1023/B:NERV.0000009485.76839.b7; Geuze E, 2009, DEPRESS ANXIETY, V26, P7, DOI 10.1002/da.20476; Gilbertson MW, 1997, ANN NY ACAD SCI, V821, P476, DOI 10.1111/j.1749-6632.1997.tb48309.x; Hamner M B, 1999, Depress Anxiety, V9, P1; Heim C, 2009, CNS SPECTRUMS, V14, P13; Jeon WT, 2008, PSYCHIAT INVEST, V5, P213, DOI 10.4306/pi.2008.5.4.213; JOELS M, 1990, P NATL ACAD SCI USA, V87, P4495, DOI 10.1073/pnas.87.12.4495; Johnsen GE, 2008, J AFFECT DISORDERS, V111, P74, DOI 10.1016/j.jad.2008.02.007; Karl A, 2010, NEUROSCI BIOBEHAV R, V34, P7, DOI 10.1016/j.neubiorev.2009.06.008; KEANE TM, 1984, J CONSULT CLIN PSYCH, V52, P888, DOI 10.1037/0022-006X.52.5.888; Kim H.K., 1999, REY KIM MEMORY TEST; Kim HK, 1999, FRONTAL EXECUTIVE NE; Kim JJ, 1998, TRENDS NEUROSCI, V21, P505, DOI 10.1016/S0166-2236(98)01322-8; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Klein E, 2003, CAN J PSYCHIAT, V48, P28, DOI 10.1177/070674370304800106; Kozaric-Kovacic D, 2001, MIL MED, V166, P677, DOI 10.1093/milmed/166.8.677; Krysinska Karolina, 2009, J Trauma Nurs, V16, P103, DOI 10.1097/JTN.0b013e3181ac921f; Lee Y, 2001, AM J PREV MED, V20, P225, DOI 10.1016/S0749-3797(00)00282-8; Maddock Richard J, 2012, Curr Top Behav Neurosci, V11, P199; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; Miller B., 1999, HUMAN FRONTAL LOBES; Ministry of Unification, 2017, UN WHIT PAP; Neylan TC, 2004, J TRAUMA STRESS, V17, P41, DOI 10.1023/B:JOTS.0000014675.75686.ee; Neylan TC, 2003, BIOL PSYCHIAT, V54, P1118, DOI 10.1016/S0006-3223(02)01974-1; Oitzl MS, 2001, P NATL ACAD SCI USA, V98, P12790, DOI 10.1073/pnas.231313998; Olff M, 2014, NEUROBIOL LEARN MEM, V112, P114, DOI 10.1016/j.nlm.2014.01.003; Park YS, 2014, PSYCHIAT INVEST, V11, P363, DOI 10.4306/pi.2014.11.4.363; Parslow RA, 2007, AM J PSYCHIAT, V164, P509, DOI 10.1176/appi.ajp.164.3.509; Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rey A, 1964, LEXAMEN CLINIQUE PSY; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; RYABININ AE, 1995, J NEUROSCI, V15, P721; Samuelson Kristin W, 2011, Dialogues Clin Neurosci, V13, P346; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sapolsky RM, 1992, STRESS AGING BRAIN M; Schuff N, 2001, BIOL PSYCHIAT, V50, P952, DOI 10.1016/S0006-3223(01)01245-8; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Siegmund A, 2009, BIOL PSYCHIAT, V65, P258, DOI 10.1016/j.biopsych.2008.08.023; Soares DP, 2009, CLIN RADIOL, V64, P12, DOI 10.1016/j.crad.2008.07.002; SPIELBERGER CD, 1970, STAI MANUAL STAIT TR; Trzesniak C, 2008, ACTA NEUROPSYCHIATR, V20, P56, DOI 10.1111/j.1601-5215.2008.00270.x; Villarreal G, 2002, BIOL PSYCHIAT, V52, P119, DOI 10.1016/S0006-3223(02)01359-8; Villarreal G, 2002, CAN J PSYCHIAT, V47, P666, DOI 10.1177/070674370204700709; Wechsler D., 2010, WAIS R MANUAL, VUK 4th Edn; Wisdom NM, 2014, CLIN NEUROPSYCHOL, V28, P128, DOI 10.1080/13854046.2013.863977; Wrocklage KM, 2016, J INT NEUROPSYCH SOC, V22, P399, DOI 10.1017/S1355617716000059; Xi GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028686; Yehuda R, 2000, AM J PSYCHIAT, V157, P1252, DOI 10.1176/appi.ajp.157.8.1252; Yehuda R, 1998, BIOL PSYCHIAT, V44, P1305, DOI 10.1016/S0006-3223(98)00276-5; YEHUDA R, 1995, AM J PSYCHIAT, V152, P982; Yeum TH, 1992, KOREAN WECHSLER ADUL	64	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188953	10.1371/journal.pone.0188953	http://dx.doi.org/10.1371/journal.pone.0188953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216235	Green Submitted, Green Published, gold			2022-12-27	WOS:000417337800051
J	Watson, CH; Coriakula, J; Ngoc, DTT; Flasche, S; Kucharski, AJ; Lau, CL; Thieu, NTV; de Waroux, OL; Rawalai, K; Van, TT; Taufa, M; Baker, S; Nilles, EJ; Kama, M; Edmunds, WJ				Watson, Conall H.; Coriakula, Jeremaia; Dung Tran Thi Ngoc; Flasche, Stefan; Kucharski, Adam J.; Lau, Colleen L.; Nga Tran Vu Thieu; de Waroux, Olivier le Polain; Rawalai, Kitione; Tan Trinh Van; Taufa, Mere; Baker, Stephen; Nilles, Eric J.; Kama, Mike; Edmunds, W. John			Social mixing in Fiji: Who-eats-with-whom contact patterns and the implications of age and ethnic heterogeneity for disease dynamics in the Pacific Islands	PLOS ONE			English	Article							MEDICAL-RESEARCH; TYPHOID-FEVER; TRANSMISSION; SPREAD; EPIDEMIOLOGY; INFECTIONS; PARAMETERS; NETWORKS; OUTBREAK; BEHAVIOR	Empirical data on contact patterns can inform dynamic models of infectious disease transmission. Such information has not been widely reported from Pacific islands, nor strongly multi-ethnic settings, and few attempts have been made to quantify contact patterns relevant for the spread of gastrointestinal infections. As part of enteric fever investigations, we conducted a cross-sectional survey of the general public in Fiji, finding that within the 9,650 mealtime contacts reported by 1,814 participants, there was strong like-with-like mixing by age and ethnicity, with higher contact rates amongst iTaukei than non-iTaukei Fijians. Extra-domiciliary lunchtime contacts follow these mixing patterns, indicating the overall data do not simply reflect household structures. Inter-ethnic mixing was most common amongst school-age children. Serological responses indicative of recent Salmonella Typhi infection were found to be associated, after adjusting for age, with increased contact rates between meal-sharing iTaukei, with no association observed for other contact groups. Animal ownership and travel within the geographical division were common. These are novel data that identify ethnicity as an important social mixing variable, and use retrospective mealtime contacts as a socially acceptable metric of relevance to enteric, contact and respiratory diseases that can be collected in a single visit to participants. Application of these data to other island settings will enable communicable disease models to incorporate locally relevant mixing patterns in parameterisation.	[Watson, Conall H.; Flasche, Stefan; Kucharski, Adam J.; de Waroux, Olivier le Polain; Edmunds, W. John] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England; [Coriakula, Jeremaia; Tan Trinh Van] Fiji Natl Univ, Sch Med, Suva, Fiji; [Dung Tran Thi Ngoc; Nga Tran Vu Thieu; Baker, Stephen] Hosp Trop Dis, Oxford Univ Clin Res Unit Vietnam, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Lau, Colleen L.] Australian Natl Univ, Res Sch Populat Hlth, Dept Global Hlth, Canberra, ACT, Australia; [Rawalai, Kitione] Project HEAVEN, Suva, Fiji; [Taufa, Mere; Kama, Mike] Minist Hlth & Med Serv, Fiji Ctr Communicable Dis Control, Suva, Fiji; [Baker, Stephen] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England; [Baker, Stephen] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Kama, Mike] World Hlth Org Western Pacific Region, Div Pacific Tech Support, Suva, Fiji	University of London; London School of Hygiene & Tropical Medicine; Fiji National University (FNU); Australian National University; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Watson, CH (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.	conall.watson@lshtm.ac.uk	Lau, Colleen L/F-5974-2012; Nilles, Eric/ABA-4757-2021	Lau, Colleen L/0000-0001-8288-4169; Nilles, Eric/0000-0001-7044-5257; Flasche, Stefan/0000-0002-5808-2606; le Polain de Waroux, Olivier/0000-0003-3458-2945; Coriakula, Jeremaia/0000-0002-9973-0980; Watson, Conall/0000-0002-2469-791X; Baker, Stephen/0000-0003-1308-5755	World Health Organization Western Pacific Region; UK Medical Research Council [MR/J003999/1]; Chadwick Trust; Australian National Health and Medical Research Council (NHMRC) Fellowship [1109035]; Global Change Institute at The University of Queensland [607562]; Wellcome Trust [100087/Z/12/Z]; Royal Society [100087/Z/12/Z]; Medical Research Council [1263989] Funding Source: researchfish	World Health Organization Western Pacific Region; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chadwick Trust; Australian National Health and Medical Research Council (NHMRC) Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Global Change Institute at The University of Queensland; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Fieldwork was funded by the World Health Organization Western Pacific Region as part of typhoid and leptospirosis control. CHW is supported by the UK Medical Research Council (grant MR/J003999/1) and the Chadwick Trust. CLL was supported by an Australian National Health and Medical Research Council (NHMRC) Fellowship (1109035), and a research grant from the Global Change Institute (607562) at The University of Queensland. SB is a Sir Henry Dale Fellow, jointly funded by the Wellcome Trust and the Royal Society (100087/Z/12/Z). EJN was an employee of the WHO. The other funders had no role in the design of the study, preparation of the manuscript or decision to publish.	[Anonymous], R LANG ENV STAT COMP; [Anonymous], 2016, AUSTR OCEANIA FRENCH; Baguelin M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001527; Bakach I, 2015, T ROY SOC TROP MED H, V109, P679, DOI 10.1093/trstmh/trv075; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Bates SJ, 2007, AM J EPIDEMIOL, V166, P1088, DOI 10.1093/aje/kwm184; Bausch DG, 2006, NEW ENGL J MED, V355, P909, DOI 10.1056/NEJMoa051465; Bengtsson L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08923; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Cornell S., 2007, ETHNICITY RACE MAKIN; Craig A, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2012.3.4.007, 10.5365/WPSAR.2012.3.4.007]; Cvjetanovic B, 1978, TYPHOID FEVER ENDEMI, P45; Dodd PJ, 2016, AM J EPIDEMIOL, V183, P156, DOI 10.1093/aje/kwv160; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Eames KT, 2010, HEAL TECHNOL ASSESS, V14; Edmunds WJ, 1997, P R SOC B, V264; Feachem R, 1983, SANITATION DIS; Fiji Bureau of Statistics, 2012, FIJ 2007 CENS POP HO; Fu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045113; Goeyvaerts N, 2010, J R STAT SOC C-APPL, V59, P255, DOI 10.1111/j.1467-9876.2009.00693.x; Hens N., 2012, MODELING INFECT DIS; Hethcote H, 1984, LECT NOTES BIOMATH, P111; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Ibuka Y, 2015, J EPIDEMIOL COMMUNIT; Johnstone-Robertson SP, 2011, AM J EPIDEMIOL, V174, P1246, DOI 10.1093/aje/kwr251; Kiti MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104786; Lau CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004405; Lau CL, 2012, AM J TROP MED HYG, V86, P309, DOI 10.4269/ajtmh.2012.11-0398; Lauritsen J.M., 2005, EPIDATA ENTRY COMPRE; Marks M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003988; McKenzie K, 1996, BRIT MED J, V312, P1054; Melegaro A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170459; Melegaro A, 2011, EPIDEMICS-NETH, V3, P143, DOI 10.1016/j.epidem.2011.04.001; Moss R, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005018; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; OSBORNE NG, 1992, JAMA-J AM MED ASSOC, V267, P275, DOI 10.1001/jama.267.2.275; Phimpraphai W, 2017, ACTA TROP, V169, P150, DOI 10.1016/j.actatropica.2017.02.001; Read JM, 2012, EPIDEMIOL INFECT, V140, P2117, DOI 10.1017/S0950268812000842; Read JM, 2014, P R SOC B; Reller ME, 2003, CLIN INFECT DIS, V37, P141, DOI 10.1086/375590; Rolls DA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1237-9; Romani L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003452; Schmitt Robert C., 2001, HAWAIIAN J HIST, V35, P1; Shanks GD, 2016, AM J TROP MED HYG, V95, P273, DOI 10.4269/ajtmh.16-0169; Steer AC, 2008, EPIDEMIOL INFECT, V136, P621, DOI 10.1017/S095026880700917X; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; TAYLOR R, 1983, MED J AUSTRALIA, V2, P389, DOI 10.5694/j.1326-5377.1983.tb122536.x; Taylor R, 2013, AUST NZ J PUBL HEAL, V37, P509, DOI 10.1111/1753-6405.12116; Temple B, 2012, TROP MED INT HEALTH, V17, P197, DOI 10.1111/j.1365-3156.2011.02897.x; Thompson CN, 2014, TROP MED INT HEALTH, V19, P1284, DOI 10.1111/tmi.12367; van Hoek AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076180; Van Kerckhove K, 2013, AM J EPIDEMIOL, V178, P1655, DOI 10.1093/aje/kwt196; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Watson CH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005786; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467	58	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0186911	10.1371/journal.pone.0186911	http://dx.doi.org/10.1371/journal.pone.0186911			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211731	Green Published, gold, Green Accepted			2022-12-27	WOS:000417212200010
J	Benigni, MC; Joseph, K; Carley, KM				Benigni, Matthew C.; Joseph, Kenneth; Carley, Kathleen M.			Online extremism and the communities that sustain it: Detecting the ISIS supporting community on Twitter	PLOS ONE			English	Article							COMPLEX NETWORKS	The Islamic State of Iraq and ash-Sham (ISIS) continues to use social media as an essential element of its campaign to motivate support. On Twitter, ISIS' unique ability to leverage unaffiliated sympathizers that simply retweet propaganda has been identified as a primary mechanism in their success in motivating both recruitment and "lone wolf" attacks. The present work explores a large community of Twitter users whose activity supports ISIS propaganda diffusion in varying degrees. Within this ISIS supporting community, we observe a diverse range of actor types, including fighters, propagandists, recruiters, religious scholars, and unaffiliated sympathizers. The interaction between these users offers unique insight into the people and narratives critical to ISIS' sustainment. In their entirety, we refer to this diverse set of users as an online extremist community or OEC. We present Iterative Vertex Clustering and Classification (IVCC), a scalable analytic approach for OEC detection in annotated heterogeneous networks, and provide an illustrative case study of an online community of over 22,000 Twitter users whose online behavior directly advocates support for ISIS or contibutes to the group's propaganda dissemination through retweets.	[Benigni, Matthew C.; Joseph, Kenneth; Carley, Kathleen M.] Carnegie Mellon Univ, Sch Comp Sci, Inst Software Res, Pittsburgh, PA 15213 USA; [Joseph, Kenneth] Northeastern Univ, Network Sci Inst, Boston, MA 02115 USA; [Joseph, Kenneth] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA	Carnegie Mellon University; Northeastern University; Harvard University	Benigni, MC (corresponding author), Carnegie Mellon Univ, Sch Comp Sci, Inst Software Res, Pittsburgh, PA 15213 USA.	mbenigni@cs.cmu.edu	Joseph, Kenneth/U-5932-2019; Joseph, Kenneth/AAT-2769-2020	Carley, Kathleen M./0000-0002-6356-0238	Office of Naval Research (ONR) [N000141310835, N000141512564]	Office of Naval Research (ONR)(Office of Naval Research)	This work was supported by the Office of Naval Research (ONR) through MINERVA grant N000141310835 on State Stability, and grant N000141512564 on Tracking Covert Groups in Twitter. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Office of Naval Research or the U.S. Government.	[Anonymous], 2002, CONNECTIONS; [Anonymous], 2015, NY TIMES; [Anonymous], 2012, AAAI; [Anonymous], [No title captured]; Balakrishnan A., TWITTER SUSPENDS 100; Bartlett J., 2016, ORWELL VERSUS TERROR; Berger JM, 2015, DEFINING DESCRIBING; Berger JM, TAILORED ONLINE INTE; Berzak Y., 2016, ANCHORING AGREEMENT; Blodgett SL, 2016, EMNLP 16; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boyle D, 2017, DAILY MAIL ONLINE; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Calamur K, 2016, ATLANTIC; Carley K. M., 2006, DYNAMIC NETWORK APPR; Carley Kathleen M., 1998, DESTABILIZING TERROR, P45; Carley KM, 2003, P 8 INT COMM CONTR R; Carter Joseph, 2014, GREENBIRDS MEASURING; Chiu CM, 2006, DECIS SUPPORT SYST, V42, P1872, DOI 10.1016/j.dss.2006.04.001; Dhillon I. S., 2001, KDD-2001. Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P269, DOI 10.1145/502512.502550; Dickey C., 2014, FRENCH JIHADI MEHDI; Diesner J., 2004, P N AM ASS COMP SOC, V3; Gilbert E, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P211; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gladstone R, 2015, NY TIMES; GOODMAN LA, 1961, ANN MATH STAT, V32, P148, DOI 10.1214/aoms/1177705148; Gupta C, 2010, PROC INT CONF DATA, P569, DOI 10.1109/ICDE.2010.5447828; Harman J, 2015, FOREIGN AFFAIRS; Hoffman FG, 2009, DTIC DOCUMENT; Jessica Stern, 2015, ATLANTIC; Joseph K, 2015, CULTURE NETWORKS TWI; Joseph K., 2016, P 1 WORKSH NLP COMP, P1; Kleinig J., 2011, PRACT ETHIC PUB POL; Koschade S, 2006, STUD CONFL TERROR, V29, P589, DOI 10.1080/10576100600798418; Krebs V. E., 2002, First Monday, V7, DOI 10.5210/fm.v7i4.941; Lake David A., 2002, INT ORGAN, V1, P15, DOI DOI 10.1017/S777777770200002X; Latora V, 2004, CHAOS SOLITON FRACT, V20, P69, DOI 10.1016/S0960-0779(03)00429-6; Logan MH, 2014, VIOLENCE GEND, V1, P159, DOI 10.1089/vio.2014.0036; Lui Marco, 2012, P ACL 2012 SYST DEM; Miller B., 2011, 2011 P 14 INT C INF, P1; Mislove A, 2007, IMC'07: PROCEEDINGS OF THE 2007 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P29; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; of Staff JC, 2014, JOINT PUB 3 13 JOINT, P1; Papadopoulos S, 2012, DATA MIN KNOWL DISC, V24, P515, DOI 10.1007/s10618-011-0224-z; Poe T., CNN COM; Powers D, 2011, J MACH LEARN TECHNOL, V2, P37; Ressler S., 2006, HOMELAND SECURITY AF, V2, P1; Ross B, 2015, TWITTER ESCALATES IS; Settles Burr, 2010, ACTIVE LEARNING LIT, P11, DOI DOI 10.1111/J.1467-7687.2012.01135.X; Smith ST, 2013, LINCOLN LAB J, V20; Starr B. U. S., 2015, CNNPOLITICS; Steinfield C, 2008, J APPL DEV PSYCHOL, V29, P434, DOI 10.1016/j.appdev.2008.07.002; Strategy I Group IS, ABD PAG CAPT RIS ISI; Tang L, 2011, DATA MIN KNOWL DISC, V23, P447, DOI 10.1007/s10618-010-0210-x; Tang L, 2009, IEEE DATA MINING, P503, DOI 10.1109/ICDM.2009.20; Top NM, 2009, COUNTERTERRORISMS NE; Tunisia AaS, 2013, DAWA HISBA AND JIHAD; Veilleux-Lepage Y, 2014, 2014 6 INT TERR TRAN; Veilleux-Lepage Y., 2015, PARADIGMATIC SHIFTS; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Walsh PF, 2016, INTELL NATL SECUR, V31, P345, DOI 10.1080/02684527.2014.998436; Yan Holly, 2015, CNN 0505; Yang J, 2013, IEEE DATA MINING, P1151, DOI 10.1109/ICDM.2013.167	64	51	55	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0181405	10.1371/journal.pone.0181405	http://dx.doi.org/10.1371/journal.pone.0181405			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194446	Green Published, Green Submitted, gold			2022-12-27	WOS:000416867800002
J	Hsu, SD; Lee, SY; Lin, KT; Lin, CS; Chien, WC; Chen, CJ; Chung, CH; Chang, WK				Hsu, Sheng-Der; Lee, Shih-Yu; Lin, Kuen-Tze; Lin, Chun-Shu; Chien, Wu-Chien; Chen, Cheng-Jueng; Chung, Chi-Hsiang; Chang, Wei-Kuo			Risk of infertility following pelvic angiographic embolization in female patients with pelvic fractures: A nationwide population-based cohort study in Taiwan	PLOS ONE			English	Article							INTERNAL ILIAC ARTERY; POSTPARTUM HEMORRHAGE; GLUTEAL NECROSIS; TRAUMA; PREGNANCY; FERTILITY; CANCER	Pelvic angiographic embolization is an effective procedure to provide haemostasis in patients with pelvic fractures. However, management with repeated follow-up radiographs may result in infertility. The study aimed to evaluate the risk of infertility following pelvic fracture treated with pelvic angiographic embolization in female patients. We used data from the National Health Insurance Research Database (NHIRD) provided by the Bureau of National Health Insurance of the Department of Health in Taiwan from the period of 1997 +/- 2010. A total of 36 and 18,029 patients were included in the case and control cohorts, respectively. The risk estimations for the case and control cohorts were compared using a Cox's proportional hazards regression model. The significance level was set at < 0.05. After adjusting for possible confounding factors, the incidence of infertility in the case cohort was nearly 30.7-fold higher than that in the control cohort (adjust hazard ratio [HR] = 30.7, 95% confidence interval [CI] = 10.643 +/- 70.109). Patients between 15 +/- 35 years of age had a much higher incidence of infertility in the case cohort than in the control cohort (adjusted HR = 49.9, 95% CI = 15.177 +/- 64.099). Taken together, pelvic fractures in female patients treated with arter-ioembolization for haemostasis might be associated with a higher risk of infertility in Taiwan. Physicians should be aware of the link and inform patients of this risk prior to arterioembolization.	[Hsu, Sheng-Der; Chen, Cheng-Jueng] Natl Def Med Ctr, Triserv Gen Hosp, Dept Surg, Div Traumat & Gen Surg, Taipei, Taiwan; [Lee, Shih-Yu] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan; [Lin, Kuen-Tze; Lin, Chun-Shu] Natl Def Med Ctr, Triserv Gen Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Natl Def Med Ctr, Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan; [Chang, Wei-Kuo] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital	Chang, WK (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan.	weikuohome@hotmail.com	Chung, Chi-Hsiang/AAY-3386-2021	Hsu, Sheng-Der/0000-0001-9698-8954; Lee, Shih-Yu/0000-0002-4713-6410; Chang, Wei-Kuo/0000-0002-5738-2797				Amer Soc Reprod Med, 2008, FERTIL STERIL, V90, pS60, DOI 10.1016/j.fertnstert.2008.08.065; [Anonymous], 1992, World Health Organ Tech Rep Ser, V820, P1; Auerbach AD, 2012, J ORTHOP TRAUMA, V26, P290, DOI 10.1097/BOT.0b013e31821f9574; Barton SE, 2013, LANCET ONCOL, V14, P873, DOI 10.1016/S1470-2045(13)70251-1; Chauleur C, 2008, HUM REPROD, V23, P1553, DOI 10.1093/humrep/den122; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; COLLINS JA, 1992, INT J GYNECOL OBSTET, V39, P267, DOI 10.1016/0020-7292(92)90257-J; Copeland CE, 1997, J ORTHOP TRAUMA, V11, P73, DOI 10.1097/00005131-199702000-00001; Croce MA, 2007, J AM COLL SURGEONS, V204, P935, DOI 10.1016/j.jamcollsurg.2007.01.059; Giannoudis PV, 2007, J TRAUMA, V63, P875, DOI 10.1097/01.ta.0000242259.67486.15; HARE WSC, 1983, RADIOLOGY, V146, P47, DOI 10.1148/radiology.146.1.6849068; Heckbert SR, 1998, J TRAUMA, V45, P545, DOI 10.1097/00005373-199809000-00022; Huang WY, 2012, RADIOTHER ONCOL, V104, P338, DOI 10.1016/j.radonc.2012.08.015; Lin KT, 2015, HEAD NECK-J SCI SPEC, V37, P413, DOI 10.1002/hed.23617; Liu FX, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001462; Salomon LJ, 2003, HUM REPROD, V18, P849, DOI 10.1093/humrep/deg168; Suzuki T, 2005, ARCH ORTHOP TRAUM SU, V125, P448, DOI 10.1007/s00402-005-0827-1; Takahira N, 2001, INJURY, V32, P27, DOI 10.1016/S0020-1383(00)00098-X; THONNEAU P, 1992, HUM REPROD, V7, P55, DOI 10.1093/oxfordjournals.humrep.a137557; THONNEAU P, 1993, INT J FERTIL, V38, P37; van Vugt AB, 2006, J BONE JOINT SURG BR, V88B, P427, DOI 10.1302/0301-620x.88b4.16693	21	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0174733	10.1371/journal.pone.0174733	http://dx.doi.org/10.1371/journal.pone.0174733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194450	gold, Green Published, Green Submitted			2022-12-27	WOS:000416867800001
J	Boin, F; Torchia, MLG; Borrello, I; Noonan, KA; Neil, M; Soloski, MJ; Cimbro, R				Boin, Francesco; Torchia, Maria Letizia Giardino; Borrello, Ivan; Noonan, Kimberly A.; Neil, Matthew; Soloski, Mark J.; Cimbro, Raffaello			Flow cytometric discrimination of seven lineage markers by using two fluorochromes	PLOS ONE			English	Article							CD8(+) T-CELLS; DIFFERENTIAL EXPRESSION; HELPER-CELLS; ACTIVATION	Flow cytometry is the primary immunological technique used to analyze multiple parameters on complex cell populations. We present a staining method that identifies major human mononuclear lymphoid and myeloid populations (CD4+ and CD8+ T cells, gamma delta T cells, B cells, NK cells and monocytes), using only two fluorochromes and a minimal number of cells. Our approach increases the number of markers recordable on most flow cytometers allowing for a deeper and more comprehensive immunophenotyping.	[Boin, Francesco; Neil, Matthew; Soloski, Mark J.; Cimbro, Raffaello] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD 21218 USA; [Torchia, Maria Letizia Giardino] Natl Canc Inst, Lab Immune Cell Biol, NIH, Bethesda, MD USA; [Borrello, Ivan; Noonan, Kimberly A.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Boin, Francesco] Univ Calif San Francisco, Div Rheumatol, San Francisco, CA USA; [Torchia, Maria Letizia Giardino] Medimmune LLC, Oncol Res, Gaithersburg, MD USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; University of California System; University of California San Francisco; AstraZeneca; Medimmune	Cimbro, R (corresponding author), Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD 21218 USA.	rcimbro1@jhmi.edu	Boin, Francesco/AAI-1471-2021	Boin, Francesco/0000-0003-4840-3063; Cimbro, Raffaello/0000-0002-6251-5160; Neil, Matthew/0000-0003-0972-0859	National Institute of Arthritis and Musculoskeletal and Skin Diseases [P30-AR053503]; Stabler Foundation; National Institute of Allergy and Infectious Disease [T32AI007247]; Nina Ireland Program for Lung Health, (NIPLH)	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Stabler Foundation; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Nina Ireland Program for Lung Health, (NIPLH)	This study was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, https://www.niams.nih.gov/, award number P30-AR053503; The Stabler Foundation, www.stablerfoundation.org; National Institute of Allergy and Infectious Disease, www.niaid.nih.gov, T32AI007247; Nina Ireland Program for Lung Health, (NIPLH), https://pulmonary.ucsf.edu/ireland/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010; Bocsi J, 2014, CYTOM PART A, V85A, P781, DOI 10.1002/cyto.a.22505; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Bradford JA, 2004, CYTOM PART A, V61A, P142, DOI 10.1002/cyto.a.20037; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Caruso A, 1997, CYTOMETRY, V27, P71, DOI 10.1002/(SICI)1097-0320(19970101)27:1<71::AID-CYTO9>3.0.CO;2-O; Focosi D, 2010, J LEUKOCYTE BIOL, V87, P107, DOI 10.1189/jlb.0809566; Fujimiya Y, 1997, CLIN CANCER RES, V3, P633; Ginaldi L, 1996, J CLIN PATHOL, V49, P539, DOI 10.1136/jcp.49.7.539; Lambert C, 2004, CYTOM PART B-CLIN CY, V61B, P45, DOI 10.1002/cyto.b.20005; Mahnke YD, 2013, CYTOM PART A, V83A, P439, DOI 10.1002/cyto.a.22269; MANSOUR I, 1990, CYTOMETRY, V11, P636, DOI 10.1002/cyto.990110512; Noonan KA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7014; Park J, 2012, ANN LAB MED, V32, P171, DOI 10.3343/alm.2012.32.3.171; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Speiser DE, 2001, EUR J IMMUNOL, V31, P459, DOI 10.1002/1521-4141(200102)31:2<459::AID-IMMU459>3.0.CO;2-Y; van Dongen JJM, 2012, LEUKEMIA, V26, P1908, DOI 10.1038/leu.2012.120; Ye ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031710; Zola H, LEUKOCYTE STROMAL CE	20	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188916	10.1371/journal.pone.0188916	http://dx.doi.org/10.1371/journal.pone.0188916			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190813	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900168
J	Jiao, DM; Yan, L; Wang, LS; Hu, HZ; Tang, XL; Chen, J; Wang, J; Li, Y; Chen, QY				Jiao, De-min; Yan, Li; Wang, Li-shan; Hu, Hui-zhen; Tang, Xia-li; Chen, Jun; Wang, Jian; Li, You; Chen, Qing-yong		PLOS ONE Editors	RETRACTION: Exploration of inhibitory mechanisms of curcumin in lung cancer metastasis using a miRNA-transcription factor-target gene network (Retraction of Vol 12, art no E0172470, 2017)	PLOS ONE			English	Retraction																		Jiao DM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172470	1	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0189070	10.1371/journal.pone.0189070	http://dx.doi.org/10.1371/journal.pone.0189070			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190828	gold, Green Submitted, Green Published			2022-12-27	WOS:000416841900198
J	Puls, TJ; Tan, XH; Whittington, CF; Voytik-Harbin, SL				Puls, T. J.; Tan, Xiaohong; Whittington, Catherine F.; Voytik-Harbin, Sherry L.			3D collagen fibrillar microstructure guides pancreatic cancer cell phenotype and serves as a critical design parameter for phenotypic models of EMT	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; IN-VITRO; TUMOR-MICROENVIRONMENT; INVASION; DESMOPLASIA; EXPRESSION; BIOMARKERS; TRANSPORT; STIFFNESS; PROMOTES	Pancreatic cancer, one of the deadliest cancers, is characterized by high rates of metastasis and intense desmoplasia, both of which are associated with changes in fibrillar type I collagen composition and microstructure. Epithelial to mesenchymal transition (EMT), a critical step of metastasis, also involves a change in extracellular matrix (ECM) context as cells detach from basement membrane (BM) and engage interstitial matrix (IM). The objective of this work was to develop and apply an in-vitro three-dimensional (3D) tumor-ECM model to define how ECM composition and biophysical properties modulate pancreatic cancer EMT. Three established pancreatic ductal adenocarcinoma (PDAC) lines were embedded within 3D matrices prepared with type I collagen Oligomer (IM) at various fibril densities to control matrix stiffness or Oligomer and Matrigel combined at various ratios while maintaining constant matrix stiffness. Evaluation of cell morphology and protein expression at both the cellular-and population-levels revealed a spectrum of matrix-driven EMT phenotypes that were dependent on ECM composition and architecture as well as initial PDAC phenotype. In general, exposure to fibrillar IM was sufficient to drive EMT, with cells displaying spindle-shaped morphology and mesenchymal markers, and non-fibrillar BM promoted more epithelial behavior. When cultured within low density Oligomer, only a subpopulation of epithelial BxPC-3 cells displayed EMT while mesenchymal MiaPaCa-2 cells displayed more uniform spindle-shaped morphologies and mesenchymal marker expression. Interestingly, as IM fibril density increased, associated changes in spatial constraints and matrix stiffness resulted in all PDAC lines growing as tight clusters; however mesenchymal marker expression was maintained. Collectively, the comparison of these results to other in-vitro tumor models highlights the role of IM fibril microstructure in guiding EMT heterogeneity and showcases the potential of standardized 3D matrices such as Oligomer to serve as robust platforms for mechanistic study of metastasis and creation of predictive drug screening models.	[Puls, T. J.; Tan, Xiaohong; Whittington, Catherine F.; Voytik-Harbin, Sherry L.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Whittington, Catherine F.] Eli Lilly & Co, Dept Oncol, Indianapolis, IN 46285 USA; [Voytik-Harbin, Sherry L.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Eli Lilly; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Voytik-Harbin, SL (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.; Voytik-Harbin, SL (corresponding author), Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA.	harbins@purdue.edu		Whittington, Catherine/0000-0002-5821-4437	Birck Nanotechnology Graduate Research Fellowship; Lilly Innovation Fellowship Award; Purdue University Office of the Executive Vice President for Research and Partnerships Incentive Grant Program; Eli Lilly	Birck Nanotechnology Graduate Research Fellowship; Lilly Innovation Fellowship Award; Purdue University Office of the Executive Vice President for Research and Partnerships Incentive Grant Program; Eli Lilly(Eli Lilly)	This study was supported by a Birck Nanotechnology Graduate Research Fellowship (TJP), a Lilly Innovation Fellowship Award (CFW), and the Purdue University Office of the Executive Vice President for Research and Partnerships Incentive Grant Program (SLVH). Eli Lilly provided support in the form of salary for CFW and research supplies, but did not have any additional role in the study design, data collection or analysis. Because of this affiliation, CFW's mentors at Eli Lilly provided editorial review of the manuscript, and Eli Lilly gave internal approval for publication.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Armstrong T, 2004, CLIN CANCER RES, V10, P7427, DOI 10.1158/1078-0432.CCR-03-0825; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; ASTM International, 2014, ASTM STAND F3089 STA; Bailey JL, 2011, BIOPOLYMERS, V95, P77, DOI 10.1002/bip.21537; Benton G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123312; Benton G, 2014, ADV DRUG DELIVER REV, V79-80, P3, DOI 10.1016/j.addr.2014.06.005; Benton G, 2011, INT J CANCER, V128, P1751, DOI 10.1002/ijc.25781; Benton G, 2009, FASEB J, V23, P3884, DOI 10.1096/fj.08-128702; Bidarra SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27072; Birk DE, 2011, BIOL EXTRACELL MATR, P77, DOI 10.1007/978-3-642-16555-9_3; Blum KM, 2016, BIOMATER SCI-UK, V4, P711, DOI 10.1039/c5bm00443h; Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003; Brightman AO, 2000, BIOPOLYMERS, V54, P222; Brookes S, 2017, LARYNGOSCOPE; Carey SP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42088; Cassereau L, 2015, J BIOTECHNOL, V193, P66, DOI 10.1016/j.jbiotec.2014.11.008; Creighton Chad J, 2013, Cancer Manag Res, V5, P187, DOI 10.2147/CMAR.S35171; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Gore J, 2014, CANCER CELL, V25, P711, DOI 10.1016/j.ccr.2014.05.026; Guzman A, 2014, BIOMATERIALS, V35, P6954, DOI 10.1016/j.biomaterials.2014.04.086; Hamed SS, 2013, CANCER CHEMOTH PHARM, V72, P553, DOI 10.1007/s00280-013-2226-6; Han B, 2016, CANCER LETT, V380, P319, DOI 10.1016/j.canlet.2015.12.003; Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001; Herrera-Perez M, 2015, TISSUE ENG PT A, V21, P2572, DOI [10.1089/ten.tea.2014.0504, 10.1089/ten.TEA.2014.0504]; Johnson KR, 2007, METHOD CELL BIOL, V83, P547, DOI 10.1016/S0091-679X(07)83023-8; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Katz E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017083; Ki CS, 2014, BIOMATERIALS, V35, P9668, DOI 10.1016/j.biomaterials.2014.08.014; Nguyen-Ngoc KV, 2012, P NATL ACAD SCI USA, V109, pE2595, DOI 10.1073/pnas.1212834109; Kimlin LC, 2013, MOL CARCINOGEN, V52, P167, DOI 10.1002/mc.21844; Klemm F, 2015, TRENDS CELL BIOL, V25, P198, DOI 10.1016/j.tcb.2014.11.006; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Koenig A, 2006, CANCER RES, V66, P4662, DOI 10.1158/0008-5472.CAN-05-2804; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Kreger ST, 2010, BIOPOLYMERS, V93, P690, DOI 10.1002/bip.21431; Lam CRI, 2014, MOL PHARMACEUT, V11, P2016, DOI 10.1021/mp500059q; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee DW, 2014, ANAL CHEM, V86, P535, DOI 10.1021/ac402546b; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Malik R, 2015, TRENDS BIOTECHNOL, V33, P230, DOI 10.1016/j.tibtech.2015.01.004; Mandal M, 2016, INTEGR BIOL-UK, V8, P167, DOI 10.1039/c5ib00219b; Markowski MC, 2012, J BIOMED MATER RES A, V100A, P2119, DOI 10.1002/jbm.a.34068; Medici D, 2010, MATRIX BIOL, V29, P161, DOI 10.1016/j.matbio.2009.12.003; Menke A, 2001, CANCER RES, V61, P3508; Monteleon CL, 2012, MOL BIOL CELL, V23, P4495, DOI 10.1091/mbc.E12-03-0246; Morris HT, 2015, BRIT J CANCER, V112, P613, DOI 10.1038/bjc.2014.658; Multhaupt HAB, 2016, ADV DRUG DELIVER REV, V97, P28, DOI 10.1016/j.addr.2015.10.013; National Cancer Institute, 2014, SCI FRAM PANCR DUCT; O'Connor JW, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-23; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g; Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Sapudom J, 2015, BIOMATERIALS, V52, P367, DOI 10.1016/j.biomaterials.2015.02.022; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Shields MA, 2012, BIOCHEM J, V441, P541, DOI 10.1042/BJ20111240; Tang D, 2013, INT J CANCER, V132, P993, DOI 10.1002/ijc.27715; Taubenberger AV, 2016, ACTA BIOMATER, V36, P73, DOI 10.1016/j.actbio.2016.03.017; Teixido C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053645; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; van der Zee JA, 2012, BRIT J CANCER, V107, P1153, DOI 10.1038/bjc.2012.373; Walsh LA, 2011, MATRIX BIOL, V30, P243, DOI 10.1016/j.matbio.2011.03.007; Wei SC, 2015, CELL CYCLE, V14, P2387, DOI 10.1080/15384101.2015.1063296; Wei SC, 2015, NAT CELL BIOL, V17, P678, DOI 10.1038/ncb3157; Weigelt B, 2014, ADV DRUG DELIVER REV, V69, P42, DOI 10.1016/j.addr.2014.01.001; Whatcott CJ., 2012, DESMOPLASIA CHEMORES; Whatcott CJ, 2015, CLIN CANCER RES, V21, P3561, DOI 10.1158/1078-0432.CCR-14-1051; Whittington CF, 2013, MICROSC MICROANAL, V19, P1323, DOI 10.1017/S1431927613001931; Whittington CF, 2013, MACROMOL BIOSCI, P1; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	81	38	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188870	10.1371/journal.pone.0188870	http://dx.doi.org/10.1371/journal.pone.0188870			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190794	gold, Green Published, Green Submitted			2022-12-27	WOS:000416841900150
J	Morera-Fumero, AL; Diaz-Mesa, E; Abreu-Gonzalez, P; Fernandez-Lopez, L; Guillen-Pino, F				Morera-Fumero, Armando L.; Diaz-Mesa, Estefania; Abreu-Gonzalez, Pedro; Fernandez-Lopez, Lourdes; Guillen-Pino, Fernando			A three-month longitudinal study of changes in day/night serum total antioxidant capacity in paranoid schizophrenia	PLOS ONE			English	Article							NEGATIVE SYMPTOMS; OXIDATIVE STRESS; MELATONIN; SYSTEMS	Free radicals and an oxidant/antioxidant imbalance have been involved in the schizophrenia pathophysiology. The total antioxidant capacity (TAC) is a measure of the antioxidant capacity of a system. Day/night changes are a biological characteristic of hormones such as melatonin or cortisol. There is little information about TAC day/night changes in schizophrenia patients. The aim of this research is to study if there are day/night changes in serum TAC levels of schizophrenia patients. Thirty-two DSM-IV schizophrenia paranoid patients were studied. Blood was sampled at 12:00 and 00:00 h at admission, discharge and three months after hospital discharge (TMAHD). TAC results are expressed as mmol of Trolox/L. Patients did not have day/night TAC differences at admission (12:00:0.67 +/- 0.12 vs. 00:00:0.61 +/- 0.14, p > 0.14) or discharge (12:00:0.65 +/- 0.15 vs. 00:00:0.65 +/- 0.12, p > 0.99). At TMHD, patients had significantly higher TAC levels at midday than midnight (12:00:0.83 +/- 0.10 vs. 00:00:0.74 +/- 0.12, p < 0.006) as it has been reported in healthy subjects. There were no significant TAC differences at 12.00 and 00:00 between admission and discharge. At TMAHD, patients had significantly higher TAC levels than at admission and discharge, both at 12:00 and 00:00 h. In conclusion, the absence of day/night serum TAC changes when clinically relapsed and the normalization of day/night serum TAC changes at TMHD can be considered as a biological marker of schizophrenia evolution.	[Morera-Fumero, Armando L.; Fernandez-Lopez, Lourdes; Guillen-Pino, Fernando] Univ La Laguna, Fac Ciencias Salud, Dept Med Interna Dermatol & Psiquiatria, San Cristobal la Laguna, Santa Cruz De T, Spain; [Morera-Fumero, Armando L.] Consultoria Psiquiatr SC, Santa Cruz De Tenerife, Spain; [Diaz-Mesa, Estefania] Hosp Univ Canarias, Serv Psiquiatria, San Cristobal la Laguna, Santa Cruz De T, Spain; [Abreu-Gonzalez, Pedro] Univ La Laguna, Fac Ciencias Salud, Unidad Fisiol, Dept Ciencias Med Basicas, San Cristobal la Laguna, Santa Cruz De T, Spain; [Fernandez-Lopez, Lourdes] Soc Invest & Asistencia Salud Mental, Santa Cruz De Tenerife, Spain	Universidad de la Laguna; Universidad de la Laguna; Universidad de la Laguna	Morera-Fumero, AL (corresponding author), Univ La Laguna, Fac Ciencias Salud, Dept Med Interna Dermatol & Psiquiatria, San Cristobal la Laguna, Santa Cruz De T, Spain.; Morera-Fumero, AL (corresponding author), Consultoria Psiquiatr SC, Santa Cruz De Tenerife, Spain.	amorera@ull.es	Fumero, Armando Morera/M-3394-2019; Abreu-Gonzalez, Pedro/AAC-7790-2020	Fumero, Armando Morera/0000-0002-7663-1154; Abreu-Gonzalez, Pedro/0000-0002-7553-1784	Fundacion Canaria de Investigacion y Salud (FUNCIS) [PI: 08/115]; Consultoria Psiquiatrica SC	Fundacion Canaria de Investigacion y Salud (FUNCIS); Consultoria Psiquiatrica SC	This work was partly supported by a research grant (PI: 08/115) of the Fundacion Canaria de Investigacion y Salud (FUNCIS), which is part of the local government of the Canary Islands. The Consultoria Psiquiatrica SC provided support in the form of salary for authors (ALMF) but did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Al-Chalabi BM, 2009, NEUROPSYCHOBIOLOGY, V59, P8, DOI 10.1159/000202823; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Benot S, 1999, J PINEAL RES, V27, P59, DOI 10.1111/j.1600-079X.1999.tb00597.x; Chen DC, 2010, J PSYCHIATR RES, V44, P1111, DOI 10.1016/j.jpsychires.2010.03.008; Dietrich-Muszalska A, 2010, PSYCHIAT CLIN NEUROS, V64, P469, DOI 10.1111/j.1440-1819.2010.02132.x; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Falkai P, 2012, EUR ARCH PSY CLIN N, V262, P93, DOI 10.1007/s00406-012-0294-y; Flatow J, 2013, BIOL PSYCHIAT, V74, P400, DOI 10.1016/j.biopsych.2013.03.018; Gunes M, 2017, PSYCHIAT CLIN PSYCH, V27, P54, DOI 10.1080/24750573.2017.1293243; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; International Union of Pure and Applied Chemistry (IUPAC), 1997, RAD FREE RAD COMP CH, P1234; MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407; Morera AL, 2007, J PINEAL RES, V43, P313, DOI 10.1111/j.1600-079X.2007.00467.x; Morera AL, 2009, WORLD J BIOL PSYCHIA, V10, P576, DOI 10.1080/15622970801901802; Morera-Fumero AL, 2018, MED CHEM, V14, P225, DOI 10.2174/1573406413666171002123158; Morera-Fumero AL, 2017, PSYCHIAT RES, V249, P200, DOI 10.1016/j.psychres.2017.01.043; Morera-Fumero AL, 2013, INT J MOL SCI, V14, P9037, DOI 10.3390/ijms14059037; Nakano Y, 2010, HUM PSYCHOPHARM CLIN, V25, P139, DOI 10.1002/hup.1102; Pazvantoglu O, 2009, PSYCHIAT CLIN NEUROS, V63, P693, DOI 10.1111/j.1440-1819.2009.02015.x; Raffa M, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-124; Raffa M, 2012, PROG NEURO-PSYCHOPH, V39, P52, DOI 10.1016/j.pnpbp.2012.05.005; Sarandol A, 2007, PROG NEURO-PSYCHOPH, V31, P1164, DOI 10.1016/j.pnpbp.2007.03.008; Ustundag B, 2006, PSYCHIAT CLIN NEUROS, V60, P458, DOI 10.1111/j.1440-1819.2006.01532.x; Virit O, 2009, NEUROPSYCHOBIOLOGY, V60, P87, DOI 10.1159/000239684; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Wu JQ, 2013, PROG NEURO-PSYCHOPH, V46, P200, DOI 10.1016/j.pnpbp.2013.02.015; Yao JK, 1998, SCHIZOPHR RES, V32, P1, DOI 10.1016/S0920-9964(98)00030-9; Zhang XY, 2012, SCHIZOPHR RES, V139, P66, DOI 10.1016/j.schres.2012.04.009	28	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189348	10.1371/journal.pone.0189348	http://dx.doi.org/10.1371/journal.pone.0189348			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP2SV	29220388	gold, Green Submitted, Green Published			2022-12-27	WOS:000417469900052
J	Zheng, XW; Li, XH; Ge, C; Chang, JZ; Shi, MM; Chen, JL; Qiao, LY; Chang, ZJ; Zheng, J; Zhang, JC				Zheng, Xingwei; Li, Xiaohua; Ge, Chuan; Chang, Jianzhong; Shi, Mengmeng; Chen, Jianli; Qiao, Linyi; Chang, Zhijian; Zheng, Jun; Zhang, Jiancheng			Characterization of the CCT family and analysis of gene expression in Aegilops tauschii	PLOS ONE			English	Article							CONSTANS-LIKE GENE; PHOTOPERIOD SENSITIVITY; RESPONSE REGULATOR; NATURAL VARIATION; RICE CULTIVATION; PERIOD LENGTH; PROTEIN; ENCODES; TOC1; FT	Flowering is crucial for reproductive success in flowering plant. The CCT domain-containing genes widely participate in the regulation of flowering process in various plant species. So far, the CCT family in common wheat is largely unknown. Here, we characterized the structure, organization, molecular evolution and expression of the CCT genes in Aegilops tauschii, which is the D genome donor of hexaploid wheat. Twenty-six CCT genes (AetCCT) were identified from the full genome of A. tauschii and these genes were distributed on all 7 chromosomes. Phylogenetic analysis classified these AetCCT genes into 10 subgroups. Thirteen AetCCT members in group A, C, H and G achieved rapid evolution based on evolutionary rate analysis. The AetCCT genes respond to different exogenous hormones and abiotic treatments, the expression of AetCCT4, 7, 8, 11, 12, 16, 17, 19, 21 and 22 showed a significant 24 h rhythm. This study may provide a reference for common wheat's evolution, domestication and evolvement rules, and also help us to understand the ecological ability of A. tauschii.	[Zheng, Xingwei; Li, Xiaohua; Shi, Mengmeng; Zheng, Jun; Zhang, Jiancheng] Shanxi Acad Agr Sci, Inst Wheat Res, Linfen, Peoples R China; [Ge, Chuan; Chang, Jianzhong; Qiao, Linyi; Chang, Zhijian] Shanxi Acad Agr Sci, Inst Crop Sci, Shanxi Key Lab Crop Genet & Mol Improvement, Taiyuan, Shanxi, Peoples R China; [Chen, Jianli] Univ Idaho, Dept Plant Soil & Entomol Sci, Moscow, ID 83843 USA	Shanxi Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Shanxi Agricultural University; Idaho; University of Idaho	Zheng, J; Zhang, JC (corresponding author), Shanxi Acad Agr Sci, Inst Wheat Res, Linfen, Peoples R China.	sxnkyzj@126.com; zhangjc@126.com			National Natural Science Foundation of China [31601307]; Natural Science Foundation of Shanxi Province, China [2016011001]; National Key Research Project [2017YFD0100600]; Shanxi Academy of Agricultural Sciences [17yzgc010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanxi Province, China(Natural Science Foundation of Shanxi Province); National Key Research Project; Shanxi Academy of Agricultural Sciences	This work was supported by the National Natural Science Foundation of China (31601307); Natural Science Foundation of Shanxi Province, China (2016011001); The National Key Research Project (2017YFD0100600); Breeding Project of Shanxi Academy of Agricultural Sciences (17yzgc010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng XF, 2005, PLANT J, V43, P758, DOI 10.1111/j.1365-313X.2005.02491.x; Cockram J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045307; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Fang F., 2013, CIRP ANN-MANUF TECHN, V62, P2; Gao H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003281; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P140, DOI 10.1073/pnas.0407735101; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Groussin M, 2011, MOL BIOL EVOL, V28, P2661, DOI 10.1093/molbev/msr098; Grundy J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00648; Harmon F, 2008, PLANT J, V55, P568, DOI 10.1111/j.1365-313X.2008.03527.x; Haydon MJ, 2013, NATURE, V502, P689, DOI 10.1038/nature12603; Hicks KA, 2001, PLANT CELL, V13, P1281, DOI 10.1105/tpc.13.6.1281; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Kappler BF, 2002, WEED TECHNOL, V16, P102, DOI 10.1614/0890-037X(2002)016[0102:WPDIJG]2.0.CO;2; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Khanna R, 2009, PLANT CELL, V21, P3416, DOI 10.1105/tpc.109.069088; Kim J, 2008, PLANT CELL, V20, P307, DOI 10.1105/tpc.107.055715; Kim SK, 2008, PLANTA, V228, P355, DOI 10.1007/s00425-008-0742-0; Kim SK, 2013, PLANT SCI, V199, P71, DOI 10.1016/j.plantsci.2012.09.019; Koo BH, 2013, MOL PLANT, V6, P1877, DOI 10.1093/mp/sst088; Lee YS, 2010, PLANT J, V63, P18, DOI 10.1111/j.1365-313X.2010.04226.x; Li C, 2012, MOL BIOL EVOL, V29, P3227, DOI 10.1093/molbev/mss131; Li JH, 2007, PLANT J, V51, P18, DOI 10.1111/j.1365-313X.2007.03125.x; Liu JH, 2016, J EXP BOT, V67, P5785, DOI 10.1093/jxb/erw344; Lu SX, 2011, PLANT PHYSIOL, V157, P1537, DOI 10.1104/pp.111.179846; Murakami M, 2003, PLANT CELL PHYSIOL, V44, P1229, DOI 10.1093/pcp/pcg135; Nakamura Y, 2007, BIOSCI BIOTECH BIOCH, V71, P1183, DOI 10.1271/bbb.60643; Ogiso E, 2010, PLANT PHYSIOL, V152, P808, DOI 10.1104/pp.109.148908; Panda S, 2002, DEV CELL, V3, P51, DOI 10.1016/S1534-5807(02)00200-9; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Saito H, 2012, PLANT CELL PHYSIOL, V53, P717, DOI 10.1093/pcp/pcs029; Strader LC, 2010, PLANT J, V64, P874, DOI 10.1111/j.1365-313X.2010.04373.x; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; [苏亚蕊 SU Yarui], 2010, [生态学报, Acta Ecologica Sinica], V30, P969; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Wang L, 2010, EMBO J, V29, P1903, DOI 10.1038/emboj.2010.76; Weng XY, 2014, PLANT PHYSIOL, V164, P735, DOI 10.1104/pp.113.231308; Wu FQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085754, 10.1371/journal.pone.0087251]; Wu WX, 2013, P NATL ACAD SCI USA, V110, P2775, DOI 10.1073/pnas.1213962110; Yan WH, 2013, CELL RES, V23, P969, DOI 10.1038/cr.2013.43; Yang Q, 2013, P NATL ACAD SCI USA, V110, P16969, DOI 10.1073/pnas.1310949110; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Young FL, 2010, WEED TECHNOL, V24, P430, DOI 10.1614/WT-D-10-00046.1; Zhang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep07663	45	12	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189333	10.1371/journal.pone.0189333	http://dx.doi.org/10.1371/journal.pone.0189333			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220383	Green Published, gold, Green Submitted			2022-12-27	WOS:000417469900050
J	Cheng, B; Knaack, C; Forkert, ND; Schnabel, R; Gerloff, C; Thomalla, G				Cheng, Bastian; Knaack, Christian; Forkert, Nils Daniel; Schnabel, Renate; Gerloff, Christian; Thomalla, Goetz			Stroke subtype classification by geometrical descriptors of lesion shape	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; ISCHEMIC-STROKE; UNDETERMINED SOURCE; EMBOLIC STROKE; PATTERNS; VOLUME; VALIDITY; INFARCTS; MRI	Background and purpose Inference of etiology from lesion pattern in acute magnetic resonance imaging is valuable for management and prognosis of acute stroke patients. This study aims to assess the value of three-dimensional geometrical lesion-shape descriptors for stroke-subtype classification, specifically regarding stroke of cardioembolic origin. Methods Stroke Etiology was classified according to ASCOD in retrospectively selected patients with acute stroke. Lesions were segmented on diffusion-weighed datasets, and descriptors of lesion shape quantified: surface area, sphericity, bounding box volume, and ratio between bounding box and lesion volume. Morphological measures were compared between stroke subtypes classified by ASCOD and between patients with embolic stroke of cardiac and non-cardiac source. Results 150 patients (mean age 77 years; 95% CI, 65-80 years; median NIHSS 6, range 0-22) were included. Group comparison of lesion shape measures demonstrated that lesions caused by small-vessel disease were smaller and more spherical compared to other stroke subtypes. No significant differences of morphological measures were detected between patients with cardioembolic and non-cardioembolic stroke. Conclusion Stroke lesions caused by small vessel disease can be distinguished from other stroke lesions based on distinctive morphological properties. However, within the group of embolic strokes, etiology could not be inferred from the morphology measures studied in our analysis.	[Cheng, Bastian; Knaack, Christian; Gerloff, Christian; Thomalla, Goetz] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Forkert, Nils Daniel] Hotchkiss Brains Inst, Dept Radiol, Calgary, AB, Canada; [Schnabel, Renate] Univ Heart Ctr Hamburg Eppendorf, Dept Gen & Intervent Cardiol, German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; University of Hamburg; University Medical Center Hamburg-Eppendorf	Cheng, B (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.	b.cheng@uke.de	Schnabel, Renate B/ABE-6668-2021; Forkert, Nils Daniel/K-6273-2012	Schnabel, Renate B/0000-0001-7170-9509; Forkert, Nils Daniel/0000-0003-2556-3224; Gerloff, Christian/0000-0002-6484-8882	Deutsche Stiftung fur Herzforschung (German Heart Research Foundation) [F 24/16]	Deutsche Stiftung fur Herzforschung (German Heart Research Foundation)	We disclose that this work has been funded by the Deutsche Stiftung fur Herzforschung (German Heart Research Foundation) via grant no. F 24/16 (Recipient: Bastian Cheng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2015, STROKE, V46, pE114, DOI 10.1161/STROKEAHA.114.007773; Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Alhadramy O, 2010, STROKE, V41, P2596, DOI 10.1161/STROKEAHA.109.570382; Amarenco P, 2013, CEREBROVASC DIS, V36, P1, DOI 10.1159/000352050; Arboix A, 2012, CURR CARDIOL REV, V8, P54, DOI 10.2174/157340312801215791; Asdaghi N, 2014, STROKE, V45, P2952, DOI 10.1161/STROKEAHA.114.005211; Ay H, 2014, STROKE, V45, P3589, DOI 10.1161/STROKEAHA.114.007362; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bernstein RA, 2015, CEREBROVASC DIS, V40, P91, DOI 10.1159/000437018; Bhatt A, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/172074; Depuydt S, 2014, J NEUROL SCI, V337, P151, DOI 10.1016/j.jns.2013.11.039; Forkert ND, 2014, METHOD INFORM MED, V53, P1; Frindel C, 2015, STROKE, V46, P976, DOI 10.1161/STROKEAHA.114.008046; Gan R, 1997, NEUROLOGY, V48, P1204, DOI 10.1212/WNL.48.5.1204; Hart RG, 2014, ANN INTERNAL MED REV; Hart RG, 2014, LANCET NEUROL, V13, P429, DOI 10.1016/S1474-4422(13)70310-7; Herve D, 2005, STROKE, V36, P2384, DOI 10.1161/01.STR.0000185678.26296.38; Jorgensen HS, 1996, STROKE, V27, P1765, DOI 10.1161/01.STR.27.10.1765; Kamel H, 2016, STROKE, V47, P895, DOI 10.1161/STROKEAHA.115.012004; Kang DW, 2003, ARCH NEUROL-CHICAGO, V60, P1730, DOI 10.1001/archneur.60.12.1730; Kim YD, 2011, EUR NEUROL, V66, P145, DOI 10.1159/000330563; Kishore A, 2014, STROKE, V45, P520, DOI 10.1161/STROKEAHA.113.003433; Kolominsky-rabas PL, 2001, EPIDEMIOLOGY ISCHEMI, P2735; Lee BI, 2001, CEREBROVASC DIS, V12, P145, DOI 10.1159/000047697; Novotny V, 2016, ACUTE CEREBRAL INFAR, P1; Ogata T, 2011, STROKE, V42, P1596, DOI 10.1161/STROKEAHA.110.609016; Olivot JM, 2009, STROKE, V40, P3245, DOI 10.1161/STROKEAHA.109.558635; Perera KS, 2016, STROKE, V47, P2197, DOI 10.1161/STROKEAHA.116.013378; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; Wessels T, 2005, STROKE, V36, P757, DOI 10.1161/01.STR.0000158908.48022.d7; Wessels T, 2006, CONTRIBUTION DIFFUSI	31	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0185063	10.1371/journal.pone.0185063	http://dx.doi.org/10.1371/journal.pone.0185063			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216218	gold, Green Submitted, Green Published			2022-12-27	WOS:000417337800001
J	Cheng, LM; Yan, W; Zhu, LP; Chen, YY; Liu, J; Xu, Y; Ji, L; He, JR				Cheng, Lengmei; Yan, Wei; Zhu, Liping; Chen, Yiying; Liu, Jie; Xu, Yan; Ji, Lu; He, Junrong			Comparative analysis of IDF, ATPIII and CDS in the diagnosis of metabolic syndrome among adult inhabitants in Jiangxi Province, China	PLOS ONE			English	Article							PREVALENCE	Background Currently, the prevalence of metabolic syndrome (MS) has attracted widespread public attention. However, there is a war regarding the applicability of the diagnosis in different populations regarding the distinct criteria for the diagnosis of MS. Data about the prevalence rate of MS and its components in Jiangxi Province are limited. Thus, our goals were to compare the consistency rates and applicability of three criteria, i.e., those of the International Diabetes Federation (IDF), the National Cholesterol Education Program Adult Treatment PanelIII (ATPIII), and the Chinese Diabetes Society (CDS). Methods From September 2013 to March 2014, 5959 residents (age >= 18 years) from Jiangxi Province were selected by multistage stratified cluster random sampling methods. The prevalence rate of MS and its components were calculated according to the IDF, ATPIII and CDS criteria, and the protocols of the different criteria were measured in terms of consistency with the kappa statistic and Youden's index. Receiver operator characteristic (ROC) curve analysis was used to explore the optimal cut-off points of body mass index (BMI) and waist circumference (WC). Results The mean age of the participants was 50.52 +/- 13.92 years among the total of 5959 individuals (2451 male and 3508 female). The standardized prevalence rate of MS was 19.85%, 24.77% and 9.95% according to the IDF, ATPIII and CDS criteria, respectively. The order of the prevalence rates of the different components of MS according to the IDF or ATPIII criteria from high to low were as follows: elevated blood pressure, central obesity, reduced high density lipoprotein cholesterol (HDL-C), hyperglycemia, and hypertriglyceridemia. The most prevalent component of MS, according to the CDS criterion, was being overweight or obese, followed by elevated blood pressure, dyslipidemia and hyperglycemia. The Youden's index in IDF criterion was higher than which in CDS criterion (0.79 for IDF vs. 0.38 for CDS) referring to the ATPIII criterion. The agreement between the IDF and ATPIII criteria was good (kappa = 0.85), whereas the agreement of the CDS with the IDF and ATPIII criteria was moderate (kappa = 0.46 and 0.46, respectively). The ability to predict MS risk factors clusters was superior when the BMI cut-off point was 24/24kg/m(2) (male/female), and the WC cut-off point was 87/80cm (male/female). Among the 18 similar to 59 years old male group, BMI was superior to WC in predicting clusters of risk factors for MS; while in the 60 years and above male group and all-age female group, WC was superior to BMI. Conclusion Our results revealed that the prevalence rate of metabolic syndrome among adults was high in Jiangxi Province. BMI and WC had different ability to predict clusters of risk factors for MS in different age groups and gender. Among the three criteria for MS, there was bigger difference in applicability for the adults of Jiangxi Province. The choice of the appropriate criteria should be based on the actual conditions of the site.	[Cheng, Lengmei; Zhu, Liping] Nanchang Univ, Sch Publ Hlth, Nanchang, Jiangxi, Peoples R China; [Yan, Wei; Zhu, Liping; Chen, Yiying; Liu, Jie; Xu, Yan; Ji, Lu] Jiangxi Prov Ctr Dis Control & Prevent, Nanchang, Jiangxi, Peoples R China; [He, Junrong] Ganzhou Peoples Hosp, Ganzhou, Peoples R China	Nanchang University	Zhu, LP (corresponding author), Nanchang Univ, Sch Publ Hlth, Nanchang, Jiangxi, Peoples R China.; Zhu, LP (corresponding author), Jiangxi Prov Ctr Dis Control & Prevent, Nanchang, Jiangxi, Peoples R China.	zlp210@126.com			Central Government of China	Central Government of China	This work was supported by Programs of Transfer Payment from Central Government of China (2013).; We are grateful to the residents who participated in the research, to the Centers for Disease Control and Prevention of the 10 disease surveillance points and to all field investigators for their support and hard work during the research. This study was funded by the Programs of Transfer Payment from the Central Government of China (2013).	Al-Daghri NM, 2013, NUTRIENTS, V5, P4587, DOI 10.3390/nu5114587; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; [Anonymous], 2007, ZHONGHUA XIN XUE GUA, V35, P390, DOI DOI 10.3760/J.ISSN:0253-3758.2007.05.003; Bener A, 2013, J OBES, V2013, DOI 10.1155/2013/269038; Tran BT, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3936-6; Cameron AJ, 2007, DIABETES RES CLIN PR, V77, P471, DOI 10.1016/j.diabres.2007.02.002; Chen Rong, 2008, Zhonghua Fu Chan Ke Za Zhi, V43, P36; Falkner B, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0449-5; Fei Yang-Fan, 2012, Sichuan Da Xue Xue Bao Yi Xue Ban, V43, P547; Gharipour M, 2013, CHOLESTEROL, DOI 10.1155/2013/198384; group C.D.S.M.S.R.C, 2004, CHIN J DIABETES, V12, P151, DOI [10.3321/j.issn:1006-6187.2004.03.002, DOI 10.3321/J.ISSN:1006-6187.2004.03.002]; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gundogan K, 2013, ARCH MED SCI, V9, P243, DOI 10.5114/aoms.2013.34560; Guo H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148976; [韩延柏 Han Yanbai], 2015, [中国公共卫生, China Journal of Public Health], V31, P1342; Hong RD, 2012, S CHINA J PREV MED, V38, P11; [蒋升 Jiang Sheng], 2012, [中国动脉硬化杂志, Chinese Journal of Arteriosclerosis], V20, P181; Lam BCC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122985; Li Jin, 2013, Zhonghua Nei Ke Za Zhi, V52, P659; LiY Li SH, 2012, CHIN J DIS CONTROL P, V16, P392; Moreira GC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105056; Obeidat AA, 2015, PAK J MED SCI, V31, P1377, DOI 10.12669/pjms.316.7714; Population census office under the State Council, 2012, TAB 2010 POP CENS PE; Ramli AS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/760963; Ruan Ye, 2012, Journal of Environmental & Occupational Medicine, V29, P217; Scuteri A, 2015, EUR J PREV CARDIOL, V22, P486, DOI 10.1177/2047487314525529; Suyilaqimuge SU X., 2016, CHINA MODERN MED, V23, P13; [陶然 Tao Ran], 2015, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V41, P181; Wang H., 2011, J SCH HLTH, V32, P338; Xi B, 2013, PREV MED, V57, P867, DOI 10.1016/j.ypmed.2013.09.023; [余鹏 Yu Peng], 2015, [中华高血压杂志, Chinese Journal of Hypertension], V23, P57; 刘瑛, 2013, [中国老年学杂志, Chinese Journal of Gerontology], V33, P5713; 李江源, 2008, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V24, P113	34	7	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189046	10.1371/journal.pone.0189046	http://dx.doi.org/10.1371/journal.pone.0189046			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216328	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800059
J	Nakamine, S; Tachikawa, H; Aiba, M; Takahashi, S; Noguchi, H; Takahashi, H; Tamiya, N				Nakamine, Shin; Tachikawa, Hirokazu; Aiba, Miyuki; Takahashi, Sho; Noguchi, Haruko; Takahashi, Hideto; Tamiya, Nanako			Changes in social capital and depressive states of middle-aged adults in Japan	PLOS ONE			English	Article							SELF-RATED HEALTH; OLDER-ADULTS; INDIVIDUAL-LEVEL; MENTAL-ILLNESS; ASSOCIATION; REJECTION; ANXIETY; MOOD	The present study examines the relationships between changes in bonding and bridging types of social capital and depressive states among middle-aged adults in Japan using a nationally representative sample. Data was collected from a nationwide, population-based survey conducted from 2005 to 2013 in nine annual waves. A total of 16,737 middle-aged men and 17,768 middle-aged women provided data. They reported about depressive states, measured by Kessler 6 scores, and bonding and bridging types of social capital, measured by reported participation in different social activities. Latent growth modeling was conducted to examine relations between changes in bonding and bridging types of social capital and depressive states within individuals across the nine waves. The results showed that, for both men and women, increases in bonding social capital were associated with decreases in depressive states, while changes in bridging social capital were not related to changes in depressive states. In addition, the results showed that changes in bonding social capital, but not bonding social capital at the baseline, affected changes in depressive states. Future studies should take changes in social capital as an independent variable into consideration.	[Nakamine, Shin] Univ Tsukuba, Fac Human Sci, Tsukuba, Ibaraki, Japan; [Tachikawa, Hirokazu; Takahashi, Sho] Univ Tsukuba, Dept Psychiat, Tsukuba, Ibaraki, Japan; [Aiba, Miyuki] Toyo Gakuen Univ, Fac Human Sci, Bunkyo Ku, Tokyo, Japan; [Noguchi, Haruko] Waseda Univ, Sch Polit Sci & Econ, Shinjuku Ku, Tokyo, Japan; [Takahashi, Hideto] Natinal Inst Publ Hlth, Wako, Saitama, Japan; [Tamiya, Nanako] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; Waseda University; University of Tsukuba	Nakamine, S (corresponding author), Univ Tsukuba, Fac Human Sci, Tsukuba, Ibaraki, Japan.	shinn.syr833@gmail.com	Miyuki, Aiba/AHE-7344-2022; Takahashi, Sho/AAI-2113-2020; Noguchi, Haruko/ABF-3059-2020; Nakamine, Shin/AHD-6970-2022	Noguchi, Haruko/0000-0002-4437-8238; NAKAMINE, Shin/0000-0002-0462-7885	Research on Policy Planning and Evaluation [H27-Seisaku-Senryaku-012]; Ministry of Health, Labour and Welfare; Health and Labour Sciences Research Grant, Japan; Comprehensive Research on Life Style Related Diseases; Cardiovascular Deseases and Diabetes Mellitus [H28-junkankitouippan-009]	Research on Policy Planning and Evaluation; Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Health and Labour Sciences Research Grant, Japan; Comprehensive Research on Life Style Related Diseases; Cardiovascular Deseases and Diabetes Mellitus	This study was financially supported by Research on Policy Planning and Evaluation (H27-Seisaku-Senryaku-012) under the aegis of the MHLW (PI: Prof. Nanako Tamiya at Tsukuba University). This research was supported by a grant-in-aid from the Ministry of Health, Labour and Welfare; Health and Labour Sciences Research Grant, Japan; Comprehensive Research on Life Style Related Diseases including Cardiovascular Deseases and Diabetes Mellitus (H28-junkankitouippan-009). This research project has received official approval to use the secondary data from the Statistics and Information Department of the MHLW under Tohatsu-1218-1 as of December 18, 2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, ANN HLTH LAB WELF RE; Asch S.E., 1951, GROUPS LEADERSHIP ME, P177, DOI DOI 10.1037/10025-01; Beaudoin CE, 2009, SOC SCI MED, V68, P2129, DOI 10.1016/j.socscimed.2009.04.015; Byers AL, 2010, ARCH GEN PSYCHIAT, V67, P489, DOI 10.1001/archgenpsychiatry.2010.35; Carney RM, 2009, AM J PSYCHIAT, V166, P410, DOI 10.1176/appi.ajp.2008.08081239; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; Daoud N, 2016, SOC PSYCH PSYCH EPID, V51, P529, DOI 10.1007/s00127-016-1173-z; De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Forsman AK, 2012, AGING MENT HEALTH, V16, P771, DOI 10.1080/13607863.2012.667784; Fujiwara T, 2008, J EPIDEMIOL COMMUN H, V62, P627, DOI 10.1136/jech.2007.064261; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Harpham T, 2002, HEALTH POLICY PLANN, V17, P106, DOI 10.1093/heapol/17.1.106; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.21427/D7CF7R, 10.21427/D79B73]; Islam M Kamrul, 2006, Int J Equity Health, V5, P3, DOI 10.1186/1475-9276-5-3; Ivan SZ, 2015, J AFFECT DISORDERS, V179, P134, DOI 10.1016/j.jad.2015.03.015; Iwase T, 2012, J EPIDEMIOL COMMUN H, V66, P557, DOI 10.1136/jech.2010.115592; Joormann J., 2008, HDB ADOLESCENT DEPRE, P441; Kawachi I, 2013, GLOBAL PERSPECTIVES; Kawachi I., 2008, SOCIAL CAPITAL HLTH, P1, DOI DOI 10.1007/978-0-387-71311-3_1; Kawachi I., 2000, SOCIAL EPIDEMIOLOGY, P174; Kawakami N, MENTAL HLTH RES REGA; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kikuchi M, 2002, B TEIKYO SOCIOLOGY, V15, P63; Kishimoto Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1189; Ministry of Education Culture Sports Science and Technology Ministry of Health Labour and Welfare of Japan, 2002, ETH GUID EP RES; Ministry of Health Labour and Welfare, 2015, 2014 SUMM PAT SURV; Ministry of Internal Affairs and Communications, WHAT IS RES ASS NEIG; Mitchell C. U., 2002, CITY COMMUNITY, V1, P199, DOI DOI 10.1111/1540-6040.00017; Murayama H, 2013, SOC SCI MED, V98, P247, DOI 10.1016/j.socscimed.2013.09.026; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Oshio T, 2016, J EPIDEMIOL COMMUN H, V70, P25, DOI 10.1136/jech-2015-205962; PATERSON CR, 1984, J CLIN PSYCHOL, V40, P534, DOI 10.1002/1097-4679(198403)40:2<534::AID-JCLP2270400225>3.0.CO;2-Q; Putnam RD., 2000, BOWLING ALONE COLLAP; SCHACHTER S, 1951, J ABNORM SOC PSYCH, V46, P190, DOI 10.1037/h0062326; Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013; Takeda F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139777; Valencia-Garcia D, 2012, J CONSULT CLIN PSYCH, V80, P177, DOI 10.1037/a0027207; Wade TJ, 2000, J NERV MENT DIS, V188, P741, DOI 10.1097/00005053-200011000-00004	42	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189112	10.1371/journal.pone.0189112	http://dx.doi.org/10.1371/journal.pone.0189112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216253	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800073
J	Nuwagaba, S; Zhang, F; Hui, C				Nuwagaba, Savannah; Zhang, Feng; Hui, Cang			Robustness of rigid and adaptive networks to species loss	PLOS ONE			English	Article							II FUNCTIONAL-RESPONSE; PREDATOR-PREY MODEL; FOOD WEBS; BIODIVERSITY LOSS; STABILITY; BEHAVIOR; COMPLEX; EXTINCTIONS; INCREASES; DYNAMICS	Controversies in the complexity-stability debate have been attributed to the methodologies used such as topological vs. dynamical approaches or rigid vs. adaptive foraging behaviour of species. Here, we use a bipartite network model that incorporates both topological and population dynamics to investigate the robustness of 60 real ecological networks to the loss of generalist and specialist species. We compare the response in both adaptive and rigid networks. Our results show that the removal of generalists leads to the most secondary extinctions, implying that conservation strategies should aim to protect generalist species in the ecosystem. We also show that adaptive behaviour renders networks vulnerable to species loss at initial stages but enhances long term stability of the system. However, whether adaptive networks are more robust to species loss than rigid ones depends on the structure of the network. Specifically, adaptive networks with modularity < 0.3 are more robust than rigid networks of the same modularity. Interestingly, the more modular a network is, the less robust it is to external perturbations.	[Nuwagaba, Savannah; Hui, Cang] Stellenbosch Univ, Dept Math Sci, Ctr Invas Biol, Stellenbosch, South Africa; [Zhang, Feng] Gansu Agr Univ, MOE Key Lab Grassland Ecosyst, Lanzhou, Gansu, Peoples R China; [Zhang, Feng] Gansu Agr Univ, Ctr Quantitat Biol, Lanzhou, Gansu, Peoples R China; [Hui, Cang] African Inst Math Sci, Math & Phys Biosci, Muizenberg, South Africa	Stellenbosch University; Gansu Agricultural University; Gansu Agricultural University	Hui, C (corresponding author), Stellenbosch Univ, Dept Math Sci, Ctr Invas Biol, Stellenbosch, South Africa.; Zhang, F (corresponding author), Gansu Agr Univ, MOE Key Lab Grassland Ecosyst, Lanzhou, Gansu, Peoples R China.; Zhang, F (corresponding author), Gansu Agr Univ, Ctr Quantitat Biol, Lanzhou, Gansu, Peoples R China.; Hui, C (corresponding author), African Inst Math Sci, Math & Phys Biosci, Muizenberg, South Africa.	fzhang188@163.com; chui@sun.ac.za	Hui, Cang/A-1781-2008	Hui, Cang/0000-0002-3660-8160	National Natural Science Foundation of China [31360104]; South African Research Chair Initiative (SARChI); National Research Foundation of South Africa [81825, 76912]; DST-NRF Centre of Excellence for Invasion Biology (C.I.B); African Institute for Mathematical Sciences (AIMS); German Academic Exchange Service (DAAD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); South African Research Chair Initiative (SARChI); National Research Foundation of South Africa(National Research Foundation - South Africa); DST-NRF Centre of Excellence for Invasion Biology (C.I.B); African Institute for Mathematical Sciences (AIMS); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This project is supported by National Natural Science Foundation of China (No. 31360104), South African Research Chair Initiative (SARChI), National Research Foundation of South Africa (grants 81825 and 76912), DST-NRF Centre of Excellence for Invasion Biology (C.I.B), African Institute for Mathematical Sciences (AIMS). SN receives a PhD Scholarship from the German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Baskaran N, 2012, J NAT CONSERV, V20, P56, DOI 10.1016/j.jnc.2011.08.004; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Brose U, 2011, BASIC APPL ECOL, V12, P557, DOI 10.1016/j.baae.2011.09.010; Cai GQ, 2007, ECOL COMPLEX, V4, P242, DOI 10.1016/j.ecocom.2007.06.011; de Visser SN, 2011, J ANIM ECOL, V80, P484, DOI 10.1111/j.1365-2656.2010.01787.x; Donohue I, 2013, ECOL LETT, V16, P421, DOI 10.1111/ele.12086; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Eklof A, 2006, J ANIM ECOL, V75, P239, DOI 10.1111/j.1365-2656.2006.01041.x; Estrada E, 2007, J THEOR BIOL, V244, P296, DOI 10.1016/j.jtbi.2006.08.002; FRYXELL JM, 1994, EVOL ECOL, V8, P407, DOI 10.1007/BF01238191; Gilljam D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9412; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Guimera R, 2010, ECOLOGY, V91, P2941, DOI 10.1890/09-1175.1; Holland JN, 2006, SCIENCE, V313, P1887, DOI 10.1126/science.1129547; Hui C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3454; Kiers ET, 2010, ECOL LETT, V13, P1459, DOI 10.1111/j.1461-0248.2010.01538.x; Kimbrell T, 2005, EVOL ECOL RES, V7, P53; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Ko W, 2006, J DIFFER EQUATIONS, V231, P534, DOI 10.1016/j.jde.2006.08.001; Krivan V, 1999, THEOR POPUL BIOL, V55, P111, DOI 10.1006/tpbi.1998.1399; Landi P, 2015, J THEOR BIOL, V365, P204, DOI 10.1016/j.jtbi.2014.10.017; Liu B, 2006, J COMPUT APPL MATH, V193, P347, DOI 10.1016/j.cam.2005.06.023; Loeuille N, 2010, FUNCT ECOL, V24, P18, DOI 10.1111/j.1365-2435.2009.01617.x; May R.M., 1973, STABILITY COMPLEXITY; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Minoarivelo HO, 2014, OIKOS, V123, P1250, DOI 10.1111/oik.00857; Montoya JM, 2009, ECOLOGY, V90, P2426, DOI 10.1890/08-0657.1; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; Nuwagaba S, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0320; PIMM SL, 1978, NATURE, V275, P542, DOI 10.1038/275542a0; Rohr RP, 2014, SCIENCE, V345, P416, DOI 10.1126/science.1253497; Staniczenko PPA, 2010, ECOL LETT, V13, P891, DOI 10.1111/j.1461-0248.2010.01485.x; Stephens D.W., 1986, pi; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Suweis S, 2013, NATURE, V500, P449, DOI 10.1038/nature12438; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thierry A, 2011, BASIC APPL ECOL, V12, P562, DOI 10.1016/j.baae.2011.09.005; TILMAN D, 1986, AM ZOOL, V26, P5; Uchida S, 2007, J THEOR BIOL, V247, P713, DOI 10.1016/j.jtbi.2007.04.019; Valdovinos FS, 2010, ECOL LETT, V13, P1546, DOI 10.1111/j.1461-0248.2010.01535.x; van Baalen M, 2001, AM NAT, V157, P512, DOI 10.1086/319933; Vincent TLS, 1996, AM NAT, V148, P1038, DOI 10.1086/285970; Visser AW, 2012, J R SOC INTERFACE, V9, P1373, DOI 10.1098/rsif.2011.0686; Zhang F, 2011, ECOL LETT, V29, P47; Zhang F, 2014, ANIM BEHAV, V88, P13, DOI 10.1016/j.anbehav.2013.11.002	51	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189086	10.1371/journal.pone.0189086	http://dx.doi.org/10.1371/journal.pone.0189086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216245	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800068
J	Woods, C; Fernee, C; Browne, M; Zakrzewski, S; Dickinson, A				Woods, Christopher; Fernee, Christianne; Browne, Martin; Zakrzewski, Sonia; Dickinson, Alexander			The potential of statistical shape modelling for geometric morphometric analysis of human teeth in archaeological research	PLOS ONE			English	Article							TOOTH WEAR; SEXUAL-DIMORPHISM; PERMANENT MOLARS; MORPHOLOGY; ENAMEL; COVARIATION; TOMOGRAPHY; INFERENCES; PHENOTYPE; HOMININS	This paper introduces statistical shape modelling (SSM) for use in osteoarchaeology research. SSM is a full field, multi-material analytical technique, and is presented as a supplementary geometric morphometric (GM) tool. Lower mandibular canines from two archaeological populations and one modern population were sampled, digitised using micro-CT, aligned, registered to a baseline and statistically modelled using principal component analysis (PCA). Sample material properties were incorporated as a binary enamel/dentin parameter. Results were assessed qualitatively and quantitatively using anatomical landmarks. Finally, the technique's application was demonstrated for inter-sample comparison through analysis of the principal component (PC) weights. It was found that SSM could provide high detail qualitative and quantitative insight with respect to archaeological inter-and intra-sample variability. This technique has value for archaeological, biomechanical and forensic applications including identification, finite element analysis (FEA) and reconstruction from partial datasets.	[Woods, Christopher; Browne, Martin; Dickinson, Alexander] Univ Southampton, Bioengn Sci Res Grp, Highfield Campus, Southampton, Hants, England; [Fernee, Christianne; Zakrzewski, Sonia] Univ Southampton, Dept Archaeol, Ave Campus, Southampton, Hants, England	University of Southampton; University of Southampton	Dickinson, A (corresponding author), Univ Southampton, Bioengn Sci Res Grp, Highfield Campus, Southampton, Hants, England.	alex.dickinson@soton.ac.uk	Browne, Martin/M-8229-2013; Zakrzewski, Sonia/AAA-9200-2022; Dickinson, Alex/D-2693-2012	Browne, Martin/0000-0001-5184-050X; Zakrzewski, Sonia/0000-0003-1796-065X; Dickinson, Alex/0000-0002-9647-1944	Royal Academy of Engineering [RF/130]; InnovateUK [KTP 8930]; Arts and Humanities Research Council (AHRC) PhD Studentship [AH/L503939/1]; EPSRC [EP-H01506X]	Royal Academy of Engineering(Royal Academy of Engineering - UK); InnovateUK(UK Research & Innovation (UKRI)Innovate UK); Arts and Humanities Research Council (AHRC) PhD Studentship(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors were funded by the following research grants: AD - Royal Academy of Engineering (Grant RF/130) - http://www.raeng.org.uk; AD/CW - InnovateUK (Grant KTP 8930) -https://www.gov.uk/government/organisations/innovate-uk; CF - Arts and Humanities Research Council (AHRC) PhD Studentship (Grant AH/L503939/1) - http//www.ahrc.ac.uk. Facilities funding for the MuVis Centre were provided by EPSRC grant EP-H01506X. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SA., 1984, COMP STUDY TOOTH ROO; Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Al-Gunaid T, 2012, MESIODISTAL TOOTH WI; Al-Shahrani I, 2014, FRONT PHYSIOL, P5; [Anonymous], 2016, HDB FORENSIC ANTHR A; Arambawatta Kapila, 2009, J Oral Sci, V51, P623; Ashar N Md, 2012, DENT CROWN ARCH SIZE; Babalola K, 2008, MICCAI, V2008, P401; Bah MT, 2015, MED ENG PHYS, V37, P995, DOI 10.1016/j.medengphy.2015.08.004; Bailey SE, 2016, AM J PHYS ANTHROPOL, V159, P93, DOI 10.1002/ajpa.22842; Baldwin MA, 2010, COMPUT METH PROG BIO, V97, P232, DOI 10.1016/j.cmpb.2009.07.005; Ballester MAG, 2004, MED IMAGE ANAL, V8, P361, DOI 10.1016/j.media.2004.06.012; Bardsley PF, 2008, CLIN ORAL INVEST, V12, pS15, DOI 10.1007/s00784-007-0184-2; Barratt DC, 2008, MED IMAGE ANAL, V12, P358, DOI 10.1016/j.media.2007.12.006; Bastir M, 2010, J HUM EVOL, V58, P68, DOI 10.1016/j.jhevol.2009.08.006; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bondioli L, 2010, AM J PHYS ANTHROPOL, V142, P328, DOI 10.1002/ajpa.21271; Bookstein FL, 1998, ACTA ZOOL ACAD SCI H, V44, P7; Bredbenner TL, 2010, J BIOMECH, V43, P1780, DOI 10.1016/j.jbiomech.2010.02.015; Brothwell D.R., 1981, DIGGING BONES EXCAVA; Bryan R., 2010, LARGE SCALE MULTIFEM; Bryan R, 2010, MED ENG PHYS, V32, P57, DOI 10.1016/j.medengphy.2009.10.008; Buchaillard SI, 2007, COMPUT BIOL MED, V37, P1461, DOI 10.1016/j.compbiomed.2007.01.003; Butler PM, 1939, STUDIES MAMMALIAN DE; Cameriere R, 2004, J FORENSIC SCI, V49, P1, DOI DOI 10.1520/JFS2003259; Cooke SB, 2015, ANAT REC, V298, P5, DOI 10.1002/ar.23065; Cootes T. F., 2004, TECHNICAL REPORT; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; Crevecoeur I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084652; DAHLBERG AA, 1945, J AM DENT ASSOC, V32, P676, DOI 10.14219/jada.archive.1945.0112; Davies RH, 2001, BIENN INT C INF PROC; Dreier F. G., 1994, INT J OSTEOARCHAEOL, V4, P137; Efeoglu N, 2005, J DENT, V33, P561, DOI 10.1016/j.jdent.2004.12.001; Elewa AM., 2010, MORPHOMETRICS NONMOR; Elliot J, 1989, APPL XRAY MICROTOMOG, VV; Fearne J, 2004, BRIT DENT J, V196, P634, DOI 10.1038/sj.bdj.4811282; Fernee CL, 2017, AM J PHYS ANTHROPOL, V162, P179; Fornai C, 2016, QUATERN INT, V398, P175, DOI 10.1016/j.quaint.2015.11.102; GARN SM, 1966, J DENT RES, V45, P1819, DOI 10.1177/00220345660450064301; Gomez-Robles A, 2007, J HUM EVOL, V53, P272, DOI 10.1016/j.jhevol.2007.02.002; Gomez-Robles A, 2008, J HUM EVOL, V55, P627, DOI 10.1016/j.jhevol.2008.03.011; Gomez-Robles A, 2012, EVOLUTION, V66, P1024, DOI 10.1111/j.1558-5646.2011.01508.x; Goose DH, 1963, DENT ANTHR, V125, P148; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Guatelli-Steinberg D, 2013, TEETH MORPHOGENESIS, P69; Hanihara T, 2005, AM J PHYS ANTHROPOL, V128, P287, DOI 10.1002/ajpa.20080; Harris MD, 2013, J ORTHOP RES, V31, P1620, DOI 10.1002/jor.22389; Hillson S, 2005, AM J PHYS ANTHROPOL, V126, P413, DOI 10.1002/ajpa.10430; Howells W., 1968, CRANIUM MAXILLARY DE, V2; Huang TTY, 2007, J DENT, V35, P737, DOI 10.1016/j.jdent.2007.06.001; Humphries SM, 2016, MED BIOL ENG COMPUT, V54, P899, DOI 10.1007/s11517-015-1445-x; Irish J.D., 2015, COMPANION DENT ANTHR; Johnston T, 1996, ENDOD DENT TRAUMATOL, V12, P277; Jolliffe I. T., 2002, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; KAMBE T, 1991, FORENSIC SCI INT, V50, P97, DOI 10.1016/0379-0738(91)90138-9; Kanazawa E, 2015, NEW DIRECTIONS DENT; Kato A., 2011, DENT ANTHR, V24, P1; Kenyhercz MW, 2014, AM J PHYS ANTHROPOL, V153, P269, DOI 10.1002/ajpa.22429; Kondo S, 2004, HOMO, V55, P53, DOI 10.1016/j.jchb.2003.10.001; Lamecker H, 2002, MICCAI, V2002, P421; Lasker GW, 1957, J FORENSIC SCI, V2, P401; Le Cabec A, 2013, J HUM EVOL, V64, P169, DOI 10.1016/j.jhevol.2012.08.011; Liu W, 2010, SCI CHINA EARTH SCI, V53, P1141, DOI 10.1007/s11430-010-4013-0; Liu Y, 2010, ANGLE ORTHOD, V80, P160, DOI 10.2319/121608-639.1; Lucas PW, 2008, J ANAT, V212, P486, DOI 10.1111/j.1469-7580.2008.00877.x; Martinon-Torres M, 2006, J HUM EVOL, V50, P523, DOI 10.1016/j.jhevol.2005.12.004; MOLNAR S, 1971, AM J PHYS ANTHROPOL, V34, P175, DOI 10.1002/ajpa.1330340204; MOLNAR S, 1983, AM J PHYS ANTHROPOL, V61, P51, DOI 10.1002/ajpa.1330610106; Morita W, 2016, J ANAT, V229, P343, DOI 10.1111/joa.12482; MOSHFEGHI M, 1994, IEEE T IMAGE PROCESS, V3, P128, DOI 10.1109/83.277895; Nelson SJ, 2014, WHEELERS DENT ANATOM; Nicolella DP, 2012, COMPUT METHOD BIOMEC, V15, P101, DOI 10.1080/10255842.2010.515984; Oi T, 2004, INT ENDOD J, V37, P46, DOI 10.1111/j.1365-2591.2004.00757.x; Perinetti G., 2018, S EUR J ORTHOD DENTO, V5, P3; Pilloud M.A., 2016, BIOL DISTANCE ANAL F; Pilloud MA, 2011, AM J PHYS ANTHROPOL, V145, P519, DOI 10.1002/ajpa.21520; Polychronis G, 2014, J ANAT, V225, P220, DOI 10.1111/joa.12202; Polychronis G, 2013, AM J PHYS ANTHROPOL, V152, P186, DOI 10.1002/ajpa.22340; Querol LB, 2006, LECT NOTES COMPUT SC, V4190, P405; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; Rao C, 2013, MED ENG PHYS, V35, P1450, DOI 10.1016/j.medengphy.2013.03.021; Rizk Oliver T., 2008, CAMBRIDGE STUD BIOEV, P317; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rossi M, 2004, NUCL INSTRUM METH B, V213, P747, DOI 10.1016/S0168-583X(03)01697-5; Sarkalkan N, 2014, BONE, V60, P129, DOI 10.1016/j.bone.2013.12.006; Schatz D, 2001, DENT TRAUMATOL, V17, P167, DOI 10.1034/j.1600-9657.2001.170406.x; SCOTT EC, 1979, AM J PHYS ANTHROPOL, V51, P213, DOI 10.1002/ajpa.1330510208; Scott G, 2008, TECHNIQUE APPL DENT; Scott G.R., 2013, ANTHR PERSPECTIVES T; Singleton M, 2011, ANAT REC, V294, P322, DOI 10.1002/ar.21315; Skinner MM, 2016, J HUM EVOL, V93, P63, DOI 10.1016/j.jhevol.2016.01.010; Skinner MM, 2010, J ANAT, V217, P245, DOI 10.1111/j.1469-7580.2010.01265.x; Skinner MM, 2009, AM J PHYS ANTHROPOL, V140, P234, DOI 10.1002/ajpa.21057; Skinner MM, 2008, J HUM EVOL, V55, P979, DOI 10.1016/j.jhevol.2008.08.013; SMITH BGN, 1984, BRIT DENT J, V156, P435, DOI 10.1038/sj.bdj.4805394; SMITH BH, 1984, AM J PHYS ANTHROPOL, V63, P39, DOI 10.1002/ajpa.1330630107; SMITH P, 1986, AM J PHYS ANTHROPOL, V70, P339, DOI 10.1002/ajpa.1330700309; SPOOR CF, 1993, AM J PHYS ANTHROPOL, V91, P469, DOI 10.1002/ajpa.1330910405; Star H, 2011, J FORENSIC SCI, V56, pS77, DOI 10.1111/j.1556-4029.2010.01633.x; Strauss RE, 2010, MORPHOMETRICS NONMOR, P73, DOI [10.1007/978-3-540-95853-6_4, DOI 10.1007/978-3-540-95853-6_4]; Teaford M.F., 2007, DEV FUNCTION EVOLUTI; Thompson AR, 2015, AM J PHYS ANTHROPOL, V158, P341, DOI 10.1002/ajpa.22791; Townsend G, 2012, NEW APPROACHES DENT; Ungar PS, 2009, FRONT ORAL BIOL, V13, P38, DOI 10.1159/000242388; van Reenen Frans, 1982, TEETH FORM FUNCTION, P182; Vodanovic M, 2007, J ARCHAEOL SCI, V34, P905, DOI 10.1016/j.jas.2006.09.004; Vollmer J, 1999, COMPUTER GRAPHICS FO; Vos F, 2004, PATT REC 2004 ICPR 2; WALKER PL, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P169; Weber GW, 2011, VIRTUAL ANTHROPOLOGY: GUIDE TO A NEW INTERDISCIPLINARY FIELD, P1, DOI 10.1007/978-3-211-49347-2; Weber GW, 2015, QUATERN INT, V30, pe16; WOLPOFF MH, 1971, METRIC TRENDS HOMINI; Wong FSL, 2004, ARCH ORAL BIOL, V49, P937, DOI 10.1016/j.archoralbio.2004.05.011; Yang F, 2006, FORENSIC SCI INT, V159, pS78, DOI 10.1016/j.forsciint.2006.02.031; Yong R, 2014, AUST DENT J, V59, P34, DOI 10.1111/adj.12156; Zanolli C., 2015, BRIEF COMMUNICATION; Zanolli C, 2015, AM J PHYS ANTHROPOL, V157, P666, DOI 10.1002/ajpa.22748; Zanolli C, 2015, AM J PHYS ANTHROPOL, V156, P148, DOI 10.1002/ajpa.22611; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	119	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0186754	10.1371/journal.pone.0186754	http://dx.doi.org/10.1371/journal.pone.0186754			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216199	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000417337800006
J	Yassin, AF; Langenberg, S; Huntemann, M; Clum, A; Pillay, M; Palaniappan, K; Varghese, N; Mikhailova, N; Mukherjee, S; Reddy, TBK; Daum, C; Shapiro, N; Ivanova, N; Woyke, T; Kyrpides, NC				Yassin, Atteyet F.; Langenberg, Stefan; Huntemann, Marcel; Clum, Alicia; Pillay, Manoj; Palaniappan, Krishnaveni; Varghese, Neha; Mikhailova, Natalia; Mukherjee, Supratim; Reddy, T. B. K.; Daum, Chris; Shapiro, Nicole; Ivanova, Natalia; Woyke, Tanja; Kyrpides, Nikos C.			Draft genome sequence of Actinotignum schaalii DSM 15541(T): Genetic insights into the lifestyle, cell fitness and virulence	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEMS; ENTNER-DOUDOROFF PATHWAY; CYTOCHROME BD OXIDASE; GRAM-POSITIVE COCCI; ESCHERICHIA-COLI; OXIDATIVE STRESS; ACTINOBACULUM-SCHAALII; METRONIDAZOLE RESISTANCE; AZOTOBACTER-VINELANDII; BACTEROIDES-FRAGILIS	The permanent draft genome sequence of Actinotignum schaalii DSM 15541(T) is presented. The annotated genome includes 2,130,987 bp, with 1777 protein-coding and 58 rRNA-coding genes. Genome sequence analysis revealed absence of genes encoding for: components of the PTS systems, enzymes of the TCA cycle, glyoxylate shunt and gluconeogensis. Genomic data revealed that A. schaalii is able to oxidize carbohydrates via glycolysis, the nonoxidative pentose phosphate and the Entner-Doudoroff pathways. Besides, the genome harbors genes encoding for enzymes involved in the conversion of pyruvate to lactate, acetate and ethanol, which are found to be the end products of carbohydrate fermentation. The genome contained the gene encoding Type I fatty acid synthase required for de novo FAS biosynthesis. The plsY and plsX genes encoding the acyltransferases necessary for phosphatidic acid biosynthesis were absent from the genome. The genome harbors genes encoding enzymes responsible for isoprene biosynthesis via the mevalonate (MVA) pathway. Genes encoding enzymes that confer resistance to reactive oxygen species (ROS) were identified. In addition, A. schaalii harbors genes that protect the genome against viral infections. These include restriction-modification (RM) systems, type II toxin-antitoxin (TA), CRISPR-Cas and abortive infection system. A. schaalii genome also encodes several virulence factors that contribute to adhesion and internalization of this pathogen such as the tad genes encoding proteins required for pili assembly, the nanI gene encoding exo-alpha-sialidase, genes encoding heat shock proteins and genes encoding type VII secretion system. These features are consistent with anaerobic and pathogenic lifestyles. Finally, resistance to ciprofloxacin occurs by mutation in chromosomal genes that encode the subunits of DNA-gyrase (GyrA) and topisomerase IV (ParC) enzymes, while resistant to metronidazole was due to the frxA gene, which encodes NADPH-flavin oxidoreductase.	[Yassin, Atteyet F.] Univ Bonn, Inst Med Mikrobiol & Immunol, Bonn, Germany; [Langenberg, Stefan; Varghese, Neha] Klin & Poliklin Hals Nasen Ohrenheilkunde Chirurg, Bonn, Germany; [Huntemann, Marcel; Clum, Alicia; Pillay, Manoj; Palaniappan, Krishnaveni; Mikhailova, Natalia; Mukherjee, Supratim; Reddy, T. B. K.; Daum, Chris; Shapiro, Nicole; Ivanova, Natalia; Woyke, Tanja; Kyrpides, Nikos C.] US DOE, Joint Genome Inst, Genome Biol Program, Walnut Creek, DC USA	University of Bonn; University of Bonn; United States Department of Energy (DOE)	Yassin, AF (corresponding author), Univ Bonn, Inst Med Mikrobiol & Immunol, Bonn, Germany.	yassin@mibi03.meb.uni-bonn.de	Mukherjee, Supratim/K-1151-2019; Langenberg, Stefan/O-4526-2016; Huntemann, Marcel/HCH-8928-2022; Kyrpides, Nikos C./A-6305-2014	Mukherjee, Supratim/0000-0002-6322-2271; Langenberg, Stefan/0000-0001-5817-5469; Huntemann, Marcel/0000-0002-1284-3748; Kyrpides, Nikos C./0000-0002-6131-0462; Reddy, TBK/0000-0002-0871-5567; Varghese, Neha/0000-0003-0580-0675	US Department of Energy's Office of Science, Biological and Environmental Research Program; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]	US Department of Energy's Office of Science, Biological and Environmental Research Program(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory(University of California System)	This work was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231.	ANANTHARAM V, 1989, J BIOL CHEM, V264, P7244; ANDREESEN JR, 1969, ARCH MIKROBIOL, V69, P160, DOI 10.1007/BF00409760; Andriole VT, 2005, CLIN INFECT DIS, V41, pS113, DOI 10.1086/428051; Bank S, 2010, EMERG INFECT DIS, V16, P76, DOI 10.3201/eid1601.090761; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Belevich I, 2007, BIOCHEMISTRY-US, V46, P11177, DOI 10.1021/bi700862u; Bempt IV, 2011, J CLIN MICROBIOL, V49, P2369, DOI 10.1128/JCM.00272-11; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Carlier JP, 1997, ANTIMICROB AGENTS CH, V41, P1495, DOI 10.1128/AAC.41.7.1495; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Cattoir V, 2010, J ANTIMICROB CHEMOTH, V65, P2514, DOI 10.1093/jac/dkq383; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Das A, 2005, J BACTERIOL, V187, P2020, DOI 10.1128/JB.187.6.2020-2029.2005; EGAN SE, 1992, J BACTERIOL, V174, P4638, DOI 10.1128/JB.174.14.4638-4646.1992; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Field D, 2014, STAND GENOMIC SCI, V9; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Francke C, 2005, TRENDS MICROBIOL, V13, P550, DOI 10.1016/j.tim.2005.09.001; Gal M, 2004, J ANTIMICROB CHEMOTH, V54, P109, DOI 10.1093/jac/dkh296; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Giuffre A, 2014, BBA-BIOENERGETICS, V1837, P1178, DOI 10.1016/j.bbabio.2014.01.016; Goeders N, 2014, TOXINS, V6, P304, DOI 10.3390/toxins6010304; Goldman BS, 1996, J BACTERIOL, V178, P6348, DOI 10.1128/jb.178.21.6348-6351.1996; Govantes F, 2000, MOL MICROBIOL, V37, P1456, DOI 10.1046/j.1365-2958.2000.02100.x; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Henderson B, 2006, INFECT IMMUN, V74, P3693, DOI 10.1128/IAI.01882-05; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HILL S, 1990, J BACTERIOL, V172, P2071, DOI 10.1128/jb.172.4.2071-2078.1990; Hoenigl M, 2010, EMERG INFECT DIS, V16, P1171, DOI 10.3201/eid1607.100349; Hooper DC, 2002, LANCET INFECT DIS, V2, P530, DOI 10.1016/S1473-3099(02)00369-9; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hu Y, 2014, CANCER INFORM, V13, P13, DOI 10.4137/CIN.S13495; Hung GC, 2012, J CLIN MICROBIOL, V50, P2770, DOI 10.1128/JCM.01155-12; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; INFERNAL, INF RNA AL; JUKES T H, 1969, P21; KELLY MJS, 1990, J BACTERIOL, V172, P6010, DOI 10.1128/jb.172.10.6010-6019.1990; Kim S, 2006, J BIOCHEM, V139, P591, DOI 10.1093/jb/mvj057; Klemm P, 1996, J BACTERIOL, V178, P61, DOI 10.1128/jb.178.1.61-67.1996; Kristiansen R, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00880-14; Kwon DH, 2000, ANTIMICROB AGENTS CH, V44, P2133, DOI 10.1128/AAC.44.8.2133-2142.2000; Kyrpides NC, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001920; Kyrpides NC, 2014, STAND GENOMIC SCI, V9, P628, DOI 10.4056/sigs.5068949; Laabei M, 2014, GENOME RES, V24, P839, DOI 10.1101/gr.165415.113; Lawson PA, 1997, INT J SYST BACTERIOL, V47, P899, DOI 10.1099/00207713-47-3-899; Lemos RS, 2001, FEBS LETT, V496, P40, DOI 10.1016/S0014-5793(01)02399-7; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Lesniak J, 2003, PROTEIN SCI, V12, P2838, DOI 10.1110/ps.03375603; Li M, 2011, DUK FAST EF IN PRESS; Lindqvist A, 2000, ANTON LEEUW INT J G, V78, P23, DOI 10.1023/A:1002779201379; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Matsumoto M, 2004, INT J FOOD MICROBIOL, V93, P109, DOI 10.1016/j.ijfoodmicro.2003.10.009; Mruk I, 2014, NUCLEIC ACIDS RES, V42, P70, DOI 10.1093/nar/gkt711; Mukherjee S, 2017, NAT BIOTECHNOL, V35, P676, DOI 10.1038/nbt.3886; Olsen AB, 2013, BJU INT, V112, P394, DOI 10.1111/j.1464-410X.2012.11739.x; Pati A, 2010, NAT METHODS, V7, P455, DOI [10.1038/nmeth.1457, 10.1038/NMETH.1457]; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Prakash S, 2003, BBA-BIOMEMBRANES, V1618, P79, DOI 10.1016/j.bbamem.2003.10.010; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ren D, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-263; Rhee SG, 2016, MOL CELLS, V39, P1, DOI 10.14348/molcells.2016.2368; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Rowe-Magnus DA, 2003, GENOME RES, V13, P428, DOI 10.1101/gr.617103; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schlosser A, 1997, J BACTERIOL, V179, P2092, DOI 10.1128/jb.179.6.2092-2095.1997; Schneider E, 2001, RES MICROBIOL, V152, P303, DOI 10.1016/S0923-2508(01)01201-3; Shin DH, 2004, ACTA CRYSTALLOGR D, V60, P903, DOI 10.1107/S0907444904005013; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Theron MM, 2004, J ANTIMICROB CHEMOTH, V54, P240, DOI 10.1093/jac/dkh270; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; TOMLINSON GA, 1974, CAN J MICROBIOL, V20, P1085, DOI 10.1139/m74-170; Tschudin-Sutter S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-289; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Watanabe S, 2006, J BIOL CHEM, V281, P33521, DOI 10.1074/jbc.M606727200; Yassin AF, 2015, INT J SYST EVOL MICR, V65, P615, DOI 10.1099/ijs.0.069294-0; Yassin AF, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0036-7; Zankari E, 2013, J ANTIMICROB CHEMOTH, V68, P771, DOI 10.1093/jac/dks496; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	90	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188914	10.1371/journal.pone.0188914	http://dx.doi.org/10.1371/journal.pone.0188914			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216246	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800048
J	Zahouli, JBZ; Koudou, BG; Muller, P; Malone, D; Tano, Y; Utzinger, J				Zahouli, Julien B. Z.; Koudou, Benjamin G.; Mueller, Pie; Malone, David; Tano, Yao; Utzinger, Juerg			Effect of land-use changes on the abundance, distribution, and host-seeking behavior of Aedes arbovirus vectors in oil palm-dominated landscapes, southeastern Cote d'Ivoire	PLOS ONE			English	Article							MOSQUITO; MONOCULTURE; ALBOPICTUS; EMERGENCE; IMPACTS; EASTERN; FEVER; RISK	Background Identifying priority areas for vector control is of considerable public health relevance. Arthropod-borne viruses (arboviruses) spread by Aedes mosquitoes are (re) emerging in many parts of the tropics, partially explained by changes in agricultural land-use. We explored the effects of land-use changes on the abundance, distribution, and host-seeking behavior of Aedes mosquitoes along a gradient of anthropogenic disturbance in oil palm-dominated landscapes in southeastern Cote d'Ivoire. Methodology Between January and December 2014, eggs, larvae, pupae, and adults of Aedes mosquitoes were sampled in four types of macrohabitats (rainforest, polyculture, oil palm monoculture, and rural housing areas), using standard procedures (bamboo-ovitraps, metallicovitraps, larval surveys, and human-baited double-net traps). Immature stages were reared and adult mosquitoes identified at species level. Principal findings A total of 28,276 Aedes specimens belonging to 11 species were collected. No Aedes-positive microhabitat and only four specimens of Ae. aegypti were found in oil palm monoculture. The highest abundance of Aedes mosquitoes (60.9%) was found in polyculture, while the highest species richness (11 species) was observed in rainforest. Ae. aegypti was the predominant Aedes species, and exhibited high anthropophilic behavior inflicting 93.0% of total biting to humans. The biting rate of Aedes mosquitoes was 34.6 and 7.2-fold higher in polyculture and rural housing areas, respectively, compared to rainforest. Three species (Ae. aegypti, Ae. dendrophilus, and Ae. vittatus) bit humans in polyculture and rural housing areas, with respective biting rates of 21.48 and 4.48 females/person/day. Unexpectedly, all three species were also feeding during darkness. Aedes females showed bimodal daily feeding cycles with peaks at around 08: 00 a. m. and 05: 00 p. m. Host-seeking activities were interrupted between 11: 00 a. m. and 02: 00 p. m. in rural housing areas, while no such interruption was observed in polyculture. Some rainforest-dwelling Aedes species displayed little preference to feed on humans. Conclusions In southeastern Co A te d'Ivoire, the agricultural land-use/land-cover changes due to the conversion of rainforest into oil palm monocultures influence the abundance, distribution, and host-seeking behaviors of anthropophagic and non-anthropophagic Aedes vectors. As a result, there is higher risk of humans to arbovirus transmission in polyculture and rural housing areas. There is a need for integrated vector management, including landscape epidemiology and ecotope-based vector control.	[Zahouli, Julien B. Z.; Mueller, Pie; Utzinger, Juerg] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Zahouli, Julien B. Z.; Mueller, Pie; Utzinger, Juerg] Univ Basel, Basel, Switzerland; [Zahouli, Julien B. Z.; Koudou, Benjamin G.] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire; [Zahouli, Julien B. Z.; Tano, Yao] Univ Felix Houphouet Boigny, Unite Format & Rech Biosci, Abidjan, Cote Ivoire; [Koudou, Benjamin G.] Univ Liverpool Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool, Merseyside, England; [Koudou, Benjamin G.] Univ Nangui Abrogoua, Unite Format & Rech Sci Nat, Abidjan, Cote Ivoire; [Malone, David] Univ Liverpool Liverpool Sch Trop Med, Innovat Vector Control Consortium, Liverpool, Merseyside, England	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Liverpool School of Tropical Medicine; Liverpool School of Tropical Medicine	Zahouli, JBZ (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Zahouli, JBZ (corresponding author), Univ Basel, Basel, Switzerland.; Zahouli, JBZ (corresponding author), Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire.; Zahouli, JBZ (corresponding author), Univ Felix Houphouet Boigny, Unite Format & Rech Biosci, Abidjan, Cote Ivoire.	zahouli2julien@yahoo.fr	Muller, Pie/R-7275-2018	Muller, Pie/0000-0003-0181-5781	Centre Suisse de Recherches Scientifiques en Cote dIvoire, Abidjan, Cote d'Ivoire; Swiss Tropical and Public Health Institute, Basel, Switzerland; Swiss Government, through the Federal Commission for Scholarships for Foreign Students (FCS), Bern, Switzerland [2014.0567]	Centre Suisse de Recherches Scientifiques en Cote dIvoire, Abidjan, Cote d'Ivoire; Swiss Tropical and Public Health Institute, Basel, Switzerland; Swiss Government, through the Federal Commission for Scholarships for Foreign Students (FCS), Bern, Switzerland	The work was funded by the Centre Suisse de Recherches Scientifiques en Cote dIvoire, Abidjan, Cote d'Ivoire; Swiss Tropical and Public Health Institute, Basel, Switzerland; Swiss Government, through the Federal Commission for Scholarships for Foreign Students (FCS), Bern, Switzerland (no 2014.0567). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Centre Suisse de Recherches Scientifiques en Cote dIvoire (Abidjan, Cote dIvoire), the Swiss Tropical and Public Health Institute (Basel, Switzerland); the Swiss government, through the Federal Commission for Scholarships for Foreign Students (Bern, Switzerland; no 2014.0567), which funded the study and supported its execution. The authors would also like to extend their thanks to PALMCI staff, health authorities, local authorities, and residents in the study areas and the mosquito collection teams.	Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227; Barton M, 2014, J THERM BIOL, V41, P65, DOI 10.1016/j.jtherbio.2014.02.004; Bernues-Baneres Alberto, 2013, Biodiversity Journal, V4, P335; Birkhofer K, 2017, J ANIM ECOL, V86, P511, DOI 10.1111/1365-2656.12641; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; CORDELLIER R, 1983, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V21, P165; CORDELLIER R, 1977, GUIDE PRATIQUE ETUDE; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442; Diallo D, 2013, T ROY SOC TROP MED H, V107, P200, DOI 10.1093/trstmh/trs095; Diallo D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-286; Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649; Diarrassouba S, 1997, B SOC PATHOL EXOT, V90, P361; Dieng H, 2015, ACTA TROP, V145, P68, DOI 10.1016/j.actatropica.2015.01.004; Dislich C, 2017, BIOL REV, V92, P1539, DOI 10.1111/brv.12295; Dorville LFM, 1996, STUD NEOTROP FAUNA E, V31, P68, DOI 10.1076/snfe.31.2.68.13331; Ferraguti M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29002; Ghazali A, 2016, J ASIA-PAC ENTOMOL, V19, P415, DOI 10.1016/j.aspen.2016.04.016; HARBACH RE, 2007, ZOOTAXA, V1668, P1; Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703; Kaewwaen W., 2015, INTERDISCIP PERSPECT, V2015, P1, DOI [10.1155/2015/909106, DOI 10.1155/2015/909106]; Kamgang B, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-57; Leisnham PT, 2012, ECOHEALTH, V9, P217, DOI 10.1007/s10393-012-0773-7; Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18; N'go A. Y., 2013, Journal of Environmental Protection, V4, P1373, DOI 10.4236/jep.2013.412158; Palmafrique, PALM OIL IV EC; Rochlin I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13604; Sadia-Kacou CMA, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1804-1; de Abreu FVS, 2015, MEM I OSWALDO CRUZ, V110, P669, DOI 10.1590/0074-02760140490; Savilaakso S, 2014, ENVIRON EVID, V3, DOI 10.1186/2047-2382-3-4; Steiger DBM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1675-2; Syafiq M, 2016, ACTA OECOL, V74, P11, DOI 10.1016/j.actao.2016.06.005; Tangena JAA, 2016, TRENDS PARASITOL, V32, P402, DOI 10.1016/j.pt.2016.01.009; Tangena JAA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138735; van Strien AJ, 2012, ECOL INDIC, V14, P202, DOI 10.1016/j.ecolind.2011.07.007; Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595; Vijay V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159668; Wong J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001632; Zahouli Julien B.Z., 2017, PLoS Neglected Tropical Diseases, V11, pe0005751, DOI 10.1371/journal.pntd.0005751; Zahouli JBZ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1778-9	40	24	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189082	10.1371/journal.pone.0189082	http://dx.doi.org/10.1371/journal.pone.0189082			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216248	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000417337800067
J	Alahmari, DM; Chan, KYY; Stojanovska, V; LaRosa, D; Barton, SK; Nitsos, I; Zahra, V; Barbuto, J; Farrell, M; Yamaoka, S; Pearson, JT; Polglase, GR				Alahmari, Dhafer M.; Chan, Kyra Y. Y.; Stojanovska, Vanesa; LaRosa, Domenic; Barton, Samantha K.; Nitsos, Ilias; Zahra, Valerie; Barbuto, Jade; Farrell, Michael; Yamaoka, Shigeo; Pearson, James T.; Polglase, Graeme R.			Diffusion tensor imaging detects ventilation-induced brain injury in preterm lambs	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; CEREBRAL ENERGY FAILURE; WHITE-MATTER INJURY; HYPOXIA-ISCHEMIA; MR SPECTROSCOPY; DYSMYELINATION; CONSEQUENCES; OUTCOMES; PALSY; BIRTH	Purpose Injurious mechanical ventilation causes white matter (WM) injury in preterm infants through inflammatory and haemodynamic pathways. The relative contribution of each of these pathways is not known. We hypothesised that in vivo magnetic resonance imaging (MRI) can detect WM brain injury resulting from mechanical ventilation 24 h after preterm delivery. Further we hypothesised that the combination of inflammatory and haemodynamic pathways, induced by umbilical cord occlusion (UCO) increases brain injury at 24 h. Methods Fetuses at 124 +/- 2 days gestation were exposed, instrumented and either ventilated for 15 min using a high tidal-volume (V-T) injurious strategy with the umbilical cord intact (INJ; inflammatory pathway only), or occluded (INJ+UCO; inflammatory and haemodynamic pathway). The ventilation groups were compared to lambs that underwent surgery but were not ventilated (Sham), and lambs that did not undergo surgery (unoperated control; Cont). Fetuses were placed back in utero after the 15 min intervention and ewes recovered. Twenty-four hours later, lambs were delivered, placed on a protective ventilation strategy, and underwent MRI of the brain using structural, diffusion tensor imaging (DTI) and magnetic resonance spectroscopy (MRS) techniques. Results Absolute MRS concentrations of creatine and choline were significantly decreased in INJ+UCO compared to Cont lambs (P = 0.03, P = 0.009, respectively); no significant differences were detected between the INJ or Sham groups and the Cont group. Axial diffusivities in the internal capsule and frontal WM were lower in INJ and INJ+UCO compared to Cont lambs (P = 0.05, P = 0.04, respectively). Lambs in the INJ and INJ+UCO groups had lower mean diffusivities in the frontal WM compared to Cont group (P = 0.04). DTI colour mapping revealed lower diffusivity in specific WM regions in the Sham, INJ, and INJ+UCO groups compared to the Cont group, but the differences did not reach significance. INJ+UCO lambs more likely to exhibit lower WM diffusivity than INJ lambs. Conclusions Twenty-four hours after injurious ventilation, DTI and MRS showed increased brain injury in the injuriously ventilated lambs compared to controls. DTI colour mapping threshold approach provides evidence that the haemodynamic and inflammatory pathways have additive effects on the progression of brain injury compared to the inflammatory pathway alone.	[Alahmari, Dhafer M.; Farrell, Michael] Monash Univ, Monash Biomed Discovery Inst, Clayton, Vic, Australia; [Alahmari, Dhafer M.; Farrell, Michael] Monash Univ, Dept Med Imaging & Radiat Sci, Clayton, Vic, Australia; [Alahmari, Dhafer M.; Farrell, Michael; Pearson, James T.] Monash Univ, Monash Biomed Imaging, Clayton, Vic, Australia; [Alahmari, Dhafer M.] King Saud Med City, Dept Diagnost Imaging, Riyadh, Saudi Arabia; [Chan, Kyra Y. Y.; Stojanovska, Vanesa; LaRosa, Domenic; Barton, Samantha K.; Nitsos, Ilias; Zahra, Valerie; Barbuto, Jade; Yamaoka, Shigeo; Polglase, Graeme R.] Monash Univ, Ritchie Ctr, Hudson Inst Med Res, Clayton, Vic, Australia; [Chan, Kyra Y. Y.; Stojanovska, Vanesa; LaRosa, Domenic; Barton, Samantha K.; Nitsos, Ilias; Zahra, Valerie; Barbuto, Jade; Yamaoka, Shigeo; Polglase, Graeme R.] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic, Australia; [Pearson, James T.] Monash Univ, Dept Physiol, Clayton, Vic, Australia; [Pearson, James T.] Natl Cerebral & Cardiovasc Ctr, Dept Cardiac Physiol, Suita, Osaka, Japan	Monash University; Monash University; Monash University; King Saud Medical City; Hudson Institute of Medical Research; Monash University; Monash University; Monash University; National Cerebral & Cardiovascular Center - Japan	Polglase, GR (corresponding author), Monash Univ, Ritchie Ctr, Hudson Inst Med Res, Clayton, Vic, Australia.; Polglase, GR (corresponding author), Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic, Australia.	graeme.polglase@monash.edu	Farrell, Michael/H-4571-2019; Pearson, James/B-4631-2012	Farrell, Michael/0000-0003-4126-8911; Barton, Samantha/0000-0001-7601-0238; Chan, Kyra/0000-0003-1355-5470; Pearson, James/0000-0002-3318-5406; Polglase, Graeme/0000-0002-8906-614X	National Institutes of Health [R01HD072848-04]; National Heart Foundation of Australia; National Health and Medical Research Council (NH&MRC) Career Development Fellowship [1105526]; National Health and Medical Research Council (AU)-Australian Research Council Dementia Research Development Fellowship [1110040]; Victorian Government's Operational Infrastructure Support Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart Foundation of Australia(National Heart Foundation of Australia); National Health and Medical Research Council (NH&MRC) Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (AU)-Australian Research Council Dementia Research Development Fellowship; Victorian Government's Operational Infrastructure Support Program	This research was supported by the National Institutes of Health (R01HD072848-04), a joint National Heart Foundation of Australia and National Health and Medical Research Council (NH&MRC) Career Development Fellowship (1105526), National Health and Medical Research Council (AU)-Australian Research Council Dementia Research Development Fellowship (SKB; 1110040) and Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahmari DM, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00070; Alahmari DM, 2017, IMAGING MED, V9, P67, DOI [10.14303/Imaging-Medicine.1000061, DOI 10.14303/IMAGING-MEDICINE.1000061]; Alkan A, 2003, MAGN RESON IMAGING, V21, P77, DOI 10.1016/S0730-725X(02)00625-2; Barton SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112402; Bassi L, 2011, PEDIATR RES, V69, P561, DOI 10.1203/PDR.0b013e3182182836; Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602; Bhatt S, 2013, J PHYSIOL-LONDON, V591, P2113, DOI 10.1113/jphysiol.2012.250084; Brown NC, 2009, J PEDIATR-US, V155, P32, DOI 10.1016/j.jpeds.2009.01.038; Cheong JLY, 2006, AM J NEURORADIOL, V27, P1546; Cheong JLY, 2009, AM J NEURORADIOL, V30, P623, DOI 10.3174/ajnr.A1399; Duerden EG, 2015, AM J NEURORADIOL, V36, P1565, DOI 10.3174/ajnr.A4312; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; Grether J K, 1992, Paediatr Perinat Epidemiol, V6, P339, DOI 10.1111/j.1365-3016.1992.tb00774.x; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Haseler LJ, 1997, PEDIATRICS, V99, P4, DOI 10.1542/peds.99.1.4; Hillman NH, 2012, PEDIATR RES, V72, P593, DOI 10.1038/pr.2012.135; Hoch SE, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3710; Huppi P KR, 1998, REGIONAL MATURATION, VI, P94; Inder TE, 2003, AM J NEURORADIOL, V24, P805; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; LETH H, 1995, ACTA PAEDIATR, V84, P495, DOI 10.1111/j.1651-2227.1995.tb13681.x; Lodygensky GA, 2008, INT J DEV NEUROSCI, V26, P13, DOI 10.1016/j.ijdevneu.2007.08.018; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; Nelson KB, 2002, MENT RETARD DEV D R, V8, P146, DOI 10.1002/mrdd.10037; Nitsos I, 2014, REPROD SCI, V21, P658, DOI 10.1177/1933719111399928; Penrice J, 1997, PEDIATR RES, V41, P443, DOI 10.1203/00006450-199703000-00024; Petrou S, 2005, BJOG-INT J OBSTET GY, V112, P10, DOI 10.1111/j.1471-0528.2005.00577.x; Polglase GR, 2004, PEDIATR RES, V56, P932, DOI 10.1203/01.PDR.0000145254.66447.C0; Polglase GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039535; Poulton DA, 2011, RESUSCITATION, V82, P175, DOI 10.1016/j.resuscitation.2010.10.012; Rabe H, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003248.pub4, 10.1002/14651858.CD003248.pub3]; Raymond M, 2011, J NEUROSCI, V31, P17864, DOI 10.1523/JNEUROSCI.3179-11.2011; Roelants-Van Rijn AM, 2001, PEDIATR RES, V49, P356, DOI 10.1203/00006450-200103000-00009; ROTHMAN DL, 1991, MAGN RESON MED, V21, P302, DOI 10.1002/mrm.1910210215; Salmaso N, 2014, NAT NEUROSCI, V17, P341, DOI 10.1038/nn.3604; Serenius F, 2013, JAMA-J AM MED ASSOC, V309, P1810, DOI 10.1001/jama.2013.3786; Skiold B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095804; Soares DP, 2009, CLIN RADIOL, V64, P12, DOI 10.1016/j.crad.2008.07.002; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037; URENJAK J, 1992, J NEUROCHEM, V59, P55, DOI 10.1111/j.1471-4159.1992.tb08875.x; van der Graaf M, 2010, EUR BIOPHYS J BIOPHY, V39, P527, DOI 10.1007/s00249-009-0517-y; Volpe JJ, 1998, ARCH NEUROL-CHICAGO, V55, P297, DOI 10.1001/archneur.55.3.297; Wen Shi Wu, 2004, Semin Fetal Neonatal Med, V9, P429, DOI 10.1016/j.siny.2004.04.002; Wise-Faberowski L, 2014, BRAIN SCI, V4, P295, DOI 10.3390/brainsci4020295; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Zeisel SH, 2000, J AM COLL NUTR, V19, p528S, DOI 10.1080/07315724.2000.10718976; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156	51	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188737	10.1371/journal.pone.0188737	http://dx.doi.org/10.1371/journal.pone.0188737			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211751	gold, Green Published			2022-12-27	WOS:000417212200046
J	Kuhn, CE; Chumbley, K; Fritz, L; Johnson, D				Kuhn, Carey E.; Chumbley, Kathryn; Fritz, Lowell; Johnson, Devin			Estimating dispersal rates of Steller sea lion (Eumetopias jubatus) mother-pup pairs from a natal rookery using mark-resight data	PLOS ONE			English	Article							MATERNAL ATTENDANCE PATTERNS; MOVEMENT PATTERNS; ALASKA; ABUNDANCE; ISLAND; POPULATION; SURVIVAL; BEHAVIOR; COUNTS; FEMALE	To monitor population trends of Steller sea lions (Eumetopias jubatus) in Alaska, newborn pups are counted during aerial surveys. These surveys are scheduled to occur after the majority of pups are born, but before pups begin to spend significant time in the water. Some studies have reported dispersal of mother-pup pairs away from breeding beaches during the pupping season (July), which may influence survey results. Using a multistate mark-recapture model with state uncertainty, we estimated the amount of dispersal during the pupping season based on observations of permanently marked sea lions. Research was conducted at land-based observation sites on Marmot Island, Alaska, between 2000 and 2013. Both marked adult females with dependent pups and marked pups were observed at two rookery beaches from May to July. Cumulative dispersal rates were minimal (< 1%) prior to the planned start of the aerial survey (23 June) and increased to 11.2% by the planned survey completion date (10 July). The increased cumulative dispersal rate during the remainder of the observation period (end of July) suggests potential bias in surveys that occur beyond 10 July, however surveys past this date are rare (< 10% between 1973 and 2016). As a result, movements of mother-pup pairs during the pupping season are not likely to influence aerial survey estimates.	[Kuhn, Carey E.; Chumbley, Kathryn; Fritz, Lowell; Johnson, Devin] NOAA, Marine Mammal Lab, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Kuhn, CE (corresponding author), NOAA, Marine Mammal Lab, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	Carey.Kuhn@noaa.gov						BERKSON JM, 1985, CAN J FISH AQUAT SCI, V42, P873, DOI 10.1139/f85-111; Burkanov V, 2011, J MAMMAL, V92, P352, DOI 10.1644/10-MAMM-A-194.1; Calkins DG, 1982, POPULATION ASSESSMEN; CHUMBLEY K, 1997, NMFSAFSC77 NOAA US D; Davis RW, 2006, LOW WAKE FI, P13; Fritz L., 2016, NMFSAFSC321 NOAA US; Fritz L, 2017, COUNTS ALASKA STELLE; Fritz L, 2013, NMFSAFSC251 NOAA US; Fritz LW, 2014, ENDANGER SPECIES RES, V26, P13, DOI 10.3354/esr00634; GALES NJ, 1992, WILDLIFE RES, V19, P405, DOI 10.1071/WR9920405; Gales NJ, 1999, WILDLIFE RES, V26, P35, DOI 10.1071/WR98022; Gentry RL, 1970, THESIS; Harris J. D., 2016, THESIS; Hastings KK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00215.1; Hastings KK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176840; Hastings KK, 2016, MAR MAMMAL SCI, V32, P777, DOI 10.1111/mms.12288; Hastings KK, 2009, J WILDLIFE MANAGE, V73, P1040, DOI 10.2193/2007-208; HIGGINS LV, 1988, MAR MAMMAL SCI, V4, P44, DOI 10.1111/j.1748-7692.1988.tb00181.x; HINDELL MA, 1988, J MAMMAL, V69, P81, DOI 10.2307/1381750; Hood WR, 1997, CAN J ZOOL, V75, P1241, DOI 10.1139/z97-146; Jemison LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070167; Johanos TC, 2014, MAR MAMMAL SCI, V30, P1165, DOI 10.1111/mms.12084; Johnson DS, 2014, METHODS ECOL EVOL, V5, P1110, DOI 10.1111/2041-210X.12231; Kaplan CC, 2008, MAR MAMMAL SCI, V24, P443, DOI 10.1111/j.1748-7692.2008.00203.x; Kenyon K. W., 1961, Journal of Mammalogy, V43, P223; Kuhn CE, 2017, ENDANGER SPECIES RES, V32, P213, DOI 10.3354/esr00796; Laake J.L., 2013, 201304 AFSC NOAA, P34; Laake JL, 2013, METHODS ECOL EVOL, V4, P885, DOI 10.1111/2041-210X.12065; LING JK, 1969, PAC SCI, V23, P399; LOUGHLIN TR, 1984, J WILDLIFE MANAGE, V48, P729, DOI 10.2307/3801420; Lowry MS, 1999, MAR MAMMAL SCI, V15, P143, DOI 10.1111/j.1748-7692.1999.tb00786.x; Maniscalco JM, 2006, J MAMMAL, V87, P304, DOI 10.1644/05-MAMM-A-163R2.1; Merrick R, 1988, NMFSFNWC143 NOAA US; Merrick RL, 1997, CAN J ZOOL, V75, P776, DOI 10.1139/z97-099; Merrick RL, 1996, NMFSAFSC68 NOAA, P21; Milette LL, 2003, CAN J ZOOL, V81, P340, DOI 10.1139/Z03-008; National Marine Fisheries Service, 1997, FED REGISTER, V62, P24345; NMFS (National Marine Fisheries Service), 2013, STAT REV E DIST POP; NMFS (National Marine Fisheries Service), 2008, REC PLAN STELL SEA L; Pitcher KW, 2005, CAN J ZOOL, V83, P1214, DOI 10.1139/Z05-098; Pitcher KW, 2001, J MAMMAL, V82, P1047, DOI 10.1644/1545-1542(2001)082<1047:SATVIT>2.0.CO;2; Raum-Suryan KL, 2004, MAR MAMMAL SCI, V20, P823, DOI 10.1111/j.1748-7692.2004.tb01195.x; Raum-Suryan KL, 2002, MAR MAMMAL SCI, V18, P746, DOI 10.1111/j.1748-7692.2002.tb01071.x; Sandegren FE, 1970, THESIS; Snyder GM, 2001, MAR MAMMAL SCI, V17, P136, DOI 10.1111/j.1748-7692.2001.tb00984.x; Stirling I., 1983, Special Publication American Society of Mammalogists, P489; Trites Andrew W., 2006, Aquatic Mammals, V32, P85, DOI 10.1578/AM.32.1.2006.85; Westlake RL, 1997, MAR MAMMAL SCI, V13, P207, DOI 10.1111/j.1748-7692.1997.tb00628.x; Wilson K, 2012, MAR MAMMAL SCI, V28, pE58, DOI 10.1111/j.1748-7692.2011.00485.x; Young JK, 2007, MAR MAMMAL SCI, V23, P926, DOI 10.1111/j.1748-7692.2007.00138.x	50	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189061	10.1371/journal.pone.0189061	http://dx.doi.org/10.1371/journal.pone.0189061			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211808	Green Published, Green Submitted, gold			2022-12-27	WOS:000417212200062
J	Lu, TM; Lee, TS; Lin, SJ; Chan, WL; Hsu, CP				Lu, Tse-Min; Lee, Tzong-Shyuan; Lin, Shing-Jong; Chan, Wan-Leong; Hsu, Chiao-Po			The prognostic value of asymmetric dimethylarginine in patients with cardiac syndrome X	PLOS ONE			English	Article							ADVERSE CARDIOVASCULAR EVENTS; NORMAL CORONARY ANGIOGRAMS; OXIDE SYNTHASE INHIBITOR; ENDOTHELIAL DYSFUNCTION; L-ARGININE; ANGINA-PECTORIS; ARTERY-DISEASE; RISK; PLASMA	Background The pathophysiology of cardiac syndrome X is multifactorial and endothelial dysfunction has been implicated as important contributing factor. Asymmetric dimethylarginine (ADMA), characterized as a circulating endogenous inhibitor of nitric oxide synthase, may have been implicated as an important contributing factor for the development of endothelial dysfunction. In this study, we aim to assess the predictive power of ADMA for long-term prognosis in patients with cardiac syndrome X. Methods and results We enrolled 239 consecutive patients with cardiac syndrome X diagnosed by coronary angiography. The mean age was 58.7 +/- 10.1 years. The patients were grouped into tertiles according to the plasma ADMA levels: <0.38 mu mol/l (tertile I), 0.38-0.44 mu mol/l (tertile II), and >0.44 mu mol/l (tertile III). All patients were followed up for a mean period of 6.5 +/- 1.5 years (median: 6.3 years, inter-quartile range: 5.7-8.0 years). During the follow-up period, major adverse events (MAE) were observed in 15 patients (6.3%), including 13 deaths. The plasma ADMA levels in patients who developed MAE were significantly higher than those who did not (0.48 +/- 0.06 mu mol/l vs. 0.42 +/- 0.08 mu mol/l, p = 0.005). In multivariate Cox regression analysis adjusted for age, eGFR and LVEF, ADMA tertile I and II were identify to be associated with a significantly lower risk of MAE compared to ADMA tertile III (p = 0.017). By considering the plasma ADMA level as a continuous variable, the plasma ADMA level remained a significant independent predictor for outcomes of MAE, and the relative risk of MACE increased by 50% when plasma ADMA level increased by 1 SD of value (p = 0.018). Conclusions In patients with cardiac syndrome X, elevated plasma ADMA levels appeared to be an independent predictor of long-term adverse clinical outcomes.	[Lu, Tse-Min; Lin, Shing-Jong; Chan, Wan-Leong] Taipei Vet Gen Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Lu, Tse-Min; Chan, Wan-Leong] Taipei Vet Gen Hosp, Dept Hlth Care Ctr, Taipei, Taiwan; [Lu, Tse-Min; Hsu, Chiao-Po] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Lee, Tzong-Shyuan] Natl Yang Ming Univ, Dept Physiol, Taipei, Taiwan; [Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Hsu, Chiao-Po] Taipei Vet Gen Hosp, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Hsu, CP (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Hsu, CP (corresponding author), Taipei Vet Gen Hosp, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan.	hsucp@vghtpe.gov.tw	Lee, Tzong-Shyuan/AAE-5803-2020	Lee, Tzong-Shyuan/0000-0002-9593-4062				Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Cannon RO, 2009, J AM COLL CARDIOL, V54, P877, DOI 10.1016/j.jacc.2009.03.080; Chen C, 2017, CIRC J, V81, P3, DOI 10.1253/circj.CJ-16-1002; Crea F, 2014, EUR HEART J, V35, P1101, DOI 10.1093/eurheartj/eht513; EGASHIRA K, 1993, NEW ENGL J MED, V328, P1659, DOI 10.1056/NEJM199306103282302; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Hsu CP, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0156-1; Hurst T, 2006, AM J MED, V119, P560, DOI 10.1016/j.amjmed.2005.07.009; KAKIMOTO Y, 1970, J BIOL CHEM, V245, P5751; Lamendola P, 2010, INT J CARDIOL, V140, P197, DOI 10.1016/j.ijcard.2008.11.026; Leiper J, 1999, CARDIOVASC RES, V43, P542, DOI 10.1016/S0008-6363(99)00162-5; Lu TM, 2003, EUR HEART J, V24, P1912, DOI 10.1016/j.ehj.2003.08.013; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Meinitzer A, 2007, CLIN CHEM, V53, P273, DOI 10.1373/clinchem.2006.076711; Okyay K, 2007, CORONARY ARTERY DIS, V18, P539, DOI 10.1097/MCA.0b013e3282f08ece; Pepine CJ, 2010, J AM COLL CARDIOL, V55, P2825, DOI 10.1016/j.jacc.2010.01.054; Perticone F, 2005, J AM COLL CARDIOL, V46, P518, DOI 10.1016/j.jacc.2005.04.040; Piatti PM, 2003, CIRCULATION, V107, P429, DOI 10.1161/01.CIR.0000046489.24563.79; Schnabel Renate, 2005, Circ Res, V97, pe53, DOI 10.1161/01.RES.0000181286.44222.61; Sen Nihat, 2009, Atherosclerosis, V204, pe82, DOI 10.1016/j.atherosclerosis.2008.09.029; Singh M, 2010, INT J CARDIOL, V142, P113, DOI 10.1016/j.ijcard.2009.11.021; Stuhlinger MC, 2002, JAMA-J AM MED ASSOC, V287, P1420, DOI 10.1001/jama.287.11.1420; Suda O, 2004, ARTERIOSCL THROM VAS, V24, P1682, DOI 10.1161/01.ATV.0000136656.26019.6e; Thum T, 2005, J AM COLL CARDIOL, V46, P1693, DOI 10.1016/j.jacc.2005.04.066; Valkonen VP, 2001, LANCET, V358, P2127, DOI 10.1016/S0140-6736(01)07184-7; VALLANCE P, 1992, LANCET, V339, P572; Vermeltfoort IAC, 2010, CLIN RES CARDIOL, V99, P475, DOI 10.1007/s00392-010-0159-1	28	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188995	10.1371/journal.pone.0188995	http://dx.doi.org/10.1371/journal.pone.0188995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206850	Green Submitted, Green Published, gold			2022-12-27	WOS:000417110700037
J	Kadipasaoglu, CM; Conner, CR; Baboyan, VG; Rollo, M; Pieters, TA; Tandon, N				Kadipasaoglu, Cihan Mehmet; Conner, Christopher Richard; Baboyan, Vatche George; Rollo, Matthew; Pieters, Thomas Allyn; Tandon, Nitin			Network dynamics of human face perception	PLOS ONE			English	Article							CORTICOCORTICAL EVOKED-POTENTIALS; VENTRAL TEMPORAL CORTEX; SOURCE DENSITY ANALYSIS; ELECTRICAL-STIMULATION; INFEROTEMPORAL CORTEX; FUSIFORM GYRUS; VISUAL-CORTEX; HUMAN BRAIN; FUNCTIONAL ARCHITECTURE; SELECTIVE REGIONS	Prevailing theories suggests that cortical regions responsible for face perception operate in a serial, feed-forward fashion. Here, we utilize invasive human electrophysiology to evaluate serial models of face-processing via measurements of cortical activation, functional connectivity, and cortico-cortical evoked potentials. We find that task-dependent changes in functional connectivity between face-selective regions in the inferior occipital (f-IOG) and fusiform gyrus (f-FG) are bidirectional, not feed-forward, and emerge following feed-forward input from early visual cortex (EVC) to both of these regions. Cortico-cortical evoked potentials similarly reveal independent signal propagations between EVC and both f-IOG and f-FG. These findings are incompatible with serial models, and support a parallel, distributed network underpinning face perception in humans.	[Kadipasaoglu, Cihan Mehmet; Conner, Christopher Richard; Baboyan, Vatche George; Rollo, Matthew; Pieters, Thomas Allyn; Tandon, Nitin] Univ Texas Houston, Med Sch Houston, Vivian Smith Dept Neurosurg, Houston, TX 77030 USA; [Tandon, Nitin] Texas Med Ctr, Mem Hermann Hosp, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Tandon, N (corresponding author), Univ Texas Houston, Med Sch Houston, Vivian Smith Dept Neurosurg, Houston, TX 77030 USA.; Tandon, N (corresponding author), Texas Med Ctr, Mem Hermann Hosp, Houston, TX 77030 USA.	Nitin.tandon@uth.tmc.edu	; Kadipasaoglu, Cihan/G-6077-2016	Tandon, Nitin/0000-0002-2752-2365; Kadipasaoglu, Cihan/0000-0001-5390-372X; Baboyan, Vatche/0000-0001-9025-591X	National Center for Advancing Translational Sciences of the National Institutes of Health [5TL1TR000369-07]; National Institute for Deafness and Communication Disorders [U01NS098981, R01DC014589]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014589] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute for Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (5TL1TR000369-07), and the National Institute for Deafness and Communication Disorders (Grants U01NS098981 and R01DC014589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2010, J NEUROSCI METH, V191, P191, DOI 10.1016/j.jneumeth.2010.06.019; ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Atkinson AP, 2011, PHILOS T R SOC B, V366, P1726, DOI 10.1098/rstb.2010.0349; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Barbeau EJ, 2008, CEREB CORTEX, V18, P997, DOI 10.1093/cercor/bhm140; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BLUM JS, 1950, J COMP NEUROL, V93, P53, DOI 10.1002/cne.900930105; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Bruns A, 2000, NEUROREPORT, V11, P1509, DOI 10.1097/00001756-200005150-00028; Bruns A, 2004, INT J PSYCHOPHYSIOL, V51, P97, DOI 10.1016/j.ijpsycho.2003.07.001; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Chen G, 2012, NEUROIMAGE, V60, P747, DOI 10.1016/j.neuroimage.2011.12.060; Chong SC, 2013, NEUROIMAGE, V77, P70, DOI 10.1016/j.neuroimage.2013.01.074; Conner CR, 2011, J NEUROSCI, V31, P12855, DOI 10.1523/JNEUROSCI.1457-11.2011; Conner CR, 2013, CEREB CORTEX; Conner CR, 2011, COMPUT BIOL MED; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DAMASIO AR, 1990, ANNU REV NEUROSCI, V13, P89, DOI 10.1146/annurev.ne.13.030190.000513; Davidesco I, 2014, CEREB CORTEX, V24, P1879, DOI 10.1093/cercor/bht038; Davies-Thompson J, 2012, J NEUROPHYSIOL, V108, P3087, DOI 10.1152/jn.01171.2011; DESIMONE R, 1984, J NEUROSCI, V4, P2051; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Duchaine B, 2015, ANNU REV VIS SCI, V1, P393, DOI 10.1146/annurev-vision-082114-035518; Engell AD, 2011, CEREB CORTEX, V21, P1213, DOI 10.1093/cercor/bhq206; Esterman M, 2010, CEREB CORTEX, V20, P1245, DOI 10.1093/cercor/bhp188; EZURE K, 1985, JPN J PHYSIOL, V35, P223, DOI 10.2170/jjphysiol.35.223; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fisch L, 2009, NEURON, V64, P562, DOI 10.1016/j.neuron.2009.11.001; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Florence M., 1990, COG NEUROPSY, V7, P81; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Ghuman AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6672; Gomez J, 2015, NEURON, V85, P216, DOI 10.1016/j.neuron.2014.12.027; Grill-Spector K, 2014, NAT REV NEUROSCI, V15, P536, DOI 10.1038/nrn3747; Grimaldi P, 2016, NEURON, V90, P1325, DOI 10.1016/j.neuron.2016.05.009; GROSS CG, 1994, CEREB CORTEX, V4, P455, DOI 10.1093/cercor/4.5.455; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; GROSS CG, 1971, J COMP PHYSIOL PSYCH, V76, P1, DOI 10.1037/h0031039; GROSS CG, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1303; Gross CG, 2008, NEUROPSYCHOLOGIA, V46, P841, DOI 10.1016/j.neuropsychologia.2007.11.009; Gschwind M, 2012, CEREB CORTEX, V22, P1564, DOI 10.1093/cercor/bhr226; Haxby J.V., 2011, OXFORD HDB FACE PERC, P93, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0006; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hermes D, 2014, CEREB CORTEX; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Jacques C, 2015, NEUROPSYCHOLOGIA; Jiang F, 2011, J NEUROPHYSIOL, V106, P2720, DOI 10.1152/jn.00672.2010; Jonas J, 2012, NEUROSCIENCE, V222, P281, DOI 10.1016/j.neuroscience.2012.07.021; Jonas J, 2016, P NATL ACAD SCI USA, V113, pE4088, DOI 10.1073/pnas.1522033113; Jonas J, 2014, NEUROIMAGE, V99, P487, DOI 10.1016/j.neuroimage.2014.06.017; Kadipasaoglu CM, 2014, NEUROIMAGE, V101, P215, DOI 10.1016/j.neuroimage.2014.07.006; Kadipasaoglu CM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01008; Kadipasaoglu CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157109; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2011, OXFORD HDB FACE PERC, P111, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0007; Keller CJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0528; Keller CJ, 2014, J NEUROSCI, V34, P9152, DOI 10.1523/JNEUROSCI.4289-13.2014; Keller CJ, 2011, P NATL ACAD SCI USA, V108, P10308, DOI 10.1073/pnas.1019750108; Kim M, 2006, MAGN RESON IMAGING, V24, P583, DOI 10.1016/j.mri.2005.12.005; Kluver H, 1938, J PSYCHOL, V5, P33; Lachaux JP, 2012, PROG NEUROBIOL, V98, P279, DOI 10.1016/j.pneurobio.2012.06.008; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Lewis CM, 2016, P NATL ACAD SCI USA, V113, pE606, DOI 10.1073/pnas.1513773113; Liu HS, 2009, NEURON, V62, P281, DOI 10.1016/j.neuron.2009.02.025; Lohse M, 2016, J NEUROSCI, V36, P3821, DOI 10.1523/JNEUROSCI.3621-15.2016; Matsumoto R, 2004, BRAIN, V127, P2316, DOI 10.1093/brain/awh246; Matsuzaki N, 2013, CLIN NEUROPHYSIOL, V124, P1290, DOI 10.1016/j.clinph.2013.02.007; Miller KJ, 2014, NEUROIMAGE, V85, P711, DOI 10.1016/j.neuroimage.2013.08.070; MISHKIN M, 1954, J COMP PHYSIOL PSYCH, V47, P187, DOI 10.1037/h0057551; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; MISHKIN M, 1954, J COMP PHYSIOL PSYCH, V47, P14, DOI 10.1037/h0061230; Mishkin M, 1966, FRONTIERS PHYSL PSYC, P93; MITZDORF U, 1978, EXP BRAIN RES, V33, P371; Munk H., 1890, BRAIN, V13, P450; Murphey DK, 2009, P NATL ACAD SCI USA, V106, P5389, DOI 10.1073/pnas.0804998106; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Parvizi J, 2012, J NEUROSCI, V32, P14915, DOI 10.1523/JNEUROSCI.2609-12.2012; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; Pieters TA, 2013, J NEUROSURG, V118, P1086, DOI 10.3171/2013.2.JNS121450; Pitcher D, 2011, EXP BRAIN RES, V209, P481, DOI 10.1007/s00221-011-2579-1; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; PRIBRAM KH, 1953, J COMP NEUROL, V99, P347, DOI 10.1002/cne.900990208; Privman E, 2007, J NEUROSCI, V27, P6234, DOI 10.1523/JNEUROSCI.4627-06.2007; Puce A, 1999, CEREB CORTEX, V9, P445, DOI 10.1093/cercor/9.5.445; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; Puce A, 1998, J NEUROSCI, V18, P2188; Puri AM, 2009, BRAIN RES, V1301, P89, DOI 10.1016/j.brainres.2009.08.085; Rossion B, 2003, BRAIN, V126, P2381, DOI 10.1093/brain/awg241; Rossion B., 2015, BRAIN MAP ENCY REF, V2, P515; Rossion B, 2008, NEUROIMAGE, V40, P423, DOI 10.1016/j.neuroimage.2007.10.047; Rossion B, 2014, TRENDS COGN SCI, V18, P310, DOI 10.1016/j.tics.2014.02.013; Rossion Bruno, 2014, Front Biosci (Elite Ed), V6, P258; Rossion B, 2011, VISION RES, V51, P1297, DOI 10.1016/j.visres.2011.04.003; Rossion B, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00225; Saad ZS, 2012, NEUROIMAGE, V62, P768, DOI 10.1016/j.neuroimage.2011.09.016; Schroeder CE, 1998, CEREB CORTEX, V8, P575, DOI 10.1093/cercor/8.7.575; Seeck M, 1997, NEUROREPORT, V8, P2749, DOI 10.1097/00001756-199708180-00021; SERGENT J, 1992, PHILOS T ROY SOC B, V335, P55, DOI 10.1098/rstb.1992.0007; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Solomon-Harris LM, 2013, BRAIN COGNITION, V83, P245, DOI 10.1016/j.bandc.2013.08.007; Summerfield C, 2009, TRENDS COGN SCI, V13, P403, DOI 10.1016/j.tics.2009.06.003; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tandon N, 2008, TXB EPILEPSY SURG, P1001, DOI DOI 10.3109/9780203091708-129; Tang HL, 2014, NEURON, V83, P736, DOI 10.1016/j.neuron.2014.06.017; Tsao DY, 2008, P NATL ACAD SCI USA, V105, P19514, DOI 10.1073/pnas.0809662105; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vidal JR, 2012, J NEUROSCI, V32, P6421, DOI 10.1523/JNEUROSCI.4363-11.2012; Vidal JR, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00195; Wang L, 2014, CEREB CORTEX; Weiner KS, 2016, J NEUROSCI, V36, P8425, DOI 10.1523/JNEUROSCI.4509-15.2016; Weiner KS, 2013, PSYCHOL RES-PSYCH FO, V77, P74, DOI 10.1007/s00426-011-0392-x; Weiner KSM L., 2014, SOC NEUROSCIENCE; Winawer J, 2013, CURR BIOL, V23, P1145, DOI 10.1016/j.cub.2013.05.001; Winawer J, 2010, J VISION, V10, DOI 10.1167/10.5.1; Yoshor D, 2007, CEREB CORTEX, V17, P2293, DOI 10.1093/cercor/bhl138; Zhang H, 2009, NEUROSCI LETT, V454, P1, DOI 10.1016/j.neulet.2009.02.054; Zhu Q, 2011, J NEUROSCI, V31, P10323, DOI 10.1523/JNEUROSCI.0873-11.2011	125	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188834	10.1371/journal.pone.0188834	http://dx.doi.org/10.1371/journal.pone.0188834			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190811	Green Submitted, Green Published, gold			2022-12-27	WOS:000416841900138
J	Huang, J; Jin, N; Qin, H; Shi, X; Liu, YY; Cheung, WC; Wang, CC; Chan, TF; Li, TC				Huang, Jin; Jin, Nana; Qin, Hao; Shi, Xiao; Liu, Yingyu; Cheung, Wingching; Wang, Chi Chiu; Chan, Ting Fung; Li, Tin Chiu			Transcriptomic profiles in peripheral blood between women with unexplained recurrent implantation failure and recurrent miscarriage and the correlation with endometrium: A pilot study	PLOS ONE			English	Article							GENE-EXPRESSION; RECEPTIVITY; IDENTIFICATION; BIOMARKERS	Aim To study the transcriptome profiles in the blood of recurrent implantation failure (RIF), recurrent miscarriage (RM) and fertile women during the window of implantation, and further analysis the correlation of transcriptome profiles between blood and endometrium. Methods This is an observational prospective study. In total 9 subjects were recruited, 3 RIF, 3 RM, and 3 controls. Paired samples (endometrium and peripheral blood) from the same subjects were precisely timed on the 7th days after luteal hormone surge (LH+7). RNA sequencing was applied to investigate the transcriptome profiles. Results The results of transcriptome in peripheral blood cannot be used to characterize women with RIF and unexplained RM. There was a medium level correlation between transcriptome in peripheral blood and endometrium during the window of implantation. Conclusion The differential transcriptome patterns in blood are not representative of those in endometrium, and the blood transcriptome cannot differentiate among the women with RIF, RM or fertile.	[Huang, Jin; Shi, Xiao; Liu, Yingyu; Cheung, Wingching; Wang, Chi Chiu; Li, Tin Chiu] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Jin, Nana; Qin, Hao; Chan, Ting Fung] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, Chi Chiu] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, Chi Chiu] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Li, TC (corresponding author), Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China.	tinchiu.li@cuhk.edu.hk	Chan, TingFung/A-6161-2013; Wang, Ronald/C-6541-2014; Yingyu, LIU/O-5676-2015	Chan, TingFung/0000-0002-0489-3884; Wang, Ronald/0000-0002-3928-7278; Yingyu, LIU/0000-0003-4211-026X; Li, Tin Chiu/0000-0002-0554-2031	Chinese University of Hong Kong [2014.1.042]; Hong Kong Government [GRF14102014]	Chinese University of Hong Kong(Chinese University of Hong Kong); Hong Kong Government	Direct Grant for Research (Ref No. 2014.1.042) from the Chinese University of Hong Kong. HQ is supported by a General Research Fund (GRF14102014) from the Hong Kong Government to TFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Alles MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004710; Altmae S, 2010, MOL HUM REPROD, V16, P178, DOI 10.1093/molehr/gap102; Chim SSC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081709; Coughlan C, 2014, REPROD BIOMED ONLINE, V28, P14, DOI 10.1016/j.rbmo.2013.08.011; Farina A, 2011, PRENATAL DIAG, V31, P181, DOI 10.1002/pd.2675; Founds SA, 2009, PLACENTA, V30, P15, DOI 10.1016/j.placenta.2008.09.015; Haouzi D, 2009, HUM REPROD, V24, P198, DOI 10.1093/humrep/den360; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Huang J, 2017, REPRODUCTION, V153, P749, DOI 10.1530/REP-16-0574; Jalbrzikowski M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132542; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koler M, 2009, HUM REPROD, V24, P2541, DOI 10.1093/humrep/dep193; Koot YEM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19411; Kosova G, 2015, HUM REPROD, V30, P519, DOI 10.1093/humrep/deu355; Krjutskov K, 2016, SCI REP-UK, V6, DOI 10.1038/srep31584; Ledee N, 2011, J PATHOL, V225, P554, DOI 10.1002/path.2948; Othman R, 2012, REPROD BIOL, V12, P183, DOI 10.1016/S1642-431X(12)60085-0; Paiva P, 2011, J CLIN ENDOCR METAB, V96, pE1807, DOI 10.1210/jc.2011-1233; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Petrov PD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155361; Riad ON, 2014, GYNECOL ENDOCRINOL, V30, P70, DOI 10.3109/09513590.2013.859668; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Ruiz-Alonso M, 2013, FERTIL STERIL, V100, P818, DOI 10.1016/j.fertnstert.2013.05.004; Rumsey DJ, 2015, U CAN STAT DUMMIES; Saravelos SH, 2012, HUM REPROD, V27, P1882, DOI 10.1093/humrep/des102; Song FH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182294; Tsui NBY, 2014, CLIN CHEM, V60, P954, DOI 10.1373/clinchem.2014.221648; Warnes G.R., 2009, GPLOTS VARIOUS R PRO; Whitehead C, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-256; Whitehead CL, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.01.191; Zeller T, 2017, HYPERTENSION, V70, P743, DOI 10.1161/HYPERTENSIONAHA.117.09458	32	6	7	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189159	10.1371/journal.pone.0189159	http://dx.doi.org/10.1371/journal.pone.0189159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216287	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800082
J	Koyama, K; Yamauchi, J				Koyama, Keiji; Yamauchi, Junichiro			Altered postural sway following fatiguing foot muscle exercises	PLOS ONE			English	Article							TOE FLEXOR STRENGTH; BALANCE; PLANTAR; ARCH	This study investigated the acute effects of fatiguing foot muscle exercises on the maximum muscle strength of the foot and postural control ability. Eighteen healthy young individuals performed fatiguing foot muscle strength exercises, and their toe flexor and ankle plantar flexor strength and postural control ability were measured before and after the exercises. Postural control ability was evaluated using the path of the center of pressure (COP) during three balance tasks: double-leg standing with eyes open; double-leg standing with eyes closed; and single-leg standing with eyes open. After the exercises, the muscle strength of both the toe and ankle plantar flexor significantly decreased. Under all of the conditions, most COP variables did not significantly differ before and after the exercises; however, the total length and mean velocity in the single-leg standing with eyes open significantly decreased after the exercises. Postural sway velocities in the anteroposterior direction of double-leg standing with eyes closed and in both anteroposterior and mediolateral directions of singleleg standing with eyes open significantly decreased after the exercises. The associations between relative changes in muscle strength after the exercise and relative changes in COP variables after the exercise were not found. These results indicate that postural control while standing could be maintained even though foot muscle strength is decreased after fatiguing foot muscle exercises.	[Koyama, Keiji] Toin Univ Yokohama, Yokohama, Kanagawa, Japan; [Yamauchi, Junichiro] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Tokyo, Japan; [Yamauchi, Junichiro] Khon Kaen Univ, Res Ctr Back Neck Other Joint Pain & Human Perfor, Khon Kaen, Thailand	Toin University of Yokohama; Tokyo Metropolitan University; Khon Kaen University	Yamauchi, J (corresponding author), Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Tokyo, Japan.; Yamauchi, J (corresponding author), Khon Kaen Univ, Res Ctr Back Neck Other Joint Pain & Human Perfor, Khon Kaen, Thailand.	yamauchi@tmu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology - Grant-in-Aid for Young Scientists (A) to JY; Grant-in-Aid for Exploratory Research to JY; and Grant-in-Aid for Scientists (C) to KK.	Adlerton AK, 1996, SCAND J MED SCI SPOR, V6, P211; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; Bisson EJ, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-39; BOJSENMOLLER F, 1979, ACTA ORTHOP SCAND, V50, P471, DOI 10.3109/17453677908989792; Boyas S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072482; BURKE RE, 1973, J PHYSIOL-LONDON, V234, P723, DOI 10.1113/jphysiol.1973.sp010369; de Ruiter CJ, 2010, EUR J APPL PHYSIOL, V108, P247, DOI 10.1007/s00421-009-1209-0; DUCHATEAU J, 1986, EUR J APPL PHYSIOL, V55, P476, DOI 10.1007/BF00421640; Falgairolle M, 2006, J PHYSIOL-PARIS, V100, P304, DOI 10.1016/j.jphysparis.2007.05.003; Goldmann JP, 2013, J SPORT SCI, V31, P424, DOI 10.1080/02640414.2012.736627; Gribble PA, 2004, ARCH PHYS MED REHAB, V85, P589, DOI 10.1016/j.apmr.2003.06.031; HAGG GM, 1992, J APPL PHYSIOL, V73, P1211, DOI 10.1152/jappl.1992.73.4.1211; Harkins KM, 2005, J ATHL TRAINING, V40, P191; Hess DM, 2001, J SPORT REHABIL, V10, P24, DOI 10.1123/jsr.10.1.24; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Johnston RB, 1998, MED SCI SPORT EXER, V30, P1703, DOI 10.1097/00005768-199812000-00008; Kaji A, 2010, J STRENGTH COND RES, V24, P382, DOI 10.1519/JSC.0b013e3181c06bdd; Kelly LA, 2012, CLIN BIOMECH, V27, P46, DOI 10.1016/j.clinbiomech.2011.07.013; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; Kurihara T, 2014, J FOOT ANKLE RES, V7, DOI 10.1186/1757-1146-7-26; Loram ID, 2002, J PHYSIOL-LONDON, V540, P1111, DOI 10.1113/jphysiol.2001.013077; MANN R, 1964, J BONE JOINT SURG AM, V46, P469, DOI 10.2106/00004623-196446030-00001; Menz HB, 2005, J GERONTOL A-BIOL, V60, P1546, DOI 10.1093/gerona/60.12.1546; Mochizuki G, 2006, EXP BRAIN RES, V175, P584, DOI 10.1007/s00221-006-0575-7; Morita N, 2015, MED SCI SPORT EXER, V47, P350, DOI 10.1249/MSS.0000000000000402; Nardone A, 1997, ELECTROMYOGR MOTOR C, V105, P309, DOI 10.1016/S0924-980X(97)00040-4; Otsuka M., 2015, GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, V174, P307; Palmieri RM, 2002, J SPORT REHABIL, V11, P51, DOI 10.1123/jsr.11.1.51; PANZER VP, 1995, ARCH PHYS MED REHAB, V76, P151, DOI 10.1016/S0003-9993(95)80024-7; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; SCHIEPPATI M, 1994, ELECTROEN CLIN NEURO, V93, P286, DOI 10.1016/0168-5597(94)90031-0; Sturnieks DL, 2008, NEUROPHYSIOL CLIN, V38, P467, DOI 10.1016/j.neucli.2008.09.001; Wang TY, 2008, CLIN BIOMECH, V23, P493, DOI 10.1016/j.clinbiomech.2007.11.014; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Yamauchi J, 2015, INT J SPORTS MED, V36, P592, DOI 10.1055/s-0034-1396824; Zhang SQ, 2013, GAIT POSTURE, V37, P532, DOI 10.1016/j.gaitpost.2012.09.012	36	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189184	10.1371/journal.pone.0189184	http://dx.doi.org/10.1371/journal.pone.0189184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216267	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800090
J	Robertson, BA; Rathbone, L; Cirillo, G; D'Eath, RB; Bateson, M; Boswell, T; Wilson, PW; Dunn, IC; Smulders, TV				Robertson, Barbara-Anne; Rathbone, Lucy; Cirillo, Giselda; D'Eath, Richard B.; Bateson, Melissa; Boswell, Timothy; Wilson, Peter W.; Dunn, Ian C.; Smulders, Tom V.			Food restriction reduces neurogenesis in the avian hippocampal formation	PLOS ONE			English	Article							CHICKADEES POECILE-GAMBELI; MESSENGER-RNA EXPRESSION; CELL-PROLIFERATION RATES; ADULT NEUROGENESIS; DENTATE GYRUS; DIETARY RESTRICTION; BROILER BREEDERS; SPATIAL MEMORY; MOUNTAIN CHICKADEES; GLUCOCORTICOID-RECEPTOR	The mammalian hippocampus is particularly vulnerable to chronic stress. Adult neurogenesis in the dentate gyrus is suppressed by chronic stress and by administration of glucocorticoid hormones. Post-natal and adult neurogenesis are present in the avian hippocampal formation as well, but much less is known about its sensitivity to chronic stressors. In this study, we investigate this question in a commercial bird model: the broiler breeder chicken. Commercial broiler breeders are food restricted during development to manipulate their growth curve and to avoid negative health outcomes, including obesity and poor reproductive performance. Beyond knowing that these chickens are healthier than fully-fed birds and that they have a high motivation to eat, little is known about how food restriction impacts the animals' physiology. Chickens were kept on a commercial food-restricted diet during the first 12 weeks of life, or released from this restriction by feeding them ad libitum from weeks 7-12 of life. To test the hypothesis that chronic food restriction decreases the production of new neurons (neurogenesis) in the hippocampal formation, the cell proliferation marker bromodeoxyuridine was injected one week prior to tissue collection. Corticosterone levels in blood plasma were elevated during food restriction, even though molecular markers of hypothalamic- pituitary-adrenal axis activation did not differ between the treatments. The density of new hippocampal neurons was significantly reduced in the food-restricted condition, as compared to chickens fed ad libitum, similar to findings in rats at a similar developmental stage. Food restriction did not affect hippocampal volume or the total number of neurons. These findings indicate that in birds, like in mammals, reduction in hippocampal neurogenesis is associated with chronically elevated corticosterone levels, and therefore potentially with chronic stress in general. This finding is consistent with the hypothesis that the response to stressors in the avian hippocampal formation is homologous to that of the mammalian hippocampus.	[Robertson, Barbara-Anne; Cirillo, Giselda; Bateson, Melissa; Boswell, Timothy; Smulders, Tom V.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Robertson, Barbara-Anne; Cirillo, Giselda; Bateson, Melissa; Boswell, Timothy; Smulders, Tom V.] Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne, Tyne & Wear, England; [Robertson, Barbara-Anne; Rathbone, Lucy; Smulders, Tom V.] Newcastle Univ, Sch Psychol, Newcastle Upon Tyne, Tyne & Wear, England; [D'Eath, Richard B.] Scotlands Rural Coll, Anim Behav & Welf Grp, Easter Bush, Scotland; [Boswell, Timothy] Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Wilson, Peter W.; Dunn, Ian C.] Univ Edinburgh, Roslin Inst, Edinburgh, Easter Bush, Scotland	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Scotland's Rural College; Newcastle University - UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Smulders, TV (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.; Smulders, TV (corresponding author), Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne, Tyne & Wear, England.; Smulders, TV (corresponding author), Newcastle Univ, Sch Psychol, Newcastle Upon Tyne, Tyne & Wear, England.	Tom.smulders@ncl.ac.uk	Smulders, Tom/G-3955-2011; Bateson, Melissa/AAE-7075-2022; Dunn, Ian/C-7689-2013	Smulders, Tom/0000-0002-6673-7596; Bateson, Melissa/0000-0002-0861-0191; D'Eath, Rick/0000-0002-1801-254X; Dunn, Ian/0000-0003-3630-0120	Department for the Environment, Food and Rural Affairs (Defra) [AW1141]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/K003534/1]; BBSRC [BB/L000288/1, BBS/E/D/30002276, BB/K003534/1, BBS/E/D/20320000, BB/L000199/1, BBS/E/D/20221655, BBS/E/D/05191132] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K003534/1, BBS/E/D/20320000, BBS/E/D/20221655, BBS/E/D/05191132, BB/L000199/1, BB/L000288/1, BBS/E/D/30002276] Funding Source: researchfish	Department for the Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the following funders: Department for the Environment, Food and Rural Affairs (Defra), Grant number: AW1141 to RBD, MB, TB, ICD and TVS; The Biotechnology and Biological Sciences Research Council (BBSRC), Grant number: BB/K003534/1 to TVS, RBD and TB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, except that Defra requires to see the manuscript before submission.	Abellan A, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00059; Aberg MAI, 2000, J NEUROSCI, V20, P2896; Allen TA, 2013, P NATL ACAD SCI USA, V110, P10379, DOI 10.1073/pnas.1301199110; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; ALVAREZBUYLLA A, 1990, NEURON, V5, P101, DOI 10.1016/0896-6273(90)90038-H; ALVAREZBUYLLA A, 1994, J COMP NEUROL, V347, P233, DOI 10.1002/cne.903470207; ASTHEIMER LB, 1992, ORNIS SCAND, V23, P355, DOI 10.2307/3676661; Atoji Y, 2004, J COMP NEUROL, V475, P426, DOI 10.1002/cne.20186; Atoji Y, 2006, REV NEUROSCIENCE, V17, P3; BARAMI K, 1995, J NEUROBIOL, V28, P82, DOI 10.1002/neu.480280108; Barnea A, 2006, BEHAV BRAIN RES, V167, P63, DOI 10.1016/j.bbr.2005.08.018; Barnea A, 2011, EUR J NEUROSCI, V34, P884, DOI 10.1111/j.1460-9568.2011.07851.x; Biegler R, 2001, P NATL ACAD SCI USA, V98, P6941, DOI 10.1073/pnas.121034798; BOUILLE C, 1973, NEUROENDOCRINOLOGY, V13, P264, DOI 10.1159/000122211; Brummelte S, 2010, NEUROSCIENCE, V168, P680, DOI 10.1016/j.neuroscience.2010.04.023; Bureau C, 2009, BMC GENOMICS, V10, DOI [10.1186/1471-2164-10-430, 10.3201/eid1508.080772]; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Cardoso A, 2016, NEUROBIOL LEARN MEM, V133, P214, DOI 10.1016/j.nlm.2016.07.013; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Czeh B, 2007, EUR ARCH PSY CLIN N, V257, P250, DOI 10.1007/s00406-007-0728-0; D'Eath RB, 2009, ANIM BEHAV, V77, P275, DOI 10.1016/j.anbehav.2008.10.028; de Andrade JS, 2013, BEHAV BRAIN RES, V250, P81, DOI 10.1016/j.bbr.2013.04.031; De Jong IC, 2011, WORLD POULTRY SCI J, V67, P73, DOI 10.1017/S0043933911000067; Decuypere E, 2006, WORLD POULTRY SCI J, V62, P443, DOI [10.1017/S0043933906001073, 10.1079/WPS2005107]; Dickens M, 2009, J NEUROENDOCRINOL, V21, P832, DOI 10.1111/j.1365-2826.2009.01908.x; Dickens MJ, 2011, GEN COMP ENDOCR, V170, P569, DOI 10.1016/j.ygcen.2010.11.018; Dixon LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102322; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Dunn IC, 2015, J NEUROENDOCRINOL, V27, P681, DOI 10.1111/jne.12295; Dunn IC, 2013, J NEUROENDOCRINOL, V25, P920, DOI 10.1111/jne.12088; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Giachetto PF, 2003, PESQUI AGROPECU BRAS, V38, P697, DOI 10.1590/S0100-204X2003000600005; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Goldman SA, 1998, J NEUROBIOL, V36, P267, DOI 10.1002/(SICI)1097-4695(199808)36:2<267::AID-NEU12>3.3.CO;2-N; Gould E, 1997, DEV BRAIN RES, V103, P91, DOI 10.1016/S0165-3806(97)00079-5; Gould E, 2000, BIOL PSYCHIAT, V48, P715, DOI 10.1016/S0006-3223(00)01021-0; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; Gould E, 1997, J NEUROSCI, V17, P2492; HARVEY S, 1984, J EXP ZOOL, V232, P633, DOI 10.1002/jez.1402320332; Herold C, 2015, HIPPOCAMPUS, V25, P1193, DOI 10.1002/hipo.22463; Ho YC, 2010, NEUROSCIENCE, V171, P153, DOI 10.1016/j.neuroscience.2010.08.062; HOCKING PM, 1993, BRIT POULTRY SCI, V34, P793, DOI 10.1080/00071669308417638; Hocking PM, 2004, POULTRY SCI, V83, P2044, DOI 10.1093/ps/83.12.2044; HOCKING PM, 1993, BRIT POULTRY SCI, V34, P443, DOI 10.1080/00071669308417600; Hodgson ZG, 2007, P ROY SOC B-BIOL SCI, V274, P239, DOI 10.1098/rspb.2006.3704; Holzenberger M, 1997, J NEUROSCI, V17, P6974; Krause JS, 2015, J NEUROENDOCRINOL, V27, P66, DOI 10.1111/jne.12237; LaDage LD, 2010, P ROY SOC B-BIOL SCI, V277, P1071, DOI 10.1098/rspb.2009.1769; Lattin CR, 2013, AUK, V130, P591, DOI 10.1525/auk.2013.13043; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lee J, 2002, J NEUROCHEM, V80, P539, DOI 10.1046/j.0022-3042.2001.00747.x; Lee J, 2002, J NEUROCHEM, V81, P57; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Lehmann ML, 2013, J NEUROSCI, V33, P2961, DOI 10.1523/JNEUROSCI.3878-12.2013; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Lukoyanov NV, 2002, BEHAV BRAIN RES, V134, P283, DOI 10.1016/S0166-4328(02)00036-0; MAES M, 1995, PROG NEURO-PSYCHOPH, V19, P11, DOI 10.1016/0278-5846(94)00101-M; Mahar I, 2014, NEUROSCI BIOBEHAV R, V38, P173, DOI 10.1016/j.neubiorev.2013.11.009; Maniam J, 2012, NEUROPHARMACOLOGY, V63, P97, DOI 10.1016/j.neuropharm.2012.04.017; MARTI O, 1994, PHYSIOL BEHAV, V55, P747, DOI 10.1016/0031-9384(94)90055-8; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McGregor A, 2004, BEHAV NEUROSCI, V118, P1011, DOI 10.1037/0735-7044.118.5.1011; Mench JA, 2002, WORLD POULTRY SCI J, V58, P23, DOI 10.1079/WPS20020004; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Mormede P, 2007, PHYSIOL BEHAV, V92, P317, DOI 10.1016/j.physbeh.2006.12.003; Nikolakopoulou AM, 2006, EUR J NEUROSCI, V24, P2631, DOI 10.1111/j.1460-9568.2006.05133.x; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; Pravosudov VV, 2003, P ROY SOC B-BIOL SCI, V270, P2599, DOI 10.1098/rspb.2003.2551; Pravosudov VV, 2001, P ROY SOC B-BIOL SCI, V268, P363, DOI 10.1098/rspb.2000.1401; Pravosudov VV, 2005, J NEUROBIOL, V62, P31, DOI 10.1002/neu.20065; Pravosudov VV, 2005, J NEUROBIOL, V62, P82, DOI 10.1002/neu.20069; Puelles L., 2009, CHICK BRAIN STEREOTA; Rattenborg NC, 2011, BEHAV BRAIN RES, V222, P236, DOI 10.1016/j.bbr.2011.03.030; Saaltink DJ, 2014, CELL MOL LIFE SCI, V71, P2499, DOI 10.1007/s00018-014-1568-5; Sapolsky RM, 2003, NEUROCHEM RES, V28, P1735, DOI 10.1023/A:1026021307833; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Sapolsky RM, 2015, NAT NEUROSCI, V18, P1344, DOI 10.1038/nn.4109; Saraulli D, 2017, CURR NEUROPHARMACOL, V15, P519, DOI 10.2174/1570159X14666160412150223; SAVORY CJ, 1993, ANIM WELFARE, V2, P131; Shahbazi M, 2011, GEN COMP ENDOCR, V174, P354, DOI 10.1016/j.ygcen.2011.09.017; Shini S, 2009, Stress, V12, P388, DOI 10.1080/10253890802526894; SLOVITER RS, 1989, SCIENCE, V243, P535, DOI 10.1126/science.2911756; Smulders TV, 2017, BRAIN BEHAV EVOLUT, V90, P81, DOI 10.1159/000477654; Smulders TV, 2000, J NEUROBIOL, V43, P244, DOI 10.1002/(SICI)1097-4695(20000605)43:3<244::AID-NEU3>3.0.CO;2-#; Striedter GF, 2016, J COMP NEUROL, V524, P496, DOI 10.1002/cne.23803; Sufka KJ, 2006, BEHAV PHARMACOL, V17, P681, DOI 10.1097/FBP.0b013e3280115fac; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; Tarr BA, 2009, DEV NEUROBIOLOGY; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Wu MV, 2014, HIPPOCAMPUS, V24, P751, DOI 10.1002/hipo.22265	97	13	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189158	10.1371/journal.pone.0189158	http://dx.doi.org/10.1371/journal.pone.0189158			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211774	gold, Green Published, Green Submitted			2022-12-27	WOS:000417212200072
J	Martin, S; Choi, CTM				Martin, Sebastien; Choi, Charles T. M.			A novel post-processing scheme for two-dimensional electrical impedance tomography based on artificial neural networks	PLOS ONE			English	Article							IMAGE-RECONSTRUCTION	Objective Electrical Impedance Tomography (EIT) is a powerful non-invasive technique for imaging applications. The goal is to estimate the electrical properties of living tissues by measuring the potential at the boundary of the domain. Being safe with respect to patient health, non-invasive, and having no known hazards, EIT is an attractive and promising technology. However, it suffers from a particular technical difficulty, which consists of solving a nonlinear inverse problem in real time. Several nonlinear approaches have been proposed as a replacement for the linear solver, but in practice very few are capable of stable, high-quality, and real-time EIT imaging because of their very low robustness to errors and inaccurate modeling, or because they require considerable computational effort. Methods In this paper, a post-processing technique based on an artificial neural network (ANN) is proposed to obtain a nonlinear solution to the inverse problem, starting from a linear solution. While common reconstruction methods based on ANNs estimate the solution directly from the measured data, the method proposed here enhances the solution obtained from a linear solver. Conclusion Applying a linear reconstruction algorithm before applying an ANN reduces the effects of noise and modeling errors. Hence, this approach significantly reduces the error associated with solving 2D inverse problems using machine-learning-based algorithms.	[Martin, Sebastien; Choi, Charles T. M.] Natl Chiao Tung Univ, Dept Elect & Comp Engn, Hsinchu, Taiwan; [Choi, Charles T. M.] Natl Chiao Tung Univ, Inst Biomed Engn, Hsinchu, Taiwan; [Martin, Sebastien; Choi, Charles T. M.] Natl Chiao Tung Univ, Dept Elect & Comp Engn, Neural Engn & Interface Lab, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Choi, CTM (corresponding author), Natl Chiao Tung Univ, Dept Elect & Comp Engn, Hsinchu, Taiwan.; Choi, CTM (corresponding author), Natl Chiao Tung Univ, Inst Biomed Engn, Hsinchu, Taiwan.; Choi, CTM (corresponding author), Natl Chiao Tung Univ, Dept Elect & Comp Engn, Neural Engn & Interface Lab, Hsinchu, Taiwan.	c.t.choi@ieee.org		Choi, Charles T./0000-0002-4551-2603; Martin, Sebastien/0000-0003-4119-3382	Ministry of Science and Technology of Taiwan [102-2221-E-009-038-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	Partial funding from research grant 102-2221-E-009-038-MY3 from the Ministry of Science and Technology of Taiwan (http://www.most.gov.tw) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adler A, 2006, PHYSIOL MEAS, V27, pS25, DOI 10.1088/0967-3334/27/5/S03; ADLER A, 1994, IEEE T MED IMAGING, V13, P594, DOI 10.1109/42.363109; Adler A, 1996, IEEE T MED IMAGING, V15, P170, DOI 10.1109/42.491418; Adler A, 2009, PHYSIOL MEAS, V30, pS35, DOI 10.1088/0967-3334/30/6/S03; Ammari H, 2004, RECONSTRUCTION SMALL; Astala K, 2010, APPL COMPUT HARMON A, V29, P2, DOI 10.1016/j.acha.2009.08.001; Bayford RH, 2006, ANNU REV BIOMED ENG, V8, P63, DOI 10.1146/annurev.bioeng.8.061505.095716; Borsic A, 2010, IEEE T MED IMAGING, V29, P44, DOI 10.1109/TMI.2009.2022540; Calderon AP, 1980, INVERSE BOUNDARY VAL, P65; Carbonetto P, 1992, INTUITION PRIMAL DUA, P1; Cheney M, 1999, SIAM REV, V41, P85, DOI 10.1137/S0036144598333613; Cheney M., 1990, International Journal of Imaging Systems and Technology, V2, P66, DOI 10.1002/ima.1850020203; Egmont-Petersen M, 2002, PATTERN RECOGN, V35, P2279, DOI 10.1016/S0031-3203(01)00178-9; Fortier N., 1993, Journal of Visual Communication and Image Representation, V4, P157, DOI 10.1006/jvci.1993.1014; GhasemAzar M, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND INFORMATION TECHNOLOGY, VOLS 1-3, P868; Holder D. S, 2005, ELECT IMPEDANCE TOMO; Isaacson D, 2006, PHYSIOL MEAS, V27, pS43, DOI 10.1088/0967-3334/27/5/S04; Jin KH, 2017, IEEE T IMAGE PROCESS, V26, P4509, DOI 10.1109/TIP.2017.2713099; Kwon O, 2002, IEEE T BIO-MED ENG, V49, P160, DOI 10.1109/10.979355; Lampinen J., 1999, IJCNN'99. International Joint Conference on Neural Networks. Proceedings (Cat. No.99CH36339), P3942, DOI 10.1109/IJCNN.1999.830787; Lionheart WRB, 1999, ANN NY ACAD SCI, V873, P466, DOI 10.1111/j.1749-6632.1999.tb09495.x; Martin S, POSTPROCESSING METHO; Martin S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07727-2; Martin S, 2016, PHYSIOL MEAS, V37, P801, DOI 10.1088/0967-3334/37/6/801; Mayer M, 2006, PHYSIOL MEAS, V27, pS93, DOI 10.1088/0967-3334/27/5/S08; McEwan A, 2007, PHYSIOL MEAS, V28, pS197, DOI 10.1088/0967-3334/28/7/S15; Miao LW, 2014, IEEE T INSTRUM MEAS, V63, P2903, DOI 10.1109/TIM.2014.2326765; Ramirez M. P. T., 2010, 2010 7th International Conference on Electrical Engineering, Computing Science and Automatic Control (CCE 2010) (Formerly known as ICEEE), P274, DOI 10.1109/ICEEE.2010.5608621; Sharma OP, 2013, INT J SOFT COMPUTING, V2, P220; Singh D, 2016, IEEE T MAGN, V52, DOI 10.1109/TMAG.2016.2590384; Stasiak M, 2007, ENG ANAL BOUND ELEM, V31, P713, DOI 10.1016/j.enganabound.2006.12.003; Tu C. -Y, 2015, DEV HIGH RESOLUTION; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9; Uhlmann G, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/12/123011; Wu SG, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND INFORMATION TECHNOLOGY, VOLS 1-3, P120; Zhou Z, 2015, PHYSIOL MEAS, V36, P1193, DOI 10.1088/0967-3334/36/6/1193	38	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188993	10.1371/journal.pone.0188993	http://dx.doi.org/10.1371/journal.pone.0188993			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206856	Green Submitted, Green Published, gold			2022-12-27	WOS:000417110700036
J	Wang, P; Tuvblad, C; Younan, D; Franklin, M; Lurmann, F; Wu, J; Baker, LA; Chen, JC				Wang, Pan; Tuvblad, Catherine; Younan, Diana; Franklin, Meredith; Lurmann, Fred; Wu, Jun; Baker, Laura A.; Chen, Jiu-Chiuan			Socioeconomic disparities and sexual dimorphism in neurotoxic effects of ambient fine particles on youth IQ: A longitudinal analysis	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; AGE-RELATED-CHANGES; FLUID INTELLIGENCE; PRENATAL EXPOSURE; YOUNG ADULTHOOD; AIR-POLLUTION; WHITE-MATTER; CHILD IQ; BRAIN-DEVELOPMENT; ADOLESCENCE	Mounting evidence indicates that early-life exposure to particulate air pollutants pose threats to children's cognitive development, but studies about the neurotoxic effects associated with exposures during adolescence remain unclear. We examined whether exposure to ambient fine particles (PM2.5) at residential locations affects intelligence quotient (IQ) during pre-/early- adolescence (ages 9-11) and emerging adulthood (ages 18-20) in a demographicallydiverse population (N = 1,360) residing in Southern California. Increased ambient PM2.5 levels were associated with decreased IQ scores. This association was more evident for Performance IQ (PIQ), but less for Verbal IQ, assessed by the Wechsler Abbreviated Scale of Intelligence. For each inter-quartile (7.73 mu g/m(3)) increase in one-year PM2.5 preceding each assessment, the average PIQ score decreased by 3.08 points (95% confidence interval = [-6.04, -0.12]) accounting for within-family/within-individual correlations, demographic characteristics, family socioeconomic status (SES), parents' cognitive abilities, neighborhood characteristics, and other spatial confounders. The adverse effect was 150% greater in low SES families and 89% stronger in males, compared to their counterparts. Better understanding of the social disparities and sexual dimorphism in the adverse PM2.5-IQ effects may help elucidate the underlying mechanisms and shed light on prevention strategies.	[Wang, Pan] Univ Calif Los Angeles, Ctr Hlth Policy Res, Los Angeles, CA 90095 USA; [Tuvblad, Catherine] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Tuvblad, Catherine] Orebro Univ, Sch Law Psychol & Social Work, Orebro, Sweden; [Younan, Diana; Franklin, Meredith; Chen, Jiu-Chiuan] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Lurmann, Fred] Sonoma Technol Inc, Petaluma, CA USA; [Wu, Jun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA USA	University of California System; University of California Los Angeles; University of Southern California; Orebro University; University of Southern California; University of California System; University of California Irvine	Wang, P (corresponding author), Univ Calif Los Angeles, Ctr Hlth Policy Res, Los Angeles, CA 90095 USA.	panwang@ucla.edu			National Institute of Environmental Health Sciences [R21 ES022369]; National Institute of Mental Health [R01 MH058354]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences (grant R21 ES022369 to JC), https.//www.niehs.nih.gov/. The USC RFAB Twin Study is funded by the National Institute of Mental Health (grant R01 MH058354 to LB), https://www.nimh.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author FL worked at Sonoma Technology Inc. while engaged in this research. Sonoma provided support in the form of salaries for author FL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of FL is articulated in the 'author contributions' section.	Allen JL, 2014, TOXICOL SCI, V140, P160, DOI 10.1093/toxsci/kfu059; Baker LA, 2013, TWIN RES HUM GENET, V16, P336, DOI 10.1017/thg.2012.127; Barbey AK, 2014, BRAIN STRUCT FUNCT, V219, P485, DOI 10.1007/s00429-013-0512-z; Bellinger DC, 2016, ENVIRON INT, V94, P103, DOI 10.1016/j.envint.2016.05.014; Bergen SE, 2007, TWIN RES HUM GENET, V10, P423, DOI 10.1375/twin.10.3.423; Block ML, 2012, NEUROTOXICOLOGY, V33, P972, DOI 10.1016/j.neuro.2012.08.014; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; Calderon-Garciduenas L, 2011, BRAIN COGNITION, V77, P345, DOI 10.1016/j.bandc.2011.09.006; Cattell R. B., 1971, ABILITIES THEIR STRU; CATTELL RB, 1963, J EDUC PSYCHOL, V54, P1, DOI 10.1037/h0046743; Chiu YHM, 2016, ENVIRON INT, V87, P56, DOI 10.1016/j.envint.2015.11.010; CHRISTIAN K, 2001, ENV EFFECTS COGNITIV, P287; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; Davies W, 2006, BRAIN RES, V1126, P36, DOI 10.1016/j.brainres.2006.09.105; DUNCAN J, 1995, NEUROPSYCHOLOGIA, V33, P261, DOI 10.1016/0028-3932(94)00124-8; Edwards SC, 2010, ENVIRON HEALTH PERSP, V118, P1326, DOI 10.1289/ehp.0901070; Fonken LK, 2011, MOL PSYCHIATR, V16, P987, DOI 10.1038/mp.2011.76; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Grosse SD, 2002, ENVIRON HEALTH PERSP, V110, P563, DOI 10.1289/ehp.02110563; Guxens M, 2016, EPIDEMIOLOGY ISEE; Halpern DF, 2000, EDUC PSYCHOL REV, V12, P229, DOI 10.1023/A:1009027516424; Harris MH, 2015, ENVIRON HEALTH PERSP, V123, P1072, DOI 10.1289/ehp.1408803; Herlitz A, 2013, DEV NEUROPSYCHOL, V38, P167, DOI 10.1080/87565641.2012.759580; Hoekstra RA, 2007, LEARN INDIVID DIFFER, V17, P97, DOI 10.1016/j.lindif.2007.05.005; Jedrychowski WA, 2015, ENVIRON SCI POLLUT R, V22, P3631, DOI 10.1007/s11356-014-3627-8; Johnson S. B., 2016, PEDIATRICS, V137, P2015; Kaufman A.S., 2005, ASSESSING ADOLESCENT; Knezevic A, OVERLAPPING CONFIDEN; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Lovasi GS, 2014, J CHILD FAM STUD, V23, P785, DOI 10.1007/s10826-013-9731-4; Lynn R., 2006, IQ GLOBAL INEQUALITY; McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037/0003-066X.53.2.185; MILLER DI, 2014, SCI ENG ETHICS, V18, P37, DOI DOI 10.1016/J.TICS.2013.10.011; Nisbett RE, 2012, AM PSYCHOL, V67, P130, DOI 10.1037/a0026699; Noble KG, 2015, NAT NEUROSCI, V18, P773, DOI 10.1038/nn.3983; Noble KG, 2013, DEVELOPMENTAL SCI, V16, P653, DOI 10.1111/desc.12077; Perera F, 2012, ENVIRON RES, V114, P40, DOI 10.1016/j.envres.2011.12.011; Perera FP, 2009, PEDIATRICS, V124, pE195, DOI 10.1542/peds.2008-3506; Peterson BS, 2015, JAMA PSYCHIAT, V72, P531, DOI 10.1001/jamapsychiatry.2015.57; Porta D., 2015, EPIDEMIOLOGY; Ramsden S, 2011, NATURE, V479, P113, DOI 10.1038/nature10514; Roca M, 2010, BRAIN, V133, P234, DOI 10.1093/brain/awp269; Sirivelu MP, 2006, ENVIRON HEALTH PERSP, V114, P870, DOI 10.1289/ehp.8619; Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004; Suglia SF, 2008, AM J EPIDEMIOL, V167, P280, DOI 10.1093/aje/kwm308; Sunyer J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001792; Suzuki T, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-7; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Tsukue N, 2004, J HEALTH SCI, V50, P174, DOI 10.1248/jhs.50.174; Turkheimer E, 2003, PSYCHOL SCI, V14, P623, DOI 10.1046/j.0956-7976.2003.psci_1475.x; van Ijzendoorn MH, 2005, PSYCHOL BULL, V131, P301, DOI 10.1037/0033-2909.131.2.301; Vishnevetsky J, 2015, NEUROTOXICOL TERATOL, V49, P74, DOI 10.1016/j.ntt.2015.04.002; Vuoksimaa E, 2012, PSYCHONEUROENDOCRINO, V37, P1791, DOI 10.1016/j.psyneuen.2012.03.013; Wechsler D., 2007, WASI 2 WECHSLER ABBR; Weiss B, 2002, ENVIRON HEALTH PERSP, V110, P387, DOI 10.1289/ehp.02110s3387; White Aaron M, 2005, Recent Dev Alcohol, V17, P161, DOI 10.1007/0-306-48626-1_8; WHO, 2016, AD DEV2011; Woolgar A, 2010, P NATL ACAD SCI USA, V107, P14899, DOI 10.1073/pnas.1007928107	59	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188731	10.1371/journal.pone.0188731	http://dx.doi.org/10.1371/journal.pone.0188731			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO8CU	29206872	Green Published, Green Submitted, gold			2022-12-27	WOS:000417110700020
J	Zhang, H; Diao, HX; Jia, LX; Yuan, YJ; Thamm, DH; Wang, HA; Jin, YP; Pei, SM; Zhou, B; Yu, F; Zhao, LN; Cheng, N; Du, HC; Huang, Y; Zhang, D; Lin, DG				Zhang, Hong; Diao, Hongxiu; Jia, Lixin; Yuan, Yujing; Thamm, Douglas H.; Wang, Huanan; Jin, Yipeng; Pei, Shimin; Zhou, Bin; Yu, Fang; Zhao, Linna; Cheng, Nan; Du, Hongchao; Huang, Ying; Zhang, Di; Lin, Degui			Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; CARBONIC-ANHYDRASE-IX; MAMMARY-CARCINOMA 4T1; DENDRITIC CELLS; SALMONELLA-TYPHIMURIUM; IN-VIVO; TARGETED THERAPY; TUMOR-GROWTH; POOR SURVIVAL; HYPOXIA	A variety of bacteria have been used as agents and vectors for antineoplastic therapy. A series of mechanisms, including native bacterial toxicity, sensitization of the immune system and competition for nutrients, may contribute to antitumor effects. However, the antitumor effects of Proteus species have been minimally studied, and it is not clear if bacteria can alter tumor hypoxia as a component of their antineoplastic effect. In the present study, Proteus mirabilis bacteria were evaluated for the ability to proliferate and accumulate in murine tumors after intravenous injection. To further investigate the efficacy and safety of bacterial injection, mice bearing 4T1 tumors were treated with an intravenous dose of 5x10(7) CFU Proteus mirabilis bacteria via the tail vein weekly for three treatments. Histopathology, immunohistochemistry (IHC) and western analysis were then performed on excised tumors. The results suggested Proteus mirabilis localized preferentially to tumor tissues and remarkably suppressed the growth of primary breast cancer and pulmonary metastasis in murine 4T1 models. Results showed that the expression of NKp46 and CD11c was significantly increased after bacteria treatment. Furthermore, tumor expression of carbonic anhydrase IX (CA IX) and hypoxia inducible factor-1a (HIF-1a), surrogates for hypoxia, was significantly lower in the treated group than the control group mice as assessed by IHC and western analysis. These findings demonstrated that Proteus mirabilis may a promising bacterial strain for used against primary tumor growth and pulmonary metastasis, and the immune system and reduction of tumor hypoxia may contribute to the antineoplastic and antimetastatic effects observed.	[Zhang, Hong; Diao, Hongxiu; Jia, Lixin; Yuan, Yujing; Jin, Yipeng; Yu, Fang; Zhao, Linna; Cheng, Nan; Du, Hongchao; Huang, Ying; Zhang, Di; Lin, Degui] China Agr Univ, Dept Vet Clin Sci, Coll Vet Med, Beijing, Peoples R China; [Thamm, Douglas H.] Colorado State Univ, Dept Clin Sci, Coll Vet Med & Biomed Sci, Ft Collins, CO 80523 USA; [Wang, Huanan] Zhejiang Univ, Dept Vet, Coll Anim Sci, Hangzhou, Zhejiang, Peoples R China; [Pei, Shimin] Hainan Univ, Dept Vet Med, Haikou, Hainan, Peoples R China; [Zhou, Bin] Zhejiang Agr & Forestry Univ, Coll Anim Sci & Technol, Hangzhou, Zhejiang, Peoples R China	China Agricultural University; Colorado State University; Zhejiang University; Hainan University; Zhejiang A&F University	Zhang, D; Lin, DG (corresponding author), China Agr Univ, Dept Vet Clin Sci, Coll Vet Med, Beijing, Peoples R China.	dzhangdvm@cau.edu.cn; csama@sina.com	Thamm, Douglas H/I-5976-2013; Thamm, Douglas/AAG-3672-2020	Thamm, Douglas H/0000-0002-8914-7767; 	National Natural Science Foundation of China [3157130419]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/), grant number No. 3157130419, which DL received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2004, P NATL ACAD SCI USA, V101, P15172, DOI 10.1073/pnas.0406242101; Peixoto RCA, 2015, TUMOR BIOL, V36, P3325, DOI 10.1007/s13277-014-2966-x; Barbe S, 2005, FEMS MICROBIOL LETT, V246, P67, DOI 10.1016/j.femsle.2005.03.037; Bassaganya-Riera J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034676; Beketic-Oreskovic L, 2011, PATHOL ONCOL RES, V17, P593, DOI 10.1007/s12253-010-9355-6; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Browder T, 2000, CANCER RES, V60, P1878; Chen JX, 2012, CANCER SCI, V103, P325, DOI 10.1111/j.1349-7006.2011.02147.x; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Coley WB, 1906, AM J MED SCI, V131, P375; Coutermarsh-Ott SL, 2017, ONCOTARGET, V8, P33601, DOI 10.18632/oncotarget.16830; Cuenca AG, 2014, J IMMUNOL, V192, P6111, DOI 10.4049/jimmunol.1302895; Dales JP, 2005, INT J CANCER, V116, P734, DOI 10.1002/ijc.20984; Douglas H., 2005, CLIN CANC RES OFFICI, V11, P7; Dupre SA, 2007, INT J EXP PATHOL, V88, P351, DOI 10.1111/j.1365-2613.2007.00539.x; duPre' SA, 2007, EXP MOL PATHOL, V82, P12, DOI 10.1016/j.yexmp.2006.06.007; Fang J, 2014, J PHARM SCI-US, V103, P3235, DOI 10.1002/jps.24083; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Forbes NS, 2010, NAT REV CANCER, V10, P784, DOI 10.1038/nrc2934; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Gieling RG, 2013, BIOORGAN MED CHEM, V21, P1470, DOI 10.1016/j.bmc.2012.09.062; Gillies RJ, 2012, NAT REV CANCER, V12, P487, DOI 10.1038/nrc3298; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Hayashi K, 2009, J CELL BIOCHEM, V106, P992, DOI 10.1002/jcb.22078; Heap JT, 2014, ONCOTARGET, V5, P1761, DOI 10.18632/oncotarget.1761; Hussain SA, 2007, BRIT J CANCER, V96, P104, DOI 10.1038/sj.bjc.6603530; Hye-Jin, 2010, J CELL SCI, V124, P1077; Jain RK, 2001, P NATL ACAD SCI USA, V98, P14748, DOI 10.1073/pnas.261606598; Jeong J.-M., 2014, BOUND VALUE PROBL, V255, P1, DOI DOI 10.1016/J.CHI.2014.01.017; Jiang SN, 2010, MOL THER, V18, P635, DOI 10.1038/mt.2009.295; Josien R, 1997, J EXP MED, V186, P467, DOI 10.1084/jem.186.3.467; Kaya AO, 2012, J BUON, V17, P663; Kim EJ, 2011, BREAST CANCER RES TR, V130, P61, DOI 10.1007/s10549-010-1299-8; Krick EL, 2012, AM J VET RES, V73, P112, DOI 10.2460/ajvr.73.1.112; Li ZY, 2012, INT J CANCER, V131, P2584, DOI 10.1002/ijc.27572; Low KB, 1999, NAT BIOTECHNOL, V17, P37, DOI 10.1038/5205; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; MURATA TOYOICHIRO, 1965, LIFE SCI, V4, P1055; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; OLTMANN LF, 1979, FEBS LETT, V106, P43, DOI 10.1016/0014-5793(79)80691-2; Parks SK, 2016, MOL ASPECTS MED, V47-48, P3, DOI 10.1016/j.mam.2015.12.001; Pawelek JM, 2003, LANCET ONCOL, V4, P548, DOI 10.1016/S1470-2045(03)01194-X; Pearson MM, 2008, J BACTERIOL, V190, P4027, DOI 10.1128/JB.01981-07; Rankin EB, 2016, SCIENCE, V352, P175, DOI 10.1126/science.aaf4405; Roberts N.J., 2014, SCI TRANSL MED, V6, P249, DOI DOI 10.1126/SCITRANSLMED.3008982; SAKAMOTO K, 1988, JPN J CANCER RES, V79, P109, DOI 10.1111/j.1349-7006.1988.tb00017.x; Schaffer JN, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.UTI-0017-2013; Semenza GL, 2012, TRENDS MOL MED, V18, P534, DOI 10.1016/j.molmed.2012.08.001; Shafey SABHME, 2013, EUROPEAN SCI J, V9, P14; Sznol M, 2000, J CLIN INVEST, V105, P1027, DOI 10.1172/JCI9818; Tabaries S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0558-3; Toso JF, 2002, J CLIN ONCOL, V20, P142, DOI 10.1200/JCO.20.1.142; Trastour C, 2007, INT J CANCER, V120, P1451, DOI 10.1002/ijc.22436; UNDEN G, 1994, ANTON LEEUW INT J G, V66, P3, DOI 10.1007/BF00871629; van der Groep P, 2004, BREAST CANCER RES TR, V88, pS152; Vanderheyde N, 2001, J IMMUNOL, V167, P3565, DOI 10.4049/jimmunol.167.7.3565; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vleugel MM, 2005, J CLIN PATHOL, V58, P172, DOI 10.1136/jcp.2004.019885; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Weibel S, 2008, CELL MICROBIOL, V10, P1235, DOI 10.1111/j.1462-5822.2008.01122.x; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Yan LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131518; Yu HJ, 2016, THERANOSTICS, V6, P14, DOI 10.7150/thno.13515; Zhang T, 2015, NANOMEDICINE-UK, V10, P573, DOI 10.2217/nnm.14.141; Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102; Zhao M, 2006, CANCER RES, V66, P7647, DOI 10.1158/0008-5472.CAN-06-0716; Zhao X, 2014, CANCER RES, V74, P2455, DOI 10.1158/0008-5472.CAN-13-3009; Zitvogel L, 2002, J EXP MED, V195, pf9, DOI 10.1084/jem.20012040	69	12	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188960	10.1371/journal.pone.0188960	http://dx.doi.org/10.1371/journal.pone.0188960			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206859	Green Published, Green Submitted, gold			2022-12-27	WOS:000417110700034
J	Chua, MMJ; Lee, M; Dominguez, I				Chua, Melissa M. J.; Lee, Migi; Dominguez, Isabel			Cancer-type dependent expression of CK2 transcripts	PLOS ONE			English	Article							PROTEIN-KINASE CK2; SQUAMOUS-CELL CARCINOMA; NF-KAPPA-B; MALIGNANT PLEURAL MESOTHELIOMA; UNFAVORABLE PROGNOSTIC MARKER; GENE-EXPRESSION; MULTIPLE-MYELOMA; ALPHA-SUBUNIT; IN-VIVO; BARRETTS METAPLASIA	A multitude of proteins are aberrantly expressed in cancer cells, including the oncogenic serine-threonine kinase CK2. In a previous report, we found increases in CK2 transcript expression that could explain the increased CK2 protein levels found in tumors from lung and bronchus, prostate, breast, colon and rectum, ovarian and pancreatic cancers. We also found that, contrary to the current notions about CK2, some CK2 transcripts were downregulated in several cancers. Here, we investigate all other cancers using Oncomine to determine whether they also display significant CK2 transcript dysregulation. As anticipated from our previous analysis, we found cancers with all CK2 transcripts upregulated (e.g. cervical), and cancers where there was a combination of upregulation and/or downregulation of the CK2 transcripts (e.g. sarcoma). Unexpectedly, we found some cancers with significant downregulation of all CK2 transcripts (e.g. testicular cancer). We also found that, in some cases, CK2 transcript levels were already dysregulated in benign lesions (e.g. Barrett's esophagus). We also found that CK2 transcript upregulation correlated with lower patient survival in most cases where data was significant. However, there were two cancer types, glioblastoma and renal cell carcinoma, where CK2 transcript upregulation correlated with higher survival. Overall, these data show that the expression levels of CK2 genes is highly variable in cancers and can lead to different patient outcomes.	[Chua, Melissa M. J.; Lee, Migi; Dominguez, Isabel] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University	Dominguez, I (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	isdoming@bu.edu		Lee, Migi/0000-0002-6571-267X; /0000-0001-9617-4141; Chua, Melissa/0000-0002-2832-4002	National Institutes of General Medical Sciences [1R01GM098367]; Barbur Kalique Scholarship through the Boston University School of Medicine Medical Student Summer Research Program (MSSRP); Boston University Undergraduate Research Opportunities Program (UROP); National Institutes of General Medical Sciences (NIGMS) [1R01GM098367]	National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Barbur Kalique Scholarship through the Boston University School of Medicine Medical Student Summer Research Program (MSSRP); Boston University Undergraduate Research Opportunities Program (UROP); National Institutes of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported in part with funding from the National Institutes of General Medical Sciences; 1R01GM098367 [http://www.nigms.nih.gov/]. M.C. was supported by a Barbur Kalique Scholarship through the Boston University School of Medicine Medical Student Summer Research Program (MSSRP); and M.L. was supported by a fellowship from the Boston University Undergraduate Research Opportunities Program (UROP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Dominguez lab for discussions. We thank Janice Weinberg and Na Wang, Biostatistics Consultants in the Department of Medicine, for their help with statistical analysis. We thank Kevan Hartshorn, Anurag Singh, Barbara Guerra and Sam Thiangalingam for their comments to the manuscript. This work was partially supported with funding from the National Institutes of General Medical Sciences (NIGMS); 1R01GM098367. M.C. was supported by a Barbur Kalique Scholarship through the Boston University School of Medicine Medical Student Summer Research Program (MSSRP); and M.L. was supported by a fellowship from the Boston University Undergraduate Research Opportunities Program (UROP). Data from WHO, NCI, CDC, ACS, Oncomine and Kaplan Meier Plotter are cited as per their requirements.	Agnelli L, 2009, GENE CHROMOSOME CANC, V48, P603, DOI 10.1002/gcc.20668; Ahmad KA, 2008, ADV ENZYME REGUL, V48, P179, DOI 10.1016/j.advenzreg.2008.04.002; Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; Ahmed K, 2000, J CELL BIOCHEM, P130; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Andersson A, 2007, LEUKEMIA, V21, P1198, DOI 10.1038/sj.leu.2404688; [Anonymous], **DROPPED REF**, Patent No. 2001.016009606.x; Bae JS, 2015, INT J CANCER, V136, P797, DOI 10.1002/ijc.29043; Bai XY, 2009, NUCLEIC ACIDS RES, V37, P2699, DOI 10.1093/nar/gkp094; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bian YS, 2015, INT J BIOL SCI, V11, P411, DOI 10.7150/ijbs.10745; Bibby AC, 2005, INT J BIOL SCI, V1, P67; Bilous N, 2005, EXP ONCOL, V27, P325; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Brown MS, 2010, CLIN CANCER RES, V16, P2295, DOI 10.1158/1078-0432.CCR-09-3200; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; Cannon CM, 2017, HUM GENE THER CL DEV, V28, P80, DOI 10.1089/humc.2017.008; Canton DA, 2006, CELL SIGNAL, V18, P267, DOI 10.1016/j.cellsig.2005.07.008; Channavajhala P, 2002, ONCOGENE, V21, P5280, DOI 10.1038/sj.onc.1205640; [陈勃 Chen Bo], 2012, [南方医科大学学报, Journal of Southern Medical University], V32, P1491; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; Choi SE, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00006-17; Choi YL, 2007, ONCOGENE, V26, P1245, DOI 10.1038/sj.onc.1209898; Chua MMJ, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10010018; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Coustan-Smith E, 2011, BLOOD, V117, P6267, DOI 10.1182/blood-2010-12-324004; Cozza G, 2016, EXPERT OPIN THER TAR, V20, P319, DOI 10.1517/14728222.2016.1091883; Cutcliffe C, 2005, CLIN CANCER RES, V11, P7986, DOI 10.1158/1078-0432.CCR-05-1354; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Deffenbacher KE, 2012, BLOOD, V119, P3757, DOI 10.1182/blood-2011-05-349662; Deshiere A, 2013, ONCOGENE, V32, P1373, DOI 10.1038/onc.2012.165; Detwiller KY, 2005, CANCER RES, V65, P5881, DOI 10.1158/0008-5472.CAN-04-4078; Dixit D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.10; Dominguez I, 2009, CELL MOL LIFE SCI, V66, P1850, DOI 10.1007/s00018-009-9153-z; Dubois N, 2016, INT J ONCOL, V48, P2445, DOI 10.3892/ijo.2016.3490; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Eckerle S, 2009, LEUKEMIA, V23, P2129, DOI 10.1038/leu.2009.161; Faust RA, 1999, INT J BIOCHEM CELL B, V31, P941, DOI 10.1016/S1357-2725(99)00050-3; Faust RA, 1996, CANCER LETT, V101, P31, DOI 10.1016/0304-3835(96)04110-9; Ferrer-Font L, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10010024; Filhol O., 2013, ROLE CK2 CONTROL CEL; French PJ, 2005, CANCER RES, V65, P11335, DOI 10.1158/0008-5472.CAN-05-1886; GAPANY M, 1995, MOL MED, V1, P659, DOI 10.1007/BF03401606; Gordon GJ, 2005, AM J PATHOL, V166, P1827, DOI 10.1016/S0002-9440(10)62492-3; Guerra B, 1999, FEBS LETT, V462, P353, DOI 10.1016/S0014-5793(99)01553-7; Guerra B, 2008, CURR MED CHEM, V15, P1870, DOI 10.2174/092986708785132933; Guo CH, 2001, J BIOL CHEM, V276, P5992, DOI 10.1074/jbc.M004862200; Guo M, 2014, ASIAN PAC J CANCER P, V15, P7425, DOI 10.7314/APJCP.2014.15.17.7425; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Hung MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011418; Jeppesen DK, 2014, PROTEOMICS, V14, P699, DOI 10.1002/pmic.201300452; Jiang H, 2009, EXP HEMATOL, V37, P1201, DOI 10.1016/j.exphem.2009.07.010; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kim HS, 2014, FEBS J, V281, P851, DOI 10.1111/febs.12652; Kim JS, 2007, CLIN CANCER RES, V13, P1019, DOI 10.1158/1078-0432.CCR-06-1602; Kim SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015074; Kimchi ET, 2005, CANCER RES, V65, P3146, DOI 10.1158/0008-5472.CAN-04-2490; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Kramerov AA, 2008, MOL CELL BIOCHEM, V316, P177, DOI 10.1007/s11010-008-9831-4; Krick R, 2006, BIOCHEM BIOPH RES CO, V341, P343, DOI 10.1016/j.bbrc.2005.12.190; Ladha J, 2010, CANCER RES, V70, P6437, DOI 10.1158/0008-5472.CAN-10-0819; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee YS, 2014, HELICOBACTER, V19, P465, DOI 10.1111/hel.12144; Lin KY, 2010, ANN SURG ONCOL, V17, P1695, DOI 10.1245/s10434-010-0911-9; LITCHFIELD DW, 1990, J BIOL CHEM, V265, P7638; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Litchfield DW, 2001, MOL CELL BIOCHEM, V227, P21, DOI 10.1023/A:1013188101465; Liu YF, 2016, EBIOMEDICINE, V8, P173, DOI 10.1016/j.ebiom.2016.04.038; Lou DY, 2008, MOL CELL BIOL, V28, P131, DOI 10.1128/MCB.01119-07; LOZEMAN FJ, 1990, BIOCHEMISTRY-US, V29, P8436, DOI 10.1021/bi00488a034; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Macias Alvarez L., 2013, WILEY IUBMB SERIES B; Maia S, 2005, CANCER RES, V65, P10050, DOI 10.1158/0008-5472.CAN-05-1574; Mandal T, 2014, CELL SIGNAL, V26, P1725, DOI 10.1016/j.cellsig.2014.04.003; Manni S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075280; Gomes AM, 2014, HAEMATOLOGICA, V99, P1062, DOI 10.3324/haematol.2013.096438; MARIDOR G, 1991, J BIOL CHEM, V266, P2362; Martins LR, 2010, BLOOD, V116, P2724, DOI 10.1182/blood-2010-04-277947; Massimi P, 2000, VIROLOGY, V276, P388, DOI 10.1006/viro.2000.0514; Michiels S, 2016, ANN ONCOL, V27, P2160, DOI 10.1093/annonc/mdw307; Morrison C, 2004, AM J PATHOL, V165, P565, DOI 10.1016/S0002-9440(10)63321-4; Nitta RT, 2015, ONCOGENE, V34, P3688, DOI 10.1038/onc.2014.299; O-charoenrat P, 2004, CLIN CANCER RES, V10, P5792, DOI 10.1158/1078-0432.CCR-03-0317; Ortega CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115609; Oshida K, 2011, J APPL TOXICOL, V31, P790, DOI 10.1002/jat.1637; Pascual V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146276; Pencheva N, 2017, CELL REP, V20, P48, DOI 10.1016/j.celrep.2017.06.036; Peng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023452; Peng XN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005591; Piazza FA, 2006, BLOOD, V108, P1698, DOI 10.1182/blood-2005-11-013672; Piccaluga PP, 2007, J CLIN INVEST, V117, P823, DOI 10.1172/JCI26833; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Pizzi M, 2015, ONCOTARGET, V6, P6544, DOI 10.18632/oncotarget.3446; Posch C, 2016, J INVEST DERMATOL, V136, P1330, DOI 10.1016/j.jid.2016.03.006; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Quade BJ, 2004, GENE CHROMOSOME CANC, V40, P97, DOI 10.1002/gcc.20018; Rabjerg M, 2017, ONCOTARGET, V8, P1613, DOI 10.18632/oncotarget.13693; Rabjerg M, 2016, APMIS, V124, P372, DOI 10.1111/apm.12519; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; ROELANTS C, 2015, DYSR EXPR PROT KIN, V12, P241; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Ruzzene M, 2010, BBA-PROTEINS PROTEOM, V1804, P499, DOI 10.1016/j.bbapap.2009.07.018; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Seldin DC, 2005, MOL CELL BIOCHEM, V274, P63, DOI 10.1007/s11010-005-3078-0; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; SELDIN DC, 1995, CURR OPIN IMMUNOL, V7, P665, DOI 10.1016/0952-7915(95)80075-1; Sengupta A, 2006, J GENE MED, V8, P1251, DOI 10.1002/jgm.959; Shai R, 2003, ONCOGENE, V22, P4918, DOI 10.1038/sj.onc.1206753; Shimada K, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-8; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Skotheim RI, 2005, CANCER RES, V65, P5588, DOI 10.1158/0008-5472.CAN-05-0153; Song CH, 2015, BLOOD, V126, P1813, DOI 10.1182/blood-2015-06-651505; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; STALTER G, 1994, BIOCHEM BIOPH RES CO, V202, P141, DOI 10.1006/bbrc.1994.1904; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Storz MN, 2003, J INVEST DERMATOL, V120, P865, DOI 10.1046/j.1523-1747.2003.12142.x; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Takahashi K, 2017, ONCOL REP, V37, P1141, DOI 10.3892/or.2016.5310; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Talbot SG, 2005, CANCER RES, V65, P3063, DOI 10.1158/0008-5472.CAN-04-1985; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Timofeeva OA, 2006, ONCOGENE, V25, P7555, DOI 10.1038/sj.onc.1209742; Trembley J.H., 2013, CK2 SUPPRESSION APOP, P219; Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96; Tubi LQ, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-78; Tugizov S, 2005, J VIROL, V79, P1099, DOI 10.1128/JVI.79.2.1099-1112.2005; Wang S, 2006, ONCOGENE, V25, P3346, DOI 10.1038/sj.onc.1209357; WIRKNER U, 1992, BIOCHIM BIOPHYS ACTA, V1131, P220, DOI 10.1016/0167-4781(92)90083-C; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Xu X, 1999, NAT GENET, V23, P118, DOI 10.1038/12729; Yusenko MV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-152; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077; Zhang HX, 2015, ONCOTARGET, V6, P34800, DOI 10.18632/oncotarget.5470; Zhang SL, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0093-6; Zhang XL, 2016, ONCOTARGET, V7, P87361, DOI 10.18632/oncotarget.13571; Zheng Y, 2013, CLIN CANCER RES, V19, P6484, DOI 10.1158/1078-0432.CCR-13-0265; Zhou BY, 2016, J BIOL CHEM, V291, P17804, DOI 10.1074/jbc.M115.712885	151	36	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188854	10.1371/journal.pone.0188854	http://dx.doi.org/10.1371/journal.pone.0188854			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29206231	Green Published, gold, Green Submitted			2022-12-27	WOS:000417033200016
J	Osthushenrich, T; Frisch, M; Herzog, E				Osthushenrich, Tanja; Frisch, Matthias; Herzog, Eva			Genomic selection of crossing partners on basis of the expected mean and variance of their derived lines	PLOS ONE			English	Article							GENETIC VARIANCE; MAIZE; PREDICTION; LOCI; POPULATIONS; PERFORMANCE	In a line or a hybrid breeding program superior lines are selected from a breeding pool as parental lines for the next breeding cycle. From a cross of two parental lines, new lines are derived by single-seed descent (SSD) or doubled haploid (DH) technology. However, not all possible crosses between the parental lines can be carried out due to limited resources. Our objectives were to present formulas to characterize a cross by the mean and variance of the genotypic values of the lines derived from the cross, and to apply the formulas to predict means and variances of flowering time traits in recombinant inbred line families of a publicly available data set in maize. We derived formulas which are based on the expected linkage disequilibrium (LD) between two loci and which can be used for arbitrary mating systems. Results were worked out for SSD and DH lines derived from a cross after an arbitrary number of intermating generations. The means and variances were highly correlated with results obtained by the simulation software PopVar. Compared with these simulations, computation time for our closed formulas was about ten times faster. The means and variances for flowering time traits observed in the recombinant inbred line families of the investigated data set showed correlations of around 0.9 for the means and of 0.46 and 0.65 for the standard deviations with the estimated values. We conclude that our results provide a framework that can be exploited to increase the efficiency of hybrid and line breeding programs by extending genomic selection approaches to the selection of crossing partners.	[Osthushenrich, Tanja; Frisch, Matthias; Herzog, Eva] Justus Liebig Univ, Inst Agron & Plant Breeding 2, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany	Justus Liebig University Giessen	Herzog, E (corresponding author), Justus Liebig Univ, Inst Agron & Plant Breeding 2, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany.	eva.herzog@uni-giessen.de	Frisch, Matthias/R-1564-2019	Frisch, Matthias/0000-0003-4234-8972				Bernardo R, 2006, CROP SCI, V46, P1972, DOI 10.2135/cropsci2006.01-0057; Bernardo R, 2014, CROP SCI, V54, P2586, DOI 10.2135/cropsci2014.01.0088; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; COCKERHAM CC, 1973, THEOR POPUL BIOL, V4, P300, DOI 10.1016/0040-5809(73)90013-0; Falconer DS, 1996, INTRO QUANTITATIVE G; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Frisch M, 2007, GENETICS, V176, P477, DOI 10.1534/genetics.106.065433; Haldane JBS, 1919, J GENET, V8, P299; Hofheinz N, 2014, G3-GENES GENOM GENET, V4, P539, DOI 10.1534/g3.113.010025; Hofheinz N, 2012, THEOR APPL GENET, V125, P1639, DOI 10.1007/s00122-012-1940-5; Lian L, 2015, CROP SCI, V55, P1181, DOI 10.2135/cropsci2014.10.0729; Maurer HP, 2008, EUPHYTICA, V161, P133, DOI 10.1007/s10681-007-9493-4; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Meuwissen THE, 2001, GENETICS, V157, P1819; Mohammadi M, 2015, CROP SCI, V55, P2068, DOI 10.2135/cropsci2015.01.0030; Schnell F. W., 1975, Bericht uber die Arbeitstagung 1975 der "Arbeitsgemeinschaft der Saatzuchtleiter"., P243; Tiede T, 2015, POPVAR GENOMIC BREED; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zenke-Philippi C, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2580-y; Zhong SQ, 2007, GENETICS, V177, P567, DOI 10.1534/genetics.107.075358	20	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188839	10.1371/journal.pone.0188839	http://dx.doi.org/10.1371/journal.pone.0188839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29200436	gold, Green Submitted, Green Published			2022-12-27	WOS:000417033200014
J	Bollinger, JL; Collins, KE; Patel, R; Wellman, CL				Bollinger, Justin L.; Collins, Kaitlyn E.; Patel, Rushi; Wellman, Cara L.			Behavioral stress alters corticolimbic microglia in a sex- and brain region-specific manner	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; PREFRONTAL CORTEX; DENDRITIC MORPHOLOGY; GENDER-DIFFERENCES; PYRAMIDAL NEURONS; DIFFERENT STATES; INDUCED ATROPHY; IN-VIVO; ACTIVATION; NEUROINFLAMMATION	Women are more susceptible to numerous stress-linked psychological disorders (e.g., depression) characterized by dysfunction of corticolimbic brain regions critical for emotion regulation and cognitive function. Although sparsely investigated, a number of studies indicate sex differences in stress effects on neuronal structure, function, and behaviors associated with these regions. We recently demonstrated a basal sex difference in-and differential effects of stress on-microglial activation in medial prefrontal cortex (mPFC). The resident immune cells of the brain, microglia are implicated in synaptic and dendritic plasticity, and cognitive-behavioral function. Here, we examined the effects of acute (3h/day, 1 day) and chronic (3h/day, 10 days) restraint stress on microglial density and morphology, as well as immune factor expression in orbitofrontal cortex (OFC), basolateral amygdala (BLA), and dorsal hippocampus (DHC) in male and female rats. Microglia were visualized, classified based on their morphology, and stereologically counted. Microglia-associated transcripts (CD40, iNOS, Arg1, CX3CL1, CX3CR1, CD200, and CD200R) were assessed in brain punches from each region. Expression of genes linked with cellular stress, neuroimmune state, and neuron-microglia communication varied between unstressed male and female rats in a region-specific manner. In OFC, chronic stress upregulated a wider variety of immune factors in females than in males. Acute stress increased microglia-associated transcripts in BLA in males, whereas chronic stress altered immune factor expression in BLA more broadly in females. In DHC, chronic stress increased immune factor expression in males but not females. Moreover, acute and chronic stress differentially affected microglial morphological activation state in male and female rats across all brain regions investigated. In males, chronic stress altered microglial activation in a pattern consistent with microglial involvement in stress-induced dendritic remodeling across OFC, BLA, and DHC. Together, these data suggest the potential for microglia-mediated sex differences in stress effects on neural structure, function, and behavior.	[Bollinger, Justin L.; Collins, Kaitlyn E.; Patel, Rushi; Wellman, Cara L.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Bollinger, Justin L.; Wellman, Cara L.] Indiana Univ, Program Neurosci, Bloomington, IN 47405 USA; [Bollinger, Justin L.; Wellman, Cara L.] Indiana Univ, Ctr Integrat Study Anim Behav, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Wellman, CL (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.; Wellman, CL (corresponding author), Indiana Univ, Program Neurosci, Bloomington, IN 47405 USA.; Wellman, CL (corresponding author), Indiana Univ, Ctr Integrat Study Anim Behav, Bloomington, IN 47405 USA.	wellmanc@indiana.edu		Bollinger, Justin/0000-0002-1424-8694; Wellman, Cara/0000-0002-3064-4259	Indiana University; National Institute of Mental Health [T32MH103213]; National Institute of Child Health and Human Development [T32HD049336]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD049336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH103213] Funding Source: NIH RePORTER	Indiana University; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Indiana University, the National Institute of Mental Health (T32MH103213, JLB), and the National Institute of Child Health and Human Development (T32HD049336, JLB) for their generous support of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Gene expression techniques were made possible by equipment provided in the Center for the Integrative Study of Animal Behavior's Mechanisms of Behavior Laboratory and the Center for Genomics and Bioinformatics Genomics Core Facility.	Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Bekhbat M, 2017, BRAIN BEHAV IMMUNITY; Bijlsma EY, 2011, NEUROSCIENCE, V173, P82, DOI 10.1016/j.neuroscience.2010.11.026; Bisht K, 2016, GLIA, V64, P826, DOI 10.1002/glia.22966; Bollinger JL, 2016, BRAIN BEHAV IMMUN, V52, P88, DOI 10.1016/j.bbi.2015.10.003; Bowman RE, 2009, PHYSIOL BEHAV, V97, P21, DOI 10.1016/j.physbeh.2009.01.012; Bowman RE, 2003, HORM BEHAV, V43, P48, DOI 10.1016/S0018-506X(02)00022-3; Connor TJ, 1998, NEUROSCIENCE, V84, P923, DOI 10.1016/S0306-4522(97)00533-2; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Cox FF, 2012, BRAIN BEHAV IMMUN, V26, P789, DOI 10.1016/j.bbi.2011.10.004; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Delpech JC, 2015, NEUROPHARMACOLOGY, V96, P19, DOI 10.1016/j.neuropharm.2014.12.034; Frank MG, 2007, BRAIN BEHAV IMMUN, V21, P47, DOI 10.1016/j.bbi.2006.03.005; Galea LAM, 1997, NEUROSCIENCE, V81, P689, DOI 10.1016/S0306-4522(97)00233-9; Garrett JE, 2009, NEUROSCIENCE, V162, P195, DOI 10.1016/j.neuroscience.2009.04.057; Grillo CA, 2015, NEUROSCIENCE, V284, P430, DOI 10.1016/j.neuroscience.2014.09.047; Habib P, 2014, J STEROID BIOCHEM MO; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; HEWETT SJ, 1994, NEURON, V13, P487, DOI 10.1016/0896-6273(94)90362-X; Hinwood M, 2012, CEREB CORTEX, V22, P1442, DOI 10.1093/cercor/bhr229; Hinwood M, 2013, CEREB CORTEX, V23, P1784, DOI 10.1093/cercor/bhs151; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Ishihara Y, 2015, J STEROID BIOCHEM, V145, P85, DOI 10.1016/j.jsbmb.2014.10.002; Kitraki E, 2004, NEUROSCIENCE, V125, P47, DOI 10.1016/j.neuroscience.2003.12.024; Konkle ATM, 2003, BRAIN RES, V992, P227, DOI 10.1016/j.brainres.2003.08.047; Kopp BL, 2013, PHYSIOL BEHAV, V122, P246, DOI 10.1016/j.physbeh.2013.05.030; Kroenke K, 1998, PSYCHOSOM MED, V60, P150, DOI 10.1097/00006842-199803000-00006; Lehmann ML, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0672-x; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Lynch MA, 2009, MOL NEUROBIOL, V40, P139, DOI 10.1007/s12035-009-8077-9; Lyons A, 2007, J NEUROSCI, V27, P8309, DOI 10.1523/JNEUROSCI.1781-07.2007; Maciejewski PK, 2001, PSYCHOL MED, V31, P593, DOI 10.1017/S0033291701003877; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; Michels M, 2015, MOL MED, V21, P219, DOI 10.2119/molmed.2015.00070; Mika A, 2012, BEHAV NEUROSCI, V126, P605, DOI 10.1037/a0029642; Milior G., 2015, BRAIN BEHAV IMMUNITY; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mitra R, 2005, NEUROSCI LETT, V383, P278, DOI 10.1016/j.neulet.2005.04.037; Moench KM, 2017, NEUROSCIENCE, V357, P145, DOI 10.1016/j.neuroscience.2017.05.049; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Pan Y, 2014, BRAIN BEHAV IMMUN, V41, P90, DOI 10.1016/j.bbi.2014.04.007; Paolicelli RC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00129; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rappert A, 2004, J NEUROSCI, V24, P8500, DOI 10.1523/JNEUROSCI.2451-04.2004; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Schwarz JM, 2012, HORM BEHAV, V62, P243, DOI 10.1016/j.yhbeh.2012.02.018; Schwarz JM, 2012, J NEUROCHEM, V120, P948, DOI 10.1111/j.1471-4159.2011.07630.x; Seedat S, 2009, ARCH GEN PSYCHIAT, V66, P785, DOI 10.1001/archgenpsychiatry.2009.36; Shansky RM, 2010, CEREB CORTEX, V20, P2560, DOI 10.1093/cercor/bhq003; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Sierra A, 2008, GLIA, V56, P659, DOI 10.1002/glia.20644; Solomon MB, 2009, PHYSIOL BEHAV, V97, P250, DOI 10.1016/j.physbeh.2009.02.033; Torres-Platas SG, 2014, BRAIN BEHAV IMMUN, V42, P50, DOI 10.1016/j.bbi.2014.05.007; Tynan RJ, 2010, BRAIN BEHAV IMMUN, V24, P1058, DOI 10.1016/j.bbi.2010.02.001; Ulrich-Lai YM, 2006, AM J PHYSIOL-ENDOC M, V291, pE965, DOI 10.1152/ajpendo.00070.2006; Vyas A, 2004, BEHAV NEUROSCI, V118, P1450, DOI 10.1037/0735-7044.118.6.1450; Vyas A, 2002, J NEUROSCI, V22, P6810; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wei J, 2014, MOL PSYCHIATR, V19, P588, DOI 10.1038/mp.2013.83; Wohleb ES, 2014, J NEUROSCI, V34, P2583, DOI 10.1523/JNEUROSCI.3723-13.2014; Wohleb ES, 2017, BIOL PSYCHIAT; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001	69	46	47	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0187631	10.1371/journal.pone.0187631	http://dx.doi.org/10.1371/journal.pone.0187631			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO5CX	29194444	gold, Green Published, Green Submitted			2022-12-27	WOS:000416867800006
J	Andersen, S; Richardsen, E; Rakaee, M; Bertilsson, H; Bremnes, R; Borset, M; Busund, LT; Slordahl, T				Andersen, Sigve; Richardsen, Elin; Rakaee, Mehrdad; Bertilsson, Helena; Bremnes, Roy; Borset, Magne; Busund, Lill-Tove; Slordahl, Tobias			Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer	PLOS ONE			English	Article							POOR-PROGNOSIS; PRL-3 PHOSPHATASE; GASTRIC-CANCER; BREAST-CANCER; METASTASIS; PROTEIN; OVEREXPRESSION; MIGRATION; GROWTH; SUPPRESSES	Background Prostate cancer (PC) stratification needs new prognostic tools to reduce overtreatment. Phosphatase of regenerating liver (PRL-3) is a phosphatase found at high levels in several cancer types, where its expression is associated with survival. A recent PC cell line study has shown it to be involved in PC growth and migration. Methods We used a monoclonal antibody to evaluate the expression of PRL-3 in PC tissue of patients in an unselected cohort of 535 prostatectomy patients. We analyzed associations between PRL-3 expression and biochemical failure-free survival (BFFS), clinical failure-free survival (CFFS) and PC death-free survival (PCDFS). Results Cytoplasmic PRL-3 staining in tumor cells was significantly correlated to expression of molecules in the VEGFR-axis, but not to the clinicopathological variables. High PRL-3 was not significantly associated with survival in the univariate analysis for BFFS (p = 0.131), but significantly associated with CFFS (p = 0.044) and PCDFS (p = 0.041). In multivariate analysis for the various end points, PRL-3 came out as an independent and significant indicator of poor survival for BFFS (HR = 1.53, CI95% 1.10-2.13, p = 0.012), CFFS (HR = 2.41, CI95% 1.17-4.98, p = 0.017) and PCDFS (HR = 3.99, CI95% 1.21-13.1, p = 0.023). Conclusions PRL-3 is independently associated with all PC endpoints in this study. Since high PRL-3 expression also correlates with poor prognosis in other cancers and functional studies in PC support these findings, PRL-3 emerges as a potential treatment target in PC.	[Andersen, Sigve; Bremnes, Roy] Arctic Univ Norway, UiT, Dept Clin Med, Translat Canc Res Grp, Tromso, Norway; [Andersen, Sigve; Bremnes, Roy] Univ Hosp North Norway, Dept Oncol, Tromso, Norway; [Richardsen, Elin; Rakaee, Mehrdad; Busund, Lill-Tove] Arctic Univ Norway, UiT, Dept Med Biol, Translat Canc Res Grp, Tromso, Norway; [Richardsen, Elin; Busund, Lill-Tove] Univ Hosp North Norway, Dept Pathol, Tromso, Norway; [Bertilsson, Helena; Borset, Magne; Slordahl, Tobias] NTNU Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Trondheim, Norway; [Bertilsson, Helena] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Urol, Trondheim, Norway; [Borset, Magne] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Immunol & Transfus Med, Trondheim, Norway; [Slordahl, Tobias] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Hematol, Trondheim, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Andersen, S (corresponding author), Arctic Univ Norway, UiT, Dept Clin Med, Translat Canc Res Grp, Tromso, Norway.; Andersen, S (corresponding author), Univ Hosp North Norway, Dept Oncol, Tromso, Norway.	sigve.andersen@uit.no	Borset, Magne/AAY-1713-2021; Rakaee, Mehrdad/GMX-0729-2022	Rakaee, Mehrdad/0000-0002-9080-0153	NTNU Norwegian University of Science and Technology, Trondheim, Norway; Kreftforeningen; HelseNord RHF	NTNU Norwegian University of Science and Technology, Trondheim, Norway; Kreftforeningen; HelseNord RHF	Funders are NTNU Norwegian University of Science and Technology, Trondheim, Norway, Kreftforeningen and HelseNord RHF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi P, 2016, MOL CANC RES; Ahn JH, 2006, BIOORG MED CHEM LETT, V16, P2996, DOI 10.1016/j.bmcl.2006.02.060; Al-aidaroos AQO, 2013, J CLIN INVEST, V123, P3459, DOI 10.1172/JCI66824; Andersen S, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-49; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Choi SK, 2006, NAT PROD RES, V20, P341, DOI 10.1080/14786410500463312; Da N, 2009, WORLD J GASTROENTERO, V15, P1499, DOI 10.3748/wjg.15.1499; Daouti S, 2008, CANCER RES, V68, P1162, DOI 10.1158/0008-5472.CAN-07-2349; den Hollander P, 2016, CANCER RES, V76, P1942, DOI 10.1158/0008-5472.CAN-14-0673; Dong Q, 2016, J ORAL PATHOL MED, V45, P111, DOI 10.1111/jop.12331; Epstein JI, 2016, AM J SURG PATHOL, V40, P244, DOI 10.1097/PAS.0000000000000530; Fagerli UM, 2008, BLOOD, V111, P806, DOI 10.1182/blood-2007-07-101139; Feik E, 2013, PROSTATE, V73, P1413, DOI 10.1002/pros.22688; Ferlay, 2016, CANC TODAY; Gari HH, 2016, ONCOTARGET, V7, P15757, DOI 10.18632/oncotarget.7462; Gronberg H, 2015, LANCET ONCOL, V16, P1667, DOI 10.1016/S1470-2045(15)00361-7; Guo K, 2012, ONCOTARGET, V3, P158; Han Y, 2012, J NANOMATER, V2012, P10; Hao RT, 2010, J CANCER RES CLIN, V136, P1349, DOI 10.1007/s00432-010-0786-y; Hoeger B, 2014, EUR J MED CHEM, V88, P89, DOI 10.1016/j.ejmech.2014.08.060; Jiang YJ, 2011, CANCER RES, V71, P234, DOI 10.1158/0008-5472.CAN-10-1487; Lee JD, 2016, EXP THER MED, V12, P2974, DOI 10.3892/etm.2016.3722; Li J, 2005, CLIN CANCER RES, V11, P2195, DOI 10.1158/1078-0432.CCR-04-1984; Li ZR, 2007, SURG TODAY, V37, P646, DOI 10.1007/s00595-006-3437-9; Liang F, 2008, J BIOL CHEM, V283, P10339, DOI 10.1074/jbc.M708285200; Ma YX, 2011, MED ONCOL, V28, P775, DOI 10.1007/s12032-010-9514-3; Mayinuer A, 2013, ANN SURG ONCOL, V20, P305, DOI 10.1245/s10434-012-2395-2; Min G, 2013, BIOORG MED CHEM LETT, V23, P3769, DOI 10.1016/j.bmcl.2013.04.092; Min Li, 2015, Asian Pac J Cancer Prev, V16, P2819; Ming J, 2009, PATHOLOGY, V41, P118, DOI 10.1080/00313020802579268; Miskad UA, 2007, VIRCHOWS ARCH, V450, P303, DOI 10.1007/s00428-006-0361-8; Mollevi DG, 2008, BRIT J CANCER, V99, P1718, DOI 10.1038/sj.bjc.6604747; Moon MK, 2010, ARCH PHARM RES, V33, P1747, DOI 10.1007/s12272-010-1106-4; Ooki A, 2009, ONCOL REP, V21, P1467, DOI 10.3892/or_00000376; Peng LR, 2004, J CANCER RES CLIN, V130, P521, DOI 10.1007/s00432-004-0563-x; Polato F, 2005, CLIN CANCER RES, V11, P6835, DOI 10.1158/1078-0432.CCR-04-2357; Radke I, 2006, BRIT J CANCER, V95, P347, DOI 10.1038/sj.bjc.6603261; Ren TT, 2009, PATHOL ONCOL RES, V15, P555, DOI 10.1007/s12253-009-9153-1; Rios P, 2013, FEBS J, V280, P505, DOI 10.1111/j.1742-4658.2012.08565.x; Rubio T, 2016, BIOCHEM SOC T, V44, P1305, DOI 10.1042/BST20160146; Sager JA, 2004, CANCER BIOL THER, V3, P952, DOI 10.4161/cbt.3.10.1115; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Salamoun JM, 2016, ORG BIOMOL CHEM, V14, P6398, DOI 10.1039/c6ob00946h; Shin Y, 2013, MAR DRUGS, V11, P2472, DOI 10.3390/md11072472; Stadlbauer S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134336; Thura M, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87607; Ustaalioglu BBO, 2012, CLIN TRANSL ONCOL, V14, P911, DOI 10.1007/s12094-012-0880-5; Van der Kwast TH, 2013, NAT REV UROL, V10, P473, DOI 10.1038/nrurol.2013.112; Vandsemb EN, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0830-z; Wang HH, 2010, CANCER CELL, V18, P52, DOI 10.1016/j.ccr.2010.04.028; Wang L, 2006, ANN ONCOL, V17, P1517, DOI 10.1093/annonc/mdl159; Wang L, 2009, MOL PHARMACOL, V76, P1238, DOI 10.1124/mol.109.059105; Wang Y, 2007, INT J COLORECTAL DIS, V22, P1179, DOI 10.1007/s00384-007-0303-1; Wang Z, 2009, ANN SURG ONCOL, V16, P208, DOI 10.1245/s10434-008-0214-6; Xing XF, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-309; Xing XF, 2009, HISTOPATHOLOGY, V54, P309, DOI 10.1111/j.1365-2559.2009.03226.x; Xu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027165; Xu YJ, 2010, PATHOL ONCOL RES, V16, P169, DOI 10.1007/s12253-009-9200-y; Ye Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep17046; Zhou J, 2009, INT J CANCER, V124, P1879, DOI 10.1002/ijc.24096	60	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0189000	10.1371/journal.pone.0189000	http://dx.doi.org/10.1371/journal.pone.0189000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190795	Green Published, Green Submitted, gold			2022-12-27	WOS:000416841900187
J	Flaherty, M; Dent, ML; Sawusch, JR				Flaherty, Mary; Dent, Micheal L.; Sawusch, James R.			Experience with speech sounds is not necessary for cue trading by budgerigars (Melopsittacus undulatus) (vol 12, e0177676, 2017)	PLOS ONE			English	Correction													Flaherty, Mary/AAU-3768-2020					Flaherty M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177676	1	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0189014	10.1371/journal.pone.0189014	http://dx.doi.org/10.1371/journal.pone.0189014			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190773	Green Submitted, Green Published, gold			2022-12-27	WOS:000416841900192
J	Ma, JH; Song, CY; Ceder, A; Liu, T; Guan, W				Ma, Jihui; Song, Cuiying; Ceder, Avishai (Avi); Liu, Tao; Guan, Wei			Fairness in optimizing bus-crew scheduling process	PLOS ONE			English	Article							SMART CARD DATA; DRIVER; TRANSPORT; ALGORITHM; SYSTEM	This work proposes a model considering fairness in the problem of crew scheduling for bus drivers (CSP-BD) using a hybrid ant-colony optimization (HACO) algorithm to solve it. The main contributions of this work are the following: (a) a valid approach for cases with a special cost structure and constraints considering the fairness of working time and idle time; (b) an improved algorithm incorporating Gamma heuristic function and selecting rules. The relationships of each cost are examined with ten bus lines collected from the Beijing Public Transport Holdings (Group) Co., Ltd., one of the largest bus transit companies in the world. It shows that unfair cost is indirectly related to common cost, fixed cost and extra cost and also the unfair cost approaches to common and fixed cost when its coefficient is twice of common cost coefficient. Furthermore, the longest time for the tested bus line with 1108 pieces, 74 blocks is less than 30 minutes. The results indicate that the HACO-based algorithm can be a feasible and efficient optimization technique for CSP-BD, especially with large scale problems.	[Ma, Jihui; Song, Cuiying; Ceder, Avishai (Avi); Guan, Wei] Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China; [Liu, Tao] Univ Auckland, Dept Civil & Environm Engn, Auckland, New Zealand	Beijing Jiaotong University; University of Auckland	Song, CY (corresponding author), Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China.	13114205@bjtu.edu.cn	Liu, Tao/N-7884-2013	Liu, Tao/0000-0001-6101-1924; Ceder, Avishai (Avi)/0000-0003-3302-9486	National Natural Science Foundation of China [71131001-2, 71471014, 71621001]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by National Natural Science Foundation of China (no. 71131001-2, no. 71471014) WG, JHM; National Natural Science Foundation of China (under grant no. 71621001) WG, JHM; The Fundamental Research Funds for the Central Universities, CYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], 2007, PUBLIC TRANSIT PLANN; Ceder A., 1988, Computer-Aided Transit Scheduling. Proceedings of the Fourth International Workshop on Computer-Aided Scheduling of Public Transport, P212; Ceder A., 2016, PUBLIC TRANSIT PLANN; Chen S., 2013, J INFORM COMPUTATION, V10, P175; Costa MF, 2013, SCI FOR, V41, P299; Crawford B, 2006, LECT NOTES ARTIF INT, V4293, P381; De Leone R, 2011, J HEURISTICS, V17, P441, DOI 10.1007/s10732-010-9141-3; Deng GF, 2011, EXPERT SYST APPL, V38, P5787, DOI 10.1016/j.eswa.2010.10.053; Fores S, 2002, J OPER RES SOC, V53, P1093, DOI 10.1057/palgrave.jors.2601271; Fores S, 1999, LECT NOTES ECON MATH, V471, P43; Forsyth P, 1997, 7 INT WORKSH COMP AI; Ghoseiri K., 2006, J APPL MATH DECISION, DOI [10.1155/JAMDS/2006/95060, DOI 10.1155/JAMDS/2006/95060]; Hao N, 2014, SHANDONG SCI, V27, P76; Huisman D, 2004, THESIS; Kwan A. S. K, 1996, RES REPORT SERIES; Kwan RSK, 2000, IEEE C EVOL COMPUTAT, P285, DOI 10.1109/CEC.2000.870308; Li JP, 2005, J HEURISTICS, V11, P351, DOI 10.1007/s10732-005-2220-1; Li JP, 2003, EUR J OPER RES, V147, P334, DOI 10.1016/S0377-2217(02)00564-7; Lin L, 2013, TRANSPORT RES REC, P40, DOI 10.3141/2392-05; Liu T, 2016, IEEE T INTELL TRANSP, V18, P1023; Ma JH, 2016, J ADV TRANSPORT, V50, P434, DOI 10.1002/atr.1333; Ma XL, 2017, J TRANSP GEOGR, V58, P135, DOI 10.1016/j.jtrangeo.2016.12.001; Ma XL, 2013, TRANSPORT RES C-EMER, V36, P1, DOI 10.1016/j.trc.2013.07.010; Ramalhinho H, 1998, EC WORKING PAPERS, V35, P331; Shen Y., 2001, LECT NOTES EC MATH S, V505, P121, DOI DOI 10.1007/978-3-642-56423-9_7; Shen Y., 2002, LECT NOTES EC MATH S, V505, P121; Shen YD, 2013, TRANSPORT RES B-METH, V56, P174, DOI 10.1016/j.trb.2013.08.003; Shen YD, 2009, INT T OPER RES, V16, P227, DOI 10.1111/j.1475-3995.2009.00673.x; Song C.G., 2015, PLOS ONE, V10, P1, DOI DOI 10.1155/2015/719409; Toth A, 2013, CENT EUR J OPER RES, V21, pS75, DOI 10.1007/s10100-012-0274-3; Valouxis C, 2002, COMPUT OPER RES, V29, P243, DOI 10.1016/S0305-0548(00)00067-8; Wren A, 1998, J HEURISTICS, V4, P87, DOI 10.1023/A:1009694422257; Wren A, 1995, P 6 INT WORKSH COMP, P173; Yin L., 2011, MATH PRACTICE THEORY, V6, P150; Yu H, 2016, IEEE T INTELL TRANSP, V99, P1; Yu HY, 2016, TRANSPORT RES C-EMER, V72, P45, DOI 10.1016/j.trc.2016.09.007; Zhao M., 2014, GENETIC EVOLUTIONARY, V238, P331	38	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0187623	10.1371/journal.pone.0187623	http://dx.doi.org/10.1371/journal.pone.0187623			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190772	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900019
J	McCormack, SW; Witzel, U; Watson, PJ; Fagan, MJ; Groning, F				McCormack, Steven W.; Witzel, Ulrich; Watson, Peter J.; Fagan, Michael J.; Groning, Flora			Inclusion of periodontal ligament fibres in mandibular finite element models leads to an increase in alveolar bone strains	PLOS ONE			English	Article							ORTHODONTIC TOOTH MOVEMENT; TRABECULAR BONE; COMPUTED-TOMOGRAPHY; BIOMECHANICAL STRESS; FEMORAL-HEAD; BITE FORCE; VOLUME 44; ISSUE 10; LOADS; SIMPLIFICATIONS	Alveolar bone remodelling is vital for the success of dental implants and orthodontic treatments. However, the underlying biomechanical mechanisms, in particular the function of the periodontal ligament (PDL) in bone loading and remodelling, are not well understood. The PDL is a soft fibrous connective tissue that joins the tooth root to the alveolar bone and plays a critical role in the transmission of loads from the tooth to the surrounding bone. However, due to its complex structure, small size and location within the tooth socket it is difficult to study in vivo. Finite element analysis (FEA) is an ideal tool with which to investigate the role of the PDL, however inclusion of the PDL in FE models is complex and time consuming, therefore consideration must be given to how it is included. The aim of this study was to investigate the effects of including the PDL and its fibrous structure in mandibular finite element models. A high-resolution model of a human molar region was created from micro-computed tomography scans. This is the first time that the fibrous structure of the PDL has been included in a model with realistic tooth and bone geometry. The results show that omission of the PDL creates a more rigid model, reducing the strains observed in the mandibular corpus which are of interest when considering mandibular functional morphology. How the PDL is modelled also affects the strains. The inclusion of PDL fibres alters the strains in the mandibular bone, increasing the strains in the tooth socket compared to PDL modelled without fibres. As strains in the alveolar bone are thought to play a key role in bone remodelling during orthodontic tooth movement, future FE analyses aimed at improving our understanding and management of orthodontic treatment should include the fibrous structure of the PDL.	[McCormack, Steven W.; Watson, Peter J.; Fagan, Michael J.] Univ Hull, Sch Engn & Comp Sci, Med & Biol Engn Res Grp, Kingston Upon Hull, N Humberside, England; [Witzel, Ulrich] Ruhr Univ Bochum, Fak Maschinenbau, Univ Str 150, Bochum, Germany; [Groning, Flora] Univ Aberdeen, Sch Med Med Sci & Nutr, Arthrit & Musculoskeletal Med Res Programme, Aberdeen, Scotland	University of Hull; Ruhr University Bochum; University of Aberdeen	Groning, F (corresponding author), Univ Aberdeen, Sch Med Med Sci & Nutr, Arthrit & Musculoskeletal Med Res Programme, Aberdeen, Scotland.	f.groening@abdn.ac.uk	Groning, Flora/C-2220-2012	Groning, Flora/0000-0002-8127-4112	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I008462/1]; Marie Curie Actions Integration Grant [FP7-PEOPLE PERG7-GA-2010-268430]; BBSRC [BB/I008462/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I008462/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie Actions Integration Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (www.bbsrc.ac.uk; BB/I008462/1) (FG and MJF) and Marie Curie Actions Integration Grant (ec.europa.eu/research/mariecurieactions; FP7-PEOPLE PERG7-GA-2010-268430) (FG and MJF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sukhun J, 2007, J BIOMED MATER RES A, V80A, P234, DOI 10.1002/jbm.a.30894; ATMARAM GH, 1981, J DENT RES, V60, P873, DOI 10.1177/00220345810600050301; BAUMRIND S, 1969, AMER J ORTHODONTICS, V55, P12, DOI 10.1016/S0002-9416(69)90170-5; BERKOVITZ BKB, 1990, EUR J ORTHODONT, V12, P51, DOI 10.1093/ejo/12.1.51; Bourauel C, 1999, J Orofac Orthop, V60, P136, DOI 10.1007/BF01298963; Bourauel C, 2000, J Orofac Orthop, V61, P266, DOI 10.1007/s000560050012; Burr DB, 2002, BONE, V30, P781, DOI 10.1016/S8756-3282(02)00707-X; Cattaneo PM, 2009, ORTHOD CRANIOFAC RES, V12, P120, DOI 10.1111/j.1601-6343.2009.01445.x; Cattaneo PM, 2008, AM J ORTHOD DENTOFAC, V133, P681, DOI 10.1016/j.ajodo.2006.05.038; Cattaneo PM, 2005, J DENT RES, V84, P428, DOI 10.1177/154405910508400506; Chen JN, 2014, J BIOMECH, V47, P1689, DOI 10.1016/j.jbiomech.2014.02.030; Coleman MN, 2007, AM J PHYS ANTHROPOL, V133, P723, DOI 10.1002/ajpa.20583; CURREY JD, 1968, J THEOR BIOL, V20, P91, DOI 10.1016/0022-5193(68)90094-5; Daegling DJ, 2000, AM J PHYS ANTHROPOL, V112, P541, DOI 10.1002/1096-8644(200008)112:4<541::AID-AJPA8>3.0.CO;2-Z; Daegling DJ, 1997, J HUM EVOL, V33, P705, DOI 10.1006/jhev.1997.0164; Dalstra M, 2015, J BIOMECH, V48, P801, DOI 10.1016/j.jbiomech.2014.12.014; Dalstra M, 2006, Orthod Craniofac Res, V9, P199; Dorow Christina, 2003, J Orofac Orthop, V64, P100, DOI 10.1007/s00056-003-0225-7; Dorow Christina, 2002, J Orofac Orthop, V63, P94, DOI 10.1007/s00056-002-0107-4; Fajardo RJ, 2002, AM J PHYS ANTHROPOL, V118, P1, DOI 10.1002/ajpa.10086; Fajardo RJ, 2007, ANAT REC, V290, P422, DOI 10.1002/ar.20493; Fill Ted S, 2011, J Dent Biomech, V2011, P312980, DOI 10.4061/2011/312980; Fill TS, 2012, J BIOMECH, V45, P9, DOI 10.1016/j.jbiomech.2011.09.020; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Groning F, 2012, J BIOMECH, V45, P1749, DOI 10.1016/j.jbiomech.2011.10.042; Groning F, 2011, J BIOMECH, V44, P1304, DOI 10.1016/j.jbiomech.2011.01.008; Groning F, 2012, ANAT REC, V295, P853, DOI 10.1002/ar.22455; Grosse IR, 2012, J BIOMECH, V45, P1750, DOI 10.1016/j.jbiomech.2012.01.047; HERT J, 1969, Folia Morphologica (Prague), V17, P389; Hohmann A, 2011, AM J ORTHOD DENTOFAC, V139, P775, DOI 10.1016/j.ajodo.2009.11.014; HYLANDER WL, 1984, AM J PHYS ANTHROPOL, V64, P1, DOI 10.1002/ajpa.1330640102; HYLANDER WL, 1985, AM ZOOL, V25, P315; Jones M L, 2001, J Orthod, V28, P29; Katona TR, 2001, AM J ORTHOD DENTOFAC, V120, P263, DOI 10.1067/mod.2001.116086; Kohnke P., 2009, THEORY REFERENCE MEC; Krishnan V, 2009, J DENT RES, V88, P597, DOI 10.1177/0022034509338914; Krishnan V, 2006, AM J ORTHOD DENTOFAC, V129, P1, DOI DOI 10.1016/J.AJ0D0.2005.10.007; LANYON LE, 1982, J BIOMECH, V15, P141, DOI 10.1016/0021-9290(82)90246-9; LANYON LE, 1984, J BIOMECH, V17, P897, DOI 10.1016/0021-9290(84)90003-4; Limbert Georges, 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P337, DOI 10.1080/10255840310001637572; LISKOVA M, 1971, Folia Morphologica (Prague), V19, P301; Mac Donald BJ., 2007, PRACTICAL STRESS ANA; Marinescu R, 2005, ANAT REC PART A, V283A, P300, DOI 10.1002/ar.a.20166; McCormack SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102387; McCulloch CAG, 2000, PERIODONTOL 2000, V24, P56, DOI 10.1034/j.1600-0757.2000.2240104.x; Melsen B, 2001, EUR J ORTHODONT, V23, P671, DOI 10.1093/ejo/23.6.671; Melsen B, 1999, ANGLE ORTHOD, V69, P151; Meyer BN, 2010, AM J ORTHOD DENTOFAC, V137, P354, DOI 10.1016/j.ajodo.2008.03.029; Middleton J, 1996, AM J ORTHOD DENTOFAC, V109, P155, DOI 10.1016/S0889-5406(96)70176-2; de Abreu RAM, 2014, ARCH ORAL BIOL, V59, P1065, DOI 10.1016/j.archoralbio.2014.05.005; Naveh GRS, 2012, ARCH ORAL BIOL, V57, P1575, DOI 10.1016/j.archoralbio.2012.07.006; Naveh GRS, 2012, J STRUCT BIOL, V177, P477, DOI 10.1016/j.jsb.2011.11.019; O'Connor CF, 2005, AM J PHYS ANTHROPOL, V127, P129, DOI 10.1002/ajpa.20025; Provatidis CG, 2000, MED ENG PHYS, V22, P359, DOI 10.1016/S1350-4533(00)00055-2; Qian HH, 2001, AM J ORTHOD DENTOFAC, V120, P272, DOI 10.1067/mod.2001.116085; Ralph WJ, 1998, J ORAL REHABIL, V15, P499; Ramos A, 2011, EXP MECH, V51, P1053, DOI 10.1007/s11340-010-9403-x; Rees JS, 1997, BIOMATERIALS, V18, P995, DOI 10.1016/S0142-9612(97)00021-5; Robling AG, 2002, J BONE MINER RES, V17, P1545, DOI 10.1359/jbmr.2002.17.8.1545; Ryan TM, 2002, J HUM EVOL, V43, P1, DOI 10.1006/jhev.2002.0552; Ryan TM, 2002, J HUM EVOL, V43, P241, DOI 10.1006/jhev.2002.0575; Scherf H, 2009, AM J PHYS ANTHROPOL, V140, P39, DOI 10.1002/ajpa.21033; Schroeder H.E., 2000, ORALE STRUKTURBIOLOG, V5th; Schwarz A.M., 1932, INT J ORTHODONTIA OR, V18, P331, DOI [10.1016/S0099-6963(32)80074-8, DOI 10.1016/S0099-6963(32)80074-8]; SLOAN P, 1979, J ROY SOC MED, V72, P188, DOI 10.1177/014107687907200308; SPOOR CF, 1993, AM J PHYS ANTHROPOL, V91, P469, DOI 10.1002/ajpa.1330910405; Toms SR, 2002, J BIOMECH, V35, P1411, DOI 10.1016/S0021-9290(02)00166-5; van Driel WD, 2000, P I MECH ENG H, V214, P497, DOI 10.1243/0954411001535525; Warden SJ, 2005, J BONE MINER RES, V20, P809, DOI 10.1359/JBMR.041222; Witzel U, 1998, TARGET, V1, P10; Yasar F, 2005, DENTOMAXILLOFAC RAD, V34, P261, DOI 10.1259/dmfr/85149245; Zhao LP, 2001, P ANN INT IEEE EMBS, V23, P2509, DOI 10.1109/IEMBS.2001.1017289	72	19	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188707	10.1371/journal.pone.0188707	http://dx.doi.org/10.1371/journal.pone.0188707			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190785	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900105
J	Robineau, O; Velter, A; Barin, F; Boelle, PY				Robineau, Olivier; Velter, Annie; Barin, Francis; Boelle, Pierre-Yves			HIV transmission and pre-exposure prophylaxis in a high risk MSM population: A simulation study of location-based selection of sexual partners	PLOS ONE			English	Article							UNITED-STATES; RACIAL DISPARITIES; COST-EFFECTIVENESS; BISEXUAL MEN; WHITE MEN; PREVALENCE; INFECTION; EPIDEMIC; BEHAVIOR; VENUES	Objective In France, indications for pre-exposure prophylaxis (PrEP) for HIV prevention are based on individual-level risk factors for HIV infection. However, the risk of HIV infection may also depend on characteristics of sexual partnerships. Here we study how place-based selection of partners change transmission and the overall efficiency of PrEP. Methods We used the PREVAGAY survey of sexual behavior and HIV serostatus in men who have sex with men (MSM) in a Parisian district to look for associations between sexual network characteristics and HIV infection. We then simulated HIV transmission in a high-risk MSM population. We used information about venues visited to meet casual sexual partners (clubs, backrooms or saunas) to define sexual networks. We then simulated HIV transmission in these networks and assessed the impact of PrEP in this population. Results In the PREVAGAY study, we found that HIV serostatus changed with the type of venues visited, in addition to other individual risk factors. In simulations, we found similar differences in HIV incidence when the choice of venues visited was not random. The use of PrEP allowed reducing incidence, irrespective of the venues visited by PrEP users. However, with the same amount of PrEP, the number of infections adverted could almost double depending on network structure and venues visited by PrEP users. Conclusion This study shows that characteristics of the sexual network structure can strongly impact the effectiveness of PrEP interventions. These should be considered further to refine individual risk assessment and maximize the effect of individual-based prevention policies.	[Robineau, Olivier; Boelle, Pierre-Yves] Univ Paris 06, Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ,U1136, Paris, France; [Robineau, Olivier] Ctr Hosp Gustave Dron, Serv Univ Malad Infect & Voyageur, Tourcoing, France; [Robineau, Olivier] Univ Lille 2, Dept Malad Infect, Lille, France; [Velter, Annie] Sante Publ France, St Maurice, France; [Barin, Francis] Univ Tours, INSERM, UMR966, Tours, France; [Barin, Francis] Ctr Hosp Reg Univ, Ctr Natl Ref VIH, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; Universite de Lille; Institute of Public Health Surveillance; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours	Robineau, O (corresponding author), Univ Paris 06, Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ,U1136, Paris, France.; Robineau, O (corresponding author), Ctr Hosp Gustave Dron, Serv Univ Malad Infect & Voyageur, Tourcoing, France.; Robineau, O (corresponding author), Univ Lille 2, Dept Malad Infect, Lille, France.	olivier.robineau82@gmail.com			Agence publique francaise de recherches sur le sida et les hepatites virales	Agence publique francaise de recherches sur le sida et les hepatites virales	PYB received grant from Agence publique francaise de recherches sur le sida et les hepatites virales: www.anrs.fr.	[Anonymous], 2016, DIAGN TREATM CAR KEY; Beltzer N, 2013, AIDS, V27, P1011, DOI 10.1097/QAD.0b013e32835e1583; Beymer MR, 2017, SEX TRANSM DIS, V44, P49, DOI 10.1097/OLQ.0000000000000535; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Binson D, 2001, AM J PUBLIC HEALTH, V91, P1482, DOI 10.2105/AJPH.91.9.1482; Carnegie NB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043048; Cassels S, 2008, JAIDS-J ACQ IMM DEF, V47, pS34, DOI 10.1097/QAI.0b013e3181605da3; Centers for Disease Control and Prevention, 2014, PREEXP PROPH PREV HI; Cremin I, LANCET HIV; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; deWit JBF, 1997, INT J STD AIDS, V8, P130, DOI 10.1258/0956462971919552; Doherty IA, 2006, SEX TRANSM DIS, V33, P368, DOI 10.1097/01.olq.0000194586.66409.7a; Gilead Sciences Inc, 2017, ANN M STOCKH W SAN F; Gomez GB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001323; Goodreau SM, 2007, SEX TRANSM INFECT, V83, P458, DOI 10.1136/sti.2007.025627; Goodreau SM, 2007, SOC NETWORKS, V29, P231, DOI 10.1016/j.socnet.2006.08.001; Goodreau SM, 2017, LANCET HIV, V4, pE311, DOI 10.1016/S2352-3018(17)30067-X; Goodreau SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050522; Goodreau SM, 2012, AIDS BEHAV, V16, P312, DOI 10.1007/s10461-010-9858-x; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grov C, 2007, AIDS BEHAV, V11, P915, DOI 10.1007/s10461-006-9199-y; Grov C, 2013, ARCH SEX BEHAV, V42, P291, DOI 10.1007/s10508-011-9854-x; Grov C, 2012, AIDS EDUC PREV, V24, P102, DOI 10.1521/aeap.2012.24.2.102; Grov C, 2010, AIDS EDUC PREV, V22, P496, DOI 10.1521/aeap.2010.22.6.496; Handcock Mark S, 2008, J Stat Softw, V24, P1548; Handcock MS, STATISTICS, V26; Hunter David R, 2008, J Stat Softw, V24, pnihpa54860; Jaffe HW, 2007, JAMA-J AM MED ASSOC, V298, P2412, DOI 10.1001/jama.298.20.2412; Jenness SM, 2016, SEX TRANSM INFECT, V92, P619, DOI 10.1136/sextrans-2015-052476; Jenness SM, 2017, CLIN INFECT DIS, V65, P712, DOI 10.1093/cid/cix439; Jenness SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169484; Jenness SM, 2016, J INFECT DIS, V214, P1800, DOI 10.1093/infdis/jiw223; JUUSOLA JL, 2012, ANN INTERN MED, V156, P541, DOI DOI 10.1059/0003-4819-156-8-201204170-00001; Kasaie P, 1999, J ACQ IMMUN DEF SYND, V2017; Kerr ZY, 2015, ARCH SEX BEHAV, V44, P443, DOI 10.1007/s10508-014-0352-9; Koppenhaver RT, 2011, JAIDS-J ACQ IMM DEF, V58, pE51, DOI 10.1097/QAI.0b013e31822b74fe; Le Vu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039872; Le Vu S, 2010, LANCET INFECT DIS, V10, P682, DOI 10.1016/S1473-3099(10)70167-5; Madge S, 2008, HIV MED, V9, P208, DOI 10.1111/j.1468-1293.2008.00548.x; Marcus U, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009107; McCormack S., 2015, LANCET, V9; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Mitchell KM, 2014, J THEOR BIOL, V355, P140, DOI 10.1016/j.jtbi.2014.04.005; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Molina JM., 2017, 9 INT AIDS C AIDS 20; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; Nichols BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059549; Omori R, 2017, AIDS, V31, P1721, DOI [10.1097/QAD.0000000000001542, 10.1097/qad.0000000000001542]; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Pretorius C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013646; Prise en charge medicale des personnes vivant avec le VIH, PRIS CHARG MED PERS; Punyacharoensin N, 2016, LANCET HIV, V3, pE94, DOI 10.1016/S2352-3018(15)00056-9; R Development Core Team, 2012, R LANG ENV STAT COMP; Rocha LEC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001109; Rusow JA, 2017, AIDS BEHAV, V21, P1149, DOI 10.1007/s10461-016-1630-4; Smith AMA, 2004, SEX TRANSM INFECT, V80, P455, DOI 10.1136/sti.2004.010355; Smith DK, 2015, MMWR-MORBID MORTAL W, V64, P1291, DOI 10.15585/mmwr.mm6446a4; Stromgren M, 2017, EPIDEMIOL INFECT, V145, P2582, DOI 10.1017/S0950268817001169; Sullivan PS, 2015, ANN EPIDEMIOL, V25, P445, DOI 10.1016/j.annepidem.2015.03.006; Sullivan PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090514; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Supervie V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00185; Supervie V, 2010, P NATL ACAD SCI USA, V107, P12381, DOI 10.1073/pnas.1006061107; Velter A, 2013, AIDS BEHAV, V17, P1266, DOI 10.1007/s10461-012-0303-1; Weinstein M, 2017, AIDS, V31, P2303, DOI 10.1097/QAD.0000000000001626	65	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0189002	10.1371/journal.pone.0189002	http://dx.doi.org/10.1371/journal.pone.0189002			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190784	Green Published, Green Submitted, gold			2022-12-27	WOS:000416841900189
J	Bastos, ML; Menzies, D; Hone, T; Dehghani, K; Trajman, A				Bastos, Mayara Lisboa; Menzies, Dick; Hone, Thomas; Dehghani, Kianoush; Trajman, Anete			The impact of the Brazilian family health on selected primary care sensitive conditions: A systematic review (vol 12, e0182336, 2017)	PLOS ONE			English	Correction													Trajman, Anete/C-7679-2016	Trajman, Anete/0000-0002-4000-4984				Bastos ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182336	1	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189557	10.1371/journal.pone.0189557	http://dx.doi.org/10.1371/journal.pone.0189557			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216304	Green Submitted, Green Published, gold			2022-12-27	WOS:000417337800131
J	Hwang, IC; Chang, J; Park, SM				Hwang, In Cheol; Chang, Jooyoung; Park, Sang Min			Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study	PLOS ONE			English	Article							GASTRIN; CARCINOMA; THERAPY; SAFETY; DRUGS; ASIA	Purpose Despite plausible mechanisms, the clinical significance of long-term proton pump inhibitor (PPI) use to colorectal cancer (CRC) remains unknown. The purpose of this study was to investigate the association between PPI use and CRC development. Methods We conducted a population-based prospective cohort study using the Korean nationwide claims database merged with national health examination data. The study cohort included a total of 451,284 participants who were tracked to identify cases of CRC since 2007. We assessed and standardized PPI use before the index date using the Defined Daily Dose system. We calculated the hazard ratios and their 95% confidence intervals to assess the association between PPI use and CRC occurrence using Cox proportional hazard regression models with adjustment for potential confounders. We performed subgroup analyses of the effect of PPI exposure on CRC development stratified by the CRC risk. Results There were 5,304 cases of CRC during the study period of 2,908,152 person-years. PPI use was not associated with CRC risk overall. The incidence of CRC was higher among individuals who were elderly, male, more obese, and drank alcohol more frequently and among those who had more comorbidities. Further subgroup analyses revealed that the hazard effect of PPI use increased linearly in a dose-dependent manner with the number of CRC risk factors for which the risk level was considered low. Conclusion Within the low-risk population, PPI use was associated with an increased risk of CRC, although the association did not weigh the effects of conventional risk factors.	[Hwang, In Cheol] Gachon Univ, Gil Med Ctr, Dept Family Med, Incheon, South Korea; [Chang, Jooyoung] Seoul Natl Univ, Coll Med, Dept Med, Seoul, South Korea; [Park, Sang Min] Seoul Natl Univ, Dept Family Med, Coll Med, Seoul, South Korea; [Park, Sang Min] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea	Gachon University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Park, SM (corresponding author), Seoul Natl Univ, Dept Family Med, Coll Med, Seoul, South Korea.; Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.	smpark.snuh@gmail.com	Park, Sang Min/V-9194-2019		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2017R1D1A1 B03033721]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant no. 2017R1D1A1 B03033721). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JS, 2012, KOREAN J FAM MED, V33, P272, DOI 10.4082/kjfm.2012.33.5.272; Attwood SE, 2015, ALIMENT PHARM THER, V41, P1162, DOI 10.1111/apt.13194; Boursi B, 2016, DIGEST LIVER DIS, V48, P1386, DOI 10.1016/j.dld.2016.07.011; Byun Ju-Young, 2014, J Prev Med Public Health, V47, P84, DOI 10.3961/jpmph.2014.47.2.84; Chubak J, 2009, PHARMACOEPIDEM DR S, V18, P540, DOI 10.1002/pds.1749; CICCOTOSTO GD, 1995, GASTROENTEROLOGY, V109, P1142, DOI 10.1016/0016-5085(95)90572-3; EIDE TJ, 1986, INT J CANCER, V38, P173, DOI 10.1002/ijc.2910380205; Goh LY, 2014, J DIGEST DIS, V15, P463, DOI 10.1111/1751-2980.12164; Han YM, 2015, J PHYSIOL PHARMACOL, V66, P159; La Vecchia C, 2002, EUR J CANCER PREV, V11, P117, DOI 10.1097/00008469-200204000-00002; Lai SW, 2013, ASIA-PAC J CLIN ONCO, V9, P192, DOI 10.1111/ajco.12054; Lowery JT, 2016, CANCER-AM CANCER SOC, V122, P2633, DOI 10.1002/cncr.30080; Lundell L, 2015, ALIMENT PHARM THER, V42, P649, DOI 10.1111/apt.13324; Maddalo G, 2014, EUR J CANCER PREV, V23, P258, DOI 10.1097/CEJ.0000000000000008; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Raghunath AS, 2005, ALIMENT PHARM THERAP, V22, P55, DOI 10.1111/j.1365-2036.2005.02611.x; Robertson DJ, 2007, GASTROENTEROLOGY, V133, P755, DOI 10.1053/j.gastro.2007.06.014; Shin JY, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3517; Siersema PD, 2006, GASTROINTEST ENDOSC, V63, P581, DOI 10.1016/j.gie.2005.08.043; Thorburn CM, 1998, GASTROENTEROLOGY, V115, P275, DOI 10.1016/S0016-5085(98)70193-3; Van Soest EM, 2006, ALIMENT PHARM THERAP, V24, P377, DOI 10.1111/j.1365-2036.2006.02982.x; van Soest EM, 2008, AM J GASTROENTEROL, V103, P966, DOI 10.1111/j.1572-0241.2007.01665.x; WATSON SA, 1995, INT J CANCER, V61, P233, DOI 10.1002/ijc.2910610216; Watson SA, 2002, BRIT J CANCER, V87, P567, DOI 10.1038/sj.bjc.6600509; Watson SA, 2001, CANCER RES, V61, P625; Wedemeyer RS, 2014, DRUG SAFETY, V37, P201, DOI 10.1007/s40264-014-0144-0; Yang YX, 2007, GASTROENTEROLOGY, V133, P748, DOI 10.1053/j.gastro.2007.06.022; Yang YX, 2010, GASTROENTEROLOGY, V139, P1115, DOI 10.1053/j.gastro.2010.08.023; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zumkeller N, 2006, HELICOBACTER, V11, P75, DOI 10.1111/j.1523-5378.2006.00381.x	30	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189114	10.1371/journal.pone.0189114	http://dx.doi.org/10.1371/journal.pone.0189114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216279	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800074
J	Munoz-Gutierrez, C; Caceres-Rojas, D; Adasme-Carreno, F; Palomo, I; Fuentes, E; Caballero, J				Munoz-Gutierrez, Camila; Caceres-Rojas, Daniela; Adasme-Carreno, Francisco; Palomo, Ivaan; Fuentes, Eduardo; Caballero, Julio			Docking and quantitative structure-activity relationship of bi-cyclic heteroaromatic pyridazinone and pyrazolone derivatives as phosphodiesterase 3A (PDE3A) inhibitors	PLOS ONE			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; BRONCHODILATORY ACTIVITY; ACCURATE DOCKING; TEMPLATE COMFA; MOLECULES; PROTEINS; PREDICTION; DESIGN; PLATELETS; PROGRAM	PDE3s belong to the phosphodiesterases family, where the PDE3A isoform is the major subtype in platelets involved in the cAMP regulation pathway of platelet aggregation. PDE3A inhibitors have been designed as potential antiplatelet agents. In this work, a homology model of PDE3A was developed and used to obtain the binding modes of bicyclic heteroaromatic pyridazinones and pyrazolones. Most of the studied compounds adopted similar orientations within the PDE3A active site, establishing hydrogen bonds with catalytic amino acids. Besides, the structure-activity relationship of the studied inhibitors was described by using a field-based 3D-QSAR method. Different structure alignment strategies were employed, including template-based and docking-based alignments. Adequate correlation models were obtained according to internal and external validations. In general, QSAR models revealed that steric and hydrophobic fields describe the different inhibitory activities of the compounds, where the hydrogen bond donor and acceptor fields have minor contributions. It should be stressed that structural elements of PDE3A inhibitors are reported here, through descriptions of their binding interactions and their differential affinities. In this sense, the present results could be useful in the future design of more specific and potent PDE3A inhibitors that may be used for the treatment of cardiovascular diseases.	[Munoz-Gutierrez, Camila; Caceres-Rojas, Daniela; Adasme-Carreno, Francisco; Caballero, Julio] Univ Talca, CBSM, Talca, Chile; [Palomo, Ivaan; Fuentes, Eduardo] Univ Talca, Fac Hlth Sci, Interdisciplinary Excellence Res Program Hlth Agi, Platelet Res Lab,Dept Clin Biochem & Immunohemato, Talca, Chile; [Fuentes, Eduardo] Univ Talca, Nucleo Cient Multidisciplinario, Talca, Chile	Universidad de Talca; Universidad de Talca; Universidad de Talca	Caballero, J (corresponding author), Univ Talca, CBSM, Talca, Chile.	jcaballero@utalca.cl	Palomo, Iván/I-4321-2018; Caballero, Julio/G-3654-2014	Caballero, Julio/0000-0003-0182-1444; Fuentes Quinteros, Eduardo/0000-0003-0099-4108; Adasme Carreno, Francisco/0000-0003-0971-9081; Munoz Gutierrez, Camila/0000-0003-0919-6903; Palomo, Ivan/0000-0002-9618-8778	'Fondo Nacional de Desarrollo Cientifico y Tecnologico' (Fondecyt), Chile [1170718]	'Fondo Nacional de Desarrollo Cientifico y Tecnologico' (Fondecyt), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by the grant no. 1170718 (J.C.) from 'Fondo Nacional de Desarrollo Cientifico y Tecnologico' (Fondecyt), Chile. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allcock RW, 2011, BIOORG MED CHEM LETT, V21, P3307, DOI 10.1016/j.bmcl.2011.04.021; ALVAREZ R, 1981, MOL PHARMACOL, V20, P302; Aptula AO, 2005, QSAR COMB SCI, V24, P385, DOI 10.1002/qsar.200430909; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Bowers K. J., 2006, P 2006 ACM IEEE C SU, P84, DOI DOI 10.1145/1188455.1188544; Caballero J, 2011, CHEM BIOL DRUG DES, V78, P631, DOI 10.1111/j.1747-0285.2011.01186.x; Card GL, 2004, STRUCTURE, V12, P2233, DOI 10.1016/j.str.2004.10.004; CONTI M, 1995, ENDOCR REV, V16, P370, DOI 10.1210/er.16.3.370; Corbin JD, 1999, J BIOL CHEM, V274, P13729, DOI 10.1074/jbc.274.20.13729; CRAMER RD, 1988, J AM CHEM SOC, V110, P5959, DOI 10.1021/ja00226a005; Cramer RD, 2014, J CHEM INF MODEL, V54, P660, DOI 10.1021/ci400696v; Dawson DL, 2001, AM J CARDIOL, V87, p19D; Edmondson SD, 2003, BIOORG MED CHEM LETT, V13, P3983, DOI 10.1016/j.bmcl.2003.08.056; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Ghose AK, 1998, J PHYS CHEM A, V102, P3762, DOI 10.1021/jp980230o; Golbraikh A, 2002, J MOL GRAPH MODEL, V20, P269, DOI 10.1016/S1093-3263(01)00123-1; Guasch L, 2012, J MOL GRAPH MODEL, V36, P1, DOI 10.1016/j.jmgm.2012.03.001; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KLEBE G, 1994, J MED CHEM, V37, P4130, DOI 10.1021/jm00050a010; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mehats C, 2002, TRENDS ENDOCRIN MET, V13, P29, DOI 10.1016/S1043-2760(01)00523-9; Munoz-Gutierrez C, 2016, RSC ADV, V6, P64756, DOI 10.1039/c6ra12084a; Navarro-Retamal C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161111; Ochiai K, 2013, BIOORG MED CHEM LETT, V23, P375, DOI 10.1016/j.bmcl.2012.08.121; Ochiai K, 2012, BIOORG MED CHEM LETT, V22, P5833, DOI 10.1016/j.bmcl.2012.07.088; Ochiai K, 2012, BIOORGAN MED CHEM, V20, P1644, DOI 10.1016/j.bmc.2012.01.033; Ochiai K, 2011, BIOORG MED CHEM LETT, V21, P5451, DOI 10.1016/j.bmcl.2011.06.118; Rotella DP, 2002, NAT REV DRUG DISCOV, V1, P674, DOI 10.1038/nrd893; Sanchez R, 1997, CURR OPIN STRUC BIOL, V7, P206, DOI 10.1016/S0959-440X(97)80027-9; Scapin G, 2004, BIOCHEMISTRY-US, V43, P6091, DOI 10.1021/bi049868i; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Soderling SH, 2000, CURR OPIN CELL BIOL, V12, P174, DOI 10.1016/S0955-0674(99)00073-3; Sun B, 2007, CELL SIGNAL, V19, P1765, DOI 10.1016/j.cellsig.2007.03.012; TANI T, 1992, ADV SEC MESS PHOSPH, V25, P215; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351, DOI 10.1164/ajrccm.157.2.9708012; Vorchheimer DA, 2006, MAYO CLIN PROC, V81, P59, DOI 10.4065/81.1.59; Wendt B, 2014, J COMPUT AID MOL DES, V28, P803, DOI 10.1007/s10822-014-9761-z; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290	42	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189213	10.1371/journal.pone.0189213	http://dx.doi.org/10.1371/journal.pone.0189213			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216268	gold, Green Submitted, Green Published			2022-12-27	WOS:000417337800096
J	Munshi, SU; Tran, TTT; Vo, TNT; Tabassum, S; Sultana, N; Nguyen, TH; Jahan, M; Le, CN; Baker, S; Rahman, M				Munshi, Saif Ullah; Thanh Thi Thanh Tran; Truc Nhu Thanh Vo; Tabassum, Shahina; Sultana, Nahida; Trang Hoa Nguyen; Jahan, Munira; Chau Ngoc Le; Baker, Stephen; Rahman, Motiur			Molecular characterization of hepatitis B virus in Bangladesh reveals a highly recombinant population	PLOS ONE			English	Article							SURFACE-ANTIGEN; HBV INFECTION; GENOTYPE D; MUTATIONS; REGION; IDENTIFICATION; SUBGENOTYPES; PREVALENCE; SEQUENCES; VARIANTS	The natural history and treatment outcome of hepatitis B viruses (HBV) infection is largely dependent on genotype, subgenotype, and the presence or absence of virulence associated mutations. We have studied the prevalence of genotype and subgenotype as well as virulence and drug resistance associated mutations and prevalence of recombinant among HBV from Bangladesh. A prospective cross-sectional study was conducted among treatment naive chronic HBV patients attending at Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh for HBV viral load assessment between June and August 2015. Systematical selected 50% of HBV DNA positive patients (every second patient) were enrolled. Biochemical and serological markers for HBV infection and whole genome sequencing (WGS) was performed on virus positive sample. Genotype, subgenotype, virulence, nucleos(t)ide analogue (NA) resistance (NAr) mutations, and the prevalence of recombinant isolates were determined. Among 114 HBV DNA positive patients, 57 were enrolled in the study and 53 HBV WGS were generated for downstream analysis. Overall, 38% (22/57) and 62% (35/57) of patients had acute and chronic HBV infections, respectively. The prevalence of genotypes A, C, and D was 18.9% (10/53), 45.3% (24/53), and 35.8% (19/53), respectively. Among genotype A, C and D isolates subgenotype A1 (90%; 9/10), C1 (87.5%; 21/24) and D2 (78.9%; 15/19) predominates. The acute infection, virulence associated mutations, and viral load was higher in the genotype D isolates. Evidence of recombination was identified in 22.6% (12/53) of the HBV isolates including 20.0% (2/10), and 16.7% (4/24) and 31.6% (6/19) of genotype A, C and D isolates, respectively. The prevalence of recombination was higher in chronic HVB patients (32.2%; 10/31 versus 9.1%; 2/22); p<0.05. NAr mutations were identified in 47.2% (25/53) of the isolates including 33.9% novel mutations (18/53). HBV genotype C and D predominated in this population in Bangladesh; a comparatively high prevalence of recombinant HBV are circulating in this setting.	[Munshi, Saif Ullah; Tabassum, Shahina; Sultana, Nahida; Jahan, Munira] Bangabandhu Sheikh Mujib Med Univ, Dhaka, Bangladesh; [Thanh Thi Thanh Tran; Truc Nhu Thanh Vo; Trang Hoa Nguyen; Chau Ngoc Le; Baker, Stephen; Rahman, Motiur] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Baker, Stephen; Rahman, Motiur] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	Bangabandhu Sheikh Mujib Medical University (BSMMU); University of Oxford; University of Oxford	Rahman, M (corresponding author), Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam.; Rahman, M (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England.	mrahman@oucru.org		Jahan, Munira/0000-0002-5976-0122; Baker, Stephen/0000-0003-1308-5755	Oxford University Clinical Research Unit Core funding	Oxford University Clinical Research Unit Core funding	This study was supported by Oxford University Clinical Research Unit Core funding to Motiur Rahman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar SMF, 1997, HEPATOL RES, V7, P113, DOI 10.1016/S0928-4346(97)00027-3; [Anonymous], 2017, GLOB HEP REP 2017, P2017; Ashraf H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-208; Avellon A, 2006, J MED VIROL, V78, P24, DOI 10.1002/jmv.20516; Chandra PK, 2009, J VIRAL HEPATITIS, V16, P749, DOI 10.1111/j.1365-2893.2009.01129.x; Chen JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155654; Chen YC, 2010, HEPATOLOGY, V51, P435, DOI 10.1002/hep.23348; Coleman PF, 2006, EMERG INFECT DIS, V12, P198, DOI 10.3201/eid1203.050038; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Friedt M, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-11; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huy TTT, 2004, J MED VIROL, V74, P228, DOI 10.1002/jmv.20175; Kim H, 2015, INT J MOL SCI, V16, P13595, DOI 10.3390/ijms160613595; Lazarevic I, 2014, WORLD J GASTROENTERO, V20, P7653, DOI 10.3748/wjg.v20.i24.7653; Liu BM, 2010, ANTIVIR RES, V85, P512, DOI 10.1016/j.antiviral.2009.12.006; Ma Q, 2012, J MED VIROL, V84, P198, DOI 10.1002/jmv.23183; McMahon BJ, 2009, HEPATOL INT, V3, P334, DOI 10.1007/s12072-008-9112-z; Moradi A, 2012, VIRUS GENES, V44, P382, DOI 10.1007/s11262-012-0715-z; Pourkarim MR, 2014, WORLD J GASTROENTERO, V20, P7152, DOI 10.3748/wjg.v20.i23.7152; Qu LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098257; Rahman MA, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1840-2; Ramezani F, 2013, IRAN J ALLERGY ASTHM, V12, P269; Lay LAR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125052; Saikia A, 2015, J MED VIROL, V87, P1539, DOI 10.1002/jmv.24207; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Sheldon J, 2008, J ANTIMICROB CHEMOTH, V61, P766, DOI 10.1093/jac/dkn014; Shi WF, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-116; Shi WF, 2012, VIROLOGY, V427, P51, DOI 10.1016/j.virol.2012.01.030; Shih HH, 2008, J VIROL, V82, P2250, DOI 10.1128/JVI.02155-07; Sugauchi F, 2002, J VIROL, V76, P5985, DOI 10.1128/JVI.76.12.5985-5992.2002; Sunbul M, 2014, WORLD J GASTROENTERO, V20, P5427, DOI 10.3748/wjg.v20.i18.5427; Tanwar Sudeep, 2012, Curr Gastroenterol Rep, V14, P37, DOI 10.1007/s11894-011-0233-5; Te Helen S, 2010, Clin Liver Dis, V14, P1, DOI 10.1016/j.cld.2009.11.009; Yin JH, 2008, CARCINOGENESIS, V29, P1685, DOI 10.1093/carcin/bgm301; Zhang X, 2015, WORLD J HEPATOL, V7, P1282, DOI 10.4254/wjh.v7.i9.1282; Ziaee M, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.37806	36	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188944	10.1371/journal.pone.0188944	http://dx.doi.org/10.1371/journal.pone.0188944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216251	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800050
J	Sorrig, R; Klausen, TW; Salomo, M; Vangsted, AJ; Frolund, UC; Andersen, KT; Klostergaard, A; Helleberg, C; Pedersen, RS; Pedersen, PT; Helm-Petersen, S; Teodorescu, EM; Preiss, B; Abildgaard, N; Gimsing, P				Sorrig, Rasmus; Klausen, Tobias W.; Salomo, Morten; Vangsted, Annette J.; Frolund, Ulf Christian; Andersen, Kristian T.; Klostergaard, Anja; Helleberg, Carsten; Pedersen, Robert S.; Pedersen, Per T.; Helm-Petersen, Sissel; Teodorescu, Elena Manuela; Preiss, Birgitte; Abildgaard, Niels; Gimsing, Peter		Danish Myeloma Study Grp	Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population	PLOS ONE			English	Article							UNINVOLVED IMMUNOGLOBULINS; RISK STRATIFICATION; SUPPRESSION; MECHANISMS; CRITERIA	Immunoparesis (hypogammaglobulinemia) is associated to an unfavorable prognosis in newly diagnosed Multiple myeloma (MM) patients. However, this finding has not been validated in an unselected population-based cohort. We analyzed 2558 newly diagnosed MM patients in the Danish Multiple Myeloma Registry representing the entire MM population in Denmark from 2005-2013. Two-thousand two hundred and fifty three patients (90%) presented with reduction below lower normal levels of at least one uninvolved immunoglobulin. Using multivariable Cox regression we found that high age, high ISS score, high LDH and IgA MM were associated to both shorter overall survival and progression free survival. Furthermore, bone marrow plasma cell% was associated to short progression free survival. Immunoparesis had no independent significant effect on OS (HR 0.9 (95% CI: 0.7; 1.0; p = 0.12)). Likewise, the number of suppressed immunoglobulins or the relative degree of suppressed uninvolved immunoglobulins from lower normal level (quantitative immunoparesis) was not associated to OS in the multivariable analysis. However, quantitative immunoparesis with at least 25% reduction (from lower normal level) of uninvolved immunoglobulins was associated to shorter PFS for the entire population. The impact of quantitative immunoparesis on PFS was present irrespective of calendar periods 2005-2008 and 2009-2013. Our population-based study does not confirm that immunoparesis at diagnosis is an independent prognostic factor regarding OS. However, quantitative immunoparesis is associated to a shorter PFS.	[Sorrig, Rasmus; Salomo, Morten; Vangsted, Annette J.; Helm-Petersen, Sissel; Gimsing, Peter] Rigshosp, Dept Hematol, Copenhagen, Denmark; [Sorrig, Rasmus] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Klausen, Tobias W.] Herlev Hosp, Hematol Res Lab, Herlev, Denmark; [Frolund, Ulf Christian] Zealand Univ Hosp, Dept Hematol, Roskilde, Denmark; [Andersen, Kristian T.] Vejle Hosp, Dept Internal Med, Hematol Sect, Vejle, Denmark; [Klostergaard, Anja] Aarhus Univ Hosp, Dept Hematol, Aarhus, Denmark; [Helleberg, Carsten] Herlev Hosp, Dept Hematol, Herlev, Denmark; [Pedersen, Robert S.] Holstebro Hosp, Dept Internal Med, Hematol Sect, Holsterbro, Denmark; [Pedersen, Per T.] Esbjerg Cent Hosp, Dept Hematol, Esbjerg, Denmark; [Teodorescu, Elena Manuela] Aalborg Univ Hosp, Dept Hematol, Aalborg, Denmark; [Preiss, Birgitte] Odense Univ Hosp, Dept Pathol, Odense, Denmark; [Abildgaard, Niels] Odense Univ Hosp, Dept Hematol, Odense, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Southern Denmark; Lillebaelt Hospital; Aarhus University; University of Copenhagen; Herlev & Gentofte Hospital; Aalborg University; Aalborg University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Sorrig, R (corresponding author), Rigshosp, Dept Hematol, Copenhagen, Denmark.; Sorrig, R (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark.	soerrig@gmail.com		Pedersen, Per Trollund/0000-0002-8821-7807; Klostergaard, Anja/0000-0002-5477-746X; Johnsen, Hans Erik/0000-0001-8253-2913; Salomo, Morten/0000-0002-1660-1607	University of Copenhagen Faculty of Health and Medical Sciences [620-0032/14-3000]; The Danish Cancer Society [R152-A9822, R94-A5689] Funding Source: researchfish	University of Copenhagen Faculty of Health and Medical Sciences; The Danish Cancer Society(Danish Cancer Society)	University of Copenhagen Faculty of Health and Medical Sciences funded a PhD Schlarship to RS, Grant no 620-0032/14-3000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abildgaard N, 2016, 21 C EUR HEM ASS JUN; Blimark C, 2015, HAEMATOLOGICA, V100, P107, DOI 10.3324/haematol.2014.107714; Chng WJ, 2014, LEUKEMIA, V28, P269, DOI 10.1038/leu.2013.247; Dansk Myelomatose Studiegruppe, 2015, DIAGN BEH MYEL RETN; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Gimsing P, 2016, CLIN EPIDEMIOL, V8, P583, DOI 10.2147/CLEP.S99463; De La Calle VG, 2015, BLOOD, V126; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Heaney J.L.J., 2014, EUR SOC HAEM 2 INT C; Holmstrom MO, 2015, AM J HEMATOL, V90, pE73, DOI 10.1002/ajh.23932; Kastritis E, 2014, LEUKEMIA, V28, P2075, DOI 10.1038/leu.2014.110; Katzmann JA, 2013, LEUKEMIA, V27, P208, DOI 10.1038/leu.2012.189; KAWANO M, 1989, AM J HEMATOL, V30, P91, DOI 10.1002/ajh.2830300208; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; Kyrtsonis MC, 1999, MED ONCOL, V16, P73, DOI 10.1007/BF02785839; Munshi NC, 1997, HEMATOL ONCOL CLIN N, V11, P51, DOI 10.1016/S0889-8588(05)70415-9; Paiva B, 2009, BLOOD, V114, P4369, DOI 10.1182/blood-2009-05-221689; Palumbo A., 2015, J CLIN ONCOL, V33; Perez-Persona E, 2007, BLOOD, V110, P2586, DOI 10.1182/blood-2007-05-088443; PILARSKI LM, 1986, J CLIN IMMUNOL, V6, P491, DOI 10.1007/BF00915255; Ritchie RF, 1998, J CLIN LAB ANAL, V12, P371, DOI 10.1002/(SICI)1098-2825(1998)12:6<371::AID-JCLA7>3.3.CO;2-K; Sanchez E, 2016, CLIN CANC RES; Sari M, 2017, TURK J HEMATOL, V34, P131, DOI 10.4274/tjh.2016.0161; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Sorrig R, 2016, EUR J HAEMATOL, V97, P303, DOI 10.1111/ejh.12728; van de Donk NWCJ, 2014, HEMATOL ONCOL CLIN N, V28, P791, DOI 10.1016/j.hoc.2014.06.007; Walchner M, 1997, CLIN EXP IMMUNOL, V109, P310, DOI 10.1046/j.1365-2249.1997.4451342.x	28	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188988	10.1371/journal.pone.0188988	http://dx.doi.org/10.1371/journal.pone.0188988			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216227	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800055
J	Wang, MC; Gao, Y; Deng, JX; Lai, HY; Deng, QW; Armour, C				Wang, Meng-Cheng; Gao, Yu; Deng, Jiaxin; Lai, Hongyu; Deng, Qiaowen; Armour, Cherie			The factor structure and construct validity of the inventory of callous-unemotional traits in Chinese undergraduate students	PLOS ONE			English	Article							PROCESS SCREENING DEVICE; PROACTIVE AGGRESSION QUESTIONNAIRE; PARENT-REPORTED INVENTORY; SELF-REPORT VERSION; PSYCHOMETRIC PROPERTIES; PSYCHOPATHIC TRAITS; COMMUNITY SAMPLE; ADOLESCENTS; CHILDREN; VALIDATION	The current study assesses the factor structure and construct validity of the self-reported Inventory of Callous-Unemotional Traits (ICU) in 637 Chinese community adults (mean age = 25.98, SD = 5.79). A series of theoretical models proposed in previous studies were tested through confirmatory factor analyses. Results indicated that a shortened form that consists of 11 items (ICU-11) to assess callousness and uncaring factors has excellent overall fit. Additionally, correlations with a wide range of external variables demonstrated that this shortened form has similar construct validity compared to the original ICU. In conclusion, our findings suggest that the ICU-11 may be a promising self-report tool that could be a good substitute for the original form to assess callous-uncaring traits in adults.	[Wang, Meng-Cheng; Deng, Jiaxin; Lai, Hongyu; Deng, Qiaowen] Guangzhou Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China; [Wang, Meng-Cheng] Key Lab Juveniles Mental Hlth & Educ Neurosci Gua, Guangzhou, Guangdong, Peoples R China; [Gao, Yu] CUNY Brooklyn Coll, Brooklyn, NY 11210 USA; [Gao, Yu] CUNY, Grad Ctr, New York, NY USA; [Armour, Cherie] Univ Ulster, Psychol Res Inst, Coleraine, Londonderry, North Ireland	Guangzhou University; City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; Ulster University	Wang, MC (corresponding author), Guangzhou Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China.; Wang, MC (corresponding author), Key Lab Juveniles Mental Hlth & Educ Neurosci Gua, Guangzhou, Guangdong, Peoples R China.	wmcheng2006@126.com	Wang, Meng-cheng/K-9413-2019	Armour, Cherie/0000-0001-7649-3874; Wang, Meng-Cheng/0000-0002-0855-2219	National Natural Science Foundation of China [31400904]; Guangzhou University [2014-27]; Guangzhou University's training program for young top-notch personnels [BJ201715]; Foundation of Guangzhou Shishu Gaoxiao Project [1201431330]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou University; Guangzhou University's training program for young top-notch personnels; Foundation of Guangzhou Shishu Gaoxiao Project	This study was funded by the National Natural Science Foundation of China (Grant No. 31400904;http://www.nsfcgov.cn/).), Xinmiao project of Guangzhou University (2014-27;http:// english.gzhu.edu.cn/), Guangzhou University's 2017 training program for young top-notch personnels (BJ201715), and Foundation of Guangzhou Shishu Gaoxiao Project (Grant No. 1201431330;http://english.gzhu.edu.cn/). MCW received those funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barker C., 1994, RES METHODS CLIN COU; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Byrd AL, 2013, J PSYCHOPATHOL BEHAV, V35, P20, DOI 10.1007/s10862-012-9315-4; Campbell MA, 2009, J PERS ASSESS, V91, P584, DOI 10.1080/00223890903228679; Ciucci E, 2014, J PSYCHOPATHOL BEHAV, V36, P189, DOI 10.1007/s10862-013-9384-z; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; Colins OF, 2016, CHILD PSYCHIAT HUM D, V47, P679, DOI 10.1007/s10578-015-0601-8; Colins OF, 2016, PSYCHOL ASSESSMENT, V28, P449, DOI 10.1037/pas0000189; Cooke DJ, 2001, PSYCHOL ASSESSMENT, V13, P171, DOI 10.1037//1040-3590.13.2.171; Edens JF, 2000, PSYCHOL ASSESSMENT, V12, P132, DOI 10.1037//1040-3590.12.2.132; Essau CA, 2006, ASSESSMENT, V13, P454, DOI 10.1177/1073191106287354; Fanti KA, 2009, J PSYCHOPATHOL BEHAV, V31, P285, DOI 10.1007/s10862-008-9111-3; Feilhauer J, 2012, INT J LAW PSYCHIAT, V35, P251, DOI 10.1016/j.ijlp.2012.04.002; Forth A.E., 2003, HARE PSYCHOPATHY CHE; Frick P.J., 2004, INVENTORY CALLOUS UN, DOI DOI 10.1037/T62639-000; Frick PJ, 2008, J CHILD PSYCHOL PSYC, V49, P359, DOI 10.1111/j.1469-7610.2007.01862.x; Frick Paul J, 2006, Curr Psychiatry Rep, V8, P59, DOI 10.1007/s11920-006-0082-3; Frick PJ, 2014, PSYCHOL BULL, V140, P1, DOI 10.1037/a0033076; Frick PJ, 2009, CAN J PSYCHIAT, V54, P803, DOI 10.1177/070674370905401203; Frick PJ., 2001, ANTISOCIAL PROCESS S; Fung ALC, 2009, J PERS ASSESS, V91, P473, DOI 10.1080/00223890903088420; Gao Y, 2016, J PSYCHOPATHOL BEHAV, V38, P331, DOI 10.1007/s10862-015-9527-5; Hawes SW, 2014, J ABNORM PSYCHOL, V123, P623, DOI 10.1037/a0037078; Hawes SW, 2014, PSYCHOL ASSESSMENT, V26, P256, DOI 10.1037/a0034718; Houghton S, 2013, J PSYCHOPATHOL BEHAV, V35, P215, DOI 10.1007/s10862-012-9324-3; Hyler SE., 1994, PERSONALITY DIAGNOST; Jackson D.N., 1994, JACKSON PERSONALITY; Kimonis ER, 2008, INT J LAW PSYCHIAT, V31, P241, DOI 10.1016/j.ijlp.2008.04.002; Kimonis ER, 2016, J ABNORM CHILD PSYCH, V44, P625, DOI 10.1007/s10802-015-0075-y; Kimonis ER, 2013, PSYCHOL ASSESSMENT, V25, P84, DOI 10.1037/a0029024; Kline R.B., 2010, PRINCIPLES PRACTICE; Lahey BB, 2014, PSYCHOL BULL, V140, P58, DOI 10.1037/a0033387; LEVENSON MR, 1995, J PERS SOC PSYCHOL, V68, P151, DOI 10.1037/0022-3514.68.1.151; [李献云 Li Xianyun], 2011, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V37, P607; Lilienfeld S. O., 2006, HDB PSYCHOPATHY, P107; Lopez-Romero L, 2015, J PSYCHOPATHOL BEHAV, V37, P392, DOI 10.1007/s10862-014-9469-3; Moore AA, 2017, RELIABILITY HERITABI, V47, P141; Munoz LC, 2007, SCAND J PSYCHOL, V48, P299, DOI 10.1111/j.1467-9450.2007.00560.x; Muthen L.K., 2017, MPLUS USERS GUIDE, V8th ed.; Paiva-Salisbury ML, 2017, ASSESSMENT, V24, P763, DOI 10.1177/1073191115624546; Pihet S, 2015, J PSYCHOPATHOL BEHAV, V37, P407, DOI 10.1007/s10862-014-9472-8; Poythress NG, 2006, ASSESSMENT, V13, P107, DOI 10.1177/1073191105284279; Raine A, 2006, AGGRESSIVE BEHAV, V32, P159, DOI 10.1002/ab.20115; Ray JV, 2016, PSYCHOL ASSESSMENT, V28, P394, DOI 10.1037/pas0000183; Ray JV, 2013, PERSONAL DISORD, V4, P1, DOI 10.1037/a0026482; Roose A, 2010, ASSESSMENT, V17, P44, DOI 10.1177/1073191109344153; Salekin RT, 2008, J ABNORM PSYCHOL, V117, P386, DOI 10.1037/0021-843X.117.2.386; Simms LJ, 2011, J PERS ASSESS, V93, P380, DOI 10.1080/00223891.2011.577475; Vahl P, 2014, EUR CHILD ADOLES PSY, V23, P691, DOI 10.1007/s00787-013-0497-4; Waller R, 2015, ASSESSMENT, V22, P561, DOI 10.1177/1073191114556101; Wang M-C, FACTOR STRU IN PRESS; Wang MC, 2015, J PSYCHOPATHOL BEHAV, V37, P553, DOI 10.1007/s10862-015-9486-x; Willoughby MT, 2015, ASSESSMENT, V22, P76, DOI 10.1177/1073191114534886; Xu YY, 2008, J ABNORM CHILD PSYCH, V36, P539, DOI 10.1007/s10802-007-9198-0; 杨蕴萍, 2002, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V10, P165	56	29	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189003	10.1371/journal.pone.0189003	http://dx.doi.org/10.1371/journal.pone.0189003			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216240	Green Published, gold			2022-12-27	WOS:000417337800056
J	Gelin, ML; Branch, LC; Thornton, DH; Novaro, AJ; Gould, MJ; Caragiulo, A				Gelin, Maria L.; Branch, Lyn C.; Thornton, Daniel H.; Novaro, Andres J.; Gould, Matthew J.; Caragiulo, Anthony			Response of pumas (Puma concolor) to migration of their primary prey in Patagonia	PLOS ONE			English	Article							LAMA-GUANICOE; MOUNTAIN LIONS; CAMERA TRAPS; SOCIAL-ORGANIZATION; DENSITY-ESTIMATION; CAPTURE-RECAPTURE; ACTIVITY PATTERNS; FEEDING ECOLOGY; HABITAT USE; POPULATION	Large-scale ungulate migrations result in changes in prey availability for top predators and, as a consequence, can alter predator behavior. Migration may include entire populations of prey species, but often prey populations exhibit partial migration with some individuals remaining resident and others migrating. Interactions of migratory prey and predators have been documented in North America and some other parts of the world, but are poorly studied in South America. We examined the response of pumas (Puma concolor) to seasonal migration of guanacos (Lama guanicoe) in La Payunia Reserve in northern Patagonia Argentina, which is the site of the longest known ungulate migration in South America. More than 15,000 guanacos migrate seasonally in this landscape, and some guanacos also are resident year-round. We hypothesized that pumas would respond to the guanaco migration by consuming more alternative prey rather than migrating with guanacos because of the territoriality of pumas and availability of alternative prey throughout the year at this site. To determine whether pumas moved seasonally with the guanacos, we conducted camera trapping in the summer and winter range of guanacos across both seasons and estimated density of pumas with spatial mark-resight (SMR) models. Also, we analyzed puma scats to assess changes in prey consumption in response to guanaco migration. Density estimates of pumas did not change significantly in the winter and summer range of guanacos when guanacos migrated to and from these areas, indicating that pumas do not follow the migration of guanacos. Pumas also did not consume more alternative native prey or livestock when guanaco availability was lower, but rather fed primarily on guanacos and some alternative prey during all seasons. Alternative prey were most common in the diet during summer when guanacos also were abundant on the summer range. The response of pumas to the migration of guanacos differs from sites in the western North America where entire prey populations migrate and pumas migrate with their prey or switch to more abundant prey when their primary prey migrates.	[Gelin, Maria L.; Branch, Lyn C.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA; [Gelin, Maria L.; Branch, Lyn C.] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA; [Thornton, Daniel H.] Washington State Univ, Sch Environm, Pullman, WA 99164 USA; [Novaro, Andres J.] INIBIOMA Univ Nacl Comahue CONICET, Programa Estepa Patagon & Andina, Wildlife Conservat Soc, Junin De Los Andes, Neuquen, Argentina; [Gould, Matthew J.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Caragiulo, Anthony] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Washington State University; New Mexico State University; American Museum of Natural History (AMNH)	Branch, LC (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA.; Branch, LC (corresponding author), Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA.	branchl@ufl.edu		Gould, Matthew/0000-0002-9703-4690	Conservation Food and Health Foundation; Pittsburgh Zoo & PPG Aquariums PPG Conservation and Sustainability Fund; Rufford Small Grants for Nature Conservation; IdeaWild; Tropical Conservation and Development Program, University of Florida; BEC.AR Argentina; School of Natural Resources and the Environment, University of Florida	Conservation Food and Health Foundation; Pittsburgh Zoo & PPG Aquariums PPG Conservation and Sustainability Fund; Rufford Small Grants for Nature Conservation; IdeaWild; Tropical Conservation and Development Program, University of Florida; BEC.AR Argentina; School of Natural Resources and the Environment, University of Florida(University of Florida)	The authors gratefully acknowledge financial support and equipment from the Conservation Food and Health Foundation, Pittsburgh Zoo & PPG Aquariums PPG Conservation and Sustainability Fund, Rufford Small Grants for Nature Conservation, IdeaWild, and the Tropical Conservation and Development Program, University of Florida. During this work, M. L. Gelin was supported by scholarships from BEC.AR Argentina and the School of Natural Resources and the Environment, University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Argentinian program of the Wildlife Conservation Society and Direccion de Recursos Naturales Renovables de Mendoza for logistical support. We are grateful to Mariel Ruiz Blanco and Maria Jose Bolgeri for sharing their knowledge of La Payunia and for assistance throughout the fieldwork. We also thank all the volunteers on the project, and especially the following people for the many days they spent in the field: Uriel Menalled, Natanael Griffa, Bianca Bonaparte and park rangers Lucas Aros, Andres Castro, Anibal Soto, Edgardo Soto, Francisco Estive, Jairo Espinosa. Also, we are grateful to the park rangers of Malargue for providing lodging. We gratefully acknowledge financial support and equipment from the Conservation Food and Health Foundation, Pittsburgh Zoo & PPG Aquarium's PPG Conservation and Sustainability Fund, Rufford Small Grants for Nature Conservation, IdeaWild, and the Tropical Conservation and Development Program, University of Florida. During this work, M. L. Gelin was supported by scholarships from BEC.AR Argentina and the School of Natural Resources and the Environment, University of Florida. We thank John Goodrich and two anonymous reviewers for helpful comments on the manuscript.	Altrichter M, 2006, BIODIVERS CONSERV, V15, P2719, DOI 10.1007/s10531-005-0307-5; Arroyo-Arce S, 2014, REV BIOL TROP, V62, P1449, DOI 10.15517/rbt.v62i4.13314; Ball JP, 2001, WILDLIFE BIOL, V7, P39, DOI 10.2981/wlb.2001.007; Ballard Warren B., 1997, Wildlife Monographs, V135, P1; Bolgeri María J, 2015, Mastozool. neotrop., V22, P255; Bolgeri MJ, 2015, THESIS; Branch LC, 1996, J MAMMAL, V77, P453; Candia R., 1993, MULTEQUINA, V2, P5; Caragiulo A, 2014, MITOCHONDR DNA, V25, P304, DOI 10.3109/19401736.2013.800486; Chandler RB, 2013, ANN APPL STAT, V7, P936, DOI 10.1214/12-AOAS610; Chehebar C., 1989, Donana Acta Vertebrata, V16, P247; Donadio E, 2010, J ZOOL, V280, P33, DOI 10.1111/j.1469-7998.2009.00638.x; Efford M, 2004, OIKOS, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x; Efford M.G., 2016, SECR 2 10 SPATIALLY; Efford MG, 2009, ENVIRON ECOL STAT SE, V3, P255, DOI 10.1007/978-0-387-78151-8_11; Elbroch LM, 2017, J ZOOL, V302, P164, DOI 10.1111/jzo.12442; Elbroch LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083375; Elbroch LM, 2013, J MAMMAL, V94, P259, DOI 10.1644/12-MAMM-A-041.1; Elbroch LM, 2012, MAMM BIOL, V77, P377, DOI 10.1016/j.mambio.2012.02.010; EMMONS LH, 1987, BEHAV ECOL SOCIOBIOL, V20, P271, DOI 10.1007/BF00292180; Fernández Cynthia S, 2014, Mastozool. neotrop., V21, P331; Frame PF, 2008, ARCTIC, V61, P134; Franklin WL, 1999, BIOL CONSERV, V90, P33, DOI 10.1016/S0006-3207(99)00008-7; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Giroux MA, 2012, J ANIM ECOL, V81, P533, DOI 10.1111/j.1365-2656.2011.01944.x; Guarda N, 2016, ORYX, V51, P1; HOFER H, 1993, ANIM BEHAV, V46, P559, DOI 10.1006/anbe.1993.1223; IRIARTE JA, 1990, OECOLOGIA, V85, P185, DOI 10.1007/BF00319400; IRIARTE JA, 1991, REV CHIL HIST NAT, V64, P145; Keehner JR, 2015, BIOL CONSERV, V192, P101, DOI 10.1016/j.biocon.2015.09.006; Kelly MJ, 2008, J MAMMAL, V89, P408, DOI 10.1644/06-MAMM-A-424R.1; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Knopff KH, 2010, J WILDLIFE MANAGE, V74, P1435, DOI 10.2193/2009-314; Laundre JW, 2010, WHAT WE KNOW PUMAS L, P76; LINDZEY FG, 1994, J WILDLIFE MANAGE, V58, P619, DOI 10.2307/3809674; Llambias EJ., 2008, DISTRITO VOLCANICO P, P263; LOFT ER, 1984, J WILDLIFE MANAGE, V48, P1317, DOI 10.2307/3801792; LOGAN K.A., 2001, DESERT PUMA EVOLUTIO; LOGAN KA, 1986, J WILDLIFE MANAGE, V50, P648, DOI 10.2307/3800975; Lyamuya RD, 2014, ORYX, V48, P378, DOI 10.1017/S0030605312001706; Marker Laurie, 2003, Cat News, V38, P24; Monteith KL, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00096.1; Moraga CA, 2015, ORYX, V49, P30, DOI 10.1017/S0030605312001238; Mueller T, 2011, GLOBAL ECOL BIOGEOGR, V20, P683, DOI 10.1111/j.1466-8238.2010.00638.x; Mysterud A, 2013, ECOLOGY, V94, P1257, DOI 10.1890/12-0505.1; Mysterud A, 2011, OIKOS, V120, P1817, DOI 10.1111/j.1600-0706.2010.19439.x; Negroes N, 2010, J WILDLIFE MANAGE, V74, P1195, DOI 10.2193/2009-256; Nelson AA, 2012, ECOL APPL, V22, P2293, DOI 10.1890/11-1829.1; Niedballa J, 2016, METHODS ECOL EVOL, V7, P1457, DOI 10.1111/2041-210X.12600; Noss AJ, 2012, ANIM CONSERV, V15, P527, DOI 10.1111/j.1469-1795.2012.00545.x; Novaro A. J., 2005, LARGE CARNIVORES CON, P267; Novaro AJ, 2000, BIOL CONSERV, V92, P25, DOI 10.1016/S0006-3207(99)00065-8; Novaro AJ, 2006, TERCER INFORM AVANCE; Nunez-Regueiro MM, 2015, BIOL CONSERV, V187, P19, DOI 10.1016/j.biocon.2015.04.001; Ortega IM, 1995, REV CHIL HIST NAT, V68, P489; Paviolo A, 2009, J MAMMAL, V90, P926, DOI 10.1644/08-MAMM-A-128.1; Pierce BM, 1999, J MAMMAL, V80, P986, DOI 10.2307/1383269; Pierce BM, 2000, ECOLOGY, V81, P1533; Puig S, 1996, J ARID ENVIRON, V34, P215, DOI 10.1006/jare.1996.0103; Puig Silvia, 2003, Multequina, V12, P37; Quiroga VA, 2016, J NAT CONSERV, V31, P9, DOI 10.1016/j.jnc.2016.02.004; Rich LN, 2014, J MAMMAL, V95, P382, DOI 10.1644/13-MAMM-A-126; Royle JA, 2009, J APPL ECOL, V46, P118, DOI 10.1111/j.1365-2664.2008.01578.x; Scheel, 1995, SERENGETI; Schroeder NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085960; Seidensticker J.C. IV., 1973, Wildlife Monogr, VNo. 35, P1; Silver S., 2004, ASSESSING JAGUAR ABU, P1; Silver SC, 2004, ORYX, V38, P148, DOI 10.1017/S0030605304000286; Sollmann R, 2013, J APPL ECOL, V50, P961, DOI 10.1111/1365-2664.12098; Soria-Diaz L, 2010, ANIM BIOL, V60, P361, DOI 10.1163/157075610X523251; Stoner DC, 2006, J WILDLIFE MANAGE, V70, P1588, DOI 10.2193/0022-541X(2006)70[1588:CELIUI]2.0.CO;2; Sunquist ME, 2002, WILD CATS WORLD; Thornton DH, 2015, WILDLIFE RES, V42, P394, DOI 10.1071/WR15092; Valeix M, 2012, J APPL ECOL, V49, P73, DOI 10.1111/j.1365-2664.2011.02099.x; Villepique JT, 2011, SOUTHWEST NAT, V56, P187, DOI 10.1894/F07-TAL.1; Walton Z, 2017, OIKOS, V126, P642, DOI 10.1111/oik.03374; WEINGART E L, 1973, American Midland Naturalist, V90, P508, DOI 10.2307/2424481; White PJ, 2007, BIOL CONSERV, V135, P502, DOI 10.1016/j.biocon.2006.10.041; Wilmers CC, 2003, J ANIM ECOL, V72, P909, DOI 10.1046/j.1365-2656.2003.00766.x; Martinez JIZ, 2012, ORYX, V46, P106, DOI 10.1017/S0030605310001821; Zanon-Martinez JI, 2016, WILDLIFE RES, V43, P449, DOI 10.1071/WR16056; ZAR J.H., 2009, BIOSTAT ANAL, V5th	83	14	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188877	10.1371/journal.pone.0188877	http://dx.doi.org/10.1371/journal.pone.0188877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211753	Green Published, Green Submitted, gold			2022-12-27	WOS:000417212200050
J	Lee, JH; Kim, TJ; Kim, ER; Hong, SN; Chang, DK; Choi, LH; Woo, HI; Lee, SY; Kim, YH				Lee, Ji Hyeon; Kim, Tae Jun; Kim, Eun Ran; Hong, Sung Noh; Chang, Dong Kyung; Choi, Li-Hwa; Woo, Hye In; Lee, Soo-Youn; Kim, Young-Ho			Measurements of 6-thioguanine nucleotide levels with TPMT and NUDT15 genotyping in patients with Crohn's disease	PLOS ONE			English	Article							THIOPURINE S-METHYLTRANSFERASE; INFLAMMATORY-BOWEL-DISEASE; JAPANESE PATIENTS; AZATHIOPRINE THERAPY; INDUCED LEUKOPENIA; PEDIATRIC-PATIENTS; METABOLITE LEVELS; 5-AMINOSALICYLIC ACID; 6-MERCAPTOPURINE; POLYMORPHISMS	The association between the 6-thioguanine nucleotide (6-TGN) level and clinical remission in Crohn's disease (CD) remains controversial. Thiopurine-induced leukopenia is a life-threatening complication of CD in Asians that was recently shown to strongly correlate with NUDT15 genetic variants. This study aimed to determine the relationship between thiopurine metabolite levels and therapeutic response, and to investigate the association of NUDT15, TPMT, and thiopurine metabolites with leukopenia in patients with CD. We enrolled 165 adult patients with CD undergoing thiopurine treatment. Clinical evaluation and laboratory examinations were carried out every 2-3 months. We measured thiopurine metabolites levels and genotyped NUDT15 and TPMT. During the median 12-month observational period, 95 (67.9%) patients exhibited clinical response and 45 (32.1%) did not respond to the treatment. The median 6-TGN level was significantly higher in responders than in non-responders (P < 0.001). The odds ratio of patients with a 6-TGN level >= 230 pmol/8 x 10(8) red blood cells for showing a clinical response was 4.63 (95% CI 1.62-11.9). NUDT15 variant types were strongly associated with developing leukopenia. Patients with NUDT15 homozygous variant genotype developed severe early leukopenia with an average reduction of 88.2% (range, 84-94%) from the baseline white blood cell count at 4 weeks. Our findings support the role of therapeutic drug monitoring in thiopurine maintenance treatment to optimize thiopurine therapy, especially, for non-responding CD patients. Thiopurine treatment should not be recommended to patients with NUDT15 homozygous variant genotype due to severe early leukopenia.	[Lee, Ji Hyeon; Kim, Tae Jun; Kim, Eun Ran; Hong, Sung Noh; Chang, Dong Kyung; Kim, Young-Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Choi, Li-Hwa; Lee, Soo-Youn] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med, Seoul, South Korea; [Choi, Li-Hwa] Green Cross Labs, Dept Lab Med, Yongin, Gyeonggi, South Korea; [Woo, Hye In] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Lab Med, Chang Won, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, YH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.; Lee, SY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med, Seoul, South Korea.	suddenbz@skku.edu; bowelkim@gmail.com	Kim, Eun Ran/AAD-8003-2022	LEE, SOO-YOUN/0000-0001-7595-4042	grant of the Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI12C0130]	grant of the Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number HI12C0130 to YHK).	Amin J, 2015, INFLAMM BOWEL DIS, V21, P445, DOI 10.1097/MIB.0000000000000197; Andoh A, 2008, J GASTROEN HEPATOL, V23, P1373, DOI 10.1111/j.1440-1746.2008.05419.x; Asada A, 2016, J GASTROENTEROL, V51, P22, DOI 10.1007/s00535-015-1142-4; Ban H, 2008, INTERNAL MED, V47, P1645, DOI 10.2169/internalmedicine.47.1268; Booth RA, 2011, ANN INTERN MED, V154, P814, DOI 10.7326/0003-4819-154-12-201106210-00009; Bradford K, 2011, WORLD J GASTROENTERO, V17, P4166, DOI 10.3748/wjg.v17.i37.4166; Collie-Duguid ESR, 1999, PHARMACOGENETICS, V9, P37, DOI 10.1097/00008571-199902000-00006; Colombel JF, 2000, GASTROENTEROLOGY, V118, P1025, DOI 10.1016/S0016-5085(00)70354-4; Cuffari C, 2001, GUT, V48, P642, DOI 10.1136/gut.48.5.642; Dassopoulos T, 2014, ALIMENT PHARM THER, V39, P163, DOI 10.1111/apt.12555; de Graaf P, 2010, BRIT J PHARMACOL, V160, P1083, DOI 10.1111/j.1476-5381.2010.00731.x; Dervieux T, 2001, LEUKEMIA, V15, P1706, DOI 10.1038/sj.leu.2402259; Dewit O, 2011, CLIN BIOCHEM, V44, P1062, DOI 10.1016/j.clinbiochem.2011.06.079; Dignass A, 2010, J CROHNS COLITIS, V4, P28, DOI 10.1016/j.crohns.2009.12.002; Dubinsky MC, 2000, GASTROENTEROLOGY, V118, P705, DOI 10.1016/S0016-5085(00)70140-5; Duley JA, 2008, J GASTROEN HEPATOL, V23, P1317, DOI 10.1111/j.1440-1746.2008.05564.x; Duley JA, 2005, THER DRUG MONIT, V27, P647, DOI 10.1097/01.ftd.0000169061.52715.3e; Gao X, 2012, EUR J GASTROEN HEPAT, V24, P958, DOI 10.1097/MEG.0b013e3283545ae3; Gearry RB, 2005, J GASTROEN HEPATOL, V20, P1149, DOI 10.1111/j.1440-1746.2005.03832.x; Gilissen LPL, 2012, J CROHNS COLITIS, V6, P698, DOI 10.1016/j.crohns.2011.12.003; Gisbert JP, 2006, AM J GASTROENTEROL, V101, P2769, DOI 10.1111/j.1572-0241.2006.00843.x; Gonzalez-Lama Y, 2011, ALIMENT PHARM THER, V34, P544, DOI 10.1111/j.1365-2036.2011.04756.x; Goodhand JR, 2013, ALIMENT PHARM THER, V38, P1097, DOI 10.1111/apt.12476; Gordon M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008414.pub2; Kim HT, 2017, PHARMACOGENET GENOM, V27, P197, DOI 10.1097/FPC.0000000000000274; Kim HY, 2015, PHARMACOGENET GENOM, V25, P143, DOI 10.1097/FPC.0000000000000117; Kim JH, 2010, J CLIN GASTROENTEROL, V44, pE242, DOI 10.1097/MCG.0b013e3181d6baf5; Komiyama T, 2008, J CROHNS COLITIS, V2, P315, DOI 10.1016/j.crohns.2008.05.002; Kwan LY, 2008, DIGEST LIVER DIS, V40, P425, DOI 10.1016/j.dld.2008.01.003; Lee MN, 2015, INFLAMM BOWEL DIS, V21, P2897, DOI 10.1097/MIB.0000000000000570; Lee MN, 2015, INFLAMM BOWEL DIS, V21, P1054, DOI 10.1097/MIB.0000000000000347; Lee YJ, 2016, EUR J GASTROEN HEPAT, V28, P475, DOI 10.1097/MEG.0000000000000564; Lewis LD, 1997, CLIN PHARMACOL THER, V62, P464, DOI 10.1016/S0009-9236(97)90125-9; Moreau AC, 2014, INFLAMM BOWEL DIS, V20, P464, DOI 10.1097/01.MIB.0000439068.71126.00; Moriyama T, 2016, NAT GENET, V48, P367, DOI 10.1038/ng.3508; OBRIEN JJ, 1991, GASTROENTEROLOGY, V101, P39, DOI 10.1016/0016-5085(91)90457-V; Ohtsuka Y, 2010, J GASTROEN HEPATOL, V25, P1626, DOI 10.1111/j.1440-1746.2010.06364.x; PEARSON DC, 1995, ANN INTERN MED, V123, P132, DOI 10.7326/0003-4819-123-2-199507150-00009; Regueiro M, 2002, J CLIN GASTROENTEROL, V35, P240, DOI 10.1097/00004836-200209000-00008; Relling MV, 2011, CLIN PHARMACOL THER, V89, P387, DOI 10.1038/clpt.2010.320; Schwab M, 2002, PHARMACOGENETICS, V12, P429, DOI 10.1097/00008571-200208000-00003; Shah SA, 2016, J GASTROENTEROL HEPA; Takatsu N, 2009, J GASTROEN HEPATOL, V24, P1258, DOI 10.1111/j.1440-1746.2009.05917.x; Wong FCK, 2016, HONG KONG MED J, V22, P185, DOI 10.12809/hkmj154783; Yang SK, 2014, NAT GENET, V46, P1017, DOI 10.1038/ng.3060; Yates CR, 1997, ANN INTERN MED, V126, P608, DOI 10.7326/0003-4819-126-8-199704150-00003; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhu X, 2016, ALIMENT PHARM THER, V44, P967, DOI 10.1111/apt.13796	48	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188925	10.1371/journal.pone.0188925	http://dx.doi.org/10.1371/journal.pone.0188925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206869	gold, Green Published, Green Submitted			2022-12-27	WOS:000417110700032
J	Kunze, T; Peterson, ADH; Haueisen, J; Knosche, TR				Kunze, Tim; Peterson, Andre D. H.; Haueisen, Jens; Knoesche, Thomas R.			A model of individualized canonical microcircuits supporting cognitive operations	PLOS ONE			English	Article							NEURAL MASS MODEL; BIFURCATION-ANALYSIS; POTENTIAL GENERATION; MATHEMATICAL-MODEL; NEURONAL CIRCUITS; DYNAMIC BALANCE; CEREBRAL-CORTEX; VISUAL-CORTEX; IN-VIVO; NETWORKS	Major cognitive functions such as language, memory, and decision-making are thought to rely on distributed networks of a large number of basic elements, called canonical microcircuits. In this theoretical study we propose a novel canonical microcircuit model and find that it supports two basic computational operations: a gating mechanism and working memory. By means of bifurcation analysis we systematically investigate the dynamical behavior of the canonical microcircuit with respect to parameters that govern the local network balance, that is, the relationship between excitation and inhibition, and key intrinsic feedback architectures of canonical microcircuits. We relate the local behavior of the canonical microcircuit to cognitive processing and demonstrate how a network of interacting canonical microcircuits enables the establishment of spatiotemporal sequences in the context of syntax parsing during sentence comprehension. This study provides a framework for using individualized canonical microcircuits for the construction of biologically realistic networks supporting cognitive operations.	[Kunze, Tim; Haueisen, Jens; Knoesche, Thomas R.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Kunze, Tim; Haueisen, Jens] Ilmenau Univ Technol, Inst Biomed Engn & Informat, Ilmenau, Germany; [Peterson, Andre D. H.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia	Max Planck Society; Technische Universitat Ilmenau; University of Melbourne	Kunze, T (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.; Kunze, T (corresponding author), Ilmenau Univ Technol, Inst Biomed Engn & Informat, Ilmenau, Germany.	tkunze@cbs.mpg.de	Haueisen, Jens/B-7183-2011	Haueisen, Jens/0000-0003-3871-2890	Max Planck Society; DAAD-Go8-Germany joint research scheme [57061157]; Sir John Eccles Research Fellowship; Thuringian Ministry of Science [2015 FGR 0085]	Max Planck Society(Max Planck Society); DAAD-Go8-Germany joint research scheme; Sir John Eccles Research Fellowship; Thuringian Ministry of Science	This work was funded by the Max Planck Society and supported by the DAAD-Go8-Germany joint research scheme under the grant number 57061157. A.D.H.P was supported by a Sir John Eccles Research Fellowship. J.H. has received partly funding from the Thuringian Ministry of Science under grant number 2015 FGR 0085.	Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Bastos AM, 2015, NEUROIMAGE, V108, P460, DOI 10.1016/j.neuroimage.2014.12.081; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Beggs JM, 2008, PHILOS T R SOC A, V366, P329, DOI 10.1098/rsta.2007.2092; Beul SF, 2015, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00165; Bosman CA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00303; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Cain N, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005045; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; David O, 2006, NEUROIMAGE, V30, P1255, DOI 10.1016/j.neuroimage.2005.10.045; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; Dehghani N, 2016, SCI REP-UK, V6, DOI 10.1038/srep23176; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Douglas RJ, 2007, NEURON, V56, P226, DOI 10.1016/j.neuron.2007.10.017; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Engelborghs K, 2002, ACM T MATH SOFTWARE, V28, P1, DOI 10.1145/513001.513002; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Frazier Lyn, 1979, THESIS; Freeman WJ, 1975, MASS ACTION NERVOUS; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friederici AD, 2015, TRENDS COGN SCI, V19, P329, DOI 10.1016/j.tics.2015.03.012; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Garnier A, 2015, NEURAL COMPUT, V27, P329, DOI 10.1162/NECO_a_00696; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Goodfellow M, 2012, NEUROIMAGE, V59, P2644, DOI 10.1016/j.neuroimage.2011.08.060; Grimbert F, 2006, NEURAL COMPUT, V18, P3052, DOI 10.1162/neco.2006.18.12.3052; Haeusler S, 2007, CEREB CORTEX, V17, P149, DOI 10.1093/cercor/bhj132; Haeusler S, 2009, J PHYSIOL-PARIS, V103, P73, DOI 10.1016/j.jphysparis.2009.05.006; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Harris KD, 2015, NAT NEUROSCI, V18, P170, DOI 10.1038/nn.3917; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hesse J, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00166; Isa T, 2004, PROG BRAIN RES, V143, P299, DOI 10.1016/S0079-6123(03)43029-X; JANSEN BH, 1993, BIOL CYBERN, V68, P275, DOI 10.1007/BF00224863; JANSEN BH, 1995, BIOL CYBERN, V73, P357, DOI 10.1007/BF00199471; Johnson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050276; Kunze T, 2016, NEUROIMAGE; Liley DTJ, 2002, NETWORK-COMP NEURAL, V13, P67, DOI 10.1088/0954-898X/13/1/303; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; LOPESDAS.FH, 1974, KYBERNETIK, V15, P27, DOI 10.1007/BF00270757; Lubke J, 2007, BRAIN STRUCT FUNCT, V212, P3, DOI 10.1007/s00429-007-0144-2; Maass W, 2007, PLOS COMPUT BIOL, V3, P15, DOI 10.1371/journal.pcbi.0020165; Malagarriga D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004007; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Markert H, 2007, BIOSYSTEMS, V89, P300, DOI 10.1016/j.biosystems.2006.04.027; MARSLENWILSON W, 1980, COGNITION, V8, P1, DOI 10.1016/0010-0277(80)90015-3; Meffin H, 2004, J COMPUT NEUROSCI, V16, P159, DOI 10.1023/B:JCNS.0000014108.03012.81; Merlet I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057330; Miller KD, 2016, CURR OPIN NEUROBIOL, V37, P75, DOI 10.1016/j.conb.2016.01.008; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Peters JF, 2016, NEUROSCI LETT, V626, P99, DOI 10.1016/j.neulet.2016.03.052; Pinotsis DA, 2013, NEUROIMAGE, V66, P563, DOI 10.1016/j.neuroimage.2012.10.078; Potjans TC, 2014, CEREB CORTEX, V24, P785, DOI 10.1093/cercor/bhs358; Pulvermuller F, 2014, BIOL CYBERN, V108, P573, DOI 10.1007/s00422-014-0603-9; Pulvermuller F, 2002, PROG NEUROBIOL, V67, P85, DOI 10.1016/S0301-0082(02)00014-X; Robinson PA, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041924; Rolls ET, 2015, BRAIN RES, V1621, P316, DOI 10.1016/j.brainres.2014.09.021; Rowan MS, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00039; Royer S, 2000, J NEUROSCI, V20, P9034; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; Sammler D, 2010, BRAIN, V133, P2643, DOI 10.1093/brain/awq231; Schuaz A., 2002, CORTICAL AREAS UNITY, P377, DOI DOI 10.1201/9780203299296.CH16; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Sigurdsson T, 2016, NEUROSCIENCE, V321, P42, DOI 10.1016/j.neuroscience.2015.06.059; Silberberg G, 2002, TRENDS NEUROSCI, V25, P227, DOI 10.1016/S0166-2236(02)02151-3; Spiegler A, 2010, NEUROIMAGE, V52, P1041, DOI 10.1016/j.neuroimage.2009.12.081; Touboul J, 2011, NEURAL COMPUT, V23, P3232, DOI 10.1162/NECO_a_00206; Treves A, 2005, COGN NEUROPSYCHOL, V22, P276, DOI 10.1080/02643290442000329; Valenzuela CF, 1997, ALCOHOL HEALTH RES W, V21, P144; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vattikuti S, 2010, BIOL PSYCHIAT, V67, P672, DOI 10.1016/j.biopsych.2009.09.008; Vidyasagar TR, 1999, BRAIN RES REV, V30, P66, DOI 10.1016/S0165-0173(99)00005-3; Wendling F, 2002, EUR J NEUROSCI, V15, P1499, DOI 10.1046/j.1460-9568.2002.01985.x; Wennekers T, 2006, J PHYSIOL-PARIS, V100, P16, DOI 10.1016/j.jphysparis.2006.09.007; Yildiz IB, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003219; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Ziburkus J, 2013, J NEUROPHYSIOL, V109, P1296, DOI 10.1152/jn.00232.2012	80	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188003	10.1371/journal.pone.0188003	http://dx.doi.org/10.1371/journal.pone.0188003			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO7EC	29200435	Green Published, gold			2022-12-27	WOS:000417033200003
J	Hayashi, T; Yamaguchi, T; Yuda, K; Kato, N; Satake, Y; Shimazaki, J				Hayashi, Takahiko; Yamaguchi, Takefumi; Yuda, Kentaro; Kato, Naoko; Satake, Yoshiyuki; Shimazaki, Jun			Topographic characteristics after Descemet's membrane endothelial keratoplasty and Descemet's stripping automated endothelial keratoplasty	PLOS ONE			English	Article							HIGHER-ORDER ABERRATIONS; CORNEAL SURFACE IRREGULARITY; ANTERIOR-CHAMBER; EYES; TRANSPLANTATION; DMEK; DYSFUNCTION; KERATITIS; SURGERY; QUALITY	Purpose To investigate the topographic characteristics of the posterior corneal surface after Descemet's endothelial membrane keratoplasty (DMEK) and Descemet's stripping automated endothelial keratoplasty (DSAEK) and their effects on postoperative visual acuity. Methods Nineteen eyes of 19 patients after DMEK, 23 eyes of 23 patients after DSAEK, and 18 eyes of 18 control subjects were retrospectively analyzed. Best spectacle-corrected visual acuity (BSCVA), aberration factors (higher-order aberrations [HOAs], spherical aberrations [SAs], and coma aberrations [Comas] at 6.0 mm) were evaluated preoperatively and at 1, 3, and 6 months postoperatively. The posterior refractive pattern of the topography map was classified into 5 grades (0-5) (posterior color grade) using anterior segment optical coherence tomography. Correlations between BSCVA and some factors (abbreviation factors, posterior color grade) were analyzed. Results BSCVA was significantly better after DMEK than after DSAEK (P < 0.001). Posterior HOAs, SAs, and Comas after each type of endothelial keratoplasty were significantly greater compared to control (P < 0.01). Posterior HOAs, total/anterior/posterior SAs, and posterior color grade were significantly lower in the DMEK group than in the DSAEK group at 3 months (P < 0.024 [posterior HOAs], P = 0.047 [total SA], P < 0.001 [anterior SAs], P = 0.021 [posterior SAs], and P < 0.001 [posterior color grade]) and 6 months postoperatively (P = 0.034 [posterior HOAs], P < 0.001 [total SAs], P < 0.001 [anterior SAs], P = 0.013 [posterior SAs], and P = 0.004 [posterior color grade]). BSCVA was significantly correlated with HOAs, SAs, and posterior color grade (P < 0.001 for all except anterior HOAs [P = 0.004]). Conclusions High posterior color grades were associated with larger aberration factors and had a negative effect on visual function after endothelial keratoplasty. Rapid improvement of visual function after DMEK may be attributed to less change at the posterior surface.	[Hayashi, Takahiko; Yuda, Kentaro] Yokohama Minami Kyosai Hosp, Dept Ophthalmol, Yokohama, Kanagawa, Japan; [Hayashi, Takahiko; Yuda, Kentaro] Yokohama City Univ, Sch Med, Dept Ophthalmol, Yokohama, Kanagawa, Japan; [Hayashi, Takahiko] Jichi Med Univ, Dept Ophthalmol, Shimotsuke, Tochigi, Japan; [Hayashi, Takahiko; Kato, Naoko] Saitama Med Univ, Dept Ophthalmol, Saitama, Japan; [Yamaguchi, Takefumi; Satake, Yoshiyuki; Shimazaki, Jun] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Ophthalmol, Chiba, Japan	Yokohama City University; Jichi Medical University; Saitama Medical University; Tokyo Dental College	Hayashi, T (corresponding author), Yokohama Minami Kyosai Hosp, Dept Ophthalmol, Yokohama, Kanagawa, Japan.; Hayashi, T (corresponding author), Yokohama City Univ, Sch Med, Dept Ophthalmol, Yokohama, Kanagawa, Japan.; Hayashi, T (corresponding author), Jichi Med Univ, Dept Ophthalmol, Shimotsuke, Tochigi, Japan.; Hayashi, T (corresponding author), Saitama Med Univ, Dept Ophthalmol, Saitama, Japan.	takamed@gmail.com	Hayashi, Takahiko/ABB-7168-2020; YAMAGUCHI, Takefumi/AAY-6964-2020; Yamaguchi, Takefumi/AEV-4169-2022; Jun, Shimazaki/K-5976-2019	Hayashi, Takahiko/0000-0001-8704-680X; Yamaguchi, Takefumi/0000-0002-2546-2813				Arnalich-Montiel F, 2013, GRAEF ARCH CLIN EXP, V251, P2575, DOI 10.1007/s00417-013-2460-y; Chen MH, 2008, INVEST OPHTH VIS SCI, V49, P5645, DOI 10.1167/iovs.08-1874; Fukuda S, 2011, J CATARACT REFR SURG, V37, P461, DOI 10.1016/j.jcrs.2010.08.053; Gerber-Hollbach N, 2016, BRIT J OPHTHALMOL, V100, P1564, DOI 10.1136/bjophthalmol-2015-307783; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Hayashi T, 2017, CORNEA, V36, P390, DOI 10.1097/ICO.0000000000001093; Inoue T, 2016, JPN J OPHTHALMOL, V60, P349, DOI 10.1007/s10384-016-0459-8; Inoue T, 2014, INVEST OPHTH VIS SCI, V55, P8006, DOI 10.1167/iovs.14-14762; Kashizuka E, 2016, CORNEA, V35, P1562, DOI 10.1097/ICO.0000000000000910; Lam FC, 2014, JAMA OPHTHALMOL, V132, P1469, DOI 10.1001/jamaophthalmol.2014.3328; Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34; Montes-Mico R, 2005, INVEST OPHTH VIS SCI, V46, P1615, DOI 10.1167/iovs.05-0017; Okamoto F, 2008, OPHTHALMOLOGY, V115, P1216, DOI 10.1016/j.ophtha.2007.09.016; Okumura N, 2016, SCI REP-UK, V6, DOI 10.1038/srep26113; Oshika T, 1998, EXP EYE RES, V67, P443, DOI 10.1006/exer.1998.0558; Oshika T, 2006, OPHTHALMOLOGY, V113, P1807, DOI 10.1016/j.ophtha.2006.03.061; Price MO, 2007, CURR OPIN OPHTHALMOL, V18, P290, DOI 10.1097/ICU.0b013e3281a4775b; Roberts Bingjing, 2006, Eye Contact Lens, V32, P138, DOI 10.1097/01.icl.0000195570.73454.a5; Rudolph M, 2012, OPHTHALMOLOGY, V119, P528, DOI 10.1016/j.ophtha.2011.08.034; Shimazaki J, 2007, CORNEA, V26, P274, DOI 10.1097/ICO.0b013e31802c9e19; Shimizu E, 2017, AM J OPHTHALMOL, V175, P148, DOI 10.1016/j.ajo.2016.12.014; van Dijk K, 2014, AM J OPHTHALMOL, V158, P71, DOI 10.1016/j.ajo.2014.04.008; van Dijk K, 2013, CONTACT LENS ANTERIO, V36, P13, DOI 10.1016/j.clae.2012.10.066; Wang L, 2007, J CATARACT REFR SURG, V33, P1713, DOI 10.1016/j.jcrs.2007.07.010; Yagi-Yaguchi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161075; Yamaguchi T, 2015, CORNEA, V34, pS128, DOI 10.1097/ICO.0000000000000589; Yamaguchi T, 2011, INVEST OPHTH VIS SCI, V52, P6222, DOI 10.1167/iovs.11-7647; Yamaguchi T, 2010, CORNEA, V29, P1086, DOI 10.1097/ICO.0b013e3181d0092c; Yamaguchi T, 2009, J CATARACT REFR SURG, V35, P1725, DOI 10.1016/j.jcrs.2009.05.031; Yamaguchi TD, 2009, J CATARACT REFR SURG, V35, P688, DOI 10.1016/j.jcrs.2008.11.062	30	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188832	10.1371/journal.pone.0188832	http://dx.doi.org/10.1371/journal.pone.0188832			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190797	Green Submitted, Green Published, gold			2022-12-27	WOS:000416841900136
J	Horvei, KD; Pedersen, HL; Fismen, S; Thiyagarajan, D; Schneider, A; Rekvig, OP; Winkler, TH; Seredkina, N				Horvei, Kjersti Daae; Pedersen, Hege Lynum; Fismen, Silje; Thiyagarajan, Dhivya; Schneider, Andrea; Rekvig, Ole Petter; Winkler, Thomas H.; Seredkina, Natalya			Lupus nephritis progression in Fc gamma RIIB-/- yaa mice is associated with early development of glomerular electron dense deposits and loss of renal DNase I in severe disease	PLOS ONE			English	Article							ERYTHEMATOSUS; AUTOIMMUNITY; FCGR2B; GENE; EXPRESSION; DEFICIENT; SUSCEPTIBILITY; POLYMORPHISMS; ANTIBODIES; RECEPTORS	Fc gamma RIIB-/- yaa mice develop severe lupus glomerulonephritis due to lack of an inhibitory immune cell receptor combined with a Y-chromosome linked autoimmune accelerator mutation. In the present study, we have investigated nephritis development and progression in Fc gamma RIIB-/- yaa mice to find shared features with NZB/NZW F1 lupus prone mice and human disease. We sacrificed 25 male Fc gamma RIIB-/- yaa mice at various disease stages, and grouped them according to activity and chronicity indices for lupus nephritis. Glomerular morphology and localization of electron dense deposits containing IgG were further determined by immune electron microscopy. Renal DNase I and pro-inflammatory cytokine mRNA levels were measured by real-time quantitative PCR. DNase I protein levels was assessed by immunohistochemistry and zymography. Our results demonstrate early development of electron dense deposits containing IgG in Fc gamma RIIB-/- yaa mice, before detectable levels of serum anti-dsDNA antibodies. Similar to NZB/NZW F1, electron dense deposits in Fc gamma RIIB-/- yaa progressed from being confined to the mesangium in the early stage of lupus nephritis to be present also in capillary glomerular basement membranes. In the advanced stage of lupus nephritis, renal DNase I was lost on both transcriptional and protein levels, which has previously been shown in NZB/NZW F1 mice and in human disease. Although lupus nephritis appears on different genetic backgrounds, our findings suggest similar processes when comparing different murine models and human lupus nephritis.	[Horvei, Kjersti Daae; Pedersen, Hege Lynum; Fismen, Silje; Thiyagarajan, Dhivya; Rekvig, Ole Petter; Seredkina, Natalya] UIT Arctic Univ Norway, Dept Med Biol, RNA & Mol Pathol Res Grp, Fac Hlth Sci, Tromso, Norway; [Schneider, Andrea; Winkler, Thomas H.] Friedrich Alexander Univ Erlangen Nurnberg, Dept Biol, Nikolaus Fiebiger Zentrum Mol Med, Erlangen, Germany; [Seredkina, Natalya] UIT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Stem Cell Aging & Canc Res Grp, Tromso, Norway	UiT The Arctic University of Tromso; University of Erlangen Nuremberg; UiT The Arctic University of Tromso	Seredkina, N (corresponding author), UIT Arctic Univ Norway, Dept Med Biol, RNA & Mol Pathol Res Grp, Fac Hlth Sci, Tromso, Norway.; Seredkina, N (corresponding author), UIT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Stem Cell Aging & Canc Res Grp, Tromso, Norway.	natalya.seredkina@uit.no	Rekvig, Ole Petter/V-7113-2019	Horvei, Kjersti Daae/0000-0001-8291-3548; Pedersen, Hege Lynum/0000-0002-3768-9513	Northern Norway Regional Health Authority Medical Research Program [SFP1133-13]; Norwegian Extra Foundation for Health and Rehabilitation; University of Tromso	Northern Norway Regional Health Authority Medical Research Program; Norwegian Extra Foundation for Health and Rehabilitation; University of Tromso	This work has been made possible by the Northern Norway Regional Health Authority Medical Research Program (grant # SFP1133-13), the Norwegian Extra Foundation for Health and Rehabilitation, and the University of Tromso as a Milieu support given to OPR.	Anders HJ, 2007, CURR OPIN NEPHROL HY, V16, P177, DOI 10.1097/MNH.0b013e32803fb767; APPEL GB, 1987, AM J MED, V83, P877, DOI 10.1016/0002-9343(87)90645-0; AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; Basnakian AG, 2005, J AM SOC NEPHROL, V16, P697, DOI 10.1681/ASN.2004060494; Bastian HM, 2002, LUPUS, V11, P152, DOI 10.1191/0961203302lu158oa; Bethunaickan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077489; Bolland S, 2002, J EXP MED, V195, P1167, DOI 10.1084/jem.20020165; Bruin M, 2004, BRIT J HAEMATOL, V127, P561, DOI 10.1111/j.1365-2141.2004.05235.x; Buzder T, 2009, DNA CELL BIOL, V28, P435, DOI 10.1089/dna.2008.0850; Castellano G, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0588-3; Celhar T, 2012, IMMUNOL RES, V53, P58, DOI 10.1007/s12026-012-8270-1; Davis JC, 1999, LUPUS, V8, P68, DOI 10.1191/096120399678847380; Salgado AD, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/849684; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Dema B, 2014, J EXP MED, V211, P2159, DOI 10.1084/jem.20140066; Ding CL, 2009, J IMMUNOL, V183, P7140, DOI 10.4049/jimmunol.0901175; Fairhurst AM, 2008, EUR J IMMUNOL, V38, P1971, DOI 10.1002/eji.200838138; Feldman CH, 2013, ARTHRITIS RHEUM-US, V65, P753, DOI 10.1002/art.37795; Fenton K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008474; Fukuyama H, 2005, NAT IMMUNOL, V6, P99, DOI 10.1038/ni1151; Georg P, 2012, AUTOIMMUNITY, V45, P579, DOI 10.3109/08916934.2012.719955; Kalaaji M, 2006, AM J PATHOL, V168, P1779, DOI 10.2353/ajpath.2006.051329; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Kawano S, 2013, EUR J IMMUNOL, V43, P770, DOI 10.1002/eji.201243057; Kyogoku C, 2002, ARTHRITIS RHEUM, V46, P1242, DOI 10.1002/art.10257; Lee J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004937; Lee SG, 2012, RHEUMATOL INT, V32, P2459, DOI 10.1007/s00296-011-1986-8; Lin QS, 2010, J AUTOIMMUN, V34, P356, DOI 10.1016/j.jaut.2009.08.011; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Ludwig S, 2009, INT J BIOCHEM CELL B, V41, P1079, DOI 10.1016/j.biocel.2008.09.030; Macanovic M, 1996, CLIN EXP IMMUNOL, V106, P243, DOI 10.1046/j.1365-2249.1996.d01-839.x; Napirei M, 2004, BIOCHEM J, V380, P929, DOI 10.1042/BJ20040046; Niewold TB, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/948364; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Perry D, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/271694; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; RAVETCH JV, 1986, SCIENCE, V234, P718, DOI 10.1126/science.2946078; Richez C, 2010, J IMMUNOL, V184, P796, DOI 10.4049/jimmunol.0901748; RUBINKELLEY VE, 1991, J AM SOC NEPHROL, V2, P13; Siriboonrit U, 2003, TISSUE ANTIGENS, V61, P374, DOI 10.1034/j.1399-0039.2003.00047.x; Smith KGC, 2010, NAT REV IMMUNOL, V10, P674, DOI 10.1038/nri2762; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Tam LS, 2003, LUPUS, V12, P665, DOI 10.1191/0961203303lu446oa; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; Verthelyi D, 1998, LUPUS, V7, P223, DOI 10.1191/096120398678920037; Wahl P, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017901.77985F; Ward MM, 2009, J RHEUMATOL, V36, P63, DOI 10.3899/jrheum.080625; Willcocks LC, 2010, P NATL ACAD SCI USA, V107, P7881, DOI 10.1073/pnas.0915133107; Yung S, 2017, CLIN SCI, V131, P49, DOI 10.1042/CS20160421; Zhou XJ, 2010, NEPHROL DIAL TRANSPL, V25, P97, DOI 10.1093/ndt/gfp374; Zykova SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012096	52	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188863	10.1371/journal.pone.0188863	http://dx.doi.org/10.1371/journal.pone.0188863			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190833	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900148
J	Alampalli, SV; Thomson, MM; Sampathkumar, R; Sivaraman, K; Jesuraj, UKJA; Dhar, C; Souza, GD; Berry, N; Vyakarnam, A				Alampalli, Shuba Varshini; Thomson, Michael M.; Sampathkumar, Raghavan; Sivaraman, Karthi; Jesuraj, Anto U. K. J.; Dhar, Chirag; Souza, George D.; Berry, Neil; Vyakarnam, Annapurna			Deep sequencing of near full-length HIV-1 genomes from plasma identifies circulating subtype C and infrequent occurrence of AC recombinant form in Southern India	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PHYLOGENETIC ANALYSIS; MOLECULAR CHARACTERIZATION; MONOPHYLETIC LINEAGE; DRUG-USERS; CLONES; STRAINS; INFECTIONS; MUTATIONS; ALIGNMENT	India has the third largest number of HIV-1-infected individuals accounting for approximately 2.1 million people, with a predominance of circulating subtype C strains and a low prevalence of subtype A and A1C and BC recombinant forms, identified over the past two decades. Recovery of near full-length HIV-1 genomes from a plasma source coupled with advances in next generation sequencing (NGS) technologies and development of universal methods for amplifying whole genomes of HIV-1 circulating in a target geography or population provides the opportunity for a detailed analysis of HIV-1 strain identification, evolution and dynamics. Here we describe the development and implementation of approaches for HIV-1 NGS analysis in a southern Indian cohort. Plasma samples (n = 20) were obtained from HIV-1-confirmed individuals living in and around the city of Bengaluru. Near full-length genome recovery was obtained for 9 Indian HIV-1 patients, with recovery of full-length gag and env genes for 10 and 2 additional subjects, respectively. Phylogenetic analyses indicate the majority of sequences to be represented by subtype C viruses branching within a monophyletic clade, comprising viruses from India, Nepal, Myanmar and China and closely related to a southern African cluster, with a low prevalence of the A1C recombinant form also present. Development of algorithms for bespoke recovery and analysis at a local level will further aid clinical management of HIV-1 infected Indian subjects and delineate the progress of the HIV-1 pandemic in this and other geographical regions.	[Alampalli, Shuba Varshini; Sampathkumar, Raghavan; Sivaraman, Karthi; Vyakarnam, Annapurna] Indian Inst Sci, CIDR, Bengaluru, India; [Thomson, Michael M.] Inst Salud Carlos III, Ctr Nacl Microbiol, Ctra Majadahonda Pozuelo, Madrid, Spain; [Jesuraj, Anto U. K. J.; Dhar, Chirag; Souza, George D.] St Johns Res Inst, Dept Infect Dis, Bengaluru, India; [Souza, George D.] St Johns Res Inst, Dept Pulm Med, Bengaluru, India; [Berry, Neil] NIBSC, Div Virol, S Mimms, Herts, England; [Vyakarnam, Annapurna] Kings Coll London, Dept Infect Dis, London, England	Indian Institute of Science (IISC) - Bangalore; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); St. John's National Academy of Health Sciences; St. John's Research Institute; St. John's National Academy of Health Sciences; St. John's Research Institute; National Institute for Biological Standards & Control; University of London; King's College London	Vyakarnam, A (corresponding author), Indian Inst Sci, CIDR, Bengaluru, India.; Vyakarnam, A (corresponding author), Kings Coll London, Dept Infect Dis, London, England.	anna.vyakarnam@kcl.ac.uk	Thomson, Michael M/P-8949-2017; Dhar, Chirag/AAL-6327-2021	Thomson, Michael M/0000-0002-0622-7527; Dhar, Chirag/0000-0002-7351-485X; Vyakarnam, Annapurna/0000-0003-4260-258X; Sampathkumar, Raghavan/0000-0003-3500-9083	EC FP7 EURIPRED (FP7-INFRA) [312661]; Department of Biotechnology (DBT), India [BT/01/CEIB/12/ 111/09]	EC FP7 EURIPRED (FP7-INFRA); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India)	This work was funded partly by a EC FP7 EURIPRED (FP7-INFRA-2012 Grant Agreement No. 312661) to AV, MMT, GDS and a Centre for Excellence award from the Department of Biotechnology (DBT), India to AV (BT/01/CEIB/12/ 111/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded partly by a EC FP7 EURIPRED (FP7-INFRA-2012 Grant Agreement No. 312661) to AV, MMT, GDS and a Centre for Excellence award from the Department of Biotechnology (DBT), India to AV (BT/01/CEIB/12/III/09). We thank Mark Preston, NIBSC for discussions relating to some aspects of the study.	Andrews S., 2017, FASTQC QUALITY CONTR; Aralaguppe SG, 2016, J VIROL METHODS, V236, P98, DOI 10.1016/j.jviromet.2016.07.010; Azam M, 2013, VIRUS GENES, V47, P422, DOI 10.1007/s11262-013-0961-8; Berg Michael G, 2016, J Clin Microbiol, V54, P868, DOI 10.1128/JCM.02479-15; Bhusal N, 2016, CURR HIV RES, V14, P517, DOI 10.2174/1570162X14666161003141950; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bontell I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079193; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gall A, 2012, J CLIN MICROBIOL, V50, P3838, DOI 10.1128/JCM.01516-12; GREZ M, 1994, J VIROL, V68, P2161, DOI 10.1128/JVI.68.4.2161-2168.1994; Grossmann S, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20035; Halani N, 2001, AIDS RES HUM RETROV, V17, P637, DOI 10.1089/088922201300119743; Hanna LE, 2014, AIDS RES HUM RETROV, V30, P586, DOI [10.1089/aid.2013.0275, 10.1089/AID.2013.0275]; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hunt M, 2015, BIOINFORMATICS, V31, P2374, DOI 10.1093/bioinformatics/btv120; Kulkarni SS, 2009, VIROLOGY, V385, P505, DOI 10.1016/j.virol.2008.12.032; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lakhashe S, 2008, AIDS RES HUM RETROV, V24, P229, DOI 10.1089/aid.2007.0229; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mandal D, 2002, AIDS RES HUM RETROV, V18, P1219, DOI 10.1089/08892220260387968; Narasimhan V, 2016, BIOINFORMATICS, V32, P1749, DOI 10.1093/bioinformatics/btw044; Neogi U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039819; Novitsky VA, 1999, J VIROL, V73, P4427, DOI 10.1128/JVI.73.5.4427-4432.1999; Ode H, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01258; Oelrichs RB, 2000, J VIROL, V74, P1149, DOI 10.1128/JVI.74.3.1149-1157.2000; Pandey S, 2013, AIDS RES HUM RETROV, V29, P1245, DOI [10.1089/aid.2013.0150, 10.1089/AID.2013.0150]; Pandey SS, 2016, AIDS RES HUM RETROV, V32, P489, DOI [10.1089/AID.2015.0207, 10.1089/aid.2015.0207]; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; Ruby JG, 2013, G3-GENES GENOM GENET, V3, P865, DOI 10.1534/g3.113.005967; Sengupta S, 2005, ARCH VIROL, V150, P2117, DOI 10.1007/s00705-005-0562-5; Shankarappa R, 2001, J VIROL, V75, P10479, DOI 10.1128/JVI.75.21.10479-10487.2001; Shen CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025956; Siddappa NB, 2005, AIDS, V19, P1426, DOI 10.1097/01.aids.0000180795.49016.89; Siddappa NB, 2004, J CLIN MICROBIOL, V42, P2742, DOI 10.1128/JCM.42.6.2742-2751.2004; SIEPEL AC, 1995, AIDS RES HUM RETROV, V11, P1413, DOI 10.1089/aid.1995.11.1413; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Thomson MM, 2011, VIROLOGY, V415, P30, DOI 10.1016/j.virol.2011.03.021; Tripathy SP, 2005, AIDS RES HUM RETROV, V21, P152, DOI 10.1089/aid.2005.21.152; Wilkinson E, 2015, AIDS RES HUM RETROV, V31, P412, DOI [10.1089/aid.2014.0230, 10.1089/AID.2014.0230]; Yu XF, 1998, LANCET, V351, P1250, DOI 10.1016/S0140-6736(05)79316-8; Zanini F, 2015, ELIFE, V4, DOI 10.7554/eLife.11282	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188603	10.1371/journal.pone.0188603	http://dx.doi.org/10.1371/journal.pone.0188603			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220350	gold, Green Published, Green Submitted			2022-12-27	WOS:000417469900013
J	Ishii, T; Kimura, Y; Ichise, M; Takahata, K; Kitamura, S; Moriguchi, S; Kubota, M; Zhang, MR; Yamada, M; Higuchi, M; Okubo, Y; Suhara, T				Ishii, Tatsuya; Kimura, Yasuyuki; Ichise, Masanori; Takahata, Keisuke; Kitamura, Soichiro; Moriguchi, Sho; Kubota, Manabu; Zhang, Ming-Rong; Yamada, Makiko; Higuchi, Makoto; Okubo, Yoshinori; Suhara, Tetsuya			Anatomical relationships between serotonin 5-HT2A and dopamine D-2 receptors in living human brain	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; SUPPLEMENTARY MOTOR AREA; FRONTAL-CORTEX; DOUBLE-BLIND; RAT-BRAIN; IN-VIVO; BINDING; MEMORY; PET; MODULATION	Serotonin 2A (5-HT2A) receptors and dopamine D-2 receptors are intimately related to the physiology and pathophysiology of neuropsychiatric disorders. A large number of studies have reported the effectiveness of psychotropic agents targeting 5-HT2A and D-2 receptors in these disorders. In addition to the individual functions of these receptors, the interaction between the two neurotransmitter systems has been studied in the living brain. However, little is known about their regional relationship in individual human brains. We investigated regional relationships between 5-HT2A and D-2 receptors using positron emission tomography (PET) and a bicluster analysis of the correlation matrix of individual variation in the two receptor densities to identify groups of distinctive regional correlations between the two receptors. Methods Seven healthy volunteers underwent PET scans with [F-18] altanserin and [C-11] FLB 457 for 5-HT2A and D-2 receptors, respectively. As a measure of receptor density, a binding potential (BP) was calculated from PET data for 76 cerebral cortical regions. A correlation matrix was calculated between the binding potentials of [F-18] altanserin and [C-11] FLB 457 for those regions. The regional relationships were investigated using a bicluster analysis of the correlation matrix with an iterative signature algorithm. Results We identified two clusters of regions. The first cluster identified a distinct profile of correlation coefficients between 5-HT2A and D-2 receptors, with the former in regions related to sensorimotor integration (supplementary motor area, superior parietal gyrus, and paracentral lobule) and the latter in most cortical regions. The second cluster identified another distinct profile of correlation coefficients between 5-HT2A receptors in the bilateral hippocampi and D-2 receptors in most cortical regions. Conclusions The observation of two distinct clusters in the correlation matrix suggests regional interactions between 5-HT2A and D-2 receptors in sensorimotor integration and hippocampal function. A bicluster analysis of the correlation matrix of these neuroreceptors may be beneficial in understanding molecular networks in the human brain.	[Ishii, Tatsuya; Kimura, Yasuyuki; Ichise, Masanori; Takahata, Keisuke; Kitamura, Soichiro; Moriguchi, Sho; Kubota, Manabu; Zhang, Ming-Rong; Yamada, Makiko; Higuchi, Makoto; Suhara, Tetsuya] Natl Inst Quantum & Radiol Sci & Technol, Natl Inst Radiol Sci, Dept Funct Brain Imaging Res, Chiba, Japan; [Ishii, Tatsuya; Okubo, Yoshinori] Nippon Med Sch, Dept Neuropsychiat, Tokyo, Japan; [Kimura, Yasuyuki] Natl Ctr Geriatr & Gerontol, Dept Clin & Expt Neuroimaging, Ctr Dev Adv Med Dementia, Obu, Japan	National Institutes for Quantum Science & Technology; Nippon Medical School; National Center for Geriatrics & Gerontology	Kimura, Y (corresponding author), Natl Inst Quantum & Radiol Sci & Technol, Natl Inst Radiol Sci, Dept Funct Brain Imaging Res, Chiba, Japan.; Kimura, Y (corresponding author), Natl Ctr Geriatr & Gerontol, Dept Clin & Expt Neuroimaging, Ctr Dev Adv Med Dementia, Obu, Japan.	kimura.yasuyuki@qst.go.jp	Kimura, Yasuyuki/ABC-5158-2020	Kimura, Yasuyuki/0000-0002-7927-9483; Takahata, Keisuke/0000-0002-0884-4924				Adams KH, 2004, NEUROIMAGE, V21, P1105, DOI 10.1016/j.neuroimage.2003.10.046; Asselin MC, 2007, J CEREBR BLOOD F MET, V27, P378, DOI 10.1038/sj.jcbfm.9600340; Bauer EP, 2015, BEHAV BRAIN RES, V277, P68, DOI 10.1016/j.bbr.2014.07.028; Berman RM, 2009, CNS SPECTRUMS, V14, P197, DOI 10.1017/S1092852900020216; Blasi G, 2015, NEUROPSYCHOPHARMACOL, V40, P1600, DOI 10.1038/npp.2015.5; Bloch MH, 2006, MOL PSYCHIATR, V11, P622, DOI 10.1038/sj.mp.4001823; Boureau YL, 2011, NEUROPSYCHOPHARMACOL, V36, P74, DOI 10.1038/npp.2010.151; BURNET PWJ, 1995, BRAIN RES, V676, P157, DOI 10.1016/0006-8993(95)00104-X; Christensen R, 2008, EXP NEUROL, V210, P164, DOI 10.1016/j.expneurol.2007.10.009; Egerton A, 2008, PSYCHOPHARMACOLOGY, V200, P487, DOI 10.1007/s00213-008-1226-4; Gobert A, 1999, NEUROPHARMACOLOGY, V38, P315, DOI 10.1016/S0028-3908(98)00188-9; GOLDBERG G, 1985, BEHAV BRAIN SCI, V8, P567, DOI 10.1017/S0140525X00045167; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; Hasselbalch SG, 2008, NEUROBIOL AGING, V29, P1830, DOI 10.1016/j.neurobiolaging.2007.04.011; Ichise M, 2002, J CEREBR BLOOD F MET, V22, P1271, DOI 10.1097/01.WCB.0000038000.34930.4E; Ichise M, 2003, J CEREBR BLOOD F MET, V23, P1096, DOI 10.1097/01.WCB.0000085441.37552.CA; Ihmels J, 2004, BIOINFORMATICS, V20, P1993, DOI 10.1093/bioinformatics/bth166; Inoue M, 2001, LIFE SCI, V69, P1079, DOI 10.1016/S0024-3205(01)01205-X; Iskar M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.20; Ito H, 2008, NEUROIMAGE, V39, P555, DOI 10.1016/j.neuroimage.2007.09.011; Khan ZU, 2001, P NATL ACAD SCI USA, V98, P1964, DOI 10.1073/pnas.98.4.1964; Kimura Y, 2017, PSYCHOPHARMACOLOGY, V234, P323, DOI 10.1007/s00213-016-4464-x; Kroll T, 2013, MOL IMAGING BIOL, V15, P456, DOI 10.1007/s11307-013-0621-3; Li Z, 2005, PSYCHOPHARMACOLOGY, V183, P144, DOI 10.1007/s00213-005-0170-9; MANSBACH RS, 1988, PSYCHOPHARMACOLOGY, V94, P507, DOI 10.1007/BF00212846; Marcus RN, 2008, J CLIN PSYCHOPHARM, V28, P156, DOI 10.1097/JCP.0b013e31816774f9; Meneses A, 2007, BEHAV BRAIN RES, V184, P81, DOI 10.1016/j.bbr.2007.06.026; MORILAK DA, 1994, NEUROPSYCHOPHARMACOL, V11, P157, DOI 10.1038/sj.npp.1380102; Moses-Kolko EL, 2011, NEUROPSYCHOPHARMACOL, V36, P2729, DOI 10.1038/npp.2011.163; Muguruza C, 2013, EUR NEUROPSYCHOPHARM, V23, P852, DOI 10.1016/j.euroneuro.2012.10.006; Orang AV, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/970607; Padich RA, 1996, PSYCHOPHARMACOLOGY, V124, P107, DOI 10.1007/BF02245610; Perani D, 2008, NEUROIMAGE, V42, P306, DOI 10.1016/j.neuroimage.2008.04.233; Pinborg LH, 2003, J CEREBR BLOOD F MET, V23, P985, DOI 10.1097/01.WCB.0000074092.59115.23; Santana N, 2004, CEREB CORTEX, V14, P1100, DOI 10.1093/cercor/bhh070; Savli M, 2012, NEUROIMAGE, V63, P447, DOI 10.1016/j.neuroimage.2012.07.001; TANJI J, 1994, NEUROSCI RES, V19, P251, DOI 10.1016/0168-0102(94)90038-8; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vollenweider FX, 1999, NEUROPSYCHOPHARMACOL, V20, P424, DOI 10.1016/S0893-133X(98)00108-0; Vollenweider FX, 1998, NEUROREPORT, V9, P3897, DOI 10.1097/00001756-199812010-00024; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Zhang GL, 2017, HIPPOCAMPUS, V27, P558, DOI 10.1002/hipo.22712; Zhang GL, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00225	43	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189318	10.1371/journal.pone.0189318	http://dx.doi.org/10.1371/journal.pone.0189318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220382	Green Submitted, gold, Green Published			2022-12-27	WOS:000417469900048
J	Liu, H; Liu, N; Cheng, YD; Jin, WL; Zhang, PX; Wang, X; Yang, HW; Xu, XS; Wang, Z; Tu, YY				Liu, Hui; Liu, Nan; Cheng, Yingduan; Jin, Weilin; Zhang, Pengxing; Wang, Xin; Yang, Hongwei; Xu, Xiaoshan; Wang, Zhen; Tu, Yanyang			Hexokinase 2 (HK2), the tumor promoter in glioma, is downregulated by miR-218/Bmi1 pathway	PLOS ONE			English	Article							BREAST-CANCER; RNA INTERFERENCE; II INHIBITOR; GLIOBLASTOMA; WARBURG; GLYCOLYSIS; METABOLISM; INVASION; MITOCHONDRIA; EXPRESSION	In cancer, glycolysis driving enzymes and their regulating microRNAs are one of the key focus of oncology research lately. The glycolytic enzyme hexokinase 2 (HK2) is crucial for the Warburg effect in human glioma, the most common malignant brain tumor. In the present study, we studied the tumorigenic role of HK2 in glioma, and clarified the mechanism of miR-218 induced HK2 regulation in glioma development. The HK2 expression in patient derived glioma and non neoplastic brain tissue was quantified. The HK2 silenced U87 and U251 cell lines were assessed for their proliferation, migration and invasive potential in vitro, while the tumor forming potential of U87 cells was evaluated in vivo. The untreated cell lines served as control. The HK2 expression in (a) lentivirus-infected, miR-218 overexpressing and (b) shRNA mediated Bmi1 silenced U87 and U251 glioma cell lines were quantified. Luciferase reporter assay, qRT-PCR analysis and WB were employed as required. The HK2 expression was significantly increased in glioma tissues comparing with the non neoplastic brain tissues and was positively correlated with the glioma grade. Silencing HK2 in glioma cell lines significantly decreased their proliferation, migration, invasion and tumorigenic abilities. Although, overexpression of miR-218 significantly downregulated the HK2 expression, luciferase reporter assay failed to show HK2 as the direct target of miR-218. A direct correlation, however, was observed between HK2 and Bmi-1, the direct target of miR-218. Taken together, our findings confirmed the tumorigenic activity of HK2 in glioma, and the involvement of the miR218/Bmi1 pathway in the regulation of its expression.	[Liu, Hui; Liu, Nan; Cheng, Yingduan; Zhang, Pengxing; Xu, Xiaoshan; Wang, Zhen; Tu, Yanyang] Fourth Mil Med Univ, Tangdu Hosp, Dept Expt Surg, Xian, Shaanxi, Peoples R China; [Cheng, Yingduan] Cipher Ground, Dept Res, North Brunswick, NJ USA; [Jin, Weilin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai, Peoples R China; [Jin, Weilin] Shanghai Jiao Tong Univ, Inst Micronano Sci & Technol, Dept Bionanosci & Engn, Shanghai, Peoples R China; [Wang, Xin; Yang, Hongwei] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA USA	Air Force Military Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Tu, YY (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Expt Surg, Xian, Shaanxi, Peoples R China.	ayonst@163.com	Jin, Wei-Lin/A-8355-2013	Jin, Wei-Lin/0000-0001-8011-2405	National Natural Science Foundation of China [81272419, 81572983]; Social Development of Technology Research Projects in Shaanxi Province [2016SF191, 2015SF027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Development of Technology Research Projects in Shaanxi Province	This work was supported by the National Natural Science Foundation of China (81272419, 81572983 to Yanyang Tu) and the Social Development of Technology Research Projects in Shaanxi Province (2016SF191 to Hui Liu, 2015SF027 to Pengxing Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri S, 2016, NEURO-ONCOLOGY, V18, P160, DOI 10.1093/neuonc/nov125; Cheng GZ, 2008, CURR CANCER DRUG TAR, V8, P2; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Davis F G, 2001, Expert Rev Anticancer Ther, V1, P395, DOI 10.1586/14737140.1.3.395; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fack F, 2015, ACTA NEUROPATHOL, V129, P115, DOI 10.1007/s00401-014-1352-5; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Ge X, 2015, BIOCHEM BIOPH RES CO, V463, P1115, DOI 10.1016/j.bbrc.2015.06.068; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Jiang S, 2012, EMBO J, V31, P1985, DOI 10.1038/emboj.2012.45; Katabi MM, 1999, HUM GENE THER, V10, P155, DOI 10.1089/10430349950018959; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kim JE, 2011, J NUCL MED, V52, P1756, DOI 10.2967/jnumed.111.090266; Kim W, 2007, MOL CANCER THER, V6, P2554, DOI 10.1158/1535-7163.MCT-07-0115; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kwee SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046591; Liu G, 2016, ONCOL LETT, V11, P2903, DOI 10.3892/ol.2016.4316; Liu LF, 2016, 2016 13TH ANNUAL IEEE INTERNATIONAL CONFERENCE ON SENSING, COMMUNICATION, AND NETWORKING (SECON), P10; Liu N, 2015, CANCER TRANSL MED, P55, DOI DOI 10.4103/2395-3977.155924; Liu YW, 2012, ONCOL REP, V28, P1013, DOI 10.3892/or.2012.1902; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Otero-Albiol D, 2016, CANC TRANSL MED, V2, P175, DOI DOI 10.3892/OL.2016.4316; Palmieri D, 2009, MOL CANCER RES, V7, P1438, DOI 10.1158/1541-7786.MCR-09-0234; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pedersen PL, 2008, J BIOENERG BIOMEMBR, V40, P123, DOI 10.1007/s10863-008-9165-7; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Peng QP, 2008, CANCER BIOL THER, V7, P1128, DOI 10.4161/cbt.7.7.6199; Plas DR, 2002, TRENDS ENDOCRIN MET, V13, P74; Rempel A, 1996, CANCER RES, V56, P2468; Rho M, 2007, ANTICANCER RES, V27, P251; Roberts DJ, 2015, CELL DEATH DIFFER, V22, P248, DOI 10.1038/cdd.2014.173; Setty M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.37; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Song LB, 2010, BIOCHEM BIOPH RES CO, V402, P135, DOI 10.1016/j.bbrc.2010.10.003; Stahlhut Espinosa Carlos E, 2006, Yale J Biol Med, V79, P131; Stern R, 2002, EXP CELL RES, V276, P24, DOI 10.1006/excr.2002.5508; Tu YY, 2013, CANCER RES, V73, P6046, DOI 10.1158/0008-5472.CAN-13-0358; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weller M, 2013, NEURO-ONCOLOGY, V15, P4, DOI 10.1093/neuonc/nos273; Wicks RT, 2015, NEURO-ONCOLOGY, V17, P70, DOI 10.1093/neuonc/nou143; Wolf A, 2011, NEUROBIOL DIS, V44, P84, DOI 10.1016/j.nbd.2011.06.007; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Yang J, 2016, AM J CANCER RES, V6, P473; Yang LQ, 2012, BIOMED PHARMACOTHER, V66, P535, DOI 10.1016/j.biopha.2012.04.006; Yoshino H, 2013, CANCER SCI, V104, P1567, DOI 10.1111/cas.12280; Yu SJ, 2011, ACTA PHARMACOL SIN, V32, P912, DOI 10.1038/aps.2011.24; Zhang Y, 2012, FRONT BIOSCI-LANDMRK, V17, P700, DOI 10.2741/3952; Zhuo BB, 2015, BIOCHEM BIOPH RES CO, V464, P401, DOI 10.1016/j.bbrc.2015.06.092	52	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189353	10.1371/journal.pone.0189353	http://dx.doi.org/10.1371/journal.pone.0189353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220380	Green Published, gold, Green Submitted			2022-12-27	WOS:000417469900053
J	Pons, ED; Knauth, DR; Vigo, A; Mengue, SS				Pons, Emilia da Silva; Knauth, Daniela Riva; Vigo, Alvaro; Mengue, Sotero Serrate		PNAUM Res Grp	Predisposing factors to the practice of self-medication in Brazil: Results from the National Survey on Access, Use and Promotion of Rational Use of Medicines (PNAUM)	PLOS ONE			English	Article							HEALTH	Objective To understand the predisposing factors that lead to the practice of self-medication and the factors associated with the use of medicines via self-medication in the adult population of Brazil. Methods The analyzed data are part of the National Survey on Access, Use and Promotion of Rational Use of Medicines (PNAUM), a survey whose population consisted of individual residents permanently domiciled in urban areas in Brazil. In this work, the data references the 31 573 respondents aged 20 or higher (76.2% of the final PNAUM sample). Poisson regression models with robust variance were used for estimating the independent effect of each variable with medicine use via self-medication. Results Of the interviewees, 73.6% stated they had used some medication without medical recommendation if they had previously used the same product; 73.8% stated they had used non-prescribed medicine when the medicine was already present at home; and 35.5% stated they had used some non-prescribed medication when they knew someone who had already taken the same medication. The prevalence of self-medication was 18.3%. The variables associated with the highest probability of using medicine via self-medication were: geographic region within Brazil, gender, age group, per capita income, self-assessment of health, self-reported use of previously used non-prescribed medication, and self-reported use of non-prescribed medication when that medication was already present at home. Conclusions The use of medicines via self-medication in Brazil is relatively frequent and influenced by previous experience and familiarity with the medications, and is more common among women and individuals with low self-assessment of health.	[Pons, Emilia da Silva; Knauth, Daniela Riva; Vigo, Alvaro; Mengue, Sotero Serrate; PNAUM Res Grp] Univ Fed Rio Grande do Sul, Grad Program Epidemiol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Pons, ED (corresponding author), Univ Fed Rio Grande do Sul, Grad Program Epidemiol, Porto Alegre, RS, Brazil.	emiliapons@yahoo.com.br	Vigo, Alvaro/S-2243-2019	Vigo, Alvaro/0000-0002-5797-9470; GADELHA, CARLOS A. G./0000-0002-9148-8819; Mengue, Sotero/0000-0002-3349-8541	Ministerio da Saude, Secretaria de Ciencia e Tecnologia Insumos Estrategicos, Departamento de Assistencia Farmaceutica e Insumos Estrategicos e Departamento de Ciencia e Tecnologia [25000.111834/2]; CNPq Phd scholarship	Ministerio da Saude, Secretaria de Ciencia e Tecnologia Insumos Estrategicos, Departamento de Assistencia Farmaceutica e Insumos Estrategicos e Departamento de Ciencia e Tecnologia; CNPq Phd scholarship	This study was supported by Ministerio da Saude, Secretaria de Ciencia e Tecnologia Insumos Estrategicos, Departamento de Assistencia Farmaceutica e Insumos Estrategicos e Departamento de Ciencia e Tecnologia (Processo 25000.111834/2) to SSM PNAUM; and a CNPq Phd scholarship to ESP.	Arrais PSD, 1997, REV SAUDE PUBL, V31, P71, DOI 10.1590/S0034-89101997000100010; Bolanos H, 2005, DRUG INF J, V39, P99, DOI 10.1177/009286150503900113; BOLTANSKI Luc, 2004, CLASSES SOCIAIS CORP; Britten N., 1996, MODERN MED PERSPECTI; BUSH PJ, 1976, MED CARE, V14, P1014; BUSH PJ, 1978, J HEALTH SOC BEHAV, V19, P179, DOI 10.2307/2136533; Carrasco-Garrido P, 2008, PHARMACOEPIDEM DR S, V17, P193, DOI 10.1002/pds.1455; Carrera-Lasfuentes P, 2013, ATEN PRIM, V45, P528, DOI 10.1016/j.aprim.2013.05.006; Carvalho MF, 2005, CAD SAUDE PUBLICA S, V21, P100; de Loyola AI, 2002, REV SAUDE PUBL, V36, P55, DOI 10.1590/S0034-89102002000100009; Fainzang S, 2014, DRUG SAFETY, V37, P333, DOI 10.1007/s40264-014-0153-z; Figueiras A, 2000, EUR J EPIDEMIOL, V16, P19, DOI 10.1023/A:1007608702063; HAAK H, 1989, REV SAUDE PUBL, V23, P143, DOI 10.1590/S0034-89101989000200008; JOHNSON RE, 1983, MED CARE, V21, P225, DOI 10.1097/00005650-198302000-00009; Kaufert P, 2000, LIVING WORKING NEW M; Knopf H, 2013, BUNDESGESUNDHEITSBLA, V56, P868, DOI 10.1007/s00103-013-1667-8; LAM CLK, 1994, SOC SCI MED, V39, P1641, DOI 10.1016/0277-9536(94)90078-7; Laure P, 1998, THERAPIE, V53, P127; LEVIN LS, 1983, ANNU REV PUBL HEALTH, V4, P181, DOI 10.1146/annurev.pu.04.050183.001145; Lowy I, 2010, HIST CIENC SAUDE-MAN, V17, P53, DOI 10.1590/S0104-59702010000500004; Lopes N, 2003, THESIS; Lopes NM, 2009, RCCS ANN REV, P1; Martin E, 1996, GENDER SCI AUTHORITY; Mengue SS, 2016, REV SAUDE PUBL, V50, DOI [10.1590/s1518-8787.2016050006156, 10.1590/S1518-8787.2016050006156]; Montastruc JL, 1997, THERAPIE, V52, P105; Nielsen MW, 2003, EUR J CLIN PHARMACOL, V59, P677, DOI 10.1007/s00228-003-0678-z; SEGALL A, 1990, MED CARE, V28, P301, DOI 10.1097/00005650-199004000-00002; Vilarino JF, 1998, REV SAUDE PUBL, V32, P43, DOI 10.1590/S0034-89101998000100006; World Health Organization, 2000, REG GUID TEL PROD; World Health Organization, 1986, GUID ASS MED PROD US; World Health Organization, 1998, ROL PHARM SELF CAR S	31	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189098	10.1371/journal.pone.0189098	http://dx.doi.org/10.1371/journal.pone.0189098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP2SV	29220378	gold, Green Published, Green Submitted			2022-12-27	WOS:000417469900032
J	Qu, MN; Bunce, JA; Sicher, RC; Zhu, XC; Gao, B; Chen, GY				Qu, Mingnan; Bunce, James A.; Sicher, Richard C.; Zhu, Xiaocen; Gao, Bo; Chen, Genyun			An attempt to interpret a biochemical mechanism of C-4 photosynthetic thermotolerance under sudden heat shock on detached leaf in elevated CO2 grown maize	PLOS ONE			English	Article							HIGH-TEMPERATURE; ATMOSPHERIC CO2; PHOTOSYSTEM-II; CARBON-DIOXIDE; GAS-EXCHANGE; STRESS; WATER; METABOLITES; ACCLIMATION; ACTIVATION	Detached leaves at top canopy structures always experience higher solar irradiance and leaf temperature under natural conditions. The ability of tolerance to high temperature represents thermotolerance potential of whole-plants, but was less of concern. In this study, we used a heat-tolerant (B76) and a heat-susceptible (B106) maize inbred line to assess the possible mitigation of sudden heat shock (SHS) effects on photosynthesis (PN) and C-4 assimilation pathway by elevated [CO2]. Two maize lines were grown in field-based open top chambers (OTCs) at ambient and elevated (+ 180 ppm) [CO2]. Top-expanded leaves for 30 days after emergence were suddenly exposed to a 45 E C SHS for 2 hours in midday during measurements. Analysis on thermostability of cellular membrane showed there was 20% greater electrolyte leakage in response to the SHS in B106 compared to B76, in agreement with prior studies. Elevated [CO2] protected PN from SHS in B76 but not B106. The responses of PN to SHS among the two lines and grown CO2 treatments were closely correlated with measured decreases of NADP-ME enzyme activity and also to its reduced transcript abundance. The SHS treatments induced starch depletion, the accumulation of hexoses and also disrupted the TCA cycle as well as the C-4 assimilation pathway in the both lines. Elevated [CO2] reversed SHS effects on citrate and related TCA cycle metabolites in B106 but the effects of elevated [CO2] were small in B76. These findings suggested that heat stress tolerance is a complex trait, and it is difficult to identify biochemical, physiological or molecular markers that accurately and consistently predict heat stress tolerance.	[Qu, Mingnan; Zhu, Xiaocen; Chen, Genyun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, CAS Ctr Excellence Mol Plant Sci, Shanghai, Peoples R China; [Qu, Mingnan; Bunce, James A.; Sicher, Richard C.] USDA ARS, Crop Syst & Global Change Lab, Beltsville, MD USA; [Gao, Bo] Chinese Acad Med Sci, Inst Basic Med Sci, Centralab, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; United States Department of Agriculture (USDA); Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Qu, MN (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, CAS Ctr Excellence Mol Plant Sci, Shanghai, Peoples R China.; Qu, MN (corresponding author), USDA ARS, Crop Syst & Global Change Lab, Beltsville, MD USA.	qmn@sippe.ac.cn		Bunce, James/0000-0002-6825-7510	National Natural Science Foundation of China [31700201]; Sailing Project, Shanghai Municipal Science and Technology Commission, China [17YF1421800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sailing Project, Shanghai Municipal Science and Technology Commission, China	This work is supported by National Natural Science Foundation of China (31700201) and Sailing Project, Shanghai Municipal Science and Technology Commission, China (17YF1421800).	Ainsworth EA, 2002, GLOBAL CHANGE BIOL, V8, P695, DOI 10.1046/j.1365-2486.2002.00498.x; Atkin OK, 2009, ANN BOT-LONDON, V103, P581, DOI 10.1093/aob/mcn094; Bunce JA, 2014, CROP SCI, V54, P1744, DOI 10.2135/cropsci2013.12.0803; Chen J, 2012, J SOIL WATER CONSERV, V67, P354, DOI 10.2489/jswc.67.5.354; Chen JP, 2010, CROP SCI, V50, P2506, DOI 10.2135/cropsci2009.12.0716; Crafts-Brandner SJ, 2002, PLANT PHYSIOL, V129, P1773, DOI 10.1104/pp.002170; Crafts-Brandner SJ, 2000, PLANTA, V212, P67, DOI 10.1007/s004250000364; Fancy Sally-Ann, 2008, P317, DOI 10.1007/978-1-59745-463-6_15; Fangmeier A, 1991, VEREINIGUNG ANGEW BO, V66, P97; Feller U, 1998, PLANT PHYSIOL, V116, P539, DOI 10.1104/pp.116.2.539; Ghannoum O, 2009, ANN BOT-LONDON, V103, P635, DOI 10.1093/aob/mcn093; Hamilton EW, 2008, J INTEGR PLANT BIOL, V50, P1375, DOI 10.1111/j.1744-7909.2008.00747.x; Heckathorn SA, 1998, PLANT PHYSIOL, V116, P439, DOI 10.1104/pp.116.1.439; Heckathorn SA, 2002, FUNCT PLANT BIOL, V29, P933, DOI 10.1071/PP01191; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kim JY, 2000, PLANT PHYSIOL, V124, P71, DOI 10.1104/pp.124.1.71; LAVOLA A, 1994, OECOLOGIA, V99, P315, DOI 10.1007/BF00627744; Law RD, 1999, PLANT PHYSIOL, V120, P173, DOI 10.1104/pp.120.1.173; Maroco JP, 1999, PLANTA, V210, P115, DOI 10.1007/s004250050660; MAYER RR, 1990, PLANT PHYSIOL, V94, P796, DOI 10.1104/pp.94.2.796; MEARNS LO, 1984, J CLIM APPL METEOROL, V23, P1601, DOI 10.1175/1520-0450(1984)023<1601:EHTECI>2.0.CO;2; Morison JIL, 1999, PLANT CELL ENVIRON, V22, P659, DOI 10.1046/j.1365-3040.1999.00443.x; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qu MN, 2014, PHOTOSYNTHETICA, V52, P211, DOI 10.1007/s11099-014-0022-0; Reich PB, 2001, NEW PHYTOL, V150, P435, DOI 10.1046/j.1469-8137.2001.00114.x; Ripley B, 2010, ANN BOT-LONDON, V105, P493, DOI 10.1093/aob/mcp307; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; SAGE RF, 1994, PHOTOSYNTH RES, V39, P351, DOI 10.1007/BF00014591; Sage RF, 1999, C4 PLANT BIOL; Sharp RE, 2004, J EXP BOT, V55, P9; Sicher R, 2015, PHOTOSYNTHETICA, V53, P3, DOI 10.1007/s11099-015-0074-9; Sicher R, 2013, PLANTA, V238, P369, DOI 10.1007/s00425-013-1899-8; Sicher RC, 2008, PHYSIOL PLANTARUM, V134, P31, DOI 10.1111/j.1399-3054.2008.01127.x; Sicher RC, 2012, PHYSIOL PLANTARUM, V144, P238, DOI 10.1111/j.1399-3054.2011.01555.x; Song YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089725; Wang D, 2008, AM J BOT, V95, P165, DOI 10.3732/ajb.95.2.165	37	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0187437	10.1371/journal.pone.0187437	http://dx.doi.org/10.1371/journal.pone.0187437			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220364	Green Published, gold, Green Submitted			2022-12-27	WOS:000417469900005
J	Aadland, E; Andersen, LB; Skrede, T; Ekelund, U; Anderssen, SA; Resaland, GK				Aadland, Eivind; Andersen, Lars Bo; Skrede, Turid; Ekelund, Ulf; Anderssen, Sigmund Alfred; Resaland, Geir Kare			Reproducibility of objectively measured physical activity and sedentary time over two seasons in children; Comparing a day-by-day and a week-by-week approach	PLOS ONE			English	Article							INTRACLASS CORRELATION; INTRAINDIVIDUAL VARIATION; GENERALIZABILITY THEORY; STATISTICAL-METHODS; ACTIVITY MONITORS; RELIABILITY; ACCELEROMETRY; CHILDHOOD; STABILITY; VARIABLES	Introduction Knowledge of reproducibility of accelerometer-determined physical activity (PA) and sedentary time (SED) estimates are a prerequisite to conduct high-quality epidemiological studies. Yet, estimates of reproducibility might differ depending on the approach used to analyze the data. The aim of the present study was to determine the reproducibility of objectively measured PA and SED in children by directly comparing a day-by-day and a week-by-week approach to data collected over two weeks during two different seasons 3-4 months apart. Methods 676 11-year-old children from the Active Smarter Kids study conducted in Sogn og Fjordane county, Norway, performed 7 days of accelerometer monitoring (ActiGraph GT3X+) during January-February and April-May 2015. Reproducibility was calculated using a day-by-day and a week-by-week approach applying mixed effect modelling and the Spearman Brown prophecy formula, and reported using intra-class correlation (ICC), Bland Altman plots and 95% limits of agreement (LoA). Results Applying a week-by-week approach, no variables provided ICC estimates >= 0.70 for one week of measurement in any model (ICC = 0.29-0.66 not controlling for season; ICC = 0.49-0.67 when controlling for season). LoA for these models approximated a factor of 1.3-1.7 of the sample PA level standard deviations. Compared to the week-by-week approach, the day-by-day approach resulted in too optimistic reliability estimates (ICC = 0.62-0.77 not controlling for season; ICC = 0.64-0.77 when controlling for season). Conclusions Reliability is lower when analyzed over different seasons and when using a week-by-week approach, than when applying a day-by-day approach and the Spearman Brown prophecy formula to estimate reliability over a short monitoring period. We suggest a day-by-day approach and the Spearman Brown prophecy formula to determine reliability be used with caution.	[Aadland, Eivind; Andersen, Lars Bo; Skrede, Turid; Anderssen, Sigmund Alfred; Resaland, Geir Kare] Western Norway Univ Appl Sci, Fac Teacher Educ & Sports, Campus Sogndal, Bergen, Norway; [Ekelund, Ulf; Anderssen, Sigmund Alfred] Norwegian Sch Sport Sci, Dept Sports Med, Oslo, Norway; [Resaland, Geir Kare] Forde Cent Hosp, Ctr Hlth Res, Forde, Norway	Western Norway University of Applied Sciences; Norwegian School of Sport Sciences	Aadland, E (corresponding author), Western Norway Univ Appl Sci, Fac Teacher Educ & Sports, Campus Sogndal, Bergen, Norway.	eivind.aadland@hvl.no	Ekelund, Ulf/AAE-8471-2019	Ekelund, Ulf/0000-0003-2115-9267; Resaland, Geir K./0000-0001-7562-0552	Research Council of Norway; Gjensidige Foundation	Research Council of Norway(Research Council of Norway); Gjensidige Foundation	The study was funded by the Research Council of Norway and the Gjensidige Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadland Eivind, 2015, Prev Med Rep, V2, P635, DOI 10.1016/j.pmedr.2015.07.009; Aadland E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133296; Addy CL, 2014, PEDIATR EXERC SCI, V26, P103, DOI 10.1123/pes.2013-0021; Atkin AJ, 2016, MED SCI SPORT EXER, V48, P449, DOI 10.1249/MSS.0000000000000786; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Baranowski T, 2008, MED SCI SPORT EXER, V40, pS544, DOI 10.1249/MSS.0b013e31817c6651; Basterfield L, 2011, J PHYS ACT HEALTH, V8, P543, DOI 10.1123/jpah.8.4.543; Biddle SJH, 2010, PREV MED, V51, P345, DOI 10.1016/j.ypmed.2010.07.018; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cain KL, 2013, J PHYS ACT HEALTH, V10, P437, DOI 10.1123/jpah.10.3.437; Chinapaw MJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111205; Coleman KJ, 1998, RES Q EXERCISE SPORT, V69, P58, DOI 10.1080/02701367.1998.10607667; Esliger DW, 2005, J PHYS ACTIVITY HLTH, V3, P366, DOI DOI 10.1186/1479-5868-8-62; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Gracia-Marco L, 2013, J SPORT SCI, V31, P1831, DOI 10.1080/02640414.2013.803595; Hart TL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-62; Hinkley T, 2012, MED SCI SPORT EXER, V44, P2436, DOI 10.1249/MSS.0b013e3182661478; Hislop J, 2014, PHYSIOL MEAS, V35, P2213, DOI 10.1088/0967-3334/35/11/2213; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hutcheon JA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2289; JANZ KF, 1995, MED SCI SPORT EXER, V27, P1326; Jerome GJ, 2009, MED SCI SPORT EXER, V41, P110, DOI 10.1249/MSS.0b013e3181846cd8; John D, 2012, MED SCI SPORT EXER, V44, pS86, DOI 10.1249/MSS.0b013e3182399f5e; Jones RA, 2013, AM J PREV MED, V44, P651, DOI 10.1016/j.amepre.2013.03.001; Kang M, 2009, RES Q EXERCISE SPORT, V80, P131, DOI 10.1080/02701367.2009.10599546; Levin S, 1999, ANN EPIDEMIOL, V9, P481, DOI 10.1016/S1047-2797(99)00022-8; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1376, DOI 10.1097/00005768-200208000-00021; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Mattocks C, 2007, MED SCI SPORT EXER, V39, P622, DOI 10.1249/mss.0b013e318030631b; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Murray DM, 2004, MED SCI SPORT EXER, V36, P876, DOI 10.1249/01.MSS.0000126806.72453.1C; Ojiambo R, 2011, INT J OBESITY, V35, pS98, DOI 10.1038/ijo.2011.40; Penpraze V, 2006, PEDIATR EXERC SCI, V18, P483, DOI 10.1123/pes.18.4.483; Resaland GK, 2016, PREV MED, V91, P322, DOI 10.1016/j.ypmed.2016.09.005; Resaland GK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2049-y; Rich C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067206; Telama R, 2009, OBESITY FACTS, V2, P187, DOI 10.1159/000222244; Thompson PD, 2001, MED SCI SPORT EXER, V33, pS438, DOI 10.1097/00005768-200106001-00012; Treuth MS, 2003, MED SCI SPORT EXER, V35, P532, DOI 10.1249/01.MSS.0000053702.03884.3F; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wickel EE, 2010, MED SCI SPORT EXER, V42, P1528, DOI 10.1249/MSS.0b013e3181d107c4	44	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189304	10.1371/journal.pone.0189304	http://dx.doi.org/10.1371/journal.pone.0189304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216318	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000417337800114
J	Abdalla, Z; Walsh, T; Thakker, N; Ward, CM				Abdalla, Zahra; Walsh, Tanya; Thakker, Nalin; Ward, Christopher M.			Loss of epithelial markers is an early event in oral dysplasia and is observed within the safety margin of dysplastic and T1 OSCC biopsies	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; E-CADHERIN; EXPRESSION; TRANSITION; VIMENTIN; CATENIN; PROTEIN; HEAD	Oral squamous cell carcinoma (OSCC) is a highly aggressive cancer that is associated with poor 5-year patient survival. Disease treatment is further compounded by the difficulty in predicting pre-cancerous tissues that will progress to OSCC and the high recurrence rates following surgical resection. Here we have assessed expression of the oral epithelial markers E-cadherin, EMP1 and 5T4 and the pro-invasive N-cadherin proteins using fully characterised antibodies and quantitative immunofluorescence microscopy in normal tissue (NT), fibroepithelial polyp (FEP), low-grade dysplasia (LGD), high-grade dysplasia (HGD), T1 OSCC and T4 OSCC biopsies. Decreased E-cadherin expression was associated with FEP, LGD and HGD biopsies, demonstrating that loss of E-cadherin is an early event within abnormal epithelium and occurs in the absence of an E-to N-cadherin switch, the latter of which was only observed in T4 OSCC. Furthermore, loss of E-cadherin and EMP1 is an indicator of LGD (p = 0.0006) and loss of E-cadherin, EMP1 and 5T4 an indicator of HGD (p = 0.0006). Expression patterns of E-cadherin, EMP1 and N-cadherin could predict abnormal epithelium in LGD, HGD, T1 and T4 OSCC biopsies (z-value = 0 for all disease grades) and allowed classification of LGD (z = 1.47), HGD (z = 2.138), T1 (z = 1.05) and T4 OSCC (z = 1.49) biopsies. Therefore, these markers provide a useful means to predict abnormal epithelium in patient biopsies. Linear regression and coefficient of determination analysis revealed positive correlation with a NT>LGD>HGD disease transition but low correlation with a putative HGD>T1OSCC>T4 OSCC disease transition. Furthermore, expression of E-cadherin, EMP1, 5T4 and N-cadherin in pathologically normal surgical safety margins of LGD, HGD and T1 OSCC patient biopsies revealed significant differences to NT and the use of safety margins or FEP as 'normal tissue' controls introduced Type II errors in all patient cohorts. This work forms the basis for further investigation of the role of E-cadherin loss in abnormal epithelium and in the development of automated analyses for use in cancer diagnostics.	[Abdalla, Zahra; Walsh, Tanya; Ward, Christopher M.] Manchester Dent Sch, Stem Cell Res Grp, Manchester, Lancs, England; [Thakker, Nalin] Manchester Royal Infirm, Dept Histopathol, Manchester, Lancs, England	University of Manchester; University of Manchester	Ward, CM (corresponding author), Manchester Dent Sch, Stem Cell Res Grp, Manchester, Lancs, England.	christopher.ward@manchester.ac.uk		Thakker, Nalin/0000-0002-8664-1508; Walsh, Tanya/0000-0001-7003-8854; Ward, Christopher/0000-0001-7389-4488	United Kingdom Biotechnology and Biological Sciences Research Council [BB/K020277/1]; Engineering and Physical Sciences Research Council [EP/H046070/1]; Biotechnology and Biological Sciences Research Council [BB/K020277/1] Funding Source: researchfish; BBSRC [BB/K020277/1] Funding Source: UKRI; EPSRC [EP/H046070/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by grants from the United Kingdom Biotechnology and Biological Sciences Research Council (BB/K020277/1) and the Engineering and Physical Sciences Research Council (EP/H046070/1) to Christopher M Ward. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the United Kingdom Biotechnology and Biological Sciences Research Council (BB/K020277/1) and the Engineering and Physical Sciences Research Council (EP/H046070/1).	Bangsow T, 2008, J CEREBR BLOOD F MET, V28, P1249, DOI 10.1038/jcbfm.2008.19; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chaw SY, 2012, ORAL ONCOL, V48, P997, DOI 10.1016/j.oraloncology.2012.05.011; Colucci S, 1997, ORAL ONCOL, V33, P240, DOI 10.1016/S0964-1955(97)00027-4; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Ho PS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-260; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Kaur J, 2013, PLOS ONE, V8; Kyrodimou M, 2014, CLIN ORAL INVEST, V18, P199, DOI 10.1007/s00784-013-0937-z; Liu W, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-685; Mohamet L, 2011, J ONCOL, V2011, DOI 10.1155/2011/352616; Napier SS, 2008, J ORAL PATHOL MED, V37, P1, DOI 10.1111/j.1600-0714.2007.00579.x; NEES M, 1993, CANCER RES, V53, P4189; Noutomi Y, 2006, J PATHOL, V210, P67, DOI 10.1002/path.2015; Ogbureke KUE, 2010, CANCER-AM CANCER SOC, V116, P1709, DOI 10.1002/cncr.24938; Omura K, 2014, INT J CLIN ONCOL, V19, P423, DOI 10.1007/s10147-014-0689-z; Shaw RJ, 2013, ANN SURG ONCOL, V20, P2796, DOI 10.1245/s10434-012-2713-8; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; SLAUGHTER DP, 1946, SURGERY, V20, P133; Slaughter DP, 1944, SURG GYNECOL OBSTET, V79, P89; Soncin F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021463; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Spencer HL, 2007, MOL BIOL CELL, V18, P2838, DOI 10.1091/mbc.E06-09-0875; Sridevi Ugrappa, 2015, Eur J Dent, V9, P364, DOI 10.4103/1305-7456.163238; TAYLOR V, 1995, J BIOL CHEM, V270, P28824, DOI 10.1074/jbc.270.48.28824; von Zeidler SV, 2014, BMC CANC, V14; Waridel F, 1997, ONCOGENE, V14, P163, DOI 10.1038/sj.onc.1200812; Zhou JP, 2015, INT J CLIN EXP PATHO, V8, P3150	28	11	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0187449	10.1371/journal.pone.0187449	http://dx.doi.org/10.1371/journal.pone.0187449			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216196	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800008
J	Kim, HJ; Seo, YH; Kim, BH				Kim, Hyung Jin; Seo, Yeong Ho; Kim, Byeong Hee			New intraocular pressure measurement method using reflected pneumatic pressure from cornea deformed by air puff of ring-type nozzle	PLOS ONE			English	Article							GOLDMANN APPLANATION TONOMETRY; DYNAMIC CONTOUR TONOMETRY; NORMAL-TENSION GLAUCOMA; REBOUND TONOMETER	In this study, a non-contact type intraocular pressure (IOP) measuring system using reflected pneumatic pressure is proposed to overcome the disadvantages of existing measurement systems. A ring-type nozzle, a key component in the proposed system, is designed via computational fluid analysis. It predicts the reflected pneumatic pressure based on the nozzle exit angle and inner and outer diameters of the nozzle, which are 30 degrees, 7 mm, and 9 mm, respectively. Performance evaluation is conducted using artificial eyes fabricated using polydimethylsiloxane with the specifications of human eyes. The IOP of the fabricated artificial eyes is adjusted to 10, 30, and 50 mm Hg, and the reflected pneumatic pressure is measured as a function of the distance between the ring-type nozzle and artificial eye. The measured reflected pneumatic pressure is high when the measurement distance is short and eye pressure is low. The cornea of an artificial eye is significantly deformed at a low IOP, and the applied pneumatic pressure is more concentrated in front of the ring-type nozzle because of the deformed cornea. Thus, the reflected pneumatic pressure at a low IOP has more inflows into the pressure sensor inserted inside the nozzle. The sensitivity of the output based on the IOP at measurement distances between 3-5 mm is -0.0027, -0.0022, -0.0018, -0.0015, and -0.0012. Sensitivity decreases as the measurement distance increases. In addition, the reflected pneumatic pressure owing to the misalignment at the measurement distances of 3-5 mm is not affected within a range of 0.5 mm. Therefore, the measurement range is acceptable up to a 1 mm diameter from the center of an artificial eye. However, the accuracy gradually decreases as the reflected pneumatic pressure from a misalignment of 1 mm or more decreases by 26% or more.	[Kim, Hyung Jin; Seo, Yeong Ho; Kim, Byeong Hee] Kangwon Natl Univ, Dept Mech & Mechatron Engn, Chunchon, South Korea	Kangwon National University	Kim, BH (corresponding author), Kangwon Natl Univ, Dept Mech & Mechatron Engn, Chunchon, South Korea.	khb@kangwon.ac.kr			Human Resources Development program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant - Korea government Ministry of Trade, Industry and Energy [20154030200950]; New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry & Energy, Republic of Korea [20153010024470]	Human Resources Development program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant - Korea government Ministry of Trade, Industry and Energy; New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry & Energy, Republic of Korea	This work was supported by the Human Resources Development program (No. 20154030200950) of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant funded by the Korea government Ministry of Trade, Industry and Energy. This work was also supported by the New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) granted financial resource from the Ministry of Trade, Industry & Energy, Republic of Korea (No. 20153010024470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert DM., 1999, PRINCIPLES PRACTICE; Asman P, 2003, ACTA OPHTHALMOL, V81, P424; Caffier PP, 2003, EUR J APPL PHYSIOL, V89, P319, DOI 10.1007/s00421-003-0807-5; Chien W-Z, 1947, LARGE DEFLECTION CIR; Chitnis G, 2013, IEEE T BIO-MED ENG, V60, P250, DOI 10.1109/TBME.2012.2205248; Farhood QK, 2013, CLIN OPHTHALMOL, V7, P23, DOI 10.2147/OPTH.S38418; Fernandes P, 2005, OPHTHAL PHYSL OPT, V25, P436, DOI 10.1111/j.1475-1313.2005.00327.x; Gisler C, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.1.4; Glaucoma Rosenberg L., 1995, AM FAM PHYSICIAN, V52, P2289; Goel M, 2010, OPEN OPHTHALMOLOGY J, V4; Hamilton KE, 2008, OPTOMETRY VISION SCI, V85, P445, DOI 10.1097/OPX.0b013e3181783a70; Han ZL, 2014, J REFRACT SURG, V30, P208, DOI 10.3928/1081597X-20140212-02; Kageyama M, 2011, J GLAUCOMA, V20, P63, DOI 10.1097/IJG.0b013e3181d12dc4; Kaufmann C, 2004, INVEST OPHTH VIS SCI, V45, P3118, DOI 10.1167/iovs.04-0018; Khawaja AP, 2014, OPHTHALMOLOGY, V121, P1501, DOI 10.1016/j.ophtha.2014.02.009; Kim HJ, 2016, THESIS; Kim KH, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/3/035022; Kontiola AI, 2000, ACTA OPHTHALMOL SCAN, V78, P142, DOI 10.1034/j.1600-0420.2000.078002142.x; Koseki N, 1999, J GLAUCOMA, V8, P117; Ohnell H, 2016, OPHTHALMOLOGY, V123, P1173, DOI 10.1016/j.ophtha.2016.01.039; Pache M, 2005, GRAEF ARCH CLIN EXP, V243, P763, DOI 10.1007/s00417-005-1124-y; Rodriguez-Matas JF, 2015, PLOS ONE, V10; Schlote T, 2005, KLIN MONATSBL AUGENH, V222, P123, DOI 10.1055/s-2005-857881; Shah Sunil, 2006, Cont Lens Anterior Eye, V29, P257, DOI 10.1016/j.clae.2006.09.006; SHIELDS MB, 1980, SURV OPHTHALMOL, V24, P211, DOI 10.1016/0039-6257(80)90042-9; Singh P., IOSR J DENT MED SCI, V13, P67; Spoerl E, 2011, J REFRACT SURG, V27, P452, DOI 10.3928/1081597X-20110106-01; Stevens Sue, 2007, Community Eye Health, V20, P74; Suman S, 2014, J GLAUCOMA, V23, P633, DOI 10.1097/IJG.0b013e318285fefd; Tojo N, 2014, J GLAUCOMA, V23, pE138, DOI 10.1097/IJG.0000000000000026; Valbon BF, 2013, ARQ BRAS OFTALMOL, V76, P229, DOI 10.1590/S0004-27492013000400008	31	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0186738	10.1371/journal.pone.0186738	http://dx.doi.org/10.1371/journal.pone.0186738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216189	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800005
J	Rourke, OLC; Butts, DA				Rourke, Oliver L. C.; Butts, Daniel A.			Cortical computations via transient attractors	PLOS ONE			English	Article							SHORT-TERM-MEMORY; WORKING-MEMORY; NEURAL-NETWORKS; PERSISTENT ACTIVITY; SUSTAINED ACTIVITY; PREFRONTAL CORTEX; MODEL; NEURONS; DYNAMICS; SYSTEMS	The ability of sensory networks to transiently store information on the scale of seconds can confer many advantages in processing time-varying stimuli. How a network could store information on such intermediate time scales, between typical neurophysiological time scales and those of long-term memory, is typically attributed to persistent neural activity. An alternative mechanism which might allow for such information storage is through temporary modifications to the neural connectivity which decay on the same second-long time scale as the underlying memories. Earlier work that has explored this method has done so by emphasizing one attractor from a limited, pre-defined set. Here, we describe an alternative, a Transient Attractor network, which can learn any pattern presented to it, store several simultaneously, and robustly recall them on demand using targeted probes in a manner reminiscent of Hopfield networks. We hypothesize that such functionality could be usefully embedded within sensory cortex, and allow for a flexibly-gated short-term memory, as well as conferring the ability of the network to perform automatic de-noising, and separation of input signals into distinct perceptual objects. We demonstrate that the stored information can be refreshed to extend storage time, is not sensitive to noise in the system, and can be turned on or off by simple neuromodulation. The diverse capabilities of transient attractors, as well as their resemblance to many features observed in sensory cortex, suggest the possibility that their actions might underlie neural processing in many sensory areas.	[Rourke, Oliver L. C.; Butts, Daniel A.] Univ Maryland, Program Appl Math Stat & Sci Computat, College Pk, MD 20742 USA; [Butts, Daniel A.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Butts, Daniel A.] Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Rourke, OLC (corresponding author), Univ Maryland, Program Appl Math Stat & Sci Computat, College Pk, MD 20742 USA.	orourke@math.umd.edu	Butts, Daniel A/B-8346-2008	Butts, Daniel A/0000-0002-0158-5317	National Science Foundation [IIS-1350990]	National Science Foundation(National Science Foundation (NSF))	This work supported by National Science Foundation grant IIS-1350990, URL: https://www.nsf.gov/.	Aksay E, 2007, NAT NEUROSCI, V10, P494, DOI 10.1038/nn1877; Amit DJ, 1997, NEURAL COMPUT, V9, P1071, DOI 10.1162/neco.1997.9.5.1071; AMIT DJ, 1985, PHYS REV LETT, V55, P1530, DOI 10.1103/PhysRevLett.55.1530; Barak O, 2007, PLOS COMPUT BIOL, V3, P323, DOI 10.1371/journal.pcbi.0030035; Barak O, 2014, CURR OPIN NEUROBIOL, V25, P20, DOI 10.1016/j.conb.2013.10.008; Becker S., 1992, LEARNING CATEGORIZE; BEER RD, 1995, ADAPT BEHAV, V3, P469, DOI 10.1177/105971239500300405; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Bizley JK, 2013, NAT REV NEUROSCI, V14, P693, DOI 10.1038/nrn3565; BUHMANN J, 1986, BIOL CYBERN, V54, P319, DOI 10.1007/BF00318428; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; D'Esposito M, 2015, ANNU REV PSYCHOL, V66, P115, DOI 10.1146/annurev-psych-010814-015031; Dranias MR, 2013, J NEUROSCI, V33, P1940, DOI 10.1523/JNEUROSCI.2718-12.2013; Dubreuil AM, 2016, J COMPUT NEUROSCI, V40, P157, DOI 10.1007/s10827-016-0590-z; Erickson MA, 2010, J COGNITIVE NEUROSCI, V22, P2530, DOI 10.1162/jocn.2009.21375; Fiebig F, 2017, SPIKING WORKING MEMO, V37, P83; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Ganguli S, 2008, P NATL ACAD SCI USA, V105, P18970, DOI 10.1073/pnas.0804451105; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Hebb Donald O., 1949, ORG BEHAV; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Itskov V, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00040; Kaminski J, 2017, NAT NEUROSCI, V20, P590, DOI 10.1038/nn.4509; Kandel ER, 2014, PRINCIPLES NEURAL SC, P1248; Krishnan L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003985; Lansner A, 2003, THEOR BIOSCI, V122, P19, DOI 10.1078/1431-7613-00072; Leavitt ML, 2017, TRENDS NEUROSCI, V40, P328, DOI 10.1016/j.tins.2017.04.004; Lim S, 2013, NAT NEUROSCI, V16, P1306, DOI 10.1038/nn.3492; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Maex R, 2009, NEURAL NETWORKS, V22, P1105, DOI 10.1016/j.neunet.2009.07.022; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; Martinez-Trujillo, 2015, MECH SENSORY WORKING, VXXV, P43, DOI 10.1016/B978-0-12-801371-7.00005-3; McDougal RA, 2011, EXCITATORY INHIBITOR; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Pasternak T, 2005, NAT REV NEUROSCI, V6, DOI 10.1038/nrn1637; Petrides M, 2000, J NEUROSCI, V20, P7496; Sandberg A, 2003, NETWORK-COMP NEURAL, V14, P789, DOI 10.1088/0954-898X/14/4/309; Schneegans S., 2008, HDB COGNITIVE SCI, P241, DOI [10.1016/B978-0-08-046616-3.00013-X, DOI 10.1016/B978-0-08-046616-3.00013-X]; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Shamma S, 2013, ADV EXP MED BIOL, V787, P535, DOI 10.1007/978-1-4614-1590-9_59; Shamma SA, 2011, TRENDS NEUROSCI, V34, P114, DOI 10.1016/j.tins.2010.11.002; SHEN L, 1989, BIOL CYBERN, V61, P319, DOI 10.1007/BF00203180; Sreenivasan KK, 2014, TRENDS COGN SCI, V18, P82, DOI 10.1016/j.tics.2013.12.001; Stokes MG, 2015, TRENDS COGN SCI, V19, P394, DOI 10.1016/j.tics.2015.05.004; Sugase-Miyamoto Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000073; Szatmary B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000879; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Verduzco-Flores S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006399; Wimmer K, 2014, NAT NEUROSCI, V17, P431, DOI 10.1038/nn.3645; Zylberberg J, 2017, ANNU REV NEUROSCI, V40, P603, DOI 10.1146/annurev-neuro-070815-014006	50	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188562	10.1371/journal.pone.0188562	http://dx.doi.org/10.1371/journal.pone.0188562			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216222	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800030
J	Lind, O; Milton, I; Andersson, E; Jensen, P; Roth, LSV				Lind, Olle; Milton, Ida; Andersson, Elin; Jensen, Per; Roth, Lina S. V.			High visual acuity revealed in dogs	PLOS ONE			English	Article							GANGLION-CELLS; DOMESTIC DOGS	Humans have selectively bred and used dogs over a period of thousands of years, and more recently the dog has become an important model animal for studies in ethology, cognition and genetics. These broad interests warrant careful descriptions of the senses of dogs. Still there is little known about dog vision, especially what dogs can discriminate in different light conditions. We trained and tested whippets, pugs, and a Shetland sheepdog in a two-choice discrimination set-up and show that dogs can discriminate patterns with spatial frequencies between 5.5 and 19.5 cycle per degree (cpd) in the bright light condition (43 cd m(-2)). This is a higher spatial resolution than has been previously reported although the individual variation in our tests was large. Humans tested in the same set-up reached acuities corresponding to earlier studies, ranging between 32.1 and 44.2 cpd. In the dim light condition (0.0087 cd m(-2)) the acuity of dogs ranged between 1.8 and 3.5 cpd while in humans, between 5.9 and 9.9 cpd. Thus, humans make visual discrimination of objects from roughly a threefold distance compared to dogs in both bright and dim light.	[Lind, Olle] Lund Univ, Cognit Sci, Lund, Sweden; [Milton, Ida; Andersson, Elin; Jensen, Per; Roth, Lina S. V.] Linkoping Univ, AVIAN Behav Genom & Physiol Grp, IFM Biol, Linkoping, Sweden	Lund University; Linkoping University	Roth, LSV (corresponding author), Linkoping Univ, AVIAN Behav Genom & Physiol Grp, IFM Biol, Linkoping, Sweden.	lina.roth@liu.se	Roth, Lina S.V./J-6272-2019	Roth, Lina S V/0000-0002-3297-1130	European Research Council Advanced Research Grant GENEWELL [322206]; Swedish Research Council [637-2013-388]	European Research Council Advanced Research Grant GENEWELL; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding is acknowledged from the European Research Council Advanced Research Grant GENEWELL (grant no 322206 to PJ; http://erc.europa.eu) and from the Swedish Research Council (grant with diarienr. 637-2013-388 to OL; http./vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltran WA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090390; DeValois RL, 1990, SPATIAL VISION; Frantz LAF, 2016, SCIENCE, V352, P1228, DOI 10.1126/science.aaf3161; Freedman AH, 2014, PLOS GENET, V10; Harmening WM, 2009, J VISION, V9, DOI 10.1167/9.7.13; Harrington F.H., 2003, WOLVES BEHAV ECOLOGY; Hecht S, 1937, J GEN PHYSIOL, V20, P831, DOI 10.1085/jgp.20.6.831; Johnson H. M., 1914, J ANIM BEHAV, V4, P340; Kingdom F, 2009, PALAMEDES MATLAB ROU; Land MF, 2002, ANIMAL EYES; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; McGreevy P, 2004, BRAIN BEHAV EVOLUT, V63, P13, DOI 10.1159/000073756; Mehrkam LR, 2014, APPL ANIM BEHAV SCI, V155, P12, DOI 10.1016/j.applanim.2014.03.005; Miklosi A., 2015, DOG BEHAV EVOLUTION; Murphy CJ, 1997, AM J VET RES, V58, P414; NEUHAUS W, 1967, Z VERGL PHYSIOL, V57, P137, DOI 10.1007/BF00303069; ODOM JV, 1983, AM J PHYSIOL, V245, pR637, DOI 10.1152/ajpregu.1983.245.5.R637; Ofri R., 1993, Progress in Veterinary & Comparative Ophthalmology, V3, P111; Ollivier FJ, 2004, VET OPHTHALMOL, V7, P11, DOI 10.1111/j.1463-5224.2004.00318.x; PEICHL L, 1992, J COMP NEUROL, V324, P603, DOI 10.1002/cne.903240412; Pongracz P, 2017, BEHAV PROCESS, V140, P53, DOI 10.1016/j.beproc.2017.04.002; Range F, 2008, ANIM COGN, V11, P339, DOI 10.1007/s10071-007-0123-2; RODIECK RW, 1973, VERTEBRATE RETINA PR; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Zaine Isabela, 2014, Psychol. Neurosci., V7, P199, DOI 10.3922/j.psns.2014.014	25	6	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188557	10.1371/journal.pone.0188557	http://dx.doi.org/10.1371/journal.pone.0188557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206864	Green Published, Green Submitted, gold			2022-12-27	WOS:000417110700013
J	Islam, MM; Shareef, H; Mohamed, A				Islam, Md. Mainul; Shareef, Hussain; Mohamed, Azah			Improved approach for electric vehicle rapid charging station placement and sizing using Google maps and binary lightning search algorithm	PLOS ONE			English	Article								The electric vehicle (EV) is considered a premium solution to global warming and various types of pollution. Nonetheless, a key concern is the recharging of EV batteries. Therefore, this study proposes a novel approach that considers the costs of transportation loss, buildup, and substation energy loss and that incorporates harmonic power loss into optimal rapid charging station (RCS) planning. A novel optimization technique, called binary lightning search algorithm (BLSA), is proposed to solve the optimization problem. BLSA is also applied to a conventional RCS planning method. A comprehensive analysis is conducted to assess the performance of the two RCS planning methods by using the IEEE 34-bus test system as the power grid. The comparative studies show that the proposed BLSA is better than other optimization techniques. The daily total cost in RCS planning of the proposed method, including harmonic power loss, decreases by 10% compared with that of the conventional method.	[Islam, Md. Mainul] Uttara Univ, Dept Elect & Elect Engn, Dhaka, Bangladesh; [Shareef, Hussain] United Arab Emirates Univ, Dept Elect Engn, Al Ain 1, U Arab Emirates; [Mohamed, Azah] Univ Kebangsaan Malaysia, Dept Elect Elect & Syst Engn, Bangi, Malaysia	Uttara University; Universiti Kebangsaan Malaysia	Islam, MM (corresponding author), Uttara Univ, Dept Elect & Elect Engn, Dhaka, Bangladesh.	mhsm.eee@gmail.com	Shareef, Hussain/AAN-5968-2020; Shareef, Hussain/AFK-9223-2022	Shareef, Hussain/0000-0001-7708-6904; Shareef, Hussain/0000-0001-7708-6904; Islam, Md Mainul/0000-0002-8079-2065	UAEU	UAEU	The authors gratefully acknowledge the UAEU under Research Start-up (3) 2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrle M., 2013, INT MONETARY FUND, V2013, P1; [Anonymous], 2012, P IEEE PES INN SMART; [Anonymous], 2010, MOD ELECT POWER; Dharmakeerthi CH, 2012, IEEE POW ENER SOC GE; Dharmakeerthi CH, 2014, INT J ELEC POWER, V57, P241, DOI 10.1016/j.ijepes.2013.12.005; Ge S, 2011, 2011 INT C EL CONTR, P2726, DOI DOI 10.1109/ICECENG.2011.6057636; Hu XS, 2017, IEEE POWER ENERGY M, V15, P20, DOI 10.1109/MPE.2017.2708812; Hu XS, 2017, MECH SYST SIGNAL PR, V87, P4, DOI 10.1016/j.ymssp.2016.03.004; Hu XS, 2016, IEEE T CONTR SYST T, V24, P1036, DOI 10.1109/TCST.2015.2476799; Islam Md Mainul, 2015, Przeglad Elektrotechniczny, V91, P122, DOI 10.15199/48.2015.08.29; Islam MM, 2017, SOFT COMPUT, V21, P2971, DOI 10.1007/s00500-016-2171-5; Islam MM, 2016, TURK J ELECTR ENG CO, V24, P3933, DOI 10.3906/elk-1412-136; Jia L, 2014, 2014 INTERNATIONAL CONFERENCE ON POWER SYSTEM TECHNOLOGY (POWERCON), P3354, DOI 10.1109/POWERCON.2014.6993928; Liu ZP, 2013, IEEE T POWER DELIVER, V28, P102, DOI 10.1109/TPWRD.2012.2223489; Mainul Islam Md, 2015, Applied Mechanics and Materials, V785, P697, DOI 10.4028/www.scientific.net/AMM.785.697; Phonrattanasak P., 2012, INT J INNOV MANAGE T, V3, P675; Sadeghi-Barzani P, 2014, APPL ENERG, V125, P289, DOI 10.1016/j.apenergy.2014.03.077; Shareef H, 2016, RENEW SUST ENERG REV, V64, P403, DOI 10.1016/j.rser.2016.06.033; Teng JH, 2007, IEEE T POWER DELIVER, V22, P1665, DOI 10.1109/TPWRD.2007.899523; Wang GB, 2013, IEEE T POWER DELIVER, V28, P2363, DOI 10.1109/TPWRD.2013.2269142; Watson N. R., 2015, P EEA C EXH WELL, P1; Wu XH, 2017, J POWER SOURCES, V363, P277, DOI 10.1016/j.jpowsour.2017.07.086; Wu XH, 2016, J POWER SOURCES, V333, P203, DOI 10.1016/j.jpowsour.2016.09.157; Yan X., 2014, P INT C EL SCI TECHN, P1; Zhang L, 2016, J POWER SOURCES, V314, P28, DOI 10.1016/j.jpowsour.2016.01.066; Zhang L, 2015, J POWER SOURCES, V274, P899, DOI 10.1016/j.jpowsour.2014.10.170	26	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189170	10.1371/journal.pone.0189170	http://dx.doi.org/10.1371/journal.pone.0189170			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220396	gold, Green Submitted, Green Published			2022-12-27	WOS:000417469900036
J	Mussbacher, M; Schrottmaier, WC; Salzmann, M; Brostjan, C; Schmid, JA; Starlinger, P; Assinger, A				Mussbacher, Marion; Schrottmaier, Waltraud C.; Salzmann, Manuel; Brostjan, Christine; Schmid, Johannes A.; Starlinger, Patrick; Assinger, Alice			Optimized plasma preparation is essential to monitor platelet-stored molecules in humans	PLOS ONE			English	Article							FLOW-CYTOMETRIC EVALUATION; HUMAN BLOOD; P-SELECTIN; ANGIOGENESIS; ACTIVATION; SECRETION; ADENOSINE; MONOPHOSPHATE; THEOPHYLLINE; AGGREGATION	Platelets store a plethora of different molecules within their granules, modulating numerous pathways, not only in coagulation, but also in angiogenesis, wound healing, and inflammatory diseases. These molecules get rapidly released upon activation and therefore represent an easily accessible indirect marker for platelet activation. Accurate analysis of platelet-derived molecules in the plasma requires appropriate anticoagulation to avoid in vitro activation and subsequent degranulation of platelets, potentially causing artificially high levels and masking biologically relevant differences within translational research studies. However, there is still enormous heterogeneity among anticoagulants used to prevent unwanted platelet activation, so that plasma levels reported for platelet granule contents range over several orders of magnitude. To address this problem and to define the most robust method of plasma preparation to avoid in vitro platelet activation during processing, we compared plasma concentrations of the three platelet-stored factors thrombospondin (TSP-1), platelet factor 4 (PF4), and soluble P-selectin (sCD62P) between human blood samples anticoagulated with either citrate-theophylline-adenosinedipyridamole (CTAD), acid-citrate-dextrose (ACD), citrate, ethylenediaminetetraacetic acid (EDTA) or heparin. Additionally, we assessed the effect of storage temperature and time between blood drawing and sample processing within the differentially anticoagulated samples. Our data strongly support the use of CTAD as anticoagulant for determining plasma concentrations of platelet-stored molecules, as anticoagulation with heparin or EDTA led to a 12.4-or 8.3-fold increase in plasma levels of PF4, respectively. Whereas ACD was similar effective as CTAD, citrate only showed comparable PF4 plasma levels when plasma was kept at 4 degrees C. Moreover, blood sampling with CTAD as anticoagulant resulted in the most reproducible values, even when samples were processed at ambient temperature or after storage over 6 hours. In the latter case, anticoagulation with heparin or EDTA led to artificially high plasma levels indicative of in vitro platelet activation. Therefore, we want to raise scientific awareness for choosing CTAD as optimal anticoagulant for the detection of platelet-stored molecules in plasma.	[Mussbacher, Marion; Schrottmaier, Waltraud C.; Salzmann, Manuel; Schmid, Johannes A.; Assinger, Alice] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria; [Brostjan, Christine; Starlinger, Patrick] Med Univ Vienna, Gen Hosp, Dept Surg, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Starlinger, P (corresponding author), Med Univ Vienna, Gen Hosp, Dept Surg, Vienna, Austria.	patrick.starlinger@meduniwien.ac.at	Schrottmaier, Waltraud Cornelia/ADY-2164-2022; Mussbacher, Marion/AAF-3788-2021; Salzmann, Manuel/ABC-3916-2021; Schmid, Johannes A./C-7659-2009	Schrottmaier, Waltraud Cornelia/0000-0003-0550-4120; Mussbacher, Marion/0000-0001-5346-6785; Salzmann, Manuel/0000-0001-5477-3533; Schmid, Johannes A./0000-0002-6586-3507; Brostjan, Christine/0000-0003-1462-5397; Assinger, Alice/0000-0002-5670-5910	Austrian Science Fund FWF [FWF-P24978, SFB-F54]	Austrian Science Fund FWF(Austrian Science Fund (FWF))	The work was supported by Austrian Science Fund FWF (FWF-P24978, SFB-F54).	Ammerlaan W, 2014, BIOPRESERV BIOBANK, V12, P269, DOI 10.1089/bio.2014.0003; Assinger A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00649; ASTER RH, 1964, J CLIN INVEST, V43, P843, DOI 10.1172/JCI104970; Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Berger G, 1998, BLOOD, V92, P4446, DOI 10.1182/blood.V92.11.4446; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Bowen RAR, 2014, BIOCHEM MEDICA, V24, P31, DOI 10.11613/BM.2014.006; Golebiewska EM, 2015, BLOOD REV, V29, P153, DOI 10.1016/j.blre.2014.10.003; Jonnalagadda D, 2012, BLOOD, V120, P5209, DOI 10.1182/blood-2012-07-445080; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kral JB, 2016, TRANSFUS MED HEMOTH, V43, P78, DOI 10.1159/000444807; KUHNE T, 1995, AM J HEMATOL, V50, P40, DOI 10.1002/ajh.2830500108; Martinez MC, 2011, CIRC RES, V109, P110, DOI 10.1161/CIRCRESAHA.110.233049; Michelson AD, 1996, P NATL ACAD SCI USA, V93, P11877, DOI 10.1073/pnas.93.21.11877; MILLS DCB, 1971, BIOCHEM J, V121, P185, DOI 10.1042/bj1210185; Mody M, 1999, TRANSFUSION MED, V9, P147; Mohamadkhani Ashraf, 2015, Middle East J Dig Dis, V7, P61; Neufeld M, 1999, CLIN CHEM, V45, P2030; Ogundele MO, 2000, BRIT J BIOMED SCI, V57, P312; PAUL S, 1990, MOL PHARMACOL, V37, P870; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; SALZMAN EW, 1972, ANN NY ACAD SCI, V201, P61, DOI 10.1111/j.1749-6632.1972.tb16287.x; Senzel L, 2009, CURR OPIN HEMATOL, V16, P329, DOI 10.1097/MOH.0b013e32832e9dc6; Smolenski A, 2012, J THROMB HAEMOST, V10, P167, DOI 10.1111/j.1538-7836.2011.04576.x; Starlinger P, 2016, HEPATOLOGY, V63, P1675, DOI 10.1002/hep.28331; Starlinger P, 2011, DIS MARKERS, V31, P55, DOI [10.1155/2011/535109, 10.3233/DMA-2011-0798]; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Yokota M, 2003, J AUTOM METHOD MANAG, V25, P17, DOI [10.1155/S1463924603000038, 10.1080/1463924031000066212]	28	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188921	10.1371/journal.pone.0188921	http://dx.doi.org/10.1371/journal.pone.0188921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220362	Green Published, Green Submitted, gold			2022-12-27	WOS:000417469900020
J	Scire, A; Annovazzi-Lodi, V				Scire, Alessandro; Annovazzi-Lodi, Valerio			Self-organization in a diversity induced thermodynamics	PLOS ONE			English	Article							SYNCHRONIZATION; BEHAVIOR; DYNAMICS; NETWORK	In this work we show how global self-organized patterns can come out of a disordered ensemble of point oscillators, as a result of a deterministic, and not of a random, cooperative process. The resulting system dynamics has many characteristics of classical thermodynamics. To this end, a modified Kuramoto model is introduced, by including Euclidean degrees of freedom and particle polarity. The standard deviation of the frequency distribution is the disorder parameter, diversity, acting as temperature, which is both a source of motion and of disorder. For zero and low diversity, robust static phase-synchronized patterns (crystals) appear, and the problem reverts to a generic dissipative many-body problem. From small to moderate diversity crystals display vibrations followed by structure disintegration in a competition of smaller dynamic patterns, internally synchronized, each of which is capable to manage its internal diversity. In this process a huge variety of self-organized dynamic shapes is formed. Such patterns can be seen again as (more complex) oscillators, where the same description can be applied in turn, renormalizing the problem to a bigger scale, opening the possibility of pattern evolution. The interaction functions are kept local because our idea is to build a system able to produce global patterns when its constituents only interact at the bond scale. By further increasing the oscillator diversity, the dynamics becomes erratic, dynamic patterns show short lifetime, and finally disappear for high diversity. Results are neither qualitatively dependent on the specific choice of the interaction functions nor on the shape of the probability function assumed for the frequencies. The system shows a phase transition and a critical behaviour for a specific value of diversity.	[Scire, Alessandro; Annovazzi-Lodi, Valerio] Univ Pavia, Dipartimento Ingn Ind & Informaz, Via Ferrata 5, I-27100 Pavia, Italy	University of Pavia	Annovazzi-Lodi, V (corresponding author), Univ Pavia, Dipartimento Ingn Ind & Informaz, Via Ferrata 5, I-27100 Pavia, Italy.	valerio.annovazzi@unipv.it						Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; ADLER R, 1946, P IRE, V34, P351, DOI 10.1109/JRPROC.1946.229930; Ansari MH, 2008, CLASSICAL QUANT GRAV, V25, DOI 10.1088/0264-9381/25/9/095016; Athanasiou KA, 2013, ANNU REV BIOMED ENG, V15, P115, DOI [10.1146/annurev-bioeng-071812-15242, 10.1146/annurev-bioeng-071812-152423]; Atmanspacher H., 2007, CHANCE CHOICE INTERD; Axel HE, 2011, SELF ORG NANOSTRUCTU; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; BRUSH SG, 1967, REV MOD PHYS, V39, P883, DOI 10.1103/RevModPhys.39.883; Chen HS, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026207; Chen JX, 2018, COMMUN NONLINEAR SCI, V54, P202, DOI 10.1016/j.cnsns.2017.05.034; Chen JX, 2016, EPL-EUROPHYS LETT, V113, DOI 10.1209/0295-5075/113/38004; Chen JX, 2014, EPL-EUROPHYS LETT, V107, DOI 10.1209/0295-5075/107/38001; Fatima B, 2015, COMPLEX ADAPT SYST M, V3, DOI 10.1186/s40294-015-0008-1; Gerstman BS, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1990110; Hirschberg JHKK, 2000, NATURE, V407, P167, DOI 10.1038/35025027; Horsthemke W., 1984, NOISE INDUCED TRANSI; Jantsch E, 1980, SELF ORG UNIVERSE; Kauffman S.A., 1993, ORIGINS ORDER; Kuramoto, 1975, LECT NOTE PHYS, V30, P420, DOI DOI 10.1007/BFB0013365; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Lipowski A, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.052811; Lv M, 2016, NEUROCOMPUTING, V205, P375, DOI 10.1016/j.neucom.2016.05.004; Ma J, 2017, NONLINEAR DYNAM, V89, P1569, DOI 10.1007/s11071-017-3565-3; Ma J, 2015, SCI CHINA TECHNOL SC, V58, P2038, DOI 10.1007/s11431-015-5961-6; Mao CD, 1997, NATURE, V386, P137, DOI 10.1038/386137b0; Miguel M. S., 2000, INSTABILITIES NONEQU, P35, DOI DOI 10.1007/978-94-011-4247-2_; Millor J, 1999, P NATL ACAD SCI USA, V96, P12611, DOI 10.1073/pnas.96.22.12611; Naka K, 2007, TOP CURR CHEM, V270, P1, DOI 10.1007/978-3-540-46380-1; Orlik M., 2012, SELF ORG ELECTROCHEM; Percec V, 2002, NATURE, V419, P384, DOI 10.1038/nature01072; RIGER S, 1981, AM J COMMUN PSYCHOL, V9, P55, DOI 10.1007/BF00896360; Rosen BM, 2009, CHEM REV, V109, P6275, DOI 10.1021/cr900157q; Sweetman AM, 2014, NATURE COMMUNICATION, V5, P3921; Tadros T.F, 2011, SELF ORG SURFACTANT; Tessone CJ, 2008, EUR PHYS J B, V62, P319, DOI 10.1140/epjb/e2008-00162-5; Tessone CJ, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016203; Ulrich H, 2012, SELF ORG MANAGEMENT; Wang CN, 2014, COMPLEXITY, V20, P64, DOI 10.1002/cplx.21497; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; WINFREE AT, 1984, J CHEM EDUC, V61, P661, DOI 10.1021/ed061p661	40	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188753	10.1371/journal.pone.0188753	http://dx.doi.org/10.1371/journal.pone.0188753			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220363	Green Published, gold, Green Submitted			2022-12-27	WOS:000417469900014
J	Bruno, W; Andreotti, V; Bisio, A; Pastorino, L; Fornarini, G; Sciallero, S; Bianchi-Scarra, G; Inga, A; Ghiorzo, P				Bruno, William; Andreotti, Virginia; Bisio, Alessandra; Pastorino, Lorenza; Fornarini, Giuseppe; Sciallero, Stefania; Bianchi-Scarra, Giovanna; Inga, Alberto; Ghiorzo, Paola			Functional analysis of a CDKN2A 5'UTR germline variant associated with pancreatic cancer development	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; MESSENGER-RNA TRANSLATION; MELANOMA FAMILIES; RISK; MUTATIONS; SEQUENCE; PATHWAY; HUMANS; IMPACT	CDKN2A coding region germline variants are associated with pancreatic adenocarcinoma (PC) susceptibility. Recently, we described functional germline 5'UTR CDKN2A variants from melanoma patients affecting the post-transcriptional regulation of p16(INK4a) mRNA that is dependent, at least in part, on an Internal Ribosome Entry Site (IRES) in the 5'UTR region. Here we describe a 5'UTR c.-201_-198delinsCTTT CDKN2A variant (frequency 0.0028 based on 350 PC patients), which seems to be private to PC, since it has never been found in public databases nor in thousands of melanoma patients tested. Functional analyses confirmed IRES activity of the 5'UTR in BX-PC3 PC cells and revealed a functional impact of the identified variant. Using gene reporter assays we observed reduced translation potential in cells treated with the mTOR inhibitor Torin1, a condition that favors the assessment of IRES activity. At the endogenous gene level we quantified allelic imbalance among polysome-associated mRNAs using a patient-derived cell line heterozygous for the c.-201_-198delinsCTTT. Overall, we conclude that this very rare private variant can be considered a potential mutation, specifically associated with PC. Our data indicate that sequencing of the entire 5'UTR of CDKN2A should be included in routine screening of PC cases with suspected inherited susceptibility.	[Bruno, William; Andreotti, Virginia; Pastorino, Lorenza; Bianchi-Scarra, Giovanna; Ghiorzo, Paola] Univ Genoa, Dept Internal Med & Med Specialties DiMI, Genet Rare Canc, Genoa, Italy; [Bruno, William; Andreotti, Virginia; Pastorino, Lorenza; Bianchi-Scarra, Giovanna; Ghiorzo, Paola] Osped Policlin San Martino, Genoa, Italy; [Bisio, Alessandra; Inga, Alberto] Ctr Integrat Biol CIBIO, Trento, Italy; [Bisio, Alessandra; Inga, Alberto] Univ Trento, Trento, Italy; [Fornarini, Giuseppe; Sciallero, Stefania] Osped Policlin San Martino, Med Oncol Unit, Genoa, Italy	University of Genoa; University of Trento	Ghiorzo, P (corresponding author), Univ Genoa, Dept Internal Med & Med Specialties DiMI, Genet Rare Canc, Genoa, Italy.; Ghiorzo, P (corresponding author), Osped Policlin San Martino, Genoa, Italy.	paola.ghiorzo@unige.it	Pastorino, Lorenza/E-6084-2018; Andreotti, Virginia/K-4506-2016; Bruno, William/N-7477-2013; Fornarini, Giuseppe/AAB-1921-2020; Inga, Alberto/AAC-3815-2022; Sciallero, Maria Stefania/AAC-4875-2020; Ghiorzo, Paola/CAG-0673-2022	Pastorino, Lorenza/0000-0002-2575-8331; Andreotti, Virginia/0000-0002-2569-0832; Bruno, William/0000-0002-0337-0168; Fornarini, Giuseppe/0000-0003-4754-6572; Inga, Alberto/0000-0002-8767-1637; Sciallero, Maria Stefania/0000-0002-1325-1701; Ghiorzo, Paola/0000-0002-3651-8173; BISIO, Alessandra/0000-0002-3326-1923	IRCCS AOU San Martino-IST 5 per mille per la Ricerca Corrente; Italian Association for Cancer Research [AIRC IG15460]	IRCCS AOU San Martino-IST 5 per mille per la Ricerca Corrente; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported by: IRCCS AOU San Martino-IST 5 per mille per la Ricerca Corrente to PG, Italian Association for Cancer Research AIRC IG15460 to PG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by: IRCCS AOU San Martino-IST 5 per mille per la Ricerca Corrente to PG, Italian Association for Cancer Research AIRC IG15460 to PG.	Andreotti V, 2016, PIGM CELL MELANOMA R, V29, P210, DOI 10.1111/pcmr.12444; Bisio A, 2015, ONCOTARGET, V6, P39980, DOI 10.18632/oncotarget.5387; Bisio A, 2010, HUM MOL GENET, V19, P1479, DOI 10.1093/hmg/ddq022; Bond GL, 2007, ONCOGENE, V26, P1317, DOI 10.1038/sj.onc.1210199; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bruno W, 2016, J AM ACAD DERMATOL, V74, P325, DOI 10.1016/j.jaad.2015.09.053; Bruno W, 2009, J AM ACAD DERMATOL, V61, P775, DOI 10.1016/j.jaad.2009.03.039; Chio IIC, 2016, CELL, V166, P963, DOI 10.1016/j.cell.2016.06.056; Feigin ME, 2017, NAT GENET, V49, P825, DOI 10.1038/ng.3861; Ghiorzo P, 1999, INT J CANCER, V83, P441, DOI 10.1002/(SICI)1097-0215(19991112)83:4<441::AID-IJC2>3.0.CO;2-R; Ghiorzo P, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12047; Ghiorzo P, 2004, ANN ONCOL, V15, P70, DOI 10.1093/annonc/mdg498; Ghiorzo P, 2006, HUM MOL GENET, V15, P2682, DOI 10.1093/hmg/ddl199; Ghiorzo P, 2014, WORLD J GASTROENTERO, V20, P10778, DOI 10.3748/wjg.v20.i31.10778; Ghiorzo P, 2012, J MED GENET, V49, P164, DOI 10.1136/jmedgenet-2011-100281; Goldstein AM, 2006, CANCER RES, V66, P9818, DOI 10.1158/0008-5472.CAN-06-0494; GOLDSTEIN AM, 1995, NEW ENGL J MED, V333, P970, DOI 10.1056/NEJM199510123331504; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Khurana E, 2016, NAT REV GENET, V17, P93, DOI 10.1038/nrg.2015.17; Leachman SA, 2017, CANCER METAST REV, V36, P77, DOI 10.1007/s10555-017-9661-5; Petersen GM, 2016, SEMIN ONCOL, V43, P548, DOI 10.1053/j.seminoncol.2016.09.002; Ransohoff KJ, 2016, J AM ACAD DERMATOL, V74, P423, DOI 10.1016/j.jaad.2015.09.070; Scaini MC, 2014, HUM MUTAT, V35, P828, DOI 10.1002/humu.22550; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Yang XH, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2968462	25	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189123	10.1371/journal.pone.0189123	http://dx.doi.org/10.1371/journal.pone.0189123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216274	Green Submitted, Green Published, gold			2022-12-27	WOS:000417337800075
J	Fagundes, AD; Monteiro, EP; Franzoni, LT; Fraga, BS; Pantoja, PD; Fischer, G; Peyre-Tartaruga, LA				Fagundes, Alex de O.; Monteiro, Elren P.; Franzoni, Leandro T.; Fraga, Bruna S.; Pantoja, Patricia D.; Fischer, Gabriela; Peyre-Tartaruga, Leonardo A.			Effects of load carriage on physiological determinants in adventure racers	PLOS ONE			English	Article							AEROBICALLY TRAINED MEN; RUNNING ECONOMY; ENERGY-COST; EXERCISE; PERFORMANCE; THRESHOLD; RUNNERS; PREDICTION; INTENSITY; RESPONSES	Adventure racing athletes need run carrying loads during the race. A better understanding of how different loads influence physiological determinants in adventure racers could provide useful insights to gauge training interventions to improve running performance. We compare the maximum oxygen uptake (VO2max), the cost of transport (C) and ventilatory thresholds of twelve adventure running athletes at three load conditions: unloaded, 7 and 15% of body mass. Twelve healthy men experienced athletes of Adventure Racing (age 31.3 +/- 7.7 years, height 1.81 +/- 0.05 m, body mass 75.5 +/- 9.1 kg) carried out three maximal progressive (VO2max protocol) and three submaximal constant-load (running cost protocol) tests, defined in the following quasi-randomized conditions: unloaded, 7% and, 15% of body mass. The VO2max (unload: 59.7 +/- 5.9; 7%: 61.7 +/- 6.6 and 15%: 64.6 +/- 5.4 ml kg(-1) min(-1)) did not change among the conditions. While the 7% condition does neither modify the C nor the ventilatory thresholds, the 15% condition resulted in a higher C (5.2 +/- 0.9 J kg(-1) m(-1); P = 0.001; d = 1.48) than the unloaded condition (4.0 +/- 0.7 J kg(-1) m(-1)). First ventilatory threshold was greater at 15% than control condition (+/- 15.5%; P = 0.003; d = 1.44). Interestingly, the velocities on the severe-intensity domain (between second ventilatory threshold and VO2max) were reduced 1% equivalently to 1% increasing load (relative to body mass). The loading until 15% of body mass seems to affect partially the crucial metabolic and ventilatory parameters, specifically the C but not the VO2max. These findings are compatible with the concept that interventions that enhance running economy with loads may improve the running performance of adventure racing's athletes.	[Fagundes, Alex de O.; Monteiro, Elren P.; Franzoni, Leandro T.; Fraga, Bruna S.; Pantoja, Patricia D.; Fischer, Gabriela; Peyre-Tartaruga, Leonardo A.] Univ Fed Rio Grande do Sul, Exercise Res Lab, Escola Educ Fis Fisioterapia & Danca, Porto Alegre, RS, Brazil; [Monteiro, Elren P.] Univ Fed Ciencias Saude Porto Alegre, Neurosci & Rehabil Lab, Porto Alegre, RS, Brazil; [Fischer, Gabriela] Univ Fed Santa Catarina, Ctr Desportos, Florianopolis, SC, Brazil; [Peyre-Tartaruga, Leonardo A.] Univ Fed Rio Grande do Sul, Postgrad Pulmonol Sci, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal de Ciencias da Saude de Porto Alegre; Universidade Federal de Santa Catarina (UFSC); Universidade Federal do Rio Grande do Sul	Peyre-Tartaruga, LA (corresponding author), Univ Fed Rio Grande do Sul, Exercise Res Lab, Escola Educ Fis Fisioterapia & Danca, Porto Alegre, RS, Brazil.; Peyre-Tartaruga, LA (corresponding author), Univ Fed Rio Grande do Sul, Postgrad Pulmonol Sci, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.	leonardo.tartaruga@ufrgs.br	Franzoni, Leandro Tolfo/ADE-5339-2022; Peyré-Tartaruga, Leonardo Alexandre/C-7103-2013; de Oliveira Fagundes, Alex/CAF-6548-2022; Fischer, Gabriela/AAG-9084-2019; Fischer, Gabriela/F-4591-2015	Peyré-Tartaruga, Leonardo Alexandre/0000-0003-1742-5016; de Oliveira Fagundes, Alex/0000-0002-3246-0613; Fischer, Gabriela/0000-0003-2202-5017; Fischer, Gabriela/0000-0003-2202-5017	Brazilian Research Council - CNPq [483510/2013, 422193/2016-0]; LAPEX [29/2015]	Brazilian Research Council - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); LAPEX	This work was supported by the Brazilian Research Council - CNPq under Grant number 483510/2013 and 422193/2016-0; and LAPEX under Grant number 29/2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe D, 2011, J PHYSIOL ANTHROPOL, V30, P153, DOI 10.2114/jpa2.30.153; Anglem N, 2008, WILD ENVIRON MED, V19, P30, DOI 10.1580/07-WEME-OR-091.1; Baudinette RV, 1998, NATURE, V395, P653, DOI 10.1038/27111; Borgenvik M, 2012, EUR J APPL PHYSIOL, V112, P3679, DOI 10.1007/s00421-012-2350-8; Bourdin M, 1995, J APPL PHYSIOL, V79, P2078, DOI 10.1152/jappl.1995.79.6.2078; Bowen RL, 2006, INTJ SPORT PHYSIOL, V1, P176, DOI 10.1123/ijspp.1.2.176; Cavagna GA, 2015, J EXP BIOL, V218, P3276, DOI 10.1242/jeb.127142; Cavagna GA, 2009, EUR J APPL PHYSIOL, V107, P739, DOI 10.1007/s00421-009-1179-2; Enqvist JK, 2010, J SPORT SCI, V28, P947, DOI 10.1080/02640411003734069; EPSTEIN Y, 1987, EUR J APPL PHYSIOL O, V56, P495, DOI 10.1007/BF00635360; Fletcher JR, 2009, J APPL PHYSIOL, V107, P1918, DOI 10.1152/japplphysiol.00307.2009; Fordham S, 2004, BRIT J SPORT MED, V38, P300, DOI 10.1136/bjsm.2002.003350; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Jones AM, 1996, J SPORT SCI, V14, P321, DOI 10.1080/02640419608727717; Knapik JJ, 2012, J STRENGTH COND RES, V26, P585, DOI 10.1519/JSC.0b013e3182429853; Levada-Pires AC, 2010, EUR J APPL PHYSIOL, V109, P447, DOI 10.1007/s00421-010-1363-4; Lipman GS, 2014, WILD ENVIRON MED, V25, P457, DOI 10.1016/j.wem.2014.06.013; Lucas SJE, 2008, J SPORT SCI, V26, P477, DOI 10.1080/02640410701552872; Malek MH, 2007, J STRENGTH COND RES, V21, P29, DOI 10.1519/00124278-200702000-00006; Malek MH, 2009, CLIN PHYSIOL FUNCT I, V29, P143, DOI 10.1111/j.1475-097X.2008.00850.x; Pedersen AV, 2007, EUR J APPL PHYSIOL, V102, P27, DOI 10.1007/s00421-007-0553-1; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; RIBEIRO JP, 1986, EUR J APPL PHYSIOL O, V55, P215, DOI 10.1007/BF00715008; Saibene F, 2003, EUR J APPL PHYSIOL, V88, P297, DOI 10.1007/s00421-002-0654-9; Saunders PU, 2004, SPORTS MED, V34, P465, DOI 10.2165/00007256-200434070-00005; Shaw AJ, 2014, MED SCI SPORT EXER, V46, P1968, DOI 10.1249/MSS.0000000000000311; Simpson D, 2014, J HUMANIST PSYCHOL, V54, P113, DOI 10.1177/0022167813482188; Solomonson AA, 2016, J STRENGTH COND RES, V30, P1391, DOI 10.1519/JSC.0000000000001209; Sun XG, 2002, AM J RESP CRIT CARE, V166, P1443, DOI 10.1164/rccm.2202033; Tartaruga MP, 2014, INT J SPORT PHYSIOL, V9, P650, DOI [10.1123/ijspp.2013-0165, 10.1123/IJSPP.2013-0165]; WASSERMAN K, 1973, J APPL PHYSIOL, V35, P236, DOI 10.1152/jappl.1973.35.2.236; Zalcman I, 2007, NUTRITION, V23, P404, DOI 10.1016/j.nut.2007.01.001	32	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189516	10.1371/journal.pone.0189516	http://dx.doi.org/10.1371/journal.pone.0189516			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216289	Green Submitted, Green Published, gold			2022-12-27	WOS:000417337800125
J	Obuchi, T; Ikeda, S; Akiyama, K; Kabashima, Y				Obuchi, Tomoyuki; Ikeda, Shiro; Akiyama, Kazunori; Kabashima, Yoshiyuki			Accelerating cross-validation with total variation and its application to super-resolution imaging	PLOS ONE			English	Article								We develop an approximation formula for the cross-validation error (CVE) of a sparse linear regression penalized by l(1)-norm and total variation terms, which is based on a perturbative expansion utilizing the largeness of both the data dimensionality and the model. The developed formula allows us to reduce the necessary computational cost of the CVE evaluation significantly. The practicality of the formula is tested through application to simulated black-hole image reconstruction on the event-horizon scale with super resolution. The results demonstrate that our approximation reproduces the CVE values obtained via literally conducted cross-validation with reasonably good precision.	[Obuchi, Tomoyuki; Kabashima, Yoshiyuki] Tokyo Inst Technol, Dept Math & Comp Sci, Yokohama, Kanagawa 2268502, Japan; [Ikeda, Shiro] Inst Stat Math, Tachikawa, Tokyo 1908562, Japan; [Akiyama, Kazunori] MIT, Haystack Observ, Westford, MA 01886 USA; [Akiyama, Kazunori] Natl Astron Observ Japan, Osawa 2-21-1, Mitaka, Tokyo 1818588, Japan; [Akiyama, Kazunori] Harvard Univ, Black Hole Initiat, Cambridge, MA 02138 USA	Tokyo Institute of Technology; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; Massachusetts Institute of Technology (MIT); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Harvard University	Obuchi, T (corresponding author), Tokyo Inst Technol, Dept Math & Comp Sci, Yokohama, Kanagawa 2268502, Japan.	obuchi@c.titech.ac.jp	Ikeda, Shiro/E-1736-2016; Kabashima, Yoshiyuki/F-4719-2015	Ikeda, Shiro/0000-0002-2462-1448; Akiyama, Kazunori/0000-0002-9475-4254; Kabashima, Yoshiyuki/0000-0002-2949-7108; Obuchi, Tomoyuki/0000-0003-1216-489X	Japan Society for the Promotion of Science [25120008, 26870185, 25120013, 17H00764]; Research Abroad Program; National Science Foundation [AST-1614868]; Direct For Mathematical & Physical Scien [1614868] Funding Source: National Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Abroad Program; National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by Japan Society for the Promotion of Science 25120008 to Prof. Shiro Ikeda; 26870185 to Dr. Tomoyuki Obuchi; 25120013 to Prof. Yoshiyuki Kabashima; 17H00764 to Dr. Tomoyuki Obuchi and Prof. Yoshiyuki Kabashima; Research Abroad Program to Dr. Kazunori Akiyama; and National Science Foundation AST-1614868 to Dr. Kazunori Akiyama.	Akiyama K, 2017, ASTROPHYS J, V838, DOI 10.3847/1538-4357/aa6305; Akiyama K, 2017, ASTRON J, V153, DOI 10.3847/1538-3881/aa6302; Akiyama K, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/2/150; Asada K, ARXIV170504776; Bouman KL, 2016, PROC CVPR IEEE, P913, DOI 10.1109/CVPR.2016.105; Chael AA, 2016, ASTROPHYS J, V829, DOI 10.3847/0004-637X/829/1/11; Chambolle A, 2004, J MATH IMAGING VIS, V20, P89; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P231, DOI 10.1109/83.902288; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Hastie T., 2015, STAT LEARNING SPARSI; Honma M, 2016, J PHYS CONF SER, V699, DOI 10.1088/1742-6596/699/1/012006; Honma M, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu070; Ikeda S, 2016, PUBL ASTRON SOC JPN, V68, DOI 10.1093/pasj/psw042; Kabashima Y, ARXIV161007733; Li F., 2011, A A, VA31, P528; Mairal J, ARXIV14113230V2; Obuchi T., 2016, J STAT MECH-THEORY E, V2016; Rish I., 2014, SPARSE MODELING THEO; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wiaux Y, 2009, MON NOT R ASTRON SOC, V395, P1733, DOI 10.1111/j.1365-2966.2009.14665.x	21	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188012	10.1371/journal.pone.0188012	http://dx.doi.org/10.1371/journal.pone.0188012			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216215	Green Submitted, gold, Green Published			2022-12-27	WOS:000417337800016
J	Onelli, E; Moscatelli, A; Gagliardi, A; Zaninelli, M; Bini, L; Baldi, A; Caccianiga, M; Reggi, S; Rossi, L				Onelli, Elisabetta; Moscatelli, Alessandra; Gagliardi, Assunta; Zaninelli, Mauro; Bini, Luca; Baldi, Antonella; Caccianiga, Marco; Reggi, Serena; Rossi, Luciana			Retarded germination of Nicotiana tabacum seeds following insertion of exogenous DNA mimics the seed persistent behavior	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CLASS-I BETA-1,3-GLUCANASE; STORAGE PROTEINS; MOLECULAR CHAPERONES; DISULFIDE-ISOMERASE; ASPARTIC PROTEINASE; TOBACCO SEEDS; ENDOPLASMIC-RETICULUM; DORMANCY RELEASE; GENE-EXPRESSION	Tobacco seeds show a coat-imposed dormancy in which the seed envelope tissues (testa and endosperm) impose a physical constraint on the radicle protrusion. The germination-limiting process is represented by the endosperm rupture which is induced by cell-wall weakening. Transgenic tobacco seeds, obtained by insertion of exogenous genes codifying for seed-based oral vaccines (F18 and VT2eB), showed retarded germination with respect to the wild type and modified the expression of endogenous proteins. Morphological and proteomic analyses of wild type and transgenic seeds revealed new insights into factors influencing seed germination. Our data showed that the interference of exogenous DNA influences the germination rather than the dormancy release, by modifying the maturation process. Dry seeds of F18 and VT2eB transgenic lines accumulated a higher amount of reserve and stress-related proteins with respect to the wild type. Moreover, the storage proteins accumulated in tobacco F18 and VT2eB dry seeds have structural properties that do not enable the early limited proteolysis observed in the wild type. Morphological observations by electron and light microscopy revealed a retarded mobilization of the storage material from protein and lipid bodies in transgenic seeds, thus impairing water imbibition and embryo elongation. In addition, both F18 and VT2eB dry seeds are more rounded than the wild type. Both the morphological and biochemical characteristics of transgenic seeds mimic the seed persistent profile, in which their roundness enables them to be buried in the soil, while the higher content of storage material enables the hypocotyl to elongate more and the cotyledons to emerge.	[Onelli, Elisabetta; Moscatelli, Alessandra; Caccianiga, Marco] Univ Milan, Dept Biosci, Milan, Italy; [Gagliardi, Assunta; Bini, Luca] Univ Siena, Dept Life Sci, Lab Funct Prote, Siena, Italy; [Zaninelli, Mauro] Univ Telemat San Raffaele Roma, Dept Human Sci & Qual Life Promot, Rome, Italy; [Baldi, Antonella; Rossi, Luciana] Univ Milan, Dept Hlth Anim Sci & Food Safety, Milan, Italy; [Reggi, Serena] Plantechno Srl, Vicomoscano, Cremona, Italy; [Gagliardi, Assunta] Univ Trento, CIBIO, Trento, Italy	University of Milan; University of Siena; Universita Telematica San Raffaele; University of Milan; University of Trento	Moscatelli, A (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	alessandra.moscatelli@unimi.it	Rossi, Luciana/I-5142-2012; Zaninelli, Mauro/D-4626-2018; Moscatelli, alessandra/B-1138-2017	Rossi, Luciana/0000-0003-1178-4683; Zaninelli, Mauro/0000-0001-8800-1777; Moscatelli, alessandra/0000-0003-0912-5697	Linea B, VESPA Department, University of Milan; Plantechno SRL	Linea B, VESPA Department, University of Milan; Plantechno SRL	This study was funded by Linea B, VESPA Department, University of Milan. Plantechno SRL provided support in the form of salary for author [SR], but did not have any additional role in study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andriotis VME, 2010, NEW PHYTOL, V185, P649, DOI 10.1111/j.1469-8137.2009.03113.x; Barba-Espin G, 2011, PLANT CELL ENVIRON, V34, P1907, DOI 10.1111/j.1365-3040.2011.02386.x; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Bazin J, 2011, PLANT CELL, V23, P2196, DOI 10.1105/tpc.111.086694; BELOZERSKY MA, 1989, PLANTA, V177, P321, DOI 10.1007/BF00403589; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; Bove J, 2005, PLANT MOL BIOL, V57, P593, DOI 10.1007/s11103-005-0953-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cerabolini B, 2003, SEED SCI RES, V13, P75, DOI 10.1079/SSR2002126; Cervantes E, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/5691825; Chibani K, 2006, PLANT PHYSIOL, V142, P1493, DOI 10.1104/pp.106.087452; Cohen J, 2002, SCIENCE, V296, P2164, DOI 10.1126/science.296.5576.2164; Colville L, 2010, PLANT GROWTH REGUL, V62, P241, DOI 10.1007/s10725-010-9482-9; Cuming AC, 1999, SEED PROTEINS, P753; DURE L, 1983, PLANT MOL BIOL, V2, P199, DOI 10.1007/BF01578379; Fait A, 2006, PLANT PHYSIOL, V142, P839, DOI 10.1104/pp.106.086694; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Funes G, 1999, SEED SCI RES, V9, P341, DOI 10.1017/S0960258599000355; Gao F, 2013, PLANT BIOTECHNOL J, V11, P921, DOI 10.1111/pbi.12083; Gardarin A, 2013, WEED RES, V55, P14; Gardarin A, 2011, ECOL MODEL, V222, P626, DOI 10.1016/j.ecolmodel.2010.10.005; Gendreau E, 2008, J EXP BOT, V59, P203, DOI 10.1093/jxb/erm296; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hendrick JP, 1995, FASEB J, V9, P1559, DOI 10.1096/fasebj.9.15.8529835; Hiraiwa N, 1997, EUR J BIOCHEM, V246, P133, DOI 10.1111/j.1432-1033.1997.00133.x; HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P412, DOI 10.1016/0003-2697(88)90208-4; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Holdsworth MJ, 2008, TRENDS PLANT SCI, V13, P7, DOI 10.1016/j.tplants.2007.11.002; Hua ShuiJin, 2012, African Journal of Agricultural Research, V7, P2475; Jiang LW, 2001, J CELL BIOL, V155, P991, DOI 10.1083/jcb.200107012; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; Jung R, 1998, PLANT CELL, V10, P343, DOI 10.1105/tpc.10.3.343; Jung YuJin, 2014, Plant Breeding and Biotechnology, V2, P370, DOI 10.9787/PBB.2014.2.4.370; Kalemba E.M., 2007, BIOL LETT, V44, P3; Kim YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044493; Kimura S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0460-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laino P, 2010, PROTEOMICS, V10, P2359, DOI 10.1002/pmic.200900803; Lal SK, 1998, PLANT PHYSIOL, V118, P1285, DOI 10.1104/pp.118.4.1285; Leborgne-Castel N, 1999, PLANT CELL, V11, P459, DOI 10.1105/tpc.11.3.459; Lee GJ, 2000, PLANT PHYSIOL, V122, P189, DOI 10.1104/pp.122.1.189; Leishman MR, 1998, FUNCT ECOL, V12, P480, DOI 10.1046/j.1365-2435.1998.00215.x; Leprince O, 2010, PLANT SCI, V179, P554, DOI 10.1016/j.plantsci.2010.02.011; Leubner-Metzger G, 2005, PLANT J, V41, P133, DOI 10.1111/j.1365-313X.2004.02284.x; Leubner-Metzger G, 2003, SEED SCI RES, V13, P17, DOI 10.1079/SSR2002121; Leubner-Metzger G, 2002, PLANTA, V215, P959, DOI 10.1007/s00425-002-0837-y; Leubner-Metzger G, 2001, J EXP BOT, V52, P1753, DOI 10.1093/jexbot/52.362.1753; Li QB, 2001, PLANT PHYSIOL, V125, P1633, DOI 10.1104/pp.125.4.1633; Lichtenthaler HK, 1997, PHYSIOL PLANTARUM, V101, P643, DOI 10.1111/j.1399-3054.1997.tb01049.x; Long RL, 2015, BIOL REV, V90, P31, DOI 10.1111/brv.12095; Lubaretz O, 2002, PLANTA, V215, P220, DOI 10.1007/s00425-002-0745-1; Lytle BL, 2009, PROTEINS, V76, P237, DOI 10.1002/prot.22396; MADISON JT, 1981, ANN BOT-LONDON, V47, P65, DOI 10.1093/oxfordjournals.aob.a086001; Manz B, 2005, PLANT PHYSIOL, V138, P1538, DOI 10.1104/pp.105.061663; MEEKSWAGNER DR, 1989, PLANT CELL, V1, P25, DOI 10.1105/tpc.1.1.25; Moles AT, 2000, OIKOS, V89, P541, DOI 10.1034/j.1600-0706.2000.890313.x; Moscatelli A, 2015, BIOL OPEN, V4, P378, DOI 10.1242/bio.201410249; Muller K, 2010, PROTEOMICS, V10, P406, DOI 10.1002/pmic.200900548; Mutlu A, 1998, PHYTOCHEMISTRY, V47, P1453, DOI 10.1016/S0031-9422(97)00834-0; Mutlu A, 1999, SEED SCI RES, V9, P75, DOI 10.1017/S0960258599000082; Myernic JA, 1996, TRENDS PLANT SCI, V2, P180; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; NEALE AD, 1990, PLANT CELL, V2, P673, DOI 10.1105/tpc.2.7.673; NESSLER CL, 1985, PLANT PHYSIOL, V79, P499, DOI 10.1104/pp.79.2.499; NESSLER CL, 1992, PLANT MOL BIOL, V20, P749, DOI 10.1007/BF00046460; Nielsen KM, 2003, NAT BIOTECHNOL, V21, P227, DOI 10.1038/nbt0303-227; Nonogaki H, 2010, PLANT SCI, V179, P574, DOI 10.1016/j.plantsci.2010.02.010; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; Onda Y, 2011, PLANT CELL, V23, P210, DOI 10.1105/tpc.110.079509; Ondzighi CA, 2008, PLANT CELL, V20, P2205, DOI 10.1105/tpc.108.058339; Oracz K, 2007, PLANT J, V50, P452, DOI 10.1111/j.1365-313X.2007.03063.x; Osmark P, 1998, PLANT MOL BIOL, V38, P1243, DOI 10.1023/A:1006060224012; Otegui MS, 2006, PLANT CELL, V18, P2567, DOI 10.1105/tpc.106.040931; Penfield S, 2004, PLANT CELL, V16, P2705, DOI 10.1105/tpc.104.024711; QI QG, 1994, PLANTA, V194, P193, DOI 10.1007/BF01101678; Rajjou L, 2012, ANNU REV PLANT BIOL, V63, P507, DOI 10.1146/annurev-arplant-042811-105550; Reggi S, 2005, PLANT MOL BIOL, V57, P101, DOI 10.1007/s11103-004-6832-x; Rossi L, 2011, IJAS S, V1, P19; Rossi L, 2014, VET RES COMMUN, V38, P39, DOI 10.1007/s11259-013-9583-9; Rossi L, 2013, J VET SCI, V14, P263, DOI 10.4142/jvs.2013.14.3.263; RUNEBERGROOS P, 1994, PLANT PHYSIOL, V105, P321, DOI 10.1104/pp.105.1.321; Sadiq I, 2011, J PLANT PHYSIOL, V168, P2234, DOI 10.1016/j.jplph.2011.07.009; Satoh-Cruz M, 2010, PLANT CELL PHYSIOL, V51, P1581, DOI 10.1093/pcp/pcq098; SCHULZESIEBERT D, 1984, PLANT PHYSIOL, V76, P465, DOI 10.1104/pp.76.2.465; Sharma A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148449; Shutov AD, 2003, J EXP BOT, V54, P1645, DOI 10.1093/jxb/erg165; SHUTOV AD, 1987, PHYTOCHEMISTRY, V26, P1557, DOI 10.1016/S0031-9422(00)82245-1; Sinha P, 2001, PROTEOMICS, V1, P835, DOI 10.1002/1615-9861(200107)1:7<835::AID-PROT835>3.3.CO;2-U; Soskic V, 1999, BIOCHEMISTRY-US, V38, P1757, DOI 10.1021/bi982093r; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; Takemoto Y, 2002, PLANT PHYSIOL, V128, P1212, DOI 10.1104/pp.010624; Tan-Wilson AL, 2012, PHYSIOL PLANTARUM, V145, P140, DOI 10.1111/j.1399-3054.2011.01535.x; THOMPSON K, 1993, FUNCT ECOL, V7, P236, DOI 10.2307/2389893; Thompson K, 2001, SEED SCI RES, V11, P345; Nguyen PT, 2015, J EXP BOT, V66, P6399, DOI 10.1093/jxb/erv348; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Voll LM, 2009, NEW PHYTOL, V184, P607, DOI 10.1111/j.1469-8137.2009.02998.x; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Wehmeyer N, 2000, PLANT PHYSIOL, V122, P1099, DOI 10.1104/pp.122.4.1099; Wehmeyer N, 1996, PLANT PHYSIOL, V112, P747, DOI 10.1104/pp.112.2.747; Wise MJ, 2004, TRENDS PLANT SCI, V9, P13, DOI 10.1016/j.tplants.2003.10.012; Witzel K, 2010, PLANT CELL ENVIRON, V33, P211, DOI 10.1111/j.1365-3040.2009.02071.x; Yan DW, 2014, PLANT CELL PHYSIOL, V55, P1521, DOI 10.1093/pcp/pcu089; Yeh CH, 2002, PLANT PHYSIOL, V128, P661, DOI 10.1104/pp.010594; Yuen CYL, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0869-2; ZURNIEDEN U, 1995, PLANTA, V196, P530	113	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0187929	10.1371/journal.pone.0187929	http://dx.doi.org/10.1371/journal.pone.0187929			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216220	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800015
J	Sugano, Y; Keetels, M; Vroomen, J				Sugano, Yoshimori; Keetels, Mirjam; Vroomen, Jean			Audio-motor but not visuo-motor temporal recalibration speeds up sensory processing	PLOS ONE			English	Article							DELAYED AUDITORY-FEEDBACK; REACTION-TIME; CROSSMODAL INTERACTION; BEAT PERCEPTION; INTERNAL CLOCK; CAUSAL BINDING; NEURAL BASIS; ADAPTATION; ORDER; ATTENTION	Perception of synchrony between one's own action (a finger tap) and the sensory feedback thereof (a visual flash or an auditory pip) can be recalibrated after exposure to an artificially inserted delay between them (temporal recalibration effect: TRE). TRE might be mediated by a compensatory shift of motor timing (when did I tap?) and/or the sensory timing of the feedback (when did I hear/see the feedback?). To examine this, we asked participants to voluntarily tap their index finger at a constant pace while receiving visual or auditory feedback (a flash or pip) that was either synced or somewhat delayed relative to the tap. Following this exposure phase, they then performed a simple reaction time (RT) task to measure the sensory timing of the exposure stimulus, and a sensorimotor synchronization (SMS) task (tapping in synchrony with a flash or pip as pacing stimulus) to measure the point of subjective synchrony between the tap and pacing stimulus. The results showed that after exposure to delayed auditory feedback, participants tapped earlier (similar to 21.5 ms) relative to auditory pacing stimuli (= temporal recalibration) and reacted faster (similar to 5.6 ms) to auditory stimuli. For visual exposure and test stimuli, there were no such compensatory effects. These results indicate that adjustments of audio-motor synchrony can to some extent be explained by a change in the speed of auditory sensory processing. We discuss this in terms of an attentional modulation of sensory processing.	[Sugano, Yoshimori] Kyushu Sangyo Univ, Dept Ind Management, Fukuoka, Japan; [Keetels, Mirjam; Vroomen, Jean] Tilburg Univ, Dept Cognit Neuropsychol, Tilburg, Netherlands	Tilburg University	Sugano, Y (corresponding author), Kyushu Sangyo Univ, Dept Ind Management, Fukuoka, Japan.; Vroomen, J (corresponding author), Tilburg Univ, Dept Cognit Neuropsychol, Tilburg, Netherlands.	sugano@ip.kyusan-u.ac.jp; J.Vroomen@uvt.nl	Vroomen, Jean/K-1033-2013	Vroomen, Jean/0000-0001-5923-5988; Keetels, Mirjam/0000-0002-1554-9229	Kyushu Sangyo University; Tilburg University; JSPS KAKENHI [JP26380998, 26380998]	Kyushu Sangyo University; Tilburg University; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by Kyushu Sangyo University, Tilburg University and JSPS KAKENHI Grant Number JP26380998. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Kyushu Sangyo University, Tilburg University and JSPS KAKENHI Grant Number 26380998. We thank the editor and two anonymous reviewers for their helpful comments and suggestions on a previous version of this manuscript.	Allman MJ, 2014, ANNU REV PSYCHOL, V65, P743, DOI 10.1146/annurev-psych-010213-115117; [Anonymous], 1990, PSYCHOL RES, V52, P28; Aschersleben G, 2003, INT J PSYCHOPHYSIOL, V50, P157, DOI 10.1016/S0167-8760(03)00131-4; Aschersleben G, 2002, BRAIN COGNITION, V48, P66, DOI 10.1006/brcg.2001.1304; Aschersleben G, 1997, J MOTOR BEHAV, V29, P35, DOI 10.1080/00222899709603468; Balota DA, 1999, J EXP PSYCHOL GEN, V128, P32, DOI 10.1037/0096-3445.128.1.32; Bertelson P, 2003, INT J PSYCHOPHYSIOL, V50, P147, DOI 10.1016/S0167-8760(03)00130-2; Buehner MJ, 2009, PSYCHOL SCI, V20, P1221, DOI 10.1111/j.1467-9280.2009.02435.x; Buhusi CV, 2009, PHILOS T R SOC B, V364, P1875, DOI 10.1098/rstb.2009.0022; Burge J, 2010, J NEUROSCI, V30, P7714, DOI 10.1523/JNEUROSCI.6427-09.2010; Cai MB, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00470; Cardoso-Leite P, 2007, J VISION, V7, DOI 10.1167/7.6.11; Chen LH, 2013, ATTEN PERCEPT PSYCHO, V75, P244, DOI [10.3758/s13414-012-0395-8, 10.3758/s13414-013-0475-4]; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; Coull JT, 1998, J NEUROSCI, V18, P7426; Coull JT, 2004, COGNITIVE BRAIN RES, V21, P216, DOI 10.1016/j.cogbrainres.2004.02.011; Cunningham DW, 2001, PSYCHOL SCI, V12, P532, DOI 10.1111/1467-9280.d01-17; Desantis A, 2011, CONSCIOUS COGN, V20, P1211, DOI 10.1016/j.concog.2011.02.012; Di Luca M, 2009, J VISION, V9, DOI 10.1167/9.12.7; ELLIOTT R, 1968, PSYCHON SCI, V10, P335; Engbert K, 2007, J EXP PSYCHOL HUMAN, V33, P1261, DOI 10.1037/0096-1523.33.6.1261; Engbert K, 2008, COGNITION, V107, P693, DOI 10.1016/j.cognition.2007.07.021; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Fraisse Paul, INTERSENSORY PERCEPT, P217, DOI DOI 10.1007/978-1-4615-9197-9_7; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Fujisaki W, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00061; GIRAY M, 1993, J EXP PSYCHOL HUMAN, V19, P1278, DOI 10.1037/0096-1523.19.6.1278; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Grahn JA, 2012, EXP BRAIN RES, V220, P51, DOI 10.1007/s00221-012-3114-8; Grahn JA, 2009, J NEUROSCI, V29, P7540, DOI 10.1523/JNEUROSCI.2018-08.2009; GRONDIN S, 1993, PERCEPT PSYCHOPHYS, V54, P383, DOI 10.3758/BF03205274; Grondin S, 1998, PSYCHOL RES-PSYCH FO, V61, P261, DOI 10.1007/s004260050030; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Hanson JVM, 2008, EXP BRAIN RES, V185, P347, DOI 10.1007/s00221-008-1282-3; Harrar V, 2008, EXP BRAIN RES, V186, P517, DOI 10.1007/s00221-007-1253-0; Harrar V, 2017, EXP BRAIN RES, V235, P763, DOI 10.1007/s00221-016-4822-2; Heron J, 2012, P ROY SOC B-BIOL SCI, V279, P690, DOI 10.1098/rspb.2011.1131; Heron J, 2010, EUR J NEUROSCI, V31, P1755, DOI 10.1111/j.1460-9568.2010.07194.x; Heron J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007681; HILLYARD SA, 1984, PERCEPT PSYCHOPHYS, V36, P185, DOI 10.3758/BF03202679; Hove MJ, 2013, NEUROIMAGE, V67, P313, DOI 10.1016/j.neuroimage.2012.11.032; Howell D.C., 2010, STAT METHODS PSYCHOL, V7; Hughes RW, 2005, J EXP PSYCHOL LEARN, V31, P736, DOI 10.1037/0278-7393.31.4.736; Humphreys GR, 2009, J EXP PSYCHOL HUMAN, V35, P1542, DOI 10.1037/a0014492; Ikumi N, 2014, PLOS ONE, V9; JASKOWSKI P, 1990, PSYCHOL RES-PSYCH FO, V52, P35, DOI 10.1007/BF00867209; Jaskowski P., 1999, ADV PSYCHOL, V129, DOI [10.1016/S0166- 4115(99)80026-0, DOI 10.1016/S0166-4115(99)80026-0]; Keetels M., 2012, NEURAL BASEMULTISE, P147; Keetels M, 2007, EXP BRAIN RES, V182, P559, DOI 10.1007/s00221-007-1012-2; Keetels M, 2012, EXP BRAIN RES, V219, P431, DOI 10.1007/s00221-012-3081-0; Kennedy JS, 2009, Q J EXP PSYCHOL, V62, P453, DOI 10.1080/17470210801985235; Kieffaber PD, 2006, SCHIZOPHR RES, V84, P345, DOI 10.1016/j.schres.2006.01.022; KOLERS PA, 1985, J EXP PSYCHOL HUMAN, V11, P150, DOI 10.1037/0096-1523.11.2.150; Large EW, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00159; Leiva A, 2015, EXP PSYCHOL, V62, P54, DOI 10.1027/1618-3169/a000273; Luce RD, 1986, RESPONSE TIMES THEIR; LUPP U, 1976, VISION RES, V16, P969, DOI 10.1016/0042-6989(76)90228-5; Matzke D, 2009, PSYCHON B REV, V16, P798, DOI 10.3758/PBR.16.5.798; McDonald JJ, 2005, NAT NEUROSCI, V8, P1197, DOI 10.1038/nn1512; MECK WH, 1984, ANN NY ACAD SCI, V423, P528, DOI 10.1111/j.1749-6632.1984.tb23457.x; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Moore J, 2008, CONSCIOUS COGN, V17, P136, DOI 10.1016/j.concog.2006.12.004; Moore JW, 2012, CONSCIOUS COGN, V21, P546, DOI 10.1016/j.concog.2011.12.002; Navarra J, 2005, COGNITIVE BRAIN RES, V25, P499, DOI 10.1016/j.cogbrainres.2005.07.009; Navarra J, 2007, NEUROSCI LETT, V413, P72, DOI 10.1016/j.neulet.2006.11.027; Navarra J, 2009, P NATL ACAD SCI USA, V106, P9169, DOI 10.1073/pnas.0810486106; NIEMI P, 1979, ACTA PSYCHOL, V43, P299, DOI 10.1016/0001-6918(79)90038-6; Nijhawan R, 2008, BEHAV BRAIN SCI, V31, P179, DOI 10.1017/S0140525X08003804; Parsons BD, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00046; Perruchoud D, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00458; Pesavento MJ, 2006, EXP BRAIN RES, V174, P435, DOI 10.1007/s00221-006-0476-9; Pfordresher PQ, 2011, J EXP PSYCHOL HUMAN, V37, P566, DOI 10.1037/a0021487; Pfordresher PQ, 2002, PSYCHOL RES-PSYCH FO, V66, P71, DOI 10.1007/s004260100075; Pikovsky A, 2001, SYNCHRONIZATION UNIV; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; RATCLIFF R, 1979, PSYCHOL BULL, V86, P446, DOI 10.1037/0033-2909.86.3.446; RATCLIFF R, 1976, PSYCHOL REV, V83, P190, DOI 10.1037/0033-295X.83.3.190; Repp BH, 2000, PSYCHOL RES-PSYCH FO, V63, P106, DOI 10.1007/PL00008170; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2004, PSYCHOL RES-PSYCH FO, V68, P252, DOI 10.1007/s00426-003-0143-8; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P1085, DOI 10.1037//0096-1523.28.5.1085; Roach NW, 2011, P ROY SOC B-BIOL SCI, V278, P1314, DOI 10.1098/rspb.2010.1737; Rohde M., 2013, FRONT PSYCHOL, V3, P599, DOI [10.3389/fpsyg.2012.00599, DOI 10.3389/fpsyg.2012.00599]; Rohde M, 2014, J VISION, V14, DOI 10.1167/14.3.4; Rohde M, 2014, ACTA PSYCHOL, V147, P127, DOI 10.1016/j.actpsy.2013.07.011; Roseboom W, 2011, PSYCHOL SCI, V22, P872, DOI 10.1177/0956797611413293; SANFORD AJ, 1974, J EXP PSYCHOL, V102, P443, DOI 10.1037/h0035871; Schmidt R. A, 2011, MOTOR CONTROL LEARNI; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Spence C, 2001, J EXP PSYCHOL GEN, V130, P799, DOI 10.1037//0096-3445.130.4.799; Stauffer CC, 2012, PSYCHOL RES-PSYCH FO, V76, P20, DOI 10.1007/s00426-011-0333-8; Stekelenburg JJ, 2011, BRAIN RES, V1397, P46, DOI 10.1016/j.brainres.2011.04.045; Sternberg S., 1973, ATTENTION PERFORM, VIV, P629; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; Sugano Y, 2015, IEICE TECHNICAL REPO, V115, P71; Sugano Y, 2017, P 33 ANN M INT SOC P, P118; Sugano Y, 2016, EXP BRAIN RES, V234, P1249, DOI 10.1007/s00221-015-4497-0; Sugano Y, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00140; Sugano Y, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00246; Sugano Y, 2010, EXP BRAIN RES, V201, P393, DOI 10.1007/s00221-009-2047-3; Takahashi K, 2008, NEUROREPORT, V19, P319, DOI 10.1097/WNR.0b013e3282f4f039; Teki S, 2012, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00090; Teki S, 2011, J NEUROSCI, V31, P3805, DOI 10.1523/JNEUROSCI.5561-10.2011; Thaut MH, 1999, IEEE ENG MED BIOL, V18, P101, DOI 10.1109/51.752991; Timm J, 2014, CONSCIOUS COGN, V23, P42, DOI 10.1016/j.concog.2013.11.002; Titchener E. B., 1908, LECT ELEMENTARY PSYC, DOI 10.1037/10867-000; Toida K, 2014, P 15 INT MULT RES FO, P216; Toida K, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00688; Tsujita M, 2016, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00064; Tsujita M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00487; ULRICH R, 1984, PERCEPT PSYCHOPHYS, V36, P545, DOI 10.3758/BF03207515; Vatakis A, 2008, EXP BRAIN RES, V185, P521, DOI 10.1007/s00221-007-1168-9; Vercillo T, 2015, DEVELOPMENTAL SCI, V18, P703, DOI 10.1111/desc.12247; Vibell J, 2007, J COGNITIVE NEUROSCI, V19, P109, DOI 10.1162/jocn.2007.19.1.109; Vorberg D., 1996, HDB PERCEPT ACTION, P181, DOI [10.1016/S1874-5822(06)80007-1, DOI 10.1016/S1874-5822(06)80007-1, 10.1016/S1874-5822(06)80007-1.]; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Wenke D, 2009, EXP BRAIN RES, V196, P311, DOI 10.1007/s00221-009-1848-8; Winter R, 2008, BRAIN RES, V1242, P54, DOI 10.1016/j.brainres.2008.06.090; Wohlschlager A, 2003, CONSCIOUS COGN, V12, P708, DOI 10.1016/S1053-8100(03)00083-7; Wohlschlager A., 2000, RHYTHM PERCEPTION PE, P115; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Yabe Y, 2015, J NEUROSCI, V35, P5023, DOI 10.1523/JNEUROSCI.4386-14.2015; Yamamoto K, 2014, EXP BRAIN RES, V232, P3707, DOI 10.1007/s00221-014-4055-1; Yamamoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029414; Yarrow K, 2013, J EXP PSYCHOL HUMAN, V39, P1678, DOI 10.1037/a0032534; Yuan XY, 2015, ATTEN PERCEPT PSYCHO, V77, P1321, DOI 10.3758/s13414-015-0856-y	131	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189242	10.1371/journal.pone.0189242	http://dx.doi.org/10.1371/journal.pone.0189242			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216307	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800106
J	Muniz-Talavera, H; Schmidt, JV				Muniz-Talavera, Hilmarie; Schmidt, Jennifer V.			The mouse Jhy gene regulates ependymal cell differentiation and ciliogenesis	PLOS ONE			English	Article							NEURAL STEM-CELLS; PRIMARY CILIARY DYSKINESIA; ADHERENS JUNCTIONS; PLANAR POLARITY; VENTRICULAR ZONE; RADIAL GLIA; N-CADHERIN; HYDROCEPHALUS FORMATION; ABNORMAL NEUROGENESIS; CATENIN COMPLEX	During the first postnatal week of mouse development, radial glial cells lining the ventricles of the brain differentiate into ependymal cells, undergoing a morphological change from pseudostratified cuboidal cells to a flattened monolayer. Concomitant with this change, multiple motile cilia are generated and aligned on each nascent ependymal cell. Proper ependymal cell development is crucial to forming the brain tissue:CSF barrier, and to the establishment of ciliary CSF flow, but the mechanisms that regulate this differentiation event are poorly understood. The Jhy(lacZ) mouse line carries an insertional mutation in the Jhy gene (formerly 4931429I11Rik), and homozygous Jhy(lacZ/lacZ) mice develop a rapidly progressive juvenile hydrocephalus, with defects in ependymal cilia morphology and ultrastructure. Here we show that beyond just defective motile cilia, Jhy(lacZ/lacZ) mice display abnormal ependymal cell differentiation. Ventricular ependyma in Jhy(lacZ/lacZ) mice retain an unorganized and multi-layered morphology, representative of undifferentiated ependymal (radial glial) cells, and they show altered expression of differentiation markers. Most Jhy(lacZ/lacZ) ependymal cells do eventually acquire some differentiated ependymal characteristics, suggesting a delay, rather than a block, in the differentiation process, but ciliogenesis remains perturbed. Jhy(lacZ/lacZ) ependymal cells also manifest disruptions in adherens junction formation, with altered N-cadherin localization, and have defects in the polarized organization of the apical motile cilia that do form. Functional studies showed that cilia of Jhy(lacZ/lacZ) mice have severely reduced motility, a potential cause for the development of hydrocephalus. This work shows that JHY does not only control ciliogenesis, but is a crucial component of the ependymal differentiation process, with ciliary defects likely a consequence of altered ependymal differentiation.	[Muniz-Talavera, Hilmarie; Schmidt, Jennifer V.] Univ Illinois, Dept Biol Sci, S Ashland Ave, Chicago, IL 60680 USA; [Muniz-Talavera, Hilmarie] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Schmidt, Jennifer V.] Shark Res Inst, Sci Res, Crystal Beach, TX 77550 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; St Jude Children's Research Hospital	Schmidt, JV (corresponding author), Univ Illinois, Dept Biol Sci, S Ashland Ave, Chicago, IL 60680 USA.; Schmidt, JV (corresponding author), Shark Res Inst, Sci Res, Crystal Beach, TX 77550 USA.	jennifer@sharks.org			National Institutes of Health [NS065188, S10RR025629]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by grants from the National Institutes of Health (NS065188) to JVS, and (S10RR025629) to Peter Toth.	Abouhamed M, 2009, MOL BIOL CELL, V20, P5074, DOI 10.1091/mbc.E09-04-0291; Appelbe OK, 2013, DEV BIOL, V382, P172, DOI 10.1016/j.ydbio.2013.07.003; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baas D, 2006, EUR J NEUROSCI, V24, P1020, DOI 10.1111/j.1460-9568.2006.05002.x; Bertocchi Cristina, 2012, J Signal Transduct, V2012, P125295, DOI 10.1155/2012/125295; Boutin C, 2014, P NATL ACAD SCI USA, V111, pE3129, DOI 10.1073/pnas.1404988111; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; BRUNI JE, 1985, BRAIN RES REV, V9, P1, DOI 10.1016/0165-0173(85)90016-5; Bruni JE, 1998, MICROSC RES TECHNIQ, V41, P2, DOI 10.1002/(SICI)1097-0029(19980401)41:1<2::AID-JEMT2>3.3.CO;2-T; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Chilov D, 2011, DEV BIOL, V357, P259, DOI 10.1016/j.ydbio.2011.06.029; Choksi SP, 2014, DEVELOPMENT, V141, P3410, DOI 10.1242/dev.108209; Clare DK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5888; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Davy BE, 2003, HUM MOL GENET, V12, P1163, DOI 10.1093/hmg/ddg122; Del Bigio MR, 2010, ACTA NEUROPATHOL, V119, P55, DOI 10.1007/s00401-009-0624-y; Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld; DIDIER M, 1986, CELL TISSUE RES, V245, P343; Etienne-Manneville S, 2011, SEMIN CELL DEV BIOL, V22, P850, DOI 10.1016/j.semcdb.2011.07.023; Batiz LF, 2011, ACTA NEUROPATHOL, V121, P721, DOI 10.1007/s00401-011-0799-x; Garcia-Verdugo JM, 2002, BRAIN RES BULL, V57, P765, DOI 10.1016/S0361-9230(01)00769-9; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Harding MJ, 2014, DEVELOPMENT, V141, P2549, DOI 10.1242/dev.101444; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hirota Y, 2010, DEVELOPMENT, V137, P3037, DOI 10.1242/dev.050120; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Ibanez-Tallon I, 2002, HUM MOL GENET, V11, P715, DOI 10.1093/hmg/11.6.715; Ivliev AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035618; Jacquet BV, 2011, J NEUROSCI, V31, P9368, DOI 10.1523/JNEUROSCI.0171-11.2011; Jacquet BV, 2009, DEVELOPMENT, V136, P4021, DOI 10.1242/dev.041129; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Kishimoto N, 2012, DIFFERENTIATION, V83, pS86, DOI 10.1016/j.diff.2011.10.007; Kowalczyk Andrew P, 2012, Subcell Biochem, V60, P197, DOI 10.1007/978-94-007-4186-7_9; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Ladoux B, 2015, INTEGR BIOL-UK, V7, P1109, DOI 10.1039/c5ib00070j; Lattke M, 2012, J NEUROSCI, V32, P11511, DOI 10.1523/JNEUROSCI.0182-12.2012; Lavado A, 2011, DEVELOPMENT, V138, P5291, DOI 10.1242/dev.067470; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Lechtreck KF, 2007, J CELL BIOL, V176, P473, DOI 10.1083/jcb.200611115; Lindqvist M, 2010, J CELL SCI, V123, P472, DOI 10.1242/jcs.048074; McEwen Abbye E, 2012, Subcell Biochem, V60, P171, DOI 10.1007/978-94-007-4186-7_8; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Mirzadeh Z, 2010, J NEUROSCI, V30, P2600, DOI 10.1523/JNEUROSCI.3744-09.2010; Guerra MM, 2015, J NEUROPATH EXP NEUR, V74, P653, DOI 10.1097/NEN.0000000000000203; Nagaoka T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06940; Nakamura T, 2008, GENE DEV, V22, P1244, DOI 10.1101/gad.1632308; O'Callaghan Chris, 2012, Cilia, V1, P8, DOI 10.1186/2046-2530-1-8; Ohata S, 2015, J NEUROSCI, V35, P11153, DOI 10.1523/JNEUROSCI.0686-15.2015; Ohata S, 2014, NEURON, V83, P558, DOI 10.1016/j.neuron.2014.06.022; Oliver C, 2013, J NEUROPATH EXP NEUR, V72, P846, DOI 10.1097/NEN.0b013e3182a2d5fe; Orsulic S, 1999, J CELL SCI, V112, P1237; Peng X, 2013, PROTEIN CELL, V4, P231, DOI 10.1007/s13238-012-2098-2; Rappl A, 2008, J CELL SCI, V121, P4089, DOI 10.1242/jcs.027995; Rodriguez EM, 2012, BIOL RES, V45, P231, DOI 10.4067/S0716-97602012000300005; Rubenstein JL, 2013, COMPREHENSIVE DEV NE, P974; Sadot E, 1998, P NATL ACAD SCI USA, V95, P15339, DOI 10.1073/pnas.95.26.15339; Shibata T, 1997, J NEUROSCI, V17, P9212; Shindo M, 2008, DEVELOPMENT, V135, P1355, DOI 10.1242/dev.015982; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Stocker AM, 2015, CELL ADHES MIGR, V9, P167, DOI 10.1080/19336918.2015.1027478; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; Wallingford JB, 2010, CURR OPIN CELL BIOL, V22, P597, DOI 10.1016/j.ceb.2010.07.011; Yamamoto H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080356; Ying GX, 2014, J NEUROSCI, V34, P6377, DOI 10.1523/JNEUROSCI.0067-14.2014; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; Zhang JN, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-7; Zhou J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002516	76	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0184957	10.1371/journal.pone.0184957	http://dx.doi.org/10.1371/journal.pone.0184957			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211732	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200003
J	Vacquie-Garcia, J; Lydersen, C; Biuw, M; Haug, T; Fedak, MA; Kovacs, KM				Vacquie-Garcia, Jade; Lydersen, Christian; Biuw, Martin; Haug, Tore; Fedak, Mike A.; Kovacs, Kit M.			Hooded seal Cystophora cristata foraging areas in the Northeast Atlantic Ocean-Investigated using three complementary methods	PLOS ONE			English	Article							SOUTHERN ELEPHANT SEALS; HARP PAGOPHILUS-GROENLANDICUS; TRACKED KING PENGUINS; DRIFT ICE WATERS; DIVING BEHAVIOR; HABITAT USE; SATELLITE TELEMETRY; SEXUAL SEGREGATION; EAST-COAST; MOVEMENTS	Identifying environmental characteristics that define the ecological niche of a species is essential to understanding how changes in physical conditions might affect its distribution and other aspects of its ecology. The present study used satellite relay data loggers (SRDLs) to study habitat use by Northeast Atlantic hooded seals (N = 20; 9 adult females, 3 adult males, and 8 juveniles). Three different methods were used in combination to achieve maximum insight regarding key foraging areas for hooded seals in this region, which have decline by 85% in recent decades: 1) first passage time (FPT); 2) vertical transit rate and; 3) change in dive drift rate. Generalized additive mixed models (GAMM) were applied to each method to determine whether specific habitat characteristics were associated with foraging. Separate models were run for the post-molting and the post-breeding seasons; sex and age classes were included in the GAMMs. All three methods highlighted a few common geographic areas as being important foraging zones; however, there were also some different areas identified by the different methods, which highlights the importance of using multiple indexes when analyzing tracking and diving data to study foraging behavior. Foraging occurred most commonly in relatively shallow areas with high Sea Surface Temperatures (SST), corresponding to continental shelf areas with Atlantic Water masses. All age and sex classes overlapped spatially to some extent, but the different age and sex groups showed differences in the bathymetry of their foraging areas as well as in their vertical use of the water column. When foraging, pups dove in the upper part of the water column in relatively deep areas. Adult females foraged relatively shallowly in deep water areas too, though in shallower areas than pups. Adult males foraged close to the bottom in shallower areas.	[Vacquie-Garcia, Jade; Lydersen, Christian; Biuw, Martin; Kovacs, Kit M.] Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway; [Biuw, Martin; Haug, Tore] Inst Marine Res, Tromso, Norway; [Fedak, Mike A.] Univ St Andrews, Scottish Oceans Inst, St Andrews, Fife, Scotland	Norwegian Polar Institute; Institute of Marine Research - Norway; University of St Andrews	Vacquie-Garcia, J (corresponding author), Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway.	jadevacquiegarcia@gmail.com	Fedak, Michael A/B-3987-2009; Biuw, Martin/AAF-9895-2021	Fedak, Michael A/0000-0002-9569-1128; Biuw, Martin/0000-0001-8051-3399; VACQUIE GARCIA, Jade/0000-0002-3126-3423	Norwegian Research Council within Norwegian International Polar Year programme [176477/S30]; Norwegian Polar Institute	Norwegian Research Council within Norwegian International Polar Year programme; Norwegian Polar Institute	This work was funded by the Norwegian Research Council (grant number 176477/S30), within the Norwegian International Polar Year programme and the Norwegian Polar Institute.	Amente C, 2009, NGDC24 NOAA NESDIS; Andersen JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103072; Andersen JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080438; Andersen JM, 2013, ICES J MAR SCI, V70, P173, DOI 10.1093/icesjms/fss133; Andersen Julie M., 2009, Journal of Northwest Atlantic Fishery Science, V42, P1; Bailleul F, 2008, J ANIM ECOL, V77, P948, DOI 10.1111/j.1365-2656.2008.01407.x; Bailleul F, 2007, PHILOS T R SOC B, V362, P2169, DOI 10.1098/rstb.2007.2109; Bajzak CE, 2009, MAR ECOL PROG SER, V385, P285, DOI 10.3354/meps08015; Beck CA, 2003, ANIM BEHAV, V66, P777, DOI 10.1006/anbe.2003.2284; Beck CA, 2000, J EXP BIOL, V203, P2323; Beck CA, 2007, J ANIM ECOL, V76, P490, DOI 10.1111/j.1365-2656.2007.01215.x; BENHAMOU S, 1989, ANIM BEHAV, V38, P375, DOI 10.1016/S0003-3472(89)80030-2; Bennett KA, 2010, PHYSIOL BIOCHEM ZOOL, V83, P911, DOI 10.1086/656925; Biuw M, 2003, J EXP BIOL, V206, P3405, DOI 10.1242/jeb.00583; Blanchet MA, 2014, AQUAT BIOL, V21, P167, DOI 10.3354/ab00580; Boehme L, 2009, OCEAN SCI, V5, P685, DOI 10.5194/os-5-685-2009; Bost CA, 1997, MAR ECOL PROG SER, V150, P21, DOI 10.3354/meps150021; BOWEN WD, 1985, CAN J ZOOL, V63, P2841, DOI 10.1139/z85-424; Bowen WD, 2002, MAR ECOL PROG SER, V244, P235, DOI 10.3354/meps244235; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Burns JM, 2015, PHYSIOL BIOCHEM ZOOL, V88, P167, DOI 10.1086/680015; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cavalieri D.J., 1996, SEA ICE CONCENTRATIO; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Coltman DW, 2007, MOL ECOL, V16, P1639, DOI 10.1111/j.1365-294X.2007.03229.x; Crocker DE, 1997, CAN J ZOOL, V75, P27, DOI 10.1139/z97-004; CROXALL JP, 1985, J ANIM ECOL, V54, P1, DOI 10.2307/4616; Davis RW, 2003, MAR ECOL PROG SER, V264, P109, DOI 10.3354/meps264109; Enoksen S, 2017, POLAR BIOL, V40, P931, DOI 10.1007/s00300-016-2002-2; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fauchald P, 2006, OECOLOGIA, V149, P383, DOI 10.1007/s00442-006-0463-7; Fedak M, 2000, AM ZOOL, V40, P1013; Fedak MA, 2001, MAR MAMMAL SCI, V17, P94, DOI 10.1111/j.1748-7692.2001.tb00982.x; Folkow LP, 2010, POLAR BIOL, V33, P433, DOI 10.1007/s00300-009-0718-y; Folkow LP, 1996, POLAR BIOL, V16, P179, DOI 10.1007/BF02329206; Folkow LP, 1999, POLAR BIOL, V22, P61, DOI 10.1007/s003000050391; Folkow LP, 1995, DEV MAR BIO, V4, P193; Freitas C, 2013, PACKAGE ARGOSFILTER; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Geiseler SJ, 2013, J EXP BIOL, V216, P1793, DOI 10.1242/jeb.082099; Guinet C, 1997, MAR ECOL PROG SER, V150, P11, DOI 10.3354/meps150011; Guinet C, 2014, MAR ECOL PROG SER, V499, P285, DOI 10.3354/meps10660; Hamilton CD, 2016, MAR ECOL PROG SER, V545, P261, DOI 10.3354/meps11598; Hammill M.O., 2000, Journal of Northwest Atlantic Fishery Science, V26, P1, DOI 10.2960/J.v26.a1; HAMMILL MO, 1993, POLAR BIOL, V13, P307; Hammill MO, 1960, ABUNDANCE NW ATLANTI, P19; Haug T, 2004, POLAR RES, V23, P35, DOI 10.1111/j.1751-8369.2004.tb00127.x; Haug T, 2007, MAR BIOL RES, V3, P123, DOI 10.1080/17451000701358531; Henriksen S, NORWEGIAN RED LIST S; Hindell MA, 1999, CAN J ZOOL, V77, P1807, DOI 10.1139/cjz-77-11-1807; *ICES, 2008, REP WORK GROUP WID D; Johnson D, 2013, CRAWL FIT CONTINUOUS; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Kapel Finn O., 1996, Northwest Atlantic Fisheries Organization Scientific Council Studies, V26, P87; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kirkman SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152370; Kooyman G.L., 1989, DIVERSE DIVERS PHYSL; Kovacs K.M., 2016, CYSTOPHORA CRISTATA; Kovacs KM, 1996, CAN J ZOOL, V74, P1521, DOI 10.1139/z96-166; Lagoy H, 2012, MAR BIOL RES, V8, P5; LeBoeuf BJ, 1996, CAN J ZOOL, V74, P1632; Lestyk KC, 2009, J COMP PHYSIOL B, V179, P985, DOI 10.1007/s00360-009-0378-9; McIntyre T, 2010, MAR ECOL PROG SER, V412, P293, DOI 10.3354/meps08680; Miller PJO, 2012, J EXP BIOL, V215, P3622, DOI 10.1242/jeb.070128; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Mori Y, 1998, J THEOR BIOL, V190, P187, DOI 10.1006/jtbi.1997.0550; Ng P, 2007, STAT MODEL, V7, P315, DOI 10.1177/1471082X0700700403; Noren SR, 2005, PHYSIOL BIOCHEM ZOOL, V78, P782; Nottestad L, 2016, ICES J MAR SCI, V73, P359, DOI 10.1093/icesjms/fsv218; Oritsiand T., 1959, FAUNA OSLO, V12, P70; Page B, 2005, MAR ECOL PROG SER, V304, P249, DOI 10.3354/meps304249; Patterson TA, 2009, J ANIM ECOL, V78, P1113, DOI 10.1111/j.1365-2656.2009.01583.x; Photopoulou T., 2015, ANIMAL BIOTELEMETRY, V3, P21, DOI DOI 10.1186/S40317-015-0053-8; R Development Core Team, R LANG ENV STAT COMP; Rasmussen B., 1960, Fisken og Havet, VNo. 1, P1; Rey AR, 2010, J ORNITHOL, V151, P933, DOI 10.1007/s10336-010-0531-y; Ropert-Coudert Y, 2006, MAR BIOL, V149, P139, DOI 10.1007/s00227-005-0188-x; Ropert-Coudert Y, 2001, POLAR BIOL, V24, P467, DOI 10.1007/s003000100235; Sergeant D.E., 1974, Polarforschung, V44, P1; Suzuki I, 2009, POLAR BIOL, V32, P667, DOI 10.1007/s00300-009-0596-3; THOMPSON D, 1991, J ZOOL, V224, P223, DOI 10.1111/j.1469-7998.1991.tb04801.x; Thompson D., 1993, Symposia of the Zoological Society of London, V66, P349; Thums M, 2008, J EXP MAR BIOL ECOL, V363, P75, DOI 10.1016/j.jembe.2008.06.024; TRIVELPIECE WZ, 1986, AUK, V103, P777, DOI 10.1093/auk/103.4.777; Tucker S, 2009, MAR ECOL PROG SER, V384, P287, DOI 10.3354/meps08000; Vacquie-Garcia J, 2015, MAR ECOL PROG SER, V541, P265, DOI 10.3354/meps11511; Vacquie-Garcia J, 2015, DEEP-SEA RES PT II, V113, P145, DOI 10.1016/j.dsr2.2014.10.029; Vacquie-Garcia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043565; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; Wilson RP, 2002, MAR BIOL, V140, P17, DOI 10.1007/s002270100659; WILSON RP, 1992, J EXP BIOL, V167, P267; Wolf JBW, 2005, BEHAV ECOL SOCIOBIOL, V59, P293, DOI 10.1007/s00265-005-0042-7; Zuur AF, 2007, STAT BIOL HEALTH, P163	95	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187889	10.1371/journal.pone.0187889	http://dx.doi.org/10.1371/journal.pone.0187889			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211797	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000417212200021
J	Bao, AH; Che, KF; Bozinovski, S; Ji, J; Gregory, JA; Georen, SK; Adner, M; Cardell, LO; Linden, A				Bao, Aihua; Che, Karlhans Fru; Bozinovski, Steven; Ji, Jie; Gregory, Joshua A.; Georen, Susanna Kumlien; Adner, Mikael; Cardell, Lars-Olaf; Linden, Anders			Recombinant human IL-26 facilitates the innate immune response to endotoxin in the bronchoalveolar space of mice in vivo	PLOS ONE			English	Article							NEUTROPHIL RECRUITMENT; EPITHELIAL-CELLS; OZONE EXPOSURE; INFLAMMATION; INTERLEUKIN-26; EXPRESSION; IL-17	Interleukin (IL)-26 is released in response to bacterial endotoxin (LPS) in the bronchoalveolar space of humans in vivo and it may potentiate neutrophil chemotaxis by enhanced IL-26 receptor stimulation. However, the effects of extracellular IL-26 protein on the innate immune response in the lungs in vivo remain unknown. Here, we characterized these effects of IL-26 on a wide range of aspects of the innate immune response to LPS in different compartments of the lungs in vivo over time. We administrated recombinant human (rh) IL-26 protein in the bronchoalveolar space using intranasal instillation in a mouse in vivo model, with and without prior instillation of LPS. We verified gene expression of the IL-26 receptor complex in mouse lungs and observed that, after instillation of LPS, rhIL-26 increases the phosphorylation of STAT3, a signaling molecule of the IL-26 receptor complex. We also observed that rhIL-26 exerted additional stimulatory and inhibitory actions that are compartment- and time-dependent, resulting in alterations of cytokines, proteinases, tissue inflammation and the accumulation of innate effector cells. Without the prior instillation of LPS, rhIL-26 exerted time-dependent effects on total gelatinase activity but few other effects. Most important, after instillation of LPS, rhIL-26 cleared inflammatory cells from local tissue and increased the accumulation of innate effector cells in the bronchoalveolar space. Tentatively, rhIL-26 may facilitate the innate immune response towards the bronchoalveolar space in vivo and represents a potential target for therapy in lung disorders involving the innate immune response.	[Bao, Aihua; Che, Karlhans Fru; Ji, Jie; Linden, Anders] Karolinska Inst, Unit Lung & Airway Res, Inst Environm Med, Stockholm, Sweden; [Bao, Aihua] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Resp Med, Shanghai, Peoples R China; [Bozinovski, Steven] RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic, Australia; [Gregory, Joshua A.; Georen, Susanna Kumlien; Adner, Mikael; Cardell, Lars-Olaf] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; [Gregory, Joshua A.; Adner, Mikael] Inst Environm Med, Unit Expt Asthma & Allergy Res, Stockholm, Sweden; [Georen, Susanna Kumlien; Cardell, Lars-Olaf] Karolinska Inst, Div ENT Dis, CLINTEC, Stockholm, Sweden; [Linden, Anders] Karolinska Univ Hosp, Lung Allergy Clin, Stockholm, Sweden	Karolinska Institutet; Shanghai Jiao Tong University; Royal Melbourne Institute of Technology (RMIT); Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Linden, A (corresponding author), Karolinska Inst, Unit Lung & Airway Res, Inst Environm Med, Stockholm, Sweden.; Linden, A (corresponding author), Karolinska Univ Hosp, Lung Allergy Clin, Stockholm, Sweden.	anders.linden@ki.se		Linden, Anders/0000-0003-1258-2928; Bozinovski, Steven/0000-0001-6533-8641; Kumlien Georen, Susanna/0000-0001-7292-9255	Swedish Heart-Lung Foundation; Swedish Institute; Swedish Research Council; King Gustaf V's and Queen Victoria's Freemason Research Fund; federal funding from Karolinska Institutet; ALF; LUA; Chinese Scholarship Council; Shanghai Municipal Commission of Health and Family Planning grant	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Institute; Swedish Research Council(Swedish Research CouncilEuropean Commission); King Gustaf V's and Queen Victoria's Freemason Research Fund; federal funding from Karolinska Institutet(Karolinska Institutet); ALF; LUA; Chinese Scholarship Council(China Scholarship Council); Shanghai Municipal Commission of Health and Family Planning grant	This study was funded by the Swedish Heart-Lung Foundation (AL), the Swedish Institute (AL), the Swedish Research Council (AL and LOC), King Gustaf V's and Queen Victoria's Freemason Research Fund (AL), federal funding from Karolinska Institutet (AL) and from ALF (SLL) and LUA (VGR) grants (AL for both). This publication is a result of Aihua Bao's postdoctoral research work at Karolinska Institutet, made possible by the support of Chinese Scholarship Council (AB and AL) and the Swedish Institute, as well as the Shanghai Municipal Commission of Health and Family Planning grant (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Swedish Heart-Lung Foundation (AL), the Swedish Institute (AL), the Swedish Research Council (AL and LOC), King Gustaf V's and Queen Victoria's Freemason Research Fund (AL), federal funding from Karolinska Institutet (AL) and from ALF (SLL) and LUA (VGR) grants (AL for both). This publication is a result of Aihua Bao's postdoctoral research work at Karolinska Institutet, made possible by the support of Chinese Scholarship Council (AB and AL) and the Swedish Institute, as well as the Shanghai Municipal Commission of Health and Family Planning grant (AB).	Bao AH, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0126-x; Bao AH, 2013, FRONT BIOSCI-LANDMRK, V18, P838, DOI 10.2741/4147; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Che KF, 2014, AM J RESP CRIT CARE, V190, P1022, DOI 10.1164/rccm.201404-0689OC; Che KF, 2017, MOL MED, V23, P247, DOI 10.2119/molmed.2016.00064; Donnelly RP, 2010, CYTOKINE GROWTH F R, V21, P393, DOI 10.1016/j.cytogfr.2010.09.001; Glader P, 2010, EUR RESPIR J, V36, P1155, DOI 10.1183/09031936.00170609; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Laan M, 1999, J IMMUNOL, V162, P2347; Linden Anders, 2007, Sci STKE, V2007, pre4, DOI 10.1126/stke.3982007re4; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Meller S, 2015, NAT IMMUNOL, V16, P970, DOI 10.1038/ni.3211; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; Ohnuma K, 2015, J IMMUNOL, V194, P3697, DOI 10.4049/jimmunol.1402785; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Peters M, 2016, AM J RESP CELL MOL B; Ramezanpour M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9798206; Smith ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075032; Srisodsai A, 2004, J BIOL CHEM, V279, P54358, DOI 10.1074/jbc.M405331200; Tachiiri A, 2003, GENES IMMUN, V4, P153, DOI 10.1038/sj.gene.6363934; Tengvall S, 2016, J INNATE IMMUN, V8, P15, DOI 10.1159/000434646; Uriarte Silvia M, 2011, J Immunol, V187, P391, DOI 10.4049/jimmunol.1003112; Vlahos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033277; Vlahos R, 2010, AM J RESP CRIT CARE, V182, P34, DOI 10.1164/rccm.200912-1794OC; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497	27	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188909	10.1371/journal.pone.0188909	http://dx.doi.org/10.1371/journal.pone.0188909			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206862	Green Published, gold, Green Submitted			2022-12-27	WOS:000417110700030
J	Kiware, SS; Chitnis, N; Tatarsky, A; Wu, S; Castellanos, HMS; Gosling, R; Smith, D; Marshall, JM				Kiware, Samson S.; Chitnis, Nakul; Tatarsky, Allison; Wu, Sean; Castellanos, Hector Manuel Sanchez; Gosling, Roly; Smith, David; Marshall, John M.			Attacking the mosquito on multiple fronts: Insights from the Vector Control Optimization Model (VCOM) for malaria elimination	PLOS ONE			English	Article							TRANSMISSION	Background Despite great achievements by insecticide-treated nets (ITNs) and indoor residual spraying (IRS) in reducing malaria transmission, it is unlikely these tools will be sufficient to eliminate malaria transmission on their own in many settings today. Fortunately, field experiments indicate that there are many promising vector control interventions that can be used to complement ITNs and/or IRS by targeting a wide range of biological and environmental mosquito resources. The majority of these experiments were performed to test a single vector control intervention in isolation; however, there is growing evidence and consensus that effective vector control with the goal of malaria elimination will require a combination of interventions. Method and findings We have developed a model of mosquito population dynamic to describe the mosquito life and feeding cycles and to optimize the impact of vector control intervention combinations at suppressing mosquito populations. The model simulations were performed for the main three malaria vectors in sub-Saharan Africa, Anopheles gambiae s.s, An. arabiensis and An. funestus. We considered areas having low, moderate and high malaria transmission, corresponding to entomological inoculation rates of 10, 50 and 100 infective bites per person per year, respectively. In all settings, we considered baseline ITN coverage of 50% or 80% in addition to a range of other vector control tools to interrupt malaria transmission. The model was used to sweep through parameters space to select the best optimal intervention packages. Sample model simulations indicate that, starting with ITNs at a coverage of 50% (An. gambiae s.s. and An. funestus) or 80% (An. arabiensis) and adding interventions that do not require human participation (e.g. larviciding at 80% coverage, endectocide treated cattle at 50% coverage and attractive toxic sugar baits at 50% coverage) may be sufficient to suppress all the three species to an extent required to achieve local malaria elimination. Conclusion The Vector Control Optimization Model (VCOM) is a computational tool to predict the impact of combined vector control interventions at the mosquito population level in a range of eco-epidemiological settings. The model predicts specific combinations of vector control tools to achieve local malaria elimination in a range of eco-epidemiological settings and can assist researchers and program decision-makers on the design of experimental or operational research to test vector control interventions. A corresponding graphical user interface is available for national malaria control programs and other end users.	[Kiware, Samson S.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Dept, Morogoro, Tanzania; [Kiware, Samson S.] Marquette Univ, Math Stat & Comp Sci Dept, Milwaukee, WI 53233 USA; [Chitnis, Nakul] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Tatarsky, Allison] Univ Basel, Basel, Switzerland; [Tatarsky, Allison; Gosling, Roly] Univ Calif San Francisco, Global Hlth Grp, Malaria Eliminat Initiat, San Francisco, CA 94143 USA; [Wu, Sean; Castellanos, Hector Manuel Sanchez; Marshall, John M.] Univ Calif Berkeley, Div Biostat, Berkeley, CA 94720 USA; [Wu, Sean; Castellanos, Hector Manuel Sanchez; Marshall, John M.] Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94720 USA; [Castellanos, Hector Manuel Sanchez] Tecnol Monterrey, Sch Med, Atizapan De Zaragoza, Estado De Mexic, Mexico; [Smith, David] Univ Washington, Dept Global Hlth, Seattle, WA USA	Ifakara Health Institute; Marquette University; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Tecnologico de Monterrey; University of Washington; University of Washington Seattle	Kiware, SS (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Dept, Morogoro, Tanzania.; Kiware, SS (corresponding author), Marquette Univ, Math Stat & Comp Sci Dept, Milwaukee, WI 53233 USA.	skiware@ihi.or.tz	Smith, David L/L-8850-2013; Smith, David/GQQ-8257-2022	Smith, David L/0000-0003-4367-3849; Kiware, Samson/0000-0001-7252-520X	Wellcome Trust Training Fellowship grant [107599/Z/15/Z]; UC-MEXUS grant; University of California, San Francisco, Group Health Group Malaria Elimination Initiative through Parker Foundation	Wellcome Trust Training Fellowship grant; UC-MEXUS grant; University of California, San Francisco, Group Health Group Malaria Elimination Initiative through Parker Foundation	SSK acknowledges financial support from a Wellcome Trust Training Fellowship grant # 107599/Z/15/Z. HS and JM acknowledges financial support from UC-MEXUS grant. This work was supported by the University of California, San Francisco, Group Health Group Malaria Elimination Initiative through funding from The Parker Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achee NL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-164; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4; Bhatt S, 2015, ELIFE, V4, DOI 10.7554/eLife.09672; BLOWER SM, 1991, PHILOS T R SOC B, V331, P171, DOI 10.1098/rstb.1991.0006; Chitnis N, 2010, AM J TROP MED HYG, V83, P230, DOI 10.4269/ajtmh.2010.09-0179; Control mCGoV, 2011, PLOS MED, V8; Diabate A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0961-8; Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; DYE C, 1986, Parasitology Today, V2, P203; Eckhoff PA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-303; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Gu WD, 2006, P NATL ACAD SCI USA, V103, P17560, DOI 10.1073/pnas.0608452103; Imbahale SS, 2012, BMC PUBLIC HEALTH, V12, P1; Karunamoorthi K, 2011, CLIN MICROBIOL INFEC, V17, P1608, DOI 10.1111/j.1469-0691.2011.03664.x; Killeen G.F., 2012, MAL J, V1, P1; Killeen GF, 2001, T ROY SOC TROP MED H, V95, P469, DOI 10.1016/S0035-9203(01)90005-7; Killeen GF, 2014, MALARIA J, V13, P1, DOI DOI 10.1186/1475-2875-13-330; Killeen GF, 2013, PARASITE VECTOR, V6, P1; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Kiware SS, 2012, BIOL LETTERS, V8, P874, DOI 10.1098/rsbl.2012.0352; Le Menach A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-10; Lengeler C., 1998, COCHRANE DATABASE SY; Lyimo IN, 2009, TRENDS PARASITOL, V25, P189, DOI 10.1016/j.pt.2009.01.005; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Muller GC, 2010, MALARIA J, V9, P1; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011573; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Poche RM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0883-0; R Core T, 2013, R LANG ENV STAT COMP; Rowland M, 2001, LANCET, V357, P1837, DOI 10.1016/S0140-6736(00)04955-2; Russell T. L., 2011, MALARIA J, V10, P1; SAUL AJ, 1990, J APPL ECOL, V27, P123, DOI 10.2307/2403572; Slater HC, 2015, NATURE, V528, pS94, DOI 10.1038/nature16040; Tusting LS, 2013, MOSQUITO LARVAL SOUR; Tusting LS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0724-1; WEATHERSBEE AA, 1991, J AM MOSQUITO CONTR, V7, P238; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2; White MT, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-153; Wilson AL, 2014, ARE TOPICAL INSECT R, V13, P1; Yakob L., 2016, Parasite Epidemiology and Control, V1, P2, DOI 10.1016/j.parepi.2015.12.001; Yuval B., 1992, Bulletin of the Society for Vector Ecology, V17, P150	47	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0187680	10.1371/journal.pone.0187680	http://dx.doi.org/10.1371/journal.pone.0187680			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194440	Green Published, gold, Green Accepted			2022-12-27	WOS:000416867800007
J	Nagata, Y; Kiyono, T; Okamura, K; Goto, Y; Matsuo, M; Ikemoto-Uezumi, M; Hashimoto, N				Nagata, Yuki; Kiyono, Tohru; Okamura, Kikuo; Goto, Yu-ichi; Matsuo, Masafumi; Ikemoto-Uezumi, Madoka; Hashimoto, Naohiro			Interleukin-1beta (IL-1 beta)-induced Notch ligand Jagged1 suppresses mitogenic action of IL-1 beta on human dystrophic myogenic cells	PLOS ONE			English	Article							NF-KAPPA-B; DUCHENNE MUSCULAR-DYSTROPHY; HUMAN SKELETAL-MUSCLE; MOLECULAR SIGNATURE; PROGENITOR CELLS; CYCLIN D1; P38 MAPK; DIFFERENTIATION; EXPRESSION; REGENERATION	Duchenne muscular dystrophy (DMD) is a severe X-linked recessive muscle disorder caused by mutations in the dystrophin gene. Nonetheless, secondary processes involving perturbation of muscle regeneration probably exacerbate disease progression, resulting in the fatal loss of muscle in DMD patients. A dysfunction of undifferentiated myogenic cells is the most likely cause for the reduction of regenerative capacity of muscle. To clarify molecular mechanisms in perturbation of the regenerative capacity of DMD muscle, we have established several NCAM (CD56)-positive immortalized human dystrophic and non-dystrophic myogenic cell lines from DMD and healthy muscles. A pro-inflammatory cytokine, IL-1 beta, promoted cell cycle progression of non-dystrophic myogenic cells but not DMD myogenic cells. In contrast, IL-1 beta upregulated the Notch ligand Jagged1 gene in DMD myogenic cells but not in non-dystrophic myogenic cells. Knockdown of Jagged1 in DMD myogenic cells restored the IL-1 beta-promoted cell cycle progression. Conversely, enforced expression of Jagged1-blocked IL-1 beta promoted proliferation of non-dystrophic myogenic cells. In addition, IL-1 beta prevented myogenic differentiation of DMD myogenic cells depending on Jagged1 but not of non-dystrophic myogenic cells. These results demonstrate that Jagged1 induced by IL-1 beta in DMD myogenic cells modified the action of IL-1 beta and reduced the ability to proliferate and differentiate. IL-1 beta induced Jagged1 gene expression may be a feedback response to excess stimulation with this cytokine because high IL-1 beta (200-1000 pg/ml) induced Jagged1 gene expression even in non-dystrophic myogenic cells. DMD myogenic cells are likely to acquire the susceptibility of the Jagged1 gene to IL-1 beta under the microcircumstances in DMD muscles. The present results suggest that Jagged1 induced by IL-1 beta plays a crucial role in the loss of muscle regeneration capacity of DMD muscles. The IL-1 beta/Jagged1 pathway may be a new therapeutic target to ameliorate exacerbation of muscular dystrophy in a dystrophin-independent manner.	[Nagata, Yuki; Ikemoto-Uezumi, Madoka; Hashimoto, Naohiro] Natl Ctr Geriatr & Gerontol, Dept Regenerat Med, Oobu, Aichi, Japan; [Kiyono, Tohru] Natl Canc Ctr Res Inst, Div Carcinogenesis & Canc Prevent, Chuo Ku, Tsukiji, Tokyo, Japan; [Okamura, Kikuo] Natl Ctr Geriatr & Gerontol, Dept Urol, Oobu, Aichi, Japan; [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci Nervous & Muscular Disorders, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo, Japan; [Matsuo, Masafumi] Kobegakuin Univ, Fac Rehabil, Dept Rehabil Med, Nishi Ku, Ikawadani Cho, Kobe, Hyogo, Japan; [Okamura, Kikuo] Higashinagoya Natl Hosp, Dept Clin Res, Meito Ku, Nagoya, Aichi, Japan; [Ikemoto-Uezumi, Madoka] Tokyo Metropolitan Geriatr Hosp, Gerontol Motor Syst, Res Team Geriatr Med, Itabashi Ku, Tokyo, Japan; [Ikemoto-Uezumi, Madoka] Inst Gerontol, Itabashi Ku, Tokyo, Japan	National Center for Geriatrics & Gerontology; National Cancer Center - Japan; National Center for Geriatrics & Gerontology; National Center for Neurology & Psychiatry - Japan; Kobe Gakuin University	Hashimoto, N (corresponding author), Natl Ctr Geriatr & Gerontol, Dept Regenerat Med, Oobu, Aichi, Japan.	nao@ncgg.go.jp		Ikemoto-Uezumi, Madoka/0000-0003-2771-9851	Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP, Japan [25-5, 28-6]; National Center for Geriatrics and Gerontology (NCGG), Japan [28-24, 28-39];  [15K10426]	Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP, Japan; National Center for Geriatrics and Gerontology (NCGG), Japan(National Center for Geriatrics & Gerontology); 	This work was supported by Grants-in Aid for Scientific Research (KAKENHI,15K10426), Japan, Intramural Research Grant (25-5, 28-6) for Neurological and Psychiatric Disorders of NCNP, Japan, and The Research Funding for Longevity Sciences (28-24, 28-39) from National Center for Geriatrics and Gerontology (NCGG), Japan.	Agley CC, 2013, J CELL SCI, V126, P5610, DOI 10.1242/jcs.132563; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; Bakkar N, 2010, PHYSIOL REV, V90, P495, DOI 10.1152/physrev.00040.2009; Bash J, 1999, EMBO J, V18, P2803, DOI 10.1093/emboj/18.10.2803; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; CASHMAN NR, 1987, ANN NEUROL, V21, P481, DOI 10.1002/ana.410210512; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; Chen X, 2010, ONCOTARGET, V1, P210, DOI 10.18632/oncotarget.127; Chen YW, 2000, J CELL BIOL, V151, P1321, DOI 10.1083/jcb.151.6.1321; Church JE, 2014, EXP PHYSIOL, V99, P675, DOI 10.1113/expphysiol.2013.077255; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; HASHIMOTO N, 1994, FEBS LETT, V352, P236, DOI 10.1016/0014-5793(94)00964-3; HASHIMOTO N, 1995, EUR J BIOCHEM, V227, P379, DOI 10.1111/j.1432-1033.1995.tb20400.x; Hashimoto N, 2004, DEVELOPMENT, V131, P5481, DOI 10.1242/dev.01395; Hashimoto N., 2008, RECENT ADV SKELETAL, P1; Hashimoto N, 2008, MECH DEVELOP, V125, P257, DOI 10.1016/j.mod.2007.11.004; Hashimoto N, 2006, BIOCHEM BIOPH RES CO, V348, P1383, DOI 10.1016/j.bbrc.2006.08.006; Kitamoto T, 2010, STEM CELLS, V28, P2205, DOI 10.1002/stem.547; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Malm C, 2000, J PHYSIOL-LONDON, V529, P243, DOI 10.1111/j.1469-7793.2000.00243.x; McGreevy JW, 2015, DIS MODEL MECH, V8, P195, DOI 10.1242/dmm.018424; Meng JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017454; MILLER SC, 1988, MOL CELL BIOL, V8, P2295, DOI 10.1128/MCB.8.6.2295; Miyoshi Hiroyuki, 2004, Methods Mol Biol, V246, P429; Mourkioti F, 2008, J MOL MED, V86, P747, DOI 10.1007/s00109-008-0308-4; Oexle K, 2001, NEUROPEDIATRICS, V32, P123, DOI 10.1055/s-2001-16613; Osipo C, 2008, ONCOGENE, V27, P5019, DOI 10.1038/onc.2008.149; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; Pescatori M, 2007, FASEB J, V21, P1210, DOI 10.1096/fj.06-7285com; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Shiomi K, 2011, GENE THER, V18, P857, DOI 10.1038/gt.2011.44; Spencer MJ, 2001, NEUROMUSCULAR DISORD, V11, P556, DOI 10.1016/S0960-8966(01)00198-5; Sun H, 2007, J CELL BIOL, V177, P647, DOI 10.1083/jcb.200609007; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Trendelenburg AU, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-3; Vasyutina E, 2007, CELL CYCLE, V6, P1451; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Vieira NM, 2015, CELL, V163, P1204, DOI 10.1016/j.cell.2015.10.049; Wada MR, 2002, DEVELOPMENT, V129, P2987; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06	47	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0188821	10.1371/journal.pone.0188821	http://dx.doi.org/10.1371/journal.pone.0188821			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194448	Green Published, Green Submitted, gold			2022-12-27	WOS:000416867800015
J	Bini, F; Pica, A; Marinozzi, A; Marinozzi, F				Bini, Fabiano; Pica, Andrada; Marinozzi, Andrea; Marinozzi, Franco			3D diffusion model within the collagen apatite porosity: An insight to the nanostructure of human trabecular bone	PLOS ONE			English	Article							ELECTRON-MICROSCOPIC TOMOGRAPHY; MECHANICAL-PROPERTIES; POROUS-MEDIA; TORTUOSITY; WATER; ORGANIZATION; CRYSTALS; ORIENTATION; FIBRILS; SAMPLES	Bone tissue at nanoscale is a composite mainly made of apatite crystals, collagen molecules and water. This work is aimed to study the diffusion within bone nanostructure through Monte-Carlo simulations. To this purpose, an idealized geometric model of the apatite-collagen structure was developed. Gaussian probability distribution functions were employed to design the orientation of the apatite crystals with respect to the axes (length L, width W and thickness T) of a plate-like trabecula. We performed numerical simulations considering the influence of the mineral arrangement on the effective diffusion coefficient of water. To represent the hindrance of the impermeable apatite crystals on the water diffusion process, the effective diffusion coefficient was scaled with the tortuosity, the constrictivity and the porosity factors of the structure. The diffusion phenomenon was investigated in the three main directions of the single trabecula and the introduction of apatite preferential orientation allowed the creation of an anisotropic medium. Thus, different diffusivities values were observed along the axes of the single trabecula. We found good agreement with previous experimental results computed by means of a genetic algorithm.	[Bini, Fabiano; Pica, Andrada; Marinozzi, Franco] Sapienza Univ Rome, Dept Mech & Aerosp Engn, Rome, Italy; [Marinozzi, Andrea] Campus Biomed Univ, Orthopedy & Traumatol Area, Rome, Italy	Sapienza University Rome; University Campus Bio-Medico - Rome Italy	Bini, F (corresponding author), Sapienza Univ Rome, Dept Mech & Aerosp Engn, Rome, Italy.	fabiano.bini@uniroma1.it	Pica, Andrada/GRY-3154-2022	Pica, Andrada/0000-0002-6877-4120	"Sapienza" University of Rome [C26A14FWJL]	"Sapienza" University of Rome	This work was supported by grant from the "Sapienza" University of Rome (Research Program 2014 - C26A14FWJL).	Burger C, 2008, BIOPHYS J, V95, P1985, DOI 10.1529/biophysj.107.128355; Chiavazzo E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4565; Cowin SC, 1999, J BIOMECH, V32, P217, DOI 10.1016/S0021-9290(98)00161-4; CURRIE JA, 1960, BRIT J APPL PHYS, V11, P314, DOI 10.1088/0508-3443/11/8/302; Danilchenko SN, 2002, CRYST RES TECHNOL, V37, P1234, DOI 10.1002/1521-4079(200211)37:11<1234::AID-CRAT1234>3.0.CO;2-X; Di Tommaso D, 2017, CRYSTALS, V7, DOI 10.3390/cryst7020057; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; Georgiadis M, 2015, BONE, V71, P42, DOI 10.1016/j.bone.2014.10.002; GERSTENFELD LC, 1993, J BONE MINER RES, V8, P1031; Giannini C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00435; Guo PJ, 2012, TRANSPORT POROUS MED, V95, P285, DOI 10.1007/s11242-012-0043-8; Hambli R, 2012, J THEOR BIOL, V301, P28, DOI 10.1016/j.jtbi.2012.02.007; Hassenkam T, 2004, BONE, V35, P4, DOI 10.1016/j.bone.2004.02.024; Hodge A, 1963, ASPECTS PROTEIN STRU, P289; Hong SI, 2009, J MATER SCI-MATER M, V20, P1419, DOI 10.1007/s10856-009-3708-2; Jager I, 2000, BIOPHYS J, V79, P1737, DOI 10.1016/S0006-3495(00)76426-5; Jaschouz D, 2003, J APPL CRYSTALLOGR, V36, P494, DOI 10.1107/S0021889803000566; LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003; Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192; Lemaire T, 2015, J BIOMECH, V48, P3066, DOI 10.1016/j.jbiomech.2015.07.025; Liebi M, 2015, NATURE, V527, P349, DOI 10.1038/nature16056; Marinozzi F., 2013, EUR CELLS MAT S6, V26, P109; Marinozzi F, 2014, COMPUT METHOD BIOMEC, V10, P1, DOI DOI 10.4161/BI0M.28237; Marinozzi F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/796519; Marinozzi F, 2013, ANN I SUPER SANITA, V49, P300, DOI 10.4415/ANN_13_03_11; Marinozzi F, 2012, ANN I SUPER SANITA, V48, P19, DOI 10.4415/ANN_12_01_04; Marinozzi F, 2011, J BIOMECH, V44, P988, DOI 10.1016/j.jbiomech.2010.11.030; Nyman JS, 2008, BONE, V42, P193, DOI 10.1016/j.bone.2007.09.049; Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001; Rai RK, 2015, J PHYS CHEM B, V119, P201, DOI 10.1021/jp511288g; Reznikov N, 2015, BONE, V71, P189, DOI 10.1016/j.bone.2014.10.017; Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1; Rubin MA, 2003, BONE, V33, P270, DOI 10.1016/S8756-3282(03)00194-7; Saripalli KP, 2002, GROUND WATER, V40, P346, DOI 10.1111/j.1745-6584.2002.tb02512.x; Seidel R, 2012, BIOINSPIR BIOMIM NAN, V1, P123, DOI 10.1680/bbn.11.00014; Shen L, 2007, CHEM ENG SCI, V62, P3748, DOI 10.1016/j.ces.2007.03.041; Su X, 2003, BONE, V32, P150, DOI 10.1016/S8756-3282(02)00945-6; Tong W, 2003, CALCIFIED TISSUE INT, V72, P592, DOI 10.1007/s00223-002-1077-7; TRAUB W, 1989, P NATL ACAD SCI USA, V86, P9822, DOI 10.1073/pnas.86.24.9822; Valdes-Parada FJ, 2011, TRANSPORT POROUS MED, V88, P1, DOI 10.1007/s11242-010-9613-9; VANBRAKEL J, 1974, INT J HEAT MASS TRAN, V17, P1093, DOI 10.1016/0017-9310(74)90190-2; Vercher-Martinez A, 2015, J MECH BEHAV BIOMED, V42, P243, DOI 10.1016/j.jmbbm.2014.11.022; Wang Y, 2013, NAT MATER, V12, P1144, DOI [10.1038/NMAT3787, 10.1038/nmat3787]; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; WEINER S, 1991, FEBS LETT, V285, P49, DOI 10.1016/0014-5793(91)80722-F; Wilson EE, 2006, BIOPHYS J, V90, P3722, DOI 10.1529/biophysj.105.070243; Yun MJ, 2006, CAN J CHEM ENG, V84, P301	47	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189041	10.1371/journal.pone.0189041	http://dx.doi.org/10.1371/journal.pone.0189041			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220377	Green Published, Green Submitted, gold			2022-12-27	WOS:000417469900029
J	Clark, R; Kimbrough, SO				Clark, Robin; Kimbrough, Steven O.			Social structure, opportunistic punishment and the evolution of honest signaling	PLOS ONE			English	Article							ALTRUISTIC PUNISHMENT; CONSEQUENCES; AVERSION	Honest signaling is generally taken to be a necessary pre-condition for a stable signaling system, because deceptive signaling at a high enough rate should cause receivers to ignore the signal, which in turn undermines the utility of sending signals. Deception is normally thought to occur because of benefits it has to the deceiver. This raises the question of why signaling systems should exist and persist over time, especially in cases in which the interests of the senders and receivers are not well aligned. Punishment has been seen as a way of imposing costs on deceptive signalers. We investigate the effects of opportunistic D that is, non-altruistic punishment D on the evolution of an honest signaling system. Our model is based on research done on social insects. We model a society of agents, divided into three castes differing in aggressiveness. Under severe punishment deception is indeed asymptotically eliminated. Under somewhat less severe punishment, deception persists and the rates of deception correlate with social structure. We find that social structure robustly mediates the level of deception under regimes of punishment and that this is evident except in the most stringent of punishment regimes.	[Clark, Robin] Univ Penn, Dept Linguist, Philadelphia, PA 19104 USA; [Kimbrough, Steven O.] Univ Penn, Dept Operat Informat & Decis, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Clark, R (corresponding author), Univ Penn, Dept Linguist, Philadelphia, PA 19104 USA.; Kimbrough, SO (corresponding author), Univ Penn, Dept Operat Informat & Decis, Philadelphia, PA 19104 USA.	rclark@sas.upenn.edu; kimbrough@wharton.upenn.edu						Ahern C, 2015, THESIS; Ahern C, SEMANTICS P IN PRESS; Austin J., 1975, DO THINGS WORDS; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Clark H.H., 1996, USING LANGUAGE; CRAWFORD VP, 1982, ECONOMETRICA, V50, P1431, DOI 10.2307/1913390; DePaulo BM, 1996, J PERS SOC PSYCHOL, V70, P979, DOI 10.1037/0022-3514.70.5.979; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Gambetta D, 2009, CODES OF THE UNDERWORLD: HOW CRIMINALS COMMUNICATE, P1; Gino F, 2009, PSYCHOL SCI, V20, P393, DOI 10.1111/j.1467-9280.2009.02306.x; Gneezy U, 2005, AM ECON REV, V95, P384, DOI 10.1257/0002828053828662; Gneezy U, 2013, J ECON BEHAV ORGAN, V93, P293, DOI 10.1016/j.jebo.2013.03.025; Godfrey-Smith P, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003282; Granovetter M, 2005, J ECON PERSPECT, V19, P33, DOI 10.1257/0895330053147958; Harsanyi J.C., 1967, MANAGE SCI, V14, P159, DOI [DOI 10.1287/MNSC.14.3.159, 10.1287/mnsc.14.3.159]; HARSANYI JC, 1968, MANAGE SCI, V14, P486, DOI 10.1287/mnsc.14.7.486; HARSANYI JC, 1968, MANAGE SCI, V14, P320, DOI 10.1287/mnsc.14.5.320; Henrich J, 2016, SECRET OF OUR SUCCESS: HOW CULTURE IS DRIVING HUMAN EVOLUTION, DOMESTICATING OUR SPECIES, AND MAKING US SMARTER, P1; Hobson EA, 2015, PLOS COMPUTATIONAL B, V11, P1; Irlenbusch B, 2013, J ECON BEHAV ORGAN, V93, P321, DOI 10.1016/j.jebo.2013.03.023; Jacobson P., 2014, COMPOSITIONAL SEMANT; Kratzer, 1998, SEMANTICS GENERATIVE; Levinson S. C., 1983, PRAGMATICS; Lightle JP, 2013, J ECON BEHAV ORGAN, V93, P347, DOI 10.1016/j.jebo.2013.04.006; Montague R., 1974, FORMAL PHILOS SELECT; Morgan J.L., 1975, SYNTAX SEMANTICS, P41, DOI DOI 10.1163/9789004368811_003; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; Panasiti MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019465; Parreira BR, 2015, P NATL ACAD SCI USA, V112, pE3318, DOI 10.1073/pnas.1414463112; Pettit M., 2013, SCI DECEPTION PSYCHO; Reich W, 2011, J PRAGMATICS, V43, P1349, DOI 10.1016/j.pragma.2010.10.024; Samuelson L, 2006, REPEATED GAMES REPUT; Santos FC, 2006, PLOS COMPUTATIONAL B, V2, P1; Santos FP, 2016, PLOS COMPUTATIONAL B, V12, P1, DOI DOI 10.1371/J0URNAL.PCBI.1004709; SCOTT-PHILLIPS T., 2014, SPEAKING OUR MINDS W; Scott-Phillips T.C., 2011, LECT NOTES ARTIFICIA, P117; Searcy WA., 2005, EVOLUTION ANIMAL COM; Smith J. Maynard, 2003, OXFORD SERIES ECOLOG; Sperber D., 1995, RELEVANCE COMMUNICAT, V2nd ed.; Thompson D.W., 1943, GROWTH FORM; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; Tibbetts EA, 2010, CURR BIOL, V20, P1637, DOI 10.1016/j.cub.2010.07.042; Trivers R., 2011, FOLLY FOOLS LOGIC DE; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	44	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188249	10.1371/journal.pone.0188249	http://dx.doi.org/10.1371/journal.pone.0188249			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP2SV	29220400	Green Submitted, gold, Green Published			2022-12-27	WOS:000417469900008
J	Wells, G; Palethorpe, S; Pesci, EC				Wells, Greg; Palethorpe, Samantha; Pesci, Everett C.			PsrA controls the synthesis of the Pseudomonas aeruginosa quinolone signal via repression of the FadE homolog, PA0506	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; QUORUM-SENSING SYSTEMS; TRANSCRIPTIONAL REGULATOR; NUTRIENT ACQUISITION; ESCHERICHIA-COLI; FATTY-ACIDS; GENES; EXPRESSION; PATHOGENESIS; OPERON	Pseudomonas aeruginosa is a ubiquitous, Gram-negative opportunistic pathogen that can cause disease in various sites within the human body. This bacterium is a major source of nosocomial infections that are often difficult to treat due to high intrinsic antibiotic resistance and coordinated virulence factor production. P. aeruginosa utilizes three cell-to-cell signaling systems to regulate numerous genes in response to cell density. One of these systems utilizes the small molecule 2-heptyl-3-hydroxy-4-quinolone (Pseudomonas quinolone signal [PQS]) as a signal that acts as a co-inducer for the transcriptional regulator PqsR. Quinolone signaling is required for virulence in multiple infection models, and PQS is produced during human infections, making this system an attractive target for potential drug development. In this study we have examined the role of a TetR-type transcriptional regulator, PsrA, in the regulation of PQS production by P. aeruginosa. Previous studies showed that PsrA regulates genes of the fatty acid beta-oxidation pathway, including PA0506, which encodes a FadE homolog. In this report, we show that deletion of psrA resulted in a large decrease in PQS production and that co-deletion of PA0506 allowed PQS production to be restored to a wild type level. We also found that PQS production could be restored to the psrA mutant by the addition of oleic or octanoic acid. Taken together, our data suggest that psrA positively affects PQS production by repressing the transcription of PA0506, which leads to a decrease in the conversion of acyl-CoA compounds to enoyl-CoA compounds, thereby allowing some octanoyl-CoA to escape the beta-oxidation pathway and serve as a PQS precursor.	[Wells, Greg; Palethorpe, Samantha; Pesci, Everett C.] East Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Pesci, EC (corresponding author), East Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA.	pescie@ecu.edu		Palethorpe, Samantha/0000-0002-3317-6534; Pesci, Everett/0000-0002-7490-7591	National Institute of Allergy and Infectious Disease [R01-AI076272]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076272] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by National Institute of Allergy and Infectious Disease grant number R01-AI076272.	Bredenbruch F, 2005, J BACTERIOL, V187, P3630, DOI 10.1128/JB.187.11.3630-3635.2005; Cerceo E, 2016, MICROB DRUG RESIST, V22, P412, DOI 10.1089/mdr.2015.0220; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Coleman JP, 2008, J BACTERIOL, V190, P1247, DOI 10.1128/JB.01140-07; Collier DN, 2002, FEMS MICROBIOL LETT, V215, P41, DOI 10.1111/j.1574-6968.2002.tb11367.x; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Dulcey CE, 2013, CHEM BIOL, V20, P1481, DOI 10.1016/j.chembiol.2013.09.021; Enderle PJ, 1998, BIOTECHNIQUES, V25, P954, DOI 10.2144/98256bm05; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Farrow JM, 2008, J BACTERIOL, V190, P7043, DOI 10.1128/JB.00753-08; Farrow JM, 2017, MOL MICROBIOL, V104, P78, DOI 10.1111/mmi.13611; Fujita Y, 2007, MOL MICROBIOL, V66, P829, DOI 10.1111/j.1365-2958.2007.05947.x; Gilbert KB, 2009, MOL MICROBIOL, V73, P1072, DOI 10.1111/j.1365-2958.2009.06832.x; Gooderham WJ, 2008, J BACTERIOL, V190, P5624, DOI 10.1128/JB.00594-08; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Kang Y, 2008, MICROBIOL-SGM, V154, P1584, DOI 10.1099/mic.0.2008/018135-0; Kang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013557; Kang Y, 2009, MOL MICROBIOL, V73, P120, DOI 10.1111/j.1365-2958.2009.06757.x; Knoten CA, 2011, J BACTERIOL, V193, P6567, DOI 10.1128/JB.05803-11; Kojic M, 2005, FEMS MICROBIOL LETT, V246, P175, DOI 10.1016/j.femsle.2005.04.003; LEISINGER T, 1979, MICROBIOL REV, V43, P422, DOI 10.1128/MMBR.43.3.422-442.1979; McGrath S, 2004, FEMS MICROBIOL LETT, V230, P27, DOI 10.1016/S0378-1097(03)00849-8; Miller RM, 2008, J BACTERIOL, V190, P4038, DOI 10.1128/JB.00129-08; Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; PEARSON JP, 1995, P NATL ACAD SCI USA, V92, P1490, DOI 10.1073/pnas.92.5.1490; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Schertzer JW, 2010, MOL MICROBIOL, V77, P1527, DOI 10.1111/j.1365-2958.2010.07303.x; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2013, ANNU REV MICROBIOL, V67, P43, DOI 10.1146/annurev-micro-092412-155635; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; Tipton KA, 2013, J BACTERIOL, V195, P3433, DOI 10.1128/JB.00448-13; Wade DS, 2005, J BACTERIOL, V187, P4372, DOI 10.1128/JB.187.13.4372-4380.2005; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Weir TL, 2008, APPL ENVIRON MICROB, V74, P5784, DOI 10.1128/AEM.00860-08; Whiteley M, 2000, J BACTERIOL, V182, P4356, DOI 10.1128/JB.182.15.4356-4360.2000; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469	43	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189331	10.1371/journal.pone.0189331	http://dx.doi.org/10.1371/journal.pone.0189331			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220387	Green Submitted, Green Published, gold			2022-12-27	WOS:000417469900049
J	Cuzin, L; Pugliese, P; Allavena, C; Rey, D; Chirouze, C; Bani-Sadr, F; Cabie, A; Huleux, T; Poizot-Martin, I; Cotte, L; Bagnis, CI; Flandre, P				Cuzin, Lise; Pugliese, Pascal; Allavena, Clotilde; Rey, David; Chirouze, Catherine; Bani-Sadr, Firouze; Cabie, Andre; Huleux, Thomas; Poizot-Martin, Isabelle; Cotte, Laurent; Bagnis, Corinne Isnard; Flandre, Philippe		Dat'AIDS study Grp	Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; HIV-INFECTED PATIENTS; GLOMERULAR-FILTRATION-RATE; DOUBLY ROBUST ESTIMATION; PROPENSITY SCORE; POSITIVE PERSONS; RENAL-FUNCTION; PROSPECTIVE COHORT; TENOFOVIR; ASSOCIATION	Objective We investigated whether patients receiving selected antiretroviral combinations had a higher risk of chronic kidney disease (CKD) using traditional regression modeling and a causal approach in a large prospective cohort. Patients and methods For the purpose of this study, we selected 6301 patients who (i) started their first antiretroviral regimen after 1st January 2004, (ii) had at least one serum creatinine measurement within 6 months before ART initiation (study entry), and (iii) had at least two measurements after study entry. Baseline eGFR was defined from the last serum creatinine measurement before study entry. All eGFR values were calculated using the Modification of Diet and Renal Disease (MDRD) equation. Both traditional Cox proportional hazards model and Cox marginal structural models were applied. Distinct coding for antiretroviral therapy exposure were investigated as well as double robust estimators. Results Overall we showed that patients receiving tenofovir (TDF) with a ritonavir boosted protease inhibitor (rbPI) exhibited a higher risk of CKD compared with patients who received TDF with a non-nucleosidic reverse transcriptase inhibitor (NNRTI). Such an increased risk was observed considering both initial and current regimens. Our analysis revealed a clinician-driven switch away from TDF among persons experiencing a decline in renal function while receiving this drug. Conclusion Our results show that combination of TDF and boosted protease inhibitor is associated with a higher CKD risk than TDF and a NNRTI.	[Cuzin, Lise] INSERM, UMR 1027, Toulouse, France; [Cuzin, Lise] Univ Toulouse III, Toulouse, France; [Cuzin, Lise] CHU Toulouse, COREVIH Toulouse, Toulouse, France; [Pugliese, Pascal] CHU Archet, Dept Infect Dis, Nice, France; [Allavena, Clotilde] CHU Hotel Dieu, Dept Infect Dis, Nantes, France; [Rey, David] Hop Univ, HIV Infect Care Ctr, Strasbourg, France; [Chirouze, Catherine] Univ Franche Comte, CNRS, UMR Chronoenvironm 6249, Besancon, France; [Chirouze, Catherine] CHRU Besancon, Serv Malad Infect, Besancon, France; [Bani-Sadr, Firouze] Reims Champagne Ardenne Univ, Fac Med, CHU Reims, Hop Robert Debre,Trop & Infect Dis, Reims, France; [Cabie, Andre] INSERM, CIC1424, Dept Infect Dis, Fort De France, Martinique, France; [Huleux, Thomas] CH Tourcoing, Univ Dept Infect Dis, Tourcoing, France; [Poizot-Martin, Isabelle] Aix Marseille Univ, Hop St Marguerite, AP HM, Immunohematol Clin, Marseille, France; [Poizot-Martin, Isabelle] INSERM, U912, SESSTIM, Marseille, France; [Cotte, Laurent] Hosp Civils Lyon, Dept Infect Dis, Lyon, France; [Cotte, Laurent] INSERM, U1052, Lyon, France; [Bagnis, Corinne Isnard] AP HP, Dept Nephrol, Paris, France; [Bagnis, Corinne Isnard] UPMC Univ, Paris, France; [Flandre, Philippe] UPMC Univ, Sorbonne Univ, INSERM, UMRS 1136,IPLESP, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU Nice; Nantes Universite; CHU de Nantes; CHU Strasbourg; Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; CHU de Reims; Universite de Reims Champagne-Ardenne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Cuzin, L (corresponding author), INSERM, UMR 1027, Toulouse, France.; Cuzin, L (corresponding author), Univ Toulouse III, Toulouse, France.; Cuzin, L (corresponding author), CHU Toulouse, COREVIH Toulouse, Toulouse, France.	cuzin.l@gmail.com	Bagnis, corinne/AAY-1034-2020; Flandre, Philippe/N-6314-2017; Allavena, Clotilde/AAH-4310-2019; Cuzin, Lise/AAF-8812-2020	Bagnis, corinne/0000-0002-1048-6636; Flandre, Philippe/0000-0002-2612-3522; Cuzin, Lise/0000-0002-6345-497X; BANI-SADR, Firouze/0000-0001-8268-866X; Cabie, Andre/0000-0003-0117-3061; Poizot-Martin, Isabelle/0000-0002-5676-5411				Albini L, 2012, JAIDS-J ACQ IMM DEF, V59, P18, DOI 10.1097/QAI.0b013e31823a6124; Alsauskas ZC, 2011, EXPERT OPIN PHARMACO, V12, P691, DOI 10.1517/14656566.2011.535518; Bang H, 2005, BIOMETRICS, V61, P962, DOI 10.1111/j.1541-0420.2005.00377.x; Brennan A, 2011, AIDS, V25, P1603, DOI 10.1097/QAD.0b013e32834957da; Choi AI, 2009, AIDS, V23, P2143, DOI 10.1097/QAD.0b013e3283313c91; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; El-Sadr WM, 2008, ANN INTERN MED, V149, P289, DOI 10.7326/0003-4819-149-5-200809020-00003; Flandre P, 2011, CLIN J AM SOC NEPHRO, V6, P1700, DOI 10.2215/CJN.09191010; Funk MJ, 2011, AM J EPIDEMIOL, V173, P761, DOI 10.1093/aje/kwq439; Goicoechea M, 2008, J INFECT DIS, V197, P102, DOI 10.1086/524061; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Jose S, 2014, J INFECT DIS, V210, P363, DOI 10.1093/infdis/jiu107; Kalayjian RC, 2012, AIDS, V26, P1907, DOI 10.1097/QAD.0b013e328357f5ed; Kang JDY, 2007, STAT SCI, V22, P523, DOI 10.1214/07-STS227; Lucas GM, 2014, CLIN INFECT DIS, V59, pE96, DOI 10.1093/cid/ciu617; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; McCaffrey DF, 2013, STAT MED, V32, P3388, DOI 10.1002/sim.5753; Mocroft A, 2016, LANCET HIV, V3, pE23, DOI 10.1016/S2352-3018(15)00211-8; Mocroft A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001809; Pugliese P, 2009, HIV MED, V10, P504, DOI 10.1111/j.1468-1293.2009.00719.x; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Ryom L, 2014, CURR OPIN HIV AIDS, V9, P41, DOI 10.1097/COH.0000000000000023; Ryom L, 2014, AIDS, V28, P187, DOI 10.1097/QAD.0000000000000042; Scherzer R, 2014, AIDS, V28, P1289, DOI 10.1097/QAD.0000000000000258; Young J, 2012, AIDS, V26, P567, DOI 10.1097/QAD.0b013e32834f337c	27	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0187517	10.1371/journal.pone.0187517	http://dx.doi.org/10.1371/journal.pone.0187517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216208	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800010
J	Langrand-Escure, J; Rivoirard, R; Oriol, M; Tinquaut, F; Rancoule, C; Chauvin, F; Magne, N; Bourmaud, A				Langrand-Escure, Julien; Rivoirard, Romain; Oriol, Mathieu; Tinquaut, Fabien; Rancoule, Chloe; Chauvin, Frank; Magne, Nicolas; Bourmaud, Aurelie			Quality of reporting in oncology phase II trials: A 5-year assessment through systematic review	PLOS ONE			English	Review							CLINICAL-TRIALS; END-POINTS; TASK-FORCE; CANCER; DESIGN; RECOMMENDATIONS; SUCCESS; ISSUES	Background Phase II clinical trials are a cornerstone of the development in experimental treatments They work as a "filter" for phase III trials confirmation. Surprisingly the attrition ratio in Phase III trials in oncology is significantly higher than in any other medical specialty. This suggests phase II trials in oncology fail to achieve their goal. Objective The present study aims at estimating the quality of reporting in published oncology phase II clinical trials. Data sources A literature review was conducted among all phase II and phase II/III clinical trials published during a 5-year period (2010-2015). Study eligibility criteria All articles electronically published by three randomly-selected oncology journals with Impact-Factors>4 were included: Journal of Clinical Oncology, Annals of Oncology and British Journal of Cancer. Intervention Quality of reporting was assessed using the Key Methodological Score. Results 557 articles were included. 315 trials were single-arm studies (56.6%), 193 (34.6%) were randomized and 49 (8.8%) were non-randomized multiple-arm studies. The Methodological Score was equal to 0 (lowest level), 1, 2, 3 (highest level) respectively for 22 (3.9%), 119 (21.4%), 270 (48.5%) and 146 (26.2%) articles. The primary end point is almost systematically reported (90.5%), while sample size calculation is missing in 66% of the articles. 3 variables were independently associated with reporting of a high standard: presence of statistical design (p-value < 0.001), multicenter trial (p-value = 0.012), per-protocol analysis (p-value < 0.001). Limitations Screening was mainly performed by a sole author. The Key Methodological Score was based on only 3 items, making grey zones difficult to translate. Conclusions & implications of key findings This literature review highlights the existence of gaps concerning the quality of reporting. It therefore raised the question of the suitability of the methodology as well as the quality of these trials, reporting being incomplete in the corresponding articles.	[Langrand-Escure, Julien; Oriol, Mathieu; Tinquaut, Fabien; Chauvin, Frank; Bourmaud, Aurelie] Lucien Neuwirth Canc Inst, Publ Hlth Dept, Ctr Hygee, St Priest En Jarez, France; [Langrand-Escure, Julien; Rancoule, Chloe; Magne, Nicolas] Lucien Neuwirth Canc Inst, Radiotherapy Dept, St Priest En Jarez, France; [Rivoirard, Romain] Lucien Neuwirth Canc Inst, Oncol Dept, St Priest En Jarez, France; [Oriol, Mathieu; Tinquaut, Fabien; Chauvin, Frank; Bourmaud, Aurelie] INSERM 1408 CIC EC, St Etienne, France; [Chauvin, Frank; Bourmaud, Aurelie] Lyon 1 Univ, HESPER 7425, EA Hlth Serv Performance Res, Lyon, France	Institut de Cancerologie de la Loire; Institut de Cancerologie de la Loire; Institut de Cancerologie de la Loire; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bourmaud, A (corresponding author), Lucien Neuwirth Canc Inst, Publ Hlth Dept, Ctr Hygee, St Priest En Jarez, France.; Bourmaud, A (corresponding author), INSERM 1408 CIC EC, St Etienne, France.; Bourmaud, A (corresponding author), Lyon 1 Univ, HESPER 7425, EA Hlth Serv Performance Res, Lyon, France.	Aurelie.bourmaud@icloire.fr		Bourmaud, Aurelie/0000-0002-2228-6471				Adjei AA, 2009, CLIN CANCER RES, V15, P1866, DOI 10.1158/1078-0432.CCR-08-2035; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Booth CM, 2008, EUR J CANCER, V44, P25, DOI 10.1016/j.ejca.2007.07.031; Brown SR, 2011, BRIT J CANCER, V105, P194, DOI 10.1038/bjc.2011.235; Cannistra SA, 2009, J CLIN ONCOL, V27, P3073, DOI 10.1200/JCO.2009.23.1811; DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; El-Maraghi RH, 2008, J CLIN ONCOL, V26, P1346, DOI 10.1200/JCO.2007.13.5913; Grellety T, 2014, ANN ONCOL, V25, P536, DOI 10.1093/annonc/mdt550; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kramar A, 1996, BRIT J CANCER, V74, P1317, DOI 10.1038/bjc.1996.537; Lee JJ, 2005, J CLIN ONCOL, V23, P4450, DOI 10.1200/JCO.2005.03.197; Mariani L, 2000, J CLIN ONCOL, V18, P429, DOI 10.1200/JCO.2000.18.2.429; Mathoulin-Pelissier C, METHODES BIOSTATISTI; Medioni JR, 2000, B CANCER, V87, P551; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Nickolich M, 2014, CLIN LUNG CANCER, V15, P207, DOI 10.1016/j.cllc.2013.12.001; Ottaiano A, 2005, CANCER IMMUNOL IMMUN, V54, P44, DOI 10.1007/s00262-004-0567-z; Parulekar WR, 2002, ANN ONCOL, V13, P139, DOI 10.1093/annonc/mdf651; Penel N, 2010, B CANCER, V97, P55, DOI 10.1684/bdc.2010.1016; Perrone F, 2003, LANCET ONCOL, V4, P305, DOI 10.1016/S1470-2045(03)01078-7; Piedbois P, 2007, B CANCER, V94, P953; Ratain MJ, 2008, EUR J CANCER, V44, P8, DOI 10.1016/j.ejca.2007.09.011; Ratain MJ, 2009, EUR J CANCER, V45, P275, DOI 10.1016/j.ejca.2008.10.029; Riechelmann R, 2008, J CLIN ONCOL; Rubinstein LV, 2005, J CLIN ONCOL, V23, P7199, DOI 10.1200/JCO.2005.01.149; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Seymour L, 2010, CLIN CANCER RES, V16, P1764, DOI 10.1158/1078-0432.CCR-09-3287; Thezenas S, 2004, EUR J CANCER, V40, P1244, DOI 10.1016/j.ejca.2004.01.008; Tuma RS, 2008, J NATL CANCER I, V100, P164, DOI 10.1093/jnci/djn006; Walter T, 2012, NEUROENDOCRINOLOGY, V96, P238, DOI 10.1159/000337662	30	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0185536	10.1371/journal.pone.0185536	http://dx.doi.org/10.1371/journal.pone.0185536			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216190	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800002
J	Mikhaylova, VV; Eronina, TB; Chebotareva, NA; Kleymenov, SY; Shubin, VV; Kurganov, BI				Mikhaylova, Valeriya V.; Eronina, Tatiana B.; Chebotareva, Natalia A.; Kleymenov, Sergey Yu.; Shubin, Vladimir V.; Kurganov, Boris I.			A thermal after-effect of UV irradiation of muscle glycogen phosphorylase b	PLOS ONE			English	Article							CHAPERONE-LIKE ACTIVITY; DIFFERENTIAL SCANNING CALORIMETRY; RABBIT SKELETAL-MUSCLE; ALPHA-CRYSTALLIN; PROTEIN AGGREGATION; CIRCULAR-DICHROISM; KINETICS; DENATURATION; MECHANISM; INACTIVATION	Different test systems are used to characterize the anti-aggregation efficiency of molecular chaperone proteins and of low-molecular-weight chemical chaperones. Test systems based on aggregation of UV-irradiated protein are of special interest because they allow studying the protective action of different agents at physiological temperatures. The kinetics of UV-irradiated glycogen phosphorylase b (UV-Phb) from rabbit skeletal muscle was studied at 37 degrees C using dynamic light scattering in a wide range of protein concentrations. It has been shown that the order of aggregation with respect to the protein is equal to unity. A conclusion has been made that the rate-limiting stage of the overall process of aggregation is heat-induced structural reorganization of a UV-Phb molecule, which contains concealed damage.	[Mikhaylova, Valeriya V.; Eronina, Tatiana B.; Chebotareva, Natalia A.; Kleymenov, Sergey Yu.; Shubin, Vladimir V.; Kurganov, Boris I.] Russian Acad Sci, Fed Res Ctr Fundamentals Biotechnol, Fed State Inst, Dept Struct Biochem Prot,Bach Inst Biochem, Moscow, Russia; [Kleymenov, Sergey Yu.] Russian Acad Sci, Koltsov Inst Dev Biol, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences	Mikhaylova, VV; Kurganov, BI (corresponding author), Russian Acad Sci, Fed Res Ctr Fundamentals Biotechnol, Fed State Inst, Dept Struct Biochem Prot,Bach Inst Biochem, Moscow, Russia.	mikhaylova.inbi@inbox.ru; kurganov@inbi.ras.ru	Mikhaylova, Valeriya/V-1209-2017; Kleymenov, Sergey/R-1195-2018; Kurganov, Boris/M-1286-2019	Mikhaylova, Valeriya/0000-0002-2148-1697; Kleymenov, Sergey/0000-0001-5085-0327; 	Russian Science Foundation of Russian Academy of Sciences [16-14-10055]; Russian Science Foundation [16-14-10055] Funding Source: Russian Science Foundation	Russian Science Foundation of Russian Academy of Sciences; Russian Science Foundation(Russian Science Foundation (RSF))	This work was funded by the Russian Science Foundation (grant number 16-14-10055) of Russian Academy of Sciences (http://grant/rscf.ru/bids/asmaster).Authors who received the fundung: BIK, WM, TBE, NAC.	Abdul-Gader A, 2011, BIOINFORMATICS, V27, P1630, DOI 10.1093/bioinformatics/btr234; Amani M, 2011, J CHEM ENG DATA, V56, P1158, DOI 10.1021/je101087j; Bekasova OD, 2013, INT J BIOL MACROMOL, V62, P623, DOI 10.1016/j.ijbiomac.2013.10.010; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Chebotareva Natalia A, 2016, Biophys Rev, V8, P397, DOI 10.1007/s12551-016-0220-z; Clark JH, 1935, J GEN PHYSIOL, V19, P199, DOI 10.1085/jgp.19.2.199; Eronina TB, 2016, INT J BIOL MACROMOL, V92, P1252, DOI 10.1016/j.ijbiomac.2016.08.038; Eronina TB, 2009, BIOPHYS CHEM, V141, P66, DOI 10.1016/j.bpc.2008.12.007; Fujii N, 2004, MOL VIS, V10, P814; Golub N, 2007, FEBS LETT, V581, P4223, DOI 10.1016/j.febslet.2007.07.066; Ibarra-Molero B, 2016, METHOD ENZYMOL, V567, P281, DOI 10.1016/bs.mie.2015.08.027; KASTENSCHMIDT LL, 1968, BIOCHEMISTRY-US, V7, P3590, DOI 10.1021/bi00850a037; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Krivandin AV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P633, DOI 10.1134/S0006297909060078; KURGANOV B. I., 1965, BIOFIZIKA, V10, P875; Kurganov B. I., 2015, BIOCH ANAL BIOCH, V4, pe 155, DOI [10.4172/2161-1009.1000e155, DOI 10.4172/2161-1009.1000E155]; Kurganov B.I., 2002, USP BIOL KHIM, V42, P89; Kurganov B.I., 2005, CHEM BIOL KINETICS N, V2, P251; Kurganov BI, 2000, BIOCHEMISTRY-US, V39, P13144, DOI 10.1021/bi000975w; Kurganov BI, 1997, BIOPHYS CHEM, V69, P125, DOI 10.1016/S0301-4622(97)80552-2; Kurganov BI, 2002, BIOCHEMISTRY-MOSCOW+, V67, P409, DOI 10.1023/A:1015277805345; Kurganov BI, 2017, INT J BIOL MACROMOL, V100, P104, DOI 10.1016/j.ijbiomac.2016.07.066; Laue TM, 1992, ROYAL SOC CHEM, P90; LUZIKOV V. N., 1966, BIOFIZIKA, V11, P701; Lyubarev A.E., 2000, USP BIOL KHIM, V40, P43; Lyubarev AE, 2000, J THERM ANAL CALORIM, V62, P51, DOI 10.1023/A:1010102525964; LYUBAREV AE, 2001, RRD BIOPHYS CHEM, V2, P141; Maloletkina OI, 2012, BIOPHYS CHEM, V163, P11, DOI 10.1016/j.bpc.2012.02.001; Meremyanin AV, 2008, BIOPOLYMERS, V89, P124, DOI 10.1002/bip.20872; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Muranov KO, 2011, EXP EYE RES, V92, P76, DOI 10.1016/j.exer.2010.11.005; Podzimek S, 2011, LIGHT SCATTERING SIZ, DOI DOI 10.1002/9780470877975; Roberts CJ, 2007, BIOTECHNOL BIOENG, V98, P927, DOI 10.1002/bit.21627; ROBERTS CJ, 2006, MISBEHAVING PROTEINS, P17; Roman SG, 2012, INT J BIOL MACROMOL, V50, P1341, DOI 10.1016/j.ijbiomac.2012.03.015; Roman SG, 2011, BIOCHEMISTRY-US, V50, P10607, DOI 10.1021/bi201030y; Scientist for Experimental Data Fitting, 1995, MICR WIND VERS 2 0; SETLOW R, 1957, BIOCHIM BIOPHYS ACTA, V24, P27, DOI 10.1016/0006-3002(57)90142-7; SETLOW R, 1954, ARCH BIOCHEM BIOPHYS, V48, P441, DOI 10.1016/0003-9861(54)90361-6; SHARMA Y, 1993, PHOTOCHEM PHOTOBIOL, V57, P739, DOI 10.1111/j.1751-1097.1993.tb02947.x; SUGROBOVA N P, 1982, Biokhimiya, V47, P1883; SUGROBOVA NP, 1983, J BIOCHEM BIOPH METH, V8, P299, DOI 10.1016/0165-022X(83)90004-0; VLADIMIROV YA, 1970, PHOTOCHEM PHOTOBIOL, V11, P227, DOI 10.1111/j.1751-1097.1970.tb05992.x; Wang KY, 2003, BIOPHYS CHEM, V106, P97, DOI 10.1016/S0301-4622(03)00134-0; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371	45	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189125	10.1371/journal.pone.0189125	http://dx.doi.org/10.1371/journal.pone.0189125			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216272	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800077
J	Takeshita, J; Nishiyama, K; Beppu, S; Sasahashi, N; Shime, N				Takeshita, Jun; Nishiyama, Kei; Beppu, Satoru; Sasahashi, Nozomu; Shime, Nobuaki			Combined short- and long-axis ultrasound-guided central venous catheterization is superior to conventional techniques: A cross-over randomized controlled manikin trial	PLOS ONE			English	Article							INTERNAL JUGULAR-VEIN; CANNULATION; PLACEMENT; GUIDANCE; SUCCESS; COMPLICATIONS; MAXIMIZE; VIEW	Objectives Visualizing the needle tip using the short-axis (SA) ultrasound-guided central venous catheterization approach can be challenging. It has been suggested to start the process with the SA approach and then switch to the long-axis (LA); however, to our knowledge, this combination has not been evaluated. We compared the combined short-and long-axis (SLA) approach with the SA approach in a manikin study. Methods We performed a prospective randomized controlled cross-over study in an urban emergency department and intensive care unit. Resident physicians in post-graduate years 1-2 performed a simulated ultrasound-guided internal jugular vein puncture using the SA and SLA approaches on manikins. Twenty resident physicians were randomly assigned to two equal groups: (1) one group performed punctures using the SA approach followed by SLA; and (2) the other performed the same procedures in the opposite order. We compared the success rate and procedure duration for the two approaches. Procedural success was defined as insertion of the guide-wire into the vein while visualizing the needle tip at the time of anterior wall puncture, without penetrating the posterior wall. Results Six resident physicians (30%) performed both approaches successfully, while 12 (60%) performed the SLA approach, but not the SA, successfully. Those who performed the SA approach successfully also succeeded with the SLA approach. Two resident physicians (10%) failed to perform both approaches. The SLA approach had a significantly higher success rate than the SA approach (P < 0.001). The median (interquartile range) procedure duration was 59.5 [46.0-88.5] seconds and 45.0 [37.5-84.0] seconds for the SLA and SA approaches, respectively. The difference of the duration between the two procedures was 15.5 [0-28.5] seconds. There was no significant difference in duration between the two approaches (P = 0.12). Conclusions Using the SLA approach significantly improved the success rate of internal jugular vein puncture performed by novice physicians on a manikin model, without increasing procedural duration. Further clinical trials are warranted to confirm the procedure's utility in actual patients.	[Takeshita, Jun; Nishiyama, Kei; Beppu, Satoru; Sasahashi, Nozomu] Natl Hosp Org, Kyoto Med Ctr, Dept Emergency & Crit Care Med, Kyoto, Japan; [Shime, Nobuaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Emergency & Crit Care Med, Hiroshima, Japan	Hiroshima University	Takeshita, J (corresponding author), Natl Hosp Org, Kyoto Med Ctr, Dept Emergency & Crit Care Med, Kyoto, Japan.	t-k-s-t@koto.kpu-m.ac.jp		Nishiyama, Kei/0000-0003-3676-0135; BEPPU, SATORU/0000-0002-1434-5697				Blaivas M, 2003, ACAD EMERG MED, V10, P1307, DOI 10.1197/S1069-6563(03)00534-7; Blaivas M, 2009, CRIT CARE MED, V37, P2345, DOI 10.1097/CCM.0b013e3181a067d4; Brass P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006962.pub2; Chittoodan S, 2011, MED ULTRASON, V13, P21; DiLisio R, 2012, J CARDIOTHOR VASC AN, V26, P982, DOI 10.1053/j.jvca.2012.04.013; Gillman LM, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-39; Hind D, 2003, BMJ-BRIT MED J, V327, P361, DOI 10.1136/bmj.327.7411.361; Iken M, 2015, PAN AFR MED J, V20, DOI [10.11604/pamj.2015.20.127.6152, 10.11604/pamj.2015.20.226.4927]; Karakitsos D, 2006, CRIT CARE, V10, DOI 10.1186/cc5101; Keenan SR, 2002, J CRIT CARE, V17, P126, DOI 10.1053/jcrc.2002.34364; Leung J, 2006, ANN EMERG MED, V48, P540, DOI 10.1016/j.annemergmed.2006.01.011; MALLORY DL, 1990, CHEST, V98, P157, DOI 10.1378/chest.98.1.157; Miller AH, 2002, ACAD EMERG MED, V9, P800, DOI 10.1111/j.1553-2712.2002.tb02168.x; Milling TJ, 2005, CRIT CARE MED, V33, P1764, DOI 10.1097/01.CCM.0000171533.92856.E5; Moon CH, 2010, ACAD EMERG MED, V17, P1138, DOI 10.1111/j.1553-2712.2010.00869.x; Oguzkurt L, 2005, EUR J RADIOL, V55, P125, DOI 10.1016/j.ejrad.2004.10.004; Randolph AG, 1996, CRIT CARE MED, V24, P2053, DOI 10.1097/00003246-199612000-00020; Schofer JM, 2010, ACAD EMERG MED, V17, pE83, DOI 10.1111/j.1553-2712.2010.00784.x; Slama M, 1997, INTENS CARE MED, V23, P916, DOI 10.1007/s001340050432; Stone MB, 2010, AM J EMERG MED, V28, P343, DOI 10.1016/j.ajem.2008.11.022; TROIANOS CA, 1991, ANESTH ANALG, V72, P823; Vezzani A, 2017, INTENS CARE MED, V43, P1594, DOI 10.1007/s00134-017-4756-6; Vogel JA, 2015, CRIT CARE MED, V43, P832, DOI 10.1097/CCM.0000000000000823; Yang Eu Jeen, 2015, Korean J Pediatr, V58, P136, DOI 10.3345/kjp.2015.58.4.136	24	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189258	10.1371/journal.pone.0189258	http://dx.doi.org/10.1371/journal.pone.0189258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216331	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800110
J	Flick, RJ; Munthali, A; Simon, K; Hosseinipour, M; Kim, MH; Mlauzi, L; Kazembe, PN; Ahmed, S				Flick, Robert J.; Munthali, Adamson; Simon, Katherine; Hosseinipour, Mina; Kim, Maria H.; Mlauzi, Lameck; Kazembe, Peter N.; Ahmed, Saeed			Assessing infection control practices to protect health care workers and patients in Malawi from nosocomial transmission of Mycobacterium tuberculosis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; HIV-ASSOCIATED TUBERCULOSIS; SETTINGS; EPIDEMIC; OUTBREAK; THERAPY; AFRICA; RISK	Transmission of Mycobacterium tuberculosis (TB) in health settings threatens health care workers and people living with HIV in sub-Saharan Africa. Nosocomial transmission is reduced with implementation of infection control (IC) guidelines. The objective of this study is to describe implementation of TB IC measures in Malawi. We conducted a cross-sectional study utilizing anonymous health worker questionnaires, semi-structured interviews with facility managers, and direct observations at 17 facilities in central Malawi. Of 592 health care workers surveyed, 34% reported that all patients entering the facility were screened for cough and only 8% correctly named the four most common signs and symptoms of TB in adults. Of 33 managers interviewed, 7 (21%) and 1 (3%) provided the correct TB screening questions for use in adults and children, respectively. Of 592 health workers, only 2.4% had been screened for TB in the previous year. Most (90%) reported knowing their HIV status, 53% were tested at their facility of employment, and half reported they would feel comfortable receiving ART or TB treatment at their facility of employment. We conclude that screening is infrequently conducted and knowledge gaps may undercut its effectiveness. Further, health care workers do not routinely access TB and HIV diagnostic and treatment services at their facility of employment.	[Flick, Robert J.; Munthali, Adamson; Simon, Katherine; Kim, Maria H.; Kazembe, Peter N.; Ahmed, Saeed] Childrens Fdn Malawi, Baylor Coll Med, Lilongwe, Malawi; [Flick, Robert J.; Hosseinipour, Mina] Univ North Carolina Project Malawi, Lilongwe, Malawi; [Flick, Robert J.] Univ Colorado, Sch Med, Denver, CO USA; [Simon, Katherine; Kim, Maria H.; Kazembe, Peter N.; Ahmed, Saeed] Baylor Coll Med, Baylor Int Pediat AIDS Initiat, Texas Childrens Hosp, Houston, TX 77030 USA; [Hosseinipour, Mina] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Mlauzi, Lameck] Malawi Minist Hlth, Natl TB Control Programme, Lilongwe, Malawi	Baylor College of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Ahmed, S (corresponding author), Childrens Fdn Malawi, Baylor Coll Med, Lilongwe, Malawi.; Ahmed, S (corresponding author), Baylor Coll Med, Baylor Int Pediat AIDS Initiat, Texas Childrens Hosp, Houston, TX 77030 USA.	sahmed@tingathe.org		Flick, Robert/0000-0002-8155-6398	United States Agency for International Development [674-A-00-10-00093-00]; Fogarty International Center of the National Institutes of Health (NIH; Bethesda, MD, USA) [K01 TW009644]; Doris Duke Charitable Foundation (New York, NY, USA); NIH - Fogarty International Center [R25 TW009340]; USAID [674-A-00-10-00093-00]; Fogarty International Center of the National Institutes of Health [K01 TW009644]; FOGARTY INTERNATIONAL CENTER [K01TW009644] Funding Source: NIH RePORTER	United States Agency for International Development(United States Agency for International Development (USAID)); Fogarty International Center of the National Institutes of Health (NIH; Bethesda, MD, USA); Doris Duke Charitable Foundation (New York, NY, USA)(Doris Duke Charitable Foundation (DDCF)); NIH - Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); USAID(United States Agency for International Development (USAID)); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The study was made possible by the Tingathe Program supported by the United States Agency for International Development cooperative agreement number 674-A-00-10-00093-00. MHK was supported by the Fogarty International Center of the National Institutes of Health (NIH; Bethesda, MD, USA) under award number K01 TW009644. RF was supported by the Doris Duke Charitable Foundation (New York, NY, USA) and NIH Research Training Grant number R25 TW009340 funded by the Fogarty International Center.; This publication was made possible by support from USAID cooperative agreement number 674-A-00-10-00093-00. MHK was supported by the Fogarty International Center of the National Institutes of Health under award number K01 TW009644. RF was supported by the Doris Duke Charitable Foundation (New York, NY, USA) and NIH Research Training Grant number R25 TW009340 funded by the Fogarty International Center. The funders had no role in study design, data collection and analysis, decision to publish or preparation of this manuscript. The contents are the responsibility of the authors and do not necessarily reflect the views of the funders, including the National Institutes of Health, USAID and the United States Government. This study was presented in part at the 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention in Vancouver, Canada and was awarded the IAS TB/HIV Research Prize.	Ahmed S, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19305; Atkinson J, 2009, NATURAL VENTILATION FOR INFECTION CONTROL IN HEALTH-CARE SETTINGS, P1; Atukunda R., 2013, GLOBAL J MED PUBLIC, V2, P1; Barrera E, 2015, INT J TUBERC LUNG D, V19, P381, DOI 10.5588/ijtld.14.0680; Bates M, 2015, LANCET INFECT DIS, V15, P544, DOI 10.1016/S1473-3099(15)70058-7; Bates M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040774; Daley CL, 1992, NEW ENGL J MED, P326; DIPERRI G, 1989, LANCET, V2, P1502; EDLIN BR, 1992, NEW ENGL J MED, V326, P1514, DOI 10.1056/NEJM199206043262302; Eyob G, 2002, INT J TUBERC LUNG D, V6, P85; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Government of Malawi Ministry of Health, 2009, GUID LIN INF PREV CO; Government of Malawi Ministry of Health, MAL HLTH INF MAN SYS; Government of Malawi Ministry of Health UNICEF UNFPA World Health Organization AMDD, 2010, MASL 20110 EMONC NEE; Harries AD, 2002, B WORLD HEALTH ORGAN, V80, P526; Harries AD, 1999, T ROY SOC TROP MED H, V93, P32, DOI 10.1016/S0035-9203(99)90170-0; Kanyerere HS, 2003, INT J TUBERC LUNG D, V7, P489; Kassim S, 2000, INT J TUBERC LUNG D, V4, P321; Kim MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072421; Kranzer K, 2010, SAMJ S AFR MED J, V100, P224, DOI 10.7196/SAMJ.3903; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Lawn SD, 2009, CLIN CHEST MED, V30, P685, DOI 10.1016/j.ccm.2009.08.010; Malawi Ministry of Health Department of HIV & AIDS, 2015, INT HIV PROGR REP OC; Malawi National Statistical Office, 2014, 2014 MAL POP; MALONEY SA, 1995, ANN INTERN MED, V122, P90, DOI 10.7326/0003-4819-122-2-199501150-00002; Namakhoma I, 2010, AIDS CARE, V22, P68, DOI 10.1080/09540121003607241; Nardell EA, 2016, INDOOR AIR, V26, P79, DOI 10.1111/ina.12232; SEPKOWITZ KA, 1994, ANN INTERN MED, V120, P71, DOI 10.7326/0003-4819-120-1-199401010-00012; Shisana O, 2004, SAMJ S AFR MED J, V94, P846; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; UNAIDS, 2013, GLOBAL REPORT UNAIDS; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2015, GLOB TUB REP 2015; ZAZA S, 1995, J INFECT DIS, V172, P1542, DOI 10.1093/infdis/172.6.1542	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189140	10.1371/journal.pone.0189140	http://dx.doi.org/10.1371/journal.pone.0189140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211793	gold, Green Submitted, Green Published			2022-12-27	WOS:000417212200068
J	Ghith, N; Frolich, A; Merlo, J				Ghith, Nermin; Frolich, Anne; Merlo, Juan			The role of the clinical departments for understanding patient heterogeneity in one-year mortality after a diagnosis of heart failure: A multilevel analysis of individual heterogeneity for profiling provider outcomes	PLOS ONE			English	Article							BRIEF CONCEPTUAL TUTORIAL; SOCIAL EPIDEMIOLOGY; CARE; SURVIVAL; RATES; HOSPITALIZATION; PERFORMANCE; SWEDEN; RISK; READMISSION	Purpose To evaluate the general contextual effect (GCE) of the hospital department on one-year mortality in Swedish and Danish patients with heart failure (HF) by applying a multilevel analysis of individual heterogeneity. Methods Using the Swedish patient register, we obtained data on 36,943 patients who were 45-80 years old and admitted for HF to the hospital between 2007 and 2009. From the Danish Heart Failure Database (DHFD), we obtained data on 12,001 patients with incident HF who were 18 years or older and treated at hospitals between June 2010 and June2013. For each year, we applied two-step single and multilevel logistic regression models. We evaluated the general effects of the department by quantifying the intra-class correlation coefficient (ICC) and the increment in the area under the receiver operating characteristic curve (AUC) obtained by adding the random effects of the department in a multilevel logistic regression analysis. Results One-year mortality for Danish incident HF patients was low in the three audit years (around 11.1% - 13.1%) and departments performed homogeneously (ICC approximate to 1.5% -3.5%). The discriminatory accuracy of a model including age and gender was rather high (AUC approximate to 0.71-0.73) but the increment in AUC after adding the department random effects into these models was only about 0.011-0.022 units in the three years. One-year mortality in Swedish patients with first hospitalization for heart failure, was relatively higher for 2007-2009 (approximate to 21.3% -22%) and departments performed homogeneously ICC approximate to 1.5% - 3%). The discriminatory accuracy of a model including age, gender and patient risk score was rather high (AUC approximate to 0.726-0.728) but the increment in AUC after adding the department random effects was only about 0.010-0.017 units in the three years. Conclusion Using the DHFD standard benchmark for one-year mortality, Danish departments had a good, homogeneous performance. In reference to literature, Swedish departments had a homogeneous performance and the mortality rates for patients with first hospitalization for heart failure were similar to those reported since 2000. Considering this, if health authorities decide to further reduce mortality rates, a comprehensive quality strategy should focus on all Swedish hospitals. Yet, a complementary assessment for the period after the study period is required to confirm whether department performance is still homogeneous or not to determine the most appropriate action.	[Ghith, Nermin; Frolich, Anne] Bispebjerg & Frederiksberg Univ Hosp, Dept Clin Epidemiol, Res Unit Chron Condit, Copenhagen, Denmark; [Ghith, Nermin; Merlo, Juan] Lund Univ, Fac Med, Unit Social Epidemiol, Malmo, Sweden	University of Copenhagen; Bispebjerg Hospital; Lund University	Ghith, N (corresponding author), Bispebjerg & Frederiksberg Univ Hosp, Dept Clin Epidemiol, Res Unit Chron Condit, Copenhagen, Denmark.; Ghith, N (corresponding author), Lund Univ, Fac Med, Unit Social Epidemiol, Malmo, Sweden.	nermin_m.ghith@med.lu.se	Ghith, Nermin/B-3163-2013; Merlo, Juan/E-2136-2011	Ghith, Nermin/0000-0002-5863-5442; Merlo, Juan/0000-0001-8379-9708	University of Copenhagen; Association of Hospitals in Copenhagen; Swedish Research Council (VR) [2013-2484]	University of Copenhagen; Association of Hospitals in Copenhagen; Swedish Research Council (VR)(Swedish Research Council)	This work was supported by grants from the University of Copenhagen and the Association of Hospitals in Copenhagen for Nermin Ghith as a PHD candidate and by the Swedish Research Council (VR) [#2013-2484, Juan Merlo]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arah OA, 2006, INT J QUAL HEALTH C, V18, P5, DOI 10.1093/intqhc/mzl024; Ash AS, 2012, STAT ISSUES ASSESSIN; Austin PC, 2016, MEDIAN HAZARD RATIO; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Browne WJ., 2013, MCMC ESTIMATIN MLWIN; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; DeSalvo KB, 2005, HEALTH SERV RES, V40, P1234, DOI 10.1111/j.1475-6773.2005.00404.x; Ding VY, 2013, HEALTH SERV OUTCOME, V13, P1, DOI 10.1007/s10742-012-0099-5; Diya L, 2014, J R STAT SOC A STAT, V177, P237, DOI 10.1111/rssa.12012; Elliott MN, 2005, ANAL CASE MIX STRATE; Emilsson L, 2015, J INTERN MED, V277, P94, DOI 10.1111/joim.12303; Ghith N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148187; Goldstein H., 2002, Understanding Statistics, V1, P223, DOI 10.1207/S15328031US0104_02; Hayes AF, 2006, HUM COMMUN RES, V32, P385, DOI 10.1111/j.1468-2958.2006.00281.x; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172; Jong P, 2002, ARCH INTERN MED, V162, P1689, DOI 10.1001/archinte.162.15.1689; Krein SL, 2002, HEALTH SERV RES, V37, P1159, DOI 10.1111/1475-6773.01102; Krumholz HM, 2013, JAMA-J AM MED ASSOC, V309, P587, DOI 10.1001/jama.2013.333; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Krumholz HM, 2006, CIRCULATION, V113, P456, DOI 10.1161/CIRCULATIONAHA.105.170769; Mehta HB, 2016, J SURG RES, V204, P326, DOI 10.1016/j.jss.2016.05.008; Merlo J, 2005, MED CARE, V43, P1092, DOI 10.1097/01.mlr.0000182484.14608.b9; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P1022, DOI 10.1136/jech.2004.028035; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Merlo J, 2001, J EPIDEMIOL COMMUN H, V55, P323, DOI 10.1136/jech.55.5.323; Merlo J, 2001, LAKARTIDNINGEN, V98, P4838; Merlo J, 2013, EUR J EPIDEMIOL, V28, P135; Merlo J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153778; Merlo J, 2012, SOC SCI MED, V75, P1477, DOI 10.1016/j.socscimed.2012.06.004; Moons KGM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001744; Nakano A, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-391; Nezlek JB, 2008, SOC PERSONAL PSYCHOL, V2, P842, DOI 10.1111/j.1751-9004.2007.00059.x; Normand SLT, 2016, ANNU REV STAT APPL, V3, P21, DOI 10.1146/annurev-statistics-022513-115617; Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545; O'Brien SM, 2016, CIRC-CARDIOVASC QUAL, V9, P560, DOI 10.1161/CIRCOUTCOMES.116.002756; OECD, 2013, OECD REV HLTH CAR QU; Ohlsson H, 2011, MED CARE, V49, P327, DOI 10.1097/MLR.0b013e31820325c5; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Rasbash J, 2013, MLWIN 2; Rasbash J, 2015, USERS GUIDE MLWIN; Romano P. S., 2010, SELECTING QUALITY RE; Schaufelberger M, 2004, EUR HEART J, V25, P300, DOI 10.1016/j.ehj.2003.12.012; Schjodt I, 2016, CLIN EPIDEMIOL, V8, P497, DOI 10.2147/CLEP.S99504; Schmidt M, 2016, EUR J HEART FAIL, V18, P490, DOI 10.1002/ejhf.486; Selby JV, 2010, MED CARE, V48, P133, DOI 10.1097/MLR.0b013e3181c15a6e; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Thorvaldsen T, 2016, EUR J HEART FAIL, V18, P503, DOI 10.1002/ejhf.496; Urbanoski KA, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-63; Wagner P, 2015, INT J EPIDEMIOL, V44, P49; Wagner P, 2014, 20 IEA WORLD C EP 17	53	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189050	10.1371/journal.pone.0189050	http://dx.doi.org/10.1371/journal.pone.0189050			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211785	Green Submitted, gold, Green Published			2022-12-27	WOS:000417212200059
J	Jedroszka, D; Orzechowska, M; Hamouz, R; Gorniak, K; Bednarek, AK				Jedroszka, Dorota; Orzechowska, Magdalena; Hamouz, Raneem; Gorniak, Karolina; Bednarek, Andrzej K.			Markers of epithelial-to-mesenchymal transition reflect tumor biology according to patient age and Gleason score in prostate cancer	PLOS ONE			English	Article							ISUP CONSENSUS CONFERENCE; ESTROGEN-RECEPTOR-ALPHA; ANDROGEN RECEPTOR; E-CADHERIN; INTERNATIONAL-SOCIETY; BETA-CATENIN; YOUNG-AGE; EXPRESSION; ADHESION; SNAIL	Introduction Prostate carcinoma (PRAD) is one of the most frequently diagnosed malignancies amongst men worldwide. It is well-known that androgen receptor (AR) plays a pivotal role in a vast majority of prostate tumors. However, recent evidence emerged stating that estrogen receptors (ERs) may also contribute to prostate tumor development. Moreover, progression and aggressiveness of prostate cancer may be associated with differential expression genes of epithelial-to-mesenchymal transition (EMT). Therefore we aimed to assess the significance of receptors status as well as EMT marker genes expression among PRAD patients in accordance to their age and Gleason score. Materials and methods We analyzed TCGA gene expression profiles of 497 prostate tumor samples according to 43 genes involved in EMT and 3 hormone receptor genes (AR, ESR1, ESR2) as well as clinical characteristic of cancer patients. Then patients were divided into four groups according to their age and 5 groups according to Gleason score. Next, we evaluated PRAD samples according to relationship between the set of variables in different combinations and compared differential expression in subsequent groups of patients. The analysis was applied using R packages: FactoMineR, gplots, RColorBrewer and NMF. Results MFA analysis resulted in distinct grouping of PRAD patients into four age categories according to expression level of AR, ESR1 and ESR2 with the most distinct group of age less than 50 years old. Further investigations indicated opposite expression profiles of EMT markers between different age groups as well as strong association of EMT gene expression with Gleason score. We found that depending on age of prostate cancer patients and Gleason score EMT genes with distinctly altered expression are: KRT18, KRT19, MUC1 and COL4A1, CTNNB1, SNAI2, ZEB1 and MMP3. Conclusions Our major observation is that prostate cancer from patients under 50 years old compared to older ones has entirely different EMT gene expression profiles showing potentially more aggressive invasive phenotype, despite Gleason score classification.	[Jedroszka, Dorota; Orzechowska, Magdalena; Hamouz, Raneem; Bednarek, Andrzej K.] Med Univ Lodz, Dept Mol Carcinogenesis, Lodz, Poland; [Gorniak, Karolina] Med Univ Lodz, Dept Pathol, Lodz, Poland	Medical University Lodz; Medical University Lodz	Bednarek, AK (corresponding author), Med Univ Lodz, Dept Mol Carcinogenesis, Lodz, Poland.	andrzej.bednarek@umed.lodz.pl	Orzechowska, Magdalena/AAB-9812-2019; Bednarek, Andrzej K./S-9664-2016; Hammouz, Raneem Y./AAC-5258-2019; Jędroszka, Dorota/Z-1827-2019	Orzechowska, Magdalena/0000-0002-8301-8059; Bednarek, Andrzej K./0000-0002-4570-4154; Hammouz, Raneem Y./0000-0002-2726-3922; Jędroszka, Dorota/0000-0002-8213-2802	Medical University of Lodz Scientific [. 503/0-078-0 2/ 503-01 -004]	Medical University of Lodz Scientific	The study was funded by Medical University of Lodz Scientific Grant No. 503/0-078-0 2/ 503-01 -004. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; [Anonymous], 2017, R LANG ENV STAT COMP; Anose BM, 2008, ADV EXP MED BIOL, V617, P541, DOI 10.1007/978-0-387-69080-3_55; Atala A, 2015, J UROLOGY, V193, P1725, DOI 10.1016/j.juro.2015.02.021; Baritaki S, 2009, ONCOGENE, V28, P3573, DOI 10.1038/onc.2009.214; Bastid J, 2012, CANCER METAST REV, V31, P277, DOI 10.1007/s10555-011-9344-6; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Bussemakers MJG, 2000, INT J CANCER, V85, P446, DOI 10.1002/(SICI)1097-0215(20000201)85:3<446::AID-IJC23>3.3.CO;2-2; Christoforou P, 2014, MOL MED, V20, P427, DOI 10.2119/molmed.2014.00105; Corey E, 2002, CLIN CANCER RES, V8, P1003; Deep G, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-37; Deryugina EI, 2015, MATRIX BIOL, V44-46, P94, DOI 10.1016/j.matbio.2015.04.004; Dey P, 2012, MOL ENDOCRINOL, V26, P1991, DOI 10.1210/me.2012.1227; Dong P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083519; Drake JM, 2009, MOL BIOL CELL, V20, P2207, DOI 10.1091/mbc.E08-10-1076; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Epstein JI, 2016, AM J SURG PATHOL, V40, P244, DOI 10.1097/PAS.0000000000000530; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Huang TH, 2017, J CHIN MED ASSOC, V80, P39, DOI 10.1016/j.jcma.2016.10.004; Humphrey PA, 2004, MODERN PATHOL, V17, P292, DOI 10.1038/modpathol.3800054; Hussein S, 2015, J CLIN PATHOL, V68, P511, DOI 10.1136/jclinpath-2015-202993; Jaggi M, 2005, UROL ONCOL-SEMIN ORI, V23, P402, DOI 10.1016/j.urolonc.2005.03.024; Jiang YG, 2007, INT J UROL, V14, P1034, DOI 10.1111/j.1442-2042.2007.01866.x; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Koivisto P, 1997, CANCER RES, V57, P314; Kypta RM, 2012, NAT REV UROL, V9, P418, DOI 10.1038/nrurol.2012.116; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Lau KM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091434; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Leav I, 2001, AM J PATHOL, V159, P79, DOI 10.1016/S0002-9440(10)61676-8; Lee David, 2003, Clin Prostate Cancer, V2, P13; Lee K, 2012, INT REV CEL MOL BIO, V294, P171, DOI 10.1016/B978-0-12-394305-7.00004-5; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Lin DW, 2009, CANCER-AM CANCER SOC, V115, P2863, DOI 10.1002/cncr.24324; Merrill RM, 2002, CANCER CAUSE CONTROL, V13, P435, DOI 10.1023/A:1015764507609; Milonas D, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9858923; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Mooney SM, 2016, ASIAN J ANDROL, V18, P704, DOI 10.4103/1008-682X.183570; Nauseef JT, 2011, NAT REV UROL, V8, P428, DOI 10.1038/nrurol.2011.85; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Orwoll E, 2006, J CLIN ENDOCR METAB, V91, P1336, DOI 10.1210/jc.2005-1830; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Pierorazio PM, 2013, BJU INT, V111, P753, DOI 10.1111/j.1464-410X.2012.11611.x; Powell E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030993; Ricciardelli C, 2005, PROSTATE, V63, P19, DOI 10.1002/pros.20154; Ricke WA, 2008, FASEB J, V22, P1512, DOI 10.1096/fj.07-9526com; Safarinejad MR, 2012, MOL CARCINOGEN, V51, pE104, DOI 10.1002/mc.21870; Saha B, 2008, PROSTATE, V68; Salinas CA, 2014, NAT REV UROL, V11, P317, DOI 10.1038/nrurol.2014.91; Steinestel K, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-17; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 1996, J CELL BIOCHEM, V61, P489; Tomita K, 2000, CANCER RES, V60, P3650; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Tran NL, 1999, AM J PATHOL, V155, P787, DOI 10.1016/S0002-9440(10)65177-2; UMBAS R, 1994, CANCER RES, V54, P3929; UMBAS R, 1992, CANCER RES, V52, P5104; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Yadav N, 2012, MINERVA UROL NEFROL, V64, P35; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008	67	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188842	10.1371/journal.pone.0188842	http://dx.doi.org/10.1371/journal.pone.0188842			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29206234	gold, Green Published, Green Submitted			2022-12-27	WOS:000417033200015
J	Lin, C; Fesi, BD; Marquis, M; Bosak, NP; Lysenko, A; Koshnevisan, MA; Duke, FF; Theodorides, ML; Nelson, TM; McDaniel, AH; Avigdor, M; Arayata, CJ; Shaw, L; Bachmanov, AA; Reed, DR				Lin, Cailu; Fesi, Brad D.; Marquis, Michael; Bosak, Natalia P.; Lysenko, Anna; Koshnevisan, Mohammed Amin; Duke, Fujiko F.; Theodorides, Maria L.; Nelson, Theodore M.; McDaniel, Amanda H.; Avigdor, Mauricio; Arayata, Charles J.; Shaw, Lauren; Bachmanov, Alexander A.; Reed, Danielle R.			Adiposity QTL Adip20 decomposes into at least four loci when dissected using congenic strains	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BODY-FAT DISTRIBUTION; OBESITY QTLS; CANDIDATE GENE; DIETARY OBESITY; MOUSE STRAINS; F-2 INTERCROSS; KNOCKOUT MICE; INBRED MICE; GENOME-WIDE	An average mouse in midlife weighs between 25 and 30 g, with about a gram of tissue in the largest adipose depot (gonadal), and the weight of this depot differs between inbred strains. Specifically, C57BL/6ByJ mice have heavier gonadal depots on average than do 129P3/J mice. To understand the genetic contributions to this trait, we mapped several quantitative trait loci (QTLs) for gonadal depot weight in an F-2 intercross population. Our goal here was to fine-map one of these QTLs, Adip20 (formerly Adip5), on mouse chromosome 9. To that end, we analyzed the weight of the gonadal adipose depot from newly created congenic strains. Results from the sequential comparison method indicated at least four rather than one QTL; two of the QTLs were less than 0.5 Mb apart, with opposing directions of allelic effect. Different types of evidence (missense and regulatory genetic variation, human adiposity/body mass index orthologues, and differential gene expression) implicated numerous candidate genes from the four QTL regions. These results highlight the value of mouse congenic strains and the value of this sequential method to dissect challenging genetic architecture.	[Lin, Cailu; Fesi, Brad D.; Marquis, Michael; Bosak, Natalia P.; Lysenko, Anna; Koshnevisan, Mohammed Amin; Duke, Fujiko F.; Theodorides, Maria L.; Nelson, Theodore M.; McDaniel, Amanda H.; Avigdor, Mauricio; Arayata, Charles J.; Shaw, Lauren; Bachmanov, Alexander A.; Reed, Danielle R.] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA	Monell Chemical Senses Center	Reed, DR (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	reed@monell.org	Lin, Cailu/E-5316-2011; Bachmanov, Alexander A./AAH-8857-2020	Lin, Cailu/0000-0001-8909-7758; Bachmanov, Alexander A./0000-0002-2861-3322	National Institutes of Health [R01 DK094759, R01 DK058797, P30 DC011735, OD018125, RR025607, RR026752, G20 OD020296]; institutional funds from the Monell Chemical Senses Center; National Institutes of Health provided genotyping services	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); institutional funds from the Monell Chemical Senses Center; National Institutes of Health provided genotyping services	The National Institutes of Health grants R01 DK094759, R01 DK058797, P30 DC011735, OD018125, RR025607, RR026752, G20 OD020296 and institutional funds from the Monell Chemical Senses Center funded this work including genotyping and the purchase of equipment. The Center for Inherited Disease Research through the auspices of the National Institutes of Health provided genotyping services.	[Anonymous], 2015, MUS MUSC LAB MOUS GE; [Anonymous], 2015, SIFT WEB SERVER PRED; [Anonymous], 2016, DBSNP SINGLE NUCLEOT; Bachmanov AA, 2001, PHYSIOL BEHAV, V72, P603, DOI 10.1016/S0031-9384(01)00412-7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boardman JD, 2014, DEMOGRAPHY, V51, P119, DOI 10.1007/s13524-013-0259-4; Brockmann GA, 1998, GENETICS, V150, P369; Brockmann GA, 2000, GENOME RES, V10, P1941, DOI 10.1101/gr.GR1499R; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Cheverud JM, 2004, DIABETES, V53, P3328, DOI 10.2337/diabetes.53.12.3328; Cheverud JM, 1996, GENETICS, V142, P1305; Cinti S, 1999, ADIPOSE ORGAN; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; de Buhr MF, 2006, PHYSIOL GENOMICS, V25, P426, DOI 10.1152/physiolgenomics.00022.2005; de Ledesma AMR, 2006, MAMM GENOME, V17, P111, DOI 10.1007/s00335-005-0107-y; Delignette-Muller ML., 2014, FITDISTRPLUS HELP FI; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; DIETRICH W, 1992, GENETICS, V131, P423; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Drinkwater NR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002975; EISEN EJ, 1990, J ANIM SCI, V68, P3557; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Farber CR, 2007, MAMM GENOME, V18, P635, DOI 10.1007/s00335-007-9046-0; Farber CR, 2007, GENETICS, V175, P349, DOI 10.1534/genetics.106.063693; Fesi B, 2013, KROC LECT S U PENNS; Fontenla M., OPTREES OPTIMAL TREE; Fried SK, 2015, OBESITY, V23, P1345, DOI 10.1002/oby.21133; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Gularte-Merida R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1191-8; GWAS Catalog, 2015, GWAS CAT NHGRI EBI C; Halldorsdottir Solveig, 2009, Int J Body Compos Res, V7, P147; Hayakawa T, 2001, COLOR ATLAS SECTIONA; Horvat S, 2000, MAMM GENOME, V11, P2, DOI 10.1007/s003350010002; Ishikawa A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170652; Ishimori N, 2004, J LIPID RES, V45, P1624, DOI 10.1194/jlr.M400098-JLR200; Jerez-Timaure NC, 2004, OBES RES, V12, P1408, DOI 10.1038/oby.2004.177; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Keightley PD, 1998, GENETICS, V148, P1931; Keightley PD, 1998, HEREDITY, V81, P630, DOI 10.1046/j.1365-2540.1998.00450.x; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kin TS, 2007, BIOINFORMATICS, V23, P2945, DOI 10.1093/bioinformatics/btm455; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; Koscielny G, 2014, NUCLEIC ACIDS RES, V42, pD802, DOI 10.1093/nar/gkt977; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lawson HA, 2013, NAT REV GENET, V14, P608, DOI 10.1038/nrg3543; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; Lin CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132589; McDaniel AH, 2006, MAMM GENOME, V17, P1078, DOI 10.1007/s00335-006-0055-1; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mollah MBR, 2011, MAMM GENOME, V22, P282, DOI 10.1007/s00335-011-9323-9; Moustafa JSES, 2013, NAT REV ENDOCRINOL, V9, P402, DOI 10.1038/nrendo.2013.57; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; Oey H, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0047-z; Ogino T, 2000, GENOMICS, V70, P19, DOI 10.1006/geno.2000.6349; Olsson AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004735; Pond C.M., 1998, FATS LIFE; Raab RM, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-40; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; Reed DR, 2007, PHYSIOL BEHAV, V91, P593, DOI 10.1016/j.physbeh.2007.03.026; Reed DR, 2006, MAMM GENOME, V17, P1065, DOI 10.1007/s00335-006-0054-2; Reed DR, 2011, PHYSIOL BEHAV, V103, P523, DOI 10.1016/j.physbeh.2011.04.006; Reed DR, 2003, MAMM GENOME, V14, P302, DOI 10.1007/s00335-002-2170-y; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Shao HF, 2010, MAMM GENOME, V21, P276, DOI 10.1007/s00335-010-9267-5; SKaI J, 2016, CRAN2016; Stylianou IM, 2005, PHYSIOL GENOMICS, V20, P224, DOI 10.1152/physiolgenomics.00183.2004; Suto J, 1998, MAMM GENOME, V9, P506, DOI 10.1007/s003359900809; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Taylor BA, 1996, GENOMICS, V34, P389, DOI 10.1006/geno.1996.0302; Taylor BA, 1999, MAMM GENOME, V10, P963, DOI 10.1007/s003359901141; Taylor BA, 1997, GENOMICS, V43, P249, DOI 10.1006/geno.1997.4835; Taylor BA, 2001, MAMM GENOME, V12, P95, DOI 10.1007/s003350010254; WEST DB, 1994, MAMM GENOME, V5, P546, DOI 10.1007/BF00354928; WEST DB, 1994, J CLIN INVEST, V94, P1410, DOI 10.1172/JCI117477; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Wickham H CW, 2016, CRAN2016; Wolf JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000091; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432; Yamamoto Y, 2010, OBESITY, V18, P872, DOI 10.1038/oby.2009.512; Yick CY, 2013, EUR RESPIR J, V42, P662, DOI 10.1183/09031936.00115412; York B, 1997, MAMM GENOME, V8, P726, DOI 10.1007/s003359900554; York B, 1996, MAMM GENOME, V7, P677, DOI 10.1007/s003359900204; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhao W, 2004, PHYSIOL GENOMICS, V19, P218, DOI 10.1152/physiolgenomics.00129.2004; Zhuang Y, 2007, GENETICS, V177, P1987, DOI 10.1534/genetics.107.080325	88	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0188972	10.1371/journal.pone.0188972	http://dx.doi.org/10.1371/journal.pone.0188972			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194435	Green Submitted, Green Published, gold			2022-12-27	WOS:000416867800017
J	Jo, A; Hoi, H; Zhou, H; Gupta, M; Montemagno, CD				Jo, Andrew; Hoi, Hiofan; Zhou, Hang; Gupta, Manisha; Montemagno, Carlo D.			Single-molecule study of full-length NaChBac by planar lipid bilayer recording	PLOS ONE			English	Article							GATED SODIUM-CHANNEL; PHOSPHOLIPID-VESICLES; FUNCTIONAL-ANALYSIS; MEMBRANE-PROTEINS; RECONSTITUTION	Planar lipid bilayer device, alternatively known as BLM, is a powerful tool to study functional properties of conducting membrane proteins such as ion channels and porins. In this work, we used BLM to study the prokaryotic voltage-gated sodium channel (Nav) NaChBac in a well-defined membrane environment. Navs are an essential component for the generation and propagation of electric signals in excitable cells. The successes in the biochemical, biophysical and crystallographic studies on prokaryotic Navs in recent years has greatly promoted the understanding of the molecular mechanism that underlies these proteins and their eukaryotic counterparts. In this work, we investigated the single-molecule conductance and ionic selectivity behavior of NaChBac. Purified NaChBac protein was first reconstituted into lipid vesicles, which is subsequently incorporated into planar lipid bilayer by fusion. At single-molecule level, we were able to observe three distinct long-lived conductance substates of NaChBac. Change in the membrane potential switches on the channel mainly by increasing its opening probability. In addition, we found that individual NaChBac has similar permeability for Na+, K+, and Ca2+. The single-molecule behavior of the full-length protein is essentially highly stochastic. Our results show that planar lipid bilayer device can be used to study purified ion channels at single-molecule level in an artificial environment, and such studies can reveal new protein properties that are otherwise not observable in in vivo ensemble studies.	[Jo, Andrew; Hoi, Hiofan; Zhou, Hang; Montemagno, Carlo D.] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada; [Jo, Andrew; Hoi, Hiofan; Zhou, Hang; Gupta, Manisha; Montemagno, Carlo D.] Ingenu Lab, Edmonton, AB, Canada; [Gupta, Manisha] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada; [Montemagno, Carlo D.] Natl Inst Nanotechnol, Edmonton, AB, Canada; [Montemagno, Carlo D.] Southern Illinois Univ, Carbondale, IL 62901 USA	University of Alberta; University of Alberta; National Research Council Canada; Southern Illinois University System; Southern Illinois University	Hoi, H; Montemagno, CD (corresponding author), Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada.; Hoi, H; Montemagno, CD (corresponding author), Ingenu Lab, Edmonton, AB, Canada.; Montemagno, CD (corresponding author), Natl Inst Nanotechnol, Edmonton, AB, Canada.; Montemagno, CD (corresponding author), Southern Illinois Univ, Carbondale, IL 62901 USA.	hiofan@ualberta.ca; chancellor@siu.edu			Alberta Innovates [20090279/PSI14420-2011]; AITF iCORE chairship [16326-2014]	Alberta Innovates; AITF iCORE chairship	This work was funded by Alberta Innovates (Grant # 20090279/PSI14420-2011) and an AITF iCORE chairship to C.D.M (grant #16326-2014). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; COHEN FS, 1982, SCIENCE, V217, P458, DOI 10.1126/science.6283637; COHEN FS, 1993, METHOD ENZYMOL, V220, P50, DOI 10.1016/0076-6879(93)20073-C; COHEN FS, 1989, J GEN PHYSIOL, V93, P201, DOI 10.1085/jgp.93.2.201; Gutsmann T, 2015, NAT PROTOC, V10, P188, DOI 10.1038/nprot.2015.003; HARTSHORNE RP, 1984, J BIOL CHEM, V259, P1667; Kelly ML, 2003, MEMBR SCI T, V7, P699, DOI 10.1016/S0927-5193(03)80049-9; Kuszak AJ, 2015, J BIOL CHEM, V290, P26204, DOI 10.1074/jbc.M115.642173; Lee S, 2012, J GEN PHYSIOL, V139, P507, DOI 10.1085/jgp.201210779; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; Li Y, 2015, PROTEIN CELL, V6, P413, DOI 10.1007/s13238-015-0152-6; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; MONTAL M, 1981, Q REV BIOPHYS, V14, P1, DOI 10.1017/S0033583500002079; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; MUELLER P, 1962, NATURE, V194, P979, DOI 10.1038/194979a0; Patti JT, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/32/325103; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Puopolo M, 2013, J NEUROPHYSIOL, V109, P1704, DOI 10.1152/jn.00012.2013; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Saha SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131286; Shaya D, 2014, J MOL BIOL, V426, P467, DOI 10.1016/j.jmb.2013.10.010; Siontorou CG, 2017, MEMBRANES-BASEL, V7, DOI 10.3390/membranes7030038; Stock L, 2013, J PHYS CHEM B, V117, P3782, DOI 10.1021/jp401403b; Studer A, 2011, BIOSENS BIOELECTRON, V26, P1924, DOI 10.1016/j.bios.2010.06.008; Sula A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14205; Tao X, 2008, J MOL BIOL, V382, P24, DOI 10.1016/j.jmb.2008.06.085; Ulmschneider MB, 2013, P NATL ACAD SCI USA, V110, P6364, DOI 10.1073/pnas.1214667110; Zakharian Eleonora, 2013, Methods Mol Biol, V998, P109, DOI 10.1007/978-1-62703-351-0_8	30	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188861	10.1371/journal.pone.0188861	http://dx.doi.org/10.1371/journal.pone.0188861			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190805	Green Submitted, Green Published, gold			2022-12-27	WOS:000416841900147
J	Rahmanian, A; Jamali, M; Lankarani, KB; Ghahramani, S				Rahmanian, Abdolkarim; Jamali, Mohammad; Lankarani, Kamran Bagheri; Ghahramani, Sulmaz			Aneurysmal subarachnoid haemorrhage (aSAH): Five consecutive years' experience of Fars province, Iran	PLOS ONE			English	Article							RISK-FACTORS; INTRACRANIAL ANEURYSMS; CASE-FATALITY; SUDDEN-DEATH; RUPTURE; PROBABILITY; PREVALENCE	Objective Subarachnoid haemorrhage (SAH), caused by the rupture of intracranial aneurysms, is a devastating event with high rates of morbidity and mortality. Aneurysmal subarachnoid haemorrhage (aSAH) plays a critical role in the potential loss of life as its sufferers are usually of a young age. We aimed to investigate the incidence of aSAH along with the patients' characteristics over five consecutive years in Fars, a large province located in Southern Iran. Methods In this prospective study, anonymous data of all patients diagnosed with aSAH in Fars province were collected after patient admission and surgery. Data from the last national census in 2011 were used to calculate the incidence. The data were analysed using SPSS software version 18 using independent sample t test, chi square test and ANOVA. The significance level was set at 0.05. Results The number of aSAH cases identified in Fars, Iran, each year varied between 78 (2011) and 98 (2015) for a total of 421 aSAH cases within the 5-year study period. The annual aSAH incidence estimates showed no differences and were 1.65 [95% confidence interval (CI): 1.58-1.72], 1.70 (95% CI: 1.68-1.72), 1.71 (95% CI: 1.63-1.78), 1.82 (95% CI: 1.74-1.9), and 2.05 (95% CI: 1.97-2.13) per 100,000 persons, respectively, for the five consecutive years from 21 March 2011 to 20 March 2016. Hypertension was the most common risk factor, and was found in 198 (48%) aSAH patients. Ninety-four (22.5%) patients had moderate hydrocephalus on admission. Middle cerebral artery and anterior communicating artery were the most common sites of aneurysms. On admission, 351 (83%) patients had a Glasgow Coma Scale score > 7, 197 (47%) presented with Hunt and Hess score of 1, and 365 (87%) had a Fisher score of <= 3. Multiple aneurysms were found in 59 (14%) of the 421 cases and the most common risk factors in multiple aneurysms were hypertension in 30 (51%) and smoking in 26 (44%) cases. Survival data were available only on patients diagnosed in year 2015, and the six-month survival rate was 89.8%. Conclusions This study revealed that although the incidence of aSAH remained stable, the survival of aSAH patients who reached the hospital alive and were operated on, improved in Shiraz (the six-month survival rate was 89.8% in year 2015). The incidence and survival study on aSAH in other geographic areas of Iran as a multi-centre study is recommended. There is a need to inform primary healthcare workers regarding the possibility of aSAH in a patient with signs of the sentinel headache.	[Rahmanian, Abdolkarim; Jamali, Mohammad] Shiraz Univ Med Sci, Dept Neurosurg, Shiraz, Iran; [Lankarani, Kamran Bagheri; Ghahramani, Sulmaz] Shiraz Univ Med Sci, Hlth Policy Res Ctr, Inst Hlth, Shiraz, Iran	Shiraz University of Medical Science; Shiraz University of Medical Science	Ghahramani, S (corresponding author), Shiraz Univ Med Sci, Hlth Policy Res Ctr, Inst Hlth, Shiraz, Iran.	suli.ghahraman@gmail.com	Lankarani, Kamran B/P-5336-2019; jamali, mohammad/AAN-4369-2020; Ghahramani, Sulmaz/S-3942-2019; Lankarani, Kamran Bagheri/P-2066-2017; lankarani, kamran b/D-5901-2012; Ghahramani, Sulmaz/S-7384-2017	Lankarani, Kamran B/0000-0002-7524-9017; jamali, mohammad/0000-0001-8391-9175; Ghahramani, Sulmaz/0000-0002-4161-5146; Lankarani, Kamran Bagheri/0000-0002-7524-9017; Ghahramani, Sulmaz/0000-0002-4161-5146				Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; de Rooij NK, 2007, J NEUROLOGY NEUROSUR; Ellamushi HE, 2001, J NEUROSURG, V94, P728, DOI 10.3171/jns.2001.94.5.0728; Gudmundsson G, 1973, STROKE, V4, P764, DOI 10.1161/01.STR.4.5.764; Huang J, 2002, NEUROSURGERY, V51, P1101, DOI 10.1097/00006123-200211000-00001; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Inagawa T, 2001, STROKE, V32, P1499, DOI 10.1161/01.STR.32.7.1499; INGALL TJ, 1989, STROKE, V20, P718, DOI 10.1161/01.STR.20.6.718; Isaksen J, 2002, J NEUROL NEUROSUR PS, V73, P185, DOI 10.1136/jnnp.73.2.185; JUVELA S, 1993, STROKE, V24, P639, DOI 10.1161/01.STR.24.5.639; Juvela S, 2000, STROKE, V31, P392, DOI 10.1161/01.STR.31.2.392; Juvela S, 2008, J NEUROSURG, V108, P1052, DOI 10.3171/JNS/2008/108/5/1052; Lindekleiv HM, 2011, ACTA NEUROL SCAND, V123, P34, DOI 10.1111/j.1600-0404.2010.01336.x; Menghini VV, 1998, NEUROLOGY, V51, P405, DOI 10.1212/WNL.51.2.405; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Ohkuma H, 2003, STROKE, V34, P96, DOI 10.1161/01.STR.0000048161.57536.42; Rahmanian A, 2012, SURG NEUROLOGY INT, V3; Rakei S, 2008, IRAN RED CRESCENT ME, V2008, P228; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; SCHIEVINK WI, 1995, NEUROLOGY, V45, P871, DOI 10.1212/WNL.45.5.871; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tromp G, 2014, ANN MED, V46, P597, DOI 10.3109/07853890.2014.949299; Winn HR, 2017, YOUMANS NEUROLOGICAL; Wood MJ, 2005, J CLIN NEUROSCI, V12, P770, DOI 10.1016/j.jocn.2004.10.006; Zabihyan S, 2011, WORLD NEUROSURG, V76, P372, DOI 10.1016/j.wneu.2011.08.029; Ziemba-Davis M, 2014, J STROKE CEREBROVASC, V23, P1073, DOI 10.1016/j.jstrokecerebrovasdis.2013.09.010	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0189005	10.1371/journal.pone.0189005	http://dx.doi.org/10.1371/journal.pone.0189005			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190810	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900190
J	Gruskin, S; Ferguson, L; Kumar, S; Nicholson, A; Ali, M; Khosla, R				Gruskin, Sofia; Ferguson, Laura; Kumar, Shubha; Nicholson, Alexandra; Ali, Moazzam; Khosla, Rajat			A novel methodology for strengthening human rights based monitoring in public health: Family planning indicators as an illustrative example	PLOS ONE			English	Article								Objective The last few years have seen a rise in the number of global and national initiatives that seek to incorporate human rights into public health practice. Nonetheless, a lack of clarity persists regarding the most appropriate indicators to monitor rights concerns in these efforts. The objective of this work was to develop a systematic methodology for use in determining the extent to which indicators commonly used in public health capture human rights concerns, using contraceptive services and programmes as a case study. Methods The approach used to identify, evaluate, select and review indicators for their human rights sensitivity built on processes undertaken in previous work led by the World Health Organization (WHO). With advice from an expert advisory group, an analytic framework was developed to identify and evaluate quantitative, qualitative, and policy indicators in relation to contraception for their sensitivity to human rights. To test the framework's validity, indicators were reviewed to determine their feasibility to provide human rights analysis with attention to specific rights principles and standards. Findings This exercise resulted in the identification of indicators that could be used to monitor human rights concerns as well as key gaps where additional indicators are required. While indicators generally used to monitor contraception programmes have some degree of sensitivity to human rights, breadth and depth are lacking. Conclusion The proposed methodology can be useful to practitioners, researchers, and policy makers working in any area of health who are interested in monitoring and evaluating attention to human rights in commonly used health indicators.	[Gruskin, Sofia; Ferguson, Laura; Kumar, Shubha; Nicholson, Alexandra] Univ Southern Calif, Inst Global Hlth, Program Global Hlth & Human Rights, Los Angeles, CA USA; [Ali, Moazzam; Khosla, Rajat] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland	University of Southern California; World Health Organization	Gruskin, S (corresponding author), Univ Southern Calif, Inst Global Hlth, Program Global Hlth & Human Rights, Los Angeles, CA USA.	gruskin@med.usc.edu	Ferguson, Laura/AAO-9694-2021	Ferguson, Laura/0000-0002-1340-793X; Grusin, Sofia/0000-0002-2418-011X; Ali, Moazzam/0000-0001-6949-8976	UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP); World Health Organization (WHO); Bill and Melinda Gates Foundation	UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP); World Health Organization (WHO)(World Health Organization); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was funded by the UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), a cosponsored program executed by the World Health Organization (WHO), with support from the Bill and Melinda Gates Foundation. The Bill and Melinda Gates Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the authors' employers or funders.; Authors would like to gratefully acknowledge the Expert Advisory Group (EAG) members for their important contributions to this work at every step of the process: Pascale Allotey, Jacqueline Darroch, Sandra Jordan, Scott Radloff, T.K. Sundari Ravindran, Chelsea Ricker, Iqbal Shah, and Kelsey Wright. We would also like to acknowledge, Ian Askew, Theopista Kabuteni, James Kiare, Joyce Lavussa and Taiwo Oyelade for their feedback and field testing support. This work was funded by the UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), a cosponsored program executed by the World Health Organization (WHO), with support from the Bill and Melinda Gates Foundation.	[Anonymous], 2015, IND MON FRAM GLOB ST; [Anonymous], 2016, 4 M INT EXP GROUP SU; Bustreo F, 2013, WOMENS CHILDRENS HLT; Gruskin S, 2015, INTEGRATING HUMAN RI; Gruskin S, 2010, J PUBLIC HEALTH POL, V31, P129, DOI 10.1057/jphp.2010.7; Gruskin S, 2009, B WORLD HEALTH ORGAN, V87, P714, DOI 10.2471/BLT.08.058321; International Service for Human Rights, 2015, SIMPL GUID TREAT BOD, P38; Sustainable Development Goals, 2015, UN SUST DEV GOALS 17; WHO, 2017, LEAD REAL HUM RIGHTS; World Health Organization, 2017, MON HUM RIGHTS CONTR; World Health Organization, 2014, ENS HUM RIGHTS CONTR	11	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0186330	10.1371/journal.pone.0186330	http://dx.doi.org/10.1371/journal.pone.0186330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220365	Green Submitted, gold, Green Published			2022-12-27	WOS:000417469900003
J	Hanemoto, T; Hikichi, Y; Kikuchi, N; Kozawa, T				Hanemoto, Tsukasa; Hikichi, Yusuke; Kikuchi, Norimasa; Kozawa, Tadahiko			The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting	PLOS ONE			English	Article							INTRAVITREAL AFLIBERCEPT INJECTION; DISEASE BURDEN; RANIBIZUMAB; PREVALENCE; OUTCOMES	Objective To describe the burden associated with different anti-vascular endothelial growth factor (VEGF) treatment strategies for wet age-related macular degeneration (wAMD) in a real-word setting in Japan. Methods Single-center, cross-sectional survey of caregivers of patients with wAMD performed in a hospital in Mito-City, a rural area in Japan. Caregiver burden was evaluated using the Burden Index of Caregivers (BIC-11), and depressive symptoms were assessed by the Center for Epidemiologic Studies Depression scale. Retrospective medical chart review was conducted to monitor resource use and visual acuity outcomes in patients. The productivity loss of caregivers accompanying patients on hospital visits was estimated using the human capital method. Results Seventy-one patient-caregiver pairs were included. Most caregivers were female (74.6%), spouse/partner (54.9%), employed (46.5%), and the primary caregiver (85.9%). Patients received anti-VEGF treatment as follows: treat-and-extend (T & E; n = 42), switch (from as-needed [PRN] to T & E; n = 18), PRN (n = 10), and other (n = 1). Caregiver-related burden (total BIC-11 scores) were 4.29 (T&E) 4.60 (PRN), and 5.33 (switch) (p = NS). The mean number of hospital visits was lower with T&E than PRN (7.88 vs. 14.0 [p = 0.00674] in year 1 and 5.68 vs. 9.0 in year 2). For patients who switched from PRN to T&E, the mean number of hospital visits decreased from 13.21 to 7.43 (p<0.0001) in the first year after switch. The productivity loss associated with accompanying patients to the hospital was lower for caregivers of patients receiving T&E than PRN (mean differences: 74,456.04 JPY [p = 0.00284] in year 1 and 40843.14 JPY in year 2), and was also reduced for caregivers of patients who switched from PRN to T&E. Conclusion wAMD treatment with anti-VEGF agents via T&E reduced hospital visits compared with PRN, where associated monitoring visits are necessary to provide good patient outcomes. T&E was associated with a reduction trend in caregiver burden, including time and costs.	[Hanemoto, Tsukasa; Kozawa, Tadahiko] Kozawa Eye Hosp, Dept Ophthalmol, Ibaraki, Japan; [Hikichi, Yusuke] Bayer Yakuhin Ltd, Market Access Hlth Econ & Outcomes Res, Tokyo, Japan; [Kikuchi, Norimasa] Clinical Study Support Inc, CR Div, Nagoya, Aichi, Japan	Bayer AG	Hanemoto, T (corresponding author), Kozawa Eye Hosp, Dept Ophthalmol, Ibaraki, Japan.	hanemoto@tb3.so-net.ne.jp		Hikichi, Yusuke/0000-0002-1699-6821; Hanemoto, Tsukasa/0000-0002-2444-4234	Bayer Yakuhin, Ltd.; Clinical Study Support, Inc.; Bayer Pharmaceuticals	Bayer Yakuhin, Ltd.; Clinical Study Support, Inc.; Bayer Pharmaceuticals(Bayer AG)	This study was funded by Bayer Yakuhin, Ltd. The funder provided support in the form of salary for YH, and was involved in the study design, data collection, data analysis, decision to publish, and preparation of the manuscript. Clinical Study Support, Inc., was contracted by Bayer Yakuhin, Ltd, and provided support in the form of salary for NK, and was involved in data collection and data analysis.; Medical writing assistance was provided by PAREXEL and was funded by Bayer Pharmaceuticals.	Berg K, 2015, OPHTHALMOLOGY, V122, P146, DOI 10.1016/j.ophtha.2014.07.041; Braich PS, 2012, OPHTHALMOLOGY, V119, P221, DOI 10.1016/j.ophtha.2011.07.038; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Chin-Yee D, 2016, BRIT J OPHTHALMOL, V100, P914, DOI 10.1136/bjophthalmol-2015-306987; Dilokthornsakul P, 2014, INT J OPHTHALMOL-CHI, V7, P145, DOI 10.3980/j.issn.2222-3959.2014.01.27; Forbes A, 2007, CLIN REHABIL, V21, P563, DOI 10.1177/0269215507075035; Giannakaki-Zimmermann H, 2016, OPHTHALMOLOGICA, V236, P201, DOI 10.1159/000452929; Gohil R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129361; Gopinath B, 2015, AGING MENT HEALTH, V19, P239, DOI 10.1080/13607863.2014.924477; Hanemoto T., 2013, 67 ANN C JAP CLIN OP; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Ministry of Health Labour and Welfare and Ministry of Education Culture Sports Science and Technology, 2015, CULT SPORTS SCI TECH; Miyashita M, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-52; Ogura Y, 2015, BRIT J OPHTHALMOL, V99, P92, DOI 10.1136/bjophthalmol-2014-305076; Ohnaka M, 2016, GRAEFES ARCH CLIN EX; Prenner JL, 2015, AM J OPHTHALMOL, V160, P725, DOI 10.1016/j.ajo.2015.06.023; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schmidt-Erfurth U, 2014, OPHTHALMOLOGY, V121, P193, DOI 10.1016/j.ophtha.2013.08.011; Shima S., 1985, PSYCHIATRY, V27, P717, DOI DOI 10.11477/MF.1405203967; Tsuchiya A, 2001, EC EVALUATION HLTH C, P22; Varano M, 2016, CLIN OPHTHALMOL, V10, P257, DOI 10.2147/OPTH.S92616; Varano M, 2015, CLIN OPHTHALMOL, V9, P2243, DOI 10.2147/OPTH.S92548; Vukicevic M, 2016, EYE, V30, P413, DOI 10.1038/eye.2015.235; Weyer-Wendl H, 2016, HEALTH ECON REV, V6, DOI 10.1186/s13561-016-0116-4; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; World Health Organization, ICD 10 VERS 2016 VIS; Yamada M, 2010, OPHTHAL EPIDEMIOL, V17, P50, DOI 10.3109/09286580903450346; Yasuda M, 2009, OPHTHALMOLOGY, V116, P2135, DOI 10.1016/j.ophtha.2009.04.017	29	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189035	10.1371/journal.pone.0189035	http://dx.doi.org/10.1371/journal.pone.0189035			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220371	Green Published, gold, Green Submitted			2022-12-27	WOS:000417469900028
J	Paquin, S; Lacourse, E; Brendgen, M; Vitaro, F; Dionne, G; Tremblay, RE; Boivin, M				Paquin, Stephane; Lacourse, Eric; Brendgen, Mara; Vitaro, Frank; Dionne, Ginette; Tremblay, Richard Ernest; Boivin, Michel			Heterogeneity in the development of proactive and reactive aggression in childhood: Common and specific genetic-environmental factors	PLOS ONE			English	Article							PHYSICAL AGGRESSION; CONDUCT PROBLEMS; ANTISOCIAL-BEHAVIOR; LONGITUDINAL TWIN; EARLY ADOLESCENCE; DYNAMIC GENOME; CHILDREN; BOYS; MODEL; PEER	Background Few studies are grounded in a developmental framework to study proactive and reactive aggression. Furthermore, although distinctive correlates, predictors and outcomes have been highlighted, proactive and reactive aggression are substantially correlated. To our knowledge, no empirical study has examined the communality of genetic and environmental underpinning of the development of both subtypes of aggression. The current study investigated the communality and specificity of genetic-environmental factors related to heterogeneity in proactive and reactive aggression's development throughout childhood. Methods Participants were 223 monozygotic and 332 dizygotic pairs. Teacher reports of aggression were obtained at 6, 7, 9, 10 and 12 years of age. Joint development of both phenotypes were analyzed through a multivariate latent growth curve model. Set point, differentiation, and genetic maturation/environmental modulation hypotheses were tested using a biometric decomposition of intercepts and slopes. Results Common genetic factors accounted for 64% of the total variation of proactive and reactive aggression's intercepts. Two other sets of uncorrelated genetic factors accounted for reactive aggression's intercept (17%) on the one hand, and for proactive (43%) and reactive (13%) aggression's slopes on the other. Common shared environmental factors were associated with proactive aggression's intercept (21%) and slope (26%) and uncorrelated shared environmental factors were also associated with reactive aggression's slope (14%). Common nonshared environmental factors explained most of the remaining variability of proactive and reactive aggression slopes. Conclusions A genetic differentiation hypothesis common to both phenotypes was supported by common genetic factors associated with the developmental heterogeneity of proactive and reactive aggression in childhood. A genetic maturation hypothesis common to both phenotypes, albeit stronger for proactive aggression, was supported by common genetic factors associated with proactive and reactive aggression slopes. A shared environment set point hypothesis for proactive aggression was supported by shared environmental factors associated with proactive aggression baseline and slope. Although there are many common features to proactive and reactive aggression, the current research underscores the advantages of differentiating them when studying aggression.	[Paquin, Stephane; Lacourse, Eric; Brendgen, Mara; Vitaro, Frank; Dionne, Ginette; Tremblay, Richard Ernest; Boivin, Michel] Ste Justine Hosp, Res Unit Childrens Psychosocial Adjustment, Res Ctr, Montreal, PQ, Canada; [Paquin, Stephane; Lacourse, Eric] Univ Montreal, Dept Sociol, Montreal, PQ, Canada; [Brendgen, Mara] Univ Quebec Montreal, Dept Psychol, Montreal, PQ, Canada; [Vitaro, Frank] Univ Montreal, Sch Psychoeduc, Montreal, PQ, Canada; [Dionne, Ginette; Boivin, Michel] Univ Laval, Dept Psychol, Montreal, PQ, Canada; [Tremblay, Richard Ernest] Univ Montreal, Dept Pediat, Montreal, PQ, Canada; [Tremblay, Richard Ernest] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Tremblay, Richard Ernest] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin, Ireland; [Tremblay, Richard Ernest; Boivin, Michel] Tomsk State Univ, Inst Genet Neurobiol & Social, Fdn Child Dev, Tomsk, Russia	Universite de Montreal; Universite de Montreal; University of Quebec; University of Quebec Montreal; Universite de Montreal; Laval University; Universite de Montreal; Universite de Montreal; University College Dublin; Tomsk State University	Paquin, S; Lacourse, E (corresponding author), Ste Justine Hosp, Res Unit Childrens Psychosocial Adjustment, Res Ctr, Montreal, PQ, Canada.; Paquin, S; Lacourse, E (corresponding author), Univ Montreal, Dept Sociol, Montreal, PQ, Canada.	s.paquin@umontreal.ca; eric.lacourse@umontreal.ca	Tremblay, Richard E./O-1360-2014; Paquin, Stephane/B-4347-2010; Lacourse, Eric/B-3861-2013	Paquin, Stephane/0000-0001-9957-5696; Lacourse, Eric/0000-0002-4779-9900; Boivin, Michel/0000-0001-8621-9844	Social Sciences and Humanities Research Council of Canada	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was supported by Social Sciences and Humanities Research Council of Canada. http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx Canadian Institutes of Health Research. http://www.cihr-irsc.gc.ca/e/193.html; Fonds de Recherche en Sante du Quebec. http://www.frqs.gouv.qc.ca/; Fonds de Recherche Societe et Culture. http://www.frqsc.gouv.qc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alink LRA, 2006, CHILD DEV, V77, P954, DOI 10.1111/j.1467-8624.2006.00912.x; Baker LA, 2008, J ABNORM CHILD PSYCH, V36, P1265, DOI 10.1007/s10802-008-9249-1; BANDURA A, 1961, J ABNORM SOC PSYCH, V63, P575, DOI 10.1037/h0045925; Bandura A, 1973, AGGRESSION SOCIAL LE, VIX; Bandura A., 1983, AGGRESSION THEORETIC, V1, P1; Barker ED, 2010, AGGRESSIVE BEHAV, V36, P127, DOI 10.1002/ab.20337; BERKOWITZ L, 1989, PSYCHOL BULL, V106, P59, DOI 10.1037/0033-2909.106.1.59; Berkowitz L., 1993, AGGRESSION ITS CAUSE, DOI 3.0.CO;2-9; Berkowtiz Leonard, 1983, AGGRESSION THEORETIC, P103; Blakemore SJ, 2012, NAT NEUROSCI, V15, P1184, DOI 10.1038/nn.3177; Boivin M, 2013, TWIN RES HUM GENET, V16, P64, DOI 10.1017/thg.2012.129; Bowen F, 1998, REACTIVELY PROACTIVE; Brendgen M, 2001, J ABNORM CHILD PSYCH, V29, P293, DOI 10.1023/A:1010305828208; Brendgen M, 2006, DEV PSYCHOL, V42, P1299, DOI 10.1037/0012-1649.42.6.1299; Burt SA, 2009, PSYCHOL BULL, V135, P608, DOI 10.1037/a0015702; Card NA, 2006, INT J BEHAV DEV, V30, P466, DOI 10.1177/0165025406071904; Cima M, 2009, PERS INDIV DIFFER, V47, P835, DOI 10.1016/j.paid.2009.06.031; Coie J.D., 1998, HDB CHILD PSYCHOL, P153, DOI [DOI 10.1002/9780470147658, 10.4324/9780429493898-8]; Connor DF, 2004, AM J ORTHOPSYCHIAT, V74, P129, DOI 10.1037/0002-9432.74.2.129; Crick NR, 1996, CHILD DEV, V67, P993, DOI 10.1111/j.1467-8624.1996.tb01778.x; Cui L, 2015, J ABNORMAL CHILD PSY, P1; Curran PJ, 2010, J COGN DEV, V11, P121, DOI 10.1080/15248371003699969; de Castro BO, 2002, CHILD DEV, V73, P916, DOI 10.1111/1467-8624.00447; DODGE KA, 1987, J PERS SOC PSYCHOL, V53, P1146, DOI 10.1037/0022-3514.53.6.1146; Dodge KA, 1997, J ABNORM PSYCHOL, V106, P37, DOI 10.1037/0021-843X.106.1.37; Dodge KA, 1991, DEV TREATMENT CHILDH, P201; Eley TC, 2003, DEV PSYCHOPATHOL, V15, P383, DOI 10.1017/S095457940300021X; Ellis ML, 2009, J ABNORM CHILD PSYCH, V37, P945, DOI 10.1007/s10802-009-9321-5; Fite PJ, 2008, J CLIN CHILD ADOLESC, V37, P412, DOI 10.1080/15374410801955920; Fontaine RG, 2008, CHILD DEV, V79, P462, DOI 10.1111/j.1467-8624.2007.01136.x; Forget-Dubois N, 2003, TWIN RES, V6, P479, DOI 10.1375/twin.6.6.479; Frick PJ, 2003, J ABNORM CHILD PSYCH, V31, P457, DOI 10.1023/A:1023899703866; Giancola PR, 1996, ALCOHOL CLIN EXP RES, V20, P740, DOI 10.1111/j.1530-0277.1996.tb01680.x; GOLDSMITH HH, 1991, BEHAV GENET, V21, P257; Hay DF, 2014, DEVELOPMENTAL SCI, V17, P471, DOI 10.1111/desc.12133; Hay DF, 2011, INFANCY, V16, P471, DOI 10.1111/j.1532-7078.2011.00069.x; Hubbard JA, 2010, INTERNATIONAL HANDBOOK OF ANGER, P231, DOI 10.1007/978-0-387-89676-2_14; Kempes M, 2005, EUR CHILD ADOLES PSY, V14, P11, DOI 10.1007/s00787-005-0432-4; Lacourse E, 2014, PSYCHOL MED, V44, P2617, DOI 10.1017/S0033291713003218; Lamarche V, 2007, J ABNORM CHILD PSYCH, V35, P665, DOI 10.1007/s10802-007-9122-7; Lansford J, 2002, DEV TRAJECTORIES REA; LEDINGHAM JE, 1982, J ABNORM CHILD PSYCH, V10, P363, DOI 10.1007/BF00912327; Little TD, 2003, INT J BEHAV DEV, V27, P122, DOI 10.1080/01650250244000128; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; Marsee MA, 2005, BEHAV SCI LAW, V23, P803, DOI 10.1002/bsl.662; McArdle JJ, 2003, BEHAV GENET, V33, P137, DOI 10.1023/A:1022553901851; Miller JD, 2006, PERS INDIV DIFFER, V41, P1469, DOI 10.1016/j.paid.2006.06.004; Molenaar PCM, 2009, CURR DIR PSYCHOL SCI, V18, P112, DOI 10.1111/j.1467-8721.2009.01619.x; Paquin S, 2014, MONATS KRIMINOL, V97, P398, DOI 10.1515/mks-2014-975-609; Phillips NC, 2003, AGGRESSIVE BEHAV, V29, P215, DOI 10.1002/ab.10028; Pingault JB, 2015, SCI REP-UK, V5, DOI 10.1038/srep10053; Porsch RM, 2016, AM J MED GENET B, V171, P697, DOI 10.1002/ajmg.b.32420; Poulin F, 2000, DEV PSYCHOL, V36, P233, DOI 10.1037//0012-1649.36.2.233; Poulin F, 2000, PSYCHOL ASSESSMENT, V12, P115, DOI 10.1037/1040-3590.12.2.115; Pulkkinen L, 1996, AGGRESSIVE BEHAV, V22, P241, DOI 10.1002/(SICI)1098-2337(1996)22:4<241::AID-AB1>3.0.CO;2-O; Pulkkinen L, 1969, DESCRIPTIVE MODEL AG; Quebec S, 1998, 2001 ILL BE 5 YEARS; Raine A, 2006, AGGRESSIVE BEHAV, V32, P159, DOI 10.1002/ab.20115; Rathert J, 2011, CHILD PSYCHIAT HUM D, V42, P609, DOI 10.1007/s10578-011-0236-3; Seguin JR, 2005, DEVELOPMENTAL ORIGINS OF AGGRESSION, P307; Somerville LH, 2010, CURR OPIN NEUROBIOL, V20, P236, DOI 10.1016/j.conb.2010.01.006; Stoltz S, 2016, AGGRESSIVE BEHAV, V42, P29, DOI 10.1002/ab.21603; Tremblay R. E., 1999, CRIM BEHAV MENT HEAL, V9, P8, DOI [DOI 10.1002/CBM.288, 10.1002/CBM.288]; Tremblay RE, 2009, BEHAV BRAIN SCI, V32, P290, DOI 10.1017/S0140525X09990288; Tuvblad C, 2011, BEHAV GENET, V41, P629, DOI 10.1007/s10519-011-9463-4; Tuvblad C, 2009, AGGRESSIVE BEHAV, V35, P437, DOI 10.1002/ab.20319; VALLERAND RJ, 1989, CAN PSYCHOL, V30, P662, DOI 10.1037/h0079856; Vitaro F, 1998, J CHILD PSYCHOL PSYC, V39, P377, DOI 10.1017/S0021963097002102; Vitaro F, 2005, DEVELOPMENTAL ORIGINS OF AGGRESSION, P178; Vitaro F, 2002, J CHILD PSYCHOL PSYC, V43, P495, DOI 10.1111/1469-7610.00040; Vitaro F, 2006, INT J BEHAV DEV, V30, P12, DOI 10.1177/0165025406059968; Vitaro F, 2006, J ABNORM CHILD PSYCH, V34, P685, DOI 10.1007/s10802-006-9055-6; Waltes R, 2015, AM J MED GENETICS B; Wilkowski BM, 2010, J PERS, V78, P9, DOI 10.1111/j.1467-6494.2009.00607.x	74	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188730	10.1371/journal.pone.0188730	http://dx.doi.org/10.1371/journal.pone.0188730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211810	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000417212200045
J	Williams, AD; Korolkova, OY; Sakwe, AM; Geiger, TM; James, SD; Muldoon, RL; Herline, AJ; Goodwin, JS; Izban, MG; Washington, MK; Smoot, DT; Ballard, BR; Gazouli, M; M'Koma, AE				Williams, Amanda D.; Korolkova, Olga Y.; Sakwe, Amos M.; Geiger, Timothy M.; James, Samuel D.; Muldoon, Roberta L.; Herline, Alan J.; Goodwin, J. Shawn; Izban, Michael G.; Washington, Mary K.; Smoot, Duane T.; Ballard, Billy R.; Gazouli, Maria; M'Koma, Amosy E.			Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease (vol 12, e0179710, 2017)	PLOS ONE			English	Correction													Sakwe, Amos/AAU-7639-2020; Gazouli, Maria/I-2572-2018; Korolkova, Olga/ABH-9870-2020	Sakwe, Amos/0000-0002-2283-794X; Gazouli, Maria/0000-0002-3295-6811; 	NIGMS NIH HHS [R25 GM059994] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM059994] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Williams AD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179710	1	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189551	10.1371/journal.pone.0189551	http://dx.doi.org/10.1371/journal.pone.0189551			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211779	gold, Green Published, Green Submitted			2022-12-27	WOS:000417212200082
J	Secades-Villa, R; Gonzalez-Roz, A; Garcia-Perez, A; Becona, E				Secades-Villa, Roberto; Gonzalez-Roz, Alba; Garcia-Perez, Angel; Becona, Elisardo			Psychological, pharmacological, and combined smoking cessation interventions for smokers with current depression: A systematic review and meta-analysis	PLOS ONE			English	Review							PAST MAJOR DEPRESSION; MENTAL-HEALTH; CIGARETTE-SMOKING; RANDOMIZED-TRIAL; ABSTINENCE RATES; SYMPTOMS; MANAGEMENT; EXERCISE; THERAPY; ADULTS	We conducted a systematic literature review and meta-analysis (ID: CRD42016051017) of smoking cessation interventions for patients with current depression. We examined the effectiveness of smoking cessation treatments in improving abstinence rates and depressive symptoms. The following electronic databases were used for potentially eligible studies: PUBMED, PSYCINFO, DIALNET and WEB OF KNOWLEDGE. The search terms used were: smoking cessation, depressive disorder, depression, mood, depressive, depressed, smoking, smokers, nicotine, nicotine dependence, and tobacco cigarette smoking. The methodological quality of included studies was assessed using the Effective Public Health Practice Project Quality assessment tool (EPHPP). Of the 6,584 studies identified, 20 were eligible and included in the review. Trial designs of studies were 16 randomized controlled trials and 4 secondary studies. Studies included three types of intervention: psychological (6/30%), pharmacological (6/30%) or combined (8/40%). Four trials comprised special populations of smokers. Four studies received a strong methodological quality, 7 were scored as moderate and 9 studies received a weak methodological rating. Analyses of effectiveness showed that smoking cessation interventions appear to increase short-term and long-term smoking abstinence in individuals with current depression. Subgroup analyses revealed stronger effects among studies that provided pharmacological treatments than in studies using psychological treatments. However, the evidence is weak due to the small number of studies. Smoking abstinence appears to be associated with an improvement in depressive symptoms. Heterogeneity in protocols in similar types of treatment also prevent firm conclusions being drawn on the effectiveness of any particular treatment model to optimally manage abstinence among depressed smokers. Further research is required to strengthen the evidence base.	[Secades-Villa, Roberto; Gonzalez-Roz, Alba; Garcia-Perez, Angel] Univ Oviedo, Dept Psychol, Oviedo, Spain; [Becona, Elisardo] Univ Santiago de Compostela, Dept Clin Psychol & Psychobiol, Santiago De Compostela, Spain	University of Oviedo; Universidade de Santiago de Compostela	Secades-Villa, R (corresponding author), Univ Oviedo, Dept Psychol, Oviedo, Spain.	secades@uniovi.es	González-Roz, Alba/ABF-7751-2020; García-Pérez, Ángel/ACP-8091-2022; Becoña, Elisardo/F-9716-2010; Secades-Villa, Roberto/B-6571-2014	Becoña, Elisardo/0000-0002-6639-3834; Garcia-Perez, Angel/0000-0003-2862-2584; Secades-Villa, Roberto/0000-0001-8106-6594	Spanish Ministry of Economy and Competitiveness; European Regional Development Fund [PSI2015-64371-P]; Spanish Ministry of Education, Culture and Sport [FPU15/04327]; Spanish Ministry of Economy, Industry and Competitiveness [BES-2016-076663]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund(European Commission); Spanish Ministry of Education, Culture and Sport(Spanish Government); Spanish Ministry of Economy, Industry and Competitiveness(Spanish Government)	This research was supported by the Spanish Ministry of Economy and Competitiveness, the European Regional Development Fund (grant PSI2015-64371-P. MINECO/FEDER), by the Predoctoral Grant FPU15/04327, from the Spanish Ministry of Education, Culture and Sport, and the Predoctoral Grant BES-2016-076663 from the Spanish Ministry of Economy, Industry and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthenelli RM, 2013, ANN INTERN MED, V159, P390, DOI 10.7326/0003-4819-159-6-201309170-00005; Armijo-Olivo S, 2012, J EVAL CLIN PRACT, V18, P12, DOI 10.1111/j.1365-2753.2010.01516.x; Bernard P, 2015, J DUAL DIAGN, V11, P205, DOI 10.1080/15504263.2015.1113842; Blalock JA, 2008, PSYCHOL ADDICT BEHAV, V22, P122, DOI 10.1037/0893-164X.22.1.122; Borenstein M., 2009, INTRO METAANALYSIS; Borenstein M., 1999, COMPREHENSIVE META A; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P161, DOI 10.1001/archpsyc.55.2.161; Cahill K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004307.pub5; Cahill K, 2014, JAMA-J AM MED ASSOC, V311, P193, DOI 10.1001/jama.2013.283787; Catley D, 2003, NICOTINE TOB RES, V5, P61, DOI 10.1080/1462220021000060464; Cinciripini PM, 2010, J CONSULT CLIN PSYCH, V78, P44, DOI 10.1037/a0018168; Deeks J J, 2003, Health Technol Assess, V7, piii; Evins AE, 2008, J CLIN PSYCHOPHARM, V28, P660, DOI 10.1097/JCP.0b013e31818ad7d6; FLEISS JL, 1986, CONTROL CLIN TRIALS, V7, P267, DOI 10.1016/0197-2456(86)90034-6; Fluharty M, 2017, NICOTINE TOB RES, V19, P3, DOI 10.1093/ntr/ntw140; Fowler JS, 1996, NATURE, V379, P733, DOI 10.1038/379733a0; Gierisch JM, 2012, J GEN INTERN MED, V27, P351, DOI 10.1007/s11606-011-1915-2; Hall SM, 2006, AM J PUBLIC HEALTH, V96, P1808, DOI 10.2105/AJPH.2005.080382; Hall SM, 2009, ANNU REV CLIN PSYCHO, V5, P409, DOI 10.1146/annurev.clinpsy.032408.153614; Hayes RB, 2010, J BEHAV MED, V33, P209, DOI 10.1007/s10865-010-9254-z; Hitsman B, 2013, ADDICTION, V108, P294, DOI 10.1111/add.12009; Hitsman B, 2009, CAN J PSYCHIAT, V54, P368, DOI 10.1177/070674370905400604; Japuntich SJ, 2007, NICOTINE TOB RES, V9, P677, DOI 10.1080/14622200701365301; Kinnunen T, 2008, INT J PSYCHIAT MED, V38, P373, DOI 10.2190/PM.38.3.k; Lancaster T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001292.pub2, 10.1002/14651858.CD001292.pub3]; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Ledgerwood David M, 2008, Curr Drug Abuse Rev, V1, P340; Luger TM, 2014, ADDICT BEHAV, V39, P1418, DOI 10.1016/j.addbeh.2014.05.011; Mathew AR, 2013, NICOTINE TOB RES, V15, P1807, DOI 10.1093/ntr/ntt036; McFall M, 2010, JAMA-J AM MED ASSOC, V304, P2485, DOI 10.1001/jama.2010.1769; Mills EJ, 2012, ANN MED, V44, P588, DOI 10.3109/07853890.2012.705016; Minami H, 2015, ADDICT DISORD TREAT, V14, DOI 10.1097/ADT.0000000000000042; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Munoz RF, 2006, NICOTINE TOB RES, V8, P77, DOI 10.1080/14622200500431940; Munoz RF, 1997, AM J COMMUN PSYCHOL, V25, P325, DOI 10.1023/A:1024676626955; Munoz RF, 2009, NICOTINE TOB RES, V11, P1025, DOI 10.1093/ntr/ntp090; Patten CA, 2017, NICOTINE TOB RES, V19, P77, DOI 10.1093/ntr/ntw208; Prochaska JJ, 2004, J CONSULT CLIN PSYCH, V72, P1144, DOI 10.1037/0022-006X.72.6.1144; Prochaska JJ, 2010, DRUG ALCOHOL DEPEN, V110, P177, DOI 10.1016/j.drugalcdep.2010.03.002; Prochazka AV, 1998, ARCH INTERN MED, V158, P2035, DOI 10.1001/archinte.158.18.2035; Schnoll RA, 2010, CANCER CAUSE CONTROL, V21, P811, DOI 10.1007/s10552-010-9507-8; Secades-Villa R, 2015, EXP CLIN PSYCHOPHARM, V23, P351, DOI 10.1037/pha0000044; Sigmon SC, 2012, PREV MED, V55, pS24, DOI 10.1016/j.ypmed.2012.04.007; Taylor G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1151; Thorsteinsson HS, 2001, NEUROPSYCHOPHARMACOL, V24, P350, DOI 10.1016/S0893-133X(00)00217-7; Ussher MH, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002295.pub3; van der Meer RM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006102.pub2; van der Meer RM, 2010, ADDICTION, V105, P1991, DOI 10.1111/j.1360-0443.2010.03057.x; Vickers KS, 2009, NICOTINE TOB RES, V11, P985, DOI 10.1093/ntr/ntp101; Ward KD, 2013, ADDICTION, V108, P394, DOI 10.1111/j.1360-0443.2012.04048.x; Weinberger AH, 2017, AM J DRUG ALCOHOL AB, V43, P416, DOI 10.3109/00952990.2016.1171327; Weinberger AH, 2010, NICOTINE TOB RES, V12, P937, DOI 10.1093/ntr/ntq120; World Health Organization, 2012, WHO GLOB REP MORT AT	53	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188849	10.1371/journal.pone.0188849	http://dx.doi.org/10.1371/journal.pone.0188849			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO8CU	29206852	gold, Green Published, Green Submitted			2022-12-27	WOS:000417110700029
J	de Candia, P; Spinetti, G; Specchia, C; Sangalli, E; La Sala, L; Uccellatore, A; Lupini, S; Genovese, S; Matarese, G; Ceriello, A				de Candia, Paola; Spinetti, Gaia; Specchia, Claudia; Sangalli, Elena; La Sala, Lucia; Uccellatore, Annachiara; Lupini, Silvia; Genovese, Stefano; Matarese, Giuseppe; Ceriello, Antonio			A unique plasma microRNA profile defines type 2 diabetes progression	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; CIRCULATING MICRORNAS; INSULIN TRANSCRIPTION; MYOCARDIAL-INFARCTION; GLYCEMIC VARIABILITY; GLUCOSE; RISK; BIOMARKERS; METABOLISM; MELLITUS	A major unmet medical need to better manage Type 2 Diabetes (T2D) is the accurate disease prediction in subjects who show glucose dysmetabolism, but are not yet diagnosed as diabetic. We investigated the possibility to predict/monitor the progression to T2D in these subjects by retrospectively quantifying blood circulating microRNAs in plasma of subjects with i) normal glucose tolerance (NGT, n = 9); ii) impaired glucose tolerance (IGT, n = 9), divided into non-progressors (NP, n = 5) and progressors (P, n = 4) based on subsequent diabetes occurrence, and iii) newly diagnosed T2D (n = 9). We found that impaired glucose tolerance associated with a global increase of plasma circulating microRNAs. While miR-148 and miR-222 were specifically modulated in diabetic subjects and correlated with parameters of glucose tolerance, the most accentuated microRNA dysregulation was found in NP IGT subjects, with increased level of miR-122, miR-99 and decreased level of let-7d, miR-18a, miR-18b, miR-23a, miR-27a, miR-28 and miR-30d in comparison with either NGT or T2D. Interestingly, several of these microRNAs significantly correlated with parameters of cholesterol metabolism. In conclusion, we observed the major perturbation of plasma circulating microRNA in NP pre-diabetic subjects and identified a unique microRNA profile that may become helpful in predicting diabetic development.	[de Candia, Paola; Spinetti, Gaia; Specchia, Claudia; Sangalli, Elena; La Sala, Lucia; Uccellatore, Annachiara; Lupini, Silvia; Genovese, Stefano; Ceriello, Antonio] IRCCS MultiMed, Dept Diabetol & Dysmetabol Dis, Milan, Italy; [Specchia, Claudia] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Matarese, Giuseppe] Natl Res Council IEOS CNR, Inst Endocrinol & Expt Oncol, Immunol Lab, Naples, Italy; [Matarese, Giuseppe] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Ceriello, Antonio] IDIBAPS, Barcelona, Spain; [Ceriello, Antonio] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain	IRCCS Multimedica; University of Brescia; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	de Candia, P (corresponding author), IRCCS MultiMed, Dept Diabetol & Dysmetabol Dis, Milan, Italy.	paola.decandia@multimedica.it	de Candia, Paola/Z-1498-2019; de Candia, Paola/HGC-8826-2022; Matarese, Giuseppe/AAO-4077-2021; La Sala, Lucia/A-4467-2019; La Sala, Lucia/AAC-3458-2022; Genovese, Stefano/F-9706-2017	de Candia, Paola/0000-0003-4767-446X; de Candia, Paola/0000-0003-4767-446X; Matarese, Giuseppe/0000-0001-9429-0616; La Sala, Lucia/0000-0002-7580-1377; La Sala, Lucia/0000-0002-7580-1377; Genovese, Stefano/0000-0002-6085-437X	Fondazione Invernizzi; Italian Ministry of Healthy [RRC-2017-2364948]; Juvenile Diabetes Research Foundation [1-SRA-2018-477-S-B]; European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Lilly program; European Research Council [310496]; European Foundation for the Study of Diabetes [JDRF Lilly 2015_4] Funding Source: researchfish	Fondazione Invernizzi; Italian Ministry of Healthy(Ministry of Health, Italy); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Lilly program; European Research Council(European Research Council (ERC)European Commission); European Foundation for the Study of Diabetes	This work was supported by Fondazione Invernizzi and by the Italian Ministry of Healthy (RRC-2017-2364948). PdC is also funded by the Juvenile Diabetes Research Foundation (1-SRA-2018-477-S-B). GM is also funded by the European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Lilly program 2015 and the European Research Council Grant "menTORinTregs" (n. 310496). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; P.d.C, S.G., G.S. and A.C. designed the study. A.U., S.L. and L.L provided samples, clinical information and were responsible of data curation. P.d.C. and E.S. performed the experiments. P.d.C. and C.S. performed statistical analysis. P.d.C., G.S., G.M. and A.C. wrote the manuscript. This work was supported by Fondazione Invernizzi and by the Italian Ministry of Healthy (RRC-2017-2364948). PdC is also funded by the Juvenile Diabetes Research Foundation (1-SRA-2018-477-S-B). GM is also funded by the European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Lilly program 2015 and the European Research Council Grant "menTORinTregs" (n. 310496). We thank Prof. Annibale Puca for advice and useful discussion of the results. The authors have no conflicts of interest to declare.	Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43; American Diabetes Association, 2017, Clin Diabetes, V35, P5, DOI 10.2337/cd16-0067; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Ceriello A, 2010, DIABETIC MED, V27, P862, DOI 10.1111/j.1464-5491.2010.02967.x; Ceriello A, 2013, DIABETES CARE, V36, pS272, DOI 10.2337/dcS13-2030; Chen Y, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-8; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Desgagne V, 2017, CLIN CHEM LAB MED, V55, P667, DOI 10.1515/cclm-2016-0575; Franciosi M, 2005, DIABETES CARE, V28, P1187, DOI 10.2337/diacare.28.5.1187; Gao W, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-55; Goretti E, 2013, INT J CARDIOL, V168, P4548, DOI 10.1016/j.ijcard.2013.06.092; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Kalis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029166; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; La Sala L, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0390-9; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Liu Y, 2014, INT J MOL SCI, V15, P10567, DOI 10.3390/ijms150610567; Lopez YON, 2017, INT J OBESITY, V41, P1121, DOI 10.1038/ijo.2017.84; Maynard JD, 2007, DIABETES CARE, V30, P1120, DOI 10.2337/dc06-2377; Meijnikman AS, 2016, J DIABETES COMPLICAT, V30, P1043, DOI 10.1016/j.jdiacomp.2016.05.004; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Moussay E, 2011, P NATL ACAD SCI USA, V108, P6573, DOI 10.1073/pnas.1019557108; Parrizas M, 2015, J CLIN ENDOCR METAB, V100, pE407, DOI 10.1210/jc.2014-2574; Prabu P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128372; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Roderburg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054612; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Salvoza NC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153497; Sebastiani G, 2017, J ENDOCRINOL INVEST, V40, P591, DOI 10.1007/s40618-017-0611-4; Seyhan AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep31479; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Wang J, 2016, J CELL PHYSIOL, V231, P25, DOI 10.1002/jcp.25056; Willeit P, 2017, DIABETES, V66, P347, DOI 10.2337/db16-0731; Zhao XM, 2012, J BIOL CHEM, V287, P31155, DOI 10.1074/jbc.M112.362632	38	66	66	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188980	10.1371/journal.pone.0188980	http://dx.doi.org/10.1371/journal.pone.0188980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29200427	Green Submitted, Green Published, gold			2022-12-27	WOS:000417033200024
J	Guilhem, A; Fargeton, AE; Simon, AC; Duffau, P; Harle, JR; Lavigne, C; Carette, MF; Bletry, O; Kaminsky, P; Leguy, V; Lerolle, N; Roux, D; Lambert, M; Chinet, T; Bonnet, D; Dupuis-Girod, S; Riviere, S				Guilhem, Alexandre; Fargeton, Anne-Emmanuelle; Simon, Anne-Claire; Duffau, Pierre; Harle, Jean-Robert; Lavigne, Christian; Carette, Marie-France; Bletry, Olivier; Kaminsky, Pierre; Leguy, Vanessa; Lerolle, Nathalie; Roux, Dominique; Lambert, Marc; Chinet, Thierry; Bonnet, Delphine; Dupuis-Girod, Sophie; Riviere, Sophie			Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46 patients	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RENDU-OSLER-DISEASE; VASCULAR MALFORMATIONS; CANCER-PATIENTS; FACTOR VEGF; COMPLICATIONS; INFLAMMATION; INCREASES; MORTALITY; HYPOXIA	Background Bevacizumab, an anti-VEGF monoclonal antibody, has recently emerged as a new option for severe forms of hereditary hemorrhagic telangiectasia (HHT). Its utilization in this orphan disease has rapidly spread despite the lack of randomized trials and international guidelines. The objective of this study is to report the main clinical data (baseline characteristics, dose schedule, efficacy, adverse events and deaths) of HHT patients treated by intravenous bevacizumab in France. Methods Retrospective observational study of HHT patients treated with bevacizumab for a severe form of the disease in the 14 centers of the French HHT network. Results Forty-six patients (median age: 68 years) were treated between March 2009 and May 2015. Ten patients were treated for high output cardiac failure, 20 patients for severe hemorrhages and 16 for both indications. The standard protocol (6 infusions of 5mg/kg every 2 weeks) was initially used in 89% of the cases but diverse strategies were subsequently applied. A clinical improvement was noted by the referent physician for 74% of the patients with a median effect's duration of 6 months. Wound healing complications led to 2 amputations. Arthralgia/arthritis and arterial hypertension occurred in 5 patients each. One third of the patients were dead at the time of the final update, coherently with age and the poor prognosis of these highly symptomatic patients. Conclusion Intravenous bevacizumab seems to provide a clinical benefice in severe HHT patients. Precautions concerning wound healing and vascular pathologies must be respected. Prospective double blinded versus placebo trials are needed.	[Guilhem, Alexandre; Riviere, Sophie] Hop St Eloi, Med Interne Malad Multiorgan, Montpellier, France; [Fargeton, Anne-Emmanuelle; Dupuis-Girod, Sophie] Hop Femme Mere Enfant, Ctr Ref Natl Malad Rendu Osler, Serv Genet, Bron, France; [Simon, Anne-Claire] CHU Poitiers, Serv Pneumol, Poitiers, France; [Duffau, Pierre] Hop St Andre, Serv Med Interne & Immunol Clin, Bordeaux, France; [Harle, Jean-Robert] Hop La Timone, Dept Med Interne, Marseille, France; [Lavigne, Christian] CHU Angers, Med Interne & Malad Vasc, Angers, France; [Carette, Marie-France] Hop Tenon, Serv Radiol, Paris, France; [Bletry, Olivier] Hop Foch, Serv Med Interne, Suresnes, France; [Kaminsky, Pierre] Hop Brabois, Serv Med Interne, Vandoeuvre Les Nancy, France; [Leguy, Vanessa] Hop Francois Mitterrand, Serv Med Interne & Immunol Clin, Dijon, France; [Lerolle, Nathalie] Hop Bicetre, Serv Med Interne, Paris, France; [Roux, Dominique] Ctr Hosp, Med Serv, Ambert, France; [Lambert, Marc] Hop Huriez, Serv Med Interne, Lille, France; [Chinet, Thierry] Hop Ambroise, Serv Pneumol, Boulogne, France; [Bonnet, Delphine] CHU Purpan, Serv Med Interne Digestif, Toulouse, France	Universite de Montpellier; CHU de Montpellier; CHU Lyon; CHU Poitiers; Universite de Poitiers; CHU Bordeaux; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Hospital Foch; CHU de Nancy; CHU Dijon Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; CHU de Toulouse	Guilhem, A (corresponding author), Hop St Eloi, Med Interne Malad Multiorgan, Montpellier, France.	alexandre.guilhem@gmail.com	Dupuis-Girod, Sophie/D-6268-2014; lambert, marc/V-7380-2017	lambert, marc/0000-0002-3485-8238; BONNET, Delphine/0000-0002-8108-0852				Amit L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051780; Ardelean DS, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00035; Arizmendez NP, 2015, INT FORUM ALLERGY RH, V5, P1042, DOI 10.1002/alr.21587; Azzopardi N, 2015, MABS-AUSTIN, V7, P630, DOI 10.1080/19420862.2015.1022693; Bailly S, 2010, M S-MED SCI, V26, P855, DOI 10.1051/medsci/20102610855; Blazevic A, 2014, NETH J MED, V72, P49; Chen X, 2013, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2013-10; Cordon CR, 2009, ANN PLAS SURG, V62, P707, DOI 10.1097/SAP.0b013e3181828141; Donaldson JW, 2015, NEUROLOGY, V84, P1886, DOI 10.1212/WNL.0000000000001538; Dupuis-Girod S, 2017, 12 HHT INT C CROAT 2; Dupuis-Girod S, 2007, CLIN INFECT DIS, V44, P841, DOI 10.1086/511645; Dupuis-Girod S, 2016, LIVER INT, V36, P1741, DOI 10.1111/liv.13210; Dupuis-Girod S, 2012, JAMA-J AM MED ASSOC, V307, P948, DOI 10.1001/jama.2012.250; Fangusaro J, 2013, CANCER-AM CANCER SOC, V119, P4180, DOI 10.1002/cncr.28343; Flieger D, 2006, ANN HEMATOL, V85, P631, DOI 10.1007/s00277-006-0147-8; Garg N, 2014, J BLOOD MED, V5, P191, DOI 10.2147/JBM.S45295; Kjeldsen AD, 1999, J INTERN MED, V245, P31, DOI 10.1046/j.1365-2796.1999.00398.x; Konisti S, 2012, NAT REV RHEUMATOL, V8, P153, DOI 10.1038/nrrheum.2011.205; Letteboer TGW, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00067; Luijten KMAC, 2012, AUTOIMMUN REV, V11, P326, DOI 10.1016/j.autrev.2011.06.011; Maestraggi Q, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001966; Mir O, 2012, INVEST NEW DRUG, V30, P702, DOI 10.1007/s10637-010-9549-5; Mitchell A, 2008, LIVER TRANSPLANT, V14, P210, DOI 10.1002/lt.21417; Ng CT, 2010, ANN RHEUM DIS, V69, P1389, DOI 10.1136/ard.2009.119776; Ou G, 2016, WORLD J GASTRO SURG, V8, P792, DOI 10.4240/wjgs.v8.i12.792; Pawlikowska L, 2015, AM J MED GENET A, V167, P1262, DOI 10.1002/ajmg.a.36936; PETRI M, 1992, J RHEUMATOL, V19, P53; Qi WX, 2015, CRIT REV ONCOL HEMAT, V94, P323, DOI 10.1016/j.critrevonc.2015.02.007; Qi WX, 2014, CLIN DRUG INVEST, V34, P681, DOI 10.1007/s40261-014-0222-1; Ranieri G, 2006, CURR MED CHEM, V13, P1845, DOI 10.2174/092986706777585059; Rehal B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017520; Sadick H, 2005, HAEMATOLOGICA, V90, P818; Schutz FAB, 2011, ANN ONCOL, V22, P1404, DOI 10.1093/annonc/mdq587; Slusarz KM, 2014, CANCER CHEMOTH PHARM, V73, P1197, DOI 10.1007/s00280-014-2456-2; Thompson AB, 2014, ALLERGY RHINOL, V5, pE91, DOI 10.2500/ar.2014.5.0091; Ungprasert P, 2013, JCR-J CLIN RHEUMATOL, V19, P360, DOI 10.1097/RHU.0b013e31829d56da; Wee JW, 2014, BLOOD RES, V49, P192, DOI 10.5045/br.2014.49.3.192; Zuo PY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102484	38	42	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188943	10.1371/journal.pone.0188943	http://dx.doi.org/10.1371/journal.pone.0188943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190827	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900175
J	McLachlan, SMS; Kaiser, GW; Longrich, NR				McLachlan, Sandy M. S.; Kaiser, Gary W.; Longrich, Nicholas R.			Maaqwi cascadensis: A large, marine diving bird (Avialae: Ornithurae) from the Upper Cretaceous of British Columbia, Canada	PLOS ONE			English	Article							NANAIMO GROUP; VANCOUVER-ISLAND; GULF ISLANDS; MAESTRICHTIAN FORAMINIFERA; SEDIMENTARY-ROCKS; WASHINGTON-STATE; SPRAY FORMATIONS; FOSSIL EVIDENCE; NORTH-AMERICA; UPPER LAMBERT	Mesozoic bird fossils from the Pacific Coast of North America are rare, but small numbers are known from the Late Cretaceous aged sediments of Hornby Island, British Columbia. Most are unassociated fragments that offer little information, but additional preparation of a large coracoid has revealed more details of its structure, as well as three associated wing bones. Phylogenetic analysis suggests that Maaqwi cascadensis, gen. et sp. nov. represents a derived crown or near-crown member of Ornithurae, and specifically suggests affinities with Vegaviidae. M. cascadensis is characterized by large size, and regressions based on dimensions of the coracoid suggest a large bird, with an estimated body mass of approximately 1.5 kilograms. The bones are robust, with thick walls, suggesting that M. cascadensis was a bird adapted for diving, similar to modern loons and grebes. The wings are short, while the coracoid is unusually short and broad, similar to modern loons. Along with the Ichthyornithes and Hesperornithes, M. cascadensis and Vegaviidae appear to represent a third clade of bird that evolved to exploit marine habitats in the Late Cretaceous, one specialized for foot-propelled diving and rapid cruising flight over water.	[McLachlan, Sandy M. S.] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada; [McLachlan, Sandy M. S.; Kaiser, Gary W.] Royal BC Museum, Dept Nat Hist, Victoria, BC, Canada; [Longrich, Nicholas R.] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Longrich, Nicholas R.] Univ Bath, Milner Ctr Evolut, Bath, Avon, England	University of Victoria; University of Bath; University of Bath	McLachlan, SMS (corresponding author), Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada.; McLachlan, SMS (corresponding author), Royal BC Museum, Dept Nat Hist, Victoria, BC, Canada.	sandymcl@uvic.ca	McLachlan, Sandy/ABD-2408-2021	McLachlan, Sandy/0000-0003-3902-7190; Longrich, Nicholas/0000-0002-9586-8907				Hospitaleche CA, 2015, ANN PALEONTOL, V101, P315, DOI 10.1016/j.annpal.2015.10.002; Angnolin FL, 2017, SCI NATURE, V104; Aotsuka K, 2016, CRETACEOUS RES, V63, P154, DOI 10.1016/j.cretres.2016.03.003; Bain HA, 2016, SEDIMENT GEOL, V337, P113, DOI 10.1016/j.sedgeo.2016.03.010; Bell A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141690; Brodkorb P., 1963, P 13 INT ORN C AM OR, VVol. 1, P55; Bullard T, 1999, BRITISH COLUMBIA PAL, V22, P11; Burnham D, 2005, J VERTEBR PALEONTOL, V25, p41A; Cameron BEB, 1988, UNPUB, P1; Carter E. S., 2006, GEOLOGICAL ASS CANAD, P109; Cerda IA, 2015, HIST BIOL, V27, P549, DOI 10.1080/08912963.2014.896907; CHIAPPE LM, 1991, ALCHERINGA, V15, P333, DOI 10.1080/03115519108619028; Chiappe Luis M., 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P203; Chiappe Luis M., 2002, P240; Clarke J, 2004, B AM MUS NAT HIST, P1; Clarke JA, 2006, J ANAT, V208, P287, DOI 10.1111/j.1469-7580.2006.00534.x; Clarke JA, 2005, NATURE, V433, P305, DOI 10.1038/nature03150; Clarke JA, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)387<0001:TMAPPO>2.0.CO;2; Clarke JA, 2016, NATURE, V538, P502, DOI 10.1038/nature19852; Davis Leo Carson, 1997, Journal of the Arkansas Academy of Science, V51, P197; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; Dyke G, 2011, CAN J EARTH SCI, V48, P1489, DOI 10.1139/E11-050; Elzanowski A, 2000, J VERTEBR PALEONTOL, V20, P712, DOI 10.1671/0272-4634(2000)020[0712:AAQFTL]2.0.CO;2; Elzanowski A, 2012, PALAEONTOLOGY, V55, P1199, DOI 10.1111/j.1475-4983.2012.01187.x; Enkin RJ, 2001, CAN J EARTH SCI, V38, P1403, DOI 10.1139/e01-031; Field DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082000; Gaston A.J., 2004, SEABIRDS NATURAL HIS; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Haggart J., 1991, FIELD GUIDE PALEONTO, P223; HAGGART J W, 1989, Geological Survey of Canada Bulletin, P181; Haggart JW, 2005, CAN J EARTH SCI, V42, P2001, DOI 10.1139/E05-066; Haggart JW, 2000, ABSTRACTS PROGRAM, V32, pA; Haggart JW, 2017, CRETACEOUS RES; Hasegawa T, 2015, GEOLOGICAL SOC AM AB, V45, P517; Hayashi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059146; Hope S., 2002, MESOZOIC BIRDS HEADS, P239; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; HOWARD H, 1969, CONDOR, V71, P68, DOI 10.2307/1366050; Ibrahim N, 2014, SCIENCE, V345, P1613, DOI 10.1126/science.1258750; Katnick DC, 2003, CAN J EARTH SCI, V40, P375, DOI 10.1139/E03-005; Kim BY, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002696; Klein N, 2015, CONTRIB ZOOL, V84, P59, DOI 10.1163/18759866-08401005; Kodama KP, 2001, GEOL SOC AM BULL, V113, P1171, DOI 10.1130/0016-7606(2001)113<1171:CCPPFL>2.0.CO;2; Krijgsman W, 2006, EARTH PLANET SC LETT, V242, P205, DOI 10.1016/j.epsl.2005.11.052; LAMBRECHT K., 1929, PALAEONTOLOGISCHE ZEITSCHR, V11, P121; Longrich NR, 2011, P NATL ACAD SCI USA, V108, P15253, DOI 10.1073/pnas.1110395108; Longrich N, 2009, CRETACEOUS RES, V30, P161, DOI 10.1016/j.cretres.2008.06.007; Ludvigsen R, 1995, 1 BRIT COL PAL S COU, P1; Ludvigsen R., 1998, W COAST FOSSILS GUID; Ludvigsen Rolf, 1996, P156; Mahoney JB, 1999, GEOLOGY, V27, P195; Marsh O.C., 1880, ODONTORNITHES MONOGR, DOI [10.5962/bhl.title.61298, DOI 10.5962/BHL.TITLE.61298]; Marshall JL, 2017, HDB IMMUNOSENESCENCE, P1; Martin Larry D., 2012, Palaeoworld, V21, P59, DOI 10.1016/j.palwor.2012.02.005; Martin Larry D., 2002, P165; Martin-Silverstone E, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160333; Matthews WA, 2017, TECTONICS, V36, P854, DOI 10.1002/2017TC004531; Mayr G, 2005, J ZOOL SYST EVOL RES, V43, P61, DOI 10.1111/j.1439-0469.2004.00291.x; MCGUGAN A, 1982, MICROPALEONTOLOGY, V28, P399, DOI 10.2307/1485452; MCGUGAN A, 1979, CAN J EARTH SCI, V16, P2263, DOI 10.1139/e79-211; McGugan A., 1962, J ALBERTA SOC PETROL, V10, P585; McLachlan SMS, 2017, J SYSTEMATIC PALAEON; Miller IM, 2006, EARTH PLANET SC LETT, V245, P95, DOI 10.1016/j.epsl.2006.02.022; Morrison K, 2005, CAN J EARTH SCI, V42, P2097, DOI 10.1139/E05-081; Muller J.E., 1970, GEOLOGICAL SURVEY CA, V69-25, P1, DOI DOI 10.4095/102353; Mustard P., 2003, GEOLOGICAL FIELD TRI, P103; Mustard P.S., 1994, GEOLOGY GEOLOGIC HAZ, V481, P27, DOI [DOI 10.4095/203246, 10.4095/203246]; Mustard PS, 2000, GEOL SOC AM CORD SEC, V32, pA; NICHOLLS EL, 1992, CAN J EARTH SCI, V29, P377, DOI 10.1139/e92-033; Nicholls EL, 2002, CAN J EARTH SCI, V39, P1591, DOI 10.1139/E02-075; Nicholls EL, 2001, PALEOBIOS S, V21, P97; Norberg U., 1990, VERTEBRATE FLIGHT ME; Nudds RL, 2004, P ROY SOC B-BIOL SCI, V271, pS324, DOI 10.1098/rsbl.2004.0167; Ogg JG, 2016, CONCISE GEOLOGIC TIME SCALE 2016, P167, DOI 10.1016/B978-0-444-59467-9.00013-3; Olson S.L., 1985, Avian Biology, V8, P79; Olson S.L., 1992, Journal of Vertebrate Paleontology, V12, P122; Peecook BR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127792; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Raub T.D., 1998, EOS T AM GEOPHYS UN, V79, P223; Simons EM, 2009, THESIS; SLITER W V, 1973, Journal of Foraminiferal Research, V3, P167; Smith NA, 2014, ANAT REC, V297, P188, DOI 10.1002/ar.22841; Usher JL, 1952, GEOLOGICAL SURVEY CA, V21, P1; Vullo R, 2012, J VERTEBR PALEONTOL, V32, P1198, DOI 10.1080/02724634.2012.681078; WARD PD, 1978, CAN J EARTH SCI, V15, P405, DOI 10.1139/e78-045; Ward PD, 1997, SCIENCE, V277, P1642, DOI 10.1126/science.277.5332.1642; Ward PD, 2012, GEOL SOC AM BULL, V124, P957, DOI 10.1130/B30077.1; Wilson LE, 2016, CAN J EARTH SCI, V53, P1476, DOI 10.1139/cjes-2016-0053; Zakharov YD, 2013, SEDIMENT GEOL, V295, P77, DOI 10.1016/j.sedgeo.2013.08.004; Zhou ZH, 2008, J ANAT, V212, P565, DOI 10.1111/j.1469-7580.2008.00880.x; [No title captured]	91	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189473	10.1371/journal.pone.0189473	http://dx.doi.org/10.1371/journal.pone.0189473			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220405	gold, Green Published			2022-12-27	WOS:000417469900061
J	Prudden, HJ; Hamilton, M; Foss, AM; Adams, ND; Stockton, M; Black, V; Nyblade, L				Prudden, Holly J.; Hamilton, Matthew; Foss, Anna M.; Adams, Nicole Dzialowy; Stockton, Melissa; Black, Vivian; Nyblade, Laura			Can mother-to-child transmission of HIV be eliminated without addressing the issue of stigma? Modeling the case for a setting in South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV/AIDS STIGMA; PREGNANT-WOMEN; PREVENTION; PMTCT; CARE; DISCRIMINATION; JOHANNESBURG; ZIDOVUDINE; COMMUNITY	Background Stigma and discrimination ontinue to undermine the effectiveness of the HIV response. Despite a growing body of evidence of the negative relationship between stigma and HIV outcomes, there is a paucity of data available on the prevalence of stigma and its impact. We present a probabilistic cascade model to estimate the magnitude of impact stigma has on mother-to-child-transmission (MTCT). Methods The model was parameterized using 2010 data from Johannesburg, South Africa, from which loss-to-care at each stage of the antenatal cascade were available. Three scenarios were compared to assess the individual contributions of stigma, non-stigma related barriers, and drug ineffectiveness on the overall number of infant infections. Uncertainty analysis was used to estimate plausible ranges. The model follows the guidelines in place in 2010 when the data were extracted (WHO Option A), and compares this with model results had Option B+ been implemented at the time. Results The model estimated under Option A, 35% of infant infections being attributed to stigma. This compares to 51% of total infections had Option B+ been implemented in 2010. Under Option B+, the model estimated fewer infections than Option A, due to the availability of more effective drugs. Only 8% (Option A) and 9% (Option B+) of infant infections were attributed to drug ineffectiveness, with the trade-off in the proportion of infections being between stigma and non-stigma-related barriers. Conclusions The model demonstrates that while the effect of stigma on retention of women at any given stage along the cascade can be relatively small, the cumulative effect can be large. Reducing stigma may be critical in reaching MTCT elimination targets, because as countries improve supply-side factors, the relative impact of stigma becomes greater. The cumulative nature of the PMTCT cascade results in stigma having a large effect, this feature may be harnessed for efficiency in investment by prioritizing interventions that can affect multiple stages of the cascade simultaneously.	[Prudden, Holly J.; Foss, Anna M.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Fac Publ Hlth & Policy, London, England; [Hamilton, Matthew] Avenir Hlth, Washington, DC USA; [Adams, Nicole Dzialowy] Dept Hlth & Human Serv, Communicable Dis Branch, Raleigh, NC USA; [Stockton, Melissa; Nyblade, Laura] RTI Int, Washington, DC USA; [Stockton, Melissa; Nyblade, Laura] HP, Washington, DC USA; [Black, Vivian] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Fac Hlth Sci, Johannesburg, South Africa; [Black, Vivian] Univ Witwatersrand, Clin Microbiol & Infect Dis, Fac Hlth Sci, Johannesburg, South Africa	University of London; London School of Hygiene & Tropical Medicine; Research Triangle Institute; University of Witwatersrand; University of Witwatersrand	Prudden, HJ (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Fac Publ Hlth & Policy, London, England.	holly.prudden@lshtm.ac.uk		Stockton, Melissa Ann/0000-0002-0737-7180; Nyblade, Laura/0000-0001-8067-4192	U.S. Agency for International Development (USAID); U.S. President's Emergency Plan for AIDS Relief (PEPFAR) [AID-OAA-A-10-00067]; UKaid from the Department for International Development; RTI International; STRIVE research programme consortium; United Kingdom's Department for International Development; Department for International Development (DFID) [201447] Funding Source: researchfish	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); UKaid from the Department for International Development; RTI International; STRIVE research programme consortium; United Kingdom's Department for International Development; Department for International Development (DFID)	The study was funded by the U.S. Agency for International Development (USAID) and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through funding to the Health Policy Project [agreement number AID-OAA-A-10-00067]. The content of this publication is the sole responsibility of the authors and does not necessarily reflect the views or policies of U.S. Agency for International Development or the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), and does not imply endorsement by the U.S. Government. Additional funding from UKaid from the Department for International Development (the views expressed do not necessarily reflect the department's official policies) and RTI International was provided to support the completion of this publication.; The study was funded by the U.S. Agency for International Development (USAID) and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through funding to the Health Policy Project [agreement number AID-OAA-A-10-00067]. The content of this publication is the sole responsibility of the authors and does not necessarily reflect the views or policies of U.S. Agency for International Development or the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), and does not imply endorsement by the U.S. Government. Agency for International Development or the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), and does not imply endorsement by the U.S. Government.; The authors gratefully acknowledge the contributions of the monitoring and evaluation team at the Wits Reproductive Health and HIV Institute (WRHI) and early inputs by Charlotte Watts, Nathan Wallace, Philippe Monfiston, Cathy Zimmerman and Heidi Stockl on preliminary work from which this paper grew. Thoughtful comments on earlier drafts by Beth Robinson and Ron MacInnis of the Health Policy Project and Anouk Amzel, Emily Roseman, and Michelle Wu of the U.S. Agency for International Development (USAID) have strengthened the paper, and we are grateful for the graphics and editorial support that Ginny Gordon, Debbie McGill, and Lori Merritt provided. We would also like to express our special thanks for additional funding from STRIVE research programme consortium funded by UKaid from the Department for International Development (the views expressed do not necessarily reflect the department's official policies) and RTI International to complete this publication. This report builds on past work carried out by the London School of Hygiene and Tropical Medicine and the International Centre for Research on Women, initially conducted to identify actions and priorities for an expanded response to HIV stigma and discrimination. This initial work was supported by the United Kingdom's Department for International Development.	[Anonymous], 2014, GLOB UPD HLTH SECT R; Balcha Taye T, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P187, DOI 10.1177/1545109710369935; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Chimoyi L, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.26950; Creek T, 2009, AIDS BEHAV, V13, P356, DOI 10.1007/s10461-007-9322-8; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; Desclaux A, 2009, SOC SCI MED, V69, P821, DOI 10.1016/j.socscimed.2009.06.007; District Health Information System, 2011, RAW DAT JOH REG F AP; Dube S, 2008, JAIDS-J ACQ IMM DEF, V48, P72, DOI 10.1097/QAI.0b013e31816bcdbb; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; El-Khatib Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-88; Fitzgerald FC, 2010, SAMJ S AFR MED J, V100, P827, DOI 10.7196/SAMJ.4045; Gilbert L, 2010, HEALTH SOC CARE COMM, V18, P139, DOI 10.1111/j.1365-2524.2009.00881.x; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Hodgson I, 2014, SYSTEMATIC REV INDIV; Hoffman RM, 2010, JAIDS-J ACQ IMM DEF, V54, P35, DOI 10.1097/QAI.0b013e3181cf9979; Horwood C, 2010, TROP MED INT HEALTH, V15, P992, DOI 10.1111/j.1365-3156.2010.02576.x; IATT, 2016, OPT B COUNTR PMTCT R; Igwegbe AO., 2010, INTJ MEDICAL SCI, V2, P238; Joint United Nations Programme on HIV/AIDS (UNAIDs), 2009, UNAIDS ANN REPORT 20; Kasenga F, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1883; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kunihira NR, 2010, AFR HEALTH SCI, V10, P120; Laher F, 2011, AIDS BEHAV; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Loomba Foundation, 2015, GLOB WID REP 2015 GL; Maughan-Brown B, 2010, SOC SCI MED, V70, P368, DOI 10.1016/j.socscimed.2009.09.041; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Mekonnen G., 2009, FACTORS INFLUENCING; Mepham S, 2011, AIDS CARE, V23, P741, DOI 10.1080/09540121.2010.516341; Minsasny B., 2004, LATIN HYPERCUBE SAMP; Morgan MC, 2010, AIDS CARE, V22, P866, DOI 10.1080/09540120903483000; Moses AE, 2009, INTERNET J 3 WORLD M, V8, P9; Musheke M, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-220, 10.1186/1472-6963-13-97]; National Department of Health, 2013, S AFR ANT TREATM GUI; National Department of Health SAaSANAC, 2010, CLIN GUID PMTCT PREV; Onono MA, 2011, AFR HEALTH SCI, V11, P464; Oosterhoff P, 2008, AIDS CARE, V20, P654, DOI 10.1080/09540120701687026; Orie EF, 2009, S AFR FAM PRACT, V51, P492, DOI 10.1080/20786204.2009.10873912; Otieno PA, 2010, AIDS CARE, V22, P729, DOI 10.1080/09540120903373565; Pai NP, 2009, WOMENS HEALTH, V5, P55, DOI 10.2217/17455057.5.1.55; Piot P, 2015, LANCET, V386, P171, DOI 10.1016/S0140-6736(15)60658-4; Rahangdale L, 2010, AIDS CARE, V22, P836, DOI 10.1080/09540120903499212; Rakoasi S., 2005, J HLTH POPULATION NU, P58; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Sibeko L, 2009, PUBLIC HEALTH NUTR, V12, P1983, DOI 10.1017/S1368980009005199; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Sprague C, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-10; Stangl AL, 2013, J INT AIDS SOC, V16; Thu AN, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-39; Turan JM, 2008, AIDS CARE, V20, P938, DOI 10.1080/09540120701767224; Turan JM, 2013, AIDS BEHAV, V17, P2528, DOI 10.1007/s10461-013-0446-8; Turan JM, 2011, AIDS BEHAV, V15, P1111, DOI 10.1007/s10461-010-9798-5; U.S. Department of State, 2014, PEPF 3 0 CONTR EP DE; Ujiji OA, 2011, CULT HEALTH SEX, V13, P829, DOI 10.1080/13691058.2011.583682; UNAIDS, 2016, FAST TRACK AIDS FREE; UNAIDS, 2011, COUNT ZER GLOB PLAY; UNAIDS, 2003, UNAIDS FACTSH STIGM; UNAIDS, 2014, 90 90 90 AMB TREATM; UNAIDS Reference Group on Estimates, 2011, WORK PAP MOTH TO CHI; UNICEF, 2013, UNICEFS HIV AIDS PRO; UNICEF, 2011, MEK PARTN UNICEF HIV; UNICEF, 2012, OPT B B KEY CONS COU; van Lettow M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-426; Visser MJ, 2009, AIDS CARE, V21, P197, DOI 10.1080/09540120801932157; Warstrom, 2014, MENTIMETER; Watts C, 2010, MODELLING IMPACT STI; World Health Organization, 2010, GLOB HLTH OBS DAT RE; World Health Organization, 2014, GLOB GUID CRIT PROC; Youngleson M, 2010, PLOS ONE, V5, P1	73	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189079	10.1371/journal.pone.0189079	http://dx.doi.org/10.1371/journal.pone.0189079			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP2SV	29220369	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000417469900030
J	Giannakou, A; Sicko, RJ; Zhang, W; Romitti, P; Browne, ML; Caggana, M; Brody, LC; Jelliffe-Pawlowski, L; Shaw, GM; Kay, DM; Mills, JL				Giannakou, Andreas; Sicko, Robert J.; Zhang, Wei; Romitti, Paul; Browne, Marilyn L.; Caggana, Michele; Brody, Lawrence C.; Jelliffe-Pawlowski, Laura; Shaw, Gary M.; Kay, Denise M.; Mills, James L.			Copy number variants in Ebstein anomaly	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; AVIAN PREGASTRULA EPIBLAST; 2ND HEART FIELD; CARDIAC MYOGENESIS; TRICUSPID-VALVE; SKELETAL ABNORMALITIES; DILATED CARDIOMYOPATHY; DEFINITIVE ENDODERM; ACTIVIN-A; IN-VITRO	Background Ebstein anomaly (EA) is a rare congenital defect characterized by apical displacement of the septal tricuspid leaflets and atrialization of the right ventricle. The etiology of EA is unclear; however, recurrence in families and the association of EA with genetic syndromes and copy number variants (CNVs) suggest a genetic component. Objective We performed a population-based study to search for recurrent and novel CNVs in a previously unreported set of EA cases. Methods We genotyped 60 EA cases identified from all live births (2,891,076) from selected California counties (1991-2010) using the Illumina HumanOmni 2.5-8 array. We identified 38 candidate CNVs in 28 (46%) cases and prioritized and validated 11 CNVs based on the genes included. Results Five CNVs (41%) overlapped or were close to genes involved in early myocardial development, including NODAL, PDLIM5, SIX1, ASF1A and FGF12. We also replicated a previous association of EA with CNVs at 1p34.1 and AKAP12. Finally, we identified four CNVs overlapping or in close proximity to the transcription factors HES3, TRIM71, CUX1 and EIF4EBP2. Conclusions This study supports the relationship of genetic factors to EA and demonstrates that defects in cardiomyocytes and myocardium differentiation may play a role. Abnormal differentiation of cardiomyocytes and how genetic factors contribute should be examined for their association with EA.	[Giannakou, Andreas; Zhang, Wei; Mills, James L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Intramural Populat Hlth Res, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Sicko, Robert J.; Caggana, Michele; Kay, Denise M.] New York State Dept Hlth, Wadsworth Ctr, Div Genet, Albany, NY USA; [Romitti, Paul] Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Iowa City, IA USA; [Browne, Marilyn L.] SUNY Albany, Dept Epidemiol & Biostat, Sch Publ Hlth, Rensselaer, NY USA; [Brody, Lawrence C.] NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA; [Jelliffe-Pawlowski, Laura] Univ Calif San Francisco, Calif San Francisco Sch Med, San Francisco, CA 94143 USA; [Shaw, Gary M.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); State University of New York (SUNY) System; Wadsworth Center; University of Iowa; State University of New York (SUNY) System; State University of New York (SUNY) Albany; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California San Francisco; Stanford University	Mills, JL (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Intramural Populat Hlth Res, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	jamesmills@nih.gov		Sicko, Robert/0000-0001-7521-9742; Shaw, Gary/0000-0001-7438-4914; Mills, James/0000-0003-4496-332X; Kay, Denise/0000-0002-9928-2698; Romitti, Paul/0000-0001-5393-9984	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health; Intramural Research Program of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [HHSN2752011000011, HHSN27500005]; Intramural Research Program of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD contract) [N01-DK-73431]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008951] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000167] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural Research Program of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Intramural Research Program of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD contract); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by the Intramural Research Program of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (contract numbers HHSN2752011000011 and HHSN27500005; NICHD contract N01-DK-73431). This study was internally funded by the investigators' institution. No outside funding was involved and the investigators had total control over data collection and analysis, decision to publish and preparation of the manuscript.; This research was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health.	Ai D, 2007, P NATL ACAD SCI USA, V104, P9319, DOI 10.1073/pnas.0701212104; BALAJI S, 1991, BRIT HEART J, V66, P26; Bettinelli AL, 2013, AM J MED GENET A, V161, P3187, DOI 10.1002/ajmg.a.36182; Black BL, 2007, SEMIN CELL DEV BIOL, V18, P67, DOI 10.1016/j.semcdb.2007.01.001; Boghossian NS, 2016, AM J MED GENET A, V170, P622, DOI 10.1002/ajmg.a.37493; Booker OJ, 2015, ECHOCARDIOGR-J CARD, V32, P69, DOI 10.1111/echo.12486; Bowman A, 2017, NUCLEIC ACIDS RES, V45, P643, DOI 10.1093/nar/gkw892; Budde BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001362; Cheng HQ, 2010, CIRC RES, V107, P348, DOI 10.1161/CIRCRESAHA.110.218735; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; CORREAVILLASENOR A, 1994, TERATOLOGY, V50, P137, DOI 10.1002/tera.1420500208; Croen L A, 1991, Paediatr Perinat Epidemiol, V5, P423, DOI 10.1111/j.1365-3016.1991.tb00728.x; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Dilg D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161096; DONEGAN CC, 1968, AM HEART J, V75, P375, DOI 10.1016/0002-8703(68)90095-1; Fesslova V, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/368067; Foley AC, 2007, DEV BIOL, V303, P57, DOI 10.1016/j.ydbio.2006.10.033; Fost CHA, 2005, SWISS MED WKLY, V135, P269; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; GUERON M, 1966, AM J CARDIOL, V18, P105, DOI 10.1016/0002-9149(66)90202-5; Guillory AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074784; Guo CS, 2011, J CLIN INVEST, V121, P1585, DOI 10.1172/JCI44630; Hartung H, 1997, MECH DEVELOP, V64, P31, DOI 10.1016/S0925-4773(97)00042-7; Hennessey JA, 2013, HEART RHYTHM, V10, P1886, DOI 10.1016/j.hrthm.2013.09.064; Hutson MR, 2006, DEV BIOL, V295, P486, DOI 10.1016/j.ydbio.2006.02.052; Ito J, 2015, CELL SIGNAL, V27, P2425, DOI 10.1016/j.cellsig.2015.09.007; Ito J, 2013, BIOCHEM BIOPH RES CO, V435, P483, DOI 10.1016/j.bbrc.2013.05.016; Jost CHA, 2005, MAYO CLIN PROC, V80, P361, DOI 10.4065/80.3.361; Katoh M, 2007, INT J ONCOL, V31, P461; Ladd AN, 1998, DEV BIOL, V204, P407, DOI 10.1006/dbio.1998.9094; Laitenberger G, 2008, PEDIATR CARDIOL, V29, P1104, DOI 10.1007/s00246-007-9150-7; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Liang J, 2008, MOL CELL BIOCHEM, V307, P93, DOI 10.1007/s11010-007-9588-1; Lupo PJ, 2011, AM J MED GENET A, V155A, P1007, DOI 10.1002/ajmg.a.33883; MANGIACAPRA FJ, 1995, CELL TISSUE RES, V282, P227, DOI 10.1007/s004410050475; Margalit-Stashefski Ruti, 1998, Harefuah, V134, P762; Martinez-Jacobo L, 2013, MOL SYNDROMOL, V4, P285, DOI 10.1159/000353510; Matsui H, 2005, DEV DYNAM, V233, P1419, DOI 10.1002/dvdy.20477; Mu YX, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001950; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Osada SI, 1999, DEVELOPMENT, V126, P3229; Oxenius A, 2013, CARDIOL YOUNG, V23, P27, DOI 10.1017/S1047951112000224; Parisi S, 2003, J CELL BIOL, V163, P303, DOI 10.1083/jcb.200303010; Postma AV, 2011, CIRC-CARDIOVASC GENE, V4, P43, DOI 10.1161/CIRCGENETICS.110.957985; Pradat P, 2003, PEDIATR CARDIOL, V24, P195, DOI 10.1007/s00246-002-9401-6; Rigler SL, 2015, GENET MED, V17, P348, DOI 10.1038/gim.2014.112; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Schonberger J, 2005, NAT GENET, V37, P418, DOI 10.1038/ng1527; SCHULMAN J, 1993, PUBLIC HEALTH REP, V108, P91; Shimasaki N, 2004, PEDIATR CARDIOL, V25, P411, DOI 10.1007/s00246-003-0271-3; Sicko RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165174; SIMCHA A, 1971, BRIT HEART J, V33, P46; Sinkovec M, 2005, INT J CARDIOL, V102, P297, DOI 10.1016/j.ijcard.2004.05.033; Song ZZ, 2010, INT J CARDIOL, V143, pE30, DOI 10.1016/j.ijcard.2008.12.024; Stefanovic S, 2009, J CELL BIOL, V186, P665, DOI 10.1083/jcb.200901040; SUGI Y, 1995, DEV BIOL, V168, P567, DOI 10.1006/dbio.1995.1102; SUMNER RG, 1964, CIRCULATION, V30, P578, DOI 10.1161/01.CIR.30.4.578; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Trost D, 1999, DEUT MED WOCHENSCHR, V124, P3, DOI 10.1055/s-2008-1062601; Uyan C, 2002, INT J CARDIOVAS IMAG, V18, P435, DOI 10.1023/A:1021153504393; Vitelli F, 2006, DEV BIOL, V295, P559, DOI 10.1016/j.ydbio.2006.03.044; Walsh R, 2010, CARDIOLOGY, V115, P49, DOI 10.1159/000252808; Weins A, 2001, J CELL BIOL, V155, P393, DOI 10.1083/jcb.200012039; Xu CH, 1998, DEV BIOL, V196, P237, DOI 10.1006/dbio.1998.8862; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yatskievych TA, 1997, DEVELOPMENT, V124, P2561; Yuan SM, 2016, PEDIAT NEONATOLOGY; ZUBERBUHLER JR, 1979, J THORAC CARDIOV SUR, V77, P202	68	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188168	10.1371/journal.pone.0188168	http://dx.doi.org/10.1371/journal.pone.0188168			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216221	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800018
J	Raed, A; Bhagatwala, J; Zhu, HD; Pollock, NK; Parikh, SJ; Huang, Y; Havens, R; Kotak, I; Guo, DH; Dong, YB				Raed, Anas; Bhagatwala, Jigar; Zhu, Haidong; Pollock, Norman K.; Parikh, Samip J.; Huang, Ying; Havens, Robyn; Kotak, Ishita; Guo, De-Huang; Dong, Yanbin			Dose responses of vitamin D-3 supplementation on arterial stiffness in overweight African Americans with vitamin D deficiency: A placebo controlled randomized trial	PLOS ONE			English	Article							CHOLECALCIFEROL SUPPLEMENTATION; 1,25-DIHYDROXYVITAMIN D-3; CYTOKINE PRODUCTION; DISEASE; 25-HYDROXYVITAMIN-D; PREVALENCE; MECHANISMS; HEALTH	Background Clinical trials are scant and equivocal on whether vitamin D can ameliorate arterial stiffness, particularly in populations at high risk for vitamin D deficiency and cardiovascular disease (CVD). This study determined the dose-response effects of vitamin D-3 supplementation on arterial stiffness in overweight African Americans with vitamin D deficiency. Methods Seventy overweight African Americans (aged 13-45 years) with serum 25-hydroxyvitamin D [25(OH)D] levels <= 20 ng/mL were randomized to monthly oral supplementation of 18,000 IU (similar to 600 IU/day, n = 17), 60,000 IU (similar to 2000 IU/day, n = 18), or 120,000 IU (similar to 4000 IU/day, n = 18) of vitamin D-3 or placebo (n = 17) for 16-weeks. The arterial stiffness measurements, carotid-femoral pulse wave velocity (PWV) and carotid-radial PWV, were assessed by applanation tonometry at baseline and 16 weeks. Results Vitamin D-3 supplementation demonstrated a dose-response increase in serum 25(OH)D concentrations between groups (P<0.01). A significant downward linear trend was observed for carotid-femoral PWV (P<0.01), as the mean changes in carotid-femoral PWV across the four treatment groups were 0.13 m/s (95% CI: -0.24, 0.51 m/s) for placebo, 0.02 m/s (95% CI: -0.34, 0.38 m/s) for 600 IU/day group, -0.11 m/s (95% CI: -0.50, 0.27 m/s) for the 2,000 IU/day group, and -0.70 m/s (95% CI: -1.07, -0.32 m/s) for the 4,000 IU/day group. Findings were similar for carotid-radial PWV (P = 0.03), as the mean changes in carotid-radial PWV across the four treatment groups were 0.24 m/s (95% CI: -0.45, 0.92 m/s) for placebo, 0.09 m/s (95% CI: -0.54, 0.73 m/s) for 600 IU/day group, -0.57 m/s (95% CI: -1.20, 0.07 m/s) for the 2,000 IU/day group, and -0.61 m/s (95% CI: -1.25, 0.02 m/s) for the 4,000 IU/day group. Conclusion Arterial stiffness was improved by vitamin D-3 supplementation in a dose-response manner in overweight African Americans with vitamin D deficiency.	[Raed, Anas; Bhagatwala, Jigar; Zhu, Haidong; Pollock, Norman K.; Parikh, Samip J.; Huang, Ying; Havens, Robyn; Kotak, Ishita; Guo, De-Huang; Dong, Yanbin] Augusta Univ, Med Coll Georgia, Dept Populat Hlth Sci, Georgia Prevent Inst, Augusta, GA 30912 USA; [Raed, Anas; Bhagatwala, Jigar; Parikh, Samip J.] Augusta Univ, Dept Med, Med Coll Georgia, Augusta, GA USA; [Zhu, Haidong; Pollock, Norman K.; Dong, Yanbin] Augusta Univ, Dept Pediat, Med Coll Georgia, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Dong, YB (corresponding author), Augusta Univ, Med Coll Georgia, Dept Populat Hlth Sci, Georgia Prevent Inst, Augusta, GA 30912 USA.; Dong, YB (corresponding author), Augusta Univ, Dept Pediat, Med Coll Georgia, Augusta, GA 30912 USA.	YDONG@augusta.edu	Parikh, Samip/AAI-6909-2020	Pollock, Norman/0000-0002-5465-2018	Diabetes and Obesity Discovery Institute, Augusta University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131674] Funding Source: NIH RePORTER	Diabetes and Obesity Discovery Institute, Augusta University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Diabetes and Obesity Discovery Institute, Augusta University as a part of research support to AR (American board of Internal Medicine research residency track).	Al Mheid I, 2013, EUR HEART J, V34, P3691, DOI 10.1093/eurheartj/eht166; Al Mheid I, 2011, J AM COLL CARDIOL, V58, P186, DOI 10.1016/j.jacc.2011.02.051; Bhagatwala Jigar, 2015, BMC Obes, V2, P27, DOI 10.1186/s40608-015-0056-2; Breslavsky A, 2013, CLIN NUTR, V32, P970, DOI 10.1016/j.clnu.2013.01.020; Dong YB, 2010, J CLIN ENDOCR METAB, V95, P4584, DOI 10.1210/jc.2010-0606; Dong YB, 2010, PEDIATRICS, V125, P1104, DOI 10.1542/peds.2009-2055; Dreyer G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099461; Gepner AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036617; Giallauria F, 2012, J CLIN ENDOCR METAB, V97, P3717, DOI 10.1210/jc.2012-1584; Giovannini L, 2001, TRANSPLANT P, V33, P2366, DOI 10.1016/S0041-1345(01)02023-1; GLAGOV S, 1992, J HYPERTENS, V10, pS101; Harris RA, 2011, AM J HYPERTENS, V24, P557, DOI 10.1038/ajh.2011.12; Heffernan KS, 2008, AM J PHYSIOL-HEART C, V295, pH2380, DOI 10.1152/ajpheart.00902.2008; Helming L, 2005, BLOOD, V106, P4351, DOI 10.1182/blood-2005-03-1029; Larsen T, 2012, AM J HYPERTENS, V25, P1215, DOI 10.1038/ajh.2012.111; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; LEVY D, 1990, NEW ENGL J MED, V0322; Marckmann P, 2012, NEPHROL DIAL TRANSPL, V27, P3523, DOI 10.1093/ndt/gfs138; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; McGreevy C, 2015, J AM SOC HYPERTENS, V9, P176, DOI 10.1016/j.jash.2014.12.019; Melamed ML, 2008, ARTERIOSCL THROM VAS, V28, P1179, DOI 10.1161/ATVBAHA.108.165886; MOORE JE, 1994, ATHEROSCLEROSIS, V110, P225, DOI 10.1016/0021-9150(94)90207-0; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Palombo C, 2016, VASC PHARMACOL, V77, P1, DOI 10.1016/j.vph.2015.11.083; Pereira T, 2015, J MED BIOL ENG, V35, P555, DOI 10.1007/s40846-015-0086-8; Pilz S, 2008, STROKE, V39, P2611, DOI 10.1161/STROKEAHA.107.513655; Rausch-Fan X, 2002, INT ARCH ALLERGY IMM, V128, P33, DOI 10.1159/000058001; Rodriguez AJ, 2016, CLIN ENDOCRINOL, V84, P645, DOI 10.1111/cen.13031; Romagnoli E, 2008, J CLIN ENDOCR METAB, V93, P3015, DOI 10.1210/jc.2008-0350; Ross AC, 2011, PUBLIC HEALTH NUTR, V14, P938, DOI 10.1017/S1368980011000565; Ruan LT, 2009, AM J CARDIOL, V103, P985, DOI 10.1016/j.amjcard.2008.12.012; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Townsend RR, 2015, HYPERTENSION, V66, P698, DOI 10.1161/HYP.0000000000000033; Vieth R, 2001, AM J CLIN NUTR, V73, P288; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	39	38	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188424	10.1371/journal.pone.0188424	http://dx.doi.org/10.1371/journal.pone.0188424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216203	Green Published, gold			2022-12-27	WOS:000417337800021
J	Zhang, M; Shen, ZW; Meng, GQ; Lu, Y; Wang, YL				Zhang, Ming; Shen, Zhiwei; Meng, Guoqing; Lu, Yu; Wang, Yilei			Genome-wide analysis of the Brachypodium distachyon (L.) P. Beauv. Hsp90 gene family reveals molecular evolution and expression profiling under drought and salt stresses	PLOS ONE			English	Article							ARABIDOPSIS TRANSCRIPTION FACTOR; ABSCISIC-ACID; HEAT-STRESS; PROTEIN; CHAPERONE; HEAT-SHOCK-PROTEIN-90; DUPLICATION; MECHANISMS; INFERENCE; SEQUENCE	The structure, evolution, and function of heat shock proteins 90 (Hsp90s) have been investigated in great detail in fungi and animals. However, studies on the Hsp90 genes in plants are generally limited. Brachypodium distachyon (L.) P. Beauv., as a model plant for cereal crops, has become a potential biofuel grass. During its long evolution, the Hsp90 gene family in Brachypodium has developed some strategies to cope with adverse environments. How the Hsp90 gene family in Brachypodium evolved in different plant lineages and what its role is in plant responses to drought and salt stresses remains to be elucidated. We used a set of different bioinformatics tools to identify 94 Hsp90 genes from 10 species representing four plant lineages and classified into three subgroups. Eight BdHsp90 genes were detected from B. distachyon. The number of exon-intron structures differed in each subgroup, and the motif analysis revealed that these genes were relatively conservative in each group. The fragments duplication and tandem duplication, which are the prime powers for functional diversity, generally occurred during the duplication of the whole plant genome. Transcriptional analysis of the BdHsp90 genes under salt and drought stress conditions indicated that the expression of these genes was delayed or increased at different stress time points; The expression was more affected in that of Bradi3g39630, Bradi4g06370, and Bradi1g30130. Our findings suggest the involvement of BdHsp90s in plant abiotic stress response, and further consolidate our views on the stress response mechanism of Hsp90 in general.	[Zhang, Ming; Shen, Zhiwei; Meng, Guoqing; Lu, Yu; Wang, Yilei] Heze Univ, Coll Life Sci, Heze, Shandong, Peoples R China	Heze University	Wang, YL (corresponding author), Heze Univ, Coll Life Sci, Heze, Shandong, Peoples R China.	wangyilei001@163.com			Heze university scientific funds of Doctor research funds [XY16BS11]	Heze university scientific funds of Doctor research funds	This work was supported by Heze university scientific funds of Doctor research funds (XY16BS11) to MZ; Its roles lie in soft analysis and paper publish fees.	Agarwal G, 2016, PLANT BIOTECHNOL J, V14, P1563, DOI 10.1111/pbi.12520; Alfaro ME, 2006, ANNU REV ECOL EVOL S, V37, P19, DOI 10.1146/annurev.ecolsys.37.091305.110021; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Grigorova B, 2011, BIOL PLANTARUM, V55, P105, DOI 10.1007/s10535-011-0014-x; Hainzl O, 2009, J BIOL CHEM, V284, P22559, DOI 10.1074/jbc.M109.031658; Hall BG, 2005, MOL BIOL EVOL, V22, P792, DOI 10.1093/molbev/msi066; Hao PC, 2015, PROTEOMICS, V15, P1544, DOI 10.1002/pmic.201400179; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jackson SE, 2004, NAT STRUCT MOL BIOL, V11, P1152, DOI 10.1038/nsmb1204-1152; Jacob P, 2017, PLANT BIOTECHNOL J, V15, P405, DOI 10.1111/pbi.12659; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Klein EM, 2006, PLANT J, V48, P657, DOI 10.1111/j.1365-313X.2006.02904.x; Krishna P, 2001, CELL STRESS CHAPERON, V6, P238, DOI 10.1379/1466-1268(2001)006<0238:THFOPI>2.0.CO;2; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Liu HX, 2010, PLANT CELL, V22, P2630, DOI 10.1105/tpc.110.076075; Liu TK, 2014, PLANT MOL BIOL REP, V32, P1041, DOI 10.1007/s11105-014-0712-6; Liu Yunfei, 2014, Yichuan, V36, P1043, DOI 10.3724/SP.J.1005.2014.1043; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv DW, 2014, MOL CELL PROTEOMICS, V13, P632, DOI 10.1074/mcp.M113.030171; Maksymiec W, 2011, BIOL PLANTARUM, V55, P112, DOI 10.1007/s10535-011-0015-9; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; Riggs DL, 2004, CRIT REV BIOCHEM MOL, V39, P279, DOI 10.1080/10409230490892513; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sah SK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00571; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Sangster TA, 2005, CURR OPIN PLANT BIOL, V8, P86, DOI 10.1016/j.pbi.2004.11.012; Sangster TA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000648; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shinozaki F, 2006, J BIOL CHEM, V281, P16361, DOI 10.1074/jbc.M600891200; Song HM, 2009, PLANTA, V229, P955, DOI 10.1007/s00425-008-0886-y; Song WL, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-124; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Umezawa T, 2004, P NATL ACAD SCI USA, V101, P17306, DOI 10.1073/pnas.0407758101; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Valdivia ER, 2013, J EXP BOT, V64, P1333, DOI 10.1093/jxb/ers394; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Xu ZS, 2012, INT J MOL SCI, V13, P15706, DOI 10.3390/ijms131215706; Yin GJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-148; Yoshida T, 2015, PLANT CELL ENVIRON, V38, P35, DOI 10.1111/pce.12351; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhang H, 2016, BIOTECHNOLOGY BIOTEC, V30, P545; Zhang J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-532; Zhang L, 2012, J APPL PHYCOL, V24, P1601, DOI 10.1007/s10811-012-9821-5; Zhang M, 2014, J PROTEOME RES, V13, P4281, DOI 10.1021/pr500400t; Zhang S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-127; Zuehlke A, 2010, BIOPOLYMERS, V93, P211, DOI 10.1002/bip.21292	67	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189187	10.1371/journal.pone.0189187	http://dx.doi.org/10.1371/journal.pone.0189187			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216330	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800091
J	Ban, QY; Wang, XW; Pan, C; Wang, YW; Kong, L; Jiang, HG; Xu, YQ; Wang, WZ; Pan, YT; Li, YY; Jiang, CJ				Ban, Qiuyan; Wang, Xuewen; Pan, Cheng; Wang, Yiwei; Kong, Lei; Jiang, Huiguang; Xu, Yiqun; Wang, Wenzhi; Pan, Yuting; Li, Yeyun; Jiang, Changjun			Comparative analysis of the response and gene regulation in cold resistant and susceptible tea plants	PLOS ONE			English	Article							FREEZING TOLERANCE; LOW-TEMPERATURE; PROLINE BIOSYNTHESIS; STRESS TOLERANCE; WHEAT SEEDLINGS; ACCLIMATION; ARABIDOPSIS; EXPRESSION; TRANSCRIPTOME; ACCUMULATION	Cold environment is the main constraint for tea plants (Camellia sinensis) distribution and tea farming. We identified two tea cultivars, called var. sinensis cv. Shuchazao (SCZ) with a high cold-tolerance and var. assamica cv. Yinghong9 (YH9) with low cold-tolerance. To better understand the response mechanism of tea plants under cold stress for improving breeding, we compared physiological and biochemical responses, and associated genes expression in response to 7-day and 14-day cold acclimation, followed by 7-day de-acclimation in these two tea cultivars. We found that the low EL50, low Fv/Fm, and high sucrose and raffinose accumulation are responsible for higher cold tolerance in SCZ comparing with YH9. We then measured the expression of 14 key homologous genes, known as involved in these responses in other plants, for each stages of treatment in both cultivars using RT-qPCR. Our results suggested that the increased expression of CsCBF1 and CsDHNs coupling with the accumulation of sucrose play key roles in conferring higher cold resistance in SCZ. Our findings have revealed key genes regulation responsible for cold resistance, which help to understand the cold-resistant mechanisms and guide breeding in tea plants.	[Ban, Qiuyan; Wang, Xuewen; Pan, Cheng; Wang, Yiwei; Kong, Lei; Jiang, Huiguang; Xu, Yiqun; Wang, Wenzhi; Pan, Yuting; Li, Yeyun; Jiang, Changjun] Anhui Agr Univ, State Key Lab Tea Plant Biol & Utilizat, Key Lab Tea Biol & Proc, Minist Agr, Hefei, Anhui, Peoples R China; [Wang, Xuewen] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Jiang, Changjun] Xinyang Normal Univ, Henan Prov Key Lab Tea Plant Biol, Xinyang, Henan, Peoples R China	Anhui Agricultural University; Ministry of Agriculture & Rural Affairs; University System of Georgia; University of Georgia; Xinyang Normal University	Li, YY; Jiang, CJ (corresponding author), Anhui Agr Univ, State Key Lab Tea Plant Biol & Utilizat, Key Lab Tea Biol & Proc, Minist Agr, Hefei, Anhui, Peoples R China.; Jiang, CJ (corresponding author), Xinyang Normal Univ, Henan Prov Key Lab Tea Plant Biol, Xinyang, Henan, Peoples R China.	lyy@ahau.edu.cn; jiangcj@ahau.edu.cn	Wang, Xuewen/C-1362-2016	Wang, Xuewen/0000-0003-2820-9255; Ban, Qiuyan/0000-0003-4124-9542	National Natural Science Foundation of China [31270729]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [grant number: 31270729]. The URLs of funder's website http://www.nsfc.govcn/publish/portal1/. The funders had key role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee B, 1992, TEA CULTIVATION CONS, P25, DOI DOI 10.1007/978-94-011-2326-6_2; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Benedict C, 2006, PLANT CELL ENVIRON, V29, P1259, DOI 10.1111/j.1365-3040.2006.01505.x; Bertrand A, 2017, PLANT SCI; Bolouri-Moghaddam MR, 2010, FEBS J, V277, P2022, DOI 10.1111/j.1742-4658.2010.07633.x; Bonnecarrere V, 2011, PLANT SCI, V180, P726, DOI 10.1016/j.plantsci.2011.01.023; CASTONGUAY Y, 1995, CROP SCI, V35, P509, DOI 10.2135/cropsci1995.0011183X003500020038x; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Ding ZT, 2016, J HORTIC SCI BIOTECH, V91, P506, DOI 10.1080/14620316.2016.1178078; El Kayal W, 2006, J EXP BOT, V57, P2455, DOI 10.1093/jxb/erl019; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Gaete-Loyola J, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1121-4; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Hare PD, 1999, J EXP BOT, V50, P413, DOI 10.1093/jexbot/50.333.413; Iordachescu M, 2008, J INTEGR PLANT BIOL, V50, P1223, DOI 10.1111/j.1744-7909.2008.00736.x; Jaglo KR, 2001, PLANT PHYSIOL, V127, P910, DOI 10.1104/pp.010548; John R, 2016, BIOL PLANTARUM, V60, P603, DOI 10.1007/s10535-016-0648-9; Junttila O, 2002, PLANT COLD HARDINESS: GENE REGULATION AND GENETIC ENGINEERING, P65; Kamata T, 2004, CRYOLETTERS, V25, P311; Kaplan F, 2007, PLANT J, V50, P967, DOI 10.1111/j.1365-313X.2007.03100.x; Kargiotidou A, 2008, J EXP BOT, V59, P2043, DOI 10.1093/jxb/ern065; Kargiotidou A, 2010, J EXP BOT, V61, P2991, DOI 10.1093/jxb/erq124; Kaundun SS, 2003, THEOR APPL GENET, V106, P375, DOI 10.1007/s00122-002-0999-9; Khavari-Nejad RA, 2013, RUSS J PLANT PHYSL+, V60, P375, DOI 10.1134/S1021443713020106; Khokhlova LP, 2004, RUSS J PLANT PHYSL+, V51, P684, DOI 10.1023/B:RUPP.0000040757.07698.d8; Kitashiba H, 2004, J PLANT PHYSIOL, V161, P1171, DOI 10.1016/j.jplph.2004.04.008; Kumar V, 2009, ACTA PHYSIOL PLANT, V31, P261, DOI 10.1007/s11738-008-0227-6; Le Gall H, 2017, PHYTOCHEM ANALYSIS, V28, P58, DOI 10.1002/pca.2649; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Li W, 2008, J BIOL CHEM, V283, P461, DOI 10.1074/jbc.M706692200; Li WQ, 2004, NAT BIOTECHNOL, V22, P427, DOI 10.1038/nbt949; Li YeYun, 2016, Journal of Agricultural Biotechnology, V24, P332; Liu SC, 2015, SCI HORTIC-AMSTERDAM, V184, P129, DOI 10.1016/j.scienta.2014.12.036; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meijer HJG, 2003, ANNU REV PLANT BIOL, V54, P265, DOI 10.1146/annurev.arplant.54.031902.134748; Miura K, 2007, PLANT CELL, V19, P1403, DOI 10.1105/tpc.106.048397; Moieni-Korbekandi Z., 2014, J PLANT PHYSL BREED, V4, P1; Mollo L, 2011, PLANT CELL TISS ORG, V107, P141, DOI 10.1007/s11240-011-9966-y; NORDIN K, 1991, PLANT MOL BIOL, V16, P1061, DOI 10.1007/BF00016077; Novillo F, 2007, P NATL ACAD SCI USA, V104, P21002, DOI 10.1073/pnas.0705639105; PALTA JP, 1993, PLANT PHYSIOL, V103, P793, DOI 10.1104/pp.103.3.793; Pan XW, 2013, RICE SCI, V20, P165, DOI 10.1016/S1672-6308(13)60121-3; Paul A, 2013, MOL BIOL REP, V40, P3859, DOI 10.1007/s11033-012-2466-2; Pennycooke JC, 2008, PLANT PHYSIOL, V146, P1242, DOI 10.1104/pp.107.108779; Pompeiano A, 2015, GRASS FORAGE SCI, V70, P168, DOI 10.1111/gfs.12097; Rajashekar CB, 2000, BOOK SOIL P, P321; Rampino P, 2006, PLANT CELL ENVIRON, V29, P2143, DOI 10.1111/j.1365-3040.2006.01588.x; Roosens NH, 2002, MOL BREEDING, V9, P73, DOI 10.1023/A:1026791932238; Ruan YL, 2014, ANNU REV PLANT BIOL, V65, P33, DOI 10.1146/annurev-arplant-050213-040251; Sanghera GS, 2011, CURR GENOMICS, V12, P30, DOI 10.2174/138920211794520178; Schreiber U., 1995, ECOL STUD, P49, DOI DOI 10.1007/978-3-642-79354-7_3; Shen JZ, 2015, SCI HORTIC-AMSTERDAM, V192, P1, DOI 10.1016/j.scienta.2015.05.022; Sowinski P, 1999, ACTA PHYSIOL PLANT, V21, P375, DOI 10.1007/s11738-999-0009-9; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; TOGNETTI JA, 1990, PHYSIOL PLANTARUM, V78, P554, DOI 10.1111/j.1399-3054.1990.tb05241.x; Uemura M, 1997, PLANT PHYSIOL, V114, P1493, DOI 10.1104/pp.114.4.1493; Velada I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115206; Vyas D, 2005, PLANT PHYSIOL BIOCH, V43, P383, DOI 10.1016/j.plaphy.2005.02.016; Wang XC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-415; Wang Y, 2012, PLANT CELL REP, V31, P27, DOI 10.1007/s00299-011-1136-5; Warren GJ, 1998, CURR BIOL, V8, pR514, DOI 10.1016/S0960-9822(07)00335-1; Wei H, 2005, PLANTA, V221, P406, DOI 10.1007/s00425-004-1440-1; Xu HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087575; Yadav SK, 2010, AGRON SUSTAIN DEV, V30, P515, DOI 10.1051/agro/2009050; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yuan HY, 2013, ACTA BOT BOREALI-OCC, V110, P147; Yue C, 2015, PLANT MOL BIOL, V88, P591, DOI 10.1007/s11103-015-0345-7; Zhang LL, 2011, PLANTA, V234, P445, DOI 10.1007/s00425-011-1416-x; Zhang Q, 2014, RICE, V7, DOI 10.1186/s12284-014-0024-3; Zhang Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0271-x; Zuther E, 2004, FEBS LETT, V576, P169, DOI 10.1016/j.febslet.2004.09.006	75	34	38	10	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188514	10.1371/journal.pone.0188514	http://dx.doi.org/10.1371/journal.pone.0188514			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211766	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200038
J	Kim, M; Kim, M; Yoo, HJ; Lee, E; Chae, JS; Lee, SH; Lee, JH				Kim, Minjoo; Kim, Minkyung; Yoo, Hye Jin; Lee, Eunji; Chae, Jey Sook; Lee, Sang-Hyun; Lee, Jong Ho			A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients	PLOS ONE			English	Article							APOLIPOPROTEIN A5 GENE; PULSE-WAVE VELOCITY; CORONARY-HEART-DISEASE; TRIGLYCERIDE-RICH LIPOPROTEINS; MARKED HYPERTRIGLYCERIDEMIA; PLASMA; RISK; C.553G-GREATER-THAN-T; ASSOCIATION; POPULATION	Hypertriglyceridemia is recognized as an independent risk factor for coronary artery disease. The apolipoprotein A5 gene (APOA5) is a key regulator of triglyceride levels. We aimed to evaluate the associations of single nucleotide polymorphisms (SNPs) in APOA5, including -1131T>C and c.553G>T, with hypertriglyceridemia, apoA5 concentrations, atherogenic LDL cholesterol levels, and arterial stiffness in hypertriglyceridemic patients. The study population included 599 hypertriglyceridemic patients (case) and 1,549 untreated normotriglyceridemic subjects (control). We genotyped two APOA5 variants, -1131T>C (rs662799) and c.553G>T (rs2075291). The frequencies of the CC genotype of -1131T>C (0.165) and the T allele of c.553G>T (0.119) were significantly higher in hypertriglyceridemic patients than in normotriglyceridemic subjects (0.061 and 0.070, respectively; all p< 0.001). In the control and case groups, both the -1131T>C and c.553G>T variants were associated with higher triglyceride and lower HDL cholesterol levels. Controls with the -1131CC variant had lower apoA5 concentrations than controls with the -1131TT variant. Similar effects of the -1131T>C variant on apoA5 were observed in the cases. In the hypertriglyceridemic group, the -1131T>C variant was associated with a smaller LDL particle size, higher levels of oxidized LDL and malondialdehyde, and higher brachial-ankle pulse wave velocity. The -1131T>C and c.553G>T polymorphisms were associated with hypertriglyceridemia in the study population, but only the -1131T>C polymorphism directly affected apoA5 concentrations. Hypertriglyceridemic patients carrying the APOA5 -1131T>C polymorphism exhibited increased atherogenic LDL levels and arterial stiffness, probably due to an effect of the -1131T>C polymorphism on apoA5 concentrations.	[Kim, Minjoo; Kim, Minkyung; Chae, Jey Sook; Lee, Jong Ho] Yonsei Univ, Inst Symbiot Life TECH, Res Ctr Silver Sci, Seoul, South Korea; [Yoo, Hye Jin; Lee, Eunji; Lee, Jong Ho] Yonsei Univ, Dept Food & Nutr, Coll Human Ecol, Brain Korea PLUS Project 21, Seoul, South Korea; [Lee, Eunji; Lee, Jong Ho] Yonsei Univ, Dept Food & Nutr, Coll Human Ecol, Natl Leading Res Lab Clin Nutrigenet Nutrigen, Seoul, South Korea; [Lee, Sang-Hyun] Ilsan Hosp, Natl Hlth Insurance Corp, Dept Family Practice, Goyang, South Korea	Yonsei University; Yonsei University; Yonsei University; NHIS Ilsan Hospital	Lee, JH (corresponding author), Yonsei Univ, Inst Symbiot Life TECH, Res Ctr Silver Sci, Seoul, South Korea.; Lee, JH (corresponding author), Yonsei Univ, Dept Food & Nutr, Coll Human Ecol, Brain Korea PLUS Project 21, Seoul, South Korea.; Lee, JH (corresponding author), Yonsei Univ, Dept Food & Nutr, Coll Human Ecol, Natl Leading Res Lab Clin Nutrigenet Nutrigen, Seoul, South Korea.	jhleeb@yonsei.ac.kr			Bio-Synergy Research Project of the Ministry of Science [NRF-2012M3A9C4048762]; Mid-career Researcher Program of the Ministry of Science [NRF-2016R1A2B4011662]; ICT and Future Planning through National Research Foundation of the Republic of Korea	Bio-Synergy Research Project of the Ministry of Science; Mid-career Researcher Program of the Ministry of Science; ICT and Future Planning through National Research Foundation of the Republic of Korea	This study was funded by the Bio-Synergy Research Project (NRF-2012M3A9C4048762) and the Mid-career Researcher Program (NRF-2016R1A2B4011662) of the Ministry of Science and by ICT and Future Planning through the National Research Foundation of the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armas-Padilla Maria Cristina, 2007, Am J Ther, V14, P172, DOI 10.1097/01.pap.0000249914.75895.48; Belo L, 2004, ATHEROSCLEROSIS, V177, P391, DOI 10.1016/j.atherosclerosis.2004.07.023; Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; Corella D, 2007, J MOL MED-JMM, V85, P119, DOI 10.1007/s00109-006-0147-0; Cullen P, 2000, AM J CARDIOL, V86, P943, DOI 10.1016/S0002-9149(00)01127-9; DEGRAAF J, 1991, ARTERIOSCLER THROMB, V11, P298, DOI 10.1161/01.ATV.11.2.298; Dorfmeister B, 2008, ARTERIOSCL THROM VAS, V28, P1866, DOI 10.1161/ATVBAHA.108.172866; Elosua R, 2006, J LIPID RES, V47, P990, DOI 10.1194/jlr.M500446-JLR200; Garelnabi M, 2013, CLIN BIOCHEM, V46, P12, DOI 10.1016/j.clinbiochem.2012.09.007; Giera M, 2012, CHROMATOGRAPHIA, V75, P433, DOI 10.1007/s10337-012-2237-1; Grosskopf I, 2005, ARTERIOSCL THROM VAS, V25, P2573, DOI 10.1161/01.ATV.0000186189.26141.12; Guardiola M, 2015, ATHEROSCLEROSIS, V240, P98, DOI 10.1016/j.atherosclerosis.2015.03.008; He HJ, 2016, GENET TEST MOL BIOMA, V20, P758, DOI 10.1089/gtmb.2016.0047; Hsu LA, 2006, ATHEROSCLEROSIS, V185, P143, DOI 10.1016/j.atherosclerosis.2005.05.031; Huang YJ, 2012, CLIN CHIM ACTA, V413, P246, DOI 10.1016/j.cca.2011.09.045; Hung CS, 2009, NUTR METAB CARDIOVAS, V19, P241, DOI 10.1016/j.numecd.2008.07.006; Jang Y, 2009, CLIN CHIM ACTA, V402, P83, DOI 10.1016/j.cca.2008.12.024; Kao JT, 2003, HUM MOL GENET, V12, P2533, DOI 10.1093/hmg/ddg255; Kim EJ, 2007, J HUM HYPERTENS, V21, P141, DOI 10.1038/sj.jhh.1002120; Kim M, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0063-4; Kim OY, 2013, CLIN EXP HYPERTENS, V35, P382, DOI 10.3109/10641963.2012.739232; Lai CQ, 2003, J LIPID RES, V44, P2365, DOI 10.1194/jlr.M300251-JLR200; Lee KH, 2010, METABOLISM, V59, P1583, DOI 10.1016/j.metabol.2010.02.008; Matsunaga A, 2007, CIRC J, V71, P746, DOI 10.1253/circj.71.746; Merkel M, 2005, J BIOL CHEM, V280, P21553, DOI 10.1074/jbc.M411412200; Nabika T, 2002, ATHEROSCLEROSIS, V165, P201, DOI 10.1016/S0021-9150(02)00252-6; Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Pullinger CR, 2008, J LIPID RES, V49, P1846, DOI 10.1194/jlr.P800011-JLR200; Sharma V, 2014, ARTERIOSCL THROM VAS, V34, P2254, DOI 10.1161/ATVBAHA.114.304027; Shin JY, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-30; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; Szalai C, 2004, ATHEROSCLEROSIS, V173, P109, DOI 10.1016/j.atherosclerosis.2003.12.003; Talmud PJ, 2002, ARTERIOSCL THROM VAS, V22, P1918, DOI 10.1161/01.ATV.0000035521.22199.C7; Talmud PJ, 2004, J LIPID RES, V45, P750, DOI 10.1194/jlr.M300458-JLR200; Tang YB, 2006, ATHEROSCLEROSIS, V185, P433, DOI 10.1016/j.atherosclerosis.2005.06.026; Xie SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129488; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Zhao TF, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-120	39	7	8	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0186693	10.1371/journal.pone.0186693	http://dx.doi.org/10.1371/journal.pone.0186693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211729	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200008
J	Lin, WC; Chang, CW; Chen, MJ; Chu, CH; Shih, SC; Hsu, TC; Wang, HY				Lin, Wei-Chen; Chang, Chen-Wang; Chen, Ming-Jen; Chu, Cheng-Hsin; Shih, Shou-Chuan; Hsu, Tzu-Chi; Wang, Horng-Yang			Challenges in the diagnosis of ulcerative colitis with concomitant bacterial infections and chronic infectious colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; BLOODY DIARRHEA; TAIWAN SOCIETY; FIRST ATTACKS; MANAGEMENT	Ulcerative colitis (UC) is a chronic inflammation of the large bowel characterized by diarrhea and a negative stool culture. However, several enteropathogens have been implicated as causative agents in UC. The differentiation between chronic infectious colitis (IC) and UC with concurrent infection is difficult owing to their similar clinical presentations. The study aimed to explore the presentations and diagnostic clues that enable differentiation between UC with concomitant infections and chronic IC. The study included 17 UC patients with a bacterial infection and 46 with chronic IC. The UC patients (47 +/- 19 years) were younger than the chronic IC patients (58 +/- 20 years) (P = 0.022). Bloody diarrhea was more common in UC than in chronic IC (58.8% vs 10.9%, P < 0.001). Previous antibiotic usage was a risk factor for chronic IC (5.9% vs 32.6%, P = 0.031). Malignancy was a common comorbidity of chronic IC (5.9% vs 34.8%, P = 0.022). UC patients had lower antibiotic response rates than chronic IC patients (60.0% vs 87.2%, P = 0.026). Aeromonas species and Clostridium difficile were common in both groups. Histological features of cryptitis and crypt abscess were useful in the diagnosis of UC (P = 0.052 and P = 0.016, respectively). Bloody diarrhea in a young adult, decreased response to antibiotic treatment, and results of endoscopy with biopsy are important features in the diagnosis of UC with bacterial infection.	[Lin, Wei-Chen; Chang, Chen-Wang; Chen, Ming-Jen; Chu, Cheng-Hsin; Shih, Shou-Chuan; Wang, Horng-Yang] Mackay Mem Hosp, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan; [Hsu, Tzu-Chi] Mackay Mem Hosp, Div Colon & Rectal Surg, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Memorial Hospital	Lin, WC (corresponding author), Mackay Mem Hosp, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan.	b8801040@gmail.com	Chu, Chu/T-6038-2019					Alberto L, 2006, GASTROENTEROLOGY, V130, P1588, DOI 10.1053/j.gastro.2006.02.004; Campieri M, 2001, GUT, V48, P132, DOI 10.1136/gut.48.1.132; Chi CY, 2017, J MICROBIOL IMMUNOL, VS1684-1182, P30085; Danese S, 2004, AM J GASTROENTEROL, V99, P938, DOI 10.1111/j.1572-0241.2004.04129.x; Fine KD, 1999, GASTROENTEROLOGY, V116, P1464, DOI 10.1016/S0016-5085(99)70513-5; Haffajee J, 2003, AM J GASTROENTEROL, V98, pS174; Henriksen M, 2008, GUT, V57, P1518, DOI 10.1136/gut.2007.146357; Juckett G, 2011, AM FAM PHYSICIAN, V84, P1119; Kaiser L, 2012, BEST PRACT RES CL GA, V26, P563, DOI 10.1016/j.bpg.2012.11.001; Lin WC, 2016, J AM GERIATR SOC, V64, pE95, DOI 10.1111/jgs.14427; Lobaton T, 2015, INFLAMM BOWEL DIS, V21, P71, DOI 10.1097/MIB.0000000000000247; Mota MI, 2010, REV ARGENT MICROBIOL, V42, P114, DOI 10.1590/S0325-75412010000200009; Ohkusa T, 2010, AM J GASTROENTEROL, V105, P1820, DOI 10.1038/ajg.2010.84; Ricciardi R, 2009, DIS COLON RECTUM, V52, P40, DOI 10.1007/DCR.0b013e31819733fd; Sartor RB, 1996, CURR OPIN GASTROEN, V12, P327, DOI 10.1097/00001574-199607000-00003; Sasaki Maiko, 2012, J Signal Transduct, V2012, P704953, DOI 10.1155/2012/704953; SCHUMACHER G, 1993, SCAND J GASTROENTERO, V28, P1077, DOI 10.3109/00365529309098313; SCHUMACHER G, 1994, SCAND J GASTROENTERO, V29, P265, DOI 10.3109/00365529409090475; Shetty S, 2011, HISTOPATHOLOGY, V59, P850, DOI 10.1111/j.1365-2559.2011.04019.x; Talan DA, 2001, CLIN INFECT DIS, V32, P573, DOI 10.1086/318718; Tanaka M, 1999, SCAND J GASTROENTERO, V34, P55; Tremaine WJ, 2007, CLIN GASTROENTEROL H, V5, P310, DOI 10.1016/j.cgh.2006.12.030; Villafuerte-Galvez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046690; Wei SC, 2017, INTEST RES, V15, P266, DOI 10.5217/ir.2017.15.3.266; Wilks S., 1875, LECTURES PATHOLOGICA, P408; Yoshida H, 2009, INFLAMM BOWEL DIS, V15, P1245, DOI 10.1002/ibd.20896	26	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189377	10.1371/journal.pone.0189377	http://dx.doi.org/10.1371/journal.pone.0189377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211811	Green Published, Green Submitted, gold			2022-12-27	WOS:000417212200077
J	Alkishe, AA; Peterson, AT; Samy, AM				Alkishe, Abdelghafar A.; Peterson, A. Townsend; Samy, Abdallah M.			Climate change influences on the potential geographic distribution of the disease vector tick Ixodes ricinus	PLOS ONE			English	Article							BURGDORFERI SENSU-LATO; BORNE ENCEPHALITIS; BORRELIA-BURGDORFERI; SPECIES DISTRIBUTIONS; HIGHER ALTITUDES; IMPACT; EPIDEMIOLOGY; CONSTRAINTS; PREVALENCE; PATHOGENS	Background Ixodes ricinus is a species of hard tick that transmits several important diseases in Europe and North Africa, including Lyme borreliosis and tick-borne encephalitis. Climate change is affecting the geographic distributions and abundances of arthropod vectors, which in turn influence the geographic distribution and epidemiology of associated vector-borne diseases. To date, few studies have investigated effects of climate change on the spatial distribution of I. ricinus at continental extents. Here, we assessed the potential distribution of I. ricinus under current and future climate conditions to understand how climate change will influence the geographic distribution of this important tick vector in coming decades. Method We used ecological niche modeling to estimate the geographic distribution of I. ricinus with respect to current climate, and then assessed its future potential distribution under different climate change scenarios. This approach integrates occurrence records of I. ricinus with six relevant environmental variables over a continental extent that includes Europe, North Africa, and the Middle East. Future projections were based on climate data from 17 general circulation models (GCMs) under 2 representative concentration pathway emissions scenarios (RCPs), for the years 2050 and 2070. Result The present and future potential distributions of I. ricinus showed broad overlap across most of western and central Europe, and in more narrow zones in eastern and northern Europe, and North Africa. Potential expansions were observed in northern and eastern Europe. These results indicate that I. ricinus populations could emerge in areas in which they are currently lacking, posing increased risks to human health in those areas. However, the future of I. ricinus ticks in some important regions such the Mediterranean was unclear owing to high uncertainty in model predictions.	[Alkishe, Abdelghafar A.; Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Alkishe, Abdelghafar A.] Univ Tripoli, Fac Sci, Zool Dept, Tripoli, Libya; [Samy, Abdallah M.] Ain Shams Univ, Fac Sci, Entomol Dept, Cairo, Egypt	University of Kansas; Egyptian Knowledge Bank (EKB); Ain Shams University	Alkishe, AA (corresponding author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.; Alkishe, AA (corresponding author), Univ Tripoli, Fac Sci, Zool Dept, Tripoli, Libya.; Samy, AM (corresponding author), Ain Shams Univ, Fac Sci, Entomol Dept, Cairo, Egypt.	al.keesh@ku.edu; samy@sci.asu.edu.eg	Samy, Abdallah/B-4375-2010; Alkishe, Abdelghafar/AAM-6814-2020	Samy, Abdallah/0000-0003-3978-1134; Alkishe, Abdelghafar/0000-0003-2927-514X	Ministry of Higher Education, Libya; Graduate Fulbright Egyptian Mission Program (EFMP); Egyptian Fulbright Mission Program [EFMP]	Ministry of Higher Education, Libya; Graduate Fulbright Egyptian Mission Program (EFMP); Egyptian Fulbright Mission Program [EFMP]	AAA was supported by the Ministry of Higher Education, Libya. AMS was supported by the Graduate Fulbright Egyptian Mission Program (EFMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the University of Kansas Ecological Niche Modeling (KU ENM) Group, and the Surveillance, Ecology, and Epidemiology Research Group, Cairo, Egypt. Thanks to the Ministry of Higher Education, Libya, for supporting AAA during his studies at the University of Kansas; AMS was funded by the Egyptian Fulbright Mission Program [EFMP]. Special thanks to the staff of the Zoology Department, Faculty of Science, University of Tripoli, Tripoli, Libya; for their continuous support during the study. Thanks to Gengping Zhu and Katie Allen for assistance with data analysis. Thanks to Arwa Elaagip who hosted AMS during his work on this project at Khartoum University, Sudan.	[Anonymous], 2011, ECOLOGICAL NICHES GE; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Daniel M, 2004, INT J MED MICROBIOL, V293, P55, DOI 10.1016/S1433-1128(04)80009-3; Danielova V, 2008, INT J MED MICROBIOL, V298, P68, DOI 10.1016/j.ijmm.2008.02.005; Derdakova M, 2005, ANN AGR ENV MED, V12, P165; Diuk-Wasser MA, 2012, AM J TROP MED HYG, V86, P320, DOI 10.4269/ajtmh.2012.11-0395; Dobson ADM, 2011, J APPL ECOL, V48, P1029, DOI 10.1111/j.1365-2664.2011.02004.x; Estrada-Pena A, 2007, J MED ENTOMOL, V44, P1130, DOI 10.1603/0022-2585(2007)44[1130:CNOTSI]2.0.CO;2; Estrada-Pena A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1474-9; Estrada-Pena A, 2014, ANTIVIR RES, V108, P104, DOI 10.1016/j.antiviral.2014.05.016; Filippova Natalia Aleksandrovna, 2002, Acta Zoologica Lituanica, V12, P215, DOI 10.1080/13921657.2002.10512509; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Gage KL, 2008, AM J PREV MED, V35, P436, DOI 10.1016/j.amepre.2008.08.030; Gray J. S., 1991, Review of Medical and Veterinary Entomology, V79, P323; Gray JS, 2008, INT J MED MICROBIOL, V298, P19, DOI 10.1016/j.ijmm.2007.09.005; Hasle G, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00048; Hayasaka D, 2001, J GEN VIROL, V82, P1319, DOI 10.1099/0022-1317-82-6-1319; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-8; Jaenson TGT, 2011, TICKS TICK-BORNE DIS, V2, P44, DOI 10.1016/j.ttbdis.2010.10.006; Jore S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-11; Kovalev SY, 2016, TICKS TICK-BORNE DIS, V7, P113, DOI 10.1016/j.ttbdis.2015.09.005; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; Lindgren E, 2006, LYME BORRELIOSIS EUR; Materna J., 2005, Central European Journal of Public Health, V13, P24; Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5; Medlock JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-1; MILNE A, 1949, PARASITOLOGY, V39, P173, DOI 10.1017/S0031182000083736; Owens HL, 2013, ECOL MODEL, V263, P10, DOI 10.1016/j.ecolmodel.2013.04.011; Parham PE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0551; Parola P, 2001, CLIN MICROBIOL INFEC, V7, P80, DOI 10.1046/j.1469-0691.2001.00200.x; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Paulauskas A, 2016, J VECTOR ECOL, V41, P244, DOI 10.1111/jvec.12219; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Porretta Daniele, 2013, Parasites & Vectors, V6, P1; Rauter C, 2005, APPL ENVIRON MICROB, V71, P7203, DOI 10.1128/AEM.71.11.7203-7216.2005; Ruiz-Fons F, 2012, APPL ENVIRON MICROB, V78, P2669, DOI 10.1128/AEM.06564-11; Samy AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163863; Schwarz A, 2009, INT J HYG ENVIR HEAL, V212, P87, DOI 10.1016/j.ijheh.2007.12.001; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Zeman P, 2004, INT J MED MICROBIOL, V293, P48, DOI 10.1016/S1433-1128(04)80008-1; Zeman P, 2010, TICKS TICK-BORNE DIS, V1, P129, DOI 10.1016/j.ttbdis.2010.05.003; Zimmermann NE, 2010, ECOGRAPHY, V33, P985, DOI 10.1111/j.1600-0587.2010.06953.x	48	84	84	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189092	10.1371/journal.pone.0189092	http://dx.doi.org/10.1371/journal.pone.0189092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206879	Green Submitted, Green Published, gold			2022-12-27	WOS:000417110700048
J	Andryushchenko, VA; Chekmarev, SF				Andryushchenko, Vladimir A.; Chekmarev, Sergei F.			Turbulence in protein folding: Vorticity, scaling and diffusion of probability flows	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; BETA-SHEET MINIPROTEIN; TRP-CAGE; ENERGY LANDSCAPE; MECHANISMS; MODEL; THERMODYNAMICS; PERSPECTIVE; INTEGRATION; KINETICS	Recently, when studying folding of a SH3 domain, we discovered that the flows of transitions between protein states can be surprisingly similar to turbulent fluid flows. This similarity was not restricted by a vortex pattern of the flow fields but extended to a spatial correlation of flow fluctuations, resulting, in particular, in the structure functions such as in the Kolmogorov theory of homogeneous and isotropic turbulence. Here, we undertake a detailed analysis of spatial distribution of folding flows and their similarity to turbulent fluid flows. Using molecular dynamics simulations, we study folding of another benchmark system-Trp-cage miniprotein, which has different content of secondary structure elements and mechanism of folding. Calculating the probability fluxes of transitions in a three-dimensional space of collective variables, we have found that similar to the SH3 domain, the structure functions of the second and third orders correspond to the Kolmogorov functions. The spatial distributions of the probability fluxes are self-similar with a fractal dimension, and the fractal index decreases toward the native state, indicating that the flow becomes more turbulent as the native state is approached. We also show that the process of folding can be viewed as Brownian diffusion in the space of probability fluxes. The diffusion coefficient plays a role of the key parameter that defines the structures functions, similar to the rate of dissipation of kinetic energy in hydrodynamic turbulence. The obtained results, first, show that the very complex dynamics of protein folding allows a simple characterization in terms of scaling and diffusion of probability fluxes, and, secondly, they suggest that the turbulence phenomena similar to hydrodynamic turbulence are not specific of folding of a particular protein but are common to protein folding.	[Andryushchenko, Vladimir A.; Chekmarev, Sergei F.] RAS, SB, Inst Thermophys, Novosibirsk, Russia; [Andryushchenko, Vladimir A.; Chekmarev, Sergei F.] Novosibirsk State Univ, Dept Phys, Novosibirsk, Russia	Russian Academy of Sciences; S.S. Kutateladze Institute of Thermophysics, Siberian Division of the Russian Academy of Sciences; Novosibirsk State University	Chekmarev, SF (corresponding author), RAS, SB, Inst Thermophys, Novosibirsk, Russia.; Chekmarev, SF (corresponding author), Novosibirsk State Univ, Dept Phys, Novosibirsk, Russia.	chekmarev@itp.nsc.ru	Chekmarev, Sergei F/N-4255-2017	Chekmarev, Sergei F/0000-0002-5603-8193	Russian Science Foundation [14-1400325]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Science Foundation, Grant number 14-1400325, SCh, http://grant.rscf.ru/.	Andryushchenko VA, 2016, EUR BIOPHYS J BIOPHY, V45, P229, DOI 10.1007/s00249-015-1089-7; Barenghi CF, 2016, SCI REP-UK, V6, DOI 10.1038/srep35701; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chekmarev SF, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018107; Chekmarev SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121640; Chekmarev SF, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4824133; Chowdhury S, 2004, J PHYS CHEM B, V108, P13855, DOI 10.1021/jp0478920; Darmofal DL, 1996, J COMPUT PHYS, V123, P182, DOI 10.1006/jcph.1996.0015; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dinner AR, 2000, TRENDS BIOCHEM SCI, V25, P331, DOI 10.1016/S0968-0004(00)01610-8; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Eaton WA, 2000, ANNU REV BIOPH BIOM, V29, P327, DOI 10.1146/annurev.biophys.29.1.327; Eyink GL, 1996, J STAT PHYS, V83, P385, DOI 10.1007/BF02183738; Ferrara P, 2000, J PHYS CHEM B, V104, P5000, DOI 10.1021/jp994157t; Ferrara P, 2002, PROTEINS, V46, P24, DOI 10.1002/prot.10001; FRISCH U., 1995, TURBULENCE LEGACY AN; Gardiner C. W., 1983, HDB STOCHASTIC METHO; Ghashghaie S, 1996, NATURE, V381, P767, DOI 10.1038/381767a0; GRAHAM R, 1977, Z PHYS B CON MAT, V26, P397, DOI 10.1007/BF01570750; Han W, 2013, J PHYS CHEM B, V117, P13367, DOI 10.1021/jp404331d; Jolliffe I. T., 2002, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Juraszek J, 2006, P NATL ACAD SCI USA, V103, P15859, DOI 10.1073/pnas.0606692103; Kalgin IV, 2015, J PHYS CHEM B, V119, P1380, DOI 10.1021/jp5112795; Kalgin IV, 2014, J PHYS CHEM B, V118, P4287, DOI 10.1021/jp412729r; Kalgin IV, 2013, J PHYS CHEM B, V117, P6092, DOI 10.1021/jp401742y; Kalgin IV, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011920; Kalgin IV, 2009, J PHYS CHEM B, V113, P12759, DOI 10.1021/jp903325z; KOLMOGOROV AN, 1991, P ROY SOC LOND A MAT, V434, P9, DOI 10.1098/rspa.1991.0075; KOLMOGOROV AN, 1991, P R SOC-MATH PHYS SC, V434, P15, DOI 10.1098/rspa.1991.0076; Landau L.D., 1987, PHYS TODAY, V6; Lesieur M, 2008, FLUID MECH APPL, V84, P1; Lindorff-Larsen K, 2005, TRENDS BIOCHEM SCI, V30, P13, DOI 10.1016/j.tibs.2004.11.008; Moon FC., 1992, CHAOTIC FRACTAL DYNA; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; Nemirovskii SK, 2013, PHYS REP, V524, P85, DOI 10.1016/j.physrep.2012.10.005; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Qiu LL, 2002, J AM CHEM SOC, V124, P12952, DOI 10.1021/ja0279141; Richardson L.F., 1922, WEATHER PREDICTION N, DOI DOI 10.1017/CBO9780511618291; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shea JE, 2001, ANNU REV PHYS CHEM, V52, P499, DOI 10.1146/annurev.physchem.52.1.499; TOMITA K, 1974, PROG THEOR PHYS, V51, P1731, DOI 10.1143/PTP.51.1731; VanKampen N. G., 1992, STOCHASTIC PROCESSES, V1; Yaglom A. M, 1975, STAT FLUID MECH 2; Zakharov V., 1992, KOLMOGOROV SPECTRA T; Zheng WH, 2011, J PHYS CHEM B, V115, P1512, DOI 10.1021/jp1089596; Zhou RH, 2003, P NATL ACAD SCI USA, V100, P13280, DOI 10.1073/pnas.2233312100	47	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188659	10.1371/journal.pone.0188659	http://dx.doi.org/10.1371/journal.pone.0188659			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206845	gold, Green Submitted, Green Published			2022-12-27	WOS:000417110700016
J	Ordonez, A; Kennedy, EV; Diaz-Pulido, G				Ordonez, Alexandra; Kennedy, Emma V.; Diaz-Pulido, Guillermo			Reduced spore germination explains sensitivity of reef-building algae to climate change stressors	PLOS ONE			English	Article							CRUSTOSE CORALLINE ALGAE; OCEAN ACIDIFICATION; PARTIAL-PRESSURE; LOWERED PH; RESPONSES; CO2; TEMPERATURE; CALCIFICATION; RECRUITMENT; SETTLEMENT	Reduced seawater pH and changes in carbonate chemistry associated with ocean acidification (OA) decrease the recruitment of crustose coralline algae (CCAcf.), an important coralreef builder. However, it is unclear whether the observed decline in recruitment is driven by impairment of spore germination, or post-settlement processes (e.g. space competition). To address this, we conducted an experiment using a dominant CCA, Porolithon cf. onkodes to test the independent and combined effects of OA, warming, and irradiance on its germination success and early development. Elevated CO2 negatively affected several processes of spore germination, including formation of the germination disc, initial growth, and germling survival. The magnitude of these effects varied depending on the levels of temperature and irradiance. For example, the combination of high CO2 and high temperature reduced formation of the germination disc, but this effect was independent of irradiance levels, while spore abnormalities increased under high CO2 and high temperature particularly in combination with low irradiance intensity. This study demonstrates that spore germination of CCA is impacted by the independent and interactive effects of OA, increasing seawater temperature and irradiance intensity. For the first time, this provides a mechanism for how the sensitivity of critical early life history processes to global change may drive declines of adult populations of key marine calcifiers.	[Ordonez, Alexandra; Kennedy, Emma V.; Diaz-Pulido, Guillermo] Griffith Univ, Griffith Sch Environm, Nathan Campus, Brisbane, Qld, Australia; [Ordonez, Alexandra; Kennedy, Emma V.; Diaz-Pulido, Guillermo] Griffith Univ, Australian Rivers Inst, Nathan Campus, Brisbane, Qld, Australia; [Diaz-Pulido, Guillermo] ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia	Griffith University; Griffith University	Diaz-Pulido, G (corresponding author), Griffith Univ, Griffith Sch Environm, Nathan Campus, Brisbane, Qld, Australia.; Diaz-Pulido, G (corresponding author), Griffith Univ, Australian Rivers Inst, Nathan Campus, Brisbane, Qld, Australia.; Diaz-Pulido, G (corresponding author), ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.	g.diaz-pulido@griffith.edu.au	Diaz-Pulido, Guillermo/B-3648-2013; Kennedy, Emma V/M-3193-2014	Kennedy, Emma V/0000-0003-1821-9740; Diaz-Pulido, Guillermo/0000-0002-0901-3727	Australian Research Council [DP-120101778]; Great Barrier Reef Foundation	Australian Research Council(Australian Research Council); Great Barrier Reef Foundation	This project was funded by the Australian Research Council (DP-120101778) and the Great Barrier Reef Foundation through grants awarded to GDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey W.H., 1975, Atoll Res Bull, VNo. 187, P1; Adey W.H., 1982, SMITHSONIAN CONTRIBU, V15; ADEY WH, 1970, J PHYCOL, V6, P269, DOI 10.1111/j.0022-3646.1970.00269.x; Adey WH, 1998, J PHYCOL, V34, P393, DOI 10.1046/j.1529-8817.1998.340393.x; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Bertness M.D., 2001, MARINE COMMUNITY ECO; BOSENCE DWJ, 1983, J GEOL SOC LONDON, V140, P365, DOI 10.1144/gsjgs.140.3.0365; Bradassi F, 2013, MAR BIOL, V160, P2261, DOI 10.1007/s00227-013-2260-2; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Byrne M, 2011, P ROY SOC B-BIOL SCI, V278, P2376, DOI 10.1098/rspb.2010.2404; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; CHIHARA M, 1974, J PHYCOL, V10, P266, DOI 10.1111/j.1529-8817.1974.tb02712.x; Comeau S, 2013, LIMNOL OCEANOGR, V58, P388, DOI 10.4319/lo.2013.58.1.0388; Comeau S, 2014, J EXP MAR BIOL ECOL, V453, P28, DOI 10.1016/j.jembe.2013.12.013; Connell SD, 2010, P R SOC B; Cornwall CE, 2012, J PHYCOL, V48, P137, DOI 10.1111/j.1529-8817.2011.01085.x; Dean AJ, 2015, CORAL REEFS, V34, P581, DOI 10.1007/s00338-015-1263-5; Diaz-Pulido G, 2005, J EXP MAR BIOL ECOL, V317, P13, DOI 10.1016/j.jembe.2004.11.013; Diaz-Pulido G, 2010, CORAL REEFS, V29, P203, DOI 10.1007/s00338-009-0573-x; Diaz-Pulido G, 2016, CORAL REEFS, P1; Diaz-Pulido G, 2012, J PHYCOL, V48, P32, DOI 10.1111/j.1529-8817.2011.01084.x; Diaz-Pulido G, 2011, ECOL LETT, V14, P156, DOI 10.1111/j.1461-0248.2010.01565.x; Doropoulos C, 2012, ECOL LETT, V15, P338, DOI 10.1111/j.1461-0248.2012.01743.x; Fabricius KE, 2015, SCI REP-UK, V5, DOI 10.1038/srep09537; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Gao KS, 2010, GLOBAL CHANGE BIOL, V16, P2388, DOI 10.1111/j.1365-2486.2009.02113.x; Gattuso J.P., 2010, GUIDE BEST PRACTICES; Greer SP, 2002, J PHYCOL, V38, P116, DOI 10.1046/j.1529-8817.2002.00178.x; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Harvey A.S., 2005, CORALLINE ALGAE CENT; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Ichiki Shigeo, 2000, Phycological Research, V48, P115, DOI 10.1046/j.1440-1835.2000.00193.x; Irvine LM, 1994, SEAWEEDS BRIT IS 2 B, V1; Johnson MD, 2012, J EXP MAR BIOL ECOL, V434, P94, DOI 10.1016/j.jembe.2012.08.005; Johnson MD, 2014, PEERJ, V2, DOI 10.7717/peerj.411; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Jones W. E., 1973, MBAI SPECIAL PUBLICA, V1, P293; Kamenos NA, 2004, J EXP MAR BIOL ECOL, V313, P241, DOI 10.1016/j.jembe.2004.08.007; KENDRICK GA, 1991, J EXP MAR BIOL ECOL, V147, P47, DOI 10.1016/0022-0981(91)90036-V; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kubler JE, 1999, PLANT CELL ENVIRON, V22, P1303, DOI 10.1046/j.1365-3040.1999.00492.x; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Littler M. M, 1972, OCEANOGR MAR BIOL, V10, P103; LITTLER MM, 1975, J ECOL, V63, P117, DOI 10.2307/2258846; LUNING K, 1984, HELGOLANDER MEERESUN, V38, P305, DOI 10.1007/BF01997486; Maneveldt GW, 2014, TAXONOMIC REV BASED, V190, P34; Marcos Alvarez A, 2016, THESIS; Martin S, 2013, ECOL EVOL, V3, P676, DOI 10.1002/ece3.475; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; McCoy SJ, 2014, NAT CLIM CHANGE, V4, P719, DOI 10.1038/NCLIMATE2273; MEDFORD JI, 1992, PLANT CELL, V4, P631, DOI 10.1105/tpc.4.6.631; Morse JW, 2006, GEOCHIM COSMOCHIM AC, V70, P5814, DOI 10.1016/j.gca.2006.08.017; Myhre G., 2013, CONTRIBUTION WORKING; Noisette F, 2013, J EXP MAR BIOL ECOL, V448, P179, DOI 10.1016/j.jembe.2013.07.006; NORTON TA, 1992, BRIT PHYCOL J, V27, P293, DOI 10.1080/00071619200650271; Ordonez A, 2014, BIOL BULL-US, V226, P255, DOI 10.1086/BBLv226n3p255; Pfister CA, 2016, P R SOC B, V283; Porzio L, 2011, J EXP MAR BIOL ECOL, V400, P278, DOI 10.1016/j.jembe.2011.02.011; Price N, 2010, OECOLOGIA, V163, P747, DOI 10.1007/s00442-010-1578-4; Price NN, 2011, MAR ECOL PROG SER, V440, P67, DOI 10.3354/meps09309; Ragazzola F, 2012, GLOBAL CHANGE BIOL, V18, P2804, DOI 10.1111/j.1365-2486.2012.02756.x; Raven JA, 2003, PHOTOSYNTH RES, V77, P155, DOI 10.1023/A:1025877902752; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Ringeltaube P, 2005, BOT MAR, V43, P409; Roleda MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140394; Roleda MY, 2012, J PHYCOL, V48, P840, DOI 10.1111/j.1529-8817.2012.01195.x; Roleda MY, 2012, GLOBAL CHANGE BIOL, V18, P854, DOI 10.1111/j.1365-2486.2011.02594.x; Rosler A, 2016, J PHYCOL, V52, P412, DOI 10.1111/jpy.12404; SANTELICES B, 1990, OCEANOGR MAR BIOL, V28, P177; Santelices B, 1999, J PHYCOL, V35, P1127, DOI 10.1046/j.1529-8817.1999.3561127.x; Semesi IS, 2009, ESTUAR COAST SHELF S, V84, P337, DOI 10.1016/j.ecss.2009.03.038; Short JA, 2015, ESTUAR COAST SHELF S, V164, P463, DOI 10.1016/j.ecss.2015.08.006; SOROKIN C, 1962, NATURE, V194, P496, DOI 10.1038/194496a0; Underwood AJ, 1996, EXPT ECOLOGY; Wallace D, 2006, MS EXCEL PROGRAM DEV; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x	78	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189122	10.1371/journal.pone.0189122	http://dx.doi.org/10.1371/journal.pone.0189122			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206887	Green Published, gold, Green Submitted			2022-12-27	WOS:000417110700050
J	Cortes-Hernandez, P; Dominguez-Ramirez, L				Cortes-Hernandez, Paulina; Dominguez-Ramirez, Lenin			Role of cis-trans proline isomerization in the function of pathogenic enterobacterial Periplasmic Binding Proteins	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; SIDE-CHAIN; ARGININE; LYSINE; TRANSPORTER; HISTIDINE; SOFTWARE; MOTIONS; SYSTEMS	Periplasmic Binding Proteins (PBPs) trap nutrients for their internalization into bacteria by ABC transporters. Ligand binding triggers PBP closure by bringing its two domains together like a Venus flytrap. The atomic determinants that control PBP opening and closure for nutrient capture and release are not known, although it is proposed that opening and ligand release occur while in contact with the ABC transporter for concurrent substrate translocation. In this paper we evaluated the effect of the isomerization of a conserved proline, located near the binding site, on the propensity of PBPs to open and close. ArgT/LAO from Salmonella typhimurium and HisJ from Escherichia coli were studied through molecular mechanics at two different temperatures: 300 and 323 K. Eight microseconds were simulated per protein to analyze protein opening and closure in the absence of the ABC transporter. We show that when the studied proline is in trans, closed empty LAO and HisJ can open. In contrast, with the proline in cis, opening transitions were much less frequent and characterized by smaller changes. The proline in trans also renders the open trap prone to close over a ligand. Our data suggest that the isomerization of this conserved proline modulates the PBP mechanism: the proline in trans allows the exploration of conformational space to produce trap opening and closure, while in cis it restricts PBP movement and could limit ligand release until in productive contact with the ABC transporter. This is the first time that a proline isomerization has been related to the control of a large conformational change like the PBP flytrap mechanism.	[Cortes-Hernandez, Paulina] IMSS, Ctr Invest Biomed Oriente CIBIOR, Puebla, Mexico; [Dominguez-Ramirez, Lenin] Univ Amer Puebla UDLAP, Chem & Biol Sci, Puebla, Mexico	Universidad Americas Puebla (UDLAP)	Dominguez-Ramirez, L (corresponding author), Univ Amer Puebla UDLAP, Chem & Biol Sci, Puebla, Mexico.	julio.dominguez@udlap.mx	Cortes-Hernandez, Paulina/GLQ-5915-2022; Dominguez-Ramirez, Lenin/AAG-9864-2020; Cortes-Hernandez, Paulina/ABC-1133-2020	Dominguez-Ramirez, Lenin/0000-0002-3483-4658; Cortes-Hernandez, Paulina/0000-0001-8226-1703	NVIDIA Corporation; CONACyT Basic Science grant [CB2014-2429]	NVIDIA Corporation; CONACyT Basic Science grant	NVIDIA Corporation provided material support for this study by donating the Tesla K40 GPU used for this research. Lenin Dominguez-Ramirez is supported by a CONACyT Basic Science grant (CB2014-2429). We, the authors, declare that the funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Best RB, 2013, P NATL ACAD SCI USA, V110, P17874, DOI 10.1073/pnas.1311599110; Biegert A, 2009, P NATL ACAD SCI USA, V106, P3770, DOI 10.1073/pnas.0810767106; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho SS, 2006, P NATL ACAD SCI USA, V103, P586, DOI 10.1073/pnas.0509768103; Chu BCH, 2014, PROTEINS, V82, P386, DOI 10.1002/prot.24396; Chu BCH, 2013, J BIOL CHEM, V288, P31409, DOI 10.1074/jbc.M113.490441; Dodge RW, 1996, BIOCHEMISTRY-US, V35, P1548, DOI 10.1021/bi952348q; DOIGE CA, 1993, ANNU REV MICROBIOL, V47, P291, DOI 10.1146/annurev.micro.47.1.291; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Hardin C, 1999, PROTEINS, V34, P281; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Koukos PI, 2013, J COMPUT CHEM, V34, P2310, DOI 10.1002/jcc.23381; Liu PQ, 1998, P NATL ACAD SCI USA, V95, P3495, DOI 10.1073/pnas.95.7.3495; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Merdanovic M, 2011, ANNU REV MICROBIOL, V65, P149, DOI 10.1146/annurev-micro-090110-102925; Miot M, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-4; OH BH, 1993, J BIOL CHEM, V268, P11348; OH BH, 1994, J BIOL CHEM, V269, P26323; Okazaki K, 2006, P NATL ACAD SCI USA, V103, P11844, DOI 10.1073/pnas.0604375103; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; ONUCHIC JN, 1995, P NATL ACAD SCI USA, V92, P3626, DOI 10.1073/pnas.92.8.3626; Pang A, 2005, PROTEINS, V61, P809, DOI 10.1002/prot.20672; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Rice AJ, 2014, CRIT REV BIOCHEM MOL, V49, P426, DOI 10.3109/10409238.2014.953626; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Schmidpeter PAM, 2015, BBA-GEN SUBJECTS, V1850, P1973, DOI 10.1016/j.bbagen.2014.12.019; Schneider E, 2012, EUR J CELL BIOL, V91, P311, DOI 10.1016/j.ejcb.2011.02.008; Silva DA, 2011, PROTEINS, V79, P2097, DOI 10.1002/prot.23030; Silva DA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002054; Stockner T, 2005, BIOPHYS J, V89, P3362, DOI 10.1529/biophysj.105.069443; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; Yamada KD, 2016, BIOINFORMATICS, V32, P3246, DOI 10.1093/bioinformatics/btw412; Yang AYC, 2008, J COMPUT AID MOL DES, V22, P799, DOI 10.1007/s10822-008-9215-6; YAO NH, 1994, BIOCHEMISTRY-US, V33, P4769, DOI 10.1021/bi00182a004	38	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188935	10.1371/journal.pone.0188935	http://dx.doi.org/10.1371/journal.pone.0188935			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190818	gold, Green Submitted, Green Published			2022-12-27	WOS:000416841900173
J	Li, Z; Sun, DY; Zhu, RQ; Lin, ZH				Li, Ze; Sun, Duoyong; Zhu, Renqi; Lin, Zihan			Detecting event-related changes in organizational networks using optimized neural network models	PLOS ONE			English	Article							ALGORITHM	Organizational external behavior changes are caused by the internal structure and interactions. External behaviors are also known as the behavioral events of an organization. Detecting event-related changes in organizational networks could efficiently be used to monitor the dynamics of organizational behaviors. Although many different methods have been used to detect changes in organizational networks, these methods usually ignore the correlation between the internal structure and external events. Event-related change detection considers the correlation and could be used for event recognition based on social network modeling and supervised classification. Detecting event-related changes could be effectively useful in providing early warnings and faster responses to both positive and negative organizational activities. In this study, event-related change in an organizational network was defined, and artificial neural network models were used to quantitatively determine whether and when a change occurred. To achieve a higher accuracy, Back Propagation Neural Networks (BPNNs) were optimized using Genetic Algorithms (GAs) and Particle Swarm Optimization (PSO). We showed the feasibility of the proposed method by comparing its performance with that of other methods using two cases. The results suggested that the proposed method could identify organizational events based on a correlation between the organizational networks and events. The results also suggested that the proposed method not only has a higher precision but also has a better robustness than the previously used techniques.	[Li, Ze; Sun, Duoyong; Zhu, Renqi; Lin, Zihan] Natl Univ Def Technol, Coll Informat Syst & Management, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Li, Z (corresponding author), Natl Univ Def Technol, Coll Informat Syst & Management, Changsha, Hunan, Peoples R China.	plalize@nudt.edu.cn			National Natural Science Foundation of China [71473263]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20134307110020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Natural Science Foundation of China (Grant no. 71473263) to Duoyong Sun. The Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant no. 20134307110020) to Duoyong Sun.	[Anonymous], 2004, WASHINGTON POST; ARTIS JJ, 2009, J JAY ARTIS TRANSNAT; Asur S, 2009, ACM T KNOWL DISCOV D, V3, DOI 10.1145/1631162.1631164; Ball B, 2011, CONTEMP SOCIOL, V84, P109; Brelger R, 2004, DYNAMIC SOCIAL NETWO, P423; Carley KM, 2009, ORA USERS GUIDE 2009; Carrington PJ, 2005, MODELS METHODS SOCIA, P118; Clauset A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048633; Crenshaw M, 1998, P NATL ACAD SCI USA, V98, P15056; Dandy GC, 1996, WATER RESOUR RES, V32, P449, DOI 10.1029/95WR02917; Du B, 2016, CATCH ME IF YOU CAN, P87; Eberhart R., 1995, P MHS 95 P 6 INT S M, P39, DOI DOI 10.1109/MHS.1995.494215; Gao Y, 2014, NETWORK TRAFFIC PRED; Gupta M, 2012, COMMUNITY TREND OUTL, P692; Heard NA, 2010, ANN APPL STAT, V4, P645, DOI 10.1214/10-AOAS329; Huayu S., 2008, J TIANJIN U TECHNOL, V5, P13; Li S, 2016, DETECTING WEAK CHANG; Liu B, 2007, IEEE T SYST MAN CY B, V37, P18, DOI 10.1109/TSMCB.2006.883272; Mannes A, 2013, INDIAN MUJAHIDEEN CO; Mcculloh I, 2008, DETECTING CHANGE LON; McCulloh I, 2007, SOCIAL NETWORK MONIT; Medina R, 2008, GEOSPATIAL ANAL DYNA; Meng X, 2007, BP NETWORK OPTIMIZED, P1630; Najgebauer A., 2008, J TELECOMMUNICATIONS, V2008, P14; Peel L, 2015, AAAI CONF ARTIF INTE, P2914; Prasad NR, 2009, CMC-COMPUT MATER CON, V14, P1, DOI 10.1145/1541880.1541882; Priebe C. Y., 2005, Computational & Mathematical Organization Theory, V11, P229, DOI 10.1007/s10588-005-5378-z; Qiu MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155133; Raghavan V, 2013, ANN APPL STAT, V7, P2402, DOI 10.1214/13-AOAS682; Rong FU, 2009, RENEWABLE ENERGY RES; Sarevska M., 2004, GENERALIZATION CAPAB; Shazwani S, 2016, PLOS ONE, V11; Shetty J., 2004, ENRON EMAIL DATASET; Silva J, 2008, 2008 42ND ANNUAL CONFERENCE ON INFORMATION SCIENCES AND SYSTEMS, VOLS 1-3, P636, DOI 10.1109/CISS.2008.4558601; Sliva A, 2009, MATHEMATICAL METHODS IN COUNTERTERRORISM, P253, DOI 10.1007/978-3-211-09442-6_15; Snijders T, 2000, SIMULATION STAT INFE, P493; Subrahmanian VS, 2013, JAPANESE J ED PSYCHO, V37, P67; Sun JM, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P687; Vigliotti MG, 2015, SOC NETWORKS, V41, P18, DOI 10.1016/j.socnet.2014.12.001; Wang JZ, 2010, ENERGY, V35, P1671, DOI 10.1016/j.energy.2009.12.015; Wu Bin, 2011, Journal of Software, V22, P1488, DOI 10.3724/SP.J.1001.2011.03841; Xue A, 2011, TERRORIST ORG BEHAV, P332; Zhao Xin, 2009, Computer Engineering and Applications, V45, P53, DOI 10.3778/j.issn.1002-8331.2009.26.015	43	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188733	10.1371/journal.pone.0188733	http://dx.doi.org/10.1371/journal.pone.0188733			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190799	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900111
J	Merino, I; Porter, SB; Johnston, BD; Clabots, C; Shaw, E; Horcajada, JP; Canton, R; Ruiz-Garbajosa, P; Johnson, JR				Merino, Irene; Porter, Stephen B.; Johnston, Brian D.; Clabots, Connie; Shaw, Evelyn; Pablo Horcajada, Juan; Canton, Rafael; Ruiz-Garbajosa, Patricia; Johnson, James R.		ITUBRAS-GEIH Grp	Virulence genes and subclone status as markers of experimental virulence in a murine sepsis model among Escherichia coli sequence type 131 clinical isolates from Spain	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; MULTIDRUG-RESISTANT; H30-RX SUBCLONES; UNITED-STATES; E. COLI; URINARY; ST131; INFECTIONS; STRAINS; TRAITS	Objective To assess experimental virulence among sequence type 131 (ST131) Escherichia coli bloodstream isolates in relation to virulence genotype and subclone. Methods We analysed 48 Spanish ST131 bloodstream isolates (2010) by PCR for ST131 subclone status (H30Rx, H30 non-Rx, or non-H30), virulence genes (VGs), and O-type. Then we compared these traits with virulence in a murine sepsis model, as measured by illness severity score (ISS) and rapid lethality (mean ISS >= 4). Results Of the 48 study isolates, 65% were H30Rx, 21% H30 non-Rx, and 15% non-H30; 44% produced ESBLs, 98% were O25b, and 83% qualified as extraintestinal pathogenic E. coli (ExPEC). Of 49 VGs, ibeA and iss were associated significantly with non-H30 isolates, and sat, iha and malX with H30 isolates. Median VG scores differed by subclone, i.e., 12 (H30Rx), 10 (H30 non-Rx), and 11 (non-H30) (p < 0.01). Nearly 80% of isolates represented a described virotype. In mice, H30Rx and non-H30 isolates were more virulent than H30 non-Rx isolates (according to ISS [p = 0.03] and rapid lethality [p = 0.03]), as were ExPEC isolates compared with non-ExPEC isolates (median ISS, 4.3 vs. 2.7: p = 0.03). In contrast, most individual VGs, VG scores, VG profiles, and virotypes were not associated with mouse virulence. Conclusions ST131 subclone and ExPEC status, but not individual VGs, VG scores or profiles, or virotypes, predicted mouse virulence. Given the lower virulence of non-Rx H30 isolates, hyper-virulence probably cannot explain the ST131-H30 clade's epidemic emergence.	[Merino, Irene; Canton, Rafael; Ruiz-Garbajosa, Patricia] Hosp Univ Ramon y Cajal, IRYCIS, Serv Microbiol, Madrid, Spain; [Merino, Irene; Shaw, Evelyn; Canton, Rafael; Ruiz-Garbajosa, Patricia] Spanish Network Res Infect Dis REIPI, Madrid, Spain; [Porter, Stephen B.; Clabots, Connie; Johnson, James R.] Minneapolis Vet Hlth Care Syst, Minneapolis, MN USA; [Johnston, Brian D.; Johnson, James R.] Univ Minnesota, Minneapolis, MN USA; [Shaw, Evelyn] Hosp Univ Bellvitge, IDIBELL, Serv Enfermedades Infecciosas, Barcelona, Spain; [Pablo Horcajada, Juan] CEXS Univ Pompeu Fabra, Hosp del Mar, Med Res Inst Hosp del Mar IMIM, Barcelona, Spain	Hospital Universitario Ramon y Cajal; University of Minnesota System; University of Minnesota Twin Cities; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University	Ruiz-Garbajosa, P (corresponding author), Hosp Univ Ramon y Cajal, IRYCIS, Serv Microbiol, Madrid, Spain.; Ruiz-Garbajosa, P (corresponding author), Spanish Network Res Infect Dis REIPI, Madrid, Spain.	pruizg@salud.madrid.org	Merino, Irene/P-5874-2017; Horcajada, Juan P./AAU-7717-2021; CANTON, RAFAEL/ABF-6353-2020; Cantón, Rafael/AAP-8669-2021	Merino, Irene/0000-0001-5841-7392; Horcajada, Juan P./0000-0001-9873-5459; Canton, Rafael/0000-0003-1675-3173; Shaw, Evelyn/0000-0002-1882-1259	Instituto de Salud Carlos III of Spain [PI13/02092]; Spanish Network for Research in Infectious Diseases or REIPI [RD12/0015/0004, RD16/0016/0011]; European Development Regional Fund (ERDF); REIPI [RD12/0015/0004]; Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Ayuda a la formacion de la SEIMC, IMV); Office of Research and Development, Medical Research Service, Department of Veterans Affairs [1 I01 CX000192 01]; Veterans Affairs [I01CX000920] Funding Source: NIH RePORTER	Instituto de Salud Carlos III of Spain(Instituto de Salud Carlos III); Spanish Network for Research in Infectious Diseases or REIPI; European Development Regional Fund (ERDF)(European Commission); REIPI; Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Ayuda a la formacion de la SEIMC, IMV); Office of Research and Development, Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Instituto de Salud Carlos III of Spain (www.isciii.es) with the grant PI13/02092; and Spanish Network for Research in Infectious Diseases or REIPI (www.reipi.org): RD12/0015/0004 and RD16/0016/0011; and co-financed by the European Development Regional Fund (ERDF), "A Way to Achieve Europe". IMV is supported by a research contract from the REIPI (RD12/0015/0004). Part of this work was supported by a grant from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Ayuda a la formacion de la SEIMC 2014, IMV). This material also is based partly upon work supported by Office of Research and Development, Medical Research Service, Department of Veterans Affairs, grant # 1 I01 CX000192 01 (JRJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghoribi MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101547; Ben Zakour NL, 2016, MBIO, V7, P1, DOI DOI 10.3391/mbi.2016.7.1.01; Blanco J, 2013, J CLIN MICROBIOL, V51, P3358, DOI 10.1128/JCM.01555-13; Burgess MJ, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv011; Ciesielczuk H, 2015, VIRULENCE, V6, P145, DOI 10.4161/21505594.2014.988095; Clermont O, 2008, J ANTIMICROB CHEMOTH, V61, P1024, DOI 10.1093/jac/dkn084; Dahbi G, 2014, INT J MED MICROBIOL, V304, P1247, DOI 10.1016/j.ijmm.2014.10.002; Horcajada JP, 2013, CLIN MICROBIOL INFEC, V19, P962, DOI 10.1111/1469-0691.12089; Johnson JR, 2006, J INFECT DIS, V194, P1141, DOI 10.1086/507305; Johnson JR, 2014, J CLIN MICROBIOL, V52, P1358, DOI 10.1128/JCM.03502-13; Johnson JR, 2012, ANTIMICROB AGENTS CH, V56, P2364, DOI 10.1128/AAC.05824-11; Johnson JR, 2012, INFECT IMMUN, V80, P1554, DOI 10.1128/IAI.06388-11; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Johnson JR, 2009, ANTIMICROB AGENTS CH, V53, P2733, DOI 10.1128/AAC.00297-09; Johnson JR, 2004, J INFECT DIS, V190, P1739, DOI 10.1086/425018; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Lahlaoui H, 2014, MED MALADIES INFECT, V44, P400, DOI 10.1016/j.medmal.2014.03.010; Lavigne JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034294; Merino I, 2016, J ANTIMICROB CHEMOTH, V71, P2125, DOI 10.1093/jac/dkw133; Mora A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087025; Moreno E, 2008, J CLIN MICROBIOL, V46, P2529, DOI 10.1128/JCM.00813-08; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Olesen B, 2014, ANTIMICROB AGENTS CH, V58, P6886, DOI 10.1128/AAC.03679-14; Park Hae-Kyung, 2011, Journal of Bacteriology and Virology, V41, P245; Peirano G, 2014, EMERG INFECT DIS, V20, P1928, DOI 10.3201/eid2011.141388; Peirano G, 2014, ANTIMICROB AGENTS CH, V58, P3762, DOI 10.1128/AAC.02428-14; Peirano G, 2010, INT J ANTIMICROB AG, V35, P316, DOI 10.1016/j.ijantimicag.2009.11.003; Vimont S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046547	28	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188838	10.1371/journal.pone.0188838	http://dx.doi.org/10.1371/journal.pone.0188838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190804	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900139
J	Sasabe, E; Tomomura, A; Tomita, R; Sento, S; Kitamura, N; Yamamoto, T				Sasabe, Eri; Tomomura, Ayumi; Tomita, Riki; Sento, Shinya; Kitamura, Naoya; Yamamoto, Tetsuya			Ephrin-B2 reverse signaling regulates progression and lymph node metastasis of oral squamous cell carcinoma	PLOS ONE			English	Article							EPH RECEPTORS; CANCER-CELLS; SOLID TUMORS; NECK; HEAD; EXPRESSION; GROWTH; PHOSPHORYLATION; ANGIOGENESIS; INHIBITION	Oral squamous cell carcinoma (OSCC) is a common malignant tumor of the head and neck and frequently metastasizes to cervical lymph nodes. Aggressive local invasion and metastasis of OSCC are significant factors for poor prognosis. In this study, we investigated whether ephrin-B2 expressed in OSCC contributed to tumor progression and lymph node metastasis. Clinical specimens from patients with OSCC had robust ephrin-B2-positive tumor cells and ephrin-B2 protein level was associated with clinical stage, lymph node metastasis, and poor survival outcomes. We also determined that ephrin-B2 protein level was increased in OSCC cell lines compared to normal human oral keratinocytes and that its levels were associated with the migratory and invasive potential of OSCC cell lines. Transfection of an EFNB2-specific small interfering RNA (siRNA) into SAS-L1 cells significantly reduced proliferation, attachment, migration, and invasion through phosphorylation of the epidermal growth factor receptor, FAK, ERK1/2, p38, AKT, and JNK1/2 pathways. Furthermore, knockdown of EFNB2 significantly suppressed adhesion and transmigration of SAS-L1 cells toward human lymphatic endothelial cells. In addition, the growth rate of tumor xenografts and cervical lymph node metastases of OSCC were suppressed by local injection of EFNB2 siRNA. These results suggest that ephrin-B2 overexpression and activation of the ephrin-B2 reverse signaling pathway in tumor microenvironment in OSCC facilitates progression and lymph node metastasis via enhancement of malignant potential and interaction with surrounding cells.	[Sasabe, Eri; Tomomura, Ayumi; Tomita, Riki; Sento, Shinya; Kitamura, Naoya; Yamamoto, Tetsuya] Kochi Univ, Kochi Med Sch, Dept Oral & Maxillofacial Surg, Oko Cho, Nankoku, Kochi, Japan	Kochi University	Sasabe, E (corresponding author), Kochi Univ, Kochi Med Sch, Dept Oral & Maxillofacial Surg, Oko Cho, Nankoku, Kochi, Japan.	yoshieri@kochi-u.ac.jp		Sasabe, Eri/0000-0001-6865-1772	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23792353]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (23792353). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bochenek ML, 2010, J CELL SCI, V123, P1235, DOI 10.1242/jcs.061903; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Chiu YW, 2016, LAB INVEST, V96, P296, DOI 10.1038/labinvest.2015.151; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; da Silva SD, 2011, ORAL ONCOL, V47, P783, DOI 10.1016/j.oraloncology.2011.07.004; Daar IO, 2012, SEMIN CELL DEV BIOL, V23, P65, DOI 10.1016/j.semcdb.2011.10.012; Ferguson BD, 2014, GROWTH FACTORS, V32, P202, DOI 10.3109/08977194.2014.980904; Fujimoto R., 2004, J JPN ORAL MUCO MEMB, V8, P1, DOI [10.6014/jjomm1995.8.1, DOI 10.6014/jjomm1995.8.1]; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kimura M, 2009, INT J ONCOL, V34, P321, DOI 10.3892/ijo_00000154; Koo BS, 2015, ONCOGENE, V34, P2317, DOI 10.1038/onc.2014.174; Liao CT, 2012, ORAL ONCOL, V48, P329, DOI 10.1016/j.oraloncology.2011.10.017; Martiny-Baron G, 2004, NEOPLASIA, V6, P248, DOI 10.1593/neo.03457; Masood R, 2006, INT J CANCER, V119, P1236, DOI 10.1002/ijc.21926; Meyer S, 2005, INT J ONCOL, V27, P1197; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mydlarz Wojciech K, 2010, Expert Opin Med Diagn, V4, P53; Nakada M, 2010, INT J CANCER, V126, P1155, DOI 10.1002/ijc.24849; Noguti J, 2012, CANCER GENOM PROTEOM, V9, P329; Noren NK, 2004, P NATL ACAD SCI USA, V101, P5583, DOI 10.1073/pnas.0401381101; Oku N, 2006, CANCER RES, V66, P5251, DOI 10.1158/0008-5472.CAN-05-4478; Okura M, 2009, ORAL ONCOL, V45, P908, DOI 10.1016/j.oraloncology.2009.03.013; OSAKI T, 1994, ORAL ONCOL, V30B, P296, DOI 10.1016/0964-1955(94)90028-0; Oweida A, 2017, MOL CARCINOGEN, V56, P1189, DOI 10.1002/mc.22574; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Rutkowski R, 2012, INT J CANCER, V131, pE614, DOI 10.1002/ijc.27392; Salvucci O, 2009, BLOOD, V114, P1707, DOI 10.1182/blood-2008-12-192294; Sasabe E, 2007, INT J CANCER, V120, P268, DOI 10.1002/ijc.22294; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Shintani S, 2002, ORAL ONCOL, V38, P664, DOI 10.1016/S1368-8375(01)00131-2; SINHA UK, 2003, ENT-EAR NOSE THROAT, V82, P869; Tanaka M, 2005, EMBO J, V24, P3700, DOI 10.1038/sj.emboj.7600831; Tanaka M, 2007, J CELL SCI, V120, P2179, DOI 10.1242/jcs.008607; Vihanto MM, 2005, FASEB J, V19, P1689, DOI 10.1096/fj.04-3647fje; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wei S, 2010, DEV CELL, V19, P345, DOI 10.1016/j.devcel.2010.07.012; XIE X, 1992, CLIN EXP METASTAS, V10, P201, DOI 10.1007/BF00132752; Yavrouian EJ, 2008, ARCH OTOLARYNGOL, V134, P985, DOI 10.1001/archotol.134.9.985	41	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188965	10.1371/journal.pone.0188965	http://dx.doi.org/10.1371/journal.pone.0188965			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190834	gold, Green Published, Green Submitted			2022-12-27	WOS:000416841900180
J	Yadav, K; Patel, P; Srivastava, AK; Ganapathi, TR				Yadav, Karuna; Patel, Prashanti; Srivastava, Ashish Kumar; Ganapathi, T. R.			Overexpression of native ferritin gene MusaFer1 enhances iron content and oxidative stress tolerance in transgenic banana plants	PLOS ONE			English	Article							EXPRESSION PROFILES; NITRIC-OXIDE; ARABIDOPSIS-THALIANA; MINERAL-COMPOSITION; ZINC ACCUMULATION; SOYBEAN FERRITIN; MESSENGER-RNA; RICE; HOMEOSTASIS; RESPONSES	Iron is an indispensable element for plant growth and defense and hence it is essential to improve the plant's ability to accumulate iron. Besides, it is also an important aspect for human health. In view of this, we attempted to increase the iron content in banana cultivar Rasthali using MusaFer1 as a candidate gene. Initially, the expression of all five genes of the MusaFer family (MusaFer1-5) was quantified under iron-excess and -deficient conditions. The supplementation of 250 and 350 mu M iron enhanced expression of all MusaFer genes; however, MusaFer1 was increased maximally by 2- and 4-fold in leaves and roots respectively. Under iron deficient condition, all five MusaFer genes were downregulated, indicating their iron dependent regulation. In MusaFer1 overexpressing lines, iron content was increased by 2- and 3-fold in leaves and roots respectively, as compared with that of untransformed lines. The increased iron was mainly localized in the epidermal regions of petiole. The analysis of MusaFer1 promoter indicated that it might control the expression of iron metabolism related genes and also other genes of MusaFer family. MusaFer1 overexpression led to downregulated expression of MusaFer3, MusaFer4 and MusaFer5 in transgenic leaves which might be associated with the plant's compensatory mechanism in response to iron flux. Other iron metabolism genes like Ferric reductase (FRO), transporters (IRT, VIT and YSL) and chelators (NAS, DMAS and NAAT) were also differentially expressed in transgenic leaf and root, suggesting the multifaceted impact of MusaFer1 towards iron uptake and organ distribution. Additionally, MusaFer1 overexpression increased plant tolerance against methyl viologen and excess iron which was quantified in terms of photosynthetic efficiency and malondialdehyde content. Thus, the study not only broadens our understanding about iron metabolism but also highlights MusaFer1 as a suitable candidate gene for iron fortification in banana.	[Yadav, Karuna; Patel, Prashanti; Ganapathi, T. R.] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Plant Cell Culture Technol Sect, Bombay, Maharashtra, India; [Srivastava, Ashish Kumar] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Plant Stress Physiol & Biotechnol Sect, Bombay, Maharashtra, India	Bhabha Atomic Research Center (BARC); Bhabha Atomic Research Center (BARC)	Ganapathi, TR (corresponding author), Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Plant Cell Culture Technol Sect, Bombay, Maharashtra, India.	trgana@barc.gov.in		Srivastava, Ashish Kumar/0000-0001-9863-528X	DBT-BIRAC	DBT-BIRAC	The authors received funding from DBT-BIRAC for conducting this work.	Badigannavar A, 2016, CROP J, V4, P61, DOI 10.1016/j.cj.2015.07.002; Beasley JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177061; Bouis HE, 2010, CROP SCI, V50, pS20, DOI 10.2135/cropsci2009.09.0531; Briat JF, 2010, ANN BOT-LONDON, V105, P811, DOI 10.1093/aob/mcp128; Bruce BD, 2001, BIOCH BIOPHYSIC 1212, P1541; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Camaschella C, 2016, POSTGRADUATE HAEMATOLOGY, 7TH EDITION, P21; CHANDRA RK, 1990, ANN NY ACAD SCI, V587, P9, DOI 10.1111/j.1749-6632.1990.tb00128.x; Cheng Z, 2002, ZHONGGUO SHUIDAO KEX, V17, P85; Deak M, 1999, NAT BIOTECHNOL, V17, P192, DOI 10.1038/6198; Dixit P, 2010, PLANT CELL ENVIRON, V33, P1697, DOI 10.1111/j.1365-3040.2010.02174.x; Drakakaki G, 2005, PLANT MOL BIOL, V59, P869, DOI 10.1007/s11103-005-1537-3; Ganapathi TR, 2001, PLANT CELL REP, V20, P157, DOI 10.1007/s002990000287; Gaymard F, 1996, BIOCHEM J, V318, P67, DOI 10.1042/bj3180067; Giehl RFH, 2012, PLANT CELL, V24, P33, DOI 10.1105/tpc.111.092973; Hardisson A, 2001, FOOD CHEM, V73, P153, DOI 10.1016/S0308-8146(00)00252-1; Huang X, 2004, PLANTA, V218, P938, DOI 10.1007/s00425-003-1178-1; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jin CW, 2009, PLANT PHYSIOL, V150, P272, DOI 10.1104/pp.109.136721; Jithesh MN, 2006, PLANT CELL REP, V25, P865, DOI 10.1007/s00299-006-0127-4; Kanobe MN, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00196; Kennedy BC, 2016, FETAL DEV, P295; Liu HJ, 2017, CHEMOSPHERE, V171, P240, DOI 10.1016/j.chemosphere.2016.12.081; Lopez-Bucio J, 2002, PLANT PHYSIOL, V129, P244, DOI 10.1104/pp.010934; Masuda H, 2013, FRONTIERS PLANT SCI, V4; Merchant SS, 2010, PLANT PHYSIOL, V154, P512, DOI 10.1104/pp.110.161810; Mukherjee I, 2006, PLANTA, V223, P1178, DOI 10.1007/s00425-005-0165-0; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murgia I, 2002, PLANT J, V30, P521, DOI 10.1046/j.1365-313X.2002.01312.x; Petit JM, 2001, BIOCHEM J, V359, P575, DOI 10.1042/0264-6021:3590575; Ravet K, 2009, PLANT J, V57, P400, DOI 10.1111/j.1365-313X.2008.03698.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shekhawat UKS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075506; Shekhawat UKS, 2011, PLANTA, V234, P915, DOI 10.1007/s00425-011-1455-3; Sreedharan S, 2012, PLANT MOL BIOL, V80, P503, DOI 10.1007/s11103-012-9964-4; Srivastava S, 2009, J EXP BOT, V60, P3419, DOI 10.1093/jxb/erp181; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Van Wuytswinkel O, 1999, PLANT J, V17, P93, DOI 10.1046/j.1365-313X.1999.00349.x; Vasconcelos M, 2003, PLANT SCI, V164, P371, DOI 10.1016/S0168-9452(02)00421-1; Wall MM, 2006, J FOOD COMPOS ANAL, V19, P434, DOI 10.1016/j.jfca.2006.01.002; Wang JW, 2005, PLANT CELL PHYSIOL, V46, P923, DOI 10.1093/pcp/pci098; Wang Minqi, 2013, FEATURES TREATMENT S, P4; Wintz H, 2003, J BIOL CHEM, V278, P47644, DOI 10.1074/jbc.M309338200; Xing CH, 2008, J ZHEJIANG UNIV-SC B, V9, P261, DOI 10.1631/jzus.B0710627	46	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188933	10.1371/journal.pone.0188933	http://dx.doi.org/10.1371/journal.pone.0188933			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190821	Green Submitted, gold, Green Published			2022-12-27	WOS:000416841900171
J	McGee, JA; Ergas, C; Greiner, PT; Clement, MT				McGee, Julius Alexander; Ergas, Christina; Greiner, Patrick Trent; Clement, Matthew Thomas			How do slums change the relationship between urbanization and the carbon intensity of well-being?	PLOS ONE			English	Article							LESS-DEVELOPED-COUNTRIES; ENERGY-CONSUMPTION; CHILD-MORTALITY; CO2 EMISSIONS; IMPACT; POPULATION; STIRPAT; WATER	This study examines how the relationship between urbanization (measured as the percentage of total population living in urban areas) and the carbon intensity of well-being (CIWB) (measured as a ratio of carbon dioxide emissions and life expectancy) in most nations from 1960-2013 varies based on the economic context and whereabouts of a substantial portion of a nation's urban population. To accomplish this, we use the United Nations' (UN) definition of slum households to identify developing countries that have substantial slum populations, and estimate a Prais-Winsten regression model with panel-corrected standard errors (PCSE), allowing for disturbances that are heteroskedastic and contemporaneously correlated across panels. Our findings indicate that the rate of increase in CIWB for countries without substantial slum populations begins to slow down at higher levels of urbanization, however, the association between urbanization and CIWB is much smaller in countries with substantial slum populations. Overall, while urbanization is associated with increases in CIWB, the relationship between urban development and CIWB is vastly different in developed nations without slums than in under-developed nations with slums.	[McGee, Julius Alexander] Portland State Univ, Dept Sociol, Portland, OR 97207 USA; [Ergas, Christina] Univ Tennessee, Dept Sociol, Knoxville, TN USA; [Greiner, Patrick Trent] Univ Oregon, Dept Sociol, Eugene, OR 97403 USA; [Clement, Matthew Thomas] Texas State Univ, Dept Sociol, San Marcos, TX USA	Portland State University; University of Tennessee System; University of Tennessee Knoxville; University of Oregon; Texas State University System; Texas State University San Marcos	McGee, JA (corresponding author), Portland State Univ, Dept Sociol, Portland, OR 97207 USA.	cjulius@pdx.edu						Al-mulali U, 2013, RENEW SUST ENERG REV, V23, P107, DOI 10.1016/j.rser.2013.02.041; Andrew K Jorgenson, 2015, PLOS ONE, V10; Andrew K. Jorgenson, 2015, PLOS ONE, V10; [Anonymous], 2002, BANGLADESH DEV STUDI, V28; BECK N, 1995, AM POLIT SCI REV, V89, P634, DOI 10.2307/2082979; Becker D.R., 2003, ENVIRON IMPACT ASSES, V23, P367, DOI 10.1016/S0195-9255(02)00098-7; Brady D., 2007, STUD COMP INT DEV, V42, P1; Brant Liddle, 2013, CONSUMPTION DRIVEN E; Brundtland G., 1987, OUR COMMON FUTURE, V383; Chun-yan R. E. N., 2006, INFLUENCE URBANIZATI, V25, P233; Creutzig F, 2015, P NATL ACAD SCI USA, V112, P6283, DOI 10.1073/pnas.1315545112; Davis M, 2017, PLANET SLUMS; Dietz T, 2012, APPL GEOGR, V32, P21, DOI 10.1016/j.apgeog.2010.10.011; Dinda S, 2004, ECOL ECON, V49, P431, DOI 10.1016/j.ecolecon.2004.02.011; Fan Y, 2006, ENVIRON IMPACT ASSES, V26, P377, DOI 10.1016/j.eiar.2005.11.007; Farmer P., 1999, INFECT INEQUALITIES; Givens J. E, 2016, HUMAN ECOLOGY REV, V22, P107; Jorgenson A., 2012, URBAN STUD, V49, P3495; Jorgenson A. K., 2010, ORG ENV, V23, P189; Jorgenson A. K., 2012, SOC SCI RES, V41, P242, DOI DOI 10.1016/J.SSRESEARCH; JORGENSON AK, 2005, AM J SOCIOL, V118, P1, DOI DOI 10.1086/665990; Jorgenson AK., 2015, J ENV STUDIES SCI, V5, P277, DOI [10.1007/s13412-015-0234-z, DOI 10.1007/S13412-015-0234-Z]; Jorgenson AK, 2007, ORGAN ENVIRON, V20, P137, DOI 10.1177/1086026607302153; Jorgenson AK, 2016, SUSTAIN DEV, V24, P53, DOI 10.1002/sd.1606; Jorgenson AK, 2014, NAT CLIM CHANGE, V4, P186, DOI 10.1038/NCLIMATE2110; Jorgenson AK, 2010, J POVERTY, V14, P382, DOI 10.1080/10875549.2010.517073; Liddle B, 2004, POPUL ENVIRON, V26, P23, DOI 10.1023/B:POEN.0000039951.37276.f3; Liddle B., 1989, J TRANSP GEOGR, V28, P22; Liddle B, 2014, POPUL ENVIRON, V35, P286, DOI 10.1007/s11111-013-0198-4; Martinez-Zarzoso I, 2011, ECOL ECON, V70, P1344, DOI 10.1016/j.ecolecon.2011.02.009; Menz T, 2011, POPUL ENVIRON, V33, P55, DOI 10.1007/s11111-011-0132-6; Mishra V, 2009, RESOUR ENERGY ECON, V31, P210, DOI 10.1016/j.reseneeco.2009.04.002; Poumanyvong P, 2012, ENERG POLICY, V46, P268, DOI 10.1016/j.enpol.2012.03.059; ROGERS RG, 1989, J BIOSOC SCI, V21, P245, DOI 10.1017/S0021932000017934; Scanlan SJ, 2010, INT J COMP SOCIOL, V51, P211, DOI 10.1177/0020715210363458; Shandra CL, 2011, ORGAN ENVIRON, V24, P107, DOI 10.1177/1086026611413931; Suneeta D Fernandes, 2007, GLOBAL BIOGEOCHEMICA, V21; UN-HABITAT, 2006, STAT WORLDS CIT; United Nations Environment Program, 2012, GUID GREEN EC DIV SU; United Nations Environment Programme, 2011, GREEN EC; World Bank, 2020, WORLD DEV IND 2020; York R, 2003, ECOL ECON, V46, P351, DOI 10.1016/S0921-8009(03)00188-5; York R, 2007, SOC SCI RES, V36, P855, DOI 10.1016/j.ssresearch.2006.06.007; Zhu HM, 2012, ECON LETT, V117, P848, DOI 10.1016/j.econlet.2012.09.001	44	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189024	10.1371/journal.pone.0189024	http://dx.doi.org/10.1371/journal.pone.0189024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP2SV	29220352	Green Published, Green Submitted, gold			2022-12-27	WOS:000417469900026
J	Yeh, SJ; Tang, SC; Tsai, LK; Lee, CW; Chen, YF; Liu, HM; Yang, SH; Kuo, MF; Jeng, JS				Yeh, Shin-Joe; Tang, Sung-Chun; Tsai, Li-Kai; Lee, Chung-Wei; Chen, Ya-Fang; Liu, Hon-Man; Yang, Shih-Hung; Kuo, Meng-Fai; Jeng, Jiann-Shing			Color Doppler ultrasonography as an alternative tool for postoperative evaluation of collaterals after indirect revascularization surgery in Moyamoya disease	PLOS ONE			English	Article							DURO-ARTERIO-SYNANGIOSIS; CHILDHOOD MOYAMOYA; SUBARACHNOID HEMORRHAGE; ADULT PATIENTS; SONOGRAPHY; ANGIOGRAPHY; NATIONWIDE	The cerebral hypoperfusion caused by chronic progressive stenosis or occlusion of intracranial arteries in moyamoya disease can be treated by direct bypass or indirect revascularization procedures. The extent of collaterals from the external carotid artery (ECA) after indirect revascularization surgery is the key point of angiographic follow-up, and the invasiveness of angiography impelled us to investigate the role of ultrasonography in the evaluation of collaterals. We hypothesized that the collaterals shown on angiography might produce corresponding hemodynamic changes in color Doppler ultrasonography. We prospectively recruited moyamoya patients who underwent indirect revascularization surgery and received both preoperative and postoperative angiography and color Doppler ultrasound studies. The collaterals on angiography were graded according to Matsushima method. A total of 21 patients (age, 17 +/- 10.2 years) with 24 operated hemispheres were enrolled. Patients who showed better collateral establishment by angiography had higher end-diastolic velocity (EDV), lower resistance index (RI), and larger flow volume in the superficial temporal artery (STA) and ECA (all p < 0.05). In STA, increase of EDV greater than 13.5 cm/sec or reduction of RI greater than 0.19 after operation corresponded to 94% of Matsushima grade A+B. In ECA, post-operative EDV greater than 22 cm/sec or increase of EDV greater than 6.4 cm/sec also corresponded to 94% of Matsushima grade A+B. Our findings revealed potential roles of color Doppler ultrasonography in identifying patients with poor collaterals after indirect revascularization procedures.	[Yeh, Shin-Joe; Tang, Sung-Chun; Tsai, Li-Kai; Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan; [Yeh, Shin-Joe; Tang, Sung-Chun; Tsai, Li-Kai; Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lee, Chung-Wei; Chen, Ya-Fang; Liu, Hon-Man] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Yang, Shih-Hung; Kuo, Meng-Fai] Natl Taiwan Univ Hosp, Dept Neurosurg, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Kuo, MF (corresponding author), Natl Taiwan Univ Hosp, Dept Neurosurg, Taipei, Taiwan.	mfkenator@gmail.com	yeh, shin-joe/HGV-0244-2022	LEE, CHUNG-WEI/0000-0002-3573-2506; CHEN, YA-FANG/0000-0003-2995-9189; Tsai, Li-Kai/0000-0001-8420-6951; LIU, HON-MAN/0000-0001-6715-6366; Yeh, Shin-Joe/0000-0003-1511-6295; JENG, JIANN-SHING/0000-0002-1456-3686; KUO, MENG-FAI/0000-0002-1803-2719; Tang, Sung-Chun/0000-0003-3731-5973; YANG, SHIH-HUNG/0000-0002-8572-4977	National Science Council of the Republic of China, Taiwan [NSC 101-2321-B-002-085, NSC 102-2321-B-002-064, MOST 103-2321-B-002-033, MOST 103-2321-B-002-032]; National Taiwan University Hospital [104-N2871, MOST 104-2314-B-002-131]	National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This study was supported by grants from the National Science Council of the Republic of China, Taiwan (NSC 101-2321-B-002-085, NSC 102-2321-B-002-064 and MOST 103-2321-B-002-033; all of these grants were for Dr. Meng-Fai Kuo. MOST 103-2321-B-002-032, for Ya-Fang Chen) for maintaining the multi-year project of "Platform establishment, validation, and biomarkers study in cerebrovascular diseases: using pediatric moyamoya disease as a pilot", as well as National Taiwan University Hospital grants (104-N2871 and MOST 104-2314-B-002-131, for Dr. Shin-Joe Yeh) in paying for English editing of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn IM, 2014, STROKE, V45, P1090, DOI 10.1161/STROKEAHA.113.004273; Blauwblomme T, 2016, AM J NEURORADIOL, V37, P706, DOI 10.3174/ajnr.A4592; Chen PC, 2014, STROKE, V45, P1258, DOI 10.1161/STROKEAHA.113.004160; Cho HH, 2016, AM J NEURORADIOL, V37, P932, DOI 10.3174/ajnr.A4614; Fushimi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148925; Huang APH, 2009, CEREBROVASC DIS, V28, P247, DOI 10.1159/000228254; Kim T, 2016, J STROKE, V18, P21, DOI 10.5853/jos.2015.01739; Kleinloog R, 2012, J NEUROL NEUROSUR PS, V83, P531, DOI 10.1136/jnnp-2011-301387; Kohno K, 1998, NEUROSURGERY, V42, P752, DOI 10.1097/00006123-199804000-00043; Lee YS, 2004, J NEUROIMAGING, V14, P319, DOI 10.1177/1051228404264958; MATSUSHIMA T, 1990, ACTA NEUROCHIR, V104, P96, DOI 10.1007/BF01842826; Mizoi K, 1996, SURG NEUROL, V45, P541, DOI 10.1016/0090-3019(95)00475-0; Patel NN, 2010, NEUROSURG CLIN N AM, V21, P553, DOI 10.1016/j.nec.2010.03.008; Perren F, 2005, J NEUROSURG, V103, P869, DOI 10.3171/jns.2005.103.5.0869; Perren F, 2005, NEUROLOGY, V64, P558, DOI 10.1212/01.WNL.0000150546.70817.87; Ruan LT, 2006, J CLIN ULTRASOUND, V34, P60, DOI 10.1002/jcu.20201; Sakamoto S, 2006, ACTA NEUROCHIR, V148, P77, DOI 10.1007/s00701-005-0634-z; STEINMEIER R, 1993, NEUROSURGERY, V33, P10; Toscano M, 2014, EUR NEUROL, V72, P330, DOI 10.1159/000364862; YAMADA I, 1992, NEURORADIOLOGY, V34, P318, DOI 10.1007/BF00588191; Yeh SJ, 2016, ULTRASOUND MED BIOL, V42, P2844, DOI 10.1016/j.ultrasmedbio.2016.07.016	21	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188948	10.1371/journal.pone.0188948	http://dx.doi.org/10.1371/journal.pone.0188948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220356	Green Published, gold, Green Submitted			2022-12-27	WOS:000417469900022
J	Hill, J; Peer, N; Oldenburg, B; Kengne, AP				Hill, Jillian; Peer, Nasheeta; Oldenburg, Brian; Kengne, Andre Pascale			Roles, responsibilities and characteristics of lay community health workers involved in diabetes prevention programmes: A systematic review	PLOS ONE			English	Review							LIFE-STYLE INTERVENTION; WEIGHT-LOSS INTERVENTION; LIVING PARTNERSHIPS; WORKSITE TRANSLATION; OUTCOMES; LATINAS; MODEL; FUEL; IMPLEMENTATION; FEASIBILITY	Aim To examine the characteristics of community health workers (CHWs) involved in diabetes prevention programmes (DPPs) and their contributions to expected outcomes. Methods Electronic databases including PubMed-MEDLINE, EBSCOHost, and SCOPUS/EMBASE were searched for studies published between January 2000 and March 2016. All studies that used CHWs to implement DPP in >= 18-year-old participants without diabetes but at high risk for developing the condition, irrespective of the study design, setting or outcomes measured, were included. Results were synthesized narratively. Results Forty papers of 30 studies were identified. Studies were mainly community-based and conducted in minority populations in USA. Sample sizes ranged from 20 participants in a single community to 2369 participants in 46 communities. Although CHWs were generally from the local community, their qualifications, work experience and training received differed across studies. Overall the training was culturally sensitive and/or appropriate, covering topics such as the importance of good nutrition and the benefits of increased physical activity, communication and leadership. CHWs delivered a variety of interventions and also screened or recruited participants. The shared culture and language between CHWs and participants likely contributed to better programme implementation and successful outcomes. Conclusions The complexity of DPPs and the diverse CHW roles preclude attributing specific outcomes to CHW involvement. Nevertheless, documenting potential CHW roles and the relevant training required may optimise CHW contributions and facilitate their involvement in DPPs in the future.	[Hill, Jillian; Peer, Nasheeta; Kengne, Andre Pascale] South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa; [Peer, Nasheeta; Kengne, Andre Pascale] Univ Cape Town, Dept Med, Cape Town, South Africa; [Oldenburg, Brian] Univ Melbourne, Melbourne Sch Publ Hlth & Global Hlth, Melbourne, Vic, Australia	South African Medical Research Council; University of Cape Town; University of Melbourne	Hill, J (corresponding author), South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa.	jillian@mrc.ac.za	Kengne, Andre Pascal/ABB-3696-2020	Peer, Nasheeta/0000-0003-2131-8344; Kengne, Andre Pascal/0000-0002-5183-131X	South African Medical Research Council; South African National Research Foundation, under the Thuthuka Funding Instrument [TTK160517165315]	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); South African National Research Foundation, under the Thuthuka Funding Instrument	Study funded by the South African Medical Research Council, and the South African National Research Foundation, under the Thuthuka Funding Instrument (Reference: TTK160517165315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MK, 2012, HEALTH AFFAIR, V31, P67, DOI 10.1377/hlthaff.2011.1009; Aponte Judith, 2015, J Community Med Health Educ, V5; Aziz Z, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0354-6; Balagopal P, 2012, DIABETES EDUCATOR, V38, P822, DOI 10.1177/0145721712459890; Benyshek Daniel C, 2013, J Diabetes Mellitus, V3, P184; Blackwell CS, 2011, CONTEMP CLIN TRIALS, V32, P40, DOI 10.1016/j.cct.2010.10.006; Brace AM, 2015, HEALTH PROMOT PRACT, V16, P28, DOI 10.1177/1524839914539329; Cadzow Renee B, 2014, Diabetes Spectr, V27, P246, DOI 10.2337/diaspect.27.4.246; Cadzow RB, 2013, DIABETES EDUCATOR, V39, P100, DOI 10.1177/0145721712465342; Cene CW, 2013, DIABETES EDUCATOR, V39, P776, DOI 10.1177/0145721713507114; Cherrington Andrea L, 2015, BMC Obes, V2, P17, DOI 10.1186/s40608-015-0047-3; Cohen Stuart J, 2005, Prev Chronic Dis, V2, pA05; Coppell KJ, 2009, DIABETES RES CLIN PR, V85, P220, DOI 10.1016/j.diabres.2009.05.009; Dejoy DM, 2013, HEALTH PROMOT PRACT, V14, P506, DOI 10.1177/1524839912461014; Duggan C, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130119; Horowitz CR, 2011, TRANSL BEHAV MED, V1, P443, DOI 10.1007/s13142-011-0067-6; Islam NS, 2014, INT J ENV RES PUB HE, V11, P5462, DOI 10.3390/ijerph110505462; Islam NS, 2013, J COMMUN HEALTH, V38, P1030, DOI 10.1007/s10900-013-9711-z; Katula JA, 2013, AM J PREV MED, V44, pS324, DOI 10.1016/j.amepre.2012.12.015; Katula JA, 2011, DIABETES CARE, V34, P1451, DOI 10.2337/dc10-2115; Katula JA, 2010, CONTEMP CLIN TRIALS, V31, P71, DOI 10.1016/j.cct.2009.09.002; Kok MC, 2015, HEALTH POLICY PLANN, V30, P1207, DOI 10.1093/heapol/czu126; Koniak-Griffin D, 2015, INT J NURS STUD, V52, P75, DOI 10.1016/j.ijnurstu.2014.09.005; Kousar R, 2016, QUAL HEALTH RES, V26, P603, DOI 10.1177/1049732315578401; Kramer MK, 2009, AM J PREV MED, V37, P505, DOI 10.1016/j.amepre.2009.07.020; Krukowski RA, 2013, PREV MED, V57, P400, DOI 10.1016/j.ypmed.2013.06.027; Krukowski RA, 2013, GERONTOLOGIST, V53, P162, DOI 10.1093/geront/gns094; Lawlor MS, 2013, AM J PREV MED, V44, pS381, DOI 10.1016/j.amepre.2012.12.016; Norris SL, 2006, DIABETIC MED, V23, P544, DOI 10.1111/j.1464-5491.2006.01845.x; O'Brien MJ, 2015, DIABETES EDUCATOR, V41, P485, DOI 10.1177/0145721715586576; Oba N, 2011, NURS HEALTH SCI, V13, P352, DOI 10.1111/j.1442-2018.2011.00627.x; Ockene IS, 2012, AM J PUBLIC HEALTH, V102, P336, DOI 10.2105/AJPH.2011.300357; Perez A, 2015, CONTEMP CLIN TRIALS, V45, P320, DOI 10.1016/j.cct.2015.10.011; Philis-Tsimikas A, 2014, TRANSL BEHAV MED, V4, P18, DOI 10.1007/s13142-014-0253-4; Promotion NCfCDPaH, 2015, ADDR CHRON DIS COMM; Reinschmidt KM, 2010, J PRIM PREV, V31, P69, DOI 10.1007/s10935-010-0208-6; Rosenthal EL, 2010, HEALTH AFFAIR, V29, P1338, DOI 10.1377/hlthaff.2010.0081; Ruggiero L, 2011, DIABETES EDUCATOR, V37, P564, DOI 10.1177/0145721711411107; Sathish T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1035; Schneider H, 2008, HEALTH POLICY PLANN, V23, P179, DOI 10.1093/heapol/czn006; Schulz AJ, 2005, AM J PUBLIC HEALTH, V95, P645, DOI 10.2105/AJPH.2004.048256; Shah M, 2013, CURR DIABETES REP, V13, P163, DOI 10.1007/s11892-012-0359-3; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7647; Simmons D, 2008, PUBLIC HEALTH NUTR, V11, P1318, DOI 10.1017/S1368980008002711; Sosa ET, 2013, J HLTH DISPAR RES PR, V6, P1; Staten Lisa K, 2005, Prev Chronic Dis, V2, pA18; Staten Lisa K, 2012, Prev Chronic Dis, V9, pE08; Swider SM, 2002, PUBLIC HEALTH NURS, V19, P11, DOI 10.1046/j.1525-1446.2002.19003.x; Teufel-Shone NI, 2005, PREVENTING CHRONIC D; Thompson RH, 2015, J COMMUN HEALTH, V40, P131, DOI 10.1007/s10900-014-9910-2; Treadwell Henrie, 2010, J Natl Med Assoc, V102, P794; West DS, 2011, AM J PREV MED, V41, P385, DOI 10.1016/j.amepre.2011.06.041; Whittemore R, 2014, PUBLIC HEALTH NURS, V31, P317, DOI 10.1111/phn.12093; Wilson MG, 2016, AM J HEALTH PROMOT, V30, P188, DOI 10.4278/ajhp.130411-QUAN-169; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE	55	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189069	10.1371/journal.pone.0189069	http://dx.doi.org/10.1371/journal.pone.0189069			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216263	Green Published, gold			2022-12-27	WOS:000417337800065
J	Lavania, S; Anthwal, D; Bhalla, M; Singh, N; Haldar, S; Tyagi, JS				Lavania, Surabhi; Anthwal, Divya; Bhalla, Manpreet; Singh, Nagendra; Haldar, Sagarika; Tyagi, Jaya Sivaswami			Direct detection of Mycobacterium tuberculosis rifampin resistance in bio-safe stained sputum smears	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PULMONARY TUBERCULOSIS; MICROSCOPY METHOD; INCOME COUNTRIES; NORTHERN INDIA; GENE-MUTATIONS; RPOB GENE; DNA; DIAGNOSIS; PCR	Direct smear microscopy of sputum forms the mainstay of TB diagnosis in resource-limited settings. Stained sputum smear slides can serve as a ready-made resource to transport sputum for molecular drug susceptibility testing. However, bio-safety is a major concern during transport of sputum/stained slides and for laboratory workers engaged in processing Mycobacterium tuberculosis infected sputum specimens. In this study, a bio-safe USP (Universal Sample Processing) concentration-based sputum processing method (Bio-safe method) was assessed on 87 M. tuberculosis culture positive sputum samples. Samples were processed for Ziehl-Neelsen (ZN) smear, liquid culture and DNA isolation. DNA isolated directly from sputum was subjected to an IS6110 PCR assay. Both sputum DNA and DNA extracted from bio-safe ZN concentrated smear slides were subjected to rpoB PCR and simultaneously assessed by DNA sequencing for determining rifampin (RIF) resistance. All sputum samples were rendered sterile by Bio-safe method. Bio-safe smears exhibited a 5% increment in positivity over direct smear with a 14% increment in smear grade status. All samples were positive for IS6110 and rpoB PCR. Thirty four percent samples were RIF resistant by rpoB PCR product sequencing. A 100% concordance (kappa value = 1) was obtained between sequencing results derived from bio-safe smear slides and bio-safe sputum. This study demonstrates that Bio-safe method can address safety issues associated with sputum processing, provide an efficient alternative to sample transport in the form of bio-safe stained concentrated smear slides and can also provide information on drug (RIF) resistance by direct DNA sequencing.	[Lavania, Surabhi; Tyagi, Jaya Sivaswami] All India Inst Med Sci, Dept Biotechnol, New Delhi, India; [Lavania, Surabhi; Singh, Nagendra] Gautam Buddha Univ, Sch Biotechnol, Yamuna Express Way, Greater Noida, Uttar Pradesh, India; [Anthwal, Divya; Haldar, Sagarika; Tyagi, Jaya Sivaswami] NCR Biotech Sci Cluster, Ctr Biodesign & Diagnost, Translat Hlth Sci & Technol Inst, 3rd Milestone,Faridabad Gurgaon Express Way, Faridabad, India; [Bhalla, Manpreet] Natl Inst TB & Resp Dis, Dept Microbiol, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Gautam Buddha University; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Tyagi, JS (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi, India.; Haldar, S; Tyagi, JS (corresponding author), NCR Biotech Sci Cluster, Ctr Biodesign & Diagnost, Translat Hlth Sci & Technol Inst, 3rd Milestone,Faridabad Gurgaon Express Way, Faridabad, India.	sagarikahaldar@thsti.res.in; jayatyagi.aiims@gmail.com	Anthwal, Divya/AAV-1472-2021	Singh, Nagendra/0000-0003-0419-0684	SBIRI grant by BIRAC, Government of India, JST [BT/SBIRI/SP-0001/13]	SBIRI grant by BIRAC, Government of India, JST	This work was supported by SBIRI grant by BIRAC, Government of India (BT/SBIRI/SP-0001/13), JST.	Anthwal D, 2017, J CLIN MICROBIOL; Arora J, 2013, INT J MYCOBACT, V2, P109, DOI 10.1016/j.ijmyco.2013.03.001; Bhutia R, 2013, INT J TUBERC LUNG D, V17, P258, DOI 10.5588/ijtld.12.0452; Cauwelaert ND, 2011, J CLIN MICROBIOL, V49, P3600, DOI 10.1128/JCM.00745-11; Chakravorty S, 2005, J CLIN MICROBIOL, V43, P2697, DOI 10.1128/JCM.43.6.2697-2702.2005; Chedore P, 2002, J CLIN MICROBIOL, V40, P4077, DOI 10.1128/JCM.40.11.4077-4080.2002; de Almeida IN, 2015, REV ARGENT MICROBIOL, V47, P47, DOI 10.1016/j.ram.2014.12.002; EISENACH KD, 1990, J INFECT DIS, V161, P977, DOI 10.1093/infdis/161.5.977; Ereqat S, 2011, TROP MED INT HEALTH, V16, P360, DOI 10.1111/j.1365-3156.2010.02697.x; Gupta A, 2013, J CLIN LAB ANAL, V27, P31, DOI 10.1002/jcla.21558; Jain A, 2008, INDIAN J MED RES, V128, P300; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kumar M, 2011, J MED MICROBIOL, V60, P1410, DOI 10.1099/jmm.0.031633-0; Kumar P, 2014, TUBERCULOSIS, V94, P73, DOI 10.1016/j.tube.2013.10.001; Kwiecien R, 2011, DTSCH ARZTEBL INT, V108, P515, DOI 10.3238/arztebl.2011.0515; Lingala M. A. L., 2010, Journal of Microbiology and Antimicrobials, V2, P13; Makadia JS, 2012, INDIAN J CLIN BIOCHE, V27, P370, DOI 10.1007/s12291-012-0228-5; Maurya AK, 2013, INDIAN J MED MICROBI, V31, P40, DOI 10.4103/0255-0857.108720; Nathavitharana RR, 2016, J CLIN MICROBIOL, V54, P1624, DOI 10.1128/JCM.00251-16; Rakotosamimanana N, 2017, INT J INFECT DIS, V56, P248, DOI 10.1016/j.ijid.2016.12.005; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Revised national tuberculosis control programme (RNTCP), 2005, MOD LAB TECHN; Selvakumar N, 2002, J CLIN MICROBIOL, V40, P3017, DOI 10.1128/JCM.40.8.3017-3020.2002; Shenai S, 2009, INT J INFECT DIS, V13, P46, DOI 10.1016/j.ijid.2008.03.025; Singhal R, 2013, INT J MYCOBACT, V2, P84, DOI 10.1016/j.ijmyco.2013.03.003; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Suresh N, 2007, J MICROBIOL METH, V68, P291, DOI 10.1016/j.mimet.2006.09.001; Swaminathan S, 2016, TUBERCULOSIS, V101, P31, DOI 10.1016/j.tube.2016.08.002; Thirumurugan R, 2015, J INFECT PUBLIC HEAL, V8, P619, DOI 10.1016/j.jiph.2015.05.003; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; UNITAID, 2015, UNITAID TUB DIAGN TE, Vfourth.; Watson PF, 2010, THERIOGENOLOGY, V73, P1167, DOI 10.1016/j.theriogenology.2010.01.003; WHO, 2016, US LOOP MED IS AMPL; WHO, 2016, GLOB TUB REP; World Health Organization, 2016, US MOL LIN PROB ASS; World Health Organization, 2017, WHO M REP TECHN EXP; World Health Organization (WHO), MULT RES TUB MDR TB	37	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189149	10.1371/journal.pone.0189149	http://dx.doi.org/10.1371/journal.pone.0189149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216262	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800081
J	Lu, G; Huang, J; Yang, QL; Xu, HB; Wu, PX; Fu, C; Li, SJ				Lu, Gang; Huang, Ji; Yang, Qiliang; Xu, Haibin; Wu, Peixin; Fu, Cheng; Li, Shoujun			Identification and genetic characterization of hepacivirus and pegivirus in commercial equine serum products in China	PLOS ONE			English	Article							HEPATITIS-C VIRUS; GB-VIRUS; NONPRIMATE HEPACIVIRUS; HORSES; TRANSMISSION; PURIFICATION; GONADOTROPIN; INFECTION	Equine hepacivirus (EqHV), equine pegivirus (EPgV) and Theiler's disease-associated virus (TDAV) are three novel equine viruses in the family Flaviviridae. EqHV and EPgV have been identified to circulate in the equine population worldwide, whereas TDAV has not been detected in equines since the first reported case. To date, no studies have focused on investigating EqHV, EPgV and TDAV in commercial equine sera or equine blood products in China. Considering the potential threat of EqHV, EPgV and TDAV to biosecurity and considering their possible influences on research results, equine sera for cell culture propagation and pregnant mare serum gonadotropin (PMSG) were purchased from different companies in China and investigated for EqHV, EPgV and TDAV in this study. By performing nested PCR or two rounds of PCR targeting the viral NS3 gene, four serum samples were confirmed to be EqHV-, EPgV-, or TDAV-RNA positive; all of the PMSG samples were negative for these three viruses. Subsequent sequencing results indicated that the serum samples contained multiple viral variants of EqHV, EPgV or TDAV, and a genetic analysis based on the partial NS3 gene of the three equine viruses was performed. Our study is the first to confirm the presence of EqHV, EPgV and TDAV in equine sera for cell culture propagation that is commercially available in China and provides the first demonstration of the presence of TDAV in China.	[Lu, Gang; Huang, Ji; Yang, Qiliang; Xu, Haibin; Wu, Peixin; Fu, Cheng; Li, Shoujun] South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Lu, Gang; Huang, Ji; Yang, Qiliang; Xu, Haibin; Wu, Peixin; Fu, Cheng; Li, Shoujun] Guangdong Prov Key Lab Prevent & Control Severe C, Guangzhou, Guangdong, Peoples R China; [Lu, Gang; Huang, Ji; Yang, Qiliang; Xu, Haibin; Wu, Peixin; Fu, Cheng; Li, Shoujun] Guangdong Technol Engn Res Ctr Pet Guangzhou, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Li, SJ (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.; Li, SJ (corresponding author), Guangdong Prov Key Lab Prevent & Control Severe C, Guangzhou, Guangdong, Peoples R China.; Li, SJ (corresponding author), Guangdong Technol Engn Res Ctr Pet Guangzhou, Guangzhou, Guangdong, Peoples R China.	shoujunli@scau.edu.cn			National Natural Science Foundation of China [31372448, 31672563, 31402259]; Special Fund for Agro-scientific Research in the Public Interest [201303042]; National Key Research and Development Program of China [2016YFD0501004, 2016YFD0501010]; Promote Scientific and Technological Development Program [2013B040200032]; Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases [2013A061401013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; National Key Research and Development Program of China; Promote Scientific and Technological Development Program; Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases	This work was supported by the National Natural Science Foundation of China (31372448, 31672563), The Special Fund for Agro-scientific Research in the Public Interest (201303042), The National Key Research and Development Program of China (2016YFD0501004, 2016YFD0501010), The National Natural Science Foundation of China (31402259), The Promote Scientific and Technological Development Program (2013B040200032), and The Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases (2013A061401013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter HJ, 1997, NEW ENGL J MED, V336, P747, DOI 10.1056/NEJM199703133361102; Burbelo PD, 2012, J VIROL, V86, P6171, DOI 10.1128/JVI.00250-12; Chandriani S, 2013, P NATL ACAD SCI USA, V110, pE1407, DOI 10.1073/pnas.1219217110; CHRISTAKOS S, 1979, J BIOL CHEM, V254, P4253; Elia G, 2017, TRANSBOUND EMERG DIS, V64, P1354, DOI 10.1111/tbed.12679; Feucht HH, 1997, LANCET, V349, P435, DOI 10.1016/S0140-6736(97)80062-1; Gemaque BS, 2014, EMERG INFECT DIS, V20, P2180, DOI 10.3201/eid2012.140603; GOSPODAROWICZ D, 1972, ENDOCRINOLOGY, V91, P101, DOI 10.1210/endo-91-1-101; Kapoor A, 2015, MBIO, V6, DOI 10.1128/mBio.01466-15; Kapoor A, 2013, J VIROL, V87, P7185, DOI 10.1128/JVI.00324-13; Kapoor A, 2011, P NATL ACAD SCI USA, V108, P11608, DOI 10.1073/pnas.1101794108; Kapoor A, 2013, ANTIMICROB AGENTS CH, V57, P2761, DOI 10.1128/AAC.00029-13; Leary TP, 1996, J VIROL, V70, P9028, DOI 10.1128/JVI.70.12.9028-9030.1996; Leary TP, 1996, J MED VIROL, V48, P60, DOI 10.1002/(SICI)1096-9071(199601)48:1&lt;60::AID-JMV10&gt;3.0.CO;2-A; Lefrere JJ, 1999, TRANSFUSION, V39, P83, DOI 10.1046/j.1537-2995.1999.39199116899.x; Lu G, 2017, ARCH VIROLOGY; Lu G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155662; Lyons S, 2014, J GEN VIROL, V95, P1701, DOI 10.1099/vir.0.065094-0; Lyons S, 2012, EMERG INFECT DIS, V18, P1976, DOI 10.3201/eid1812.120498; Postel A, 2016, VET MICROBIOL, V182, P8, DOI 10.1016/j.vetmic.2015.10.032; Quan PL, 2013, P NATL ACAD SCI USA, V110, P8194, DOI 10.1073/pnas.1303037110; Ramsay JD, 2015, HEPATOLOGY, V61, P1533, DOI 10.1002/hep.27689; Reuter G, 2014, ACTA VET HUNG, V62, P422, DOI 10.1556/AVet.2014.011; Sibley SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098569; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; de Souza AJS, 2015, ACTA TROP, V152, P56, DOI 10.1016/j.actatropica.2015.08.014; Sulbaran MZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014315	28	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189208	10.1371/journal.pone.0189208	http://dx.doi.org/10.1371/journal.pone.0189208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216266	gold, Green Published, Green Submitted			2022-12-27	WOS:000417337800095
J	Takeuchi, H; Abe, M; Takumi, Y; Hashimoto, T; Kobayashi, R; Osoegawa, A; Miyawaki, M; Okamoto, T; Sugio, K				Takeuchi, Hideya; Abe, Miyuki; Takumi, Yohei; Hashimoto, Takafumi; Kobayashi, Ryoji; Osoegawa, Atsushi; Miyawaki, Michiyo; Okamoto, Tatsuro; Sugio, Kenji			The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer	PLOS ONE			English	Article							GROWTH-FACTOR; CELL-GROWTH; EXPRESSION; VOLUME; ACTIVATION; DISEASE; OSTEOSARCOMA; INFLAMMATION; COAGULATION; THROMBOSIS	Activated platelets promote tumor cell growth, angiogenesis, and invasion. Platelet activity can be inferred by platelet volume indices (PVIs), which include platelet distribution width (PDW), mean platelet volume (MPV), platelet distribution width-to-platelet count ratio (PDW/P), and mean platelet volume-to-platelet count ratio. Platelets and platelet-related markers, such as the platelet-to-lymphocyte ratio, have been found to be significant prognostic factors in patients with breast cancer. However, the role of PVIs for predicting survival in breast cancer remains unknown; hence, we performed this retrospective analysis of 275 patients with breast cancer. PVIs were compared with clinicopathological variables, and were assessed to identify independent indicators associated with disease-free survival (DFS) using the Cox proportional hazards model. An elevated PDW/P significantly correlated with age and HER2 status. Univariate analysis revealed that elevated PDW, MPV, and PDW/P as well as tumor size, nuclear grade, and lymph node involvement were significantly associated with inferior DFS rates (tumor size: p<0.01; nuclear grade, lymph node involvement, PDW, MPV, and PDW/P: p<0.05). On multivariate analysis, a large tumor size and elevated PDW/P were significant prognostic factors for DFS, with hazard ratios of 3.24 (95% confidence interval [CI]: 1.24-8.47) and 2.99 (95% CI: 1.18-7.57), respectively (p<0.05). Our study is the first to reveal that an elevated PDW/P significantly reduces DFS in patients with breast carcinoma. Measuring the PDW/P is simple, relatively inexpensive, and almost universally available using routine blood counts; this makes it an attractive biomarker for improved risk assessment.	[Takeuchi, Hideya; Abe, Miyuki; Takumi, Yohei; Hashimoto, Takafumi; Kobayashi, Ryoji; Osoegawa, Atsushi; Miyawaki, Michiyo; Okamoto, Tatsuro; Sugio, Kenji] Oita Univ, Fac Med, Dept Thorac & Breast Surg, Oita, Japan	Oita University	Takeuchi, H (corresponding author), Oita Univ, Fac Med, Dept Thorac & Breast Surg, Oita, Japan.	takeuchi@oita-u.ac.jp		Osoegawa, Atsushi/0000-0002-8327-3631				Cho SY, 2013, PLATELETS, V24, P375, DOI 10.3109/09537104.2012.701028; De Luca G, 2010, PLATELETS, V21, P508, DOI 10.3109/09537104.2010.494743; Drukker CA, 2013, INT J CANCER, V133, P929, DOI 10.1002/ijc.28082; Franco AT, 2015, BLOOD, V126, P582, DOI 10.1182/blood-2014-08-531582; Gasparyan AY, 2011, CURR PHARM DESIGN, V17, P47; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gu ML, 2016, BREAST CANCER-TOKYO, V23, P752, DOI 10.1007/s12282-015-0635-6; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; Inagaki N, 2014, LUNG CANCER, V83, P97, DOI 10.1016/j.lungcan.2013.08.020; ISHIKAWA F, 1989, NATURE, V338, P557, DOI 10.1038/338557a0; Kaito K, 2005, BRIT J HAEMATOL, V128, P698, DOI 10.1111/j.1365-2141.2004.05357.x; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kang DW, 2010, CANCER LETT, V294, P125, DOI 10.1016/j.canlet.2010.01.031; Kapoor JR, 2008, NEW ENGL J MED, V358, P1638, DOI 10.1056/NEJMc080056; Kaushansky K, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345.Con1_345_344; Kayacan O, 2006, AM J CLIN ONCOL-CANC, V29, P328, DOI 10.1097/01.coc.0000221300.72657.e0; Kraeima J, 2013, BRIT J CANCER, V109, P866, DOI 10.1038/bjc.2013.401; Kumagai S, 2015, MOL CLIN ONCOL, V3, P197, DOI 10.3892/mco.2014.436; MARTIN JF, 1991, LANCET, V338, P1409, DOI 10.1016/0140-6736(91)92719-I; MATSUO K, 1993, J CLIN ENDOCR METAB, V77, P996, DOI 10.1210/jc.77.4.996; MIYAZONO K, 1990, ANN NY ACAD SCI, V593, P51, DOI 10.1111/j.1749-6632.1990.tb16099.x; Noh H, 2013, J BREAST CANCER, V16, P55, DOI 10.4048/jbc.2013.16.1.55; Paulsson J, 2009, AM J PATHOL, V175, P334, DOI 10.2353/ajpath.2009.081030; Qiu D, 2009, INT J CANCER, V124, P443, DOI 10.1002/ijc.23911; Shen J, 2009, THROMB RES, V123, P604, DOI 10.1016/j.thromres.2008.04.004; Stegner D, 2014, THROMB RES, V133, pS149, DOI 10.1016/S0049-3848(14)50025-4; Sulzbacher I, 2003, MODERN PATHOL, V16, P66, DOI 10.1097/01.MP.0000043522.76788.0A; Takagi S, 2014, CANCER SCI, V105, P983, DOI 10.1111/cas.12464; Takeuchi H, 2016, ADV BREAST CANC RES, V5, P49; Takeuchi H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177137; Vagdatli E, 2010, HIPPOKRATIA, V14, P28; Zhang F, 2016, TUMOR BIOL, V37, P9323, DOI 10.1007/s13277-015-4774-3	32	39	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189166	10.1371/journal.pone.0189166	http://dx.doi.org/10.1371/journal.pone.0189166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216259	Green Submitted, gold, Green Published			2022-12-27	WOS:000417337800085
J	Chauta, A; Whitehead, S; Amaya-Marquez, M; Poveda, K				Chauta, Alexander; Whitehead, Susan; Amaya-Marquez, Marisol; Poveda, Katja			Leaf herbivory imposes fitness costs mediated by hummingbird and insect pollinators	PLOS ONE			English	Article							PALICOUREA-PADIFOLIA RUBIACEAE; ECOLOGICAL COSTS; FLORAL CHARACTERS; PLANT; EVOLUTION; NECTAR; ATTRACTIVENESS; PSYCHOTRIEAE; VOLATILES; IMPACTS	Plant responses induced by herbivore damage can provide fitness benefits, but can also have important costs due to altered interactions with mutualist pollinators. We examined the effects of plant responses to herbivory in a hummingbird-pollinated distylous shrub, Palicourea angustifolia. Through a series of field experiments we investigated whether damage from foliar herbivores leads to a reduction in fruit set, influences floral visitation, or alters floral traits that may influence pollinator preference or pollinator efficiency. Foliar herbivory by a generalist grasshopper led to reduced fruit set in branches that were directly damaged as well as in adjacent undamaged branches on the same plant. Furthermore, herbivory resulted in reduced floral visitation from two common hummingbird species and two bee species. An investigation into the potential mechanisms behind reduced floral visitation in induced plants showed that foliar herbivore damage resulted in shorter styles and lower nectar volumes. This reduction in style length could reduce pollen deposition between different floral morphs that is required for optimal pollination in a distylous plant. We did not detect any differences in the volatile blends released by damaged and undamaged branches, suggesting that foliar herbivore-induced changes in floral morphology and rewards, and not volatile blends, are the primary mechanism mediating changes in visitation. Our results provide novel mechanisms for how plant responses induced by foliar herbivores can lead to ecological costs.	[Chauta, Alexander] Univ Nacl Colombia, Dept Biol, Ciudad Univ, Bogota, Colombia; [Whitehead, Susan; Poveda, Katja] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Amaya-Marquez, Marisol] Univ Nacl Colombia, Inst Ciencias Nat, Ciudad Univ, Bogota, Colombia; [Chauta, Alexander] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA	Universidad Nacional de Colombia; Cornell University; Universidad Nacional de Colombia; Cornell University	Chauta, A (corresponding author), Univ Nacl Colombia, Dept Biol, Ciudad Univ, Bogota, Colombia.; Chauta, A (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA.	jachautam@unal.edu.co		Whitehead, Susan/0000-0002-7089-4594; Amaya- Marquez, Marisol/0000-0001-6135-8063	Programa Jovenes investigadores e innovadores, Colciencias	Programa Jovenes investigadores e innovadores, Colciencias	This work was supported by Programa Jovenes investigadores e innovadores-2012, Colciencias.	Adler LS, 2005, ECOLOGY, V86, P2968, DOI 10.1890/05-0118; Adler LS, 2006, ECOL LETT, V9, P960, DOI 10.1111/j.1461-0248.2006.00944.x; Aldea M, 2005, PLANT CELL ENVIRON, V28, P402, DOI 10.1111/j.1365-3040.2005.01279.x; BARRETT SCH, 1990, TRENDS ECOL EVOL, V5, P144, DOI 10.1016/0169-5347(90)90220-8; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bronstein Judith L., 2007, P75, DOI 10.1017/CBO9780511542701.005; Diaz-Uriarte R, 2015, PACKAGE VARSELRF; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; GANDERS FR, 1979, NEW ZEAL J BOT, V17, P607, DOI 10.1080/0028825X.1979.10432574; Gehring CA, 2002, ECOL STU AN, V157, P295; Heil M, 2002, CURR OPIN PLANT BIOL, V5, P345, DOI 10.1016/S1369-5266(02)00267-4; Hernandez A, 2007, ECOSCIENCE, V14, P8, DOI 10.2980/1195-6860(2007)14[8:DPTIDP]2.0.CO;2; Herrera CM, 2002, P NATL ACAD SCI USA, V99, P16823, DOI 10.1073/pnas.252362799; Hilty SL, 2001, GUIA AVES COLOMBIA; Hothorn AT, 2015, PACKAGE MULTCOMP; Johnson SD, 1997, EVOLUTION, V51, P45, DOI 10.1111/j.1558-5646.1997.tb02387.x; KARBAN R, 1997, INDUCED RESPONSES HE; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler A, 2011, ECOLOGY, V92, P1769, DOI 10.1890/10-1945.1; Kessler A, 2009, FUNCT ECOL, V23, P901, DOI 10.1111/j.1365-2435.2009.01639.x; Kessler D, 2007, PLANT J, V49, P840, DOI 10.1111/j.1365-313X.2006.02995.x; Knudsen JT, 2004, BOT J LINN SOC, V146, P191, DOI 10.1111/j.1095-8339.2004.00329.x; Krupnick GA, 1999, ECOLOGY, V80, P125, DOI 10.1890/0012-9658(1999)080[0125:TCOFHF]2.0.CO;2; Lehtila K, 1997, OECOLOGIA, V111, P396, DOI 10.1007/s004420050251; Leonard A.S., 2011, EVOLUTION PLANT POLL, P261, DOI DOI 10.1016/J.ANBEHAV.2012.01.007; Lopes S, 2004, BIOCHEM SYST ECOL, V32, P1187, DOI 10.1016/j.bse.2004.04.015; Lucas-Barbosa D, 2011, PHYTOCHEMISTRY, V72, P1647, DOI 10.1016/j.phytochem.2011.03.013; Massinga PH, 2005, ANN BOT-LONDON, V95, P389, DOI 10.1093/aob/mci040; Mothershead K, 2000, ECOLOGY, V81, P30, DOI 10.2307/177131; NILSSON LA, 1988, NATURE, V334, P147, DOI 10.1038/334147a0; Ornelas JF, 2004, AM J BOT, V91, P1052, DOI 10.3732/ajb.91.7.1052; OSTLIE KR, 1984, ENVIRON ENTOMOL, V13, P1675, DOI 10.1093/ee/13.6.1675; Porras MF, 2007, REV COLOMB ENTOMOL, V33, P70; Poveda K, 2003, OECOLOGIA, V135, P601, DOI 10.1007/s00442-003-1228-1; R Team Core, 2014, R LANG ENV STAT COMP; Ranganathan Y, 2010, PLANT BIOLOGY, V12, P735, DOI 10.1111/j.1438-8677.2009.00278.x; RENNER S, 1983, BIOTROPICA, V15, P251, DOI 10.2307/2387649; Rivera-Diaz O, 2012, GUIA CAMPO PLANTAS C; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; STEPHENSON AG, 1982, J CHEM ECOL, V8, P1025, DOI 10.1007/BF00987883; Strauss SY, 1997, ECOLOGY, V78, P1640, DOI 10.1890/0012-9658(1997)078[1640:FCLHPA]2.0.CO;2; Strauss SY, 1996, AM NAT, V147, P1098, DOI 10.1086/285896; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; TAMM S, 1986, OECOLOGIA, V70, P20, DOI 10.1007/BF00377107; Taylor CM, 1997, ANN MO BOT GARD, V84, P224, DOI 10.2307/2400003; Taylor CM, 2000, NOVON, V10, P78, DOI 10.2307/3393191; Torres I, 2008, ECOSCIENCE, V15, P65, DOI 10.2980/1195-6860(2008)15[65:AATEIA]2.0.CO;2; Valois-Cuesta H, 2006, BIODIVERSIDAD, P40; Whitehead SR, 2011, J ECOL, V99, P964, DOI 10.1111/j.1365-2745.2011.01819.x; Zuur A. F., 2013, BEGINNERS GUIDE GLM	52	17	17	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188408	10.1371/journal.pone.0188408	http://dx.doi.org/10.1371/journal.pone.0188408			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211805	gold, Green Submitted, Green Published			2022-12-27	WOS:000417212200030
J	Denslow, A; Switalska, M; Jarosz, J; Papiernik, D; Porshneva, K; Nowak, M; Wietrzyk, J				Denslow, Agnieszka; Switalska, Marta; Jarosz, Joanna; Papiernik, Diana; Porshneva, Kseniia; Nowak, Marcin; Wietrzyk, Joanna			Clopidogrel in a combined therapy with anticancer drugs-effect on tumor growth, metastasis, and treatment toxicity: Studies in animal models	PLOS ONE			English	Article							PLATELET ACTIVATION; P-SELECTIN; CANCER; CELLS; BREAST; INHIBITION; CARCINOMA; SURVIVAL; ANGIOGENESIS; ANTIOXIDANT	Clopidogrel, a thienopyridine derivative with antiplatelet activity, is widely prescribed for patients with cardiovascular diseases. In addition to antiplatelet activity, antiplatelet agents possess anticancer and antimetastatic properties. Contrary to this, results of some studies have suggested that the use of clopidogrel and other thienopyridines accelerates the progression of breast, colorectal, and prostate cancer. Therefore, in this study, we aimed to evaluate the efficacy of clopidogrel and various anticancer agents as a combined treatment using mouse models of breast, colorectal, and prostate cancer. Metastatic dissemination, selected parameters of platelet morphology and biochemistry, as well as angiogenesis were assessed. In addition, body weight, blood morphology, and biochemistry were evaluated to test toxicity of the studied compounds. According to the results, clopidogrel increased antitumor and/or antimetastatic activity of chemotherapeutics such as 5-fluorouracil, cyclophosphamide, and mitoxantrone, whereas it decreased the anticancer activity of doxorubicin, cisplatin, and tamoxifen. The mechanisms of such divergent activities may be based on the modulation of tumor vasculature via factors, such as transforming growth factor beta 1 released from platelets. Moreover, clopidogrel increased the toxicity of docetaxel and protected against mitoxantrone-induced toxicity, which may be due to the modulation of hepatic enzymes and protection of the vasculature, respectively. These results demonstrate that antiplatelet agents can be useful but also dangerous in anticancer treatment and therefore use of thienopyridines in patients undergoing chemotherapy should be carefully evaluated.	[Denslow, Agnieszka; Switalska, Marta; Jarosz, Joanna; Papiernik, Diana; Porshneva, Kseniia; Wietrzyk, Joanna] Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Dept Expt Oncol, Wroclaw, Poland; [Nowak, Marcin] Wroclaw Univ Environm & Life Sci, Fac Vet Med, Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Wroclaw University of Environmental & Life Sciences	Wietrzyk, J (corresponding author), Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Dept Expt Oncol, Wroclaw, Poland.	wietrzyk@iitd.pan.wroc.pl	Wietrzyk, Joanna/O-4392-2018; Nowak, Marcin/A-8768-2017	Wietrzyk, Joanna/0000-0003-4980-6606; Nowak, Marcin/0000-0002-2468-107X; Switalska, Marta/0000-0001-7920-2251; Jarosz, Joanna/0000-0002-9287-6207	European Union; National Center for Research and Development under Polish Strategic Framework Program STRATEGMED [STRATEGMED1/233226/11/NCBR/2015]; Wroclaw Center of Biotechnology within a Program of The Leading National Research Center (KNOW); European Regional Development Fund within the Innovative Economy Program [POIG.01.01.02-00-069/09]	European Union(European Commission); National Center for Research and Development under Polish Strategic Framework Program STRATEGMED; Wroclaw Center of Biotechnology within a Program of The Leading National Research Center (KNOW); European Regional Development Fund within the Innovative Economy Program	This study was supported by the European Union from the resources of the European Regional Development Fund within the Innovative Economy Program (grant coordinated by the JCET-UJ, No. POIG.01.01.02-00-069/09) and The National Center for Research and Development under the Polish Strategic Framework Program STRATEGMED (grant coordinated by JCET-UJ No. STRATEGMED1/233226/11/NCBR/2015). The publication was supported by Wroclaw Center of Biotechnology within a Program of The Leading National Research Center (KNOW) for years 2014-2018. The funding bodies did not participate in the design of the study and collection, analysis, and interpretation of data or in writing the manuscript.	Agergaard K, 2017, CLIN PHARM THER; Battinelli EM, 2014, BLOOD, V123, P101, DOI 10.1182/blood-2013-02-485011; Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Bendas Gerd, 2012, Int J Cell Biol, V2012, P676731, DOI 10.1155/2012/676731; Bergmann TK, 2016, BRIT J CLIN PHARMACO, V81, P313, DOI 10.1111/bcp.12795; Bryckaert M, 2015, CELL MOL LIFE SCI, V72, P307, DOI 10.1007/s00018-014-1743-8; Chiodoni C, 2006, J EXP MED, V203, P2441, DOI 10.1084/jem.20060844; Cho MS, 2012, BLOOD, V120, P4869, DOI 10.1182/blood-2012-06-438598; Choe KS, 2010, CANCER-AM CANCER SOC, V116, P1820, DOI 10.1002/cncr.24890; Coupland LA, 2012, CANCER RES, V72, P4662, DOI 10.1158/0008-5472.CAN-11-4010; Damiani RM, 2016, ARCH TOXICOL, V90, P2063, DOI 10.1007/s00204-016-1759-y; Danckwardt S, 2013, J MOL MED, V91, P1257, DOI 10.1007/s00109-013-1074-5; Desta Z, 2004, J PHARMACOL EXP THER, V310, P1062, DOI 10.1124/jpet.104.065607; Dredge K, 2011, BRIT J CANCER, V104, P635, DOI 10.1038/bjc.2011.11; duPre' SA, 2007, EXP MOL PATHOL, V82, P12, DOI 10.1016/j.yexmp.2006.06.007; Erez N, 2011, INT J CANCER, V128, P2536, DOI 10.1002/ijc.26032; Finsterer J, 2015, EXPERT OPIN DRUG MET, V11, P15, DOI 10.1517/17425255.2015.973401; Floyd JS, 2010, ARCH INTERN MED, V170, P1078, DOI 10.1001/archinternmed.2010.154; Ford NF, 2016, J CLIN PHARMACOL, V56, P1474, DOI 10.1002/jcph.769; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gawron-Skarbek A, 2014, NUTR METAB CARDIOVAS, V24, pE21, DOI 10.1016/j.numecd.2014.02.011; Gong DP, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-31; Han Hui, 2014, ScientificWorldJournal, V2014, P878209, DOI 10.1155/2014/878209; Heitzer T, 2006, ARTERIOSCL THROM VAS, V26, P1648, DOI 10.1161/01.ATV.0000225288.74170.dc; Herbert J-M, 1998, PLATELETS, V9, P251; Hicks BM, 2015, PHARMACOEPIDEM DR S, V24, P830, DOI 10.1002/pds.3807; Ivanovic V, 2006, CLIN CHIM ACTA, V371, P191, DOI 10.1016/j.cca.2006.02.027; Jakubowski A, 2005, PROSTAG LEUKOTR ESS, V72, P139, DOI 10.1016/j.plefa.2004.10.011; Jonas RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138701; Kenmotsu H, 2015, CANCER SCI, V106, P497, DOI 10.1111/cas.12647; Kispert SE, 2014, AM J PHYSIOL-CELL PH, V307, pC951, DOI 10.1152/ajpcell.00218.2014; Kotronias RA, 2016, DRUG SAFETY, P1; Krzeminski P, 2007, FEBS J, V274, P1970, DOI 10.1111/j.1742-4658.2007.05741.x; Kunapuli SP, 2003, CURR PHARM DESIGN, V9, P2303, DOI 10.2174/1381612033453947; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Leader A, 2017, AM J MED, V130, P826, DOI 10.1016/j.amjmed.2017.01.022; Lee PC, 2016, ANN SURG ONCOL, V23, pS874, DOI 10.1245/s10434-016-5520-9; Lukasik M, 2011, THROMB RES, V128, pE73, DOI 10.1016/j.thromres.2011.06.016; Mannori G, 2000, CLIN EXP METASTAS, V18, P89, DOI 10.1023/A:1026548700247; McDonald GB, 2003, BLOOD, V101, P2043, DOI 10.1182/blood-2002-06-1860; Medina C, 2006, J PHARMACOL EXP THER, V317, P739, DOI 10.1124/jpet.105.098384; Mezouar S, 2015, INT J CANCER, V136, P462, DOI 10.1002/ijc.28997; Milczarek M, 2013, ANTICANCER RES, V33, P433; Mir O, 2009, ANN ONCOL, V20, P736, DOI 10.1093/annonc/mdn698; Miyashita T, 2015, J SURG RES, V193, P289, DOI 10.1016/j.jss.2014.07.037; Moo-Young TA, 2009, J IMMUNOTHER, V32, P12, DOI 10.1097/CJI.0b013e318189f13c; Oshiro C, 2009, PHARMACOGENET GENOM, V19, P979, DOI 10.1097/FPC.0b013e3283335277; Pajtasz-Piasecka E, 2004, FOLIA BIOL-PRAGUE, V50, P7; Pandey A, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/44/445101; Panis C, 2013, ANTICANCER RES, V33, P737; Radziwon-Balicka A, 2012, BRIT J PHARMACOL, V167, P787, DOI 10.1111/j.1476-5381.2012.01991.x; Sarangi S, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0567-y; Schrottmaier WC, 2015, THROMB HAEMOSTASIS, V114, P478, DOI 10.1160/TH14-11-0943; Serebruany VL, 2009, AM J MED, V122, P407, DOI 10.1016/j.amjmed.2008.11.023; Sitia G, 2012, P NATL ACAD SCI USA, V109, pE2165, DOI 10.1073/pnas.1209182109; Suzuki-Inoue K, 2011, J BIOCHEM, V150, P127, DOI 10.1093/jb/mvr079; Symeonidis D, 2012, WORLD J GASTRO ENDOS, V4, P409, DOI 10.4253/wjge.v4.i9.409; Takagi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073609; Van Kolen K, 2006, FEBS J, V273, P1843, DOI 10.1111/j.1742-4658.2006.05205.x; Wagenblast E, 2015, NATURE, V520, P358, DOI 10.1038/nature14403; Williamson SC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13322; Woulfe D, 2001, J CLIN INVEST, V107, P1503, DOI 10.1172/JCI13361; Zahno A, 2013, FREE RADICAL BIO MED, V65, P208, DOI 10.1016/j.freeradbiomed.2013.06.007	63	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188740	10.1371/journal.pone.0188740	http://dx.doi.org/10.1371/journal.pone.0188740			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206871	Green Published, Green Submitted, gold			2022-12-27	WOS:000417110700021
J	Brand, SL; Coon, JT; Fleming, LE; Carroll, L; Bethel, A; Wyatt, K				Brand, Sarah L.; Coon, Jo Thompson; Fleming, Lora E.; Carroll, Lauren; Bethel, Alison; Wyatt, Katrina			Whole-system approaches to improving the health and wellbeing of healthcare workers: A systematic review	PLOS ONE			English	Review							MENTAL-HEALTH; INTERVENTION; STRESS; PROMOTION; IMPACT; TRIAL	Background Healthcare professionals throughout the developed world report higher levels of sickness absence, dissatisfaction, distress, and "burnout" at work than staff in other sectors. There is a growing call for the 'triple aim' of healthcare delivery (improving patient experience and outcomes and reducing costs; to include a fourth aim: improving healthcare staff experience of healthcare delivery. A systematic review commissioned by the United Kingdom's (UK) Department of Health reviewed a large number of international healthy workplace interventions and recommended five whole-system changes to improve healthcare staff health and wellbeing: identification and response to local need, engagement of staff at all levels, and the involvement, visible leadership from, and up-skilling of, management and board-level staff. Objectives This systematic review aims to identify whole-system healthy workplace interventions in healthcare settings that incorporate (combinations of) these recommendations and determine whether they improve staff health and wellbeing. Methods A comprehensive and systematic search of medical, education, exercise science, and social science databases was undertaken. Studies were included if they reported the results of interventions that included all healthcare staff within a healthcare setting (e.g. whole hospital; whole unit, e.g. ward) in collective activities to improve physical or mental health or promote healthy behaviours. Results Eleven studies were identified which incorporated at least one of the whole-system recommendations. Interventions that incorporated recommendations to address local need and engage the whole workforce fell in to four broad types: 1) pre-determined (one-size-fits-all) and no choice of activities (two studies); or 2) pre-determined and some choice of activities (one study); 3) A wide choice of a range of activities and some adaptation to local needs (five studies); or, 3) a participatory approach to creating programmes responsive and adaptive to local staff needs that have extensive choice of activities to participate in (three studies). Only five of the interventions included substantial involvement and engagement of leadership and efforts aimed at up-skilling the leadership of staff to support staff health and wellbeing. Incorporation of more of the recommendations did not appear to be related to effectiveness. The heterogeneity of study designs, populations and outcomes excluded a meta-analysis. All studies were deemed by their authors to be at least partly effective. Two studies reported statistically significant improvement in objectively measured physical health (BMI) and eight in subjective mental health. Six studies reported statistically significant positive changes in subjectively assessed health behaviours. Conclusions This systematic review identified 11 studies which incorporate at least one of the Boorman recommendations and provides evidence that whole-system healthy workplace interventions can improve health and wellbeing and promote healthier behaviours in healthcare staff.	[Brand, Sarah L.; Fleming, Lora E.] Univ Exeter, European Ctr Environm & Human Hlth, Med Sch, Knowledge Spa,Royal Cornwall Hosp, Truro, Cornwall, England; [Brand, Sarah L.; Carroll, Lauren] Cardiff Univ, Sch Social Sci, Lab Publ Serv Innovat Lab Wales Y, Cardiff, S Glam, Wales; [Coon, Jo Thompson; Bethel, Alison; Wyatt, Katrina] Univ Exeter, Med Sch, St Lukes Campus, Exeter, Devon, England	Royal Cornwall Hospital; University of Exeter; Cardiff University; University of Exeter	Brand, SL (corresponding author), Univ Exeter, European Ctr Environm & Human Hlth, Med Sch, Knowledge Spa,Royal Cornwall Hosp, Truro, Cornwall, England.; Brand, SL (corresponding author), Cardiff Univ, Sch Social Sci, Lab Publ Serv Innovat Lab Wales Y, Cardiff, S Glam, Wales.	brands@cardiff.ac.uk	Fleming, Lora E/ABH-1310-2021; Coon, Jo Thompson/C-7923-2017	Fleming, Lora E/0000-0003-1076-9967; Coon, Jo Thompson/0000-0002-5161-0234; Bethel, Alison/0000-0002-0963-9201	European Regional Development Fund Programme; European Social Fund Convergence Programme for Cornwall; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula at the Royal Devon; Exeter NHS Foundation Trust	European Regional Development Fund Programme; European Social Fund Convergence Programme for Cornwall; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula at the Royal Devon; Exeter NHS Foundation Trust	Funding provided in part to the European Centre for Environment and Human Health (part of the University of Exeter Medical School) by the European Regional Development Fund Programme 2007 to 2013 (https://www.gov.uk/guidance/erdf-programmes-and-resources) and European Social Fund Convergence Programme for Cornwall and the Isles of Scilly (http://www.erdfconvergence.org.uk/esf). This research was also funded in part by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula (http//clahrc-peninsula.nihr.ac.uk/) at the Royal Devon and Exeter NHS Foundation Trust (http://www.rdehospital.nhs.uk/). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding provided in part to the European Centre for Environment and Human Health (part of the University of Exeter Medical School) by the European Regional Development Fund Programme 2007 to 2013 and European Social Fund Convergence Programme for Cornwall and the Isles of Scilly; and by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula at the Royal Devon and Exeter NHS Foundation Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	AbuAlRub RF, 2004, J NURS SCHOLARSHIP, V36, P73, DOI 10.1111/j.1547-5069.2004.04016.x; Black C., 2008, WORKING HLTH TOMORRO; Blake H, 2013, PERSPECT PUBLIC HEAL, V133, P262, DOI 10.1177/1757913913489611; Bodenheimer T, 2014, ANN FAM MED, V12, P573, DOI 10.1370/afm.1713; Bodenheimer T, 2009, HEALTH AFFAIR, V28, P64, DOI 10.1377/hlthaff.28.1.64; Boorman S, 2009, NHS HLTH WELL BEING; Centre for Reviews and Dissemination (CRD), 2009, CTR REV DISS; Cochrane Effective Practice and Organisation of Care Group, 2002, DAT COLL CHECKL; Cooper CL., 2017, HDB STRESS HLTH GUID; Corrigan J. M., 2004, 1 ANN CROSSING QUALI; Department of Health, 2011, NHS HLTH WELL BEING; Dobie A, 2016, AUSTRALAS PSYCHIATRY, V24, P42, DOI 10.1177/1039856215618524; Edwards D, 2003, J ADV NURS, V42, P169, DOI 10.1046/j.1365-2648.2003.02600.x; Hess I, 2011, HEALTH PROMOT J AUST, V22, P44, DOI 10.1071/HE11044; Jasperson DB., 2009, RADIOLOGY MANAGEMENT, V32, P48; Lee DJ, 2012, J OCCUP ENVIRON MED, V54, P497, DOI 10.1097/JOM.0b013e318247a379; Lemon SC, 2010, AM J PREV MED, V38, P27, DOI 10.1016/j.amepre.2009.08.028; McElligott D, 2010, J HOLIST NURS, V28, P175, DOI 10.1177/0898010110368860; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Nan Sun XZ, 2014, PLOSONE; Petterson IL, 1998, SOC SCI MED, V47, P1763, DOI 10.1016/S0277-9536(98)00245-7; Poland B, 2009, HEALTH PROMOT PRACT, V10, P505, DOI 10.1177/1524839909341025; Raiger Janet, 2005, J Transcult Nurs, V16, P71, DOI 10.1177/1043659604270980; Ruotsalainen J, 2008, SCAND J WORK ENV HEA, V34, P169, DOI 10.5271/sjweh.1240; Schaufeli W. B., 2003, S AFRICAN J IND PSYC, V29, P1, DOI DOI 10.4102/SAJIP.V29I4.127; Sikka R., 2015, QUADRUPLE AIM CARE H; Sorensen G, 1999, AM J PUBLIC HEALTH, V89, P54, DOI 10.2105/AJPH.89.1.54; Stevens S., 2014, 5 YEAR FORW VIEW; Uchiyama A, 2013, J OCCUP HEALTH, V55, P173, DOI 10.1539/joh.12-0228-OA; Wells G.A., 2011, NEWCASTLE OTTAWA SCA; Wieneke KC, 2016, AM J HEALTH BEHAV, V40, P215, DOI 10.5993/AJHB.40.2.6; Workforce and Facilities Team Health and Social Care Information Centre, 2014, NHS SICKN ABS RAT JA	32	69	70	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188418	10.1371/journal.pone.0188418	http://dx.doi.org/10.1371/journal.pone.0188418			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO7EC	29200422	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000417033200006
J	Liu, HH; Zhang, LW; Shi, M; Chen, L; Flanagan, JG				Liu, Hsin-Hua; Zhang, Liwei; Shi, Meng; Chen, Lu; Flanagan, John G.			Comparison of laser and circumlimbal suture induced elevation of intraocular pressure in albino CD-1 mice	PLOS ONE			English	Article							OCULAR HYPERTENSION; EXPERIMENTAL GLAUCOMA; MOUSE MODEL; GENERAL-ANESTHETICS; RODENT MODELS; OPTIC-NERVE; CELL LOSS; RATS; RETINA; PHOTOCOAGULATION	Animal models of ocular hypertension are important tools for glaucoma studies. Both acute transient models and chronic models of ocular hypertension may be useful to investigate specific aspects of neurodegeneration. In this study, we compare the intraocular pressure (IOP) and inner retinal changes induced by 1) laser photocoagulation of both episcleral veins and limbal vessels and 2) circumlimbal suture in CD-1 mice. The suture group is divided into 3 subgroups depending on the level of the immediate IOP spike (acute > 55 mmHg or chronic < 55 mmHg) and time period of monitoring (7 or 28 days). The laser group is followed for 7 days. IOP data show that it peaks at 5 hours and returns to normal level within 7 days in the laser group. In all suture groups, IOP spikes initially and decreases gradually, but it remains significantly elevated at 7 days. In 7 days, the acute suture model generates rapid loss of retinal nerve fiber layer (RNFL) and retinal ganglion cells (RGCs) when compared to the gradual loss by the chronic suture model, possibly due to retinal ischemia and reperfusion within the first few hours after treatment. The laser model falls between the acute suture and chronic suture models resulting in less RNFL and RGC loss than the acute suture model but significantly more loss than the chronic suture model. These results suggest that when using suture models of IOP elevation, it is critical to take the initial IOP spike into consideration and to choose between the acute and chronic models depending on respective research purposes.	[Liu, Hsin-Hua; Zhang, Liwei; Shi, Meng; Chen, Lu; Flanagan, John G.] Univ Calif Berkeley, Sch Optometry & Vis Sci, Berkeley, CA 94720 USA; [Liu, Hsin-Hua; Zhang, Liwei; Shi, Meng; Chen, Lu; Flanagan, John G.] Univ Calif Berkeley, Vis Sci Grad Program, Ctr Eye Dis & Dev, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Liu, HH (corresponding author), Univ Calif Berkeley, Sch Optometry & Vis Sci, Berkeley, CA 94720 USA.; Liu, HH (corresponding author), Univ Calif Berkeley, Vis Sci Grad Program, Ctr Eye Dis & Dev, Berkeley, CA 94720 USA.	edhhliu@gmail.com		zhang, liwei/0000-0002-4349-5360; Liu, Hsin-Hua/0000-0001-7215-0356				Adachi M, 1996, GRAEF ARCH CLIN EXP, V234, P445, DOI 10.1007/BF02539411; Bouhenni RA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/692609; Bui BV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070513; Cone FE, 2012, EXP EYE RES, V99, P27, DOI 10.1016/j.exer.2012.04.006; Devereux JG, 2000, ARCH OPHTHALMOL-CHIC, V118, P257; Ding C, 2011, EXP EYE RES, V92, P512, DOI 10.1016/j.exer.2011.03.016; Fan J, 2016, INVEST OPHTH VIS SCI, V57, P4476, DOI 10.1167/iovs.16-19717; Frankfort BJ, 2013, INVEST OPHTH VIS SCI, V54, P762, DOI 10.1167/iovs.12-10581; Fu CT, 2010, INVEST OPHTH VIS SCI, V51, P980, DOI 10.1167/iovs.09-4324; Gramlich OW, 2014, INVEST OPHTH VIS SCI, V55, P600, DOI 10.1167/iovs.13-12714; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Ishikawa M., 2015, BIOMED RES INT, V2015; Ito YA, 2016, JOVE-J VIS EXP, DOI 10.3791/53731; Jia LJ, 2000, INVEST OPHTH VIS SCI, V41, P3415; Johnson TV, 2008, J OCUL PHARMACOL TH, V24, P175, DOI 10.1089/jop.2007.0114; Johnson TV, 2010, BRAIN RES BULL, V81, P349, DOI 10.1016/j.brainresbull.2009.04.004; Joos KM, 2010, INVEST OPHTH VIS SCI, V51, P6431, DOI 10.1167/iovs.10-5212; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kipfer-Kauer A, 2010, CURR EYE RES, V35, P828, DOI 10.3109/02713683.2010.494240; Kong Y.X., 2012, NEUROBIOL AGING, V33, P1126; Levin-Arama M, 2016, J AM ASSOC LAB ANIM, V55, P794; Levkovitch-Verbin H, 2002, INVEST OPHTH VIS SCI, V43, P402; Liu HH, 2017, INVEST OPHTH VIS SCI, V58, P353, DOI 10.1167/iovs.16-20576; Liu HH, 2017, OPHTHAL PHYSL OPT, V37, P71, DOI 10.1111/opo.12331; Liu HH, 2015, INVEST OPHTH VIS SCI, V56, P2811, DOI 10.1167/iovs.14-16009; Morrison JC, 2008, PROG BRAIN RES, V173, P285, DOI 10.1016/S0079-6123(08)01121-7; Nguyen C, 2013, INVEST OPHTH VIS SCI, V54, P1767, DOI 10.1167/iovs.12-10952; Ou Y, 2016, J NEUROSCI, V36, P9240, DOI 10.1523/JNEUROSCI.0940-16.2016; Pang IH, 2007, J GLAUCOMA, V16, P483, DOI 10.1097/IJG.0b013e3181405d4f; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Reinhard J, 2017, SCI REP-UK, V7, DOI 10.1038/srep43470; Schmid H, 2014, INVEST OPHTH VIS SCI, V55, P2777, DOI 10.1167/iovs.13-13372; SHAREEF SR, 1995, EXP EYE RES, V61, P379, DOI 10.1016/S0014-4835(05)80131-9; Shen HH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164035; Smith R S, 2001, BMC Dev Biol, V1, P3, DOI 10.1186/1471-213X-1-3; Steinhart MR, 2014, EXP EYE RES, V119, P54, DOI 10.1016/j.exer.2013.12.008; Ueda J, 1998, JPN J OPHTHALMOL, V42, P337, DOI 10.1016/S0021-5155(98)00026-4; Urcola JH, 2006, EXP EYE RES, V83, P429, DOI 10.1016/j.exer.2006.01.025; Werling D, 2016, INVEST OPHTH VIS SCI, V57, P6683, DOI 10.1167/iovs.16-20630; Yun HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107446; Zhang LW, 2017, INVEST OPHTH VIS SCI, V58, P3879, DOI 10.1167/iovs.16-20807; Zhao Da, 2017, Front Neurosci, V11, P41, DOI 10.3389/fnins.2017.00041	42	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0189094	10.1371/journal.pone.0189094	http://dx.doi.org/10.1371/journal.pone.0189094			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190824	Green Published, Green Submitted, gold			2022-12-27	WOS:000416841900200
J	Diaz, G				Diaz, Giacomo			Contour recognition of complex leaf shapes	PLOS ONE			English	Article							ELLIPTIC FOURIER-ANALYSIS; FEATURES	The leaf shape is an important taxonomic character. Compared to the classic morphological leaf features such as veins, margin indentations, sinuses, etc., the shape is simpler to obtain by using the 'magic wand' or other contouring tools that are available in most of imaging applications. The only exception is when leaves develop large lobes that get in touch or overlap each other, as the presence of hidden or closed portions of the leaf border precludes the application of automatic methods and forces the leaf contour to be traced manually. This is a time consuming and relatively accurate operation that, nevertheless, can not be avoided, as overlapping lobes are characteristic features of the leaves of several plant species and varieties. The method described in the paper overcomes this problem as it allows the leaf contour to be achieved even in the presence of touching or overlapping lobes. The method involves three steps: (1) the acquisition of leaf images using a transilluminator, (2) a two-level image segmentation that allows all leaf components (blade, overlapping lobes and closed sinuses) to be represented in a single binary image, and (3) the contouring and concatenation of all binary outlines in a single, self-intersecting closed contour that reproduces accurately the leaf shape. The method can be extended to acquire the shape of leaves of herbarium specimens, that are often overlapped but can not be easily handled and repositioned because of their extreme fragility and relevant taxonomic value.	[Diaz, Giacomo] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy	University of Cagliari	Diaz, G (corresponding author), Univ Cagliari, Dept Biomed Sci, Cagliari, Italy.	gdiaz@unica.it		DIAZ, GIACOMO/0000-0003-1214-2383				Bylesjo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-82; Chitwood DH, 2016, NEW PHYTOL, V210, P343, DOI 10.1111/nph.13754; Chitwood DH, 2014, PLANT PHYSIOL, V164, P259, DOI 10.1104/pp.113.229708; Corney DPA, 2012, TAXON, V61, P231, DOI 10.1002/tax.611016; DIAZ G, 1989, COMPUT BIOMED RES, V22, P405, DOI 10.1016/0010-4809(89)90034-7; DIAZ G, 1991, Journal International des Sciences de la Vigne et du Vin, V25, P37; Du JX, 2013, NEUROCOMPUTING, V116, P150, DOI 10.1016/j.neucom.2012.03.028; Jensen RJ, 2002, TAXON, V51, P475, DOI 10.2307/1554860; KAPUR JN, 1985, COMPUT VISION GRAPH, V29, P273, DOI 10.1016/0734-189X(85)90125-2; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Mancuso S, 1999, VITIS, V38, P73; Mokhtarian F, 2004, IEEE T IMAGE PROCESS, V13, P653, DOI 10.1109/TIP.2004.826126	12	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189427	10.1371/journal.pone.0189427	http://dx.doi.org/10.1371/journal.pone.0189427			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220401	Green Submitted, Green Published, gold			2022-12-27	WOS:000417469900057
J	Irons, JL; Jeon, M; Leber, AB				Irons, Jessica L.; Jeon, Minjeong; Leber, Andrew B.			Pre-stimulus pupil dilation and the preparatory control of attention	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; LOCUS-COERULEUS; VISUAL-SEARCH; COGNITIVE CONTROL; NEURONAL-ACTIVITY; ADAPTIVE GAIN; NEURAL BASIS; TASK; CONFLICT; SIZE	Task preparation involves multiple component processes, including a general evaluative process that signals the need for adjustments in control, and the engagement of task-specific control settings. Here we examined the dynamics of these different mechanisms in preparing the attentional control system for visual search. We explored preparatory activity using pupil dilation, a well-established measure of task demands and effortful processing. In an initial exploratory experiment, participants were cued at the start of each trial to search for either a salient color singleton target (an easy search task) or a low-salience shape singleton target (a difficult search task). Pupil dilation was measured during the preparation period from cue onset to search display onset. Mean dilation was larger in preparation for the difficult shape target than the easy color target. In two additional experiments, we sought to vary effects of evaluative processing and task-specific preparation separately. Experiment 2 showed that when the color and shape search tasks were matched for difficulty, the shape target no longer evoked larger dilations, and the pattern of results was in fact reversed. In Experiment 3, we manipulated difficulty within a single feature dimension, and found that the difficult search task evoked larger dilations. These results suggest that pupil dilation reflects expectations of difficulty in preparation for a search task, consistent with the activity of an evaluative mechanism. We did not find consistent evidence for relationship between pupil dilation and search performance (accuracy and response timing), suggesting that pupil dilation during search preparation may not be strongly linked to ongoing task-specific preparation.	[Irons, Jessica L.; Leber, Andrew B.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Jeon, Minjeong] Univ Calif Los Angeles, Grad Sch Educ & Informat Studies, Los Angeles, CA USA	University System of Ohio; Ohio State University; University of California System; University of California Los Angeles	Irons, JL; Leber, AB (corresponding author), Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA.	irons.39@osu.edu; leber.30@osu.edu	Leber, Andrew B/F-1887-2010	Leber, Andrew B/0000-0002-3537-1093; Irons, Jessica/0000-0002-0671-5168	National Science Foundation Perception, Action & Cognition grant [BCS-1632296]; NSF [BCS-1632296]	National Science Foundation Perception, Action & Cognition grant; NSF(National Science Foundation (NSF))	This work was supported by a National Science Foundation (https.//www.nst.gov/) Perception, Action & Cognition grant (BCS-1632296) awarded to ABL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support was provided by NSF BCS-1632296 to A.B.L. We thank Lisa Heisterberg for help with data collection. We also thank Antonino Vallesi and two anonymous reviewers for their valuable comments on the manuscript.	ALLPORT A, 1994, ATTENTION PERFORM, V15, P421; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Aston-Jones G., 2002, SOC NEUR ABSTR, V2002, P86; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Boehler CN, 2011, J NEUROSCI, V31, P4955, DOI 10.1523/JNEUROSCI.4845-10.2011; Botvinick M, 2015, ANNU REV PSYCHOL, V66, P83, DOI 10.1146/annurev-psych-010814-015044; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Cavanagh JF, 2014, J EXP PSYCHOL GEN, V143, P1476, DOI 10.1037/a0035813; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Chiew KS, 2016, J EXP PSYCHOL HUMAN, V42, P52, DOI 10.1037/xhp0000129; Chiew KS, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00015; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Ebitz RB, 2015, NEURON, V85, P628, DOI 10.1016/j.neuron.2014.12.053; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Floden D, 2011, J COGNITIVE NEUROSCI, V23, P867, DOI 10.1162/jocn.2010.21492; Folk CL, 1998, J EXP PSYCHOL HUMAN, V24, P847, DOI 10.1037/0096-1523.24.3.847; Giesbrecht B, 2006, BRAIN RES, V1080, P63, DOI 10.1016/j.brainres.2005.09.068; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Goldinger SD, 2012, CURR DIR PSYCHOL SCI, V21, P90, DOI 10.1177/0963721412436811; HESS EH, 1964, SCIENCE, V143, P1190, DOI 10.1126/science.143.3611.1190; HESS EH, 1960, SCIENCE, V132, P349, DOI 10.1126/science.132.3423.349; Ives HE, 1912, PHILOS MAG, V24, P149, DOI 10.1080/14786440708637317; Joshi S, 2016, NEURON, V89, P221, DOI 10.1016/j.neuron.2015.11.028; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Kahneman D., 1973, ATTENTION EFFORT; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Leber AB, 2010, J NEUROSCI, V30, P11458, DOI 10.1523/JNEUROSCI.0809-10.2010; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mathot S, 2015, J EXP PSYCHOL GEN, V144, P513, DOI 10.1037/a0039168; Nassar MR, 2012, NAT NEUROSCI, V15, P1040, DOI 10.1038/nn.3130; Peelena MV, 2011, P NATL ACAD SCI USA, V108, P12125, DOI 10.1073/pnas.1101042108; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Porter G, 2007, Q J EXP PSYCHOL, V60, P211, DOI 10.1080/17470210600673818; Porter G, 2010, CORTEX, V46, P621, DOI 10.1016/j.cortex.2009.04.013; Porter G, 2010, CORTEX, V46, P637, DOI 10.1016/j.cortex.2009.04.014; Privitera CM, 2010, J VISION, V10, DOI 10.1167/10.10.3; Rajkowski J., 2000, SOC NEUR ABSTR, V26, P838; RICHER F, 1985, PSYCHOPHYSIOLOGY, V22, P204, DOI 10.1111/j.1469-8986.1985.tb01587.x; RICHER F, 1983, J EXP PSYCHOL HUMAN, V9, P360, DOI 10.1037/0096-1523.9.3.360; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Siegle GJ, 2008, PSYCHOPHYSIOLOGY, V45, P679, DOI 10.1111/j.1469-8986.2008.00681.x; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; Stokes M, 2009, P NATL ACAD SCI USA, V106, P19569, DOI 10.1073/pnas.0905306106; TAYLOR MM, 1967, J ACOUST SOC AM, V41, P782, DOI 10.1121/1.1910407; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; Vallesi A, 2014, BRAIN RES, V1579, P65, DOI 10.1016/j.brainres.2014.07.018; van Steenbergen H, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00215; VanRullen R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00060; Vo MLH, 2008, PSYCHOPHYSIOLOGY, V45, P130, DOI 10.1111/j.1469-8986.2007.00606.x; Walton ME, 2003, J NEUROSCI, V23, P6475; Wang CA, 2015, EUR J NEUROSCI, V41, P1102, DOI 10.1111/ejn.12883; Yantis S, 2008, CURR DIR PSYCHOL SCI, V17, P86, DOI 10.1111/j.1467-8721.2008.00554.x	58	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188787	10.1371/journal.pone.0188787	http://dx.doi.org/10.1371/journal.pone.0188787			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP2SV	29220361	Green Published, gold, Green Submitted			2022-12-27	WOS:000417469900017
J	Papegaaij, S; Hortobagyi, T; Godde, B; Kaan, WA; Erhard, P; Voelcker-Rehage, C				Papegaaij, Selma; Hortobagyi, Tibor; Godde, Ben; Kaan, Wim A.; Erhard, Peter; Voelcker-Rehage, Claudia			Neural correlates of motor-cognitive dual-tasking in young and old adults	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; BRAIN ACTIVITY; FUNCTIONAL NEUROANATOMY; BALANCE PERFORMANCE; ATTENTIONAL DEMANDS; PHYSICAL-ACTIVITY; WORKING-MEMORY; WALKING SPEED; SINGLE-TASK; INTERFERENCE	When two tasks are performed simultaneously, performance often declines in one or both tasks. These so-called dual-task costs are more pronounced in old than in young adults. One proposed neurological mechanism of the dual-task costs is that old compared with young adults tend to execute single-tasks with higher brain activation. In the brain regions that are needed for both tasks, the reduced residual capacity may interfere with performance of the dual-task. This competition for shared brain regions has been called structural interference. The purpose of the study was to determine whether structural interference indeed plays a role in the age-related decrease in dual-task performance. Functional magnetic resonance imaging (fMRI) was used to investigate 23 young adults (20-29 years) and 32 old adults (66-89 years) performing a calculation (serial subtraction by seven) and balance-simulation (plantar flexion force control) task separately or simultaneously. Behavioral performance decreased during the dual-task compared with the single-tasks in both age groups, with greater dual-task costs in old compared with young adults. Brain activation was significantly higher in old than young adults during all conditions. Region of interest analyses were performed on brain regions that were active in both tasks. Structural interference was apparent in the right insula, as quantified by an age-related reduction in upregulation of brain activity from single-to dual-task. However, the magnitude of upregulation did not correlate with dual-task costs. Therefore, we conclude that the greater dual-task costs in old adults were probably not due to increased structural interference.	[Papegaaij, Selma; Hortobagyi, Tibor; Kaan, Wim A.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Godde, Ben; Voelcker-Rehage, Claudia] Jacobs Univ Bremen, Jacobs Ctr Lifelong Learning & Inst Dev, Bremen, Germany; [Erhard, Peter] Univ Bremen, Brain Res Inst, Bremen, Germany; [Voelcker-Rehage, Claudia] Tech Univ Chemnitz, Fac Behav & Social Sci, Inst Human Movement Sci & Hlth, Chemnitz, Germany	University of Groningen; Jacobs University; University of Bremen; Technische Universitat Chemnitz	Papegaaij, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.; Voelcker-Rehage, C (corresponding author), Jacobs Univ Bremen, Jacobs Ctr Lifelong Learning & Inst Dev, Bremen, Germany.; Voelcker-Rehage, C (corresponding author), Tech Univ Chemnitz, Fac Behav & Social Sci, Inst Human Movement Sci & Hlth, Chemnitz, Germany.	selmapapegaaij@gmail.com; claudia.voelcker-rehage@hsw.tu-chemnitz.de	Voelcker-Rehage, Claudia/ABA-2163-2020; Godde, Ben/F-5045-2013	Voelcker-Rehage, Claudia/0000-0001-5398-4099; Godde, Ben/0000-0001-9101-7286	Gratama Stichting [2014-08]; Graduate School of Medical Sciences [653013]	Gratama Stichting; Graduate School of Medical Sciences	This work was supported by the Gratama Stichting (2014-08, http://www.gratama.net/) and by a startup fund from the Graduate School of Medical Sciences (653013, http://www.rug.nl/research/gradschool-medical-sciences/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock RA, 2000, P NATL ACAD SCI USA, V97, P3567, DOI 10.1073/pnas.060588897; Amaro E, 2006, BRAIN COGNITION, V60, P220, DOI 10.1016/j.bandc.2005.11.009; Beauchet O, 2009, EUR J NEUROL, V16, P786, DOI 10.1111/j.1468-1331.2009.02612.x; Beauchet O, 2008, J AM GERIATR SOC, V56, P1265, DOI 10.1111/j.1532-5415.2008.01766.x; Bock O, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-27; Boisgontier MP, 2013, NEUROSCI BIOBEHAV R, V37, P1824, DOI 10.1016/j.neubiorev.2013.07.014; Cabeza R, 2001, SCAND J PSYCHOL, V42, P277, DOI 10.1111/1467-9450.00237; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cherry B., 2005, AGING NEUROPSYCHOL; Cowell SF, 2000, NEUROIMAGE, V12, P565, DOI 10.1006/nimg.2000.0640; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Damian AM, 2011, DEMENT GERIATR COGN, V31, P126, DOI 10.1159/000323867; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Dreher JC, 2003, CEREB CORTEX, V13, P329, DOI 10.1093/cercor/13.4.329; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; Fera F, 2005, J NEUROSCI, V25, P11340, DOI 10.1523/JNEUROSCI.2736-05.2005; Gill DP, 2016, MED SCI SPORT EXER, V48, P297, DOI 10.1249/MSS.0000000000000758; Goble DJ, 2011, J NEUROSCI, V31, P16344, DOI 10.1523/JNEUROSCI.4159-11.2011; Godde B, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00139; Granacher U, 2011, SPORTS MED, V41, P377, DOI 10.2165/11539920-000000000-00000; Hamacher D, 2015, NEUROSCI BIOBEHAV R, V57, P310, DOI 10.1016/j.neubiorev.2015.08.002; Hartley AA, 2001, PSYCHOL AGING, V16, P47, DOI 10.1037//0882-7974.16.1.47; Herath P, 2001, CEREB CORTEX, V11, P796, DOI 10.1093/cercor/11.9.796; Heuninckx S, 2008, J NEUROSCI, V28, P91, DOI 10.1523/JNEUROSCI.3300-07.2008; Hoaglin D.C., 1987, J AM STAT ASS; Jahn K, 2004, NEUROIMAGE, V22, P1722, DOI 10.1016/j.neuroimage.2004.05.017; Johannsen L, 2013, NEUROPSYCHOLOGIA, V51, P2142, DOI 10.1016/j.neuropsychologia.2013.07.009; Just MA, 2001, NEUROIMAGE, V14, P417, DOI 10.1006/nimg.2001.0826; Just MA, 2008, BRAIN RES, V1205, P70, DOI 10.1016/j.brainres.2007.12.075; Karim HT, 2014, BRAIN RES, V1555, P20, DOI 10.1016/j.brainres.2014.01.033; Kenny RA, 2013, J AM GERIATR SOC, V61, pS279, DOI [10.1111/jgs.12195, 10.1111/jgs.12200]; Klingberg T, 1997, COGNITIVE BRAIN RES, V6, P1, DOI 10.1016/S0926-6410(97)00010-4; Kong H, 2005, COGNITIVE BRAIN RES, V22, P397, DOI 10.1016/j.cogbrainres.2004.09.011; Kouzaki M, 2010, MUSCLE NERVE, V42, P78, DOI 10.1002/mus.21599; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Langan J, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00017; Maki BE, 1996, J VESTIBUL RES-EQUIL, V6, P53, DOI 10.1016/0957-4271(95)00014-3; Maquestiaux F, 2004, PSYCHOL AGING, V19, P649, DOI 10.1037/0882-7974.19.4.649; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; Maylor EA, 1996, J GERONTOL B-PSYCHOL, V51, pP143, DOI 10.1093/geronb/51B.3.P143; McGregor KM, 2011, BEHAV BRAIN RES, V222, P158, DOI 10.1016/j.bbr.2011.03.042; Mello EM, 2013, HUM MOVEMENT SCI, V32, P1310, DOI 10.1016/j.humov.2013.05.004; Menant JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109802; NAVON D, 1987, J EXP PSYCHOL HUMAN, V13, P435, DOI 10.1037/0096-1523.13.3.435; Ni YR, 2011, BRAIN RES BULL, V86, P395, DOI 10.1016/j.brainresbull.2011.08.016; Niemann C, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9837321; Nijboer M, 2014, NEUROIMAGE, V100, P60, DOI 10.1016/j.neuroimage.2014.05.082; Nijboer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079583; O'Caoimh R, 2016, J ALZHEIMERS DIS, V51, P619, DOI 10.3233/JAD-150881; Ouchi Y, 1999, BRAIN, V122, P329, DOI 10.1093/brain/122.2.329; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; Papegaaij S., 2014, FRONTIERS AGING NEUR, V6; Park DC, 2004, P NATL ACAD SCI USA, V101, P13091, DOI 10.1073/pnas.0405148101; Park DC, 2013, PERSPECT PSYCHOL SCI, V8, P62, DOI 10.1177/1745691612469034; PASHLER H, 1984, J EXP PSYCHOL HUMAN, V10, P358, DOI 10.1037/0096-1523.10.3.358; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Prosperini L, 2015, GAIT POSTURE, V41, P780, DOI 10.1016/j.gaitpost.2015.02.002; Reuter-Lorenz PA, 1999, PSYCHOL SCI, V10, P494, DOI 10.1111/1467-9280.00195; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Riecker A, 2006, NEUROIMAGE, V32, P1345, DOI 10.1016/j.neuroimage.2006.05.021; Riley MA, 2005, J MOTOR BEHAV, V37, P311, DOI 10.3200/JMBR.37.4.311-324; Ruffieux J, 2015, SPORTS MED, V45, P1739, DOI 10.1007/s40279-015-0369-9; Salo E, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00102; Salvucci DD, 2008, PSYCHOL REV, V115, P101, DOI 10.1037/0033-295X.115.1.101; Samanez-Larkin GR, 2008, SOC COGN AFFECT NEUR, V3, P290, DOI 10.1093/scan/nsn029; Schubert T, 2003, COGNITIVE BRAIN RES, V17, P733, DOI 10.1016/S0926-6410(03)00198-8; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Shinkai S, 2000, AGE AGEING, V29, P441, DOI 10.1093/ageing/29.5.441; Sigman M, 2005, PLOS BIOL, V3, P334, DOI 10.1371/journal.pbio.0030037; Silsupadol P, 2009, ARCH PHYS MED REHAB, V90, P381, DOI 10.1016/j.apmr.2008.09.559; Siu KC, 2007, GAIT POSTURE, V25, P121, DOI 10.1016/j.gaitpost.2006.02.002; Sosnoff JJ, 2014, DISABIL REHABIL, V36, P205, DOI 10.3109/09638288.2013.782361; Stelzel C, 2011, PSYCHOL RES-PSYCH FO, V75, P476, DOI 10.1007/s00426-011-0368-x; Szameitat AJ, 2002, J COGNITIVE NEUROSCI, V14, P1184, DOI 10.1162/089892902760807195; Szameitat AJ, 2011, NEUROIMAGE, V54, P1765, DOI 10.1016/j.neuroimage.2010.07.069; Talley KMC, 2014, J AGING HEALTH, V26, P616, DOI 10.1177/0898264314526619; Taube W, 2015, CORTEX, V64, P102, DOI 10.1016/j.cortex.2014.09.022; TEASDALE N, 1993, EXP AGING RES, V19, P1, DOI 10.1080/03610739308253919; Tukey J. W., 1977, EXPLORATORY DATA ANA; Van Impe A, 2013, AGE, V35, P2111, DOI 10.1007/s11357-012-9499-2; Van Impe A, 2011, NEUROPSYCHOLOGIA, V49, P2400, DOI 10.1016/j.neuropsychologia.2011.04.016; Vansteensel MJ, 2014, HUM BRAIN MAPP, V35, P5903, DOI 10.1002/hbm.22593; Voelcker-Rehage C, 2007, J GERONTOL B-PSYCHOL, V62, pP141, DOI 10.1093/geronb/62.3.P141; Voelcker-Rehage C, 2006, AGING NEUROPSYCHOL C, V13, P366, DOI 10.1080/138255890969339; Waldron-Perrine B., 2012, INT J; Walshe EA, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00200; Wang XQ, 2015, AGE AGEING, V44, P205, DOI 10.1093/ageing/afu175; Ward NS, 2003, BRAIN, V126, P873, DOI 10.1093/brain/awg071; Wollesen B, 2015, AGING CLIN EXP RES, V27, P447, DOI 10.1007/s40520-014-0301-4; Wu T, 2008, J NEUROL NEUROSUR PS, V79, P760, DOI 10.1136/jnnp.2007.126599; Wu T, 2013, NEUROIMAGE, V65, P466, DOI 10.1016/j.neuroimage.2012.10.004; Zwergal A, 2012, NEUROBIOL AGING, V33, P1073, DOI 10.1016/j.neurobiolaging.2010.09.022	93	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189025	10.1371/journal.pone.0189025	http://dx.doi.org/10.1371/journal.pone.0189025			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP2SV	29220349	Green Published, gold, Green Submitted			2022-12-27	WOS:000417469900027
J	Falcucci, A; Conard, NJ; Peresani, M				Falcucci, Armando; Conard, Nicholas J.; Peresani, Marco			A critical assessment of the Protoaurignacian lithic technology at Fumane Cave and its implications for the definition of the earliest Aurignacian	PLOS ONE			English	Article							UPPER PALEOLITHIC TRANSITION; HUMAN-CLIMATE INTERACTION; MODERN HUMANS; CULTURAL INNOVATIONS; PROTO-AURIGNACIAN; ADAPTIVE SHIFT; MIDDLE; EUROPE; CHRONOLOGY; DISPERSAL	In the scenario of the spread of the anatomically modern humans (AMHs) into Europe, the techno-complex known as Protoaurignacian is defined by the production of blades and bladelets within a single and continuous stone knapping sequence from the same core as the result of its progressive reduction. However, the growing re-evaluation of some assemblages is revealing that bladelets are frequently obtained from independent reduction sequences, hence discouraging the direct application of the model developed in southwestern France. High-resolution regional signatures are thus needed to reconstruct a more accurate portrait of the AMH colonization dynamic. Northeastern Italy, with the key site of Fumane Cave, is one among the regions of Mediterranean Europe worthy of consideration for reconstructing this colonization process and its cultural dynamics. Within the framework of a critical discussion of the technological definition of the Protoaurignacian and its relationship with contemporaneous industries on a regional and supra-regional scale, we present the results of a detailed analysis of the lithic technology from units A2-A1 based on reduction sequence and attribute analyses. Results show that bladelets are the first goal of production and they do not originate from reduced blade cores but from a broad range of independent and simultaneous core reduction strategies. One implication is that the most commonly used technological trait that is said to define the Protoaurignacian has been over-emphasized and that the Protoaurignacian is technologically consistent across its geographical extent. Additional data based on carinated core technology imply that this techno-complex shares a common technological background with the Early Aurignacian and that no features are restricted to one of the two facies. Furthermore, the major difference between the Protoaurignacian and Early Aurignacian appears to be more typological in nature, with retouched bladelets being less common in the Early Aurignacian.	[Falcucci, Armando; Conard, Nicholas J.] Univ Tubingen, Dept Early Prehist & Quaternary Ecol, Tubingen, Germany; [Conard, Nicholas J.] Tubingen Senckenberg Ctr Human Evolut & Paleoecol, Tubingen, Germany; [Peresani, Marco] Univ Ferrara, Dipartimento Studi Umanistici, Sez Sci Preistor & Antropol, Ferrara, Italy	Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Ferrara	Falcucci, A (corresponding author), Univ Tubingen, Dept Early Prehist & Quaternary Ecol, Tubingen, Germany.; Peresani, M (corresponding author), Univ Ferrara, Dipartimento Studi Umanistici, Sez Sci Preistor & Antropol, Ferrara, Italy.	armando.falcucci@ifu.uni-tuebingen.de; marco.peresani@unife.it	Falcucci, Armando/ABD-3390-2020; Peresani, Marco/X-1343-2019	Conard, Nicholas/0000-0002-4633-0385; Falcucci, Armando/0000-0002-3255-1005; Peresani, Marco/0000-0001-6562-6336	Ministry of Culture - Veneto Archaeological Superintendency; Lessinia Mountain Community - Regional Natural Park; Fumane Municipality; Leakey Foundation; Deutsche Forschungsgemeinschaft; Tuebingen University	Ministry of Culture - Veneto Archaeological Superintendency; Lessinia Mountain Community - Regional Natural Park; Fumane Municipality; Leakey Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University	Research at Fumane is coordinated by the Ferrara University in the framework of a project supported by the Ministry of Culture - Veneto Archaeological Superintendency, public institutions (Lessinia Mountain Community - Regional Natural Park, Fumane Municipality), Foundations (Leakey Foundation, Spring 2015 Grant), and private associations and companies. The doctoral studies of Armando Falcucci are founded by the state of Baden-Wurttemberg and the University of Tuebingen. The authors acknowledge support by the Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, SYSTEMES MOBILITE PR; Andrefsky W., 1998, LITHICS MACROSCOPIC; Arrizabalaga A., 2000, HIENAS HUMANOS ALBOR; Aurignacien Hahn J., 1977, FUNDAMENTA; Bailey SE, 2009, J HUM EVOL, V57, P11, DOI 10.1016/j.jhevol.2009.02.003; Banks WE, 2013, J HUM EVOL, V64, P232, DOI 10.1016/j.jhevol.2013.01.001; Bar-Yosef O., 2012, NEANDERTHALS MODERN, P467; Barshay-Szmidt C, 2013, PALEO, V23, P1; Bartolomei G., 1992, ANNUARIO STORICO VAL, P9; Bataille G., 2012, FLAKES NOT BLADES RO, V5, P261; Bataille G., 2017, MITTEILUNGEN GESELLS, V25, P49; Bazile F., PRODUCTIONS LAMELLAI; Becerra-Valdivia L, 2017, J HUM EVOL, V109, P57, DOI 10.1016/j.jhevol.2017.05.011; Benazzi S, 2015, SCIENCE, V348, P793, DOI 10.1126/science.aaa2773; Benazzi S, 2014, J HUM EVOL, V70, P61, DOI 10.1016/j.jhevol.2014.03.001; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; Bertola S., 2001, CONTRIBUTO ALLO STUD; Bertola S., 2013, PREIST ALP, V47, P17; Bietti A, 2008, ARCH I PALEONTOLOGIE, V39, P133; Boeda E., 1990, PAL O, V2, P43, DOI DOI 10.3406/PAL.1990.988; BOLUS M., 2012, WISSENSCHAFTLICHE SC, V5, P153; Bon F., 2006, AUTOUR CONCEPTS PROT; Bon F., 2005, PRODUCTIONS LAMELLAI, P479; Bon F., 2002, ALAUDA, P29; Bon F, AURIGNACIEN GROTTE R; Bon F., 2010, AURIGNACIENS, P46; Bordes JG, 2002, J HUM EVOL, V42, pA7; Bordes JG, TRABALHOS ARQUEOLOGI, P45; BORDES JG, 2005, MUSEE NATL HIST ART, V1, P123; Breuil H., 1912, C INT ANTHR ARCH PRE; Broglio A, 2005, PITTURE PALEOLITICHE; Broglio A., 2006, KOSTENKI EARLY UPPER, P263; Broglio A, 2003, BRIT ARCHAEOLOGICAL, P93; Broglio A, 2006, CAHIERS TYPOLOGIE AN; Broglio A, PRODUCTIONS LAMELLAI, P415; Broglio A, 2009, ANTHROPOLOGIE, V113, P753, DOI 10.1016/j.anthro.2009.09.016; Cavallo G, ARCHAEOMETR IN PRESS; Cavallo G, 2017, GEOARCHAEOLOGY, V32, P437, DOI 10.1002/gea.21617; Chiotti L., 2005, BAR INT SERIES; Conard N, 2015, SCIENCE; Conard N., 2006, TRABALHOS ARQUEOLOGI, P219; Conard N.J., 2002, TERRA NOSTRA, V6, P82; Conard NJ, 2009, NATURE, V459, P248, DOI 10.1038/nature07995; Conard NJ, 1997, J ANTHROPOL RES, V53, P147, DOI 10.1086/jar.53.2.3631275; Conard NJ, 2004, S AFR ARCHAEOL BULL, V59, P12, DOI 10.2307/3889318; Conard NJ, 2003, J HUM EVOL, V44, P331, DOI 10.1016/S0047-2484(02)00202-6; Conard NJ., 2011, SAND SEA ARCHAEOLOGY, P33; Dauvois M, 1976, PERIGUEUX; Davies W., 2007, RETHINKING HUMAN REV, P263; Davies W., 2008, PRAEHISTORIA, V9, P35; Davies W, 2015, QUATERNARY SCI REV, V118, P211, DOI 10.1016/j.quascirev.2014.12.003; de Sonneville-Bordes D, 1960, PALEOLITHIQUE SUPERI, P11; Demars P.-Y., 1992, TYPES OUTILS LITHIQU; Demidenko YE, 2012, LATE MIDDLE PALEOLIT; Dini M, 2012, ANTHROPOLOGIE, V116, P550, DOI 10.1016/j.anthro.2012.10.003; Douka K, 2014, J HUM EVOL, V68, P1, DOI 10.1016/j.jhevol.2013.12.007; Douka K, 2012, J HUM EVOL, V62, P286, DOI 10.1016/j.jhevol.2011.11.009; Driscoll K, 2014, J ARCHAEOL SCI, V47, P134, DOI 10.1016/j.jas.2014.04.008; Falcucci A, 2016, ARCHAEOLOGICAL ANTHR; Falcucci A, PROTOAURIGNACIAN COR; Fiore I, 2004, INT J OSTEOARCHAEOL, V14, P273, DOI 10.1002/oa.761; Gambassini P., 1997, PALEOLITICO CASTELCI; Garrod D., 1938, P PREHISTORIC SOC, VIV, P1; Ghasidian E, 2017, J ANTHROPOL ARCHAEOL, V47, P33, DOI 10.1016/j.jaa.2017.03.001; Goring-Morris N, 2003, MORE MEETS EYE STUDI; Grimaldi S, 2014, QUARTAR, V61, P113, DOI DOI 10.7485/QU61_; Gurioli F, 2005, 4 CONV NAZ ARCH PORD, P59; Higham T, 2012, J HUM EVOL, V62, P664, DOI 10.1016/j.jhevol.2012.03.003; Higham T, 2009, QUATERNARY SCI REV, V28, P1257, DOI 10.1016/j.quascirev.2008.12.018; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Higham T, 2013, J HUM EVOL, V65, P806, DOI 10.1016/j.jhevol.2013.06.010; Hoffecker JF, 2009, P NATL ACAD SCI USA, V106, P16040, DOI 10.1073/pnas.0903446106; HOLM S, 1979, SCAND J STAT, V6, P65; Hublin JJ, 2015, QUATERNARY SCI REV, V118, P194, DOI 10.1016/j.quascirev.2014.08.011; Inizan M.-L., 1995, TECHNOLOGIE PIERRE T; J-G Bordes, 2002, INTERSTRATIFICATIONS; J-P Chadelle, 2005, PRODUCTIONS LAMELLAI, P193; Kadowaki S, 2015, J HUM EVOL, V82, P67, DOI 10.1016/j.jhevol.2015.02.017; Kuhn SL, 1998, CURR ANTHROPOL, V39, pS175, DOI 10.1086/204694; Laplace G, 1966, RECHERCHES ORIGINE E; Le Brun-Ricalens F, PRODUCTIONS LAMELLAI; LE BRUN-RICALENS F., 1993, PALEO, V5, P127; Le Brun-Ricalens F, CHRONIQUE RECONNAISS; Le Brun-Ricalens F., 2009, MEDITERRANEAN 50 000, P11; Le Brun-Ricalens F, 1990, B SOC PREHIST FRANCA, V87, P275; LeBrun-Ricalens F., 2005, PRODUCTIONS LAMELLAI, P157; Magnani M, 2014, J ARCHAEOL SCI, V46, P37, DOI 10.1016/j.jas.2014.02.029; Maillo-Fernandez J.-M., 2012, WISSENSCHAFTLICHE SC, P69; Maillo-Fernandez JM, 2006, TRABALHOS ARQUEOLOGI; Maillo-Fernandez JM, 2003, TRANSICION PALEOLITI; MAILLOFERNANDEZ JM, 2005, PRODUCTIONS LAMELLAI, P339; Lopez-Garcia JM, 2015, QUATERNARY SCI REV, V128, P1, DOI 10.1016/j.quascirev.2015.09.013; Maroto J., 1996, LAST NEANDERTALS 1 A, P219; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Mellars P, 2004, NATURE, V432, P461, DOI 10.1038/nature03103; Mellars P, 2006, EVOL ANTHROPOL, V15, P167, DOI 10.1002/evan.20103; Moreau L, 2015, J HUM EVOL, V78, P158, DOI 10.1016/j.jhevol.2014.09.007; Nigst P. R., 2012, EARLY UPPER PALAEOLI; Nigst PR, 2014, P NATL ACAD SCI USA, V111, P14394, DOI 10.1073/pnas.1412201111; Normand C, C CENT SOC PREH QUE; Normand C., 2006, AUTOUR CONCEPTS PROT; Normand C., 2005, PRODUCTIONS LAMELLAI, P375; Normand C., 2008, PALETHNOLOGIE, V1, P7; Odell GH, 2004, LITHIC ANAL; Ortega Cobos D, PRODUCTIONS LAMELLAI; Otte M, 2004, ANTHROPOLOGIE, V108, P395, DOI 10.1016/j.anthro.2004.10.005; Paris C., 2005, PRODUCTION LAMELLES; Pelegrin J., 2000, MEMOIRES PREHISTOIRE, P73; Pelegrin J., 1995, CAHIERS QUATERNAIRE, V20, P297; Peresani M., 2008, CURR ANTHROPOL, V49, P725, DOI DOI 10.1086/588540; Peresani M, 2016, J HUM EVOL, V91, P36, DOI 10.1016/j.jhevol.2015.10.012; Peresani M, 2013, CR PALEVOL, V12, P211, DOI 10.1016/j.crpv.2013.02.005; Peresani M, 2012, QUATERN INT, V247, P125, DOI 10.1016/j.quaint.2011.02.006; Perpere M, AURIGNACIEN GROTTE R, V34; Peyrony D, 1933, BULL SOC PREHIST FR, V30, P543, DOI 10.3406/bspf.1933.6793; Porraz G, 2010, IDENTITE TECHNIQUE C; Porraz G, 2016, SOUTH AFR HUMANIT, V29, P203; Riel-Salvatore J, 2009, MEDITERRANEAN 50000, P211; Rios Garaizar J., 2012, IND LITICA SOC PALEO; Ronchitelli A, 2014, J HUM EVOL, V73, P107, DOI 10.1016/j.jhevol.2013.12.010; Roussel M, 2016, J HUM EVOL, V95, P13, DOI 10.1016/j.jhevol.2016.02.003; Roussel M., 2013, PALEOLITHIQUE SUPERI, V56, P283; Roussel M., 2011, NORMES VARIATIONS PR, V385, P513; Roussel M, 2009, BULL SOC PREHIST FR, V106, P219, DOI 10.3406/bspf.2009.13846; Santamaria D., TRANSICION PALEOLITI; Shott Michael J., 2003, LITHIC TECHNOL, V28, P95, DOI DOI 10.1080/01977261.2003.11721005; Sicard S., 1995, THESIS U PARIS PANTH; Sitlivy V., 2012, QUARTAR, V59, P85, DOI DOI 10.7485/QU59_4; Sitlivy V, MODES CONTACTS DEPLA, P140; Sitlivy V, 2014, QUATERN INT, V351, P193, DOI 10.1016/j.quaint.2012.07.024; Skrdla P., 2003, J ISRAEL PREHISTORIC, V33, P33; Slimak L., 2006, AUTOUR CONCEPTS PROT; Slimak L, 2006, CR PALEVOL, V5, P909, DOI 10.1016/j.crpv.2006.05.002; Soressi M., 2011, PALEOANTHROPOLOGY, V334, P334, DOI DOI 10.4207/PA.2011.ART63; Soriano S, 2007, J ARCHAEOL SCI, V34, P681, DOI 10.1016/j.jas.2006.06.017; Szmidt CC, 2010, J ARCHAEOL SCI, V37, P3320, DOI 10.1016/j.jas.2010.08.001; Szmidt CC, 2010, J ARCHAEOL SCI, V37, P758, DOI 10.1016/j.jas.2009.11.006; Tafelmaier I., 2017, TECHNOLOGICAL VARIAB; Tejero JM, 2015, J ARCHAEOL SCI, V61, P59, DOI 10.1016/j.jas.2015.05.003; Teyssandier N., 2007, ROUTE VERS OUEST BU; Teyssandier N, 2010, J ANTHROPOL RES, V66, P209, DOI 10.3998/jar.0521004.0066.203; Teyssandier N, 2008, WORLD ARCHAEOL, V40, P493, DOI 10.1080/00438240802452676; Tixier J, 1963, TYPOLOGIE EPIPALEOLI; Tostevin G.B., 2013, SEEING LITHICS MIDDL; Tsanova T., 2008, DEBUTS PALEOLITHIQUE; Tsanova T, 2013, J HUM EVOL, V65, P39, DOI 10.1016/j.jhevol.2013.04.005; Tsanova T, 2012, ANTHROPOLOGIE, V116, P469, DOI 10.1016/j.anthro.2011.10.005; Vanhaeren M, 2006, J ARCHAEOL SCI, V33, P1105, DOI 10.1016/j.jas.2005.11.017; Walczak J., 1998, BULL SOC PREHIST FR, V95, P203, DOI [10.3406/bspf.1998.10768, DOI 10.3406/BSPF.1998.10768]; Wei&beta;muller W., 1995, SILEXARTEFAKTE UNTER; Wood RE, 2014, J HUM EVOL, V69, P91, DOI 10.1016/j.jhevol.2013.12.017; Zilhao J, 2007, J ARCHAEOL RES, V15, P1, DOI 10.1007/s10814-006-9008-1; Zilhao J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131181; Zwyns N., 2012, SIUREN ROCK SHELTER, P359; Zwyns N., 2012, LAMINAR TECHNOLOGY O	155	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189241	10.1371/journal.pone.0189241	http://dx.doi.org/10.1371/journal.pone.0189241			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216284	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800105
J	Hight, RE; Beck, TW; Bemben, DA; Black, CD				Hight, Robert E.; Beck, Travis W.; Bemben, Debra A.; Black, Christopher D.			Adaptations in antagonist co-activation: Role in the repeated-bout effect	PLOS ONE			English	Article							INDUCED MUSCLE DAMAGE; ELBOW FLEXOR MUSCLES; EMG SIGNAL DECOMPOSITION; HUMAN MOTOR UNITS; ECCENTRIC EXERCISE; SURFACE EMG; RECRUITMENT THRESHOLD; BICEPS-BRACHII; FIRING RATE; VOLUNTARY CONTRACTIONS	Eccentric exercise results in an adaptation which attenuates muscle damage from subsequent exercise-termed the "repeated-bout effect (RBE)." Purpose: Study examined antagonist co-activation and motor-unit recruitment strategy, assessed via dEMG, concomitant to the RBE. Methods: Nine participants performed 5 sub-maximal isometric trapezoid (ramp-up, hold, ramp-down) contractions at force levels corresponding to 50% and 80% of maximal isometric strength (MVC). Surface EMG signals of the biceps brachii were decomposed into individual motor-unit action potential trains. The relationship between mean firing rate (MFR) of each motor-unit and its recruitment threshold (RT) was examined using linear regression. Eccentric exercise was then performed until biceps brachii MVC had decreased by similar to 40%. Surface EMG of the biceps and triceps were collected during eccentric exercise. MVC, range-of-motion (ROM), and delayed onset muscle soreness (DOMS) were measured 24-hours, 72-hours, and 1-week following eccentric exercise. Three weeks later all procedures were repeated. Results: Changes in MVC (-32 +/- 14% vs -25 +/- 10%; p = 0.034), ROM (-11% vs 6%; p = 0.01), and DOMS (31.0 +/- 19mm vs 19 +/- 12mm; p = 0.015) were attenuated following the second bout of exercise. Triceps EMG was reduced (16.8 +/- 9.5% vs. 12.6 +/- 7.2%; p = 0.03) during the second bout of eccentric exercise. The slope (-0.60 +/- 0.13 vs -0.70 +/- 0.18; p = 0.029) and y-intercept (46.5 +/- 8.3 vs 53.3 +/- 8.8; p = 0.020) of the MFR vs. RT relationship was altered during contractions at 80% of MVC prior to the second bout of eccentric exercise. No changes were observed at 50% of MVC. Conclusion: A reduction in antagonist co-activation during the second bout of eccentric exercise suggests less total force was required to move an identical external load. This finding is supported by the increased negative slope coefficient and an increased y-intercept of the linear relationship between RT and MFR.	[Hight, Robert E.; Beck, Travis W.; Bemben, Debra A.; Black, Christopher D.] Univ Oklahoma, Dept Hlth & Exercise Sci, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Black, CD (corresponding author), Univ Oklahoma, Dept Hlth & Exercise Sci, Norman, OK 73019 USA.	cblack@ou.edu		Black, Christopher/0000-0003-2662-8341	University of Oklahoma Graduate College Robberson Grant; University of Oklahoma Graduate College Robberson Research and Creative Endeavors Grant	University of Oklahoma Graduate College Robberson Grant; University of Oklahoma Graduate College Robberson Research and Creative Endeavors Grant	Funded by University of Oklahoma Graduate College Robberson Grant. Role: No role was played by the funder in any aspect of the study.; The authors are thankful for the University of Oklahoma Graduate College Robberson Research and Creative Endeavors Grant for support of this project. Thanks are also due to Stephanie Rehm for her assistance with data collection and analysis.	Beck TW, 2012, MUSCLE NERVE, V46, P759, DOI 10.1002/mus.23386; Beck TW., 2011, CLIN KINESIOL, V65, P1; Black CD, 2008, MED SCI SPORT EXER, V40, P1605, DOI 10.1249/MSS.0b013e3181788dbe; Black CD, 2008, MED SCI SPORT EXER, V40, P1596, DOI 10.1249/MSS.0b013e3181757182; Black CD, 2008, J APPL PHYSIOL, V104, P639, DOI 10.1152/japplphysiol.00322.2007; Chang S-S, 2008, ENG MED BIOL SOC 200; Chen TC, 2003, EUR J APPL PHYSIOL, V89, P115, DOI 10.1007/s00421-002-0791-1; CLARKSON PM, 1992, MED SCI SPORT EXER, V24, P512; Dartnall TJ, 2008, J NEUROPHYSIOL, V99, P1008, DOI 10.1152/jn.00686.2007; Dartnall TJ, 2011, J NEUROPHYSIOL, V105, P1225, DOI 10.1152/jn.00854.2010; Dartnall TJ, 2009, J NEUROPHYSIOL, V102, P413, DOI 10.1152/jn.91285.2008; De Luca CJ, 2006, J NEUROPHYSIOL, V96, P1646, DOI 10.1152/jn.00009.2006; De Luca CJ, 2015, J APPL PHYSIOL, V118, P1084, DOI 10.1152/japplphysiol.00061.2015; De Luca CJ, 2015, J NEUROPHYSIOL, V113, P1941, DOI 10.1152/jn.00555.2014; De Luca CJ, 2012, J NEUROPHYSIOL, V107, P178, DOI 10.1152/jn.00961.2010; De Luca CJ, 2011, J NEUROPHYSIOL, V105, P983, DOI 10.1152/jn.01060.2010; De Luca CJ, 2010, J NEUROPHYSIOL, V104, P1034, DOI 10.1152/jn.01018.2009; DE LUCA CJ, 1982, J PHYSIOL-LONDON, V329, P113, DOI 10.1113/jphysiol.1982.sp014293; DE LUCA CJ, 1982, J PHYSIOL-LONDON, V329, P129, DOI 10.1113/jphysiol.1982.sp014294; DE LUCA CJ, 1994, TRENDS NEUROSCI, V17, P299, DOI 10.1016/0166-2236(94)90064-7; Duclay J, 2008, MED SCI SPORT EXER, V40, P722, DOI 10.1249/MSS.0b013e31816184dc; Enoka RM, 1996, J APPL PHYSIOL, V81, P2339, DOI 10.1152/jappl.1996.81.6.2339; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Farina D, 2015, J APPL PHYSIOL, V118, P1085, DOI 10.1152/japplphysiol.00107.2015; Farina D, 2011, J NEUROPHYSIOL, V105, P981, DOI 10.1152/jn.00855.2010; Farina D, 2010, CLIN NEUROPHYSIOL, V121, P1616, DOI 10.1016/j.clinph.2009.10.040; FRIDEN J, 1983, INT J SPORTS MED, V4, P170, DOI 10.1055/s-2008-1026030; GOLDEN CL, 1992, MED SCI SPORT EXER, V24, P926; Goodall S, 2017, ACTA PHYSIOL, V220, P486, DOI 10.1111/apha.12844; Hentzen ER, 2006, J PHYSIOL-LONDON, V570, P157, DOI 10.1113/jphysiol.2005.093005; Herda TJ, 2015, MUSCLE NERVE, V52, P832, DOI 10.1002/mus.24597; Hortobagyi T, 1996, J APPL PHYSIOL, V80, P765, DOI 10.1152/jappl.1996.80.3.765; Howatson G, 2007, EUR J APPL PHYSIOL, V101, P207, DOI 10.1007/s00421-007-0489-5; Hu XG, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026007; Hu XG, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-99; Hu XG, 2013, MUSCLE NERVE, V48, P557, DOI 10.1002/mus.23819; Hu XG, 2013, J NEUROPHYSIOL, V110, P1205, DOI 10.1152/jn.00301.2012; Hubal MJ, 2007, MED SCI SPORT EXER, V39, P461, DOI 10.1249/01.mss.0000247007.19127.da; Kline JC, 2014, J NEUROPHYSIOL, V112, P2718, DOI 10.1152/jn.00724.2013; KOMI PV, 1972, ERGONOMICS, V15, P417, DOI 10.1080/00140137208924444; McHugh MP, 1999, SPORTS MED, V27, P157, DOI 10.2165/00007256-199927030-00002; Merletti R, 2008, J ELECTROMYOGR KINES, V18, P879, DOI 10.1016/j.jelekin.2008.09.002; NARDONE A, 1989, J PHYSIOL-LONDON, V409, P451, DOI 10.1113/jphysiol.1989.sp017507; Nawab SH, 2010, CLIN NEUROPHYSIOL, V121, P1602, DOI 10.1016/j.clinph.2009.11.092; NOSAKA K, 1995, MED SCI SPORT EXER, V27, P1263; Nosaka K, 2001, MED SCI SPORT EXER, V33, P1490, DOI 10.1097/00005768-200109000-00011; Nosaka K, 2001, EUR J APPL PHYSIOL, V85, P34, DOI 10.1007/s004210100430; Park I, 1999, MEAS PHYS ED EXERC S, V3, P249; Piitulainen H, 2012, SCAND J MED SCI SPOR, V22, P418, DOI 10.1111/j.1600-0838.2010.01228.x; Piitulainen H, 2011, EUR J APPL PHYSIOL, V111, P261, DOI 10.1007/s00421-010-1652-y; Piitulainen H, 2010, J ELECTROMYOGR KINES, V20, P879, DOI 10.1016/j.jelekin.2009.10.001; Starbuck C, 2012, EUR J APPL PHYSIOL, V112, P1005, DOI 10.1007/s00421-011-2053-6; Stock MS, 2012, MUSCLE NERVE, V45, P100, DOI 10.1002/mus.22266; Warren GL, 1999, SPORTS MED, V27, P43, DOI 10.2165/00007256-199927010-00004; Warren GL, 2000, MED SCI SPORT EXER, V32, P820, DOI 10.1097/00005768-200004000-00015; Weerakkody N, 2003, EXP BRAIN RES, V149, P141, DOI 10.1007/s00221-002-1341-0; Ye X, 2015, HUM MOVEMENT SCI, V40, P24, DOI 10.1016/j.humov.2014.11.011	57	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189323	10.1371/journal.pone.0189323	http://dx.doi.org/10.1371/journal.pone.0189323			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216288	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800117
J	Kaireit, TF; Sorrentino, SA; Renne, J; Schoenfeld, C; Voskrebenzev, A; Gutberlet, M; Schulz, A; Jakob, PM; Hansen, G; Wacker, F; Welte, T; Tummler, B; Vogel-Claussen, J				Kaireit, Till F.; Sorrentino, Sajoscha A.; Renne, Julius; Schoenfeld, Christian; Voskrebenzev, Andreas; Gutberlet, Marcel; Schulz, Angela; Jakob, Peter M.; Hansen, Gesine; Wacker, Frank; Welte, Tobias; Tuemmler, Burkhard; Vogel-Claussen, Jens			Functional lung MRI for regional monitoring of patients with cystic fibrosis	PLOS ONE			English	Article							OBSTRUCTIVE-PULMONARY-DISEASE; HYPERTONIC SALINE; FOURIER DECOMPOSITION; CLEARANCE INDEX; MUCOCILIARY CLEARANCE; RESPIRATORY PHASE; CONTROLLED-TRIAL; T-1; PERFUSION; PERFORMANCE	Purpose To test quantitative functional lung MRI techniques in young adults with cystic fibrosis (CF) compared to healthy volunteers and to monitor immediate treatment effects of a single inhalation of hypertonic saline in comparison to clinical routine pulmonary function tests. Materials and methods Sixteen clinically stable CF patients and 12 healthy volunteers prospectively underwent two functional lung MRI scans and pulmonary function tests before and 2h after a single treatment of inhaled hypertonic saline or without any treatment. MRI-derived oxygen enhanced T-1 relaxation measurements, fractional ventilation, first-pass perfusion parameters and a morpho-functional CF-MRI score were acquired. Results Compared to healthy controls functional lung MRI detected and quantified significantly increased ventilation heterogeneity in CF patients. Regional functional lung MRI measures of ventilation and perfusion as well as the CF-MRI score and pulmonary function tests could not detect a significant treatment effect two hours after a single treatment with hypertonic saline in young adults with CF (p>0.05). Conclusion This study shows the feasibility of functional lung MRI as a non-invasive, radiation-free tool for monitoring patients with CF.	[Kaireit, Till F.; Sorrentino, Sajoscha A.; Renne, Julius; Schoenfeld, Christian; Voskrebenzev, Andreas; Gutberlet, Marcel; Wacker, Frank; Vogel-Claussen, Jens] Hannover Med Sch, Dept Diagnost & Intervent Radiol, Hannover, Germany; [Kaireit, Till F.; Renne, Julius; Schoenfeld, Christian; Voskrebenzev, Andreas; Gutberlet, Marcel; Hansen, Gesine; Wacker, Frank; Welte, Tobias; Tuemmler, Burkhard; Vogel-Claussen, Jens] German Ctr Lung Res, Biomed Res Endstage & Obstruct Lung Dis BREATH, Hannover, Germany; [Schulz, Angela; Hansen, Gesine; Tuemmler, Burkhard] Hannover Med Sch, Dept Pediat Pulmonol Allergol & Neonatol, Hannover, Germany; [Jakob, Peter M.] Univ Wurzburg, Dept Expt Phys 5, Wurzburg, Germany; [Welte, Tobias] Hannover Med Sch, Dept Resp Med, Hannover, Germany	Hannover Medical School; Hannover Medical School; University of Wurzburg; Hannover Medical School	Vogel-Claussen, J (corresponding author), Hannover Med Sch, Dept Diagnost & Intervent Radiol, Hannover, Germany.; Vogel-Claussen, J (corresponding author), German Ctr Lung Res, Biomed Res Endstage & Obstruct Lung Dis BREATH, Hannover, Germany.	vogel-claussen.jens@mh-hannover.de	Vogel-Claussen, Jens/Q-3374-2019	Vogel-Claussen, Jens/0000-0001-5595-6948	Ernst-August-Schrader; BMBF; German Center for Lung Research, Disease Area CF	Ernst-August-Schrader; BMBF(Federal Ministry of Education & Research (BMBF)); German Center for Lung Research, Disease Area CF	This work was supported by the Ernst-August-Schrader and the BMBF, German Center for Lung Research, Disease Area CF. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2016, RESP MED, V112, P59, DOI 10.1016/j.rmed.2016.01.020; Amin R, 2010, THORAX, V65, P379, DOI 10.1136/thx.2009.125831; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bauman G, 2017, MAGN RESON MED, V77, P74, DOI 10.1002/mrm.26490; Bauman G, 2013, MAGN RESON MED, V69, P229, DOI 10.1002/mrm.24236; Bauman G, 2011, RADIOLOGY, V260, P551, DOI 10.1148/radiol.11102313; Bauman G, 2009, MAGN RESON MED, V62, P656, DOI 10.1002/mrm.22031; Bellin MF, 2008, EUR J RADIOL, V66, P160, DOI 10.1016/j.ejrad.2008.01.023; Deimling M, 2016, ISMRM 16 SCI M EXH; Dietrich O, 2010, INVEST RADIOL, V45, P165, DOI 10.1097/RLI.0b013e3181cd74e2; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; Eichinger M, 2012, EUR J RADIOL, V81, P1321, DOI 10.1016/j.ejrad.2011.02.045; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Ellemunter H, 2016, J CYST FIBROS, V15, P123, DOI 10.1016/j.jcf.2015.06.009; Fuchs SI, 2016, RESP MED, V116, P93, DOI 10.1016/j.rmed.2016.04.015; Hueper K, 2015, AM J RESP CRIT CARE, V192, P570, DOI 10.1164/rccm.201411-2120OC; Hueper K, 2013, INVEST RADIOL, V48, P223, DOI 10.1097/RLI.0b013e318281057d; Jakob PM, 2004, MAGN RESON MED, V51, P1009, DOI 10.1002/mrm.20051; Jakob PM, 2001, J MAGN RESON IMAGING, V14, P795, DOI 10.1002/jmri.10024; Liou TG, 2010, J CYST FIBROS, V9, P250, DOI 10.1016/j.jcf.2010.04.002; Maffessanti M, 1996, J THORAC IMAG, V11, P27, DOI 10.1097/00005382-199601110-00002; Marshall H, 2017, THORAX, V72, P760, DOI 10.1136/thoraxjnl-2016-208948; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Meyer KC, 1997, AM J RESP CRIT CARE, V156, P1536, DOI 10.1164/ajrccm.156.5.9701098; Nichols MB, 2008, J MAGN RESON IMAGING, V27, P224, DOI 10.1002/jmri.21243; O'Sullivan BP, 2009, SEMIN RESP CRIT CARE, V30, P505, DOI 10.1055/s-0029-1238909; Paulin GA, 2015, J MAGN RESON IMAGING, V41, P1701, DOI 10.1002/jmri.24744; Puderbach M, 2007, INVEST RADIOL, V42, P715, DOI 10.1097/RLI.0b013e318074fd81; Ratjen F, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.10; Reeves EP, 2012, SCI WORLD J, DOI 10.1100/2012/465230; Renne J, 2015, J MAGN RESON IMAGING, V41, P60, DOI 10.1002/jmri.24535; Robinson M, 1996, AM J RESP CRIT CARE, V153, P1503, DOI 10.1164/ajrccm.153.5.8630593; Robinson M, 1997, THORAX, V52, P900, DOI 10.1136/thx.52.10.900; Robinson PD, 2013, EUR RESPIR J, V41, P507, DOI 10.1183/09031936.00069712; Schonfeld C, 2015, J MAGN RESON IMAGING, V42, P72, DOI 10.1002/jmri.24764; Smith L, 2017, AM J RESP CRIT CARE; Sourbron S, 2007, PHYS MED BIOL, V52, P429, DOI 10.1088/0031-9155/52/2/009; Stadler A, 2005, J MAGN RESON IMAGING, V21, P759, DOI 10.1002/jmri.20319; Stadler A, 2008, MAGN RESON MED, V59, P96, DOI 10.1002/mrm.21446; Stoltz DA, 2015, NEW ENGL J MED, V372, P1574, DOI 10.1056/NEJMc1502191; Triphan SMF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172479; Triphan SMF, 2015, J MAGN RESON IMAGING, V41, P1708, DOI 10.1002/jmri.24692; Voskrebenzev A, 2016, MAGN RESON MED; Voskrebenzev A, 2016, MAGN RESON MED, V76, P1542, DOI 10.1002/mrm.26047; Wark P, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001506.pub3; Wielputz MO, 2014, AM J RESP CRIT CARE, V189, P956, DOI 10.1164/rccm.201309-1659OC; Zapke M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-106; Zhang WJ, 2016, RADIOLOGY, V278, P906, DOI 10.1148/radiol.2015141876	49	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0187483	10.1371/journal.pone.0187483	http://dx.doi.org/10.1371/journal.pone.0187483			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216201	gold, Green Published, Green Submitted			2022-12-27	WOS:000417337800009
J	Klutsch, JG; Shamoun, SF; Erbilgin, N				Klutsch, Jennifer G.; Shamoun, Simon Francis; Erbilgin, Nadir			Drought stress leads to systemic induced susceptibility to a nectrotrophic fungus associated with mountain pine beetle in Pinus banksiana seedlings	PLOS ONE			English	Article							SPRUCE PICEA-ABIES; METHYL JASMONATE; INDUCED RESISTANCE; CLIMATE-CHANGE; NORWAY SPRUCE; BARK BEETLES; MEDIATED INTERACTIONS; DEFENSE RESPONSES; DENDROCTONUS-PONDEROSAE; CHEMICAL DEFENSES	Conifers have complex defense responses to initial attacks by insects and pathogens that can have cascading effects on success of subsequent colonizers. However, drought can affect a plant's ability to respond to biotic agents by potentially altering the resources needed for the energetically costly production of induced defense chemicals. We investigated the impact of reduced water on induced chemical defenses of jack pine (Pinus banksiana) seedlings from initial attack by biotic agents and resistance to subsequent challenge inoculation with a pathogenic fungal associate of mountain pine beetle (Dendroctonus ponderosae), Grosmannia clavigera. Applications of phytohormones (methyl salicylate and methyl jasmonate) and G. clavigera were used for initial induction of defenses. Monoterpene concentrations varied with initial induction from fungal and phytohormone application while watering treatment had no effect. Seedlings treated with G. clavigera and methyl jasmonate had the greatest monoterpene concentrations compared to the control and methyl salicylate-treated seedlings. However, the monoterpene response to the challenge inoculation varied with watering treatments, not with prior induction treatments, with lower monoterpene concentrations in fungal lesions on seedlings in the low to moderate watering treatments compared to normal watering treatment. Furthermore, prior induction from phytohormones resulted in systemic cross-induction of resistance to G. clavigera under normal watering treatment but susceptibility under low watering treatment. Seedlings stressed by low water conditions, which also had lower stomatal conductance than seedlings in the normal watering treatment, likely allocated resources to initial defense response but were left unable to acquire further resources for subsequent responses. Our results demonstrate that drought can affect interactions among tree-infesting organisms through systemic cross-induction of susceptibility.	[Klutsch, Jennifer G.; Erbilgin, Nadir] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Shamoun, Simon Francis] Nat Resources Canada, Canadian Forest Serv, Pacific Forestry Ctr, Victoria, BC, Canada	University of Alberta; Natural Resources Canada; Canadian Forest Service	Klutsch, JG (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.	klutsch@ualberta.ca	Erbilgin, Nadir/F-3675-2014; Shamoun, Simon Francis/K-3003-2015	Erbilgin, Nadir/0000-0001-9912-8095; Shamoun, Simon Francis/0000-0002-5228-9884; Klutsch, Jennifer/0000-0001-8839-972X	Alberta Innovates New Faculty Award; Canada Research Chairs program; NSERC-Discovery; Vanier Canada Graduate Scholarship; Izzak Walton Killam Memorial Scholarship	Alberta Innovates New Faculty Award; Canada Research Chairs program(Canada Research Chairs); NSERC-Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); Vanier Canada Graduate Scholarship; Izzak Walton Killam Memorial Scholarship	This work was funded by an Alberta Innovates New Faculty Award, Canada Research Chairs program, and NSERC-Discovery to NE Alberta Innovates Technology Futures, the Vanier Canada Graduate Scholarship, and the Izzak Walton Killam Memorial Scholarship to JGK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Arango-Velez A, 2016, PLANT CELL ENVIRON, V39, P726, DOI 10.1111/pce.12615; Arango-Velez A, 2014, TREE PHYSIOL, V34, P1220, DOI 10.1093/treephys/tpt101; Arnold T, 2004, NEW PHYTOL, V164, P157, DOI 10.1111/j.1469-8137.2004.01157.x; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Beckers GJM, 2006, PLANT BIOLOGY, V8, P1, DOI 10.1055/s-2005-872705; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; Bleiker KP, 2009, MYCOL RES, V113, P3, DOI 10.1016/j.mycres.2008.06.004; Bonello P, 2006, PHYSIOL MOL PLANT P, V68, P95, DOI 10.1016/j.pmpp.2006.12.002; Bostock RM, 2014, ANNU REV PHYTOPATHOL, V52, P517, DOI 10.1146/annurev-phyto-081211-172902; Bostock RM, 2001, EUR J PLANT PATHOL, V107, P103, DOI 10.1023/A:1008703904253; Breshears DD, 2009, FRONT ECOL ENVIRON, V7, P185, DOI 10.1890/080016; Colgan LJ, 2011, ECOL ENTOMOL, V36, P425, DOI 10.1111/j.1365-2311.2011.01283.x; Corcuera L, 2012, TREES-STRUCT FUNCT, V26, P799, DOI 10.1007/s00468-011-0651-x; Creeden EP, 2014, FOREST ECOL MANAG, V312, P239, DOI 10.1016/j.foreco.2013.09.051; CROISE L, 1993, ANN SCI FOREST, V50, P91, DOI 10.1051/forest:19930107; Croteau R., 1975, International Flavours and Food Additives, V6, P292; Cullingham CI, 2011, MOL ECOL, V20, P2157, DOI 10.1111/j.1365-294X.2011.05086.x; Davis JM, 2002, MOL PLANT MICROBE IN, V15, P380, DOI 10.1094/MPMI.2002.15.4.380; Erb M, 2011, NEW PHYTOL, V189, P308, DOI 10.1111/j.1469-8137.2010.03450.x; Erbilgin N, 2006, OECOLOGIA, V148, P426, DOI 10.1007/s00442-006-0394-3; Erbilgin N, 2017, TREE PHYSIOL, V37, P338, DOI 10.1093/treephys/tpw105; Erbilgin N, 2014, PEERJ, V2, DOI 10.7717/peerj.491; Erbilgin N, 2014, NEW PHYTOL, V201, P940, DOI 10.1111/nph.12573; Erbilgin N, 2012, TREE PHYSIOL, V32, P946, DOI 10.1093/treephys/tps047; Eyles A, 2007, OECOLOGIA, V153, P365, DOI 10.1007/s00442-007-0741-z; Eyles A, 2010, NEW PHYTOL, V185, P893, DOI 10.1111/j.1469-8137.2009.03127.x; Fischer EM, 2013, NAT CLIM CHANGE, V3, P1033, DOI [10.1038/NCLIMATE2051, 10.1038/nclimate2051]; Franceschi VR, 2005, NEW PHYTOL, V167, P353, DOI 10.1111/j.1469-8137.2005.01436.x; Goodsman DW, 2013, NEW PHYTOL, V197, P586, DOI 10.1111/nph.12019; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Hudgins JW, 2004, PLANT PHYSIOL, V135, P2134, DOI 10.1104/pp.103.037929; Keefover-Ring K, 2016, J CHEM ECOL, V42, P1, DOI 10.1007/s10886-015-0659-6; Klutsch JG, 2016, OECOLOGIA, V182, P1, DOI 10.1007/s00442-016-3559-8; Klutsch JG, J CHEM ECOL IN PRESS; Kolb TE, 2016, FOREST ECOL MANAG, V380, P321, DOI 10.1016/j.foreco.2016.04.051; Kozlowski G, 1999, PHYSIOL MOL PLANT P, V55, P53, DOI 10.1006/pmpp.1999.0205; Krokene P, 2008, TREE PHYSIOL, V28, P29, DOI 10.1093/treephys/28.1.29; Lieutier F, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009066; Llusia J, 1998, CAN J BOT, V76, P1366, DOI 10.1139/cjb-76-8-1366; Lopez-Goldar X, 2016, ENVIRON EXP BOT, V130, P141, DOI 10.1016/j.envexpbot.2016.05.010; Lundborg L, 2016, PHYTOCHEMISTRY, V130, P99, DOI 10.1016/j.phytochem.2016.06.002; Lusebrink I, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00002; Lusebrink I, 2011, J CHEM ECOL, V37, P1013, DOI 10.1007/s10886-011-0008-3; Martin D, 2002, PLANT PHYSIOL, V129, P1003, DOI 10.1104/pp.011001; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; Pallardy SG, 2008, PHYSIOLOGY OF WOODY PLANTS, 3RD EDITION, P1; Preisler HK, 2012, ECOLOGY, V93, P2421, DOI 10.1890/11-1412.1; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; RAFFA KF, 1983, ECOL MONOGR, V53, P27, DOI 10.2307/1942586; Robinson DA, 2003, VADOSE ZONE J, V2, P444, DOI 10.2113/2.4.444; Sheffield J, 2012, NATURE, V491, P435, DOI 10.1038/nature11575; Sherwood P, 2016, PHYSIOL MOL PLANT P, V94, P118, DOI 10.1016/j.pmpp.2016.06.002; Sherwood P, 2015, TREE PHYSIOL, V35, P549, DOI 10.1093/treephys/tpv026; Six DL, 2004, SYMBIOSIS, V37, P207; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; Sturrock RN, 2011, PLANT PATHOL, V60, P133, DOI 10.1111/j.1365-3059.2010.02406.x; Tack AJM, 2012, ECOL LETT, V15, P177, DOI 10.1111/j.1461-0248.2011.01724.x; Teskey RO, 1987, TREE PHYSIOL, V3, P41, DOI 10.1093/treephys/3.1.41; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Thaler JS, 2010, ECOLOGY, V91, P1075, DOI 10.1890/08-2347.1; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Walters D, 2007, PHYSIOL MOL PLANT P, V71, P3, DOI 10.1016/j.pmpp.2007.09.008; Weed AS, 2013, ECOL MONOGR, V83, P441, DOI 10.1890/13-0160.1	66	13	13	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189203	10.1371/journal.pone.0189203	http://dx.doi.org/10.1371/journal.pone.0189203			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216258	gold, Green Published, Green Submitted			2022-12-27	WOS:000417337800093
J	Lin, CC; Wu, YT; Yang, WC; Tsai, MJ; Liu, JS; Yang, CY; Li, SY; Ou, SM; Tarng, DC; Hsu, CC				Lin, Chih-Ching; Wu, Yu-Te; Yang, Wu-Chang; Tsai, Min-Juei; Liu, Jia-Sin; Yang, Chi-Yu; Li, Szu-Yuan; Ou, Shuo-Ming; Tarng, Der-Cherng; Hsu, Chih-Cheng			Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITION; DIABETIC-NEPHROPATHY; COMBINATION THERAPY; RENAL-DISEASE; HEMODIALYSIS; ANTAGONIST; BENAZEPRIL; LOSARTAN; OUTCOMES; TRIAL	Dual renin angiotensin system (RAS) blockade using angiotensin-receptor blockers (ARBs) in combination with angiotensin converting enzyme inhibitors (ACEIs) is reported to improve proteinuria in both diabetic and non-diabetic patients. However, its renoprotective effect and safety remain uncertain in patients with advanced chronic kidney disease (CKD). From January 1, 2000 through June 30, 2009, we enrolled 14,117 pre-dialytic stage 5 CKD patients with serum creatinine >6mg/dL and hematocrit <28% under the treatment with erythropoiesis stimulating agents and RAS blockade. We used Cox proportional hazards regression models to estimate the hazard ratios (HRs) against the commencement of long-term dialysis and all-cause mortality for ACEI/ARB users. Over a median follow-up of 7 months, 9,867 patients (69.9%) required long-term dialysis and 2,805 (19.9%) died before progression to end-stage renal disease requiring dialysis. In comparison with the ARB-only users, dual blockade with ACEIs and ARBs was associated with a significantly higher risk of (1) death in all CKD patients (HR = 1.49, [95% CI, 1.30-1.71]; P = 0.02) and in diabetic subgroup (HR = 1.58, [95% CI, 1.34-1.86]; P = 0.02); (2) composite endpoint of long-term dialysis or death in diabetic subgroup (HR = 1.10, [95% CI, 1.01-1.20]; P = 0.04); (3) hyperkalemia-associated hospitalization in non-diabetic subgroup (HR, 2.74, [95% CI, 1.05-7.15]; P = 0.04). However, ACEIs users were associated with higher mortality than ARBs users in all CKD patients (HR = 1.17, [95% CI, 1.07-1.27]; P = 0.03) and in diabetic subgroup (HR = 1.32, [95% CI, 1.18-1.48]; P = 0.03). Monotherapy of RAS blockade, especially ARB, is more effective and safer than dual RAS blockade in pre-dialytic stage 5 CKD patients.	[Lin, Chih-Ching; Yang, Chi-Yu; Li, Szu-Yuan; Ou, Shuo-Ming; Tarng, Der-Cherng] Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan; [Lin, Chih-Ching; Wu, Yu-Te; Yang, Wu-Chang; Tsai, Min-Juei; Yang, Chi-Yu; Li, Szu-Yuan; Ou, Shuo-Ming; Tarng, Der-Cherng] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Wu, Yu-Te] Ho Ho Ho Hlth Manage Syst, Sungho Clin, Taoyuan, Taiwan; [Yang, Wu-Chang] Landseed Hosp, Dept Med, Div Nephrol, Taoyuan, Taiwan; [Tsai, Min-Juei] Chang Hua Hosp, Minist Hlth & Welf, Dept Med, Changhua, Taiwan; [Liu, Jia-Sin; Hsu, Chih-Cheng] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Hsu, Chih-Cheng] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Hsu, Chih-Cheng] Min Sheng Gen Hosp, Dept Family Med, Taoyuan, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; China Medical University Taiwan	Tarng, DC (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan.; Tarng, DC (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Hsu, CC (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan.; Hsu, CC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.; Hsu, CC (corresponding author), Min Sheng Gen Hosp, Dept Family Med, Taoyuan, Taiwan.	dctarng@vghtpe.gov.tw; cch@nhri.org.tw		Yang, Chih-Yu/0000-0001-9899-3159	Taipei Veterans General Hospital [V102E2-001]; National Science Council [NSC101-2314-6010-024-MY3]; Foundation for Poison Control; Ministry of Science and Technology in Taiwan [MOST 104-2314-B-010 -032 -MY3];  [V101C-188];  [V102C-060];  [V102C-129];  [V103C-043];  [V104C-026];  [V104C-050];  [V105C-075];  [V106C-036]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan); Foundation for Poison Control; Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan); ; ; ; ; ; ; ; 	This work was supported by intramural grants (V101C-188, V102C-060, V102C-129, V103C-043, V104C-026, V104C-050, V105C-075, V106C-036) and grants for the Integrated Genome Project (V102E2-001) from Taipei Veterans General Hospital, and the National Science Council (NSC101-2314-6010-024-MY3), Foundation for Poison Control, and the Ministry of Science and Technology (MOST 104-2314-B-010 -032 -MY3) in Taiwan.	An JN, 2012, CRIT CARE, V16, DOI 10.1186/cc11872; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chan KE, 2011, KIDNEY INT, V80, P978, DOI 10.1038/ki.2011.228; Einhorn LM, 2009, ARCH INTERN MED, V169, P1156, DOI 10.1001/archinternmed.2009.132; Fink HA, 2012, ANN INTERN MED, V156, P570, DOI [10.7326/0003-4819-156-8-201204170-00008, 10.7326/0003-4819-156-8-201204170-00004]; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; Gamboa JL, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0162-x; Gamboa JL, 2012, J AM SOC NEPHROL, V23, P334, DOI 10.1681/ASN.2011030287; Hou FF, 2007, J AM SOC NEPHROL, V18, P1889, DOI 10.1681/ASN.2006121372; Hsu TW, 2014, JAMA INTERN MED, V174, P347, DOI 10.1001/jamainternmed.2013.12700; Kim MJ, 2003, YONSEI MED J, V44, P463, DOI 10.3349/ymj.2003.44.3.463; Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Li SY, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-89; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Ruilope LM, 2000, J HYPERTENS, V18, P89, DOI 10.1097/00004872-200018010-00013; Shikata K, 2013, J DIABETES INVEST, V4, P142, DOI 10.1111/jdi.12050; Song JH, 2003, CLIN NEPHROL, V60, P318; Taal MW, 2000, KIDNEY INT, V57, P1803, DOI 10.1046/j.1523-1755.2000.00031.x; URIBARRI J, 1990, Journal of Diabetic Complications, V4, P3, DOI 10.1016/0891-6632(90)90057-C; Zhou Z, 2005, AM J EPIDEMIOL, V162, P1016, DOI 10.1093/aje/kwi307	22	10	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189126	10.1371/journal.pone.0189126	http://dx.doi.org/10.1371/journal.pone.0189126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216260	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800078
J	Liou, LS; Chang, CY; Chen, HJ; Tseng, CH; Chen, CY; Sung, FC				Liou, Li-Syue; Chang, Chih-Ya; Chen, Hsuan-Ju; Tseng, Chun-Hung; Chen, Cheng-Yu; Sung, Fung-Chang			Increased risk of peripheral arterial occlusive disease in patients with Bell's palsy using population data	PLOS ONE			English	Article							VIRUS VASCULOPATHY; HIGH PREVALENCE; FACIAL-NERVE; PROGRESSION; BURDEN; STROKE; DNA	Objective This population-based cohort study investigated the risk of developing peripheral arterial occlusive disease (PAOD) in patients with Bell's palsy. Methods We used longitudinal claims data of health insurance of Taiwan to identify 5,152 patients with Bell's palsy newly diagnosed in 2000-2010 and a control cohort of 20,608 patients without Bell's palsy matched by propensity score. Incidence and hazard ratio (HR) of PAOD were assessed by the end of 2013. Results The incidence of PAOD was approximately 1.5 times greater in the Bell's palsy group than in the non-Bell's palsy controls (7.75 vs. 4.99 per 1000 person-years). The Cox proportional hazards regression analysis measured adjusted HR was 1.54 (95% confidence interval (CI) = 1.35-1.76) for the Bell's palsy group compared to the non-Bell's palsy group, after adjusting for sex, age, occupation, income and comorbidities. Men were at higher risk of PAOD than women in the Bell's palsy group, but not in the controls. The incidence of PAOD increased with age in both groups, but the Bell's palsy group to control group HR of PAOD decreased as age increased. The systemic steroid treatment reduced 13% of PAOD hazard for Bell's palsy patients, compared to those without the treatment, but not significant. Conclusions Bell's palsy appears to be associated with an increased risk of developing PAOD. Further pathophysiologic, histopathology and immunologic research is required to explore the underlying biologic mechanism.	[Liou, Li-Syue] Hualien Tzu Chi Hosp, Dept Family Med, Buddhist Tzu Chi Med Fdn, Hualien, Hualien County, Taiwan; [Liou, Li-Syue; Chen, Cheng-Yu] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Family Med, New Taipei, Taiwan; [Liou, Li-Syue] TriServ Gen Hosp, Dept Family & Community Med, Taipei, Taiwan; [Liou, Li-Syue; Chang, Chih-Ya] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Chang, Chih-Ya] TriServ Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chen, Hsuan-Ju; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ, Sch Med, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan	Sung, FC (corresponding author), China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan.; Sung, FC (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.; Sung, FC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.	fcsung1008@yahoo.com	chihya, Chang/AAI-6537-2021		Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW106-TDU-B-212-113004]; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 105-2325-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Financial Disclosure This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDU-B-212-113004), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 105-2325-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.; The authors thank Dr. Jih-I Yeh, Dr. Shinn-Zong Lin, and Professor Jon-Son Kuo for their feedback regarding the manuscript drafts. This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDU-B-212-113004), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 105-2325-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.	BENDITT EP, 1983, P NATL ACAD SCI-BIOL, V80, P6386, DOI 10.1073/pnas.80.20.6386; Brevetti G, 2008, J CARDIOVASC MED, V9, P382, DOI 10.2459/JCM.0b013e3282f03b90; Criqui MH, 2008, J AM COLL CARDIOL, V52, P1736, DOI 10.1016/j.jacc.2008.07.060; Elkind Mitchell S. V., 2010, Infectious Disorders - Drug Targets, V10, P84; Espinola-Klein C, 2002, STROKE, V33, P2581, DOI 10.1161/01.STR.0000034789.82859.A4; Fabricant C, 1983, FEDERATION P; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; FURUTA Y, 1992, ACTA NEUROPATHOL, V84, P39, DOI 10.1007/BF00427213; Furuta Y, 2000, CLIN INFECT DIS, V30, P529, DOI 10.1086/313721; Gilden DH, 2004, NEW ENGL J MED, V351, P1323, DOI 10.1056/NEJMcp041120; Greco A, 2012, AUTOIMMUN REV, V12, P323, DOI 10.1016/j.autrev.2012.05.008; Hiramoto JS, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000651; Hirsch AT, 2012, CIRCULATION, V125, P1449, DOI 10.1161/CIR.0b013e31824c39ba; Holland J, 2008, CLIN EVIDENCE, V2008; Holland NJ, 2004, BMJ-BRIT MED J, V329, P553, DOI 10.1136/bmj.329.7465.553; Jackson CG, 1999, MED CLIN N AM, V83, P179, DOI 10.1016/S0025-7125(05)70096-1; Joosten MM, 2012, JAMA-J AM MED ASSOC, V308, P1660, DOI 10.1001/jama.2012.13415; Lee CC, 2013, EUR J NEUROL, V20, P616, DOI 10.1111/j.1468-1331.2012.03765.x; Murakami S, 1996, ANN INTERN MED, V124, P27, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00005; Nagel MA, 2011, NEUROLOGY, V77, P364, DOI 10.1212/WNL.0b013e3182267bfa; Nagel M. A., 2010, Infectious Disorders - Drug Targets, V10, P105; Novo S, 2002, DIABETES OBES METAB, V4, pS1, DOI 10.1046/j.1463-1326.2002.0040s20s1.x; Peitersen E, 2002, ACTA OTO-LARYNGOL, V122, P4, DOI 10.1080/000164802320401694; Powers JF, 2005, AM J CLIN PATHOL, V123, P261, DOI 10.1309/2996TT2CTLTKN0KT; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Shi Y, 2002, PATHOL INT, V52, P31, DOI 10.1046/j.1440-1827.2002.01312.x; Sturmer T, 2014, J INTERN MED, V275, P570, DOI 10.1111/joim.12197; Alzamora MT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-38; Zandian A, 2014, MED SCI MONITOR, V20, P83, DOI 10.12659/MSM.889876; Zhu JH, 2000, AM J CARDIOL, V85, P140, DOI 10.1016/S0002-9149(99)00653-0	30	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188982	10.1371/journal.pone.0188982	http://dx.doi.org/10.1371/journal.pone.0188982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216223	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800054
J	Lucas, KN; Dabiri, JO; Lauder, GV				Lucas, Kelsey N.; Dabiri, John O.; Lauder, George V.			A pressure-based force and torque prediction technique for the study of fish-like swimming	PLOS ONE			English	Article							UNDULATORY LOCOMOTION; BODY STIFFNESS; WAKE; FIELDS; KINEMATICS; SPEED; HYDRODYNAMICS; PERFORMANCE; MORPHOLOGY; DYNAMICS	Many outstanding questions about the evolution and function of fish morphology are linked to swimming dynamics, and a detailed knowledge of time-varying forces and torques along the animal's body is a key component in answering many of these questions. Yet, quantifying these forces and torques experimentally represents a major challenge that to date prevents a full understanding of fish-like swimming. Here, we develop a method for obtaining these force and torque data non-invasively using standard 2D digital particle image velocimetry in conjunction with a pressure field algorithm. We use a mechanical flapping foil apparatus to model fish-like swimming and measure forces and torques directly with a load cell, and compare these measured values to those estimated simultaneously using our pressure-based approach. We demonstrate that, when out-of-plane flows are relatively small compared to the planar flow, and when pressure effects sufficiently dominate shear effects, this technique is able to accurately reproduce the shape, magnitude, and timing of locomotor forces and torques experienced by a fish-like swimmer. We conclude by exploring of the limits of this approach and its feasibility in the study of freely-swimming fishes.	[Lucas, Kelsey N.; Lauder, George V.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Dabiri, John O.] Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; [Dabiri, John O.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	Harvard University; Stanford University; Stanford University	Lucas, KN (corresponding author), Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA.	kelsey.n.lucas@gmail.com			National Science Foundation [DGE-1144152]; Harvard University; Office of Naval Research Multi-University Research Initiative [N000141410533]	National Science Foundation(National Science Foundation (NSF)); Harvard University; Office of Naval Research Multi-University Research Initiative	This work was supported by a National Science Foundation Graduate Research Fellowship under grant DGE-1144152 and a Harvard University Chapman Fellowship to KNL and by the Office of Naval Research Multi-University Research Initiative Grant N000141410533 monitored by Dr. Bob Brizzolara to GVL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a National Science Foundation Graduate Research Fellowship under grant DGE-1144152 and a Harvard University Chapman Fellowship to KNL and by the Office of Naval Research Multi-University Research Initiative Grant N000141410533 monitored by Dr. Bob Brizzolara to GVL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Thanks to Francis Carr, Ryan Feather, Patrick Thornycroft, Brad Gemmell, and Eric Tytell for technical assistance, and to Iman Borazjani, Kara Feilich, Elena Kramer, and Pete Girguis for helpful discussions. We also thank Eric Tytell, Sean Colin, and the anonymous reviewers for their feedback on earlier versions of this manuscript. The authors declare that no competing interests exist.	Akanyeti O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11044; Akanyeti O, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/2/026001; Alben S, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4709477; Bale R., 2014, SCI REP-UK, V4, P1; Blake RW, 2004, J FISH BIOL, V65, P1193, DOI 10.1111/j.0022-1112.2004.00568.x; Borazjani I, 2010, J EXP BIOL, V213, P89, DOI 10.1242/jeb.030932; Dabiri JO, 2005, J EXP BIOL, V208, P3519, DOI 10.1242/jeb.01813; Dabiri JO, 2014, J EXP BIOL, V217, P331, DOI 10.1242/jeb.092767; de Kat R, 2012, EXP FLUIDS, V52, P1089, DOI 10.1007/s00348-011-1237-5; Domenici P, 2001, COMP BIOCHEM PHYS A, V131, P169, DOI 10.1016/S1095-6433(01)00465-2; Domenici P., 2009, FISH LOCOMOTION ECO; Donley JM, 2000, J EXP BIOL, V203, P3103; Drucker EG, 1999, J EXP BIOL, V202, P2393; Drucker EG, 2000, J EXP BIOL, V203, P2379; DUBOIS AB, 1974, J EXP BIOL, V60, P581; Feilich KL, 2016, EVOLUTION, V70, P2247, DOI 10.1111/evo.13021; Feilich KL, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/3/036002; Gemmell BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9790; Hefetz D., 1999, 3 INT WORKSH PART IM, P671; JAYNE BC, 1995, J EXP BIOL, V198, P585; Lamb H., 1945, HYDRODYNAMICS; Laskari A, 2016, EXP FLUIDS, V57, DOI 10.1007/s00348-016-2129-5; Lauder GV, 2011, MAR TECHNOL SOC J, V45, P41, DOI 10.4031/MTSJ.45.4.8; Lauder GV, 2002, NEWS PHYSIOL SCI, V17, P235, DOI 10.1152/nips.01398.2002; LIGHTHILL MJ, 1969, ANNU REV FLUID MECH, V1, P413, DOI 10.1146/annurev.fl.01.010169.002213; Liu XF, 2006, EXP FLUIDS, V41, P227, DOI 10.1007/s00348-006-0152-7; Long JH, 1998, AM ZOOL, V38, P771; Lucas KN, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/5/056019; Lucas KN, 2014, NAT COMMUN, P5; MCHENRY MJ, 1995, J EXP BIOL, V198, P2293; Muller UK, 1997, J EXP BIOL, V200, P2893; Muller UK, 2001, J EXP BIOL, V204, P2751; Noca F, 1997, J FLUID STRUCT, V11, P345, DOI 10.1006/jfls.1997.0081; Pritchard P.J., 2011, FOX MCDONALDS INTRO; Quinn DB, 2015, J FLUID MECH, V767, P430, DOI 10.1017/jfm.2015.35; Quinn DB, 2014, J FLUID MECH, V738, P250, DOI 10.1017/jfm.2013.597; Rosic MLN, 2017, BIOINSPIR BIOMIM, V12, DOI 10.1088/1748-3190/aa5113; Schlueter-Kuck K, 2016, PHYS REV FLUIDS, V1, DOI 10.1103/PhysRevFluids.1.012501; Shelton RM, 2014, J EXP BIOL, V217, P2110, DOI 10.1242/jeb.098046; STAMHUIS EJ, 1995, J EXP BIOL, V198, P283; Standen EM, 2007, J EXP BIOL, V210, P325, DOI 10.1242/jeb.02661; Tytell ED, 2004, J EXP BIOL, V207, P3265, DOI 10.1242/jeb.01139; Tytell ED, 2010, P NATL ACAD SCI USA, V107, P19832, DOI 10.1073/pnas.1011564107; Usherwood JR, 2005, J EXP BIOL, V208, P355, DOI 10.1242/jeb.01359; van Oudheusden BW, 2007, EXP FLUIDS, V43, P153, DOI 10.1007/s00348-007-0261-y; van Oudheusden BW, 2013, MEAS SCI TECHNOL, V24, DOI 10.1088/0957-0233/24/3/032001; Vogel S., 1994, LIFE MOVING FLUIDS P; Wang ZY, 2016, EXP FLUIDS, V57, DOI 10.1007/s00348-016-2189-6; Webb PW, 2015, INTEGR COMP BIOL, V55, P753, DOI 10.1093/icb/icv053; WEBB PW, 1984, AM ZOOL, V24, P107; Weihs D., 1983, P339; White F., 2005, VISCOUS FLUID FLOW; WILLERT CE, 1991, EXP FLUIDS, V10, P181; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Yates G.T., 1983, P177; Zar JH., 2010, BIOSTAT ANAL, V5th	56	20	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189225	10.1371/journal.pone.0189225	http://dx.doi.org/10.1371/journal.pone.0189225			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216264	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000417337800100
J	Russ, GR; Lowe, JR; Rizzari, JR; Bergseth, BJ; Alcala, AC				Russ, Garry R.; Lowe, Jake R.; Rizzari, Justin R.; Bergseth, Brock J.; Alcala, Angel C.			Partitioning no-take marine reserve (NTMR) and benthic habitat effects on density of small and large-bodied tropical wrasses	PLOS ONE			English	Article							CORAL-REEF FISH; GREAT-BARRIER-REEF; LABRID FISHES; EXTINCTION VULNERABILITY; TROPHIC RELATIONSHIPS; PATTERNS; MANAGEMENT; ABUNDANCE; IMPACTS; BIODIVERSITY	No-take marine reserves (NTMRs) are increasingly implemented for fisheries management and biodiversity conservation. Yet, assessing NTMR effectiveness depends on partitioning the effects of NTMR protection and benthic habitat on protected species. Such partitioning is often difficult, since most studies lack well-designed sampling programs (i.e. Before-After-Control-Impact-Pair designs) spanning long-term time scales. Spanning 31 years, this study quantifies the effects of NTMR protection and changes to benthic habitat on the density of tropical wrasses (F. Labridae) at Sumilon and Apo Islands, Philippines. Five species of wrasse were studied: two species of large-bodied (40-50 cm TL) Hemigymnus that were vulnerable to fishing, and three species of small-bodied (10-25 cm TL) Thalassoma and Cirrhilabrus that were not targeted by fishing. NTMR protection had no measurable effect on wrasse density, irrespective of species or body size, over 20 (Sumilon) and 31 (Apo) years of protection. However, the density of wrasses was often affected strongly by benthic cover. Hemigymnus spp. had a positive association with hard coral cover, while Thalassoma spp. and Cirrhilabrus spp. had strong positive associations with cover of rubble and dead substratum. These associations were most apparent after environmental disturbances (typhoons, coral bleaching, crown of thorns starfish (COTS) outbreaks, use of explosives and drive nets) reduced live hard coral cover and increased cover of rubble, dead substratum and sand. Disturbances that reduced hard coral cover often reduced the density of Hemigymnus spp. and increased the density of Thalassoma spp. and Cirrhilabrus spp. rapidly (1- 2 years). As hard coral recovered, density of Hemigymnus spp. often increased while density of Thalassoma spp. and Cirrhilabrus spp. often decreased, often on scales of 5-10 years. This study demonstrates that wrasse population density was influenced more by changes to benthic cover than by protection from fishing.	[Russ, Garry R.; Lowe, Jake R.; Rizzari, Justin R.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Russ, Garry R.; Rizzari, Justin R.; Bergseth, Brock J.] James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld, Australia; [Rizzari, Justin R.] Univ Tasmania, Inst Marine & Antarctic Studies, Fisheries & Aquaculture Ctr, Hobart, Tas, Australia; [Alcala, Angel C.] SUAKCREM, Dumaguete, Negros, Philippines	James Cook University; James Cook University; University of Tasmania	Lowe, JR (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia.	jake.lowe@my.jcu.edu.au	Lowe, Jake/AAI-4407-2020	Lowe, Jake/0000-0002-2001-646X; Bergseth, Brock/0000-0002-5486-175X	ARC; Pew Fellowship; ARC Centre of Excellence for Coral Reef Studies [CE0561435, CE140100020]; Australian Government Research Training Program (RTP) Scholarship	ARC(Australian Research Council); Pew Fellowship; ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This research was funded by a Pew Fellowship (GRR and ACA), an ARC Discovery grant (GRR and ACA) and the ARC Centre of Excellence for Coral Reef Studies (GRR) (CE0561435, CE140100020). JRL was supported by an Australian Government Research Training Program (RTP) Scholarship.	Abesamis RA, 2014, REV FISH BIOL FISHER, V24, P1033, DOI 10.1007/s11160-014-9362-x; Ackerman JL, 2004, THESIS; Alcala AC, 2002, ASIAN FISH SC, V15, P177; Alcala AC, 2006, AMBIO, V35, P245, DOI 10.1579/05-A-054R1.1; [Anonymous], 2017, R LANG ENV STAT COMP; Arceo HO, 2001, B MAR SCI, V69, P579; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Bellwood DR, 2001, CORAL REEFS, V20, P139, DOI 10.1007/s003380100156; Bergseth BJ, 2015, FISH FISH, V16, P240, DOI 10.1111/faf.12051; Bernardi G, 2004, MARINE FRESHWATER B, V144; BRETT JR, 1965, J FISH RES BOARD CAN, V22, P1491, DOI 10.1139/f65-128; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Cheal AJ, 2008, MAR ECOL PROG SER, V372, P211, DOI 10.3354/meps07708; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Coker DJ, 2014, REV FISH BIOL FISHER, V24, P89, DOI 10.1007/s11160-013-9319-5; Connell SD, 1998, CORAL REEFS, V17, P49, DOI 10.1007/s003380050094; Cowlishaw M, 2014, THESIS; Dalzell P, 1996, OCEANOGR MAR BIOL, V34, P395; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; ECKERT GJ, 1984, MAR BIOL, V78, P123, DOI 10.1007/BF00394691; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Emslie MJ, 2015, CURR BIOL, V25, P983, DOI 10.1016/j.cub.2015.01.073; Emslie MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105384; Fulton CJ, 2002, MAR ECOL PROG SER, V236, P255, DOI 10.3354/meps236255; Fulton CJ, 2002, MAR ECOL PROG SER, V226, P135, DOI 10.3354/meps226135; GBRMPA (Great Barrier Reef Marine Park Authority), 2014, GREAT BARR REEF OUTL; Gouezo M, 2015, MAR ECOL PROG SER, V540, P73, DOI 10.3354/meps11518; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Graham NAJ, 2011, ECOL LETT, V14, P341, DOI 10.1111/j.1461-0248.2011.01592.x; Grant JWA, 1997, BEHAV ECOLOGY TELEOS, P83; Green AL, 1996, MAR ECOL PROG SER, V133, P1, DOI 10.3354/meps133001; Grutter AS, 1998, J FISH BIOL, V53, P49, DOI 10.1111/j.1095-8649.1998.tb00108.x; Grutter AS, 1995, MAR FRESHWATER RES, V46, P897, DOI 10.1071/MF9950897; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Hawkins JP, 2006, BIOL CONSERV, V127, P487, DOI 10.1016/j.biocon.2005.09.008; Holbrook SJ, 1996, STRUCTURE DYNAMICS T, P19; Hubble M, 2003, THESIS; Hughes TP, 2015, NAT CLIM CHANGE, V5, P508, DOI 10.1038/nclimate2604; Hughes TP, 2017, NATURE, V546, P82, DOI 10.1038/nature22901; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Komyakova V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083178; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; Kramer MJ, 2014, MAR ECOL PROG SER, V511, P105, DOI 10.3354/meps10953; Kuiter R.H., 2001, ZOONETICS, V2001, P304; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; McClanahan T, 2002, AMBIO, V31, P543, DOI 10.1639/0044-7447(2002)031[0543:EOTCME]2.0.CO;2; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; McClanahan TR, 2014, MAR ECOL PROG SER, V497, P13, DOI 10.3354/meps10605; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; McLaren BW, 2015, J EXP MAR BIOL ECOL, V471, P153, DOI 10.1016/j.jembe.2015.06.002; Miller KI, 2014, OCEAN COAST MANAGE, V96, P51, DOI 10.1016/j.ocecoaman.2014.05.003; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Nottestad L, 1999, CAN J FISH AQUAT SCI, V56, P26, DOI 10.1139/cjfas-56-S1-26; Pasko L, 2010, ZOO BIOL, V29, P767, DOI 10.1002/zoo.20307; Polunin NVC, 1996, REEF FISHERIES; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Pratchett Morgan S., 2011, Diversity, V3, P424, DOI 10.3390/d3030424; Randall JE, 1990, FISHES GREAT BARRIER; Randall JE, 1997, FISHES GREAT BARRIER; Russ GR, 2017, MAR BIOL, V164, DOI 10.1007/s00227-016-3056-y; Russ GR, 2015, MAR BIOL, V162, P2029, DOI 10.1007/s00227-015-2728-3; Russ GR, 2015, CORAL REEFS, V34, P773, DOI 10.1007/s00338-015-1296-9; Russ GR, 2015, MAR ECOL PROG SER, V529, P233, DOI 10.3354/meps11246; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Russ GR, 1998, CORAL REEFS, V17, P399, DOI 10.1007/s003380050146; RUSS GR, 1989, MAR ECOL PROG SER, V56, P13, DOI 10.3354/meps056013; Sadovy Y., 2000, REEF FISHES HONG KON; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Soler GA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140270; SPRINGER VG, 1974, ISRAEL J ZOOL, V23, P45; THRESHER RE, 1986, B MAR SCI, V38, P253; Wainwright PC, 2004, BIOL J LINN SOC, V82, P1, DOI 10.1111/j.1095-8312.2004.00313.x; Westneat M, 2001, FAO SPECIES IDENTIFI, P3381; Westneat MW, 2005, P ROY SOC B-BIOL SCI, V272, P993, DOI 10.1098/rspb.2004.3013; Williams ID, 2008, ENVIRON CONSERV, V35, P261, DOI 10.1017/S0376892908004876; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	87	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188515	10.1371/journal.pone.0188515	http://dx.doi.org/10.1371/journal.pone.0188515			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216194	Green Published, gold, Green Accepted			2022-12-27	WOS:000417337800029
J	Wahabzada, M; Besser, M; Khosravani, M; Kuska, MT; Kersting, K; Mahlein, AK; Sturmer, E				Wahabzada, Mirwaes; Besser, Manuela; Khosravani, Milad; Kuska, Matheus Thomas; Kersting, Kristian; Mahlein, Anne-Katrin; Stuermer, Ewa			Monitoring wound healing in a 3D wound model by hyperspectral imaging and efficient clustering	PLOS ONE			English	Article								Wound healing is a complex and dynamic process with different distinct and overlapping phases from homeostasis, inflammation and proliferation to remodelling. Monitoring the healing response of injured tissue is of high importance for basic research and clinical practice. In traditional application, biological markers characterize normal and abnormal wound healing. Understanding functional relationships of these biological processes is essential for developing new treatment strategies. However, most of the present techniques (in vitro or in vivo) include invasive microscopic or analytical tissue sampling. In the present study, a non-invasive alternative for monitoring processes during wound healing is introduced. Within this context, hyperspectral imaging (HSI) is an emerging and innovative non-invasive imaging technique with different opportunities in medical applications. HSI acquires the spectral reflectance of an object, depending on its biochemical and structural characteristics. An in-vitro 3-dimensional (3-D) wound model was established and incubated without and with acute and chronic wound fluid (AWF, CWF), respectively. Hyperspectral images of each individual specimen of this 3-D wound model were assessed at day 0/5/10 in vitro, and reflectance spectra were evaluated. For analysing the complex hyperspectral data, an efficient unsupervised approach for clustering massive hyperspectral data was designed, based on efficient hierarchical decomposition of spectral information according to archetypal data points. It represents, to the best of our knowledge, the first application of an advanced Data Mining approach in context of non-invasive analysis of wounds using hyperspectral imagery. By this, temporal and spatial pattern of hyperspectral clusters were determined within the tissue discs and among the different treatments. Results from non-invasive imaging were compared to the number of cells in the various clusters, assessed by Hematoxylin/Eosin (H/E) staining. It was possible to correlate cell quantity and spectral reflectance during wound closure in a 3-D wound model in vitro.	[Wahabzada, Mirwaes; Kuska, Matheus Thomas; Mahlein, Anne-Katrin] Univ Bonn, INRES Phytomed, Nussalle 9, Bonn, Germany; [Besser, Manuela; Khosravani, Milad; Stuermer, Ewa] Univ Witten Herdecke, Dept Translat Wound Res, Ctr Biomed Educ & Res ZBAF, Witten, Germany; [Kersting, Kristian] Tech Univ Darmstadt, CS Dept, Darmstadt, Germany; [Mahlein, Anne-Katrin] Inst Sugar Beet Res IfZ, Gottingen, Germany	University of Bonn; Witten Herdecke University; Technical University of Darmstadt	Mahlein, AK (corresponding author), Univ Bonn, INRES Phytomed, Nussalle 9, Bonn, Germany.; Mahlein, AK (corresponding author), Inst Sugar Beet Res IfZ, Gottingen, Germany.	mahlein@ifz-goettingen.de		Mahlein, Anne-Katrin/0000-0003-1091-3690				Bauckhage C, 2013, KUNSTL INTELL, V27, P313, DOI 10.1007/s13218-013-0273-0; Bock CH, 2010, CRIT REV PLANT SCI, V29, P59, DOI 10.1080/07352681003617285; Carter GA, 2001, AM J BOT, V88, P677, DOI 10.2307/2657068; Dasgupta S, 2009, IEEE T INFORM THEORY, V55, P3229, DOI 10.1109/TIT.2009.2021326; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Edelman GJ, 2012, FORENSIC SCI INT, V223, P28, DOI 10.1016/j.forsciint.2012.09.012; Faloutsos C., 1995, SIGMOD Record, V24, P163, DOI 10.1145/568271.223812; Farkas DL, 2001, PIGM CELL RES, V14, P2, DOI 10.1034/j.1600-0749.2001.140102.x; Gerstner AOH, 2014, LARYNGO RHINO OTOL, V92; Gillies Robert, 2003, Diabetes Technol Ther, V5, P847, DOI 10.1089/152091503322527058; Greenman RL, 2005, LANCET, V366, P1711, DOI 10.1016/S0140-6736(05)67696-9; Jansson K, 1996, IN VITRO CELL DEV-AN, V32, P534; Kersting K, 2010, JMLR WORKSH CONF PRO, V13, P253; Kester RT, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3574756; Kiyotoki S, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.026010; Kuska M, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0073-7; Leucker M, FUNCTIONAL PLANT BIO, V44, P1; Mahlein AK, 2016, PLANT DIS, V100, P241, DOI 10.1094/PDIS-03-15-0340-FE; Mahlein AK, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-3; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Meroni M, 2009, REMOTE SENS ENVIRON, V113, P2037, DOI 10.1016/j.rse.2009.05.003; Moore G.K., 1979, HYDROLOGICAL SCI B, V24, P477, DOI [10.1080/02626667909491887, DOI 10.1080/02626667909491887]; Muldoon TJ, 2012, HEAD NECK-J SCI SPEC, V34, P305, DOI 10.1002/hed.21735; Neidrauer M, 2009, STUD MECHANOBIOL TIS, V1, P381; Paul DW, 2015, WOUND REPAIR REGEN, V23, P149, DOI 10.1111/wrr.12262; Payette JR, 2005, PLAST RECONSTR SURG, V115, P539, DOI 10.1097/01.PRS.0000148415.54546.CA; Qin JW, 2009, J FOOD ENG, V93, P183, DOI 10.1016/j.jfoodeng.2009.01.014; Randeberg LL, 2014, HYPERSPECTRAL CHARAC; Rumpf T, 2010, COMPUT ELECTRON AGR, V74, P91, DOI 10.1016/j.compag.2010.06.009; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schmidt WD, 2001, J INVEST DERMATOL, V116, P531, DOI 10.1046/j.1523-1747.2001.01297.x; Sen CK, 2016, PLAST RECONSTR SURG, V138, p119S, DOI 10.1097/PRS.0000000000002654; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Sowa MG, 2001, BURNS, V27, P241, DOI 10.1016/S0305-4179(00)00111-X; Thomas S, 2017, FUNCT PLANT BIOL, V44, P23, DOI 10.1071/FP16127; Thurau C, 2012, DATA MIN KNOWL DISC, V24, P325, DOI 10.1007/s10618-011-0216-z; Ustin SL, 2009, REMOTE SENS ENVIRON, V113, pS67, DOI 10.1016/j.rse.2008.10.019; Wollina Uwe, 2005, Int J Low Extrem Wounds, V4, P97, DOI 10.1177/1534734605277465; Xu RX, 2012, BIOMED OPT EXPRESS, V3, P1433, DOI 10.1364/BOE.3.001433; Yudovsky D, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3535592; Yudovsky Dmitry, 2010, J Diabetes Sci Technol, V4, P1099	41	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0186425	10.1371/journal.pone.0186425	http://dx.doi.org/10.1371/journal.pone.0186425			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216188	Green Submitted, gold, Green Published			2022-12-27	WOS:000417337800004
J	Han, XL; Xu, ZY; Cao, SB; Zhao, YP; Wu, WM				Han, Xianlin; Xu, Zhiyan; Cao, Shaobo; Zhao, Yupei; Wu, Wenming			The effect of somatostatin analogues on postoperative outcomes following pancreatic surgery: A meta-analysis	PLOS ONE			English	Article							PROPHYLACTIC OCTREOTIDE; RANDOMIZED-TRIAL; HOSPITAL VOLUME; PANCREATICODUODENECTOMY; COMPLICATIONS; FISTULA; PREVENTION; MULTICENTER; RESECTION; EFFICACY	Background Leakage from the pancreatic stump is a leading cause of morbidity following pancreatic surgery. It is essential to evaluate the effect of somatostatin analogues (SAs) following pancreatic surgery by analyzing all recent clinical trials. Data sources We performed a literature search in the Medline, EMBASE, Cochrane Central Register of Controlled Trials and Web of Science databases up to May 29, 2016. Publication bias was assessed with Egger's test. Study quality was assessed using the Jadad Composite Scale. Conclusions Twelve clinical trials involving 1703 patients from Jan 1st, 2000 to May 29th, 2016 were included in the study. With improvements in surgical management and peri-operative patient care, prophylactic use of somatostatin and its analogues reduced the overall incidence of pancreatic fistulas (RR 0.72, 95% CI 0.55-0.94; p = 0.02) and decreased the post-operative hospital stay after pancreatic surgery (the weighted mean difference was -1.06, 95% CI-1/88 to -0.23; p = 0.01). Other post-operative outcomes did not change significantly with the use of somatostatin analogues.	[Han, Xianlin; Xu, Zhiyan; Zhao, Yupei; Wu, Wenming] Chinese Acad Med Sci, Dept Gen Surg, Peking Union Med Coll Hosp, Beijing, Peoples R China; [Han, Xianlin; Xu, Zhiyan; Zhao, Yupei; Wu, Wenming] Peking Union Med Coll, Beijing, Peoples R China; [Cao, Shaobo] Huazhong Univ Sci & Technol, Wuhan Cent Hosp, Dept Vasc Surg, Tongji Med Coll, Wuhan, Hubei, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Huazhong University of Science & Technology	Wu, WM (corresponding author), Chinese Acad Med Sci, Dept Gen Surg, Peking Union Med Coll Hosp, Beijing, Peoples R China.; Wu, WM (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	doctorwuu@126.com		Xu, Zhiyan/0000-0002-3674-8198	National Natural Science Foundation of China [81573009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [grant number 81573009] to WW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghamdi AA, 2007, CAN J SURG, V50, P459; Allen PJ, 2014, NEW ENGL J MED, V370, P2014, DOI 10.1056/NEJMoa1313688; Anderson R, 2014, WORLD J SURG, V38, P2138, DOI 10.1007/s00268-014-2512-4; Balzano G, 2008, BRIT J SURG, V95, P357, DOI 10.1002/bjs.5982; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; BUCHLER M, 1992, AM J SURG, V163, P125, DOI 10.1016/0002-9610(92)90264-R; Butturini G, 2008, J HEPATO-BILIARY-PAN, V15, P247, DOI 10.1007/s00534-007-1301-y; Connor S, 2005, BRIT J SURG, V92, P1059, DOI 10.1002/bjs.5107; Datta J, 2016, GASTROENTEROL CLIN N, V45, P129, DOI 10.1016/j.gtc.2015.10.002; de Wilde RF, 2012, BRIT J SURG, V99, P404, DOI 10.1002/bjs.8664; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Drymousis P, 2013, INT J SURG, V11, P779, DOI 10.1016/j.ijsu.2013.06.013; Fernandez-Cruz L, 2013, HPB, V15, P392, DOI 10.1111/j.1477-2574.2012.00608.x; FUESSL HS, 1987, DIGESTION, V36, P101, DOI 10.1159/000199407; Glasgow RE, 1996, WESTERN J MED, V165, P294; Gouillat C, 2001, BRIT J SURG, V88, P1456, DOI 10.1046/j.0007-1323.2001.01906.x; Grobmyer SR, 2007, J AM COLL SURGEONS, V204, P356, DOI 10.1016/j.jamcollsurg.2006.11.017; Hesse UJ, 2005, WORLD J SURG, V29, P1325, DOI 10.1007/s00268-005-7546-1; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jin KZ, 2015, DIGEST SURG, V32, P196, DOI 10.1159/000381032; Katsourakis A, 2010, CLIN EXP GASTROENTER, V3, P179, DOI 10.2147/CEG.S13984; Kollmar O, 2008, EJSO-EUR J SURG ONC, V34, P868, DOI 10.1016/j.ejso.2008.01.014; Koti RS, 2010, HPB, V12, P155, DOI 10.1111/j.1477-2574.2010.00157.x; Kurumboor P, 2015, J GASTROINTEST SURG, V19, P2038, DOI 10.1007/s11605-015-2925-x; LANGE JR, 1992, SURGERY, V112, P1033; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Mckay A, 2006, BRIT J SURG, V93, P929, DOI 10.1002/bjs.5407; MONTORSI M, 1995, SURGERY, V117, P26, DOI 10.1016/S0039-6060(05)80225-9; NEWELL DJ, 1992, INT J EPIDEMIOL, V21, P837, DOI 10.1093/ije/21.5.837; Ohwada S, 1998, WORLD J SURG, V22, P494, DOI 10.1007/s002689900423; RAPTIS S, 1978, METABOLISM, V27, P1321, DOI 10.1016/0026-0495(78)90066-5; Sarr MG, 2003, J AM COLL SURGEONS, V196, P556, DOI 10.1016/S1072-7515(03)00104-2; Shan YS, 2005, WORLD J SURG, V29, P1319, DOI 10.1007/s00268-005-7943-5; Suc B, 2004, ARCH SURG-CHICAGO, V139, P288, DOI 10.1001/archsurg.139.3.288; Wang WG, 2013, HEPATO-GASTROENTEROL, V60, P400, DOI 10.5754/hge12669; Winter JM, 2006, J GASTROINTEST SURG, V10, P1199, DOI 10.1016/j.gassur.2006.08.018; Yeo CJ, 1997, ANN SURG, V226, P248, DOI 10.1097/00000658-199709000-00004; Yeo CJ, 2000, ANN SURG, V232, P419, DOI 10.1097/00000658-200009000-00014	39	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188928	10.1371/journal.pone.0188928	http://dx.doi.org/10.1371/journal.pone.0188928			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211787	Green Submitted, gold, Green Published			2022-12-27	WOS:000417212200051
J	Kropp, HM; Betz, K; Wirth, J; Diederichs, K; Marx, A				Kropp, Heike M.; Betz, Karin; Wirth, Johannes; Diederichs, Kay; Marx, Andreas			Crystal structures of ternary complexes of archaeal B-family DNA polymerases	PLOS ONE			English	Article							ENZYMATIC INCORPORATION; CATALYZED INCORPORATION; STRUCTURE VALIDATION; URACIL RECOGNITION; NUCLEOTIDE; REPLICATION; MECHANISM; VISUALIZATION; MOLPROBITY; SUBSTRATE	Archaeal B-family polymerases drive biotechnology by accepting a wide substrate range of chemically modified nucleotides. By now no structural data for archaeal B-family DNA polymerases in a closed, ternary complex are available, which would be the basis for developing next generation nucleotides. We present the ternary crystal structures of KOD and 9 degrees N DNA polymerases complexed with DNA and the incoming dATP. The structures reveal a third metal ion in the active site, which was so far only observed for the eukaryotic B-family DNA polymerase delta and no other B-family DNA polymerase. The structures reveal a wide inner channel and numerous interactions with the template strand that provide space for modifications within the enzyme and may account for the high processivity, respectively. The crystal structures provide insights into the superiority over other DNA polymerases concerning the acceptance of modified nucleotides.	[Kropp, Heike M.; Betz, Karin; Wirth, Johannes; Diederichs, Kay; Marx, Andreas] Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany; [Marx, Andreas] Univ Konstanz, Dept Chem, Constance, Baden Wurttembe, Germany	University of Konstanz; University of Konstanz	Marx, A (corresponding author), Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany.; Marx, A (corresponding author), Univ Konstanz, Dept Chem, Constance, Baden Wurttembe, Germany.	andreas.marx@uni-konstanz.de		Wirth, Johannes/0000-0002-2216-3332	European Research Council (ERC) [339834]; Konstanz Research School Chemical Biology	European Research Council (ERC)(European Research Council (ERC)); Konstanz Research School Chemical Biology	This work was supported by the European Research Council (ERC Advanced Grant 339834) and the Konstanz Research School Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; Baccaro A, 2012, ANGEW CHEM INT EDIT, V51, P254, DOI 10.1002/anie.201105717; Balintova J, 2015, CHEM SCI, V6, P575, DOI 10.1039/c4sc01906g; Banerjee A, 2015, BIOCONJUGATE CHEM, V26, P1582, DOI 10.1021/acs.bioconjchem.5b00221; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bergen K, 2013, CHEMBIOCHEM, V14, P1058, DOI 10.1002/cbic.201300175; Bergen K, 2012, J AM CHEM SOC, V134, P11840, DOI 10.1021/ja3017889; Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; Bloomfield V.A., 2000, NUCL ACIDS STRUCTURE, V1st ed.; Borsenberger V, 2009, ORG BIOMOL CHEM, V7, P3826, DOI 10.1039/b906956a; Brown JA, 2011, BIOCHEMISTRY-US, V50, P1135, DOI 10.1021/bi101915z; Burak MJ, 2016, EMBO J, V35, P2045, DOI 10.15252/embj.201694332; Busskamp H, 2014, CHEM COMMUN, V50, P10827, DOI 10.1039/c4cc04332d; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Connolly BA, 2003, BIOCHEM SOC T, V31, P699, DOI 10.1042/bst0310699; Darmostuk M, 2015, BIOTECHNOL ADV; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867; Forterre P, 2013, J MOL BIOL, V425, P4714, DOI 10.1016/j.jmb.2013.09.032; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Freudenthal BD, 2015, NATURE, V517, P635, DOI 10.1038/nature13886; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; Fuller CW, 2016, P NATL ACAD SCI USA, V113, P5233, DOI 10.1073/pnas.1601782113; Gao Y, 2016, SCIENCE, V352, P1334, DOI 10.1126/science.aad9633; Guo J, 2017, ACTA CRYSTALLOGR D, V73; Guo J, 2008, P NATL ACAD SCI USA, V105, P9145, DOI 10.1073/pnas.0804023105; Hashimoto H, 2001, J MOL BIOL, V306, P469, DOI 10.1006/jmbi.2000.4403; Held HA, 2002, NUCLEIC ACIDS RES, V30, P3857, DOI 10.1093/nar/gkf500; Hikida Y, 2017, BIOCHEM BIOPH RES CO, V483, P52, DOI 10.1016/j.bbrc.2017.01.007; Hogg M, 2007, J BIOL CHEM, V282, P1432, DOI 10.1074/jbc.M605675200; Hogg M, 2014, NAT STRUCT MOL BIOL, V21, P49, DOI 10.1038/nsmb.2712; Hopfner KP, 1999, P NATL ACAD SCI USA, V96, P3600, DOI 10.1073/pnas.96.7.3600; Hottin A, 2017, CHEM-EUR J, V23, P2109, DOI 10.1002/chem.201604515; Jager S, 2005, J AM CHEM SOC, V127, P15071, DOI 10.1021/ja051725b; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Ju JY, 2006, P NATL ACAD SCI USA, V103, P19635, DOI 10.1073/pnas.0609513103; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaufmann GF, 2005, ANGEW CHEM INT EDIT, V44, P2144, DOI 10.1002/anie.200461143; Kuwahara M, 2006, NUCLEIC ACIDS RES, V34, P5383, DOI 10.1093/nar/gkl637; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Li Y, 2001, PROTEIN SCI, V10, P1225, DOI 10.1110/ps.250101; Mackova M, 2015, CHEMBIOCHEM, V16, P2225, DOI 10.1002/cbic.201500315; Masud MM, 2003, CHEMBIOCHEM, V4, P584, DOI 10.1002/cbic.200200539; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Obeid S, 2013, J AM CHEM SOC, V135, P15667, DOI 10.1021/ja405346s; Obeid S, 2012, CHEM COMMUN, V48, P8320, DOI 10.1039/c2cc34181f; Obeid S, 2010, P NATL ACAD SCI USA, V107, P21327, DOI 10.1073/pnas.1013804107; Obeid S, 2010, EMBO J, V29, P1738, DOI 10.1038/emboj.2010.64; Ostergaard ME, 2011, CHEM-EUR J, V17, P3157, DOI 10.1002/chem.201002109; Perera RL, 2013, ELIFE, V2, DOI 10.7554/eLife.00482; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ren XM, 2014, BIOORGAN MED CHEM, V22, P4384, DOI 10.1016/j.bmc.2014.05.050; Rodriguez AC, 2000, J MOL BIOL, V299, P447, DOI 10.1006/jmbi.2000.3728; Sefah K, 2014, P NATL ACAD SCI USA, V111, P1449, DOI 10.1073/pnas.1311778111; Smart OS, 2011, GRADE VERSION 1212; Southworth MW, 1996, P NATL ACAD SCI USA, V93, P5281, DOI 10.1073/pnas.93.11.5281; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Takagi M, 1997, APPL ENVIRON MICROB, V63, P4504, DOI 10.1128/AEM.63.11.4504-4510.1997; Tan LJ, 2016, CHEM COMMUN, V52, P954, DOI 10.1039/c5cc09131d; Tasara T, 2003, NUCLEIC ACIDS RES, V31, P2636, DOI 10.1093/nar/gkg371; Verga D, 2015, CHEM COMMUN, V51, P7379, DOI 10.1039/c5cc01387a; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Vyas R, 2015, J AM CHEM SOC, V137, P5225, DOI 10.1021/jacs.5b02109; Wang F, 2009, CELL, V139, P1279, DOI 10.1016/j.cell.2009.11.043; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Wang MN, 2011, BIOCHEMISTRY-US, V50, P581, DOI 10.1021/bi101192f; Wynne SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070892; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yang W, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0118-2; Zheng GH, 2009, NUCLEIC ACIDS RES, V37, pW240, DOI 10.1093/nar/gkp358	76	28	29	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188005	10.1371/journal.pone.0188005	http://dx.doi.org/10.1371/journal.pone.0188005			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211756	Green Published, Green Submitted, gold			2022-12-27	WOS:000417212200024
J	Schmidt, P; Sanchez, OS; Kind, CJ				Schmidt, Patrick; Sanchez, Oceane Spinelli; Kind, Claus-Joachim			Stone heat treatment in the Early Mesolithic of southwestern Germany: Interpretation and identification	PLOS ONE			English	Article							LENGTH-FAST CHALCEDONY; SOUTH-AFRICA; WATER; FLINT; TRANSFORMATIONS; SILCRETE; CAVE; AGE; BEHAVIOR; QUARTZ	The Early Mesolithic of southwestern Germany, the so-called Beuronian (9600-7100 BC), is a period of important transformations in the way people lived, in their subsistence and in the stone tools they produced. One of the perhaps most spectacular re-inventions of that time is heat treatment of stones prior to their manufacture into tools. Although heat treatment has been understood as one of the defining characteristics of the Beuronian of southwestern Germany, and although its existence has been known for almost 30 years now, relatively few systematic studies on it are available. In this paper, we present such a study, aiming to shed light on two questions: (1) what technique and heating parameters were used in the Beuronian and (2) how reliable are the macroscopic proxies traditionally used to identify heat treatment in this context? We investigate these questions using a non-destructive archaeometric technique for measuring past heating temperatures of heat-treated stones and a quantitative surface roughness analysis aiming to understand the relations between surface aspect and heat treatment. These methods are applied to 46 Jurassic chert artefacts from the site Helga-Abri located in the Swabian Alb region of southwestern Germany. Our results document that an opportunistic low-investment procedure was used to heat stone, probably relying on the use of the above-ground part of regular camp-fires. We also found that the traditionally used macroscopic criteria, such as colour and surface gloss, cannot be unambiguously used to identify heat treatment in assemblages made from Jurassic chert. These findings have important implications for our understanding of the Beuronian lithic chaine operatoire in terms of the investment in time and resources necessary, and for the refinement of archaeological techniques used to identify heat treatment in the Mesolithic of the Swabian Alb.	[Schmidt, Patrick] Eberhard Karls Univ Tubingen, Dept Early Prehist & Quaternary Ecol, Tubingen, Germany; [Schmidt, Patrick] Eberhard Karls Univ Tubingen, Dept Geosci, Appl Mineral, Tubingen, Germany; [Sanchez, Oceane Spinelli] Univ Bordeaux Montaigne, IRAMAT, CRP2A, UMR 5060, Maison Archeol, Pessac, France; [Kind, Claus-Joachim] State Off Cultural Heritage Baden Wurttemberg, Esslingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux-Montaigne; Universite de Orleans; Universite de Technologie de Belfort-Montbeliard (UTBM); CNRS - Institute for Humanities & Social Sciences (INSHS)	Schmidt, P (corresponding author), Eberhard Karls Univ Tubingen, Dept Early Prehist & Quaternary Ecol, Tubingen, Germany.; Schmidt, P (corresponding author), Eberhard Karls Univ Tubingen, Dept Geosci, Appl Mineral, Tubingen, Germany.	patrick.schmidt@uni-tuebingen.de	Schmidt, Patrick/D-3925-2016	Schmidt, Patrick/0000-0002-8727-6127	Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Tubingen; Deutsche Forschungsgemeinschaft (DFG) [SCHM 3275/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen. Financial support for PS was provided by the Deutsche Forschungsgemeinschaft (DFG) (grant number SCHM 3275/2-1).	[Anonymous], 1974, PLAINS ANTHROPOL; [Anonymous], 1964, TEBIWA; Bentsen SE, 2014, J ARCHAEOL RES, V22, P141, DOI 10.1007/s10814-013-9069-x; Blumentritt R, 1978, HOHLEFELS BEI SCHELK, V46; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; BURKERT W., 2001, THESIS; Collins M.B., 1974, PLAINS ANTHROPOL, V19, P134, DOI [10.1080/2052546.1974.11908696, DOI 10.1080/2052546.1974.11908696]; Conard N.J., 2015, EISZEITARCHAOLOGIE S; Conard N. J., 2015, HUMAN ORIGIN SITES W, V41, P6; Conard NJ, 2009, NATURE, V459, P248, DOI 10.1038/nature07995; Conard NJ, 2009, NATURE, V460, P737, DOI 10.1038/nature08169; Domanski M., 1994, ARCHAEOMETRY, V36, P177, DOI DOI 10.1111/J.1475-4754.1994.TB00963.X; Domanski M, 2009, J ARCHAEOL SCI, V36, P1400, DOI 10.1016/j.jas.2009.02.002; Dutkiewicz E., 2015, WORLD HERITAGE PAPER, V41, P74; Eriksen BV, 2006, COLOURFUL LITHICS CH; Fernandes P., 2012, QUATERNAIRE CONTINEN, P22; Fisher L, 2008, NEOLITHIC CHERT EXPL, P1; FLORKE OW, 1982, CONTRIB MINERAL PETR, V80, P324, DOI 10.1007/BF00378005; Fukuda J, 2009, MINERAL MAG, V73, P825, DOI 10.1180/minmag.2009.073.5.825; GRAETSCH H, 1985, PHYS CHEM MINER, V12, P300, DOI 10.1007/BF00310343; Griffiths DR, 1987, HUMAN USES FLINT CHE, P43; Guilbert R., 2003, BULL SOC PREHIST FR, V100, P463; Guilbert R., 2001, PALEO, V13, P245; Hahn J., 1983, ARCH OLOGISCHES KORR, V13, P19; Hahn J, 1998, AKTUELLE FORSCHUNGEN, V12, P251; Hess T., 2014, MITTEILUNGEN GESELLS, V23, P37; Hess T., 2019, HELGA ABRI ACHTAL DI; Inizan ML, 1976, QUATERNARIA, V19, P1; Jochim M., 1998, HUNTER GATHERER LAND, DOI DOI 10.1007/978-1-4419-8664-1; Jochim MA, 1979, HUNTER GATHERER SUBS; Kind C.-J., 2012, MESOLITHIKUM TALAUE; Kind C.-J., 2009, PREISTORIA ALPINA, V44, P137; Kind C-J, 2003, MESOLITHIKUM TALAUE; Kind Claus-Joachim, 2014, Quartaer, V61, P129; Koltsov L.V., 1999, TANGED POINTS CULTUR, P346; Lea V, 2005, ANTIQUITY, V79, P51, DOI 10.1017/S0003598X00113699; Lea V, 26 C SOC PREH FRANC, P263; Mandeville M.D., 1973, PLAINS ANTHROPOL, V18, P177, DOI [DOI 10.1080/2052546.1973.11908640, https://doi.org/10.1080/2052546.1973.11908640]; Micheelsen H., 1966, MEDD DANSK GEOL FORE, V16, P285; Milot J, 2017, ARCHAEOMETRY, V59, P417, DOI 10.1111/arcm.12256; Mourre V, 2010, SCIENCE, V330, P659, DOI 10.1126/science.1195550; OLAUSSON DS, 1982, J ARCHAEOL SCI, V9, P275, DOI 10.1016/0305-4403(82)90023-1; Pasda C., 1994, FUNDBERICHTE BADEN W, V19, P99; Patterson L.W., 1979, PLAINS ANTHROPOL, V24, P255; Peters E., 1934, GERMANICA, V18, P81; Porraz G, 2016, SOUTH AFR HUMANIT, V29, P203; Price T.D., 1982, P PREHIST SOC, V48, P467, DOI DOI 10.1017/50079497X00008483; Reinerth H, 1930, AUSGRABUNG MESOLITHI, V6, P200; Roque-Rosell J, 2010, INT C NOV 2010 BOST; Schild R, 1997, MAN FLINT, P325; Schmidt P, 2013, ARCHAEOMETRY, V55, P794, DOI 10.1111/j.1475-4754.2012.00712.x; Schmidt P, 2017, ARCHAEOMETRY; Schmidt P, 2017, J ARCHAEOL SCI-REP, V15, P611, DOI 10.1016/j.jasrep.2016.08.014; Schmidt P, 2017, PHYS CHEM MINER, V44, P21, DOI 10.1007/s00269-016-0833-6; Schmidt P, 2016, ARCHAEOL ANTHROP SCI, V8, P839, DOI 10.1007/s12520-015-0259-y; Schmidt P, 2015, J HUM EVOL, V85, P22, DOI 10.1016/j.jhevol.2015.05.001; Schmidt P, 2014, ARCHAEOL ANTHROP SCI, V6, P107, DOI 10.1007/s12520-013-0162-3; Schmidt P, 2013, J ARCHAEOL SCI, V40, P3519, DOI 10.1016/j.jas.2012.10.016; Schmidt P, 2013, PHYS CHEM MINER, V40, P331, DOI 10.1007/s00269-013-0574-8; Schmidt P, 2012, J ARCHAEOL SCI, V39, P135, DOI 10.1016/j.jas.2011.09.012; Schmidt P, 2011, SPECTROCHIM ACTA A, V81, P552, DOI 10.1016/j.saa.2011.06.050; Schmidt RR., 1913, ALTSTEINZEITLICHEN S; Szymczak K., 2002, SWIATOWIT, V5, P229; Taute W, 1973, ARCH OLOGISCHE INFOR, V2, P59; Terradas X., 2001, CYPSELA, V13, P31; Tixier J, 1980, PREHISTOIRE PIERRE T; Wadley L, 2014, J HUM EVOL, V70, P49, DOI 10.1016/j.jhevol.2013.11.003; Was M., 2005, MONOGRAFIE INSTYTUTU, V3, P271; Was M., 2006, STONE TECHNIQUE TECH, P173; Wisniewski A., 2006, STONE TECHNIQUE TECH, P179	70	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188576	10.1371/journal.pone.0188576	http://dx.doi.org/10.1371/journal.pone.0188576			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211749	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200040
J	Yang, H; Chen, QX; Sun, FY; Zhao, NN; Wen, LR; Li, L; Ran, G				Yang, Hui; Chen, Qiuxia; Sun, Fangyun; Zhao, Nana; Wen, Lirong; Li, Lin; Ran, Gai			Down-regulation of the klf5-c-Myc interaction due to klf5 phosphorylation mediates resveratrol repressing the caveolin-1 transcription through the PI3K/PKD1/Akt pathway	PLOS ONE			English	Article							C-MYC; CELLS; ACETYLATION; INHIBITION; STEATOSIS; MECHANISM; FACTOR-5; GLUCOSE; BINDING; ALTERS	Resveratrol (RSV), a natural polyphenol, has been reported to produce effect on genes transcription in lipid metabolism. In this study, we aim to explore the novel mechanisms of RSV on the regulation of caveolin-1 (Cav-1) transcription. Via body weight, blood glucose, serum lipid, and liver pathology detection, we found that RSV decreased body weight, blood glucose and lipid accumulation in rats fed high-fat diet. Based on co-immunoprecipitation (CoIP) and western blotting assay, we found that RSV up-regulated klf5 phosphorylation and decreased the interaction of klf5 with c-Myc, which were accompanied by down-regulation of Cav-1 expression in livers of rats fed with high-fat diet. Moreover, in HEK293 cells, we observed RSV enhanced klf5 phosphorylation and separated the interaction of klf5 with c-Myc through inhibiting the activation of PI3K/PKD1/Akt pathway, which maybe promoted c-Myc binding to the promoter to inhibit Cav-1 expression. The results of the present study demonstrated that RSV activated klf5 phosphorylation by inhibiting PI3K/PKD1/Akt pathway, and then attenuated the interaction of klf5 with c-Myc, subsequently probably promoted the c-Myc binding to the promoter to repress Cav-1 expression.	[Yang, Hui; Chen, Qiuxia] Kecheng Peoples Hosp, Dept Clin Nutr, Quzhou, Zhejiang, Peoples R China; [Sun, Fangyun; Li, Lin; Ran, Gai] Wenzhou Med Univ, Dept Prevent Med, Wenzhou, Zhejiang, Peoples R China; [Zhao, Nana] Shandong Med Coll, Sch Basic Med Sci, Linyi, Shandong, Peoples R China; [Wen, Lirong] Huazhong Univ Sci & Technol, Sch Econ, Wuhan, Hubei, Peoples R China	Wenzhou Medical University; Huazhong University of Science & Technology	Ran, G (corresponding author), Wenzhou Med Univ, Dept Prevent Med, Wenzhou, Zhejiang, Peoples R China.	15958706236@163.com						Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chang H, 2011, J CELL PHYSIOL, V226, P1660, DOI 10.1002/jcp.22497; Chattopadhyay M, 2011, DIABETES, V60, P1483, DOI 10.2337/db10-0869; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Fernandez-Rojo MA, 2016, TRENDS MOL MED, V22, P889, DOI 10.1016/j.molmed.2016.08.007; Fernandez-Rojo MA, 2013, CELL REP, V4, P238, DOI 10.1016/j.celrep.2013.06.017; Fernandez-Rojo MA, 2012, HEPATOLOGY, V55, P1574, DOI 10.1002/hep.24810; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; Ishikawa K, 2015, SCI REP-UK, V5, DOI 10.1038/srep16386; Kessoku T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22251; Kim S, 2011, BIOCHEM PHARMACOL, V81, P1343, DOI 10.1016/j.bcp.2011.03.012; Leontieva OV, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.202; Matsumura T, 2005, J BIOL CHEM, V280, P12123, DOI 10.1074/jbc.M410578200; Miao BC, 2010, P NATL ACAD SCI USA, V107, P20126, DOI 10.1073/pnas.1004522107; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; Oishi Y, 2008, NAT MED, V14, P656, DOI 10.1038/nm1756; Oishi Yumiko, 2011, Nihon Rinsho, V69 Suppl 1, P264; Park DS, 2001, BIOCHEMISTRY-US, V40, P3354, DOI 10.1021/bi002787b; Thiel G, 2014, MOL NUTR FOOD RES, V58, P1402, DOI 10.1002/mnfr.201300913; Wang HB, 2015, ONCOTARGET, V6, P15857, DOI 10.18632/oncotarget.4327; Wei GB, 2016, CELL PHYSIOL BIOCHEM, V39, P33, DOI 10.1159/000445603; Wu Y, 2016, STEM CELLS, V34, P83, DOI 10.1002/stem.2209; Zhang XH, 2009, FEBS LETT, V583, P1231, DOI 10.1016/j.febslet.2009.03.016; Zhang Y, 2015, MOL NUTR FOOD RES, V59, P1443, DOI 10.1002/mnfr.201500016; Zhang ZP, 2003, NUCLEIC ACIDS RES, V31, P2196, DOI 10.1093/nar/gkg310	25	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189156	10.1371/journal.pone.0189156	http://dx.doi.org/10.1371/journal.pone.0189156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211809	gold, Green Published, Green Submitted			2022-12-27	WOS:000417212200071
J	Figorilli, F; Putignano, A; Roux, O; Houssel-Debry, P; Francoz, C; Paugam-Burtz, C; Soubrane, O; Agarwal, B; Durand, F; Jalan, R				Figorilli, Francesco; Putignano, Antonella; Roux, Olivier; Houssel-Debry, Pauline; Francoz, Claire; Paugam-Burtz, Catherine; Soubrane, Olivier; Agarwal, Banwari; Durand, Francois; Jalan, Rajiv			Development of an organ failure score in acute liver failure for transplant selection and identification of patients at high risk of futility	PLOS ONE			English	Article							FULMINANT HEPATIC-FAILURE; INFLAMMATORY RESPONSE SYNDROME; COLLEGE-HOSPITAL CRITERIA; SINGLE-CENTER EXPERIENCE; EARLY INDICATORS; DISEASE MELD; APACHE-II; PROGNOSIS; MODEL; MULTICENTER	Introduction King's College Hospital criteria are currently used to select liver transplant candidates in acetaminophen- related acute liver failure (ALF). Although widely accepted, they show a poor sensitivity in predicting pre-transplant mortality and cannot predict the outcome after surgery. In this study we aimed to develop a new prognostic score that can allow patient selection for liver transplantation more appropriately and identify patients at high risk of futile transplantation. Methods We analysed consecutive patients admitted to the Royal Free and Beaujon Hospitals between 1990 and 2015. Clinical and laboratory data at admission were collected. Predictors of 3-month mortality in the non-transplanted patients admitted to the Royal Free Hospital were used to develop the new score, which was then validated against the Beaujon cohort. The Beaujon-transplanted group was also used to assess the ability of the new score in identifying patients at high risk of transplant futility. Results 152 patients were included of who 44 were transplanted. SOFA, CLIF-C OF and CLIF-ACLF scores were the best predictors of 3-month mortality among non-transplanted patients. CLIF-C OF score and high dosages of norepinephrine requirement were the only significant predictors of 3-month mortality in the non-transplanted patients, and therefore were included in the ALF-OFs score. In non-transplanted patients, ALF-OFs showed good performance in both exploratory (AUC = 0.89; sensitivity = 82.6%; specificity = 89.5%) and the validation cohort (AUC = 0.988; sensitivity = 100%; specificity = 92.3%). ALF-OFs score was also able to identify patients at high risk of transplant futility (AUC = 0.917; sensitivity = 100%; specificity = 79.2%). Conclusion ALF-OFs is a new prognostic score in acetaminophen-related ALF that can predict both the need for liver transplant and high risk of transplant futility, improving candidate selection for liver transplantation.	[Figorilli, Francesco; Putignano, Antonella; Jalan, Rajiv] UCL Med Sch, UCL Inst Liver & Digest Hlth, Liver Failure Grp, Royal Free Campus, London, England; [Roux, Olivier; Houssel-Debry, Pauline; Francoz, Claire; Durand, Francois] Hosp Beaujon, AP HP, Hepatol & Liver Intens Care Unit, Clichy, France; [Paugam-Burtz, Catherine] Univ Paris Diderot, Hosp Beaujon, AP HP, Anaesthesiol Intens Care Unit, Clichy, France; [Soubrane, Olivier] Hosp Beaujon, AP HP, Hepatobiliary Pancreat Surg, Clichy, France; [Agarwal, Banwari] Royal Free Hosp, Royal Free London NHS Fdn Trust, Intens Care Unit, London, England	University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Figorilli, F; Jalan, R (corresponding author), UCL Med Sch, UCL Inst Liver & Digest Hlth, Liver Failure Grp, Royal Free Campus, London, England.	francesco.figorilli@gmail.com; r.jalan@ucl.ac.uk	Soubrane, Olivier/H-7799-2016; Roux, Olivier/AAE-1002-2020; Soubrane, Olivier/ABB-4434-2021	Roux, Olivier/0000-0003-1563-7066; Agarwal, Banwari/0000-0001-5508-2590; Putignano, Antonella/0000-0002-4083-2405				Bailey B, 2003, CRIT CARE MED, V31, P299, DOI 10.1097/00003246-200301000-00048; Barber KM, 2007, HEPATOLOGY, V46, p510A; Barshes NR, 2006, TRANSPLANTATION, V81, P195, DOI 10.1097/01.tp.0000188149.90975.63; Bateman DN, 2014, BRIT J CLIN PHARMACO, V78, P610, DOI 10.1111/bcp.12362; Bernal W, 2002, LANCET, V359, P558, DOI 10.1016/S0140-6736(02)07743-7; Bernal W, 2015, J HEPATOL, V62, pS112, DOI 10.1016/j.jhep.2014.12.016; Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937; Bernal W, 2013, J HEPATOL, V59, P74, DOI 10.1016/j.jhep.2013.02.010; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; Bernal W, 2009, J HEPATOL, V50, P306, DOI 10.1016/j.jhep.2008.09.012; Cholongitas EB, 2006, HEPATOLOGY, V43, P881, DOI 10.1002/hep.21121; Cholongitas E, 2012, LIVER TRANSPLANT, V18, P405, DOI 10.1002/lt.23370; Craig DGN, 2010, ALIMENT PHARM THER, V31, P1064, DOI 10.1111/j.1365-2036.2010.04279.x; Dhiman RK, 2007, LIVER TRANSPLANT, V13, P814, DOI 10.1002/lt.21050; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Germani G, 2012, J HEPATOL, V57, P288, DOI 10.1016/j.jhep.2012.03.017; Jalan R, 2014, J HEPATOL, V61, P1038, DOI 10.1016/j.jhep.2014.06.012; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; O'Grady J, 2014, J HEPATOL, V60, P663, DOI 10.1016/j.jhep.2013.10.024; OGRADY JG, 1993, LANCET, V342, P273; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; Reuben A, 2016, ANN INTERN MED; Rolando N, 2000, HEPATOLOGY, V32, P734, DOI 10.1053/jhep.2000.17687; Rutherford A, 2012, GASTROENTEROLOGY, V143, P1237, DOI 10.1053/j.gastro.2012.07.113; Schmidt LE, 2007, HEPATOLOGY, V45, P789, DOI 10.1002/hep.21503; Schmidt LE, 2006, CRIT CARE MED, V34, P337, DOI 10.1097/01.CCM.0000194724.70031.B6; Speiser JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122929; Wei G, 2007, J INTERN MED, V262, P393, DOI 10.1111/j.1365-2796.2007.01818.x; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; William A., 1991, CHEST, V100, P1619	32	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188151	10.1371/journal.pone.0188151	http://dx.doi.org/10.1371/journal.pone.0188151			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206839	gold, Green Submitted, Green Published			2022-12-27	WOS:000417110700008
J	Koire, A; Gilbert, BE; Sucgang, R; Zechiedrich, L				Koire, Amanda; Gilbert, Brian E.; Sucgang, Richard; Zechiedrich, Lynn			Repurposed Transcriptomic Data Reveal Small Viral RNA Produced by Influenza Virus during Infection in Mice (vol 11, e0165729, 2017)	PLOS ONE			English	Correction															Baylor College of Medicine Comprehensive Cancer Training Program [RP160283]	Baylor College of Medicine Comprehensive Cancer Training Program	This work was supported by RP160283-Baylor College of Medicine Comprehensive Cancer Training Program.	Koire A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165729	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							0189384	10.1371/journal.pone.0189384	http://dx.doi.org/10.1371/journal.pone.0189384			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206873	Green Published, Green Submitted, gold			2022-12-27	WOS:000417110700055
J	Mousa, AA; Roche, DB; Terkawi, MA; Kameyama, K; Kamyingkird, K; Vudriko, P; Salama, A; Cao, SN; Orabi, S; Khalifa, H; Ahmed, M; Attia, M; Elkirdasy, A; Nishikawa, Y; Xuan, XN; Cornillot, E				Mousa, Ahmed Abdelmoniem; Roche, Daniel Barry; Terkawi, Mohamad Alaa; Kameyama, Kyohko; Kamyingkird, Ketsarin; Vudriko, Patrick; Salama, Akram; Cao, Shinuo; Orabi, Sahar; Khalifa, Hanem; Ahmed, Mohamed; Attia, Mabrouk; Elkirdasy, Ahmed; Nishikawa, Yoshifumi; Xuan, Xuenan; Cornillot, Emmanuel			Human babesiosis: Indication of a molecular mimicry between thrombospondin domains from a novel Babesia microti BmP53 protein and host platelets molecules (vol 12, e0185372, 2017)	PLOS ONE			English	Correction									[Terkawi, Mohamad Alaa; Nishikawa, Yoshifumi; Xuan, Xuenan] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido, Japan	Obihiro University of Agriculture & Veterinary Medicine	Terkawi, MA (corresponding author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido, Japan.		Cao, Shinuo/AAD-1027-2020; Cao, Shinuo/ABH-3244-2021; Mousa, Ahmed Abdelmoniem/J-5451-2017; Mousa, Ahmed Amin/AAH-2827-2019; Mousa, Ahmed Abdelmoniem/AAC-1769-2019; Khalifa, Hanem/ABE-7256-2020	Mousa, Ahmed Abdelmoniem/0000-0001-8058-6176; Mousa, Ahmed Abdelmoniem/0000-0001-8058-6176; Khalifa, Hanem/0000-0002-4893-1117; Terkawi, Alaa/0000-0002-5481-8516; orabi, sahar/0000-0001-8551-9298; Abd Eldaim, Mabrouk/0000-0001-9842-9777; Ahmed, Mohamed/0000-0001-6106-8947; Salama, Akram/0000-0002-8047-8965				Mousa AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185372	1	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189383	10.1371/journal.pone.0189383	http://dx.doi.org/10.1371/journal.pone.0189383			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206874	Green Published, Green Submitted, gold			2022-12-27	WOS:000417110700054
J	Ahlgren, EC; Fekry, M; Wiemann, M; Soderberg, CA; Bernfur, K; Gakh, O; Rasmussen, M; Hojrup, P; Emanuelsson, C; Isaya, G; Al-Karadaghi, S				Ahlgren, Eva-Christina; Fekry, Mostafa; Wiemann, Mathias; Soederberg, Christopher A.; Bernfur, Katja; Gakh, Olex; Rasmussen, Morten; Hojrup, Peter; Emanuelsson, Cecilia; Isaya, Grazia; Al-Karadaghi, Salam			Iron-induced oligomerization of human FXN81-210 and bacterial CyaY frataxin and the effect of iron chelators	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; YEAST FRATAXIN; FRIEDREICH ATAXIA; BINDING-PROPERTIES; CLUSTER SYNTHESIS; ESCHERICHIA-COLI; N-TERMINUS; PROTEIN; FERROCHELATASE; MATURATION	Patients suffering from the progressive neurodegenerative disease Friedreich's ataxia have reduced expression levels of the protein frataxin. Three major isoforms of human frataxin have been identified, FXN42-210, FXN56-210 and FXN81-210, of which FXN81-210 is considered to be the mature form. Both long forms, FXN42-210 and FXN56-210, have been shown to spontaneously form oligomeric particles stabilized by the extended N-terminal sequence. The short variant FXN81-210, on other hand, has only been observed in the monomeric state. However, a highly homologous E. coli frataxin CyaY, which also lacks an N-terminal extension, has been shown to oligomerize in the presence of iron. To explore the mechanisms of stabilization of short variant frataxin oligomers we compare here the effect of iron on the oligomerization of CyaY and FXN81-210. Using dynamic light scattering, small-angle X-ray scattering, electron microscopy (EM) and cross linking mass spectrometry (MS), we show that at aerobic conditions in the presence of iron both FXN81-210 and CyaY form oligomers. However, while CyaY oligomers are stable over time, FXN81-210 oligomers are unstable and dissociate into monomers after about 24 h. EM and MS studies suggest that within the oligomers FXN81-210 and CyaY monomers are packed in a head-to-tail fashion in ring-shaped structures with potential iron-binding sites located at the interface between monomers. The higher stability of CyaY oligomers can be explained by a higher number of acidic residues at the interface between monomers, which may result in a more stable iron binding. We also show that CyaY oligomers may be dissociated by ferric iron chelators deferiprone and DFO, as well as by the ferrous iron chelator BIPY. Surprisingly, deferiprone and DFO stimulate FXN81-210 oligomerization, while BIPY does not show any effect on oligomerization in this case. The results suggest that FXN81-210 oligomerization is primarily driven by ferric iron, while both ferric and ferrous iron participate in CyaY oligomer stabilization. Analysis of the amino acid sequences of bacterial and eukaryotic frataxins suggests that variations in the position of the acidic residues in helix 1, beta-strand 1 and the loop between them may control the mode of frataxin oligomerization.	[Ahlgren, Eva-Christina; Fekry, Mostafa; Wiemann, Mathias; Soederberg, Christopher A.; Bernfur, Katja; Emanuelsson, Cecilia; Al-Karadaghi, Salam] Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, Lund, Sweden; [Fekry, Mostafa] Cairo Univ, Fac Sci, Dept Biophys, Giza, Egypt; [Gakh, Olex] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN USA; [Gakh, Olex; Isaya, Grazia] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA; [Rasmussen, Morten; Hojrup, Peter] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark	Lund University; Egyptian Knowledge Bank (EKB); Cairo University; Mayo Clinic; Mayo Clinic; University of Southern Denmark	Al-Karadaghi, S (corresponding author), Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, Lund, Sweden.	Salam.Al-Karadaghi@biochemistry.lu.se	Højrup, Peter/ABG-8477-2020	Wiemann, Mathias/0000-0003-0803-0370; Fekry, Mostafa/0000-0003-1818-5683; Hojrup, Peter/0000-0002-7838-6180	National Institute of Health (NIH) [AG15709-19]; Swedish Natural Sciences Research Council (Vetenskapsradet); European Union Mobility Program Erasmus; School in Pharmaceutical Sciences at Lund University (FLAEK); Villum Fonden [00007292] Funding Source: researchfish	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Natural Sciences Research Council (Vetenskapsradet); European Union Mobility Program Erasmus; School in Pharmaceutical Sciences at Lund University (FLAEK); Villum Fonden(Villum Fonden)	The funding or sources of support received during this study include National Institute of Health (NIH) Award Number AG15709-19 to Grazia Isaya, Swedish Natural Sciences Research Council (Vetenskapsradet, www.vr.se), European Union Mobility Program Erasmus (https://ec.europa.eu/programmes/erasmus-plus/), The researsh School in Pharmaceutical Sciences at Lund University (FLAEK, http://www.flak.lu.se). There was no additional external funding received for this study.	Abrahao A, 2015, NEUROGENETICS; Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Adinolfi S, 2002, HUM MOL GENET, V11, P1865, DOI 10.1093/hmg/11.16.1865; Bedekovics T, 2007, FEMS YEAST RES, V7, P1276, DOI 10.1111/j.1567-1364.2007.00296.x; Bencze KZ, 2007, CHEM COMMUN, P1798, DOI 10.1039/b703195e; Boddaert N, 2007, BLOOD, V110, P401, DOI 10.1182/blood-2006-12-065433; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Brittenham GM, 2003, ALCOHOL, V30, P151, DOI 10.1016/S0741-8329(03)00101-0; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Cavadini P, 2002, HUM MOL GENET, V11, P217, DOI 10.1093/hmg/11.3.217; Condo I, 2007, HUM MOL GENET, V16, P1534, DOI 10.1093/hmg/ddm102; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; Faraj SE, 2013, FEBS OPEN BIO, V3, P310, DOI 10.1016/j.fob.2013.07.004; Gakh O, 2002, BIOCHEMISTRY-US, V41, P6798, DOI 10.1021/bi025566+; Gakh O, 2016, J BIOL CHEM, V291, P21296, DOI 10.1074/jbc.M116.738542; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Gentry LE, 2013, BIOCHEMISTRY-US, V52, P6085, DOI 10.1021/bi400443n; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koutnikova H, 1998, HUM MOL GENET, V7, P1485, DOI 10.1093/hmg/7.9.1485; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Marmolino D, 2011, BRAIN RES REV, V67, P311, DOI 10.1016/j.brainresrev.2011.04.001; Merkley ED, 2014, PROTEIN SCI, V23, P747, DOI 10.1002/pro.2458; Mielcarek A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122538; MODELL B, 1982, BRIT MED J, V284, P1081, DOI 10.1136/bmj.284.6322.1081; Mounsey Ross B, 2012, Int J Cell Biol, V2012, P983245, DOI 10.1155/2012/983245; Nair M, 2004, STRUCTURE, V12, P2037, DOI 10.1016/j.str.2004.08.012; Nichol H, 2003, BIOCHEMISTRY-US, V42, P5971, DOI 10.1021/bi027021l; O'Neill HA, 2005, BIOCHEMISTRY-US, V44, P537, DOI 10.1021/bi048459j; O'Neill HA, 2005, J MOL BIOL, V345, P433, DOI 10.1016/j.jmb.2004.10.074; Pandolfo M, 2013, J NEUROCHEM, V126, P142, DOI 10.1111/jnc.12300; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Pastore C, 2007, FEBS J, V274, P4199, DOI 10.1111/j.1742-4658.2007.05946.x; Perez LR, 2010, DALTON T, V39, P2177, DOI 10.1039/b919237a; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Prischi F, 2009, FEBS J, V276, P6669, DOI 10.1111/j.1742-4658.2009.07381.x; Ranatunga W, 2016, J BIOL CHEM, V291, P10378, DOI 10.1074/jbc.M115.712414; Schagerlof U, 2008, BIOCHEMISTRY-US, V47, P4948, DOI 10.1021/bi800052m; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Scott LE, 2009, CHEM REV, V109, P4885, DOI 10.1021/cr9000176; Soderberg C.G., 2016, J BIOL CHEM; Soderberg CAG, 2013, J BIOL CHEM, V288, P8156, DOI 10.1074/jbc.M112.442285; Soderberg CAG, 2011, J MOL BIOL, V414, P783, DOI 10.1016/j.jmb.2011.10.034; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Vaubel RA, 2013, MOL CELL NEUROSCI, V55, P50, DOI 10.1016/j.mcn.2012.08.003; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i	57	13	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188937	10.1371/journal.pone.0188937	http://dx.doi.org/10.1371/journal.pone.0188937			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29200434	Green Published, gold			2022-12-27	WOS:000417033200023
J	Raleigh, MD; Peterson, SJ; Laudenbach, M; Baruffaldi, F; Carroll, FI; Comer, SD; Navarro, HA; Langston, TL; Runyon, SP; Winston, S; Pravetoni, M; Pentel, PR				Raleigh, M. D.; Peterson, S. J.; Laudenbach, M.; Baruffaldi, F.; Carroll, F. I.; Comer, S. D.; Navarro, H. A.; Langston, T. L.; Runyon, S. P.; Winston, S.; Pravetoni, M.; Pentel, P. R.			Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse	PLOS ONE			English	Article							CONJUGATE VACCINE; RELEASE NALTREXONE; HEROIN-ADDICTS; DRUG-ABUSE; NICOTINE; COCAINE; DEPENDENCE; ANTIBODY; MORPHINE; BRAIN	Among vaccines aimed at treating substance use disorders, those targeting opioids present several unique medication development challenges. 1) Opioid overdose is a common complication of abuse, so it is desirable for an opioid vaccine to block the toxic as well as the addictive effects of opioids. 2) It is important that an opioid vaccine not interfere with the action of opioid antagonists used to reverse opioid overdose or treat addiction. 3) Some opioids are immunosuppressive and chronic ongoing opioid use could interfere with vaccine immunogenicity. 4) Although antibody-bound oxycodone is unable to enter the brain because of its size, it might still be able to activate peripheral opioid receptors. To assess vaccine impact on opioid toxicity, rats vaccinated with oxycodone conjugated to keyhole limpet hemocyanin subunit dimer (OXY-dKLH) adsorbed to alum or controls vaccinated with dKLH were compared with regard to oxycodone-induced hotplate analgesia and oxycodone-induced respiratory depression and bradycardia. Vaccination shifted the dose-response curves to the right, representing protection, for each of these endpoints. Naloxone was equally effective in both OXY-dKLH and control groups, providing complete and rapid reversal of respiratory depression. The administration of a long-acting naltrexone formulation during vaccination did not impair vaccine immunogenicity in mice. Similarly, serum anti-oxycodone antibody titers were not altered by continuous morphine infusion during vaccination compared to opioid-naive controls. Competitive ELISA assay showed negligible or low affinity of immune antiserum for endogenous opioids or opioid antagonists. In vitro receptor binding assays showed that antibody-bound oxycodone does not activate mu opioid receptors. These data support further study of OXY-dKLH as a potential treatment for oxycodone abuse and suggest that vaccination might also reduce the severity of oxycodone overdose.	[Raleigh, M. D.; Peterson, S. J.; Laudenbach, M.; Baruffaldi, F.; Pravetoni, M.; Pentel, P. R.] Minneapolis Med Res Fdn Inc, Minneapolis, MN 55404 USA; [Carroll, F. I.; Navarro, H. A.; Langston, T. L.; Runyon, S. P.] Res Triangle Inst, POB 12194, Res Triangle Pk, NC 27709 USA; [Comer, S. D.] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, New York, NY USA; [Comer, S. D.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Winston, S.] Winston Biopharmaceut Consulting, Boulder, CO USA; [Pravetoni, M.; Pentel, P. R.] Univ Minnesota, Med Sch, Dept Med, Minneapolis, MN USA; [Pravetoni, M.] Univ Minnesota, Med Sch, Ctr Immunol, Minneapolis, MN USA	Minneapolis Medical Research Foundation; Research Triangle Institute; Columbia University; New York State Psychiatry Institute; Columbia University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Raleigh, MD (corresponding author), Minneapolis Med Res Fdn Inc, Minneapolis, MN 55404 USA.	rale0011@umn.edu		Pravetoni, Marco/0000-0003-1036-0184	National Institutes of Health, National Institute on Drug Abuse [DA038876]	National Institutes of Health, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This work was supported by National Institutes of Health, National Institute on Drug Abuse (https://www.drugabuse.gov/) grant DA038876 (MP, PRP). SW was a consultant on this study and owns the company Winston Pharmaceutical Consulting. The specific roles of this author are articulated in the 'author contributions' section.	Akbarzadeh A., 2009, Journal of Pharmacology and Toxicology, V4, P30, DOI 10.3923/jpt.2009.30.35; Akbarzadeh A, 2007, ASAIN J BIOCH, V2, P58; Alexander M, 2005, J SURG RES, V129, P161, DOI 10.1016/j.jss.2005.04.028; Appel PW, 2004, AM J DRUG ALCOHOL AB, V30, P129, DOI 10.1081/ADA-120029870; Borg L, 1999, ADDICTION, V94, P489, DOI 10.1046/j.1360-0443.1999.9444894.x; Bremer PT, 2016, ANGEW CHEM INT EDIT, V55, P3772, DOI 10.1002/anie.201511654; Cabral GA, 2006, J NEUROIMMUNE PHARM, V1, P280, DOI 10.1007/s11481-006-9023-5; Comer SD, 2007, EXPERT OPIN INV DRUG, V16, P1285, DOI 10.1517/13543784.16.8.1285; Cooper ZD, 2012, BEHAV PHARMACOL, V23, P271, DOI 10.1097/FBP.0b013e3283536d6f; Fahim REF, 2013, EXPERT REV VACCINES, V12, P333, DOI [10.1586/erv.13.13, 10.1586/ERV.13.13]; Fiellin DA, 2002, ANN INTERN MED, V137, P688, DOI 10.7326/0003-4819-137-8-200210150-00014; Fiellin DA, 2006, CLIN INFECT DIS, V43, pS173, DOI 10.1086/508180; Gentry WB, 2006, INT IMMUNOPHARMACOL, V6, P968, DOI 10.1016/j.intimp.2006.01.008; Giglio Rebecca E, 2015, Inj Epidemiol, V2, P10; Hatsukami DK, 2011, CLIN PHARMACOL THER, V89, P392, DOI 10.1038/clpt.2010.317; He GA, 2001, ACTA PHARMACOL SIN, V22, P530; Jones JD, 2011, AM J ADDICTION, V20, P190, DOI 10.1111/j.1521-0391.2011.00120.x; Kimishima A, 2017, ACS CHEM BIOL, V12, P36, DOI 10.1021/acschembio.6b00977; Kosten T, 2014, BRIT J CLIN PHARMACO, V77, P368, DOI 10.1111/bcp.12115; Kosten TR, 2014, DRUG ALCOHOL DEPEN, V140, P42, DOI 10.1016/j.drugalcdep.2014.04.003; Krupitsky E, 2013, ADDICTION, V108, P1628, DOI 10.1111/add.12208; Le Bars D, 2001, PHARMACOL REV, V53, P597; Lebrec H, 2014, J IMMUNOTOXICOL, V11, P213, DOI 10.3109/1547691X.2013.822948; LEHMAN TM, 1979, LIFE SCI, V25, P1591, DOI 10.1016/0024-3205(79)90442-9; Li Q, 2014, INT J NEUROPSYCHOPHA; Moroz E, 2016, VACCINE, V34, P1363, DOI 10.1016/j.vaccine.2016.01.051; Orson FM, 2014, EXPERT OPIN BIOL TH, V14, P1271, DOI 10.1517/14712598.2014.920319; Pentel P, 2015, BIOL TREAT SUBSTANCE, P37; Pentel PR, 2014, ADV PHARMACOL, V69, P553, DOI 10.1016/B978-0-12-420118-7.00014-7; Pentel PR, 2000, PHARMACOL BIOCHEM BE, V65, P191, DOI 10.1016/S0091-3057(99)00206-3; Pravetoni M, 2012, VACCINE, V30, P4617, DOI 10.1016/j.vaccine.2012.04.101; Pravetoni M, 2012, J PHARMACOL EXP THER, V341, P225, DOI 10.1124/jpet.111.189506; Pravetoni M, 2016, HUM VACC IMMUNOTHER, V12, P3005, DOI 10.1080/21645515.2016.1212785; Pravetoni M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101807; Pravetoni M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096547; Pravetoni M, 2013, J MED CHEM, V56, P915, DOI 10.1021/jm3013745; Quaglio G, 2002, ADDICTION, V97, P985, DOI 10.1046/j.1360-0443.2002.00147.x; Rahim RT, 2001, INT IMMUNOPHARMACOL, V1, P2001, DOI 10.1016/S1567-5769(01)00128-X; Raleigh MD, 2013, J PHARMACOL EXP THER, V344, P397, DOI 10.1124/jpet.112.201194; Rosenberg H, 2003, PSYCHOL ADDICT BEHAV, V17, P203, DOI 10.1037/0893-164X.17.3.203; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Schlosburg JE, 2013, P NATL ACAD SCI USA, V110, P9036, DOI 10.1073/pnas.1219159110; Shen XYY, 2013, DRUG ALCOHOL DEPEN, V129, P41, DOI 10.1016/j.drugalcdep.2012.09.007; Skolnick P, 2015, TRENDS PHARMACOL SCI, V36, P628, DOI 10.1016/j.tips.2015.07.002; Strang J, 2010, LANCET, V375, P1885, DOI 10.1016/S0140-6736(10)60349-2; Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Behavioral Health Statistics and Quality, NAT SURV DRUG US HLT; Treweek JB, 2012, MOL PHARMACEUT, V9, P969, DOI 10.1021/mp200588v; Tuncok Y, 2001, EXP CLIN PSYCHOPHARM, V9, P228; Volkow ND, 2017, NEW ENGL J MED, V377, P391, DOI 10.1056/NEJMsr1706626; Wheeler E, 2015, MMWR-MORBID MORTAL W, V64, P631; Wong J, 2012, POISONING DRUG OVERD, P514; Woody GE, 2004, NEW TREATMENTS ADDIC, P125	52	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0184876	10.1371/journal.pone.0184876	http://dx.doi.org/10.1371/journal.pone.0184876			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO5CX	29194445	Green Published, gold, Green Submitted			2022-12-27	WOS:000416867800003
J	Janghorban, M; Langer, EM; Wang, XY; Zachman, D; Daniel, CJ; Hooper, J; Fleming, WH; Agarwal, A; Sears, RC				Janghorban, Mahnaz; Langer, Ellen M.; Wang, Xiaoyan; Zachman, Derek; Daniel, Colin J.; Hooper, Jody; Fleming, William H.; Agarwal, Anupriya; Sears, Rosalie C.			The tumor suppressor phosphatase PP2A-56a regulates stemness and promotes the initiation of malignancies in a novel murine model	PLOS ONE			English	Article							C-MYC PROTEIN; BETA-CATENIN; 2A; SUBUNIT; PHOSPHORYLATION; EXPRESSION; SKIN; GROWTH; STABILIZATION; CELLS	dProtein phosphatase 2A (PP2A) is a ubiquitously expressed Serine-Threonine phosphatase mediating 30-50% of protein phosphatase activity. PP2A functions as a heterotrimeric complex, with the B subunits directing target specificity to regulate the activity of many key pathways that control cellular phenotypes. PP2A-B56 alpha has been shown to play a tumor suppressor role and to negatively control c-MYC stability and activity. Loss of B56 alpha promotes cellular transformation, likely at least in part through its regulation of c-MYC. Here we report generation of a B56 alpha hypomorph mouse with very low B56 alpha expression that we used to study the physiologic activity of the PP2A-B56 alpha phosphatase. The predominant phenotype we observed in mice with B56 alpha deficiency in the whole body was spontaneous skin lesion formation with hyperproliferation of the epidermis, hair follicles and sebaceous glands. Increased levels of c-MYC phosphorylation on Serine62 and c-MYC activity were observed in the skin lesions of the B56 alpha(hm/hm) mice. B56 alpha deficiency was found to increase the number of skin stem cells, and consistent with this, papilloma initiation was accelerated in a carcinogenesis model. Further analysis of additional tissues revealed increased inflammation in spleen, liver, lung, and intestinal lymph nodes as well as in the skin lesions, resembling elevated extramedullary hematopoiesis phenotypes in the B56 alpha(hm/hm) mice. We also observed an increase in the clonogenicity of bone marrow stem cells in B56 alpha(hm/hm) mice. Overall, this model suggests that B56 alpha is important for stem cells to maintain homeostasis and that B56 alpha loss leading to increased activity of important oncogenes, including c-MYC, can result in aberrant cell growth and increased stem cells that can contribute to the initiation of malignancy.	[Janghorban, Mahnaz; Langer, Ellen M.; Wang, Xiaoyan; Daniel, Colin J.; Sears, Rosalie C.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Zachman, Derek; Fleming, William H.] Oregon Stem Cell Ctr, Pape Family Pediat Res Inst, Dept Pediat, Portland, OR USA; [Hooper, Jody] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Fleming, William H.; Agarwal, Anupriya; Sears, Rosalie C.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Agarwal, Anupriya] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA; [Sears, Rosalie C.] Oregon Hlth & Sci Univ, Brenden Colson Ctr Pancreat Care, Portland, OR 97201 USA	Oregon Health & Science University; Johns Hopkins University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Sears, RC (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA.; Sears, RC (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA.; Sears, RC (corresponding author), Oregon Hlth & Sci Univ, Brenden Colson Ctr Pancreat Care, Portland, OR 97201 USA.	searsr@ohsu.edu		Sears, Rosalie/0000-0003-1558-2413; , Jody/0000-0002-8209-3559	National Cancer Institute [R01 CA129040, R01 CA100855, R01 CA100855-05S3]; NATIONAL CANCER INSTITUTE [R01CA186241, R01CA196228] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute R01 CA129040, R01 CA100855, and R01 CA100855-05S3 to RCS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; z	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Agarwal A, 2008, BLOOD, V112, P1960, DOI 10.1182/blood-2007-09-113860; Agarwal A, 2014, CLIN CANCER RES, V20, P2092, DOI 10.1158/1078-0432.CCR-13-2575; Apostolidis SA, 2016, NAT IMMUNOL, V17, P556, DOI 10.1038/ni.3390; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Arnold HK, 2008, CANCER METAST REV, V27, P147, DOI 10.1007/s10555-008-9128-9; Arnold HK, 2009, EMBO J, V28, P500, DOI 10.1038/emboj.2008.279; Baek S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-139; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163; Breuer R, 2014, J BIOL CHEM, V289, P14996, DOI 10.1074/jbc.M113.533547; Bull JJ, 2005, BRIT J DERMATOL, V152, P1125, DOI 10.1111/j.1365-2133.2005.06458.x; Cotsarelis G, 1999, EXP DERMATOL, V8, P80, DOI 10.1111/j.1600-0625.1999.tb00351.x; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Eitelhuber AC, 2011, EMBO J, V30, P594, DOI 10.1038/emboj.2010.331; Everett AD, 2002, AM J PHYSIOL-LUNG C, V282, pL1266, DOI 10.1152/ajplung.00262.2001; Farrell AS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014365; Farrell AS, 2013, MOL CELL BIOL, V33, P2930, DOI 10.1128/MCB.01455-12; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Haesen D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00347; Hansen GM, 2008, GENOME RES, V18, P1670, DOI 10.1101/gr.078352.108; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Honeycutt KA, 2010, MOL CARCINOGEN, V49, P315, DOI 10.1002/mc.20617; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Little SC, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa5876; Louis JV, 2011, P NATL ACAD SCI USA, V108, P6957, DOI 10.1073/pnas.1018777108; Malempati S, 2006, LEUKEMIA, V20, P1572, DOI 10.1038/sj.leu.2404317; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Sablina AA, 2008, CANCER METAST REV, V27, P137, DOI 10.1007/s10555-008-9116-0; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Sohawon D, 2012, J MED IMAG RADIAT ON, V56, P538, DOI 10.1111/j.1754-9485.2012.02397.x; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Tyagi N, 2015, SCI REP-UK, V5, DOI 10.1038/srep13894; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Varadkar P, 2014, DEV DYNAM, V243, P778, DOI 10.1002/dvdy.24111; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Wang XY, 2011, CANCER RES, V71, P925, DOI 10.1158/0008-5472.CAN-10-1032; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Xu P, 2013, BIOL OPEN, V2, P479, DOI 10.1242/bio.20134051; Yoon BS, 2010, STEM CELLS, V28, P874, DOI 10.1002/stem.412; Zachman DK, 2013, STEM CELL RES, V11, P1013, DOI 10.1016/j.scr.2013.07.001; Zhang Q, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00094; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P2790, DOI 10.1073/pnas.1100764108; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	58	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188910	10.1371/journal.pone.0188910	http://dx.doi.org/10.1371/journal.pone.0188910			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190822	gold, Green Published, Green Submitted			2022-12-27	WOS:000416841900166
J	Kim, SJ; Kim, SJ; Han, KT; Park, EC				Kim, Seung Ju; Kim, Sun Jung; Han, Kyu-Tae; Park, Eun-Cheol			Medical costs, Cesarean delivery rates, and length of stay in specialty hospitals vs. non-specialty hospitals in South Korea	PLOS ONE			English	Article							LONGITUDINAL DATA; CARE; QUALITY; LOG; COMPLICATIONS; ASSOCIATION; COMPETITION; IMPROVE; MODELS; IMPACT	Background Since 2011, specialty hospitals in South Korea have been known for providing high-quality care in specific clinical areas. Much research related to specialty hospitals and their performance in many such areas has been performed, but investigations about their performance in obstetrics and gynecology are lacking. Thus, we aimed to compare specialty vs. non-specialty hospitals with respect to mode of obstetric delivery, especially the costs and length of stay related to Cesarean section (CS) procedures, and to provide evidence to policy-makers for evaluating the success of hospitals that specialize in obstetric and gynecological (OBGYN) care. Methods We obtained National Health Insurance claim data from 2012 to 2014, which included information from 418,141 OBGYN cases at 214 hospitals. We used a generalized estimating equation model to identify a potential association between the likelihood of CS at specialty hospitals compared with other hospitals. We also evaluated medical costs and length of stay in specialty hospitals according to type of delivery. Results We found that 150,256 (35.9%) total deliveries were performed by CS. The odds ratio of CS was significantly lower in specialty hospitals (OR: 0.95, 95% CI: 0.93-0.96 compared to other hospitals Medical costs (0.74%) and length of stay (1%) in CS cases increased in specialty hospitals, although length of stay following vaginal delivery was lower (0.57%) in specialty hospitals compared with other hospitals. Conclusions We determined that specialty hospitals are significantly associated with a lower likelihood of CS delivery and shorter length of stay after vaginal delivery. Although they are also associated with higher costs for delivery, the increased cost could be due to the high level of intensive care provided, which leads to improve quality of care. Policy-makers should consider incentive programs to maintain performance of specialty hospitals and promote efficiency that could reduce medical costs accrued by patients.	[Kim, Seung Ju] Eulji Univ, Coll Nursing, Dept Nursing, Seongnam, South Korea; [Kim, Sun Jung] Soonchunhyang Univ, Dept Hlth Adm, Chungnam, South Korea; [Han, Kyu-Tae] Ilsan Hosp, Natl Hlth Insurance Serv, Dept Policy Res Affairs, Ilsan, South Korea; [Park, Eun-Cheol] Yonsei Univ, Inst Hlth Serv Res, Seoul, South Korea; [Park, Eun-Cheol] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Eulji University; Soonchunhyang University; National Health Insurance Service; NHIS Ilsan Hospital; Yonsei University; Yonsei University; Yonsei University Health System	Park, EC (corresponding author), Yonsei Univ, Inst Hlth Serv Res, Seoul, South Korea.; Park, EC (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	ecpark@yuhs.ac	Kim, Sun Jung/AAM-7334-2020; Park, Eun-Cheol/O-5644-2019	Kim, Sun Jung/0000-0003-1756-1376; Park, Eun-Cheol/0000-0002-2306-5398; Kim, Seungju/0000-0003-3308-3802				Allen VM, 2005, AM J OBSTET GYNECOL, V193, P192, DOI 10.1016/j.ajog.2004.10.635; ASHTON CM, 1995, ANN INTERN MED, V122, P415, DOI 10.7326/0003-4819-122-6-199503150-00003; Barro JR, 2006, J HEALTH ECON, V25, P702, DOI 10.1016/j.jhealeco.2005.11.001; Basu A, 2004, HEALTH ECON, V13, P749, DOI 10.1002/hec.852; Casalino LP, 2003, HEALTH AFFAIR, V22, P56, DOI 10.1377/hlthaff.22.6.56; Devers KJ, 2003, SPECIALTY HOSP FOCUS, P1; Faddy M, 2009, VALUE HEALTH, V12, P309, DOI 10.1111/j.1524-4733.2008.00421.x; Feng CY, 2013, STAT MED, V32, P230, DOI 10.1002/sim.5486; Grant D, 2009, J HEALTH ECON, V28, P244, DOI 10.1016/j.jhealeco.2008.09.005; Greenwald L, 2006, HEALTH AFFAIR, V25, P106, DOI 10.1377/hlthaff.25.1.106; Gruber J, 1999, J HEALTH ECON, V18, P473, DOI 10.1016/S0167-6296(99)00009-0; Guterman S, 2006, HEALTH AFFAIR, V25, P95, DOI 10.1377/hlthaff.25.1.95; Han KT, 2015, J NEUROL SCI, V353, P137, DOI 10.1016/j.jns.2015.04.034; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Heffner LJ, 2003, OBSTET GYNECOL, V102, P287, DOI 10.1016/S0029-7844(03)00531-3; Hemmila MR, 2008, SURGERY, V144, P307, DOI 10.1016/j.surg.2008.05.003; Kim SJ, 2016, EUR J PUBLIC HEALTH, V26, P935, DOI 10.1093/eurpub/ckw102; Kim SJ, 2015, YONSEI MED J, V56, P1721, DOI 10.3349/ymj.2015.56.6.1721; Kim SJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006525; Kim SJ, 2013, HEALTH POLICY, V113, P93, DOI 10.1016/j.healthpol.2013.09.013; Kwon S, 2009, HEALTH POLICY PLANN, V24, P63, DOI 10.1093/heapol/czn037; Lydon-Rochelle M, 2000, JAMA-J AM MED ASSOC, V283, P2411, DOI 10.1001/jama.283.18.2411; Malehi AS, 2015, HEALTH ECON REV, V5, DOI 10.1186/s13561-015-0045-7; Mitchell JM, 2007, MED CARE RES REV, V64, P395, DOI 10.1177/1077558707301953; Moore Keith, 2005, Healthc Financ Manage, V59, P84; National Health and Family Planning Commission of the People's Republic of China, 2014, 2014 CHIN AIDS RESP, P1; Organisation for Economic Co-operation and Development (OECD), 2015, HLTH AT A GLANC; Propper C, 2004, J PUBLIC ECON, V88, P1247, DOI 10.1016/S0047-2727(02)00216-5; Sari N, 2002, HEALTH ECON, V11, P571, DOI 10.1002/hec.726; Shactman D, 2005, HEALTH AFFAIR, V24, P868, DOI 10.1377/hlthaff.24.3.868; Swartzmeyer Sarah, 2004, Mod Healthc, V34, P21; Vonlanthen R, 2011, ANN SURG, V254, P907, DOI 10.1097/SLA.0b013e31821d4a43; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	34	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188612	10.1371/journal.pone.0188612	http://dx.doi.org/10.1371/journal.pone.0188612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190768	gold, Green Published, Green Submitted			2022-12-27	WOS:000416841900083
J	Ezaki, T; Masuda, N				Ezaki, Takahiro; Masuda, Naoki			Reinforcement learning account of network reciprocity	PLOS ONE			English	Article							PROMOTE COOPERATION; EVOLUTIONARY GAMES; PRISONERS-DILEMMA; SOCIAL NETWORKS; STRATEGY; COEVOLUTION; EMERGENCE; DYNAMICS; BEHAVIOR	Evolutionary game theory predicts that cooperation in social dilemma games is promoted when agents are connected as a network. However, when networks are fixed over time, humans do not necessarily show enhanced mutual cooperation. Here we show that reinforcement learning (specifically, the so-called Bush-Mosteller model) approximately explains the experimentally observed network reciprocity and the lack thereof in a parameter region spanned by the benefit-to-cost ratio and the node's degree. Thus, we significantly extend previously obtained numerical results.	[Ezaki, Takahiro] Japan Sci & Technol Agcy, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama, Japan; [Masuda, Naoki] Univ Bristol, Dept Engn Math, Bristol, Avon, England	Japan Science & Technology Agency (JST); University of Bristol	Masuda, N (corresponding author), Univ Bristol, Dept Engn Math, Bristol, Avon, England.	naoki.masuda@bristol.ac.uk		Ezaki, Takahiro/0000-0003-4175-3028; Masuda, Naoki/0000-0003-1567-801X	PRESTO, Japan Science and Technology Agency [JPMJPR16D2]; ERATO, Japan Science and Technology Agency [JPMJER1201]; CREST, Japan Science and Technology Agency [JPMJCR1304]; PRESTO, JST [JPMJPR16D2]; ERATO, JST [JPMJER1201]; CREST, JST [JPMJCR1304]	PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); ERATO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); PRESTO, JST(Japan Science & Technology Agency (JST)); ERATO, JST(Japan Science & Technology Agency (JST)); CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	TE acknowledges the support provided through PRESTO, Japan Science and Technology Agency (No. JPMJPR16D2); and Kawarabayashi Large Graph Project, ERATO, Japan Science and Technology Agency (No. JPMJER1201, URL: http://www.jst.go.ip/erato/kawarabayashi/english/index.html). NM acknowledges the support provided through CREST, Japan Science and Technology Agency (No. JPMJCR1304); and Kawarabayashi Large Graph Project, ERATO, Japan Science and Technology Agency (No. JPMJER1201, URL: http://www.jst.go.jp/erato/kawarabayashi/english/index.html).; We acknowledge Hisashi Ohtsuki for valuable comments on the manuscript. TE acknowledges the support provided through PRESTO, JST (No. JPMJPR16D2) and Kawarabayashi Large Graph Project, ERATO, JST (No. JPMJER1201). NM acknowledges the support provided through, CREST, JST (No. JPMJCR1304) and Kawarabayashi Large Graph Project, ERATO, JST (No. JPMJER1201).	Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barabasi AL, 2016, NETWORK SCIENCE, P1; Bendor J., 2001, INT GAME THEORY REV, V3, P159, DOI DOI 10.1142/S0219198901000348; Bush Robert R., 1955, STOCHASTIC MODELS LE; Cassar A, 2007, GAME ECON BEHAV, V58, P209, DOI 10.1016/j.geb.2006.03.008; Cimini G, 2015, JASSS-J ARTIF SOC S, V18, DOI 10.18564/jasss.2726; Cimini G, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1186; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Du JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep08014; Du JM, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0077; Eguiluz VM, 2005, AM J SOCIOL, V110, P977, DOI 10.1086/428716; Ezaki T, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005034; Fehl K, 2011, ECOL LETT, V14, P546, DOI 10.1111/j.1461-0248.2011.01615.x; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; Grujic J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047718; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Horita Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep39275; Jordan JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066199; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; MACY MW, 1991, AM J SOCIOL, V97, P808, DOI 10.1086/229821; Macy MW, 2002, P NATL ACAD SCI USA, V99, P7229, DOI 10.1073/pnas.092080099; Masuda N, 2011, J THEOR BIOL, V278, P55, DOI 10.1016/j.jtbi.2011.03.005; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; NOWAK MA, 1995, J MATH BIOL, V33, P703; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, J THEOR BIOL, V243, P86, DOI 10.1016/j.jtbi.2006.06.004; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Pacheco JM, 2006, J THEOR BIOL, V243, P437, DOI 10.1016/j.jtbi.2006.06.027; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Rand DG, 2014, P NATL ACAD SCI USA, V111, P17093, DOI 10.1073/pnas.1400406111; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Rapoport A., 1965, PRISONERS DILEMMA ST; Shirado H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3814; Sigmund K., 2010, CALCULUS SELFISHNESS; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; van Veelen M, 2009, J THEOR BIOL, V259, P589, DOI 10.1016/j.jtbi.2009.04.019; Wang J, 2012, P NATL ACAD SCI USA, V109, P14363, DOI 10.1073/pnas.1120867109; Zimmermann MG, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056118; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	48	8	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189220	10.1371/journal.pone.0189220	http://dx.doi.org/10.1371/journal.pone.0189220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP2SV	29220413	Green Published, gold, Green Submitted			2022-12-27	WOS:000417469900042
J	Suzuki, C; Aoki-Yoshida, A; Aoki, R; Sasaki, K; Takayama, Y; Mizumachi, K				Suzuki, Chise; Aoki-Yoshida, Ayako; Aoki, Reiji; Sasaki, Keisuke; Takayama, Yoshiharu; Mizumachi, Koko			The distinct effects of orally administered Lactobacillus rhamnosus GG and Lactococcus lactis subsp lactis C59 on gene expression in the murine small intestine	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; STRAIN GG; PROBIOTICS; OLIGODEOXYNUCLEOTIDE; EXOPOLYSACCHARIDE; BIOSYNTHESIS; MODULATION; PREVENTION; COMMENSAL; ADHESION	The molecular mechanisms of strain-specific probiotic effects and the impact of the oral administration of probiotic strains on the host's gene expression are not yet well understood. The aim of this study was to investigate the strain-specific effects of probiotic strain intake on gene expression in the murine small intestine. Two distinct strains of lactic acid bacteria, Lactobacillus rhamnosus GG (GG) and Lactococcus lactis subsp. lactis C59 (C59), were orally administered to BALB/c mice, daily for 2 weeks. The total RNA was isolated from the upper (including the duodenum) and lower (the terminal ileum) small intestine, and gene expression was assessed by microarray analysis. The data revealed (1) oral administration of C59 and GG markedly down-regulated the expression of genes encoding fibrinogen subunits and plasminogen in the upper small intestine; (2) administration of more than 1 x 10(7) CFU/day of GG changed the gene expression of the host ileum. (3) strain-and dose-related effects on various GO biological processes; and (4) enrichment for B cell-related Gene Ontology terms among up-regulated genes in the terminal ileum of mice administered the 1 x 10(9) CFU/day of GG. The distinct effects of GG and C59 on gene expression in the intact small intestine provide clues to understand how the health beneficial effects of specific strains of probiotic bacteria are mediated by interactions with intestinal cells.	[Suzuki, Chise; Aoki-Yoshida, Ayako; Aoki, Reiji; Sasaki, Keisuke; Takayama, Yoshiharu; Mizumachi, Koko] Natl Agr & Food Res Org NARO, Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan; [Aoki-Yoshida, Ayako] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Mizumachi, Koko] NARO, Western Reg Agr Res Ctr, Fukuyama, Hiroshima, Japan	National Agriculture & Food Research Organization - Japan; University of Tokyo; National Agriculture & Food Research Organization - Japan	Suzuki, C (corresponding author), Natl Agr & Food Res Org NARO, Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan.	csuzuki@affrc.go.jp	Takayama, Yoshiharu/M-8826-2019; SUZUKI, Chise/AAR-1986-2020; Takayama, Yoshiharu/E-3662-2010; Sasaki, Keisuke/AAK-3516-2020; Aoki, Ayako/GXV-4979-2022	Takayama, Yoshiharu/0000-0003-4532-7114; SUZUKI, Chise/0000-0001-7148-8101; Takayama, Yoshiharu/0000-0003-4532-7114; Aoki, Ayako/0000-0003-4535-8586	Ministry of Agriculture, Forestry, and Fisheries (MAFF); Council for Science, Technology, and Innovation (CSTI); Cross-Ministerial Strategic Innovation Promotion Program (SIP); "Technologies for creating next generation agriculture, forestry, and fisheries (Japanese)" (NARO) [14532924]	Ministry of Agriculture, Forestry, and Fisheries (MAFF)(Ministry of Agriculture Forestry & Fisheries - Japan); Council for Science, Technology, and Innovation (CSTI); Cross-Ministerial Strategic Innovation Promotion Program (SIP); "Technologies for creating next generation agriculture, forestry, and fisheries (Japanese)" (NARO)	This study was supported in part by a grant "Development of evaluation and management methods for supply of safe, reliable, and functional food and farm produce (2006-2010)" from the Ministry of Agriculture, Forestry, and Fisheries (MAFF) to CS; and by the Council for Science, Technology, and Innovation (CSTI), Cross-Ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next generation agriculture, forestry, and fisheries (grant no. 14532924, URL http://www.naro.affrc.go.jp/brain/sip/introduction/index.html (Japanese)" (NARO) to YT, CS, MY, and RA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki-Yoshida A, 2016, BENEF MICROBES, V7, P421, DOI 10.3920/BM2015.0169; Aoki-Yoshida A, 2016, J PROTEOME RES, V15, P3126, DOI 10.1021/acs.jproteome.6b00262; Ballouz S, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw957; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Canani RB, 2017, J ALLERGY CLIN IMMUN, V139, P1906, DOI 10.1016/j.jaci.2016.10.050; Canani RB, 2016, ISME J, V10, P742, DOI 10.1038/ismej.2015.151; Carasi P, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/361604; Collado MC, 2015, PEDIATR RES, V77, P182, DOI 10.1038/pr.2014.173; Chen ZX, 2007, BIOINFORMATICS, V23, P321, DOI 10.1093/bioinformatics/btl609; Claes IJJ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-161; Di Caro S, 2005, DIGEST LIVER DIS, V37, P320, DOI 10.1016/j.dld.2004.12.008; Espino E, 2015, J PROTEOME RES, V14, P1010, DOI 10.1021/pr501041a; FAO/WHO, 2002, GUIDL EV PROB FOODS; Finamore A, 2012, J NUTR, V142, P375, DOI 10.3945/jn.111.148924; Fukuda S, 2014, SEMIN IMMUNOPATHOL, V36, P103, DOI 10.1007/s00281-013-0399-z; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Garcia CEV, 2015, APPL ENVIRON MICROB, V81, P2050, DOI 10.1128/AEM.03949-14; Goldin BR, 2008, CLIN INFECT DIS, V46, pS96, DOI 10.1086/523333; GORBACH SL, 1987, LANCET, V2, P1519; Harata G, 2016, EUR J NUTR; Haro C, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-28; He F, 2005, MICROBIOL IMMUNOL, V49, P995; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; Hojsak I, 2010, PEDIATRICS, V125, pE1171, DOI 10.1542/peds.2009-2568; Iliev ID, 2008, SCAND J IMMUNOL, V67, P370, DOI 10.1111/j.1365-3083.2008.02080.x; Iliev ID, 2005, CELL MICROBIOL, V7, P403, DOI 10.1111/j.1462-5822.2004.00470.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Isolauri E, 2003, GUT, V52, P436, DOI 10.1136/gut.52.3.436; KAILA M, 1995, ARCH DIS CHILD, V72, P51, DOI 10.1136/adc.72.1.51; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kalliomaki M, 2007, J ALLERGY CLIN IMMUN, V119, P1019, DOI 10.1016/j.jaci.2006.12.608; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kawashima T, 2013, IMMUNITY, V38, P1187, DOI 10.1016/j.immuni.2013.02.024; Kikuchi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086416; Kitazawa H, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00201; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Lin PW, 2008, PEDIATR RES, V64, P511, DOI 10.1203/PDR.0b013e3181827c0f; McDonald KG, 2007, BIOTECHNIQUES, V43, P50, DOI 10.2144/000112514; McDonald KG, 2007, AM J PATHOL, V170, P1229, DOI 10.2353/ajpath.2007.060817; McDonald KG, 2011, IMMUN AGEING, V8, DOI 10.1186/1742-4933-8-1; McDonald KG, 2010, AM J PATHOL, V176, P2367, DOI 10.2353/ajpath.2010.090723; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Miyazawa K, 2015, MICROBIOL IMMUNOL, V59, P99, DOI 10.1111/1348-0421.12226; Nomura M, 2006, J APPL MICROBIOL, V101, P396, DOI 10.1111/j.1365-2672.2006.02949.x; Nomura M, 2012, BIOSCI BIOTECH BIOCH, V76, P1459, DOI 10.1271/bbb.120121; Segers ME, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S7; Suzuki C, 2008, INT J FOOD MICROBIOL, V123, P159, DOI 10.1016/j.ijfoodmicro.2007.12.022; Suzuki C, 2013, BIOSCI BIOTECH BIOCH, V77, P2013, DOI 10.1271/bbb.130322; Szajewska H, 2013, ALIMENT PHARM THER, V38, P467, DOI 10.1111/apt.12403; Tuomola EM, 1998, INT J FOOD MICROBIOL, V41, P45, DOI 10.1016/S0168-1605(98)00033-6; Uematsu Satoshi, 2008, V183, P1; Vajro P, 2011, J PEDIATR GASTR NUTR, V52, P740, DOI 10.1097/MPG.0b013e31821f9b85; Vandenplas Y, 2015, J PEDIAT-BRAZIL, V91, P6, DOI 10.1016/j.jped.2014.08.005; Velez MP, 2007, APPL ENVIRON MICROB, V73, P3595, DOI 10.1128/AEM.02083-06; Yan F, 2017, MUCOSAL IMMUNOL, V10, P117, DOI 10.1038/mi.2016.43; Yoshida A, 2011, FEMS IMMUNOL MED MIC, V61, P315, DOI 10.1111/j.1574-695X.2010.00777.x	58	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188985	10.1371/journal.pone.0188985	http://dx.doi.org/10.1371/journal.pone.0188985			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220366	Green Published, gold, Green Submitted			2022-12-27	WOS:000417469900023
J	Baciu, C; Pasini, E; Angeli, M; Schwenger, K; Afrin, J; Humar, A; Fischer, S; Patel, K; Allard, J; Bhat, M				Baciu, Cristina; Pasini, Elisa; Angeli, Marc; Schwenger, Katherine; Afrin, Jenifar; Humar, Atul; Fischer, Sandra; Patel, Keyur; Allard, Johane; Bhat, Mamatha			Systematic integrative analysis of gene expression identifies HNF4A as the central gene in pathogenesis of non-alcoholic steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; NUCLEAR FACTOR 4-ALPHA; ALPHA; PPAR; TRANSPLANTATION; INFLAMMATION; ASSOCIATION; METABOLISM; DISCOVERY; DIAGNOSIS	Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world, and encompasses a spectrum from simple steatosis to steatohepatitis (NASH). There is currently no approved pharmacologic therapy against NASH, partly due to an incomplete understanding of its molecular basis. The goal of this study was to determine the key differentially expressed genes (DEGs), as well as those genes and pathways central to its pathogenesis. We performed an integrative computational analysis of publicly available gene expression data in NASH from GEO (GSE17470, GSE24807, GSE37031, GSE89632). The DEGs were identified using GEOquery, and only the genes present in at least three of the studies, to a total of 190 DEGs, were considered for further analyses. The pathways, networks, molecular interactions, functional analyses were generated through the use of Ingenuity Pathway Analysis (IPA). For selected networks, we computed the centrality using igraph package in R. Among the statistically significant predicted networks (p-val < 0.05), three were of most biological interest: the first is involved in antimicrobial response, inflammatory response and immunological disease, the second in cancer, organismal injury and development and the third in metabolic diseases. We discovered that HNF4A is the central gene in the network of NASH connected to metabolic diseases and that it regulates HNF1A, an additional transcription regulator also involved in lipid metabolism. Therefore, we show, for the first time to our knowledge, that HNF4A is central to the pathogenesis of NASH. This adds to previous literature demonstrating that HNF4A regulates the transcription of genes involved in the progression of NAFLD, and that HNF4A genetic variants play a potential role in NASH progression.	[Baciu, Cristina; Pasini, Elisa; Angeli, Marc; Afrin, Jenifar; Humar, Atul; Patel, Keyur; Allard, Johane; Bhat, Mamatha] Univ Hlth Network, Multi Organ Transplant Program, Toronto, ON, Canada; [Schwenger, Katherine; Patel, Keyur; Bhat, Mamatha] Div Gastroenterol & Hepatol, Toronto, ON, Canada; [Schwenger, Katherine; Patel, Keyur; Bhat, Mamatha] Univ Toronto, Toronto, ON, Canada; [Fischer, Sandra] Univ Hlth Network, Div Pathol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Bhat, M (corresponding author), Univ Hlth Network, Multi Organ Transplant Program, Toronto, ON, Canada.; Bhat, M (corresponding author), Div Gastroenterol & Hepatol, Toronto, ON, Canada.; Bhat, M (corresponding author), Univ Toronto, Toronto, ON, Canada.	Mamatha.Bhat@uhn.ca	Bhat, Mamatha/AAC-4333-2020	Schwenger, Katherine/0000-0002-7146-5505; Bhat, Mamatha/0000-0003-1960-8449				Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Agopian VG, 2012, ANN SURG, V256, P624, DOI 10.1097/SLA.0b013e31826b4b7e; Arrese M, 2016, DIGEST DIS SCI, V61, P1294, DOI 10.1007/s10620-016-4049-x; Auguet T, 2016, INT J MOL SCI, V17; Bagwell AM, 2005, DIABETES, V54, P1185, DOI 10.2337/diabetes.54.4.1185; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Bartoov-Shifman R, 2002, J BIOL CHEM, V277, P25914, DOI 10.1074/jbc.M201582200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertola A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013577; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Dowman JK, 2011, ALIMENT PHARM THER, V33, P525, DOI 10.1111/j.1365-2036.2010.04556.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ellard S, 2006, HUM MUTAT, V27, P854, DOI 10.1002/humu.20357; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Frades I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124544; Ganz M, 2013, HEPATOL INT, V7, pS771, DOI 10.1007/s12072-013-9468-6; Hansen SK, 2005, DIABETOLOGIA, V48, P452, DOI 10.1007/s00125-005-1671-0; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Inoue Y, 2006, J LIPID RES, V47, P215, DOI 10.1194/jlr.M500430-JLR200; Jafri MA, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0324-x; Kubrusly MS, 2010, HISTOL HISTOPATHOL, V25, P1123, DOI 10.14670/HH-25.1123; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; Lake AD, 2016, BIOCHEM PHARMACOL, V122, P62, DOI 10.1016/j.bcp.2016.11.006; Lake AD, 2016, TOXICOL SCI, V149, P312, DOI 10.1093/toxsci/kfv236; Lake AD, 2011, DRUG METAB DISPOS, V39, P1954, DOI 10.1124/dmd.111.040592; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Martel C, 2012, CURR PHARM BIOTECHNO, V13, P726, DOI 10.2174/138920112799857558; Meli R, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00177; Moylan CA, 2014, HEPATOLOGY, V59, P471, DOI 10.1002/hep.26661; Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4; Nassirpour R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079655; Ng CT, 2015, CELL HOST MICROBE, V17, P653, DOI 10.1016/j.chom.2015.04.005; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Riordan JD, 2014, MAMM GENOME, V25, P473, DOI 10.1007/s00335-014-9521-3; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Sepe V, 2016, SCI REP-UK, V6, DOI 10.1038/srep19008; Song MY, 2017, BIOL PHARM BULL, V40, P339, DOI 10.1248/bpb.b16-00853; Souza-Mello V, 2015, WORLD J HEPATOL, V7, P1012, DOI 10.4254/wjh.v7.i8.1012; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Tamimi TIAR, 2011, J HEPATOL, V54, P1224, DOI 10.1016/j.jhep.2010.08.023; Team RC., 2022, LANG ENV STAT COMP; Tegude H, 2007, DRUG METAB DISPOS, V35, P946, DOI 10.1124/dmd.106.013565; Villegas R, 2014, ANN HUM GENET, V78, P23, DOI 10.1111/ahg.12044; Wang HY, 2000, J BIOL CHEM, V275, P35953, DOI 10.1074/jbc.M006612200; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Zhu LX, 2011, METABOLISM, V60, P1001, DOI 10.1016/j.metabol.2010.10.003	54	31	31	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189223	10.1371/journal.pone.0189223	http://dx.doi.org/10.1371/journal.pone.0189223			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216278	Green Submitted, Green Published, gold			2022-12-27	WOS:000417337800099
J	Grygorowicz, M; Michalowska, M; Walczak, T; Owen, A; Grabski, JK; Pyda, A; Piontek, T; Kotwicki, T				Grygorowicz, Monika; Michalowska, Martyna; Walczak, Tomasz; Owen, Adam; Grabski, Jakub Krzysztof; Pyda, Andrzej; Piontek, Tomasz; Kotwicki, Tomasz			Discussion about different cut-off values of conventional hamstring-to-quadriceps ratio used in hamstring injury prediction among professional male football players	PLOS ONE			English	Article							SOCCER PLAYERS; RISK-FACTORS; ISOKINETIC STRENGTH; MUSCLE STRENGTH; SPECIFICITY; POSITION; TORQUE; TESTS; LEG	Objective To measure the sensitivity and specificity of differences cut-off values for isokinetic H-con/Q(con) ratio in order to improve the capacity to evaluate (retrospectively) the injury of hamstring muscles in professional soccer screened with knee isokinetic tests. Design Retrospective study. Methods Medical and biomechanical data of professional football players playing for the same team for at least one season between 2010 and 2016 were analysed. Hamstring strain injury cases and the reports generated via isokinetic testing were investigated. Isokinetic concentric( con) hamstring(H) and quadriceps(Q) absolute strength in addition with H-con/Q(con) ratio were examined for the injured versus uninjured limbs among injured players, and for the injured and non-injured players. 2 x 2 contingency table was used for comparing variables: predicted injured or predicted uninjured with actual injured or actual uninjured. Sensitivity, specificity, accuracy, positive and negative predictive values, and positive and negative likelihood ratio were calculated for three different cut-off values (0.47 vs. 0.6 vs. 0.658) to compare the discriminative power of an isokinetic test, whilst examining the key value of H-con/Q(con) ratio which may indicate the highest level of ability to predispose a player to injury. McNemar's chi(2) test with Yates's correction was used to determine agreement between the tests. PQStat software was used for all statistical analysis, and an alpha level of p <0.05 was used for all statistical comparisons. Results 340 isokinetic test reports on both limbs of 66 professional soccer players were analysed. Eleven players suffered hamstring injuries during the analysed period. None of these players sustained recurrence of hamstring injury. One player sustained hamstring strain injury on both legs, thus the total number of injuries was 12. Application of different cut-off values for H-con/Q(con) significantly affected the sensitivity and specificity of isokinetic test used as a tool for muscle injury detection. The use of 0.47 of H-con/Q(con) as a discriminate value resulted in significantly lower sensitivity when compared to 0.658 threshold (sensitivity of 16.7% vs. 91.7%, respectively; t = 6.125, p = 0.0133). Calculated values of specificity (when three different cut-off were applied) were also significantly different. Threshold of 0.6 of H-con/Q(con) resulted with significantly lower specificity compared to 0.47 value (specificity of 46.9% vs. 94.5%, respectively; t = 153.0, p<0.0001), and significantly higher specificity when compared to 0.658 (specificity of 46.9% vs. 24.1%, respectively; t = 229.0, p<0.0001). Conclusion The use of different cut-off values for H-con/Q(con) significantly affected the sensitivity and specificity of isokinetic testing. The interpretation of usefulness of isokinetic test as a screening tool in a group of male professional football players to predict hamstring injury occurrence within the next 12 months might be therefore significantly biased due to the different threshold values of H-con/Q(con). Using one "normative" value as a cut-off (e.g. 0.47 or 0.60, or 0.658) to quantify soccer players (or not) to the group with a higher risk of knee injury might result in biased outcomes due to the natural strength asymmetry that is observed within the group of soccer players.	[Grygorowicz, Monika] Poznan Univ Med Sci, Dept Spondyloortopaed & Biomech Spine, Poznan, Poland; [Grygorowicz, Monika; Michalowska, Martyna; Owen, Adam; Pyda, Andrzej; Piontek, Tomasz] FIFA Med Ctr Excellence, Rehasport Clin, Poznan, Poland; [Michalowska, Martyna; Walczak, Tomasz; Grabski, Jakub Krzysztof] Poznan Univ Tech, Inst Appl Mech, Poznan, Poland; [Piontek, Tomasz; Kotwicki, Tomasz] Poznan Univ Med Sci, Spine Disorders & Paediat Orthopaed Dept, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Technology; Poznan University of Medical Sciences	Grygorowicz, M (corresponding author), Poznan Univ Med Sci, Dept Spondyloortopaed & Biomech Spine, Poznan, Poland.; Grygorowicz, M (corresponding author), FIFA Med Ctr Excellence, Rehasport Clin, Poznan, Poland.	monika.grygorowicz@rehasport.pl	Białecka, Martyna/V-6895-2017; Walczak, Tomasz/H-4149-2014; Grabski, Jakub Krzysztof/F-7509-2014; Grygorowicz, Monika Małgorzata/A-1357-2012; Grygorowicz, Monika/GWU-5803-2022	Białecka, Martyna/0000-0002-0409-3123; Walczak, Tomasz/0000-0001-9211-6235; Grabski, Jakub Krzysztof/0000-0002-0553-1084; Grygorowicz, Monika Małgorzata/0000-0002-9575-2074; Grygorowicz, Monika/0000-0002-9575-2074				Ardern CL, 2015, J STRENGTH COND RES, V29, P997, DOI 10.1519/JSC.0000000000000747; Bahr R, 2016, BRIT J SPORT MED, V50, P776, DOI 10.1136/bjsports-2016-096256; BALOGUN J A, 1987, Journal of Orthopaedic and Sports Physical Therapy, V8, P525; Bangsbo J, 2006, J SPORT SCI, V24, P665, DOI 10.1080/02640410500482529; Bennell K, 1998, BRIT J SPORT MED, V32, P309, DOI 10.1136/bjsm.32.4.309; Carvalho Alberto, 2016, J Hum Kinet, V51, P19, DOI 10.1515/hukin-2015-0166; Cohen DD, 2015, INT J SPORT PHYSIOL, V10, P325, DOI 10.1123/ijspp.2014-0088; Cotte T, 2011, BIOL SPORT, V28, P89, DOI 10.5604/942736; Croisier J. L., 1999, Annales de Readaptation et de Medecine Physique, V42, P497, DOI 10.1016/S0168-6054(00)87704-1; Croisier J. L., 1999, Annales de Readaptation et de Medecine Physique, V42, P538, DOI 10.1016/S0168-6054(00)88381-6; Croisier JL, 2008, AM J SPORT MED, V36, P1469, DOI 10.1177/0363546508316764; Croisier JL, 2002, AM J SPORT MED, V30, P199, DOI 10.1177/03635465020300020901; Dauty M., 2003, Annales de Readaptation et de Medecine Physique, V46, P601, DOI 10.1016/j.annrmp.2003.04.001; Dauty M, 2003, ISOKINET EXERC SCI, V11, P139; Dauty M, 2016, MLTJ-MUSCLE LIGAMENT, V6, P116, DOI 10.11138/mltj/2016.6.1.116; Dibrezzo R, 1985, J Orthop Sports Phys Ther, V7, P65; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Ekstrand J, 2011, AM J SPORT MED, V39, P1226, DOI 10.1177/0363546510395879; Fonseca S.T., 2007, REV BRAS MED ESPORTE, V13, p125e; Fousekis K, 2011, BRIT J SPORT MED, V45, P709, DOI 10.1136/bjsm.2010.077560; Fousekis K, 2010, J SPORT SCI MED, V9, P364; Freckleton G, 2013, BRIT J SPORT MED, V47, P351, DOI 10.1136/bjsports-2011-090664; Fritz JM, 2001, PHYS THER, V81, P1546, DOI 10.1093/ptj/81.9.1546; Gayardo A, 2012, REV BRAS MED ESPORTE, V18, P186, DOI 10.1590/S1517-86922012000300010; HEISER TM, 1984, AM J SPORT MED, V12, P368, DOI 10.1177/036354658401200506; Henderson G, 2010, J SCI MED SPORT, V13, P397, DOI 10.1016/j.jsams.2009.08.003; Hopkins WG, 2007, CLIN J SPORT MED, V17, P208, DOI 10.1097/JSM.0b013e3180592a68; Houweling TAW, 2009, ISOKINET EXERC SCI, V17, P213, DOI 10.3233/IES-2009-0356; Huber J, 2013, ARCH ORTHOP TRAUM SU, V133, P541, DOI 10.1007/s00402-013-1681-1; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Lehance C, 2009, SCAND J MED SCI SPOR, V19, P243, DOI 10.1111/j.1600-0838.2008.00780.x; Little T, 2005, J STRENGTH COND RES, V19, P76; MANGINE R E, 1990, Journal of Orthopaedic and Sports Physical Therapy, V12, P147; McCall A, 2015, BRIT J SPORT MED, V49, P583, DOI 10.1136/bjsports-2014-094104; Orchard J, 1997, AM J SPORT MED, V25, P81, DOI 10.1177/036354659702500116; Parikh R, 2008, INDIAN J OPHTHALMOL, V56, P45, DOI 10.4103/0301-4738.37595; PATON RW, 1989, J BIOMED ENG, V11, P229, DOI 10.1016/0141-5425(89)90147-7; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Rahnama N, 2005, ERGONOMICS, V48, P1568, DOI 10.1080/00140130500101585; Reid N, 2010, WIRES COMPUT STAT, V2, P517, DOI 10.1002/wics.110; Ruas CV, 2015, J STRENGTH COND RES, V29, P1220, DOI 10.1519/JSC.0000000000000766; Sliwowski R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144021; Tourny-Chollet C, 2000, ISOKINET EXERC SCI, V8, P187, DOI 10.3233/IES-2000-0050; van Dyk N, 2016, AM J SPORT MED, V44, P1789, DOI 10.1177/0363546516632526; WYSE JP, 1994, BRIT J SPORT MED, V28, P167, DOI 10.1136/bjsm.28.3.167; Zabka FF, 2011, REV BRAS MED ESPORTE, V17, P189, DOI 10.1590/S1517-86922011000300008; Zakas A, 1995, J SPORT MED PHYS FIT, V35, P199; Zvijac JE, 2013, AM J SPORT MED, V41, P1511, DOI 10.1177/0363546513487983	48	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188974	10.1371/journal.pone.0188974	http://dx.doi.org/10.1371/journal.pone.0188974			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216241	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800053
J	Kim, YG; Baltabekova, AZ; Zhiyenbay, EE; Aksambayeva, AS; Shagyrova, ZS; Khannanov, R; Ramanculov, EM; Shustov, AV				Kim, Yuriy G.; Baltabekova, Aliya Zh.; Zhiyenbay, Erzhan E.; Aksambayeva, Altynai S.; Shagyrova, Zhadyra S.; Khannanov, Rinat; Ramanculov, Erlan M.; Shustov, Alexandr V.			Recombinant Vaccinia virus-coded interferon inhibitor B18R: Expression, refolding and a use in a mammalian expression system with a RNA-vector	PLOS ONE			English	Article							EQUINE ENCEPHALITIS-VIRUS; NONCYTOPATHIC REPLICATION; ANTIVIRAL RESPONSES; MEMBRANE-PROTEINS; I IFN; CELLS; ALPHA; INDUCTION; INFECTION; DETERMINANT	B18R protein of Vaccinia virus binds to type I interferons and inhibits activation of interferon-mediated signal transduction. Cells which have unimpaired interferon signaling such as primary cell cultures or some industrially important cell lines are capable of development of an antiviral state. An establishment of the antiviral state limits replication of RNA-viruses and can suppress replication of RNA vectors. The interferon inhibitor B18R effectively prevents the establishment of the antiviral state. For this reason, B18R has become a ubiquitous component of protocols for epigenetic reprogramming which use transfections of RNA replicons or mRNA. Despite wide practical applicability, commercially available B18R is predominantly produced in cell cultures and little information has been published on a production and use of bacterially expressed B18R. Objectives of this study were to produce B18R in an E.coli expression system and to confirm the product's biological activity by using it to maintain RNA-vectors in cell cultures capable of the antiviral state. The described method allows the expression and efficient refolding to obtain 10-100 mg of B18R from a small-scale culture and the production process is economically attractive compared to a use of an eukaryotic expression. To check for a presence of the biological activity of bacterially-expressed B18R the protein was used to support persistence of an autonomously replicating RNA-vector in a cell culture which is capable of the antiviral state. A RNA-containing virus, Venezuelan equine encephalitis virus (VEE) can serve as an efficient vector for heterologous expression in cell cultures, although its replication is sensitive to the effects of type I interferons which limit a range of cell lines for a use with this vector. The VEE replicon was utilized to direct an expression of recombinant human granulocyte colony stimulating factor (G-CSF). The producing replicon could persist in HEK293 cells for sufficiently long time only in presence of B18R, whereas addition of B18R not only allowed persistence of the replicon but also increased production from the replicon. A model product granulocyte colony stimulating factor accumulated to 35.5 mu g/ml during a 7 day experiment. This work describes efficacious expression and refolding of the viral cytokine inhibitor and demonstrates a utility of bacterially-expressed B18R.	[Kim, Yuriy G.; Zhiyenbay, Erzhan E.; Ramanculov, Erlan M.] Nazarbayev Univ, Natl Lab Astana, Astana, Kazakhstan; [Baltabekova, Aliya Zh.; Aksambayeva, Altynai S.; Shagyrova, Zhadyra S.; Khannanov, Rinat; Shustov, Alexandr V.] Natl Ctr Biotechnol, Astana, Kazakhstan	Nazarbayev University; National Center for Biotechnology (NCB)	Shustov, AV (corresponding author), Natl Ctr Biotechnol, Astana, Kazakhstan.	shustov@biocenter.kz	Ramankulov, Yerlan/AAG-7450-2019; Shustov, Alexander V/K-1148-2013; Khannanov, Rinat/ABG-6012-2021	Ramankulov, Yerlan/0000-0001-6786-3028; Shustov, Alexander V/0000-0001-9880-9382; Ramanculov, Erlan/0000-0001-6791-4497; Khannanov, Rinat/0000-0001-5085-7596	Ministry of Education and Science of the Republic of Kazakhstan [0115RK01788, 0214RK02428]	Ministry of Education and Science of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan)	This work was supported by a funding from Ministry of Education and Science of the Republic of Kazakhstan by grants with numbers 0115RK01788 and 0214RK02428.	Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Aranda Alejandro, 2011, Recent Pat Biotechnol, V5, P212; Casales E, 2008, VIROLOGY, V376, P242, DOI 10.1016/j.virol.2008.03.016; Casales E, 2010, NEW BIOTECHNOL, V27, P138, DOI 10.1016/j.nbt.2010.02.005; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; Cruz CC, 2010, VIROLOGY, V399, P1, DOI 10.1016/j.virol.2009.12.031; Farazmandfar T, 2012, CELL J, V14, P76; Fritz-French C, 2014, J INTERF CYTOK RES, V34, P510, DOI 10.1089/jir.2013.0072; Frolov I, 1999, J VIROL, V73, P3854, DOI 10.1128/JVI.73.5.3854-3865.1999; Frolov I, 2012, J VIROL, V86, P5055, DOI 10.1128/JVI.07223-11; Gardner CL, 2009, VIROLOGY, V390, P338, DOI 10.1016/j.virol.2009.05.030; Gehrke R, 2005, J GEN VIROL, V86, P1045, DOI 10.1099/vir.0.80677-0; Gomez AM, 2015, J IMMUNOL, V194, P2300, DOI 10.4049/jimmunol.1402147; Grieder FB, 1999, VIROLOGY, V257, P106, DOI 10.1006/viro.1999.9662; Ho TH, 2016, J VIROL, V90, P1557, DOI 10.1128/JVI.02161-15; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Kawaguchi S, 2009, IMMUNOL LETT, V123, P9, DOI 10.1016/j.imlet.2009.01.008; Konopka JL, 2009, J VIROL, V83, P12432, DOI 10.1128/JVI.00564-09; Kremer Melanie, 2012, Methods Mol Biol, V890, P59, DOI 10.1007/978-1-61779-876-4_4; Kummerer BM, 2012, J GEN VIROL, V93, P1991, DOI 10.1099/vir.0.043752-0; Kunert R, 2016, APPL MICROBIOL BIOT, V100, P3451, DOI 10.1007/s00253-016-7388-9; Lackner A, 2012, METHODS MOL BIOL, V801, P75, DOI 10.1007/978-1-61779-352-3_6; Liptakova H, 1997, VIROLOGY, V232, P86, DOI 10.1006/viro.1997.8527; Lundstrom K, 2003, BBA-BIOMEMBRANES, V1610, P90, DOI 10.1016/S0005-2736(02)00721-6; Lundstrom K, 2010, METHODS MOL BIOL, V601, P149, DOI 10.1007/978-1-60761-344-2_10; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Meyers JA, 2006, CYTOKINE, V35, P235, DOI 10.1016/j.cyto.2006.09.001; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nivitchanyong T, 2009, VIRUS RES, V141, P1, DOI 10.1016/j.virusres.2008.12.019; Petrakova O, 2005, J VIROL, V79, P7597, DOI 10.1128/JVI.79.12.7597-7608.2005; Philp A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077200; Quabius ES, 2015, NEW BIOTECHNOL, V32, P229, DOI 10.1016/j.nbt.2014.04.008; Quetglas JI, 2012, GENE THER, V19, P271, DOI 10.1038/gt.2011.99; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Ryman KD, 2000, J VIROL, V74, P3366, DOI 10.1128/JVI.74.7.3366-3378.2000; Schlaeger TM, 2015, NAT BIOTECHNOL, V33, P58, DOI 10.1038/nbt.3070; Schott JW, 2015, CURR OPIN PHARMACOL, V24, P135, DOI 10.1016/j.coph.2015.09.004; Spotts DR, 1998, J VIROL, V72, P10286, DOI 10.1128/JVI.72.12.10286-10291.1998; Vancova I, 1998, J GEN VIROL, V79, P1647, DOI 10.1099/0022-1317-79-7-1647; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Xiong AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh094; Yoshioka N, 2013, CELL STEM CELL, V13, P246, DOI 10.1016/j.stem.2013.06.001; Zhou SH, 2010, J VIROL, V84, P9452, DOI 10.1128/JVI.00155-10	43	8	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189308	10.1371/journal.pone.0189308	http://dx.doi.org/10.1371/journal.pone.0189308			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216299	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800115
J	Nadarajah, S; Zhang, YY				Nadarajah, Saralees; Zhang, Yuanyuan			Wrapped: An R package for circular data	PLOS ONE			English	Article							ASYMMETRIC LAPLACE DISTRIBUTION; DIRECTIONAL-DATA; T-DISTRIBUTION; PARTICLE-SIZE; DISTRIBUTIONS; MODELS; REGRESSION; CIRCLE; SPHERE; FAMILY	The Wrapped package computes the probability density function, cumulative distribution function, quantile function and also generates random samples for many univariate wrapped distributions. It also computes maximum likelihood estimates, standard errors, confidence intervals and measures of goodness of fit for nearly fifty univariate wrapped distributions. Numerical illustrations of the package are given.	[Nadarajah, Saralees; Zhang, Yuanyuan] Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England	University of Manchester	Nadarajah, S (corresponding author), Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England.	mbbsssn2@manchester.ac.uk						Aas K., 2006, J FINANC ECON, V4, P275, DOI DOI 10.1093/jjfinec/nbj006; Adnan MAS, 2013, J STAT MANAG SYST, V16, P1, DOI 10.1080/09720510.2013.777578; Agostinelli C, 2017, CIRCULAR STAT; Akkaya AD, 2008, TEST-SPAIN, V17, P282, DOI 10.1007/s11749-006-0032-8; [Anonymous], 1908, BIOMETRIKA, V6, P1; [Anonymous], 1994, CONTINUOUS UNIVARIAT; [Anonymous], 2001, LAPLACE DISTRIBUTION; AZZALINI A, 1985, SCAND J STAT, V12, P171; Azzalini A, 2003, J R STAT SOC B, V65, P367, DOI 10.1111/1467-9868.00391; Azzalini A., 2016, SKEW NORMAL SKEW T D; Azzalini A., 1986, STATISTICA, V46, P199, DOI [10.6092/ISSN.1973-2201/711, DOI 10.6092/ISSN.1973-2201/711]; BARNDORFFNIELSEN O, 1977, P ROY SOC LOND A MAT, V353, P401, DOI 10.1098/rspa.1977.0041; BREITENBERGER E, 1963, BIOMETRIKA, V50, P81; Chen W, 2016, FITS; Chubaty A, 2016, SPATIALLY EXPLICIT D; Coelho CA, 2007, J STAT THEORY PRACT, V1, P1, DOI 10.1080/15598608.2007.10411821; Computes Pdf Cdf Quantile, 2017, RAND NUMB PROV EST U; de Moivre A., 1738, DOCTRINE CHANCES; Delignette-Muller M, 2017, PARAMETRIC DISTRIBUT; Fernandez C, 1998, J AM STAT ASSOC, V93, P359, DOI 10.2307/2669632; FIELLER NRJ, 1992, J R STAT SOC C-APPL, V41, P127; FISHER NI, 1989, AUST J EARTH SCI, V36, P91, DOI 10.1080/14400958985270081; Franke J, 2016, SCAND J STAT, V43, P139, DOI 10.1111/sjos.12169; Gauss C.F., 1809, THEORIA MOTVS CORPOR; GENTER FC, 1985, CAN J STAT, V13, P37, DOI 10.2307/3315165; Geraci M, 2007, BIOSTATISTICS, V8, P140, DOI 10.1093/biostatistics/kxj039; Girija S.V.S., 2014, INT J MATH ARCH, V5, P168; Gumbel EJ, 1954, APPL MATH SERIES, V33; Gupta A. K., 2004, HDB BETA DISTRIBUTIO; Jacob S, 2013, J STAT THEORY APPL, V12, P348, DOI 10.2991/jsta.2013.12.4.3; Jammalamadaka SR, 2004, COMMUN STAT-THEOR M, V33, P2059, DOI 10.1081/STA-200026570; Jayakumar K., 2012, OPEN J STAT, V2, P106, DOI DOI 10.4236/OJS.2012.21011; Johnson N., 1954, TRABAJOS ESTADISTICA, V5, P283, DOI DOI 10.1007/BF03005988; Johnson NL, 1995, CONTINUOUS UNIVARIAT; Jones M., 2005, APPL STAT, V54, P546; Jones MC, 2009, BIOMETRIKA, V96, P761, DOI 10.1093/biomet/asp053; Joshi S, 2017, WRAPPED LINDLEY DIST; Lund U, 2001, CIRCULAR STAT TOPICS; LUTKENHONER B, 1991, ACTA OTO-LARYNGOL, P52; Marinho P, 2016, MODELS GEN PURPOSE O; MCDONALD JB, 1995, J ECONOMETRICS, V66, P133, DOI 10.1016/0304-4076(94)01612-4; Michelot T, 2017, MARKOV MODELS; Mineo A., 2014, HOUTINES ROUTINES EX; Oliveira M, 2015, NONPARAMETIC CIRCULA; Paolella M., 1997, TAIL ESTIMATION COND; Pewsey A, 2000, COMMUN STAT-THEOR M, V29, P2459, DOI 10.1080/03610920008832616; Pewsey A, 2008, COMPUT STAT DATA AN, V52, P1516, DOI 10.1016/j.csda.2007.04.017; Pewsey A, 2007, AUST NZ J STAT, V49, P79, DOI 10.1111/j.1467-842X.2006.00465.x; R Development Core Team, 2017, R LANG ENV STAT COMP; Rao JS., 2001, TOPICS CIRCULAR STAT; Reed WJ, 2006, STAT IND TECHNOL, P61, DOI 10.1007/0-8176-4487-3_4; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Roy S, 2012, STAT PROBABIL LETT, V82, P77, DOI 10.1016/j.spl.2011.08.023; Sarma R, 2011, J STAT COMPUT SIM, V81, P579, DOI 10.1080/00949650903436547; Schulz J, 2015, J COMPUT GRAPH STAT, V24, P539, DOI 10.1080/10618600.2014.914947; Scott D, 2015, NORMAL LAPLACE DISTR; Sengupta A, 2014, COMMUN STAT-THEOR M, V43, P2563, DOI 10.1080/03610926.2013.800883; Sousa T, 2015, GEVSTABLEGARCH ARMA; Thavaneswaran A, 2016, INT J STAT PROBABILI, V5, P1; Theodossiou P, 1998, MANAGE SCI, V44, P1650, DOI 10.1287/mnsc.44.12.1650; Uesu K, 2015, J MULTIVARIATE ANAL, V134, P146, DOI 10.1016/j.jmva.2014.11.004; van Staden PJ, 2015, STAT PROBABIL LETT, V96, P109, DOI 10.1016/j.spl.2014.09.001; Wang FP, 2014, J AM STAT ASSOC, V109, P1565, DOI 10.1080/01621459.2014.934454; Yu KM, 2005, COMMUN STAT-THEOR M, V34, P1867, DOI 10.1080/03610920500199018	64	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188512	10.1371/journal.pone.0188512	http://dx.doi.org/10.1371/journal.pone.0188512			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216219	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800028
J	Scharf, M; Oezdemir, D; Schmid, A; Kemmler, W; von Stengel, S; May, MS; Uder, M; Lell, MM				Scharf, Michael; Oezdemir, Derya; Schmid, Axel; Kemmler, Wolfgang; von Stengel, Simon; May, Matthias S.; Uder, Michael; Lell, Michael M.			Myocardial adaption to HI(R) T in previously untrained men with a randomized, longitudinal cardiac MR imaging study (Physical adaptions in Untrained on Strength and Heart trial, PUSH-trial)	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; CARDIOVASCULAR ADAPTATIONS; PROGNOSTIC IMPLICATIONS; ATHLETES HEART; ENDURANCE; METAANALYSIS; HYPERTROPHY; GEOMETRY; EXERCISE; SPORTS	Objective Although musculoskeletal effects in resistance training are well described, little is known about structural and functional cardiac adaption in formerly untrained subjects. We prospectively evaluated whether short term high intensity (resistance) training (HI(R)T) induces detectable morphologic cardiac changes in previously untrained men in a randomized controlled magnetic resonance imaging (MRI) study. Materials and methods 80 untrained middle-aged men were randomly assigned to a HI(R) T-group (n = 40; 43.5 +/- 5.9 years) or an inactive control group (n = 40; 42.0 +/- 6.3 years). HI(R) T comprised 22 weeks of training focusing on a single-set to failure protocol in 2-3 sessions/week, each with 10-13 exercises addressing main muscle groups. Repetitions were decreased from 8-10 to 3-5 during study period. Before and after HI(R)T all subjects underwent physiologic examination and cardiac MRI (cine imaging, tagging). Results Indexed left (LV) and right ventricular (RV) volume (LV: 76.8 +/- 15.6 to 78.7 +/- 14.8 ml/m(2); RV: 77.0 +/- 15.5 to 78.7 +/- 15.1 ml/m 2) and mass (LV: 55.5 +/- 9.7 to 57.0 +/- 8.8 g/m 2; RV: 14.6 +/- 3.0 to 15.0 +/- 2.9 g/m 2) significantly increased with HI(R) T (all p< 0.001). Mean LV and RV remodeling indices of HI(R) T-group did not alter with training (0.73g/mL and 0.19g/mL, respectively [p = 0.96 and p = 0.87]), indicating balanced cardiac adaption. Indexed LV (48.4 +/- 11.1 to 50.8 +/- 11.0 ml/m(2)) and RV (48.5 +/- 11.0 to 50.6 +/- 10.7 ml/m(2)) stroke volume significantly increased with HI(R) T (p< 0.001). Myocardial strain and strain rates did not change following resistance exercise. Left atrial volume at end systole slightly increased after HI(R) T (36.2 +/- 7.9 to 37.0 +/- 8.4 ml/m(2), p = 0.411), the ratio to end- diastolic LV volume at baseline and posttraining was unchanged (0.47 vs. 0.47, p = 0.79). Conclusion 22 weeks of HI(R)T lead to measurable, physiological changes in cardiac atrial and ventricular morphologic characteristics and function in previously untrained men.	[Scharf, Michael; Oezdemir, Derya; Schmid, Axel; May, Matthias S.; Uder, Michael] Friedrich Alexander Univ Erlangen Nuremberg, Dept Radiol, Erlangen, Bavaria, Germany; [Kemmler, Wolfgang; von Stengel, Simon] Friedrich Alexander Univ Erlangen Nuremberg, Dept Med Phys, Erlangen, Bavaria, Germany; [Lell, Michael M.] Paracelsus Med Univ, Hosp Nuremberg, Dept Radiol & Nucl Med, Nurnberg, Bavaria, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Scharf, M (corresponding author), Friedrich Alexander Univ Erlangen Nuremberg, Dept Radiol, Erlangen, Bavaria, Germany.	michael.scharf@uk-erlangen.de	May, Matthias/AAZ-4877-2021; Kemmler, Wolfgang/AAM-6653-2020	May, Matthias/0000-0002-2540-850X; 	Bayer-Healthcare, Leverkusen, Germany	Bayer-Healthcare, Leverkusen, Germany(Bayer AGBayer Healthcare Pharmaceuticals)	The authors (MS, ML) received a research grant from Bayer-Healthcare, Leverkusen, Germany.	Alves JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110317; Barauna VG, 2005, CLIN EXP PHARMACOL P, V32, P249, DOI 10.1111/j.1440-1681.2005.04180.x; Christiaens L, 2009, INT J CARDIOL, V131, P217, DOI 10.1016/j.ijcard.2007.10.020; Dantas PS, 2016, LIFE SCI, V152, P156, DOI 10.1016/j.lfs.2016.03.040; De Castro S, 2006, HEART, V92, P975, DOI 10.1136/hrt.2005.069401; Dickerman RD, 1998, CARDIOLOGY, V90, P145, DOI 10.1159/000006834; DOHERTY NE, 1992, AM J CARDIOL, V69, P1223, DOI 10.1016/0002-9149(92)90940-Z; FAGARD R H, 1992, Cardiology Clinics, V10, P241; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FLECK SJ, 1993, MED SCI SPORT EXER, V25, P522; FLECK SJ, 1989, INT J SPORTS MED, V10, P329, DOI 10.1055/s-2007-1024923; Francis P, 2016, BIOGERONTOLOGY; Gaasch WH, 2011, J AM COLL CARDIOL, V58, P1733, DOI 10.1016/j.jacc.2011.07.022; George KP, 1998, EUR J APPL PHYSIOL, V79, P88, DOI 10.1007/s004210050478; Giuliano C, 2017, INT J CARDIOL, V227, P413, DOI 10.1016/j.ijcard.2016.11.023; Hoogsteen J, 2004, INT J CARDIOVAS IMAG, V20, P19, DOI 10.1023/B:CAIM.0000013160.79903.19; Huttin O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168349; Jeung MY, 2012, RADIOGRAPHICS, V32, P1381, DOI 10.1148/rg.325115098; Kalam K, 2014, HEART, V100, P1673, DOI 10.1136/heartjnl-2014-305538; Kemmler W, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9705287; Kuijer JPA, 2002, J CARDIOV MAGN RESON, V4, P341, DOI 10.1081/JCMR-120013299; Lalande S, 2007, AM J CARDIOL, V100, P1177, DOI 10.1016/j.amjcard.2007.05.036; Lemes IR, 2016, BR J SPORTS MED; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; LONGHURST J C, 1992, Cardiology Clinics, V10, P281; Lorenz CH, 1999, J CARDIOVASC MAGN R, V1, P7, DOI 10.3109/10976649909080829; Luijkx T, 2012, BRIT J SPORT MED, V46, P1119, DOI 10.1136/bjsports-2011-090520; Maron BJ, 2006, CIRCULATION, V114, P1633, DOI 10.1161/CIRCULATIONAHA.106.613562; Mihl C, 2008, NETH HEART J, V16, P129, DOI 10.1007/BF03086131; Mor-Avi V, 2011, EUR J ECHOCARDIOGR, V12, P167, DOI 10.1093/ejechocard/jer021; NIELSEN PMF, 1991, AM J PHYSIOL, V260, pH1365, DOI 10.1152/ajpheart.1991.260.4.H1365; PELLICCIA A, 1993, AM J CARDIOL, V72, P1048, DOI 10.1016/0002-9149(93)90861-6; Petersen SE, 2006, J MAGN RESON IMAGING, V24, P297, DOI 10.1002/jmri.20633; Pluim BM, 2000, CIRCULATION, V101, P336, DOI 10.1161/01.CIR.101.3.336; Scharf M, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002566; Scharf M, 2010, RADIOLOGY, V257, P71, DOI 10.1148/radiol.10092377; Schmidt JF, 2014, SCAND J MED SCI SPOR, V24, P86, DOI 10.1111/sms.12217; Spence AL, 2013, MED SCI SPORT EXER, V45, P534, DOI 10.1249/MSS.0b013e3182780b0e; Utomi V, 2013, HEART, V99, P1727, DOI 10.1136/heartjnl-2012-303465; Vernuccio Federica, 2013, Recenti Progressi in Medicina, V104, P559, DOI 10.1701/1370.15224; Vinereanu D, 2002, CLIN SCI, V103, P249, DOI 10.1042/cs1030249; Vogelsang TW, 2008, SCAND J MED SCI SPOR, V18, P354, DOI 10.1111/j.1600-0838.2007.00706.x; Whyte G, 2008, BRIT J SPORT MED, V42, P304, DOI 10.1136/bjsm.2007.038158	44	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189204	10.1371/journal.pone.0189204	http://dx.doi.org/10.1371/journal.pone.0189204			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216285	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800094
J	Berry, RS; Xiong, MJ; Greenbaum, A; Mortaji, P; Nofchissey, RA; Schultz, F; Martinez, C; Luo, L; Morris, KT; Hanson, JA				Berry, Ryan S.; Xiong, Meng-Jun; Greenbaum, Alissa; Mortaji, Parisa; Nofchissey, Robert A.; Schultz, Fred; Martinez, Cathleen; Luo, Li; Morris, Katherine T.; Hanson, Joshua A.			High levels of tumor-associated neutrophils are associated with improved overall survival in patients with stage II colorectal cancer	PLOS ONE			English	Article							EOSINOPHILS; EXPRESSION	Conflicting reports regarding whether high tumor-associated neutrophils (TAN) are associated with outcomes in colorectal cancer (CRC) exist. Previous investigators have counted TAN using non-neutrophil-specific immunohistochemistry (IHC) stains. We examined whether TAN levels as determined by multi-field manual counting would predict prognosis. IRB approval was obtained and two pathologists, blinded to stage/outcome, counted TAN in 20 high power fields (HPF) per specimen. TAN score was defined as the mean of these counts. High TAN was defined as at or greater than the median score for that stage. Demographics, tumor characteristics, and overall survival (OS) were obtained from the records and examined for association with TAN score. IHC for arginase expression was performed in a subset of samples. 221 patients were included. Stage II patients with high TAN scores had an OS of 232 months as compared to those with low TAN (OS = 85 months, p = 0.03). The survival benefit persisted in multivariable analysis (HR 0.48, CI 0.25-0.91, p = 0.026) controlling for age and sex. Women had increased survival as compared to men, and there were no significant prognostic associations with TAN count in stage III/IV patients, although there were only 12 stage IV patients. Arginase staining did not provide additional information. Stage II colorectal cancer patients with high TAN live nearly 3 times longer than those with low TAN. Women with stage II disease and high TAN counts appear to be driving the survival benefit seen in the stage II patients and have increased overall survival in all stages.	[Berry, Ryan S.] Geisinger Med Ctr, Dept Dermatol, Danville, PA 17822 USA; [Berry, Ryan S.] Geisinger Med Ctr, Dept Lab Med, Danville, PA 17822 USA; [Xiong, Meng-Jun; Schultz, Fred; Martinez, Cathleen; Hanson, Joshua A.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Greenbaum, Alissa] Univ New Mexico, Dept Surg, Albuquerque, NM 87131 USA; [Mortaji, Parisa] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA; [Nofchissey, Robert A.; Morris, Katherine T.] Univ Oklahoma, Dept Surg, Oklahoma City, OK USA; [Luo, Li] Univ New Mexico, Div Epidemiol Biostat & Prevent Med, Dept Internal Med, Albuquerque, NM 87131 USA	Geisinger Medical Center; Geisinger Medical Center; University of New Mexico; University of New Mexico; University of New Mexico; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of New Mexico	Morris, KT (corresponding author), Univ Oklahoma, Dept Surg, Oklahoma City, OK USA.	kmorris4@ouhsc.edu		Xiong, Meng-Jun/0000-0002-1940-3972	National Institute of Health [5U54GM104944-03]; Mentored Research Scholar Grant from the American Cancer Society [MRSG-15-136-01-CCE]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mentored Research Scholar Grant from the American Cancer Society	Funded by National Institute of Health 5U54GM104944-03 (KTM), and Mentored Research Scholar Grant, MRSG-15-136-01-CCE from the American Cancer Society (KTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algars A, 2012, INT J CANCER, V131, P864, DOI 10.1002/ijc.26457; Barry TS, 2003, AM J SURG PATHOL, V27, P1513, DOI 10.1097/00000478-200312000-00003; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fridlender ZG, 2012, CARCINOGENESIS, V33, P949, DOI 10.1093/carcin/bgs123; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Galdiero MR, 2016, INT J CANCER, V139, P446, DOI 10.1002/ijc.30076; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-205; Harbaum L, 2015, MODERN PATHOL, V28, P403, DOI 10.1038/modpathol.2014.104; Hernandez-Campo PM, 2007, CYTOM PART B-CLIN CY, V72B, P34, DOI 10.1002/cyto.b.20143; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Jang TJ, 2013, KOREAN J PATHOL, V47, P340, DOI 10.4132/KoreanJPathol.2013.47.4.340; Jensen HK, 2009, J CLIN ONCOL, V27, P4709, DOI 10.1200/JCO.2008.18.9498; Kansal R, 2002, AM J CLIN PATHOL, V117, P29; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Lerdkiattikorn P, 2014, EXPERT REV PHARM OUT, P1; Lindskog EB, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-948; Niccoli G, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.115.002554; Pepe MS, 2015, CANCER EPIDEM BIOMAR, V24, P944, DOI 10.1158/1055-9965.EPI-14-1227; Rao HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030806; Sionov R.V., 2014, CANC MICROENVIRON; Torsteinsdottir I, 1999, SCAND J IMMUNOL, V50, P433, DOI 10.1046/j.1365-3083.1999.00602.x; Trellakis S, 2011, INT J CANCER, V129, P2183, DOI 10.1002/ijc.25892; Wikberg ML, 2017, HUMAN PATHOLOGY; Yang L, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000266; Zhao JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033655	25	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188799	10.1371/journal.pone.0188799	http://dx.doi.org/10.1371/journal.pone.0188799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211768	Green Submitted, gold, Green Published			2022-12-27	WOS:000417212200049
J	Goldstein, B; Moses, R; Sammons, N; Birkved, M				Goldstein, Benjamin; Moses, Rebekah; Sammons, Norman; Birkved, Morten			Potential to curb the environmental burdens of American beef consumption using a novel plant-based beef substitute	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; LIFE-CYCLE ASSESSMENTS; AGRICULTURAL LAND; FOOD CHOICES; MEAT; IMPACTS; LIVESTOCK; OPPORTUNITIES; FOOTPRINT; EXPANSION	The food demands of the United States (US) impart significant environmental pressures. The high rate of consumption of beef has been shown to be the largest driver of food-borne greenhouse gas emissions, water use and land occupation in the US diet. The environmental benefits of substituting animal products with vegetal foods are well documented, but significant psychological barriers persist in reducing meat consumption. Here we use life cycle assessment to appraise the environmental performance of a novel vegetal protein source in the mean US diet where it replaces ground beef, and in vegetarian and vegan diets where it substitutes for legumes, tofu and other protein sources. We find that relative to the mean US diet, vegetarian and vegan diets significantly reduce per-capita food-borne greenhouse gas emission (32% and 67%, respectively), blue water use (70% and 75%, respectively) and land occupation (70% and 79%, respectively), primarily in the form of rangeland. The substitution of 10%, 25% and 50% of ground beef with plant-based burger (PBB) at the national scale results in substantial reductions in annual US dietary greenhouse gas emissions (4.55-45.42 Mt CO2 equivalents), water consumption (1.30-12.00 km(3)) and land occupation (22300-190100 km(2)). Despite PBB's elevated environmental pressures compared to other vegetal protein sources, we demonstrate that minimal risk exists for the disservices of PBB substitution in non-meat diets to outweigh the benefits of ground-beef substitution in the omnivorous American diet. Demand for plant-based oils in PBB production has the potential to increase land use pressures in biodiversity hotspots, though these could be obviated through responsible land stewardship. Although the apparent environmental benefits of the PBB are contingent on actual uptake of the product, this study demonstrates the potential for non-traditional protein substitutes to play a role in a transition towards more sustainable consumption regimes in the US and potentially abroad.	[Goldstein, Benjamin; Birkved, Morten] Tech Univ Denmark, Quantitat Sustainabil Assessment Div, Dept Management Engn, Lyngby, Denmark; [Moses, Rebekah; Sammons, Norman] Impossible Foods, Redwood City, CA USA	Technical University of Denmark	Goldstein, B (corresponding author), Tech Univ Denmark, Quantitat Sustainabil Assessment Div, Dept Management Engn, Lyngby, Denmark.	bgol@dtu.dk	Birkved, Morten/AAA-4736-2020; Goldstein, Benjamin Paul/N-2745-2015; Birkved, Morten/O-8585-2018	Goldstein, Benjamin Paul/0000-0003-0055-1323; Birkved, Morten/0000-0001-6989-1647	Impossible Foods	Impossible Foods	Impossible Foods provided support in the form of salaries for authors RM and NS, but did not have any additional role in the study design, data collection and analysis or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The CEO of Impossible Foods had minor say on the final decision to publish, but this did not affect the manner in which data collection, calculations, results interpretation or manuscript drafting were performed.	Achard F, 2014, GLOBAL CHANGE BIOL, V20, P2540, DOI 10.1111/gcb.12605; Barlow J, 2016, BIORESOURCE TECHNOL, V220, P360, DOI 10.1016/j.biortech.2016.08.091; Baroni L, 2007, EUR J CLIN NUTR, V61, P279, DOI 10.1038/sj.ejcn.1602522; Boucher D., 2011, ROOT PROBLEM WHATS D; Boyd W, 2001, TECHNOL CULT, V42, P631, DOI 10.1353/tech.2001.0150; Capper JL, 2011, J ANIM SCI, V89, P4249, DOI 10.2527/jas.2010-3784; Cattlemen's Beef Board and Cattlemen's Beef Association, 2016, BEEF RETAIL MARK; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Cunningham J, 2009, VEG J, V29; Daniel CR, 2011, PUBLIC HEALTH NUTR, V14, P575, DOI 10.1017/S1368980010002077; Davis J, 2010, FOOD RES INT, V43, P1874, DOI 10.1016/j.foodres.2009.08.017; de Boer J, 2007, FOOD QUAL PREFER, V18, P985, DOI 10.1016/j.foodqual.2007.04.002; de Vries M, 2010, LIVEST SCI, V128, P1, DOI 10.1016/j.livsci.2009.11.007; Dumont B, 2013, ANIMAL, V7, P1028, DOI 10.1017/S1751731112002418; Eshel G, 2016, ENVIRON SCI TECHNOL, V50, P8164, DOI 10.1021/acs.est.6b01006; Eshel G, 2014, P NATL ACAD SCI USA, V111, P11996, DOI 10.1073/pnas.1402183111; Fellet M, 2015, ACS CENTRAL SCI, V1, P347, DOI 10.1021/acscentsci.5b00307; Finnveden G, 2009, J ENVIRON MANAGE, V91, P1, DOI 10.1016/j.jenvman.2009.06.018; FLEISCHNER TL, 1994, CONSERV BIOL, V8, P629, DOI 10.1046/j.1523-1739.1994.08030629.x; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Fraser R., 2017, US Patent, Patent No. [9700067B2, 9700067]; Frieden T, 2013, ANTIBIOTIC RESISTANC, V23, P11; Garnett T, 2011, FOOD POLICY, V36, pS23, DOI 10.1016/j.foodpol.2010.10.010; Gerber PJ, 2013, TACKING CLIMATE CHAN; Gibbs HK, 2015, SCIENCE, V347, P377, DOI 10.1126/science.aaa0181; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gibbs HK, 2016, CONSERV LETT, V9, P32, DOI 10.1111/conl.12175; Gilchrist MJ, 2007, ENVIRON HEALTH PERSP, V115, P313, DOI 10.1289/ehp.8837; Gliessman S, 2015, AGROECOLOGY: THE ECOLOGY OF SUSTAINABLE FOOD SYSTEMS, 3RD EDITION, pXI; Goldstein B, 2016, FOOD POLICY, V59, P139, DOI 10.1016/j.foodpol.2016.01.006; Haddad EH, 2003, AM J CLIN NUTR, V78, p626S, DOI 10.1093/ajcn/78.3.626S; Harnisch J, 2005, SAFEGUARDING OZONE L, P118; Heller MC, 2015, J IND ECOL, V19, P391, DOI 10.1111/jiec.12174; Hellweg S, 2014, SCIENCE, V344, P1109, DOI 10.1126/science.1248361; Herrero M, 2013, P NATL ACAD SCI USA, V110, P20878, DOI 10.1073/pnas.1321844111; Herrero M, 2013, P NATL ACAD SCI USA, V110, P20888, DOI 10.1073/pnas.1308149110; Hoekstra AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032688; IPCC, 2013, CLIMATE CHANGE 2022; Jalava M, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/7/074016; Jolliet O, 2003, INT J LIFE CYCLE ASS, V8, P324, DOI 10.1007/BF02978505; Jones CM, 2011, ENVIRON SCI TECHNOL, V45, P4088, DOI 10.1021/es102221h; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Macdiarmid JI, 2016, APPETITE, V96, P487, DOI 10.1016/j.appet.2015.10.011; Magat SS, 2007, COCONUT PRODUCTIVITY, P23; Matthews K, 2013, ALTERNATIVE BEEF PRO; Mattick CS, 2015, ENVIRON SCI TECHNOL, V49, P11941, DOI 10.1021/acs.est.5b01614; Meier T, 2013, ENVIRON SCI TECHNOL, V47, P877, DOI 10.1021/es302152v; Mekonnen MM, 2012, ECOSYSTEMS, V15, P401, DOI 10.1007/s10021-011-9517-8; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Munoz I, 2010, INT J LIFE CYCLE ASS, V15, P794, DOI 10.1007/s11367-010-0188-z; Nijdam D, 2012, FOOD POLICY, V37, P760, DOI 10.1016/j.foodpol.2012.08.002; Noojipady Praveen, 2015, Ecosystem Health and Sustainability, V1, P27, DOI 10.1890/EHS15-0020.1; OECD, 2016, MEAT CONS; Oonincx DGAB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051145; Pelletier N, 2010, P NATL ACAD SCI USA, V107, P18371, DOI 10.1073/pnas.1004659107; Pelletier N, 2010, AGR SYST, V103, P380, DOI 10.1016/j.agsy.2010.03.009; Peters CJ, 2016, ELEMENTA-SCI ANTHROP, V4, DOI 10.12952/journal.elementa.000116; Piazza J, 2015, APPETITE, V91, P114, DOI 10.1016/j.appet.2015.04.011; Pimentel D, 2003, AM J CLIN NUTR, V78, p660S, DOI 10.1093/ajcn/78.3.660S; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Rothgerber H., 2012, PSYCHOL MEN MASCULIN, V14; Sammons N, 2016, P 2016 LCA FOOD C DU; Scarborough P, 2014, CLIMATIC CHANGE, V125, P179, DOI 10.1007/s10584-014-1169-1; Selig ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082898; Shepon A, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/10/105002; Smil V, 2002, ENZYME MICROB TECH, V30, P305, DOI 10.1016/S0141-0229(01)00504-X; Smith DL, 2002, P NATL ACAD SCI USA, V99, P6434, DOI 10.1073/pnas.082188899; Smith P, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P811; Sneeringer S, 2015, ERR200; Springmann M, 2016, P NATL ACAD SCI USA, V113, P4146, DOI 10.1073/pnas.1523119113; Steinfeld H., 2006, Renewable Resources Journal, V24, P15; Steinfeld H, 2013, GREENHOUSE GAS EMISS; Steinfeld H, 2010, P NATL ACAD SCI USA, V107, P18237, DOI 10.1073/pnas.1012541107; The United States Geological Survey, 2016, USGS WAT SCI SCH; Thomson KJ, 2003, LAND USE POLICY, V20, P375, DOI 10.1016/S0264-8377(03)00047-4; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tuomisto HL, 2011, ENVIRON SCI TECHNOL, V45, P6117, DOI 10.1021/es200130u; U.S. Department of Agriculture (USDA), 2016, FOOD AV PER CAP DAT; U. S. Department of Health and Human Services and U. S. Department of Agriculture, 2015, 2015 2020 DIET GUID; United States Department of Agriculture-Economic Research Service, 2016, CATTL BEEF TRAD; United States Environmental Protection Agency, 2008, AV ANN EM FUEL CONS; van Dooren C, 2014, FOOD POLICY, V44, P36, DOI 10.1016/j.foodpol.2013.11.002; Van Kernebeek HRJ, 2016, INT J LIFE CYCLE ASS, V21, P677, DOI 10.1007/s11367-015-0923-6; Weber CL, 2008, ENVIRON SCI TECHNOL, V42, P3508, DOI 10.1021/es702969f; Wells HF, 2008, EC INFORM B NUMBER, V33, P1; Wilkinson JM, 2011, ANIMAL, V5, P1014, DOI 10.1017/S175173111100005X; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Young HS, 2010, P NATL ACAD SCI USA, V107, P2072, DOI 10.1073/pnas.0914169107	89	40	42	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189029	10.1371/journal.pone.0189029	http://dx.doi.org/10.1371/journal.pone.0189029			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211775	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200057
J	Verstappen, KM; Huijbregts, L; Spaninks, M; Wagenaar, JA; Fluit, AC; Duim, B				Verstappen, Koen M.; Huijbregts, Loes; Spaninks, Mirlin; Wagenaar, Jaap A.; Fluit, Ad C.; Duim, Birgitta			Development of a real-time PCR for detection of Staphylococcus pseudintermedius using a novel automated comparison of whole-genome sequences (vol 12, e0183925, 2017)	PLOS ONE			English	Correction																		Verstappen KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183925	1	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189520	10.1371/journal.pone.0189520	http://dx.doi.org/10.1371/journal.pone.0189520			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211783	Green Submitted, Green Published, gold			2022-12-27	WOS:000417212200080
J	Berzaczy, D; Mayerhoefer, ME; Azizi, AA; Haug, AR; Senn, D; Beitzke, D; Weber, M; Traub-Weidinger, T				Berzaczy, Dominik; Mayerhoefer, Marius E.; Azizi, Amedeo A.; Haug, Alexander R.; Senn, Daniela; Beitzke, Dietrich; Weber, Michael; Traub-Weidinger, Tatjana			Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?	PLOS ONE			English	Article							STANDARDIZED UPTAKE VALUE; DIFFUSION-WEIGHTED MRI; F-18-FDG PET/CT; DIAGNOSIS	Purpose To investigate whether elevated glucose metabolism in neurofibroma, determined by [F18]FDG-PET, is correlated with cell density in MRI, as expressed through the apparent diffusion coefficient. Materials and methods Patients diagnosed with neurofibromatosis type 1 and peripheral nerve sheath tumors (PNST) were enrolled in this prospective, IRB-approved study. After a single [F18]-FDG injection, patients consecutively underwent [F18]-FDG-PET/CT and [F18]-FDG-PET/MRI on the same day. Maximum and mean standardized uptake values (SUVmax, SUVmean) on [F18]-FDG-PET/CT and [F18]-FDG-PET/MRI were compared, and correlated with minimum and mean apparent diffusion coefficients (ADCmean, ADCmin). Results A total of 12 (6 male/6 female, mean age was 16.2 +/- 5.2 years) patients were prospectively included and analyzed on a per-lesion (n = 39) basis. The SUVmean of examined PNST showed a moderate negative correlation with the ADCmean (r = -. 441) and ADCmin (r = -. 477), which proved to be statistically significant (p =.005 and p =.002). The SUVmax of the respective lesions, however, showed a weaker negative correlation for ADCmean (r: -. 311) and ADCmin (r: -. 300) and did not reach statistical significance (p =.054 and p =.057). Lesion-based correlation between [F18]-FDG-PET/MRI and [F18]-FDG-PET/CT showed a moderate correlation for SUVmax (r =.353; p =.027) and a strong one for SUVmean (r =.879; p =.001)). Patient-based liver uptake (SUVmax and mean) of [F18]-FDG-PET/MRI and [F18]-FDG-PET/CT were strongly positively correlated (r =.827; p <.001 and r =.721; p <.001) but differed significantly (p <.001). Conclusions We found a statistically significant, negative correlation between glucose metabolism and cell density in PNST. Thus, ADCmean and ADCmin could possibly add complimentary information to the SUVmax and SUVmean and may serve as a potential determinant of malignant transformation of PNST.	[Berzaczy, Dominik; Mayerhoefer, Marius E.; Beitzke, Dietrich; Weber, Michael] Med Univ Vienna, Div Gen & Pediat Radiol, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Azizi, Amedeo A.] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Haug, Alexander R.; Senn, Daniela; Traub-Weidinger, Tatjana] Med Univ Vienna, Div Nucl Med, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Berzaczy, D (corresponding author), Med Univ Vienna, Div Gen & Pediat Radiol, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.	dominik.berzaczy@meduniwien.ac.at	Mayerhoefer, Marius/AAD-2156-2021; Weber, Michael/L-9836-2016	Mayerhoefer, Marius/0000-0001-8786-8686; Traub-Weidinger, Tatjana/0000-0003-1118-926X; Azizi, Amedeo/0000-0002-1347-6644; Weber, Michael/0000-0002-8507-2219; Haug, Alexander/0000-0002-8308-6174	Austrian Science Fund (FWF) [KLIF 382]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF), project number KLIF 382 to Marius E. Mayerhoefer. https://www.fwf.ac.at/en/.	Adams MC, 2010, AM J ROENTGENOL, V195, P310, DOI 10.2214/AJR.10.4923; Azizi AA, 2017, PEDIAT BLOOD CANC; Benz MR, 2010, CANCER-AM CANCER SOC, V116, P451, DOI 10.1002/cncr.24755; Chirindel A, 2015, J NUCL MED, V56, P379, DOI 10.2967/jnumed.114.142372; Chirindel A, 2015, CLIN NUCL MED, V40, pE17, DOI 10.1097/RLU.0000000000000446; Combemale P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085954; Derlin T, 2013, CLIN NUCL MED, V38, pE19, DOI 10.1097/RLU.0b013e318266ce84; DUCATMAN BS, 1986, CANCER-AM CANCER SOC, V57, P2006, DOI 10.1002/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Ferner RE, 2002, CANCER RES, V62, P1573; Ferner RE, 2007, J MED GENET, V44, P81, DOI 10.1136/jmg.2006.045906; Grueneisen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096751; Mayerhoefer ME, 2016, CLIN NUCL MED, V41, P837, DOI 10.1097/RLU.0000000000001395; Ohno Y, 2012, AM J ROENTGENOL, V198, P75, DOI 10.2214/AJR.11.6525; Pemov A, 2017, ONCOGENE, V36, P3168, DOI 10.1038/onc.2016.464; Rakheja R, 2013, AM J ROENTGENOL, V201, P1115, DOI 10.2214/AJR.13.11304; Rasmussen SA, 2001, AM J HUM GENET, V68, P1110, DOI 10.1086/320121; Salamon J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143305; Salamon J, 2014, EUR RADIOL, V24, P405, DOI 10.1007/s00330-013-3020-x; Salamon J, 2013, EUR J NUCL MED MOL I, V40, P685, DOI 10.1007/s00259-012-2314-6; Schaarschmidt BM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122545; Stucky CCH, 2012, ANN SURG ONCOL, V19, P878, DOI 10.1245/s10434-011-1978-7; Tovmassian D, 2016, INT J SURG ONCOL, V2016, DOI 10.1155/2016/6162182; Uusitalo E, 2016, J CLIN ONCOL, V34, P1978, DOI 10.1200/JCO.2015.65.3576; Van Der Gucht A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151809; Warbey VS, 2009, EUR J NUCL MED MOL I, V36, P751, DOI 10.1007/s00259-008-1038-0; Yap YS, 2014, ONCOTARGET, V5, P5873, DOI 10.18632/oncotarget.2194	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189093	10.1371/journal.pone.0189093	http://dx.doi.org/10.1371/journal.pone.0189093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206885	Green Published, Green Submitted, gold			2022-12-27	WOS:000417110700049
J	Suresh, S; Abdurehman, L; Osmani, AH; Osmani, SA				Suresh, Subbulakshmi; Abdurehman, Leymaan; Osmani, Aysha H.; Osmani, Stephen A.			Tools for retargeting proteins within Aspergillus nidulans	PLOS ONE			English	Article							CONNECTIVITY; LOCALIZATION; MANIPULATION; CONSTRUCTION; VERSATILE; COMPLEX; MARKER	Endogenously tagging proteins with green fluorescent protein (GFP) enables the visualization of the tagged protein using live cell microscopy. GFP-tagging is widely utilized to study biological processes in model experimental organisms including filamentous fungi such as Aspergillus nidulans. Many strains of A. nidulans have therefore been generated with different proteins endogenously tagged with GFP. To further enhance experimental approaches based upon GFP-tagging, we have adapted the GFP Binding Protein (GBP) system for A. nidulans. GBP is a genetically encoded Llama single chain antibody against GFP which binds GFP with high affinity. Using gene replacement approaches, it is therefore possible to link GBP to anchor proteins, which will then retarget GFP-tagged proteins away from their normal location to the location of the anchor-GBP protein. To facilitate this approach in A. nidulans, we made four base plasmid cassettes that can be used to generate gene replacement GBP-tagging constructs by utilizing fusion PCR. Using these base cassettes, fusion PCR, and gene targeting approaches, we generated strains with SPA10-GBP and Tom20-GBP gene replacements. These strains enabled test targeting of GFP-tagged proteins to septa or to the surface of mitochondria respectively. SPA10-GBP is shown to effectively target GFP-tagged proteins to both forming and mature septa. Tom20-GBP has a higher capacity to retarget GFP-tagged proteins being able to relocate all Nup49-GFP from its location within nuclear pore complexes (NPCs) to the cytoplasm in association with mitochondria. Notably, removal of Nup49-GFP from NPCs causes cold sensitivity as does deletion of the nup49 gene. The cassette constructs described facilitate experimental approaches to generate precise protein-protein linkages in fungi. The A. nidulans SPA10-GBP and Tom20-GBP strains can be utilized to modulate other GFP-tagged proteins of interest.	[Suresh, Subbulakshmi; Abdurehman, Leymaan; Osmani, Aysha H.; Osmani, Stephen A.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Suresh, Subbulakshmi] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA	University System of Ohio; Ohio State University; Rockefeller University	Osmani, SA (corresponding author), Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA.	osmani.2@osu.edu	Suresh, Subbulakshmi/AAE-8714-2019; Osmani, Stephen A./AAS-3904-2021					Borg S, 2015, MBIO, V6, DOI 10.1128/mBio.02117-14; Chen YH, 2017, J CELL SCI, V130, P1003, DOI 10.1242/jcs.198457; CLUTTERBUCK AJ, 1970, J GEN MICROBIOL, V60, P133, DOI 10.1099/00221287-60-1-133; De Souza CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090911; De Souza CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058008; Harris SD, 1997, FUNGAL GENET BIOL, V22, P1, DOI 10.1006/fgbi.1997.0990; Harris SD, 2001, CURR OPIN MICROBIOL, V4, P736, DOI 10.1016/S1369-5274(01)00276-4; Hulett JM, 2008, J MOL BIOL, V376, P694, DOI 10.1016/j.jmb.2007.12.021; Lai JL, 2012, P NATL ACAD SCI USA, V109, P15781, DOI 10.1073/pnas.1207467109; Liu HL, 2010, EUKARYOT CELL, V9, P831, DOI 10.1128/EC.00032-10; Liu HL, 2009, MOL BIOL CELL, V20, P616, DOI 10.1091/mbc.E08-06-0628; Markossian S, 2015, MOL BIOL CELL, V26, P605, DOI 10.1091/mbc.E14-09-1359; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Osmani AH, 2006, MOL BIOL CELL, V17, P4946, DOI 10.1091/mbc.E06-07-0657; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Schornack S, 2009, PLANT J, V60, P744, DOI 10.1111/j.1365-313X.2009.03982.x; Shen KF, 2014, MOL BIOL CELL, V25, P763, DOI 10.1091/mbc.E13-12-0718; Suelmann R, 2000, CELL MOTIL CYTOSKEL, V45, P42, DOI 10.1002/(SICI)1097-0169(200001)45:1<42::AID-CM4>3.0.CO;2-C; Suresh S, 2017, J CELL BIOL, V216, P2813, DOI 10.1083/jcb.201610019; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Todd RB, 2007, NAT PROTOC, V2, P811, DOI 10.1038/nprot.2007.112; Toews MW, 2004, CURR GENET, V45, P383, DOI 10.1007/s00294-004-0495-7; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004; Zhang Y, 2017, MOL MICROBIOL, V106, P285, DOI 10.1111/mmi.13763	26	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2017	12	12							e0189077	10.1371/journal.pone.0189077	http://dx.doi.org/10.1371/journal.pone.0189077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5CX	29194456	Green Submitted, Green Published, gold			2022-12-27	WOS:000416867800019
J	Lugoboni, F; Zamboni, L; Federico, A; Tamburin, S				Lugoboni, Fabio; Zamboni, Lorenzo; Federico, Angela; Tamburin, Stefano		GICS	Erectile dysfunction and quality of life in men receiving methadone or buprenorphine maintenance treatment. A cross-sectional multicentre study	PLOS ONE			English	Article							SEXUAL DYSFUNCTION; RISK-FACTORS; HEROIN-ADDICTS; THERAPY; ASSOCIATION; PREVALENCE; QUESTIONNAIRE; TESTOSTERONE; METAANALYSIS; INFECTION	Background Erectile dysfunction (ED) is common among men on opioid replacement therapy (ORT), but most previous studies exploring its prevalence and determinants yielded contrasting findings. Moreover, the impact of ED on patients' quality of life (QoL) has been seldom explored. Objective To explore the prevalence and determinants of ED in men on ORT, and the impact on QoL. Methods In a multicentre cross-sectional study, we recruited 797 consecutive male patients on methadone and buprenorphine treatment, collected data on demographic, clinical, and psychopathological factors, and explored their role as predictors of ED and QoL through univariate and multivariate analysis. ED severity was assessed with a self-assessment questionnaire. Results Nearly half of patients in our sample were sexually inactive or reported some degree of ED. Some demographic, clinical and psychopathological variables significantly differed according to the presence or absence of ED. Multivariate regression analysis indicated that age, employment, smoke, psychoactive drugs, opioid maintenance dosage, and severity of psychopathological factors significantly influenced the risk and severity of ED. QoL was worse in patients with ED and significantly correlated with ED severity. Age, education, employment, opioid maintenance dosage, ED score, and severity of psychopathology significantly influenced QoL in the multivariate analysis. Conclusions ED complaints can be explored in male opioid users on ORT through a simple and quick self-assessment tool. ED may have important effects on emotional and social well-being, and may affect outcome.	[Lugoboni, Fabio; Zamboni, Lorenzo; Federico, Angela] Verona Univ Hosp, Dept Med, Addict Med Unit, Verona, Italy; [Federico, Angela; Tamburin, Stefano] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona	Tamburin, S (corresponding author), Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy.	stefano.tamburin@univr.it	Tamburin, Stefano/AAB-9500-2019	Tamburin, Stefano/0000-0002-1561-2187				Aghighi A, 2015, INT J IMPOT RES, V27, P63, DOI 10.1038/ijir.2014.34; Bacon CG, 2006, J UROLOGY, V176, P217, DOI 10.1016/S0022-5347(06)00589-1; Baldwin David S, 2004, Expert Opin Drug Saf, V3, P457, DOI 10.1517/14740338.3.5.457; Bang-Ping J, 2009, J SEX MED, V6, P1072, DOI 10.1111/j.1743-6109.2007.00707.x; Bliesener N, 2005, J CLIN ENDOCR METAB, V90, P203, DOI 10.1210/jc.2004-0929; Brown R, 2005, J ADDICT DIS, V24, P91, DOI 10.1300/J069v24n02_08; Chen W, 2012, J ADDICT MED, V6, P212, DOI 10.1097/ADM.0b013e318259b2c4; Cioe PA, 2013, J SUBST ABUSE TREAT, V45, P451, DOI 10.1016/j.jsat.2013.06.004; Cioe PA, 2010, J ADDICT DIS, V29, P455, DOI 10.1080/10550887.2010.509279; CROWLEY TJ, 1978, INT J ADDICT, V13, P285, DOI 10.3109/10826087809039281; Derogatis L.R., 1994, SYMPTOM CHECKLIST 90; Deyo RA, 2013, SPINE, V38, P909, DOI 10.1097/BRS.0b013e3182830482; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), ANN REP 2016 STAT DR; Frederick LR, 2014, J SEX MED, V11, P2546, DOI 10.1111/jsm.12647; Gerra G, 2016, EUR ADDICT RES, V22, P163, DOI 10.1159/000441470; Hallinan R, 2009, INT J ANDROL, V32, P131, DOI 10.1111/j.1365-2605.2007.00824.x; Hallinan R, 2008, J SEX MED, V5, P684, DOI 10.1111/j.1743-6109.2007.00702.x; Heidari Z, 2012, INT J HIGH RISK BEHA, V1, P12; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Johnson SD, 2004, ARCH SEX BEHAV, V33, P55, DOI 10.1023/B:ASEB.0000007462.97961.5a; Meldrum DR, 2012, INT J IMPOT RES, V24, P61, DOI 10.1038/ijir.2011.51; National Institutes of Health, 1993, IMP NIH CONS STAT; Nguyen HV, 2006, INTERN MED J, V36, P362, DOI 10.1111/j.1445-5994.2006.01093.x; Nielsen S, 2014, 329 1 NEW S WAL; Pajusco B, 2012, INT J ENV RES PUB HE, V9, P932, DOI 10.3390/ijerph9030932; PICCINELLI M, 1993, COMPR PSYCHIAT, V34, P198, DOI 10.1016/0010-440X(93)90048-9; Ponholzer A, 2005, EUR UROL, V47, P80, DOI 10.1016/j.eururo.2004.08.017; Prunas A, 2012, EUR PSYCHIAT, V27, P591, DOI 10.1016/j.eurpsy.2010.12.006; Quaglio G, 2008, DRUG ALCOHOL DEPEN, V94, P12, DOI 10.1016/j.drugalcdep.2007.09.025; Rao J, 2009, J CLIN GASTROENTEROL, V43, P94, DOI 10.1097/MCG.0b013e3180cabc14; Resnick MJ, 2015, EUR UROL, V67, P1019, DOI 10.1016/j.eururo.2014.08.035; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Selvin E, 2007, AM J MED, V120, P151, DOI 10.1016/j.amjmed.2006.06.010; Smith HS, 2012, PAIN PHYSICIAN, V15, pES145; Teoh JBF, 2017, J ADDICT MED, V11, P40, DOI 10.1097/ADM.0000000000000267; Vuong C, 2010, ENDOCR REV, V31, P98, DOI 10.1210/er.2009-0009; Xia YH, 2013, PSYCHOL HEALTH MED, V18, P321, DOI 10.1080/13548506.2012.729845; Yee A, 2014, INT J IMPOT RES, V26, P161, DOI 10.1038/ijir.2014.18; Yee A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147852; Yee A, 2014, J SEX MED, V11, P22, DOI 10.1111/jsm.12352; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088289	41	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188994	10.1371/journal.pone.0188994	http://dx.doi.org/10.1371/journal.pone.0188994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190831	Green Submitted, Green Published, gold			2022-12-27	WOS:000416841900185
J	De Bruyn, S; Wouters, E; Ponnet, K; Van Damme, J; Van Hal, G				De Bruyn, Sara; Wouters, Edwin; Ponnet, Koen; Van Damme, Joris; Van Hal, Guido		Task Force Subst Use Flemish Univ	The psychometric properties of a shortened Dutch version of the consequences scale used in the Core Alcohol and Drug Survey	PLOS ONE			English	Article							DISORDERS IDENTIFICATION TEST; COLLEGE-STUDENTS; DRINKING PATTERNS; SUBSTANCE USE; TEST AUDIT; VALIDATION; QUESTIONNAIRE; RELIABILITY; MAGNITUDE; DRINKERS	Background Alcohol and drug misuse among college students has been studied extensively and has been clearly identified as a public health problem. Within more general populations alcohol misuse remains one of the leading causes of disease, disability and death worldwide. Conducting research on alcohol misuse requires valid and reliable instruments to measure its consequences. One scale that is often used is the consequences scale in the Core Alcohol and Drug Survey (CADS). However, psychometric studies on the CADS are rare and the ones that do exist report varying results. This article aims to address this imbalance by examining the psychometric properties of a Dutch version of the CADS in a large sample of Flemish university and college students. Methods The analyses are based on data collected by the inter-university project 'Head in the clouds', measuring alcohol use among students. In total, 19,253 students participated (22.1% response rate). The CADS scale was measured using 19 consequences, and participants were asked how often they had experienced these on a 6-point scale. Firstly, the factor structure of the CADS was examined. Two models from literature were compared by performing confirmatory factor analyses (CFA) and were adapted if necessary. Secondly, we assessed the composite reliability as well as the convergent, discriminant and concurrent validity. Results The two-factor model, identifying personal consequences (had a hangover; got nauseated or vomited; missed a class) and social consequences (got into an argument or fight; been criticized by someone I know; done something I later regretted; been hurt or injured) was indicated to be the best model, having both a good model fit and an acceptable composite reliability. In addition, construct validity was evaluated to be acceptable, with good discriminant validity, although the convergent validity of the factor measuring 'social consequences' could be improved. Concurrent validity was evaluated as good. Conclusions In deciding which model best represents the data, it is crucial that not only the model fit is evaluated, but the importance of factor reliability and validity issues is also taken into account. The two-factor model, identifying personal consequences and social consequences, was concluded to be the best model. This shortened Dutch version of the CADS (CADS_D) is a useful tool to screen alcohol-related consequences among college students.	[De Bruyn, Sara; Wouters, Edwin; Ponnet, Koen] Univ Antwerp, Dept Sociol, Antwerp, Belgium; [Ponnet, Koen] Univ Antwerp, Dept Commun Studies, Antwerp, Belgium; [Ponnet, Koen] Univ Ghent, Dept Commun Studies, MICT IMEC, Ghent, Belgium; [Van Damme, Joris] Assoc Alcohol & Other Drug Problems, Brussels, Belgium; [Van Hal, Guido] Univ Antwerp, Dept Epidemiol & Social Med, Med Sociol & Hlth Policy, Antwerp, Belgium	University of Antwerp; University of Antwerp; Ghent University; University of Antwerp	De Bruyn, S (corresponding author), Univ Antwerp, Dept Sociol, Antwerp, Belgium.	sara.debruyn@uantwerpen.be	Wouters, Edwin/AAE-1649-2021; Van Hal, Guido F/B-5948-2017; Ponnet, Koen/K-9389-2017; De Bruyn, Sara/S-2835-2016	Wouters, Edwin/0000-0003-2268-3829; Van Hal, Guido F/0000-0002-4611-4076; Ponnet, Koen/0000-0002-6911-7632; De Bruyn, Sara/0000-0003-0764-9008	Research Council of the University of Antwerp [41/FA040100/FFB140326]; Research Foundation Flanders (FWO) [1163517N]	Research Council of the University of Antwerp; Research Foundation Flanders (FWO)(FWO)	This work was supported by: 1. The Research Council of the University of Antwerp - https://www.uantwerpen.be/nl/ -Grant number: 41/FA040100/FFB140326 - Received by SDB; 2. the Research Foundation Flanders (FWO) - http://www. fwo.be/en/ - Grant number: 1163517N - Received by SDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuya AO, 2005, ALCOHOL ALCOHOLISM, V40, P575, DOI 10.1093/alcalc/agh197; Annemans L., 2013, M INT ALC DEP BELG M; Babor T. F, 2001, GUIDELINES USE PRIMA; Bollen K.A., 1993, TESTING STRUCTURAL E, DOI DOI 10.1093/SF/73.3.1161; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Brown T.A., 2015, CONFIRMATORY FACTOR; Browne MW., 1993, SOCIOL METHOD RES, V154, P136; Cashin JR, 1998, J STUD ALCOHOL, V59, P63, DOI 10.15288/jsa.1998.59.63; CORE I, ALCOHOL DRUG SURVEYS; Delk EW, 1996, J AM COLL HEALTH, V44, P274, DOI 10.1080/07448481.1996.9936855; DeMartini KS, 2012, PSYCHOL ASSESSMENT, V24, P954, DOI 10.1037/a0028519; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Gfroerer JC, 1997, AM J PUBLIC HEALTH, V87, P62, DOI 10.2105/AJPH.87.1.62; Hildebrand M, 2015, SUBST USE MISUSE, V50, P1294, DOI 10.3109/10826084.2014.998238; Hingson RW, 2010, ALCOHOL RES HEALTH, V33, P45; Hingson RW, 2009, J STUD ALCOHOL DRUGS, P12, DOI 10.15288/jsads.2009.s16.12; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; International TC, 2015, INT GUID PRACT US TE; Johnston L. D., 2010, MONITORING FUTURE NA; Kahler CW, 2008, J STUD ALCOHOL DRUGS, V69, P611, DOI 10.15288/jsad.2008.69.611; Kahler CW, 2005, ALCOHOL CLIN EXP RES, V29, P1180, DOI 10.1097/01.ALC.0000171940.95813.A5; Kokotailo PK, 2004, ALCOHOL CLIN EXP RES, V28, P914, DOI 10.1097/01.ALC.0000128239.87611.F5; Kuntsche E, 2004, SOC SCI MED, V59, P113, DOI 10.1016/j.socscimed.2003.10.009; Leichliter JS, 1998, J AM COLL HEALTH, V46, P257, DOI 10.1080/07448489809596001; Maddock JE, 2001, ADDICT BEHAV, V26, P385, DOI 10.1016/S0306-4603(00)00116-7; Mallett KA, 2006, J STUD ALCOHOL, V67, P269, DOI 10.15288/jsa.2006.67.269; Martens MP, 2007, J STUD ALCOHOL DRUGS, V68, P597, DOI 10.15288/jsad.2007.68.597; Martens MP, 2005, MEAS EVAL COUNS DEV, V38, P164, DOI 10.1080/07481756.2005.11909777; Martinotti G, 2016, J HEALTH PSYCHOL; NIAAA, COLL DRINK 2015; OHare T, 1997, J SUBST ABUSE TREAT, V14, P383, DOI 10.1016/S0740-5472(97)00033-0; Paschall MJ, 2002, J STUD ALCOHOL, V63, P447, DOI 10.15288/jsa.2002.63.447; Perkins HW, 2002, J STUD ALCOHOL, P91, DOI 10.15288/jsas.2002.s14.91; Pilatti A, 2014, ADDICT BEHAV, V39, P842, DOI 10.1016/j.addbeh.2014.01.026; Presley C A, 1994, J Am Coll Health, V42, P248; Presley C. A., 1993, USE CONSEQUENCES PER, VI, P1989; Presley CA, 1997, J AM COLL HEALTH, V46, P3, DOI 10.1080/07448489709595580; Read JP, 2007, ADDICT BEHAV, V32, P2597, DOI 10.1016/j.addbeh.2007.06.021; Read JP, 2006, J STUD ALCOHOL, V67, P169, DOI 10.15288/jsa.2006.67.169; Rosiers J, 2014, ONDERZOEK NAAR MIDDE, V3; Rumpf HJ, 2013, EUR ADDICT RES, V19, P121, DOI 10.1159/000342331; Schippers G., 2010, AUDIT NEDERLANDSE VE; Slutske WS, 2004, J ABNORM PSYCHOL, V113, P530, DOI 10.1037/0021-843X.113.4.530; VAD, 2016, RICHTL ALC; Verster JC, 2009, ADDICT BEHAV, V34, P411, DOI 10.1016/j.addbeh.2007.09.013; WECHSLER H, 1994, JAMA-J AM MED ASSOC, V272, P1672, DOI 10.1001/jama.272.21.1672; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2010, ATL SUBST US 2010 RE; Wicki M, 2006, ADDICTION, V101, P522, DOI 10.1111/j.1360-0443.2006.01368.x; Wu M.L, 2010, STRUCTURAL EQUATION	50	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0187876	10.1371/journal.pone.0187876	http://dx.doi.org/10.1371/journal.pone.0187876			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216206	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800014
J	Liu, JY; Summers, D				Liu, Junyan; Summers, David			Indole at low concentration helps exponentially growing Escherichia coli survive at high temperature	PLOS ONE			English	Article							TRYPTOPHANASE OPERON EXPRESSION; INHIBITION; SIGNAL; GENES; ACID; K-12; CONTRIBUTES; MAINTENANCE; RESISTANCE; INDUCTION	A culture of stationary phase Escherichia coli cells has been reported to produce copious indole when exposed to high temperature (50 degrees C), and this response has been proposed to aid survival. We reinvestigated this phenomenon and found that indole production under these conditions is probably not a direct response to heat stress. Rather, E. coli produces indole when growth is prevented, irrespective of whether this is due to heat stress, antibiotic treatment or the removal of nutrients. Moreover, 300 mu M indole produced at 50 degrees C does not improve the viability of heat stressed cells. Interestingly, a much lower concentration of indole (20 mu M) improves the survival of an indole-negative strain (Delta tnaA) when heat stressed during exponential growth. In addition we have shown that the distribution of tryptophanase, the enzyme responsible for indole synthesis, is highly heterogeneous among cells in a population, except during the transition between exponential and stationary phases. The observation that, despite the presence of the tryptophanase, very little indole is produced during early exponential phase suggests that there is post-translational regulation of the enzyme.	[Liu, Junyan; Summers, David] Univ Cambridge, Dept Genet, Cambridge, England	University of Cambridge	Summers, D (corresponding author), Univ Cambridge, Dept Genet, Cambridge, England.	d.summers@gen.cam.ac.uk	liu, junyan/HGV-1505-2022					Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barbosa TM, 2000, J BACTERIOL, V182, P3467, DOI 10.1128/JB.182.12.3467-3474.2000; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Blankenhorn D, 1999, J BACTERIOL, V181, P2209, DOI 10.1128/JB.181.7.2209-2216.1999; Bordi C, 2003, MOL MICROBIOL, V48, P211, DOI 10.1046/j.1365-2958.2003.03428.x; Chant EL, 2007, MOL MICROBIOL, V63, P35, DOI 10.1111/j.1365-2958.2006.05481.x; Chimerel C, 2012, BBA-BIOMEMBRANES, V1818, P1590, DOI 10.1016/j.bbamem.2012.02.022; Darkoh C, 2015, APPL ENVIRON MICROB, V81, P8093, DOI 10.1128/AEM.02787-15; DEELEY MC, 1982, J BACTERIOL, V151, P942, DOI 10.1128/JB.151.2.942-951.1982; Field CM, 2012, PLASMID, V67, P88, DOI 10.1016/j.plasmid.2011.11.004; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Gaimster H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136691; Gaimster H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093168; Gayan E, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01845; Gong F, 2002, J BIOL CHEM, V277, P17095, DOI 10.1074/jbc.M201213200; Gong F, 2001, P NATL ACAD SCI USA, V98, P8997, DOI 10.1073/pnas.171299298; Govers SK, 2017, ENVIRON MICROBIOL, V19, P511, DOI 10.1111/1462-2920.13460; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Hirakawa H, 2010, MICROB PATHOGENESIS, V49, P90, DOI 10.1016/j.micpath.2010.05.002; Hu Y, 2015, ENVIRON MICROBIOL, V17, P1275, DOI 10.1111/1462-2920.12567; Juneja VK, 1997, INT J FOOD MICROBIOL, V35, P231, DOI 10.1016/S0168-1605(96)01237-8; Kim J, 2015, J MICROBIOL, V53, P421, DOI 10.1007/s12275-015-5273-3; Kim J, 2013, MICROBIOL-SGM, V159, P2616, DOI 10.1099/mic.0.070615-0; Kim J, 2013, FEMS MICROBIOL LETT, V343, P89, DOI 10.1111/1574-6968.12135; Kuczynska-Wisnik D, 2015, MICROBIOL-SGM, V161, P786, DOI 10.1099/mic.0.000012; Kwan BW, 2015, BIOTECHNOL BIOENG, V112, P588, DOI 10.1002/bit.25456; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Lee JT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-42; Li G, 2014, MICROBIOL-SGM, V160, P2079, DOI 10.1099/mic.0.080705-0; Li G, 2013, MICROBIOL-SGM, V159, P402, DOI 10.1099/mic.0.064139-0; PATIENT ME, 1993, MOL MICROBIOL, V9, P1089, DOI 10.1111/j.1365-2958.1993.tb01238.x; Stancik LM, 2002, J BACTERIOL, V184, P4246, DOI 10.1128/JB.184.15.4246-4258.2002; STEWART V, 1986, J BACTERIOL, V166, P217, DOI 10.1128/jb.166.1.217-223.1986; STEWART V, 1985, J BACTERIOL, V164, P731, DOI 10.1128/JB.164.2.731-740.1985; Han TH, 2011, RES MICROBIOL, V162, P108, DOI 10.1016/j.resmic.2010.11.005; Tomberlin JK, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600203; vandeVossenberg JLCM, 1995, MOL MICROBIOL, V18, P925, DOI 10.1111/j.1365-2958.1995.18050925.x; Vega NM, 2012, NAT CHEM BIOL, V8, P431, DOI [10.1038/NCHEMBIO.915, 10.1038/nchembio.915]; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126; WOOD WA, 1947, J BIOL CHEM, V170, P313	42	5	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188853	10.1371/journal.pone.0188853	http://dx.doi.org/10.1371/journal.pone.0188853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216232	Green Submitted, Green Published, gold			2022-12-27	WOS:000417337800044
J	Van Nieuwenhuyse, E; Seemann, G; Panfilov, AV; Vandersickel, N				Van Nieuwenhuyse, Enid; Seemann, Gunnar; Panfilov, Alexander V.; Vandersickel, Nele			Effects of early afterdepolarizations on excitation patterns in an accurate model of the human ventricles	PLOS ONE			English	Article							LONG QT SYNDROME; CARDIAC-ARRHYTHMIAS; HUMAN HEART; REPOLARIZATION RESERVE; TRIGGERED ACTIVITY; DE-POINTES; TISSUE; REENTRY; WAVE; SIMULATION	Early Afterdepolarizations, EADs, are defined as the reversal of the action potential before completion of the repolarization phase, which can result in ectopic beats. However, the series of mechanisms of EADs leading to these ectopic beats and related cardiac arrhythmias are not well understood. Therefore, we aimed to investigate the influence of this single cell behavior on the whole heart level. For this study we used a modified version of the Ten Tusscher-Panfilov model of human ventricular cells (TP06) which we implemented in a 3D ventricle model including realistic fiber orientations. To increase the likelihood of EAD formation at the single cell level, we reduced the repolarization reserve (RR) by reducing the rapid delayed rectifier Potassium current and raising the L-type Calcium current. Varying these parameters defined a 2D parametric space where different excitation patterns could be classified. Depending on the initial conditions, by either exciting the ventricles with a spiral formation or burst pacing protocol, we found multiple different spatio-temporal excitation patterns. The spiral formation protocol resulted in the categorization of a stable spiral (S), a meandering spiral (MS), a spiral break-up regime (SB), spiral fibrillation type B (B), spiral fibrillation type A (A) and an oscillatory excitation type (O). The last three patterns are a 3D generalization of previously found patterns in 2D. First, the spiral fibrillation type B showed waves determined by a chaotic bi-excitable regime, i.e. mediated by both Sodium and Calcium waves at the same time and in same tissue settings. In the parameter region governed by the B pattern, single cells were able to repolarize completely and different (spiral) waves chaotically burst into each other without finishing a 360 degree rotation. Second, spiral fibrillation type A patterns consisted of multiple small rotating spirals. Single cells failed to repolarize to the resting membrane potential hence prohibiting the Sodium channel gates to recover. Accordingly, we found that Calcium waves mediated these patterns. Third, a further reduction of the RR resulted in a more exotic parameter regime whereby the individual cells behaved independently as oscillators. The patterns arose due to a phase-shift of different oscillators as disconnection of the cells resulted in continuation of the patterns. For all patterns, we computed realistic 9 lead ECGs by including a torso model. The B and A type pattern exposed the behavior of Ventricular Tachycardia (VT). We conclude that EADs at the single cell level can result in different types of cardiac fibrillation at the tissue and 3D ventricle level.	[Van Nieuwenhuyse, Enid; Panfilov, Alexander V.; Vandersickel, Nele] Univ Ghent, Dept Phys & Astron, Ghent, Belgium; [Seemann, Gunnar] Univ Heart Ctr Freiburg, Inst Expt Cardiovasc Med, Bad Krozingen, Germany; [Seemann, Gunnar] Univ Freiburg, Fac Med, Freiburg, Germany	Ghent University; Universitats Herzzentrum Freiburg; University of Freiburg	Van Nieuwenhuyse, E (corresponding author), Univ Ghent, Dept Phys & Astron, Ghent, Belgium.	enid.vannieuwenhuyse@ugent.be	Vandersickel, Nele/B-2984-2016; Seemann, Gunnar/D-3091-2011; Panfilov, Alexander/G-8459-2016	Seemann, Gunnar/0000-0001-7111-7992; Panfilov, Alexander/0000-0003-2643-642X	Research Foundation Flanders (FWO)	Research Foundation Flanders (FWO)(FWO)	NV received funding from Research Foundation Flanders (FWO).; N. Vandersickel is funded by the Research Foundation Flanders (FWO).	Akar Fadi G, 2001, AM J PHYSL HEART CIR; Auerbach DS, 2011, J PHYSIOL-LONDON, V589, P2363, DOI 10.1113/jphysiol.2010.200576; Boyden Penelope A., 2010, CARDIAC PURKINJE CEL; Bray MA, 2002, IEEE T BIO-MED ENG, V49, P1086, DOI 10.1109/TBME.2002.803516; Bray MA, 2001, AM PHYS SOC; Chang MG, 2013, HEART RHYTHM, V10, P575, DOI 10.1016/j.hrthm.2012.12.017; Chang MG, 2012, HEART RHYTHM, V9, P115, DOI 10.1016/j.hrthm.2011.08.014; Clayton R. H., 2010, PROGR BIOPHYSICS MOL; CRANEFIELD PF, 1977, CIRC RES, V41, P415, DOI 10.1161/01.RES.41.4.415; de Lange E, 2012, BIOPHYS J, V103, P365, DOI 10.1016/j.bpj.2012.06.007; Dessertenne F, 1966, Arch Mal Coeur Vaiss, V59, P263; Fenton F, 1998, CHAOS, V8, P20, DOI 10.1063/1.166311; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Fritz T, 2014, BIOMECH MODEL MECHAN, V13, P627, DOI 10.1007/s10237-013-0523-y; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Glukhov AV, 2010, CIRC RES, V106, P981, DOI 10.1161/CIRCRESAHA.109.204891; Huffaker R, 2004, HEART RHYTHM, V1, P441, DOI 10.1016/j.hrthm.2004.06.005; Huffaker RB, 2007, AM J PHYSIOL-HEART C, V292, pH3089, DOI 10.1152/ajpheart.01309.2006; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Keener JP, 1996, BIOPHYS J, V71, P1335, DOI 10.1016/S0006-3495(96)79333-5; Keldermann RH, 2008, AM J PHYSIOL-HEART C, V294, pH764, DOI 10.1152/ajpheart.00906.2007; Keldermann RH, 2009, AM J PHYSIOL-HEART C, V296, pH370, DOI 10.1152/ajpheart.00952.2008; Keller DUJ, 2012, IEEE T BIO-MED ENG, V59, P311, DOI 10.1109/TBME.2011.2168397; Keller DUJ, 2011, IEEE T BIO-MED ENG, V58, P2109, DOI 10.1109/TBME.2011.2147785; Keller DUJ, 2010, IEEE T BIO-MED ENG, V57, P1568, DOI 10.1109/TBME.2010.2046485; Kim TY, 2015, HEART RHYTHM, V12, P220, DOI 10.1016/j.hrthm.2014.10.003; Kogan BY, 2003, MODELING AND SIMULATION: THEORY AND PRACTICE, P177; Liang P, 2013, CIRCULATION, V127, P1677, DOI 10.1161/CIRCULATIONAHA.113.001883; Liu GX, 2012, J PHYSIOL-LONDON, V590, P1171, DOI 10.1113/jphysiol.2011.218164; Mark-Anthony Bray, 2001, J CARDIOVASCULAR ELE; Morita H, 2008, LANCET, V372, P750, DOI 10.1016/S0140-6736(08)61307-0; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Qu ZL, 2013, CARDIOVASC RES, V99, P6, DOI 10.1093/cvr/cvt104; Richards DF, 2013, COMPUT METHOD BIOMEC, V16, P802, DOI 10.1080/10255842.2013.795556; Roden DM, 2005, J CLIN INVEST, V115, P2025, DOI 10.1172/JCI25539; Sato D, 2009, P NATL ACAD SCI USA, V106, P2983, DOI 10.1073/pnas.0809148106; Scarle S, 2009, MED BIOL ENG COMPUT, V47, P291, DOI 10.1007/s11517-008-0405-0; Sipido KR, 2007, ANN NY ACAD SCI, V1099, P339, DOI 10.1196/annals.1387.066; Taggart P, 2000, J MOL CELL CARDIOL, V32, P621, DOI 10.1006/jmcc.2000.1105; Ten Tusscher KHWJ, 2008, PROG BIOPHYS MOL BIO, V96, P152, DOI 10.1016/j.pbiomolbio.2007.07.026; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; TYSON JJ, 1988, PHYSICA D, V32, P327, DOI 10.1016/0167-2789(88)90062-0; Umapathy Karthikeyan MSK, 2009, CIRCULATION ARRHYTHM; Vandersickel N, 2016, J PHYSIOL-LONDON, V594, P6865, DOI 10.1113/JP271728; Vandersickel N, 2015, HEART RHYTHM, V12, P1088, DOI 10.1016/j.hrthm.2015.01.033; Vandersickel N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084595; Volders PGA, 2000, CARDIOVASC RES, V46, P376, DOI 10.1016/S0008-6363(00)00022-5; Weiss JN, 2010, HEART RHYTHM, V7, P1891, DOI 10.1016/j.hrthm.2010.09.017; Xie YF, 2010, BIOPHYS J, V99, P1408, DOI 10.1016/j.bpj.2010.06.042; ZENG JL, 1995, BIOPHYS J, V68, P949, DOI 10.1016/S0006-3495(95)80271-7; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254; Zimik S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130632	54	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188867	10.1371/journal.pone.0188867	http://dx.doi.org/10.1371/journal.pone.0188867			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216239	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800045
J	Zhao, Q; Zhang, CH; Zhao, Z				Zhao, Qi; Zhang, Chuanhao; Zhao, Zheng			A decoy chain deployment method based on SDN and NFV against penetration attack	PLOS ONE			English	Article							INTRUSION DETECTION	Penetration attacks are one of the most serious network security threats. However, existing network defense technologies do not have the ability to entirely block the penetration behavior of intruders. Therefore, the network needs additional defenses. In this paper, a decoy chain deployment (DCD) method based on SDN+NFV is proposed to address this problem. This method considers about the security status of networks, and deploys decoy chains with the resource constraints. DCD changes the attack surface of the network and makes it difficult for intruders to discern the current state of the network. Simulation experiments and analyses show that DCD can effectively resist penetration attacks by increasing the time cost and complexity of a penetration attack.	[Zhao, Qi] Jilin Univ, Comp Sci & Technol Coll, Changchun, Jilin, Peoples R China; [Zhang, Chuanhao] Railway Police Coll, Dept Publ Secur Technol, Zhengzhou, Henan, Peoples R China; [Zhang, Chuanhao] Natl Digital Switching Syst Engn & Technol R&D Ct, Zhengzhou, Henan, Peoples R China; [Zhao, Zheng] Zhengzhou Sci & Technol Inst, Dept Network Engn, Zhengzhou, Henan, Peoples R China	Jilin University; Railway Police College; PLA Information Engineering University; PLA Information Engineering University	Zhao, Z (corresponding author), Zhengzhou Sci & Technol Inst, Dept Network Engn, Zhengzhou, Henan, Peoples R China.	diyigemsn@hotmail.com			Ministry of Public Security Technical Research Plan [2016JSYJB38]; Scientific and Technological Research Program [172102210441]	Ministry of Public Security Technical Research Plan; Scientific and Technological Research Program	This study was funded by the Ministry of Public Security Technical Research Plan (2016JSYJB38) and the Scientific and Technological Research Program (172102210441) to Chuanhao Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonatos S, 2007, COMPUT NETW, V51, P3471, DOI 10.1016/j.comnet.2007.02.006; Badishi G, 2007, IEEE T DEPEND SECURE, V4, P191, DOI [10.1109/TDSC.2007.70209, 10.1109/TDSC.2007.70209.]; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Butun I, 2014, IEEE COMMUN SURV TUT, V16, P266, DOI 10.1109/SURV.2013.050113.00191; Carvalho M, 2014, IEEE SECUR PRIV, V12, P73, DOI 10.1109/MSP.2014.30; Chen PJ, 2015, INT CARN CONF SECU, P141, DOI 10.1109/CCST.2015.7389672; Clark A, 2015, GAME THEORETIC APPRO, P3; Clark A. L., 2013, DEC CONTR CDC 2013 I, V11, P10; Duan Q, 2013, IEEE CONF COMM NETW, P260, DOI 10.1109/CNS.2013.6682715; Falliere N., 2011, SECURITY RESPONSE, V5, P6; Fang I, 2015, ALPHABET INTERNET ME; Han WY, 2016, SDN-NFV SECURITY'16: PROCEEDINGS OF THE 2016 ACM INTERNATIONAL WORKSHOP ON SECURITY IN SOFTWARE DEFINED NETWORKS & NETWORK FUNCTION VIRTUALIZATION, P1, DOI 10.1145/2876019.2876022; Huang H., 2017, IEEE T CLOUD COMPUTI; Huang HW, 2017, CONCURR COMP-PRACT E, V29, DOI 10.1002/cpe.3967; ISG N, 2013, NETW FUNCT VIRT NFV; Jafarian Jafar Haadi, 2013, Computer Security - ESORICS 2013. 18th European Symposium on Research in Computer Security. Proceedings: LNCS 8134, P237, DOI 10.1007/978-3-642-40203-6_14; Jafarian J. H., 2012, P 1 WORKSH HOT TOP S, P127, DOI DOI 10.1145/2342441.2342467; Jajodia S., 2013, ADV INFORM SECURITY, V100, P203; Khan S, 2016, J NETW COMPUT APPL, V66, P214, DOI 10.1016/j.jnca.2016.03.005; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kumar A., 2015, IITM J MANAGEMENT IT, V6, P44; Kuwatly I, 2004, IEEE/ACS INTERNATIONAL CONFERENCE ON PERVASIVE SERVICES, PROCEEDINGS, P95, DOI 10.1109/PERSER.2004.3; Linn M. C., 2005, INTERNET ENV SCI ED; McKeown N, 2009, INFOCOM KEYNOTE TALK, V17, P30; Mcknight LW, 1997, INTERNET EC, V49, P569; Medina A., 2000, BRITE FLEXIBLE GENER; Mell P, 2006, IEEE SECUR PRIV, V4, P85, DOI 10.1109/MSP.2006.145; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Modi C, 2013, J NETW COMPUT APPL, V36, P42, DOI 10.1016/j.jnca.2012.05.003; Portokalidis G., 2006, ACM SIGOPS OPERATING, V40, P15; Shakarian P, 2014, E BUSINESS TELECOMMU, P191; Smith R, 2008, LECT NOTES ARTIF INT, V5032, P308; Spitzner L., 2003, IEEE Security & Privacy, V1, P15, DOI 10.1109/MSECP.2003.1193207; Spitzner L., 2002, HONEYTOKENS OTHER HO; Spitzner L., 2003, HONEYPOTS TRACKING H; Tang Yong, 2007, Journal of Chinese Computer Systems, V28, P1345; Ujcich BE, 2015, IRMA VIA SDN INTRUSI; Wagener G, 2011, IFIP IEEE INT S INT, P345; Wang H, 2005, IEEE T KNOWL DATA EN, V17, P425, DOI 10.1109/TKDE.2005.35; Wang HX, 2014, COMPUT COMMUN, V46, P10, DOI 10.1016/j.comcom.2014.03.009; Wang LY, 2008, LECT NOTES COMPUT SC, V5094, P283; Wang W, 2008, ACM T INFORM SYST SE, V12, DOI 10.1145/1410234.1410238; Xiang Y, 2011, IEEE T INF FOREN SEC, V6, P426, DOI 10.1109/TIFS.2011.2107320; Xiang Y, 2009, IEEE T PARALL DISTR, V20, P567, DOI 10.1109/TPDS.2008.132; Zheng WW, 2016, IEEE ICC, P138, DOI 10.1109/ICC.2016.7510682; Zheng Zhao, 2016, Mathematical Problems in Engineering, V2016, DOI 10.1155/2016/8927169; Zuech R., 2015, J BIG DATA, V2, P3, DOI DOI 10.1186/S40537-015-0013-4	47	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189095	10.1371/journal.pone.0189095	http://dx.doi.org/10.1371/journal.pone.0189095			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216257	gold, Green Published, Green Submitted			2022-12-27	WOS:000417337800070
J	Amoakoh-Coleman, M; Ogum-Alangea, D; Modey-Amoah, E; Ntumy, MY; Adanu, RM; Oppong, SA				Amoakoh-Coleman, Mary; Ogum-Alangea, Deda; Modey-Amoah, Emefa; Ntumy, Michael Yao; Adanu, Richard M.; Oppong, Samuel A.			Blood pressure patterns and body mass index status in pregnancy: An assessment among women reporting for antenatal care at the Korle-Bu Teaching hospital, Ghana	PLOS ONE			English	Article							RISK-FACTORS; WEIGHT-GAIN; OBESITY; PREECLAMPSIA; OVERWEIGHT; OUTCOMES; BOOKING	Background Maternal obesity in pregnancy has been linked with increased risk of pregnancy induced hypertension (PIH). In some tertiary referral hospitals in Ghana, PIH is the leading cause of institutional maternal mortality. Objective To evaluate blood pressure changes during pregnancy amongst different body mass index (BMI) groups and how this relates to the risk of developing PIH. Methods Women who had a dating ultrasound before 20 weeks gestation and registering for antenatal care at the Korle-Bu Teaching Hospital in Accra, between February and December 2013 and met the inclusion criteria were recruited into a cohort study. BMI was assessed at baseline. Blood pressure measurements were taken at (+/- 2) 24, 28 and 36 weeks. Primary outcome measure of interest during follow-up was a diagnosis of PIH at these points. BP changes during follow up at the three points were measured. Descriptive analysis of baseline factors was carried out and compared for the BMI groups. Relative risk (RR) of PIH was estimated at 95% confidence interval. Results Mean (SD) age for the 361 women was 30.9 (4.8) years. Incidence of PIH amongst the cohort was 10.5% (95% CI: 7.45% - 14.45%) and 40.4% and 33.0% of them were overweight and obese respectively at baseline. Pregnant women who were obese at baseline had a three-fold increased risk of PIH compared to those with normal BMI [RR = 3.01 (1.06-8.52), p = 0.04]. Conclusion Obese women have a significantly increased risk of PIH. Women should be screened at booking for obesity status. Antenatal protocols should have interventions for prevention or early detection of obesity and management of obesity to improve outcomes.	[Amoakoh-Coleman, Mary] Univ Ghana, Dept Epidemiol, Noguchi Mem Inst Med Res, Legon, Ghana; [Amoakoh-Coleman, Mary] Univ Ghana, Dept Epidemiol & Dis Control, Sch Publ Hlth, Legon, Ghana; [Amoakoh-Coleman, Mary] Univ Med Ctr, Julius Global Hlth, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Ogum-Alangea, Deda; Modey-Amoah, Emefa; Adanu, Richard M.] Univ Ghana, Dept Populat Family & Reprod Hlth, Sch Publ Hlth, Legon, Ghana; [Ntumy, Michael Yao; Oppong, Samuel A.] Univ Ghana, Dept Obstet & Gynecol, Sch Med & Dent, Accra, Ghana	University of Ghana; University of Ghana; Utrecht University; Utrecht University Medical Center; University of Ghana; University of Ghana	Oppong, SA (corresponding author), Univ Ghana, Dept Obstet & Gynecol, Sch Med & Dent, Accra, Ghana.	wak72@yahoo.com	Alangea, Deda Ogum/AAB-3257-2020	Alangea, Deda Ogum/0000-0001-7496-8514; Modey, Emefa Judith/0000-0002-9116-462X	Fogarty International Centre, Chronic Diseases (NCD-LIFESPAN) Programme, through the Cardiovascular Research Training (CaRT) Institute, Accra, Ghana	Fogarty International Centre, Chronic Diseases (NCD-LIFESPAN) Programme, through the Cardiovascular Research Training (CaRT) Institute, Accra, Ghana	The study was funded by the Fogarty International Centre, Chronic Diseases (NCD-LIFESPAN) Programme, through the Cardiovascular Research Training (CaRT) Institute, Accra, Ghana. The funder have no role in data collection, analysis of results, data interpretation and the final decision to submit this manuscript.	Addo V N, 2010, Ghana Med J, V44, P64; Adu-Bonsaffoh K, MATERNAL DEATHS ATTR; Agyemang C, 2009, PUBLIC HEALTH NUTR, V12, P909, DOI 10.1017/S1368980008003510; Amoah AGB, 2003, PUBLIC HEALTH NUTR, V6, P751, DOI 10.1079/PHN2003506; Athukorala C, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-56; Baeten JM, 2001, AM J PUBLIC HEALTH, V91, P436, DOI 10.2105/AJPH.91.3.436; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Biritwum Rb, 2005, Ghana Med J, V39, P82; Conde-Agudelo A, 2000, BRIT J OBSTET GYNAEC, V107, P75, DOI 10.1111/j.1471-0528.2000.tb11582.x; Conklin AI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150736; de-Graft Aikins Ama, 2007, Ghana Med J, V41, P154; Der E M, 2013, Ghana Med J, V47, P158; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Ehrenthal DB, 2011, J WOMENS HEALTH, V20, P67, DOI 10.1089/jwh.2010.1970; Ghana Statistical Service, 2011, GHAN DEM HLTH SURV 2; Ghana Statistical Service Noguchi Memorial Institute for Medical Research & ORC Macro., 2004, DEM HLTH SURV 2003; Jeremiah Israel NSACAN, 2011, J MED MED SCI, V2, P1152; Kanagalingam MG, 2005, BJOG-INT J OBSTET GY, V112, P1431, DOI 10.1111/j.1471-0528.2005.00685.x; Kongubol A, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-59; Lee QY, MATERNAL MORTALITY G; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; Lord J, 2007, BJOG-INT J OBSTET GY, V114, P236, DOI 10.1111/j.1471-0528.2006.01199.x; Measure DHS, 2008, GHAN DEM HLTH SURV 2; Measure DHS. Ghana Statistical Service-GSS Ghana Health Service-GHS and ICF International, 2015, GHANA DEMOGRAPHIC HL; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Muti M, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0110-5; Nohr EA, PREPREGNANCY OBESITY; Nour Nawal M, 2008, Rev Obstet Gynecol, V1, P77; Reynolds RM, 2010, J CLIN ENDOCR METAB, V95, P5365, DOI 10.1210/jc.2010-0697; Satpathy HK, 1941, MATERNAL OBESITY PRE; Savitri AI, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011626; Soni-Trinidad CF, MATERNAL MORBIDITY M; Stringhini S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3589-5; Tsukamoto H, 2007, EUR J OBSTET GYN R B, V133, P53, DOI 10.1016/j.ejogrb.2006.07.031; van Middendorp D, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-59; Ziraba AK, 2009, BMC HEALTH SERV RES, V9, DOI [10.1186/1471-2458-9-465, 10.1186/1472-6963-9-46]	36	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188671	10.1371/journal.pone.0188671	http://dx.doi.org/10.1371/journal.pone.0188671			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211781	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200042
J	Cattaneo, ER; Prieto, ED; Garcia-Fabiani, MB; Montanaro, MA; Guillou, H; Gonzalez-Baro, MR				Cattaneo, Elizabeth R.; Prieto, Eduardo D.; Garcia-Fabiani, Maria B.; Montanaro, Mauro A.; Guillou, Herve; Gonzalez-Baro, Maria R.			Glycerol-3-phosphate acyltransferase 2 expression modulates cell roughness and membrane permeability: An atomic force microscopy study	PLOS ONE			English	Article							ARACHIDONIC-ACID; CANCER CELLS; VISCOELASTICITY; DISCRIMINATION; FIXATION	In mammalian cells, de novo glycerolipid synthesis begins with the acylation of glycerol-3-phosphate, catalyzed by glycerol-3-phosphate acyltransferases (GPAT). GPAT2 is a mitochondrial isoform primarily expressed in testis under physiological conditions, and overexpressed in several types of cancers and cancer-derived human cell lines where its expression contributes to the tumor phenotype. Using gene silencing and atomic force microscopy, we studied the correlation between GPAT2 expression and cell surface topography, roughness and membrane permeability in MDA-MB-231 cells. In addition, we analyzed the glycerolipid composition by gas-liquid chromatography. GPAT2 expression altered the arachidonic acid content in glycerolipids, and the lack of GPAT2 seems to be partially compensated by the overexpression of another arachidonic-acid-metabolizing enzyme, AGPAT11. GPAT2 expressing cells exhibited a rougher topography and less membrane damage than GPAT2 silenced cells. Pore-like structures were present only in GPAT2 subexpressing cells, correlating with higher membrane damage evidenced by lactate dehydrogenase release. These GPAT2-induced changes are consistent with its proposed function as a tumor-promoting gene, and might be used as a phenotypic differentiation marker. AFM provides the basis for the identification and quantification of those changes, and demonstrates the utility of this technique in the study of cancer cell biology.	[Cattaneo, Elizabeth R.; Garcia-Fabiani, Maria B.; Montanaro, Mauro A.; Gonzalez-Baro, Maria R.] Univ Nacl La Plata, Fac Ciencias Med, CONICET, Inst Invest Bioquim La Plata Rodolfo R Brenner, La Plata, Buenos Aires, Argentina; [Prieto, Eduardo D.] Inst Invest Fis Quim Teor & Aplicadas INIFTA, La Plata, Buenos Aires, Argentina; [Guillou, Herve] Univ Toulouse, Toxalim, INRA, ENVT,INP Purpan,UPS, Toulouse, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; INIFTA; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Toulouse III - Paul Sabatier	Gonzalez-Baro, MR (corresponding author), Univ Nacl La Plata, Fac Ciencias Med, CONICET, Inst Invest Bioquim La Plata Rodolfo R Brenner, La Plata, Buenos Aires, Argentina.	mgbaro@med.unlp.edu.ar	Guillou, Herve/AAG-2826-2020; Guillou, Hervé/AGL-0750-2022	Guillou, Herve/0000-0002-5363-9081; Guillou, Hervé/0000-0002-5363-9081; Gonzalez-Baro, Maria R./0000-0002-6778-284X	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [PICT2014-3214]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [PIP20013-0310]; Universidad Nacional de La Plata [M202]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de La Plata(National University of La Plata)	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina-PICT2014-3214 (MRGB), http:/www.agencia.mincyt.gob.ar/frontend/agencia/convocatoria/304; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina. PIP20013-0310 (MRGB), http://proyectosinv.concet.gov.ar/; Universidad Nacional de La Plata M202 (MRGB), http://secyt.presi.unlp.edu.ar/Wordpress/?p=5090. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MODERN RES ED TOPICS; Atilla-Gokcumen GE, 2014, CELL, V156, P428, DOI 10.1016/j.cell.2013.12.015; Berdyyeva T, 2005, ULTRAMICROSCOPY, V102, P189, DOI 10.1016/j.ultramic.2004.09.008; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Canetta E, 2014, ACTA BIOMATER, V10, P2043, DOI 10.1016/j.actbio.2013.12.057; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Cattaneo ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042986; Cheng Yan-Ho, 2011, Spermatogenesis, V1, P209, DOI 10.4161/spmg.1.3.17990; Cho SJ, 2002, CELL BIOL INT, V26, P35, DOI 10.1006/cbir.2001.0849; Corsetto PA, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-73; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Fonteh AN, 2001, J BIOL CHEM, V276, P1439, DOI 10.1074/jbc.M006551200; Francis LW, 2010, BIOL CELL, V102, P133, DOI 10.1042/BC20090127; Francis LW, 2009, BIOL CELL, V101, P481, DOI 10.1042/BC20080189; Garcia-Fabiani MB, 2015, BIOCHEM J, V471, P211, DOI 10.1042/BJ20150730; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Girasole M, 2007, BBA-BIOMEMBRANES, V1768, P1268, DOI 10.1016/j.bbamem.2007.01.014; Girasole M, 2003, AIP C P, V696, P467; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Jaureguiberry MS, 2010, J MEMBRANE BIOL, V234, P183, DOI 10.1007/s00232-010-9245-6; Kaul-Ghanekar R, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-350; Kronlage C, 2015, BIOPHYS J, V109, P687, DOI 10.1016/j.bpj.2015.06.066; Lara-Cruz C, 2016, INT J NANOMED, V11, P5149, DOI 10.2147/IJN.S108768; Lara-Cruz C, 2008, 9 C NAC MICR AS MEX; Layton BE, 2004, BIOTECHNIQUES, V37, P564, DOI 10.2144/04374BI01; Lekka M, 2012, NAT NANOTECHNOL, V7, P691, DOI 10.1038/nnano.2012.196; Li M, 2016, BIONANOSCIENCE, V6, P22, DOI 10.1007/s12668-015-0180-y; Moloney M, 2004, ULTRAMICROSCOPY, V100, P153, DOI 10.1016/j.ultramic.2003.12.010; Pellon-Maison M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100896; Perez R, 2006, J LIPID RES, V47, P484, DOI 10.1194/jlr.M500397-JLR200; Perez-Chacon G, 2010, J IMMUNOL, V184, P1071, DOI 10.4049/jimmunol.0902257; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Peter A, 2008, AM J PHYSIOL-ENDOC M, V295, pE339, DOI 10.1152/ajpendo.00022.2008; Ricci D., 2004, METH MOL B, V242, P25; Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Sokolov I, 2007, CANCER NANOTECHNOL, V1, P1; Wang JY, 2009, BIOSENS BIOELECTRON, V25, P721, DOI 10.1016/j.bios.2009.08.011; Wang YH, 2016, SCANNING, V38, P558, DOI 10.1002/sca.21300; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Weyn B, 1998, J MICROSC-OXFORD, V189, P172, DOI 10.1046/j.1365-2818.1998.00299.x; Whitehurst AW, 2014, ANNU REV PHARMACOL, V54, P251, DOI 10.1146/annurev-pharmtox-011112-140326; Wolf Leslie A., 1999, Cell Biochemistry and Biophysics, V30, P353, DOI 10.1007/BF02738119; Yeow N., 2017, ADV COLLOID INTERFAC	44	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189031	10.1371/journal.pone.0189031	http://dx.doi.org/10.1371/journal.pone.0189031			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211789	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200058
J	Daga, FB; Diniz, A; Boer, ER; Gracitelli, CPB; Abe, RY; Medeiros, FA				Daga, Fablo B.; Diniz-Filho, Alberto; Boer, Erwin R.; Gracitelli, Carolina P. B.; Abe, Ricardo Y.; Medeiros, Felipe A.			Fear of falling and postural reactivity in patients with glaucoma	PLOS ONE			English	Article							RISK-FACTORS; OLDER-ADULTS; VISUAL IMPAIRMENT; MOTION PERCEPTION; ELDERLY-PATIENTS; ASSOCIATION; PERFORMANCE; MOBILITY; VISION	Purpose To investigate the relationship between postural metrics obtained by dynamic visual stimulation in a virtual reality environment and the presence of fear of falling in glaucoma patients. Methods This cross-sectional study included 35 glaucoma patients and 26 controls that underwent evaluation of postural balance by a force platform during presentation of static and dynamic visual stimuli with head-mounted goggles (Oculus Rift). In dynamic condition, a peripheral translational stimulus was used to induce vection and assess postural reactivity. Standard deviations of torque moments (SDTM) were calculated as indicative of postural stability. Fear of falling was assessed by a standardized questionnaire. The relationship between a summary score of fear of falling and postural metrics was investigated using linear regression models, adjusting for potentially confounding factors. Results Subjects with glaucoma reported greater fear of falling compared to controls (-0.21 vs. 0.27; P = 0.039). In glaucoma patients, postural metrics during dynamic visual stimulus were more associated with fear of falling (R-2 = 18.8%; P = 0.001) than static (R-2 = 3.0%; P = 0.005) and dark field (R-2 = 5.7%; P = 0.007) conditions. In the univariable model, fear of falling was not significantly associated with binocular standard perimetry mean sensitivity (P = 0.855). In the multivariable model, each 1 Nm larger SDTM in anteroposterior direction during dynamic stimulus was associated with a worsening of 0.42 units in the fear of falling questionnaire score (P = 0.001). Conclusion In glaucoma patients, postural reactivity to a dynamic visual stimulus using a virtual reality environment was more strongly associated with fear of falling than visual field testing and traditional balance assessment.	[Daga, Fablo B.; Medeiros, Felipe A.] Duke Univ, Duke Eye Ctr, Durham, NC 27708 USA; [Daga, Fablo B.; Medeiros, Felipe A.] Duke Univ, Dept Ophthalmol, Durham, NC 27708 USA; [Daga, Fablo B.; Gracitelli, Carolina P. B.] Univ Fed Sao Paulo, Dept Ophthalmol & Vis Sci, Sao Paulo, Brazil; [Daga, Fablo B.; Diniz-Filho, Alberto; Boer, Erwin R.; Gracitelli, Carolina P. B.; Abe, Ricardo Y.; Medeiros, Felipe A.] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA	Duke University; Duke University; Universidade Federal de Sao Paulo (UNIFESP); University of California System; University of California San Diego	Medeiros, FA (corresponding author), Duke Univ, Duke Eye Ctr, Durham, NC 27708 USA.; Medeiros, FA (corresponding author), Duke Univ, Dept Ophthalmol, Durham, NC 27708 USA.; Medeiros, FA (corresponding author), Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA.	felipe.medeiros@duke.edu	; Diniz-Filho, Alberto/C-8564-2015	Abe, Ricardo/0000-0002-7023-2144; Diniz-Filho, Alberto/0000-0002-0371-2359	National Institutes of Health/National Eye Institute [EY021818]; Brazilian National Council for Scientific and Technological Development (CNPq) [233829/2014-8]; Alcon Laboratories (Fort Worth, TX); Bausch & Lomb (Garden City, NY); Carl Zeiss Meditec (Jena, Germany); Heidelberg Engineering (Heidelberg, Germany); Merck (White House Station, NJ); Allergan (Irvine, CA); Sensimed (Lausanne, Switzerland); Topcon (Livermore, CA); Reichert (Dewey, NY); National Eye Institute (Bethesda, MD); Novartis (Basel, Switzerland); nGoggle (San Diego, CA)	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Alcon Laboratories (Fort Worth, TX); Bausch & Lomb (Garden City, NY); Carl Zeiss Meditec (Jena, Germany); Heidelberg Engineering (Heidelberg, Germany); Merck (White House Station, NJ)(Merck & Company); Allergan (Irvine, CA)(AbbVieAllergan); Sensimed (Lausanne, Switzerland); Topcon (Livermore, CA); Reichert (Dewey, NY); National Eye Institute (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Novartis (Basel, Switzerland); nGoggle (San Diego, CA)	National Institutes of Health/National Eye Institute grant EY021818 (F.A.M), fellowship grant from Brazilian National Council for Scientific and Technological Development (CNPq) 233829/2014-8 (A.D.F.). Financial support FAM: Alcon Laboratories (Fort Worth, TX), Bausch & Lomb (Garden City, NY), Carl Zeiss Meditec (Jena, Germany), Heidelberg Engineering (Heidelberg, Germany), Merck (White House Station, NJ), Allergan (Irvine, CA), Sensimed (Lausanne, Switzerland), Topcon (Livermore, CA), Reichert (Dewey, NY), National Eye Institute (Bethesda, MD); Research support Alcon Laboratories (Fort Worth, TX), Allergan (Irvine, CA), Carl Zeiss Meditec (Jena, Germany), Reichert (Dewey, NY); Consultant Allergan (Irvine, CA), Carl-Zeiss Meditec, (Jena, Germany), Novartis (Basel, Switzerland), nGoggle (San Diego, CA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berencsi A, 2005, HUM MOVEMENT SCI, V24, P689, DOI 10.1016/j.humov.2005.10.014; Black AA, 2011, OPTOMETRY VISION SCI, V88, P1275, DOI 10.1097/OPX.0b013e31822f4d6a; Boer ER, 2015, INVESTIGATIVE OPHTHA, V56; Caldwell G., 2004, RES METHODS BIOMECHA, P73; CAMPBELL A J, 1981, Age and Ageing, V10, P264, DOI 10.1093/ageing/10.4.264; Coleman AL, 2004, OPHTHALMOLOGY, V111, P857, DOI 10.1016/j.ophtha.2003.09.033; Diniz A, 2015, OPHTHALMOLOGY, V122, P1131, DOI 10.1016/j.ophtha.2015.02.010; Friedman SM, 2002, J AM GERIATR SOC, V50, P1329, DOI 10.1046/j.1532-5415.2002.50352.x; GLYNN RJ, 1991, ARCH OPHTHALMOL-CHIC, V109, P205, DOI 10.1001/archopht.1991.01080020051041; Habak C, 2002, VISION RES, V42, P2843, DOI 10.1016/S0042-6989(02)00355-3; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; Karwatsky P, 2006, OPTOMETRY VISION SCI, V83, P466, DOI 10.1097/01.opx.0000225107.38719.0d; Klein BEK, 2003, OPHTHALMOLOGY, V110, P644, DOI 10.1016/S0161-6420(02)01935-8; Lach HW, 2005, PUBLIC HEALTH NURS, V22, P45, DOI 10.1111/j.0737-1209.2005.22107.x; Lamoreux EL, 2008, INVEST OPHTH VIS SCI, V49, P528, DOI 10.1167/iovs.07-1036; Lawson SN, 2013, PHYSIOTHER CAN, V65, P31, DOI 10.3138/ptc.2011-17; MAKI BE, 1991, J GERONTOL, V46, pM123, DOI 10.1093/geronj/46.4.M123; Nelson-Quigg JM, 2000, INVEST OPHTH VIS SCI, V41, P2212; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; NICKENS H, 1985, ARCH INTERN MED, V145, P1089, DOI 10.1001/archinte.145.6.1089; Peterka R J, 1990, J Vestib Res, V1, P73; Peterka R J, 1990, J Vestib Res, V1, P87; Piponnier JC, 2009, J VISION, V9, DOI 10.1167/9.1.13; PREVIC FH, 1993, PERCEPT PSYCHOPHYS, V54, P93, DOI 10.3758/BF03206941; Ramulu PY, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.037; RING C, 1988, ARCH PHYS MED REHAB, V69, P261; Scheffer AC, 2008, AGE AGEING, V37, P19, DOI 10.1093/ageing/afm169; Shabana N, 2003, SURV OPHTHALMOL, V48, P92, DOI 10.1016/S0039-6257(02)00401-0; Suzuki Mizue, 2002, Nurs Health Sci, V4, P155, DOI 10.1046/j.1442-2018.2002.00123.x; Tanabe S, 2012, CLIN OPHTHALMOL, V6, P327, DOI 10.2147/OPTH.S28281; TINETTI ME, 1993, J GERONTOL, V48, P35, DOI 10.1093/geronj/48.Special_Issue.35; TINETTI ME, 1986, AM J MED, V80, P429, DOI 10.1016/0002-9343(86)90717-5; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; TOBIS JS, 1985, J AM GERIATR SOC, V33, P330, DOI 10.1111/j.1532-5415.1985.tb07132.x; Turano KA, 1999, INVEST OPHTH VIS SCI, V40, P2803; Vellas BJ, 1997, AGE AGEING, V26, P189, DOI 10.1093/ageing/26.3.189; Velozo CA, 2001, AM J PHYS MED REHAB, V80, P662, DOI 10.1097/00002060-200109000-00006; Wang MY, 2012, INVEST OPHTH VIS SCI, V53, P7967, DOI 10.1167/iovs.12-10701; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Wood JM, 2011, INVEST OPHTH VIS SCI, V52, P5088, DOI 10.1167/iovs.10-6644; Yuki K, 2013, INVEST OPHTH VIS SCI, V54, P7739, DOI 10.1167/iovs.13-12079	41	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187220	10.1371/journal.pone.0187220	http://dx.doi.org/10.1371/journal.pone.0187220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211742	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200013
J	Saison-Ridinger, M; DelGiorno, KE; Zhang, TJ; Kraus, A; French, R; Jaquish, D; Tsui, C; Erikson, G; Spike, BT; Shokhirev, MN; Liddle, C; Yu, RT; Downes, M; Evans, RM; Saghatelian, A; Lowy, AM; Wahl, GM				Saison-Ridinger, Maya; DelGiorno, Kathleen E.; Zhang, Tejia; Kraus, Annabelle; French, Randall; Jaquish, Dawn; Tsui, Crystal; Erikson, Galina; Spike, Benjamin T.; Shokhirev, Maxim N.; Liddle, Christopher; Yu, Ruth T.; Downes, Michael; Evans, Ronald M.; Saghatelian, Alan; Lowy, Andrew M.; Wahl, Geoffrey M.			Reprogramming pancreatic stellate cells via p53 activation: A putative target for pancreatic cancer therapy	PLOS ONE			English	Article							GENETIC ALTERATIONS; TUMOR-GROWTH; VITAMIN-D; FIBROBLASTS; STROMA; MICROENVIRONMENT; BREAST; IDENTIFICATION; SUPPRESSION; MUTATIONS	Pancreatic ductal adenocarcinoma (PDAC) is characterized by an extremely dense fibrotic stroma, which contributes to tumor growth, metastasis, and drug resistance. During tumorigenesis, quiescent pancreatic stellate cells (PSCs) are activated and become major contributors to fibrosis, by increasing growth factor signaling and extracellular matrix deposition. The p53 tumor suppressor is known to restrict tumor initiation and progression through cell autonomous mechanisms including apoptosis, cell cycle arrest, and senescence. There is growing evidence that stromal p53 also exerts anti-tumor activity by paracrine mechanisms, though a role for stromal p53 in PDAC has not yet been described. Here, we demonstrate that activation of stromal p53 exerts anti-tumor effects in PDAC. We show that primary cancer-associated PSCs (caPSCs) isolated from human PDAC express wild-type p53, which can be activated by the Mdm2 antagonist Nutlin-3a. Our work reveals that p53 acts as a major regulator of PSC activation and as a modulator of PDAC fibrosis. In vitro, p53 activation by Nutlin-3a induces profound transcriptional changes, which reprogram activated PSCs to quiescence. Using immunofluorescence and lipidomics, we have also found that p53 activation induces lipid droplet accumulation in both normal and tumor-associated fibroblasts, revealing a previously undescribed role for p53 in lipid storage. In vivo, treatment of tumor-bearing mice with the clinical form of Nutlin-3a induces stromal p53 activation, reverses caPSCs activation, and decreases fibrosis. All together our work uncovers new functions for stromal p53 in PDAC.	[Saison-Ridinger, Maya; DelGiorno, Kathleen E.; Kraus, Annabelle; Tsui, Crystal; Yu, Ruth T.; Downes, Michael; Evans, Ronald M.; Wahl, Geoffrey M.] Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Zhang, Tejia; Saghatelian, Alan] Salk Inst Biol Studies, Clayton Fdn Peptide Biol Lab, Helmsley Ctr Genom Med, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [French, Randall; Jaquish, Dawn; Lowy, Andrew M.] Univ Calif San Diego, Dept Surg, Div Surg Oncol, Moores Canc Ctr, La Jolla, CA 92093 USA; [Erikson, Galina; Shokhirev, Maxim N.] Salk Inst Biol Studies, Integrat Genom & Bioinformat Core, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Spike, Benjamin T.] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT USA; [Liddle, Christopher] Univ Sydney, Westmead Hosp, Storr Liver Ctr, Westmead Inst Med Res, Westmead, NSW, Australia; [Liddle, Christopher] Univ Sydney, Westmead Hosp, Sydney Med Sch, Westmead, NSW, Australia	Salk Institute; Salk Institute; University of California System; University of California San Diego; Salk Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Sydney; Westmead Institute for Medical Research; University of Sydney	Wahl, GM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wahl@salk.edu	DelGiorno, Kathy/AAJ-9911-2021; Evans, Ronald/AAF-4001-2019	DelGiorno, Kathy/0000-0002-5749-8394; Evans, Ronald/0000-0002-9986-5965; Yu, Ruth/0000-0002-9527-9627	San Diego NCI Cancer Centers Council [PTC2014]; NIH [CA155620, CA014195]; Leona M. and Harry B Helmsley Charitable Trust [2012-PG-MED002]; Lustgarten Foundation; Stand Up to Cancer Dream Team Translational Cancer Research grant [SU2C-AACR-DT0509, SU2C-AACR-DT2016]; Freeberg Foundation; Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals; Salk Alumni Faculty fellowship; Helmsley Charitable Trust; Salk Women and Science award; NCI Cancer Center Support Grant [CA014195]; NATIONAL CANCER INSTITUTE [P30CA014195, R01CA155620, T32CA009370] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG008962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978, R24DK090962] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021815] Funding Source: NIH RePORTER	San Diego NCI Cancer Centers Council; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B Helmsley Charitable Trust; Lustgarten Foundation; Stand Up to Cancer Dream Team Translational Cancer Research grant; Freeberg Foundation; Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals(Ferring Pharmaceuticals); Salk Alumni Faculty fellowship; Helmsley Charitable Trust; Salk Women and Science award; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the San Diego NCI Cancer Centers Council (#PTC2014 to G. M.W and A.M.L), NIH grants (CA155620 to A.M.L, CA014195 to R.M.E), the Leona M. and Harry B Helmsley Charitable Trust grant (2012-PG-MED002 to G.M.W and R.M.E), the Lustgarten Foundation (to R.M.E), Stand Up to Cancer Dream Team Translational Cancer Research grant (SU2C-AACR-DT0509 to G.M.W and R.M.E and SU2C-AACR-DT2016 to R.M.E), the Freeberg Foundation (to G.M.W) and Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals (to A.S.). M.S.R was partly supported by the Salk Alumni Faculty fellowship, the Helmsley Charitable Trust and the Salk Women and Science award. This study was also supported by the following Salk core facilities and their staff: the Advanced Biophotonics, Flow Cytometry, Functional Genomics, Integrative Genomics and Bioinformatics (G.E and M.N.S), Next Generation Sequencing and Mass Spectrometry Cores. Salk cores are supported by the NCI Cancer Center Support Grant P30 (CA014195) and the Helmsley Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi Y, 2010, CANCER RES, V70, P9650, DOI 10.1158/0008-5472.CAN-10-1146; Apte MV, 2015, PANCREATOLOGY, V15, pS32, DOI 10.1016/j.pan.2015.02.013; Apte MV, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00344; Assaily W, 2011, MOL CELL, V44, P491, DOI 10.1016/j.molcel.2011.08.038; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bar J, 2009, ONCOGENE, V28, P933, DOI 10.1038/onc.2008.445; Bar J, 2010, SEMIN CELL DEV BIOL, V21, P47, DOI 10.1016/j.semcdb.2009.11.006; Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006; Blachnio-Zabielska AU, 2013, J LIPID RES, V54, P1705, DOI 10.1194/jlr.D035006; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boren J, 2012, CELL DEATH DIFFER, V19, P1561, DOI 10.1038/cdd.2012.34; Campbell I, 2009, CANCER RES, V69, P6769; Campbell I, 2009, CANCER RES, V69, P6765, DOI 10.1158/0008-5472.CAN-08-4253; Chai MG, 2013, JOVE-J VIS EXP, DOI 10.3791/50395; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Davis TA, 2011, CHEM SCI, V2, P1076, DOI 10.1039/c1sc00061f; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Erkan M, 2012, NAT REV GASTRO HEPAT, V9, P454, DOI 10.1038/nrgastro.2012.115; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Froeling FEM, 2011, GASTROENTEROLOGY, V141, P1486, DOI 10.1053/j.gastro.2011.06.047; Fukino K, 2007, JAMA-J AM MED ASSOC, V297, P2103, DOI 10.1001/jama.297.19.2103; Gao ZJ, 2010, PANCREATOLOGY, V10, P186, DOI 10.1159/000236012; Hamada S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00318; He XY, 2015, CELL REP, V13, P888, DOI 10.1016/j.celrep.2015.09.045; Herreros-Villanueva M, 2012, WORLD J GASTROENTERO, V18, P1286, DOI 10.3748/wjg.v18.i12.1286; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jacobetz MA, 2013, GUT, V62, P112, DOI 10.1136/gutjnl-2012-302529; Jiang SX, 2015, ANAL METHODS-UK, V7, P8466, DOI 10.1039/c5ay01413a; Kang SY, 2009, P NATL ACAD SCI USA, V106, P12115, DOI 10.1073/pnas.0903120106; Kiaris H, 2005, CANCER RES, V65, P1627, DOI 10.1158/0008-5472.CAN-04-3791; Kranz D, 2006, CANCER RES, V66, P10274, DOI 10.1158/0008-5472.CAN-06-1527; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liu W, 2013, J LIPID RES, V54, P244, DOI 10.1194/jlr.M031732; Lizardo DY, 2017, MOL BIOSYST, V13, P498, DOI 10.1039/c6mb00842a; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Masamune A, 2009, J GASTROENTEROL, V44, P249, DOI 10.1007/s00535-009-0013-2; McAnoy AM, 2005, J AM SOC MASS SPECTR, V16, P1498, DOI 10.1016/j.jasms.2005.04.017; Mei L, 2016, J GASTROINTEST ONCOL, V7, P487, DOI 10.21037/jgo.2016.03.03; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Procopio MG, 2015, NAT CELL BIOL, V17, P1193, DOI 10.1038/ncb3228; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Reichrath J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00166; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Sanchez-Macedo N, 2013, CELL DEATH DIFFER, V20, P659, DOI 10.1038/cdd.2012.168; Sharon Y, 2013, JOVE-J VIS EXP, DOI 10.3791/4425; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001; Tang D, 2013, INT J CANCER, V132, P993, DOI 10.1002/ijc.27715; Thiam AR, 2017, J CELL SCI, V130, P315, DOI 10.1242/jcs.192021; Thompson T, 2010, MOL CANCER THER, V9, P1158, DOI 10.1158/1535-7163.MCT-09-1036; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Vassilev LT, 2004, CELL CYCLE, V3, P419; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Wade M, 2006, J BIOL CHEM, V281, P33036, DOI 10.1074/jbc.M605405200; Welte MA, 2015, CURR BIOL, V25, pR470, DOI 10.1016/j.cub.2015.04.004; Wernert N, 2001, ANTICANCER RES, V21, P2259; Yahagi N, 2003, J BIOL CHEM, V278, P25395, DOI 10.1074/jbc.M302364200; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211	71	22	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189051	10.1371/journal.pone.0189051	http://dx.doi.org/10.1371/journal.pone.0189051			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211796	Green Published, Green Submitted, gold			2022-12-27	WOS:000417212200060
J	Sanz-Torrent, M; Andreu, L; Ferreiro, JR; Coll-Florit, M; Trueswell, JC				Sanz-Torrent, Monica; Andreu, Llorenc; Rodriguez Ferreiro, Javier; Coll-Florit, Marta; Trueswell, John C.			Auditory word recognition of verbs: Effects of verb argument structure on referent identification	PLOS ONE			English	Article							TIME-COURSE; SENTENCE COMPREHENSION; EYE-MOVEMENTS; LANGUAGE COMPREHENSION; LEXICAL ORGANIZATION; SPOKEN LANGUAGE; COMPLEXITY; APHASIA; NOUNS; RETRIEVAL	Word recognition includes the activation of a range of syntactic and semantic knowledge that is relevant to language interpretation and reference. Here we explored whether or not the number of arguments a verb takes impinges negatively on verb processing time. In this study, three experiments compared the dynamics of spoken word recognition for verbs with different preferred argument structure. Listeners' eye movements were recorded as they searched an array of pictures in response to hearing a verb. Results were similar in all the experiments. The time to identify the referent increased as a function of the number of arguments, above and beyond any effects of label appropriateness (and other controlled variables, such as letter, phoneme and syllable length, phonological neighborhood, oral and written lexical frequencies, imageability and rated age of acquisition). The findings indicate that the number of arguments a verb takes, influences referent identification during spoken word recognition. Representational complexity and amount of information generated by the lexical item that aids target identification are discussed as possible sources of this finding.	[Sanz-Torrent, Monica; Rodriguez Ferreiro, Javier] Univ Barcelona, Grp Recerca Cognit & Llenguatge GRECIL, Dept Cognicio Desenvolupament & Psicol Educ, Barcelona, Spain; [Andreu, Llorenc] Univ Oberta Catalunya, Grp Recerca Cognit & Llenguatge GRECIL, Estudis Psicol & Ciencies Educ, Barcelona, Spain; [Trueswell, John C.] Univ Oberta Catalunya, Estudis Arts & Humanitats, Barcelona, Spain; [Trueswell, John C.] Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA	University of Barcelona; UOC Universitat Oberta de Catalunya; UOC Universitat Oberta de Catalunya; University of Pennsylvania	Andreu, L (corresponding author), Univ Oberta Catalunya, Grp Recerca Cognit & Llenguatge GRECIL, Estudis Psicol & Ciencies Educ, Barcelona, Spain.	landreub@uoc.edu	Andreu, Llorenç/P-2099-2019; Rodríguez-Ferreiro, Javier/B-5232-2011; Andreu, Llorenç/K-4286-2015	Andreu, Llorenç/0000-0001-8568-2511; Rodríguez-Ferreiro, Javier/0000-0001-9828-8302; Andreu, Llorenç/0000-0001-8568-2511; Coll-Florit, Marta/0000-0002-8636-458X; Sanz-Torrent, Monica/0000-0002-2012-1956	Ministerio de Economia y Competitividad (Madrid, Spain) [EDU2013-44678-P]	Ministerio de Economia y Competitividad (Madrid, Spain)	This work was supported by the Ministerio de Economia y Competitividad (Madrid, Spain), Grant number: EDU2013-44678-P to PI: LA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allopenna PD, 1998, J MEM LANG, V38, P419, DOI 10.1006/jmla.1997.2558; Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Assadollahi R, 2008, BMC NEUROSCI, V21, P1; Atchley RA, 2006, BRAIN LANG, V99, P236, DOI 10.1016/j.bandl.2005.08.005; Baayen RH, 2006, J MEM LANG, V55, P290, DOI 10.1016/j.jml.2006.03.008; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Balconi C, 2005, J PSYCHOLINGUIST RES, V34, P71, DOI 10.1007/s10936-005-3633-6; Bastiaanse R, 1998, APHASIOLOGY, V12, P951, DOI 10.1080/02687039808249463; Bates E, 2003, PSYCHON B REV, V10, P344, DOI 10.3758/BF03196494; Bedny M, 2008, J NEUROSCI, V28, P11347, DOI 10.1523/JNEUROSCI.3039-08.2008; Bedny M, 2006, BRAIN LANG, V98, P127, DOI 10.1016/j.bandl.2006.04.008; Berndt RS, 2002, APHASIOLOGY, V16, P83, DOI 10.1080/02687040143000212; Breedin SD, 1996, COGNITIVE NEUROPSYCH, V13, P51, DOI 10.1080/026432996382060; Breedin SD, 1998, BRAIN LANG, V63, P1, DOI 10.1006/brln.1997.1923; CARAMAZZA A, 1991, NATURE, V349, P788, DOI 10.1038/349788a0; CARLSON GN, 1988, SYNTAX SEMANTICS, V21, P263; COOPER RM, 1974, COGNITIVE PSYCHOL, V6, P84, DOI 10.1016/0010-0285(74)90005-X; Cuetos F, 2011, PSICOLOGICA, V32, P133; Dahan D, 2005, PSYCHON B REV, V12, P453, DOI 10.3758/BF03193787; Dahan D, 2001, LANG COGNITIVE PROC, V16, P507, DOI 10.1080/01690960143000074; Dahan D, 2001, COGNITIVE PSYCHOL, V42, P317, DOI 10.1006/cogp.2001.0750; De Bleser R, 2003, J NEUROLINGUIST, V16, P213, DOI 10.1016/S0911-6044(02)00015-5; Dobel C, 2001, EXP BRAIN RES, V140, P77, DOI 10.1007/s002210100794; Duchon A, 2013, BEHAV RES METHODS, V45, P1246, DOI 10.3758/s13428-013-0326-1; Fischer B., 1992, EYE MOVEMENTS VISUAL, P31, DOI [DOI 10.1007/978-1-4612-2852-3_3, 10.1007/978-1-4612-2852-3_3]; Forsythe A, 2008, BEHAV RES METHODS, V40, P116, DOI 10.3758/BRM.40.1.116; Gelman A., 2007, DATA ANAL USING REGR; Gennari S, 2003, COGNITION, V89, pB27, DOI 10.1016/S0010-0277(03)00069-6; Gennari SP, 2009, COGNITION, V111, P1, DOI 10.1016/j.cognition.2008.12.006; Gillette J, 1999, COGNITION, V73, P135, DOI 10.1016/S0010-0277(99)00036-0; *GRUP SINT ESP, 2012, BAS DAT SINT ESP ACT; HILLIS AE, 1995, J COGNITIVE NEUROSCI, V7, P396, DOI 10.1162/jocn.1995.7.3.396; INHOFF AW, 1985, J PSYCHOLINGUIST RES, V14, P45, DOI 10.1007/BF01067473; Jackendoff R. S., 2002, FDN LANGUAGE BRAIN M; Johnson CJ, 1996, PSYCHOL BULL, V120, P113, DOI 10.1037/0033-2909.120.1.113; Jonkers R, 1996, BRAIN LANG, V55, P37; JONKERS R, 1998, APHASIOLOGY, V12, P193; Kauschke C, 2008, J PSYCHOLINGUIST RES, V37, P443, DOI 10.1007/s10936-008-9073-3; Kim M, 2000, BRAIN LANG, V74, P1, DOI 10.1006/brln.2000.2315; KOHN SE, 1989, CORTEX, V25, P57, DOI 10.1016/S0010-9452(89)80006-1; MacWhinney B., 2000, CHILDES PROJECT DATA, V2; Magnuson JS, 2003, J EXP PSYCHOL GEN, V132, P202, DOI 10.1037/0096-3445.132.2.202; Marslen-Wilson W., 2007, OXFORD HDB PSYCHOLIN, P175, DOI DOI 10.1093/OXFORDHB/9780198568971.013.0011; MATIN E, 1993, PERCEPT PSYCHOPHYS, V53, P372, DOI 10.3758/BF03206780; McElree B, 2001, COGNITION, V78, pB17, DOI 10.1016/S0010-0277(00)00113-X; McRae K, 1998, J MEM LANG, V38, P283, DOI 10.1006/jmla.1997.2543; Melinger A, 2007, J MEM LANG, V56, P472, DOI 10.1016/j.jml.2006.12.001; Moss H.E., 2007, OXFORD HDB PSYCHOLIN, P217; Novick JM, 2003, J PSYCHOLINGUIST RES, V32, P57, DOI 10.1023/A:1021985032200; Olmos J., 2012, EFFECT VERB ARGUMENT, V47, P637; RAYNER K, 1986, MEM COGNITION, V14, P191, DOI 10.3758/BF03197692; Rodriguez-Ferreiro J, 2009, J NEUROLINGUIST, V22, P37, DOI 10.1016/j.jneuroling.2008.05.003; SASLOW MG, 1967, J OPT SOC AM, V57, P1030, DOI 10.1364/JOSA.57.001030; SCHMAUDER AR, 1991, J EXP PSYCHOL LEARN, V17, P49, DOI 10.1037/0278-7393.17.1.49; SCHMAUDER AR, 1991, J EXP PSYCHOL LEARN, V17, P1188; Sebastian N., 2000, LEXESP LEXICO INFORM; Seidenberg M. S., 2007, OXFORD HDB PSYCHOLIN, P235, DOI [DOI 10.1093/0XF0RDHB/9780198568971.013.0014, 10.1093/oxfordhb/9780198568971.013.0014]; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; Seidenberg MS, 1996, J EXP PSYCHOL LEARN, V22, P48, DOI 10.1037/0278-7393.22.1.48; Shapiro K, 2003, NEUROPSYCHOLOGIA, V41, P1189, DOI 10.1016/S0028-3932(03)00037-X; Shapiro K, 2003, J NEUROLINGUIST, V16, P85, DOI 10.1016/S0911-6044(02)00010-6; SHAPIRO LP, 1987, COGNITION, V27, P219, DOI 10.1016/S0010-0277(87)80010-0; SHAPIRO LP, 1990, BRAIN LANG, V38, P21, DOI 10.1016/0093-934X(90)90100-U; SHAPIRO LP, 1989, J PSYCHOLINGUIST RES, V18, P223; STEIGER JH, 1985, PSYCHOMETRIKA, V50, P253, DOI 10.1007/BF02294104; Szekely A., 2000, CTR RES LANGUAGE NEW, V12; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Trueswell JC, 1998, J MEM LANG, V39, P102, DOI 10.1006/jmla.1998.2565; Valle-Arroyo F, 1999, NORMAS IMAGINABILIDA; WILLIAMS SE, 1987, BRAIN LANG, V32, P124, DOI 10.1016/0093-934X(87)90120-9	70	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188728	10.1371/journal.pone.0188728	http://dx.doi.org/10.1371/journal.pone.0188728			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO8CU	29206841	Green Published, Green Submitted, gold			2022-12-27	WOS:000417110700019
J	Yang, J; Huang, C; Wu, SS; Xu, Y; Cai, T; Chai, SB; Yang, ZR; Sun, F; Zhan, SY				Yang, Jun; Huang, Chao; Wu, Shanshan; Xu, Yang; Cai, Ting; Chai, Sanbao; Yang, Zhirong; Sun, Feng; Zhan, Siyan			The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials	PLOS ONE			English	Article							PEPTIDE-1 RECEPTOR AGONISTS; RISK; INCONSISTENCY; GLIMEPIRIDE; SAFETY; SULFONYLUREAS; SAXAGLIPTIN; GENERATION; EFFICACY; DENSITY	Aim The association between dipeptidyl peptidase-4 inhibitors (DPP-4is), a class of anti-diabetes, and bone fracture in patients with type 2 diabetes mellitus (T2DM) is unknown. This meta-analysis aimed to systematically evaluate the effects of DPP-4is on bone fracture in T2DM patients. Methods We searched the Cochrane Library, Embase, Medline and ClinicalTrials.gov from inception through April 28th, 2016 to identify randomized controlled trials (RCTs) that compared DPP-4is with placebo or other anti-diabetes in T2DM patients. RCTs lasting more than 12 weeks and having data on bone fracture were included. We conducted random-effects meta-analysis to estimate odds ratios (ORs) and their 95% confidence intervals (CIs), and network meta-analysis (NMA) to supplement direct comparisons. Predictive interval plot and node-splitting method were used to evaluate the heterogeneity and inconsistency for NMA, while the funnel plot was applied to explore publication bias. Besides, study quality was assessed according to Cochrane risk of bias tool. Results We identified 75 RCTs with a total of 70,207 patients and 11 treatments: interventions included 5 DPP-4is (alogliptin, linagliptin, saxagliptin, sitagliptin, vildagliptin), while controls included placebo and 5 other anti-diabetes (sulfonylureas, glucagon-like peptide-1 receptor agonists, metformin, thiazolidinediones, sodium-glucose co-transporter 2 inhibitors). In the NMA, the risk of fracture for alogliptin tended to decrease when versus placebo (OR, 0.51; 95% CI, 0.29 to 0.88). Besides, aloglitpin had a lower risk compared with linagliptin (OR, 0.45; 95% CI, 0.20 to 0.99) and saxagliption (OR, 0.46; 95% CI, 0.25 to 0.84); the risk was higher with saxagliptin when versus sitagliptin (OR, 1.90; 95% CI, 1.04 to 3.47) and sulfonylureas (OR, 1.98; 95% CI, 1.06 to 3.71). In the direct pairwise meta-analysis, alogliptin was associated with a non-significant tendency to reduction of bone fracture compared with placebo (OR, 0.54; 95% CI, 0.29 to 1.01). Ranking probability analysis indicated alogliptin decreased the risk of bone fracture most with a probability of 76.3%. Conclusion Alogliptin may be associated with a lower risk of bone fracture compared with placebo, linagliptin, or saxagliptin, while other anti-diabetes did not seem to have an association with the risk of bone fracture.	[Yang, Jun; Huang, Chao; Xu, Yang; Cai, Ting; Sun, Feng; Zhan, Siyan] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China; [Wu, Shanshan] Capital Med Univ, Beijing Friendship Hosp, Natl Clin Res Ctr Digest Dis, Beijing, Peoples R China; [Chai, Sanbao] Peking Univ, Int Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China; [Yang, Zhirong] Univ Cambridge, Sch Clin Med, Primary Care Unit, Cambridge, England	Peking University; Capital Medical University; Peking University; University of Cambridge	Sun, F; Zhan, SY (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China.	sunfeng@bjmu.edu.cn; siyan-zhan@bjmu.edu.cn	Sun, Feng/AGF-7912-2022	Sun, Feng/0000-0003-4334-6805; Cai, Ting/0000-0001-5926-9280	National Natural Science Foundation of China [81302508, 71673003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We were supported by the fund from National Natural Science Foundation of China (81302508, 71673003), but the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the assistance of Hailong Li in directing the analytical methods. We also thank the fund from National Natural Science Foundation of China (81302508, 71673003).	Barchetta I, 2016, ACTA DIABETOL, V53, P839, DOI 10.1007/s00592-016-0882-9; Billington EO, 2015, DIABETOLOGIA, V58, P2238, DOI 10.1007/s00125-015-3660-2; Bunck MC, 2012, J DIABETES, V4, P181, DOI 10.1111/j.1753-0407.2011.00168.x; Ceccarelli Elena, 2013, Front Endocrinol (Lausanne), V4, P73, DOI 10.3389/fendo.2013.00073; Conti F, 2013, AGING CLIN EXP RES, V25, pS39, DOI 10.1007/s40520-013-0084-z; Dede AD, 2014, METABOLISM, V63, P1480, DOI 10.1016/j.metabol.2014.09.002; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Driessen JHM, 2017, BRIT J CLIN PHARMACO, V83, P923, DOI 10.1111/bcp.13167; Driessen JHM, 2015, CALCIFIED TISSUE INT, V97, P506, DOI 10.1007/s00223-015-0037-y; Driessen JHM, 2015, CALCIFIED TISSUE INT, V97, P104, DOI 10.1007/s00223-015-9993-5; Driessen JHM, 2014, BONE, V68, P124, DOI 10.1016/j.bone.2014.07.030; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Evans PMS, 2016, EXPERT OPIN PHARMACO, V17, P1947, DOI 10.1080/14656566.2016.1218472; Fadini GP, 2016, J CLIN ENDOCR METAB, V101, P748, DOI 10.1210/jc.2015-3716; Fan Y, 2016, OSTEOPOROSIS INT, V27, P219, DOI 10.1007/s00198-015-3279-7; Fronczek-Sokol J, 2014, PHARMACOL REP, V66, P412, DOI 10.1016/j.pharep.2013.12.013; Fu JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29104; Giangregorio LM, 2012, J BONE MINER RES, V27, P301, DOI 10.1002/jbmr.556; Glorie L, 2014, AM J PHYSIOL-ENDOC M, V307, pE447, DOI 10.1152/ajpendo.00217.2014; Godoy-Matos AF, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-91; Hermansen K, 2007, DIABETES OBES METAB, V9, P733, DOI 10.1111/j.1463-1326.2007.00744.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Hirshberg B, 2014, DIABETES-METAB RES, V30, P556, DOI 10.1002/dmrr.2502; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Kania DS, 2011, CLIN THER, V33, P1005, DOI 10.1016/j.clinthera.2011.06.016; Kawanami D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081223; Lapane KL, 2015, DIABETES RES CLIN PR, V109, P411, DOI 10.1016/j.diabres.2015.05.009; Lapane KL, 2013, DRUG AGING, V30, P527, DOI 10.1007/s40266-013-0081-0; Ma P, 2010, METABOLISM, V59, P359, DOI 10.1016/j.metabol.2009.08.003; Mabilleau G, 2014, J DIABETES, V6, P260, DOI 10.1111/1753-0407.12102; Mamza J, 2016, DIABETES RES CLIN PR, V116, P288, DOI 10.1016/j.diabres.2016.04.029; Mannucci E, 2015, CLIN CASES MINER BON, V12, P130, DOI 10.11138/ccmbm/2015.12.2.130; Monami M, 2011, DIABETES CARE, V34, P2474, DOI 10.2337/dc11-1099; Mosenzon O, 2015, DIABETES CARE, V38, P2142, DOI 10.2337/dc15-1068; Pratley RE, 2007, CURR MED RES OPIN, V23, P919, DOI 10.1185/030079906X162746; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Rucker G, 2009, STAT MED, V28, P721, DOI 10.1002/sim.3511; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Scheen AJ, 2010, DIABETES OBES METAB, V12, P648, DOI 10.1111/j.1463-1326.2010.01212.x; Shah Z, 2011, CIRCULATION, V124, P2339, DOI 10.1161/CIRCULATIONAHA.111.041418; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; Strotmeyer ES, 2011, CURR GERONTOL GERIAT, V2011; Su B, 2015, ENDOCRINE, V48, P107, DOI 10.1007/s12020-014-0361-4; van Valkenhoef G, 2016, RES SYNTH METHODS, V7, P80, DOI 10.1002/jrsm.1167; van Valkenhoef G, 2012, RES SYNTH METHODS, V3, P285, DOI 10.1002/jrsm.1054; Wang MC, 2005, BONE, V37, P474, DOI 10.1016/j.bone.2005.04.038; White IR, 2012, RES SYNTH METHODS, V3, P111, DOI 10.1002/jrsm.1045; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Xie D, 2005, BONE, V37, P759, DOI 10.1016/j.bone.2005.06.021; Yabe D, 2016, EXPERT OPIN DRUG SAF, V15, P249, DOI 10.1517/14740338.2016.1125467; Yabe D, 2012, J DIABETES INVEST, V3, P347, DOI 10.1111/j.2040-1124.2012.00219.x; Yamaguchi Toru, 2012, Bonekey Rep, V1, P36, DOI 10.1038/bonekey.2012.27; Zhong Q, 2007, AM J PHYSIOL-ENDOC M, V292, pE543, DOI 10.1152/ajpendo.00364.2006; Zinman B, 2010, J CLIN ENDOCR METAB, V95, P134, DOI 10.1210/jc.2009-0572	56	26	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0187537	10.1371/journal.pone.0187537	http://dx.doi.org/10.1371/journal.pone.0187537			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206832	Green Submitted, Green Published, gold			2022-12-27	WOS:000417110700005
J	Kumari, K; Koivisto, H; Viluksela, M; Paldanius, KMA; Marttinen, M; Hiltunen, M; Naarala, J; Tanila, H; Juutilainen, J				Kumari, Kajal; Koivisto, Hennariikka; Viluksela, Matti; Paldanius, Kaisa M. A.; Marttinen, Mikael; Hiltunen, Mikko; Naarala, Jonne; Tanila, Heikki; Juutilainen, Jukka			Behavioral testing of mice exposed to intermediate frequency magnetic fields indicates mild memory impairment	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY; SPATIAL MEMORY; NEUROGENESIS; EXPRESSIONS; HIPPOCAMPUS; ACQUISITION; RETENTION; DEFICITS; BRAIN; RATS	Human exposure to intermediate frequency magnetic fields (MF) is increasing due to applications like electronic article surveillance systems and induction heating cooking hobs. However, limited data is available on their possible health effects. The present study assessed behavioral and histopathological consequences of exposing mice to 7.5 kHz MF at 12 or 120 mu T for 5 weeks. No effects were observed on body weight, spontaneous activity, motor coordination, level of anxiety or aggression. In the Morris swim task, mice in the 120 mu T group showed less steep learning curve than the other groups, but did not differ from controls in their search bias in the probe test. The passive avoidance task indicated a clear impairment of memory over 48 h in the 120 mu T group. No effects on astroglial activation or neurogenesis were observed in the hippocampus. The mRNA expression of brain-derived neurotrophic factor did not change but expression of the proinflammatory cytokine tumor necrosis factor alpha mRNA was significantly increased in the 120 mu T group. These findings suggest that 7.5 kHz MF exposure may lead to mild learning and memory impairment, possibly through an inflammatory reaction in the hippocampus.	[Kumari, Kajal; Viluksela, Matti; Naarala, Jonne; Juutilainen, Jukka] Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland; [Koivisto, Hennariikka; Tanila, Heikki] Univ Eastern Finland, AI Virtanen Inst, Kuopio, Finland; [Viluksela, Matti] Natl Inst Hlth & Welf, Environm Hlth Unit, Kuopio, Finland; [Paldanius, Kaisa M. A.; Marttinen, Mikael; Hiltunen, Mikko] Univ Eastern Finland, Inst Biomed, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; Finland National Institute for Health & Welfare; University of Eastern Finland	Kumari, K (corresponding author), Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland.	kajal.kumari@uef.fi		Marttinen, Mikael/0000-0001-5861-4601	European Community - GERONIMO [603794]; University of Eastern Finland	European Community - GERONIMO; University of Eastern Finland	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant agreement no: 603794 - the GERONIMO project, 603794.; The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant agreement no: 603794 - the GERONIMO project, and from the University of Eastern Finland. We are grateful to Pasi Miettinen who provided his skilful technical assistance.	Ahlbom A, 2008, TOXICOLOGY, V246, P248, DOI 10.1016/j.tox.2008.02.004; Bornhausen M, 2000, BIOELECTROMAGNETICS, V21, P566; Cui YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032196; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Foroozandeh E, 2013, TOXICOL IND HEALTH, V29, P293, DOI 10.1177/0748233711433931; He LH, 2011, CHINESE MED J-PEKING, V124, P3362, DOI 10.3760/cma.j.issn.0366-6999.2011.20.028; Int Commission Non-Ionizing, 2010, HEALTH PHYS, V99, P818, DOI 10.1097/HP.0b013e3181f06c86; JENSEN RA, 1979, PSYCHOPHARMACOLOGY, V64, P125, DOI 10.1007/BF00427358; Kumari K, 2017, ENVIRON RES, V157, P64, DOI 10.1016/j.envres.2017.05.014; Lai H, 1998, BIOELECTROMAGNETICS, V19, P117, DOI 10.1002/(SICI)1521-186X(1998)19:2<117::AID-BEM10>3.0.CO;2-N; Lai H, 1996, BIOELECTROMAGNETICS, V17, P494, DOI 10.1002/(SICI)1521-186X(1996)17:6<494::AID-BEM9>3.0.CO;2-Z; Lai JS, 2016, NEUROTOXICOLOGY, V52, P104, DOI 10.1016/j.neuro.2015.11.010; Li C, 2014, ENVIRON RES, V134, P74, DOI 10.1016/j.envres.2014.06.025; Liu TT, 2008, NEUROREPORT, V19, P549, DOI 10.1097/WNR.0b013e3282f8b1a0; LYSKOV E, 1993, INT J PSYCHOPHYSIOL, V14, P227, DOI 10.1016/0167-8760(93)90036-O; LYSKOV EB, 1993, BIOELECTROMAGNETICS, V14, P87, DOI 10.1002/bem.2250140202; Maei HR, 2009, INTEGR NEUROSCI, V3; Marcussen AB, 2008, ACTA NEUROL SCAND, V117, P94, DOI 10.1111/j.1600-0404.2007.00910.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nicolas LB, 2006, EUR J PHARMACOL, V547, P106, DOI 10.1016/j.ejphar.2006.07.015; Podda MV, 2014, EUR J NEUROSCI, V39, P893, DOI 10.1111/ejn.12465; Roivainen P, 2014, BIOELECTROMAGNETICS, V35, P245, DOI 10.1002/bem.21850; Sienkiewicz ZJ, 1998, BIOELECTROMAGNETICS, V19, P79, DOI 10.1002/(SICI)1521-186X(1998)19:2<79::AID-BEM4>3.0.CO;2-0; Sienkiewicz ZJ, 1998, BIOELECTROMAGNETICS, V19, P486, DOI 10.1002/(SICI)1521-186X(1998)19:8<486::AID-BEM6>3.0.CO;2-K; Tanila H, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00011; van Meer P, 2007, BEHAV BRAIN RES, V176, P372, DOI 10.1016/j.bbr.2006.10.024; WILLNER P, 1981, PHARMACOL BIOCHEM BE, V14, P475, DOI 10.1016/0091-3057(81)90305-1; Win-Shwe TT, 2015, INT J ENV RES PUB HE, V12, P4406, DOI 10.3390/ijerph120404406; Win-Shwe TT, 2013, J TOXICOL SCI, V38, P169, DOI 10.2131/jts.38.169; Wojtowicz JM, 2006, HIPPOCAMPUS, V16, P261, DOI 10.1002/hipo.20158; Yavich L, 2005, NEUROBIOL DIS, V20, P303, DOI 10.1016/j.nbd.2005.03.010; Zhang YM, 2015, INT J RADIAT BIOL, V91, P28, DOI 10.3109/09553002.2014.954058; Zhao QR, 2015, SCI REP-UK, V5, DOI 10.1038/srep11768; Ziegelberger G, 2008, HEALTH PHYS, V94, P376, DOI 10.1097/01.HP.0000304155.41715.73	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188880	10.1371/journal.pone.0188880	http://dx.doi.org/10.1371/journal.pone.0188880			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29206232	Green Submitted, Green Published, gold			2022-12-27	WOS:000417033200019
J	Gromova, I; Svensson, S; Gromov, P; Moreira, JMA				Gromova, Irina; Svensson, Sofia; Gromov, Pavel; Moreira, Jose M. A.			Identification of BLCAP as a novel STAT3 interaction partner in bladder cancer	PLOS ONE			English	Article							IN-SITU; PROXIMITY LIGATION; CERVICAL-CANCER; YXXQ MOTIF; PROTEIN; CELLS; ACTIVATION; CARCINOMA; APOPTOSIS; EXPRESSION	Bladder cancer associated protein (Blcap) expression is commonly down-regulated in invasive bladder cancer, and may have prognostic value given that its expression is negatively correlated with patient survival. We have previously investigated the expression patterns and cellular localization of Blcap in bladder cancer, where we found that about 20% of the lesions examined displayed strong nuclear expression of Blcap, and that this phenotype was associated with overall poor disease outcome. Here we report on the analysis of possible functional associations between nuclear expression of Blcap and canonical signaling pathways. We performed serial immunohistochemistry (IHC) analysis of bladder tissue samples, with serial sections stained with phospho-specific antibodies recognizing key signaling intermediates, such as P-Stat3, P-Akt, and P-Erk1/2, among others, in an immunophenotyping approach we have established and reported previously. Using this approach, we found that nuclear localization of Blcap was associated with expression of P-Stat3. A parallel analysis, cytokine profiling of bladder tumor interstitial fluids of samples expressing (or not) Blcap, showed interleukin (IL)-6, IL-8, and monocyte chemotactic protein 1 (MCP-1) to be correlated with nuclear expression of Blcap, independently supporting a role for Stat3 signaling in localization of Blcap. Multiple indirect immunofluorescence analysis of tissue biopsies confirmed that Blcap co-localized with Stat3. Furthermore, we could also demonstrate, using an in situ proximity ligation assay that Blcap and Stat3 are in close physical proximity of each other in bladder tissue, and that Blcap physically interacts with Stat3 as determined by co-immunoprecipitation of these proteins. Our data indicates that Blcap is a novel Stat3 interaction partner and suggests a role for Blcap in the Stat3-mediated progression of precancerous lesions to invasive tumors of the bladder.	[Gromova, Irina; Svensson, Sofia; Gromov, Pavel] Danish Canc Soc, Res Ctr, Genome Instabil Unit, Canc Prote, Copenhagen, Denmark; [Moreira, Jose M. A.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Svensson, Sofia] Novo Nordisk AS, Biopharm API, Bagsvaerd, Denmark	Danish Cancer Society; University of Copenhagen; Novo Nordisk	Moreira, JMA (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark.	jomo@sund.ku.dk		Moreira, Jose/0000-0002-9944-1214; Gromova, Irina/0000-0003-4357-5958	Danish Cancer Society through the budget of the Institute of Cancer Biology	Danish Cancer Society through the budget of the Institute of Cancer Biology	This work was funded by the Danish Cancer Society through the budget of the Institute of Cancer Biology.	Abe K, 2001, ONCOGENE, V20, P3464, DOI 10.1038/sj.onc.1204461; Antoni S, 2017, EUR UROL, V71, P96, DOI 10.1016/j.eururo.2016.06.010; Babjuk M, 2016, EUR UROL; Bellucci A, 2014, METHODS MOL BIOL, V1174, P397, DOI 10.1007/978-1-4939-0944-5_27; Bergkvist A, 1965, Acta Chir Scand, V130, P371; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chen CL, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-78; Chen W, 2017, ONCOTARGET, V8, P39417, DOI 10.18632/oncotarget.17034; Daino K, 2009, INT J CANCER, V125, P612, DOI 10.1002/ijc.24392; Fan DG, 2011, EXP BIOL MED, V236, P1030, DOI 10.1258/ebm.2011.010315; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Galeano F, 2010, INT J CANCER, V127, P127, DOI 10.1002/ijc.25022; Golabesk T, 2016, UROLOGY; Gromov P, 2008, PROTEOM CLIN APPL, V2, P974, DOI 10.1002/prca.200780163; Gromov P, 2016, METHODS MOL BIOL, V1459, P231, DOI 10.1007/978-1-4939-3804-9_16; Gromova I, 2002, INT J CANCER, V98, P539, DOI 10.1002/ijc.10244; Gromova I, 2015, MOL ONCOL, V9, P1636, DOI 10.1016/j.molonc.2015.05.003; Higashi N, 2004, GENES CELLS, V9, P233, DOI 10.1111/j.1356-9597.2004.00715.x; Hirano Toshio, 1997, Cytokine and Growth Factor Reviews, V8, P241, DOI 10.1016/S1359-6101(98)80005-1; Ho PL, 2012, CANCER RES, V72, P3135, DOI 10.1158/0008-5472.CAN-11-3195; Hu XD, 2015, CANCER LETT, V357, P510, DOI 10.1016/j.canlet.2014.12.006; Itoh M, 2006, ONCOGENE, V25, P1195, DOI 10.1038/sj.onc.1209149; Moreira JMA, 2010, MOL CELL PROTEOMICS, V9, P161, DOI 10.1074/mcp.M900294-MCP200; Pencik J, 2016, CYTOKINE, V87, P26, DOI 10.1016/j.cyto.2016.06.017; Peng M, 2012, EXP THER MED, V3, P336, DOI 10.3892/etm.2011.408; Rae FK, 2000, INT J CANCER, V88, P726, DOI 10.1002/1097-0215(20001201)88:5<726::AID-IJC7>3.0.CO;2-H; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Shao H, 2004, J BIOL CHEM, V279, P18967, DOI 10.1074/jbc.M314037200; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Sylvester RJ, 2005, UROLOGY, V66, P90, DOI 10.1016/j.urology.2005.06.135; Ulaganathan VK, 2015, NATURE, V528, P570, DOI 10.1038/nature16449; Yamanaka Y, 1996, EMBO J, V15, P1557, DOI 10.1002/j.1460-2075.1996.tb00500.x; Yao J, 2007, MOL CELL BIOCHEM, V297, P81, DOI 10.1007/s11010-006-9332-2; Zhao M, 2016, ONCOL REP, V35, P3050, DOI 10.3892/or.2016.4686; Zilberman DE, 2011, UROL ONCOL-SEMIN ORI, V29, P21, DOI 10.1016/j.urolonc.2008.11.006; Zuo ZH, 2006, TUMOR BIOL, V27, P221, DOI 10.1159/000093057	37	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188827	10.1371/journal.pone.0188827	http://dx.doi.org/10.1371/journal.pone.0188827			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190807	Green Submitted, Green Published, gold			2022-12-27	WOS:000416841900134
J	Ruark, A; Chase, R; Hembling, J; Davis, VR; Perrin, PC; Brewster-Lee, D				Ruark, Allison; Chase, Rachel; Hembling, John; Davis, Valerie Rhoe; Perrin, Paul Clayton; Brewster-Lee, Dorothy			Measuring couple relationship quality in a rural African population: Validation of a Couple Functionality Assessment Tool in Malawi	PLOS ONE			English	Article							HOUSEHOLD DECISION-MAKING; MATERNAL HEALTH-CARE; SOUTH-AFRICA; CHILD-TRANSMISSION; RELATIONSHIP POWER; MARITAL QUALITY; HIV; DISCLOSURE; INVOLVEMENT; PREVENTION	Available data suggest that individual and family well-being are linked to the quality of women's and men's couple relationships, but few tools exist to assess couple relationship functioning in low-and middle-income countries. In response to this gap, Catholic Relief Services has developed a Couple Functionality Assessment Tool (CFAT) to capture valid and reliable data on various domains of relationship quality. This tool is designed to be used by interventions which aim to improve couple and family well-being as a means of measuring the effectiveness of these interventions, particularly related to couple relationship quality. We carried out a validation study of the CFAT among 401 married and cohabiting adults (203 women and 198 men) in rural Chikhwawa District, Malawi. Using psychometric scales, the CFAT addressed six domains of couple relationship quality (intimacy, partner support, sexual satisfaction, gender roles, decision-making, and communication and conflict management), and included questions on intimate partner violence. We used exploratory factor analysis to assess scale performance of each domain and produce a shortened Relationship Quality Index (RQI) composed of items from five relationship quality domains. This article reports the performance of the RQI. Internal reliability and validity of the RQI were found to be good. Regression analyses examined the relationship of the RQI to outcomes important to health and development: intra-household cooperation, positive health behaviors, intimate partner violence, and gender-equitable norms. We found many significant correlations between RQI scores and these couple-and family-level development issues. There is a need to further validate the tool with use in other populations as well as to continue to explore whether the observed linkages between couple functionality and development outcomes are causal relationships.	[Ruark, Allison] Brown Univ, Dept Med, Providence, RI 02912 USA; [Chase, Rachel] Johns Hopkins Univ, Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Hembling, John; Davis, Valerie Rhoe; Perrin, Paul Clayton; Brewster-Lee, Dorothy] Catholic Relief Serv, Baltimore, MD USA	Brown University; Johns Hopkins University	Ruark, A (corresponding author), Brown Univ, Dept Med, Providence, RI 02912 USA.	AHRuark@gmail.com	Ruark, Allison/AAG-8028-2022; Ruark, Allison/AFL-8077-2022; Perrin, Paul/Q-7176-2019	Ruark, Allison/0000-0002-5131-1568; Ruark, Allison/0000-0002-5131-1568; Perrin, Paul/0000-0003-2043-0262; Hembling, John/0000-0002-0917-5259; Chase, Rachel/0000-0002-1503-4954	Catholic Relief Services; National Institute on Drug Abuse (NIDA) [T32DA13911]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	Catholic Relief Services; National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Catholic Relief Services (www.crs.org) funded this study. AR acknowledges support from National Institute on Drug Abuse (NIDA) grant T32DA13911. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all the Malawian women and men who participated in this study, as well as Dr. Lynae Darbes and Dr. Henry Mosley for advising the project. Catholic Relief Services (www.crs.org) funded this study. AR acknowledges support from National Institute on Drug Abuse (NIDA) grant T32DA13911 in the preparation of this manuscript, although this funder had no role in study design, data collection or data analysis.	Allendorf K, 2010, STUD FAMILY PLANN, V41, P263, DOI 10.1111/j.1728-4465.2010.00252.x; Antelman G, 2001, AIDS, V15, P1865, DOI 10.1097/00002030-200109280-00017; Brittain K, 2015, AIDS CARE, V27, P1020, DOI 10.1080/09540121.2015.1018862; Christensen A., 1988, MONOGRAPHS SOCIAL PS, P31, DOI DOI 10.1037/0022-3514.59.1.73; Conroy AA, 2016, SOC SCI MED, V153, P1, DOI 10.1016/j.socscimed.2016.01.035; Conroy AA, 2015, SOC SCI MED, V144, P28, DOI 10.1016/j.socscimed.2015.09.007; Conroy AA, 2015, J SEX RES, V52, P347, DOI 10.1080/00224499.2014.883590; Conroy AA, 2014, CULT HEALTH SEX, V16, P397, DOI 10.1080/13691058.2014.883645; Cox CM, 2013, INT PERSPECT SEX R H, V39, P185, DOI 10.1363/3918513; Danforth EJ, 2009, J HEALTH POPUL NUTR, V27, P696; ERICKSON RJ, 1993, J MARRIAGE FAM, V55, P888, DOI 10.2307/352770; Higgins JA, 2014, AM J PUBLIC HEALTH, V104, P612, DOI 10.2105/AJPH.2013.301670; Holden G, 2001, HDB FAMILY MEASUREME, V1, P137; Hudson WW., 2007, MEASURES CLIN PRACTI, P114; Iloh GUP, 2013, J FAM COMMUNITY MED, V20, P12, DOI 10.4103/2230-8229.108178; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kwena Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095298; Larsson EC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-769; Lawrence E., 2008, PSYCHOL RELATIONSHIP, P173; Lawrence E, 2011, PSYCHOL ASSESSMENT, V23, P44, DOI 10.1037/a0021096; Lesch E, 2016, J SEX RES, V53, P1082, DOI 10.1080/00224499.2016.1144170; Li Y, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18845; Maman S, 2001, AIDS CARE, V13, P595, DOI 10.1080/09540120120063223; Matovu JKB, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19160; Mboane R, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0010-2; Minnis AM, 2015, INT J WOMENS HEALTH, V7, P517, DOI 10.2147/IJWH.S77398; Mkwanazi NB, 2015, AIDS CARE, V27, P65, DOI 10.1080/09540121.2015.1028881; Nanda G, 2011, COMPENDIUM GENDER SC, P13; National Statistical Office (NSO) and ICF Macro, 2011, MAL DEM HLTH SURV 20; Pettifor A, 2014, AIDS CARE, V26, P476, DOI 10.1080/09540121.2013.841827; Pulerwitz J, 2008, MEN MASC, V10, P322, DOI 10.1177/1097184X06298778; Putthakeo P, 2009, J PAEDIATR CHILD H, V45, P487, DOI 10.1111/j.1440-1754.2009.01547.x; Robles TF, 2014, PSYCHOL BULL, V140, P140, DOI 10.1037/a0031859; Rogers AJ, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21224; Schwartz P, 2009, SEX RES SOC POLICY, V6, P1, DOI 10.1525/srsp.2009.6.1.1; Sendo EG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-765; Shroff MR, 2011, SOC SCI MED, V73, P447, DOI 10.1016/j.socscimed.2011.05.040; Smith C, 2017, AIDS BEHAV, V21, P106, DOI 10.1007/s10461-016-1323-z; Speizer IS, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0398-7; Sternberg RJ, 1997, EUR J SOC PSYCHOL, V27, P313, DOI 10.1002/(SICI)1099-0992(199705)27:3<313::AID-EJSP824>3.3.CO;2-W; Story WT, 2012, SOC SCI MED, V75, P2403, DOI 10.1016/j.socscimed.2012.09.017; Tabana H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066390; Thapa DK, 2013, SOC SCI MED, V93, P1, DOI 10.1016/j.socscimed.2013.06.003; Villar-Loubet OM, 2013, CULT HEALTH SEX, V15, P253, DOI 10.1080/13691058.2012.716166	44	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188561	10.1371/journal.pone.0188561	http://dx.doi.org/10.1371/journal.pone.0188561			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO4UI	29190769	Green Submitted, gold, Green Published			2022-12-27	WOS:000416841900074
J	Cho, IJ; Chang, HJ; Sung, JM; Yun, YM; Kim, HC; Chung, N				Cho, In-Jeong; Chang, Hyuk-Jae; Sung, Ji Min; Yun, Young Mi; Kim, Hyeon Chang; Chung, Namsik			Associations of changes in body mass index with all-cause and cardiovascular mortality in healthy middle-aged adults	PLOS ONE			English	Article							WEIGHT CHANGE; OLD-AGE; HEART-FAILURE; RISK-FACTORS; LEAN MASS; OBESITY; VARIABILITY; DISEASE; MEN; EPIDEMIOLOGY	Background Conflicting data exist regarding the association of body mass index (BMI) changes with all-cause and cardiovascular (CV) mortality. The current study investigated the association between changes in BMI and all-cause, CV, and non-CV mortality in a large cohort of middle-aged adults. Methods A total of 379,535 adults over 40 years of age without pre-existing CV disease or cancer at baseline were enrolled to undergo a series of at least three health examinations of biennial intervals. Changes in BMI between baseline, midpoint follow-up, and final health examination during mean 9.3 years were defined according to the pattern of BMI change as follows: stable, sustained gain, sustained loss, and fluctuation. The relationship between BMI change category and mortality was assessed by multivariate Cox regression reporting hazard ratio (HR) with 95% confidence interval (95% CI). Results During a mean follow-up of 10.7 years for mortality, 12,378 deaths occurred from all causes, of which 2,114 were CV and 10,264 were non-CV deaths. Sustained BMI gain was associated with the lower risk of all-cause (HR 0.89, 95% CI: 0.83-0.95), CV (HR 0.84, 95% CI 0.72-0.98), and non-CV mortality (HR 0.90, 95% CI 0.84-0.96) compared with stable BMI. Conversely, sustained BMI loss (HR 1.25, 95% CI 1.19-1.32) and fluctuation (HR 1.13, 95% CI 1.08-1.19) displayed a higher risk of all-cause mortality compared with stable BMI, which was mainly attributable to the increase in non-CV mortality. Conclusion Sustained BMI gains were associated with reduced risk of all-cause, CV, and non-CV mortality in middle-aged healthy adults.	[Cho, In-Jeong; Chang, Hyuk-Jae; Sung, Ji Min; Kim, Hyeon Chang; Chung, Namsik] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul, South Korea; [Chang, Hyuk-Jae] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Yun, Young Mi] Yonsei Univ, Coll Med, Hlth IT Accelerat Platform Technol Innovat Ctr, Seoul, South Korea; [Kim, Hyeon Chang] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Chang, HJ (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul, South Korea.; Chang, HJ (corresponding author), Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea.	hjchang@yuhs.ac	; Kim, Hyeon Chang/F-8796-2019	Chang, Hyuk-Jae/0000-0002-6139-7545; Kim, Hyeon Chang/0000-0001-7867-1240	Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP) [2012027176]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0715]	Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This research was supported by Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (MSIP) (No. 2012027176) and the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C0715).	Andersen KK, 2013, INT J STROKE, V12, P12016; ANDRES R, 1993, ANN INTERN MED, V119, P737, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00022; Antonopoulos AS, 2016, OBES REV, V13, P12440; Bastien M, 2014, PROG CARDIOVASC DIS, V56, P369, DOI 10.1016/j.pcad.2013.10.016; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219; Field AE, 2009, ARCH INTERN MED, V169, P881, DOI 10.1001/archinternmed.2009.67; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Gallagher D, 2000, AM J PHYSIOL-ENDOC M, V279, pE366, DOI 10.1152/ajpendo.2000.279.2.E366; Hainer V, 2013, DIABETES CARE, V36, pS276, DOI 10.2337/dcS13-2023; Heiat Asefeh, 2003, Prev Cardiol, V6, P104, DOI 10.1111/j.1520-037X.2003.01046.x; Hughes VA, 2002, AM J CLIN NUTR, V76, P473, DOI 10.1093/ajcn/76.2.473; Jung SH, 2016, YONSEI MED J, V57, P674, DOI 10.3349/ymj.2016.57.3.674; Kim NH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139924; Lavie CJ, 2015, NAT REV ENDOCRINOL, V11, P55, DOI 10.1038/nrendo.2014.165; Lavie CJ, 2012, J AM COLL CARDIOL, V60, P1374, DOI 10.1016/j.jacc.2012.05.037; Lee JS, 2001, INT J OBESITY, V25, P1063, DOI 10.1038/sj.ijo.0801633; Lee YM, 2017, OBES REV, V18, P129, DOI 10.1111/obr.12481; LISSNER L, 1991, NEW ENGL J MED, V324, P1839, DOI 10.1056/NEJM199106273242602; Morkedal B, 2014, J AM COLL CARDIOL, V63, P1071, DOI 10.1016/j.jacc.2013.11.035; Newman AB, 2005, AM J CLIN NUTR, V82, P872, DOI 10.1093/ajcn/82.4.872; Newman AB, 2001, J AM GERIATR SOC, V49, P1309, DOI 10.1046/j.1532-5415.2001.49258.x; NHIS, NAT HLTH SCREEN STAT; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Rzehak P, 2007, EUR J EPIDEMIOL, V22, P665, DOI 10.1007/s10654-007-9167-5; Stern D, 2014, INT J OBESITY, V38, P1503, DOI 10.1038/ijo.2014.74; Strandberg TE, 2003, INT J OBESITY, V27, P950, DOI 10.1038/sj.ijo.0802313; Tamakoshi K, 2003, INT J OBESITY, V27, P1059, DOI 10.1038/sj.ijo.0802386; WALLACE JI, 1995, J AM GERIATR SOC, V43, P329, DOI 10.1111/j.1532-5415.1995.tb05803.x; Wannamethee SG, 2002, ARCH INTERN MED, V162, P2575, DOI 10.1001/archinte.162.22.2575; WILLIAMSON DF, 1993, ANN INTERN MED, V119, P646, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00004; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Zamboni M, 2003, AGING CLIN EXP RES, V15, P321, DOI 10.1007/BF03324517; Zhang JY, 1996, CIRCULATION, V94, P1089, DOI 10.1161/01.CIR.94.5.1089	35	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189180	10.1371/journal.pone.0189180	http://dx.doi.org/10.1371/journal.pone.0189180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216261	Green Submitted, gold, Green Published			2022-12-27	WOS:000417337800088
J	Cho, SM; Jeong, A; Ha, JH; Kim, EY				Cho, Sun Mi; Jeong, Ansuk; Ha, Jung Hee; Kim, Eun Young			Social relationship changes in victim families due to a social disaster: Experiences of student victims' families in the South Korean Sewol ferry disaster	PLOS ONE			English	Article							SUPPORT; SPEAK; CHILD	The Sewol ferry incident on April 16, 2014 in South Korea claimed the lives of 304 individuals, including about 250 high school students on a school trip. The majority of South Korean citizens were watching live updates on the capsized Sewol ferry, anxiously watching on TV how the vessel fully sunk over time. They were desperately hoping for the rescue of the survivors inside. However, their anxiety had become shock, anger, and helplessness, and the disaster has become a daunting, collective trauma, not just to the victims and their families, but also to the citizens who were exposed only through the media. In this study, we interviewed victims' families two years after the incident. We explored how they have experienced changes in their social relationships. We conducted semi-structured interviews of 54 family members of the student victims. We qualitatively examined the data applying a thematic analysis. Changes in their social relationships were largely divided into the relationships in the proximal environment and the relationships in distal environments. The former included subcategories such as immediate family, coworkers, friends, relatives, survived students and their parents, and concepts corresponding to each subcategory. The latter involved subcategories such as neighbors, other citizens, the victims' family committee, government, and society, and concepts subject to each subcategory. Based on these findings, rehabilitation plans for trauma victims and their families should take into account the significant changes in their social relationships and the further consequences of those changes.	[Cho, Sun Mi] Ajou Univ, Dept Psychiat, Sch Med, Kyunggi Do, South Korea; [Jeong, Ansuk] Univ Utah, Dept Psychol, Asia Campus, Incheon, South Korea; [Ha, Jung Hee] Hanyang Univ, Grad Sch Counseling Psychol, Seoul, South Korea; [Kim, Eun Young] Kyungpook Natl Univ, Dept Educ, Daegu, South Korea	Ajou University; Hanyang University; Kyungpook National University	Ha, JH (corresponding author), Hanyang Univ, Grad Sch Counseling Psychol, Seoul, South Korea.	hajung366@hanyang.ac.kr			Committee of Special Investigations of the Sewol Ferry Disaster [2015023427-00, 20151023571-00]; South Korean government	Committee of Special Investigations of the Sewol Ferry Disaster; South Korean government(Korean Government)	This study (Research Project #1 & #2 on Victims in South Korean Sewol Ferry Disaster) was supported by grant number 2015023427-00 (Research Project #1) and grant number 20151023571-00 (Research Project #2), funded by A Committee of Special Investigations of the Sewol Ferry Disaster (www.416commission.go.kr; this website has been closed since Jan. 2017 because it was temporarily run), received by SM Cho. In 2015, the Korean government launched the Committee of Special Investigation for the Sewol ferry disaster. The committee solicited applications for general investigations of the Sewol victims and their families. As a recipient of the investigation grant, this study was funded by the South Korean government. The committee for special investigation of the Sewol ferry disaster provided a register of the student victims' families who had signed a consent form for release of information. The funder had no role in study design, data analysis, decision to publish, or preparation of the manuscript.; In 2015, the Korean government launched the Sewol special investigation commission. The commission solicited applications for general investigations of the Sewol victims and their families. As a recipient of the investigation grant, this study was funded by the South Korean government.	Almedom AM, 2004, J BIOSOC SCI, V36, P381, DOI 10.1017/S0021932004006832; Boss P, 2014, BEREAVE CARE, V33, P63, DOI 10.1080/02682621.2014.933573; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Cleiren M, 1994, Crisis, V15, P22; Doka KJ, 2011, HELPING BEREAVED CHI; Dong-il Kim, 2015, [Korea Journal of Counseling, 상담학연구], V16, P473, DOI 10.15703/kjc.16.3.201506.473; Dyregrov K, 2004, SOC SCI MED, V58, P391, DOI 10.1016/S0277-9536(03)00205-3; Dyregrov K, 2015, J LOSS TRAUMA, V20, P556, DOI 10.1080/15325024.2014.957603; Erikson K., 1995, NEW SPECIES TROUBLE; Gosney J, 2011, J REHABIL MED, V43, P965, DOI 10.2340/16501977-0890; Hightower J, 2006, J GERONTOL SOC WORK, V46, P205, DOI 10.1300/J083v46n03_12; Horowitz MJ, 1993, INT HDB TRAUMATIC ST; KANIASTY K, 1993, J PERS SOC PSYCHOL, V64, P395, DOI 10.1037/0022-3514.64.3.395; Kellerman P. F., 2007, SOCIODRAMA COLLECTIV; Kim BS, 2014, KOREAN PUBLIC ADM RE, V48, P99; Kim DG, 2011, ENV DISASTER CHANGES; LaCapra D., 2004, HIST TRANSIT EXPERIE; LEHMAN DR, 1987, J PERS SOC PSYCHOL, V52, P218, DOI 10.1037/0022-3514.52.1.218; Lincoln Y, 1985, NATURALISTIC ENQUIRY; MIDDLETON W, 1993, AUST NZ J PSYCHIAT, V27, P457, DOI 10.3109/00048679309075803; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Norris FH, 2002, PSYCHIATRY, V65, P240, DOI 10.1521/psyc.65.3.240.20169; Patton M. Q., 1990, QUALITATIVE EVALUATI; Pedersen D., 2010, TRAUMA DISASTERS SOC; Picou JS, 2007, SOCIOL SPECTRUM, V27, P767, DOI 10.1080/02732170701534267; Picou JS, 2004, SOC FORCES, V82, P1493, DOI 10.1353/sof.2004.0091; Ramirez M, 2005, EPIDEMIOL REV, V27, P47, DOI 10.1093/epirev/mxi005; Rogers CH, 2008, J FAM PSYCHOL, V22, P203, DOI 10.1037/0893-3200.22.2.203; Schnittker J, 2007, J AGING HEALTH, V19, P659, DOI 10.1177/0898264307301178; WEISAETH L, 1989, ACTA PSYCHIAT SCAND, V80, P25, DOI 10.1111/j.1600-0447.1989.tb05251.x; Yun Sun Jin, 2008, ECO, V12, P145	31	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188699	10.1371/journal.pone.0188699	http://dx.doi.org/10.1371/journal.pone.0188699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216210	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800036
J	Finke, JB; Larra, MF; Merz, MU; Schachinger, H				Finke, Johannes B.; Larra, Mauro F.; Merz, Martina U.; Schaechinger, Hartmut			Startling similarity: Effects of facial self-resemblance and familiarity on the processing of emotional faces	PLOS ONE			English	Article							PREPULSE INHIBITION; EYEBLINK RESPONSE; NEURAL MECHANISMS; GAZE DIRECTION; OWN FACE; RECOGNITION; MODULATION; EXPRESSIONS; PERCEPTION; ATTENTION	Facial self-resemblance has been associated with positive emotional evaluations, but this effect may be biased by self-face familiarity. Here we report two experiments utilizing startle modulation to investigate how the processing of facial expressions of emotion is affected by subtle resemblance to the self as well as to familiar faces. Participants of the first experiment (I) (N = 39) were presented with morphed faces showing happy, neutral, and fearful expressions which were manipulated to resemble either their own or unknown faces. At SOAs of either 300 ms or 3500-4500 ms after picture onset, startle responses were elicited by binaural bursts of white noise (50 ms, 105 dB), and recorded at the orbicularis oculi via EMG. Manual reaction time was measured in a simple emotion discrimination paradigm. Pictures preceding noise bursts by short SOA inhibited startle (prepulse inhibition, PPI). Both affective modulation and PPI of startle in response to emotional faces was altered by physical similarity to the self. As indexed both by relative facilitation of startle and faster manual responses, self-resemblance apparently induced deeper processing of facial affect, particularly in happy faces. Experiment II (N = 54) produced similar findings using morphs of famous faces, yet showed no impact of mere familiarity on PPI effects (or response time, either). The results are discussed with respect to differential (presumably pre-attentive) effects of self-specific vs. familiar information in face processing.	[Finke, Johannes B.; Larra, Mauro F.; Merz, Martina U.; Schaechinger, Hartmut] Univ Trier, Inst Psychobiol, Dept Clin Psychophysiol, Trier, Germany	Universitat Trier	Finke, JB (corresponding author), Univ Trier, Inst Psychobiol, Dept Clin Psychophysiol, Trier, Germany.	finke@uni-trier.de	Finke, Johannes Bernd/AFN-2947-2022	Finke, Johannes Bernd/0000-0003-0713-5285	German Research Foundation (DFG) [SCHA 1067/5-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	None of the authors have potential conflicts of interest to declare. The study was funded by the German Research Foundation (DFG, grant No. SCHA 1067/5-1 to HS). The funding source did not play any role in study design, data collection and analysis, interpretation of results, or in writing and submitting of the manuscript.; We would like to thank the German Research Foundation (DFG) for providing financial support (grant SCHA 1067/5-1), as well as the Max Planck Institute for Human Development (Berlin) for granting access to the FACES database.	Angrilli A, 1996, BRAIN, V119, P1991, DOI 10.1093/brain/119.6.1991; Anokhin AP, 2010, BIOL PSYCHOL, V83, P37, DOI 10.1016/j.biopsycho.2009.10.001; Baudouin JY, 2000, MEMORY, V8, P285, DOI 10.1080/09658210050117717; Blumenthal T. D., 2008, STARTLE MODIFICATION, P51; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Blumenthal TD, 2004, PSYCHOPHYSIOLOGY, V41, P326, DOI 10.1111/j.1469-8986.2003.00144.x; Bohmelt AH, 1999, INT J PSYCHOPHYSIOL, V32, P239, DOI 10.1016/S0167-8760(99)00019-7; Bradley MM, 2006, PSYCHOPHYSIOLOGY, V43, P486, DOI 10.1111/j.1469-8986.2006.00412.x; BRADLEY MM, 1993, PSYCHOPHYSIOLOGY, V30, P541, DOI 10.1111/j.1469-8986.1993.tb02079.x; BRADLEY MM, 1990, PSYCHOPHYSIOLOGY, V27, P513, DOI 10.1111/j.1469-8986.1990.tb01966.x; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Bredart S, 2006, Q J EXP PSYCHOL, V59, P46, DOI 10.1080/17470210500343678; BROWN JD, 1986, SOC COGNITION, V4, P353, DOI 10.1521/soco.1986.4.4.353; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; DeBruine LM, 2008, ARCH SEX BEHAV, V37, P64, DOI 10.1007/s10508-007-9266-0; DeBruine LM, 2002, P ROY SOC B-BIOL SCI, V269, P1307, DOI 10.1098/rspb.2002.2034; DeBruine LM, 2004, P ROY SOC B-BIOL SCI, V271, P2085, DOI 10.1098/rspb.2004.2824; Devue C, 2011, CONSCIOUS COGN, V20, P40, DOI 10.1016/j.concog.2010.09.007; Devue C, 2009, COGNITION, V111, P114, DOI 10.1016/j.cognition.2009.01.003; Dobel C, 2008, PSYCHOL RES-PSYCH FO, V72, P580, DOI 10.1007/s00426-007-0132-4; Dunning JP, 2010, PSYCHOPHYSIOLOGY, V47, P874, DOI 10.1111/j.1469-8986.2010.01007.x; Duval ER, 2013, INT J PSYCHOPHYSIOL, V90, P354, DOI 10.1016/j.ijpsycho.2013.08.006; Ebner NC, 2010, BEHAV RES METHODS, V42, P351, DOI 10.3758/BRM.42.1.351; Enticott PG, 2008, NEUROPSYCHOLOGIA, V46, P2851, DOI 10.1016/j.neuropsychologia.2008.04.022; Epley N, 2008, PERS SOC PSYCHOL B, V34, P1159, DOI 10.1177/0146167208318601; Farmer H, 2014, PSYCHOL SCI, V25, P290, DOI 10.1177/0956797613494852; Feng MC, 2011, PSYCHOL AGING, V26, P752, DOI 10.1037/a0023110; Finke JB, 2015, INT J PSYCHOPHYSIOL, V96, P162, DOI 10.1016/j.ijpsycho.2015.04.009; Gainotti G, 2007, BRAIN RES REV, V56, P214, DOI 10.1016/j.brainresrev.2007.07.009; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gawronski B, 2013, J EXP SOC PSYCHOL, V49, P120, DOI 10.1016/j.jesp.2012.07.016; Giang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047809; Gillihan SJ, 2005, PSYCHOL BULL, V131, P76, DOI 10.1037/0033-2909.131.1.76; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Herbert C, 2010, SOC COGN AFFECT NEUR; Herbert C, 2010, INT J PSYCHOPHYSIOL, V76, P64, DOI 10.1016/j.ijpsycho.2010.02.004; Hungr CJ, 2012, Q J EXP PSYCHOL, V65, P1250, DOI 10.1080/17470218.2012.690769; Kaufmann JM, 2004, PERCEPTION, V33, P399, DOI 10.1068/p5083; Keenan JP, 1999, NEUROPSYCHOLOGIA, V37, P1421, DOI 10.1016/S0028-3932(99)00025-1; Koch M, 1997, BEHAV BRAIN RES, V89, P35, DOI 10.1016/S0166-4328(97)02296-1; KOCH M, 1993, EXP BRAIN RES, V97, P71; Krupp DB, 2008, EVOL HUM BEHAV, V29, P49, DOI 10.1016/j.evolhumbehav.2007.08.002; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; Lass-Hennemann J, 2011, ARCH SEX BEHAV, V40, P1007, DOI 10.1007/s10508-010-9662-8; Lass-Hennemann J, 2009, INT J PSYCHOPHYSIOL, V72, P111, DOI 10.1016/j.ijpsycho.2008.11.001; Li YH, 2013, EMOTION, V13, P196, DOI 10.1037/a0030755; Luthy M, 2003, APPETITE, V41, P191, DOI 10.1016/S0195-6663(03)00080-1; Ma YN, 2010, J EXP PSYCHOL HUMAN, V36, P619, DOI 10.1037/a0015797; Maister L, 2013, EMOTION, V13, P7, DOI 10.1037/a0030884; Miller MW, 2002, PSYCHOPHYSIOLOGY, V39, P519, DOI 10.1017/S0048577202394095; N'Diaye K, 2009, EMOTION, V9, P798, DOI 10.1037/a0017845; Negro E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129970; Paladino MP, 2010, PSYCHOL SCI, V21, P1202, DOI 10.1177/0956797610379234; Pannese A, 2011, NEUROPSYCHOLOGIA, V49, P564, DOI 10.1016/j.neuropsychologia.2010.12.019; Paulus A, 2014, COGNITION EMOTION, V28, P1493, DOI 10.1080/02699931.2014.886557; Paulus A, 2014, COGNITION EMOTION, V28, P656, DOI 10.1080/02699931.2013.849659; Pelham BW, 2005, CURR DIR PSYCHOL SCI, V14, P106, DOI 10.1111/j.0963-7214.2005.00344.x; Peskin M, 2004, PERCEPTION, V33, P147, DOI 10.1068/p5028; Platek SM, 2006, HUM BRAIN MAPP, V27, P91, DOI 10.1002/hbm.20168; Platek SM, 2003, EVOL HUM BEHAV, V24, P81, DOI 10.1016/S1090-5138(02)00117-4; PRENTICE DA, 1990, J PERS SOC PSYCHOL, V59, P369, DOI 10.1037/0022-3514.59.3.369; Ro T, 2001, PSYCHOL SCI, V12, P94, DOI 10.1111/1467-9280.00317; Robins RW, 2001, PERS SOC PSYCHOL B, V27, P151, DOI 10.1177/0146167201272002; Sander D, 2007, EUR J COGN PSYCHOL, V19, P470, DOI 10.1080/09541440600757426; Schweinberger SR, 1999, PERCEPT PSYCHOPHYS, V61, P1102, DOI 10.3758/BF03207617; Sforza A, 2010, SOC NEUROSCI-UK, V5, P148, DOI 10.1080/17470910903205503; Soussignan R, 2013, EMOTION, V13, P330, DOI 10.1037/a0029892; Tao R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047103; Theeuwes J, 2006, VIS COGN, V13, P657, DOI 10.1080/13506280500410949; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Tong F, 1999, J EXP PSYCHOL HUMAN, V25, P1016, DOI 10.1037/0096-1523.25.4.1016; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; Verosky SC, 2010, NEUROIMAGE, V49, P1690, DOI 10.1016/j.neuroimage.2009.10.017; Wangelin BC, 2012, BIOL PSYCHOL, V91, P103, DOI 10.1016/j.biopsycho.2012.05.002; Watson LA, 2007, BRAIN RES, V1152, P106, DOI 10.1016/j.brainres.2007.03.049; Wild-Wall N, 2008, BIOL PSYCHOL, V77, P138, DOI 10.1016/j.biopsycho.2007.10.001; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848	78	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189028	10.1371/journal.pone.0189028	http://dx.doi.org/10.1371/journal.pone.0189028			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216226	Green Submitted, Green Published, gold			2022-12-27	WOS:000417337800057
J	Lin, YC; Chen, HS				Lin, Yi-Chun; Chen, Harn-Shen			Longer time to peak glucose during the oral glucose tolerance test increases cardiovascular risk score and diabetes prevalence	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; FASTING PLASMA-GLUCOSE; INSULIN-RESISTANCE; HYPERGLYCEMIA; SENSITIVITY; ASSOCIATION; INTOLERANCE; PROGRESSION; SECRETION; MORTALITY	Introduction The pattern of glucose levels during an oral glucose tolerance test (OGTT) may be useful for predicting diabetes or cardiovascular disease (CVD). Our aim was to determine whether the time to peak glucose during the OGTT is associated with CVD risk scores and diabetes. Methods Individuals with impaired fasting glucose (IFG) were enrolled in this observational study. Participants were grouped by the measured time to peak glucose (30, 60, 90 and 120 min) during the 75g OGTT. The primary outcome was 10-year CVD risk scores (using the Framingham risk score calculator). Secondary outcomes evaluated effect of time to peak glucose on prevalence of diabetes and indicators of glucose homeostasis. Results A total of 125 patients with IFG underwent OGTTs. Framingham 10-year risk score for the 90-min group was 1.7 times higher than for the 60-min group (6.98 +/- 6.56% vs. 4.05 +/- 4.60%, P = 0.023). Based on multivariate linear regression, time to peak glucose at 90 min was associated with a higher Framingham risk score than 60-min group (beta coefficient: 2.043, 95% confidence interval: 0.067-6.008, P = 0.045). The percentages of patients with HbA(1c) >= 6.5%, isolated post-challenge hyperglycemia (IPH) and diabetes (combined IPH and HbA(1c) >= 6.5%) were significantly increased with longer times to peak glucose. Prevalence of diabetes was higher in the 90-min group than in the 60-min group (31.5% vs. 5.7%, P = 0.001). Conclusions In subjects with IFG, those with a longer time to peak glucose had a higher Framingham 10-year risk score and were associated with a greater likelihood of IPH and diabetes.	[Lin, Yi-Chun; Chen, Harn-Shen] Taipei Vet Gen Hosp, Div Endocrinol & Metab, Dept Med, Taipei, Taiwan; [Lin, Yi-Chun; Chen, Harn-Shen] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chen, HS (corresponding author), Taipei Vet Gen Hosp, Div Endocrinol & Metab, Dept Med, Taipei, Taiwan.; Chen, HS (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan.	chenhs@vghtpe.gov.tw			Taipei Veterans General Hospital [V102C-043, V105C-161]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was supported by Taipei Veterans General Hospital (V102C-043 and V105C-161)	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1613, DOI 10.2337/dc05-1711; BERGSTROM RW, 1990, J CLIN ENDOCR METAB, V71, P1447, DOI 10.1210/jcem-71-6-1447; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Borch-Johnsen K, 1999, LANCET, V354, P617; Crandall JP, 2009, J CLIN ENDOCR METAB, V94, P1595, DOI 10.1210/jc.2008-1829; Dinh W, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-63; EFENDIC S, 1984, ENDOCR REV, V5, P395, DOI 10.1210/edrv-5-3-395; Funk SD, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/569654; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hayashi T, 2013, DIABETES CARE, V36, P1229, DOI 10.2337/dc12-0246; Kim JY, 2012, DIABETES CARE, V35, P1925, DOI 10.2337/dc11-2476; KOSAKA K, 1977, DIABETES, V26, P944, DOI 10.2337/diab.26.10.944; Kramer CK, 2014, DIABETES RES CLIN PR, V105, P88, DOI 10.1016/j.diabres.2014.04.023; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ning F, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-76; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Qian L, 2008, CLIN ENDOCRINOL, V69, P575, DOI 10.1111/j.1365-2265.2008.03209.x; Qiao Q, 2002, EUR HEART J, V23, P1267, DOI 10.1053/euhj.2001.3113; REAVEN GM, 1976, AM J MED, V60, P80, DOI 10.1016/0002-9343(76)90536-2; Retnakaran R, 2010, CLIN ENDOCRINOL, V73, P476, DOI 10.1111/j.1365-2265.2010.03834.x; Selvarajah S, 2014, INT J CARDIOL, V176, P211, DOI 10.1016/j.ijcard.2014.07.066; Smith NL, 2002, ARCH INTERN MED, V162, P209, DOI 10.1001/archinte.162.2.209	23	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189047	10.1371/journal.pone.0189047	http://dx.doi.org/10.1371/journal.pone.0189047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216249	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800060
J	Olliac, B; Crespin, G; Laznik, MC; El Ganouni, OCI; Sarradet, JL; Bauby, C; Dandres, AM; Ruiz, E; Bursztejn, C; Xavier, J; Falissard, B; Bodeau, N; Cohen, D; Saint-Georges, C				Olliac, Bertrand; Crespin, Graciela; Laznik, Marie-Christine; Idrissi El Ganouni, Oussama Cherif; Sarradet, Jean-Louis; Bauby, Colette; Dandres, Anne-Marie; Ruiz, Emeline; Bursztejn, Claude; Xavier, Jean; Falissard, Bruno; Bodeau, Nicolas; Cohen, David; Saint-Georges, Catherine			Infant and dyadic assessment in early community-based screening for autism spectrum disorder with the PREAUT grid	PLOS ONE			English	Article							MODIFIED CHECKLIST; EARLY INTERVENTION; HIGH-RISK; YOUNG-CHILDREN; HOME MOVIES; 1ST YEAR; AT-RISK; TODDLERS; AGE; SIBLINGS	Background The need for early treatment of autism spectrum disorders (ASD) necessitates early screening. Very few tools have been prospectively tested with infants of less than 12 months of age. The PREAUT grid is based on dyadic assessment through interaction and shared emotion and showed good metrics for predicting ASD in very-high-risk infants with West syndrome. Methods We assessed the ability of the PREAUT grid to predict ASD in low-risk individuals by prospectively following and screening 12,179 infants with the PREAUT grid at four (PREAUT4) and nine (PREAUT-9) months of age. A sample of 4,835 toddlers completed the Checklist for Autism in Toddlers (CHAT) at 24 months (CHAT-24) of age. Children who were positive at one screening (N = 100) were proposed a clinical assessment (including the Children Autism Rating Scale, a Developmental Quotient, and an ICD-10-based clinical diagnosis if appropriate) in the third year of life. A randomly selected sample of 1,100 individuals who were negative at all screenings was followed by the PMI team from three to five years of age to identify prospective false negative cases. The clinical outcome was available for 45% (N = 45) of positive children and 52.6% (N = 579) of negative children. Results Of the 100 children who screened positive, 45 received a diagnosis at follow-up. Among those receiving a diagnosis, 22 were healthy, 10 were diagnosed with ASD, seven with intellectual disability (ID), and six had another developmental disorder. Thus, 50% of infants positive at one screening subsequently received a neurodevelopmental diagnosis. The PREAUT grid scores were significantly associated with medium and high ASD risk status on the CHAT at 24 months (odds ratio of 12.1 (95% CI: 3.0 - 36.8), p < 0.001, at four months and 38.1 (95% CI: 3.65 - 220.3), p < 0.001, at nine months). Sensitivity (Se), specificity, negative predictive values, and positive predictive values (PPVs) for PREAUT at four or nine months, and CHAT at 24 months, were similar [PREAUT-4: Se = 16.0 to 20.6%, PPV = 25.4 to 26.3%; PREAUT-9: Se = 30.5 to 41.2%, PPV = 20.2 to 36.4%; and CHAT-24: Se = 33.9 to 41.5%, PPV = 27.3 to 25.9%]. The repeated use of the screening instruments increased the Se but not PPV estimates [PREAUT and CHAT combined: Se = 67.9 to 77.7%, PPV = 19.0 to 28.0%]. Conclusions The PREAUT grid can contribute to very early detection of ASD and its combination with the CHAT may improve the early diagnosis of ASD and other neurodevelopmental disorders.	[Olliac, Bertrand; Xavier, Jean; Bodeau, Nicolas; Cohen, David; Saint-Georges, Catherine] Hop La Pitie Salpetriere, AP HP, Dept Child & Adolescent Psychiat, Paris, France; [Olliac, Bertrand] Ctr Hosp Esquirol, Dept Child & Adolescent Psychiat, Limoges, France; [Olliac, Bertrand] INSERM, Trop Neuroepidemiol, Unite Mixte Rech 1094, Limoges, France; [Crespin, Graciela; Sarradet, Jean-Louis; Bauby, Colette; Dandres, Anne-Marie; Ruiz, Emeline] PREAUT Assoc Programme Rech & Etud Autisme, Paris, France; [Laznik, Marie-Christine] Assoc Sante Mentale 13eme, Dept Child & Adolescent Psychiat, Paris, France; [Idrissi El Ganouni, Oussama Cherif] Mohamed VI Polytech Univ, Simlab, Ben Guerir, Morocco; [Bauby, Colette; Dandres, Anne-Marie] PMI Ctr, Ctr Protect Mother & Infant, Paris, France; [Bursztejn, Claude] Strasbourg Univ Hosp, Dept Child & Adolescent Psychiat, Strasbourg, France; [Xavier, Jean; Cohen, David; Saint-Georges, Catherine] UMPC, CNRS, ISIR, UMR 7222, Paris, France; [Falissard, Bruno] Univ Paris Sud, INSERM U669, Paris, France; [Falissard, Bruno] Univ Paris 05, Paris, France; [Saint-Georges, Catherine] Assoc CEREP PHYMENTIN, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Mohammed VI Polytechnic University; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Saint-Georges, C (corresponding author), Hop La Pitie Salpetriere, AP HP, Dept Child & Adolescent Psychiat, Paris, France.; Saint-Georges, C (corresponding author), UMPC, CNRS, ISIR, UMR 7222, Paris, France.; Saint-Georges, C (corresponding author), Assoc CEREP PHYMENTIN, Paris, France.	catherine.saintgeorges@gmail.com		Olliac, Bertrand/0000-0002-7442-2586	Association PREAUT; Programme Hospitalier de Recherche Clinique (PHRC) at Strasbourg University Hospital [2244]; team of physicians from the Mother and Child Health Protection Centre (Centre de Protection Maternelle et Infantile - PMI)	Association PREAUT; Programme Hospitalier de Recherche Clinique (PHRC) at Strasbourg University Hospital; team of physicians from the Mother and Child Health Protection Centre (Centre de Protection Maternelle et Infantile - PMI)	This research was supported by the Association PREAUT, the Programme Hospitalier de Recherche Clinique (PHRC no 2244) at Strasbourg University Hospital, and by the team of physicians from the Mother and Child Health Protection Centre (Centre de Protection Maternelle et Infantile - PMI).	Allison C, 2012, J AM ACAD CHILD PSY, V51, P202, DOI 10.1016/j.jaac.2011.11.003; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Baghdadli A, 2003, EUR CHILD ADOLES PSY, V12, P122, DOI 10.1007/s00787-003-0314-6; Baird G, 2000, J AM ACAD CHILD PSY, V39, P694, DOI 10.1097/00004583-200006000-00007; Barbaro J, 2010, J DEV BEHAV PEDIATR, V31, P376, DOI 10.1097/DBP.0b013e3181df7f3c; Baron-Cohen S, 2000, J ROY SOC MED, V93, P521, DOI 10.1177/014107680009301007; BARONCOHEN S, 1992, BRIT J PSYCHIAT, V161, P839, DOI 10.1192/bjp.161.6.839; BARONCOHEN S, 1996, BRIT J PSYCHIAT, V168, P158, DOI DOI 10.1192/BJP.168.2.158; Bedford R, 2016, MOL AUTISM, V7, DOI 10.1186/s13229-016-0081-0; Ben-Sasson A, 2014, J PEDIATR NURS, V29, P238, DOI 10.1016/j.pedn.2013.11.001; Blumberg Stephen J, 2013, Natl Health Stat Report, P1; Bradshaw J, 2015, J AUTISM DEV DISORD, V45, P778, DOI 10.1007/s10803-014-2235-2; Chamak B, 2011, AUTISM, V15, P83, DOI 10.1177/1362361309354756; Chlebowski C, 2013, PEDIATRICS, V131, pE1121, DOI 10.1542/peds.2012-1525; Christensen DL, 2016, MMWR SURVEILL SUMM, V65, P1; Clark A, 1999, J CHILD PSYCHOL PSYC, V40, P287, DOI 10.1017/S0021963098003400; Cohen D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061402; Costanzo V, 2015, NEUROSCI BIOBEHAV R, V55, P627, DOI 10.1016/j.neubiorev.2015.06.006; Daniels AM, 2011, J AUTISM DEV DISORD, V41, P110, DOI 10.1007/s10803-010-1031-x; Dawson G, 2008, DEV PSYCHOPATHOL, V20, P775, DOI 10.1017/S0954579408000370; De Giacomo A, 1998, EUR CHILD ADOLES PSY, V7, P131, DOI 10.1007/s007870050058; Delobel M, 2013, NEUROPSYCHIAT ENFAN, V61, P23, DOI [10.1016/j.neurenf.2012.09.007, DOI 10.1016/J.NEURENF.2012.09.007]; Dereu M, 2012, EUR CHILD ADOLES PSY, V21, P541, DOI 10.1007/s00787-012-0280-y; Dereu M, 2010, J AUTISM DEV DISORD, V40, P1247, DOI 10.1007/s10803-010-0984-0; Dietz C, 2006, J AUTISM DEV DISORD, V36, P713, DOI 10.1007/s10803-006-0114-1; Feldman R, 2007, J CHILD PSYCHOL PSYC, V48, P329, DOI 10.1111/j.1469-7610.2006.01701.x; Gammer I, 2015, INFANT BEHAV DEV, V38, P107, DOI 10.1016/j.infbeh.2014.12.017; GLASCOE FP, 1991, CLIN PEDIATR, V30, P8, DOI 10.1177/000992289103000101; Goin-Kochel RP, 2006, AUTISM, V10, P439, DOI 10.1177/1362361306066601; Green J, 2015, LANCET PSYCHIAT, V2, P133, DOI 10.1016/S2215-0366(14)00091-1; Green J, 2013, J AUTISM DEV DISORD, V43, P2502, DOI 10.1007/s10803-013-1797-8; Guinchat V, 2012, RES AUTISM SPECT DIS, V6, P589, DOI 10.1016/j.rasd.2011.10.005; Hansen SN, 2015, JAMA PEDIATR, V169, P56, DOI 10.1001/jamapediatrics.2014.1893; Harker CM, 2016, J AUTISM DEV DISORD, V46, P2399, DOI 10.1007/s10803-016-2772-y; Haute Autorite de Sante, 2010, AUT AUTR TROUBL ENV; Honda H, 2009, J CHILD PSYCHOL PSYC, V50, P972, DOI 10.1111/j.1469-7610.2009.02055.x; Jeste SS, 2014, NAT REV NEUROL, V10, P74, DOI 10.1038/nrneurol.2013.278; Jones E, 2016, PSYCHOLOGIST; Jones EJH, 2017, AUTISM RES, V10, P961, DOI 10.1002/aur.1754; Kamio Y, 2014, J AUTISM DEV DISORD, V44, P194, DOI 10.1007/s10803-013-1864-1; Kleinman JM, 2008, J AUTISM DEV DISORD, V38, P606, DOI 10.1007/s10803-007-0427-8; Klin A, 2015, REV NEUROLOGIA, V60, pS3; Latif AHA, 2007, AUTISM, V11, P479, DOI 10.1177/1362361307083256; Laznik MC, 2003, PSYCHIAT FRANCAISE, V34, P14; Leclere C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113571; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C., 2008, AUTISM DIAGNOSTIC OB, V2nd; Lung FW, 2011, RES AUTISM SPECT DIS, V5, P1385, DOI 10.1016/j.rasd.2011.01.024; Maestro S, 2006, ACTA PSYCHIAT SCAND, V113, P68, DOI 10.1111/j.1600-0447.2005.00695.x; Maestro S, 1999, PSYCHOPATHOLOGY, V32, P292, DOI 10.1159/000029102; Mandell DS, 2005, PEDIATRICS, V116, P1480, DOI 10.1542/peds.2005-0185; Masten AS, 2010, DEV PSYCHOPATHOL, V22, P491, DOI 10.1017/S0954579410000222; Matson JL, 2011, RES AUTISM SPECT DIS, V5, P418, DOI 10.1016/j.rasd.2010.06.004; Mottron L., 2017, EUR CHILD ADOLESC PS; Narzisi A, 2014, CURR CLIN PHARMACOL, V9, P17, DOI 10.2174/15748847113086660071; Oosterling IJ, 2010, J CHILD PSYCHOL PSYC, V51, P250, DOI 10.1111/j.1469-7610.2009.02150.x; Oosterling IJ, 2009, J AUTISM DEV DISORD, V39, P897, DOI 10.1007/s10803-009-0692-9; Ouss L, 2014, EUR CHILD ADOLES PSY, V23, P143, DOI 10.1007/s00787-013-0430-x; Ozonoff S, 2015, J CHILD PSYCHOL PSYC, V56, P988, DOI 10.1111/jcpp.12421; Ozonoff S, 2009, J DEV BEHAV PEDIATR, V30, P367, DOI 10.1097/DBP.0b013e3181ba0fcf; Pandey J, 2008, AUTISM, V12, P513, DOI 10.1177/1362361308094503; Pierce K, 2011, J PEDIATR-US, V159, P458, DOI 10.1016/j.jpeds.2011.02.036; Prior M., 2011, REV RES IDENTIFY MOS; Quigley J, 2016, LANG LEARN DEV, V12, P295, DOI 10.1080/15475441.2015.1075405; Robins DL, 2008, AUTISM, V12, P537, DOI 10.1177/1362361308094502; Robins DL, 2014, PEDIATRICS, V133, P37, DOI 10.1542/peds.2013-1813; Rogers SJ, 2014, J AUTISM DEV DISORD, V44, P2981, DOI 10.1007/s10803-014-2202-y; Rogers SJ, 2008, J CLIN CHILD ADOLESC, V37, P8, DOI 10.1080/15374410701817808; Rogers SJ, 2009, AUTISM RES, V2, P125, DOI 10.1002/aur.81; Rondeau E, 2011, J AUTISM DEV DISORD, V41, P1267, DOI 10.1007/s10803-010-1155-z; Rowberry J, 2015, J AUTISM DEV DISORD, V45, P221, DOI 10.1007/s10803-014-2211-x; Saint-Georges C, 2013, EARLY SIGNS AUTISM H, P400; Saint-Georges C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022393; Saint-Georges C, 2010, RES AUTISM SPECT DIS, V4, P355, DOI 10.1016/j.rasd.2009.10.017; Salomone E, 2016, AUTISM, V20, P233, DOI 10.1177/1362361315577218; Salomone E, 2015, EUR J PEDIATR, V174, P1277, DOI 10.1007/s00431-015-2531-7; Schieve LA, 2011, ANN EPIDEMIOL, V21, P930, DOI 10.1016/j.annepidem.2011.08.009; Stenberg N, 2014, PAEDIATR PERINAT EP, V28, P255, DOI 10.1111/ppe.12114; Sunita, 2013, J PAEDIATR CHILD H, V49, P438, DOI 10.1111/j.1440-1754.2012.02558.x; Swain NR, 2015, INT J LANG COMM DIS, V50, P488, DOI 10.1111/1460-6984.12150; Trevarthen C., 2016, SURVIVING EARLY YEAR, P19; Turner-Brown LM, 2013, AUTISM, V17, P527, DOI 10.1177/1362361312439633; van Bakel MME, 2015, J AUTISM DEV DISORD, V45, P3255, DOI 10.1007/s10803-015-2486-6; VanDenHeuvel A, 2007, Ir Med J, V100, P565; Wan MW, 2012, RES DEV DISABIL, V33, P924, DOI 10.1016/j.ridd.2011.12.011; Wendland J, 2014, J PEDIATR PSYCHOL, V39, P562, DOI 10.1093/jpepsy/jsu016; Wetherby AM, 2008, AUTISM, V12, P487, DOI 10.1177/1362361308094501; Windham GC, 2014, J AUTISM DEV DISORD, V44, P1621, DOI 10.1007/s10803-014-2032-y; Xavier J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01954; Zwaigenbaum L, 2005, INT J DEV NEUROSCI, V23, P143, DOI 10.1016/j.ijdevneu.2004.05.001; Zwaigenbaum L, 2015, PEDIATRICS, V136, pS41, DOI 10.1542/peds.2014-3667D; Zwaigenbaum L, 2015, PEDIATRICS, V136, pS60, DOI 10.1542/peds.2014-3667E	93	8	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188831	10.1371/journal.pone.0188831	http://dx.doi.org/10.1371/journal.pone.0188831			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216234	Green Published, gold			2022-12-27	WOS:000417337800043
J	Dai, L; Mukai, H; Lindholm, B; Heimburger, O; Barany, P; Stenvinkel, P; Qureshi, AR				Dai, Lu; Mukai, Hideyuki; Lindholm, Bengt; Heimburger, Olof; Barany, Peter; Stenvinkel, Peter; Qureshi, Abdul Rashid			Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients	PLOS ONE			English	Article							PERITONEAL-DIALYSIS PATIENTS; BODY-MASS INDEX; STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; SERUM-ALBUMIN; PARADOXICAL ASSOCIATION; MALNUTRITION; INFLAMMATION; VALIDITY; ATHEROSCLEROSIS	Background The value of subjective global assessment (SGA) as nutritional assessor of protein-energy wasting (PEWSGA) in chronic kidney disease (CKD) patients depends on its mortality predictive capacity. We investigated associations of PEWSGA with markers of nutritional status and all-cause mortality in CKD patients. Methods In 1031 (732 CKD1-5 non-dialysis and 299 dialysis) patients, SGA and body (BMI), lean (LBMI) and fat (FBMI) body mass indices, % handgrip strength (% HGS), serum albumin, and high sensitivity C-reactive protein (hsCRP) were examined at baseline. The five-year all-cause mortality predictive strength of baseline PEWSGA and during follow-up were investigated. Results PEWSGA was present in 2% of CKD1-2, 16% of CKD3-4, 31% of CKD5 non-dialysis and 44% of dialysis patients. Patients with PEWSGA (n = 320; 31%) had higher hsCRP and lower BMI, LBMI, FBMI, % HGS and serum albumin. But, using receiver operating characteristics-derived cutoffs, these markers could not classify (by kappa statistic) or explain variations of (by multinomial logistic regression analysis) presence of PEWSGA. In generalized linear models, SGA independently predicted mortality after adjustments of multiple confounders (RR: 1.17; 95% CI: 1.11-1.23). Among 323 CKD5 patients who were re-assessed after median 12.6 months, 222 (69%) remained well-nourished, 37 (11%) developed PEWSGA de novo, 40 (12%) improved while 24 (8%) remained with PEWSGA. The latter independently predicted mortality (RR: 1.29; 95% CI: 1.13-1.46). Conclusions SGA, a valid assessor of nutritional status, is an independent predictor of all-cause mortality both in CKD non-dialysis and dialysis patients that outperforms non-composite nutritional markers as prognosticator.	[Dai, Lu; Mukai, Hideyuki; Lindholm, Bengt; Heimburger, Olof; Barany, Peter; Stenvinkel, Peter; Qureshi, Abdul Rashid] Karolinska Inst, Div Renal Med, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Dai, Lu; Mukai, Hideyuki; Lindholm, Bengt; Heimburger, Olof; Barany, Peter; Stenvinkel, Peter; Qureshi, Abdul Rashid] Karolinska Inst, Baxter Novum, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Dai, Lu] Tianjin Univ Tradit Chinese Med, Affiliated Teaching Hosp 1, Renal Dept, Tianjin, Peoples R China	Karolinska Institutet; Karolinska Institutet; Tianjin University of Traditional Chinese Medicine	Qureshi, AR (corresponding author), Karolinska Inst, Div Renal Med, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.; Qureshi, AR (corresponding author), Karolinska Inst, Baxter Novum, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	tony.qureshi@ki.se	Dai, Lu/ACC-9112-2022; Qureshi, Abdul Rashid Tony/G-1358-2010; Lindholm, Bengt/P-1334-2017	Qureshi, Abdul Rashid Tony/0000-0003-0536-5327; Heimburger, Olof/0000-0003-0901-4145; Stenvinkel, Peter/0000-0002-8785-4820; Lindholm, Bengt/0000-0003-4269-4293; Barany, Peter/0000-0001-6501-8293	Baxter Healthcare Corporation; Amgen Inc; China Scholarship Council; Swedish Research council; Martin Rind Foundation; Njurfonden; Westmans Foundation	Baxter Healthcare Corporation; Amgen Inc(Amgen); China Scholarship Council(China Scholarship Council); Swedish Research council(Swedish Research CouncilEuropean Commission); Martin Rind Foundation; Njurfonden; Westmans Foundation	This study was supported by grants from Baxter Healthcare Corporation and Amgen Inc to Karolinska Institutet. The grant from Baxter Healthcare Corporation was a general grant to Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, to support research activities at Karolinska Institutet to promote the understanding and treatment of renal disease which made it possible to carry out this and other studies. The grant from Amgen Inc was given to Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, to support two observational studies on inflammation in dialysis patients treated by hemodialysis and peritoneal dialysis respectively. Lu Dai received a scholarship from the China Scholarship Council. The study also benefited from generous support from Swedish Research council (Peter Stenvinkel), Martin Rind Foundation (Peter Stenvinkel), Njurfonden (Peter Stenvinkel), and Westmans Foundation. Bengt Lindholm is employed by Baxter Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acchiardo S R, 1983, Kidney Int Suppl, V16, pS199; Chan M, 2012, J RENAL NUTR, V22, P547, DOI 10.1053/j.jrn.2011.11.002; Churchill DN, 1996, J AM SOC NEPHROL, V7, P198; CIANCIARUSO B, 1995, AM J KIDNEY DIS, V26, P475, DOI 10.1016/0272-6386(95)90494-8; Cooper BA, 2002, AM J KIDNEY DIS, V40, P126, DOI 10.1053/ajkd.2002.33921; Cuppari L, 2014, J RENAL NUTR, V24, P385, DOI 10.1053/j.jrn.2014.05.004; de Mutsert R, 2008, NEPHROL DIAL TRANSPL, V23, P2957, DOI 10.1093/ndt/gfn167; de Mutsert R, 2009, CONTRIB NEPHROL, V163, P124, DOI 10.1159/000223790; de Mutsert R, 2009, AM J CLIN NUTR, V89, P787, DOI 10.3945/ajcn.2008.26970; de Mutsert R, 2009, J RENAL NUTR, V19, P127, DOI 10.1053/j.jrn.2008.08.003; Santin FGD, 2016, J RENAL NUTR, V26, P18, DOI 10.1053/j.jrn.2015.07.002; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; Dong J, 2006, BLOOD PURIFICAT, V24, P517, DOI 10.1159/000096472; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; ENIA G, 1993, NEPHROL DIAL TRANSPL, V8, P1094; Fiedler R, 2009, NEPHROL DIAL TRANSPL, V24, P3812, DOI 10.1093/ndt/gfp346; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Gama-Axelsson T, 2012, CLIN J AM SOC NEPHRO, V7, P1446, DOI 10.2215/CJN.10251011; Ghanavatian S, 2014, ANGIOLOGY, V65, P443, DOI 10.1177/0003319713483000; Isoyama N, 2015, NEPHROL DIAL TRANSPL, V30, P84, DOI 10.1093/ndt/gfu259; Jones CH, 1997, NEPHROL DIAL TRANSPL, V12, P1406, DOI 10.1093/ndt/12.7.1406; Jones CH, 2004, J RENAL NUTR, V14, P26, DOI 10.1053/j.jrn.2003.09.006; Kovesdy CP, 2007, AM J KIDNEY DIS, V49, P581, DOI 10.1053/j.ajkd.2007.02.277; Kovesdy CP, 2009, SEMIN NEPHROL, V29, P3, DOI 10.1016/j.semnephrol.2008.10.002; Kwon YE, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002714; Kyle UG, 2003, NUTRITION, V19, P597, DOI 10.1016/S0899-9007(03)00061-3; Leinig CE, 2011, J RENAL NUTR, V21, P176, DOI 10.1053/j.jrn.2010.06.026; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Moradi H, 2015, AM J NEPHROL, V41, P284, DOI 10.1159/000381991; Paudel K, 2015, J RENAL NUTR, V25, P480, DOI 10.1053/j.jrn.2015.05.003; Pifer TB, 2002, KIDNEY INT, V62, P2238, DOI 10.1046/j.1523-1755.2002.00658.x; Prasad N, 2008, J RENAL NUTR, V18, P195, DOI 10.1053/j.jrn.2007.08.002; Qureshi AR, 2015, KIDNEY INT, V88, P1356, DOI 10.1038/ki.2015.194; Qureshi AR, 1998, KIDNEY INT, V53, P773, DOI 10.1046/j.1523-1755.1998.00812.x; Siri W., 1961, TECHNIQUES MEASURING, P223; Snaedal S, 2009, AM J KIDNEY DIS, V53, P1024, DOI 10.1053/j.ajkd.2009.02.008; Steiber A, 2007, J RENAL NUTR, V17, P336, DOI 10.1053/j.jrn.2007.05.004; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Stenvinkel P, 2002, NEPHROL DIAL TRANSPL, V17, P1266, DOI 10.1093/ndt/17.7.1266; Stenvinkel P, 2016, J AM SOC NEPHROL, V27, P1479, DOI 10.1681/ASN.2015030252; Xu H, 2015, PERITON DIALYSIS INT, V35, P460, DOI 10.3747/pdi.2013.00064; Xu H, 2015, PERITON DIALYSIS INT, V35, P206, DOI 10.3747/pdi.2013.00259; YOUNG GA, 1991, AM J KIDNEY DIS, V17, P462, DOI 10.1016/S0272-6386(12)80642-1	43	36	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0186659	10.1371/journal.pone.0186659	http://dx.doi.org/10.1371/journal.pone.0186659			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211778	Green Published, Green Submitted, gold			2022-12-27	WOS:000417212200007
J	Dupeyron, A; Lanhers, C; Bastide, S; Alonso, S; Toulotte, M; Jourdan, C; Coudeyre, E				Dupeyron, Arnaud; Lanhers, Charlotte; Bastide, Sophie; Alonso, Sandrine; Toulotte, Matthias; Jourdan, Claire; Coudeyre, Emmanuel			The Back Belief Questionnaire is efficient to assess false beliefs and related fear in low back pain populations: A transcultural adaptation and validation study	PLOS ONE			English	Article							CROSS-CULTURAL ADAPTATION; AVOIDANCE BELIEFS; PSYCHOMETRIC PROPERTIES; TAMPA SCALE; KINESIOPHOBIA; MANAGEMENT; DISABILITY; GUIDELINES; VERSION; CARE	Background According to the fear avoidance model, beliefs and thoughts can modify the outcome of patient with low back pain. The Back Belief Questionnaire (BBQ)-a 14 items scale-assesses these consequences of low back pain. Objective To test the psychometric properties of the French version of the BBQ. Methods The BBQ was translated using the forward -backward translation process. Throughout three repeated evaluation time points (D1, D7 and D30), various aspects of validity were analysed: acceptability, quality of items, unidimentionality, internal consistency, temporal stability (between D1 and D7), responsiveness (between D7 and D30), and construct validity comparing it to other validated scales. Results One hundred and thirty-one patients were enrolled and 128 were analyzed. The acceptability and the quality of the items were excellent. The scale was unidimensional and reliable (internal consistency: Cronbach's a = 0.8). The responsiveness was moderate but in line with other scores. The BBQ was, as expected, convergent with day-to-day activities and fear avoidance (FABQ and Tampa), disability (Quebec and Dallas scores), or anxiety and depression (HAD); and not correlated with pain. Best correlations were found with Tampa and FABQ. The temporal stability (test-retest reliability) was poor. However, similar changes were observed in near conceptual score (FABQ), which confirmed that clinical status may have not been stable and suggesting sensitivity to early changes for BBQ. Conclusions The BBQ showed good psychometric properties to assess false beliefs and related fear in French or English LBP populations and can be used either for evaluation in international trials or as a part of self-care training.	[Dupeyron, Arnaud; Toulotte, Matthias] CHU Nimes, Serv Med Phys & Readaptat, Nimes, France; [Dupeyron, Arnaud] Univ Montpellier, EuroMov, Montpellier, France; [Lanhers, Charlotte; Coudeyre, Emmanuel] CHU Clermont Ferrand, Dept Med Phys & Readaptat, Clermont Ferrand, France; [Bastide, Sophie; Alonso, Sandrine] CHU Nimes, Dept Biostat Epidemiol Sante Publ & Infomat Med B, Nimes, France; [Jourdan, Claire] Ctr Hospitalier Univ Lapeyronie, Dept Med Phys & Readaptat, Montpellier, France; [Coudeyre, Emmanuel] CRNH Auvergne, INRA, Unite Nutr Humaine UMR 1019, Clermont Ferrand, France	Universite de Montpellier; CHU de Nimes; Universite de Montpellier; CHU Clermont Ferrand; Universite de Montpellier; CHU de Nimes; Universite de Montpellier; CHU de Montpellier; INRAE	Dupeyron, A (corresponding author), CHU Nimes, Serv Med Phys & Readaptat, Nimes, France.; Dupeyron, A (corresponding author), Univ Montpellier, EuroMov, Montpellier, France.	arnaud.dupeyron@umontpellier.fr		alonso, sandrine/0000-0001-9838-0272; Dupeyron, Arnaud/0000-0001-5085-3739	University Regional Hospital Caremeau, Nimes, France [Local/2010/AD-02]	University Regional Hospital Caremeau, Nimes, France	This research was funded by the University Regional Hospital Caremeau, Nimes, France, Grant Number: Local/2010/AD-02. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bostick GP, 2013, EUR J PAIN, V17, P1074, DOI 10.1002/j.1532-2149.2012.00275.x; Brox JI, 2014, SPINE J, V14, P2679, DOI 10.1016/j.spinee.2014.08.454; Buchbinder R, 2001, SPINE, V26, P2535, DOI 10.1097/00007632-200112010-00005; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; Chaory K, 2004, SPINE, V29, P908, DOI 10.1097/00007632-200404150-00018; Coudeyre E, 2007, CLIN J PAIN, V23, P720, DOI 10.1097/AJP.0b013e31814da407; Coudeyre E, 2006, PAIN, V124, P330, DOI 10.1016/j.pain.2006.05.003; Dupeyron A., 2011, Annals of Physical and Rehabilitation Medicine, V54, P319, DOI 10.1016/j.rehab.2011.06.001; Fermanian J., 2005, Annales de Readaptation et de Medecine Physique, V48, P281, DOI 10.1016/j.annrmp.2005.04.004; FEUERSTEIN M, 1995, PHYS THER, V75, P267, DOI 10.1093/ptj/75.4.267; Figueiredo IT, 2016, ANN PHYS REHABIL MED, V59, P289, DOI 10.1016/j.rehab.2016.03.006; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hemker BT, APPL PSYCHOL MEASURE, V19, P337; Hinkle D.E., 2003, APPL STAT BEHAV SCI; KOPEC JA, 1995, SPINE, V20, P341, DOI 10.1097/00007632-199502000-00016; Kori SH., 1990, PAIN MANAG, P35; LAWLIS GF, 1989, SPINE, V14, P511, DOI 10.1097/00007632-198905000-00007; Middel Berrie, 2002, Int J Integr Care, V2, pe15; Rainville J, 2011, SPINE J, V11, P895, DOI 10.1016/j.spinee.2011.08.006; Swinkels-Meewisse EJCM, 2003, MANUAL THER, V8, P29, DOI 10.1054/math.2002.0484; Symonds TL, 1996, OCCUP MED-OXFORD, V46, P25, DOI 10.1093/occmed/46.1.25; Thomas E. -N., 2010, Annals of Physical and Rehabilitation Medicine, V53, P3, DOI 10.1016/j.rehab.2009.11.002; WADDELL G, 1987, SPINE, V12, P632, DOI 10.1097/00007632-198709000-00002; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Wertli MM, 2014, SPINE J, V14, P2658, DOI 10.1016/j.spinee.2014.02.033; Woby SR, 2005, PAIN, V117, P137, DOI 10.1016/j.pain.2005.05.029; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	30	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0186753	10.1371/journal.pone.0186753	http://dx.doi.org/10.1371/journal.pone.0186753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211745	Green Published, Green Submitted, gold			2022-12-27	WOS:000417212200009
J	Fattuoni, C; Pietrasanta, C; Pugni, L; Ronchi, A; Palmas, F; Barberini, L; Dessi, A; Pintus, R; Fanos, V; Noto, A; Mosca, F				Fattuoni, Claudia; Pietrasanta, Carlo; Pugni, Lorenza; Ronchi, Andrea; Palmas, Francesco; Barberini, Luigi; Dessi, Angelica; Pintus, Roberta; Fanos, Vassilios; Noto, Antonio; Mosca, Fabio			Urinary metabolomic analysis to identify preterm neonates exposed to histological chorioamnionitis: A pilot study	PLOS ONE			English	Article							EMPIRICAL ANTIBIOTIC-TREATMENT; HIGH-DIMENSIONAL BIOLOGY; EARLY-ONSET SEPSIS; CLINICAL CHORIOAMNIONITIS; INFANTS; BIRTH; MANAGEMENT; DISEASE; GUIDELINES; PATTERNS	Objective Chorioamnionitis is a leading cause of preterm birth worldwide, with higher incidence at lower gestational ages. An early and reliable diagnosis of histological chorioamnionitis (HCA) in preterm infants may be helpful in guiding postnatal management, especially the administration of prophylactic antibiotics to prevent early-onset sepsis. The main aim of this study was to investigate metabolomic analysis of urines collected in the first 24 hours of life as diagnostic tool of HCA. Methods Gestational age-, birth weight-, delivery mode-and sex-matched (1: 2) preterm neonates (< 35 weeks' gestation) born to mothers with or without HCA were enrolled from an observational study. Gas chromatography-mass spectrometry (GC-MS)-based metabolomic analysis was performed on urine samples non-invasively collected in the first 24 hours of life. Univariate analysis, partial least square discriminant analysis (PLS-DA) and its associated variable importance in projection (VIP) score were performed. The most affected metabolic pathways were examined by Metabolite Sets Enrichment Analysis (MSEA). Results Fifteen cases (mean GA 30.2 +/- 3.8 weeks, mean BW 1415 +/- 471.9 grams) and 30 controls (mean GA 30.2 +/- 2.9 weeks, mean BW 1426 +/- 569.8 grams) were enrolled. Following univariate analysis, 29 metabolites had a significantly different concentration between cases and controls. The supervised PLS-DA model confirmed a separation between the two groups. Only gluconic acid, an oxidation product of glucose, was higher in cases than in controls. All other VIP metabolites were more abundant in the control group. Glutamate metabolism, mitochondrial electron transport chain, citric acid cycle, galactose metabolism, and fructose and mannose degradation metabolism were the most significantly altered pathways (P < 0.01). Conclusions For the first time, urinary metabolomics was able to discriminate neonates born to mothers with and without HCA. The identification of specifically altered metabolic pathways may be helpful in understanding metabolic derangement following chorioamnionitis.	[Fattuoni, Claudia; Palmas, Francesco] Univ Cagliari, Dept Chem & Geol Sci, Cagliari, Italy; [Pietrasanta, Carlo; Pugni, Lorenza; Ronchi, Andrea; Mosca, Fabio] Univ Milan, Dept Clin Sci & Community Hlth, Fdn IRCCS Ca Granda Osped Maggiore Policlin, NICU, Milan, Italy; [Barberini, Luigi] Univ Cagliari, Dept Med Sci & Publ Hlth, Cagliari, Italy; [Dessi, Angelica; Pintus, Roberta; Fanos, Vassilios; Noto, Antonio] AOUCA Univ Hosp Cagliari, Maternal Neonatal Dept, Neonatal Intens Care Unit, Puericulture Inst, Cagliari, Italy; [Dessi, Angelica; Pintus, Roberta; Fanos, Vassilios; Noto, Antonio] AOUCA Univ Hosp Cagliari, Neonatal Sect, Cagliari, Italy	University of Cagliari; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Cagliari	Pugni, L (corresponding author), Univ Milan, Dept Clin Sci & Community Hlth, Fdn IRCCS Ca Granda Osped Maggiore Policlin, NICU, Milan, Italy.	lorenza.pugni@mangiagalli.it	Palmas, Francesco/AAV-8482-2021; pietrasanta, carlo/K-5786-2018; Fattuoni, Claudia/N-2843-2014; Fanos, Vassilios/AHI-0685-2022; Dessì, Angelica/AHD-9828-2022; Barberini, Luigi/Q-5870-2019; Barberini, Luigi/G-3669-2012; MOSCA, FABIO/C-5826-2017	Palmas, Francesco/0000-0001-8578-6871; pietrasanta, carlo/0000-0002-1019-4422; Fattuoni, Claudia/0000-0002-6956-7967; Barberini, Luigi/0000-0002-3815-0392; Barberini, Luigi/0000-0002-3815-0392; MOSCA, FABIO/0000-0001-6477-0299	Sardinia Regional Government (P.O.R. Sardegna F.S.E. Operational Programme of the Autonomous Region of Sardinia); Sardinia Regional Government (European Social Fund-Axis IV Human Resources)	Sardinia Regional Government (P.O.R. Sardegna F.S.E. Operational Programme of the Autonomous Region of Sardinia); Sardinia Regional Government (European Social Fund-Axis IV Human Resources)	Francesco Palmas was supported for his PhD scholarship by Sardinia Regional Government (P.O.R. Sardegna F.S.E. Operational Programme of the Autonomous Region of Sardinia, European Social Fund 2007-2013-Axis IV Human Resources, Objective I.3, Line of Activity I.3.1.).	Abehsera D, 2014, PLACENTA, V35, P70, DOI 10.1016/j.placenta.2013.10.009; Alm B, 2008, PEDIATRICS, V121, P697, DOI 10.1542/peds.2007-1232; Andrews WW, 2006, AM J OBSTET GYNECOL, V195, P803, DOI 10.1016/j.ajog.2006.06.083; Been JV, 2009, ARCH DIS CHILD-FETAL, V94, pF218, DOI 10.1136/adc.2008.150458; Been JV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046217; Behrends V, 2013, J BIOL CHEM, V288, P15098, DOI 10.1074/jbc.M112.442814; Brady MT, 2013, PEDIATRICS, V132, P166, DOI 10.1542/peds.2013-1310; Buhimschi Irina A, 2013, Expert Opin Med Diagn, V7, P5, DOI 10.1517/17530059.2012.709232; Chaemsaithong P, 2016, J MATERN-FETAL NEO M, V29, P360, DOI 10.3109/14767058.2015.1006621; Cotten CM, 2015, CLIN PERINATOL, V42, P195, DOI 10.1016/j.clp.2014.10.007; Cotten CM, 2009, PEDIATRICS, V123, P58, DOI 10.1542/peds.2007-3423; De Angelis M, 2015, GUT MICROBES, V6, P207, DOI 10.1080/19490976.2015.1035855; Dessi A, 2011, J MATERN-FETAL NEO M, V24, P36, DOI 10.3109/14767058.2011.605868; Dudzik D, 2015, J PROTEOME RES, V14, P1432, DOI 10.1021/pr501087x; Fanos V, 2014, EARLY HUM DEV, V90, pS78, DOI 10.1016/S0378-3782(14)70024-6; Fanos V, 2013, EARLY HUM DEV, V89, pS58, DOI 10.1016/S0378-3782(13)70017-3; Gantert M, 2010, J PERINATOL, V30, pS21, DOI 10.1038/jp.2010.96; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Higgins RD, 2016, OBSTET GYNECOL, V127, P426, DOI 10.1097/AOG.0000000000001246; Julious SA, 2005, PHARM STAT, V4, P287, DOI 10.1002/pst.185; Kamath-Rayne BD, 2014, REPROD SCI, V21, P6, DOI 10.1177/1933719113485292; Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS29, DOI 10.1016/j.ajog.2015.08.040; Kuppala VS, 2011, J PEDIATR-US, V159, P720, DOI 10.1016/j.jpeds.2011.05.033; Lahra MM, 2009, PEDIATRICS, V123, P1314, DOI 10.1542/peds.2008-0656; Megli C, 2016, AM J OBSTET GYNECOL, V214, pS271, DOI 10.1016/j.ajog.2015.10.540; Mukhopadhyay S, 2013, J PERINATOL, V33, P198, DOI 10.1038/jp.2012.96; Ogunyemi D, 2003, J Matern Fetal Neonatal Med, V13, P102, DOI 10.1080/jmf.13.2.102.109; Palmas F, 2016, J PEDIAT NEONAT INDI, V5; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Pugni L, 2016, J MATERN-FETAL NEO M, V29, P1525, DOI 10.3109/14767058.2015.1053862; Puopolo KM, 2013, CURR OPIN PEDIATR, V25, P161, DOI 10.1097/MOP.0b013e32835e1f96; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P118, DOI 10.1111/j.1471-0528.2006.01150.x; Romero R, 2010, J MATERN-FETAL NEO M, V23, P1344, DOI 10.3109/14767058.2010.482618; Singer M, 2014, VIRULENCE, V5, P66, DOI 10.4161/viru.26907; Soraisham AS, 2013, J PERINATOL, V33, P70, DOI 10.1038/jp.2012.49; Sung JH, 2017, BJOG-INT J OBSTET GY, V124, P775, DOI 10.1111/1471-0528.14176; Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319	44	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189120	10.1371/journal.pone.0189120	http://dx.doi.org/10.1371/journal.pone.0189120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211784	Green Published, Green Submitted, gold			2022-12-27	WOS:000417212200066
J	Schiavano, GF; Carloni, E; Andreoni, F; Magi, S; Chironna, M; Brandi, G; Amagliani, G				Schiavano, Giuditta Fiorella; Carloni, Elisa; Andreoni, Francesca; Magi, Silvia; Chironna, Maria; Brandi, Giorgio; Amagliani, Giulia			Prevalence and antibiotic resistance of Pseudomonas aeruginosa in water samples in central Italy and molecular characterization of oprD in imipenem resistant isolates	PLOS ONE			English	Article							MECHANISMS; MEROPENEM	Scope This study aimed to analyse the prevalence, antibiotic resistance and genetic relatedness of P. aeruginosa isolates obtained from potable and recreational water samples (n. 8,351) collected from different settings (swimming pools, n. 207; healthcare facilities, n 1,684; accommodation facilities, n. 1,518; municipal waterworks, n. 4,500; residential buildings, n. 235). Possible mechanisms underlying resistance to imipenem, with particular focus on those involving oprD-based uptake, were also explored. Methods and results Isolation and identification of Pseudomonas aeruginosa was performed according to the standardized procedure UNI EN ISO 16266:2008 followed by PCR confirmation. Antibiotic Susceptibility testing was conducted according to EUCAST standardized disk diffusion method. Genetic relatedness of strains was carried out by RAPD. The sequence of the oprD gene was analyzed by standard method. Fifty-three samples (0.63%) were positive for P. aeruginosa, of which 10/207 (4.83%) were from swimming pools. Five isolates (9.43%) were resistant to imipenem, one to Ticarcillin + Clavulanate, one to both Piperacillin and Ticarcillin + Clavulanate. The highest isolation rate of imipenem resistant P. aeruginosa was observed in swimming pool water. Identical RAPD profiles were found in isolates from the same location in the same year or even in different years. Conclusions Imipenem resistant strains were identified as carbapenemase-negative and resistance has been associated with inactivating mutations within the oprD gene, with a concomitant loss of porin. RAPD results proved that a water system can remain colonized by one strain for long periods and the contamination may be difficult to eradicate. This study has revealed the presence of P. aeruginosa in different water samples, including resistant strains, especially in swimming pools, and confirmed the role of porins as a contributing factor in carbapenem resistance in Gram-negative bacteria.	[Schiavano, Giuditta Fiorella; Brandi, Giorgio; Amagliani, Giulia] Univ Urbino Carlo Bo, Dept Biomol Sci, Toxicol Hygienist & Environm Sci Unit, Urbino, PU, Italy; [Carloni, Elisa; Andreoni, Francesca] Univ Urbino Carlo Bo, Sect Biotechnol, Dept Biomol Sci, Fano, PU, Italy; [Magi, Silvia] Dipartimento Prov ARPAM Pesaro, Serv Acque, Pesaro, Italy; [Chironna, Maria] Aldo Moro Univ Bari, Dept Biomed Sci & Human Oncol, Hyg Sect, Bari, Italy	University of Urbino; University of Urbino; Universita degli Studi di Bari Aldo Moro	Schiavano, GF (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Toxicol Hygienist & Environm Sci Unit, Urbino, PU, Italy.	giuditta.schiavano@uniurb.it	Francesca, Andreoni/G-7505-2012	Francesca, Andreoni/0000-0002-4857-8210; Schiavano, Giuditta Fiorella/0000-0002-1427-3486; chironna, maria/0000-0002-1043-1256; Carloni, Elisa/0000-0003-1178-9353				Amagliani G, 2013, MICROCHEM J, V110, P656, DOI 10.1016/j.microc.2013.08.001; Amagliani G, 2012, INT J ENVIRON HEAL R, V22, P60, DOI 10.1080/09603123.2011.588325; Anaissie EJ, 2002, ARCH INTERN MED, V162, P1483, DOI 10.1001/archinte.162.13.1483; [Anonymous], 162662008 UNI EN ISO; ARMSTRONG JL, 1982, APPL ENVIRON MICROB, V44, P308, DOI 10.1128/AEM.44.2.308-316.1982; Bai XH, 2015, SCI TOTAL ENVIRON, V533, P24, DOI 10.1016/j.scitotenv.2015.06.082; Balasubramanian D, 2013, NUCLEIC ACIDS RES, V41, P1, DOI 10.1093/nar/gks1039; Berthelot P, 2005, PATHOL BIOL, V53, P341, DOI 10.1016/j.patbio.2004.09.006; Blanc DS, 2004, INTENS CARE MED, V30, P1964, DOI 10.1007/s00134-004-2389-z; Chalhoub H, 2016, INT J ANTIMICROB AG, V48, P740, DOI 10.1016/j.ijantimicag.2016.09.012; De Francesco MA, 2013, J INFECT PUBLIC HEAL, V6, P179, DOI 10.1016/j.jiph.2012.11.006; Cavalcanti FLD, 2015, MEM I OSWALDO CRUZ, V110, P1003, DOI 10.1590/0074-02760150233; European Centre for Disease Prevention and Control, 2017, ANN REP EUR ANT RES; Felfoldi T, 2010, ACTA MICROBIOL IMM H, V57, P165, DOI 10.1556/AMicr.57.2010.3.2; Figueira V, 2012, J WATER HEALTH, V10, P1, DOI 10.2166/wh.2011.002; Guida M, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090919; Huang JJ, 2011, WATER RES, V45, P2775, DOI 10.1016/j.watres.2011.02.026; Huhulescu S, 2011, INFECTION, V39, P265, DOI 10.1007/s15010-011-0096-6; HUNTER PR, 1993, J APPL BACTERIOL, V74, P345, DOI 10.1111/j.1365-2672.1993.tb05137.x; Italian Republic, ACC STAT REG PROV AU; Kimata N, 2004, MICROBIAL ECOL, V47, P41, DOI 10.1007/s00248-003-1032-9; Lanotte P, 2004, J MED MICROBIOL, V53, P73, DOI 10.1099/jmm.0.05324-0; Lefebvre A, 2017, J HOSP INFECT, V96, P238, DOI 10.1016/j.jhin.2016.12.007; LIVERMORE DM, 1992, ANTIMICROB AGENTS CH, V36, P2046, DOI 10.1128/AAC.36.9.2046; Lutz JK, 2011, INT J ENV RES PUB HE, V8, P554, DOI 10.3390/ijerph8020554; Mena KD, 2009, REV ENVIRON CONTAM T, V201, P71, DOI 10.1007/978-1-4419-0032-6_3; Ocampo-Sosa AA, 2012, ANTIMICROB AGENTS CH, V56, P1703, DOI 10.1128/AAC.05451-11; Pirnay JP, 2002, ENVIRON MICROBIOL, V4, P872, DOI 10.1046/j.1462-2920.2002.00281.x; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Rasamiravaka T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/759348; Riera E, 2011, J ANTIMICROB CHEMOTH, V66, P2022, DOI 10.1093/jac/dkr232; Sanbongi Y, 2009, MICROBIOL IMMUNOL, V53, P361, DOI 10.1111/j.1348-0421.2009.00137.x; Sharma VK, 2016, CHEMOSPHERE, V150, P702, DOI 10.1016/j.chemosphere.2015.12.084; Shi P, 2013, WATER RES, V47, P111, DOI 10.1016/j.watres.2012.09.046; The European Committee on Antimicrobial Susceptibility Testing, 2015, BREAKP TABL INT MICS; Wolkowicz T, 2016, J GLOB ANTIMICROB RE, V7, P119, DOI 10.1016/j.jgar.2016.08.007; Wolter DJ, 2004, FEMS MICROBIOL LETT, V236, P137, DOI 10.1016/j.femsle.2004.05.039; Xi CW, 2009, APPL ENVIRON MICROB, V75, P5714, DOI 10.1128/AEM.00382-09; YONEYAMA H, 1993, ANTIMICROB AGENTS CH, V37, P2385, DOI 10.1128/AAC.37.11.2385	40	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189172	10.1371/journal.pone.0189172	http://dx.doi.org/10.1371/journal.pone.0189172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211780	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200075
J	Spierenburg, EAJ; Smit, LAM; Krop, EJM; Heederik, D; Hylkema, MN; Wouters, IM				Spierenburg, Elisabeth A. J.; Smit, Lidwien A. M.; Krop, Esmeralda J. M.; Heederik, Dick; Hylkema, Machteld N.; Wouters, Inge M.			Occupational endotoxin exposure in association with atopic sensitization and respiratory health in adults: Results of a 5-year follow-up	PLOS ONE			English	Article							LUNG-FUNCTION DECLINE; ALLERGIC SENSITIZATION; DAIRY FARMERS	The objective of the present longitudinal study was to investigate the effects of occupational endotoxin exposure on respiratory health and atopic sensitization in adults. Health outcomes and personal endotoxin exposure estimates were determined for 234 farmers and agricultural workers both at baseline and 5 years later. A questionnaire was used to assess respiratory symptoms, spirometry tests were performed and total and specific IgE levels were measured in serum. A twofold increase in personal endotoxin exposure was associated with less hay fever (OR 0.68, 95% CI 0.54-0.87) and grass IgE positivity (OR 0.81, 95% CI 0.68-0.97) at both time points ("persistent" versus "never"). Although not statistically significant, a consistent protective pattern was observed for an increased loss of hay fever symptoms (OR 2.19, 95% CI 0.96-4.99) and grass IgE positivity (OR 1.24, 95% CI 0.76-2.02), and for less new-onset of hay fever (OR 0.87, 95% CI 0.65-1.17), grass IgE positivity (OR 0.83, 95% CI 0.61-1.12) and atopic sensitization (OR 0.75, 95% CI 0.55-1.02). Endotoxin exposure was not associated with changes in lung function. We showed that occupational endotoxin exposure is associated with a long-term protective effect on hay fever and grass IgE positivity. Results on longitudinal changes in hay fever, atopy and grass IgE positivity in adulthood were consistent with a protective effect of endotoxin exposure, but results need to be confirmed in larger cohorts. An effect of endotoxin exposure on lung function decline was not found.	[Spierenburg, Elisabeth A. J.; Smit, Lidwien A. M.; Krop, Esmeralda J. M.; Heederik, Dick; Wouters, Inge M.] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [Hylkema, Machteld N.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands; [Hylkema, Machteld N.] Univ Groningen, Univ Med Ctr Groningen, GRIAC, Groningen, Netherlands	Utrecht University; University of Groningen; University of Groningen	Wouters, IM (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands.	i.wouters@uu.nl	Smit, Lidwien AM/AFC-8689-2022	Smit, Lidwien AM/0000-0003-0292-0946; Wouters, Inge M./0000-0001-7834-9390; Krop, Esmeralda/0000-0002-6009-1181; Heederik, Dick/0000-0002-4550-1437	Dutch Lung Foundation [3.2.09.036]	Dutch Lung Foundation	This work was supported by the Dutch Lung Foundation Grant Number 3.2.09.036, http://research.longfonds.nl The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birzele LT, 2017, ALLERGY, V72, P109, DOI 10.1111/all.13002; Bolund AC, 2017, OCCUP ENV MED; Bolund ACS, 2015, OCCUP ENV MED; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Campbell BE, 2015, CLIN EXP ALLERGY, V45, P744, DOI 10.1111/cea.12429; Chaudemanche H, 2003, OCCUP ENVIRON MED, V60, P858, DOI 10.1136/oem.60.11.858; Depner M, 2015, J ALLERGY CLIN IMMUN; Doekes G, 1996, OCCUP ENVIRON MED, V53, P63, DOI 10.1136/oem.53.1.63; DOUWES J, 1995, APPL ENVIRON MICROB, V61, P1763, DOI 10.1128/AEM.61.5.1763-1769.1995; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Elholm G, 2013, J ALLERGY CLIN IMMUN, V132, P1239, DOI 10.1016/j.jaci.2013.07.003; Gaint M, 2007, EUR RESPIR J, V30, P97, DOI 10.1183/09031936.00150405; Gehring U, 2004, ALLERGY, V59, P946, DOI 10.1111/j.1398-9995.2004.00551.x; Horak F, 2002, CLIN EXP ALLERGY, V32, P1155, DOI 10.1046/j.1365-2745.2002.01448.x; Iversen M, 2000, EUR RESPIR J, V16, P404, DOI 10.1034/j.1399-3003.2000.016003404.x; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Pahwa Punam, 2003, Can Respir J, V10, P135; Portengen L, 2005, J ALLERGY CLIN IMMUN, V115, P797, DOI 10.1016/j.jaci.2004.11.046; Post W, 1998, OCCUP ENVIRON MED, V55, P349, DOI 10.1136/oem.55.5.349; Preller L, 1995, SCAND J WORK ENV HEA, V21, P504, DOI 10.5271/sjweh.67; Prior C, 2001, RESPIRATION, V68, P46, DOI 10.1159/000050462; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Robbe P, 2014, THORAX, V69, P630, DOI 10.1136/thoraxjnl-2013-204295; Senthilselvan A, 1997, CHEST, V111, P1733, DOI 10.1378/chest.111.6.1733; Smit LAM, 2008, EUR RESPIR J, V31, P1241, DOI 10.1183/09031936.00090607; Smit LAM, 2010, INT ARCH ALLERGY IMM, V152, P151, DOI 10.1159/000265536; Spierenburg EAJ, 2015, INT ARCH OCC ENV HEA, V88, P1165, DOI 10.1007/s00420-015-1047-9; Thaon I, 2011, EUR RESPIR J, V37, P767, DOI 10.1183/09031936.00122209; Thomsen GF, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0021-3; Venier AG, 2006, AM J IND MED, V49, P231, DOI 10.1002/ajim.20278; Vercelli D, 2003, CURR OPIN ALLERGY CL, V3, P343, DOI 10.1097/01.all.0000092603.76804.e4; Vogelzang PFJ, 1998, AM J RESP CRIT CARE, V157, P15, DOI 10.1164/ajrccm.157.1.9703087	34	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189097	10.1371/journal.pone.0189097	http://dx.doi.org/10.1371/journal.pone.0189097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211772	Green Published, Green Submitted, gold			2022-12-27	WOS:000417212200064
J	Garcia-Garcia, ML; Calvo, C; Ruiz, S; Pozo, F; del Pozo, V; Remedios, L; Exposito, N; Tellez, A; Casas, I				Luz Garcia-Garcia, Maria; Calvo, Cristina; Ruiz, Sara; Pozo, Francisco; del Pozo, Victoria; Remedios, Laura; Exposito, Nadia; Tellez, Ana; Casas, Inmaculada			Role of viral coinfections in asthma development	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; THYMIC STROMAL LYMPHOPOIETIN; DENDRITIC CELLS INDUCE; IMPORTANT RISK-FACTOR; BRONCHIOLITIS; ALLERGY; INFANCY; QUESTIONNAIRE; VALIDATION; EXPRESSION	Background Viral respiratory infections, especially acute bronchiolitis, play a key role in the development of asthma in childhood. However, most studies have focused on respiratory syncytial virus or rhinovirus infections and none of them have compared the long-term evolution of single versus double or multiple viral infections. Objective Our aim was to compare the frequency of asthma development at 6-8 years in children with previous admission for bronchiolitis associated with single versus double or multiple viral infection. Patients & methods A cross-sectional study was performed in 244 children currently aged 6-8 years, previously admitted due to bronchiolitis between September 2008 and December 2011. A structured clinical interview and the ISAAC questionnaire for asthma symptoms for 6-7-year-old children, were answered by parents by telephone. Specimens of nasopharyngeal aspirate for virological study (polymerase chain reaction) and clinical data were prospectively taken during admission for bronchiolitis. Results Median current age at follow-up was 7.3 years (IQR: 6.7-8.1). The rate of recurrent wheezing was 82.7% in the coinfection group and 69.7% in the single-infection group, p = 0.06. The number of wheezing-related admissions was twice as high in coinfections than in single infections, p = 0.004. Regarding the ISAAC questionnaire, 30.8% of coinfections versus 15% of single infections, p = 0.01, presented "wheezing in the last 12 months", data that strongly correlate with current prevalence of asthma. "Dry cough at night" was also reported more frequently in coinfections than in single infections, p = 0.02. The strongest independent risk factors for asthma at 6-8 years of age were: age > 9 months at admission for bronchiolitis (OR: 3.484; CI95%: 1.459-8.317, p: 0.005), allergic rhinitis (OR: 5.910; 95% CI: 2.622- 13.318, p< 0.001), and viral coinfection-bronchiolitis (OR: 3.374; CI95%: 1.542-7.386, p: 0.01). Conclusions Asthma at 6-8 years is more frequent and severe in those children previously hospitalized with viral coinfection-bronchiolitis compared with those with single infection. Allergic rhinitis and older age at admission seem also to be strong independent risk factors for asthma development in children previously hospitalised because of bronchiolitis.	[Luz Garcia-Garcia, Maria; Ruiz, Sara; Remedios, Laura; Exposito, Nadia; Tellez, Ana] Severo Ochoa Hosp, Pediat Dept, Leganes, Spain; [Luz Garcia-Garcia, Maria; Ruiz, Sara; Remedios, Laura; Exposito, Nadia; Tellez, Ana] Alfonso X El Sabio Univ, Madrid, Spain; [Luz Garcia-Garcia, Maria; Calvo, Cristina] Alfonso X El Sabio Univ, Traslat Res Network Pediat Infect Dis RITIP, La Paz Hosp, Madrid, Spain; [Calvo, Cristina] Alfonso X El Sabio Univ, TEDDY Network, European Network Excellence Pediat Clin Res, La Paz Hosp, Madrid, Spain; [Calvo, Cristina] Alfonso X El Sabio Univ, La Paz Hosp, Pediat Dept, Madrid, Spain; [Pozo, Francisco; Casas, Inmaculada] Natl Microbiol Ctr ISCIII, Resp Virus & Influenza Unit, Madrid, Spain; [del Pozo, Victoria] Fdn Jimenez Diaz, IIS, CIBERES, Dept Immunol, Madrid, Spain	Severo Ochoa University Hospital; Universidad Alfonso X el Sabio (UAX); Hospital Universitario La Paz; Universidad Alfonso X el Sabio (UAX); Hospital Universitario La Paz; Universidad Alfonso X el Sabio (UAX); Hospital Universitario La Paz; Universidad Alfonso X el Sabio (UAX); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Fundacion Jimenez Diaz	Garcia-Garcia, ML (corresponding author), Severo Ochoa Hosp, Pediat Dept, Leganes, Spain.; Garcia-Garcia, ML (corresponding author), Alfonso X El Sabio Univ, Madrid, Spain.; Garcia-Garcia, ML (corresponding author), Alfonso X El Sabio Univ, Traslat Res Network Pediat Infect Dis RITIP, La Paz Hosp, Madrid, Spain.	marialuz.hso@gmail.com	Pozo, Francisco/F-4426-2012; Casas, Inmaculada/H-9442-2015; Casas, Inmaculada/X-7579-2019; Calvo, Cristina/T-5028-2018	Pozo, Francisco/0000-0003-1828-733X; Casas, Inmaculada/0000-0003-1840-1198; Casas, Inmaculada/0000-0003-1840-1198; Calvo, Cristina/0000-0002-6503-3423	Fondo de Investigaciones Sanitarias-Spanish Health Research Fund [PI12/0129]	Fondo de Investigaciones Sanitarias-Spanish Health Research Fund(Instituto de Salud Carlos III)	This study has been partially supported by Fondo de Investigaciones Sanitarias-Spanish Health Research Fund.Grant PI12/0129. There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruvito L, 2015, CURR OPIN INFECT DIS, V28, P259, DOI 10.1097/QCO.0000000000000159; Asner SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099392; Barlow JL, 2013, J ALLERGY CLIN IMMUN, V132, P933, DOI 10.1016/j.jaci.2013.05.012; Berraies A, 2016, IMMUNOL LETT, V178, P85, DOI 10.1016/j.imlet.2016.08.004; Calvo C, 2010, ACTA PAEDIATR, V99, P883, DOI 10.1111/j.1651-2227.2010.01714.x; Calvo C, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001788; Canducci F, 2008, J MED VIROL, V80, P716, DOI 10.1002/jmv.21108; Coiras MT, 2004, J MED VIROL, V72, P484, DOI 10.1002/jmv.20008; Coiras MT, 2003, J MED VIROL, V69, P132, DOI 10.1002/jmv.10255; Fernandez CM, 2005, J INVEST ALLERG CLIN, V15, P201; Garcia-Garcia ML, 2007, PEDIATR PULM, V42, P458, DOI 10.1002/ppul.20597; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jenkins MA, 1996, INT J EPIDEMIOL, V25, P609, DOI 10.1093/ije/25.3.609; Kotaniemi-Syrjanen A, 2003, J ALLERGY CLIN IMMUN, V111, P66, DOI 10.1067/mai.2003.33; Lauhkonen Eero, 2016, Acta Paediatr, V105, P1355, DOI 10.1111/apa.13537; Lee HC, 2012, J ALLERGY CLIN IMMUN, V130, P1187, DOI 10.1016/j.jaci.2012.07.031; Lukkarinen H, 2014, J ALLERGY CLIN IMMUN, V133, P256, DOI 10.1016/j.jaci.2013.10.014; Lukkarinen M, 2013, PEDIAT ALLERG IMM-UK, V24, P237, DOI 10.1111/pai.12046; Garcia-Garcia ML, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006787; Makrinioti H, 2014, LANCET RESP MED, V2, P226, DOI 10.1016/S2213-2600(13)70261-3; MCCONNOCHIE KM, 1983, AM J DIS CHILD, V137, P11, DOI 10.1001/archpedi.1983.02140270007003; Pattarini L, 2017, J EXP MED, V214, P1529, DOI 10.1084/jem.20150402; Pereira AM, 2015, PEDIAT ALLERG IMM-UK, V26, P618, DOI 10.1111/pai.12430; Perez GF, 2015, PEDIAT ALLERG IMM-UK, V26, P145, DOI 10.1111/pai.12346; Perez GF, 2014, EUR RESPIR J, V44, P1075, DOI 10.1183/09031936.00049214; Pite H, 2016, ALLERGY ASTHMA PROC, V37, P231, DOI 10.2500/aap.2016.37.3955; Rochat MK, 2010, J ALLERGY CLIN IMMUN, V126, P1170, DOI 10.1016/j.jaci.2010.09.008; Rossi GA, 2017, PEDIAT ALLERG IMM-UK, V28, P320, DOI 10.1111/pai.12716; Rossi GA, 2015, EUR RESPIR J, V45, P774, DOI 10.1183/09031936.00062714; Saravia J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005217; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Tulah AS, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-100; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	37	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							0189083	10.1371/journal.pone.0189083	http://dx.doi.org/10.1371/journal.pone.0189083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206851	Green Published, Green Submitted, gold			2022-12-27	WOS:000417110700046
J	Charara, M; Tovmasyan, A; Batinic-Haberle, I; Craik, J; Benov, L				Charara, Malak; Tovmasyan, Artak; Batinic-Haberle, Ines; Craik, James; Benov, Ludmil			Post-illumination cellular effects of photodynamic treatment	PLOS ONE			English	Article							LIPID-PEROXIDATION; PHOTO-TREATMENT; PROTEIN; APOPTOSIS; CELLS; OXIDATION; PATHWAYS; SURVIVAL; THERAPY; DAMAGE	Increased interest in clinical application of photodynamic therapy (PDT) in various medical fields poses a demand for better understanding of processes triggered by photo-treatment. Most of the work on PDT performed so far has focused on the immediate effects of photo-treatment. It is generally accepted that cellular damage occurs during light exposure and within a short period thereafter. If cells are not killed during the PDT, they might recover, depending on the extent of the photo-induced damage. Little is known, however, about the relationship between the properties of photosensitizers (PSs) and the delayed consequences of PDT. The aim of this work was to investigate cellular responses to sub-lethal photodynamic treatment and how toxicogenic potency may be affected by molecular features of the PS. Results demonstrated that for cationic porphyrin-based PSs, lipophilicity is the main factor determining the fate of the cells in the 24-hour post-illumination period. PSs with amphiphilic properties initiated oxidative reactions that continued in the dark, long after light exposure, and caused suppression of metabolism and loss of cell viability with concomitant changes in electrophoretic mobility of proteins, including caspases. Apoptotic activity was not stimulated in the post-illumination period. This study demonstrated that in PDT mediated by amphiphilic cationic metalloporphyrin PSs, even when immediate photo-damage is relatively mild, destructive oxidative processes initiated during PDT continue in the absence of light to substantially impair metabolism, and that post-illumination protein modification may modify utilization of cell death pathways.	[Charara, Malak; Craik, James; Benov, Ludmil] Kuwait Univ, Dept Biochem, Fac Med, Kuwait, Kuwait; [Tovmasyan, Artak; Batinic-Haberle, Ines] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA	Kuwait University; Duke University	Benov, L (corresponding author), Kuwait Univ, Dept Biochem, Fac Med, Kuwait, Kuwait.	lbenov@hsc.edu.kw	Benov, Ludmil/AAD-3714-2020	Benov, Ludmil/0000-0002-0205-0146	College of Graduate Studies; Kuwait University [YM09/13]; General Research Funds; HSC Omics [SRUL02/13]	College of Graduate Studies; Kuwait University; General Research Funds; HSC Omics	LB MC JC were supported by College of Graduate Studies and grants YM09/13 from Kuwait University. IBH was supported by General Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is based on a M. Sc. Thesis submitted by Malak Charara to the College of Graduate Studies, Kuwait University. The authors thank Professor Yunus Luqmani, Faculty of Pharmacy, Kuwait University for providing the cell line used in this study. We are grateful to Ms. Milini Thomas, Ms. F. Sequeira, and the staff of HSC Omics (grant SRUL02/13), for excellent technical assistance.	Agostinis P, 2004, PHOTOCH PHOTOBIO SCI, V3, P721, DOI 10.1039/b315237e; Al Saleh S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020610; Al-Mutairi DA, 2007, BBA-GEN SUBJECTS, V1770, P1520, DOI 10.1016/j.bbagen.2007.06.006; Al-Mutairi DA, 2007, FREE RADICAL RES, V41, P89, DOI 10.1080/10715760600952869; Awad MM, 2016, APPL MICROBIOL BIOT, V100, P7679, DOI 10.1007/s00253-016-7632-3; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; BACHOWSKI GJ, 1991, J PHOTOCH PHOTOBIO B, V9, P307, DOI 10.1016/1011-1344(91)80168-H; Benov L, 2001, PROTOPLASMA, V217, P33, DOI 10.1007/BF01289410; Benov Ludmil, 2015, Med Princ Pract, V24 Suppl 1, P14, DOI 10.1159/000362416; Benov L, 2012, AMINO ACIDS, V42, P117, DOI 10.1007/s00726-010-0640-1; Benov L, 2011, ANTI-CANCER AGENT ME, V11, P233, DOI 10.2174/187152011795255975; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Broekgaarden M, 2015, CANCER METAST REV, V34, P643, DOI 10.1007/s10555-015-9588-7; Chatterjee SR, 1997, CHEM-BIOL INTERACT, V108, P27, DOI 10.1016/S0009-2797(97)00092-6; Chatterjee SR, 1997, MOL CELL BIOCHEM, V166, P25, DOI 10.1023/A:1006840714583; Davies MJ, 2016, BIOCHEM J, V473, P805, DOI 10.1042/BJ20151227; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Dean RT, 1997, BIOCHEM J, V324, P1; Ezzeddine R, 2013, J BIOL CHEM, V288, P36579, DOI 10.1074/jbc.M113.511642; FRIGUET B, 1994, J BIOL CHEM, V269, P21639; Geiger PG, 1997, FREE RADICAL BIO MED, V23, P57, DOI 10.1016/S0891-5849(96)00587-4; Girotti AW, 2001, J PHOTOCH PHOTOBIO B, V63, P103, DOI 10.1016/S1011-1344(01)00207-X; Girotti AW, 2004, ANTIOXID REDOX SIGN, V6, P301, DOI 10.1089/152308604322899369; Grebenova D, 2000, PHOTOCHEM PHOTOBIOL, V72, P16, DOI 10.1562/0031-8655(2000)072<0016:PCIHLC>2.0.CO;2; Ishii T, 2007, FREE RADICAL RES, V41, P1253, DOI 10.1080/10715760701678652; Kessel D, 1996, PHOTOCHEM PHOTOBIOL, V64, P601, DOI 10.1111/j.1751-1097.1996.tb03111.x; Lavie G, 1999, BRIT J CANCER, V79, P423, DOI 10.1038/sj.bjc.6690066; Lin D, 2008, ADV BIOACTIVATION RE; MacKenzie SH, 2012, ADV EXP MED BIOL, V747, P55, DOI 10.1007/978-1-4614-3229-6_4; Mroz Pawel, 2011, Cancers (Basel), V3, P2516, DOI 10.3390/cancers3022516; Munshi A, 2005, METH MOLEC MED, V110, P21; Noodt BB, 1996, BRIT J CANCER, V74, P22, DOI 10.1038/bjc.1996.310; Odeh AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108238; Oleinick NL, 2002, PHOTOCH PHOTOBIO SCI, V1, P1, DOI 10.1039/b108586g; Pizzimenti S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00242; Refsgaard HHF, 2000, P NATL ACAD SCI USA, V97, P611, DOI 10.1073/pnas.97.2.611; Sakharov DV, 2005, FEBS LETT, V579, P1255, DOI 10.1016/j.febslet.2005.01.024; Sakharov DV, 2003, EUR J BIOCHEM, V270, P4859, DOI 10.1046/j.1432-1033.2003.03885.x; Sayre LM, 2006, DRUG METAB REV, V38, P651, DOI 10.1080/03602530600959508; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; THOMAS JP, 1989, CANCER RES, V49, P1682; Thomas M, 2015, FUTURE MICROBIOL, V10, P709, DOI [10.2217/fmb.14.148, 10.2217/FMB.14.148]; Tsaytler PA, 2008, J PROTEOME RES, V7, P3868, DOI 10.1021/pr800189q; VERWEIJ H, 1981, BIOCHIM BIOPHYS ACTA, V647, P87, DOI 10.1016/0005-2736(81)90297-2; Weijer R, 2017, CELL MOL LIFE SCI, V74, P1133, DOI 10.1007/s00018-016-2401-0; WILKINSON F, 1995, J PHYS CHEM REF DATA, V24, P663, DOI 10.1063/1.555965; ZELENIN AV, 1984, CYTOMETRY, V5, P348, DOI 10.1002/cyto.990050410	51	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188535	10.1371/journal.pone.0188535	http://dx.doi.org/10.1371/journal.pone.0188535			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29200431	Green Published, gold, Green Submitted			2022-12-27	WOS:000417033200009
J	Kaminsky, JA				Kaminsky, Jessica A.			Culturally appropriate organization of water and sewerage projects built through public private partnerships	PLOS ONE			English	Article							CONSTRUCTION GLOBAL EVIDENCE; NATIONAL VALUES; LATIN-AMERICA; INFRASTRUCTURE; PRIVATIZATION; IMPACT; PARTICIPATION; CONSEQUENCES; SANITATION; INVESTMENT	This paper contributes to the pursuit of socially sustainable water and sanitation infrastructure for all people by discovering statistically robust relationships between Hofstede's dimensions of cross-cultural comparison and the choice of contract award types, project type, and primary revenue sources. This analysis, which represents 973 projects distributed across 24 low-and middle-income nations, uses a World Bank dataset describing high capital cost water and sewerage projects funded through private investment. The results show that cultural dimensions explain variation in the choice of contract award types, project type, and primary revenue sources. These results provide empirical evidence that strategies for water and sewerage project organization are not culturally neutral. The data show, for example, that highly individualistic contexts are more likely to select competitive contract award types and to depend on user fees to provide the primary project revenue stream post-construction. By selecting more locally appropriate ways to organize projects, project stakeholders will be better able to pursue the construction of socially sustainable water and sewerage infrastructure.	[Kaminsky, Jessica A.] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Kaminsky, JA (corresponding author), Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA.	jkaminsk@uw.edu		Kaminsky, Jessica/0000-0002-1340-7913				Bovaird T, 2004, INT REV ADM SCI, V70, P199, DOI 10.1177/0020852304044250; Cerne M, 2013, J INT MANAG, V19, P103, DOI 10.1016/j.intman.2013.03.004; Chambers R., 1983, IDEAS DEV, DOI [DOI 10.4324/9781849771665, DOI 10.4324/9781315835815-3]; Cornwall A, 2003, WORLD DEV, V31, P1325, DOI 10.1016/S0305-750X(03)00086-X; de Laet M, 2000, SOC STUD SCI, V30, P225, DOI 10.1177/030631200030002002; Estache A, 2001, WORLD DEV, V29, P1179, DOI 10.1016/S0305-750X(01)00034-1; Fellows R, 2013, CONSTR MANAG ECON, V31, P401, DOI 10.1080/01446193.2013.794296; Francis P., 2001, PARTICIPATION NEW TY; Franz BW, 2016, CONSTR MANAG ECON, V34, P160, DOI 10.1080/01446193.2016.1183800; GORDON CM, 1994, J CONSTR ENG M ASCE, V120, P196, DOI 10.1061/(ASCE)0733-9364(1994)120:1(196); Guasch JL, 2008, INT J IND ORGAN, V26, P421, DOI 10.1016/j.ijindorg.2007.05.003; Hall P. A., 2001, VARIETIES CAPITALISM; HBR, 2017, HARV BUS REV SEARCH; Hellowell M, 2010, AUST J PUBL ADMIN, V69, pS23, DOI 10.1111/j.1467-8500.2009.00658.x; Hofstede G., 2001, CULTURES CONSEQUENCE, V2nd ed.; Hofstede G., 2015, GEERT HOFSTEDE HOFST; Hopkins OS, 2015, J WATER SANIT HYG DE, V5, P493, DOI 10.2166/washdev.2015.128; House Robert., 2004, CULTURE LEADERSHIP; Jooste S., 2011, ENG PROJECT ORG J, V1, P11, DOI [DOI 10.1080/21573727.2010.549612, 10.1080/21573727.2010.549612]; Kaminsky J, 2017, J WATER SANIT HYG DE, V7, P196, DOI 10.2166/washdev.2017.240; Kaminsky JA, 2016, ENVIRON SCI TECHNOL, V50, P7723, DOI 10.1021/acs.est.6b01107; Kaminsky JA, 2015, ENVIRON SCI TECHNOL, V49, P7134, DOI 10.1021/acs.est.5b01039; Kirkman BL, 2006, J INT BUS STUD, V37, P285, DOI 10.1057/palgrave.jibs.8400202; Kuriyan R, 2009, WORLD DEV, V37, P1663, DOI 10.1016/j.worlddev.2009.03.005; Lock M, 2010, INTRO ANTHR BIOMEDIC; Mannix Elizabeth, 2005, Psychol Sci Public Interest, V6, P31, DOI 10.1111/j.1529-1006.2005.00022.x; Marks SJ, 2013, J WATER SANIT HYG DE, V3, P122, DOI 10.2166/washdev.2013.098; Markus H.R., 2010, HDB CULRURAL PSYCHOL, P3; Martinez-Fiestas M, 2016, INT J OCCUPATIONAL S, P1; McAdam D, 2010, SOCIOL FORUM, V25, P401, DOI 10.1111/j.1573-7861.2010.01189.x; Meyer E., 2014, CULTURE MAP BREAKING; Minkov M, 2014, INT J CROSS CULT MAN, V14, P161, DOI 10.1177/1470595814521600; Okten C, 2006, WORLD DEV, V34, P1537, DOI 10.1016/j.worlddev.2006.01.004; Oxford Economics, 2013, GLOB CONSTR PERSP; Oyetunji AA, 2006, J CONSTR ENG M ASCE, V132, P3, DOI 10.1061/(ASCE)0733-9364(2006)132:1(3); Pietroforte R, 2002, BUILD RES INF, V30, P425, DOI 10.1080/09613210210159875; Poulton C, 2012, WORLD DEV, V40, P96, DOI 10.1016/j.worlddev.2011.05.017; Power D, 2015, DECISION SCI, V46, P63, DOI 10.1111/deci.12121; PPI, 2012, GOVT SUPP PUBL PRIV; Prokopy LS, 2005, WORLD DEV, V33, P1801, DOI 10.1016/j.worlddev.2005.07.002; Puddicombe MS, 2009, J CONSTR ENG M, V135, P675, DOI 10.1061/(ASCE)0733-9364(2009)135:8(675); Pula K, 2016, PUBLIC PRIVATE PARTN; Ragin C. C, 2008, REDESIGNING SOCIAL I; Rayner J, 2016, J WATER SANIT HYG DE, V6, P602, DOI 10.2166/washdev.2016.068; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Roger E.M, 2003, DIFFUSION INNOVATION, V5th; Schumacher E.F., 1973, SMALL IS BEAUTIFUL E; Schwartz SH., 1994, INDIVIDUALISM COLLEC; Scott W.Richard., 2013, I ORG IDEAS INTEREST; Shin W, WORLD DEV IN PRESS; Sivakumar K, 2001, J INT BUS STUD, V32, P555, DOI 10.1057/palgrave.jibs.8490984; Spector PE, 2001, APPL PSYCHOL-INT REV, V50, P269, DOI 10.1111/1464-0597.00058; SUCHMAN MC, 1995, ACAD MANAGE REV, V20, P571, DOI 10.2307/258788; Sullivan J, 2017, J CONSTR ENG M, V143, DOI 10.1061/(ASCE)CO.1943-7862.0001282; Taras V, 2010, J APPL PSYCHOL, V95, P405, DOI 10.1037/a0018938; Trawick P, 2003, WORLD DEV, V31, P977, DOI 10.1016/S0305-750X(03)00049-4; White WC, 2011, J WATER SANIT HYG DE, V1, P269, DOI 10.2166/washdev.2011.028; World Bank, 2016, PRIV PART INFR PROJ; World Bank, 2016, PPI INV IDA COUNT 20; World Bank, 2016, METH PRIV PART INFR; World Bank, 2020, WORLD DEV IND 2020; World Bank, 2016, GLOSS TERMS PRIV PAR; Yu T, 2016, J CONSTR ENG M ASCE; ZAHEER S, 1995, ACAD MANAGE J, V38, P341, DOI 10.2307/256683; Zhang YL, 2014, WORLD DEV, V64, P473, DOI 10.1016/j.worlddev.2014.06.023	65	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188905	10.1371/journal.pone.0188905	http://dx.doi.org/10.1371/journal.pone.0188905			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO7EC	29200432	Green Published, gold, Green Submitted			2022-12-27	WOS:000417033200021
J	Lopez, J; Fernandez, SN; Gonzalez, R; Solana, MAJ; Urbano, J; Toledo, B; Lopez-Herce, J				Lopez, Jorge; Fernandez, Sarah N.; Gonzalez, Rafael; Solana, Maria A. J.; Urbano, Javier; Toledo, Blanca; Lopez-Herce, Jesus			Comparison between manual and mechanical chest compressions during resuscitation in a pediatric animal model of asphyxial cardiac arrest	PLOS ONE			English	Article							CARDIOPULMONARY-RESUSCITATION; QUALITY; DEVICE	Aims Chest compressions (CC) during cardiopulmonary resuscitation are not sufficiently effective in many circumstances. Mechanical CC could be more effective than manual CC, but there are no studies comparing both techniques in children. The objective of this study was to compare the effectiveness of manual and mechanical chest compressions with Thumper device in a pediatric cardiac arrest animal model. Material and methods An experimental model of asphyxial cardiac arrest (CA) in 50 piglets (mean weight 9.6 kg) was used. Animals were randomized to receive either manual CC or mechanical CC using a pediatric piston chest compressions device (Life-Stat (R), Michigan Instruments). Mean arterial pressure (MAP), arterial blood gases and end-tidal CO2 (etCO2) values were measured at 3, 9, 18 and 24 minutes after the beginning of resuscitation. Results There were no significant differences in MAP, DAP, arterial blood gases and etCO2 between chest compression techniques during CPR. Survival rate was higher in the manual CC (15 of 30 = 50%) than in the mechanical CC group (3 of 20 = 15%) p = 0.016. In the mechanical CC group there was a non significant higher incidence of haemorrhage through the endotracheal tube (45% vs 20%, p = 0.114). Conclusions In a pediatric animal model of cardiac arrest, mechanical piston chest compressions produced lower survival rates than manual chest compressions, without any differences in hemodynamic and respiratory parameters.	[Lopez, Jorge; Fernandez, Sarah N.; Gonzalez, Rafael; Solana, Maria A. J.; Urbano, Javier; Toledo, Blanca; Lopez-Herce, Jesus] Gregorio Maranon Gen Univ Hosp, Pediat Intens Care Dept, Madrid, Spain; [Lopez, Jorge; Fernandez, Sarah N.; Gonzalez, Rafael; Solana, Maria A. J.; Urbano, Javier; Toledo, Blanca; Lopez-Herce, Jesus] Univ Complutense Madrid, Sch Med, Pediat Dept, Madrid, Spain; [Lopez, Jorge; Fernandez, Sarah N.; Gonzalez, Rafael; Solana, Maria A. J.; Urbano, Javier; Toledo, Blanca; Lopez-Herce, Jesus] Gregorio Maranon Hosp, Hlth Res Inst, Madrid, Spain; [Lopez, Jorge; Fernandez, Sarah N.; Gonzalez, Rafael; Solana, Maria A. J.; Urbano, Javier; Toledo, Blanca; Lopez-Herce, Jesus] Red Salud Maternoinfantil & Desarrollo Red SAMID, Madrid, Spain	General University Gregorio Maranon Hospital; Complutense University of Madrid; General University Gregorio Maranon Hospital	Lopez-Herce, J (corresponding author), Gregorio Maranon Gen Univ Hosp, Pediat Intens Care Dept, Madrid, Spain.; Lopez-Herce, J (corresponding author), Univ Complutense Madrid, Sch Med, Pediat Dept, Madrid, Spain.; Lopez-Herce, J (corresponding author), Gregorio Maranon Hosp, Hlth Res Inst, Madrid, Spain.; Lopez-Herce, J (corresponding author), Red Salud Maternoinfantil & Desarrollo Red SAMID, Madrid, Spain.	pielvi@hotmail.com	Cortes, Rafael Gonzalez/ABB-4855-2020; Fernandez Lafever, Sarah Nicole/AAE-4978-2022; Lopez-Herce, Jesus/A-1602-2019; Lopez, Jorge/AAD-4109-2022	Cortes, Rafael Gonzalez/0000-0002-3259-7898; Fernandez Lafever, Sarah Nicole/0000-0003-4859-5966; Lopez-Herce, Jesus/0000-0001-6105-9178; Lopez, Jorge/0000-0002-9942-6399; Urbano, Javier/0000-0002-3511-2905	Carlos III Health Institute: Mother-Child Health and Development Network (Red SAMID) - RETICS - PN I+D+I [PI15/00743]; ISCIIISub-Directorate General for Research Assessment and Promotion; European Regional Development Fund (ERDF) [RD16/0022/0007]	Carlos III Health Institute: Mother-Child Health and Development Network (Red SAMID) - RETICS - PN I+D+I; ISCIIISub-Directorate General for Research Assessment and Promotion; European Regional Development Fund (ERDF)(European Commission)	This work was supported by Carlos III Health Institute (PI15/00743): Mother-Child Health and Development Network (Red SAMID) - RETICS funded by the PN I+D+I 2008-2011 (Spain), ISCIIISub-Directorate General for Research Assessment and Promotion and the European Regional Development Fund (ERDF), ref. RD16/0022/0007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaki-Makun O, 2013, PEDIATRICS, V131, pE797, DOI 10.1542/peds.2012-1892; Blomberg H, 2011, RESUSCITATION, V82, P1332, DOI 10.1016/j.resuscitation.2011.06.002; Botran M, 2011, INTENS CARE MED, V37, P1873, DOI 10.1007/s00134-011-2338-6; Brooks SC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007260.pub3; Cheng A, 2015, RESUSCITATION, V97, P13, DOI 10.1016/j.resuscitation.2015.08.024; Couper K, 2016, RESUSCITATION, V103, P24, DOI 10.1016/j.resuscitation.2016.03.004; Gates S, 2015, RESUSCITATION, V94, P91, DOI 10.1016/j.resuscitation.2015.07.002; Gates S, 2012, HEART, V98, P908, DOI 10.1136/heartjnl-2011-301571; Giraud R, 2015, ANN EMERG MED, V65, P23, DOI 10.1016/j.annemergmed.2014.01.020; Gonzalez R, 2014, PEDIATR CRIT CARE ME, V15, pE280, DOI 10.1097/PCC.0000000000000127; HALPERIN HR, 1993, NEW ENGL J MED, V329, P762, DOI 10.1056/NEJM199309093291104; Jin SY, 2016, CLIN EXP EMERG MED, V3, P27, DOI 10.15441/ceem.16.119; Kim MJ, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0118-y; Koga Y, 2015, RESUSCITATION, V96, P226, DOI 10.1016/j.resuscitation.2015.08.013; Li H, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0202-y; Liao QM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-53; Lopez J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162185; Lopez-Herce J, 2011, INTENS CARE MED, V37, P147, DOI 10.1007/s00134-010-2006-2; Lu Xiao-guang, 2010, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V22, P496; Maconochie IK, 2015, RESUSCITATION, V95, pE147, DOI 10.1016/j.resuscitation.2015.07.044; Maconochie IK, 2015, RESUSCITATION, V95, P223, DOI 10.1016/j.resuscitation.2015.07.028; Perkins GD, 2015, LANCET, V385, P947, DOI 10.1016/S0140-6736(14)61886-9; Putzer G, 2016, J EMERG MED, V50, P594, DOI 10.1016/j.jemermed.2015.10.002; Putzer G, 2013, AM J EMERG MED, V31, P384, DOI 10.1016/j.ajem.2012.07.018; Rubertsson S, 2014, JAMA-J AM MED ASSOC, V311, P53, DOI 10.1001/jama.2013.282538; Rudinska LI, 2016, RESUSCITATION, V103, P66, DOI 10.1016/j.resuscitation.2016.04.002; Sanchez B, 2015, J CRIT CARE, V30, P711, DOI 10.1016/j.jcrc.2015.03.001; Smekal D, 2014, RESUSCITATION, V85, P1708, DOI 10.1016/j.resuscitation.2014.09.017; Sutton RM, 2015, RESUSCITATION, V93, P150, DOI 10.1016/j.resuscitation.2015.04.010; TAYLOR GJ, 1978, JAMA-J AM MED ASSOC, V240, P644, DOI 10.1001/jama.240.7.644; Tranberg T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0114-2; Xanthos T, 2011, EUR J EMERG MED, V18, P108, DOI 10.1097/MEJ.0b013e32833e79cf	32	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188846	10.1371/journal.pone.0188846	http://dx.doi.org/10.1371/journal.pone.0188846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190801	Green Published, Green Submitted, gold			2022-12-27	WOS:000416841900141
J	Pusterla, JM; Schneck, E; Funari, SS; Deme, B; Tanaka, M; Oliveira, RG				Pusterla, Julio M.; Schneck, Emanuel; Funari, Sergio S.; Deme, Bruno; Tanaka, Motomu; Oliveira, Rafael G.			Cooling induces phase separation in membranes derived from isolated CNS myelin (vol 12, e0184881, 2017)	PLOS ONE			English	Correction													Demé, Bruno/AAG-1620-2021	Demé, Bruno/0000-0002-9523-7662; Pusterla, Julio Martin/0000-0002-2996-5290				Pusterla JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184881	1	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0189142	10.1371/journal.pone.0189142	http://dx.doi.org/10.1371/journal.pone.0189142			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190823	gold, Green Submitted, Green Published			2022-12-27	WOS:000416841900201
J	Mallinger, RE; Gaines-Day, HR; Gratton, C				Mallinger, Rachel E.; Gaines-Day, Hannah R.; Gratton, Claudio			Do managed bees have negative effects on wild bees?: A systematic review of the literature	PLOS ONE			English	Review							HONEY-BEES; BOMBUS-TERRESTRIS; BUMBLE BEES; FRUIT-SET; SPECIAL FOCUS; NATIVE BEES; POLLINATOR; PATHOGEN; COMPETITION; DIVERSITY	Managed bees are critical for crop pollination worldwide. As the demand for pollinator-dependent crops increases, so does the use of managed bees. Concern has arisen that managed bees may have unintended negative impacts on native wild bees, which are important pollinators in both agricultural and natural ecosystems. The goal of this study was to synthesize the literature documenting the effects of managed honey bees and bumble bees on wild bees in three areas: (1) competition for floral and nesting resources, (2) indirect effects via changes in plant communities, including the spread of exotic plants and decline of native plants, and (3) transmission of pathogens. The majority of reviewed studies reported negative effects of managed bees, but trends differed across topical areas. Of studies examining competition, results were highly variable with 53% reporting negative effects on wild bees, while 28% reported no effects and 19% reported mixed effects (varying with the bee species or variables examined). Equal numbers of studies examining plant communities reported positive (36%) and negative (36%) effects, with the remainder reporting no or mixed effects. Finally, the majority of studies on pathogen transmission (70%) reported potential negative effects of managed bees on wild bees. However, most studies across all topical areas documented the potential for impact (e.g. reporting the occurrence of competition or pathogens), but did not measure direct effects on wild bee fitness, abundance, or diversity. Furthermore, we found that results varied depending on whether managed bees were in their native or non-native range; managed bees within their native range had lesser competitive effects, but potentially greater effects on wild bees via pathogen transmission. We conclude that while this field has expanded considerably in recent decades, additional research measuring direct, long-term, and population-level effects of managed bees is needed to understand their potential impact on wild bees.	[Mallinger, Rachel E.; Gaines-Day, Hannah R.; Gratton, Claudio] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Mallinger, Rachel E.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA	University of Wisconsin System; University of Wisconsin Madison; State University System of Florida; University of Florida	Mallinger, RE (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.; Mallinger, RE (corresponding author), Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.	rachel.mallinger@ufl.edu		Gratton, Claudio/0000-0001-6262-9670	University of Wisconsin Vilas Associates Award; University of Wisconsin Hatch Funds [WIS201516]; United States Department of Agriculture Specialty Crop Block Grant [SCBG 1502]	University of Wisconsin Vilas Associates Award; University of Wisconsin Hatch Funds; United States Department of Agriculture Specialty Crop Block Grant	The University of Wisconsin Vilas Associates Award and University of Wisconsin Hatch Funds (WIS201516) awarded to Claudio Grafton, and the United States Department of Agriculture Specialty Crop Block Grant (SCBG 1502) awarded to Claudio Grafton and Hannah Gaines, provided funds to cover publication costs. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, BIOL INVASIONS, V13, P957, DOI 10.1007/s10530-010-9882-9; Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Balfour NJ, 2015, BEHAV ECOL SOCIOBIOL, V69, P1731, DOI 10.1007/s00265-015-1985-y; Barthell JF, 2001, ECOL APPL, V11, P1870, DOI 10.1890/1051-0761(2001)011[1870:POSSIY]2.0.CO;2; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Breeze TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082996; Cameron SA, 2016, P NATL ACAD SCI USA, V113, P4386, DOI 10.1073/pnas.1525266113; Cane JH, 2017, CONSERV LETT, V10, P205, DOI 10.1111/conl.12263; Casey LM, 2015, DIVERS DISTRIB, V21, P864, DOI 10.1111/ddi.12344; Cayuela L, 2011, ENVIRON MANAGE, V48, P910, DOI 10.1007/s00267-011-9677-5; Chen YP, 2006, J INVERTEBR PATHOL, V92, P152, DOI 10.1016/j.jip.2006.03.010; Colla SR, 2008, BIODIVERS CONSERV, V17, P1379, DOI 10.1007/s10531-008-9340-5; CONNELL J H, 1971, P298; Dafni A, 2010, APPL ENTOMOL ZOOL, V45, P101, DOI 10.1303/aez.2010.101; de Jong M, 1995, EPIDEMIC MODELS THEI, P84; Delaplane K. S., 2000, Crop pollination by bees., DOI 10.1079/9780851994482.0000; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Dolezal AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166190; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; Elbgami T, 2014, APIDOLOGIE, V45, P504, DOI 10.1007/s13592-013-0265-y; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Frund J, 2013, ECOLOGY, V94, P2042, DOI 10.1890/12-1620.1; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Goodell Karen, 2008, P166; Goulson D, 2003, ANNU REV ECOL EVOL S, V34, P1, DOI 10.1146/annurev.ecolsys.34.011802.132355; Goulson D, 2012, WEED RES, V52, P535, DOI 10.1111/j.1365-3180.2012.00935.x; Graystock P, 2016, INT J PARASITOL-PAR, V5, P64, DOI 10.1016/j.ijppaw.2015.10.001; Graystock P, 2014, PEERJ, V2, DOI 10.7717/peerj.522; Graystock P, 2013, J APPL ECOL, V50, P1207, DOI 10.1111/1365-2664.12134; Graystock P, 2013, J INVERTEBR PATHOL, V114, P114, DOI 10.1016/j.jip.2013.06.005; Gross CL, 2010, WEED RES, V50, P364, DOI 10.1111/j.1365-3180.2010.00788.x; Gross CL, 1998, BIOL CONSERV, V86, P169, DOI 10.1016/S0006-3207(98)00010-X; HANKS LM, 1993, ECOLOGY, V74, P1081, DOI 10.2307/1940478; Herbertsson L, 2016, BASIC APPL ECOL, V17, P609, DOI 10.1016/j.baae.2016.05.001; Hermansen TD, 2014, ESTUAR COAST, V37, P621, DOI 10.1007/s12237-013-9711-3; Hoehn P, 2008, P ROY SOC B-BIOL SCI, V275, P2283, DOI 10.1098/rspb.2008.0405; Hudewenz A, 2015, ECOL EVOL, V5, P5049, DOI 10.1002/ece3.1762; Hudewenz A, 2013, J INSECT CONSERV, V17, P1275, DOI 10.1007/s10841-013-9609-1; Isaacs R, 2009, FRONT ECOL ENVIRON, V7, P196, DOI 10.1890/080035; JOHNSON RA, 1986, ECOLOGY, V67, P133, DOI 10.2307/1938511; Kanbe Y, 2008, NATURWISSENSCHAFTEN, V95, P1003, DOI 10.1007/s00114-008-0415-7; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; Koch JB, 2012, NORTHWEST SCI, V86, P212, DOI 10.3955/046.086.0306; Koh I, 2016, P NATL ACAD SCI USA, V113, P140, DOI 10.1073/pnas.1517685113; Kojima Y, 2011, MICROB ECOL, V62, P895, DOI 10.1007/s00248-011-9947-z; Kuhn J., 2006, Mitteilungen der Deutschen Gesellschaft fur allgemeine und angewandte Entomologie, V15, P389; Levitt AL, 2013, VIRUS RES, V176, P232, DOI 10.1016/j.virusres.2013.06.013; Lindstrom SAM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1641; Mallinger RE, 2015, J APPL ECOL, V52, P323, DOI 10.1111/1365-2664.12377; McMahon DP, 2015, J ANIM ECOL, V84, P615, DOI 10.1111/1365-2656.12345; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Michener C. D., 2000, The bees of the world; Murray TE, 2013, BIOL CONSERV, V159, P269, DOI 10.1016/j.biocon.2012.10.021; Neumayer J., 2006, Entomologica Austriaca, V13, P7; O'Toole C., 1991, BEES OF THE WORLD; Otterstatter MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002771; Paini DR, 2005, APIDOLOGIE, V36, P613, DOI 10.1051/apido:2005046; Paini DR, 2005, BIOL CONSERV, V123, P103, DOI 10.1016/j.biocon.2004.11.001; Paini DR, 2004, AUSTRAL ECOL, V29, P399, DOI 10.1111/j.1442-9993.2004.01376.x; Patel VB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015664; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Roubik DW, 2001, POPUL ECOL, V43, P53, DOI 10.1007/PL00012016; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Scheper J, 2013, ECOL LETT, V16, P912, DOI 10.1111/ele.12128; Schweiger O, 2010, BIOL REV, V85, P777, DOI 10.1111/j.1469-185X.2010.00125.x; Smith-Ramirez C, 2014, OECOLOGIA, V176, P157, DOI 10.1007/s00442-014-3000-0; Spiesman BJ, 2016, ECOLOGY, V97, P1431, DOI 10.1890/15-1735.1; Steffan-Dewenter I, 2000, OECOLOGIA, V122, P288, DOI 10.1007/s004420050034; Sun SG, 2013, PLANT SYST EVOL, V299, P139, DOI 10.1007/s00606-012-0711-8; Szabo ND, 2012, CONSERV LETT, V5, P232, DOI 10.1111/j.1755-263X.2012.00234.x; Thomson D, 2004, ECOLOGY, V85, P458, DOI 10.1890/02-0626; Thomson DM, 2006, OIKOS, V114, P407, DOI 10.1111/j.2006.0030-1299.14604.x; Thomson DM, 2016, ECOL LETT, V19, P1247, DOI 10.1111/ele.12659; Walther-Hellwig K, 2006, APIDOLOGIE, V37, P517, DOI 10.1051/apido:2006035; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Whitehorn PR, 2013, J APICULT RES, V52, P149, DOI 10.3896/IBRA.1.52.3.06; Williams NM, 2015, ECOL APPL, V25, P2119, DOI [10.1890/14-1748.1, 10.1890/14-1748.1.sm]; Winfree R, 2008, J APPL ECOL, V45, P793, DOI 10.1111/j.1365-2664.2007.01418.x; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Zurbuchen A, 2010, J ANIM ECOL, V79, P674, DOI 10.1111/j.1365-2656.2010.01675.x	87	132	133	15	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189268	10.1371/journal.pone.0189268	http://dx.doi.org/10.1371/journal.pone.0189268			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220412	gold, Green Published			2022-12-27	WOS:000417469900043
J	Wicha, P; Tocharus, J; Janyou, A; Jittiwat, J; Changtam, C; Suksamrarn, A; Tocharus, C				Wicha, Piyawadee; Tocharus, Jiraporn; Janyou, Adchara; Jittiwat, Jinatta; Changtam, Chatchawan; Suksamrarn, Apichart; Tocharus, Chainarong			Hexahydrocurcumin protects against cerebral ischemia/reperfusion injury, attenuates inflammation, and improves antioxidant defenses in a rat stroke model	PLOS ONE			English	Article							NF-KAPPA-B; ISCHEMIC-STROKE; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; ARTERY OCCLUSION; COLON-CANCER; CURCUMIN; ACTIVATION; MICE; MECHANISMS	The purpose of the present experiment was to investigate whether hexahydrocurcumin (HHC) attenuates brain damage and improves functional outcome via the activation of anti-oxidative activities, anti-inflammation, and anti-apoptosis following cerebral ischemia/reperfusion (I/R). In this study, rats with cerebral I/R injury were induced by a transient middle cerebral artery occlusion (MCAO) for 2 h, followed by reperfusion. The male Wistar rats were randomly divided into five groups, including the sham-operated, vehicle-treated, 10 mg/kg HHC-treated, 20 mg/kg HHC-treated, and 40 mg/kg HHC-treated I/R groups. The animals were immediately injected with HHC by an intraperitoneal administration at the onset of cerebral reperfusion. After 24 h of reperfusion, the rats were tested for neurological deficits, and the pathology of the brain was studied by 2,3,5-triphenyltetrazolium chloride (TTC) staining, hematoxylin and eosin (H&E) staining, and terminal deoxynucleotidyltransferase UTP nick end labeling (TUNEL) staining. In addition, the brain tissues were prepared for protein extraction for Western blot analysis, a malondialdehyde (MDA) assay, a nitric oxide (NO) assay, a superoxide dismutase (SOD) assay, a glutathione (GSH) assay, and a glutathione peroxidase (GSH-Px) assay. The data revealed that the neurological deficit scores and the infarct volume were significantly reduced in the HHC-treated rats at all doses compared to the vehicle group. Treatment with HHC significantly attenuated oxidative stress and inflammation, with a decreased level of MDA and NO and a decreased expression of NF-kappa B (p65) and cyclooxygenase-2 (COX-2) in the I/R rats. HHC also evidently increased Nrf2 (nucleus) protein expression, heme oxygenase-1 (HO-1) protein expression, the antioxidative enzymes, and the superoxide dismutase (SOD) activity. Moreover, the HHC treatment also significantly decreased apoptosis, with a decrease in Bax and cleaved caspase-3 and an increase in Bcl-XL, which was in accordance with a decrease in the apoptotic neuronal cells. Therefore, the HHC treatment protects the brain from cerebral I/R injury by diminishing oxidative stress, inflammation, and apoptosis. The antioxidant properties of HHC may play an important role in improving functional outcomes and may offer significant neuroprotection against I/R damage.	[Wicha, Piyawadee; Janyou, Adchara; Tocharus, Chainarong] Chiang Mai Univ, Fac Med, Dept Anat, Chiang Mai, Thailand; [Tocharus, Jiraporn] Chiang Mai Univ, Fac Med, Dept Physiol, Chiang Mai, Thailand; [Jittiwat, Jinatta] Mahasarakham Univ, Fac Med, Maha Sarakham, Thailand; [Changtam, Chatchawan] Huachiew Chalermprakiet Univ, Fac Sci & Technol, Div Phys Sci, Samut Prakan, Thailand; [Suksamrarn, Apichart] Ramkhamhang Univ, Fac Sci, Dept Chem, Bangkok, Thailand; [Suksamrarn, Apichart] Ramkhamhang Univ, Fac Sci, Ctr Excellence Innovat Chem, Bangkok, Thailand; [Tocharus, Chainarong] Chiang Mai Univ, Ctr Res & Dev Nat Prod Hlth, Chiang Mai, Thailand	Chiang Mai University; Chiang Mai University; Mahasarakham University; Ramkhamhaeng University; Ramkhamhaeng University; Chiang Mai University	Tocharus, C (corresponding author), Chiang Mai Univ, Fac Med, Dept Anat, Chiang Mai, Thailand.; Tocharus, C (corresponding author), Chiang Mai Univ, Ctr Res & Dev Nat Prod Hlth, Chiang Mai, Thailand.	chainarongt@hotmail.com	Tocharus, Jiraporn/AFL-8828-2022; Suksamrarn, Apichart/R-8782-2019; Tocharus, Jiraporn/AAG-9267-2022		Thailand Research Fund [DBG5980003]; Royal Golden Jubilee (RGJ) PhD program [PHD/0008/2558]; Chiang Mai University research grant	Thailand Research Fund(Thailand Research Fund (TRF)); Royal Golden Jubilee (RGJ) PhD program; Chiang Mai University research grant	This work was supported by: 1. Thailand Research Fund (DBG5980003) to AS; 2. Royal Golden Jubilee (RGJ) PhD program (Grant No. PHD/0008/2558) to PW; 3. Chiang Mai University research grant to CT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acarin L, 2002, J NEUROSCI RES, V68, P745, DOI 10.1002/jnr.10261; Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Ansari S, 2011, JOVE-J VIS EXP, DOI 10.3791/2879; Arumugam TV, 2008, EXPERT OPIN THER TAR, V12, P19, DOI 10.1517/14728222.12.1.19; Ashwal S, 1999, PEDIATR RES, V46, P400; Bi XY, 2009, NEUROL RES, V31, P159, DOI 10.1179/174313209X393573; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Cechetto D F, 2001, Prog Brain Res, V132, P391; Changtam C, 2010, EUR J MED CHEM, V45, P941, DOI 10.1016/j.ejmech.2009.11.035; Chen LY, 2012, BRAIN RES, V1475, P80, DOI 10.1016/j.brainres.2012.07.052; Dempe JS, 2013, MOL NUTR FOOD RES, V57, P1543, DOI 10.1002/mnfr.201200113; Deters M, 2008, PHARM RES-DORDR, V25, P1822, DOI 10.1007/s11095-008-9579-2; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dong HJ, 2014, NEUROL SCI, V35, P1387, DOI 10.1007/s10072-014-1718-4; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Ekshyyan O, 2004, FRONT BIOSCI-LANDMRK, V9, P1567, DOI 10.2741/1357; Fujimura M, 1999, BRAIN RES, V842, P92, DOI 10.1016/S0006-8993(99)01843-0; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Han J, 2014, NEUROCHEM RES, V39, P1292, DOI 10.1007/s11064-014-1311-5; Harari OA, 2010, ANN NY ACAD SCI, V1207, P32, DOI 10.1111/j.1749-6632.2010.05735.x; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hicks A, 2009, ACTA NEUROBIOL EXP, V69, P1; Jablonska A, 2011, ACTA NEUROBIOL EXP, V71, P74; Jeong WS, 2004, PHARM RES-DORDR, V21, P661, DOI 10.1023/B:PHAM.0000022413.43212.cf; Ji H, 2012, BRAIN RES BULL, V87, P50, DOI 10.1016/j.brainresbull.2011.09.021; Kim JY, 2014, CURR MED CHEM, V21, P2076, DOI 10.2174/0929867321666131228205146; Le DA, 2002, P NATL ACAD SCI USA, V99, P15188, DOI 10.1073/pnas.232473399; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Liu ZJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/470975; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Metzler M, 2013, BIOFACTORS, V39, P14, DOI 10.1002/biof.1042; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Orlando RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031869; Pan H, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/217580; Permpoonputtana K, 2013, NEUROTOX RES, V23, P189, DOI 10.1007/s12640-012-9350-7; Rahme R, 2012, STROKE, V43, P550, DOI 10.1161/STROKEAHA.111.635185; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Shukla PK, 2008, NEUROCHEM RES, V33, P1036, DOI 10.1007/s11064-007-9547-y; Somparn P, 2007, BIOL PHARM BULL, V30, P74, DOI 10.1248/bpb.30.74; Srimuangwong K, 2012, WORLD J GASTROENTERO, V18, P6951, DOI 10.3748/wjg.v18.i47.6951; Srimuangwong K, 2012, WORLD J GASTROENTERO, V18, P2383, DOI 10.3748/wjg.v18.i19.2383; SWANSON RA, 1994, J CEREBR BLOOD F MET, V14, P697, DOI 10.1038/jcbfm.1994.88; Thiyagarajan M, 2004, LIFE SCI, V74, P969, DOI 10.1016/j.lfs.2003.06.042; Toyokuni S, 1999, PATHOL INT, V49, P91, DOI 10.1046/j.1440-1827.1999.00829.x; Tuorkey M, 2009, BIOMED ENVIRON SCI, V22, P488, DOI 10.1016/S0895-3988(10)60006-2; Wang L, 2010, BRAIN RES, V1321, P143, DOI 10.1016/j.brainres.2009.12.046; Yang CH, 2009, BRAIN RES, V1282, P133, DOI 10.1016/j.brainres.2009.05.009; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Young AR, 2007, J NEUROCHEM, V103, P1302, DOI 10.1111/j.1471-4159.2007.04866.x; Zhang HS, 2011, J CELL PHYSIOL, V226, P3385, DOI 10.1002/jcp.22691; Zhao J, 2010, NEUROCHEM RES, V35, P374, DOI 10.1007/s11064-009-0065-y	55	64	70	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189211	10.1371/journal.pone.0189211	http://dx.doi.org/10.1371/journal.pone.0189211			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220411	Green Published, gold, Green Submitted			2022-12-27	WOS:000417469900040
J	Jiang, F; He, JY; Navarro-Alvarez, N; Xu, J; Li, X; Li, P; Wu, WX				Jiang, Fei; He, Jinyan; Navarro-Alvarez, Nalu; Xu, Jian; Li, Xia; Li, Peng; Wu, Wenxue			Elongation Factor Tu and Heat Shock Protein 70 Are Membrane-Associated Proteins from Mycoplasma ovipneumoniae Capable of Inducing Strong Immune Response in Mice (vol 11, e0161170, 2016)	PLOS ONE			English	Correction													Navarro-Alvarez, Nalu/AAI-1034-2019	Navarro-Alvarez, Nalu/0000-0003-0118-4676				FEI J, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0161170; Jiang F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161170	2	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189562	10.1371/journal.pone.0189562	http://dx.doi.org/10.1371/journal.pone.0189562			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216313	gold, Green Submitted, Green Published			2022-12-27	WOS:000417337800135
J	Ottoy, J; Verhaeghe, J; Niemantsverdriet, E; Engelborghs, S; Stroobants, S; Staelens, S				Ottoy, Julie; Verhaeghe, Jeroen; Niemantsverdriet, Ellis; Engelborghs, Sebastiaan; Stroobants, Sigrid; Staelens, Steven			A simulation study on the impact of the blood flow-dependent component in [F-18]AV45 SUVR in Alzheimer's disease	PLOS ONE			English	Article							WHITE-MATTER REFERENCE; AMYLOID PET; REFERENCE REGION; BETA; QUANTIFICATION; RADIOTRACERS; ASSOCIATION; METABOLISM; PERFUSION; DEMENTIA	Background Increased brain uptake on [F-18]AV45 PET is a biomarker for Alzheimer's disease (AD). The standardised uptake value ratio (SUVR) is widely used for quantification but is subject to variability. Here we evaluate how SUVR of a cortical target region is affected by blood flow changes in the target and two frequently used reference regions. Methods Regional baseline time-activity curves (TACs) were simulated based on metabolite-corrected plasma input functions and pharmacokinetic parameters obtained from our previously acquired data in healthy control (HC; n = 10), amnestic mild cognitive impairment (aMCI; n = 15) and AD cohorts (n = 9). Blood flow changes were simulated by altering the regional tracer delivery rate K1 (and clearance rate k2) between -40% and +40% from its regional baseline value in the target region and/or cerebellar grey (CB) or subcortical white matter (WM) reference regions. The corresponding change in SUVR was calculated at 50-60 min post-injection. Results A -40% blood flow reduction in the target resulted in an increased SUVRtarget (e.g. SUVRprecuneus: +10.0 +/- 5% in HC, +2.5 +/- 2% in AD), irrespective of the used reference region. A -40% blood flow reduction in the WM reference region increased SUVRWM (+11.5 +/- 4% in HC, +13.5 +/- 3% in AD) while a blood flow reduction in CB decreased SUVRCB (-9.5 +/- 6% in HC, -5.5 +/- 2% in AD), irrespective of the used target region. A -40% flow reduction in both the precuneus and reference WM (i.e., global flow change) induced an increased SUVR (+22.5 +/- 8% in HC, +16.0 +/- 4% in AD). When considering reference CB instead, SUVR was decreased by less than -5% (both in HC and AD). Conclusion Blood flow changes introduce alterations in [F-18]AV45 PET SUVR. Flow reductions in the CB and WM reference regions resulted in a decreased and increased SUVR of the target, respectively. SUVR was more affected by global blood flow changes when considering WM instead of CB normalization.	[Ottoy, Julie; Verhaeghe, Jeroen; Staelens, Steven] Univ Antwerp, Mol Imaging Ctr Antwerp, Antwerp, Belgium; [Niemantsverdriet, Ellis; Engelborghs, Sebastiaan] Univ Antwerp, Reference Ctr Biol Markers Dementia BIODEM, Antwerp, Belgium; [Engelborghs, Sebastiaan] Hosp Network Antwerp ZNA Hoge Beuken & Middelheim, Dept Neurol, Antwerp, Belgium; [Engelborghs, Sebastiaan] Hosp Network Antwerp ZNA Hoge Beuken & Middelheim, Memory Clin, Antwerp, Belgium; [Stroobants, Sigrid] Antwerp Univ Hosp, Dept Nucl Med, Edegem, Belgium	University of Antwerp; University of Antwerp; University of Antwerp	Staelens, S (corresponding author), Univ Antwerp, Mol Imaging Ctr Antwerp, Antwerp, Belgium.	steven.staelens@uantwerpen.be	Verhaeghe, Jeroen/I-1539-2016; Staelens, Steven/D-8385-2017	Verhaeghe, Jeroen/0000-0002-4493-1902; Staelens, Steven/0000-0003-3376-0519; Niemantsverdriet, Ellis/0000-0002-5781-3817; Stroobants, Sigrid/0000-0002-6450-9944; Ottoy, Julie/0000-0002-9879-7497	IWT TGO BIOADAPTAD; University of Antwerp; University Hospital [120835 A14/0161]; University Hospital Antwerp; Institute Born-Bunge (IBB); Flanders Impulse Program on Networks for Dementia Research (VIND)	IWT TGO BIOADAPTAD; University of Antwerp; University Hospital; University Hospital Antwerp; Institute Born-Bunge (IBB); Flanders Impulse Program on Networks for Dementia Research (VIND)	This study was in part funded by IWT TGO BIOADAPTAD and by the University of Antwerp and its University Hospital, under grant agreement no 120835 A14/0161; University Hospital Antwerp; the University of Antwerp Research Fund; the Institute Born-Bunge (IBB, www.bornbunge.be); and the Flanders Impulse Program on Networks for Dementia Research (VIND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegret M, 2012, J ALZHEIMERS DIS, V30, P109, DOI 10.3233/JAD-2012-111850; Attems J, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0206-2; Barker R, 2014, BRAIN, V137, P1524, DOI 10.1093/brain/awu040; Becker GA, 2013, J NUCL MED, V54, P723, DOI 10.2967/jnumed.112.107185; Blautzik J, 2017, EUR J NUCL MED MOL I, V44, P1364, DOI 10.1007/s00259-017-3666-8; BRAAK H, 1989, J NEUROL SCI, V93, P277, DOI 10.1016/0022-510X(89)90197-4; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bremmer JP, 2011, MOL IMAGING BIOL, V13, P759, DOI 10.1007/s11307-010-0382-1; Brendel M, 2015, NEUROIMAGE, V108, P450, DOI 10.1016/j.neuroimage.2014.11.055; CARSON R E, 1986, P347; Catafau AM, 2015, CLIN TRANSL IMAGING, V3, P39, DOI 10.1007/s40336-014-0098-3; Chen KW, 2015, J NUCL MED, V56, P560, DOI 10.2967/jnumed.114.149732; Chen YJ, 2015, J NUCL MED, V56, P1199, DOI 10.2967/jnumed.114.152405; Choi SR, 2009, J NUCL MED, V50, P1887, DOI 10.2967/jnumed.109.065284; Cselenyi Z, 2015, J CEREBR BLOOD F MET, V35, P1485, DOI 10.1038/jcbfm.2015.66; Fleisher AS, 2017, ALZHEIMERS DEMENT, V13, P1117, DOI 10.1016/j.jalz.2017.02.009; Hauser T, 2013, ACAD RADIOL, V20, P705, DOI 10.1016/j.acra.2013.01.020; Ishii K, 1997, J NUCL MED, V38, P925; Lacalle-Aurioles M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081548; Landau SM, 2014, EUR J NUCL MED MOL I, V41, P1398, DOI 10.1007/s00259-014-2753-3; Landau SM, 2015, J NUCL MED, V56, P567, DOI 10.2967/jnumed.114.148981; Lehtovirta M, 1998, J NEUROL NEUROSUR PS, V64, P742, DOI 10.1136/jnnp.64.6.742; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Ossenkoppele R, 2013, ALZHEIMERS RES THER, V5, DOI [10.1186/1758-9193-5-36, 10.1186/alzrt195]; Ottoy J, 2017, J NUCL MED, V58, P1483, DOI 10.2967/jnumed.116.184481; Schwarz CG, 2017, NEUROIMAGE, V144, P113, DOI 10.1016/j.neuroimage.2016.08.056; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Shokouhi S, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0172-3; Slifstein M, 2001, NUCL MED BIOL, V28, P595, DOI 10.1016/S0969-8051(01)00214-1; Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004; van Berckel BNM, 2013, J NUCL MED, V54, P1570, DOI 10.2967/jnumed.112.113654; Wong DF, 2010, J NUCL MED, V51, P913, DOI 10.2967/jnumed.109.069088; Yamaji S, 1997, J NUCL MED, V38, P1471; Yang L., 2012, NEW ENGL J MED, V363, P1	35	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189155	10.1371/journal.pone.0189155	http://dx.doi.org/10.1371/journal.pone.0189155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211812	gold, Green Published, Green Submitted			2022-12-27	WOS:000417212200070
J	Gastelum, G; Poteshkina, A; Veena, M; Artiga, E; Weckstein, G; Frost, P				Gastelum, Gilberto; Poteshkina, Aleksandra; Veena, Mysore; Artiga, Edgar; Weckstein, Geraldine; Frost, Patrick			Restoration of the prolyl-hydroxylase domain protein-3 oxygen-sensing mechanism is responsible for regulation of HIF2 alpha expression and induction of sensitivity of myeloma cells to hypoxia-mediated apoptosis	PLOS ONE			English	Article							MULTIPLE-MYELOMA; IN-VIVO; MAMMALIAN TARGET; VEGF EXPRESSION; INHIBITORS; ANGIOGENESIS; RAPAMYCIN; GROWTH; PHD3; HIF-1-ALPHA	Multiple myeloma (MM) is an incurable disease of malignant plasma B-cells that infiltrate the bone marrow (BM), resulting in bone destruction, anemia, renal impairment and infections. Physiologically, the BM microenvironment is hypoxic and this promotes MM progression and contributes to resistance to chemotherapy. Since aberrant hypoxic responses may result in the selection of more aggressive tumor phenotypes, we hypothesized that targeting the hypoxia-inducible factor (HIF) pathways will be an effective anti-MM therapeutic strategy. We demonstrated that MM cells are resistant to hypoxia-mediated apoptosis in vivo and in vitro, and that constitutive expression of HIF2 alpha contributed to this resistance. Since epigenetic silencing of the prolyl-hydroxylase-domain-3 (PHD3) enzyme responsible for the O-2-dependent regulation of HIF2 alpha is frequently observed in MM tumors, we asked if PHD3 plays a role in regulating sensitivity to hypoxia. We found that restoring PHD3 expression using a lentivirus vector or overcoming PHD3 epigenetic silencing using a demethyltransferase inhibitor, 5-Aza-2'-deoxycytidine (5-Aza-dC), rescued O-2-dependent regulation of HIF2a and restored sensitivity of MM cells to hypoxia-mediated apoptosis. This provides a rationale for targeting the PHD3-mediated regulation of the adaptive cellular hypoxic response in MM and suggests that targeting the O-2-sensing pathway, alone or in combination with other anti-myeloma chemotherapeutics, may have clinical efficacy.	[Gastelum, Gilberto; Poteshkina, Aleksandra; Veena, Mysore; Artiga, Edgar; Weckstein, Geraldine; Frost, Patrick] Greater Los Angeles Vet Adm Healthcare Syst, Dept Hematol Oncol, Los Angeles, CA 90073 USA; [Veena, Mysore; Frost, Patrick] Univ Calif Los Angeles, Dept Hematol Oncol, Los Angeles, CA 90095 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles	Frost, P (corresponding author), Greater Los Angeles Vet Adm Healthcare Syst, Dept Hematol Oncol, Los Angeles, CA 90073 USA.; Frost, P (corresponding author), Univ Calif Los Angeles, Dept Hematol Oncol, Los Angeles, CA 90095 USA.	Patrick.Frost@va.gov		Frost, Patrick/0000-0003-3348-5983	MERIT grant from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service [1I01BX001532]	MERIT grant from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service	This work was supported by a MERIT grant 1I01BX001532 to PF, from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service.	Asosingh K, 2005, HAEMATOLOGICA, V90, P810; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Erez N, 2003, CANCER RES, V63, P8777; Frost P, 2007, ONCOGENE, V26, P2255, DOI 10.1038/sj.onc.1210019; Frost P, 2004, BLOOD, V104, P4181, DOI 10.1182/blood-2004-03-1153; Frost P, 2013, J ONCOL, V2013, DOI 10.1155/2013/897025; Frost P, 2009, MOL CANCER THER, V8, P83, DOI 10.1158/1535-7163.MCT-08-0254; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Hatzimichael E, 2010, EUR J HAEMATOL, V84, P47, DOI 10.1111/j.1600-0609.2009.01344.x; Henze AT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6582; Hu JS, 2013, MOL CANCER THER, V12, P1763, DOI 10.1158/1535-7163.MCT-13-0123; Hu YZ, 2009, MOL CANCER THER, V8, P2329, DOI 10.1158/1535-7163.MCT-09-0150; Iriondo O, 2015, ONCOTARGET, V6, P31721, DOI 10.18632/oncotarget.5564; Kato H, 2006, INT J CANCER, V118, P1144, DOI 10.1002/ijc.21488; Khong T, 2008, HAEMATOLOGICA, V93, P860, DOI 10.3324/haematol.12261; Kiziltepe T, 2007, BLOOD, V110, P709, DOI 10.1182/blood-2006-10-052845; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Maiso P, 2015, CANCER RES, V75, P2071, DOI 10.1158/0008-5472.CAN-14-3400; Mysore VS, 2016, MOL CANCER RES, V14, P253, DOI 10.1158/1541-7786.MCR-15-0361; Nakazawa MS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10539; Place TL, 2013, HYPOXIA, V1, P13, DOI 10.2147/HP.S50091; Place TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014617; Radhakrishnan P, 2016, CANCER RES, V76, P2219, DOI 10.1158/0008-5472.CAN-15-1474; Rajkumar SV, 2000, CLIN CANCER RES, V6, P3111; Sciorra VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040053; Shah R, 2007, BLOOD, V110, p635A, DOI 10.1182/blood.V110.11.2132.2132; Shi YJ, 2005, MOL CANCER THER, V4, P1533, DOI 10.1158/1535-7163.MCT-05-0068; Su Y, 2010, BRIT J CANCER, V103, P1571, DOI 10.1038/sj.bjc.6605936; Szablowski JO, 2015, MOL CANC THER; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Zhong H, 1999, CANCER RES, V59, P5830	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188438	10.1371/journal.pone.0188438	http://dx.doi.org/10.1371/journal.pone.0188438			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206844	Green Published, gold, Green Submitted			2022-12-27	WOS:000417110700011
J	Sundstrom, L; Myhre, S; Sundqvist, M; Ahnmark, A; McCoull, W; Raubo, P; Groombridge, SD; Polla, M; Nystrom, AC; Kristensson, L; Nagard, M; Winzell, MS				Sundstrom, Linda; Myhre, Susanna; Sundqvist, Monika; Ahnmark, Andrea; McCoull, William; Raubo, Piotr; Groombridge, Sam D.; Polla, Magnus; Nystrom, Ann-Christin; Kristensson, Lisbeth; Nagard, Mats; Winzell, Maria Sorhede			The acute glucose lowering effect of specific GPR120 activation in mice is mainly driven by glucagon-like peptide 1	PLOS ONE			English	Article							COUPLED RECEPTOR 120; CHAIN FATTY-ACIDS; SECRETION; AGONISTS; OBESITY; POTENT; CELLS; IDENTIFICATION; PHARMACOLOGY; HOMEOSTASIS	The mechanism behind the glucose lowering effect occurring after specific activation of GPR120 is not completely understood. In this study, a potent and selective GPR120 agonist was developed and its pharmacological properties were compared with the previously described GPR120 agonist Metabolex-36. Effects of both compounds on signaling pathways and GLP-1 secretion were investigated in vitro. The acute glucose lowering effect was studied in lean wild-type and GPR120 null mice following oral or intravenous glucose tolerance tests. In vitro, in GPR120 overexpressing cells, both agonists signaled through G alpha(q), G alpha(s) and the beta-arrestin pathway. However, in mouse islets the signaling pathway was different since the agonists reduced cAMP production. The GPR120 agonists stimulated GLP-1 secretion both in vitro in STC-1 cells and in vivo following oral administration. In vivo GPR120 activation induced significant glucose lowering and increased insulin secretion after intravenous glucose administration in lean mice, while the agonists had no effect in GPR120 null mice. Exendin 9-39, a GLP-1 receptor antagonist, abolished the GPR120 induced effects on glucose and insulin following an intravenous glucose challenge. In conclusion, GLP-1 secretion is an important mechanism behind the acute glucose lowering effect following specific GPR120 activation.	[Sundstrom, Linda; Kristensson, Lisbeth] AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, Sweden; [Myhre, Susanna; Sundqvist, Monika; Ahnmark, Andrea; Polla, Magnus; Nystrom, Ann-Christin; Nagard, Mats; Winzell, Maria Sorhede] AstraZeneca, IMED Biotech Unit, Cardiovasc & Metab Dis, Gothenburg, Sweden; [McCoull, William; Raubo, Piotr; Groombridge, Sam D.] AstraZeneca, IMED Biotech Unit, Med Chem, Alderley Pk, Macclesfield, Cheshire, England	AstraZeneca; AstraZeneca; AstraZeneca	Winzell, MS (corresponding author), AstraZeneca, IMED Biotech Unit, Cardiovasc & Metab Dis, Gothenburg, Sweden.	Maria.Sorhede-Winzell@astrazeneca.com		Sundstrom, Linda/0000-0002-3620-1467	AstraZeneca	AstraZeneca(AstraZeneca)	The present study was funded by AstraZeneca. The funder provided support in the form of salaries for all authors [LS, SM, MS, AA, WM, PR, SDG, MP, CAN, LK, MN, MSW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams GL, 2017, ACS MED CHEM LETT, V8, P96, DOI 10.1021/acsmedchemlett.6b00394; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Anbazhagan AN, 2016, AM J PHYSIOL-CELL PH, V310, pC612, DOI 10.1152/ajpcell.00123.2015; [Anonymous], International patent, Patent No. [WO 2020/048207, 2020048207]; Azevedo CMG, 2016, J MED CHEM, V59, P8868, DOI 10.1021/acs.jmedchem.6b00685; Bjursell M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114942; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Burns RN, 2014, BIOCHEM PHARMACOL, V87, P650, DOI 10.1016/j.bcp.2013.12.016; Chambers AP, 2017, CELL METAB, V25, P927, DOI 10.1016/j.cmet.2017.02.008; Cox JM, 2017, ACS MED CHEM LETT, V8, P49, DOI 10.1021/acsmedchemlett.6b00360; Dusaulcy R, 2016, ENDOCRINOLOGY, V157, P536, DOI 10.1210/en.2015-1725; Engelstoft MS, 2013, MOL METAB, V2, P376, DOI 10.1016/j.molmet.2013.08.006; Fredriksson R, 2003, FEBS LETT, V554, P381, DOI 10.1016/S0014-5793(03)01196-7; Gabrielsson J, 2015, EUR J PHARM SCI, V67, P144, DOI 10.1016/j.ejps.2014.11.006; Hauge M, 2015, MOL METAB, V4, P3, DOI 10.1016/j.molmet.2014.10.002; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Holliday ND, 2012, FRONT ENDOCRINOL, V2, P112, DOI DOI 10.3389/FEND0.2011.00112; Hudson BD, 2013, MOL PHARMACOL, V84, P710, DOI 10.1124/mol.113.087783; Hudson BD, 2013, MOL ENDOCRINOL, V27, P1177, DOI 10.1210/me.2013-1085; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Ichimura A, 2009, PROSTAG OTH LIPID M, V89, P82, DOI 10.1016/j.prostaglandins.2009.05.003; Inamdar V, 2015, PLATELETS, V26, P771, DOI 10.3109/09537104.2014.998993; Kebede MA, 2009, DIABETES OBES METAB, V11, P10, DOI 10.1111/j.1463-1326.2009.01114.x; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Li A, 2015, FUTURE MED CHEM, V7, P2429, DOI 10.4155/fmc.15.160; Liu HD, 2015, EUR J PHARMACOL, V763, P160, DOI 10.1016/j.ejphar.2015.06.028; Ma J, [No title captured], Patent No. [WO 2010/048207, 2010048207]; Meier Juris J, 2004, Curr Opin Investig Drugs, V5, P402; Mo XL, 2013, PROG MOL BIOL TRANSL, V114, P251, DOI 10.1016/B978-0-12-386933-3.00007-8; Moran BM, 2014, DIABETES OBES METAB, V16, P1128, DOI 10.1111/dom.12330; Nauck M, 2016, DIABETES OBES METAB, V18, P203, DOI 10.1111/dom.12591; Nauck MA, 2003, DRUG NEWS PERSPECT, V16, P413, DOI 10.1358/dnp.2003.16.7.829353; Nauck MA, 2016, DIABETES, V65, P2440, DOI 10.2337/db16-0107; Oh DY, 2014, NAT MED, V20, P942, DOI 10.1038/nm.3614; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Paulsen SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088227; Prihandoko R, 2016, MOL PHARMACOL, V89, P505, DOI 10.1124/mol.115.101949; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Shimpukade B, 2012, J MED CHEM, V55, P4511, DOI 10.1021/jm300215x; Sparks SM, 2017, BIOORG MED CHEM LETT, V27, P1278, DOI 10.1016/j.bmcl.2017.01.034; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Stone VM, 2014, DIABETOLOGIA, V57, P1182, DOI 10.1007/s00125-014-3213-0; Suckow AT, 2014, J BIOL CHEM, V289, P15751, DOI 10.1074/jbc.M114.568683; Sun Q, 2010, MOL PHARMACOL, V78, P804, DOI 10.1124/mol.110.066324; Tanagho PA, 2016, ENDOCR METAB IMMUNE, V16, P8, DOI 10.2174/1871530316666151123115611; Tsukahara T, 2015, AM J PATHOL, V185, P185, DOI 10.1016/j.ajpath.2014.09.010; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Watson SJ, 2012, MOL PHARMACOL, V81, P631, DOI 10.1124/mol.111.077388; Xiong YM, 2013, MOL CELL ENDOCRINOL, V369, P119, DOI 10.1016/j.mce.2013.01.009	52	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189060	10.1371/journal.pone.0189060	http://dx.doi.org/10.1371/journal.pone.0189060			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206860	Green Published, Green Submitted, gold			2022-12-27	WOS:000417110700042
J	Abe, S; Abe, K; Zhang, JD; Harada, T; Mizumoto, G; Oshikawa, H; Akiyama, H; Shimamura, K				Abe, Shin-ichi; Abe, Kazuko; Zhang, Jidong; Harada, Tomoaki; Mizumoto, Go; Oshikawa, Hiroki; Akiyama, Haruhiko; Shimamura, Kenji			Roles of CD34(+) cells and ALK5 signaling in the reconstruction of seminiferous tubule-like structures in 3-D re-aggregate culture of dissociated cells from neonatal mouse testes	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX COMPONENTS; TESTICULAR PERITUBULAR CELLS; FACTOR-BETA TGF-BETA-1; SERTOLI-CELLS; CORD FORMATION; FETAL MOUSE; RAT TESTIS; IN-VITRO; IMMUNOHISTOCHEMICAL LOCALIZATION; GONADAL DEVELOPMENT	Tissue reconstruction in vitro can provide, if successful, a refined and simple system to analyze the underlying mechanisms that drive the morphogenesis and maintain the ordered structure. We have recently succeeded in reconstruction of seminiferous cord-like and tubule-like structures using 3-D re-aggregate culture of dissociated testicular cells. In testis formation, endothelial cells that migrated from mesonephroi to embryonic gonads have been shown to be critical for development of testis cords, but how endothelial cells contribute to testis cord formation remains unknown. To decipher the roles of endothelial and peritubular cells in the reconstruction of cord-like and tubule-like structures, we investigated the behavior of CD34(+) endothelial and p75(+) cells, and peritubular myoid cells (PTMCs) in 3-D re-aggregate cultures of testicular cells. The results showed that these 3 types of cells had the capacity of re-aggregation on their own and with each other, and of segregation into 3 layers in a re-aggregate, which were very similar to interstitial and peritubular tissues in vivo. Observation of behaviors of fluorescent Sertoli cells and other non-fluorescent types of cells using testes from Sox9-EGFP transgenic mice showed dynamic cell movement and segregation in re-aggregate cultures. Cultures of testicular cells deprived of interstitial and peritubular cells resulted in dysmorphic structures, but re-addition of them restored tubule-like structures. Purified CD34(+) cells in culture differentiated into p75(+) cells and PTMCs. These results indicate that CD34(+) cells differentiate into p75(+) cells, which then differentiate into PTMCs. TGF beta signaling inhibitors, SB431542 and ALK5i, disturbed the reconstruction of cord-like and tubule-like structures, and the latter compromised re-construction of interstitial-like and peritubular-like structures, as well as the proliferation of CD34(+), p75(+), PTMCs, and Sertoli cells, and their movement and differentiation. These results indicate that CD34(+) cells and signaling through ALK5 play pivotal roles in the morphogenesis of interstitial-like, peritubular-like and cord-like structures.	[Abe, Shin-ichi; Abe, Kazuko; Mizumoto, Go] Kumamoto Hlth Sci Univ, Ctr Gen Educ, Kumamoto, Japan; [Zhang, Jidong] ZunYi Med Univ, Sch Basic Med Sci, Zunyi, Guizhou, Peoples R China; [Harada, Tomoaki; Oshikawa, Hiroki] Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, Kumamoto, Japan; [Akiyama, Haruhiko] Gifu Univ, Grad Sch Med, Dept Orthopaed, Gifu, Japan; [Shimamura, Kenji] Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto, Japan	Kumamoto Health Science University; Zunyi Medical University; Kumamoto University; Gifu University; Kumamoto University	Abe, S (corresponding author), Kumamoto Hlth Sci Univ, Ctr Gen Educ, Kumamoto, Japan.	abe@kumamoto-hsu.ac.jp		Zhang, jidong/0000-0002-7934-7079; Abe, Shin-ichi/0000-0002-7886-9545	Japan Society for The Promotion of Science KAKENHI [15K07129]; Kumamoto Health Science University special fellowship [2015-C-12, 2017-C-07]; National Natural Science Foundation of China [31660338]; program of the Joint Usage/Research Center for Developmental Medicine, Institute of Molecular Embryology and Genetics, Kumamoto University; Grants-in-Aid for Scientific Research [15K07129] Funding Source: KAKEN	Japan Society for The Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kumamoto Health Science University special fellowship; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program of the Joint Usage/Research Center for Developmental Medicine, Institute of Molecular Embryology and Genetics, Kumamoto University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for The Promotion of Science KAKENHI Grant Number 15K07129, Kumamoto Health Science University special fellowship grant number 2015-C-12 and 2017-C-07 to SA; the National Natural Science Foundation of China grant No. 31660338 to JZ; and the program of the Joint Usage/Research Center for Developmental Medicine, Institute of Molecular Embryology and Genetics, Kumamoto University, to SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Lopes JP, 2017, BIOMATERIALS, V130, P76, DOI 10.1016/j.biomaterials.2017.03.025; Archambeault DR, 2010, P NATL ACAD SCI USA, V107, P10526, DOI 10.1073/pnas.1000318107; BUEHR M, 1993, DEVELOPMENT, V117, P273; Campagnolo L, 2001, BIOL REPROD, V64, P464, DOI 10.1095/biolreprod64.2.464; Combes AN, 2009, DEV DYNAM, V238, P1033, DOI 10.1002/dvdy.21925; Combes AN, 2009, DEV BIOL, V326, P112, DOI 10.1016/j.ydbio.2008.10.040; Cool J, 2008, SEX DEV, V2, P128, DOI 10.1159/000143430; Cool J, 2012, WIRES DEV BIOL, V1, P847, DOI 10.1002/wdev.62; Coveney D, 2008, P NATL ACAD SCI USA, V105, P7212, DOI 10.1073/pnas.0707674105; Cupp AS, 1999, BIOL REPROD, V60, P1304, DOI 10.1095/biolreprod60.6.1304; Dunker N, 2002, ANAT EMBRYOL, V206, P73, DOI 10.1007/s00429-002-0273-6; Gassei K, 2007, ANN NY ACAD SCI, V1120, P152, DOI 10.1196/annals.1411.015; GAUTIER C, 1994, MOL CELL ENDOCRINOL, V99, P55, DOI 10.1016/0303-7207(94)90146-5; HADLEY MA, 1990, DEV BIOL, V140, P318, DOI 10.1016/0012-1606(90)90082-T; HADLEY MA, 1985, J CELL BIOL, V101, P1511, DOI 10.1083/jcb.101.4.1511; Hess RA, 2012, SERTOLI CELL BIOL, P19; Itman C, 2006, REPRODUCTION, V132, P233, DOI 10.1530/rep.1.01075; Itman C, 2013, IUBMB LIFE, V65, P85, DOI 10.1002/iub.1115; Itman C, 2011, ENDOCRINOLOGY, V152, P2076, DOI 10.1210/en.2010-1453; Jeanes A, 2005, REPRODUCTION, V130, P509, DOI 10.1530/rep.1.00718; Kita K, 2007, BIOL REPROD, V76, P211, DOI 10.1095/biolreprod.106.056895; Kuroda N, 2004, HISTOL HISTOPATHOL, V19, P743, DOI 10.14670/HH-19.743; Martineau J, 1997, CURR BIOL, V7, P958, DOI 10.1016/S0960-9822(06)00415-5; Memon MA, 2008, MOL CELL ENDOCRINOL, V294, P70, DOI 10.1016/j.mce.2008.08.017; Mendis SHS, 2011, BIOL REPROD, V84, P379, DOI 10.1095/biolreprod.110.086231; MERCHANTLARIOS H, 1993, INT J DEV BIOL, V37, P407; Miles DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054606; Nakamura Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1242; Nel-Themaat L, 2011, BIOL REPROD, V84, P342, DOI 10.1095/biolreprod.110.086900; Nel-Themaat L, 2010, J ANDROL, V31, P5, DOI 10.2164/jandrol.109.008235; Nel-Themaat L, 2009, DEV DYNAM, V238, P1100, DOI 10.1002/dvdy.21954; Nishino K, 2001, EXP CELL RES, V267, P225, DOI 10.1006/excr.2001.5238; Olaso R, 1997, MOL CELL ENDOCRINOL, V126, P165, DOI 10.1016/S0303-7207(96)03984-6; Pendergraft SS, 2017, BIOL REPROD, V96, P720, DOI 10.1095/biolreprod.116.143446; Rebourcet D, 2014, DEVELOPMENT, V141, P2139, DOI 10.1242/dev.107029; Russo MA, 1999, BIOL REPROD, V61, P1123, DOI 10.1095/biolreprod61.4.1123; Sarraj MA, 2010, BIOL REPROD, V82, P153, DOI 10.1095/biolreprod.109.078766; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; SKINNER MK, 1985, J CELL BIOL, V100, P1941, DOI 10.1083/jcb.100.6.1941; Svingen T, 2013, GENE DEV, V27, P2409, DOI 10.1101/gad.228080.113; TUNG PS, 1980, BIOL REPROD, V23, P207, DOI 10.1093/biolreprod/23.1.207; TUNG PS, 1986, DEV BIOL, V113, P119, DOI 10.1016/0012-1606(86)90114-4; Ungewitter EK, 2013, SEX DEV, V7, P7, DOI 10.1159/000338612; Zhang JD, 2014, GEN COMP ENDOCR, V205, P121, DOI 10.1016/j.ygcen.2014.03.030	46	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188705	10.1371/journal.pone.0188705	http://dx.doi.org/10.1371/journal.pone.0188705			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190781	Green Published, Green Submitted, gold			2022-12-27	WOS:000416841900104
J	Son, HJ; Sung, H; Park, SY; Kim, T; Lee, HJ; Kim, SM; Chong, YP; Lee, SO; Choi, SH; Kim, YS; Woo, JH; Kim, SH				Son, Hyo-Ju; Sung, Heungsup; Park, Se Yoon; Kim, Taeeun; Lee, Hyun Jeong; Kim, Sun-Mi; Chong, Yong Pil; Lee, Sang-Oh; Choi, Sang-Ho; Kim, Yang Soo; Woo, Jun Hee; Kim, Sung-Han			Diagnostic performance of the (1-3)-beta-D-glucan assay in patients with Pneumocystis jirovecii compared with those with candidiasis, aspergillosis, mucormycosis, and tuberculosis, and healthy volunteers	PLOS ONE			English	Article							BETA-D-GLUCAN; INVASIVE FUNGAL-INFECTIONS; SERUM 1,3-BETA-D-GLUCAN; PNEUMONIA; METAANALYSIS; ACCURACY; COLONIZATION	Background Diagnosis of pneumocystis pneumonia (PCP) relies on microscopic visualization of P. jirovecii, or detection of Pneumocystis DNA in respiratory specimens, which involves invasive procedures such as bronchoalveolar lavage. The (1-3)-beta-D-glucan (BG) assay has been proposed as a less invasive and less expensive diagnostic test to rule out PCP. We therefore compared blood levels of BG in patients with PCP with those of patients with candidemia, chronic disseminated candidiasis (CDC), invasive aspergillosis, mucormycosis, and tuberculosis and those of healthy volunteers. Methods Adult patients who were diagnosed with PCP, candidemia, CDC, invasive aspergillosis, mucormycosis, and tuberculosis whose blood samples were available, and healthy volunteers were enrolled in a tertiary hospital in Seoul, South Korea, during a 21-month period. The blood samples were assayed with the Goldstream Fungus (1-3)-beta-D-glucan test (Gold Mountain River Tech Development, Beijing, China). Results A total of 136 individuals including 50 patients P. jirovecii, 15 candidemia, 6 CDC, 15 invasive aspergillosis, 10 mucormycosis, and 40 controls (20 TB and 20 healthy volunteers) were included. The mean +/- SD of the concentration of 1-3-beta-D-glucan in the patients with PCP (290.08 pg/mL +/- 199.98) were similar to those of patients with candidemia (314.14 pg/mL +/- 205.60, p = 0.90 at an alpha = 0.005) and CDC (129.74 pg/mL +/- 182.79, p = 0.03 at an alpha = 0.005),	[Son, Hyo-Ju; Park, Se Yoon; Kim, Taeeun; Lee, Hyun Jeong; Kim, Sun-Mi; Chong, Yong Pil; Lee, Sang-Oh; Choi, Sang-Ho; Kim, Yang Soo; Woo, Jun Hee; Kim, Sung-Han] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea; [Sung, Heungsup] Univ Ulsan, Coll Med, Asan Med Ctr, Lab Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Kim, SH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea.	kimsunghanmd@hotmail.com	Lee, Sang-Oh/AGV-5413-2022; Chong, Yong Pil/AAB-2623-2021	Lee, Sang-Oh/0000-0003-1381-8787; Kim, Sung-Han/0000-0002-6596-8253	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI16C0272]; Asan Institute for Life Sciences [2015-0193]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Asan Institute for Life Sciences	This study was supported by grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant no. HI16C0272), and the Asan Institute for Life Sciences (2015-0193) to Sung-Han Kim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angebault C, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw128; de Boer MGJ, 2011, J INFECTION, V62, P93, DOI 10.1016/j.jinf.2010.10.007; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Esteves F, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.11.025; Harris JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023158; Held J, 2011, CLIN MICROBIOL INFEC, V17, P595, DOI 10.1111/j.1469-0691.2010.03318.x; Hope WW, 2005, LANCET INFECT DIS, V5, P609, DOI 10.1016/S1473-3099(05)70238-3; Jang Y-R, 2017, MED MYCOLOG IN PRESS; Jung J, 2015, CLIN INFECT DIS, V61, P1664, DOI 10.1093/cid/civ660; Karageorgopoulos DE, 2013, CLIN MICROBIOL INFEC, V19, P39, DOI 10.1111/j.1469-0691.2011.03760.x; Karageorgopoulos DE, 2011, CLIN INFECT DIS, V52, P750, DOI 10.1093/cid/ciq206; Kovacs JA, 2009, JAMA-J AM MED ASSOC, V301, P2578, DOI 10.1001/jama.2009.880; Mansharamani NG, 2000, CHEST, V118, P704, DOI 10.1378/chest.118.3.704; Masood A, 2005, LEUKEMIA RES, V29, P493, DOI 10.1016/j.leukres.2004.10.003; Nakamura H, 2009, INTERNAL MED, V48, P195, DOI 10.2169/internalmedicine.48.1680; Obayashi T, 2008, CLIN INFECT DIS, V46, P1864, DOI 10.1086/588295; Onishi A, 2012, J CLIN MICROBIOL, V50, P7, DOI 10.1128/JCM.05267-11; Ostrosky-Zeichner L, 2005, CLIN INFECT DIS, V41, P654, DOI 10.1086/432470; Pini P, 2016, INFECTION, V44, P223, DOI 10.1007/s15010-015-0849-8; Ponce CA, 2010, CLIN INFECT DIS, V50, P347, DOI 10.1086/649868; Prattes J, 2014, MYCOSES, V57, P679, DOI 10.1111/myc.12221; Sax PE, 2011, CLIN INFECT DIS, V53, P197, DOI 10.1093/cid/cir335; Tasaka S, 2007, CHEST, V131, P1173, DOI 10.1378/chest.06-1467; Tasaka S, 2014, J INFECT CHEMOTHER, V20, P678, DOI 10.1016/j.jiac.2014.07.001; Theel ES, 2013, J CLIN MICROBIOL, V51, P3478, DOI 10.1128/JCM.01737-13; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588	26	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188860	10.1371/journal.pone.0188860	http://dx.doi.org/10.1371/journal.pone.0188860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190812	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900146
J	Bognar, Z; Fekete, K; Antus, C; Hocsak, E; Bognar, R; Tapodi, A; Boronkai, A; Farkas, N; Gallyas, F; Sumegi, B; Szanto, A				Bognar, Zita; Fekete, Katalin; Antus, Csenge; Hocsak, Eniko; Bognar, Rita; Tapodi, Antal; Boronkai, Arpad; Farkas, Nelli; Gallyas, Ferenc, Jr.; Sumegi, Balazs; Szanto, Arpad			Desethylamiodarone - A metabolite of amiodarone - Induces apoptosis on T24 human bladder cancer cells via multiple pathways	PLOS ONE			English	Article							N-DESETHYLAMIODARONE; P53; CARCINOMA; THERAPY; CYCLE; KINASE; ERK; IDENTIFICATION; ACCUMULATION; PRESERVATION	Bladder cancer (BC) is a common malignancy of the urinary tract that has a higher frequency in men than in women. Cytostatic resistance and metastasis formation are significant risk factors in BC therapy; therefore, there is great interest in overcoming drug resistance and in initiating research for novel chemotherapeutic approaches. Here, we suggest that desethylamiodarone (DEA) - a metabolite of amiodarone D may have cytostatic potential. DEA activates the collapse of mitochondrial membrane potential (detected by JC1 fluorescence), and induces cell death in T24 human transitional-cell bladder carcinoma cell line at physiologically achievable concentrations. DEA induces cell cycle arrest in the G0/G1 phase, which may contribute to the inhibition of cell proliferation, and shifts the Bax/ Bcl-2 ratio to initiate apoptosis, induce AIF nuclear translocation, and activate PARP-1 cleavage and caspase-3 activation. The major cytoprotective kinases D ERK and Akt D are inhibited by DEA, which may contribute to its cell death-inducing effects. DEA also inhibits the expression of B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1) and reduces colony formation of T24 bladder carcinoma cells, indicating its possible inhibitory effect on metastatic potential. These data show that DEA is a novel anti-cancer candidate of multiple cell death-inducing effects and metastatic potential. Our findings recommend further evaluation of its effects in clinical studies.	[Bognar, Zita; Fekete, Katalin; Antus, Csenge; Hocsak, Eniko; Bognar, Rita; Tapodi, Antal; Gallyas, Ferenc, Jr.; Sumegi, Balazs] Univ Pecs, Dept Biochem & Med Chem, Pecs, Hungary; [Boronkai, Arpad] Univ Pecs, Dept Oncotherapy, Pecs, Hungary; [Farkas, Nelli] Univ Pecs, Inst Bioanal, Pecs, Hungary; [Gallyas, Ferenc, Jr.; Sumegi, Balazs] MTA PTE Nucl Mitochondrial Res Grp, Pecs, Hungary; [Gallyas, Ferenc, Jr.; Sumegi, Balazs] Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary; [Szanto, Arpad] Univ Pecs, Dept Urol, Pecs, Hungary	University of Pecs; University of Pecs; University of Pecs; University of Pecs; University of Pecs	Bognar, Z (corresponding author), Univ Pecs, Dept Biochem & Med Chem, Pecs, Hungary.	zita.bognar@aok.pte.hu	Gallyas, Ferenc/AAY-5343-2020; Gallyas, Ferenc/C-2272-2012	Farkas, Nelli/0000-0002-5349-6527	 [GINOP-2.3.2-15-2016-00049];  [GINOP-2.3.3-15-2016-00025];  [EFOP-3.6.1-16-2016-00004]	; ; 	This work was supported by GINOP-2.3.2-15-2016-00049 (Balazs Sumegi), https://www.palyazat.gov.hu; GINOP-2.3.3-15-2016-00025 (Balazs Sumegi), https://www.palyazat.gov.hu; and EFOP-3.6.1-16-2016-00004 (Balazs Sumegi), https://www.palyazat.gov.hu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PC, 1985, CIRCULATION, V72, P1064, DOI 10.1161/01.CIR.72.5.1064; Bhattacharya R, 2015, GENES DIS, V2, P225, DOI 10.1016/j.gendis.2015.04.001; BOS JL, 1989, CANCER RES, V49, P4682; Bosetti C, 2011, EUR UROL, V60, P1, DOI 10.1016/j.eururo.2011.03.047; BRIEN JF, 1987, CAN J PHYSIOL PHARM, V65, P360, DOI 10.1139/y87-062; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; COOPER MJ, 1994, ONCOL RES, V6, P569; CordonCardo C, 1997, CANCER RES, V57, P1217; DANIELS JM, 1989, TOXICOL APPL PHARM, V100, P350, DOI 10.1016/0041-008X(89)90321-9; Deng P, 2011, DRUG METAB DISPOS, V39, P1058, DOI 10.1124/dmd.110.037671; Dobashi Y, 2003, CURR MED CHEM, V10, P2549, DOI 10.2174/0929867033456495; Efstathiou JA, 2012, EUR UROL, V61, P705, DOI 10.1016/j.eururo.2011.11.010; ESRIG D, 1994, NEW ENGL J MED, V331, P1259, DOI 10.1056/NEJM199411103311903; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GOEBL MG, 1991, CELL, V66, P623, DOI 10.1016/0092-8674(91)90106-9; Grossman HB, 1998, CLIN CANCER RES, V4, P829; Grossmann M, 2000, CLIN PHARMACOL THER, V67, P22, DOI 10.1067/mcp.2000.103822; Hall MC, 2007, J UROLOGY, V178, P2314, DOI 10.1016/j.juro.2007.09.003; Himmel HM, 2000, N-S ARCH PHARMACOL, V362, P489, DOI 10.1007/s002100000301; HOLT DW, 1983, AM HEART J, V106, P840, DOI 10.1016/0002-8703(83)90006-6; Itahana Koji, 2010, Epigenomics, V2, P610; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Joshi Ashish, 2011, Perspect Health Inf Manag, V8, p1e; KANNAN R, 1989, FUND APPL TOXICOL, V13, P793, DOI 10.1016/0272-0590(89)90334-5; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li C, 2005, BRIT J CANCER, V92, P80, DOI 10.1038/sj.bjc.6602272; Malats W, 2005, LANCET ONCOL, V6, P678; Monni L, 2017, NEUROSCI LETT, V655, P95, DOI 10.1016/j.neulet.2017.06.040; PALLANDI RT, 1987, BRIT J PHARMACOL, V92, P97, DOI 10.1111/j.1476-5381.1987.tb11300.x; Park HS, 2013, MAR DRUGS, V11, P2347, DOI 10.3390/md11072347; Park HS, 2011, J FOOD SCI, V76, pT77, DOI 10.1111/j.1750-3841.2011.02099.x; Paternot S, 2010, CELL CYCLE, V9, P689, DOI 10.4161/cc.9.4.10611; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Pucci B, 2000, NEOPLASIA, V2, P291, DOI 10.1038/sj.neo.7900101; Qin ZK, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-61; Rajesh D, 1999, MOL PHARMACOL, V56, P515, DOI 10.1124/mol.56.3.515; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Robert G, 2012, ONCOTARGET, V3, P1688; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Soyama A, 2002, PHARMACOL TOXICOL, V91, P174, DOI 10.1034/j.1600-0773.2002.910404.x; Steelman LS, 2011, AGING-US, V3, P192, DOI 10.18632/aging.100296; Sternberg CN, 2007, UROLOGY, V69, P62, DOI 10.1016/j.urology.2006.10.041; Varbiro G, 2003, J PHARMACOL EXP THER, V307, P615, DOI 10.1124/jpet.103.053553; Varro A, 1996, BRIT J PHARMACOL, V117, P1181, DOI 10.1111/j.1476-5381.1996.tb16713.x; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Widelitz R, 2005, GROWTH FACTORS, V23, P111, DOI 10.1080/08977190500125746; Wu X, 2004, BJU INT, V93, P143, DOI 10.1111/j.1464-410X.2004.04574.x; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Yao WL, 2015, CANCER LETT, V364, P70, DOI 10.1016/j.canlet.2015.04.028; Ye Q, 2014, ONCOGENE, V33, P1828, DOI 10.1038/onc.2013.122	54	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189470	10.1371/journal.pone.0189470	http://dx.doi.org/10.1371/journal.pone.0189470			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220397	Green Submitted, Green Published, gold			2022-12-27	WOS:000417469900060
J	Yonekura, S; Kuniyoshi, Y				Yonekura, Shogo; Kuniyoshi, Yasuo			Bodily motion fluctuation improves reaching success rate in a neurophysical agent via geometric-stochastic resonance	PLOS ONE			English	Article							NOISE; SYSTEMS	Organisms generate a variety of noise types, including neural noise, sensory noise, and noise resulting from fluctuations associated with movement. Sensory and neural noises are known to induce stochastic resonance (SR), which improves information transfer to the subjects control systems, including the brain. As a consequence, sensory and neural noise provide behavioral benefits, such as stabilization of posture and enhancement of feeding efficiency. In contrast, the benefits of fluctuations in the movements of a biological system remain largely unclear. Here, we describe a novel type of noise-induced order (NIO) that is realized by actively exploiting the motion fluctuations of an embodied system. In particular, we describe the theoretical analysis of a feedback-controlled embodied agent system that has a geometric end-effector. Furthermore, through several numerical simulations we demonstrate that the ratio of successful reaches to goal positions and capture of moving targets are improved by the exploitation of motion fluctuations. We report that reaching success rate improvement (RSRI) is based on the interaction of the geometric size of an end-effector, the agents motion fluctuations, and the desired motion frequency. Therefore, RSRI is a geometrically induced SR-like phenomenon. We also report an interesting result obtained through numerical simulations indicating that the agents neural and motion noise must be optimized to match the prey's motion noise in order to maximize the capture rate. Our study provides a new understanding of body motion fluctuations, as they were found to be the active noise sources for a behavioral NIO.	[Yonekura, Shogo; Kuniyoshi, Yasuo] Univ Tokyo, Tokyo, Japan	University of Tokyo	Yonekura, S; Kuniyoshi, Y (corresponding author), Univ Tokyo, Tokyo, Japan.	yonekura@isi.imi.i.u-tokyo.ac.jp; kuniyosh@isi.imi.i.u-tokyo.ac.jp			New Energy and Industrial Technology Development Organization (NEDO)	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by the New Energy and Industrial Technology Development Organization (NEDO, http://www.nedogodp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Bulsara AR, 1996, PHYS TODAY, V49, P39, DOI 10.1063/1.881491; Burada PS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.130602; COLLINS JJ, 1995, NATURE, V376, P236, DOI 10.1038/376236a0; COLLINS JJ, 1995, PHYS REV E, V52, pR3321, DOI 10.1103/PhysRevE.52.R3321; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; Freund JA, 2002, J THEOR BIOL, V214, P71, DOI 10.1006/jtbi.2001.2445; Freund JA, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.031910; Gammaitoni L, 1989, PHYS REV A, V40, P2114, DOI 10.1103/PhysRevA.40.2114; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Ghosh PK, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.020601; HANGGI P, 1993, J STAT PHYS, V70, P25, DOI 10.1007/BF01053952; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; Hennig MH, 2002, NEUROCOMPUTING, V44, P115, DOI 10.1016/S0925-2312(02)00371-5; HU G, 1990, PHYS REV A, V42, P2030, DOI 10.1103/PhysRevA.42.2030; Kitajo K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.218103; Lindner B., 2002, COHERENCE STOCHASTIC; McDonnel MD, 2005, PLOS COMPUTATIONAL B, V5; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; Rolls ET, 2014, EMOTION DECISION MAK; Russell DF, 1999, NATURE, V402, P291, DOI 10.1038/46279; Soderlund G, 2007, J CHILD PSYCHOL PSYC, V48, P840, DOI 10.1111/j.1469-7610.2007.01749.x; Ward LM, 2002, BIOL CYBERN, V87, P91, DOI 10.1007/s00422-002-0328-z; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; Yonekura S, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011922; Zheng CM, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/60004	29	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188298	10.1371/journal.pone.0188298	http://dx.doi.org/10.1371/journal.pone.0188298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220402	gold, Green Published, Green Submitted			2022-12-27	WOS:000417469900009
J	Brinkhof, S; Groen, HJM; Siesling, SS; IJzerman, MJ				Brinkhof, Sander; Groen, Harry J. M.; Siesling, Sabine S.; IJzerman, Maarten J.			Resource utilization in lung cancer diagnostic procedures: Current use and budget consequences	PLOS ONE			English	Article							PLASMA DNA; FRANCE	Objectives The main objective of this study is to determine the current use of lung cancer diagnostic procedures in two large hospitals in the Netherlands, to explore deviations in guideline adherence between the hospitals, and to estimate the budget impact of the diagnostic workup as well as the over- and underutilization. Materials & methods A state transition model for the diagnostic pathway for lung cancer patients was developed using existing clinical practice guidelines (CPG) combined with a systematic literature. In addition to the CPGs depicting current practice, diagnostic utilization was gathered in two large hospitals representing an academic tertiary care hospital and a large regional teaching hospital for patients, who were selected from the Netherlands cancer registry. Results The total population consisted of 376 patients with lung cancer. Not in all cases the guideline was followed, for instance in the usage of MR brain with stage III lung cancer patients (n = 70). The state-transition model predicts an average budget impact for the diagnostic pathway per patient estimated of (sic) 2496 in the academic tertiary care hospital and (sic) 2191 in the large regional teaching hospital. Conclusion The adherence to the CPG's differed between hospitals, which questions the adherence to CPG's in general. Adherence to CPG's could lead to less costs in the diagnostic pathway for lung cancer patients.	[Brinkhof, Sander; Siesling, Sabine S.; IJzerman, Maarten J.] Univ Twente, Dept Hlth Technol & Serv Res, Enschede, Netherlands; [Groen, Harry J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands; [Siesling, Sabine S.] Comprehens Canc Org, Utrecht, Netherlands; [IJzerman, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Med Sch, Dept Radiol, Groningen, Netherlands	University of Twente; University of Groningen; University of Groningen	IJzerman, MJ (corresponding author), Univ Twente, Dept Hlth Technol & Serv Res, Enschede, Netherlands.; IJzerman, MJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Med Sch, Dept Radiol, Groningen, Netherlands.	m.j.ijzerman@utwente.nl	Groen, Harry/AAP-2242-2021; IJzerman, Maarten/AAB-6894-2020	IJzerman, Maarten/0000-0001-5788-5805; Brinkhof, Sander/0000-0002-2377-6317; Groen, Harry J.M./0000-0002-2978-5265				Bommel ACMVAN, 2016, CLIN AUDITING INSTRU, P1; Chouaid C, 2004, BRIT J CANCER, V90, P397, DOI 10.1038/sj.bjc.6601547; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Flanagan MR, 2015, ANN THORAC SURG, V100, P2006, DOI 10.1016/j.athoracsur.2015.08.010; Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600; Integraal Kankercentrum Nederland, 2013, RAPP LONGK; Integraal Kankercentrum Nederland, 2012, DUTCH CANC REG; Kneip C, 2011, J THORAC ONCOL, V6, P1632, DOI 10.1097/JTO.0b013e318220ef9a; Kumar P, 2009, CLIN MED; McGuire A, 2015, J MED ECON, V18, P525, DOI 10.3111/13696998.2015.1032974; Ostrow KL, 2010, CLIN CANCER RES, V16, P3463, DOI 10.1158/1078-0432.CCR-09-3304; Peled N, 2015, J CLIN ONCOL, V33; Siebert U, 2012, MED DECIS MAKING, V32, P690, DOI 10.1177/0272989X12455463; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Suicide, 2012, HLTH GLANC EUR 2012, P28; Taenzer A, 2012, J THORAC DIS, V4, P448, DOI 10.3978/j.issn.2072-1439.2012.08.17; Yoon KA, 2009, J MOL DIAGN, V11, P182, DOI 10.2353/jmoldx.2009.080098; Yoshida Yukihiro, 2013, Asian Cardiovasc Thorac Ann, V21, P693, DOI 10.1177/0218492312470670	18	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189251	10.1371/journal.pone.0189251	http://dx.doi.org/10.1371/journal.pone.0189251			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216302	gold, Green Published, Green Submitted			2022-12-27	WOS:000417337800108
J	Kuboyama, K; Tanga, N; Suzuki, R; Fujikawa, A; Noda, M				Kuboyama, Kazuya; Tanga, Naomi; Suzuki, Ryoko; Fujikawa, Akihiro; Noda, Masaharu			Protamine neutralizes chondroitin sulfate proteoglycan-mediated inhibition of oligodendrocyte differentiation	PLOS ONE			English	Article							RECEPTOR-TYPE-Z; PROMOTES FUNCTIONAL RECOVERY; ZETA/RPTP-BETA; DEMYELINATED LESIONS; EXTRACELLULAR-MATRIX; MULTIPLE-SCLEROSIS; REMYELINATION; PLEIOTROPHIN; ACTIVATION; ASTROCYTES	Chondroitin sulfate proteoglycans (CSPGs), which are enriched in demyelinating plaques in neurodegenerative diseases, such as multiple sclerosis (MS), impair remyelination by inhibiting the migration and differentiation of oligodendrocyte precursor cells (OPCs) in the central nervous system (CNS). We herein show that protamine (PRM, also known as a heparin antagonist) effectively neutralizes the inhibitory activities of CSPGs, thereby enhancing OPC differentiation and (re) myelination in mice. Cell-based assays using mouse OPC-like OL1 cells revealed that the PRM treatment exerted masking effects on extracellular CSPGs and improved oligodendrocyte differentiation on inhibitory CSPG-coated substrates. PRM also bound to the extracellular region of protein tyrosine phosphatase receptor type Z (PTPRZ), a membrane-spanning CSPG predominantly expressed in OPCs, and functioned as a ligand mimetic of PTPRZ, thereby suppressing its negative regulatory activity on oligodendrocyte differentiation. In primary cultures, the differentiation of OPCs from wild-type and Ptprz-deficient mice was equally enhanced by PRM. Moreover, the intranasal administration of PRM accelerated myelination in the developing mouse brain, and its intracerebro-ventricular administration stimulated remyelination after cuprizone-induced demyelination. These results indicate that PRM has CSPG-neutralizing activity which promotes oligodendrocyte differentiation under developmental and morbid conditions.	[Kuboyama, Kazuya; Tanga, Naomi; Suzuki, Ryoko; Fujikawa, Akihiro; Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi, Japan; [Tanga, Naomi; Noda, Masaharu] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Okazaki, Aichi, Japan; [Kuboyama, Kazuya] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Dept Neuropharmacol, Sanuki, Kagawa, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Tokushima Bunri University	Fujikawa, A; Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi, Japan.; Noda, M (corresponding author), Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Okazaki, Aichi, Japan.	fujikawa@nibb.ac.jp; madon@nibb.ac.jp	; Noda, Masaharu/D-7146-2016	Kuboyama, Kazuya/0000-0002-9878-1209; Noda, Masaharu/0000-0002-3796-524X	JSPS KAKENHI [26830050, 17K07355, 21700416, 24500390, 26110722, 16209008]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers: 26830050 (https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-26830050/) and 17K07355 (https://kaken.nii.ac.jp/en/search/?kw=17K07355) for KK, 21700416 (https://kaken.nii.ac.jp/en/search/?kw=21700416), 24500390 (https://kaken.nii.ac.jp/en/search/?kw=24500390), and 26110722 (https://kaken.nii.ac.jp/en/search/?kw=26110722) for AF, and 16209008 (https://kaken.nii.ac.jp/en/search/?kw=16209008) for MN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiraman K, 2015, J NEUROSCI, V35, P3676, DOI 10.1523/JNEUROSCI.3510-14.2015; Azim K, 2011, GLIA, V59, P540, DOI 10.1002/glia.21122; Balhorn R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-227; Bothwell M, 2017, ANNU REV MED, V68, P431, DOI 10.1146/annurev-med-050715-104400; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Chandran P, 2012, NEUROSCIENCE, V202, P446, DOI 10.1016/j.neuroscience.2011.10.051; Chang AS, 2012, ANN NEUROL, V72, P918, DOI 10.1002/ana.23693; Chow JPH, 2008, J BIOL CHEM, V283, P30879, DOI 10.1074/jbc.M802976200; Chow JPH, 2008, NEUROSCI LETT, V442, P208, DOI 10.1016/j.neulet.2008.07.028; Cua RC, 2013, GLIA, V61, P972, DOI 10.1002/glia.22489; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Denic Aleksandar, 2011, Pathophysiology, V18, P21, DOI 10.1016/j.pathophys.2010.04.004; Deshmukh VA, 2013, NATURE, V502, P327, DOI 10.1038/nature12647; Dror DK, 2008, NUTR REV, V66, P250, DOI 10.1111/j.1753-4887.2008.00031.x; Du CS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11120; Dyck SM, 2015, EXP NEUROL, V269, P169, DOI 10.1016/j.expneurol.2015.04.006; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Fujikawa A, 2016, NEURAL REGEN RES, V11, P549, DOI 10.4103/1673-5374.180761; Fukada M, 2005, METHODS, V35, P54, DOI 10.1016/j.ymeth.2004.07.008; Gonzalez GA, 2016, SCI REP-UK, V6, DOI 10.1038/srep31599; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Hanson LR, 2013, JOVE-J VIS EXP, DOI 10.3791/4440; Hara M, 2017, NAT MED, V23, P818, DOI 10.1038/nm.4354; HORROW JC, 1985, ANESTH ANALG, V64, P348; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Kanekiyo K, 2013, J NEUROSCI, V33, P10037, DOI 10.1523/JNEUROSCI.3137-12.2013; Karus M, 2016, GLIA, V64, P270, DOI 10.1002/glia.22928; Keough MB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11312; Kuboyama K, 2016, J BIOL CHEM, V291, P18117, DOI 10.1074/jbc.M116.742536; Kuboyama K, 2015, J NEUROSCI, V35, P12162, DOI 10.1523/JNEUROSCI.2127-15.2015; Kuboyama K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048797; Lau LW, 2013, NAT REV NEUROSCI, V14, P722, DOI 10.1038/nrn3550; Lau LW, 2012, ANN NEUROL, V72, P419, DOI 10.1002/ana.23599; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lin TT, 2016, ACTA PHARM SIN B, V6, P352, DOI 10.1016/j.apsb.2016.04.001; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Maeda N, 2011, NEUROCHEM RES, V36, P1228, DOI 10.1007/s11064-010-0324-y; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; Medina-Rodriguez EM, 2017, SCI REP-UK, V7, DOI 10.1038/srep43545; Matthews RT, 2002, J NEUROSCI, V22, P7536; Mei F, 2014, NAT MED, V20, P954, DOI 10.1038/nm.3618; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Muramoto A, 2013, NEUROSCI LETT, V550, P150, DOI 10.1016/j.neulet.2013.06.025; Murasugi A, 2003, BIOSCI BIOTECH BIOCH, V67, P2288, DOI 10.1271/bbb.67.2288; Najm FJ, 2015, NATURE, V522, P216, DOI 10.1038/nature14335; Nap RJ, 2008, BIOPHYS J, V95, P4570, DOI 10.1529/biophysj.108.133801; Park YJ, 2005, FASEB J, V19, P1555, DOI 10.1096/fj.04-2322fje; Paveliev M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33916; Pendleton JC, 2013, EXP NEUROL, V247, P113, DOI 10.1016/j.expneurol.2013.04.003; Plemel JR, 2017, NATURE REV DRUG DISC; Pujol J, 2004, NEUROIMAGE, V22, P897, DOI 10.1016/j.neuroimage.2004.01.029; Sakuda K, 2017, BIOCHEM BIOPH RES CO, V487, P450, DOI 10.1016/j.bbrc.2017.04.085; Scafidi J, 2014, NATURE, V506, P230, DOI 10.1038/nature12880; Shintani T, 1998, NEUROSCI LETT, V247, P135, DOI 10.1016/S0304-3940(98)00295-X; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sokolowska E, 2016, EXPERT OPIN DRUG MET, V12, P897, DOI 10.1080/17425255.2016.1194395; Syed YA, 2013, EMBO MOL MED, V5, P1918, DOI 10.1002/emmm.201303123; Tamura H, 2006, NEUROSCI LETT, V399, P33, DOI 10.1016/j.neulet.2006.01.045; Horssen J, 2007, J NEUROCHEM, V103, P1293, DOI 10.1111/j.1471-4159.2007.04897.x; Wolf RM, 2001, J NEUROBIOL, V49, P62, DOI 10.1002/neu.1066; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792	64	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189164	10.1371/journal.pone.0189164	http://dx.doi.org/10.1371/journal.pone.0189164			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216327	Green Submitted, Green Published, gold			2022-12-27	WOS:000417337800084
J	Canales, A; Rosinger, M; Sastre, J; Felli, IC; Jimenez-Barbero, J; Gimenez-Gallego, G; Fernandez-Tornero, C				Canales, Angeles; Rosinger, Marcel; Sastre, Javier; Felli, Isabella C.; Jimenez-Barbero, Jesus; Gimenez-Gallego, Guillermo; Fernandez-Tornero, Carlos			Hidden alpha-helical propensity segments within disordered regions of the transcriptional activator CHOP	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; ENDOPLASMIC-RETICULUM STRESS; C/EBP HOMOLOGOUS PROTEIN; SEDIMENTATION-VELOCITY; MOLECULAR RECOGNITION; ESCHERICHIA-COLI; BINDING REGIONS; DOMAIN; GENE; GCN4	C/EBP-homologous protein (CHOP) is a key determinant of the apoptotic response to endoplasmic reticulum stress or DNA damage. As a member of the C/EBP family, CHOP contains a low complexity N-terminal region involved in transcriptional activation, followed by a bZIP that binds DNA after dimerization. However, in contrast to other C/EBPs, CHOP directs binding to non-canonical C/EBP sites due to unique substitutions in its DNA-binding domain. Herein, we show that the N-terminal region of CHOP is intrinsically unstructured but contains two segments presenting a-helical propensity. One of these segments is conserved in other C/EBPs and mediates essential roles of CHOP, including regulation through phosphorylation. The second segment is placed within a proteolytic-resistant portion of the protein and exhibits reduced flexibility. Moreover, the DNA-binding region of CHOP also contains a segment with a-helical character towards its most N-terminal part. Our results suggest that structure-prone segments scattered within disordered regions may be critical for macromolecular recognition during CHOP-mediated transcriptional activation.	[Canales, Angeles] Univ Complutense Madrid, Dept Quim Organ 1, Madrid, Spain; [Rosinger, Marcel; Sastre, Javier; Jimenez-Barbero, Jesus; Gimenez-Gallego, Guillermo; Fernandez-Tornero, Carlos] CSIC, Ctr Invest Biol, Madrid, Spain; [Felli, Isabella C.] Univ Florence, Magnet Resonance Ctr, Sesto Fiorentino, Italy; [Jimenez-Barbero, Jesus] CIC bioGUNE, Bizkaia Sci & Technol Pk, Derio, Spain; [Jimenez-Barbero, Jesus] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Jimenez-Barbero, Jesus] Univ Basque Country, Fac Sci & Technol, Dept Organ Chem 2, Leioa, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Florence; CIC bioGUNE; Basque Foundation for Science; University of Basque Country	Canales, A (corresponding author), Univ Complutense Madrid, Dept Quim Organ 1, Madrid, Spain.; Fernandez-Tornero, C (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	ma.canales@quim.ucm.es; cftornero@cib.csic.es	Fernandez-Tornero, Carlos/AAV-8028-2021; Fernandez-Tornero, Carlos/I-6888-2015; Felli, Isabella C./O-1751-2015; JIMENEZ-BARBERO, JESUS/D-4431-2014; Canales, Angeles/K-7499-2015	Fernandez-Tornero, Carlos/0000-0001-5097-731X; Fernandez-Tornero, Carlos/0000-0001-5097-731X; Felli, Isabella C./0000-0002-6018-9090; JIMENEZ-BARBERO, JESUS/0000-0001-5421-8513; Canales, Angeles/0000-0003-0542-3080	Spanish Ministry of Economy and Competitiveness [BFU2013-48374-P, CTQ2016-76263-P]; Ramon Areces Foundation; European Commission [261863]; PharmaMar	Spanish Ministry of Economy and Competitiveness(Spanish Government); Ramon Areces Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); PharmaMar	This work was supported by the Spanish Ministry of Economy and Competitiveness [BFU2013-48374-P to C.F.-T., CTQ2016-76263-P to A.C.]; the Ramon Areces Foundation [to C.F.-T.]; and the European Commission [BioNMR (Contract No. 261863) to I.C.F.]. PharmaMar supported this project during the initial stages. The funders had no role in study design, data collection and analysis,	Bermel W, 2006, J AM CHEM SOC, V128, P3918, DOI 10.1021/ja0582206; Brzovic PS, 2011, MOL CELL, V44, P942, DOI 10.1016/j.molcel.2011.11.008; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lobanov MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027142; Miller M, 2003, J BIOL CHEM, V278, P15178, DOI 10.1074/jbc.M300417200; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ohoka N, 2007, J BIOL CHEM, V282, P35687, DOI 10.1074/jbc.M703735200; ONEIL KT, 1991, BIOCHEMISTRY-US, V30, P9030, DOI 10.1021/bi00101a017; ORTEGA S, 1992, BIO-TECHNOL, V10, P795, DOI 10.1038/nbt0792-795; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Singh VK, 2008, J MOL BIOL, V380, P313, DOI 10.1016/j.jmb.2008.04.069; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Ubeda M, 2003, J BIOL CHEM, V278, P40514, DOI 10.1074/jbc.M306404200; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920	37	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189171	10.1371/journal.pone.0189171	http://dx.doi.org/10.1371/journal.pone.0189171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211802	Green Published, Green Submitted, gold			2022-12-27	WOS:000417212200074
J	Li, L; Ma, XW; Zhan, RL; Wu, HX; Yao, QS; Xu, WT; Luo, C; Zhou, YG; Liang, QZ; Wang, SB				Li, Li; Ma, Xiao-Wei; Zhan, Ru-Lin; Wu, Hong-Xia; Yao, Quan-Sheng; Xu, Wen-Tian; Luo, Chun; Zhou, Yi-Gang; Liang, Qing-Zhi; Wang, Song-Biao			Profiling of volatile fragrant components in a mini-core collection of mango germplasms from seven countries	PLOS ONE			English	Article							MANGIFERA-INDICA L.; AROMA COMPONENTS; CULTIVARS; FRUIT; VARIETIES; CONSTITUENTS	Aroma is important in assessing the quality of fresh fruit and their processed products, and could provide good indicators for the development of local cultivars in the mango industry. In this study, the volatile diversity of 25 mango cultivars from China, America, Thailand, India, Cuba, Indonesia, and the Philippines was investigated. The volatile compositions, their relative contents, and the intervarietal differences were detected with headspace solid phase microextraction tandem gas chromatography-mass spectrometer methods. The similarities were also evaluated with a cluster analysis and correlation analysis of the volatiles. The differences in mango volatiles in different districts are also discussed. Our results show significant differences in the volatile compositions and their relative contents among the individual cultivars and regions. In total, 127 volatiles were found in all the cultivars, belonging to various chemical classes. The highest and lowest qualitative abundances of volatiles were detected in 'ihua' and 'allika' cultivars, respectively. Based on the cumulative occurrence of members of the classes of volatiles, the cultivars were grouped into monoterpenes (16 cultivars), proportion and balanced (eight cultivars), and nonterpene groups (one cultivars). Terpene hydrocarbons were the major volatiles in these cultivars, with terpinolene, 3-carene, caryophyllene and a-Pinene the dominant components depending on the cultivars. Monoterpenes, some of the primary volatile components, were the most abundant aroma compounds, whereas aldehydes were the least abundant in the mango pulp. beta-Myrcene, a major terpene, accounted for 58.93% of the total flavor volatile compounds in 'iaofei' (Philippens). gamma-Octanoic lactone was the only ester in the total flavor volatile compounds, with its highest concentration in 'uiya' (China). Hexamethyl cyclotrisiloxane was the most abundant volatile compound in 'agovar' (India), accounting for 46.66% of the total flavor volatiles. A typical aldehydic aroma 2,6-di-tert-butyl-4-sec-butylphenol,was detected in 'leck'. A highly significant positive correlation was detected between Alc and K, Alk and Nt, O and L. Cultivars originating from America, Thailand, Cuba, India, Indonesia and the Philippines were more similar to each other than to those from China. This study provides a high-value dataset for use in development of health care products, diversified mango breeding, and local extension of mango cultivars.	[Li, Li; Ma, Xiao-Wei; Zhan, Ru-Lin; Wu, Hong-Xia; Yao, Quan-Sheng; Xu, Wen-Tian; Luo, Chun; Zhou, Yi-Gang; Liang, Qing-Zhi; Wang, Song-Biao] Chinese Acad Trop Agr Sci, South Subtrop Crops Res Inst, Minist Agr, Key Lab Trop Fruit Biol, Zhanjiang, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Wang, SB (corresponding author), Chinese Acad Trop Agr Sci, South Subtrop Crops Res Inst, Minist Agr, Key Lab Trop Fruit Biol, Zhanjiang, Peoples R China.	wsbcjy@163.com			Special Fund for Agro-scientific Research in the Public Interest [201203092-3]; National Nature Science Foundation of Guangdong Province [2016A030307005]; Special Fund of Basic Scientific Research Project for State Level and Public Welfare-scientific Research Institutes [1630062015001, 1630062015007, 1630062016007]	Special Fund for Agro-scientific Research in the Public Interest; National Nature Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Special Fund of Basic Scientific Research Project for State Level and Public Welfare-scientific Research Institutes	This research was supported by the the Special Fund for Agro-scientific Research in the Public Interest (201203092-3), the National Nature Science Foundation of Guangdong Province (2016A030307005) and Special Fund of Basic Scientific Research Project for State Level and Public Welfare-scientific Research Institutes (1630062015001, 1630062015007, 1630062016007). All the funders of these fundings belong to Chinese government. These fundings are public welfare research funds and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade EHA, 2001, J FOOD COMPOS ANAL, V14, P227, DOI 10.1006/jfca.2000.0968; Araguez I, 2013, BIOTECHNOL J, V8, P1144, DOI 10.1002/biot.201300113; Gonzalez-Mas MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022016; El Hadi MAM, 2013, MOLECULES, V18, P8200, DOI 10.3390/molecules18078200; ENGEL KH, 1983, J AGR FOOD CHEM, V31, P796, DOI 10.1021/jf00118a029; Huang GuoDi, 2000, China Fruits, P47; IDSTEIN H, 1985, PHYTOCHEMISTRY, V24, P2313, DOI 10.1016/S0031-9422(00)83033-2; John KS, 1999, PHYTOCHEMISTRY, V52, P891, DOI 10.1016/S0031-9422(99)00296-4; Lalel HJD, 2003, POSTHARVEST BIOL TEC, V29, P205, DOI 10.1016/S0925-5214(02)00250-8; Lalel HJD, 2003, POSTHARVEST BIOL TEC, V27, P323, DOI 10.1016/S0925-5214(02)00117-5; Ledeker CN, 2014, LWT-FOOD SCI TECHNOL, V56, P138, DOI 10.1016/j.lwt.2013.11.011; Liu FX, 2013, FOOD CHEM, V138, P396, DOI 10.1016/j.foodchem.2012.09.111; MACLEOD AJ, 1985, J AGR FOOD CHEM, V33, P380, DOI 10.1021/jf00063a015; MACLEOD AJ, 1982, PHYTOCHEMISTRY, V21, P2523, DOI 10.1016/0031-9422(82)85249-7; Masibo M, 2009, FOOD REV INT, V25, P346, DOI 10.1080/87559120903153524; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Musharraf SG, 2016, FOOD CHEM, V196, P1355, DOI 10.1016/j.foodchem.2015.10.040; Negri AS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00056; Orchard J, 2012, SCI TECHNOLOGY, P108; Pandit SS, 2007, CURR SCI INDIA, V93, P1135; Pandit SS, 2009, FOOD CHEM, V114, P363, DOI 10.1016/j.foodchem.2008.09.107; Pino JA, 2005, J AGR FOOD CHEM, V53, P2213, DOI 10.1021/jf0402633; Po MS Dar, 2015, VOLATILE DIVERSITY M, p[458, 461]; Quijano CE, 2007, FLAVOUR FRAG J, V22, P401, DOI 10.1002/ffj.1812; Schwab W, 2008, PLANT J, V54, P712, DOI 10.1111/j.1365-313X.2008.03446.x; Tang CZ Yufan, 2015, PLOS ONE, V10; Wei CB, 2011, MOLECULES, V16, P5104, DOI 10.3390/molecules16065104; WILSON CW, 1990, J AGR FOOD CHEM, V38, P1556, DOI 10.1021/jf00097a028	28	22	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187487	10.1371/journal.pone.0187487	http://dx.doi.org/10.1371/journal.pone.0187487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211747	Green Submitted, Green Published, gold			2022-12-27	WOS:000417212200018
J	Tachibana, Y; Miyazaki, C; Ota, E; Mori, R; Hwang, Y; Kobayashi, E; Terasaka, A; Tang, JL; Kamio, Y				Tachibana, Yoshiyuki; Miyazaki, Celine; Ota, Erika; Mori, Rintaro; Hwang, Yeonhee; Kobayashi, Eriko; Terasaka, Akiko; Tang, Julian; Kamio, Yoko			A systematic review and meta-analysis of comprehensive interventions for pre-school children with autism spectrum disorder (ASD)	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; RESPONSIVE PARENTAL BEHAVIORS; JOINT ATTENTION INTERVENTION; SKILLS TRAINING-PROGRAM; YOUNG-CHILDREN; FOLLOW-UP; MEDIATED INTERVENTION; TODDLERS; COMMUNICATION; MODEL	Background There has an increasing number of published trials on psychosocial intervention programmes for pre-school children with autism spectrum disorder (ASD). To achieve better quality of unbiased evidence for the effectiveness of ASD interventions, it is necessary to conduct a comprehensive review that covers studies with adequate quality standards, such as randomised controlled trials (RCTs), and different types of intervention In this study, we categorize interventions for ASD as behavioural, social-communication focused, and multimodal developmental based on Howlin's classification of early interventions for children with ASD. The aim of this study was to compare these three models and investigate the strengths and weaknesses of each type of intervention and to identify the approaches that contribute to a successful outcome for children with autism. Methods We performed a systematic review and meta-analysis. We included RCTs targeting children with ASD 6 years old or younger. A random effects model was used to present the effect estimate for the outcomes. This study also performed combined meta-analyses of all the three models to investigate the overall effectiveness of the intervention programmes. Results 32 randomized controlled studies were found to be eligible for inclusion. The synthesized data included 594 children from 14 RCTs. There was no statistically significant difference in the effects on autism general symptoms between the social-communication-focused model and the multimodal developmental model (p = 0.83). The results suggest that there is evidence of an effect on 'reciprocity of social interaction towards others' (standard mean difference [95% confidential interval] = 0.53[0.29,0.78], p<0.01) and parental synchrony' (SMD = 0.99[0.70,1.29], p<0.01). Conclusion The small number of studies included in the present study limited the ability to make inferences when comparing the three models and investigating the strengths and weaknesses of each type of intervention with respect to important outcomes. Since the outcome of 'reciprocity of social interaction towards others' could be a dependent variable that might be context-bound to interactions with the child's parent, we cannot conclude the interventions for pre-school children with ASD have significant effects on a generalized skill to engage in reciprocal interactions with others. However, the outcomes of 'reciprocity of social interaction towards others' and 'parental synchrony' may be promising targets for interventions involving pre-school children with ASD.	[Tachibana, Yoshiyuki; Kobayashi, Eriko] Natl Ctr Child Hlth & Dev, Div Infant & Toddler Mental Hlth, Dept Psychosocial Med, Tokyo, Japan; [Tachibana, Yoshiyuki] Tohoku Univ, Smart Aging Int Res Ctr, IDAC, Sendai, Miyagi, Japan; [Tachibana, Yoshiyuki; Kamio, Yoko] Natl Ctr Neurol & Psychiat, Dept Child & Adolescent Mental Hlth, Tokyo, Japan; [Miyazaki, Celine; Ota, Erika; Mori, Rintaro] Natl Res Inst Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Hwang, Yeonhee] Tohoku Fukushi Univ, Dept Educ, Sendai, Miyagi, Japan; [Terasaka, Akiko] Osaka Kyoiku Univ, Dept Educ Collaborat, Osaka, Japan; [Tang, Julian] Natl Ctr Child Hlth & Dev, Dept Educ Clin Res, Tokyo, Japan; [Mori, Rintaro] St Lukes Int Univ, Grad Sch Nursing Sci, Global Hlth Nursing, Tokyo, Japan; [Kobayashi, Eriko] TELL Counseling, Tokyo, Japan	National Center for Child Health & Development - Japan; Tohoku University; National Center for Neurology & Psychiatry - Japan; National Center for Child Health & Development - Japan; Osaka University of Education; National Center for Child Health & Development - Japan; St. Luke's International Hospital	Tachibana, Y (corresponding author), Natl Ctr Child Hlth & Dev, Div Infant & Toddler Mental Hlth, Dept Psychosocial Med, Tokyo, Japan.; Tachibana, Y (corresponding author), Tohoku Univ, Smart Aging Int Res Ctr, IDAC, Sendai, Miyagi, Japan.; Tachibana, Y (corresponding author), Natl Ctr Neurol & Psychiat, Dept Child & Adolescent Mental Hlth, Tokyo, Japan.	tachibana-y@ncchd.go.jp		Mori, Rintaro/0000-0001-7656-6156; Ota, Erika/0000-0002-3945-7441	Health and Labour Science Research Grant on Children, Youth and Families [H28-Sukoyaka-Ippan-005, H29-Sukoyaka-Ippan-004]; Health and Labour Science Research Grant on Psychiatry and Neurological Disease and Mental Health by Japan's Ministry of Health, Labour and Welfare [26350301]; Grants-in-Aid for Scientific Research [16H02058] Funding Source: KAKEN	Health and Labour Science Research Grant on Children, Youth and Families; Health and Labour Science Research Grant on Psychiatry and Neurological Disease and Mental Health by Japan's Ministry of Health, Labour and Welfare; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Health and Labour Science Research Grant on Children, Youth and Families (H28-Sukoyaka-Ippan-005 and H29-Sukoyaka-Ippan-004) and the Health and Labour Science Research Grant on Psychiatry and Neurological Disease and Mental Health (26350301) provided by Japan's Ministry of Health, Labour and Welfare.	Aldred C, 2004, J CHILD PSYCHOL PSYC, V45, P1420, DOI 10.1111/j.1469-7610.2004.00338.x; Aldred C., 2001, J ED CHILD PSYCHOL, V18, P76; Aldred C, 2012, J AUTISM DEV DISORD, V42, P447, DOI 10.1007/s10803-011-1248-3; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Association AP, 1987, DIAGN STAT MAN MENT; Benevides TW, 2016, MATERN CHILD HLTH J, V20, P878, DOI 10.1007/s10995-015-1876-x; Buescher AVS, 2014, JAMA PEDIATR, V168, P721, DOI 10.1001/jamapediatrics.2014.210; Cafri G, 2010, MULTIVAR BEHAV RES, V45, P239, DOI 10.1080/00273171003680187; Camarata S, 2014, INT J SPEECH-LANG PA, V16, P1, DOI 10.3109/17549507.2013.858773; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Carter AS, 2011, J CHILD PSYCHOL PSYC, V52, P741, DOI 10.1111/j.1469-7610.2011.02395.x; Casenhiser Devin M, 2013, Autism, V17, P220, DOI 10.1177/1362361311422052; Charman T, 2014, INT J SPEECH-LANG PA, V16, P15, DOI 10.3109/17549507.2013.859732; Cummings JR, 2016, J AUTISM DEV DISORD, V46, P910, DOI 10.1007/s10803-015-2634-z; Davis NO, 2008, J AUTISM DEV DISORD, V38, P1278, DOI 10.1007/s10803-007-0512-z; Dawson Geraldine, 2010, Pediatrics, V125, pe17, DOI 10.1542/peds.2009-0958; Drew A, 2002, EUR CHILD ADOLES PSY, V11, P266, DOI 10.1007/s00787-002-0299-6; Edition F, 1994, DIAGNOSTIC STAT MANU; Eldevik S, 2009, J CLIN CHILD ADOLESC, V38, P439, DOI 10.1080/15374410902851739; Fletcher-Watson S, 2014, INTERVENTIONS BASED; Geyskens I, 2009, J MANAGE, V35, P393, DOI 10.1177/0149206308328501; Goods KS, 2013, J AUTISM DEV DISORD, V43, P1050, DOI 10.1007/s10803-012-1644-3; Green J, 2010, LANCET, V375, P2152, DOI 10.1016/S0140-6736(10)60587-9; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hastings RP, 2001, J AUTISM DEV DISORD, V31, P327, DOI 10.1023/A:1010799320795; Health NCCfM, 2013, AUT MAN SUPP CHILDR; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Howlin P., 2009, J INFORM, V114; Hunter JE, 2000, INT J SELECT ASSESS, V8, P275, DOI 10.1111/1468-2389.00156; Ichikawa K, 2013, BIOPSYCHOSOC MED, V7, DOI 10.1186/1751-0759-7-14; Ingersoll B, 2012, J AUTISM DEV DISORD, V42, P1768, DOI 10.1007/s10803-011-1423-6; Ingersoll B, 2010, J AUTISM DEV DISORD, V40, P590, DOI [10.1007/s10803-009-0907-0, 10.1007/s10803-010-0966-2]; Jocelyn LJ, 1998, J DEV BEHAV PEDIATR, V19, P326, DOI 10.1097/00004703-199810000-00002; Kaale A, 2014, J AM ACAD CHILD PSY, V53, P188, DOI 10.1016/j.jaac.2013.09.019; Kaale A, 2012, J CHILD PSYCHOL PSYC, V53, P97, DOI 10.1111/j.1469-7610.2011.02450.x; Kasari C, 2006, J CHILD PSYCHOL PSYC, V47, P611, DOI 10.1111/j.1469-7610.2005.01567.x; Kasari C, 2012, J AM ACAD CHILD PSY, V51, P487, DOI 10.1016/j.jaac.2012.02.019; Kasari C, 2010, J AUTISM DEV DISORD, V40, P1045, DOI 10.1007/s10803-010-0955-5; Kim J, 2008, J AUTISM DEV DISORD, V38, P1758, DOI 10.1007/s10803-008-0566-6; Kim J, 2009, AUTISM, V13, P389, DOI 10.1177/1362361309105660; Landa RJ, 2008, NAT CLIN PRACT NEURO, V4, P138, DOI 10.1038/ncpneuro0731; Landa RJ, 2011, J CHILD PSYCHOL PSYC, V52, P13, DOI 10.1111/j.1469-7610.2010.02288.x; Lawton K, 2012, J CONSULT CLIN PSYCH, V80, P687, DOI 10.1037/a0028506; Lawton K, 2012, J AUTISM DEV DISORD, V42, P307, DOI 10.1007/s10803-011-1231-z; Lim HA, 2010, J MUSIC THER, V47, P2, DOI 10.1093/jmt/47.1.2; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Lord C, 2004, TRAJECTORY LANGUAGE; Lovaas O.I., 1988, ADV CLIN CHILD PSYCH, V11, P285, DOI [10.1007/978-1-4613-9829-5_8, DOI 10.1007/978-1-4613-9829-5_8]; Lovaas OI, 2003, EARLY INTENSIVE BEHA; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Makrygianni MK, 2010, RES AUTISM SPECT DIS, V4, P577, DOI 10.1016/j.rasd.2010.01.014; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; MUNDY P, 1990, J AUTISM DEV DISORD, V20, P115, DOI 10.1007/BF02206861; National Collaborating Centre for Mental Health, 2013, AUT MAN SUPP CHILDR; Nefdt N, 2010, J POSIT BEHAV INTERV, V12, P23, DOI 10.1177/1098300709334796; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Oono IP., 2013, EVIDENCE BASED CHILD, V8, P2380, DOI [10.1002/ebch.1952, DOI 10.1002/EBCH.1952]; Oosterling I, 2010, J AUTISM DEV DISORD, V40, P689, DOI 10.1007/s10803-009-0915-0; Orinstein AJ, 2014, J DEV BEHAV PEDIATR, V35, P247, DOI 10.1097/DBP.0000000000000037; Orsini M, 2010, CRIT POLICY STUD, V4, P38, DOI 10.1080/19460171003714989; Ospina MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003755; Pajareya K, 2011, AUTISM, V15, P563, DOI 10.1177/1362361310386502; Payakachat N, 2016, PHARMACOECONOMICS, V34, P127, DOI 10.1007/s40273-015-0331-6; Pickles A, 2016, LANCET, V388, P2501, DOI 10.1016/S0140-6736(16)31229-6; Reichow B, 2009, J AUTISM DEV DISORD, V39, P23, DOI 10.1007/s10803-008-0596-0; Reitzel J, 2013, RES AUTISM SPECT DIS, V7, P1418, DOI 10.1016/j.rasd.2013.07.025; Rickards AL, 2009, CHILD CARE HLTH DEV, V35, P593, DOI 10.1111/j.1365-2214.2009.00953.x; Roberts J, 2011, RES AUTISM SPECT DIS, V5, P1553, DOI 10.1016/j.rasd.2011.03.001; Rogers SJ, 2008, J CLIN CHILD ADOLESC, V37, P8, DOI 10.1080/15374410701817808; Rogers SJ, 2012, J AM ACAD CHILD PSY, V51, P1052, DOI 10.1016/j.jaac.2012.08.003; Rogers SJ, 2000, COMM LANG INTERVEN, V9, P79; Rogers SJ, 2000, J AUTISM DEV DISORD, V30, P399, DOI 10.1023/A:1005543321840; Ruble LA, 2010, J EARLY INTERVENTION, V32, P286, DOI 10.1177/1053815110382973; Schertz HH, 2013, EARLY CHILD RES Q, V28, P249, DOI 10.1016/j.ecresq.2012.06.006; Siller M, 2014, J AUTISM DEV DISORD, V44, P1720, DOI 10.1007/s10803-014-2049-2; Siller M, 2013, J AUTISM DEV DISORD, V43, P540, DOI 10.1007/s10803-012-1584-y; Smith T, 2000, AM J MENT RETARD, V105, P269, DOI 10.1352/0895-8017(2000)105<0269:RTOIEI>2.0.CO;2; Smith T, 2007, J AUTISM DEV DISORD, V37, P354, DOI 10.1007/s10803-006-0173-3; Spreckley M, 2009, J PEDIATR-US, V154, P338, DOI 10.1016/j.jpeds.2008.09.012; Stijnen T, 2010, STAT MED, V29, P3046, DOI 10.1002/sim.4040; STONE WL, 1990, PEDIATRICS, V86, P267; Strain PS, 2011, TOP EARLY CHILD SPEC, V31, P133, DOI 10.1177/0271121411408740; Tachibana Y, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000679; Tarbox J., 2014, HDB EARLY INTERVENTI; Thompson G., 2012, MAKING CONNECTION RA; Tonge B, 2006, J AM ACAD CHILD PSY, V45, P561, DOI 10.1097/01.chi.0000205701.48324.26; Tonge B, 2014, AUTISM, V18, P166, DOI 10.1177/1362361312458186; Turygin N, 2013, DEV NEUROREHABIL, V16, P38, DOI 10.3109/17518423.2012.712065; Venker CE, 2012, AUTISM, V16, P568, DOI 10.1177/1362361311413396; Virues-Ortega J, 2013, CLIN PSYCHOL REV, V33, P940, DOI 10.1016/j.cpr.2013.07.005; Virues-Ortega J, 2010, CLIN PSYCHOL REV, V30, P387, DOI 10.1016/j.cpr.2010.01.008; Welterlin A, 2012, J AUTISM DEV DISORD, V42, P1827, DOI 10.1007/s10803-011-1419-2; Wong CS, 2013, AUTISM, V17, P340, DOI 10.1177/1362361312474723; Wong VCN, 2010, J AUTISM DEV DISORD, V40, P677, DOI 10.1007/s10803-009-0916-z; World Health Organization, 1993, ICD 10 CLASS MENT BE, V10th ed.	97	46	47	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0186502	10.1371/journal.pone.0186502	http://dx.doi.org/10.1371/journal.pone.0186502			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211740	gold, Green Submitted, Green Published			2022-12-27	WOS:000417212200006
J	Younis, S; Rashid, S				Younis, Saima; Rashid, Sajid			Alpha conotoxin-BuIA globular isomer is a competitive antagonist for oleoyl-L-alpha-lysophosphatidic acid binding to LPAR6; A molecular dynamics study	PLOS ONE			English	Article							RECEPTOR 1; CONOPEPTIDE; CELLS; IDENTIFICATION; VISUALIZATION; METASTASIS; SERVER	Lysophosphatidic acid receptor 6 (LPAR6) is a G-protein coupled receptor (GPCR) involved in hair development and cytoskeleton formation in mammals. Its proliferation is implicated in several forms of cancer including liver cancer, squamous cell carcinoma and metastatic prostate cancer. Current study emphasizes the isolation of competitive non-lipid and stable peptide antagonists for Lysophosphatidic acid ligand. A total of 148 conotoxin structures were characterized for their binding abilities against LPAR6. Subsequently, top 10 conotoxins were selected on the basis of binding energy values, residual contributions and conformational cluster saturations. BuIA (a member of Alpha-conotoxins family), contryphan-R and contryphan-Lo (Synthetic class) conotoxins, exhibiting efficient binding parameters were subjected to molecular dynamics simulation assays and topology analysis. We propose that BuIA might be a potent antagonist due to its predominant binding at the extracellular region of LPAR6. Current study provides a backbone for understanding structural and functional insights of LPAR6 and findings of this study may be helpful in designing novel therapeutic targets for the treatment of cancers caused by elevated LPAR6 expression.	[Younis, Saima; Rashid, Sajid] Quaid I Azam Univ, Natl Ctr Bioinformat, Islamabad, Pakistan	Quaid I Azam University	Rashid, S (corresponding author), Quaid I Azam Univ, Natl Ctr Bioinformat, Islamabad, Pakistan.	sajidrwp@yahoo.co.uk	Younis, Saima/GQP-0173-2022; Rashid, Sajid/K-8640-2019	Rashid, Sajid/0000-0003-2122-2799; Younis, Saima/0000-0002-1461-5212				Abascal JLF, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2121687; Accelrys Software Inc, 2007, DISC STUD MOD ENV RE; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dutertre S, 2008, J BIOL CHEM, V283, P7100, DOI 10.1074/jbc.M706477200; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Geach TJ, 2014, DEVELOPMENT, V141, P940, DOI 10.1242/dev.104901; Inoue A, 2011, EMBO J, V30, P4248, DOI 10.1038/emboj.2011.296; Jimenez EC, 2007, BIOCHEMISTRY-US, V46, P8717, DOI 10.1021/bi700582m; Jin AH, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-28; Kaas Q, 2008, BIOINFORMATICS, V24, P445, DOI 10.1093/bioinformatics/btm596; Kern SE, 2007, ANESTH ANALG, V104, P1514, DOI 10.1213/01.ane.0000262038.58546.e6; Ketscher A, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.34; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lewis R., CONOTOXINS MOL THERA, P45; Liao Y, 2013, DIGEST DIS SCI, V58, P3524, DOI 10.1007/s10620-013-2878-4; Llona-Minguez S, 2015, PROG LIPID RES, V58, P51, DOI 10.1016/j.plipres.2015.01.004; Lou LQ, 2013, J INT MED RES, V41, P55, DOI 10.1177/0300060512474124; Lv GM, 2011, J SURG ONCOL, V104, P685, DOI 10.1002/jso.22016; Maiga A, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.36; Marshall JCA, 2012, JNCI-J NATL CANCER I, V104, P1306, DOI 10.1093/jnci/djs319; Mazzocca A, 2015, CANCER RES, V75, P532, DOI 10.1158/0008-5472.CAN-14-1607; Millard EL, 2004, EUR J BIOCHEM, V271, P2320, DOI 10.1111/j.1432-1033.2004.04148.x; Morimoto Y, 2014, GENE, V551, P189, DOI 10.1016/j.gene.2014.08.056; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Okusa MD, 2003, AM J PHYSIOL-RENAL, V285, pF565, DOI 10.1152/ajprenal.00023.2003; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Petrel C, 2013, BIOCHEM PHARMACOL, V85, P1663, DOI 10.1016/j.bcp.2013.03.019; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raza SEA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097612; Robinson SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087648; Schleicher SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022182; Sharpe IA, 2003, J BIOL CHEM, V278, P34451, DOI 10.1074/jbc.M305410200; Stoddard NC, 2015, BIOMOL THER, V23, P1, DOI 10.4062/biomolther.2014.109; Su SC, 2013, CLIN CANCER RES, V19, P6461, DOI 10.1158/1078-0432.CCR-13-1284; Swaney JS, 2010, BRIT J PHARMACOL, V160, P1699, DOI 10.1111/j.1476-5381.2010.00828.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tusnady GE, 2005, BIOINFORMATICS, V21, P1276, DOI 10.1093/bioinformatics/bti121; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Zhao J, 2011, AM J PHYSIOL-LUNG C, V301, pL547, DOI 10.1152/ajplung.00058.2011	42	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189154	10.1371/journal.pone.0189154	http://dx.doi.org/10.1371/journal.pone.0189154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211777	Green Submitted, gold, Green Published			2022-12-27	WOS:000417212200069
J	Hornova, J; Ruzicka, P; Hrubina, M; Stastny, E; Koskova, A; Fulin, P; Gallo, J; Daniel, M				Hornova, Jana; Ruzicka, Pavel; Hrubina, Maros; Stastny, Eduard; Koskova, Andrea; Fulin, Petr; Gallo, Jiri; Daniel, Matej			Magnification of digital hip radiographs differs between clinical workplaces	PLOS ONE			English	Article							ARTHROPLASTY; ACCURACY; MARKERS; REPLACEMENT	Preoperative planning for total hip arthroplasty includes templating on anteroposterior radiographs. It is necessary to consider radiographic magnification in order to scale templates accurately. Studies dealing with hip templating report different values of radiographic magnification. It is not clear if the observed difference in magnification between the studies is caused by variability in studied groups, methodology or instrumentation. We hypothesize that there is a difference in magnification between clinical workplaces. Within this study, radiographic magnification was estimated on 337 radiographs of patients after total hip surgery from five orthopaedic departments in the Czech Republic. Magnification was determined for each patient as a ratio between diameter of implanted femoral head measured on radiogram and its true size. One-way ANOVA revealed significant differences in magnification between workplaces (F(4,332) = 132, p <= 0.001). These results suggest that radiographic magnification depends on the workplace where it is taken or more precisely on radiographic device. It indicates potential limits in generalizability of results of studies dealing with preoperative planning accuracy to other institutions.	[Hornova, Jana; Ruzicka, Pavel; Daniel, Matej] Czech Tech Univ, Fac Mech Engn, Lab Biomech, Prague, Czech Republic; [Hrubina, Maros] Hosp Pelhrimov, Dept Orthopaed, Pelhrimov, Czech Republic; [Stastny, Eduard] Charles Univ Prague, Dept Paediat & Adult Orthopaed Surg & Traumatol, Fac Med 2, Prague, Czech Republic; [Stastny, Eduard; Fulin, Petr] Teaching Hosp Motol Prague, Prague, Czech Republic; [Koskova, Andrea] Hosp Jablonec Nad Nisou, Dept Radiol, Jablonec Nad Nisou, Czech Republic; [Fulin, Petr] Charles Univ Prague, Fac Med 1, Dept Orthopaed, Prague, Czech Republic; [Gallo, Jiri] Palacky Univ, Teaching Hosp Olomouc, Fac Med & Dent, Dept Orthopaed, Olomouc, Czech Republic; [Hrubina, Maros] Comenius Univ, Jessenius Fac Med Martin, Orthopaed Clin, Bratislava, Slovakia; [Hrubina, Maros] Univ Hosp Martin, Martin, Slovakia	Czech Technical University Prague; Charles University Prague; Charles University Prague; Palacky University Olomouc; University Hospital Olomouc; Comenius University Bratislava	Daniel, M (corresponding author), Czech Tech Univ, Fac Mech Engn, Lab Biomech, Prague, Czech Republic.	matej.daniel@fs.cvut.cz	Fulín, Petr/K-5738-2017; Hrubina, Maros/X-7318-2018	Fulín, Petr/0000-0002-4604-9921; Hrubina, Maros/0000-0003-0755-5570; Gallo, Jiri/0000-0002-7424-8653; Daniel, Matej/0000-0003-0532-1965	Czech Health Research Council [15-31269A]; student grant project University Palacky [IGA_LF UPOL_2017_021]	Czech Health Research Council; student grant project University Palacky	This work was supported by Czech Health Research Council, Project No. 15-31269A (URL: https://www.rvvi.cz/cep?s=jednoduche-vyhledavani&ss=detail&n=0&h=NV15-31269A) (authors: MD PR JH); and student grant project University Palacky, Project No. IGA_LF UPOL_2017_021 (URL: http://www.psup.cz/iga-grantove-projekty/) (author: JG).	Archibeck MJ, 2016, CLIN ORTHOP RELAT R, V474, P1812, DOI 10.1007/s11999-016-4704-8; Bayne CO, 2009, J ARTHROPLASTY, V24, P407, DOI 10.1016/j.arth.2007.11.020; Boese CK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128529; Davies AM, 2006, IMAGING HIP BONY PEL; Descamps S, 2010, SKELETAL RADIOL, V39, P273, DOI 10.1007/s00256-009-0732-8; Franken M, 2010, J BONE JOINT SURG BR, V92B, P136, DOI 10.1302/0301-620X.92B1.22257; Heinert G, 2009, J BONE JOINT SURG BR, V91B, P459, DOI 10.1302/0301-620X.91B4.21730; Jahnke A, 2015, ARCH ORTHOP TRAUM SU, V135, P1609, DOI 10.1007/s00402-015-2302-y; King RJ, 2009, J BONE JOINT SURG BR, V91B, P1217, DOI 10.1302/0301-620X.91B9.22615; Leo LKH, 2015, J ORTHOP TRAUMA REHA, V19, P31, DOI 10.1016/j.jotr.2014.03.002; Petretta R, 2015, CLIN ORTHOP RELAT R, V473, P3752, DOI 10.1007/s11999-015-4321-y; Pourmoghaddam A, 2015, J ARTHROPLASTY, V30, P622, DOI 10.1016/j.arth.2014.11.021; Scheerlinck T, 2010, ACTA ORTHOP BELG, V76, P432; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sershon RA, 2017, J ARTHROPLASTY, V32, P1024, DOI 10.1016/j.arth.2016.09.020; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sinclair VF, 2014, J ARTHROPLASTY, V29, P1658, DOI 10.1016/j.arth.2014.03.013; The B, 2005, MED PHYS, V32, P2580, DOI 10.1118/1.1984293	18	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188743	10.1371/journal.pone.0188743	http://dx.doi.org/10.1371/journal.pone.0188743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190787	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900115
J	Yao, DN; Xi, XY; Huang, YK; Hu, H; Hu, YJ; Wang, YT; Yao, WB				Yao, Dongning; Xi, Xiaoyu; Huang, Yuankai; Hu, Hao; Hu, Yuanjia; Wang, Yitao; Yao, Wenbing			A national survey of clinical pharmacy services in county hospitals in China	PLOS ONE			English	Article							PHARMACEUTICAL CARE	Background Clinical pharmacy is not only a medical science but also an elaborate public health care system firmly related to its subsystems of education, training, qualification authentication, scientific research, management, and human resources. China is a developing country with a tremendous need for improvements in the public health system, including the clinical pharmacy service system. Objectives The aim of this research was to evaluate the infrastructure and personnel qualities of clinical pharmacy services in China. Setting Public county hospitals in China. Materials and method A national survey of clinical pharmacists in county hospitals was conducted. It was sampled through a stratified sampling strategy. Responses were analyzed using descriptive and inferential statistics. The main outcome measures include the coverage of clinical pharmacy services, the overall staffing of clinical pharmacists, the software and hardware of clinical pharmacy services, the charge mode of clinical pharmacy services, and the educational background, professional training acquisition, practical experience, and entry path of clinical pharmacists. Results The overall coverage of clinical pharmacy services on both the department scale (median = 18.25%) and the patient scale (median = 15.38%) does not meet the 100% coverage that is required by the government. In 57.73% of the sample hospitals, the staffing does not meet the requirement, and the size of the clinical pharmacist group is smaller in larger hospitals. In addition, 23.4% of the sample hospitals do not have management rules for the clinical pharmacists, and 43.1% do not have rational drug use software, both of which are required by the government. In terms of fees, 89.9% of the sample hospitals do not charge for the services. With regard to education, 8.5% of respondents are with unqualified degree, and among respondents with qualified degree, 37.31% are unqualified in the major; 43% of respondents lack the clinical pharmacist training required by the government. Most respondents (93.5%) have a primary or medium professional title. The median age and work seniority of respondents are 31 and four years, respectively. Only 18.5% of respondents chose this occupation by personal consideration or willingness. Conclusions The main findings in this research include the overall low coverage of clinical pharmacy services, the low rate of clinical pharmacy service software, hardware, and personnel as well as a wide variance in educational training of pharmacists at county hospitals.	[Yao, Dongning; Hu, Hao; Hu, Yuanjia; Wang, Yitao] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Xi, Xiaoyu; Huang, Yuankai; Yao, Wenbing] China Pharmaceut Univ, Sch Int Pharmaceut Business, Nanjing, Jiangsu, Peoples R China	University of Macau; China Pharmaceutical University	Wang, YT (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China.; Yao, WB (corresponding author), China Pharmaceut Univ, Sch Int Pharmaceut Business, Nanjing, Jiangsu, Peoples R China.	ytwang@umac.mo; yaowenbing_001@163.com	HU, Hao/H-7813-2018; Hu, Yuanjia/AAW-7721-2021	HU, Hao/0000-0001-9441-106X; Yao, Dongning/0000-0002-0527-8322; yuanjia, Hu/0000-0001-5244-8577				Amer Coll Clin Pharm, 2014, PHARMACOTHERAPY, V34, P794, DOI 10.1002/phar.1438; American Coll Clinical Pharm, 2008, PHARMACOTHERAPY, V28, P816, DOI 10.1592/phco.28.6.816; [Anonymous], 2015, STATE COUNCIL PEOPLE, P27; Berenguer B, 2004, CURR PHARM DESIGN, V10, P3931, DOI 10.2174/1381612043382521; Bond CA, 2002, PHARMACOTHERAPY, V22, P1489, DOI 10.1592/phco.22.16.1489.33689; Boyce EG, 2009, PHARMACOTHERAPY, V29, P124, DOI 10.1592/phco.29.1.127; Burke JM, 2008, PHARMACOTHERAPY, V28, P806, DOI 10.1592/phco.28.6.806; CAI WM, 1994, AM J HOSP PHARM, V51, P695, DOI 10.1093/ajhp/51.5.695; Chen Bing, 2015, Drug Metabolism and Personalized Therapy, V30, P215, DOI 10.1515/dmpt-2015-0009; Gray AL, 2015, INT J CLIN PHARM-NET, V37, P717, DOI 10.1007/s11096-015-0156-6; Hale Jonathan C, 2015, N C Med J, V76, P205, DOI 10.18043/ncm.76.4.205; Hughes CM, 2010, PHARM WORLD SCI, V32, P472, DOI 10.1007/s11096-010-9393-x; Jeong HS, 2009, HEALTH POLICY, V93, P165, DOI 10.1016/j.healthpol.2009.07.009; Maddux MS, 2013, PHARMACOTHERAPY, V33, P888, DOI 10.1002/phar.1285; Ming H, 2009, CHINA PHARM, P72; ming H, 2009, CHINA PHARM, P1278; ming H, 2009, CHINA PHARM, P1030; Ordinance of Hospital Pharmacy, 1982, CHINESE J HOSP PHARM, P53; Penm J, 2014, QUAL HEALTH RES, V24, P345, DOI 10.1177/1049732314523680; Pharmaceutical education, 1992, PHARMACOTHERAPY, V12, P419; Practice guidelines for pharmacotherapy specialists, 2000, PHARMACOTHERAPY, V20, P487; Provisional Rules of Pharmaceutical Affairs Management of Medical Institutions, 2002, CHINESE HOSP, P56; Rules of Pharmaceutical Affairs Management of Medical Institutions, 2011, CHIN LIC PHARM, P41; RUTLEDGE DR, 1993, PHARMACOTHERAPY, V13, P523; Ryan M, 2008, AM J PHARM EDUC, V72, DOI 10.5688/aj7206129; Smith F, 2009, PHARM WORLD SCI, V31, P351, DOI 10.1007/s11096-009-9294-z; SMITH JE, 1989, AM J HOSP PHARM, V46, P2259, DOI 10.1093/ajhp/46.11.2259; Stevenson James G, 2013, Hosp Pharm, V48, P778, DOI 10.1310/hpj4809-778; Sun AJ, 2010, HERALD MED, V29, P1251; [张策 Zhang Ce], 2012, [药学服务与研究, Pharmaceutical Care and Research], V12, P280; Zheng Hong, 2010, Zhonghua Yi Shi Za Zhi, V40, P165; Zhenhua Z, 2009, CHINA PRESCRIPTION D, P22; Zhu M, 2010, PHARM WORLD SCI, V32, P411, DOI 10.1007/s11096-010-9407-8	33	15	16	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188354	10.1371/journal.pone.0188354	http://dx.doi.org/10.1371/journal.pone.0188354			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190816	gold, Green Published, Green Submitted			2022-12-27	WOS:000416841900049
J	Rumney, RMH; Coffelt, SB; Neale, TA; Dhayade, S; Tozer, GM; Miller, G				Rumney, Robin M. H.; Coffelt, Seth B.; Neale, Terence A.; Dhayade, Sandeep; Tozer, Gillian M.; Miller, Gaynor			PyMT-Maclow: A novel, inducible, murine model for determining the role of CD68 positive cells in breast tumor development	PLOS ONE			English	Article							MAMMARY-TUMORS; MOUSE MODEL; T-CELLS; ANTICANCER THERAPIES; MEDIATED DEPLETION; DENDRITIC CELLS; PARACRINE LOOP; CANCER MODEL; MACROPHAGES; METASTASIS	CD68(+) tumor-associated macrophages (TAMs) are pro-tumorigenic, pro-angiogenic and are associated with decreased survival rates in patients with cancer, including breast cancer. Non-specific models of macrophage ablation reduce the number of TAMs and limit the development of mammary tumors. However, the lack of specificity and side effects associated with these models compromise their reliability. We hypothesized that specific and controlled macrophage depletion would provide precise data on the effects of reducing TAM numbers on tumor development. In this study, the MacLow mouse model of doxycycline-inducible and selective CD68(+) macrophage depletion was crossed with the murine mammary tumor virus (MMTV)-Polyoma virus middle T antigen (PyMT) mouse model of spontaneous ductal breast adenocarcinoma to generate the PyMT-MacLow line. In doxycyclinetreated PyMT-MacLow mice, macrophage numbers were decreased in areas surrounding tumors by 43%. Reducing the number of macrophages by this level delayed tumor progression, generated less proliferative tumors, decreased the vascularization of carcinomas and down-regulated the expression of many pro-angiogenic genes. These results demonstrate that depleting CD68(+) macrophages in an inducible and selective manner delays the development of mammary tumors and that the PyMT-MacLow model is a useful and unique tool for studying the role of TAMs in breast cancer.	[Rumney, Robin M. H.; Neale, Terence A.; Tozer, Gillian M.; Miller, Gaynor] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Coffelt, Seth B.] Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England; [Coffelt, Seth B.] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Coffelt, Seth B.; Dhayade, Sandeep] Canc Res UK Beatson Inst, Glasgow, Lanark, Scotland; Univ Portsmouth, Portsmouth, Hants, England	University of Sheffield; University of Sheffield; University of Glasgow; Beatson Institute; University of Portsmouth	Miller, G (corresponding author), Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England.; Coffelt, SB (corresponding author), Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England.; Coffelt, SB (corresponding author), Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland.; Coffelt, SB (corresponding author), Canc Res UK Beatson Inst, Glasgow, Lanark, Scotland.	Seth.Coffelt@glasgow.ac.uk; g.miller@sheffield.ac.uk	Rumney, Robin M H/H-6805-2019; Coffelt, Seth/O-9929-2019	Rumney, Robin M H/0000-0002-4266-5962; Coffelt, Seth/0000-0003-2257-2862; Dhayade, Sandeep/0000-0002-1681-8216; Miller, Gaynor/0000-0003-4527-3814	Yorkshire Cancer Research; YCR [SPP039]; Women Academic Returners' Programme (WARP), University of Sheffield; Cancer Research UK [22311] Funding Source: researchfish	Yorkshire Cancer Research; YCR; Women Academic Returners' Programme (WARP), University of Sheffield; Cancer Research UK(Cancer Research UK)	Funding was provided by Yorkshire Cancer Research, http://yorkshirecancerresearch.org.uk/. GM, GMT and RMHR were supported by pump priming funding from the YCR (SPP039). RMHR was also supported by The Women Academic Returners' Programme (WARP), University of Sheffield. These authors received no specific funding for this work: SBC, SD and TAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bluff JE, 2009, BRIT J CANCER, V101, P666, DOI 10.1038/sj.bjc.6605196; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Butowski N, 2016, NEURO-ONCOLOGY, V18, P557, DOI 10.1093/neuonc/nov245; Charlton RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083203; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Coffelt SB, 2015, TRENDS IMMUNOL, V36, P198, DOI 10.1016/j.it.2015.02.006; Dai XM, 2004, BLOOD, V103, P1114, DOI 10.1182/blood-2003-08-2739; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Engelhardt JJ, 2012, CANCER CELL, V21, P402, DOI 10.1016/j.ccr.2012.01.008; Galmbacher K, 2010, PLOS ONE, V5, pA93, DOI 10.1371/journal.pone.0009572; Gheryani N, 2013, GENESIS, V51, P41, DOI 10.1002/dvg.22343; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Lewen S, 2008, CANCER IMMUNOL IMMUN, V57, P507, DOI 10.1007/s00262-007-0389-x; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lunt SJ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-2; Mahmud SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016412; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Ostuni R, 2015, TRENDS IMMUNOL, V36, P229, DOI 10.1016/j.it.2015.02.004; Ottewell PD, 2012, BREAST CANCER RES TR, V133, P523, DOI 10.1007/s10549-011-1782-x; POLLARD JW, 1994, P NATL ACAD SCI USA, V91, P9312, DOI 10.1073/pnas.91.20.9312; Ricciardelli C, 2011, AM J PATHOL, V179, P3075, DOI 10.1016/j.ajpath.2011.08.021; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Ruffell B, 2015, CANCER CELL, V27, P462, DOI 10.1016/j.ccell.2015.02.015; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Wright E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047616; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021155; Zaynagetdinov R, 2013, AM J RESP CELL MOL, V49, P180, DOI 10.1165/rcmb.2012-0366MA; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240	39	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0188591	10.1371/journal.pone.0188591	http://dx.doi.org/10.1371/journal.pone.0188591			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220404	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000417469900012
J	Chen, MM; Ju, Y; Chen, M; Xie, ZG; Zhou, KJ; Tan, Y; Mo, JJ				Chen, Minmei; Ju, Yu; Chen, Min; Xie, Zhenguo; Zhou, Kaijiao; Tan, Yi; Mo, Jianjun			Epidemiological and genetic characteristics of EV71 in hand, foot, and mouth disease in Guangxi, southern China, from 2010 to 2015	PLOS ONE			English	Article							ENTEROVIRUS; VACCINE; TOOL	Hand, foot, and mouth disease (HFMD) is a significant public health challenge in China. Human enterovirus 71 (EV71) is regarded as the predominant causative pathogen of HFMD. Since 2015, two inactivated EV71 vaccines have been approved in mainland China, and because their use could change the HFMD pathogen spectrum, this should now be monitored. However, the epidemiological and genetic trends of EV71 with respect to HFMD in Guangxi, southern China, are still not clear. In this study, we describe the epidemiological and genetic characterization of this virus in clinically-diagnosed HFMD reported from 2010 to 2015 in Guangxi. Data showed that a two-year epidemic cycle, with a predominance of EV71 infections, contributed to HFMD outbreaks in Guangxi. Furthermore, this virus is a major causative agent of severe and fatal HFMD. Interestingly, in Guangxi, EV71-positive rates tended to decrease over time. In particular, EV71-positive rates were found in Fang-chenggang city, which reported very few severe and fatal cases over the six-year period. Phylogenetic analysis of the VP1 gene revealed that the major circulating strains belonged exclusively to genotype C, subtype 4a (C4a), and most clustered with strains circulating in southern China. The most interesting finding was that a strain isolated in 2012 clustered with Vietnamese strains isolated from 2011-2012. The data highlight the importance of pathogen surveillance for HFMD in China, especially Guangxi, which is located on the border of China and the Association of Southeast Asian Nations.	[Chen, Minmei; Ju, Yu; Chen, Min; Xie, Zhenguo; Zhou, Kaijiao; Tan, Yi; Mo, Jianjun] Guangxi Zhuang Autonomous Reg Ctr Dis Prevent & C, Inst Acute Infect Dis Control & Prevent, Nanning, Guangxi, Peoples R China		Chen, MM (corresponding author), Guangxi Zhuang Autonomous Reg Ctr Dis Prevent & C, Inst Acute Infect Dis Control & Prevent, Nanning, Guangxi, Peoples R China.	13707719199@163.com			Key research projects of medical and health care of Guangxi Zhuang Autonomous Region Center [2012051]; Guangxi Zhuang Autonomous Region Health and Familiy Planning Commision	Key research projects of medical and health care of Guangxi Zhuang Autonomous Region Center; Guangxi Zhuang Autonomous Region Health and Familiy Planning Commision	Key research projects of medical and health care of Guangxi Zhuang Autonomous Region Center (2012051). The Guangxi Zhuang Autonomous Region Health and Familiy Planning Commision http://www.gxhfpc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Donato C, 2016, VIROLOGY, V495, P1, DOI 10.1016/j.virol.2016.04.026; Geoghegan JL, 2015, J VIROL, V89, P8871, DOI 10.1128/JVI.00706-15; Huang XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08904; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Luo KW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167269; Mao QY, 2016, EXPERT REV VACCINES, V15, P599, DOI 10.1586/14760584.2016.1138862; Mao QY, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.73; Mao QY, 2014, HUM VACC IMMUNOTHER, V10, P360, DOI 10.4161/hv.27087; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Tian HF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176604; Xie YH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085440, 10.1371/journal.pone.0088065]; Yi LN, 2011, CRIT REV MICROBIOL, V37, P313, DOI 10.3109/1040841X.2011.580723; Zeng HR, 2015, SCI REP-UK, V5, DOI 10.1038/srep10550; Zhang HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100545; Zhang XA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-606; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhao JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163789	23	22	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188640	10.1371/journal.pone.0188640	http://dx.doi.org/10.1371/journal.pone.0188640			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216216	gold, Green Submitted, Green Published			2022-12-27	WOS:000417337800034
J	Gonzales, J; Tymon, T; Kupper, FC; Edwards, MS; Carrano, CJ				Gonzales, Jennifer; Tymon, Teresa; Kupper, Frithjof C.; Edwards, Matthew S.; Carrano, Carl J.			The potential role of kelp forests on iodine speciation in coastal seawater (vol 12, 2017)	PLOS ONE			English	Correction														Kuepper, Frithjof/0000-0003-1273-7109	UK Natural Environment Research Council	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The following information is missing from the Funding section: Additional funding was provided to FCK by the UK Natural Environment Research Council within the framework of the Oceans 2025 program / WP 4.5.	Gonzales J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180755	1	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189559	10.1371/journal.pone.0189559	http://dx.doi.org/10.1371/journal.pone.0189559			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216296	Green Published, gold			2022-12-27	WOS:000417337800132
J	Hang, J; Zavaljevski, N; Yang, Y; Desai, V; Ruck, RC; Macareo, LR; Jarman, RG; Reifman, J; Kuschner, RA; Keiser, PB				Hang, Jun; Zavaljevski, Nela; Yang, Yu; Desai, Valmik; Ruck, Richard C.; Macareo, Louis R.; Jarman, Richard G.; Reifman, Jaques; Kuschner, Robert A.; Keiser, Paul B.			Composition and variation of respiratory microbiota in healthy military personnel	PLOS ONE			English	Article							COMMUNITY; INFECTIONS; PROFILES; CHILDREN; DISEASE; TRACT	Certain occupational and geographical exposures have been associated with an increased risk of lung disease. As a baseline for future studies, we sought to characterize the upper respiratory microbiomes of healthy military personnel in a garrison environment. Nasal, oropharyngeal, and nasopharyngeal swabs were collected from 50 healthy active duty volunteers eight times over the course of one year (1107 swabs, completion rate = 92.25%) and subjected to pyrosequencing of the V1-V3 region of 16S rDNA. Respiratory bacterial taxa were characterized at the genus level, using QIIME 1.8 and the Ribosomal Database Project classifier. High levels of Staphylococcus, Corynebacterium, and Propionibacterium were observed among both nasal and nasopharyngeal microbiota, comprising more than 75% of all operational taxonomical units (OTUs). In contrast, Streptococcus was the sole dominant bacterial genus (approximately 50% of all OTUs) in the oropharynx. The average bacterial diversity was greater in the oropharynx than in the nasal or nasopharyngeal region at all time points. Diversity analysis indicated a significant overlap between nasal and nasopharyngeal samples, whereas oropharyngeal samples formed a cluster distinct from these two regions. The study produced a large set of pyrosequencing data on the V1-V3 region of bacterial 16S rDNA for the respiratory microbiomes of healthy active duty Service Members. Pre-processing of sequencing reads showed good data quality. The derived microbiome profiles were consistent both internally and with previous reports, suggesting their utility for further analyses and association studies based on sequence and demographic data.	[Hang, Jun; Yang, Yu; Ruck, Richard C.; Macareo, Louis R.; Jarman, Richard G.; Kuschner, Robert A.; Keiser, Paul B.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA; [Zavaljevski, Nela; Desai, Valmik; Reifman, Jaques] US Army Med Res & Mat Command, Telemed & Adv Technol Res Ctr, Dept Def Biotechnol High Performance Comp Softwar, Ft Detrick, MD USA; [Ruck, Richard C.] MCHK HC, Schofield Barracks, HI USA; [Macareo, Louis R.] US Armed Forces Res Inst Med Sci, Bangkok, Thailand	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Hang, J (corresponding author), Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA.	jun.hang.civ@mail.mil		Keiser, Paul/0000-0002-6271-4426; Hang, Jun/0000-0002-6597-7045	Immunizations Healthcare Branch; Military Infectious Diseases Research Program (MIDRP)/Defense Health Program enhancement (DHPe)/Defense Medical Research and Development Program (DMRDP) of the Department of Defense (DoD); Global Emerging Infections Surveillance and Response System (GEIS), a Division of the Armed Forces Health Surveillance Center	Immunizations Healthcare Branch; Military Infectious Diseases Research Program (MIDRP)/Defense Health Program enhancement (DHPe)/Defense Medical Research and Development Program (DMRDP) of the Department of Defense (DoD); Global Emerging Infections Surveillance and Response System (GEIS), a Division of the Armed Forces Health Surveillance Center	This work was supported by the Immunizations Healthcare Branch, the Military Infectious Diseases Research Program (MIDRP)/Defense Health Program enhancement (DHPe)/Defense Medical Research and Development Program (DMRDP) of the Department of Defense (DoD) and the Global Emerging Infections Surveillance and Response System (GEIS), a Division of the Armed Forces Health Surveillance Center.	Adar SD, 2016, ANN EPIDEMIOL, V26, P355, DOI 10.1016/j.annepidem.2016.03.010; [Anonymous], 2012, PLOS ONE, V7; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Ding T, 2014, NATURE, V509, P357, DOI 10.1038/nature13178; Dube FS, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1934-z; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fay MP, 2010, STAT SURV, V4, P1, DOI 10.1214/09-SS051; Hang J, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-31; Huang YJ, 2017, TRANSL RES, V179, P71, DOI 10.1016/j.trsl.2016.06.007; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Man WH, 2017, NAT REV MICROBIOL, V15, P259, DOI 10.1038/nrmicro.2017.14; Marsh RL, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0182-1; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Sakwinska O, 2014, J CLIN MICROBIOL, V52, P1590, DOI 10.1128/JCM.03280-13; Sanchez JL, 2015, CLIN MICROBIOL REV, V28, P743, DOI 10.1128/CMR.00039-14; Santee CA, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0179-9; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Stearns JC, 2015, ISME J, V9, P1246, DOI 10.1038/ismej.2014.250; Tarabichi Y, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0133-2; Taylor SL, 2016, CELL MICROBIOL, V18, P652, DOI 10.1111/cmi.12589; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yi H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0583-3; Zhou YJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r1	29	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188461	10.1371/journal.pone.0188461	http://dx.doi.org/10.1371/journal.pone.0188461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216202	Green Submitted, Green Published, gold			2022-12-27	WOS:000417337800024
J	Latorre, I; Minguez, S; Carrascosa, JM; Naves, J; Villar-Hernandez, R; Muriel, B; Prat, C; Garcia-Garcia, E; Casas, I; Domenech, E; Ferrandiz, C; Mateo, L; Dominguez, J				Latorre, Irene; Minguez, Sonia; Carrascosa, Jose-Manuel; Naves, Juan; Villar-Hernandez, Raquel; Muriel, Beatriz; Prat, Cristina; Garcia-Garcia, Esther; Casas, Irma; Domenech, Eugeni; Ferrandiz, Carlos; Mateo, Lourdes; Dominguez, Jose			Immune-mediated inflammatory diseases differently affect IGRAs' accuracy for latent tuberculosis infection diagnosis in clinical practice	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; QUANTIFERON-TB GOLD; MYCOBACTERIUM-TUBERCULOSIS; IFN-GAMMA; IMMUNOSUPPRESSIVE THERAPY; BLOOD-TESTS; IMMUNODIAGNOSIS; REACTIVATION; PERFORMANCE; IP-10	Background Clinical accuracy of IGRAs remains unclear on patients with immune-mediated inflammatory diseases (IMIDs). Here, we assess the impact of immunosuppressants and IMIDs on QuantiFERON-TB Gold In-Tube (QFN-G-IT) and T-SPOT. TB accuracy. Methods Patients with IMIDs who required latent tuberculosis infection (LTBI) screening were enrolled and classified into: (i) 50 patients with inflammatory rheumatic diseases, (ii) 50 patients with psoriasis and (iii) 30 patients with Crohn's disease. A total of 44 healthy individuals without immunosuppression were also included as controls. Tuberculin skin test (TST), T-SPOT. TB and QFN-G-IT assays were performed. IGRAs were performed following manufacturer's instructions. Results Immunosuppressant's intake was more frequent on patients with Crohn's disease and psoriasis. Positive IGRAs and TST results were reduced in Crohn's disease patients, whereas rate of indeterminate T-SPOT. TB results was increased in this group with respect to the other IMIDs analysed and controls. When IFN-gamma response was studied, the levels of this cytokine after mitogen stimulation were significantly lower in Crohn's and inflammatory rheumatic diseases than in psoriasis. Interestingly, psoriatic patients were the only ones not receiving corticosteroids. Furthermore, a negative correlation was observed between the IFN-gamma secreted after mitogen stimulation and corticosteroids dose. Conclusions IMIDs seem to negatively affect the clinical accuracy of IGRAs, being Crohn's disease patients the most affected individuals due to their concomitant drug-profile and impaired immune response.	[Latorre, Irene; Villar-Hernandez, Raquel; Muriel, Beatriz; Prat, Cristina; Garcia-Garcia, Esther; Dominguez, Jose] Hosp Badalona Germans Trias & Pujol, Inst Invest Germans Trias & Pujol, Serv Microbiol, Badalona, Spain; [Latorre, Irene; Minguez, Sonia; Carrascosa, Jose-Manuel; Naves, Juan; Villar-Hernandez, Raquel; Muriel, Beatriz; Prat, Cristina; Garcia-Garcia, Esther; Casas, Irma; Domenech, Eugeni; Ferrandiz, Carlos; Mateo, Lourdes; Dominguez, Jose] Univ Autonoma Barcelona, Barcelona, Spain; [Latorre, Irene; Villar-Hernandez, Raquel; Muriel, Beatriz; Prat, Cristina; Garcia-Garcia, Esther; Dominguez, Jose] Inst Salud Carlos III, CIBER Enfermedades Resp, Badalona, Spain; [Minguez, Sonia; Mateo, Lourdes] Hosp Badalona Germans Trias & Pujol, Inst Invest Germans Trias & Pujol, Serv Reumatol, Badalona, Spain; [Carrascosa, Jose-Manuel; Ferrandiz, Carlos] Hosp Badalona Germans Trias & Pujol, Inst Invest Germans Trias & Pujol, Serv Dermatol, Badalona, Spain; [Naves, Juan; Domenech, Eugeni] Hosp Badalona Germans Trias & Pujol, Inst Invest Germans Trias & Pujol, Serv Digestiu, Badalona, Spain; [Casas, Irma] Hosp Badalona Germans Trias & Pujol, Inst Invest Germans Trias & Pujol, Serv Med Prevent, Badalona, Spain; [Domenech, Eugeni] Inst Salud Carlos III, CIBER Enfermedades Hepat & Digest, Badalona, Spain	Hospital Germans Trias i Pujol; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Hospital Germans Trias i Pujol; Hospital Germans Trias i Pujol; Hospital Germans Trias i Pujol; Hospital Germans Trias i Pujol; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III	Dominguez, J (corresponding author), Hosp Badalona Germans Trias & Pujol, Inst Invest Germans Trias & Pujol, Serv Microbiol, Badalona, Spain.; Dominguez, J (corresponding author), Univ Autonoma Barcelona, Barcelona, Spain.; Dominguez, J (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp, Badalona, Spain.	jadominguez@igtp.cat	Aymerich, Cristina Prat/R-3484-2016; Villar-Hernández, Raquel/AGD-6666-2022; Latorre, Irene/H-8814-2017; Villar Hernández, Raquel/AFN-3894-2022	Aymerich, Cristina Prat/0000-0001-6974-9165; Villar-Hernández, Raquel/0000-0002-2249-0579; Latorre, Irene/0000-0001-8159-2455; Villar Hernández, Raquel/0000-0002-2249-0579; Garcia, Esther/0000-0003-3997-493X; Dominguez, Jose/0000-0001-7888-0309; Casas, Irma/0000-0002-5902-5777	Institute de Salud Carlos III, integrated in the Plan Nacional de I+D+I [PI 13/01546, PI16/01912]; ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER); Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR); Societat Catalana de Reumatologia (SCR); CERCA Programme/Generalitat de Catalunya	Institute de Salud Carlos III, integrated in the Plan Nacional de I+D+I; ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR); Societat Catalana de Reumatologia (SCR); CERCA Programme/Generalitat de Catalunya	The research was supported by grants from: (i) the Institute de Salud Carlos III (PI 13/01546 and PI16/01912), integrated in the Plan Nacional de I+D+I and cofunded by the ISCIII-Subdireccion General de Evaluacion and the Fondo Europeo de Desarrollo Regional (FEDER); (ii) Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR); (iii) Societat Catalana de Reumatologia (SCR); and (iv) CERCA Programme/Generalitat de Catalunya. JD is a researcher from the Miguel Servet programme.	Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Bao L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0103763; Barcellini L, 2016, EUR RESPIR J, V48, P1411, DOI 10.1183/13993003.00510-2016; Bassukas ID, 2011, ACTA DERM-VENEREOL, V91, P444, DOI 10.2340/00015555-1106; Belard E, 2011, INFLAMM BOWEL DIS, V17, P2340, DOI 10.1002/ibd.21605; Butera O, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-182; Calabrese C, 2015, ARTHRIT CARE RES, V67, P1063, DOI 10.1002/acr.22454; Cantini F, 2014, J RHEUMATOL, V41, P47, DOI 10.3899/jrheum.140102; Carmona L, 2005, ARTHRITIS RHEUM-US, V52, P1766, DOI 10.1002/art.21043; Casas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006686; Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Dominguez J, 2008, CLIN VACCINE IMMUNOL, V15, P168, DOI 10.1128/CVI.00364-07; Dominguez J, 2008, J CROHNS COLITIS, V2, P250, DOI 10.1016/j.crohns.2008.05.007; Edwards A, 2017, THORAX, V72, P946, DOI 10.1136/thoraxjnl-2016-209397; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Guo SJ, 2014, INT J CLIN EXP MED, V7, P93; Helwig U, 2012, J CROHNS COLITIS, V6, P419, DOI 10.1016/j.crohns.2011.09.011; Hoffmann H, 2016, CLIN MICROBIOL INFEC, V22, P701, DOI 10.1016/j.cmi.2016.05.006; Kim HC, 2014, SCAND J INFECT DIS, V46, P763, DOI 10.3109/00365548.2014.938691; Latorre I, 2014, J INFECTION, V69, P590, DOI 10.1016/j.jinf.2014.06.013; Latorre I, 2014, J INFECTION, V69, P600, DOI 10.1016/j.jinf.2014.07.026; Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07; Minguez S, 2012, CLIN RHEUMATOL, V31, P785, DOI 10.1007/s10067-012-1938-z; Petruccioli E, 2016, J INFECTION, V73, P588, DOI 10.1016/j.jinf.2016.09.008; Ramos JM, 2013, CLIN EXP MED, V13, P177, DOI 10.1007/s10238-012-0192-7; Redelman-Sidi G, 2013, AM J RESP CRIT CARE, V188, P422, DOI 10.1164/rccm.201209-1621CI; Ruiz-Manzano J, 2008, ARCH BRONCONEUMOL, V44, P551, DOI 10.1016/S1579-2129(08)60102-0; Santin M, 2016, ENFERM INFEC MICR CL, V34, P304, DOI 10.1016/j.eimc.2015.11.021; Sester M, 2014, AM J RESP CRIT CARE, V190, P1168, DOI 10.1164/rccm.201405-0967OC; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; Villar-Hernandez R, 2017, J INFECTION, V75, P315, DOI 10.1016/j.jinf.2017.07.004; Wong SH, 2014, INFLAMM BOWEL DIS, V20, P2067, DOI 10.1097/MIB.0000000000000147; Yi LN, 2016, SCI REP-UK, V6, DOI 10.1038/srep30617	34	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189202	10.1371/journal.pone.0189202	http://dx.doi.org/10.1371/journal.pone.0189202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216277	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800092
J	McKeithen, DN; Omosun, YO; Ryans, K; Mu, J; Xie, ZL; Simoneaux, T; Blas-Machado, U; Eko, FO; Black, CM; Igietseme, JU; He, Q				McKeithen, Danielle N.; Omosun, Yusuf O.; Ryans, Khamia; Mu, Jing; Xie, Zhonglin; Simoneaux, Tankya; Blas-Machado, Uriel; Eko, Francis O.; Black, Carolyn M.; Igietseme, Joseph U.; He, Qing			The emerging role of ASC in dendritic cell metabolism during Chlamydia infection	PLOS ONE			English	Article							INFLAMMASOME-INDEPENDENT ROLE; SPECK-LIKE PROTEIN; NLRP3 INFLAMMASOME; PYRUVATE-DEHYDROGENASE; NONCANONICAL INFLAMMASOMES; ACTIN POLYMERIZATION; IL-1-BETA SECRETION; AIM2 INFLAMMASOME; INDUCED ARTHRITIS; BACK AGAIN	Chlamydia trachomatis is a bacterial agent that causes sexually transmitted infections worldwide. The regulatory functions of dendritic cells (DCs) play a major role in protective immunity against Chlamydia infections. Here, we investigated the role of ASC in DCs metabolism and the regulation of DCs activation and function during Chlamydia infection. Following Chlamydia stimulation, maturation and antigen presenting functions were impaired in ASC(-/-) DCs compared to wild type (WT) DCs, in addition, ASC deficiency induced a tolerant phenotype in Chlamydia stimulated DCs. Using real-time extracellular flux analysis, we showed that activation in Chlamydia stimulated WT DCs is associated with a metabolic change in which mitochondrial oxidative phosphorylation (OXPHOS) is inhibited and the cells become committed to utilizing glucose through aerobic glycolysis for differentiation and antigen presenting functions. However, in ASC(-/-) DCs Chlamydia-induced metabolic change was prevented and there was a significant effect on mitochondrial morphology. The mitochondria of Chlamydia stimulated ASC(-/-) DCs had disrupted cristae compared to the normal narrow pleomorphic cristae found in stimulated WT DCs. In conclusion, our results suggest that Chlamydia-mediated activation of DCs is associated with a metabolic transition in which OXPHOS is inhibited, thereby dedicating the DCs to aerobic glycolysis, while ASC deficiency disrupts DCs function by inhibiting the reprogramming of DCs metabolism within the mitochondria, from glycolysis to electron transport chain.	[McKeithen, Danielle N.; Omosun, Yusuf O.; Ryans, Khamia; Simoneaux, Tankya; Eko, Francis O.; Igietseme, Joseph U.; He, Qing] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA; [McKeithen, Danielle N.; Ryans, Khamia] Clark Atlanta Univ, Dept Biol, Atlanta, GA 30314 USA; [Mu, Jing; Xie, Zhonglin] Georgia State Univ, Ctr Mol & Translat Med, Atlanta, GA 30303 USA; [Blas-Machado, Uriel] Univ Georgia, Coll Vet Med, Atlanta, GA USA; [Black, Carolyn M.; Igietseme, Joseph U.] Ctr Dis Control & Prevent CDC, Natl Ctr Emerging Zoonot & Infect Dis, Atlanta, GA USA	Morehouse School of Medicine; Clark Atlanta University; University System of Georgia; Georgia State University; University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA	He, Q (corresponding author), Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA.	qhe@msm.edu	Omosun, Yusuf/P-9944-2019	Omosun, Yusuf/0000-0003-4759-6254	NIH from National Institute on Minority Health and Health Disparities (NIM HD) [8G12MD007602]; Eunice Kennedy Shriver National Institute of Child Health and Development (NICHD) [1SC2HD086066-01A1]; National Institute of General Medical Sciences (NIGMS) [1SC1A1103041-01A1]	NIH from National Institute on Minority Health and Health Disparities (NIM HD); Eunice Kennedy Shriver National Institute of Child Health and Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by NIH grant 8G12MD007602 from the National Institute on Minority Health and Health Disparities (NIM HD), 1SC2HD086066-01A1 from Eunice Kennedy Shriver National Institute of Child Health and Development (NICHD) to Y.O. and 1SC1A1103041-01A1 from National Institute of General Medical Sciences (NIGMS) to Q.H.	Abdul-Sater AA, 2010, MICROBES INFECT, V12, P652, DOI 10.1016/j.micinf.2010.04.008; [Anonymous], 2016, CURR TOP MICROBIOL I; Bachmann MF, 2007, EMBO REP, V8, P1142, DOI 10.1038/sj.embor.7401099; Beitnes ACR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033556; Bround MJ, 2016, J BIOL CHEM, V291, P23490, DOI 10.1074/jbc.M116.756973; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Caution K, 2015, SCI REP-UK, V5, DOI 10.1038/srep18479; Conrad TA, 2016, INFECT IMMUN, V84, P467, DOI 10.1128/IAI.01171-15; Ellebedy AH, 2011, P NATL ACAD SCI USA, V108, P2927, DOI 10.1073/pnas.1012455108; Finethy R, 2015, INFECT IMMUN, V83, P4740, DOI 10.1128/IAI.00856-15; Goguet-Rubio P, 2016, P NATL ACAD SCI USA, V113, P11004, DOI 10.1073/pnas.1602751113; Hafner LM, 2015, CONTRACEPTION, V92, P108, DOI 10.1016/j.contraception.2015.01.004; He Q, 2005, J IMMUNOL, V174, P4860, DOI 10.4049/jimmunol.174.8.4860; He Q, 2007, IMMUNOLOGY, V122, P28, DOI 10.1111/j.1365-2567.2007.02608.x; Huang SCC, 2016, IMMUNITY, V45, P817, DOI 10.1016/j.immuni.2016.09.016; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Ippagunta SK, 2010, J BIOL CHEM, V285, P12454, DOI 10.1074/jbc.M109.093252; Jersmann HPA, 2005, IMMUNOL CELL BIOL, V83, P462, DOI 10.1111/j.1440-1711.2005.01370.x; Kavathas PB, 2013, MUCOSAL IMMUNOL, V6, P235, DOI 10.1038/mi.2012.63; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kolly L, 2009, J IMMUNOL, V183, P4003, DOI 10.4049/jimmunol.0802173; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Liu GT, 2004, J IMMUNOTHER, V27, P220, DOI 10.1097/00002371-200405000-00006; Maher S, 2002, IMMUNOL CELL BIOL, V80, P131, DOI 10.1046/j.1440-1711.2002.01068.x; Man SM, 2016, EUR J IMMUNOL, V46, P269, DOI 10.1002/eji.201545839; Matsuo J, 2015, INFECT IMMUN, V83, P2917, DOI 10.1128/IAI.02968-14; Nagarajan UM, 2012, J IMMUNOL, V188, P2866, DOI 10.4049/jimmunol.1103461; NOCKHER WA, 1994, CLIN EXP IMMUNOL, V98, P369, DOI 10.1111/j.1365-2249.1994.tb05499.x; O'Neill LAJ, 2014, NAT IMMUNOL, V15, P314, DOI 10.1038/ni.2852; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Omosun Y, 2015, INFECT IMMUN, V83, P4662, DOI 10.1128/IAI.00993-15; Pearce EJ, 2015, NAT REV IMMUNOL, V15, P18, DOI 10.1038/nri3771; Pender MP, 1999, IMMUNOL CELL BIOL, V77, P216, DOI 10.1046/j.1440-1711.1999.00818.x; Pettengill MA, 2016, BIOMED J, V39, P306, DOI 10.1016/j.bj.2016.07.001; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Rodriguez-Garcia M, 2016, MUCOSAL IMMUNOLOGY; Russell AN, 2016, J INFECT DIS, V214, P1884, DOI 10.1093/infdis/jiw485; Schulze A, 2011, MOL CELL, V44, P846, DOI 10.1016/j.molcel.2011.12.004; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Shao RJ, 2012, FERTIL STERIL, V98, P1175, DOI 10.1016/j.fertnstert.2012.07.1113; Shaw PJ, 2010, J IMMUNOL, V184, P4610, DOI 10.4049/jimmunol.1000217; Shimada K, 2012, MICROBES INFECT, V14, P1301, DOI 10.1016/j.micinf.2012.08.004; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shimada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021477; Sorrentino R, 2015, AM J PATHOL, V185, P3115, DOI 10.1016/j.ajpath.2015.07.009; Stary G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8205; TeKippe EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012320; Torrone E, 2007, PREVALENCE CHLAMYDIA, V63, P834; Boari JT, 2016, IMMUNOL CELL BIOL, V94, P903, DOI 10.1038/icb.2016.87; Vigano E, 2013, EUR J IMMUNOL, V43, P2240, DOI 10.1002/eji.201343800; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Wilson JE, 2015, NAT MED, V21, P906, DOI 10.1038/nm.3908; Wu DJ, 2016, IMMUNITY, V44, P1325, DOI 10.1016/j.immuni.2016.06.006; Zhao Y, 2016, CURR OPIN MICROBIOL, V29, P37, DOI 10.1016/j.mib.2015.10.003; Zhu Y, 2015, VACCINE, V33, P298, DOI 10.1016/j.vaccine.2014.11.028	58	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188643	10.1371/journal.pone.0188643	http://dx.doi.org/10.1371/journal.pone.0188643			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216217	gold, Green Published, Green Submitted			2022-12-27	WOS:000417337800035
J	Morimoto, M; Amano, Y; Oka, M; Harada, A; Fujita, H; Hikichi, Y; Tozawa, R; Yamaoka, M; Hara, T				Morimoto, Megumi; Amano, Yuichiro; Oka, Masahiro; Harada, Ayako; Fujita, Hisashi; Hikichi, Yukiko; Tozawa, Ryuichi; Yamaoka, Masuo; Hara, Takahito			Amelioration of sexual behavior and motor activity deficits in a castrated rodent model with a selective androgen receptor modulator SARM-2f	PLOS ONE			English	Article							TESTOSTERONE REPLACEMENT; SKELETAL-MUSCLE; FEMALE RATS; ESTROGEN-RECEPTOR; CANCER CACHEXIA; MICE; ENOBOSARM; MECHANISM; SURVIVAL; THERAPY	Sarcopenia and cachexia present characteristic features of a decrease in skeletal muscle mass and strength, anorexia, and lack of motivation. Treatments for these diseases have not yet been established, although selective androgen receptor modulators (SARMs) are considered as therapeutic targets. We previously reported that a novel SARM compound, SARM-2f, exhibits anabolic effect on muscles, with less stimulatory effect on prostate weight compared with testosterone, in rat Hershberger assays and cancer cachexia models. In this study, we studied the mechanism of action for SARM-2f selectivity and also assessed whether the muscle increase by this compound might lead to improvement of muscle function and physical activity. First, we examined the tissue distribution of SARM-2f. Tissue concentration was 1.2-, 1.6-, and 1.9-fold as high as the plasma concentration in the levator ani muscle, brain, and prostate, respectively. This result showed that the tissue-selective pharmacological effect did not depend on SARM-2f concentration in the tissues. The ability of SARM-2f to influence androgen receptor (AR)-mediated transcriptional activation was examined by reporter assays using human normal prostate epithelial cells (PrEC) and skeletal muscle cells (SKMC). SARM-2f exerted higher activity against AR in SKMC than in PrEC. Mammalian two hybrid assays showed different co-factor recruitment patterns between SARM-2f and dihydrotestosterone. Next, we studied the effect of SARM-2f on motivation and physical functions such as sexual behavior and motor activities in castrated rat or mouse models. SARM-2f restored the sexual behavior that was lost by castration in male rats. SARM-2f also increased voluntary running distance and locomotor activities. These results suggest that tissue-specific AR regulation by SARM-2f, but not tissue distribution, might account for its tissue specific androgenic effect, and that the muscle mass increase by SARM-2f leads to improvement of physical function. Together, these findings suggest that SARM-2f might represent an effective treatment for sarcopenia and cachexia.	[Morimoto, Megumi; Hikichi, Yukiko; Yamaoka, Masuo; Hara, Takahito] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Oncol Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Amano, Yuichiro; Oka, Masahiro; Harada, Ayako; Tozawa, Ryuichi] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, CVM Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Fujita, Hisashi] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, DMPK Unit, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Hara, T (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Oncol Drug Discovery Unit, Fujisawa, Kanagawa, Japan.	takahito.hara@takeda.com			Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	I declare that Takeda Pharmaceutical Company Limited, the funder, provided support in the form of salaries for authors [M.M., Y.A., M.O., A.H., H.F., Y.H., R.T., M.Y., and T.H.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aikawa K, 2017, BIOORGAN MED CHEM, V25, P3330, DOI 10.1016/j.bmc.2017.04.018; [Anonymous], 2016, MED LETT DRUGS THER, V58, P33; Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Baas W, 2016, TRANSL ANDROL UROL, V5, P890, DOI 10.21037/tau.2016.08.11; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Crawford J, 2016, CURR ONCOL REP, V18, DOI 10.1007/s11912-016-0522-0; Del Fabbro E, 2013, SUPPORT CARE CANCER, V21, P2599, DOI 10.1007/s00520-013-1832-5; Dillon EL, 2012, J CACHEXIA SARCOPENI, V3, P253, DOI 10.1007/s13539-012-0066-6; Garber K, 2016, NAT BIOTECHNOL, V34, P458, DOI 10.1038/nbt.3557; Gill JF, 2017, AGING CELL; Hara T, 2003, CANCER RES, V63, P149; Hayashida I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111810; Hikichi Y, 2015, EUR J PHARMACOL, V765, P322, DOI 10.1016/j.ejphar.2015.08.052; Ibebunjo C, 2011, AM J PHYSIOL-ENDOC M, V300, pE327, DOI 10.1152/ajpendo.00402.2010; Jones AB, 2016, BEHAV BRAIN RES, V311, P279, DOI 10.1016/j.bbr.2016.05.058; Joseph AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069327; Mondello P, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-828; Morimoto M, 2017, ONCOL LETT, V14, P8066, DOI 10.3892/ol.2017.7200; Narayanan R, 2017, MOL CEL IN PRESS JUN; Ogawa S, 2003, ENDOCRINOLOGY, V144, P230, DOI 10.1210/en.2002-220519; Pettan-Brewer C, 2014, PATHOBIOL AGING AGE, V4, DOI 10.3402/pba.v4.24824; Ponnusamy S, 2017, J CELL BIOCHEM, V118, P640, DOI 10.1002/jcb.25751; Rudolf AM, 2017, EXP GERONTOL, V98, P70, DOI 10.1016/j.exger.2017.08.007; Sakuma K, 2017, PFLUG ARCH EUR J PHY, V469, P573, DOI 10.1007/s00424-016-1933-3; Sinha I, 2014, CELL TISSUE RES, V357, P815, DOI 10.1007/s00441-014-1900-2; Spiteri T, 2012, BEHAV BRAIN RES, V230, P11, DOI 10.1016/j.bbr.2012.01.048; Srinath R, 2014, FUTURE ONCOL, V10, P187, DOI [10.2217/FON.13.273, 10.2217/fon.13.273]; Thoresen L, 2013, CLIN NUTR, V32, P65, DOI 10.1016/j.clnu.2012.05.009; Urban RJ, 2011, HORM RES PAEDIAT, V76, P81, DOI 10.1159/000329184; Ustunel I, 2003, ANAT HISTOL EMBRYOL, V32, P70, DOI 10.1046/j.1439-0264.2003.00441.x; Vigen R, 2013, JAMA-J AM MED ASSOC, V310, P1829, DOI 10.1001/jama.2013.280386; von Haehling S, 2014, J CACHEXIA SARCOPENI, V5, P261, DOI 10.1007/s13539-014-0164-8; von Haehling S, 2014, J AM MED DIR ASSOC, V15, P866, DOI 10.1016/j.jamda.2014.09.007; Wasley D., 2017, PSYCHO-ONCOLOGY; White JP, 2013, MOL CELL ENDOCRINOL, V365, P174, DOI 10.1016/j.mce.2012.10.019; Yamada C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140094; Zuloaga DG, 2011, ENDOCRINOLOGY, V152, P1572, DOI 10.1210/en.2010-1016	37	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189480	10.1371/journal.pone.0189480	http://dx.doi.org/10.1371/journal.pone.0189480			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216311	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800124
J	Reveles, KR; Lawson, KA; Mortensen, EM; Pugh, MJV; Koeller, JM; Argamany, JR; Frei, CR				Reveles, Kelly R.; Lawson, Kenneth A.; Mortensen, Eric M.; Pugh, Mary Jo V.; Koeller, Jim M.; Argamany, Jacqueline R.; Frei, Christopher R.			National epidemiology of initial and recurrent Clostridium difficile infection in the Veterans Health Administration from 2003 to 2014	PLOS ONE			English	Article							CLINICAL-PREDICTION RULE; HIGH-RISK ANTIBIOTICS; ACUTE-CARE FACILITIES; UNITED-STATES; ANTIMICROBIAL STEWARDSHIP; HOSPITALIZED-PATIENTS; DIARRHEA; MORTALITY; DISEASE; IMPACT	Introduction Prior studies demonstrated marked increases in Clostridium difficile infection (CDI) in the United States (U.S.) in recent years. The objective of this study was to describe the epidemiology of initial and recurrent CDI in a national Veterans Health Administration (VHA) cohort over a 12-year period. Methods This was a retrospective cohort study of all adult VHA beneficiaries with CDI (ICD-9-CM code 008.45) plus a positive CDI stool test between October 1, 2002 and September 30, 2014. Data were obtained from the VA Informatics and Computing Infrastructure. Recurrence was defined as a second ICD-9-CM code plus a new course of CDI therapy following a minimum three-day gap after the initial therapy was completed. CDI incidence and outcomes were presented descriptively and longitudinally. Results Overall, 30,326 patients met study inclusion criteria. CDI incidence increased from FY 2003 (1.6 per 10,000) to FY 2013 (5.1 per 10,000). Thereafter, CDI incidence decreased through FY 2014 (4.6 per 10,000). A total of 5,011 patients (17%) experienced a first recurrence and, of those, 1,713 (34%) experienced a second recurrence. Recurrence incidence increased 10-fold over the study period, from (0.1 per 10,000) in FY 2003, to (1.0 per 10,000) in FY 2014. Overall, 30-day mortality and median hospital length of stay (LOS) decreased among initial episodes over the study period. Mortality was higher for initial episodes (21%) compared to first recurrences (11%) and second recurrences (7%). Median hospital LOS was longer for first episodes (13 days) compared to first (9 days) and second recurrences (8 days). Conclusions Initial and recurrent CDI episodes increased among veterans over a 12-year period. Outcomes, such as mortality and hospital LOS improved in recent years; both of these outcomes are worse for initial CDI episodes than recurrent episodes.	[Reveles, Kelly R.; Lawson, Kenneth A.; Koeller, Jim M.; Argamany, Jacqueline R.; Frei, Christopher R.] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Reveles, Kelly R.; Koeller, Jim M.; Argamany, Jacqueline R.; Frei, Christopher R.] UT Hlth San Antonio, Pharmacotherapy Educ & Res Ctr, San Antonio, TX 78229 USA; [Reveles, Kelly R.; Pugh, Mary Jo V.; Frei, Christopher R.] South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; [Mortensen, Eric M.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med & Clin Sci, Dallas, TX 75390 USA; [Mortensen, Eric M.] VA North Texas Hlth Care Syst, Dallas, TX USA; [Pugh, Mary Jo V.] UT Hlth San Antonio, Dept Epidemiol & Biostat, San Antonio, TX USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Health San Antonio	Reveles, KR (corresponding author), Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA.; Reveles, KR (corresponding author), UT Hlth San Antonio, Pharmacotherapy Educ & Res Ctr, San Antonio, TX 78229 USA.; Reveles, KR (corresponding author), South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA.	kdaniels46@utexas.edu	Pugh, Mary Jo/K-5336-2019; Frei, Christopher/AAI-1421-2020; Mortensen, Eric/AAF-2713-2020; Reveles, Kelly/AAI-1575-2021	Pugh, Mary Jo/0000-0003-4196-7763; Frei, Christopher/0000-0002-0692-4787; 	American College of Clinical Pharmacy Research Institute Futures Grant; National Institutes of Health/National Institute on Aging San Antonio Claude D. Pepper Older Americans Independence Center [1P30AG044271-01A1]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR001120]	American College of Clinical Pharmacy Research Institute Futures Grant; National Institutes of Health/National Institute on Aging San Antonio Claude D. Pepper Older Americans Independence Center; National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported, in part, by an American College of Clinical Pharmacy Research Institute Futures Grant, awarded to K.R.R. This material is also the result of work supported with resources and the use of facilities at the Audie L. Murphy Memorial VA Hospital, San Antonio, TX. Furthermore, K.R.R. is supported by the National Institutes of Health/National Institute on Aging San Antonio Claude D. Pepper Older Americans Independence Center (1P30AG044271-01A1) Career Development (KL2) Program. Finally, C.R.F. is supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1 TR001120.	Aitken SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102848; Aldeyab MA, 2012, J ANTIMICROB CHEMOTH, V67, P2988, DOI 10.1093/jac/dks330; [Anonymous], 2012, STAT B; Barber C, 2013, ARTHRIT CARE RES, V65, P1343, DOI 10.1002/acr.21959; Bhangu S, 2010, COLORECTAL DIS, V12, P241, DOI 10.1111/j.1463-1318.2009.01832.x; Chou AF, 2016, INFECT CONT HOSP EP, V37, P647, DOI 10.1017/ice.2016.26; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Cornely OA, 2012, LANCET INFECT DIS, V12, P281, DOI 10.1016/S1473-3099(11)70374-7; Crook DW, 2012, CLIN INFECT DIS, V55, pS93, DOI 10.1093/cid/cis499; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dubberke ER, 2006, EMERG INFECT DIS, V12, P1576, DOI 10.3201/eid1210.060016; Evans ME, 2016, INFECT CONT HOSP EP, V37, P720, DOI 10.1017/ice.2016.27; Evans ME, 2014, INFECT CONT HOSP EP, V35, P1037, DOI 10.1086/677151; Eyre DW, 2012, CLIN INFECT DIS, V55, pS77, DOI 10.1093/cid/cis356; Freedberg DE, 2013, AM J GASTROENTEROL, V108, P1794, DOI 10.1038/ajg.2013.333; Gabriel L, 2014, J HOSP INFECT, V88, P12, DOI 10.1016/j.jhin.2014.04.011; Hensgens MPM, 2013, CLIN INFECT DIS, V56, P1108, DOI 10.1093/cid/cis1209; Hu MY, 2009, GASTROENTEROLOGY, V136, P1206, DOI 10.1053/j.gastro.2008.12.038; Huang CC, 2013, AM J EMERG MED, V31, P830, DOI 10.1016/j.ajem.2013.02.010; JOHNSON S, 1989, J INFECT DIS, V159, P340, DOI 10.1093/infdis/159.2.340; Kenneally C, 2007, CHEST, V132, P418, DOI 10.1378/chest.07-0202; Kurtzhalts KE, 2016, CLIN THER, V38, P1750, DOI 10.1016/j.clinthera.2016.06.004; Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3; Lagrotteria D, 2006, CLIN INFECT DIS, V43, P547, DOI 10.1086/506354; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; McNulty C, 1997, J ANTIMICROB CHEMOTH, V40, P707, DOI 10.1093/jac/40.5.707; Mermel LA, 2013, JT COMM J QUAL PATIE, V39, P298, DOI 10.1016/S1553-7250(13)39042-4; Moehring RW, 2013, INFECT CONT HOSP EP, V34, P1055, DOI 10.1086/673144; Musher DM, 2005, CLIN INFECT DIS, V40, P1586, DOI 10.1086/430311; Naggie S, 2010, INFECTION, V38, P297, DOI 10.1007/s15010-010-0025-0; Nair S, 1998, AM J GASTROENTEROL, V93, P1873; Noren T, 2004, J CLIN MICROBIOL, V42, P3635, DOI [10.1128/JCM.42.8.3635-3643.2004, 10.1128/jcm.42.8.3635-3643.2004]; Novak-Weekley SM, 2010, J CLIN MICROBIOL, V48, P889, DOI 10.1128/JCM.01801-09; O'Connor KA, 2004, QJM-INT J MED, V97, P423, DOI 10.1093/qjmed/hch076; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Reveles KR, 2014, AM J INFECT CONTROL, V42, P1028, DOI 10.1016/j.ajic.2014.06.011; Ricciardi R, 2007, ARCH SURG-CHICAGO, V142, P624, DOI 10.1001/archsurg.142.7.624; Schneeweiss S, 2007, J CLIN EPIDEMIOL, V60, P397, DOI 10.1016/j.jclinepi.2006.07.011; Shapiro NI, 2003, CRIT CARE MED, V31, P670, DOI 10.1097/01.CCM.0000054867.01688.D1; Tabak YP, 2013, INFECT CONT HOSP EP, V34, P588, DOI 10.1086/670621; Talpaert MJ, 2011, J ANTIMICROB CHEMOTH, V66, P2168, DOI 10.1093/jac/dkr253; Thomas C, 2002, CLIN INFECT DIS, V35, P1457, DOI 10.1086/342691; Valiquette L, 2007, CLIN INFECT DIS, V45, pS112, DOI 10.1086/519258; Wenisch C, 1996, CLIN INFECT DIS, V22, P813, DOI 10.1093/clinids/22.5.813; Wenisch JM, 2012, INFECTION, V40, P479, DOI 10.1007/s15010-012-0258-1; Yam P, 2012, AM J HEALTH-SYST PH, V69, P1142, DOI 10.2146/ajhp110512; Young-Xu Y, 2015, INFECT CONT HOSP EP, V36, P1038, DOI 10.1017/ice.2015.138; Zilberberg MD, 2008, EMERG INFECT DIS, V14, P929, DOI 10.3201/eid1406.071447; Zilberberg MD, 2014, J HOSP MED, V9, P418, DOI 10.1002/jhm.2189; Zilberberg MD, 2009, CRIT CARE MED, V37, P2583, DOI 10.1097/CCM.0b013e3181ab8388	58	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189227	10.1371/journal.pone.0189227	http://dx.doi.org/10.1371/journal.pone.0189227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216276	Green Submitted, Green Published, gold			2022-12-27	WOS:000417337800101
J	Yang, SM; Lix, LM; Yan, L; Hinds, AM; Leslie, WD				Yang, Shuman; Lix, Lisa M.; Yan, Lin; Hinds, Aynslie M.; Leslie, William D.			International Classification of Diseases (ICD)-coded obesity predicts risk of incident osteoporotic fracture	PLOS ONE			English	Article							BODY-MASS INDEX; BONE; ASSOCIATION; VALIDITY; VALIDATION; DIAGNOSIS; ICD-9-CM; UPDATE; FAT	International Classification of Diseases (ICD) codes have been used to ascertain individuals who are obese. There has been limited research about the predictive value of ICD-coded obesity for major chronic conditions at the population level. We tested the utility of ICDcoded obesity versus measured obesity for predicting incident major osteoporotic fracture (MOF), after adjusting for covariates (i.e., age and sex). In this historical cohort study (2001-2015), we selected 61,854 individuals aged 50 years and older from the Manitoba Bone Mineral Density Database, Canada. Body mass index (BMI) >= 30 kg/m(2) was used to define measured obesity. Hospital and physician ICD codes were used to ascertain ICDcoded obesity and incident MOF. Average cohort age was 66.3 years and 90.3% were female. The sensitivity, specificity and positive predictive value for ICD-coded obesity using measured obesity as the reference were 0.11 (95% confidence interval [CI]: 0.10, 0.11), 0.99 (95% CI: 0.99, 0.99) and 0.79 (95% CI: 0.77, 0.81), respectively. ICD-coded obesity (adjusted hazard ratio [HR] 0.83; 95% CI: 0.70, 0.99) and measured obesity (adjusted HR 0.83; 95% CI: 0.78, 0.88) were associated with decreased MOF risk. Although the area under the receiver operating characteristic curve (AUROC) estimates for incident MOF were not significantly different for ICD-coded obesity versus measured obesity (0.648 for ICD-coded obesity versus 0.650 for measured obesity; P = 0.056 for AUROC difference), the category-free net reclassification index for ICD-coded obesity versus measured obesity was -0.08 (95% CI: -0.11, -0.06) for predicting incident MOF. ICD-coded obesity predicted incident MOF, though it had low sensitivity and reclassified MOF risk slightly less well than measured obesity.	[Yang, Shuman] Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Changchun, Jilin, Peoples R China; [Yang, Shuman; Lix, Lisa M.; Yan, Lin; Hinds, Aynslie M.] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Yang, Shuman; Leslie, William D.] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada	Jilin University; University of Manitoba; University of Manitoba	Yang, SM (corresponding author), Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Changchun, Jilin, Peoples R China.; Yang, SM (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada.; Yang, SM (corresponding author), Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada.	shumanyang@jlu.edu.cn		Leslie, William/0000-0002-1056-1691; Yang, Shuman/0000-0002-9169-5850	Canadian Institutes of Health Research (CIHR) Foundation grant [334013]; Manitoba Research Chair; Research Manitoba Postdoctoral Fellowship Award; Manitoba Centre for Health Policy [2015/2016-52]	Canadian Institutes of Health Research (CIHR) Foundation grant(Canadian Institutes of Health Research (CIHR)); Manitoba Research Chair; Research Manitoba Postdoctoral Fellowship Award; Manitoba Centre for Health Policy	This research was supported by a Canadian Institutes of Health Research (CIHR) Foundation grant to LML (#334013). LML is supported by a Manitoba Research Chair. SY was funded by a Research Manitoba Postdoctoral Fellowship Award.; The authors acknowledge the Manitoba Centre for Health Policy for use of data contained in the Population Health Research Data Repository (HIPC#2015/2016-52). The results and conclusions are those of the authors and no official endorsement by the Manitoba Centre for Health Policy, Manitoba Health, Healthy Living, and Seniors, or other data providers is intended or should be inferred. Data used in this study are from the Population Research Data Repository housed at the Manitoba Centre for Health Policy, University of Manitoba and were derived from data provided by Manitoba Health, Healthy Living, and Seniors.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Bhan S, 2014, J BIOMECH, V47, P2391, DOI 10.1016/j.jbiomech.2014.04.026; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Chan MY, 2014, J BONE MINER RES, V29, P2327, DOI 10.1002/jbmr.2288; Chateau D, 2012, CAN J PUBLIC HEALTH, V103, pS23, DOI 10.1007/BF03403825; COX DR, 1972, J R STAT SOC B, V34, P187; Crowson CS, 2014, STAT METHODS MED RES, V25, P1692; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Eckel RH, 2011, J CLIN ENDOCR METAB, V96, P1654, DOI 10.1210/jc.2011-0585; Etherington J, 1996, J BONE MINER RES, V11, P1333; Fransoo R., 2011, ADULT OBESITY MANITO; Goff SL, 2012, PAEDIATR PERINAT EP, V26, P421, DOI 10.1111/j.1365-3016.2012.01303.x; Grumbach MM, 2000, J PEDIATR ENDOCR MET, V13, P1439; Johansson H, 2014, J BONE MINER RES, V29, P223, DOI 10.1002/jbmr.2017; Kanis JA, 2000, OSTEOPOROSIS INT, V11, P192, DOI 10.1007/s001980050281; Kanis JA, 2009, BONE, V44, P734, DOI 10.1016/j.bone.2009.01.373; Kuhle S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-173; Leslie WD, 2005, J CLIN DENSITOM, V8, P25, DOI 10.1385/JCD:8:1:025; Leslie WD, 2010, J BONE MINER RES, V25, P2350, DOI 10.1002/jbmr.123; Lix LM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-301; Lloyd JT, 2015, EVAL HEALTH PROF, V38, P508, DOI 10.1177/0163278714553661; Martin BJ, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-70; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nguyen ND, 2008, OSTEOPOROSIS INT, V19, P1431, DOI 10.1007/s00198-008-0588-0; O'Donnell S, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0143-2; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Prieto-Alhambra D, 2012, J BONE MINER RES, V27, P294, DOI 10.1002/jbmr.1466; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Reid IR, 2008, OSTEOPOROSIS INT, V19, P595, DOI 10.1007/s00198-007-0492-z; Roos LL, 1999, J CLIN EPIDEMIOL, V52, P39, DOI 10.1016/S0895-4356(98)00126-7; Roos LL, 2003, HEALTH SERV RES, V38, P1339, DOI 10.1111/1475-6773.00180; Shen J, 2016, J CLIN ENDOCR METAB, V101, P476, DOI 10.1210/jc.2015-3123; Thomas T, 2002, J BONE MINER RES, V17, P1563, DOI 10.1359/jbmr.2002.17.9.1563; Unnanuntana A, 2010, J BONE JOINT SURG AM, V92A, P743, DOI 10.2106/JBJS.I.00919; WHO, 2016, FACT SHEETS OB OV WH; World Health Organization, 2004, BMI CLASSIFICATION	37	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189168	10.1371/journal.pone.0189168	http://dx.doi.org/10.1371/journal.pone.0189168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216254	Green Published, Green Submitted, gold			2022-12-27	WOS:000417337800086
J	Belanger-Champagne, C; Vainionpaa, H; Peura, P; Toivonen, H; Eerola, P; Dendooven, P				Belanger-Champagne, Camille; Vainionpaa, Hannes; Peura, Pauli; Toivonen, Harri; Eerola, Paula; Dendooven, Peter			Design of a novel instrument for active neutron interrogation of artillery shells	PLOS ONE			English	Article							RAY ACTIVATION-ANALYSIS; EXPLOSIVES	The most common explosives can be uniquely identified by measuring the elemental H/N ratio with a precision better than 10%. Monte Carlo simulations were used to design two variants of a new prompt gamma neutron activation instrument that can achieve this precision. The instrument features an intense pulsed neutron generator with precise timing. Measuring the hydrogen peak from the target explosive is especially challenging because the instrument itself contains hydrogen, which is needed for neutron moderation and shielding. By iterative design optimization, the fraction of the hydrogen peak counts coming from the explosive under interrogation increased from 53(-7)(-7)% to 74(-10)(+8)% (statistical only) for the benchmark design. In the optimized design variants, the hydrogen signal from a high-explosive shell can be measured to a statistics-only precision better than 1% in less than 30 minutes for an average neutron production yield of 10(9) n/s.	[Belanger-Champagne, Camille; Peura, Pauli; Eerola, Paula; Dendooven, Peter] Helsinki Inst Phys, Helsinki, Finland; [Vainionpaa, Hannes] JHV Phys, Riihimaki, Finland; [Toivonen, Harri] HT Nucl, Hyvinkaa, Finland	Helsinki Institute of Physics	Belanger-Champagne, C (corresponding author), Helsinki Inst Phys, Helsinki, Finland.	camille.belanger-champagne@helsinki.fi		Belanger-Champagne, Camille/0000-0003-2368-2617; Dendooven, Peter/0000-0003-1859-1315; Peura, Pauli/0000-0002-8541-0169	Finnish Scientific Advisory Board for Defence; Tekes-The Finnish Funding agency for Innovation; Tekes [1845/31/2014]; Finnish Scientific Advisory Board for Defence [2500-0050]	Finnish Scientific Advisory Board for Defence; Tekes-The Finnish Funding agency for Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Tekes(Finnish Funding Agency for Technology & Innovation (TEKES)); Finnish Scientific Advisory Board for Defence	This work is supported by the Finnish Scientific Advisory Board for Defence and Tekes-The Finnish Funding agency for Innovation. Tekes (grant 1845/31/2014, recipient Paula Eerola, see www.tekes.fi) provided support in the form of salaries for authors C. B.-C., P.P. and P.D., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The Finnish Scientific Advisory Board for Defence (grant 2500-0050, recipient Hannes Vainionpaa, see www.defmin.fi/en/tasks and activities/defence_policy/scientific advisory board for defence) provided support in the form of part of the salary of H.V., consumable materials and consultation fees paid by the grantee to HT Nuclear Ltd, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. H. V. is a founder and majority owner of JHV Physics Oy. H.T. is the owner and only employee of HT Nuclear Ltd.; This work is supported by the Finnish Scientific Advisory Board for Defence and Tekes-The Finnish Funding agency for Innovation.	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Alfassi Z. B., 1995, PROMPT GAMMA NEUTRON; Alfassi ZB., 1994, CHEM ANAL NUCL METHO; Blachot J, 2012, NUCL DATA SHEETS, V113, P2391, DOI 10.1016/j.nds.2012.10.002; BROWN DR, 1994, NUCL INSTRUM METH A, V353, P684, DOI 10.1016/0168-9002(94)91751-5; Buffler A, 2004, RADIAT PHYS CHEM, V71, P853, DOI 10.1016/j.radphyschem.2004.04.110; CAFFREY AJ, 1992, IEEE T NUCL SCI, V39, P1422, DOI 10.1109/23.173218; Chadwick MB, 2011, NUCL DATA SHEETS, V112, P2887, DOI 10.1016/j.nds.2011.11.002; Cherubini N, 2016, CHALLENGES, V7; LEE WC, 1995, NUCL INSTRUM METH B, V99, P739, DOI 10.1016/0168-583X(95)00221-9; Litz M, 2012, ARLTR5871; Naqvi AA, 2013, APPL RADIAT ISOTOPES, V78, P145, DOI 10.1016/j.apradiso.2013.04.006; Naqvi AA, 2003, NUCL INSTRUM METH A, V511, P400, DOI 10.1016/S0168-9002(03)01949-1; ORTEC, PINS3 CF CHEM EXPL I; ORTEC, PINS3 CW PORT IS NEU; Paul RL, 2000, J RADIOANAL NUCL CH, V243, P181, DOI 10.1023/A:1006796003933; PAUL RL, 1995, J RADIOAN NUCL CH AR, V191, P245, DOI 10.1007/BF02038220; Poole CM, 2012, AUSTRALAS PHYS ENG S, V35, P329, DOI 10.1007/s13246-012-0159-8; Seabury EH, 2009, AIP CONF PROC, V1099, P928, DOI 10.1063/1.3120193; SODERN, NEUTR IND PROMPT PHO; St-Gobain Crystals, BRILLANCE SCIENT PER; THOMPSON LC, 1954, PHYS REV, V94, P941, DOI 10.1103/PhysRev.94.941; Twomey TR, 2007, INLCON0712304; Vainionpaa JH, 2015, NUCL INSTRUM METH B, V350, P88, DOI 10.1016/j.nimb.2014.12.077; Vourvopoulos G, 2001, TALANTA, V54, P459, DOI 10.1016/S0039-9140(00)00544-0; Yinon J., 1999, FORENSIC ENV DETECTI	26	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188959	10.1371/journal.pone.0188959	http://dx.doi.org/10.1371/journal.pone.0188959			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211773	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200052
J	Ghazi, Z; Jahanshahi, S; Li, YF				Ghazi, Zohaib; Jahanshahi, Shahrzad; Li, Yingfu			RiboFACSeq: A new method for investigating metabolic and transport pathways in bacterial cells by combining a riboswitch-based sensor, fluorescence-activated cell sorting and next-generation sequencing	PLOS ONE			English	Article							COENZYME B-12 SYNTHESIS; SALMONELLA-TYPHIMURIUM LT2; ESCHERICHIA-COLI; NUCLEOTIDE LOOP; VITAMIN-B12 TRANSPORT; OUTER-MEMBRANE; SUBSTRATE-SPECIFICITY; BINDING-PROTEIN; BTUB AFFECT; LAST STEP	The elucidation of the cellular processes involved in vitamin and cofactor biosynthesis is a challenging task. The conventional approaches to these investigations rely on the discovery and purification of the products (i.e proteins and metabolites) of a particular transport or bio-synthetic pathway, prior to their subsequent analysis. However, the purification of low-abundance proteins or metabolites is a formidable undertaking that presents considerable technical challenges. As a solution, we present an alternative approach to such studies that circumvents the purification step. The proposed approach takes advantage of: (1) the molecular detection capabilities of a riboswitch-based sensor to detect the cellular levels of its cognate molecule, as a means to probe the integrity of the transport and biosynthetic pathways of the target molecule in cells, (2) the high-throughput screening ability of fluorescence-activated cell sorters to isolate cells in which only these specific pathways are disrupted, and (3) the ability of next-generation sequencing to quickly identify the genes of the FACS-sorted populations. This approach was named "RiboFACSeq". Following their identification by RiboFACSeq, the role of these genes in the presumed pathway needs to be verified through appropriate functional assays. To demonstrate the utility of our approach, an adenosylcobalamin (AdoCbl)-responsive riboswitch-based sensor was used in this study to demonstrate that RiboFACSeq can be used to track and sort cells carrying genetic mutations in known AdoCbl transport and biosynthesis genes with desirable sensitivity and specificity. This method could potentially be used to elucidate any pathway of interest, as long as a suitable riboswitch-based sensor can be created. We believe that RiboFACSeq would be especially useful for the elucidation of biological pathways in which the proteins and/or their metabolites are present at very low physiological concentrations in cells, as is the case with vitamin and cofactor biosynthesis.	[Ghazi, Zohaib; Li, Yingfu] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Jahanshahi, Shahrzad; Li, Yingfu] McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada	McMaster University; McMaster University	Li, YF (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.; Li, YF (corresponding author), McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada.	liying@mcmaster.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2015-05806]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this work was provided by Natural Sciences and Engineering Research Council of Canada (NSERC) via a Discovery Grant to YL (RGPIN-2015-05806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMER BMM, 1995, J BACTERIOL, V177, P4742, DOI 10.1128/jb.177.16.4742-4747.1995; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BASSFORD PJ, 1977, J BACTERIOL, V132, P796, DOI 10.1128/JB.132.3.796-805.1977; Bohmer RM, 2011, CYTOM PART A, V79A, P646, DOI 10.1002/cyto.a.21096; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; BRADBEER C, 1993, J BACTERIOL, V175, P3146, DOI 10.1128/JB.175.10.3146-3150.1993; BRAUN V, 1989, J BACTERIOL, V171, P6387, DOI 10.1128/jb.171.11.6387-6390.1989; BRAUN V, 1993, MOL MICROBIOL, V8, P261, DOI 10.1111/j.1365-2958.1993.tb01570.x; Bushnell B., 2014, BBMAP FAST ACCURATE; Cadieux N, 2002, J BACTERIOL, V184, P706, DOI 10.1128/JB.184.3.706-717.2002; Cadieux N, 2000, J BACTERIOL, V182, P5954, DOI 10.1128/JB.182.21.5954-5961.2000; Chakravorty D, 2013, ADV ENZYME BIOTECHNO, P89; Claas KR, 2010, J BACTERIOL, V192, P145, DOI 10.1128/JB.01159-09; Crofts TS, 2013, CHEM BIOL, V20, P1265, DOI 10.1016/j.chembiol.2013.08.006; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEVEAUX LC, 1985, J BACTERIOL, V162, P888, DOI 10.1128/JB.162.3.888-896.1985; DEVEAUX LC, 1986, J BACTERIOL, V167, P920, DOI 10.1128/jb.167.3.920-927.1986; DIGIROLA.PM, 1971, J BACTERIOL, V106, P751, DOI 10.1128/JB.106.3.751-757.1971; Escalante-Semerena JC, 2007, J BACTERIOL, V189, P4555, DOI 10.1128/JB.00503-07; ESCALANTESEMERENA JC, 1990, J BACTERIOL, V172, P273, DOI 10.1128/JB.172.1.273-280.1990; FISCHER E, 1989, J BACTERIOL, V171, P5127, DOI 10.1128/jb.171.9.5127-5134.1989; Fowler CC, 2010, CHEM BIOL, V17, P756, DOI 10.1016/j.chembiol.2010.05.025; Gallo S, 2008, CHEMBIOCHEM, V9, P1408, DOI 10.1002/cbic.200800099; Grenier F, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01038-14; GUDMUNDSDOTTIR A, 1989, J BACTERIOL, V171, P6526, DOI 10.1128/jb.171.12.6526-6533.1989; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANTKE K, 1981, FEMS MICROBIOL LETT, V12, P31; Hazra AB, 2013, CHEM BIOL, V20, P1275, DOI 10.1016/j.chembiol.2013.08.007; KADNER RJ, 1973, J BACTERIOL, V115, P514, DOI 10.1128/JB.115.2.514-521.1973; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; LAWRENCE JG, 1995, J BACTERIOL, V177, P6371, DOI 10.1128/jb.177.22.6371-6380.1995; Maggio-Hall LA, 1999, P NATL ACAD SCI USA, V96, P11798, DOI 10.1073/pnas.96.21.11798; Maggio-Hall LA, 2004, MICROBIOL-SGM, V150, P1385, DOI 10.1099/mic.0.26952-0; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mireku SA, 2017, SCI REP-UK, V7, DOI 10.1038/srep41575; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; OTOOLE GA, 1994, J BIOL CHEM, V269, P26503; OTOOLE GA, 1993, J BACTERIOL, V175, P6328, DOI 10.1128/JB.175.19.6328-6336.1993; OTOOLE GA, 1993, J BACTERIOL, V175, P3317, DOI 10.1128/jb.175.11.3317-3326.1993; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Rebeille F, 2007, NAT PROD REP, V24, P949, DOI 10.1039/b703104c; RIOUX CR, 1989, MOL GEN GENET, V217, P301, DOI 10.1007/BF02464897; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; RUBINO SD, 1987, J BIOL CHEM, V262, P4382; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; SCOTT AI, 1993, ANGEW CHEM INT EDIT, V32, P1223, DOI 10.1002/anie.199312233; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; Stahl M, 2011, FUNCT INTEGR GENOMIC, V11, P241, DOI 10.1007/s10142-011-0214-7; SUH SJ, 1995, J BACTERIOL, V177, P921, DOI 10.1128/jb.177.4.921-925.1995; Thomas MG, 2000, J BIOL CHEM, V275, P27576; Trzebiatowski JR, 1997, J BIOL CHEM, V272, P17662, DOI 10.1074/jbc.272.28.17662; TRZEBIATOWSKI JR, 1994, J BACTERIOL, V176, P3568, DOI 10.1128/JB.176.12.3568-3575.1994; Van Bibber M, 1999, J BACTERIOL, V181, P5539, DOI 10.1128/JB.181.17.5539-5541.1999; Webb ME, 2007, NAT PROD REP, V24, P988, DOI 10.1039/b703105j; Zayas CL, 2007, J BACTERIOL, V189, P2210, DOI 10.1128/JB.01665-06	57	3	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188399	10.1371/journal.pone.0188399	http://dx.doi.org/10.1371/journal.pone.0188399			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211762	gold, Green Published, Green Submitted			2022-12-27	WOS:000417212200029
J	Moron-Rios, A; Gomez-Cornelio, S; Ortega-Morales, BO; De la Rosa-Garcia, S; Partida-Martinez, LP; Quintana, P; Alayon-Gamboa, JA; Cappello-Garcia, S; Gonzalez-Gomez, S				Moron-Rios, Alejandro; Gomez-Cornelio, Sergio; Otto Ortega-Morales, Benjamin; De la Rosa-Garcia, Susana; Pamela Partida-Martinez, Laila; Quintana, Patricia; Armando Alayon-Gamboa, Jose; Cappello-Garcia, Silvia; Gonzalez-Gomez, Santiago			Interactions between abundant fungal species influence the fungal community assemblage on limestone	PLOS ONE			English	Article							LABORATORY CONDITIONS; FRESH-WATER; WOOD; COLONIZATION; COMPETITION; SANDSTONE; STONE; ROCKS; BIODETERIORATION; COEXISTENCE	The assembly of fungal communities on stone materials is mainly influenced by the differential bioreceptivity of such materials and environmental conditions. However, little is known about the role of fungal interactions in the colonization and establishment of fungal species. We analyzed the effects of intra-and interspecific interactions between 11 species of fungi in oligotrophic and copiotrophic media and on limestone coupons. In a previous study, these species were the most frequently isolated in the epilithic biofilms of limestone walls exposed to a subtropical climate. In the culture media, we found a greater frequency of intra-and interspecific inhibitory effects in the oligotrophic medium than in the copiotrophic medium. On the limestone coupons, all fungi were able to establish; however, the colonization success rate varied significantly. Cladosporium cladosporioides had a less extensive colonization in isolation (control) than in dual interactions (coexistence) with other species. Phoma eupyrena exhibited the highest colonization success rate and competitive dominance among all tested species. X-ray diffraction (XRD) and scanning electron microscope (SEM) analyses revealed that Pestalotiopsis maculans and Paraconiothyrium sp. produced calcium oxalate crystals during their growth on coupon surfaces, both in isolation and in dual interactions. Our results demonstrate that interactions between abundant fungal species influence the fungal colonization on substrates, the biomineralization and the fungal community assemblage growing in limestone biofilms.	[Moron-Rios, Alejandro; Gomez-Cornelio, Sergio; Armando Alayon-Gamboa, Jose] Colegio Frontera Sur, Ciudad Ind Lerma, Campeche, Mexico; [Gomez-Cornelio, Sergio] Univ Politecn Ctr, Dept Ingn Biotecnol, Carretera Fed Villahermosa Teapa, Tumbulushal, Tabasco, Mexico; [Otto Ortega-Morales, Benjamin] Univ Autonoma Campeche, Dept Microbiol Ambiental & Biotecnol, Campeche, Mexico; [De la Rosa-Garcia, Susana; Cappello-Garcia, Silvia] Univ Juarez Autonoma Tabasco, Div Acad Ciencias Biol, Carr Villahermosa Cardenas, Villahermosa, Mexico; [Pamela Partida-Martinez, Laila] Ctr Invest Estudios Avanzados, Unidad Irapuato, Dept Ingn Genet, Irapuato, Mexico; [Quintana, Patricia; Gonzalez-Gomez, Santiago] IPN, CINVESTAV, Dept Fis Aplicada, Cordemex, Merida, Mexico	El Colegio de la Frontera Sur (ECOSUR); Universidad Juarez Autonoma de Tabasco; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Gomez-Cornelio, S (corresponding author), Colegio Frontera Sur, Ciudad Ind Lerma, Campeche, Mexico.; Gomez-Cornelio, S (corresponding author), Univ Politecn Ctr, Dept Ingn Biotecnol, Carretera Fed Villahermosa Teapa, Tumbulushal, Tabasco, Mexico.	sagomezcornelio@gmail.com	Partida, Laila Pamela/A-5935-2009; Ortega Morales, Benjamín Otto/K-3747-2018; Moron-Rios, Alejandro/E-6395-2013; Gómez-Cornelio, Sergio/HHM-9206-2022	Partida, Laila Pamela/0000-0001-8037-2856; Ortega Morales, Benjamín Otto/0000-0003-2458-244X; Moron-Rios, Alejandro/0000-0001-8790-0383; Gómez-Cornelio, Sergio/0000-0001-5102-9012; Gonzalez Gomez, William Santiago/0000-0002-6923-4425; De la Rosa-Garcia, Susana/0000-0002-6654-4532	El Colegio de la Frontera Sur; Universidad Autonoma de Campeche; Consejo Nacional de Ciencia y Tecnologia [138, 239290]	El Colegio de la Frontera Sur; Universidad Autonoma de Campeche; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding was provided by El Colegio de la Frontera Sur; Universidad Autonoma de Campeche; Consejo Nacional de Ciencia y Tecnologia (Fronteras de la Ciencia 138); Consejo Nacional de Ciencia y Tecnologia for the doctoral scholarship granted to SGC (239290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyawansa HA, 2014, FUNGAL DIVERS, V68, P69, DOI 10.1007/s13225-014-0305-6; ASTHANA A, 1990, MYCOLOGIA, V82, P554, DOI 10.2307/3760044; BARLOCHER F, 1991, MYCOLOGIA, V83, P82, DOI 10.2307/3759834; Boddy L, 2000, FEMS MICROBIOL ECOL, V31, P185, DOI 10.1111/j.1574-6941.2000.tb00683.x; Burford EP, 2003, MINERAL MAG, V67, P1127, DOI 10.1180/0026461036760154; Carlsson F, 2014, FUNGAL ECOL, V11, P100, DOI 10.1016/j.funeco.2014.05.003; Chagnon PL, 2016, OECOLOGIA, V180, P181, DOI 10.1007/s00442-015-3457-5; DELATORRE MA, 1991, SCI TOTAL ENVIRON, V107, P159, DOI 10.1016/0048-9697(91)90257-F; Duarte S, 2013, FUNGAL ECOL, V6, P187, DOI 10.1016/j.funeco.2013.02.001; Ferreira V, 2010, MYCOLOGIA, V102, P1004, DOI 10.3852/09-248; Fomina M, 2010, GEOMICROBIOL J, V27, P624, DOI 10.1080/01490451003702974; Fryar SC, 2005, FUNGAL DIVERS, V18, P59; Fryar SC, 2001, MICROBIAL ECOL, V41, P245, DOI 10.1007/s002480000075; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; Gaylarde C, 2015, INT BIODETER BIODEGR, V104, P411, DOI 10.1016/j.ibiod.2015.07.010; Giannantonio DJ, 2009, INT BIODETER BIODEGR, V63, P252, DOI 10.1016/j.ibiod.2008.10.002; Gleeson DB, 2010, GEOMICROBIOL J, V27, P559, DOI 10.1080/01490451003702982; Gomez-Cornelio S, 2016, ACTA BOT MEX, V117, P59, DOI 10.21829/abm117.2016.1168; Gomez-Cornelio S, 2012, FUNGAL BIOL-UK, V116, P1064, DOI 10.1016/j.funbio.2012.07.010; Gonzalez-Gomez WS, 2015, INT J ROCK MECH MIN, V75, P182, DOI 10.1016/j.ijrmms.2014.12.010; Gorbushina A.A., 2000, JOURNEY DIVERSE MICR, P317; Gorbushina AA, 2005, MYCOL RES, V109, P1288, DOI 10.1017/S0953756205003631; Gorbushina AA, 2002, MICROBIOLOGY+, V71, P350, DOI 10.1023/A:1015823232025; Gorbushina AA, 2007, ENVIRON MICROBIOL, V9, P1613, DOI 10.1111/j.1462-2920.2007.01301.x; GUILLITTE O, 1995, SCI TOTAL ENVIRON, V167, P215, DOI 10.1016/0048-9697(95)04582-L; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Hiscox J, 2015, FUNGAL ECOL, V14, P24, DOI 10.1016/j.funeco.2014.11.001; Holmer L, 1997, OIKOS, V79, P77, DOI 10.2307/3546092; Jain A, 2009, BUILD ENVIRON, V44, P1276, DOI 10.1016/j.buildenv.2008.09.019; Jones EBG, 2002, FUNGAL DIVERS, V10, P241; Koide RT, 2005, NEW PHYTOL, V165, P305, DOI 10.1111/j.1469-8137.2004.01216.x; Li W, 2009, MYCOPATHOLOGIA, V167, P37, DOI 10.1007/s11046-008-9143-y; Lopez-Gonzalez RC, 2017, FUNGAL ECOL, V26, P1, DOI 10.1016/j.funeco.2016.11.004; Michael G, 2014, FUNGAL BIOL REV, V28, P36, DOI 10.1016/j.fbr.2014.05.001; Miller AZ, 2008, SCI TOTAL ENVIRON, V405, P278, DOI 10.1016/j.scitotenv.2008.06.066; Ortega-Morales BO, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00201; Ruibal C, 2008, PERSOONIA, V21, P93, DOI 10.3767/003158508X371379; Schoneberg A, 2015, J APPL MICROBIOL, V118, P1165, DOI 10.1111/jam.12775; Sierra-Fernandez A, 2017, ACS APPL MATER INTER, V9, P24873, DOI 10.1021/acsami.7b06130; STAHL PD, 1992, SOIL BIOL BIOCHEM, V24, P309, DOI 10.1016/0038-0717(92)90190-9; Sterflinger K, 2000, GEOMICROBIOL J, V17, P97, DOI 10.1080/01490450050023791; Stohr SN, 2004, MICROB ECOL, V48, P431, DOI 10.1007/s00248-003-1064-1; Tiunov AV, 2005, ECOL LETT, V8, P618, DOI 10.1111/j.1461-0248.2005.00757.x; Treton C, 2004, MICROB ECOL, V48, P439, DOI 10.1007/s00248-003-0195-8; Wang XN, 2013, J AGR FOOD CHEM, V61, P4551, DOI 10.1021/jf400212y; Warscheid T, 2000, INT BIODETER BIODEGR, V46, P343, DOI 10.1016/S0964-8305(00)00109-8; Yuen TK, 1999, MICROB ECOL, V37, P257, DOI 10.1007/s002489900151	47	23	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188443	10.1371/journal.pone.0188443	http://dx.doi.org/10.1371/journal.pone.0188443			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211748	gold, Green Published, Green Submitted			2022-12-27	WOS:000417212200032
J	Dani, P; Ujaoney, AK; Apte, SK; Basu, B				Dani, Pratiksha; Ujaoney, Aman Kumar; Apte, Shree Kumar; Basu, Bhakti			Regulation of potassium dependent ATPase (kdp) operon of Deinococcus radiodurans	PLOS ONE			English	Article							ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATION; EXPRESSION; SYSTEM; ACCUMULATION; DESICCATION; RESISTANCE; SEQUENCE; PROTEIN; STRESS	The genome of D. radiodurans harbors genes for structural and regulatory proteins of Kdp ATPase, in an operon pattern, on Mega plasmid 1. Organization of its two-component regulatory genes is unique. Here we demonstrate that both, the structural as well as regulatory components of the kdp operon of D. radiodurans are expressed quickly as the cells experience potassium limitation but are not expressed upon increase in osmolarity. The cognate DNA binding response regulator (RR) effects the expression of kdp operon during potassium deficiency through specific interaction with the kdp promoter. Deletion of the gene encoding RR protein renders the mutant D. radiodurans (Delta RR) unable to express kdp operon under potassium limitation. The Delta RR D. radiodurans displays no growth defect when grown on rich media or when exposed to oxidative or heat stress but shows reduced growth following gamma irradiation. The study elucidates the functional and regulatory aspects of the novel kdp operon of this extremophile, for the first time.	[Dani, Pratiksha; Ujaoney, Aman Kumar; Apte, Shree Kumar; Basu, Bhakti] Bhabha Atom Res Ctr, Mol Biol Div, Bombay, Maharashtra, India; [Ujaoney, Aman Kumar; Apte, Shree Kumar; Basu, Bhakti] Homi Bhabha Natl Inst, Training Sch Complex, Bombay, Maharashtra, India	Bhabha Atomic Research Center (BARC); Homi Bhabha National Institute	Basu, B (corresponding author), Bhabha Atom Res Ctr, Mol Biol Div, Bombay, Maharashtra, India.; Basu, B (corresponding author), Homi Bhabha Natl Inst, Training Sch Complex, Bombay, Maharashtra, India.	bbasu@barc.gov.in		Basu, Bhakti/0000-0002-7381-6671	Department of Atomic Energy, India	Department of Atomic Energy, India(Department of Atomic Energy (DAE))	The work was funded by Department of Atomic Energy, India.	Alahari A, 2001, J BACTERIOL, V183, P5778, DOI 10.1128/JB.183.19.5778-5781.2001; Ali MK, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00570; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anaganti N, 2016, J BIOSCIENCES, V41, P193, DOI 10.1007/s12038-016-9608-y; ASHA H, 1993, J BACTERIOL, V175, P4528, DOI 10.1128/JB.175.14.4528-4537.1993; Ballal A, 2005, APPL ENVIRON MICROB, V71, P5297, DOI 10.1128/AEM.71.9.5297-5303.2005; Ballal A, 2008, ARCH BIOCHEM BIOPHYS, V474, P65, DOI 10.1016/j.abb.2008.02.017; Ballal A, 2007, J BIOSCIENCES, V32, P559, DOI 10.1007/s12038-007-0055-7; Basu B, 2008, BBA-PROTEINS PROTEOM, V1784, P1256, DOI 10.1016/j.bbapap.2008.05.009; Basu B, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011734; Battista JR, 2001, CRYOBIOLOGY, V43, P133, DOI 10.1006/cryo.2001.2357; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; BURRELL AD, 1971, BIOCHIM BIOPHYS ACTA, V247, P38, DOI 10.1016/0005-2787(71)90805-7; Checchetto V, 2016, PLANT CELL PHYSIOL, V57, P862, DOI 10.1093/pcp/pcw032; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Durand A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006114; Eltsov M, 2005, J BACTERIOL, V187, P8047, DOI 10.1128/JB.187.23.8047-8054.2005; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; EPSTEIN W, 1971, J BACTERIOL, V108, P639, DOI 10.1128/JB.108.2.639-644.1971; Epstein W, 2016, J BACTERIOL, V198, P212, DOI 10.1128/JB.00602-15; Freeman ZN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003201; Frymier JS, 1997, J BACTERIOL, V179, P3061, DOI 10.1128/jb.179.9.3061-3063.1997; Gries CM, 2013, MOL MICROBIOL, V89, P760, DOI 10.1111/mmi.12312; Grundling A, 2013, MBIO, V4, DOI 10.1128/mBio.00784-13; Gupta RS, 1998, J MOL EVOL, V46, P716, DOI 10.1007/PL00006352; Hamann K, 2008, J BACTERIOL, V190, P2360, DOI 10.1128/JB.01635-07; Heermann R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089671; Heermann R, 2010, FEMS MICROBIOL LETT, V304, P97, DOI 10.1111/j.1574-6968.2010.01906.x; Hill AV, 1910, J PHYSL, V40, piv, DOI DOI 10.1371/JOURNAL.PONE.0041098; Holland AD, 2006, APPL MICROBIOL BIOT, V72, P1074, DOI 10.1007/s00253-006-0399-1; Hughes FM, 1999, ADV ENZYME REGUL, V39, P157, DOI 10.1016/S0065-2571(98)00010-7; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Katoh H, 2004, MICROB ECOL, V47, P164, DOI 10.1007/s00248-003-1043-6; LAIMINS LA, 1981, P NATL ACAD SCI-BIOL, V78, P464, DOI 10.1073/pnas.78.1.464; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Luan HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085649; MCLAGGAN D, 1994, J BIOL CHEM, V269, P1911; Misra HS, 2004, FEBS LETT, V578, P26, DOI 10.1016/j.febslet.2004.10.061; Ochrombel I, 2011, BBA-BIOENERGETICS, V1807, P444, DOI 10.1016/j.bbabio.2011.01.008; POLAREK JW, 1992, J BACTERIOL, V174, P2145, DOI 10.1128/JB.174.7.2145-2151.1992; Price-Whelan A, 2013, MBIO, V4, DOI 10.1128/mBio.00407-13; Schramke H, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.438; Solovjev V, 2011, METAGENOMICITAPP, P61; Studier FW, 2014, METHODS MOL BIOL, V1091, P17, DOI 10.1007/978-1-62703-691-7_2; Su J, 2009, INFECT IMMUN, V77, P667, DOI 10.1128/IAI.01027-08; SUGIURA A, 1993, BIOSCI BIOTECH BIOCH, V57, P356, DOI 10.1271/bbb.57.356; SUGIURA A, 1992, MOL MICROBIOL, V6, P1769, DOI 10.1111/j.1365-2958.1992.tb01349.x; Supply, 2012, OSMOTIC STRESS KDPD, P181; TreunerLange A, 1997, J BACTERIOL, V179, P4501, DOI 10.1128/jb.179.14.4501-4512.1997; Tsai CH, 2015, APPL ENVIRON MICROB, V81, P1745, DOI 10.1128/AEM.03709-14; Ujaoney AK, 2017, BBA-PROTEINS PROTEOM, V1865, P1215, DOI 10.1016/j.bbapap.2017.06.014; Venkateswaran A, 2000, APPL ENVIRON MICROB, V66, P2620, DOI 10.1128/AEM.66.6.2620-2626.2000; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571	55	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188998	10.1371/journal.pone.0188998	http://dx.doi.org/10.1371/journal.pone.0188998			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206865	Green Submitted, Green Published, gold			2022-12-27	WOS:000417110700038
J	Mohammed, RH; Anderton, H; Brameld, JM; Sweetman, D				Mohammed, Rabeea Hazim; Anderton, Helen; Brameld, John Michael; Sweetman, Dylan			Effects of insulin like growth factors on early embryonic chick limb myogenesis (vol 12, e0185775, 2017)	PLOS ONE			English	Correction													Brameld, John/AAB-1745-2021; Mohammed, Rabeea Hazim/GYJ-3387-2022	Brameld, John/0000-0003-4942-080X; Mohammed, Dr.Rabeea/0000-0002-7757-8068	Biotechnology and Biological Sciences Research Council [BB/J014508/1]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (grant BB/J014508/1).	Mohammed RH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185775	1	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189395	10.1371/journal.pone.0189395	http://dx.doi.org/10.1371/journal.pone.0189395			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206875	gold, Green Published, Green Submitted			2022-12-27	WOS:000417110700056
J	Orengo, DJ; Aguade, M; Juan, E				Orengo, Dorcas J.; Aguade, Montserrat; Juan, Elvira			Characterization of dFOXO binding sites upstream of the Insulin Receptor P2 promoter across the Drosophila phylogeny	PLOS ONE			English	Article							TRANSCRIPTION FACTOR AFX; GENOME SEQUENCE; LIFE-SPAN; EVOLUTION; DNA; IDENTIFICATION; GENE; EXPRESSION; FEEDBACK; MELANOGASTER	The insulin/TOR signal transduction pathway plays a critical role in determining such important traits as body and organ size, metabolic homeostasis and life span. Although this pathway is highly conserved across the animal kingdom, the affected traits can exhibit important differences even between closely related species. Evolutionary studies of regulatory regions require the reliable identification of transcription factor binding sites. Here we have focused on the Insulin Receptor (InR) expression from its P2 promoter in the Drosophila genus, which in D. melanogaster is up-regulated by hypophosphorylated Drosophila FOXO (dFOXO). We have finely characterized this transcription factor binding sites in vitro along the 1.3 kb region upstream of the InR P2 promoter in five Drosophila species. Moreover, we have tested the effect of mutations in the characterized dFOXO sites of D. melanogaster in transgenic flies. The number of experimentally established binding sites varies across the 1.3 kb region of any particular species, and their distribution also differs among species. In D. melanogaster, InR expression from P2 is differentially affected by dFOXO binding sites at the proximal and distal halves of the species 1.3 kb fragment. The observed uneven distribution of binding sites across this fragment might underlie their differential contribution to regulate InR transcription.	[Orengo, Dorcas J.; Aguade, Montserrat; Juan, Elvira] Univ Barcelona, Fac Biol, Dept Genet Microbiol & Estadist, Barcelona, Spain; [Orengo, Dorcas J.; Aguade, Montserrat; Juan, Elvira] Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain	University of Barcelona; University of Barcelona	Juan, E (corresponding author), Univ Barcelona, Fac Biol, Dept Genet Microbiol & Estadist, Barcelona, Spain.; Juan, E (corresponding author), Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain.	ejuan@ub.edu	Orengo, Dorcas/AAG-6201-2021	Orengo, Dorcas/0000-0001-7911-3224; Aguade, Montserrat/0000-0002-3884-7800	 [BFU2012-35168];  [BFU2015-63732];  [2014SGR-1055]	; ; 	This study was supported by BFU2012-35168 and BFU2015-63732 (http://www.mineco.gob.es/portal/site/mineco/) and 2014SGR-1055 (http://sac.gencat.cat/sacgencat/AppJava/organisme_fitxa.jsp?codi=17422) to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alic N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.36; Bai H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003941; Bergman CM, 2005, BIOINFORMATICS, V21, P1747, DOI 10.1093/bioinformatics/bti173; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bradley RK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000343; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Burland T G, 2000, Methods Mol Biol, V132, P71; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Casas-Tinto S, 2007, BBA-GENE STRUCT EXPR, V1769, P236, DOI 10.1016/j.bbaexp.2007.03.003; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Doniger SW, 2007, PLOS COMPUT BIOL, V3, P932, DOI 10.1371/journal.pcbi.0030099; DREW HR, 1984, CELL, V37, P491, DOI 10.1016/0092-8674(84)90379-9; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Galas DJ, 1978, NUCLEIC ACIDS RES, V5, P1345; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Hafen E, 2003, PLOS BIOL, V1, P319, DOI 10.1371/journal.pbio.0000086; He BZ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002053; Housden B, 2012, G3-GENES GENOM GENET, V2, P79, DOI 10.1534/g3.111.001321; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Lang M, 2010, NUCLEIC ACIDS RES, V38, P6404, DOI 10.1093/nar/gkq504; Ling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017762; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Lynch M, 2015, P NATL ACAD SCI USA, V112, pE30, DOI 10.1073/pnas.1421641112; Marr MT, 2007, GENE DEV, V21, P175, DOI 10.1101/gad.1506407; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Nakagawa S, 2013, P NATL ACAD SCI USA, V110, P12349, DOI 10.1073/pnas.1310430110; Obsil T, 2011, BBA-MOL CELL RES, V1813, P1946, DOI 10.1016/j.bbamcr.2010.11.025; Odenwald WF, 2005, P NATL ACAD SCI USA, V102, P14700, DOI 10.1073/pnas.0506915102; PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Rebeiz M, 2002, P NATL ACAD SCI USA, V99, P9888, DOI 10.1073/pnas.152320899; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Wei YL, 2016, DEVELOPMENT, V143, P3591, DOI 10.1242/dev.138073; Weigelt J, 2001, BIOCHEMISTRY-US, V40, P5861, DOI 10.1021/bi001663w; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Wit J, 2015, J EVOLUTION BIOL, V28, P1892, DOI 10.1111/jeb.12706; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yindeeyoungyeon W, 2000, BIOTECHNIQUES, V29, P1034, DOI 10.2144/00295st05	48	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188357	10.1371/journal.pone.0188357	http://dx.doi.org/10.1371/journal.pone.0188357			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29200426	Green Published, Green Submitted, gold			2022-12-27	WOS:000417033200005
J	Liu, J; Li, G; Chen, C; Chen, DC; Zhou, QS				Liu, Jiao; Li, Guang; Chen, Chuang; Chen, Dechang; Zhou, Qingshan			MiR-6835 promoted LPS-induced inflammation of HUVECs associated with the interaction between TLR-4 and AdipoR1 in lipid rafts	PLOS ONE			English	Article							STRUCTURAL BASIS; SIGNAL-TRANSDUCTION; SEPSIS; LIPOPOLYSACCHARIDE; TRANSLOCATION; PROTEINS; CHOLESTEROL; RECEPTOR; ENDOTHELIUM; RECOGNITION	Background High mortality rate of critically-ill patients could be induced by sepsis and septic shock, which is the extremely life threatening. The purpose of this work is to identify and evaluate the potential regulatory mechanism of LPS-induced inflammation associated with miR-6835 and lipid rafts in HUVECs. Methods The 3' UTR luciferase activity of AdipoR1 was detected, which was predicted the potential target gene of miR-6835. Moreover, the treated HUVECs with or without inhibitors or mimics of miR-6835 were used. Furthermore, the bio-functions of HUVECs were explored. The protein expression levels of SIRT-1, AMPK, and AdipoR1 were assessed, which were involved in the AdipoR1 signaling pathway. Then, the interaction between TLR-4 and AdipoR1 in lipid rafts and its mediation role on LPS-induced inflammation was investigated in HUVECs. Results MiR-6835 targeted directly on AdipoR1, and suppressed its expression in mRNA (mimics of miR-6835: 0.731 +/- 0.016 vs control: 1.527 +/- 0.015, P<0.001) and proteins levels, then regulated protein expression of SIRT-1 and AMPK, which were the downstream target genes of AdipoR1 signaling pathway. MiR-6835 enhanced LPS-induced inflammation process in HUVECs (TNF-alpha: LPS+mimics of miR-6835: 1638.51 +/- 78.43 vs LPS: 918.73 +/- 39.73, P<0.001; IL-6: LPS+mimics of miR-6835: 1249.35 +/- 69.51 vs LPS: 687.52 +/- 43.64, P<0.001), which was associated with the interaction between TLR-4 and AdipoR1 in lipid rafts. Conclusions MiR-6835 is the key regulator of LPS-induced inflammation process in HUVECs. The interaction between TLR-4 and AdipoR1 mediated by lipid rafts at membrane of HUVECs with inflammation process induced by miR-6835. Our results demonstrated a hopeful strategy for treatment on sepsis by aiming at lipid rafts and miR-6835.	[Liu, Jiao; Li, Guang; Zhou, Qingshan] Wuhan Univ, Renmin Hosp, Dept Crit Care Med, Wuhan, Hubei, Peoples R China; [Chen, Chuang] Wuhan Univ, Renmin Hosp, Dept Breast & Thyroid Surg, Wuhan, Hubei, Peoples R China; [Chen, Dechang] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Emergency & Crit Care Med, Shanghai, Peoples R China	Wuhan University; Wuhan University; Naval Medical University	Zhou, QS (corresponding author), Wuhan Univ, Renmin Hosp, Dept Crit Care Med, Wuhan, Hubei, Peoples R China.	zhouqingshan688@163.com			National Natural Science Foundation of China [30600524]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 30600524). The study sponsors had no involvement in the study.; This work was supported by grants from the National Natural Science Foundation of China (No.30600524).	Abate W, 2010, J LIPID RES, V51, P334, DOI 10.1194/jlr.M000513; Aird WC, 2007, CURR DRUG TARGETS, V8, P501, DOI 10.2174/138945007780362782; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Angus Derek C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P207; Badshah H, 2016, SCI REP-UK, V6, DOI 10.1038/srep24493; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beutler B, 2001, J ENDOTOXIN RES, V7, P277, DOI 10.1177/09680519010070040901; Bockmeyer CL, 2007, HAEMATOLOGICA, V93, P137, DOI 10.3324/haematol.11677; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Boothe T, 2016, MOL METAB, V5, P366, DOI 10.1016/j.molmet.2016.01.009; Chaari A, 2016, WORLD J GASTRO ONCOL, V8, P526, DOI 10.4251/wjgo.v8.i7.526; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Fu YH, 2015, FREE RADICAL BIO MED, V89, P777, DOI 10.1016/j.freeradbiomed.2015.10.407; Henneke P, 2002, CRIT CARE MED, V30, pS207, DOI 10.1097/00003246-200205001-00006; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Iovine N, 2002, J BIOL CHEM, V277, P7970, DOI 10.1074/jbc.M109622200; Kang QX, 2016, J SURG RES, V202, P87, DOI 10.1016/j.jss.2015.12.034; Kinasewitz GT, 2005, CRIT CARE MED, V33, P2214, DOI 10.1097/01.CCM.0000181296.53204.DE; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Lecompte S, 2017, CELL MOL LIFE SCI, V74, P2487, DOI 10.1007/s00018-017-2465-5; Lee EJ, 2014, BBA-MOL CELL BIOL L, V1841, P190, DOI 10.1016/j.bbalip.2013.10.006; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Marshall JC, 2014, TRENDS MOL MED, V20, P195, DOI 10.1016/j.molmed.2014.01.007; McCall CE, 2011, J LEUKOCYTE BIOL, V90, P439, DOI 10.1189/jlb.0211075; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Opal SM, 2014, CRIT CARE MED, V42, P1714, DOI 10.1097/CCM.0000000000000325; Otto GP, 2011, CRIT CARE, V15, DOI 10.1186/cc10332; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Plociennikowska A, 2015, CELL MOL LIFE SCI, V72, P557, DOI 10.1007/s00018-014-1762-5; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Sun XL, 2016, P NATL ACAD SCI USA, V113, P769, DOI 10.1073/pnas.1524523113; Tang CH, 2007, J IMMUNOL, V179, P5483, DOI 10.4049/jimmunol.179.8.5483; Vachharajani V, 2014, EXPERT REV CLIN IMMU, V10, P1141, DOI 10.1586/1744666X.2014.943192; Vachharajani VT, 2014, J LEUKOCYTE BIOL, V96, P785, DOI 10.1189/jlb.3MA0114-034RR; Varshney P, 2016, IMMUNOLOGY, V149, P13, DOI 10.1111/imm.12617; Wang XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160431; Wood KA, 2004, PHARMACOECONOMICS, V22, P895, DOI 10.2165/00019053-200422140-00001; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Zhu Y, 2000, ARTERIOSCL THROM VAS, V20, P2465, DOI 10.1161/01.ATV.20.11.2465	43	6	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188604	10.1371/journal.pone.0188604	http://dx.doi.org/10.1371/journal.pone.0188604			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190778	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900082
J	Picart-Armada, S; Fernandez-Albert, F; Vinaixa, M; Rodriguez, MA; Aivio, S; Stracker, TH; Yanes, O; Perera-Lluna, A				Picart-Armada, Sergio; Fernandez-Albert, Francesc; Vinaixa, Maria; Rodriguez, Miguel A.; Aivio, Suvi; Stracker, Travis H.; Yanes, Oscar; Perera-Lluna, Alexandre			Null diffusion-based enrichment for metabolomics data	PLOS ONE			English	Article							PATHWAYS; LC/MS; TOOL	Metabolomics experiments identify metabolites whose abundance varies as the conditions under study change. Pathway enrichment tools help in the identification of key metabolic processes and in building a plausible biological explanation for these variations. Although several methods are available for pathway enrichment using experimental evidence, meta-bolomics does not yet have a comprehensive overview in a network layout at multiple molecular levels. We propose a novel pathway enrichment procedure for analysing summary metabolomics data based on sub-network analysis in a graph representation of a reference database. Relevant entries are extracted from the database according to statistical measures over a null diffusive process that accounts for network topology and pathway crosstalk. Entries are reported as a sub-pathway network, including not only pathways, but also modules, enzymes, reactions and possibly other compound candidates for further analyses. This provides a richer biological context, suitable for generating new study hypotheses and potential enzymatic targets. Using this method, we report results from cells depleted for an uncharacterised mitochondrial gene using GC and LC-MS data and employing KEGG as a knowledge base. Partial validation is provided with NMR-based tracking of C-13 glucose labelling of these cells.	[Picart-Armada, Sergio; Fernandez-Albert, Francesc; Perera-Lluna, Alexandre] Univ Politecn Cataluna, Dept Engn Sistemes Automat & Informat Ind, Barcelona, Spain; [Picart-Armada, Sergio; Fernandez-Albert, Francesc; Perera-Lluna, Alexandre] Networking Biomed Res Ctr Subject Area Bioengn Bi, Madrid, Spain; [Picart-Armada, Sergio; Perera-Lluna, Alexandre] Hosp St Joan Deu, Inst Recerca Pediat, Barcelona, Spain; [Vinaixa, Maria; Rodriguez, Miguel A.; Yanes, Oscar] Rovira & Virgili Univ, Ctr Om Sci, Reus, Spain; [Vinaixa, Maria; Yanes, Oscar] Rovira & Virgili Univ, Dept Elect Engn, Tarragona, Spain; [Vinaixa, Maria; Yanes, Oscar] Spanish Biomed Res Ctr Diabet & Associated Metab, Metab Platform, Madrid, Spain; [Aivio, Suvi; Stracker, Travis H.] Barcelona Inst Sci & Technol, Inst Res Biomed, Barcelona, Spain; [Fernandez-Albert, Francesc] Takeda Cambridge Ltd, Cambridge, England	Universitat Politecnica de Catalunya; University of Barcelona; Universitat Rovira i Virgili; Universitat Rovira i Virgili; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Picart-Armada, S (corresponding author), Univ Politecn Cataluna, Dept Engn Sistemes Automat & Informat Ind, Barcelona, Spain.; Picart-Armada, S (corresponding author), Networking Biomed Res Ctr Subject Area Bioengn Bi, Madrid, Spain.; Picart-Armada, S (corresponding author), Hosp St Joan Deu, Inst Recerca Pediat, Barcelona, Spain.	sergi.picart@upc.edu	Yanes, Oscar/N-3630-2016; Lluna, Alexandre Perera/R-8546-2018; Vinaixa, Maria/AAB-1176-2020; Vinaixa, Maria/L-7236-2014; Perera Lluna, Alexandre/CAG-2156-2022; Stracker, Travis H/I-2815-2015	Yanes, Oscar/0000-0003-3695-7157; Lluna, Alexandre Perera/0000-0001-6427-851X; Vinaixa, Maria/0000-0001-9804-0171; Vinaixa, Maria/0000-0001-9804-0171; Perera Lluna, Alexandre/0000-0001-6427-851X; Stracker, Travis H/0000-0002-8650-2081; Picart-Armada, Sergio/0000-0002-6426-8204; Fernandez-Albert, Francesc/0000-0001-5561-0701; Rodriguez-Gomez, Miguel Angel/0000-0001-9568-9821	Spanish Ministry of Economy and Competitiveness [BFU2012-39521, BFU2015-68354, TEC2014-60337-R, SAF2011-30578, BFU2014-57466]; Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM) of Institute de Investigacion Carlos III (ISCIII); Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) of Institute de Investigacion Carlos III (ISCIII); Finnish Cultural Society; AGAUR Fl-scholarship programme; Takeda Cambridge Ltd	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM) of Institute de Investigacion Carlos III (ISCIII); Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) of Institute de Investigacion Carlos III (ISCIII); Finnish Cultural Society; AGAUR Fl-scholarship programme; Takeda Cambridge Ltd	This work was supported by the Spanish Ministry of Economy and Competitiveness (www.mineco.gob.es) [BFU2012-39521 and BFU2015-68354 to T.S., TEC2014-60337-R to A.P., SAF2011-30578 and BFU2014-57466 to O.Y.]. O.Y., A.P. and S.P. thank for funding the Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM) and the Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), both initiatives of Institute de Investigacion Carlos III (ISCIII). S.A. was supported by a Finnish Cultural Society Fellowship. S.P. thanks the AGAUR Fl-scholarship programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Takeda Cambridge Ltd provided support in the form of salaries for authors [FF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by the Spanish Ministry of Economy and Competitiveness (www.mineco.gob.es) [BFU2012-39521 and BFU2015-68354 to T.S., TEC2014-60337-R to A.P., SAF2011-30578 and BFU2014-57466 to O.Y.].; O.Y., A.P. and S.P. thank for funding the Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM) and the Networking Biomedical Research Centre in the subject area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), both initiatives of Instituto de Investigacion Carlos III (ISCIII). S.A. was supported by a Finnish Cultural Society Fellowship. S.P. thanks the AGAUR FI-scholarship programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Takeda Cambridge Ltd provided support in the form of salaries for authors [FF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Aivio SM, 2014, THESIS; Alonso A, 2015, FRONT BIOENG BIOTECH, V3; Bapat RB, 2004, MATCH-COMMUN MATH CO, P73; Bonals LA, 2005, TRANSFERENCIA CALOR; Chagoyen M, 2013, BRIEF BIOINFORM, V14, P737, DOI 10.1093/bib/bbs055; Chagoyen M, 2011, BIOINFORMATICS, V27, P730, DOI 10.1093/bioinformatics/btr001; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Donato M, 2013, GENOME RES, V23, P1885, DOI 10.1101/gr.153551.112; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Faust K, 2010, BIOINFORMATICS, V26, P1211, DOI 10.1093/bioinformatics/btq105; Fernandez-Albert F, 2014, BIOINFORMATICS, V30, P1937, DOI 10.1093/bioinformatics/btu136; Haynes WA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002967; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Kamburov A, 2011, BIOINFORMATICS, V27, P2917, DOI 10.1093/bioinformatics/btr499; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kankainen M, 2011, BIOINFORMATICS, V27, P1878, DOI 10.1093/bioinformatics/btr278; Karnovsky A, 2012, BIOINFORMATICS, V28, P373, DOI 10.1093/bioinformatics/btr661; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kessler N, 2013, BIOINFORMATICS, V29, P2452, DOI 10.1093/bioinformatics/btt414; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Li XB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132813; Mitra K, 2013, NAT REV GENET, V14, P719, DOI 10.1038/nrg3552; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; Page L., 1999, 199966 STANF INFOLAB, P1999; Paull EO, 2013, BIOINFORMATICS, V29, P2757, DOI 10.1093/bioinformatics/btt471; Rahnenfuhrer J, 2004, STAT APPL GENET MOL, V3; Reddy J.N., 2010, FINITE ELEMENT METHO; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarca AL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-136; Team RC., 2013, R LANG ENV STAT COMP; Vandin F, 2011, J COMPUT BIOL, V18, P507, DOI 10.1089/cmb.2010.0265; Vinaixa M, 2016, TRAC-TREND ANAL CHEM, V78, P23, DOI 10.1016/j.trac.2015.09.005; Weckwerth W, 2003, ANNU REV PLANT BIOL, V54, P669, DOI 10.1146/annurev.arplant.54.031902.135014; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2010, NUCLEIC ACIDS RES, V38, pW71, DOI 10.1093/nar/gkq329	42	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0189012	10.1371/journal.pone.0189012	http://dx.doi.org/10.1371/journal.pone.0189012			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211807	gold, Green Published, Green Submitted			2022-12-27	WOS:000417212200055
J	Chancharoenthana, W; Leelahavanichkul, A; Taratummarat, S; Wongphom, J; Tiranathanagul, K; Eiam-Ong, S				Chancharoenthana, Wiwat; Leelahavanichkul, Asada; Taratummarat, Sujittra; Wongphom, Jutamas; Tiranathanagul, Khajohn; Eiam-Ong, Somchai			Cilostazol attenuates intimal hyperplasia in a mouse model of chronic kidney disease	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; ENDOTHELIAL-GROWTH-FACTOR; CORONARY STENT IMPLANTATION; NEOINTIMAL LESION FORMATION; ARTERY-DISEASE; DEPENDENT MECHANISM; MICRORNA CONTROL; BALLOON INJURY; POTENTIAL ROLE; CELLS	Intimal hyperplasia (IH) is a common cause of vasculopathy due to direct endothelial damage (such as post-coronary revascularization) or indirect injury (such as chronic kidney disease, or CKD). Although the attenuation of coronary revascularization-induced IH (direct-vascular-injury-induced IH) by cilostazol, a phosphodiesterase III inhibitor, has been demonstrated, our understanding of the effect on CKD-induced IH (indirect-vascular-injuryinduced IH) is limited. Herein, we tested if cilostazol attenuated CKD-induced IH in a mouse model of ischemic-reperfusion injury with unilateral nephrectomy (ChrI/R), a normotensive non-proteinuria CKD model. Cilostazol (50 mg/kg/day) or placebo was orally administered once daily from 1-week post-nephrectomy. At 20 weeks, cilostazol significantly attenuated aortic IH as demonstrated by a 34% reduction in the total intima area with 50% and 47% decreases in the ratios of tunica intima area/tunica media area and tunica intima area/(tunicaintima + tunica media area), respectively. The diameters of aorta and renal function were unchanged by cilostazol. Interestingly, cilostazol decreased miR-221, but enhanced miR143 and miR-145 in either in vitro or aortic tissue, as well as attenuated several pro-inflammatory mediators, including asymmetrical dimethylarginine, high-sensitivity C-reactive protein, vascular endothelial growth factor in aorta and serum pro-inflammatory cytokines (IL-6 and TNF-alpha). We demonstrated a proof of concept of the effectiveness of cilostazol in attenuating IH in a Chr I/R mouse model, a CKD model with predominantly indirect-vascular- injury-induced IH. These considerations warrant further investigation to develop a new primary prevention strategy for CKD-related IH.	[Chancharoenthana, Wiwat; Tiranathanagul, Khajohn; Eiam-Ong, Somchai] Chulalongkorn Univ, Fac Med, Dept Med, Div Nephrol, Bangkok, Thailand; [Chancharoenthana, Wiwat; Tiranathanagul, Khajohn; Eiam-Ong, Somchai] Thai Red Cross Soc, King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Chancharoenthana, Wiwat] CRA, HRH Princess Chulabhorn Coll Med Sci, Chulabhorn Hosp, Dept Med,Div Nephrol & Hypertens,Sect Intervent N, Bangkok, Thailand; [Leelahavanichkul, Asada; Taratummarat, Sujittra] Chulalongkorn Univ, Dept Microbiol, Fac Med, Bangkok, Thailand; [Leelahavanichkul, Asada] Chulalongkorn Univ, Dept Microbiol, Ctr Excellence Immunol & Immune Mediated Dis, Bangkok, Thailand; [Wongphom, Jutamas] Chulalongkorn Univ, Dept Pathol, Fac Med, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; Chulabhorn Research Institute; Chulabhorn Royal Academy; Chulabhorn Hospital; HRH Princess Chulabhorn College of Medical Science; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Leelahavanichkul, A (corresponding author), Chulalongkorn Univ, Dept Microbiol, Fac Med, Bangkok, Thailand.; Leelahavanichkul, A (corresponding author), Chulalongkorn Univ, Dept Microbiol, Ctr Excellence Immunol & Immune Mediated Dis, Bangkok, Thailand.	a_leelahavanit@yahoo.com	Chancharoenthana, Wiwat/ABA-8259-2021	Chancharoenthana, Wiwat/0000-0002-2965-146X	Ratchadapiseksomphot Research Grant, Faculty of Medicine, Chulalongkorn University [RA57/055]	Ratchadapiseksomphot Research Grant, Faculty of Medicine, Chulalongkorn University	This work was supported by the Ratchadapiseksomphot Research Grant (RA57/055), Faculty of Medicine, Chulalongkorn University.	Aoki M, 2001, DIABETOLOGIA, V44, P1034, DOI 10.1007/s001250100593; Aoki M, 1999, HYPERTENSION, V34, P192, DOI 10.1161/01.HYP.34.2.192; Baldus S, 2006, CIRCULATION, V113, P1871, DOI 10.1161/CIRCULATIONAHA.105.590083; BANAI S, 1994, CIRCULATION, V89, P2183, DOI 10.1161/01.CIR.89.5.2183; Biscetti F, 2013, INT J CARDIOL, V167, P910, DOI 10.1016/j.ijcard.2012.03.103; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Chancharoenthana W, 2013, THER APHER DIAL, V17, P557, DOI 10.1111/1744-9987.12016; Chen CY, 1997, J SURG RES, V67, P106, DOI 10.1006/jsre.1996.4922; Chen LJ, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-79; Chen ZM, 2006, MOL PHARMACOL, V69, P1527, DOI 10.1124/mol.105.020172; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Chitalia N, 2015, SEMIN DIALYSIS, V28, pE35, DOI 10.1111/sdi.12335; Dang LTH, 2013, ARTERIOSCL THROM VAS, V33, P193, DOI 10.1161/ATVBAHA.112.300142; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Ferrara N, 1999, KIDNEY INT, V56, P794, DOI 10.1046/j.1523-1755.1999.00610.x; Fischer JW, 2004, J VASC SURG, V40, P115, DOI 10.1016/j.jvs.2004.03.037; Fleissner F, 2010, CIRC RES, V107, P138, DOI 10.1161/CIRCRESAHA.110.216770; Grenda R, 2007, NEPHROL DIAL TRANSPL, V22, P3487, DOI 10.1093/ndt/gfm300; Heinen Y, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001472; Hori A, 2012, EUR J VASC ENDOVASC, V43, P62, DOI 10.1016/j.ejvs.2011.07.015; Iida O, 2013, CIRCULATION, V127, P2307, DOI 10.1161/CIRCULATIONAHA.112.000711; Inoue T, 2004, J AM COLL CARDIOL, V44, P1408, DOI 10.1016/j.jacc.2004.06.066; Ishii H, 2008, CLIN J AM SOC NEPHRO, V3, P1034, DOI 10.2215/CJN.05761207; Jeong SJ, 2013, CRIT CARE, V17, DOI 10.1186/cc12742; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kamishirado H, 2002, AM HEART J, V144, P303, DOI 10.1067/mhj.2002.122874; Knight EL, 2004, J AM SOC NEPHROL, V15, P1897, DOI 10.1097/01.asn.0000128966.55133.69; Lee HT, 2007, AM J PHYSIOL-RENAL, V293, pF713, DOI 10.1152/ajprenal.00161.2007; Leelahavanichkul A, 2015, HEPATOL RES, V45, P1341, DOI 10.1111/hepr.12501; Leelahavanichkul A, 2010, KIDNEY INT, V78, P1136, DOI 10.1038/ki.2010.287; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Malabanan KP, 2008, CIRC RES, V103, P378, DOI 10.1161/CIRCRESAHA.107.168682; Marschner JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149489; Masuda H, 1999, BRIT J PHARMACOL, V126, P211, DOI 10.1038/sj.bjp.0702298; Minami Y, 2009, EUR J CLIN INVEST, V39, P359, DOI 10.1111/j.1365-2362.2009.02110.x; MOLLER JC, 1985, VIRCHOWS ARCH A, V406, P389, DOI 10.1007/BF00710231; Nakamura T, 2001, LIFE SCI, V69, P1709, DOI 10.1016/S0024-3205(01)01258-9; Qiu JH, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0852; Quintavalle M, 2010, J CELL BIOL, V189, P13, DOI 10.1083/jcb.200912096; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Ravani P, 2005, J AM SOC NEPHROL, V16, P2449, DOI 10.1681/ASN.2005010076; Rogers M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000481; Seujange Y, 2013, RENAL FAILURE, V35, P118, DOI 10.3109/0886022X.2012.741468; Song ZF, 2010, J CARDIOVASC TRANSL, V3, P246, DOI 10.1007/s12265-010-9163-0; TANAKA T, 1988, PHARMACOLOGY, V36, P313, DOI 10.1159/000138400; Tseng CN, 2015, THROMB HAEMOSTASIS, V113, P813, DOI 10.1160/TH14-07-0608; Tsuchikane E, 1999, CIRCULATION, V100, P21, DOI 10.1161/01.CIR.100.1.21; Tsuchikane E, 1998, AM HEART J, V135, P495, DOI 10.1016/S0002-8703(98)70327-8; van der Zwan LP, 2011, CLIN SCI, V121, P71, DOI 10.1042/CS20100595; Wasse H, 2012, J VASC ACCESS, V13, P168, DOI 10.5301/jva.5000024; Yamamoto Kiyohito, 2007, Ann Thorac Cardiovasc Surg, V13, P322; Yang J, 2006, AM J PHYSIOL-HEART C, V291, pH3087, DOI 10.1152/ajpheart.00412.2006	52	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0187872	10.1371/journal.pone.0187872	http://dx.doi.org/10.1371/journal.pone.0187872			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206849	gold, Green Published, Green Submitted			2022-12-27	WOS:000417110700006
J	Arena, R; Zacchini, F; Toschi, P; Palazzese, L; Czernik, M; Ptak, GE				Arena, Roberta; Zacchini, Federica; Toschi, Paola; Palazzese, Luca; Czernik, Marta; Ptak, Grazyna Ewa			Developmental peculiarities in placentae of ovine uniparental conceptuses	PLOS ONE			English	Article							IMPRINTED GENES; GIANT-CELLS; SHEEP; MOUSE; EXPRESSION; VASCULOGENESIS; ANGIOGENESIS; DISRUPTION; PREGNANCY; EMBRYOS	Genomic imprinting is an epigenetic phenomenon regulating mono-allelic expression of genes depending on their parental origin. Defective genomic imprinting is involved in several placental disorders, such as intrauterine growth restriction and pre-eclampsia. Uniparental embryos, having maternal-only or paternal-only genomes (parthenogenotes [ PAR] and androgenotes [ AND], respectively), are useful models to study placentation. The aim of this work was to reveal the effect of parental genome (maternal and paternal) on placentation. To do this, uniparental (AND and PAR) and biparental (CTR) in vitro produced sheep embryos transferred to recipient females were collected at day 20 of pregnancy and their placentae were analyzed. qPCR analysis showed that imprinted genes (H19, IGF2R and DLK1) were expressed accordingly to their parental origin while the expression f DNA methyltransferases () was disregulated, especially in PAR (P < 0.05). AND placentae were significantly hypomethylated compared to both PAR and CTR (P = 0.023). Chorion-allantoid of AND showed impaired development of vessels and reduced mRNA expression of vasculogenetic factors (ANG2 P = 0.05; VEGFR2 P< 0.001; TIE2 P < 0.001). Morphologically, PAR placentae were characterized by abnormal structure of the trophoectodermal epithelium and reduced total number (P< 0.03) of Trophoblastic Binucleate Cells. A reduced implantation rate of both classes of uniparental embryos (P< 0.03) was also noted. Our results provide new insights into the characterization of uniparental embryos and demonstrate the complementary role of parental genomes for the correct establishment of pregnancy. Thus, our findings may suggest new targets to improve our understanding of the origin of imprinting-related placental dysfunction.	[Arena, Roberta; Zacchini, Federica; Ptak, Grazyna Ewa] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Expt Embryol, Jastrzebiec, Poland; [Toschi, Paola; Palazzese, Luca; Czernik, Marta; Ptak, Grazyna Ewa] Univ Teramo, Fac Vet Med, Teramo, Italy; [Ptak, Grazyna Ewa] Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland	Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; University of Teramo; Jagiellonian University	Ptak, GE (corresponding author), Polish Acad Sci, Inst Genet & Anim Breeding, Dept Expt Embryol, Jastrzebiec, Poland.; Ptak, GE (corresponding author), Univ Teramo, Fac Vet Med, Teramo, Italy.; Ptak, GE (corresponding author), Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland.	g.ptak@uj.edu.pl	Palazzese, Luca/AAI-6008-2020; Zacchini, Federica/GQY-5276-2022; Arena, Ross/A-3141-2008	Palazzese, Luca/0000-0002-3842-8438; Zacchini, Federica/0000-0001-7942-2625; Arena, Ross/0000-0002-6675-1996; TOSCHI, PAOLA/0000-0003-0963-7254; CZERNIK, Marta Teresa/0000-0002-4535-4932	European Union's Horizon Research and Innovation Programme [692185]; European Union Seventh Framework Programme for research, technological development and demonstration [312097]; European Research Council Programme IDEAS [210103]; Polish National Science Center [2015/19/D/NZ4/03696]	European Union's Horizon Research and Innovation Programme; European Union Seventh Framework Programme for research, technological development and demonstration; European Research Council Programme IDEAS; Polish National Science Center	The research leading to these results received funding from the European Union's Horizon 2020 Research and Innovation Programme under grant agreement No 692185 (Acronym ERAofART) and European Union Seventh Framework Programme for research, technological development and demonstration GA 312097 (Acronym FECUND) and the European Research Council Programme IDEAS GA 210103 (Acronym ANGIOPLACE) to GEP. This study was also partially financed by the Polish National Science Center GA 2015/19/D/NZ4/03696 to FZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiolini E, 2011, FASEB J, V25, P1737, DOI 10.1096/fj.10-175273; Barry JS, 2008, THERIOGENOLOGY, V69, P55, DOI 10.1016/j.theriogenology.2007.09.021; Barry JS, 2008, SEMIN PERINATOL, V32, P225, DOI 10.1053/j.semperi.2007.11.004; Bressan FF, 2009, PLACENTA, V30, P823, DOI 10.1016/j.placenta.2009.07.007; Charnock-Jones DS, 2004, PLACENTA, V25, P103, DOI 10.1016/j.placenta.2003.10.004; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Constancia M, 2004, NATURE, V432, P53, DOI 10.1038/432053a; de Waal E, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114785; Demir R, 2007, ACTA HISTOCHEM, V109, P257, DOI 10.1016/j.acthis.2007.02.008; Diplas AI, 2009, EPIGENETICS-US, V4, P235, DOI 10.4161/epi.9019; Fowden AL, 2006, HORM RES, V65, P50, DOI 10.1159/000091506; Frost JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001015; Grazul-Bilska AT, 2013, THERIOGENOLOGY, V79, P94, DOI 10.1016/j.theriogenology.2012.09.013; Gutierrez-Marcos JF, 2012, PLACENTA, V33, pE3, DOI 10.1016/j.placenta.2012.08.006; HOFFMAN LH, 1993, J EXP ZOOL, V266, P559, DOI 10.1002/jez.1402660607; Lagutina I, 2004, BIOL REPROD, V70, P400, DOI 10.1095/biolreprod.103.021972; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Mochizuki M, 1992, Nihon Sanka Fujinka Gakkai Zasshi, V44, P918; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Nelissen ECM, 2014, HUM REPROD, V29, P2821, DOI 10.1093/humrep/deu241; NewmanSmith E, 1997, DEV GENET, V20, P1, DOI 10.1002/(SICI)1520-6408(1997)20:1&lt;1::AID-DVG1&gt;3.0.CO;2-B; Ogawa H, 2009, PLACENTA, V30, P448, DOI 10.1016/j.placenta.2009.02.006; Ogawa H, 2006, FEBS LETT, V580, P5377, DOI 10.1016/j.febslet.2006.08.087; Ptak G, 2002, BIOL REPROD, V67, P1719, DOI 10.1095/biolreprod.102.006171; Ptak GE, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140027; Ptak GE, 2013, HUM REPROD, V28, P298, DOI 10.1093/humrep/des397; Srivastava M, 2003, J BIOL CHEM, V278, P5977, DOI 10.1074/jbc.M208437200; SURANI MAH, 1986, CELL, V45, P127, DOI 10.1016/0092-8674(86)90544-1; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Thurston A, 2008, REPRODUCTION, V135, P29, DOI 10.1530/REP-07-0211; WIMSATT WA, 1951, AM J ANAT, V89, P233, DOI 10.1002/aja.1000890204; Yu L, 2009, PLACENTA, V30, P443, DOI 10.1016/j.placenta.2009.02.011; Zacchini F, 2011, CELL REPROGRAM, V13, P495, DOI 10.1089/cell.2011.0021	34	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188278	10.1371/journal.pone.0188278	http://dx.doi.org/10.1371/journal.pone.0188278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190766	Green Published, gold			2022-12-27	WOS:000416841900043
J	Nomura, Y; Morozumi, T; Nakagawa, T; Sugaya, T; Kawanami, M; Suzuki, F; Takahashi, K; Abe, Y; Sato, S; Makino-Oi, A; Saito, A; Takano, S; Minabe, M; Nakayama, Y; Ogata, Y; Kobayashi, H; Izumi, Y; Sugano, N; Ito, K; Sekino, S; Numabe, Y; Fukaya, C; Yoshinari, N; Fukuda, M; Noguchi, T; Kono, T; Umeda, M; Fujise, O; Nishimura, F; Yoshimura, A; Hara, Y; Nakamura, T; Noguchi, K; Kakuta, E; Hanada, N; Takashiba, S; Amitani, Y; Yoshie, H				Nomura, Yoshiaki; Morozumi, Toshiya; Nakagawa, Taneaki; Sugaya, Tsutomu; Kawanami, Masamitsu; Suzuki, Fumihiko; Takahashi, Keiso; Abe, Yuzo; Sato, Soh; Makino-Oi, Asako; Saito, Atsushi; Takano, Satomi; Minabe, Masato; Nakayama, Yohei; Ogata, Yorimasa; Kobayashi, Hiroaki; Izumi, Yuichi; Sugano, Naoyuki; Ito, Koichi; Sekino, Satoshi; Numabe, Yukihiro; Fukaya, Chie; Yoshinari, Nobuo; Fukuda, Mitsuo; Noguchi, Toshihide; Kono, Tomoo; Umeda, Makoto; Fujise, Osamu; Nishimura, Fusanori; Yoshimura, Atsutoshi; Hara, Yoshitaka; Nakamura, Toshiaki; Noguchi, Kazuyuki; Kakuta, Erika; Hanada, Nobuhiro; Takashiba, Shogo; Amitani, Yasuharu; Yoshie, Hiromasa			Site-level progression of periodontal disease during a follow-up period	PLOS ONE			English	Article							MULTILEVEL ANALYSIS; STATISTICAL-MODELS; NATURAL-HISTORY; ATTACHMENT LOSS; TOOTH LOSS; THERAPY; RISK; QUANTIFICATION; DESTRUCTION; STABILITY	Periodontal disease is assessed and its progression is determined via observations on a site-by-site basis. Periodontal data are complex and structured in multiple levels; thus, applying a summary statistical approach (i.e., the mean) for site-level evaluations results in loss of information. Previous studies have shown the availability of mixed effects modeling. However, clinically beneficial information on the progression of periodontal disease during the follow-up period is not available. We conducted a multicenter prospective cohort study. Using mixed effects modeling, we analyzed 18,834 sites distributed on 3,139 teeth in 124 patients, and data were collected 5 times over a 24-month follow-up period. The change in the clinical attachment level (CAL) was used as the outcome variable. The CAL at baseline was an important determinant of the CAL changes, which varied widely according to the tooth surface. The salivary levels of periodontal pathogens, such as Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans, were affected by CAL progression. "Linear"-and "burst"-type patterns of CAL progression occurred simultaneously within the same patient. More than half of the teeth that presented burst-type progression sites also presented linear-type progression sites, and most of the progressions were of the linear type. Maxillary premolars and anterior teeth tended to show burst-type progression. The parameters identified in this study may guide practitioners in determining the type and extent of treatment needed at the site and patient levels. In addition, these results show that prior hypotheses concerning "burst" and "linear" theories are not valid.	[Nomura, Yoshiaki; Hanada, Nobuhiro] Tsurumi Univ, Sch Dent Med, Dept Translat Res, Yokohama, Kanagawa, Japan; [Morozumi, Toshiya; Yoshie, Hiromasa] Niigata Univ, Grad Sch Med & Dent Sci, Div Periodontol, Dept Oral Biol Sci, Niigata, Japan; [Nakagawa, Taneaki; Fukaya, Chie] Keio Univ, Dept Dent & Oral Surg, Sch Med, Tokyo, Japan; [Sugaya, Tsutomu; Kawanami, Masamitsu] Hokkaido Univ, Div Periodontol & Endodontol, Dept Oral Hlth Sci, Grad Sch Dent Med, Sapporo, Hokkaido, Japan; [Suzuki, Fumihiko] Ohu Univ, Sch Dent, Div Dent Anesthesiol, Dept Oral Surg, Koriyama, Japan; [Takahashi, Keiso] Ohu Univ, Sch Dent, Div Periodont, Dept Conservat Dent, Koriyama, Japan; [Abe, Yuzo] Nippon Dent Univ, Comprehens Dent Care, Niigata Hosp, Niigata, Japan; [Sato, Soh] Nippon Dent Univ, Sch life Dent Niigata, Dept Periodontol, Niigata, Japan; [Makino-Oi, Asako; Saito, Atsushi] Tokyo Dent Coll, Dept Periodontol, Tokyo, Japan; [Takano, Satomi; Minabe, Masato] Bunkyo Dori Dent Clin, Chiba, Japan; [Minabe, Masato] Kanagawa Dent Univ, Div Periodontol, Dept Oral Interdisciplinary Med, Sch Dent, Yokosuka, Kanagawa, Japan; [Nakayama, Yohei; Ogata, Yorimasa] Nihon Univ, Sch Dent, Dept Periodontol, Matsudo, Chiba, Japan; [Kobayashi, Hiroaki; Izumi, Yuichi] Tokyo Med & Dent Univ, Dept Periodontol, Grad Sch Med & Dent Sci, Tokyo, Japan; [Sugano, Naoyuki] Nihon Univ, Sch Dent, Dept Periodontol, Tokyo, Japan; [Ito, Koichi] Nihon Univ, Sch Dent, Tokyo, Japan; [Sekino, Satoshi; Numabe, Yukihiro] Nippon Dent Univ Tokyo, Sch Life Dent, Dept Periodontol, Tokyo, Japan; [Yoshinari, Nobuo] Matsumoto Dent Univ, Sch Dent, Dept Periodontol, Shiojiri, Japan; [Fukuda, Mitsuo; Noguchi, Toshihide] Aichi Gakuin Univ, Sch Dent, Dept Periodontol, Nagoya, Aichi, Japan; [Kono, Tomoo; Umeda, Makoto] Osaka Dent Univ, Dept Periodontol, Osaka, Japan; [Fujise, Osamu; Nishimura, Fusanori] Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Sect Periodontol, Fukuoka, Japan; [Yoshimura, Atsutoshi; Hara, Yoshitaka] Nagasaki Univ, Grad Sch Biomed Sci, Unit Translat Med, Dept Periodontol, Nagasaki, Japan; [Nakamura, Toshiaki; Noguchi, Kazuyuki] Kagoshima Univ, Dept Periodontol, Grad Sch Med & Dent Sci, Kagoshima, Japan; [Kakuta, Erika] Tsurumi Univ, Sch Dent Med, Dept Oral Microbiol, Yokohama, Kanagawa, Japan; [Takashiba, Shogo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathophysiol Periodontal Sci, Okayama, Japan; [Amitani, Yasuharu] Tsurumi Univ, Sch Dent Med, Dept Math, Yokohama, Kanagawa, Japan	Tsurumi University; Niigata University; Keio University; Hokkaido University; Nippon Dental University; Nippon Dental University; Tokyo Dental College; Kanagawa Dental College; Nihon University; Tokyo Medical & Dental University (TMDU); Nihon University; Nihon University; Nippon Dental University; Matsumoto Dental University; Aichi Gakuin University; Kyushu University; Nagasaki University; Kagoshima University; Tsurumi University; Okayama University; Tsurumi University	Nomura, Y (corresponding author), Tsurumi Univ, Sch Dent Med, Dept Translat Res, Yokohama, Kanagawa, Japan.	nomura-y@tsurumi-u.ac.jp	Numabe, Yukihiro/AAV-2060-2020; Kobayashi, Hiroaki/AAG-6812-2019; Yoshinari, Nobuo/AAI-4494-2020; Takashiba, Shogo/C-9830-2010; Hanada, Nobuhiro/C-5308-2011; Suzuki, Fumihiko/AAI-8737-2021; Sekino, Satoshi/AAV-4370-2020; Hanada, Nobuhiro/HHM-6735-2022	Takashiba, Shogo/0000-0002-4712-6829; Suzuki, Fumihiko/0000-0002-5156-9729; Hanada, Nobuhiro/0000-0002-9130-7256; Nomura, Yoshiaki/0000-0002-0814-0572; Yoshinari, Nobuo/0000-0003-4248-1415	Japanese Society of Periodontology	Japanese Society of Periodontology	This study was supported by a grant of the clinical research project for the diagnosis of periodontitis from the Japanese Society of Periodontology.	ALBANDAR JM, 1992, J PERIODONTOL, V63, P690, DOI 10.1902/jop.1992.63.8.690; ALLEN KM, 1995, J PERIODONTAL RES, V30, P15, DOI 10.1111/j.1600-0765.1995.tb01248.x; Armitage GC, 1996, PERIODONTOL 2000, V12, P33, DOI 10.1111/j.1600-0757.1996.tb00078.x; Axtelius B, 1997, J CLIN PERIODONTOL, V24, P646, DOI 10.1111/j.1600-051X.1997.tb00243.x; Axtelius B, 1999, J CLIN PERIODONTOL, V26, P67, DOI 10.1034/j.1600-051X.1999.260202.x; BECK JD, 1994, J PERIODONTOL, V65, P468, DOI 10.1902/jop.1994.65.5s.468; Buchmann R, 2000, J PERIODONTOL, V71, P444, DOI 10.1902/jop.2000.71.3.444; Cattabriga M, 1996, Quintessence Int, V27, P395; Cattabriga M, 2001, J PERIODONTOL, V72, P767, DOI 10.1902/jop.2001.72.6.767; Cho YI, 2015, J PERIODONTAL IMPLAN, V45, P2, DOI 10.5051/jpis.2015.45.1.2; CLAFFEY N, 1995, J CLIN PERIODONTOL, V22, P690, DOI 10.1111/j.1600-051X.1995.tb00828.x; COHEN ME, 1993, J PERIODONTAL RES, V28, P429, DOI 10.1111/jre.1993.28.6.429; COHEN ME, 1988, J PERIODONTOL, V59, P254, DOI 10.1902/jop.1988.59.4.254; De Sanctis M, 2000, J PERIODONTOL, V71, P606, DOI 10.1902/jop.2000.71.4.606; Eickholz P, 2008, J CLIN PERIODONTOL, V35, P165, DOI 10.1111/j.1600-051X.2007.01184.x; Gilthorpe MS, 2003, J DENT RES, V82, P200, DOI 10.1177/154405910308200310; HAFFAJEE AD, 1985, J CLIN PERIODONTOL, V12, P553, DOI 10.1111/j.1600-051X.1985.tb01389.x; HAFFAJEE AD, 1986, J CLIN PERIODONTOL, V13, P461, DOI 10.1111/j.1600-051X.1986.tb01491.x; Hujoel PP, 1998, J PERIODONTOL, V69, P357, DOI 10.1902/jop.1998.69.3.357; JOSS A, 1994, J CLIN PERIODONTOL, V21, P402, DOI 10.1111/j.1600-051X.1994.tb00737.x; Kakuta E, 2017, BMC ORAL HEALTH, V17, DOI 10.1186/s12903-017-0337-x; Konig J, 2002, J CLIN PERIODONTOL, V29, P1092, DOI 10.1034/j.1600-051X.2002.291208.x; Konig J, 2001, J CLIN PERIODONTOL, V28, P227, DOI 10.1034/j.1600-051x.2001.028003227.x; Krebs KA, 2006, J PERIODONTOL, V77, P1607, DOI 10.1902/jop.2006.069001; Kudo C, 2012, J DENT RES, V91, P1190, DOI 10.1177/0022034512461796; Lang Niklaus P, 2003, Oral Health Prev Dent, V1, P7; LANG NP, 1990, J CLIN PERIODONTOL, V17, P714, DOI 10.1111/j.1600-051X.1990.tb01059.x; LANG NP, 1986, J CLIN PERIODONTOL, V13, P590, DOI 10.1111/j.1600-051X.1986.tb00852.x; LINDHE J, 1983, J CLIN PERIODONTOL, V10, P433, DOI 10.1111/j.1600-051X.1983.tb01292.x; LOE H, 1978, J PERIODONTOL, V49, P607, DOI 10.1902/jop.1978.49.12.607; LOE H, 1992, J PERIODONTOL, V63, P489; Mancl LA, 2000, J DENT RES, V79, P1778, DOI 10.1177/00220345000790100801; Morozumi T, 2016, J PERIODONTAL RES, V51, P768, DOI 10.1111/jre.12353; MUHLEMANN HR, 1951, ORAL SURG ORAL MED O, V4, P1220, DOI 10.1016/0030-4220(51)90080-1; Nieri M, 2002, J PERIODONTOL, V73, P1485, DOI 10.1902/jop.2002.73.12.1485; Niklaus P., 2015, CLIN PERIODONTOLOGY; Nomura Y, 2012, ARCH ORAL BIOL, V57, P413, DOI 10.1016/j.archoralbio.2011.09.011; Ogawa H, 2002, J CLIN PERIODONTOL, V29, P592, DOI 10.1034/j.1600-051X.2002.290702.x; OSBORN J, 1987, J CLIN PERIODONTOL, V14, P519, DOI 10.1111/j.1600-051X.1987.tb00993.x; Persson GR, 2005, PERIODONTOL 2000, V39, P145, DOI 10.1111/j.1600-0757.2005.00130.x; RALLS SA, 1986, J PERIODONTOL, V57, P746, DOI 10.1902/jop.1986.57.12.746; Ramberg P, 2001, J CLIN PERIODONTOL, V28, P446, DOI 10.1034/j.1600-051x.2001.028005446.x; Socransky S S, 1997, Ann Periodontol, V2, P3; SOCRANSKY SS, 1984, J CLIN PERIODONTOL, V11, P21, DOI 10.1111/j.1600-051X.1984.tb01305.x; STERNE JAC, 1990, J CLIN PERIODONTOL, V17, P129, DOI 10.1111/j.1600-051X.1990.tb01076.x; Tada A, 2012, JPN J INFECT DIS, V65, P415, DOI 10.7883/yoken.65.415; Tadokoro K, 2010, MICROBIOL RES, V165, P43, DOI 10.1016/j.micres.2008.06.001; Tonetti MS, 2005, J CLIN PERIODONTOL, V32, P210, DOI 10.1111/j.1600-051X.2005.00822.x; Tu YK, 2004, J PERIODONTOL, V75, P137, DOI 10.1902/jop.2004.75.1.137; Tu YK, 2004, J PERIODONTOL, V75, P127, DOI 10.1902/jop.2004.75.1.127	50	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188670	10.1371/journal.pone.0188670	http://dx.doi.org/10.1371/journal.pone.0188670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29206238	Green Published, Green Submitted, gold			2022-12-27	WOS:000417033200011
J	Baczkiewicz, A; Szczecinska, M; Sawicki, J; Stebel, A; Buczkowska, K				Baczkiewicz, Alina; Szczecinska, Monika; Sawicki, Jakub; Stebel, Adam; Buczkowska, Katarzyna			DNA barcoding, ecology and geography of the cryptic species of Aneura pinguis and their relationships with Aneura maxima and Aneura mirabilis (Metzgeriales, Marchantiophyta)	PLOS ONE			English	Article							INTEGRATIVE TAXONOMY; PLASTID GENOME; GENE LOSSES; LIVERWORT; JUNGERMANNIOPSIDA; DELIMITATION; SPECIATION; COMPLEX; MARKERS; BRYOPHYTES	Aneura pinguis is a thalloid liverwort species with broad geographical distribution. It is composed of cryptic species, however, the number of cryptic species within A. pinguis is not known. Five cpDNA regions (matK, rbcL, rpoC1, trnH-psbA and trnL-trnF) and the entire nuclear ITS region were studied in 130 samples of A. pinguis from different geographical regions. The relationships between the cryptic species of A. pinguis, A. maxima and A. mirabilis were analyzed. All of the examined samples were clustered into 10 clades corresponding to 10 cryptic species of A. pinguis (marked A to J). Aneura mirabilis and A. maxima were nested among different cryptic species of A. pinguis, which indicates that A. pinguis is a paraphyletic taxon. Subgroups were found in cryptic species A, B, C and E. As single barcodes, all tested DNA regions had 100% discriminant power and fulfilled DNA barcode criteria for species identification; however, the only combination detected in all subgroups was trnL-trnF with trnH-psbA or ITS2. The distances between cryptic species were 11- to 35-fold higher than intraspecific distances. In all analyzed DNA regions, the distances between most pairs of cryptic A. pinguis species were higher than between A. maxima and A. mirabilis. All cryptic species of A. pinguis clearly differed in their habitat preferences, which suggests that habitat adaptation could be the main driving force behind cryptic speciation within this taxon.	[Baczkiewicz, Alina; Buczkowska, Katarzyna] Adam Mickiewicz Univ, Fac Biol, Dept Genet, Poznan, Poland; [Szczecinska, Monika; Sawicki, Jakub] Univ Warmia & Mazury, Dept Bot & Nat Protect, Olsztyn, Poland; [Stebel, Adam] Med Univ Silesia, Dept Pharmaceut Bot, Katowice, Poland	Adam Mickiewicz University; University of Warmia & Mazury; Medical University Silesia	Baczkiewicz, A (corresponding author), Adam Mickiewicz Univ, Fac Biol, Dept Genet, Poznan, Poland.	alinbacz@amu.edu.pl	Szczecinska, Monika/J-2400-2012; Sawicki, Jakub/H-4432-2012	Sawicki, Jakub/0000-0002-4759-8113; Stebel, Adam/0000-0003-2198-4216; Szczecinska, Monika/0000-0002-5377-4304	Polish National Science Centre [2011/01/B/NZ8/00364, 2013/09/B/NZ8/03274]	Polish National Science Centre	This work was supported by the Polish National Science Centre, grants no. 2011/01/B/NZ8/00364 (AB, KB, JS) and 2013/09/B/NZ8/03274 (AB, KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080563; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Baczkiewicz A., 2005, BIOL LETT, V42, P61; Baczkiewicz A, 2016, BIODIV RES CONSERV, V41, P1, DOI DOI 10.1515/BIORC-2016-0001; Baczkiewicz A, 2008, CRYPTOGAMIE BRYOL, V29, P3; Baczkiewicz A, 2016, CRYPTOGAMIE BRYOL, V37, P3, DOI 10.7872/cryb/v37.iss1.2016.3; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bell D, 2012, MOL ECOL RESOUR, V12, P36, DOI 10.1111/j.1755-0998.2011.03053.x; Buczkowska K, 2005, VARIABILITY EVOLUTIO, P97; Buczkowska K., 2006, BIOL LETT, V43, P51; Buczkowska K, 2006, CRYPTOGAMIE BRYOLOGI, V27, P1; Buczkowska K, 2016, BIOCHEM SYST ECOL, V68, P27, DOI 10.1016/j.bse.2016.06.013; Buczkowska K, 2012, PLANT SYST EVOL, V298, P549, DOI 10.1007/s00606-011-0565-5; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Damsholt K, 2002, ILLUSTRATED FLORA NO, p[654, 656]; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feldberg K, 2010, MOL PHYLOGENET EVOL, V55, P293, DOI 10.1016/j.ympev.2009.11.009; Furuki T, ANEURA CRATERIFORMIS; Hassel K, 2013, MOL ECOL RESOUR, V13, P1047, DOI 10.1111/1755-0998.12074; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Heinrichs J, 2015, TAXON, V64, P216, DOI 10.12705/642.5; Heinrichs J, 2011, AM J BOT, V98, P1252, DOI 10.3732/ajb.1100115; Heinrichs J, 2010, MOL PHYLOGENET EVOL, V56, P1105, DOI 10.1016/j.ympev.2010.05.004; Heinrichs J, 2009, MOL PHYLOGENET EVOL, V53, P113, DOI 10.1016/j.ympev.2009.05.032; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krawczyk K, 2014, MOL ECOL RESOUR, V14, P272, DOI 10.1111/1755-0998.12175; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Lang AS, 2014, POLAR BIOL, V37, P1157, DOI 10.1007/s00300-014-1509-7; Liu Y, 2010, J SYST EVOL, V48, P36, DOI 10.1111/j.1759-6831.2009.00063.x; Mayden R. L., 1997, V54, P381; Mayr E, SYSTEMATICS ORIGIN S; Medina R, 2012, TAXON, V61, P1180, DOI 10.1002/tax.616002; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Preussing M, 2010, TAXON, V59, P1424, DOI 10.1002/tax.595009; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ramaiya M, 2010, AM J BOT, V97, P1707, DOI 10.3732/ajb.1000171; Schuster RM., 1966, HEPATICAE ANTHOCEROT; Schuster RM, 1987, J HATTORI BOT LAB, V62, P299; Schuster RM, 1992, E HUNDREDTH MERIDIAN, V5; Singh D, 2016, J BRYOL, V38, P351; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Stech M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053134; Szweykowski J., 2006, BIODIVERSITY POLAND, V4, P13; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vanderpoorten A, 2010, PHYTOTAXA, V9, P229; Wachowiak W, 2007, BOT J LINN SOC, V155, P273, DOI 10.1111/j.1095-8339.2007.00692.x; Wawrzyniak R, 2014, PHYTOCHEMISTRY, V105, P115, DOI 10.1016/j.phytochem.2014.06.010; Wickett NJ, 2008, J MOL EVOL, V67, P111, DOI 10.1007/s00239-008-9133-1; Wickett NJ, 2008, MOL BIOL EVOL, V25, P393, DOI 10.1093/molbev/msm267; Wickett NJ, 2008, BOT J LINN SOC, V156, P1, DOI 10.1111/j.1095-8339.2007.00743.x; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878	59	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188837	10.1371/journal.pone.0188837	http://dx.doi.org/10.1371/journal.pone.0188837			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206876	Green Submitted, Green Published, gold			2022-12-27	WOS:000417110700028
J	Sanchez-Granero, MA; Trinidad-Segovia, JE; Clara-Rahola, J; Puertas, AM; De las Nieves, FJ				Sanchez-Granero, M. A.; Trinidad-Segovia, J. E.; Clara-Rahola, J.; Puertas, A. M.; De las Nieves, F. J.			A model for foreign exchange markets based on glassy Brownian systems	PLOS ONE			English	Article							RATE EXPECTATIONS; SPECULATIVE PRICES; STOCHASTIC-PROCESS; DISTRIBUTIONS; VOLATILITY; RATES; HETEROSCEDASTICITY; HYPOTHESIS; DEPENDENCE; VARIANCE	In this work we extend a well-known model from arrested physical systems, and employ it in order to efficiently depict different currency pairs of foreign exchange market price fluctuation distributions. We consider the exchange rate price in the time range between 2010 and 2016 at yearly time intervals and resolved at one minute frequency. We then fit the experimental datasets with this model, and find significant qualitative symmetry between price fluctuation distributions from the currency market, and the ones belonging to colloidal particles position in arrested states. The main contribution of this paper is a well-known physical model that does not necessarily assume the independent and identically distributed (i.i.d.) restrictive condition.	[Sanchez-Granero, M. A.] Univ Almeria, Dept Math, Almeria, Spain; [Trinidad-Segovia, J. E.] Univ Almeria, Dept Econ & Business, Almeria, Spain; [Clara-Rahola, J.; Puertas, A. M.; De las Nieves, F. J.] Univ Almeria, Dept Appl Phys, Almeria, Spain; [Clara-Rahola, J.] Open Univ Catalonia, Multidisciplinary Res Grp I2TiC, Barcelona, Spain	Universidad de Almeria; Universidad de Almeria; Universidad de Almeria; UOC Universitat Oberta de Catalunya	Sanchez-Granero, MA (corresponding author), Univ Almeria, Dept Math, Almeria, Spain.	misanche@ual.es	GRANERO, MIGUEL ANGEL SANCHEZ/J-9350-2014; TRINIDAD, JUAN E. E/K-7842-2012; Trinidad-Segovia, Juan E./K-5129-2019; Puertas, Antonio M/K-8962-2014	GRANERO, MIGUEL ANGEL SANCHEZ/0000-0001-9153-8321; Trinidad-Segovia, Juan E./0000-0002-5017-2615; Clara-Rahola, Joaquim/0000-0003-4909-6165; Puertas Lopez, Antonio Manuel/0000-0003-4127-1424	Universitat Oberta de Catalunya [N11-6139473]; Spanish Ministerio de Economia, Industria y Competitividad; European Regional Development Fund (ERDF) [DER2016-76053-R, FIS2015-69022-P, MTM2015-64373-P]; UOC [N11-6139473]	Universitat Oberta de Catalunya; Spanish Ministerio de Economia, Industria y Competitividad; European Regional Development Fund (ERDF)(European Commission); UOC	This work has been supported financially by the Universitat Oberta de Catalunya, under project N11-6139473, aimed at enhancing submission to H2020 calls, (J. C. -R.), the Spanish Ministerio de Economia, Industria y Competitividad and the European Regional Development Fund (ERDF) under projects No. DER2016-76053-R to J.E.T-S., FIS2015-69022-P to A.M.P. and MTM2015-64373-P to M.A.S-G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been supported financially by the UOC, under project N11-6139473, aimed at enhancing submission to H2020 calls, (J. C. -R.), the Spanish Ministerio de Economia, Industria y Competitividad and the European Regional Development Fund (ERDF) under projects No. DER2016-76053-R, FIS2015-69022-P and MTM2015-64373-P. The currency exchange data was provided by his tdata.com and oanda.com, which we acknowledge.	ALLEN H, 1990, ECON J, V100, P49, DOI 10.2307/2234183; [Anonymous], 1999, INTRO ECONOPHYSICS C; BarndorffNielsen OE, 1997, SCAND J STAT, V24, P1, DOI 10.1111/1467-9469.00045; Bouchaud J. P., 2000, THEORY FINANCIAL RIS; Boyarchenko S., 2000, INT J THEOR APPL FIN, V3, P549, DOI DOI 10.1142/S0219024900000541; Carr P, 2002, J BUS, V75, P305, DOI 10.1086/338705; Chaudhuri P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.060604; Cheung YW, 1999, ADV PAC BAS FINAN M, V5, P111; Cheung YW, 2000, J INT ECON, V51, P401, DOI 10.1016/S0022-1996(99)00009-4; Cheung YW, 1999, MACROECONOMIC IMPLIC; Clara-Rahola J, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.068301; CLARK PK, 1973, ECONOMETRICA, V41, P135, DOI 10.2307/1913889; Cont R, 2000, MACROECON DYN, V4, P170; Cont R., 2004, FINANCIAL MODELLING; DIEBOLD FX, 1989, J APPL ECONOM, V4, P1, DOI 10.1002/jae.3950040102; DIEBOLD FX, 1988, J BUS ECON STAT, V6, P105, DOI 10.2307/1391423; Eberlein E., 1995, BERNOULLI, V1, P281, DOI [DOI 10.2307/3318481), 10.2307/3318481, DOI 10.2307/3318481]; ENGLE RF, 1990, ECONOMETRICA, V58, P525, DOI 10.2307/2938189; EPPS TW, 1976, ECONOMETRICA, V44, P305, DOI 10.2307/1912726; European Central Bank, 2013, REP EUR CENTR BANK; Evans MDD, 2008, J FINANC ECON, V88, P26, DOI 10.1016/j.jfineco.2007.06.001; Evans MDD, 2002, J POLIT ECON, V110, P170, DOI 10.1086/324391; FAMA EF, 1965, J BUS, V38, P34, DOI 10.1086/294743; Flood RP, 1996, NBER CONF R, P261; Frankel J., 1995, HDB INT EC, V1st ed, P1689, DOI DOI 10.1016/S1573-4404(05)80013-9; Frankel J., 1990, R1655 NBER, P73; Frankel J., 1986, ECON REC, V62, P24; FRANKEL JA, 1990, AM ECON REV, V80, P181; FRANKEL JA, 1987, AM ECON REV, V77, P133; Gillespie DT, 1996, PHYS REV E, V54, P2084, DOI 10.1103/PhysRevE.54.2084; GOLDSTEIN M, 1969, J CHEM PHYS, V51, P3728, DOI 10.1063/1.1672587; HSIEH DA, 1989, J BUS ECON STAT, V7, P307, DOI 10.2307/1391528; HSIEH DA, 1988, J INT ECON, V24, P129, DOI 10.1016/0022-1996(88)90025-6; HSIEH DA, 1989, J BUS, V62, P339, DOI 10.1086/296466; ITO T, 1990, AM ECON REV, V80, P434; Kim YS, 2008, J BANK FINANC, V32, P1363, DOI 10.1016/j.jbankfin.2007.11.004; KOPONEN I, 1995, PHYS REV E, V52, P1197, DOI 10.1103/PhysRevE.52.1197; Kozubowski TJ, 1999, MATH COMPUT MODEL, V29, P241, DOI 10.1016/S0895-7177(99)00107-7; Kozubowski TJ, 1999, MATH COMPUT MODEL, V29, P83, DOI 10.1016/S0895-7177(99)00094-1; Kozubowski TJ, 2001, MATH COMPUT MODEL, V34, P1003, DOI 10.1016/S0895-7177(01)00114-5; Kugler P, 1990, SCHWEIZERISCHE Z VOL, V126, P113; Longin FM, 1969, J BUS, V69, P383; Lyons R. K., 2001, MICROSTRUCTURE APPRO; MADAN DB, 1987, J ROY STAT SOC B MET, V49, P163; MANDELBROT B, 1963, J BUS, V36, P394, DOI 10.1086/294632; Mandelbrot B., 2006, MISBEHAVIOR MARKETS; Masoliver J, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021112; Masoliver J, 2000, PHYSICA A, V283, P559, DOI 10.1016/S0378-4371(00)00117-5; Masoliver J, 2005, QUANTITATIVE FINANCE, V6, P423; MCCURDY TH, 1988, J APPL ECONOM, V3, P187, DOI 10.1002/jae.3950030303; McDonald J.B., 1996, HDB STAT, VVolume 14, P427; Menkhoff L, 1998, J INT MONEY FINANC, V17, P547, DOI 10.1016/S0261-5606(98)00016-3; Menkhoff L, 1997, INT J FINANC ECON, V2, P307, DOI 10.1002/(SICI)1099-1158(199710)2:4<307::AID-JFE54>3.0.CO;2-8; MILHOJ A, 1987, J BUS ECON STAT, V5, P99, DOI 10.2307/1391219; PRESS SJ, 1967, J BUS, V40, P317, DOI 10.1086/294980; Risken H., 1989, FOKKER PLANCK EQUATI, DOI DOI 10.1007/978-3-642-61544-3; Sarno L, 2001, MICROSTRUCTURE FOREI; TAKAGI S, 1991, INT MONET FUND S PAP, V38, P156; TAUCHEN GE, 1983, ECONOMETRICA, V51, P485, DOI 10.2307/1912002; TAYLOR MP, 1995, J ECON LIT, V33, P13; TAYLOR MP, 1992, J INT MONEY FINANC, V11, P304, DOI 10.1016/0261-5606(92)90048-3; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823	62	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188814	10.1371/journal.pone.0188814	http://dx.doi.org/10.1371/journal.pone.0188814			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO8CU	29206868	Green Submitted, Green Published, gold			2022-12-27	WOS:000417110700024
J	Thompson, KJ; Ingle, JN; Tang, XJ; Chia, N; Jeraldo, PR; Walther-Antonio, MR; Kandimalla, KK; Johnson, S; Yao, JZ; Harrington, SC; Suman, VJ; Wang, LW; Weinshilboum, RL; Boughey, JC; Kocher, JP; Nelson, H; Goetz, MP; Kalari, KR				Thompson, Kevin J.; Ingle, James N.; Tang, Xiaojia; Chia, Nicholas; Jeraldo, Patricio R.; Walther-Antonio, Marina R.; Kandimalla, Karunya K.; Johnson, Stephen; Yao, Janet Z.; Harrington, Sean C.; Suman, Vera J.; Wang, Liewei; Weinshilboum, Richard L.; Boughey, Judy C.; Kocher, Jean-Pierre; Nelson, Heidi; Goetz, Matthew P.; Kalari, Krishna R.			A comprehensive analysis of breast cancer microbiota and host gene expression	PLOS ONE			English	Article							ESTROGEN METABOLITES; CONTAMINATION; HALLMARKS; DATABASE; TISSUE	The inflammatory tumoral-immune response alters the physiology of the tumor microenvironment, which may attenuate genomic instability. In addition to inducing inflammatory immune responses, several pathogenic bacteria produce genotoxins. However the extent of microbial contribution to the tumor microenvironment biology remains unknown. We utilized The Cancer Genome Atlas, (TCGA) breast cancer data to perform a novel experiment utilizing unmapped and mapped RNA sequencing read evidence to minimize laboratory costs and effort. Our objective was to characterize the microbiota and associate the microbiota with the tumor expression profiles, for 668 breast tumor tissues and 72 non-cancerous adjacent tissues. The prominent presence of Proteobacteria was increased in the tumor tissues and conversely Actinobacteria abundance increase in non-cancerous adjacent tissues. Further, geneset enrichment suggests Listeria spp to be associated with the expression profiles of genes involved with epithelial to mesenchymal transitions. Moreover, evidence suggests H. influenza may reside in the surrounding stromal material and was significantly associated with the proliferative pathways: G2M checkpoint, E2F transcription factors, and mitotic spindle assembly. In summary, further unraveling this complicated interplay should enable us to better diagnose and treat breast cancer patients.	[Thompson, Kevin J.; Tang, Xiaojia; Johnson, Stephen; Suman, Vera J.; Kocher, Jean-Pierre; Kalari, Krishna R.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Thompson, Kevin J.; Tang, Xiaojia; Chia, Nicholas; Jeraldo, Patricio R.; Walther-Antonio, Marina R.; Johnson, Stephen; Yao, Janet Z.; Harrington, Sean C.; Kocher, Jean-Pierre; Kalari, Krishna R.] Mayo Clin, Dept Ctr Individualized Med, Rochester, MN 55905 USA; [Ingle, James N.; Goetz, Matthew P.] Mayo Clin, Dept Oncol, Rochester, MN USA; [Chia, Nicholas; Jeraldo, Patricio R.; Walther-Antonio, Marina R.; Boughey, Judy C.; Nelson, Heidi] Mayo Clin, Dept Surg, Rochester, MN USA; [Kandimalla, Karunya K.] Mayo Clin, Dept Pharmaceut, Rochester, MN USA; [Wang, Liewei; Weinshilboum, Richard L.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Kalari, KR (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA.; Kalari, KR (corresponding author), Mayo Clin, Dept Ctr Individualized Med, Rochester, MN 55905 USA.	Kalari.Krishna@mayo.edu	Goetz, Matthew P/AAH-2333-2020	Thompson, Kevin/0000-0002-9348-4686; Harrington, Jon/0000-0003-1293-5201; Kalari, Krishna/0000-0001-8944-8378; Walther-Antonio, Marina/0000-0002-5531-3712; Tang, Xiaojia/0000-0003-2457-9953	Mayo Clinic Breast Specialized Program of Research Excellence (SPORE) Career Enhancement Award [P50CA116201]; Mayo Clinic Center for Individualized Medicine; Division of Biostatistics and Informatics at the Mayo Clinic; NATIONAL CANCER INSTITUTE [P50CA116201] Funding Source: NIH RePORTER	Mayo Clinic Breast Specialized Program of Research Excellence (SPORE) Career Enhancement Award; Mayo Clinic Center for Individualized Medicine; Division of Biostatistics and Informatics at the Mayo Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the Mayo Clinic Breast Specialized Program of Research Excellence (SPORE) (P50CA116201) Career Enhancement Award, the Mayo Clinic Center for Individualized Medicine and by the Division of Biostatistics and Informatics at the Mayo Clinic.; Research reported in this publication was supported by the Mayo Clinic Breast Specialized Program of Research Excellence (SPORE) (P50CA116201) Career Enhancement Award, the Mayo Clinic Center for Individualized Medicine and by the Division of Biostatistics and Informatics at the Mayo Clinic. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson WF, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju165; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Baumgarten SC, 2012, MOL ENDOCRINOL, V26, P360, DOI 10.1210/me.2011-1302; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chan AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep28061; Chang SH, 2014, P NATL ACAD SCI USA, V111, P5664, DOI 10.1073/pnas.1319051111; Charrad M, 2014, J STAT SOFTW, V61, P1; Chen Y, 2015, EDGER EMPIRICAL ANAL; Chen YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128955; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Donaldson J, 2012, T DISTRIBUTED STOCHA; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Flores R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-253; Flores R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039745; Fuhrman BJ, 2014, J CLIN ENDOCR METAB, V99, P4632, DOI 10.1210/jc.2014-2222; Gierach Gretchen L, 2010, Breast Dis, V32, P5, DOI 10.3233/BD-2010-0319; Gohl DM, 2016, NAT BIOTECHNOL, V34, P942, DOI 10.1038/nbt.3601; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hanson B.A., 2016, HIVER 2D 3D HIVE PLO; Hieken TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30751; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hui LL, 2015, CANCER LETT, V368, P7, DOI 10.1016/j.canlet.2015.07.039; Jensen MA, 2017, BLOOD, V130, P453, DOI 10.1182/blood-2017-03-735654; Jeraldo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114804; Jin Y, 2010, BUS GENE NETWORK REC; Kampstra P, 2014, BEANPLOT VISUALIZATI; Kenney NJ, 1996, J MAMMARY GLAND BIOL, V1, P189, DOI 10.1007/BF02013642; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Leek JT, 2015, SVA SURROGATE VARIAB; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Maechler M., 2022, CLUSTER CLUSTER ANAL; Mahoney Douglas W, 2013, BMC Res Notes, V6, P33, DOI 10.1186/1756-0500-6-33; Merchant S, 2014, PEERJ, V2, DOI 10.7717/peerj.675; Moghaddam SJ, 2009, AM J RESP CELL MOL, V40, P443, DOI 10.1165/rcmb.2008-0198OC; Morgan XC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002808; Oksanen J., 2016, VEGAN COMMUNITY ECOL; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pevsner-Fischer M, 2016, WORLD J CLIN ONCOL, V7, P200, DOI 10.5306/wjco.v7.i2.200; Reichman H, 2016, TRENDS CANCER, V2, P664, DOI 10.1016/j.trecan.2016.10.002; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schulz A, 2013, EPADE EASY PLOTS; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smyth G, 2015, LIMMA LINEAR MODELS; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Urbaniak C, 2016, APPL ENVIRON MICROB, V82, P5039, DOI 10.1128/AEM.01235-16; Urbaniak C, 2014, APPL ENVIRON MICROB, V80, P3007, DOI 10.1128/AEM.00242-14; Wilks C, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau093; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Xuan CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083744; Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129; Zhang J, 2011, DISCRETE DYN NAT SOC, V2011, DOI [10.1155/2011/958381, 10.1093/database/bar026]	61	68	71	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188873	10.1371/journal.pone.0188873	http://dx.doi.org/10.1371/journal.pone.0188873			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190829	Green Published, Green Submitted, gold			2022-12-27	WOS:000416841900153
J	Sedlak, SM; Bauer, MS; Kluger, C; Schendel, LC; Milles, LF; Pippig, DA; Gaub, HE				Sedlak, Steffen M.; Bauer, Magnus S.; Kluger, Carleen; Schendel, Leonard C.; Milles, Lukas F.; Pippig, Diana A.; Gaub, Hermann E.			Monodisperse measurement of the biotin-streptavidin interaction strength in a well-defined pulling geometry	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; PROTEIN-LIGAND INTERACTION; MONOVALENT STREPTAVIDIN; ENERGY LANDSCAPE; SPECTROSCOPY; BINDING; AVIDIN; ADHESION; SITE; DNA	The widely used interaction of the homotetramer streptavidin with the small molecule biotin has been intensively studied by force spectroscopy and has become a model system for receptor ligand interaction. However, streptavidin's tetravalency results in diverse force propagation pathways through the different binding interfaces. This multiplicity gives rise to polydisperse force spectroscopy data. Here, we present an engineered monovalent streptavidin tetramer with a single cysteine in its functional subunit that allows for site-specific immobilization of the molecule, orthogonal to biotin binding. Functionality of streptavidin and its binding properties for biotin remain unaffected. We thus created a stable and reliable molecular anchor with a unique high-affinity binding site for biotinylated molecules or nanoparticles, which we expect to be useful for many single-molecule applications. To characterize the mechanical properties of the bond between biotin and our monovalent streptavidin, we performed force spectroscopy experiments using an atomic force microscope. We were able to conduct measurements at the single-molecule level with 1: 1-stoichiometry and a well-defined geometry, in which force exclusively propagates through a single subunit of the streptavidin tetramer. For different force loading rates, we obtained narrow force distributions of the bond rupture forces ranging from 200 pN at 1,500 pN/s to 230 pN at 110,000 pN/s. The data are in very good agreement with the standard Bell-Evans model with a single potential barrier at Delta x(0) = 0.38 nm and a zero-force off-rate k(off,0) in the 10(-6) s(-1) range.	[Sedlak, Steffen M.; Bauer, Magnus S.; Kluger, Carleen; Schendel, Leonard C.; Milles, Lukas F.; Pippig, Diana A.; Gaub, Hermann E.] Ludwig Maximilians Univ Munchen, Lehrstuhl Angew Physik, Munich, Germany; [Sedlak, Steffen M.; Bauer, Magnus S.; Kluger, Carleen; Schendel, Leonard C.; Milles, Lukas F.; Pippig, Diana A.; Gaub, Hermann E.] Ludwig Maximilians Univ Munchen, Ctr NanoSci CeNS, Munich, Germany	University of Munich; University of Munich	Gaub, HE (corresponding author), Ludwig Maximilians Univ Munchen, Lehrstuhl Angew Physik, Munich, Germany.	gaub@lmu.de		Sedlak, Steffen/0000-0002-7037-1793; Bauer, Magnus/0000-0003-1357-2852	European Research Council Advanced Grant [ERC-2011-ADG_20110310]; Deutsche Forschungsgemeinschaft [SFB1032]; Nanosystems Initiative Munich	European Research Council Advanced Grant(European Research Council (ERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Nanosystems Initiative Munich	Funding was provided by the European Research Council Advanced Grant (HEG) ERC-2011-ADG_20110310 to Hermann E. Gaub and the SFB1032 (HEG) of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SMS and MSB thank the Nanosystems Initiative Munich for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 1996, FEBS LETT, V390, P161, DOI 10.1016/0014-5793(96)00651-5; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Aschenbrenner D, 2015, CHEMPHYSCHEM, V16, P2085, DOI 10.1002/cphc.201500193; Baumann F, 2016, NAT NANOTECHNOL, V11, P89, DOI [10.1038/NNANO.2015.231, 10.1038/nnano.2015.231]; BAYER EA, 1985, ANAL BIOCHEM, V149, P529, DOI 10.1016/0003-2697(85)90609-8; Bayer EA, 1996, ELECTROPHORESIS, V17, P1319, DOI 10.1002/elps.1150170808; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; CHILKOTI A, 1995, J AM CHEM SOC, V117, P10622, DOI 10.1021/ja00148a003; Chilkoti A, 1995, BIOPHYS J, V69, P2125, DOI 10.1016/S0006-3495(95)80083-4; Chivers CE, 2010, NAT METHODS, V7, P391, DOI [10.1038/nmeth.1450, 10.1038/NMETH.1450]; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Fairhead M, 2014, J MOL BIOL, V426, P199, DOI 10.1016/j.jmb.2013.09.016; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Friedsam C, 2003, J PHYS-CONDENS MAT, V15, pS1709, DOI 10.1088/0953-8984/15/18/305; Gonzalez M, 1999, BIOMOL ENG, V16, P67, DOI 10.1016/S1050-3862(99)00041-8; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; Gumpp H, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3148224; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Hu QZ, 2016, CHEM COMMUN, V52, P3705, DOI 10.1039/c5cc10535h; Hyre DE, 2006, PROTEIN SCI, V15, P459, DOI 10.1110/ps.051970306; Kim M, 2011, ADV MATER, V23, P5684, DOI 10.1002/adma.201103316; Knezevic J, 2012, J AM CHEM SOC, V134, P15225, DOI 10.1021/ja3061276; Kriegel F, 2017, NUCLEIC ACIDS RES, V45, P5920, DOI 10.1093/nar/gkx280; Laitinen OH, 2007, TRENDS BIOTECHNOL, V25, P269, DOI 10.1016/j.tibtech.2007.04.001; LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003; Lo YS, 1999, LANGMUIR, V15, P1373, DOI 10.1021/la981003g; Lo YS, 2001, LANGMUIR, V17, P3741, DOI 10.1021/la001569g; Milles LF, 2016, J PHYS CHEM B; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Oesterhelt F, 1999, NEW J PHYS, V1, DOI 10.1088/1367-2630/1/1/006; Ott W, 2017, ACS NANO, V11, P6346, DOI 10.1021/acsnano.7b02694; Ott W, 2017, J STRUCT BIOL, V197, P3, DOI 10.1016/j.jsb.2016.02.011; Piramowicz MD, 2006, ACTA BIOCHIM POL, V53, P93; Puchner EM, 2008, BIOPHYS J, V95, P426, DOI 10.1529/biophysj.108.129999; Qureshi MH, 2002, PROTEIN EXPRES PURIF, V25, P409, DOI 10.1016/S1046-5928(02)00021-9; Rico F, 2007, J MOL RECOGNIT, V20, P495, DOI 10.1002/jmr.841; SANO T, 1995, P NATL ACAD SCI USA, V92, P3180, DOI 10.1073/pnas.92.8.3180; Schwaiger I, 2004, NAT STRUCT MOL BIOL, V11, P81, DOI 10.1038/nsmb705; Spate AK, 2016, CHEMBIOCHEM, V17, P1374, DOI 10.1002/cbic.201600197; Stevens MM, 2002, LANGMUIR, V18, P6659, DOI 10.1021/la0202024; Ta H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8977; Taninaka A, 2010, INT J MOL SCI, V11, P2134, DOI 10.3390/ijms11052134; Wilchek M, 2006, IMMUNOL LETT, V103, P27, DOI 10.1016/j.imlet.2005.10.022; Wong J, 1999, BIOMOL ENG, V16, P45, DOI 10.1016/S1050-3862(99)00035-2; Yin J, 2005, P NATL ACAD SCI USA, V102, P15815, DOI 10.1073/pnas.0507705102; Yuan CB, 2000, BIOCHEMISTRY-US, V39, P10219, DOI 10.1021/bi992715o; Zhang M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35915	55	28	28	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188722	10.1371/journal.pone.0188722	http://dx.doi.org/10.1371/journal.pone.0188722			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206886	Green Published, Green Submitted, gold			2022-12-27	WOS:000417110700018
J	de Groot, PF; Belzer, C; Aydin, O; Levin, E; Levels, JH; Aalvink, S; Boot, F; Holleman, F; van Raalte, DH; Scheithauer, TP; Simsek, S; Schaap, FG; Damink, SWMO; Roep, BO; Hoekstra, JB; de Vos, WM; Nieuwdorp, M				de Groot, Pieter F.; Belzer, Clara; Aydin, Omrum; Levin, Evgeni; Levels, Johannes H.; Aalvink, Steven; Boot, Fransje; Holleman, Frits; van Raalte, Daniel H.; Scheithauer, Torsten P.; Simsek, Suat; Schaap, Frank G.; Damink, Steven W. M. Olde; Roep, Bart O.; Hoekstra, Joost B.; de Vos, Willem M.; Nieuwdorp, Max			Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; ANTIISLET CELL AUTOIMMUNITY; GUT MICROBIOME; CHILDREN; SUSCEPTIBILITY; CONTRIBUTES; SELECTION; BACTERIA; MELLITUS; DISEASES	Objective Environmental factors driving the development of type 1 diabetes (T1D) are still largely unknown. Both animal and human studies have shown an association between altered fecal microbiota composition, impaired production of short-chain fatty acids (SCFA) and T1D onset. However, observational evidence on SCFA and fecal and oral microbiota in adults with longstanding T1D vs healthy controls (HC) is lacking. Research design and methods We included 53 T1D patients without complications or medication and 50 HC matched for age, sex and BMI. Oral and fecal microbiota, fecal and plasma SCFA levels, markers of intestinal inflammation (fecal IgA and calprotectin) and markers of low-grade systemic inflammation were measured. Results Oral microbiota were markedly different in T1D (eg abundance of Streptococci) compared to HC. Fecal analysis showed decreased butyrate producing species in T1D and less butyryl-CoA transferase genes. Also, plasma levels of acetate and propionate were lower in T1D, with similar fecal SCFA. Finally, fecal strains Christensenella and Subdoligranulum correlated with glycemic control, inflammatory parameters and SCFA. Conclusions We conclude that T1D patients harbor a different amount of intestinal SCFA (butyrate) producers and different plasma acetate and propionate levels. Future research should disentangle cause and effect and whether supplementation of SCFA-producing bacteria or SCFA alone can have disease-modifying effects in T1D.	[de Groot, Pieter F.; Aydin, Omrum; Levin, Evgeni; Levels, Johannes H.; Boot, Fransje; Holleman, Frits; Scheithauer, Torsten P.; Hoekstra, Joost B.; Nieuwdorp, Max] Univ Amsterdam, Dept Internal & Vasc Med, Acad Med Ctr, Amsterdam, Netherlands; [Belzer, Clara; Aalvink, Steven; de Vos, Willem M.] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [van Raalte, Daniel H.; Scheithauer, Torsten P.; Nieuwdorp, Max] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [van Raalte, Daniel H.; Scheithauer, Torsten P.; Nieuwdorp, Max] Vrije Univ Amsterdam, Med Ctr, ICAR, Amsterdam, Netherlands; [Simsek, Suat] Med Ctr Alkmaar, Dept Internal Med, Alkmaar, Netherlands; [Schaap, Frank G.; Damink, Steven W. M. Olde] Maastricht Univ, Dept Surg, Maastricht, Netherlands; [Schaap, Frank G.] NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands; [Schaap, Frank G.] RWTH Univ Hosp Aachen, Dept Gen Visceral & Transplantat Surg, Aachen, Germany; [Roep, Bart O.] Leiden Univ, Med Ctr, Dept Immunohaematol & Blood Transfus, Leiden, Netherlands; [Roep, Bart O.] City Hope Natl Med Ctr, Beckman Res Inst, DMRI, Duarte, CA USA; [de Vos, Willem M.] Univ Helsinki, RPU Immunobiol, Helsinki, Finland; [Nieuwdorp, Max] Univ Gothenburg, Wallenberg Lab, Dept Mol & Clin Med, Sahlgrenska Acad, Gothenburg, Sweden	University of Amsterdam; Academic Medical Center Amsterdam; Wageningen University & Research; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Medical Center Of Alkmaar; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); RWTH Aachen University; RWTH Aachen University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; City of Hope; Beckman Research Institute of City of Hope; University of Helsinki; University of Gothenburg	de Groot, PF; Nieuwdorp, M (corresponding author), Univ Amsterdam, Dept Internal & Vasc Med, Acad Med Ctr, Amsterdam, Netherlands.; Nieuwdorp, M (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Amsterdam, Netherlands.; Nieuwdorp, M (corresponding author), Vrije Univ Amsterdam, Med Ctr, ICAR, Amsterdam, Netherlands.; Nieuwdorp, M (corresponding author), Univ Gothenburg, Wallenberg Lab, Dept Mol & Clin Med, Sahlgrenska Acad, Gothenburg, Sweden.	p.f.degroot@amc.nl; m.nieuwdorp@amc.nl	Damink, Steven WM Olde/U-7919-2019; Simsek, Suat/AAH-6382-2021; Boot, Fransje/AAS-1718-2021; Belzer, Clara/P-6500-2018; Roep, Bart/AAD-7609-2021	Damink, Steven WM Olde/0000-0002-5202-9345; Boot, Fransje/0000-0001-5281-3490; Belzer, Clara/0000-0001-6922-836X; Aalvink, Steven/0000-0001-7554-1723; van Raalte, Daniel/0000-0003-2894-6124	ZONMW-VIDI grant of the Netherlands Organization for Scientific Research (NWO) [016.146.327]; CVON Young Talent grant; NWO Gravitation Grant [SIAM 024.002.002]; Spinoza Award	ZONMW-VIDI grant of the Netherlands Organization for Scientific Research (NWO); CVON Young Talent grant; NWO Gravitation Grant; Spinoza Award	M Nieuwdorp is supported by a ZONMW-VIDI grant 2013 (016.146.327) of the Netherlands Organization for Scientific Research (NWO, www.nwo.nl) and CVON Young Talent grant 2012. WM de Vos is supported by the NWO Gravitation Grant (SIAM 024.002.002) and the Spinoza Award.	Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Balmer ML, 2016, IMMUNITY; Burrows MP, 2015, P NATL ACAD SCI USA, V112, P9973, DOI 10.1073/pnas.1508740112; Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Chumpitazi BP, 2014, GUT MICROBES, V5, P165, DOI 10.4161/gmic.27923; Clausen TD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161654; Clausen TD, 2016, EPIDEMIOLOGY, V27, P547, DOI 10.1097/EDE.0000000000000488; Costa FRC, 2016, J EXP MED, V213, P1223, DOI 10.1084/jem.20150744; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; De Baere S, 2013, J PHARMACEUT BIOMED, V80, P107, DOI 10.1016/j.jpba.2013.02.032; de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; DELPRATO S, 1983, J CLIN ENDOCR METAB, V57, P904; Endesfelder D, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0163-4; Endesfelder D, 2014, DIABETES, V63, P2006, DOI 10.2337/db13-1676; Gale EA, 2014, LANCET LONDON ENGLAN, V311, P1777; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Hansen CHF, 2012, DIABETOLOGIA, V55, P2285, DOI 10.1007/s00125-012-2564-7; Hartstra AV, 2015, DIABETES CARE, V38, P159, DOI 10.2337/dc14-0769; Heintz-Buschart A, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.180; Horwitz MS, 1998, NAT MED, V4, P781, DOI 10.1038/nm0798-781; Kootte RS, 2012, DIABETES OBES METAB, V14, P112, DOI 10.1111/j.1463-1326.2011.01483.x; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Korsgren S, 2012, AM J PATHOL, V181, P1735, DOI 10.1016/j.ajpath.2012.07.022; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Louis P, 2007, APPL ENVIRON MICROB, V73, P2009, DOI 10.1128/AEM.02561-06; Marino E, 2017, NAT IMMUNOL; Planer JD, 2016, NATURE, V534, P263, DOI 10.1038/nature17940; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Ramiro-Garcia Javier, 2016, F1000Res, V5, P1791, DOI 10.12688/f1000research.9227.2; Stewart CJ, 2016, DIABET MED; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Vaarala O, 2012, IMMUNOL CELL BIOL, V90, P271, DOI 10.1038/icb.2011.115; van den Bogert B, 2013, FEMS MICROBIOL ECOL, V85, P376, DOI 10.1111/1574-6941.12127; van Eijk HMH, 2009, J CHROMATOGR B, V877, P719, DOI 10.1016/j.jchromb.2009.01.039; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Virtanen SM, 2012, AM J CLIN NUTR, V95, P471, DOI 10.3945/ajcn.111.018879; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	41	106	108	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188475	10.1371/journal.pone.0188475	http://dx.doi.org/10.1371/journal.pone.0188475			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211757	Green Submitted, Green Published, gold			2022-12-27	WOS:000417212200034
J	Jeong, HJ; Abhiraman, GC; Story, CM; Ingram, JR; Dougan, SK				Jeong, Hee-Jin; Abhiraman, Gita C.; Story, Craig M.; Ingram, Jessica R.; Dougan, Stephanie K.			Generation of Ca2+-independent sortase A mutants with enhanced activity for protein and cell surface labeling	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; LIGATION; TRANSPEPTIDASE; PEPTIDES; WALL	Sortase A, a calcium-dependent transpeptidase derived from Staphylococcus aureus, is used in a broad range of applications, such as the conjugation of fluorescent dyes and other moieties to proteins or to the surface of eukaryotic cells. In vivo and cell-based applications of sortase have been somewhat limited by the large range of calcium concentrations, as well as by the often transient nature of protein-protein interactions in living systems. In order to use sortase A for cell labeling applications, we generated a new sortase A variant by combining multiple mutations to yield an enzyme that was both calcium-independent and highly active. This variant has enhanced activity for both N-and C-terminal labeling, as well as for cell surface modification under physiological conditions.	[Jeong, Hee-Jin; Abhiraman, Gita C.; Ingram, Jessica R.; Dougan, Stephanie K.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Jeong, Hee-Jin; Ingram, Jessica R.; Dougan, Stephanie K.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Story, Craig M.] Gordon Coll, Dept Biol, Wenham, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Dougan, SK (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA.; Dougan, SK (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	Stephanie_Dougan@dfci.harvard.edu	Jeong, Hee-Jin/AGR-3650-2022	Abhiraman, Gita/0000-0002-0546-4133	Dana-Farber Center for Cancer Immunology Research; Harvard PRISE program; Claudia Adams Barr Foundation; Dana-Farber Cancer Institute/Novartis Drug Discovery Program	Dana-Farber Center for Cancer Immunology Research; Harvard PRISE program; Claudia Adams Barr Foundation; Dana-Farber Cancer Institute/Novartis Drug Discovery Program	HJJ was funded by a fellowship from the Dana-Farber Center for Cancer Immunology Research. GCA was funded by the Harvard PRISE program. SKD and JRI were funded by the Claudia Adams Barr Foundation. SKD was funded by the Dana-Farber Cancer Institute/Novartis Drug Discovery Program.	Antos John M, 2017, Curr Protoc Protein Sci, V89, DOI 10.1002/cpps.38; Antos JM, 2016, CURR OPIN STRUC BIOL, V38, P111, DOI 10.1016/j.sbi.2016.05.021; Antos JM, 2008, J AM CHEM SOC, V130, P16338, DOI 10.1021/ja806779e; Chen I, 2011, GEN STRATEGY EVOLUTI; Chen L, 2016, SCI REP NATURE PUBLI, P1; Dougan SK, 2013, CANCER IMMUNOL RES, V1, P99, DOI 10.1158/2326-6066.CIR-13-0047; Frese MA, 2009, CHEMBIOCHEM; Glasgow JE, 2016, J AM CHEM SOC, V138, P7496, DOI 10.1021/jacs.6b03836; Hirakawa H, 2015, BIOTECHNOLOGY J; Hirakawa H, 2012, BIOTECHNOLOGY AND; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Ingram JR, 2017, NATURE COMMUNICATION, P1; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Milo R., 2015, CELL BIOL NUMBERS; Nguyen GKT, 2016, NAT PROTOC, V11, P1977, DOI 10.1038/nprot.2016.118; Pishesha N, 2017, P NATL ACAD SCI USA, V114, P3157, DOI 10.1073/pnas.1701746114; Popp MWL, 2011, ANGEW CHEM INT EDIT, V50, P5024, DOI 10.1002/anie.201008267; Popp MW, 2011, SORTASE CATALYZED TR; Rashidian M, 2015, ACS CENTRAL SCI, V1, P142, DOI 10.1021/acscentsci.5b00121; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Shi JH, 2014, P NATL ACAD SCI USA, V111, P10131, DOI 10.1073/pnas.1409861111; Strijbis K, 2012, TRAFFIC, V13, P780, DOI 10.1111/j.1600-0854.2012.01345.x; Swee LK, 2015, ACS CHEM BIOL, V10, P460, DOI 10.1021/cb500462t; Swee LK, 2013, P NATL ACAD SCI USA, V110, P1428, DOI 10.1073/pnas.1214994110; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Vincke C, 2012, INTRO HEAVY CHAIN AN, P15; Witte MD, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.026; Witte MD, 2012, P NATL ACAD SCI USA, V109, P11993, DOI 10.1073/pnas.1205427109; Wu Q, 2017, ACS CHEM BIOL; Wuethrich I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109883	31	14	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0189068	10.1371/journal.pone.0189068	http://dx.doi.org/10.1371/journal.pone.0189068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29200433	Green Published, Green Submitted, gold			2022-12-27	WOS:000417033200027
J	Kriebel, R; Khabbazian, M; Sytsma, KJ				Kriebel, Ricardo; Khabbazian, Mohammad; Sytsma, Kenneth J.			A continuous morphological approach to study the evolution of pollen in a phylogenetic context: An example with the order Myrtales	PLOS ONE			English	Article							HISTORICAL BIOGEOGRAPHY; DIVERGENCE TIMES; STABILIZING SELECTION; MORPHOMETRIC-ANALYSIS; REPRODUCTIVE-BIOLOGY; MOLECULAR PHYLOGENY; FLOWERING PLANTS; TRAIT EVOLUTION; GENOME SIZE; GENUS	The study of pollen morphology has historically allowed evolutionary biologists to assess phylogenetic relationships among Angiosperms, as well as to better understand the fossil record. During this process, pollen has mainly been studied by discretizing some of its main characteristics such as size, shape, and exine ornamentation. One large plant clade in which pollen has been used this way for phylogenetic inference and character mapping is the order Myrtales, composed by the small families Alzateaceae, Crypteroniaceae, and Penaeaceae (collectively the "AP clade"), as well as the large families Combretaceae, Lythraceae, Melastomataceae, Myrtaceae, Onagraceae and Vochysiaceae. In this study, we present a novel way to study pollen evolution by using quantitative size and shape variables. We use morphometric and morphospace methods to evaluate pollen change in the order Myrtales using a time-calibrated, supermatrix phylogeny. We then test for conservatism, divergence, and morphological convergence of pollen and for correlation between the latitudinal gradient and pollen size and shape. To obtain an estimate of shape, Myrtales pollen images were extracted from the literature, and their outlines analyzed using elliptic Fourier methods. Shape and size variables were then analyzed in a phylogenetic framework under an Ornstein-Uhlenbeck process to test for shifts in size and shape during the evolutionary history of Myrtales. Few shifts in Myrtales pollen morphology were found which indicates morphological conservatism. Heterocolpate, small pollen is ancestral with largest pollen in Onagraceae. Convergent shifts in shape but not size occurred in Myrtaceae and Onagraceae and are correlated to shifts in latitude and biogeography. A quantitative approach was applied for the first time to examine pollen evolution across a large time scale. Using phylogenetic based morphometrics and an OU process, hypotheses of pollen size and shape were tested across Myrtales. Convergent pollen shifts and position in the latitudinal gradient support the selective role of harmomegathy, the mechanism by which pollen grains accommodate their volume in response to water loss.	[Kriebel, Ricardo; Sytsma, Kenneth J.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Khabbazian, Mohammad] Columbia Univ, Dept Stat, New York, NY USA	University of Wisconsin System; University of Wisconsin Madison; Columbia University	Kriebel, R (corresponding author), Univ Wisconsin, Dept Bot, Madison, WI 53706 USA.	kriebelr@gmail.com		Kriebel, Ricardo/0000-0002-1138-7533	US National Science Foundation's Dimensions of Biodiversity program [DEB-1046355]; Hofmeister Fund, Botany Department, University of Wisconsin, Madison	US National Science Foundation's Dimensions of Biodiversity program(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Hofmeister Fund, Botany Department, University of Wisconsin, Madison	US National Science Foundation's Dimensions of Biodiversity program (awards DEB-1046355) provided the time commitment of Kriebel and Sytsma. Additional support came from the Hofmeister Fund, Botany Department, University of Wisconsin, Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Khanbeygi Z., 2011, Iranian Journal of Botany, V17, P158; ALMEDA F, 1993, BRITTONIA, V45, P187, DOI 10.2307/2807100; APSA, 2007, AUSTR POLL SPOR ATL; Barth O. M., 1975, Memorias do Instituto Oswaldo Cruz, V73, P101, DOI 10.1590/S0074-02761975000100007; Barth OM, 2014, REV BIOL TROP, V62, P1209, DOI 10.15517/rbt.v62i3.12323; BEARDSELL DV, 1993, AUST J BOT, V41, P511, DOI 10.1071/BT9930511; Beaulieu JM, 2008, NEW PHYTOL, V179, P975, DOI 10.1111/j.1469-8137.2008.02528.x; Beaulieu JM, 2013, EVOLUTION, V67, P3132, DOI 10.1111/evo.12180; Beaulieu JM, 2012, EVOLUTION, V66, P2369, DOI 10.1111/j.1558-5646.2012.01619.x; Berger BA, 2016, MOL PHYLOGENET EVOL, V95, P116, DOI 10.1016/j.ympev.2015.10.001; Blackmore S, 1984, POLLEN SPORES FORM F, P137; Bonhomme V, 2014, J STAT SOFTW, V56, P1; Bonhomme V, 2013, PLANT SYST EVOL, V299, P811, DOI 10.1007/s00606-013-0762-5; Boyle B, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-16; BROWN C A, 1967, Review of Palaeobotany and Palynology, V3, P163, DOI 10.1016/0034-6667(67)90050-4; Bush MB, 2007, J BIOGEOGR, V34, P377, DOI 10.1111/j.1365-2699.2006.01645.x; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Campos D. Cos, 1964, POLLEN SPORES, V6, P303; Carrno-Oliveira R, 2009, ACTA BOT BRAS, V23, P780, DOI 10.1590/S0102-33062009000300018; Chantaranothai P, 1997, GRANA, V36, P146, DOI 10.1080/00173139709362602; Chartier M, 2014, NEW PHYTOL, V204, P841, DOI 10.1111/nph.12969; Chen WH, 2007, ACTA PHYTOTAXON SIN, V45, P587, DOI 10.1360/aps050006; Chong SML, 2014, PHILIPP J CROP SCI, V39, P1; Conti E, 1997, SYST BOT, V22, P629, DOI 10.2307/2419432; Conti E, 2004, EVOLUTION, V58, P1874; Cressler CE, 2015, SYST BIOL, V64, P953, DOI 10.1093/sysbio/syv043; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; DAGHLIAN CP, 1985, AM J BOT, V72, P1039, DOI 10.2307/2443446; DAHLGREN R, 1984, ANN MO BOT GARD, V71, P633, DOI 10.2307/2399158; De Frenne P, 2013, J ECOL, V101, P784, DOI 10.1111/1365-2745.12074; Eberle J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098536; Edlund AF, 2004, PLANT CELL, V16, pS84, DOI 10.1105/tpc.015800; Ejsmond MJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00147.1; Fiz O, 2008, SYST BOT, V33, P326, DOI 10.1600/036364408784571482; Furness CA, 2012, INT J PLANT SCI, V173, P1055, DOI 10.1086/667614; Furness CA, 2010, INT J PLANT SCI, V171, P713, DOI 10.1086/654848; Givnish TJ, 2014, MOL PHYLOGENET EVOL, V71, P55, DOI 10.1016/j.ympev.2013.10.010; GRAHAM A, 1987, AM J BOT, V74, P829, DOI 10.2307/2443864; GRAHAM A, 1990, AM J BOT, V77, P159, DOI 10.1002/j.1537-2197.1990.tb13543.x; GRAHAM A, 1985, AM J BOT, V72, P1012, DOI 10.2307/2443444; GRAHAM A, 1968, AM J BOT, V55, P1080, DOI 10.2307/2440476; GRAHAM SA, 1977, SYST BOT, V2, P61, DOI 10.2307/2418502; Graham SA, 2010, ANN MO BOT GARD, V97, P34, DOI 10.3417/2007028; Gressler Eliana, 2006, Braz. J. Bot., V29, P509, DOI 10.1590/S0100-84042006000400002; Grimsson F, 2012, PLANT SYST EVOL, V298, P671, DOI 10.1007/s00606-011-0578-0; Grimsson F, 2012, INT J PLANT SCI, V173, P297, DOI 10.1086/663968; GROSS CL, 1993, BIOTROPICA, V25, P468, DOI 10.2307/2388870; Guers J., 1974, TRAVAUX DOCUMENTS GE, V16, P86; Hansen TF, 1997, EVOLUTION, V51, P1341, DOI 10.1111/j.1558-5646.1997.tb01457.x; Harder LD, 1998, BIOL J LINN SOC, V64, P513, DOI 10.1111/j.1095-8312.1998.tb00347.x; Ho LST, 2014, METHODS ECOL EVOL, V5, P1133, DOI 10.1111/2041-210X.12285; Ho LST, 2014, SYST BIOL, V63, P397, DOI 10.1093/sysbio/syu005; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hothorn T, 2008, J STAT SOFTW, V28, P1; Hsieh Tsung-Hsin, 1999, Taiwania, V44, P529; JOHNSON LAS, 1984, ANN MO BOT GARD, V71, P700, DOI 10.2307/2399159; Katifori E, 2010, P NATL ACAD SCI USA, V107, P7635, DOI 10.1073/pnas.0911223107; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; KERI C, 1992, GRANA, V31, P119, DOI 10.1080/00173139209430731; Kerkhoff AJ, 2014, P NATL ACAD SCI USA, V111, P8125, DOI 10.1073/pnas.1308932111; Khabbazian M, 2016, METHODS ECOL EVOL, V7, P811, DOI 10.1111/2041-210X.12534; KINCAID DT, 1983, CAN J BOT, V61, P2333, DOI 10.1139/b83-256; Klingenberg CP, 2012, J EVOLUTION BIOL, V25, P115, DOI 10.1111/j.1420-9101.2011.02410.x; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Knight C.A, 2010, J BOT; Ksepka DT, 2011, BIOL LETTERS, V7, P801, DOI 10.1098/rsbl.2011.0356; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; LADD PG, 1994, BOT J LINN SOC, V115, P165, DOI 10.1006/bojl.1994.1040; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Lee S, 1979, KOREAN J BOT, V22, P115; Leslie AB, 2015, EVOLUTION, V69, P1573, DOI 10.1111/evo.12670; Lindbladh MS, 2002, AM J BOT, V89, P1459, DOI 10.3732/ajb.89.9.1459; Linder HP, 2014, J BIOGEOGR, V41, P1313, DOI 10.1111/jbi.12312; Liu YS, 2008, GRANA, V47, P262, DOI 10.1080/00173130802457255; LUMER C, 1980, BRITTONIA, V32, P512, DOI 10.2307/2806163; Magallon S, 2013, AM J BOT, V100, P556, DOI 10.3732/ajb.1200416; Makbul S, 2008, ACTA BIOL CRACOV BOT, V50, P51; Maldonado C, 2015, GLOBAL ECOL BIOGEOGR, V24, P973, DOI 10.1111/geb.12326; Mangiafico SS, 2015, R COMPANION HDB BIOL; Mayr G, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0223; Miller MA., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; MULLER J, 1981, REV PALAEOBOT PALYNO, V35, P93, DOI 10.1016/0034-6667(81)90016-6; MULLER J, 1979, ANN MO BOT GARD, V66, P593, DOI 10.2307/2398913; MULLER J, 1975, Blumea, V22, P275; Muller J, 1976, 4 INT PAL C LUCKN, V1, P194; Narayan R, 1985, J GENET, V64, P101; Narayan RKJ, 1998, ANN BOT-LONDON, V82, P57, DOI 10.1006/anbo.1998.0752; NOWICKE JW, 1984, ANN MO BOT GARD, V71, P35, DOI 10.2307/2399056; Palazzesi L, 2012, BIOL J LINN SOC, V107, P67, DOI 10.1111/j.1095-8312.2012.01910.x; Parham JF, 2011, SYSTEMATIC BIOL; PATEL V, 1983, AM J BOT, V70, P469, DOI 10.2307/2443255; PATEL VC, 1984, ANN MO BOT GARD, V71, P858, DOI 10.2307/2399170; PAYNE WW, 1981, REV PALAEOBOT PALYNO, V35, P39, DOI 10.1016/0034-6667(81)90013-0; Pires JC, 2008, ANN MO BOT GARD, V95, P275, DOI 10.3417/2007176; Premathilake R, 2001, GRANA, V40, P256, DOI 10.1080/00173130152987508; R Development Core Team, 2009, R LANG ENV STAT COMP; Rabosky DL, 2013, NATURE COMMUNICATION, V4, P55; RAVEN PH, 1979, NEW ZEAL J BOT, V17, P575, DOI 10.1080/0028825X.1979.10432572; RAVEN PH, 1984, ANN MO BOT GARD, V71, P631; RENNER S S, 1989, Memoirs of the New York Botanical Garden, V50, P1; RENNER SS, 1989, ANN MO BOT GARD, V76, P496, DOI 10.2307/2399497; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rind D, 1998, J GEOPHYS RES-ATMOS, V103, P5943, DOI 10.1029/97JD03649; ROBBINS RR, 1979, AM J BOT, V66, P538, DOI 10.2307/2442503; Rose JP, 2016, AM J BOT, V103, P652, DOI 10.3732/ajb.1500394; Roubik DW., 1991, MONOGR SYST BOT, V36, P1, DOI DOI 10.2307/4110734; Santos FAR, 1997, POLIBOTANICA, V5, P1; Sauquet H, 2003, INT J PLANT SCI, V164, P613, DOI 10.1086/375424; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schols P, 2005, SYST BOT, V30, P750, DOI 10.1600/036364405775097743; Schols P., 2004, Phyloinformatics, V1, P1; SCOTLAND RW, 1990, GRANA, V29, P37, DOI 10.1080/00173139009429975; Siver PA, 2013, GEOBIOLOGY, V11, P127, DOI 10.1111/gbi.12023; SKVARLA J J, 1978, Pollen et Spores, V20, P5; Skvarla JJ, 2005, TAXON, V54, P121, DOI 10.2307/25065308; Skvarla John J, 1975, Am J Bot, V62, P6, DOI 10.1002/j.1537-2197.1975.tb12334.x; SLATER AT, 1991, AUST J BOT, V39, P229, DOI 10.1071/BT9910229; Smith SA, 2012, BIOINFORMATICS, V28, P2689, DOI 10.1093/bioinformatics/bts492; Smith UE, 2013, SYST BIOL, V62, P366, DOI 10.1093/sysbio/syt002; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sytsma KJ, 2014, BIOL J LINN SOC, V113, P29, DOI 10.1111/bij.12297; Sytsma KJ, 2004, INT J PLANT SCI, V165, pS85, DOI 10.1086/421066; Thangaraja A, 2008, AFR J PLANT SCI, V2, P140; THIELE K, 1993, CLADISTICS, V9, P275, DOI 10.1111/j.1096-0031.1993.tb00226.x; Thornhill AH, 2015, MOL PHYLOGENET EVOL, V93, P29, DOI 10.1016/j.ympev.2015.07.007; Thornhill AH, 2012, REV PALAEOBOT PALYNO, V176, P1, DOI 10.1016/j.revpalbo.2012.03.003; Thornhill AH, 2012, AUST SYST BOT, V25, P171, DOI 10.1071/SB11019; Thornhill AH, 2012, AUST J BOT, V60, P225, DOI 10.1071/BT11176; Thornhill AH, 2012, AUST J BOT, V60, P260, DOI 10.1071/BT11177; Thornhill AH, 2012, AUST J BOT, V60, P200, DOI 10.1071/BT11175; Thornhill AH, 2012, AUST J BOT, V60, P165, DOI 10.1071/BT11174; Thornhill AH, 2012, MOL PHYLOGENET EVOL, V63, P15, DOI 10.1016/j.ympev.2011.12.003; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; TING WILLIAM S., 1966, POLLEN SPORES, V8, P9; TOBE H, 1983, ANN MO BOT GARD, V70, P71, DOI 10.2307/2399008; Tomizono S., 2013, BOXPLOTDBL DOUBLE BO; Torres C, 2000, SEX PLANT REPROD, V12, P365, DOI 10.1007/s004970000030; van der Hammen T, 1966, LEIDSE GEOLOGISCHE M, V35, P105; VANDERHAM RWJM, 1989, BLUMEA, V34, P21; Viscosi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025630; Cruz-Barros Maria Amélia Vitorino da, 2007, Hoehnea, V34, P531; Volkova OA, 2013, PLANT SYST EVOL, V299, P1769, DOI 10.1007/s00606-013-0832-8; Wang WM, 2004, REV PALAEOBOT PALYNO, V131, P117, DOI 10.1016/j.revpalbo.2004.03.005; Wang Yu-Fa, 2001, Taiwania, V46, P167; Welsh M, 2010, PLANT SYST EVOL, V285, P83, DOI 10.1007/s00606-009-0259-4; Wiens JJ, 2001, SYST BIOL, V50, P689, DOI 10.1080/106351501753328811; Wilf P, 2015, NEW PHYTOL, V207, P283, DOI 10.1111/nph.13114; Wodehouse RP., 1935, POLLEN GRAINS; Wronska-Pilarek D, 2005, ACTA SOC BOT POL, V74, P297; Wronska-Pilarek D, 2011, PLANT SYST EVOL, V295, P55, DOI 10.1007/s00606-011-0462-y	153	22	22	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187228	10.1371/journal.pone.0187228	http://dx.doi.org/10.1371/journal.pone.0187228			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211730	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200014
J	Stoeckle, BC; Beggel, S; Cerwenka, AF; Motivans, E; Kuehn, R; Geist, J				Stoeckle, Bernhard C.; Beggel, Sebastian; Cerwenka, Alexander F.; Motivans, Elena; Kuehn, Ralph; Geist, Juergen			A systematic approach to evaluate the influence of environmental conditions on eDNA detection success in aquatic ecosystems	PLOS ONE			English	Article							MARINE-SEDIMENTS; MICROBIAL DNA; INHIBITION; PCR; EXTRACTION; CONSERVATION; PURIFICATION; DEGRADATION; GOBIIDAE; IMPACT	The use of environmental DNA (eDNA) to determine the presence and distribution of aquatic organisms has become an important tool to monitor and investigate freshwater communities. The successful application of this method in the field, however, is dependent on the effectiveness of positive DNA verification, which is influenced by site-specific environmental parameters. Factors affecting eDNA concentrations in aquatic ecosystems include flow conditions, and the presence of substances that possess DNA-binding properties or inhibitory effects. In this study we investigated the influence of different environmental parameters on the detection success of eDNA using the invasive goby Neogobius melanostomus. In a standardized laboratory setup, different conditions of flow, sediment-properties, and fish density were compared, as well as different potential natural inhibitors such as algae, humic substances, and suspended sediment particles. The presence of sediment was mainly responsible for lower eDNA detection in the water samples, regardless of flow-through or standing water conditions and a delayed release of eDNA was detected in the presence of sediment. Humic substances had the highest inhibitory effect on eDNA detection followed by algae and siliceous sediment particles. The results of our study highlight that a successful application of eDNA methods in field surveys strongly depends on site-specific conditions, such as water flow conditions, sediment composition, and suspended particles. All these factors should be carefully considered when sampling, analyzing, and interpreting eDNA detection results.	[Stoeckle, Bernhard C.; Beggel, Sebastian; Motivans, Elena; Geist, Juergen] Tech Univ Munich, Aquat Syst Biol Unit, Dept Ecol & Ecosyst Management, Freising Weihenstephan, Germany; [Cerwenka, Alexander F.] SNSB Bavarian State Collect Zool ZSM, Munich, Germany; [Kuehn, Ralph] Tech Univ Munich, Dept Anim Sci, Chair Zool, Unit Mol Zool, Freising Weihenstephan, Germany; [Kuehn, Ralph] New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA	Technical University of Munich; Technical University of Munich; New Mexico State University	Geist, J (corresponding author), Tech Univ Munich, Aquat Syst Biol Unit, Dept Ecol & Ecosyst Management, Freising Weihenstephan, Germany.	geist@wzw.tum.de	Beggel, Sebastian/AAF-8068-2021; Cerwenka, Alexander/ABF-3106-2020; Geist, Juergen/C-4933-2008	Beggel, Sebastian/0000-0002-7653-1073; Cerwenka, Alexander/0000-0002-9393-0885; Geist, Juergen/0000-0001-7698-3443; Kuehn, Ralph/0000-0001-9518-0590; Motivans Svara, Elena/0000-0002-2407-9564	Chair of Aquatic Systems Biology	Chair of Aquatic Systems Biology	Funding for this study was provided by the Chair of Aquatic Systems Biology, i.e., by the institution where most of the authors work. There was no external funding.	Adrian-Kalchhauser I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147558; Albers CN, 2013, GEOMICROBIOL J, V30, P675, DOI 10.1080/01490451.2012.758193; Barnes MA, 2016, CONSERV GENET, V17, P1, DOI 10.1007/s10592-015-0775-4; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Boeker C, 2016, HYDROBIOLOGIA, V777, P171, DOI 10.1007/s10750-016-2774-y; Brandner J, 2013, HYDROBIOLOGIA, V703, P113, DOI 10.1007/s10750-012-1349-9; Bylemans J, 2017, METHODS ECOL EVOL, V8, P646, DOI 10.1111/2041-210X.12709; Cerwenka AF, 2017, ECOL EVOL, V7, P4076, DOI 10.1002/ece3.2942; Corse E, 2010, MOL ECOL RESOUR, V10, P96, DOI 10.1111/j.1755-0998.2009.02795.x; Cullen DW, 1998, SOIL BIOL BIOCHEM, V30, P983, DOI 10.1016/S0038-0717(98)00001-7; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Dell'Anno A, 2004, APPL ENVIRON MICROB, V70, P4384, DOI 10.1128/AEM.70.7.4384-4386.2004; Elzea J., 1990, APPL CLAY SCI, V3, P229, DOI [10.1016/0169-1317(90)90012-E, DOI 10.1016/0169-1317(90)90012-E]; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Graf G, 1997, J MARINE SYST, V11, P269, DOI 10.1016/S0924-7963(96)00126-1; Haertl M, 2012, SPIXIANA, V35, P155; Haile J, 2009, P NATL ACAD SCI USA, V106, P22352, DOI 10.1073/pnas.0912510106; Hartmann JT, 2016, AQUAT TOXICOL, V170, P279, DOI 10.1016/j.aquatox.2015.06.014; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Jerde CL, 2016, ENVIRON SCI TECHNOL, V50, P8770, DOI 10.1021/acs.est.6b01761; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; JUDE DJ, 1992, CAN J FISH AQUAT SCI, V49, P416, DOI 10.1139/f92-047; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kreader CA, 1996, APPL ENVIRON MICROB, V62, P1102, DOI 10.1128/AEM.62.3.1102-1106.1996; Lorenz MG, 1996, APPL ENVIRON MICROB, V53, P2948; Lydolph MC, 2005, APPL ENVIRON MICROB, V71, P1012, DOI 10.1128/AEM.71.2.1012-1017.2005; Maruyama A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114639; Matisoo-Smith E, 2008, QUATERN INT, V184, P139, DOI 10.1016/j.quaint.2007.09.013; McKee AM, 2015, BIOL CONSERV, V183, P70, DOI 10.1016/j.biocon.2014.11.031; McKnight D.M., 1998, AQUATIC HUMIC SUBSTA, P9, DOI DOI 10.1007/978-3-662-03736-2_; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; Nathan LR, 2015, CONSERV BIOL, V29, P430, DOI 10.1111/cobi.12381; OGRAM A, 1987, J MICROBIOL METH, V7, P57, DOI 10.1016/0167-7012(87)90025-X; Opel KL, 2010, J FORENSIC SCI, V55, P25, DOI 10.1111/j.1556-4029.2009.01245.x; PENNAK RW, 1971, HYDROBIOLOGIA, V38, P321, DOI 10.1007/BF00036842; Piggott MP, 2016, ECOL EVOL, V6, P2739, DOI 10.1002/ece3.2083; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Shafer ABA, 2015, TRENDS ECOL EVOL, V30, P78, DOI 10.1016/j.tree.2014.11.009; Shogren AJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05223-1; Sidstedt M, 2015, ANAL BIOCHEM, V487, P30, DOI 10.1016/j.ab.2015.07.002; STEWART GJ, 1991, FEMS MICROBIOL ECOL, V85, P1; Stoeckle BC, 2016, AQUAT CONSERV, V26, P1120, DOI 10.1002/aqc.2611; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Su WB, 2003, SCI CHINA SER D, V46, P1121, DOI 10.1360/01yd0225; SU X, 1988, ANAL BIOCHEM, V174, P650, DOI 10.1016/0003-2697(88)90068-1; Sutlovic D, 2005, CROAT MED J, V46, P556; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Theurillat JP, 2001, CLIMATIC CHANGE, V50, P77, DOI 10.1023/A:1010632015572; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; TSAI YL, 1992, APPL ENVIRON MICROB, V58, P754, DOI 10.1128/AEM.58.2.754-757.1992; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Unger H. J., 1981, VERHANDLUNGEN GEOLOG, V1981, P193; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596	60	51	52	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2017	12	12							e0189119	10.1371/journal.pone.0189119	http://dx.doi.org/10.1371/journal.pone.0189119			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2SV	29220394	Green Published, Green Submitted, gold			2022-12-27	WOS:000417469900034
J	Gong, CC; Chen, HS; He, WX; Zhang, ZL				Gong, Congcong; Chen, Haisong; He, Weixiong; Zhang, Zhanliang			Improved multi-objective clustering algorithm using particle swarm optimization	PLOS ONE			English	Article								Multi-objective clustering has received widespread attention recently, as it can obtain more accurate and reasonable solution. In this paper, an improved multi-objective clustering framework using particle swarm optimization (IMCPSO) is proposed. Firstly, a novel particle representation for clustering problem is designed to help PSO search clustering solutions in continuous space. Secondly, the distribution of Pareto set is analyzed. The analysis results are applied to the leader selection strategy, and make algorithm avoid trapping in local optimum. Moreover, a clustering solution-improved method is proposed, which can increase the efficiency in searching clustering solution greatly. In the experiments, 28 datasets are used and nine state-of-the-art clustering algorithms are compared, the proposed method is superior to other approaches in the evaluation index ARI.	[Gong, Congcong; Chen, Haisong; He, Weixiong; Zhang, Zhanliang] PLA Univ Sci & Technol, Nanjing, Jiangsu, Peoples R China	Army Engineering University of PLA	Chen, HS (corresponding author), PLA Univ Sci & Technol, Nanjing, Jiangsu, Peoples R China.	haisong_chen@outlook.com			National Natural Science Foundation of China [61473263]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is financially sponsored by the National Natural Science Foundation of China (61473263). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported by National Natural Science Foundation of China (61473263).	Abubaker A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130995; Alcala-Fdez J, 2011, J MULT-VALUED LOG S, V17, P255; Alvarezbenitez JE, 2013, 3 INT C EMO 2005 GUA; Armano G, 2016, MULTIOBJECTIVE CLUST, P184; Aupetit M, 2003, EUR S ART NEUR NETW; Cheng SX, 2016, APPL SOFT COMPUT, V47, P370, DOI 10.1016/j.asoc.2016.06.012; Coello CAC, 2002, 2002 CEC 02 P 2002 C; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Cui X, 2005, SWARM INT S 2005 SIS; Eckley DC, 2013, COMPUT ENVIRON URBAN, V37, P70, DOI 10.1016/j.compenvurbsys.2012.06.004; Ester M., 1996, INT C KNOWL DISC DAT; Frank A., 2010, UCI MACHINE LEARNING; Freitas AA, 2007, REV EVOLUTIONARY ALG, P371; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Garcia S, 2009, J HEURISTICS, V15, P617, DOI 10.1007/s10732-008-9080-4; Garcia-Piquer A, 2015, INFORM SCIENCES, V320, P12, DOI 10.1016/j.ins.2015.04.041; Han J, 2011, DATA MINING CONCEPTS, V5, P1; Handl J, 2004, LECT NOTES COMPUT SC, V3242, P1081; Handl J, 2007, IEEE T EVOLUT COMPUT, V11, P56, DOI 10.1109/TEVC.2006.877146; Hashemi SN, 2015, EARTH SCI INFORM, V8, P367, DOI 10.1007/s12145-014-0163-5; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Inkaya T, 2015, PATTERN RECOGN LETT, V52, P17, DOI 10.1016/j.patrec.2014.09.007; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Kasprzak EM, 2001, STRUCT MULTIDISCIP O, V22, P208, DOI 10.1007/s001580100138; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Kovacs L, 2011, IEEE INT S COMP INT; Li L, 2017, INFORM SCIENCES, V375, P30, DOI 10.1016/j.ins.2016.08.043; Omran MGH, 2007, INTELL DATA ANAL, V11, P583, DOI 10.3233/IDA-2007-11602; Omran MGH, 2006, PATTERN ANAL APPL, V8, P332, DOI 10.1007/s10044-005-0015-5; Phoong SM, 2004, 2004 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL IV, PROCEEDINGS, P729; Poli R, 2007, SWARM INTELLIGENCE, V1; Rana S, 2011, ARTIF INTELL REV, V35, P211, DOI 10.1007/s10462-010-9191-9; Rao ARM, 2011, J REINF PLAST COMP, V30, P1703, DOI 10.1177/0731684411417198; Raquel CR, 2005, GEN EV COMP C GECCO; Ruiz C, 2009, INT C ROUGH SETS FUZ; Santana RA, 2009, INT C INT SYST DES A; Schroff F, 2015, PROC CVPR IEEE, P815, DOI 10.1109/CVPR.2015.7298682; Shen HY, 2005, ADV NATURAL COMPUTAT, P439; Shi Y, 1997, IEEE INT C EV COMP P; Song WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031929; Szilagyi SM, 2014, COMPUT BIOL MED, V48, P94, DOI 10.1016/j.compbiomed.2014.02.016; Van dM, 2003, 2003 CEC 03 2003 C; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Yan H, 2006, 2006 WCICA 2006 6 WO; Yang F, 2013, EXPERT SYSTEMS APPL, V40, P9847	46	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0188815	10.1371/journal.pone.0188815	http://dx.doi.org/10.1371/journal.pone.0188815			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206880	Green Published, gold, Green Submitted			2022-12-27	WOS:000417110700025
J	Shendre, A; Wiener, HW; Irvin, MR; Aouizerat, BE; Overton, ET; Lazar, J; Liu, CL; Hodis, HN; Limdi, NA; Weber, KM; Gange, SJ; Zhi, DG; Floris-Moore, MA; Ofotokun, I; Qi, QB; Hanna, DB; Kaplan, RC; Shrestha, S				Shendre, Aditi; Wiener, Howard W.; Irvin, Marguerite R.; Aouizerat, Bradley E.; Overton, Edgar T.; Lazar, Jason; Liu, Chenglong; Hodis, Howard N.; Limdi, Nita A.; Weber, Kathleen M.; Gange, Stephen J.; Zhi, Degui; Floris-Moore, Michelle A.; Ofotokun, Ighovwerha; Qi, Qibin; Hanna, David B.; Kaplan, Robert C.; Shrestha, Sadeep			Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS)	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; AFRICAN-AMERICANS; INFECTED PATIENTS; RISK-FACTORS; CAROTID ATHEROSCLEROSIS; GENE POLYMORPHISMS; LOCAL ANCESTRY; VARIANTS	Cardiovascular disease (CVD) is a major comorbidity among HIV-infected individuals. Common carotid artery intima-media thickness (cCIMT) is a valid and reliable subclinical measure of atherosclerosis and is known to predict CVD. We performed genome-wide association (GWA) and admixture analysis among 682 HIV-positive and 288 HIV-negative Black, non-Hispanic women from the Women's Interagency HIV study (WIHS) cohort using a combined and stratified analysis approach. We found some suggestive associations but none of the SNPs reached genome-wide statistical significance in our GWAS analysis. The top GWAS SNPs were rs2280828 in the region intergenic to mediator complex subunit 30 and exostosin glycosyltransferase 1 (MED30 broken vertical bar EXT1) among all women, rs2907092 in the catenin delta 2 (CTNND2) gene among HIV-positive women, and rs7529733 in the region intergenic to family with sequence similarity 5, member C and regulator of G-protein signaling 18 (FAM5C broken vertical bar RGS18) genes among HIV-negative women. The most significant local European ancestry associations were in the region intergenic to the zinc finger and SCAN domain containing 5D gene and NADH: ubiquinone oxidoreductase complex assembly factor 1 (ZSCAN5D broken vertical bar NDUF1) pseudogene on chromosome 19 among all women, in the region intergenic to vomeronasal 1 receptor 6 pseudogene and zinc finger protein 845 (VN1R6P broken vertical bar ZNF845) gene on chromosome 19 among HIV-positive women, and in the region intergenic to the SEC23-interacting protein and phosphatidic acid phosphatase type 2 domain containing 1A (SEC23IP broken vertical bar PPAPDC1A) genes located on chromosome 10 among HIV-negative women. A number of previously identified SNP associations with cCIMT were also observed and included rs2572204 in the ryanodine receptor 3 (RYR3) and an admixture region in the secretion-regulating guanine nucleotide exchange factor (SERGEF) gene. We report several SNPs and gene regions in the GWAS and admixture analysis, some of which are common across HIV-positive and HIV-negative women as demonstrated using meta-analysis, and also across the two analytic approaches (i.e., GWA and admixture). These findings suggest that local European ancestry plays an important role in genetic associations of cCIMT among black women from WIHS along with other environmental factors that are related to CVD and may also be triggered by HIV. These findings warrant confirmation in independent samples.	[Shendre, Aditi; Wiener, Howard W.; Irvin, Marguerite R.; Shrestha, Sadeep] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Aouizerat, Bradley E.] NYU, Bluestone Ctr Clin Res, New York, NY USA; [Aouizerat, Bradley E.] NYU, Dept Oral & Maxillofacial Surg, New York, NY USA; [Overton, Edgar T.] Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA; [Lazar, Jason] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; [Liu, Chenglong] Georgetown Univ, Med Ctr, Dept Med, Washington, DC 20007 USA; [Hodis, Howard N.] Univ Southern Calif, Atherosclerosis Res Unit, Los Angeles, CA USA; [Limdi, Nita A.] Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA; [Weber, Kathleen M.] Cook Cty Hlth & Hosp Syst, Hektoen Inst Med, Chicago, IL USA; [Gange, Stephen J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Zhi, Degui] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Floris-Moore, Michelle A.] Univ N Carolina, Sch Med, Dept Med, Div Infect Dis, Chapel Hill, NC USA; [Ofotokun, Ighovwerha] Emory Univ, Dept Med Infect Dis, Atlanta, GA 30322 USA; [Ofotokun, Ighovwerha] Grady Healthcare Syst, Atlanta, GA USA; [Qi, Qibin; Hanna, David B.; Kaplan, Robert C.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Shendre, Aditi] Indianapolis Univ Purdue Univ Indianapolis, Richard M Fairbanks Sch Publ Hlth, Indianapolis, IN USA; [Zhi, Degui] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA	University of Alabama System; University of Alabama Birmingham; New York University; New York University; University of Alabama System; University of Alabama Birmingham; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Georgetown University; University of Southern California; University of Alabama System; University of Alabama Birmingham; John H Stroger Junior Hospital Cook County; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Emory University; Yeshiva University; Albert Einstein College of Medicine; Indiana University System; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Health Science Center Houston	Shrestha, S (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA.	sshrestha@uab.edu	Gange, Stephen/AGY-5004-2022	Gange, Stephen/0000-0001-7842-512X; Overton, Edgar/0000-0002-4013-536X; Deloukas, Panos/0000-0001-9251-070X; Shendre, Aditi/0000-0003-4123-7613; Liu, Chenglong/0000-0001-8235-8513	WIHS: UAB-MS WIHS [U01-AI-103401]; Atlanta WIHS [U01-AI-103408]; Bronx WIHS [U01-A I-035004]; Brooklyn WIHS [U01-AI-031834]; Chicago WIHS [U01-A I-034993]; Metropolitan Washington WIHS [U01-AI-034994]; Miami WIHS [U01-AI-103397]; UNC WIHS [U01-AI-103390]; Connie Wofsy Women's HIV Study, Northern California [U01-AI-034989]; WIHS Data Management and Analysis Center [U01-AI-042590]; Southern California WIHS [U01-HD-032632]; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Cancer Institute (NCI); National Institute on Drug Abuse (NIDA); National Institute on Mental Health (NIMH); National Institute of Dental and Craniofacial Research (NIDCR); National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Deafness and other Communication Disorders (NIDCD); NIH Office of Research on Women's Health; UCSFCTSA [UL1-TR000004]; Atlanta CTSA [UL1-TR000454]; WIHS [R56HL125061];  [1R01HL126543];  [1R21HL120394];  [1R01HL083760];  [1R01HL095140]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL129892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	WIHS: UAB-MS WIHS; Atlanta WIHS; Bronx WIHS; Brooklyn WIHS; Chicago WIHS; Metropolitan Washington WIHS; Miami WIHS; UNC WIHS; Connie Wofsy Women's HIV Study, Northern California; WIHS Data Management and Analysis Center; Southern California WIHS; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Deafness and other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); UCSFCTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Atlanta CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); WIHS; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Data in this manuscript were collected by the Women's Interagency HIV Study (WIHS). The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. WIHS (Principal Investigators): UAB-MS WIHS (Michael Saag, Mirjam-Colette Kempf, and Deborah Konkle-Parker), U01-AI-103401; Atlanta WIHS (Ighovwerha Ofotokun and Gina Wingood), U01-AI-103408; Bronx WIHS (Kathryn Anastos), U01-A I-035004; Brooklyn WIHS (Howard Minkoff and Deborah Gustafson), U01-AI-031834; Chicago WIHS (Mardge Cohen and Audrey French), U01-A I-034993; Metropolitan Washington WIHS (Seble Kassaye), U01-AI-034994; Miami WIHS (Margaret Fischl and Lisa Metsch), U01-AI-103397; UNC WIHS (Adaora Adimora), U01-AI-103390; Connie Wofsy Women's HIV Study, Northern California (Ruth Greenblatt,Bradley Aouizerat, and Phyllis Tien), U01-AI-034989; WIHS Data Management and Analysis Center (Stephen Gange and Elizabeth Golub), U01-AI-042590; Southern California WIHS (Joel Milam), U01-HD-032632 (WIHSI-WIHS IV). The WIHS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID), with additional co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), and the National Institute on Mental Health (NIMH). Targeted supplemental funding for specific projects is also provided by the National Institute of Dental and Craniofacial Research (NIDCR), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Deafness and other Communication Disorders (NIDCD), and the NIH Office of Research on Women's Health. WIHS data collection is also supported by UL1-TR000004 (UCSFCTSA) and UL1-TR000454 (Atlanta CTSA). The cardiovascular substudies in WIHS are also supported by 1R01HL126543, 1R21HL120394, 1R01HL083760, 1R01HL095140. The analysis in this study was supported by the pilot project funds from WIHS (Pilot project PI: Shrestha) and R56HL125061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon MC, 2005, CLIN DIAGN LAB IMMUN, V12, P1013, DOI 10.1128/CDLI.12.9.1013-1019.2005; Baran Y, 2012, BIOINFORMATICS, V28, P1359, DOI 10.1093/bioinformatics/bts144; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Bhuiyan AR, 2007, J AM SOC HYPERTENS, V1, P362, DOI 10.1016/j.jash.2007.06.006; Bis JC, 2014, CIRC-CARDIOVASC GENE, V7, P359, DOI 10.1161/CIRCGENETICS.113.000116; Bis JC, 2011, NAT GENET, V43, P940, DOI 10.1038/ng.920; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Chen YC, 2015, INT J CARDIOL, V189, P264, DOI 10.1016/j.ijcard.2015.04.034; Chow FC, 2012, JAIDS-J ACQ IMM DEF, V60, P351, DOI 10.1097/QAI.0b013e31825c7f24; Coll B, 2005, AIDS, V19, P1877, DOI 10.1097/01.aids.0000183516.22266.dd; Coll B, 2006, CYTOKINE, V34, P51, DOI 10.1016/j.cyto.2006.03.013; Connelly JJ, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-33; Debette S, 2009, STROKE, V40, P2212, DOI 10.1161/STROKEAHA.108.537159; DeBusk LM, 2010, J EXP MED, V207, P77, DOI 10.1084/jem.20091097; Delaney JAC, 2010, AIDS, V24, P2201, DOI 10.1097/QAD.0b013e32833d2132; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dumont J, 2007, ARTERIOSCL THROM VAS, V27, P2120, DOI 10.1161/ATVBAHA.107.150458; Dumont J, 2007, J MED GENET, V44, P526, DOI 10.1136/jmg.2006.047449; Farnham PG, 2013, JAIDS-J ACQ IMM DEF, V64, P183, DOI 10.1097/QAI.0b013e3182973966; Feldman DN, 2009, AIDS EDUC PREV, V21, P81, DOI 10.1521/aeap.2009.21.3_supp.81; Fox ER, 2013, CIRC-CARDIOVASC GENE, V6, P37, DOI 10.1161/CIRCGENETICS.111.962365; Frasco MA, 2012, AIDS, V26, P2097, DOI 10.1097/QAD.0b013e3283593602; Gegenbauer K, 2012, BLOOD, V119, P3799, DOI 10.1182/blood-2011-11-390369; GeneCards, PATHW INT PLPP4 GEN; Gomez F, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0196-x; Goodarzi MO, 2009, ATHEROSCLEROSIS, V205, P503, DOI 10.1016/j.atherosclerosis.2008.12.038; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Heinritz W, 2009, ANN HUM GENET, V73, P283, DOI 10.1111/j.1469-1809.2009.00508.x; Hessler N, 2016, STROKE, V47, P2904, DOI 10.1161/STROKEAHA.116.013943; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Iemitsu M, 2014, EUR J APPL PHYSIOL, V114, P1421, DOI 10.1007/s00421-014-2862-5; Kanters SDJM, 1997, STROKE, V28, P665, DOI 10.1161/01.STR.28.3.665; Kaplan RC, 2008, AIDS, V22, P1615, DOI 10.1097/QAD.0b013e328300581d; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Lang R, 2007, PHARMACOL THERAPEUT, V115, P177, DOI 10.1016/j.pharmthera.2007.05.009; Lang S, 2010, AIDS, V24, P1228, DOI 10.1097/QAD.0b013e328339192f; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Liao YC, 2008, STROKE, V39, P3159, DOI 10.1161/STROKEAHA.108.522789; Lorenz MW, 2008, ATHEROSCLEROSIS, V196, P720, DOI 10.1016/j.atherosclerosis.2006.12.022; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Mackinnon MJ, 2016, MOL BIOL EVOL; Manolio TA, 2004, ARTERIOSCL THROM VAS, V24, P1567, DOI 10.1161/01.ATV.0000138789.11433.c1; Markus HS, 2013, STROKE, V44, P1220, DOI 10.1161/STROKEAHA.111.000217; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; Melton PE, 2013, CIRC-CARDIOVASC GENE, V6, P211, DOI 10.1161/CIRCGENETICS.113.000079; MITTAL CK, 1994, BIOCHEM BIOPH RES CO, V203, P8, DOI 10.1006/bbrc.1994.2141; Mooij HL, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001274; Nambi V, 2012, EUR HEART J, V33, P183, DOI 10.1093/eurheartj/ehr192; Natarajan P, 2016, CIRC-CARDIOVASC GENE, V9, P511, DOI 10.1161/CIRCGENETICS.116.001572; O'Donnell CJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S4; Oramasionwu CU, 2013, POPUL HEALTH MANAG, V16, P201, DOI 10.1089/pop.2012.0043; Oramasionwu Christine U, 2012, Open AIDS J, V6, P29, DOI 10.2174/1874613601206010029; Pasaniuc B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001371; Pollex Rebecca L, 2006, Curr Atheroscler Rep, V8, P206, DOI 10.1007/s11883-006-0075-z; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qin HZ, 2012, GENET EPIDEMIOL, V36, P235, DOI 10.1002/gepi.21616; Qin HZ, 2010, BIOINFORMATICS, V26, P2961, DOI 10.1093/bioinformatics/btq560; Rahman TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023248; Ruiz A, 2014, J BIOL CHEM, V289, P27665, DOI 10.1074/jbc.M114.570341; Sato J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107236; Schiano C, 2014, BBA-GENE REGUL MECH, V1839, P444, DOI 10.1016/j.bbagrm.2014.04.012; Seaberg EC, 2010, STROKE, V41, P2163, DOI 10.1161/STROKEAHA.110.583856; Selzer RH, 2001, ATHEROSCLEROSIS, V154, P185, DOI 10.1016/S0021-9150(00)00461-5; Shendre A, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001569; Shendre A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004739; Shendre A, 2014, ATHEROSCLEROSIS, V233, P666, DOI 10.1016/j.atherosclerosis.2014.01.035; Shrestha S, 2014, ARTERIOSCL THROM VAS, V34, P244, DOI 10.1161/ATVBAHA.113.302191; Shrestha S, 2012, AIDS, V26, P1571, DOI 10.1097/QAD.0b013e328355359f; Shrestha S, 2010, AIDS, V24, P583, DOI 10.1097/QAD.0b013e3283353c9e; Shriner D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002325; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Stein JH, 2013, AIDS, V27, P929, DOI 10.1097/QAD.0b013e32835ce27e; Touyz RM, 2008, AM J PHYSIOL-HEART C, V294, pH1103, DOI 10.1152/ajpheart.00903.2007; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Triant VA, 2013, CURR HIV-AIDS REP, V10, P199, DOI 10.1007/s11904-013-0168-6; Wang D, 2005, STROKE, V36, P540, DOI 10.1161/01.STR.0000155746.65185.4e; Wang LY, 2012, CIRC-CARDIOVASC GENE, V5, P234, DOI 10.1161/CIRCGENETICS.111.961763; Wassel CL, 2011, OBESITY, V19, P840, DOI 10.1038/oby.2010.229; Winkler CA, 2010, ANNU REV GENOM HUM G, V11, P65, DOI 10.1146/annurev-genom-082509-141523; Yazdanpanah M, 2006, DIABETES, V55, P2922, DOI 10.2337/db06-0302; Yorgov Daniel, 2014, BMC Proc, V8, pS6, DOI 10.1186/1753-6561-8-S1-S6; Zhang JQ, 2014, GENET EPIDEMIOL, V38, P502, DOI 10.1002/gepi.21835; Zhao JY, 2013, ATHEROSCLEROSIS, V226, P238, DOI 10.1016/j.atherosclerosis.2012.10.048	87	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2017	12	12							e0188725	10.1371/journal.pone.0188725	http://dx.doi.org/10.1371/journal.pone.0188725			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO7EC	29206233	Green Published, gold, Green Submitted			2022-12-27	WOS:000417033200013
J	Brittin, J; Frerichs, L; Sirard, JR; Wells, NM; Myers, BM; Garcia, J; Sorensen, D; Trowbridge, MJ; Huang, T				Brittin, Jeri; Frerichs, Leah; Sirard, John R.; Wells, Nancy M.; Myers, Beth M.; Garcia, Jeanette; Sorensen, Dina; Trowbridge, Matthew J.; Huang, Terry			Impacts of active school design on school-time sedentary behavior and physical activity: A pilot natural experiment	PLOS ONE			English	Article							CHILDREN; MODERATE; HEALTH; ADOLESCENTS; INDICATORS; OBESITY; GENDER; RECESS; AGE	Background Children spend a significant portion of their days in sedentary behavior (SB) and on average fail to engage in adequate physical activity (PA). The school built environment may influence SB and PA, but research is limited. This natural experiment evaluated whether an elementary school designed to promote movement impacted students' school-time SB and PA. Methods Accelerometers measured SB and PA at pre and post time-points in an intervention group who moved to the new school (n = 21) and in a comparison group experiencing no school environmental change (n = 20). Difference-in-difference (DD) analysis examined SB and PA outcomes in these groups. Measures were also collected post-intervention from an independent, grade-matched group of students in the new school (n = 21). Results As expected, maturational increases in SB were observed. However, DD analysis estimated that the intervention attenuated increase in SB by 81.2 +/- 11.4 minutes/day (p<0.001), controlling for time in moderate to vigorous physical activity (MVPA). The intervention was also estimated to increase daily number of breaks from SB by 23.4 +/- 2.6 (p<.001) and to increase light physical activity (LPA) by 67.7 +/- 10.7 minutes/day (p<0.001). However, the intervention decreased MVPA by 10.3 +/- 2.3 minutes/day (p<0.001). Results of gradematched independent samples analysis were similar, with students in the new vs. old school spending 90.5 +/- 16.1 fewer minutes/day in SB, taking 21.1 +/- 2.7 more breaks from SB (p<0.001), and spending 64.5 +/- 14.8 more minutes in LPA (p<0.001), controlling for time in MVPA. Students in the new school spent 13.1 +/- 2.7 fewer minutes in MVPA (p<0.001) than their counterparts in the old school. Conclusions This pilot study found that active school design had beneficial effects on SB and LPA, but not on MVPA. Mixed results point to a need for active classroom design strategies to mitigate SB, and quick access from classrooms to areas permissive of high-intensity activities to promote MVPA. Integrating active design with programs/policies to promote PA may yield greatest impact on PA of all intensities.	[Brittin, Jeri] HDR, Dept Built Environm Res, Omaha, NE 68114 USA; [Brittin, Jeri] Univ Nebraska, Coll Architecture, Dept Interior Design, Lincoln, NE 68588 USA; [Frerichs, Leah] Univ North Carolina Chapel Hill, Sch Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA; [Sirard, John R.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Kinesiol, Amherst, MA 01003 USA; [Wells, Nancy M.; Myers, Beth M.] Cornell Univ, Coll Human Ecol, Dept Design & Environm Anal, Ithaca, NY USA; [Garcia, Jeanette] Univ Cent Florida, Coll Educ & Human Sci, Dept Educ & Human Serv, Orlando, FL 32816 USA; [Sorensen, Dina] VMDO Architects, Charlottesville, VA USA; [Trowbridge, Matthew J.] Univ Virginia, Sch Med, Dept Emergency Med, Charlottesville, VA 22908 USA; [Huang, Terry] CUNY, Grad Ctr, Sch Publ Hlth, New York, NY USA	University of Nebraska System; University of Nebraska Lincoln; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Massachusetts System; University of Massachusetts Amherst; Cornell University; State University System of Florida; University of Central Florida; University of Virginia; City University of New York (CUNY) System	Brittin, J (corresponding author), HDR, Dept Built Environm Res, Omaha, NE 68114 USA.; Brittin, J (corresponding author), Univ Nebraska, Coll Architecture, Dept Interior Design, Lincoln, NE 68588 USA.	jeri.brittin@hdrinc.com	Brittin, Jeri/P-3780-2019	Brittin, Jeri/0000-0002-1316-6451; Huang, Terry/0000-0001-5544-5187	Youth-Nex, Center to Promote Effective Youth Development at the University of Virginia; Robert Wood Johnson Foundation [69550]; U.S. Department of Agriculture (USDA) through the Food & Nutrition Service (FNS) People's Garden pilot program [CN-CGP-11-0047]; Cornell University Agricultural Experiment Station [NYC-327-465]; Cornell Cooperative Extension (Smith Lever funds) through the National Institutes for Food and Agriculture (NIFA) USDA; Cornell University's Atkinson Center for a Sustainable Future (ACSF); College of Human Ecology, Cornell University; Bronfenbrenner Center for Translational Research (BCTR), Cornell University; Cornell Cooperative Extension Summer Intern Program; HDR; VMDO	Youth-Nex, Center to Promote Effective Youth Development at the University of Virginia; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); U.S. Department of Agriculture (USDA) through the Food & Nutrition Service (FNS) People's Garden pilot program; Cornell University Agricultural Experiment Station; Cornell Cooperative Extension (Smith Lever funds) through the National Institutes for Food and Agriculture (NIFA) USDA; Cornell University's Atkinson Center for a Sustainable Future (ACSF); College of Human Ecology, Cornell University; Bronfenbrenner Center for Translational Research (BCTR), Cornell University; Cornell Cooperative Extension Summer Intern Program; HDR; VMDO	The work in Virginia was partially supported by funding from Youth-Nex, the Center to Promote Effective Youth Development at the University of Virginia (co-Pls: Huang and Trowbridge). The New York data collection (PI: Wells) was funded in part by the Robert Wood Johnson Foundation through its Active Living Research Program (#69550). Federal funding was provided by the U.S. Department of Agriculture (USDA) through the Food & Nutrition Service (FNS) People's Garden pilot program (Project #CN-CGP-11-0047) and by the Cornell University Agricultural Experiment Station (Hatch funds) (#NYC-327-465) and Cornell Cooperative Extension (Smith Lever funds) through the National Institutes for Food and Agriculture (NIFA) USDA. Additional funding for the New York data came from: Cornell University's Atkinson Center for a Sustainable Future (ACSF); The College of Human Ecology, Cornell University; The Bronfenbrenner Center for Translational Research (BCTR), Cornell University; and the Cornell Cooperative Extension Summer Intern Program. Funding organizations played no role in the design, implementation, or publication of this study. HDR and VMDO provided support in the form of salaries for JB and DS, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aibar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121238; Allison KR, 2007, CAN J PUBLIC HEALTH, V98, P97, DOI 10.1007/BF03404317; Anderson PM, 2006, FUTURE CHILD, V16, P19, DOI 10.1353/foc.2006.0001; BARANOWSKI T, 1993, RES Q EXERCISE SPORT, V64, P127, DOI 10.1080/02701367.1993.10608789; Basterfield L, 2011, PEDIATRICS, V127, pE24, DOI 10.1542/peds.2010-1935; Brittin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132597; Cain KL, 2013, J PHYS ACT HEALTH, V10, P437, DOI 10.1123/jpah.10.3.437; Carlson JA, 2015, PREV MED, V81, P67, DOI 10.1016/j.ypmed.2015.08.006; Cliff DP, 2016, OBES REV, V17, P330, DOI 10.1111/obr.12371; Committee on Accelerating Progress in Obesity Prevention, 2012, ACCELERATING PROGR O; Cradock AL, 2007, AM J PREV MED, V33, P106, DOI 10.1016/j.amepre.2007.04.009; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Francis SL, 2013, MED SCI SPORT EXER, V45, P1508, DOI 10.1249/MSS.0b013e31828b2f3a; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hamer M, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4483-5; Hinckson E, 2016, SPORTS MED, V46, P977, DOI 10.1007/s40279-015-0436-2; Huang TTK, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120084; KLESGES RC, 1990, HEALTH PSYCHOL, V9, P435, DOI 10.1037/0278-6133.9.4.435; Kohl HW., 2013, ED STUD BOD TAK PHYS; Kwon S, 2013, J PEDIATR-US, V162, P1169, DOI 10.1016/j.jpeds.2012.11.071; MEYER BD, 1995, J BUS ECON STAT, V13, P151, DOI 10.2307/1392369; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Nettlefold L, 2011, BRIT J SPORT MED, V45, P813, DOI 10.1136/bjsm.2009.068072; Ojiambo R, 2011, INT J OBESITY, V35, pS98, DOI 10.1038/ijo.2011.40; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO, pA1, DOI DOI 10.1111/J.1753-4887.2008.00136.X; Pindus DM, 2014, INT J BEHAV MED, V21, P757, DOI 10.1007/s12529-013-9344-8; Ridgers ND, 2012, AM J PREV MED, V43, P320, DOI 10.1016/j.amepre.2012.05.019; Robusto KM, 2012, J SPORT SCI, V30, P1429, DOI 10.1080/02640414.2012.710761; Skala KA, 2012, J PHYS ACT HEALTH, V9, P481, DOI 10.1123/jpah.9.4.481; Stratton G, 2005, PREV MED, V41, P828, DOI 10.1016/j.ypmed.2005.07.009; Suchert V, 2015, PREV MED, V76, P48, DOI 10.1016/j.ypmed.2015.03.026; Toftager M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099369; Tomporowski PD, 2011, PREV MED, V52, pS3, DOI 10.1016/j.ypmed.2011.01.028; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; van Ekris E, 2016, OBES REV, V17, P833, DOI 10.1111/obr.12426; Wells NM, 2014, PREV MED, V69, pS27, DOI 10.1016/j.ypmed.2014.10.012	40	14	15	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189236	10.1371/journal.pone.0189236	http://dx.doi.org/10.1371/journal.pone.0189236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216300	Green Published, gold			2022-12-27	WOS:000417337800104
J	Gong, J; Bai, T; Zhang, L; Qian, W; Song, J; Hou, XH				Gong, Jing; Bai, Tao; Zhang, Lei; Qian, Wei; Song, Jun; Hou, Xiaohua			Inhibition effect of Bifidobacterium longum, Lactobacillus acidophilus, Streptococcus thermophilus and Enterococcus faecalis and their related products on human colonic smooth muscle in vitro	PLOS ONE			English	Article							ANTIBIOTIC-ASSOCIATED DIARRHEA; GUT MICROBIOTA; GASTROINTESTINAL MOTILITY; INTESTINAL MICROBIOTA; PROBIOTIC BACTERIA; RHAMNOSUS GG; METAANALYSIS; DISEASE; TRANSIT; PREVENTION	Objective To investigate the effects of four strains, generally used in clinic, including Bifidobacterium longum, Lactobacillus acidophilus, Streptococcus thermophilus and Enterococcus faecalis, and their related products on human colonic smooth muscle in vitro. Methods Human colonic circular muscle strips obtained from disease-free margins of resected segments from 25 patients with colorectal cancer were isometrically examined in a constant-temperature organ bath and exposed to different concentrations of living bacteria, sonicated cell fractions and cell-free supernatant (CFS). The area under the curve (AUC) representing the contractility of smooth muscle strips was calculated. Results (1) The four living probiotics inhibited the contractility of human colonic muscle strips only at high concentration (10 10 CFUs/mL, all P<0.05). (2) The sonicated cell fractions from the four probiotics obviously inhibited human colonic smooth muscle strips in a dose-dependent manner (P<0.01). (3) The CFS from the four probiotics also inhibited colonic smooth muscle strips in a dose-dependent manner (all P<0.05). (4) The inhibition effect of CFS from Streptococcus thermophilus and Enterococcus faecalis decreased obviously when pretreated with NG-nitro-L-arginine (L-NNA, 10(-5) mol/L) (P<0.05), but not the Bifidobacterium longum and Lactobacillus acidophilus (P>0.05). Conclusion Four common probiotics related products, including the sonicated cell fractions and the CFS, obviously inhibited human colonic smooth muscles strips contraction in a dose-dependent manner. Only high concentration living probiotics (10(10) CFUs/mL) can inhibit the colonic smooth muscles strips contraction. The NO pathway may be partly involved in the inhibitory effect of CFS from Streptococcus thermophilus and Enterococcus faecalis.	[Gong, Jing; Bai, Tao; Zhang, Lei; Qian, Wei; Song, Jun; Hou, Xiaohua] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Div Gastroenterol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Song, J (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Div Gastroenterol, Wuhan, Hubei, Peoples R China.	song111jun@126.com	Song, Jun/T-7177-2019; Bai, Tao/ABD-7952-2020	Song, Jun/0000-0002-0255-4547; 	 [81330014];  [81670488]	; 	This work was supported by 81330014, https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list, Xiaohua Hou, 2014.01 to 2018.12; 81670488, https://isisn.nsfc.gov.cn/egrantindex/funcindex/prisearch-list, Jun Song, 2017.01 to 2020.12.	Ammoscato F, 2013, NEUROGASTROENT MOTIL, V25, P984, DOI 10.1111/nmo.12232; Bar F, 2009, NEUROGASTROENT MOTIL, V21, P575, DOI 10.1111/j.1365-2982.2008.01258.x; Bermudez-Brito M, 2014, BRIT J NUTR, V111, P1727, DOI 10.1017/S0007114513004303; Dore J, 2013, UNITED EUR GASTROENT, V1, P311, DOI 10.1177/2050640613502477; Fijan S, 2014, INT J ENV RES PUB HE, V11, P4745, DOI 10.3390/ijerph110504745; Frazier Thomas H, 2011, JPEN J Parenter Enteral Nutr, V35, p14S, DOI 10.1177/0148607111413772; Gorbach SL, 2002, DIGEST LIVER DIS, V34, pS2, DOI 10.1016/S1590-8658(02)80155-4; Grasa L, 2015, MICROB ECOL, V70, P835, DOI 10.1007/s00248-015-0613-8; Guarino MPL, 2008, J CLIN GASTROENTEROL, V42, pS185, DOI 10.1097/MCG.0b013e31817e1cac; Kale-Pradhan PB, 2010, PHARMACOTHERAPY, V30, P119, DOI 10.1592/phco.30.2.119; Kashyap PC, 2013, GASTROENTEROLOGY, V144, P967, DOI 10.1053/j.gastro.2013.01.047; Korhonen R, 2001, INFLAMMATION, V25, P223, DOI 10.1023/A:1010971703271; Marchesi J, 2007, CURR OPIN INFECT DIS, V20, P508, DOI 10.1097/QCO.0b013e3282a56a99; Massi M, 2006, WORLD J GASTROENTERO, V12, P5987, DOI 10.3748/wjg.v12.i37.5987; Mayer EA, 2014, GASTROENTEROLOGY, V146, P1500, DOI 10.1053/j.gastro.2014.02.037; McFarland LV, 2006, AM J GASTROENTEROL, V101, P812, DOI 10.1111/j.1572-0241.2006.00465.x; Miller LE, 2013, WORLD J GASTROENTERO, V19, P4718, DOI 10.3748/wjg.v19.i29.4718; Molina MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127262; Orel R, 2014, WORLD J GASTROENTERO, V20, P11505, DOI 10.3748/wjg.v20.i33.11505; Ortiz-Lucas M, 2013, REV ESP ENFERM DIG, V105, P19, DOI 10.4321/s1130-01082013000100005; Reid G, 2003, J CLIN GASTROENTEROL, V37, P105, DOI 10.1097/00004836-200308000-00004; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sanders ME, 2013, GUT, V62, P787, DOI 10.1136/gutjnl-2012-302504; Sobko T, 2006, FREE RADICAL BIO MED, V41, P985, DOI 10.1016/j.freeradbiomed.2006.06.020; Valentin N, 2015, EXPERT OPIN INV DRUG, V24, P769, DOI 10.1517/13543784.2015.1025132; Vandeputte D, 2016, GUT, V65, P57, DOI 10.1136/gutjnl-2015-309618; Verdu EF, 2004, GASTROENTEROLOGY, V127, P826, DOI 10.1053/j.gastro.2004.06.007; Wichmann A, 2013, CELL HOST MICROBE, V14, P582, DOI 10.1016/j.chom.2013.09.012	28	9	9	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189257	10.1371/journal.pone.0189257	http://dx.doi.org/10.1371/journal.pone.0189257			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216305	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800109
J	Artioli, G; Angelini, I; Kaufmann, G; Canovaro, C; Dal Sasso, G; Villa, IM				Artioli, Gilberto; Angelini, Ivana; Kaufmann, Guenther; Canovaro, Caterina; Dal Sasso, Gregorio; Villa, Igor Maria			Long-distance connections in the Copper Age: New evidence from the Alpine Iceman's copper axe (vol 12, e0179263, 2017)	PLOS ONE			English	Correction													Artioli, Gilberto/F-2149-2015; Canovaro, Caterina/AAL-8642-2020; Dal Sasso, Gregorio/J-5074-2017	Artioli, Gilberto/0000-0002-8693-7392; Canovaro, Caterina/0000-0003-3147-0219; Dal Sasso, Gregorio/0000-0002-2176-5446				Artioli G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179263	1	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0189561	10.1371/journal.pone.0189561	http://dx.doi.org/10.1371/journal.pone.0189561			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP0ZD	29216312	Green Published, gold, Green Submitted			2022-12-27	WOS:000417337800134
J	West, GL; Zendel, BR; Konishi, K; Benady-Chorney, J; Bohbot, VD; Peretz, I; Belleville, S				West, Greg L.; Zendel, Benjamin Rich; Konishi, Kyoko; Benady-Chorney, Jessica; Bohbot, Veronique D.; Peretz, Isabelle; Belleville, Sylvie			Playing Super Mario 64 increases hippocampal grey matter in older adults	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; STRUCTURAL BRAIN PLASTICITY; CAUDATE-NUCLEUS; VIDEO GAMES; MEMORY; STRATEGIES; GRAY; PERFORMANCE; NAVIGATION; LESIONS	Maintaining grey matter within the hippocampus is important for healthy cognition. Playing 3D-platform video games has previously been shown to promote grey matter in the hippocampus in younger adults. In the current study, we tested the impact of 3D-platform video game training (i.e., Super Mario 64) on grey matter in the hippocampus, cerebellum, and the dorsolateral prefrontal cortex (DLPFC) of older adults. Older adults who were 55 to 75 years of age were randomized into three groups. The video game experimental group (VID; n = 8) engaged in a 3D-platform video game training over a period of 6 months. Additionally, an active control group took a series of self-directed, computerized music (piano) lessons (MUS; n = 12), while a no-contact control group did not engage in any intervention (CON; n = 13). After training, a within-subject increase in grey matter within the hippocampus was significant only in the VID training group, replicating results observed in younger adults. Active control MUS training did, however, lead to a within-subject increase in the DLPFC, while both the VID and MUS training produced growth in the cerebellum. In contrast, the CON group displayed significant grey matter loss in the hippocampus, cerebellum and the DLPFC.	[West, Greg L.; Zendel, Benjamin Rich; Peretz, Isabelle; Belleville, Sylvie] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [West, Greg L.; Peretz, Isabelle] Univ Montreal, Ctr Rech Neuropsychol & Cognit, Montreal, PQ, Canada; [West, Greg L.; Zendel, Benjamin Rich; Peretz, Isabelle] Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada; [Zendel, Benjamin Rich; Belleville, Sylvie] Inst Univ Geriatrie Montreal, Montreal, PQ, Canada; [Zendel, Benjamin Rich] Mem Univ Newfoundland, Fac Med, Div Community Hlth & Humanities, St John, NF, Canada; [Konishi, Kyoko; Benady-Chorney, Jessica; Bohbot, Veronique D.] McGill Univ, Dept Psychiat, Douglas Hosp, Res Ctr, Verdun, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Memorial University Newfoundland; McGill University	West, GL (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.; West, GL (corresponding author), Univ Montreal, Ctr Rech Neuropsychol & Cognit, Montreal, PQ, Canada.; West, GL (corresponding author), Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada.	gregory.west@umontreal.ca		West, Greg/0000-0002-2469-8728	Canadian Institutes of Health Research; Natural science and engineering research council of Canada [436140-2013]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural science and engineering research council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by Canadian Institutes of Health Research, http://www.cihr-irsc.gc.ca/e/193.html, to Sylvie Belleville; Natural science and engineering research council of Canada (436140-2013) to Greg L West, http://www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Apostolova LG, 2006, ARCH NEUROL-CHICAGO, V63, P693, DOI 10.1001/archneur.63.5.693; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BALOH RW, 1995, J AM GERIATR SOC, V43, P638, DOI 10.1111/j.1532-5415.1995.tb07198.x; Bernard JA, 2013, CEREBELLUM, V12, P721, DOI 10.1007/s12311-013-0481-z; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Bohbot VD, 2007, J NEUROSCI, V27, P10078, DOI 10.1523/JNEUROSCI.1763-07.2007; Clemenson GD, 2015, J NEUROSCI, V35, P16116, DOI 10.1523/JNEUROSCI.2580-15.2015; Desmond JE, 1998, TRENDS COGN SCI, V2, P355, DOI 10.1016/S1364-6613(98)01211-X; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; Entertainment Software Association, 2014, GAMASUTRA; Entertainment Software Association, 2016, ESS FACTS COMP VID G; Eskildsen SF, 2012, NEUROIMAGE, V59, P2362, DOI 10.1016/j.neuroimage.2011.09.012; Etchamendy N, 2007, HIPPOCAMPUS, V17, P595, DOI 10.1002/hipo.20303; Filippi M, 1998, J NEUROL NEUROSUR PS, V64, pS88; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Head D, 2010, BEHAV BRAIN RES, V209, P49, DOI 10.1016/j.bbr.2010.01.012; Iaria G, 2003, J NEUROSCI, V23, P5945; Ilg R, 2008, J NEUROSCI, V28, P4210, DOI 10.1523/JNEUROSCI.5722-07.2008; Konishi K, 2013, HIPPOCAMPUS, V23, P1005, DOI 10.1002/hipo.22181; Konishi K, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00001; Kuhn S, 2014, MOL PSYCHIATR, V19, P265, DOI 10.1038/mp.2013.120; Kuhn S, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.53; Kuhn S., 2013, MOL PSYCHIAT; Lerch JP, 2011, NEUROIMAGE, V54, P2086, DOI 10.1016/j.neuroimage.2010.09.086; Lovden M, 2013, NEUROSCI BIOBEHAV R, V37, P2296, DOI 10.1016/j.neubiorev.2013.02.014; Lovden M., 2012, NEUROBIOL AGING, V620, pe9, DOI DOI 10.1016/J.NEUR0BI0LAGING.2011.02.013; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Menard MC, 2009, BRAIN COGNITION, V71, P38, DOI 10.1016/j.bandc.2009.03.008; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; PACKARD MG, 1989, J NEUROSCI, V9, P1465; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Sadedin SP, 2012, BIOINFORMATICS, V28, P1525, DOI 10.1093/bioinformatics/bts167; Schinazi VR, 2013, HIPPOCAMPUS, V23, P515, DOI 10.1002/hipo.22111; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Swan GE, 2007, NEUROPSYCHOL REV, V17, P259, DOI 10.1007/s11065-007-9035-9; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Voss MW, 2012, NEUROIMAGE, V59, P138, DOI 10.1016/j.neuroimage.2011.03.052; Wan CY, 2010, NEUROSCIENTIST, V16, P566, DOI 10.1177/1073858410377805; West GL, 2017, MOL PSYCHIAT; West GL, 2017, CURR DIR PSYCHOL SCI, V26, P152, DOI 10.1177/0963721416687342; West GL, 2013, ACTA PSYCHOL, V142, P38, DOI 10.1016/j.actpsy.2011.08.005; West GL, 2008, J VISION, V8, DOI 10.1167/8.16.13; Woollett K, 2011, CURR BIOL, V21, P2109, DOI 10.1016/j.cub.2011.11.018; Yoon U, 2009, NEUROIMAGE, V45, P769, DOI 10.1016/j.neuroimage.2008.12.046; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	48	32	33	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0187779	10.1371/journal.pone.0187779	http://dx.doi.org/10.1371/journal.pone.0187779			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9MS	29211727	Green Published, Green Submitted, gold			2022-12-27	WOS:000417212200020
J	Cambonie, G; Muller, JB; Ehlinger, V; Roy, J; Guedeney, A; Lebeaux, C; Kaminski, M; Alberge, C; Denizot, S; Ancel, PY; Arnaud, C				Cambonie, Gilles; Muller, Jean-Baptiste; Ehlinger, Virginie; Roy, Joel; Guedeney, Antoine; Lebeaux, Cecile; Kaminski, Monique; Alberge, Corine; Denizot, Sophie; Ancel, Pierre-Yves; Arnaud, Catherine		OLIMPE Study Writing Grp	Mother-infant interaction assessment at discharge and at 6 months in a French cohort of infants born very preterm: The OLIMPE study	PLOS ONE			English	Article							POSTTRAUMATIC STRESS; BEHAVIORAL OUTCOMES; CHILDREN BORN; BIRTH; RISK; AGE; PREMATURITY; ATTACHMENT; ANXIETY; CARE	Objectives The principal aim was to investigate the feasibility of assessing mother-infant interactions at discharge and at 6 months infant corrected age in singletons born before 32 weeks of gestation. The secondary aims were to describe these interactions and their disorders, explore the association between maternal emotional state and the interactions, and assess the relationship between disordered interactions and infant social withdrawal behaviour. Methods OLIMPE is an ancillary study of the population-based study EPIPAGE 2, which recruited preterm neonates in France in 2011. 163 dyads participated at discharge and 148 at 6 months. Interactions were observed with the Attachment During Stress (ADS) scale, which includes two behavioural subscales, for the mother (m-ADS) and her infant (i-ADS). Two professionals independently completed the ADS scales for one third of the observations. Maternal emotional state was assessed using self-administered questionnaires of depression, anxiety, and stress. Infant's social withdrawal behaviour at 6 months was measured by the Alarm Distress Baby scale. Results At discharge, 15.3% of the m-ADS scales and 43.3% of the i-ADS scales had at least one unobserved component. At 6 months, all items on both scales were noticeable in >90% of the dyads. Reliability, estimated by the kappa coefficient, ranged between 0.39 and 0.76 at discharge, and between 0.21 and 0.69 at 6 months. Disordered interactions were indicated on 48.6% of the m-ADS scales and 36.5% of the i-ADS scales at discharge. At 6 months, these rates were 32.6% and 26.0%. Disordered interactions at 6 months were associated with identified disorder at discharge. Insecure infant attachment was not influenced by maternal mental health but was strongly associated with infant social withdrawal behaviour. Conclusions The ADS scale can be used to screen for early interaction disorders after premature birth and may help to target dyads that would most benefit from early intervention.	[Cambonie, Gilles] Arnaud Villeneuve Univ Hosp, Dept Neonatal Med, Montpellier, France; [Muller, Jean-Baptiste; Denizot, Sophie] Womens & Childrens Univ Hosp, Dept Neonatal Med, Nantes, France; [Ehlinger, Virginie; Arnaud, Catherine] Univ Paul Sabatier Toulouse III, INSERM, UMR 1027, Toulouse, France; [Roy, Joel] Nimes Univ Hosp, Child & Adolescent Psychiat Unit, Nimes, France; [Guedeney, Antoine] Bichat Claude Bernard Univ Hosp, Child & Adolescent Psychiat Unit, Paris, France; [Lebeaux, Cecile; Kaminski, Monique; Ancel, Pierre-Yves] Paris Descartes Univ, DHU Risks Pregnancy, Ctr Epidemiol & Stat,Inserm UMR 1153, Sorbonne Paris Cite,Obstet Perinatal & Paediat Ep, Paris, France; [Alberge, Corine] Childrens Univ Hosp, Dept Neonatal Med, Toulouse, France	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Montpellier; CHU de Nimes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse	Cambonie, G (corresponding author), Arnaud Villeneuve Univ Hosp, Dept Neonatal Med, Montpellier, France.	g-cambonie@chu-montpellier.fr	ARNAUD, Catherine/AAC-5646-2019	ARNAUD, Catherine/0000-0002-4002-802X	French Institute of Public Health Research/Institute of Public Health; French Health Ministry; National Institute of Health and Medical Research; National Institute of Cancer; National Solidarity Fund for Autonomy; PremUp Foundation; Foundation of France; National Research Agency [ANR-11-EQPX-0038]	French Institute of Public Health Research/Institute of Public Health; French Health Ministry; National Institute of Health and Medical Research(Institut National de la Sante et de la Recherche Medicale (Inserm)); National Institute of Cancer; National Solidarity Fund for Autonomy; PremUp Foundation; Foundation of France(Fondation de France); National Research Agency(French National Research Agency (ANR))	EPIPAGE 2 was supported by the French Institute of Public Health Research/Institute of Public Health and its partners the French Health Ministry, the National Institute of Health and Medical Research, the National Institute of Cancer, and the National Solidarity Fund for Autonomy; grant ANR-11-EQPX-0038 to Pierre-Yves Ancel from the National Research Agency through the French Equipex Program of Investments in the Future; and the PremUp Foundation. OLIMPE study was supported by the Foundation of France to Catherine Arnaud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Als H, 2005, MENT RETARD DEV D R, V11, P94, DOI 10.1002/mrdd.20053; Ancel PY, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-97; Back SA, 2014, ANN NEUROL, V75, P469, DOI 10.1002/ana.24132; Beaino G, 2011, ACTA PAEDIATR, V100, P370, DOI 10.1111/j.1651-2227.2010.02064.x; Beauport L, 2017, J PEDIATR-US, V181, P29, DOI 10.1016/j.jpeds.2016.09.073; Beer C, 2013, EARLY HUM DEV, V89, P555, DOI 10.1016/j.earlhumdev.2013.02.006; Britton JR, 2006, PEDIATRICS, V118, pE1436, DOI 10.1542/peds.2005-2916; Callaghan WM, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.09.097; Carcamo R. A., 2013, J CHILD FAM STUD, V23, P766; Causadias JM, 2011, ATTACH HUM DEV, V13, P193, DOI 10.1080/14616734.2011.554008; CENSULLO M, 1987, NURS RES, V36, P244; Coughlin M, 2009, J ADV NURS, V65, P2239, DOI 10.1111/j.1365-2648.2009.05052.x; Crittenden P. M., CLIN IMPLICATIONS AT, P136; Dennis CL, 2013, J AFFECT DISORDERS, V150, P1217, DOI 10.1016/j.jad.2013.05.049; Ego A, 2006, AM J OBSTET GYNECOL, V194, P1042, DOI 10.1016/j.ajog.2005.10.816; Eutrope J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104093; Forcada-Guex M, 2006, PEDIATRICS, V118, pE107, DOI 10.1542/peds.2005-1145; Forcada-Guex M, 2011, EARLY HUM DEV, V87, P21, DOI 10.1016/j.earlhumdev.2010.09.006; Gerhold M, 2002, CHILD PSYCHIAT HUM D, V32, P277, DOI 10.1023/A:1015218527147; Guedeney A, 2001, INFANT MENT HEALTH J, V22, P559, DOI 10.1002/imhj.1018; Guedeney A, 2013, INFANT MENT HEALTH J, V34, P516, DOI 10.1002/imhj.21412; Guedeney A, 2012, EUR CHILD ADOLES PSY, V21, P185, DOI 10.1007/s00787-012-0250-4; Hale A K, 1999, J Pediatr Health Care, V13, P230, DOI 10.1016/S0891-5245(99)90004-4; Huhtala M, 2014, EARLY HUM DEV, V90, P119, DOI 10.1016/j.earlhumdev.2013.12.009; Hynan MT, 2013, J PERINATOL, V33, P748, DOI 10.1038/jp.2013.72; Johnson S, 2015, ARCH DIS CHILD-FETAL, V100, pF301, DOI 10.1136/archdischild-2014-307684; Lahti M, 2017, J AM ACAD CHILD PSY, V56, P30, DOI 10.1016/j.jaac.2016.10.007; Laughon M, 2009, PEDIATRICS, V124, P637, DOI 10.1542/peds.2008-2874; Lazaro J, 2013, STAT SOFTWARE COMPON; Lopez-Maestro M, 2017, EARLY HUM DEV, V104, P1, DOI 10.1016/j.earlhumdev.2016.11.003; Martins C, 2000, J CHILD PSYCHOL PSYC, V41, P737, DOI 10.1111/1469-7610.00661; Massie HN, 1983, FRONTIERS INFANT PSY, P394; Milligan DWA, 2010, ARCH DIS CHILD-FETAL, V95, pF234, DOI 10.1136/adc.2008.143685; Muller-Nix C, 2004, EARLY HUM DEV, V79, P145, DOI 10.1016/j.earlhumdev.2004.05.002; Petit AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151091; Pierrat V, 2016, PEDIATR CRIT CARE ME, V17, P957, DOI 10.1097/PCC.0000000000000914; Pierrehumbert B, 2004, ANN MED-PSYCHOL, V162, P711, DOI 10.1016/j.amp.2003.10.017; Prady SL, 2016, EUR CHILD ADOLES PSY, V25, P601, DOI 10.1007/s00787-015-0777-2; RADLOFF LS, 1977, J APPL PSYCHOL MEASU, V1, P385, DOI DOI 10.1177/014662167700100306; Ravn IH, 2011, INFANT BEHAV DEV, V34, P215, DOI 10.1016/j.infbeh.2010.11.004; Sameroff A., 2009, T MODEL DEV CHILDREN, DOI DOI 10.1037/11877-001; Schlapbach LJ, 2011, PEDIATRICS, V128, pE348, DOI 10.1542/peds.2010-3338; Spittle AJ, 2010, PEDIATRICS, V126, pE171, DOI 10.1542/peds.2009-3137; Treyvaud K, 2014, SEMIN FETAL NEONAT M, V19, P131, DOI 10.1016/j.siny.2013.10.008; Treyvaud K, 2009, PEDIATRICS, V123, P555, DOI 10.1542/peds.2008-0477; Tryphonopoulos PD, 2014, INFANT MENT HEALTH J, V35, P642, DOI 10.1002/imhj.21461; Wijnroks L, 1999, INF MENTAL HLTH J, V20, P393, DOI 10.1002/(SICI)1097-0355(199924)20:4<393::AID-IMHJ3>3.0.CO;2-I; Wolke D, 2015, J PEDIATR-US, V166, P1417, DOI 10.1016/j.jpeds.2015.02.055; Zelkowitz P, 2011, ACTA PAEDIATR, V100, P700, DOI 10.1111/j.1651-2227.2010.02128.x; Zelkowitz P, 2009, EARLY HUM DEV, V85, P51, DOI 10.1016/j.earlhumdev.2008.06.010	50	13	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2017	12	12							e0188942	10.1371/journal.pone.0188942	http://dx.doi.org/10.1371/journal.pone.0188942			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP0ZD	29216238	Green Submitted, gold, Green Published			2022-12-27	WOS:000417337800049
J	Elliott, AD; Bedard, N; Ustione, A; Baird, MA; Davidson, MW; Tkaczyk, T; Piston, DW				Elliott, Amicia D.; Bedard, Noah; Ustione, Alessandro; Baird, Michelle A.; Davidson, Michael W.; Tkaczyk, Tomasz; Piston, David W.			Hyperspectral imaging for simultaneous measurements of two FRET biosensors in pancreatic beta-cells	PLOS ONE			English	Article							FLUORESCENT PROTEIN FRET; MAPPING SPECTROMETER; MICROSCOPY; OPTIMIZATION; APOPTOSIS	Fluorescent protein (FP) biosensors based on Forster resonance energy transfer (FRET) are commonly used to study molecular processes in living cells. There are FP-FRET biosensors for many cellular molecules, but it remains difficult to perform simultaneous measurements of multiple biosensors. The overlapping emission spectra of the commonly used FPs, including CFP/YFP and GFP/RFP make dual FRET measurements challenging. In addition, a snapshot imaging modality is required for simultaneous imaging. The Image Mapping Spectrometer (IMS) is a snapshot hyperspectral imaging system that collects high resolution spectral data and can be used to overcome these challenges. We have previously demonstrated the IMS's capabilities for simultaneously imaging GFP and CFP/YFP-based biosensors in pancreatic beta-cells. Here, we demonstrate a further capability of the IMS to image simultaneously two FRET biosensors with a single excitation band, one for cAMP and the other for Caspase-3. We use these measurements to measure simultaneously cAMP signaling and Caspase-3 activation in pancreatic beta-cells during oxidative stress and hyperglycemia, which are essential components in the pathology of diabetes.	[Elliott, Amicia D.] Natl Inst Gen Med Sci, Bethesda, MD USA; [Bedard, Noah; Tkaczyk, Tomasz] Rice Univ, Bioengn, Houston, TX USA; [Ustione, Alessandro; Piston, David W.] Washington Univ, St Louis, MO 63130 USA; [Baird, Michelle A.; Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA	National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); Rice University; Washington University (WUSTL); State University System of Florida; Florida State University	Piston, DW (corresponding author), Washington Univ, St Louis, MO 63130 USA.	piston@wustl.edu		Elliott, Amicia/0000-0002-3089-1786	National Institutes of Health [CA124319, DK085064, DK098659, EB009186, EB016832, GM117582]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants CA124319, DK085064, DK098659, EB009186, EB016832, and GM117582. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Arai Y, 2013, MICROSCOPY-JPN, V62, P419, DOI 10.1093/jmicro/dft037; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen SY, 2014, BIOMED OPT EXPRESS, V5, P338, DOI 10.1364/BOE.5.000338; Elliott AD, 2012, J CELL SCI, V125, P4833, DOI 10.1242/jcs.108258; Favreau PF, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.4.046010; Gao LA, 2010, OPT EXPRESS, V18, P14330, DOI 10.1364/OE.18.014330; Grant DM, 2008, BIOPHYS J, V95, pL69, DOI 10.1529/biophysj.108.139204; Jonas JC, 2001, J BIOL CHEM, V276, P35375, DOI 10.1074/jbc.M105020200; Klarenbeek JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019170; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Lavagnino Z, 2016, BIOPHYS J, V111, P409, DOI 10.1016/j.bpj.2016.06.014; Lerner J. M., 2010, CURRENT PROTOCOLS CY; Li N, 2012, DIABETES, V61, P2842, DOI 10.2337/db12-0009; Mansfield JR, 2010, METHODS, V52, P271, DOI 10.1016/j.ymeth.2010.10.001; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Nagai T, 2004, BIOCHEM BIOPH RES CO, V319, P72, DOI 10.1016/j.bbrc.2004.04.147; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Rizzo MA, 2005, BIOPHYS J, V88, pL14, DOI 10.1529/biophysj.104.055442; Rizzo MA., 2009, COLD SPRING HARB PRO, V2009, DOI [10.1101/pdb.ip64, DOI 10.1101/PDB.IP64]; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Zimmermann T, 2005, ADV BIOCHEM ENG BIOT, V95, P245, DOI 10.1007/b102216	23	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0188789	10.1371/journal.pone.0188789	http://dx.doi.org/10.1371/journal.pone.0188789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211763	Green Published, gold, Green Submitted			2022-12-27	WOS:000417212200048
J	Saggu, SK; Mishra, PC				Saggu, Sandeep Kaur; Mishra, Prakash Chandra			Characterization of thermostable alkaline proteases from Bacillus infantis SKS1 isolated from garden soil	PLOS ONE			English	Article							FIBRINOLYTIC ENZYME; SP NOV.; PURIFICATION	Proteases are one of the largest groups of hydrolytic enzymes constituting about 60% of total worldwide sales of industrial enzymes due to their wide applications in detergent, leather, textile, food and pharmaceutical industry. Microbial proteases have been preferred over animal and plant proteases because of their fundamental features and ease in production. Bacillus infantis SKS1, an alkaline protease producing bacteria has been isolated from garden soil of north India and identified using morphological, biochemical and molecular methods. 16S rDNA sequence amplified using universal primers has 99% sequence identity with corresponding gene sequence of Bacillus infantis strain FM 34 and Bacillus sp. Beige. The bacterial culture and its 16S rDNA gene sequence have been deposited to Microbial Culture Collection (Pune, India) with accession number MCC 3035 and GenBank with accession number KR092197 respectively. The partially purified extract of Bacillus infantis SKS1 was thermostable and active in presence of Mg2+, acetyl acetone and laundry detergents implicating its application in industry. Production of these enzymes using this strain was maximized by optimization of various parameters including temperature, pH, media components and other growth conditions. Our results show that fructose and dextrose serve as the best carbon sources for production of these enzymes, highlighting the use of this strain for enzyme production utilizing relatively inexpensive substrates like beet molasses and corn steep liquor. Additionally, this strain showed maximum production of enzymes at 40 degrees C similar to bacterial species used for commercial production of alkaline proteases. Characterization of alkaline proteases from this strain of Bacillus infantis and optimization of parameters for its production would help in understanding its industrial application and large-scale production.	[Saggu, Sandeep Kaur; Mishra, Prakash Chandra] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India	Guru Nanak Dev University	Mishra, PC (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India.	pm.biotech@gndu.ac.in		Mishra, Prakash Chandra/0000-0002-6059-7174				Akbar SM, 2017, ARCH INSECT BIOCHEM, V94, DOI 10.1002/arch.21367; Banerjee UC, 1999, PROCESS BIOCHEM, V35, P213, DOI 10.1016/S0032-9592(99)00053-9; Banik RM, 2004, MICROBIOL RES, V159, P135, DOI 10.1016/j.micres.2004.01.002; Beg QK, 2002, PROCESS BIOCHEM, V37, P1103, DOI 10.1016/S0032-9592(01)00320-X; Bester DJ, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-64; BHOSALE SH, 1995, ENZYME MICROB TECH, V17, P136, DOI 10.1016/0141-0229(94)00045-S; Boominadhan U., 2009, BOT RES INT, V2, P83; Chatterjee S, 2015, J ADV PHARM TECHNOL, V6, P2, DOI 10.4103/2231-4040.150361; Chellappan S, 2011, J IND MICROBIOL BIOT, V38, P743, DOI 10.1007/s10295-010-0914-3; Chen TL, 2006, EXTREMOPHILES, V10, P35, DOI 10.1007/s00792-005-0469-9; Choudhary V., 2012, J ACAD IND RES, V1, P301; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Cui H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123926; Dewan S., 2017, GLOBAL MARKETS ENZYM; El Hidri D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/648141; Ellaiah P, 2002, J SCI IND RES INDIA, V61, P690; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; Hindhumathi M., 2011, Research in Biotechnology, V2, P13; HINMAN RL, 1994, CHEMTECH, V24, P45; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Johnvesly B, 2001, PROCESS BIOCHEM, V37, P139, DOI 10.1016/S0032-9592(01)00191-1; Kang BS, 1999, J MICROBIOL, V37, P14; Ko KS, 2006, INT J SYST EVOL MICR, V56, P2541, DOI 10.1099/ijs.0.64213-0; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kranthi V. S., 2012, CENTRAL EUR J EXP BI, V1, P113; Kumar CG, 2002, LETT APPL MICROBIOL, V34, P13, DOI [10.1046/j.1472-765x.2002.01044.x, 10.1046/j.1472-765X.2002.01044.x]; Kumar D J Mukesh, 2014, Pak J Biol Sci, V17, P529; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; Mienda BS., 2014, RES J PHARM BIOL CHE, V5, P388, DOI DOI 10.1007/S00253-002-1142-1; Nallusamy S, 2016, OPEN BIOTECHNOLOGY J, V10, P335, DOI [10.2174/1874070701610010335, DOI 10.2174/1874070701610010335]; Nascimento TP, 2016, J CHROMATOGR B, V1025, P16, DOI 10.1016/j.jchromb.2016.04.046; Nisha S, 2014, AFR J BIOTECHNOL, V13, P1707; Niyonzima FN, 2015, PREP BIOCHEM BIOTECH, V45, P233, DOI 10.1080/10826068.2014.907183; Oda K, 2012, J BIOCHEM, V151, P13, DOI 10.1093/jb/mvr129; Pammi N, 2015, INT J ENV BIOL, V5, P32; Pathak AP, 2012, INDIAN J EXP BIOL, V50, P569; Patil U, 2013, ISRN BIOCH; Paul D, 2007, BANGLADESH J MICROBI, V24, P57, DOI DOI 10.3329/BJM.V24I1.1239; Peng Y, 2003, COMP BIOCHEM PHYS B, V134, P45, DOI 10.1016/S1096-4959(02)00183-5; Rao K, 2007, AFR J BIOTECHNOL, V6, P2493; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Sakpal H.C., 2015, J PHARM BIOL SCI, V10, P58; Santos e Silva F. de A., 2016, African Journal of Agricultural Research, V11, P3733; Singh J, 2001, PROCESS BIOCHEM, V36, P781, DOI 10.1016/S0032-9592(00)00275-2; SINISTERRA JV, 1992, ULTRASONICS, V30, P180, DOI 10.1016/0041-624X(92)90070-3; Sivanandhini T, 2015, RES J PHARM BIOL CHE, V6, P1234; Stanbury PF, 1984, PRINCIPLES FERMENTAT; Suganthi C., 2013, J GENET ENG BIOTECHN, V11, P47, DOI [10.1016/j.jgeb.2013.02.002, DOI 10.1016/J.JGEB.2013.02.002]; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thangam EB, 2002, BIOTECHNOL APPL BIOC, V35, P149, DOI 10.1042/BA20010013; Wilson P, 2012, AFR J MICROBIOL RES, V6, P5542, DOI 10.5897/AJMR11.158	52	25	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188724	10.1371/journal.pone.0188724	http://dx.doi.org/10.1371/journal.pone.0188724			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190780	Green Published, gold, Green Submitted			2022-12-27	WOS:000416841900109
J	Airhart, SE; Shireman, LM; Risler, LJ; Anderson, GD; Gowda, GAN; Raftery, D; Tian, R; Shen, DD; O'Brien, KD				Airhart, Sophia E.; Shireman, Laura M.; Risler, Linda J.; Anderson, Gail D.; Gowda, G. A. Nagana; Raftery, Daniel; Tian, Rong; Shen, Danny D.; O'Brien, Kevin D.			An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD plus levels in healthy volunteers	PLOS ONE			English	Article							HEART-FAILURE; CARDIAC METABOLISM; MONONUCLEOTIDE; SURVIVAL; MICE	Objectives The co-primary objectives of this study were to determine the human pharmacokinetics (PK) of oral NR and the effect of NR on whole blood nicotinamide adenine dinucleotide (NAD+) levels. Background Though mitochondrial dysfunction plays a critical role in the development and progression of heart failure, no mitochondria-targeted therapies have been translated into clinical practice. Recent murine studies have reported associations between imbalances in the NADH/NAD+ ratio with mitochondrial dysfunction in multiple tissues, including myocardium. Moreover, an NAD+ precursor, nicotinamide mononucleotide, improved cardiac function, while another NAD+ precursor, nicotinamide riboside (NR), improved mitochondrial function in muscle, liver and brown adipose. Thus, PK studies of NR in humans is critical for future clinical trials. Methods In this non-randomized, open-label PK study of 8 healthy volunteers, 250 mg NR was orally administered on Days 1 and 2, then uptitrated to peak dose of 1000 mg twice daily on Days 7 and 8. On the morning of Day 9, subjects completed a 24-hour PK study after receiving 1000 mg NR at t = 0. Whole-blood levels of NR, clinical blood chemistry, and NAD+ levels were analyzed. Results Oral NR was well tolerated with no adverse events. Significant increases comparing baseline to mean concentrations at steady state (C-ave,C-ss) were observed for both NR (p = 0.03) and NAD+ (p = 0.001); the latter increased by 100%. Absolute changes from baseline to Day 9 in NR and NAD+ levels correlated highly (R-2 = 0.72, p = 0.008). Conclusions Because NR increases circulating NAD+ in humans, NR may have potential as a therapy in patients with mitochondrial dysfunction due to genetic and/or acquired diseases.	[Airhart, Sophia E.; O'Brien, Kevin D.] Univ Washington, Sch Med, Dept Med, Div Cardiol, Seattle, WA 98195 USA; [Shireman, Laura M.; Risler, Linda J.; Shen, Danny D.] Univ Washington, Sch Pharm, Dept Pharmaceut, Seattle, WA 98195 USA; [Anderson, Gail D.; Shen, Danny D.] Univ Washington, Sch Pharm, Dept Pharm, Seattle, WA 98195 USA; [Gowda, G. A. Nagana; Raftery, Daniel] Northwest Metabol Res Ctr, Dept Anesthesiol & Pain Med, Seattle, WA USA; [Gowda, G. A. Nagana; Raftery, Daniel] Univ Washington, Seattle, WA 98195 USA; [Gowda, G. A. Nagana; Raftery, Daniel; Tian, Rong] Univ Washington, Mitochondria & Metab Ctr, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Airhart, Sophia E.] Allegheny Gen Hosp, Dept Med, Pittsburgh, PA 15212 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Allegheny General Hospital	O'Brien, KD (corresponding author), Univ Washington, Sch Med, Dept Med, Div Cardiol, Seattle, WA 98195 USA.	cardiac@uw.edu	Tian, Rong/ABH-1383-2020; O'Brien, Kevin/CAH-4638-2022; O'Brien, Kevin Douglas/HDO-1461-2022	Tian, Rong/0000-0002-3676-3830; O'Brien, Kevin/0000-0002-2293-9196; O'Brien, Kevin Douglas/0000-0002-2293-9196	 [HL126209-01S1];  [HL110349];  [UL1TR000423];  [P30DK035816];  [15POST22560002]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK035816] Funding Source: NIH RePORTER	; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by HL126209-01S1, nhlbi.nih.gov, KDO and RT; HL110349, nhlbi.nih.gov, RT; UL1TR000423, ncrr.nih.gov; P30DK035816, niddk.nih.gov; 15POST22560002, heart.org, SEA and KDO.	Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Creeke PI, 2007, J NUTR, V137, P2013, DOI 10.1093/jn/137.9.2013; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Guyton JR, 2007, AM J CARDIOL, V99, p22C, DOI 10.1016/j.amjcard.2006.11.018; Hsu CP, 2009, CIRC RES, V105, P481, DOI 10.1161/CIRCRESAHA.109.203703; Karamanlidis G, 2013, CELL METAB, V18, P239, DOI 10.1016/j.cmet.2013.07.002; Kolwicz SC, 2013, CIRC RES, V113, P603, DOI 10.1161/CIRCRESAHA.113.302095; Lee CF, 2013, CIRCULATION, V128; Marin-Garcia J, 2008, HEART FAIL REV, V13, P137, DOI 10.1007/s10741-007-9079-1; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Nickel A, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0358-9; Ratajczak J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13103; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Team RC, 2015, R LANG ENV STAT COMP; Trammell SAJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12948; Wang W, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac7410; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WielgusKutrowska B, 1997, EUR J BIOCHEM, V243, P408, DOI 10.1111/j.1432-1033.1997.0408a.x; Yamamoto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098972; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	23	114	117	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2017	12	12							e0186459	10.1371/journal.pone.0186459	http://dx.doi.org/10.1371/journal.pone.0186459			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9MS	29211728	Green Submitted, Green Published, gold			2022-12-27	WOS:000417212200005
J	Shang, LN; Chen, TT; Deng, YF; Huang, YY; Huang, YH; Xian, J; Lu, WS; Yang, LH; Huang, Q				Shang, Lina; Chen, Tingting; Deng, Yufeng; Huang, Yiyuan; Huang, Yuanheng; Xian, Jing; Lu, Wensheng; Yang, Lihui; Huang, Qin			Caveolin-3 promotes glycometabolism, growth and proliferation in muscle cells	PLOS ONE			English	Article							INSULIN-RESISTANCE; SKELETAL-MUSCLE; GLUT4 TRANSLOCATION; PLASMA-MEMBRANE; GLUCOSE; MICE; HYPERTROPHY; METABOLISM; DISEASE; RATS	Objective Caveolin-3 (CAV3) protein is known to be expressed specifically in various myocytes, but its physiological function remains unclear. CAV3, located at the cell membrane, may promote the sensitivity of the Akt signaling pathway, which is closely related to glucose metabolism and to cell growth and proliferation. Methods The CAV3 gene was stably transfected into C2C12 muscle cells, and the effects were evaluated by biochemical assays, WB and confocal microscopy for the observation of cellular glucose metabolism, growth and proliferation, and the effect of CAV3 on the Akt signaling pathway with no insulin stimulation. Results After C2C12 cells were transfected with the mouse CAV3 gene, which increased CAV3 expression, the abundance of the CAV3 and GLUT4 proteins on the cell membrane increased, but the total GLUT4 protein content of the cell was unchanged. Glucose uptake was increased, and this did not affect the glycogen synthesis, but the cell surface area and cell proliferation increased. While there were significant increases in p-Akt and p-p70s6K, which is a downstream component of Akt signaling, the level of GSK3 beta protein, another component of Akt signaling did not change. Conclusions The muscle, CAV3 protein can activate Akt signaling, increase GLUT4 protein localization in the cell membrane, increase glucose uptake, and promote myocyte growth and proliferation. CAV3 protein has a physiological role in glycometabolism, growth and proliferation, independent of insulin stimulation.	[Shang, Lina; Chen, Tingting; Deng, Yufeng; Huang, Yiyuan; Huang, Yuanheng; Yang, Lihui; Huang, Qin] Guangxi Med Univ, Sch Basic Med Sci, Dept Physiol, Nanning, Guangxi, Peoples R China; [Xian, Jing] Guangxi Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanning, Guangxi, Peoples R China; [Lu, Wensheng] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Endocrinol, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Huang, Q (corresponding author), Guangxi Med Univ, Sch Basic Med Sci, Dept Physiol, Nanning, Guangxi, Peoples R China.	hqgxmu@163.com	Lu, Wen-sheng/AAW-7161-2021	lu, wensheng/0000-0003-4179-1171	National Natural Science Foundation of China [8166090188]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (No.8166090188).	BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Capozza F, 2005, AM J PHYSIOL-CELL PH, V288, pC1317, DOI 10.1152/ajpcell.00489.2004; Deng YF, 2017, BIOCHEM BIOPH RES CO, V486, P218, DOI 10.1016/j.bbrc.2017.02.072; Fecchi K, 2006, FASEB J, V20, P705, DOI 10.1096/fj.05-4661fje; Feng WW, 2015, J DIABETES INVEST, V6, P396, DOI 10.1111/jdi.12350; Gazzerro E, 2011, Handb Clin Neurol, V101, P135, DOI 10.1016/B978-0-08-045031-5.00010-4; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Ishikawa Y, 2005, CELL SIGNAL, V17, P1175, DOI 10.1016/j.cellsig.2005.03.025; Kim HS, 2009, EUR J APPL PHYSIOL, V106, P173, DOI 10.1007/s00421-009-1001-1; Li Z, 2017, AM J PHYSL ENDOCRINO; Luo J, 2017, BRIT J PHARM; Musi N, 2001, DIABETES, V50, P921, DOI 10.2337/diabetes.50.5.921; Nixon SJ, 2005, HUM MOL GENET, V14, P1727, DOI 10.1093/hmg/ddi179; Oshikawa J, 2004, P NATL ACAD SCI USA, V101, P12670, DOI 10.1073/pnas.0402053101; Otto A, 2010, EXP CELL RES, V316, P3059, DOI 10.1016/j.yexcr.2010.04.009; Park CH, 2016, MOL CELL BIOCHEM, V422, P151, DOI 10.1007/s11010-016-2814-y; Parton RG, 1997, J CELL BIOL, V136, P137, DOI 10.1083/jcb.136.1.137; Sashidhara KV, 2014, EUR J MED CHEM, V86, P570, DOI 10.1016/j.ejmech.2014.09.015; Sassi AH, 2012, J PHYSIOL BIOCHEM, V68, P683, DOI 10.1007/s13105-012-0192-9; Sato H, 2009, GENESIS, V47, P414, DOI 10.1002/dvg.20514; Scherer PE, 1997, J BIOL CHEM, V272, P20698, DOI 10.1074/jbc.272.33.20698; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Sotgia F, 2003, AM J PATHOL, V163, P2619, DOI 10.1016/S0002-9440(10)63616-4; Stoppani E, 2011, BBA-MOL BASIS DIS, V1812, P468, DOI 10.1016/j.bbadis.2010.12.005; Tan Z, 2012, J NUTR BIOCHEM, V23, P1716, DOI 10.1016/j.jnutbio.2011.12.003; Visvanathan R, 2016, FOOD CHEM, V211, P853, DOI 10.1016/j.foodchem.2016.05.090; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	29	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2017	12	12							e0189004	10.1371/journal.pone.0189004	http://dx.doi.org/10.1371/journal.pone.0189004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO8CU	29206848	Green Published, gold, Green Submitted			2022-12-27	WOS:000417110700039
J	Ahn, S; Choe, K; Lee, S; Kim, K; Song, E; Seo, H; Kim, I; Kim, P				Ahn, Soyeon; Choe, Kibaek; Lee, Seunghun; Kim, Kangsan; Song, Eunjoo; Seo, Howon; Kim, Injune; Kim, Pilhan			Intravital longitudinal wide-area imaging of dynamic bone marrow engraftment and multilineage differentiation through nuclear-cytoplasmic labeling	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; PROGENITOR CELLS; CONFOCAL MICROSCOPY; SELF-RENEWAL; MULTIPHOTON MICROSCOPY; FLUORESCENT PROTEINS; NICHE; TRANSPLANTATION; MOUSE; TRACKING	Bone marrow is a vital tissue that produces the majority of erythrocytes, thrombocytes, and immune cells. Bone marrow transplantation (BMT) has been widely performed in patients with blood disorders and cancers. However, the cellular-level behaviors of the transplanted bone marrow cells over wide-areas of the host bone marrow after the BMT are not fully understood yet. In this work, we performed a longitudinal wide-area cellular-level observation of the calvarial bone marrow after the BMT in vivo. Using a H2B-GFP/beta-actin-DsRed double-transgenic mouse model as a donor, a subcellular-level nuclear-cytoplasmic visualization of the transplanted bone marrow cells was achieved, which enabled a direct in vivo dynamic monitoring of the distribution and proliferation of the transplanted bone marrow cells. The same spots in the wide-area of the calvarial bone marrow were repeatedly identified using fluorescently labeled vasculature as a distinct landmark. It revealed various dynamic cellular-level behaviors of the transplanted BM cells in early stage such as cluster formation, migration, and active proliferation in vivo.	[Ahn, Soyeon; Choe, Kibaek; Song, Eunjoo; Seo, Howon; Kim, Pilhan] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Daejeon, South Korea; [Ahn, Soyeon; Choe, Kibaek; Song, Eunjoo; Seo, Howon; Kim, Pilhan] Korea Adv Inst Sci & Technol, KIHST, Daejeon, South Korea; [Lee, Seunghun; Kim, Kangsan; Kim, Injune] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Kim, P (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Daejeon, South Korea.; Kim, P (corresponding author), Korea Adv Inst Sci & Technol, KIHST, Daejeon, South Korea.	pilhan.kim@kaist.ac.kr	Lee, Tae-Hoon/AAR-3708-2021; Kim, Pilhan/C-1836-2011; Kim, Injune/C-1710-2011	Lee, Tae-Hoon/0000-0003-0105-1750; Kim, Pilhan/0000-0001-8388-1840; Kim, Injune/0000-0001-9244-815X; SONG, Eunjoo/0000-0003-3597-3593; Ahn, Soyeon/0000-0002-4955-523X	Global Frontier Project - Ministry of Science, ICT and Future Planning, Republic of Korea [NRF-2013M3A6A4044716]; Bio & Medical Technology Development Program - Ministry of Science, ICT and Future Planning, Republic of Korea [NRF-2017M3A9E4047243]; Korea Healthcare Technology R&D Project - Ministry of Health and Welfare, Republic of Korea [HI13C2181, HI15C0399]	Global Frontier Project - Ministry of Science, ICT and Future Planning, Republic of Korea; Bio & Medical Technology Development Program - Ministry of Science, ICT and Future Planning, Republic of Korea; Korea Healthcare Technology R&D Project - Ministry of Health and Welfare, Republic of Korea	This work was supported by the Global Frontier Project (NRF-2013M3A6A4044716) and the Bio & Medical Technology Development Program (NRF-2017M3A9E4047243) funded by the Ministry of Science, ICT and Future Planning, Republic of Korea and the Korea Healthcare Technology R&D Project (HI13C2181, HI15C0399) funded by Ministry of Health and Welfare, Republic of Korea.; Authors thank Yoonha Hwang, Jinhyo Ahn and Inwon Park at KAIST for their help on this project. This work was supported by the Global Frontier Project (NRF-2013M3A6A4044716) and the Bio & Medical Technology Development Program (NRF-2017M3A9E4047243) funded by the Ministry of Science, ICT and Future Planning, Republic of Korea and the Korea Healthcare Technology R&D Project funded by Ministry of Health and Welfare, Republic of Korea (HI13C2181, HI15C0399).	Ahn YC, 2014, BIOMED OPT EXPRESS, V5, P312, DOI 10.1364/BOE.5.000312; Appelbaum F, 2009, THOMAS HEMATOPOIETIC; Arber C, 2003, BLOOD, V102, P421, DOI 10.1182/blood-2002-12-3834; Askenasy N, 2003, BRIT J HAEMATOL, V120, P505, DOI 10.1046/j.1365-2141.2003.04114.x; BitMansour A, 2002, BLOOD, V100, P4660, DOI 10.1182/blood-2002-05-1552; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Carlson AL, 2013, PLOS ONE, V8; Choe K, 2015, J CLIN INVEST, V125, P4042, DOI 10.1172/JCI76509; Choe K, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.036005; Fuchs E, 2011, NAT CELL BIOL, V13, P513, DOI 10.1038/ncb0511-513; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Giebel B, 2008, CURR STEM CELL RES T, V3, P9, DOI 10.2174/157488808783489444; Hoffman RM, 2008, SENSORS-BASEL, V8, P1157, DOI 10.3390/s8021157; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Horan JT, 2008, J CLIN ONCOL, V26, P5797, DOI 10.1200/JCO.2007.13.5244; Hwang Y, 2014, OPT EXPRESS, V22, P11465, DOI 10.1364/OE.22.011465; Khurana M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2965545; KING MA, 1979, J NUCL MED, V20, P1142; Kohler A, 2009, BLOOD, V114, P290, DOI 10.1182/blood-2008-12-195644; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Lo Celso C, 2011, NAT PROTOC, V6, P1, DOI 10.1038/nprot.2010.168; Lo Celso C, 2009, J BIOPHOTONICS, V2, P619, DOI 10.1002/jbio.200910072; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Luznik L, 2008, BIOL BLOOD MARROW TR, V14, P641, DOI 10.1016/j.bbmt.2008.03.005; Malide D, 2014, JOVE-J VIS EXP, DOI 10.3791/51669; Malide D, 2012, BLOOD, V120, pE105, DOI 10.1182/blood-2012-06-440636; Marques PE, 2015, NAT PROTOC, V10, P258, DOI 10.1038/nprot.2015.006; Rieger MA, 2008, CELLS TISSUES ORGANS, V188, P139, DOI 10.1159/000114540; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Runnels JM, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3520571; Scott MK, 2014, JOVE-J VIS EXP, DOI 10.3791/51683; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Seo H, 2015, BIOMED OPT EXPRESS, V6, P2158, DOI 10.1364/BOE.6.002158; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Song E, 2015, BIOMED OPT EXPRESS, V6, P4154, DOI 10.1364/BOE.6.004154; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Suarez-Alvarez B, 2012, ADV EXP MED BIOL, V741, P152, DOI 10.1007/978-1-4614-2098-9_11; Sugiyama N, 2012, BIOMED OPT EXPRESS, V3, P2175, DOI 10.1364/BOE.3.002175; Tamplin OJ, 2015, CELL, V160, P241, DOI 10.1016/j.cell.2014.12.032; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Ting SB, 2012, BLOOD, V119, P2510, DOI 10.1182/blood-2011-11-393272; Turcotte R, 2014, BIOMED OPT EXPRESS, V5, P3578, DOI 10.1364/BOE.5.003578; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhao YB, 2013, METHODS MOL BIOL, V1052, P57, DOI 10.1007/7651_2013_28	49	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187660	10.1371/journal.pone.0187660	http://dx.doi.org/10.1371/journal.pone.0187660			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29190775	Green Published, gold, Green Submitted			2022-12-27	WOS:000414377900036
J	Ahn, SH; Chun, SM; Park, C; Lee, JH; Lee, SW; Lee, TH				Ahn, Sun-Hee; Chun, Sung-Min; Park, Chungoo; Lee, Jong-Hee; Lee, Seok-Woo; Lee, Tae-Hoon			Transcriptome profiling analysis of senescent gingival fibroblasts in response to Fusobacterium nucleatum infection	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS; OXIDATIVE STRESS; GENE-EXPRESSION; CELLS; PATHWAYS; SEQUENCE; DISEASES; GROWTH	Periodontal disease is caused by dental plaque biofilms. Fusobacterium nucleatum is an important periodontal pathogen involved in the development of bacterial complexity in dental plaque biofilms. Human gingival fibroblasts (GFs) act as the first line of defense against oral microorganisms and locally orchestrate immune responses by triggering the production of reactive oxygen species and pro-inflammatory cytokines (IL-6 and IL-8). The frequency and severity of periodontal diseases is known to increase in elderly subjects. However, despite several studies exploring the effects of aging in periodontal disease, the underlying mechanisms through which aging affects the interaction between F. nucleatum and human GFs remain unclear. To identify genes affected by infection, aging, or both, we performed an RNA-Seq analysis using GFs isolated from a single healthy donor that were passaged for a short period of time (P4) 'young GFs' or for longer period of time (P22) 'old GFs', and infected or not with F. nucleatum. Comparing F. nucleatum-infected and uninfected GF (P4) cells the differentially expressed genes (DEGs) were involved in host defense mechanisms (i.e., immune responses and defense responses), whereas comparing F. nucleatum-infected and uninfected GF(P22) cells the DEGs were involved in cell maintenance (i.e., TGF-beta signaling, skeletal development). Most DEGs in F. nucleatum-infected GF(P22) cells were downregulated (85%) and were significantly associated with host defense responses such as inflammatory responses, when compared to the DEGs in F. nucleatum-infected GF (P4) cells. Five genes (GADD45b, KLF10, CSRNP1, ID1, and TM4SF1) were upregulated in response to F. nucleatum infection; however, this effect was only seen in GF(P22) cells. The genes identified here appear to interact with each other in a network associated with free radical scavenging, cell cycle, and cancer; therefore, they could be potential candidates involved in the aged GF's response to F. nucleatum infection. Further studies are needed to confirm these observations.	[Ahn, Sun-Hee; Lee, Tae-Hoon] Chonnam Natl Univ, Sch Dent, Med Res Ctr Biomineralizat Disorders, Dept Oral Biochem,Dent Sci Res Inst, Gwangju, South Korea; [Chun, Sung-Min; Park, Chungoo] Chonnam Natl Univ, Sch Biol Sci & Technol, Gwangju, South Korea; [Lee, Jong-Hee] World Inst Kimchi, Gwangju, South Korea; [Lee, Seok-Woo] Chonnam Natl Univ, Dent Sci Res Inst, Sch Dent, Dept Dent Educ & Periodontol, Gwangju, South Korea; [Lee, Tae-Hoon] Chonnam Natl Univ, Grad Sch, Dept Mol Med BK21plus, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University	Lee, TH (corresponding author), Chonnam Natl Univ, Sch Dent, Med Res Ctr Biomineralizat Disorders, Dept Oral Biochem,Dent Sci Res Inst, Gwangju, South Korea.; Lee, TH (corresponding author), Chonnam Natl Univ, Grad Sch, Dept Mol Med BK21plus, Gwangju, South Korea.	thlee83@jnu.ac.kr	Lee, Tae-Hoon/AAR-3708-2021; Kim, Pilhan/C-1836-2011; Kim, Injune/C-1710-2011	Lee, Tae-Hoon/0000-0003-0105-1750; Kim, Pilhan/0000-0001-8388-1840; Kim, Injune/0000-0001-9244-815X; SONG, Eunjoo/0000-0003-3597-3593; Ahn, Soyeon/0000-0002-4955-523X	National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [2016M3A9B6903087, 2017R1A2B2005938]; NRF - Ministry of Education [2016R1A6A3A11932468]; World Institute of Kimchi [KE1701-2]	National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning; NRF - Ministry of Education; World Institute of Kimchi	This work was supported by the Bio & Medical Technology Development Program (2016M3A9B6903087) and the Basic Science Research Program (2017R1A2B2005938) of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning. Sun Hee Ahn was supported by the Basic Science Research Program (2016R1A6A3A11932468) through the NRF funded by the Ministry of Education and The grant from the World Institute of Kimchi (KE1701-2) to Dr. Jong-Hee Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2016, MOL ORAL MICROBIOL; Ahn SH, 2016, ARCH MICROBIOL, V198, P573, DOI 10.1007/s00203-016-1223-7; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; BIRKEDALHANSEN H, 1993, J PERIODONTOL, V64, P474, DOI 10.1902/jop.1993.64.5s.474; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Cao ZX, 2009, J BIOL CHEM, V284, P24914, DOI 10.1074/jbc.M109.000059; Cekici A, 2014, PERIODONTOL 2000, V64, P57, DOI 10.1111/prd.12002; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chen Z, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.300; Davanian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046440; Diaz PI, 2002, MICROBIOL-SGM, V148, P467, DOI 10.1099/00221287-148-2-467; Domon H, 2014, J PERIODONTAL RES, V49, P536, DOI 10.1111/jre.12134; Eftang LL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-9; Gavazzi G, 2004, CLIN INFECT DIS, V39, P83, DOI 10.1086/421559; Gavazzi G, 2002, LANCET INFECT DIS, V2, P659, DOI 10.1016/S1473-3099(02)00437-1; Gomes P, 2009, OXID MED CELL LONGEV, V2, P138, DOI 10.4161/oxim.2.3.8819; Gonzalez OA, 2014, J CLIN PERIODONTOL, V41, P327, DOI 10.1111/jcpe.12212; Guo W, 2013, INT J CANCER, V133, P2043, DOI 10.1002/ijc.28223; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Hajishengallis G, 2010, MOL ORAL MICROBIOL, V25, P25, DOI 10.1111/j.2041-1014.2009.00562.x; Handfield M, 2008, J DENT RES, V87, P203, DOI 10.1177/154405910808700302; Hansen KD, 2011, NAT BIOTECHNOL, V29, P572, DOI 10.1038/nbt.1910; Harrison DE, 2014, IMMUN AGEING, V11, DOI 10.1186/s12979-014-0024-6; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; He Y, 2010, ADV EXP MED BIOL, V664, P165, DOI 10.1007/978-1-4419-1399-9_20; Humphrys MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080597; Kang CI, 2011, INT J INFECT DIS, V15, pE58, DOI 10.1016/j.ijid.2010.09.012; Kim SS, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0164800, 10.1371/journal.pone.0147745]; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Krustrup U, 2006, ACTA ODONTOL SCAND, V64, P65, DOI 10.1080/00016350500377859; Liu B, 2009, NEUROBIOL DIS, V33, P104, DOI 10.1016/j.nbd.2008.09.020; Liu YC, 2013, BIOINFORMATICS, V29, P308, DOI [10.1093/bioinformatics/bts690, 10.1093/bioinformatics/btt688]; Meyer Keith C, 2005, Proc Am Thorac Soc, V2, P433, DOI 10.1513/pats.200508-081JS; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naito Y, 2005, DIGESTION, V72, P164, DOI 10.1159/000088396; Naylor RM, 2013, CLIN PHARMACOL THER, V93, P105, DOI 10.1038/clpt.2012.193; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pechenino AS, 2006, PROSTATE, V66, P522, DOI 10.1002/pros.20364; Rajendran Maheaswari, 2013, J Indian Soc Periodontol, V17, P169, DOI 10.4103/0972-124X.113064; Shaik-Dasthagirisaheb Yazdani B, 2010, Immun Ageing, V7, P15, DOI 10.1186/1742-4933-7-15; SHARMA SA, 1995, INFECT IMMUN, V63, P1681, DOI 10.1128/IAI.63.5.1681-1687.1995; Sharma-Kuinkel BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060463; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Signat B, 2011, CURR ISSUES MOL BIOL, V13, P25; Sikder HA, 2003, CANCER CELL, V3, P525, DOI 10.1016/S1535-6108(03)00141-7; Subramaniam M, 1995, NUCLEIC ACIDS RES, V23, P4907, DOI 10.1093/nar/23.23.4907; Subramaniam M, 2005, MOL CELL BIOL, V25, P1191, DOI 10.1128/MCB.25.3.1191-1199.2005; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Tal S, 2005, J INFECTION, V50, P296, DOI 10.1016/j.jinf.2004.04.004; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van Winkelhoff AJ, 2002, J CLIN PERIODONTOL, V29, P1023, DOI 10.1034/j.1600-051X.2002.291107.x; Yoshikawa TT, 2000, CLIN INFECT DIS, V30, P931, DOI 10.1086/313792; YOSHIKAWA TT, 1984, GERONTOLOGY, V30, P275, DOI 10.1159/000212646; Zhan YB, 2014, J PERIODONTOL, V85, P1059, DOI 10.1902/jop.2014.130523; Zhang HQ, 2015, FREE RADICAL BIO MED, V88, P314, DOI 10.1016/j.freeradbiomed.2015.05.036	59	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188755	10.1371/journal.pone.0188755	http://dx.doi.org/10.1371/journal.pone.0188755			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190775	Green Published, Green Submitted, gold			2022-12-27	WOS:000416841900118
